Citrus Sinensis ID: 039720

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970---
Protein Sequence
MREDSRIFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPIIG
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHccccHHHHHHHHHHHHHcccccccccccccccccccccEEEEEccccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccccccccccccEEEEccccccccccccccccccccccccccccccccccHHHHccccccEEEcccccccccccHHcccccccccEEccccccEEccccccccccccccEEEEccccccccccHHHHccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccEEEcccccccccccHHHHHcccccccEEccccEEEEcccccccccccccEEEccccccEEcccccccccccccEEEccccccEEcccHHHHcccccccEEccccEEccccccccccccccccEEcccccccccccHHHHcHHHHHHHHccccccccccccHHHHccccccccccccccccccccHHHHcccccccEEcccccccccccHHHHccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHcccccccEEEcccccEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHcccccccccEEEEccccccccccEEEEEEcccccccHHHHcccccccccHHHHHHHHHHHHHHcHHHcccccccEEEcccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEEEccccccccHHHHHHHHHHHHHccccccccccccccccccccEEEEcccccEEEEEEcccccccccccHcHccccHEEEEEcccccccccccHHHcccHHcEEEEcccccccccccccHHcccccEEEEEccccccccccHHHccccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHcccccEEEcccccccccccHHHcccccccEEEEccccccccccccccHHHHHHccccccEEEEccccccccccccHccccccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHccccccEEEccccEEEEEccHHHHHcccccEEEcccccccccccccHccccEEEEEEcccccccccccHHHHccccHcEEEcccccccccccHHHHccHHHcEEEEccccccccccccccEccccccEEcccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHccccHHcEEEccccEEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHEcccccccccccEEEEEEEcccccHHHHHcccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHHEccccccccccccccEEEEEccEcEcccHccccccEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHccccHHHHccHHHccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
MREDSRIFLFWLYSrhatshvkHATVTFnmqqlhdplgvtkswnnsinlcqwtgvtcghrhqrvtkldlesqniggflspyignLSFLRVINLAnnsfhgqipkevgRLFRLETIVlsnnsfsgkiptnlsrcFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLygnqltgqlppsignlsalqtfdiagnkldgripdslgqlrnlnylgtsendfsgmfplsvcnissldeAYLFknrfkgslpvclgfnlpKLTVLVVAQNnltgflpqslsnasklEWLELnenhfsgqvrinfnslpnlsklylgrnnlgtrtstdlDFITLLTNCSKLVKLGLVFnrfggalphsiANLSTTMTLIAMAgnqisgtippeirnlfnlnglgleynqltgtippaigelrnlqylglvgnnirgiipdpignlTLLNVLQLGFNklqgsipsylgkcqnlmqlsapnnklngtlppqifGITTLSKLLDlsenhlsgsiplevgnlkSLVQLDisrnnfsneipvtlsACTTLEYLLMQgnsfngsipQSLNALKSIKELDLScnnlsgqipihlgnlpflEYLNLSYnhfegkvpkkgvfsnetrisltgneqfcgglgelhlpachsvgprkeTITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKAtkefsssnrigkgsfgfvykgnlgedGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGsvddwlhhtndklevgkLNIVIEVASVIEYLHnhcqppivhgdlkpsnvlldhdmVAHVSDFGLArflshhpflvapegqsssiemkgtigyigpeygmggdlsmtgdVYSFGILLLEMftrrrptdnmfndgltlhgyakmalpkkvmgivdpsllmeargpskfEECLVAVVRTGVacsmespserMQMTAVVKKLCAVgeifigppiig
Flexible Loop (DISEMBL)
MREDSRIFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSnnsfsgkiptNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKefsssnrigkgsFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVapegqsssieMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACsmespsermQMTAVVKKLCAVGEIFIGPPIIG
Low Complexity Region (SEG)
MREDSRIFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPIIG
Disordered region (IsUnstruct)
*****RIFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKA********RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG***SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSM*******QMTAVVKKLCAVGEIFIGPP***
Disordered Region (DISOPRED)
**EDSRIFLFWLYSRHATSHVKHATVTFNMQQL***L*VTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLG********************KVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS***************EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPII*
Disordered Region (DISEMBL)
MREDSRIFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPIIG
Disordered Region (DISPRO)
*REDSRIFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAH***SALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL****GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGP****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MREDSRIFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPIIG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	973	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.961	0.926	0.450	0.0
C0LGT6	1031	LRR receptor-like serine/	no	no	0.938	0.885	0.445	0.0
Q9SD62	1025	Putative receptor-like pr	no	no	0.961	0.913	0.447	0.0
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.847	0.841	0.358	1e-126
Q9FL28	1173	LRR receptor-like serine/	no	no	0.876	0.727	0.324	1e-122
O49318	1124	Probable leucine-rich rep	no	no	0.931	0.806	0.310	1e-118
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.858	0.666	0.320	1e-117
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.883	0.688	0.330	1e-116
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.918	0.811	0.306	1e-114
P93194	1109	Receptor-like protein kin	N/A	no	0.951	0.834	0.300	1e-114

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  774 bits (1998), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/985 (45%), Positives = 604/985 (61%), Gaps = 49/985 (4%)

Query: 22   KHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPY 81
            + A + F  Q   D   V  SWN+S  LC W GVTCG +++RVT L+L    +GG +SP 
Sbjct: 26   RQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISPS 85

Query: 82   IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
            IGNLSFL  ++L  N F G IP+EVG+L RLE + +  N   G IP  L  C  L++  +
Sbjct: 86   IGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRL 145

Query: 142  HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
             +N L G + + +G+   + +L+LYGN + G+LP S+GNL+ L+   ++ N L+G IP  
Sbjct: 146  DSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSD 205

Query: 202  LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
            + QL  +  L    N+FSG+FP ++ N+SSL    +  N F G L   LG  LP L    
Sbjct: 206  VAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFN 265

Query: 262  VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
            +  N  TG +P +LSN S LE L +NEN+ +G +   F ++PNL  L+L  N+LG+ +S 
Sbjct: 266  MGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSR 324

Query: 322  DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
            DL+F+T LTNC++L  LG+  NR GG LP SIANLS  +  + + G  ISG+IP +I NL
Sbjct: 325  DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNL 384

Query: 382  FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
             NL  L L+ N L+G +P ++G+L NL+YL L  N + G IP  IGN+T+L  L L  N 
Sbjct: 385  INLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNG 444

Query: 442  LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN 501
             +G +P+ LG C +L++L   +NKLNGT+P +I  I  L + LD+S N L GS+P ++G 
Sbjct: 445  FEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQDIGA 503

Query: 502  LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
            L++L  L +  N  S ++P TL  C T+E L ++GN F G IP  L  L  +KE+DLS N
Sbjct: 504  LQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNN 562

Query: 562  NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLP 621
            +LSG IP +  +   LEYLNLS+N+ EGKVP KG+F N T +S+ GN   CGG+    L 
Sbjct: 563  DLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLK 622

Query: 622  ACHSVGP---RKETITLLKVVIPV-IGTKLAHKLSSALL--------------------- 656
             C S  P   +K +  L KVVI V +G  L   L  A +                     
Sbjct: 623  PCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPST 682

Query: 657  MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK 716
            +E     +SY +L  AT  FSSSN +G GSFG VYK  L  +   VAVKV+N+ ++GA K
Sbjct: 683  LEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMK 742

Query: 717  SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-------- 768
            SF+AECE+L++IRHRNL+K++T CSSIDF+G +F+A++YE+M  GS+D WLH        
Sbjct: 743  SFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIH 802

Query: 769  ---HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 825
                T   LE  +LNI I+VASV++YLH HC  PI H DLKPSNVLLD D+ AHVSDFGL
Sbjct: 803  RPSRTLTLLE--RLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGL 860

Query: 826  ARFL---SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            AR L       F      Q SS  ++GTIGY  PEYG+GG  S+ GDVYSFGILLLEMFT
Sbjct: 861  ARLLLKFDEESFF----NQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFT 916

Query: 883  RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLL-MEARGPSKFEECLVAVVRTGVAC 941
             +RPT+ +F    TL+ Y K ALP++++ IVD S+L +  R      ECL  V   G+ C
Sbjct: 917  GKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRC 976

Query: 942  SMESPSERMQMTAVVKKLCAVGEIF 966
              ESP  R+  + VVK+L ++ E F
Sbjct: 977  CEESPMNRLATSIVVKELISIRERF 1001

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  739 bits (1907), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 431/968 (44%), Positives = 585/968 (60%), Gaps = 55/968 (5%)

Query: 39   VTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSF 98
            V  SWN+S   C W GVTCG R +RV  L+L    + G +SP IGNLSFLR++NLA+NSF
Sbjct: 50   VLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSF 109

Query: 99   HGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL 158
               IP++VGRLFRL+ + +S N   G+IP++LS C  L    + +N+L   + + +G+  
Sbjct: 110  GSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLS 169

Query: 159  KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
            K+  L L  N LTG  P S+GNL++LQ  D A N++ G IPD + +L  + +   + N F
Sbjct: 170  KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229

Query: 219  SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
            SG FP ++ NISSL+   L  N F G+L    G+ LP L  L++  N  TG +P++L+N 
Sbjct: 230  SGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANI 289

Query: 279  SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKL 338
            S LE  +++ N+ SG + ++F  L NL  L +  N+LG  +S+ L+FI  + NC++L  L
Sbjct: 290  SSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYL 349

Query: 339  GLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTI 398
             + +NR GG LP SIANLSTT+T + +  N ISGTIP +I NL +L  L LE N L+G +
Sbjct: 350  DVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGEL 409

Query: 399  PPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQ 458
            P + G+L NLQ + L  N I G IP   GN+T L  L L  N   G IP  LG+C+ L+ 
Sbjct: 410  PVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLD 469

Query: 459  LSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNE 518
            L    N+LNGT+P +I  I +L+  +DLS N L+G  P EVG L+ LV L  S N  S +
Sbjct: 470  LWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528

Query: 519  IPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLE 578
            +P  +  C ++E+L MQGNSF+G+IP  ++ L S+K +D S NNLSG+IP +L +LP L 
Sbjct: 529  MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587

Query: 579  YLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPAC-HSVGPRKET-ITLL 636
             LNLS N FEG+VP  GVF N T +S+ GN   CGG+ E+ L  C     PRK   +++ 
Sbjct: 588  NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647

Query: 637  KVVIPVIGTKLAHKL------SSALLMEQQ-------------------FPIVSYAELSK 671
            K V+  I   +A  L      S    M+++                      VSY EL  
Sbjct: 648  KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHS 707

Query: 672  ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR 731
            AT  FSS+N IG G+FG V+KG LG +   VAVKV+NL K GATKSF+AECE  + IRHR
Sbjct: 708  ATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHR 767

Query: 732  NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---------HTNDKLEVGKLNIV 782
            NL+K+IT+CSS+D +G DF+A+VYE+M  GS+D WL          H+       KLNI 
Sbjct: 768  NLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIA 827

Query: 783  IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL---SHHPFLVAPE 839
            I+VAS +EYLH HC  P+ H D+KPSN+LLD D+ AHVSDFGLA+ L       FL    
Sbjct: 828  IDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFL---- 883

Query: 840  GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG 899
             Q SS  ++GTIGY  PEYGMGG  S+ GDVYSFGILLLEMF+ ++PTD  F     LH 
Sbjct: 884  NQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHS 943

Query: 900  YAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
            Y K  L          S    + G +  +E L  V++ G+ CS E P +RM+    V++L
Sbjct: 944  YTKSIL----------SGCTSSGGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVREL 993

Query: 960  CAVGEIFI 967
             ++   F 
Sbjct: 994  ISIRSKFF 1001

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  727 bits (1877), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/988 (44%), Positives = 606/988 (61%), Gaps = 52/988 (5%)

Query: 22   KHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPY 81
            K A + F  Q       V  SWN+S+ LC WTGV CG +H+RVT +DL    + G +SP+
Sbjct: 41   KQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPF 100

Query: 82   IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
            +GNLSFLR +NLA+N FHG IP EVG LFRL+ + +SNN F G IP  LS C +L    +
Sbjct: 101  VGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDL 160

Query: 142  HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
             +N+L   +    G+  K+  LSL  N LTG+ P S+GNL++LQ  D   N+++G IP  
Sbjct: 161  SSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGD 220

Query: 202  LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
            + +L+ + +   + N F+G+FP  + N+SSL    +  N F G+L    G  LP L +L 
Sbjct: 221  IARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILY 280

Query: 262  VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
            +  N+ TG +P++LSN S L  L++  NH +G++ ++F  L NL  L L  N+LG  +S 
Sbjct: 281  MGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSG 340

Query: 322  DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
            DLDF+  LTNCS+L  L + FN+ GG LP  IANLST +T +++ GN ISG+IP  I NL
Sbjct: 341  DLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNL 400

Query: 382  FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
             +L  L L  N LTG +PP++GEL  L+ + L  N + G IP  +GN++ L  L L  N 
Sbjct: 401  VSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNS 460

Query: 442  LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN 501
             +GSIPS LG C  L+ L+   NKLNG++P ++  + +L  +L++S N L G +  ++G 
Sbjct: 461  FEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGK 519

Query: 502  LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
            LK L+ LD+S N  S +IP TL+ C +LE+LL+QGNSF G IP  +  L  ++ LDLS N
Sbjct: 520  LKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKN 578

Query: 562  NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLP 621
            NLSG IP ++ N   L+ LNLS N+F+G VP +GVF N + +S+ GN   CGG+  L L 
Sbjct: 579  NLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQ 638

Query: 622  ACHSVGPRKETITLLKVVIPVIGT------------------KLAHKLSSALLMEQQ--- 660
             C    PR+ + ++ K++   +                    KL  K   A   E     
Sbjct: 639  PCSVELPRRHS-SVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSF 697

Query: 661  ------FPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
                  +  +SY EL K T  FSSSN IG G+FG V+KG LG    +VA+KV+NL K+GA
Sbjct: 698  SPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGA 757

Query: 715  TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL 774
             KSF+AECEAL  IRHRNL+K++TICSS DF+G DF+A+VYE+M  G++D WLH   D++
Sbjct: 758  AKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP--DEI 815

Query: 775  E-----------VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 823
            E             +LNI I+VAS + YLH +C  PI H D+KPSN+LLD D+ AHVSDF
Sbjct: 816  EETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDF 875

Query: 824  GLARFL---SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GLA+ L       F +    Q SS  ++GTIGY  PEYGMGG  S+ GDVYSFGI+LLE+
Sbjct: 876  GLAQLLLKFDRDTFHI----QFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEI 931

Query: 881  FTRRRPTDNMFNDGLTLHGYAKMALPKK-VMGIVDPSLLMEARGPS-KFEECLVAVVRTG 938
            FT +RPT+ +F DGLTLH + K AL K+  + I D ++L  A        ECL  V R G
Sbjct: 932  FTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVG 991

Query: 939  VACSMESPSERMQMTAVVKKLCAVGEIF 966
            V+CS ESP  R+ M   + KL ++ E F
Sbjct: 992  VSCSEESPVNRISMAEAISKLVSIRESF 1019

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  452 bits (1162), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 325/907 (35%), Positives = 471/907 (51%), Gaps = 82/907 (9%)

Query: 136 LIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNL-SALQTFDIAGNKL 194
           +I+  +   +L GEI   I N   +  L L  N   G++PP IG+L   L+   ++ N L
Sbjct: 68  VIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLL 127

Query: 195 DGRIPDSLGQLRNLNYLGTSENDFSGMFPLSV-CNISSLDEAY--LFKNRFKGSLPVCLG 251
            G IP  LG L  L YL    N  +G  P+ + CN SS    Y  L  N   G +P+   
Sbjct: 128 HGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYH 187

Query: 252 FNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN-FNSLPNLSKLYL 310
            +L +L  L++  N LTG +P SLSN++ L+W++L  N  SG++     + +P L  LYL
Sbjct: 188 CHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYL 247

Query: 311 GRNNLGTRTS-TDLD-FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGN 368
             N+  +  + T+L+ F   L N S L +L L  N  GG +  S+ +LS  +  I +  N
Sbjct: 248 SYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQN 307

Query: 369 QISGTIPPEI---------------------RNLFNLNGLGLEY---NQLTGTIPPAIGE 404
           +I G+IPPEI                     R L  L+ L   Y   N LTG IP  +G+
Sbjct: 308 RIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGD 367

Query: 405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
           +  L  L +  NN+ G IPD  GNL+ L  L L  N L G++P  LGKC NL  L   +N
Sbjct: 368 IPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHN 427

Query: 465 KLNGTLPPQIFG-ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTL 523
            L GT+P ++   +  L   L+LS NHLSG IPLE+  +  ++ +D+S N  S +IP  L
Sbjct: 428 NLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQL 487

Query: 524 SACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS 583
            +C  LE+L +  N F+ ++P SL  L  +KELD+S N L+G IP        L++LN S
Sbjct: 488 GSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFS 547

Query: 584 YNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPAC---HSVGPRKETITLLKVVI 640
           +N   G V  KG FS  T  S  G+   CG +  +   AC   H        + L  +  
Sbjct: 548 FNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLIAT 605

Query: 641 PVI-------------GTKLAHKLSSALLMEQ-------QFPIVSYAELSKATKEFSSSN 680
           PV+             G  L       +  E+       ++P +SY +L  AT  F++S+
Sbjct: 606 PVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASS 665

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK---SFVAECEALRNIRHRNLIKII 737
            IG G FG VYKG L  +   VAVKV  LD K A +   SF  EC+ L+  RHRNLI+II
Sbjct: 666 LIGSGRFGHVYKGVL-RNNTKVAVKV--LDPKTALEFSGSFKRECQILKRTRHRNLIRII 722

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVGKL-NIVIEVASVIEYLH 793
           T CS        F A+V   M  GS++  L+   +++  L++ +L NI  +VA  I YLH
Sbjct: 723 TTCSK-----PGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLH 777

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ----SSSIEMKG 849
           ++    +VH DLKPSN+LLD +M A V+DFG++R +      V+ +      S+   + G
Sbjct: 778 HYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCG 837

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV 909
           ++GYI PEYGMG   S  GDVYSFG+LLLE+ + RRPTD + N+G +LH + K   P  +
Sbjct: 838 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSL 897

Query: 910 MGIVDPSL-LMEARG-PSKFE----ECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG 963
            GI++ +L   + +G P K E    E ++ ++  G+ C+  +PS R  M  V  ++  + 
Sbjct: 898 EGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957

Query: 964 EIFIGPP 970
           E     P
Sbjct: 958 EYLFACP 964

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  441 bits (1133), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 314/967 (32%), Positives = 491/967 (50%), Gaps = 114/967 (11%)

Query: 82   IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
            IG L+ L  ++L+ N   G+IP++ G L  L+++VL+ N   G IP  +  C +L+   +
Sbjct: 212  IGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLEL 271

Query: 142  HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
            + N L G+I A +GN ++++ L +Y N+LT  +P S+  L+ L    ++ N L G I + 
Sbjct: 272  YDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEE 331

Query: 202  LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
            +G L +L  L    N+F+G FP S+ N+ +L    +  N   G LP  LG  L  L  L 
Sbjct: 332  IGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL-LTNLRNLS 390

Query: 262  VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
               N LTG +P S+SN + L+ L+L+ N  +G++   F  + NL+ + +GRN+       
Sbjct: 391  AHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEIPD 449

Query: 322  DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
            D+       NCS L  L +  N   G L   I  L   + ++ ++ N ++G IP EI NL
Sbjct: 450  DI------FNCSNLETLSVADNNLTGTLKPLIGKLQK-LRILQVSYNSLTGPIPREIGNL 502

Query: 382  FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
             +LN L L  N  TG IP  +  L  LQ L +  N++ G IP+ + ++ LL+VL L  NK
Sbjct: 503  KDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNK 562

Query: 442  LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL------------------ 483
              G IP+   K ++L  LS   NK NG++P  +  ++ L+                    
Sbjct: 563  FSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLAS 622

Query: 484  -------LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACT---TLEY-- 531
                   L+ S N L+G+IP E+G L+ + ++D+S N FS  IP +L AC    TL++  
Sbjct: 623  LKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQ 682

Query: 532  --------------------LLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHL 571
                                L +  NSF+G IPQS   +  +  LDLS NNL+G+IP  L
Sbjct: 683  NNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESL 742

Query: 572  GNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKE 631
             NL  L++L L+ N+ +G VP+ GVF N     L GN   CG   +  L  C        
Sbjct: 743  ANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCG--SKKPLKPCTIKQKSSH 800

Query: 632  TITLLKVVIPVIGTKLAH-----------------------------KLSSALLMEQQFP 662
                 +V++ ++G+  A                               L SAL +++  P
Sbjct: 801  FSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEP 860

Query: 663  IVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVA 720
                 EL +AT  F+S+N IG  S   VYKG L EDG  +AVKV+NL +  A   K F  
Sbjct: 861  ----KELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYT 915

Query: 721  ECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGK 778
            E + L  ++HRNL+KI+       ++    KA+V  +M+ G+++D +H +   +   + K
Sbjct: 916  EAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEK 971

Query: 779  LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
            +++ + +AS I+YLH+    PIVH DLKP+N+LLD D VAHVSDFG AR L    F    
Sbjct: 972  IDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILG---FREDG 1028

Query: 839  EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT--DNMFNDGLT 896
               +S+   +GTIGY+ PE+     ++   DV+SFGI+++E+ T++RPT  ++  +  +T
Sbjct: 1029 STTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMT 1088

Query: 897  LHGYAKMALPKKVMGIVDPSLLMEARGPS----KFEECLVAVVRTGVACSMESPSERMQM 952
            L    + ++     G+V   +L    G S    K EE +   ++  + C+   P +R  M
Sbjct: 1089 LRQLVEKSIGNGRKGMV--RVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDM 1146

Query: 953  TAVVKKL 959
              ++  L
Sbjct: 1147 NEILTHL 1153

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  426 bits (1094), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 336/1083 (31%), Positives = 494/1083 (45%), Gaps = 177/1083 (16%)

Query: 33   LHDPLGVTKSWNN-SINLCQWTGVTCGHRHQR-------VTKLDLESQNIGGFLSPYIGN 84
              D L    +WN      C W GV C  +          VT LDL S N+ G +SP IG 
Sbjct: 48   FQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGG 107

Query: 85   LSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTN 144
            L  L  +NLA N+  G IP+E+G   +LE + L+NN F G IP  +++   L  F +  N
Sbjct: 108  LVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNN 167

Query: 145  NLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQ 204
             L G +   IG+   +E L  Y N LTG LP S+GNL+ L TF    N   G IP  +G+
Sbjct: 168  KLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGK 227

Query: 205  LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLG------------- 251
              NL  LG ++N  SG  P  +  +  L E  L++N+F G +P  +G             
Sbjct: 228  CLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGN 287

Query: 252  ----------FNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
                       N+  L  L + QN L G +P+ L   SK+  ++ +EN  SG++ +  + 
Sbjct: 288  SLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSK 347

Query: 302  LPNLSKLYLGRNNL---------GTRTSTDLDF-ITLLT--------NCSKLVKLGLVFN 343
            +  L  LYL +N L           R    LD  I  LT        N + + +L L  N
Sbjct: 348  ISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHN 407

Query: 344  RFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIG 403
               G +P  +  L + + ++  + NQ+SG IPP I    NL  L L  N++ G IPP + 
Sbjct: 408  SLSGVIPQGLG-LYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVL 466

Query: 404  ELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPN 463
              ++L  L +VGN + G  P  +  L  L+ ++L  N+  G +P  +G CQ L +L    
Sbjct: 467  RCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAA 526

Query: 464  NKLNGTLPPQIFGITTLSKL-----------------------LDLSENHLSGSIPLEVG 500
            N+ +  LP +I  ++ L                          LDLS N   GS+P E+G
Sbjct: 527  NQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELG 586

Query: 501  NLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIK-ELDLS 559
            +L  L  L +S N FS  IP T+   T L  L M GN F+GSIP  L  L S++  ++LS
Sbjct: 587  SLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLS 646

Query: 560  CNNLSGQIPIHLGNLPFLEYL------------------------NLSYNHFEGKVPKKG 595
             N+ SG+IP  +GNL  L YL                        N SYN+  G++P   
Sbjct: 647  YNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQ 706

Query: 596  VFSNETRISLTGNEQFCGGLGELHLPAC---HSVGPRKETIT------------------ 634
            +F N T  S  GN+  CGG    HL +C   HS  P   ++                   
Sbjct: 707  IFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIG 762

Query: 635  -----LLKVVI-----PVIGTKLAHKLSSALLMEQQFPIV-----SYAELSKATKEFSSS 679
                 L+ +V+     PV  T            E     V     +  ++ +ATK F  S
Sbjct: 763  GISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDS 822

Query: 680  NRIGKGSFGFVYKGNLGEDGMSVAVKVMN-------LDKKGATKSFVAECEALRNIRHRN 732
              +G+G+ G VYK  +   G ++AVK +         +      SF AE   L  IRHRN
Sbjct: 823  YIVGRGACGTVYKAVM-PSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRN 881

Query: 733  LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH----HTNDKLEVGKLNIVIEVASV 788
            ++++ + C     +G++   ++YEYM  GS+ + LH    H+ D     +  I +  A  
Sbjct: 882  IVRLYSFCYH---QGSNSNLLLYEYMSRGSLGELLHGGKSHSMD--WPTRFAIALGAAEG 936

Query: 789  IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
            + YLH+ C+P I+H D+K +N+L+D +  AHV DFGLA+ +        P  +S S  + 
Sbjct: 937  LAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID------MPLSKSVS-AVA 989

Query: 849  GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK 908
            G+ GYI PEY     ++   D+YSFG++LLE+ T + P   +   G  L  + +      
Sbjct: 990  GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG-DLATWTRNH---- 1044

Query: 909  VMGIVDPSLLMEARGP--SKFEE-----CLVAVVRTGVACSMESPSERMQMTAVVKKLCA 961
               I D SL  E   P  +K E+      ++ V +  V C+  SPS+R  M  VV  L  
Sbjct: 1045 ---IRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101

Query: 962  VGE 964
             GE
Sbjct: 1102 SGE 1104

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  423 bits (1087), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 300/935 (32%), Positives = 467/935 (49%), Gaps = 100/935 (10%)

Query: 64   VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
            + +L L    + G +   I N   L++++L+NN+  GQIP  + +L  L  + L+NNS  
Sbjct: 339  LKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLE 398

Query: 124  GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
            G + +++S   NL +F ++ NNL G++   IG   K+E + LY N+ +G++P  IGN + 
Sbjct: 399  GTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTR 458

Query: 184  LQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK 243
            LQ  D  GN+L G IP S+G+L++L  L   EN+  G  P S+ N   +    L  N+  
Sbjct: 459  LQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLS 518

Query: 244  GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLP 303
            GS+P   GF L  L + ++  N+L G LP SL N   L  +  + N F+G          
Sbjct: 519  GSIPSSFGF-LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS--------- 568

Query: 304  NLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLI 363
                                  I+ L   S  +   +  N F G +P  +   ST +  +
Sbjct: 569  ----------------------ISPLCGSSSYLSFDVTENGFEGDIPLELGK-STNLDRL 605

Query: 364  AMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIP 423
             +  NQ +G IP     +  L+ L +  N L+G IP  +G  + L ++ L  N + G+IP
Sbjct: 606  RLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIP 665

Query: 424  DPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL 483
              +G L LL  L+L  NK  GS+P+ +    N++ L    N LNG++P +I  +  L+ L
Sbjct: 666  TWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNAL 725

Query: 484  LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLL-MQGNSFNGS 542
             +L EN LSG +P  +G L  L +L +SRN  + EIPV +     L+  L +  N+F G 
Sbjct: 726  -NLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR 784

Query: 543  IPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETR 602
            IP +++ L  ++ LDLS N L G++P  +G++  L YLNLSYN+ EGK+ K+  FS    
Sbjct: 785  IPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQA 842

Query: 603  ISLTGNEQFCGGLGELHLPACHSVGPRKE------TITL-----------LKVVIPVIGT 645
             +  GN   CG      L  C+  G + +      T+ +           L V++ ++  
Sbjct: 843  DAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFF 898

Query: 646  KLAHKLSSAL----------LMEQQFPIVS---------YAELSKATKEFSSSNRIGKGS 686
            K  H L   +              Q P+ S         + ++ +AT   +    IG G 
Sbjct: 899  KQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGG 958

Query: 687  FGFVYKGNLGEDGMSVAV-KVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF 745
             G VYK  L ++G ++AV K++  D   + KSF  E + L  IRHR+L+K++  CSS   
Sbjct: 959  SGKVYKAEL-KNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS--- 1014

Query: 746  KGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVG---KLNIVIEVASVIEYLHNHCQPP 799
            K      ++YEYM  GSV DWLH   +T  K  +G   +L I + +A  +EYLH  C PP
Sbjct: 1015 KADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPP 1074

Query: 800  IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
            IVH D+K SNVLLD ++ AH+ DFGLA+ L+ +          S+    G+ GYI PEY 
Sbjct: 1075 IVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN----YDTNTESNTMFAGSYGYIAPEYA 1130

Query: 860  MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-----PKKVMGIVD 914
                 +   DVYS GI+L+E+ T + PT+ MF++   +  + +  L      +    ++D
Sbjct: 1131 YSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLID 1190

Query: 915  PSLLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
              L  ++  P + EE    V+   + C+   P ER
Sbjct: 1191 SEL--KSLLPCE-EEAAYQVLEIALQCTKSYPQER 1222

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  421 bits (1083), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 316/957 (33%), Positives = 474/957 (49%), Gaps = 97/957 (10%)

Query: 67   LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSFSGK 125
            LDL + N+ G +     N+S L  + LANN   G +PK +      LE +VLS    SG+
Sbjct: 292  LDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGE 351

Query: 126  IPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQ 185
            IP  LS+C +L    +  N+L G I   +   +++  L L+ N L G L PSI NL+ LQ
Sbjct: 352  IPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQ 411

Query: 186  TFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGS 245
               +  N L+G++P  +  LR L  L   EN FSG  P  + N +SL    +F N F+G 
Sbjct: 412  WLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGE 471

Query: 246  LPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNL 305
            +P  +G  L +L +L + QN L G LP SL N  +L  L+L +N  SG +  +F  L  L
Sbjct: 472  IPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGL 530

Query: 306  SKLYLGRNNL---------GTRTSTDLDF--------ITLLTNCSKLVKLGLVFNRFGGA 348
             +L L  N+L           R  T ++         I  L   S  +   +  N F   
Sbjct: 531  EQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDE 590

Query: 349  LPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNL 408
            +P  + N S  +  + +  NQ++G IP  +  +  L+ L +  N LTGTIP  +   + L
Sbjct: 591  IPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKL 649

Query: 409  QYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNG 468
             ++ L  N + G IP  +G L+ L  L+L  N+   S+P+ L  C  L+ LS   N LNG
Sbjct: 650  THIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNG 709

Query: 469  TLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTT 528
            ++P +I  +  L+ +L+L +N  SGS+P  +G L  L +L +SRN+ + EIPV +     
Sbjct: 710  SIPQEIGNLGALN-VLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQD 768

Query: 529  LEYLL-MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHF 587
            L+  L +  N+F G IP ++  L  ++ LDLS N L+G++P  +G++  L YLN+S+N+ 
Sbjct: 769  LQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNL 828

Query: 588  EGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGP--RKETITLLKVVIPVIGT 645
             GK+ K+  FS     S  GN   CG      L  C+ V    +++ ++   VVI    +
Sbjct: 829  GGKLKKQ--FSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAIS 882

Query: 646  KLAH----KLSSALLMEQQFPI----------------------------------VSYA 667
             L       L  AL  +Q+                                     + + 
Sbjct: 883  ALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE 942

Query: 668  ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAV-KVMNLDKKGATKSFVAECEALR 726
            ++ +AT   S    IG G  G VYK  L E+G +VAV K++  D   + KSF  E + L 
Sbjct: 943  DIMEATHNLSEEFMIGSGGSGKVYKAEL-ENGETVAVKKILWKDDLMSNKSFSREVKTLG 1001

Query: 727  NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------- 778
             IRHR+L+K++  CSS   K      ++YEYM+ GS+ DWLH     LE  K        
Sbjct: 1002 RIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEAR 1058

Query: 779  LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
            L I + +A  +EYLH+ C PPIVH D+K SNVLLD +M AH+ DFGLA+ L+ +      
Sbjct: 1059 LRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTEN----CD 1114

Query: 839  EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
                S+     + GYI PEY      +   DVYS GI+L+E+ T + PTD++F   + + 
Sbjct: 1115 TNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMV 1174

Query: 899  GYAKMALPKKVMG-----IVDPSLLMEARGPSKFEE-CLVAVVRTGVACSMESPSER 949
             + +  L  +V G     ++DP L    +    FEE     V+   + C+  SP ER
Sbjct: 1175 RWVETHL--EVAGSARDKLIDPKL----KPLLPFEEDAACQVLEIALQCTKTSPQER 1225

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  413 bits (1061), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 322/1049 (30%), Positives = 494/1049 (47%), Gaps = 155/1049 (14%)

Query: 41   KSWNNSINL-CQWTGVTCGHRHQ--RVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNS 97
            ++WN++ ++ C WTGV C +      V  L+L S  + G LSP IG L  L+ ++L+ N 
Sbjct: 49   RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNG 108

Query: 98   FHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNW 157
              G+IPKE+G    LE + L+NN F G+IP  + +  +L +  ++ N + G +   IGN 
Sbjct: 109  LSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNL 168

Query: 158  LKIERLSLYGNQLTGQLPPSIGNLSALQTFD------------------------IAGNK 193
            L + +L  Y N ++GQLP SIGNL  L +F                         +A N+
Sbjct: 169  LSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQ 228

Query: 194  LDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGF- 252
            L G +P  +G L+ L+ +   EN+FSG  P  + N +SL+   L+KN+  G +P  LG  
Sbjct: 229  LSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDL 288

Query: 253  ----------------------NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH 290
                                  NL     +  ++N LTG +P  L N   LE L L EN 
Sbjct: 289  QSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQ 348

Query: 291  FSGQVRINFNSLPNLSKLYLGRNN------LGTRTSTDLDFITLLTNC------------ 332
             +G + +  ++L NLSKL L  N       LG +    L  + L  N             
Sbjct: 349  LTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWY 408

Query: 333  SKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYN 392
            S L  L +  N   G +P  +  L + M ++ +  N +SG IP  I     L  L L  N
Sbjct: 409  SDLWVLDMSDNHLSGRIPSYLC-LHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARN 467

Query: 393  QLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGK 452
             L G  P  + +  N+  + L  N  RG IP  +GN + L  LQL  N   G +P  +G 
Sbjct: 468  NLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGM 527

Query: 453  CQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISR 512
               L  L+  +NKL G +P +IF    L + LD+  N+ SG++P EVG+L  L  L +S 
Sbjct: 528  LSQLGTLNISSNKLTGEVPSEIFNCKMLQR-LDMCCNNFSGTLPSEVGSLYQLELLKLSN 586

Query: 513  NNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIK-ELDLSCNNLSGQIPIHL 571
            NN S  IPV L   + L  L M GN FNGSIP+ L +L  ++  L+LS N L+G+IP  L
Sbjct: 587  NNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPEL 646

Query: 572  GNLPFLEY------------------------LNLSYNHFEGKVPKKGVFSNETRISLTG 607
             NL  LE+                         N SYN   G +P   +  N +  S  G
Sbjct: 647  SNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIG 703

Query: 608  NEQFC----------------------GGLGELHLPACHSVGPRKETITLLKVVIPVIGT 645
            NE  C                      GG+    + A  +      ++ L+ +++ ++  
Sbjct: 704  NEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRR 763

Query: 646  KLAHKLSSA-------LLMEQQFPI---VSYAELSKATKEFSSSNRIGKGSFGFVYKGNL 695
             +    SSA       + ++  FP     ++ +L  AT  F  S  +G+G+ G VYK  L
Sbjct: 764  PVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVL 823

Query: 696  GEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIRHRNLIKIITICSSIDFKGADF 750
               G ++AVK +  + +G        SF AE   L NIRHRN++K+   C   + +G++ 
Sbjct: 824  -PAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC---NHQGSNL 879

Query: 751  KAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQPPIVHGDLKPSN 809
              ++YEYM  GS+ + LH  +  L+  K   I +  A  + YLH+ C+P I H D+K +N
Sbjct: 880  --LLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNN 937

Query: 810  VLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGD 869
            +LLD    AHV DFGLA+ +        P  +S S  + G+ GYI PEY     ++   D
Sbjct: 938  ILLDDKFEAHVGDFGLAKVID------MPHSKSMS-AIAGSYGYIAPEYAYTMKVTEKSD 990

Query: 870  VYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM--GIVDPSLLMEARGPSKF 927
            +YS+G++LLE+ T + P   + + G  +  + +  + +  +  G++D  L +E     + 
Sbjct: 991  IYSYGVVLLELLTGKAPVQPI-DQGGDVVNWVRSYIRRDALSSGVLDARLTLEDE---RI 1046

Query: 928  EECLVAVVRTGVACSMESPSERMQMTAVV 956
               ++ V++  + C+  SP  R  M  VV
Sbjct: 1047 VSHMLTVLKIALLCTSVSPVARPSMRQVV 1075

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2

 Score =  412 bits (1058), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 330/1097 (30%), Positives = 493/1097 (44%), Gaps = 171/1097 (15%)

Query: 12   LYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINL-CQWTGVTCGHRHQRVTKLDLE 70
            +Y+  A +    A ++        P  +T+SWN S +  C W GV C  R Q V  L+L 
Sbjct: 18   IYAAFALNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVEC-DRRQFVDTLNLS 76

Query: 71   SQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNL 130
            S  I G   P I +L  L+ + L+ N F G IP ++G    LE I LS+NSF+G IP  L
Sbjct: 77   SYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTL 136

Query: 131  SRCFNLIDFWVHTNNLV------------------------GEIQAIIGNWLKIERLSLY 166
                NL +  +  N+L+                        G I + IGN  ++  L L 
Sbjct: 137  GALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLD 196

Query: 167  GNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSV 226
             NQ +G +P S+GN++ LQ   +  N L G +P +L  L NL YL    N   G  PL  
Sbjct: 197  DNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDF 256

Query: 227  CNISSLDEAYLFKNRFKGSLPVCLG-----------------------FNLPKLTVLVVA 263
             +   +D   L  N+F G LP  LG                         L KL  L +A
Sbjct: 257  VSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLA 316

Query: 264  ------------------------QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINF 299
                                    QN L G +P  L   S+L++L L  N+ SG+V ++ 
Sbjct: 317  GNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSI 376

Query: 300  NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTT 359
              + +L  L L +NNL      D      +T   +LV L L  N F G +P  +   +++
Sbjct: 377  WKIQSLQSLQLYQNNLSGELPVD------MTELKQLVSLALYENHFTGVIPQDLG-ANSS 429

Query: 360  MTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIR 419
            + ++ +  N  +G IPP + +   L  L L YN L G++P  +G    L+ L L  NN+R
Sbjct: 430  LEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLR 489

Query: 420  GIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITT 479
            G +PD +    LL    L  N   G IP  LG  +N+  +   +N+L+G++PP++  +  
Sbjct: 490  GGLPDFVEKQNLL-FFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVK 548

Query: 480  LSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSF 539
            L   L+LS N L G +P E+ N   L +LD S N  +  IP TL + T L  L +  NSF
Sbjct: 549  LEH-LNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSF 607

Query: 540  NGSIPQSL-----------------------NALKSIKELDLSCNNLSGQIPIHLGNLPF 576
            +G IP SL                        AL++++ L+LS N L+GQ+PI LG L  
Sbjct: 608  SGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKM 667

Query: 577  LE-----------------------YLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQFC 612
            LE                       ++N+S+N F G VP     F N +  S +GN   C
Sbjct: 668  LEELDVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLC 727

Query: 613  -----GGLG----ELHLPACHSVGPRKETITLLKVVIPVIGTKL---------------- 647
                  GL      +  P        K  ++ L + + V+G  L                
Sbjct: 728  INCPADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHC 787

Query: 648  AHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM 707
               +    +  Q+       ++ +AT+  +    IGKG+ G +YK  L  D +    K++
Sbjct: 788  KKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLV 847

Query: 708  NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL 767
                K  + S V E E +  +RHRNLIK+        +   ++  I+Y YM+ GS+ D L
Sbjct: 848  FTGIKNGSVSMVREIETIGKVRHRNLIKLEEF-----WLRKEYGLILYTYMENGSLHDIL 902

Query: 768  HHTNDKLEVG---KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 824
            H TN    +    + NI +  A  + YLH  C P IVH D+KP N+LLD D+  H+SDFG
Sbjct: 903  HETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFG 962

Query: 825  LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
            +A+ L      +       S  ++GTIGY+ PE       S   DVYS+G++LLE+ TR+
Sbjct: 963  IAKLLDQSATSIP------SNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRK 1016

Query: 885  RPTDNMFNDGLTLHGYAKMALPK--KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACS 942
            +  D  FN    + G+ +    +  ++  IVDPSLL E    S  E+ +   +   + C+
Sbjct: 1017 KALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQ-VTEALSLALRCA 1075

Query: 943  MESPSERMQMTAVVKKL 959
             +   +R  M  VVK+L
Sbjct: 1076 EKEVDKRPTMRDVVKQL 1092

Possible role in short-day photoperiod floral induction.

Ipomoea nil (taxid: 35883)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	973
359482058	1040	PREDICTED: probable LRR receptor-like se	0.977	0.914	0.488	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.969	0.495	0.491	0.0
224081190	1011	predicted protein [Populus trichocarpa]	0.985	0.948	0.482	0.0
224141953	1026	predicted protein [Populus trichocarpa]	0.958	0.909	0.480	0.0
255581223	1015	receptor-kinase, putative [Ricinus commu	0.964	0.924	0.477	0.0
224127492	1022	predicted protein [Populus trichocarpa]	0.978	0.931	0.468	0.0
224115346	1017	predicted protein [Populus trichocarpa]	0.959	0.918	0.472	0.0
224119022	1021	predicted protein [Populus trichocarpa]	0.974	0.928	0.464	0.0
224117950	1018	predicted protein [Populus trichocarpa]	0.970	0.927	0.470	0.0
224116466	1008	predicted protein [Populus trichocarpa]	0.983	0.949	0.463	0.0

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  888 bits (2295), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 488/998 (48%), Positives = 644/998 (64%), Gaps = 47/998 (4%)

Query: 16   HATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIG 75
            H     + A +    Q   DPLG+T SWN+S++ C WTGVTCGHRHQRV  L+L S ++ 
Sbjct: 35   HRNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLV 94

Query: 76   GFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFN 135
            G LSP IGNL+FL  +NL  N+FHGQIP+E+GRL RL  + L+NNSFSG+IP NLSRC N
Sbjct: 95   GSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSN 154

Query: 136  LIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLD 195
            L+ F +  NNL+G I + +G++ K+ R+ L+ N LTG +P S+GNL+++++   A N L+
Sbjct: 155  LVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLE 214

Query: 196  GRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLP 255
            G IP +LGQL+ L ++G   N FSG+ P SV N+SSL+   L  N+  GSLP  L F LP
Sbjct: 215  GSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLP 274

Query: 256  KLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL 315
             L VL +  N+ TG LP SLSNAS L   ++  ++F+G+V I+F  +PNL  L+L  N L
Sbjct: 275  NLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPL 334

Query: 316  GTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIP 375
            G   + DL F+  L  C  L  L L  ++FGG LP+SIANLST +  + +  NQ+SGTIP
Sbjct: 335  GKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIP 394

Query: 376  PEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVL 435
            P I NL NL  L L  N  TG+IP  IG L+ L  + L  N + G IP  +GN+T L  L
Sbjct: 395  PGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSL 454

Query: 436  QLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSI 495
             L  N L G IPS  G    L +L    N LNGT+P ++  + +L+  L+L+ N L+G +
Sbjct: 455  HLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLL 514

Query: 496  PLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKE 555
            P EV  LK+L  LD+S N  S EIP  L +C TLE+L M+GN F GSIP S  +L+ + +
Sbjct: 515  PSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLD 574

Query: 556  LDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGL 615
            LDLS NNLSGQIP  L  L  L  LNLS+N+FEG++P KGVF+N T  S+ GN + CGG+
Sbjct: 575  LDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGI 633

Query: 616  GELHLPACHSVGPRK-ETITLLKVVIPVIGTKLAHKLSSALLMEQQFPI----------- 663
             ELHLPAC    P+  E+   LK++I ++   L   L  +LL+  +              
Sbjct: 634  PELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSAS 693

Query: 664  -------VSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK 716
                   VSY  L KAT  FSS+N IG G FG VYKG LG+D   VAVKV+ L ++GA K
Sbjct: 694  SKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVK 753

Query: 717  SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH------HT 770
            SF AECEALRNIRHRNL+K++T CSS+D++G DFKA+VYE+M  GS+++WLH        
Sbjct: 754  SFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEI 813

Query: 771  NDKLEV----GKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 826
            ND L +     +LNI I+VAS ++YLH+HC  PIVH DLKPSN+LLD+DM AHV DFGLA
Sbjct: 814  NDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLA 873

Query: 827  RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            RF+        P  QSSSI +KGTIGY  PEYGMG  +S  GD YS+GILLLEMFT +RP
Sbjct: 874  RFIPEAAGRSHPS-QSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRP 932

Query: 887  TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLL-MEARGP---------------SKFEEC 930
            T++MF+D L LH + KMALP+++  I+DP  L  EA+                  K  EC
Sbjct: 933  TESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHEC 992

Query: 931  LVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
            L++++R GV+CS+ESP ERM +T  +K+L  + +I +G
Sbjct: 993  LISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  887 bits (2292), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/990 (49%), Positives = 642/990 (64%), Gaps = 47/990 (4%)

Query: 24   ATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIG 83
            A +    Q   DPLG+T SWN+S++ C WTGVTCGHRHQRV  L+L S ++ G LSP IG
Sbjct: 74   ALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLSSLHLVGSLSPSIG 133

Query: 84   NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHT 143
            NL+FL  +NL  N+FHGQIP+E+GRL RL  + L+NNSFSG+IP NLSRC NL+ F +  
Sbjct: 134  NLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGF 193

Query: 144  NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLG 203
            NNL+G I + +G++ K+ R+ L+ N LTG +P S+GNL+++++   A N L+G IP +LG
Sbjct: 194  NNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALG 253

Query: 204  QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVA 263
            QL+ L ++G   N FSG+ P SV N+SSL+   L  N+  GSLP  L F LP L VL + 
Sbjct: 254  QLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIG 313

Query: 264  QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL 323
             N+ TG LP SLSNAS L   ++  ++F+G+V I+F  +PNL  L+L  N LG   + DL
Sbjct: 314  NNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDL 373

Query: 324  DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN 383
             F+  L  C  L  L L  ++FGG LP+SIANLST +  + +  NQ+SGTIPP I NL N
Sbjct: 374  SFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVN 433

Query: 384  LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
            L  L L  N  TG+IP  IG L+ L  + L  N + G IP  +GN+T L  L L  N L 
Sbjct: 434  LTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLS 493

Query: 444  GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLK 503
            G IPS  G    L +L    N LNGT+P ++  + +L+  L+L+ N L+G +P EV  LK
Sbjct: 494  GKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLK 553

Query: 504  SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNL 563
            +L  LD+S N  S EIP  L +C TLE+L M+GN F GSIP S  +L+ + +LDLS NNL
Sbjct: 554  NLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNL 613

Query: 564  SGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPAC 623
            SGQIP  L  L  L  LNLS+N+FEG++P KGVF+N T  S+ GN + CGG+ ELHLPAC
Sbjct: 614  SGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPAC 672

Query: 624  HSVGPRK-ETITLLKVVIPVIGTKLAHKLSSALLMEQQFPI------------------V 664
                P+  E+   LK++I ++   L   L  +LL+  +                     V
Sbjct: 673  PVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASSKDLILNV 732

Query: 665  SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
            SY  L KAT  FSS+N IG G FG VYKG LG+D   VAVKV+ L ++GA KSF AECEA
Sbjct: 733  SYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEA 792

Query: 725  LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH------HTNDKLEV-- 776
            LRNIRHRNL+K++T CSS+D++G DFKA+VYE+M  GS+++WLH        ND L +  
Sbjct: 793  LRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILS 852

Query: 777  --GKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
               +LNI I+VAS ++YLH+HC  PIVH DLKPSN+LLD+DM AHV DFGLARF+     
Sbjct: 853  LPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAG 912

Query: 835  LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG 894
               P  QSSSI +KGTIGY  PEYGMG  +S  GD YS+GILLLEMFT +RPT++MF+D 
Sbjct: 913  RSHPS-QSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQ 971

Query: 895  LTLHGYAKMALPKKVMGIVDPSLL-MEARGP---------------SKFEECLVAVVRTG 938
            L LH + KMALP+++  I+DP  L  EA+                  K  ECL++++R G
Sbjct: 972  LNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIG 1031

Query: 939  VACSMESPSERMQMTAVVKKLCAVGEIFIG 968
            V+CS+ESP ERM +T  +K+L  + +I +G
Sbjct: 1032 VSCSLESPRERMAITEAIKELQLIRKILLG 1061

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  874 bits (2258), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 479/993 (48%), Positives = 636/993 (64%), Gaps = 34/993 (3%)

Query: 7    IFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTK 66
            I L + +S H  +     ++     Q+ DPL    SWN S + C+W+GV CGHRHQR+ +
Sbjct: 19   IQLSFSFSLHEGNETDRLSLLAFKAQITDPLDALSSWNASTHFCKWSGVICGHRHQRIVE 78

Query: 67   LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKI 126
            L+L+S  + G LSP+IGNLSFLRV+NL  N F   IP+E+GRLFRL+ +VL NN+FSG+I
Sbjct: 79   LNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELGRLFRLQRLVLGNNTFSGEI 138

Query: 127  PTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQT 186
            P N+S C NL+   + +NNL G+I A +G+  K+    L GN L G +P S GNLS++Q 
Sbjct: 139  PVNISSCSNLLVLHLGSNNLTGKIPAQLGSLSKLGAFVLQGNNLVGDIPSSFGNLSSVQN 198

Query: 187  FDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSL 246
            F    N L G IP+SLG L+ L Y   +END SG  P S+CNISSL    L +N+  GSL
Sbjct: 199  FFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSICNISSLAYVSLGQNQLHGSL 258

Query: 247  PVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLS 306
            P  LG NLP L  LV+  N+L G +P +LSNASK+  ++L+ N+ +G++  +  SLP+L 
Sbjct: 259  PPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIP-DLASLPDLQ 317

Query: 307  KLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMA 366
            KL +  N+LG     DL F+  L N + L  LG+  N FGG LP  ++N ST +  I   
Sbjct: 318  KLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFSTNLKGITFG 377

Query: 367  GNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI 426
             NQI G+IP EI NL +L+ L LE NQL G IP +IG+L+NL  L L  N I G IP  +
Sbjct: 378  RNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENKISGSIPSSL 437

Query: 427  GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDL 486
            GN+T L  +    N LQG+IP+ LG    L+ L    N L+G +P ++ GI++LS LL L
Sbjct: 438  GNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGISSLSVLLYL 497

Query: 487  SENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
             +N L+GS+P EVG L +L  L +S+N  S EIP +L +C +LE L + GN F G +P  
Sbjct: 498  HDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFFEGPVPD- 556

Query: 547  LNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLT 606
            L++L++++ L LS NNLSGQIP  L +   LE L+LSYN FEG+VP++GVF N +RIS+ 
Sbjct: 557  LSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQ 616

Query: 607  GNEQFCGGLGELHLPACHS---VGPRKETITLLKVVIPV--------------IGTKLAH 649
            GN++ CGG+ +L LP C S     P+  T  +L + IP                  K   
Sbjct: 617  GNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSFLLFYSRKTKD 676

Query: 650  KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
            + +S    E  F  ++Y +L +AT  FSSSN +G G+FG VY+G L  DG  VAVKV+NL
Sbjct: 677  EPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNL 736

Query: 710  DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH- 768
             +KGA+KSF+AEC AL NIRHRNL+K+IT CSS DF+G DFKA+VYE+M  GS+++WLH 
Sbjct: 737  LRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHP 796

Query: 769  -HTNDKLE-------VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV 820
             H +D          V +LNI I+VAS ++YLHNHCQ P+VH DLKPSNVLL  DM A V
Sbjct: 797  VHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACV 856

Query: 821  SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
             DFGLARFL      + P  +SSS+ +KGTIGY  PEYGMG ++S  GDVYS+GILLLEM
Sbjct: 857  GDFGLARFLPEASNQL-PADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEM 915

Query: 881  FTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSL-----LMEARGPSKFEECLVAVV 935
            FT RRPTD MF DG  LH YAKM LP  V+  VDP+L     +       K  EC+V+++
Sbjct: 916  FTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTLREHEEMNHNDDSHKVMECMVSII 975

Query: 936  RTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
            + G+ACS E P ERM +  VV +L  + E+  G
Sbjct: 976  KVGLACSAELPGERMGIANVVVELHRIREMLDG 1008

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa]

 Score =  851 bits (2199), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 466/970 (48%), Positives = 632/970 (65%), Gaps = 37/970 (3%)

Query: 32   QLHDPLGVT-KSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRV 90
            ++ DP   T  SWN+S++ C W G+TCG RH RV  ++L  Q + G LSPY+GN+SFLR 
Sbjct: 43   KIQDPHSNTLSSWNDSLDFCNWPGITCGRRHGRVRIINLVDQKLAGTLSPYVGNISFLRE 102

Query: 91   INLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEI 150
            I LANN+ HG+IP EVGRL RL  ++L+NNS  GKIP NLS C +L + ++  N L GEI
Sbjct: 103  IRLANNTIHGEIPPEVGRLLRLRVLMLTNNSIEGKIPANLSGCSSLAELYIDRNKLGGEI 162

Query: 151  QAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNY 210
               +G   K+  LS   N L G++P SIGNL++L++  +  N L+G IPDSLG+L+ L  
Sbjct: 163  PTELGFLSKLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRNVLEGTIPDSLGRLKRLTS 222

Query: 211  LGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGF 270
            L   EN  SG  P S+ N+S +   YL  N F+GSLP  LG + P L  L + QN  +G 
Sbjct: 223  LLLGENKLSGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGLSFPHLQWLALWQNQFSGP 282

Query: 271  LPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLT 330
            +P SL+NAS+L+ +    N  +G++   F  L +LS L+ G NNLGT    ++ F+  LT
Sbjct: 283  IPGSLTNASELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGSNNLGTGGDDEMAFLASLT 342

Query: 331  NCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLE 390
            NCS L  + +  NR  G+LP ++ NLST M    ++GN I G IP  I NL NL  L ++
Sbjct: 343  NCSMLKVVSINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVGRIPSGIGNLVNLTFLYMD 402

Query: 391  YNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYL 450
             N  TG IP + G LR L+   L  N + G IP  +GNL+LL+VL L  NKL+ +IP+ L
Sbjct: 403  RNHFTGEIPTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLLSVLYLDDNKLKDTIPASL 462

Query: 451  GKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDI 510
            G C+NL+ L      LNG++P Q+FG +++   L+LS N  +GS+P  +G+LK L +LD+
Sbjct: 463  GGCKNLVSLGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLPSTIGSLKGLSELDV 522

Query: 511  SRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH 570
            S N  S EIP +   CT+LE L M+ N F GSIP S ++L+ I+ LDLSCNNLSGQ+P  
Sbjct: 523  SWNMLSGEIPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFLDLSCNNLSGQLPNF 582

Query: 571  LGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRK 630
            L  +PF+  LNLSYN+FEG+VP+KGVF+NE+ +S+ GN++ CGG+ ELHLP C +  P+K
Sbjct: 583  LVTIPFIS-LNLSYNNFEGEVPRKGVFTNESAVSVVGNDKLCGGILELHLPECPNKEPKK 641

Query: 631  ETIT----LLKVVIP--VIGT------------KLAHKLSSALLMEQQFPIVSYAELSKA 672
              ++    LL + IP  ++G             K   + SS  L+++ FP +SY  L KA
Sbjct: 642  TKMSHLQYLLAITIPCALVGAITVSSFLFCWFKKKRKEHSSDTLLKESFPQISYERLFKA 701

Query: 673  TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
            T  FS++N IG GSF  VYKG + EDG  VA+KV+NL ++GA+KSF  ECEALRNIRHRN
Sbjct: 702  TDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRRGASKSFKDECEALRNIRHRN 761

Query: 733  LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVG---------KLN 780
            L+KIIT CSSIDF+G +FKA+VYEYM  GS++ WLH    T+D  ++          ++N
Sbjct: 762  LVKIITSCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQETHDDQQINQVQRPNLLERIN 821

Query: 781  IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
            I I+VA+ ++YLH+HC  PI+H D+KPSN+LLD DM+ H+ DFGLAR          P  
Sbjct: 822  IAIDVAAALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHLGDFGLARIFQE---FSEPSL 878

Query: 841  QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY 900
            +SSS  +KGT GY  PEYG G ++S+ GDVYS+GILLLEM T +RP D+ F  GL LH +
Sbjct: 879  ESSSAGIKGTTGYAAPEYGQGREVSIDGDVYSYGILLLEMMTGKRPIDDTFEKGLNLHMF 938

Query: 901  AKMALPKKVMGIVDPSLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK 958
            AKMALP  V+ I DP LL E      +  EECL ++V+ GVACSM+SP +RM M+ VV++
Sbjct: 939  AKMALPDHVIEITDPVLLSERHLENAASMEECLTSLVKIGVACSMDSPRDRMDMSRVVRE 998

Query: 959  LCAVGEIFIG 968
            L  V + F G
Sbjct: 999  LLMVRDTFQG 1008

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  850 bits (2197), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 468/980 (47%), Positives = 627/980 (63%), Gaps = 42/980 (4%)

Query: 24   ATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIG 83
            A + F  +   DPLG    WN+S + CQW GVTC  RHQRV  L+L S  + G +SP+IG
Sbjct: 37   ALLDFKAKITDDPLGFMPLWNDSTHFCQWYGVTCSRRHQRVAILNLRSLQLAGSISPHIG 96

Query: 84   NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHT 143
            NLSFLR + L NNSF   IP EVGRL RL+ + LSNNS +G IP+N+S C  L + +   
Sbjct: 97   NLSFLRDLYLQNNSFSHGIPPEVGRLRRLQRLRLSNNSLTGNIPSNISACSKLSEIYFAY 156

Query: 144  NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLG 203
            N L GEI   +    K++ +S+  N  +G +PPSIGNLS+LQ      N L G IPD++G
Sbjct: 157  NQLEGEIPEELSLLAKLQVISIQKNYFSGSIPPSIGNLSSLQVLSAPENYLSGNIPDAIG 216

Query: 204  QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVA 263
            QL NL ++  S N+ SG  P S+ N+SS++   +  N+ +G LP  LG  LP L V  +A
Sbjct: 217  QLNNLIFISLSVNNLSGTIPPSIYNLSSINTLNIVYNQIQGRLPSNLGITLPNLQVFAIA 276

Query: 264  QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL 323
            +N+  G +P S SNAS L WL ++EN  +G+V  +   L NL  L LG N LG   + DL
Sbjct: 277  RNDFIGSIPSSFSNASNLVWLIMSENKLTGRVP-SLEQLHNLQILGLGYNYLGLE-ANDL 334

Query: 324  DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN 383
            DF++ L NC+ L +L +  N+F G LP SI+N STT + + +A N I+G IP  I NL N
Sbjct: 335  DFVSSLVNCTNLWRLEIHNNKFHGVLPESISNFSTTFSQLVIAENNIAGRIPSSISNLVN 394

Query: 384  LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
            L  L +  NQL+G IP   G L  L+ L L GN + G IP  +GNLT+L  L    N LQ
Sbjct: 395  LERLEMANNQLSGNIPSNFGNLNMLKVLHLFGNKLSGTIPSSLGNLTMLLTLSFYDNNLQ 454

Query: 444  GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLK 503
            G IPS L +C+NLM L    N L+G++P Q+FG+++LS  LDLS NH +G IP+EVGNLK
Sbjct: 455  GRIPSSLAECENLMVLDLAKNNLSGSIPLQVFGLSSLSIALDLSANHFTGVIPMEVGNLK 514

Query: 504  SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNL 563
             L QL IS N  S  IP +L +C  LE L +QGN F+G +P SL++L+ ++ LD S NNL
Sbjct: 515  DLEQLGISDNMLSGRIPDSLGSCIKLEVLALQGNFFDGLVPSSLSSLRGLRVLDFSSNNL 574

Query: 564  SGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPAC 623
            SG+IP  L +   LE LNLSYN+FEG+VP +G+F N +   + GN++ CGG+ E HL  C
Sbjct: 575  SGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIFRNASTTLVMGNDKLCGGIPEFHLAKC 634

Query: 624  HSVGPRKETITLLKVVIPVIGTKLA------HKLSSALLMEQQFPI----------VSYA 667
            ++  P+K T+ LLK+VI  I + L         L+  L  +++ P           VS+ 
Sbjct: 635  NAKSPKKLTL-LLKIVISTICSLLGLSFILIFALTFWLRKKKEEPTSDPYGHLLLNVSFQ 693

Query: 668  ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN 727
             L +AT  FSS+N IG+GSFG VYKG L E  +++AVKV+NL   GA+ SF+AECEALRN
Sbjct: 694  SLLRATDGFSSANLIGRGSFGHVYKGFLDEGNVTIAVKVLNLLHHGASTSFIAECEALRN 753

Query: 728  IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEV---------GK 778
            IRHRNL+K++T CS ID++G DFKA+VYEYM  GS+++WLH      EV          +
Sbjct: 754  IRHRNLVKVLTACSGIDYQGNDFKALVYEYMVNGSLEEWLHPIPRTEEVEPPRSLNLLQR 813

Query: 779  LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH--HPFLV 836
            LNI I+VAS ++YLHN C  PIVH DLKPSNVLLD +M  HVSDFGLA+ LS   + F  
Sbjct: 814  LNIAIDVASALDYLHNQCTTPIVHCDLKPSNVLLDSEMNGHVSDFGLAKILSESTNSF-- 871

Query: 837  APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
             P  QSSSI ++GT+G+  PEYG+G ++S  GDVYS+GILLLE+FT +RPTD+MF + L 
Sbjct: 872  -PVSQSSSIGVRGTVGFAPPEYGVGSNVSTYGDVYSYGILLLELFTGKRPTDDMFKEDLN 930

Query: 897  LHGYAKMALPKKVMGIVDPSLLME---------ARGPSKFEECLVAVVRTGVACSMESPS 947
            LH +A++A   ++  + DP LL E         +R   + EECL +++R GVACS E P 
Sbjct: 931  LHNFAEIAFRDQLAEVADPILLQETAVRETRLNSRKCQRLEECLFSMLRIGVACSTEMPQ 990

Query: 948  ERMQMTAVVKKLCAVGEIFI 967
            ERM++  VV  L A+ +  +
Sbjct: 991  ERMKINDVVTGLHAIRDKLV 1010

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  847 bits (2188), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/1003 (46%), Positives = 632/1003 (63%), Gaps = 51/1003 (5%)

Query: 8    FLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKL 67
            F F +Y  + T   K + +TF  Q   DPLG   SWN S   CQW+GVTCG RHQRV +L
Sbjct: 24   FSFSIYGGNETD--KLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGVTCGRRHQRVVEL 81

Query: 68   DLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIP 127
            DL S  + G LSP+IGNLSFLR++NLANNS    IP+E+GRLFRLE +VL NN+F G IP
Sbjct: 82   DLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLRNNTFDGGIP 141

Query: 128  TNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTF 187
             N+SRC NL        NL G++ A +G   K++ L++  N   G++P S GNLSA+   
Sbjct: 142  ANISRCANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELNNFVGEIPYSFGNLSAINAI 201

Query: 188  DIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLP 247
              + N L+G IP+  GQL+ L  L    N+ SGM P S+ N+SSL       N+  GSLP
Sbjct: 202  YGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLP 261

Query: 248  VCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSK 307
              LG  LP L V  +  N   G +P + SNAS L   ++  N+F+G+V    +S  +L  
Sbjct: 262  HTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVP-PLSSSHDLQV 320

Query: 308  LYLGRNNLGTRTSTDLDFI-TLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMA 366
            L +G NNLG   + DL+F+  L  N + L  L    N FGG LP  ++N ST +  +  A
Sbjct: 321  LGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFA 380

Query: 367  GNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI 426
             NQI G+IP +I NL NL  LGLE NQLTG IP ++G+L+ L  L L GN I G+IP  +
Sbjct: 381  RNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSM 440

Query: 427  GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDL 486
            GN+T L  + +  N L+GSIP  LG  Q L+ L+   N L+G +P ++  I +LS  L L
Sbjct: 441  GNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVL 500

Query: 487  SENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
            SEN L+GS+P+E+  L +L  LD+S+N FS EIP +L +C +LE L ++ N   G IP +
Sbjct: 501  SENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPIT 560

Query: 547  LNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLT 606
            L++L++I+EL+LS NNL+GQIP  L +   LE LNLS+N FEG+VP +G F N + IS+ 
Sbjct: 561  LSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIF 620

Query: 607  GNEQFCGGLGELHLPACHSVGP--RKETITLLKVVIPVIG-----------------TKL 647
            GN++ CGG+ +L+L  C S  P   K    L+ ++  V G                  K 
Sbjct: 621  GNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKK 680

Query: 648  AHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM 707
                +S   +E  FP V+Y +L  AT  FSS+N IG+GSFG V+KG LG D + VAVKV+
Sbjct: 681  DKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVL 740

Query: 708  NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL 767
            NL +KGA+KSF+AECEAL++IRHRNL+K++T CSSIDF+G DFKA+VYE+M  G++++WL
Sbjct: 741  NLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWL 800

Query: 768  H--HTNDKLE-------VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA 818
            H   T+D+         + +LNI I +AS + YLH+ CQ PI+H DLKPSN+LLD +M A
Sbjct: 801  HPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTA 860

Query: 819  HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLL 878
            HV DFGLARF S          Q+SS+ +KGTIGY  PEYG+GG +S  GDVYS+GILLL
Sbjct: 861  HVGDFGLARFHSE------ASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLL 914

Query: 879  EMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEAR-------------GPS 925
            EMFT +RP D MF DGL LH YAKMALP +++ +VDP L+ E R             GP 
Sbjct: 915  EMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPH 974

Query: 926  KFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
            +   CL+ +++ GVACS+E P ERM +  VV +L  + +  +G
Sbjct: 975  EISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLG 1017

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa]

 Score =  844 bits (2180), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 465/984 (47%), Positives = 642/984 (65%), Gaps = 50/984 (5%)

Query: 24   ATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIG 83
            A + F  + +HDP  +  SWN+S++ CQW GV CG RH+RVT L LES  + G +SP +G
Sbjct: 42   ALLDFKSKIIHDPQNIFGSWNDSLHFCQWQGVRCGRRHERVTVLKLESSGLVGSISPALG 101

Query: 84   NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHT 143
            NLSFL  ++L+NN+  G+IP  +GRLFRL+ +VL+NNSF G+IP NLS C  L    + +
Sbjct: 102  NLSFLWGLDLSNNTLQGKIPDGLGRLFRLQILVLNNNSFVGEIPGNLSHCSKLDYLGLAS 161

Query: 144  NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLG 203
            NNLVG+I A + +  K+E+L ++ N L+G +PP IGNL++L +   A N   GRIPD+LG
Sbjct: 162  NNLVGKIPAELVSLSKLEKLVIHKNNLSGAIPPFIGNLTSLNSISAAANNFQGRIPDTLG 221

Query: 204  QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVA 263
            QL+NL  LG   N  SG  PL + N+S+L    L +N+ +G LP  +G +LP L  + + 
Sbjct: 222  QLKNLESLGLGTNFLSGTIPLPIYNLSTLSILSLSENQLQGYLPSDIGVSLPNLQYIQIR 281

Query: 264  QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL 323
             N  +G +P S+SN+S L+ LE  +N FSG++ +NF  L +L+ + L  N +G+    +L
Sbjct: 282  ANQFSGSIPLSISNSSNLQVLEAGDNSFSGKLSVNFGGLKHLAVVSLSFNKMGSGEPGEL 341

Query: 324  DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN 383
             F+  L NC+ L  + +V N F G LP+S+ NLST +T + +  NQ+ G I   I NL N
Sbjct: 342  SFLDSLINCTSLYAIDIVGNHFEGMLPNSLGNLSTGLTFLGLGQNQLFGGIHSGIGNLIN 401

Query: 384  LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
            LN LGLE+NQL+G IP  IG+LR LQ   L  N + G IP  IGNLTLL    L  N+LQ
Sbjct: 402  LNTLGLEFNQLSGPIPLDIGKLRMLQRFSLSYNRLSGHIPSSIGNLTLLLEFDLQGNQLQ 461

Query: 444  GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLK 503
            G+IPS +G CQ L+ L    N L+G  P ++F I++LS  LDLS+N+ +GS+P E+G+LK
Sbjct: 462  GTIPSSIGNCQKLLLLHLSRNNLSGNAPKELFAISSLSVSLDLSQNYFNGSLPSEIGSLK 521

Query: 504  SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNL 563
            SL +L++S N FS EIP TL++CT+LEYL MQ N F GSIP S + L+ I++LDLS NNL
Sbjct: 522  SLAKLNVSYNEFSGEIPSTLASCTSLEYLYMQHNFFQGSIPSSFSTLRGIQKLDLSHNNL 581

Query: 564  SGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPAC 623
            SGQIP  L     L  LNLS+N FEG+VP KG F N T IS+ GN++ CGG+ EL LP C
Sbjct: 582  SGQIPKFLDTFALLT-LNLSFNDFEGEVPTKGAFGNATAISVDGNKKLCGGISELKLPKC 640

Query: 624  HSVGPRKETITLLKVVIPVIGT-----------------KLAHKLSSALLMEQQFPIVSY 666
            +    +K  I L  +++  I                   +   + SS L +++  P VSY
Sbjct: 641  NFKKSKKWKIPLWLILLLTIACGFLGVAVVSFVLLYLSRRKRKEQSSELSLKEPLPKVSY 700

Query: 667  AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALR 726
              L KAT  FSS N IG+G FG VY+G L +D   VA+KV+NL  +GA+KSFVAECEALR
Sbjct: 701  EMLLKATNGFSSDNLIGEGGFGSVYRGILDQDDTVVAIKVLNLQTRGASKSFVAECEALR 760

Query: 727  NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGS---VDDWLHHTNDKLE-VGKLNIV 782
            N+RHRNL+KIIT CSS+DF+G +FKA+VYE+M  GS   ++ WL+  N  L+ + +LNI+
Sbjct: 761  NVRHRNLLKIITSCSSVDFQGNEFKALVYEFMPNGSLEILEKWLYSHNYFLDLLQRLNIM 820

Query: 783  IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            I+VAS +EYLH+     +VH DLKPSN+LLD +MVAHVSDFG+A+ L         EG S
Sbjct: 821  IDVASALEYLHHGNATLVVHCDLKPSNILLDENMVAHVSDFGIAKLLG--------EGHS 872

Query: 843  SSIEMK-GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA 901
             +  M   T+GY+ PEYG+G  +S+ GD+YS+GI LLEM TR+RPTDNMF   L LHG+A
Sbjct: 873  ITQTMTLATVGYMAPEYGLGSQVSIYGDIYSYGIPLLEMITRKRPTDNMFEGTLNLHGFA 932

Query: 902  KMALPKKVMGIVDPSLL--------------MEARGPSKFE-----ECLVAVVRTGVACS 942
            +MALP++V+ IVDPSLL              +E    S  E     EC+ ++++ G++CS
Sbjct: 933  RMALPEQVLNIVDPSLLSSGNVKAGRMSNTSLENPTSSSGEIGTLVECVTSLIQIGLSCS 992

Query: 943  MESPSERMQMTAVVKKLCAVGEIF 966
             E P +R+++   + +LC++ +I 
Sbjct: 993  RELPRDRLEINHAITELCSIRKIL 1016

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa]

 Score =  833 bits (2151), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 466/1004 (46%), Positives = 637/1004 (63%), Gaps = 56/1004 (5%)

Query: 5    SRIFLFWLYSRHATSHVKH----ATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHR 60
            S +FL  L S   + +       A + F  + + DPLG+  SWN++I+ CQW GV+CG R
Sbjct: 10   SFVFLLSLISVTCSDYTNETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQWHGVSCGRR 69

Query: 61   HQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNN 120
            HQRV  L L+S  + G +SP+IGNLSFLR ++L NNSF  +IP +VGRL  L+   L NN
Sbjct: 70   HQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSLQIFSLHNN 129

Query: 121  SFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGN 180
            S SG+IP ++S C NLI   +  NNL GEI   +G+ LK++ L+L  N LTG +PPS+GN
Sbjct: 130  SISGQIPPSISDCSNLISIKIEFNNLTGEIPMELGSLLKLKNLTLEVNGLTGTIPPSLGN 189

Query: 181  LSALQTFDIAGNK-LDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK 239
            LS+L+   +  NK L G +P +LG+L+NL  L   +N  SG+ P S+ N+SSL    +  
Sbjct: 190  LSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSSLTALDIGF 249

Query: 240  NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINF 299
            N F G+LP  +G +LP L    +A N  TG +P S+SNAS +E L+++ N+ +G+V    
Sbjct: 250  NLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLTGEV---- 305

Query: 300  NSLPNLSKLY------LGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSI 353
               P L KL+      L  N+LG+  + DL F++ LTN + L  L +  N FGG LP  I
Sbjct: 306  ---PTLEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELPKQI 362

Query: 354  ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGL 413
            +NLST + +I++  N I G+IP  I  L NL    +  N+++G IP +IGEL+NL+ L L
Sbjct: 363  SNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGLVL 422

Query: 414  VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQ 473
              NN+ G IP  +GNLT L  L LG N L+GSIPS LG C+ L+ L+   N L+G +PP 
Sbjct: 423  DYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIPPG 482

Query: 474  IFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLL 533
            +FGI +L  +   S+NH SGS+P+E+G L +L  LD+S N  S EIP +L  C +LE L 
Sbjct: 483  LFGIFSLLYIC-FSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLEDLY 541

Query: 534  MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK 593
            M  N F+GSIP +L++L+ + + + S NNLSG+IP        LE L+LSYN+FEG +P 
Sbjct: 542  MNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMIPD 601

Query: 594  KGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSS 653
            +G+F N T +S+ GN Q CGG  EL LP C    P++  +  LK+ I  I   LA  L  
Sbjct: 602  EGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLK-LKIAIFAITVLLALALVV 660

Query: 654  ALL----------------MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGE 697
              L                M  +   VSY  L KAT  FSSSN +G GSFG VYKG L +
Sbjct: 661  TCLFLCSSRRKRREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGMLDQ 720

Query: 698  DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEY 757
            +GM +AVKV+NL ++GA++SF+AECEALRNIRHRNL+K++T CSSID+ G DFKAIVYE+
Sbjct: 721  NGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIVYEF 780

Query: 758  MQYGSVDDWLH-------HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNV 810
            M  GS++DWLH        T     + +LNI I+VA  +EYLH+HC+ PI H DLKPSNV
Sbjct: 781  MANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHCDLKPSNV 840

Query: 811  LLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDV 870
            LLD ++  HV DFGLA+FLS    L  P  +S+SI ++GTIGY  PEYG+GG++S  GD 
Sbjct: 841  LLDDELTGHVGDFGLAKFLSGAS-LDYPTNESTSIGVRGTIGYAPPEYGVGGEVSAYGDT 899

Query: 871  YSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLME---------- 920
            YS+GILLLEMFT +RPTD MF +G  LH + K A+P++V  I DP+LL E          
Sbjct: 900  YSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLLQEEPTGDDDKHE 959

Query: 921  --ARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV 962
              +   S+  ECL +++R G++CS+E P ERM+++  V +L +V
Sbjct: 960  ISSMRNSRPLECLNSILRIGISCSVEFPRERMKISDAVAQLHSV 1003

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224117950|ref|XP_002317696.1| predicted protein [Populus trichocarpa] gi|222858369|gb|EEE95916.1| predicted protein [Populus trichocarpa]

 Score =  833 bits (2151), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 462/981 (47%), Positives = 621/981 (63%), Gaps = 37/981 (3%)

Query: 22   KHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPY 81
            + A +      L DP     SWN S++ C W GV CG +HQRV  L+L S  + GFLSP+
Sbjct: 36   REALLAMKHLVLSDPFRALSSWNASLHFCTWHGVACGSKHQRVIALNLSSLQLAGFLSPH 95

Query: 82   IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
            IGNL+FLR I+L+ N+FHG IP+EVG+LFRL+ + LSNNSF  ++P NLS C NL    +
Sbjct: 96   IGNLTFLRRIDLSKNNFHGTIPEEVGQLFRLQYLSLSNNSFQDELPGNLSHCSNLRFLGM 155

Query: 142  HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
              NNL G+I + +G+   +    L  N LTG LP S GNLS+L +  +  N L+G IP  
Sbjct: 156  EGNNLTGKIPSELGSLSNLRAPGLLKNHLTGSLPRSFGNLSSLVSLSLRENNLEGSIPIE 215

Query: 202  LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
              +L  L YL  S N+ SGM P  + NISSL    +  N   G LP+ LG  LP L  L 
Sbjct: 216  FERLSRLAYLDLSFNNLSGMVPEELYNISSLSTVAMVSNNLSGRLPLDLGLTLPNLQTLY 275

Query: 262  VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
            +  N   G +P S+ N+S LE+L+L  N FSG V  N  SL  L  L  G N +G + + 
Sbjct: 276  LGLNRFLGPVPASIVNSSGLEYLDLASNSFSGPVPKNLGSLRYLQILNFGFNKIGDKNNN 335

Query: 322  DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
            DL F+T LTNC+ L ++GL  +  GG LP+SIANLST +  + M GN I+GTIP EI NL
Sbjct: 336  DLTFLTSLTNCTDLKEIGLYKSNLGGLLPNSIANLSTNLYYLVMWGNYITGTIPTEIGNL 395

Query: 382  FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
             +   L L  N LTG +P +IG+L  L+   +  N I G IP  +GN++ L  L LG N 
Sbjct: 396  KSSQALDLADNMLTGRLPESIGKLVMLKEFYVHLNKISGEIPSALGNISGLLKLDLGVNL 455

Query: 442  LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN 501
            L+G+IP  L  C +L  L   +N L+G +P +IF +++L+  L L  N LSG +P +V N
Sbjct: 456  LEGTIPVSLANCTSLNLLDISHNHLSGFIPEKIFSLSSLTLGLLLGSNRLSGRLPSQVVN 515

Query: 502  LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
            +++L+QLDISRN    EIP TL  C  LE L M GN   G+IP S   L+SI+ LD+SCN
Sbjct: 516  MRNLIQLDISRNKICGEIPSTLETCLMLETLNMSGNFLRGTIPSSFKKLRSIRVLDVSCN 575

Query: 562  NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLP 621
            NLSGQIP  L +LPFL  LNLS+N FEGKVP +G F N ++ S+ GN + CGG+  + LP
Sbjct: 576  NLSGQIPEFLADLPFLSNLNLSFNEFEGKVPAEGAFENASQFSIAGNNKLCGGIKAIQLP 635

Query: 622  ACHSVGPRKE--------------TITLLKVVIPVIG-TKLA--HKLSSALLMEQQFPIV 664
             C      K                ITLL   I  +G  KL+   K  SA  ME++F IV
Sbjct: 636  ECPRTKQHKRFSKRVVIVASSVAVFITLLLACIFAVGYRKLSANRKPLSASTMEKKFQIV 695

Query: 665  SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
            SY +L++AT  FSS+N IG G +G VYKG LG DG +VA+KV+  +++GA ++FVAECE 
Sbjct: 696  SYQDLARATDGFSSANMIGDGGYGSVYKGILGPDGQTVAIKVLKPEQRGANRTFVAECET 755

Query: 725  LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH------HTNDKLE-VG 777
            LR IRHRNL+KI+T CSSIDFKG DFKA+V+++M  GS++ WLH        + +L  + 
Sbjct: 756  LRRIRHRNLVKIVTACSSIDFKGNDFKALVFDFMPGGSLESWLHPSAVESQNSKRLSLLQ 815

Query: 778  KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
            +++++I+VAS ++YLHNHC   IVH DLKPSN+LLD+D+ AHV DFGLAR LS       
Sbjct: 816  RISMLIDVASALDYLHNHCDEQIVHCDLKPSNILLDNDLTAHVGDFGLARILSAATG-ET 874

Query: 838  PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 897
            P   +SS+ ++GT+GY+ PEYGMGG +S++GDVYS+GILLLEMFT +RPTD+MF    +L
Sbjct: 875  PSTSTSSLGVRGTVGYVAPEYGMGGQVSISGDVYSYGILLLEMFTGKRPTDSMFTGNNSL 934

Query: 898  HGYAKMALPKKVMGIVDPSLLMEAR--------GPS----KFEECLVAVVRTGVACSMES 945
            H +AK ALP +V  I+DP L ++ +        GPS    K E CL+++++ GV CS+E 
Sbjct: 935  HNFAKTALPDQVSEIIDPLLKIDTQQLAESSRNGPSSSRDKIEGCLISILQIGVLCSVEL 994

Query: 946  PSERMQMTAVVKKLCAVGEIF 966
            PSERM +  V+ +   + +I 
Sbjct: 995  PSERMVIAEVLSEFNKIRKIL 1015

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116466|ref|XP_002331904.1| predicted protein [Populus trichocarpa] gi|222874576|gb|EEF11707.1| predicted protein [Populus trichocarpa]

 Score =  830 bits (2145), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 465/1003 (46%), Positives = 628/1003 (62%), Gaps = 46/1003 (4%)

Query: 8    FLFWLYSRHATSH-----------VKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVT 56
            F+ W  S     H           +   ++     Q+ DP     SWN S++ CQW+GV 
Sbjct: 4    FILWFLSFQIIQHSFSFSLARGSEIDKLSLLAFKAQISDPTTKLSSWNESLHFCQWSGVK 63

Query: 57   CGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIV 116
            CG +HQRV +LDL S  + G LSP IGNLSFLR+++L NNSF   IP+E+GRL RL+T++
Sbjct: 64   CGRQHQRVIELDLHSSQLVGSLSPSIGNLSFLRLLSLENNSFTNAIPQEIGRLVRLQTLI 123

Query: 117  LSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP 176
            L NNSFSG+IP+N+S C NL+   +  NNL G + A +G+  K++  S   N L G++P 
Sbjct: 124  LGNNSFSGEIPSNISHCSNLLKLNLEGNNLTGNLPAGLGSLSKLQVFSFRKNNLDGKIPL 183

Query: 177  SIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY 236
            S  NLS++   D   N + G IP S+G+L+ LN+     N+ SG  P S+ NISSL    
Sbjct: 184  SFENLSSIIEIDGTLNNIQGGIPSSIGKLKTLNFFSLGSNNLSGTIPASLYNISSLIHFS 243

Query: 237  LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVR 296
            L  N+F G+LP  +G  LP L  L +  N L+G LP +L NA+K   + L+ N F+G+V 
Sbjct: 244  LPYNQFHGTLPPNIGLTLPNLQYLGIHDNRLSGQLPATLINATKFTEIYLSYNKFTGKVP 303

Query: 297  INFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANL 356
                 +PNL  L +  N LG     DL F+  L+N SKL  L +  N FGG LP  I+N 
Sbjct: 304  -TLAIMPNLRILSMEENGLGKGEDDDLSFLYTLSNSSKLEDLYIDNNNFGGVLPDIISNF 362

Query: 357  STTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGN 416
            ST +  +A   NQI GTIP  I NL +L+ LGLE N LTG+IP +IG+L+NL    L  N
Sbjct: 363  STKLKQMAFGSNQIRGTIPDGIGNLVSLDTLGLEANHLTGSIPSSIGKLQNLADFFLNEN 422

Query: 417  NIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFG 476
             + G IP  +GN+T L  +    N LQGSIP  LG CQNL+ L+   N L+G +P ++  
Sbjct: 423  KLSGSIPSSLGNITSLMQINFDQNNLQGSIPPSLGNCQNLLVLALSQNNLSGPIPKEVLS 482

Query: 477  ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQG 536
            I++LS  L LSEN L+GS+P EVG L +L  +DIS+N  S EIP +L +C +LE+L + G
Sbjct: 483  ISSLSMYLVLSENQLTGSLPFEVGKLVTLGYMDISKNRLSGEIPASLGSCESLEHLYLDG 542

Query: 537  NSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGV 596
            N   G I +SL +L+++++L+LS NNLSGQIP  LG+L  L+ L+LS+N  EG+VP  GV
Sbjct: 543  NFLQGPISESLRSLRALQDLNLSHNNLSGQIPKFLGDLK-LQSLDLSFNDLEGEVPMHGV 601

Query: 597  FSNETRISLTGNEQFCGGLGELHLPACH--SVGPRKETITLLKVVIPV--IG-------- 644
            F N + +S+ GN+  CGG+ +L+LP C   S  P+  T   L V IP   IG        
Sbjct: 602  FENTSAVSIAGNKNLCGGILQLNLPTCRSKSTKPKSSTKLTLTVAIPCGFIGLIFIASFL 661

Query: 645  -----TKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDG 699
                  K   K  + L  E  F  V+Y +L +AT  FSS N +G GSFG VYKG L  DG
Sbjct: 662  FLCCLKKSLRKTKNELSCEMPFRTVAYKDLLQATNGFSSGNLVGAGSFGSVYKGVLAFDG 721

Query: 700  MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQ 759
            ++VAVKV NL ++GA+KSF+ EC AL NIRHRNL+K++  C+ +D +G DFKA+VYE+M 
Sbjct: 722  VTVAVKVFNLLREGASKSFMRECAALLNIRHRNLVKVLFACAGVDVQGNDFKALVYEFMI 781

Query: 760  YGSVDDWLH--HTNDKLEV---------GKLNIVIEVASVIEYLHNHCQPPIVHGDLKPS 808
             GS+++WLH  HT D LEV          +LNI I+VA+ ++YLHN C+ PIVH DLKPS
Sbjct: 782  NGSLEEWLHPIHTLD-LEVHQPKNLNLIQRLNIAIDVANALDYLHNQCKMPIVHCDLKPS 840

Query: 809  NVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG 868
            NVLLD DM AHV DFGL +FLS      +   Q+SS+ +KGT+GY  PEYG+G ++S  G
Sbjct: 841  NVLLDGDMTAHVGDFGLLKFLSEA-SCQSSSSQTSSVGLKGTVGYAAPEYGIGSEVSTFG 899

Query: 869  DVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLME---ARGPS 925
            DV+S+GILLLEM T +RPTD+MF DGL LH Y K+ALP +V+ I DP LL E    +G  
Sbjct: 900  DVHSYGILLLEMITGKRPTDSMFKDGLELHSYVKIALPDRVVDIADPKLLTEVDQGKGTD 959

Query: 926  KFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
            +  ECL+++ + GV CS + P ERM ++ VV +L      F+G
Sbjct: 960  QIVECLISISKIGVFCSEKFPKERMDISNVVAELNRTKANFLG 1002

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	973
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.640	0.616	0.436	7.2e-213
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.641	0.608	0.432	7.2e-213
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.641	0.617	0.430	3.1e-212
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.627	0.592	0.442	6.9e-206
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.620	0.598	0.434	1.7e-202
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.785	0.745	0.436	8.6e-159
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.563	0.467	0.367	2.4e-127
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.578	0.574	0.336	3.9e-125
TAIR|locus:2122239	1136	AT4G36180 [Arabidopsis thalian	0.657	0.563	0.356	5.1e-121
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.594	0.462	0.327	2.2e-119

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1287 (458.1 bits), Expect = 7.2e-213, Sum P(2) = 7.2e-213
 Identities = 275/630 (43%), Positives = 386/630 (61%)

Query:    22 KHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPY 81
             + A + F  Q   D   V  SWN+S  LC W GVTCG +++RVT L+L    +GG +SP 
Sbjct:    26 RQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISPS 85

Query:    82 IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
             IGNLSFL  ++L  N F G IP+EVG+L RLE + +  N   G IP  L  C  L++  +
Sbjct:    86 IGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRL 145

Query:   142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
              +N L G + + +G+   + +L+LYGN + G+LP S+GNL+ L+   ++ N L+G IP  
Sbjct:   146 DSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSD 205

Query:   202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
             + QL  +  L    N+FSG+FP ++ N+SSL    +  N F G L   LG  LP L    
Sbjct:   206 VAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFN 265

Query:   262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
             +  N  TG +P +LSN S LE L +NEN+ +G +   F ++PNL  L+L  N+LG+ +S 
Sbjct:   266 MGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSR 324

Query:   322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
             DL+F+T LTNC++L  LG+  NR GG LP SIANLS  +  + + G  ISG+IP +I NL
Sbjct:   325 DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNL 384

Query:   382 FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
              NL  L L+ N L+G +P ++G+L NL+YL L  N + G IP  IGN+T+L  L L  N 
Sbjct:   385 INLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNG 444

Query:   442 LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN 501
              +G +P+ LG C +L++L   +NKLNGT+P +I  I  L +L D+S N L GS+P ++G 
Sbjct:   445 FEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRL-DMSGNSLIGSLPQDIGA 503

Query:   502 LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
             L++L  L +  N  S ++P TL  C T+E L ++GN F G IP  L  L  +KE+DLS N
Sbjct:   504 LQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNN 562

Query:   562 NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLP 621
             +LSG IP +  +   LEYLNLS+N+ EGKVP KG+F N T +S+ GN   CGG+    L 
Sbjct:   563 DLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLK 622

Query:   622 ACHSVGP---RKETITLLKVVIPV-IGTKL 647
              C S  P   +K +  L KVVI V +G  L
Sbjct:   623 PCLSQAPSVVKKHSSRLKKVVIGVSVGITL 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1281 (456.0 bits), Expect = 7.2e-213, Sum P(2) = 7.2e-213
 Identities = 271/627 (43%), Positives = 389/627 (62%)

Query:    22 KHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPY 81
             K A + F  Q       V  SWN+S+ LC WTGV CG +H+RVT +DL    + G +SP+
Sbjct:    41 KQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPF 100

Query:    82 IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
             +GNLSFLR +NLA+N FHG IP EVG LFRL+ + +SNN F G IP  LS C +L    +
Sbjct:   101 VGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDL 160

Query:   142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
              +N+L   +    G+  K+  LSL  N LTG+ P S+GNL++LQ  D   N+++G IP  
Sbjct:   161 SSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGD 220

Query:   202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
             + +L+ + +   + N F+G+FP  + N+SSL    +  N F G+L    G  LP L +L 
Sbjct:   221 IARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILY 280

Query:   262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
             +  N+ TG +P++LSN S L  L++  NH +G++ ++F  L NL  L L  N+LG  +S 
Sbjct:   281 MGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSG 340

Query:   322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
             DLDF+  LTNCS+L  L + FN+ GG LP  IANLST +T +++ GN ISG+IP  I NL
Sbjct:   341 DLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNL 400

Query:   382 FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
              +L  L L  N LTG +PP++GEL  L+ + L  N + G IP  +GN++ L  L L  N 
Sbjct:   401 VSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNS 460

Query:   442 LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN 501
              +GSIPS LG C  L+ L+   NKLNG++P ++  + +L  +L++S N L G +  ++G 
Sbjct:   461 FEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGK 519

Query:   502 LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
             LK L+ LD+S N  S +IP TL+ C +LE+LL+QGNSF G IP  +  L  ++ LDLS N
Sbjct:   520 LKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKN 578

Query:   562 NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLP 621
             NLSG IP ++ N   L+ LNLS N+F+G VP +GVF N + +S+ GN   CGG+  L L 
Sbjct:   579 NLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQ 638

Query:   622 ACHSVGPRKETITLLKVVIPVIGTKLA 648
              C    PR+ + ++ K++   +   +A
Sbjct:   639 PCSVELPRRHS-SVRKIITICVSAVMA 664

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1277 (454.6 bits), Expect = 3.1e-212, Sum P(2) = 3.1e-212
 Identities = 271/630 (43%), Positives = 383/630 (60%)

Query:    22 KHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPY 81
             + A + F  Q       V  SWNNS  LC W  VTCG +H+RVT L+L    +GG +SP 
Sbjct:    26 RQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGIVSPS 85

Query:    82 IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
             IGN+SFL  ++L++N+F G IP+EVG LFRLE + ++ NS  G IP  LS C  L++  +
Sbjct:    86 IGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNLDL 145

Query:   142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
             ++N L   + + +G+  K+  L L  N L G+LP S+GNL++L++     N ++G +PD 
Sbjct:   146 YSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDE 205

Query:   202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
             L +L  +  LG S N F G+FP ++ N+S+L++ +LF + F GSL    G  LP +  L 
Sbjct:   206 LARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELN 265

Query:   262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
             + +N+L G +P +LSN S L+   +N+N  +G +  NF  +P+L  L L  N LG+ T  
Sbjct:   266 LGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFG 325

Query:   322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
             DL+FI  LTNC+ L  L + + R GGALP SIAN+ST +  + + GN   G+IP +I NL
Sbjct:   326 DLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNL 385

Query:   382 FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
               L  L L  N LTG +P ++G+L  L  L L  N + G IP  IGNLT L +L L  N 
Sbjct:   386 IGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNS 445

Query:   442 LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN 501
              +G +P  LGKC +++ L    NKLNGT+P +I  I TL  L  +  N LSGS+P ++G+
Sbjct:   446 FEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNL-SMEGNSLSGSLPNDIGS 504

Query:   502 LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
             L++LV+L +  N FS  +P TL  C  +E L +QGNSF+G+IP ++  L  ++ +DLS N
Sbjct:   505 LQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDLSNN 563

Query:   562 NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLP 621
             +LSG IP +  N   LEYLNLS N+F GKVP KG F N T + + GN+  CGG+ +L L 
Sbjct:   564 DLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLK 623

Query:   622 ACHSVGPRKET---ITLLKVVIPV-IGTKL 647
              C +  P  ET     L KV I V IG  L
Sbjct:   624 PCLAQEPPVETKHSSHLKKVAILVSIGIAL 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1282 (456.3 bits), Expect = 6.9e-206, Sum P(2) = 6.9e-206
 Identities = 272/615 (44%), Positives = 382/615 (62%)

Query:    39 VTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSF 98
             V  SWN+S   C W GVTCG R +RV  L+L    + G +SP IGNLSFLR++NLA+NSF
Sbjct:    50 VLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSF 109

Query:    99 HGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL 158
                IP++VGRLFRL+ + +S N   G+IP++LS C  L    + +N+L   + + +G+  
Sbjct:   110 GSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLS 169

Query:   159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
             K+  L L  N LTG  P S+GNL++LQ  D A N++ G IPD + +L  + +   + N F
Sbjct:   170 KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229

Query:   219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
             SG FP ++ NISSL+   L  N F G+L    G+ LP L  L++  N  TG +P++L+N 
Sbjct:   230 SGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANI 289

Query:   279 SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKL 338
             S LE  +++ N+ SG + ++F  L NL  L +  N+LG  +S+ L+FI  + NC++L  L
Sbjct:   290 SSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYL 349

Query:   339 GLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTI 398
              + +NR GG LP SIANLSTT+T + +  N ISGTIP +I NL +L  L LE N L+G +
Sbjct:   350 DVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGEL 409

Query:   399 PPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQ 458
             P + G+L NLQ + L  N I G IP   GN+T L  L L  N   G IP  LG+C+ L+ 
Sbjct:   410 PVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLD 469

Query:   459 LSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNE 518
             L    N+LNGT+P +I  I +L+  +DLS N L+G  P EVG L+ LV L  S N  S +
Sbjct:   470 LWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528

Query:   519 IPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLE 578
             +P  +  C ++E+L MQGNSF+G+IP  ++ L S+K +D S NNLSG+IP +L +LP L 
Sbjct:   529 MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587

Query:   579 YLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACH-SVGPRK-ETITLL 636
              LNLS N FEG+VP  GVF N T +S+ GN   CGG+ E+ L  C     PRK + +++ 
Sbjct:   588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647

Query:   637 KVVIPVIGTKLAHKL 651
             K V+  I   +A  L
Sbjct:   648 KKVVSGICIGIASLL 662

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1213 (432.1 bits), Expect = 1.7e-202, Sum P(2) = 1.7e-202
 Identities = 265/610 (43%), Positives = 367/610 (60%)

Query:    42 SWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQ 101
             +WNNS  LC W  V CG +H+RVT+LDL    +GG +SP IGNLSFL  ++L+NNSF G 
Sbjct:    46 AWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGT 105

Query:   102 IPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIE 161
             IP+E+G LFRL+ + +  N   G+IP +LS C  L+   + +NNL   + + +G+  K+ 
Sbjct:   106 IPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLL 165

Query:   162 RLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGM 221
              L L  N L G+ P  I NL++L   ++  N L+G IPD +  L  +  L  + N+FSG+
Sbjct:   166 YLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGV 225

Query:   222 FPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKL 281
             FP +  N+SSL+  YL  N F G+L    G  LP +  L +  N LTG +P +L+N S L
Sbjct:   226 FPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTL 285

Query:   282 EWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLV 341
             E   + +N  +G +  NF  L NL  L L  N+LG+ +  DL F+  LTNCS L  L + 
Sbjct:   286 EMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVS 345

Query:   342 FNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPA 401
             +NR GGALP SI N+ST +T++ + GN I G+IP +I NL  L  L L  N LTG +P +
Sbjct:   346 YNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTS 405

Query:   402 IGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSA 461
             +G L  L  L L  N   G IP  IGNLT L  L L  N  +G +P  LG C +++ L  
Sbjct:   406 LGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQI 465

Query:   462 PNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPV 521
               NKLNGT+P +I  I TL  L ++  N LSGS+P ++G L++LV+L +  NN S  +P 
Sbjct:   466 GYNKLNGTIPKEIMQIPTLVHL-NMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQ 524

Query:   522 TLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLN 581
             TL  C ++E + +Q N F+G+IP  +  L  +K +DLS NNLSG I  +  N   LEYLN
Sbjct:   525 TLGKCLSMEVIYLQENHFDGTIPD-IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLN 583

Query:   582 LSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETI--TLLK-V 638
             LS N+FEG+VP +G+F N T +S+ GN+  CG + EL L  C +  P  ET   +LLK V
Sbjct:   584 LSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKV 643

Query:   639 VIPV-IGTKL 647
              I V +G  L
Sbjct:   644 AIGVSVGIAL 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1547 (549.6 bits), Expect = 8.6e-159, P = 8.6e-159
 Identities = 345/791 (43%), Positives = 478/791 (60%)

Query:    24 ATVTFNMQQLHDPLGVTKSWNNSIN--LCQWTGVTCGHRHQR----VTKLDLESQNIGGF 77
             A ++F    L+       SWN S +   C W GV CG R +R    V KL L S N+ G 
Sbjct:    35 ALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNLSGI 94

Query:    78 LSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLI 137
             +SP +GNLSFLR ++L +N   G+IP E+ RL RL+ + LS+NS  G IP  +  C  L 
Sbjct:    95 ISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLT 154

Query:   138 DFWVHTNNLVGEIQAIIGNWLK-IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDG 196
                +  N L G I   IG  LK +  L LY N L+G++P ++GNL++LQ FD++ N+L G
Sbjct:   155 SLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSG 214

Query:   197 RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPK 256
              IP SLGQL +L  +   +N+ SGM P S+ N+SSL    + +N+  G +P      L  
Sbjct:   215 AIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHL 274

Query:   257 LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG 316
             L V+ +  N   G +P S++NAS L  +++  N FSG +   F  L NL++LYL RN   
Sbjct:   275 LEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQ 334

Query:   317 TRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPP 376
             TR   D  FI+ LTNCSKL  L L  N  GG LP+S +NLST+++ +A+  N+I+G+IP 
Sbjct:   335 TREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPK 394

Query:   377 EIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQ 436
             +I NL  L  L L  N   G++P ++G L+NL  L    NN+ G IP  IGNLT LN+L 
Sbjct:   395 DIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILL 454

Query:   437 LGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIP 496
             LG NK  G IP  L    NL+ L    N L+G +P ++F I TLS ++++S+N+L GSIP
Sbjct:   455 LGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIP 514

Query:   497 LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKEL 556
              E+G+LK+LV+     N  S +IP TL  C  L YL +Q N  +GSIP +L  LK ++ L
Sbjct:   515 QEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETL 574

Query:   557 DLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLG 616
             DLS NNLSGQIP  L ++  L  LNLS+N F G+VP  G F+  + IS+ GN + CGG+ 
Sbjct:   575 DLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIP 634

Query:   617 ELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLME---------------QQF 661
             +LHLP C  +   ++   +L + +  +   LA   S  LL+                +  
Sbjct:   635 DLHLPRCCPLLENRKHFPVLPISVS-LAAALAILSSLYLLITWHKRTKKGAPSRTSMKGH 693

Query:   662 PIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLG-EDGMSVAVKVMNLDKKGATKSFVA 720
             P+VSY++L KAT  F+ +N +G GSFG VYKG L  +D   VAVKV+ L+   A KSF A
Sbjct:   694 PLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQD--HVAVKVLKLENPKALKSFTA 751

Query:   721 ECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL 779
             ECEALRN+RHRNL+KI+TICSSID +G DFKAIVY++M  GS++DW+H  TND+ +   L
Sbjct:   752 ECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHL 811

Query:   780 NIVIEVASVIE 790
             N+   V  +++
Sbjct:   812 NLHRRVTILLD 822

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 833 (298.3 bits), Expect = 2.4e-127, Sum P(2) = 2.4e-127
 Identities = 206/561 (36%), Positives = 287/561 (51%)

Query:    34 HDPLGVTKSWN--NSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVI 91
             +DPLGV   W    S+  C WTG+TC      V+   LE Q + G LSP I NL++L+V+
Sbjct:    43 NDPLGVLSDWTIIGSLRHCNWTGITCDSTGHVVSVSLLEKQ-LEGVLSPAIANLTYLQVL 101

Query:    92 NLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQ 151
             +L +NSF G+IP E+G+L  L  ++L  N FSG IP+ +    N+    +  N L G++ 
Sbjct:   102 DLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFYLDLRNNLLSGDVP 161

Query:   152 AIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYL 211
               I     +  +    N LTG++P  +G+L  LQ F  AGN L G IP S+G L NL  L
Sbjct:   162 EEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDL 221

Query:   212 GTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL 271
               S N  +G  P    N+ +L    L +N  +G +P  +G N   L  L +  N LTG +
Sbjct:   222 DLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIG-NCSSLVQLELYDNQLTGKI 280

Query:   272 PQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTN 331
             P  L N  +L+ L + +N  +  +  +   L  L+ L L  N+L    S ++ F+     
Sbjct:   281 PAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFL----- 335

Query:   332 CSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEY 391
                L  L L  N F G  P SI NL   +T++ +  N ISG +P ++  L NL  L    
Sbjct:   336 -ESLEVLTLHSNNFTGEFPQSITNLRN-LTVLTVGFNNISGELPADLGLLTNLRNLSAHD 393

Query:   392 NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLG 451
             N LTG IP +I     L+ L L  N + G IP   G + L   + +G N   G IP  + 
Sbjct:   394 NLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNL-TFISIGRNHFTGEIPDDIF 452

Query:   452 KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDIS 511
              C NL  LS  +N L GTL P I  +  L ++L +S N L+G IP E+GNLK L  L + 
Sbjct:   453 NCSNLETLSVADNNLTGTLKPLIGKLQKL-RILQVSYNSLTGPIPREIGNLKDLNILYLH 511

Query:   512 RNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHL 571
              N F+  IP  +S  T L+ L M  N   G IP+ +  +K +  LDLS N  SGQIP   
Sbjct:   512 SNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALF 571

Query:   572 GNLPFLEYLNLSYNHFEGKVP 592
               L  L YL+L  N F G +P
Sbjct:   572 SKLESLTYLSLQGNKFNGSIP 592

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 727 (261.0 bits), Expect = 3.9e-125, Sum P(2) = 3.9e-125
 Identities = 200/594 (33%), Positives = 305/594 (51%)

Query:   104 KEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLK-IER 162
             KE  ++  L+   +S     G+I  +++    L    +  N  VG+I   IG+  + +++
Sbjct:    63 KESTQVIELD---ISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQ 119

Query:   163 LSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSL---GQLRNLNYLGTSENDFS 219
             LSL  N L G +P  +G L+ L   D+  N+L+G IP  L   G   +L Y+  S N  +
Sbjct:   120 LSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLT 179

Query:   220 GMFPLSV-CNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLP-QSLSN 277
             G  PL+  C++  L    L+ N+  G++P  L  N   L  + +  N L+G LP Q +S 
Sbjct:   180 GEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLS-NSTNLKWMDLESNMLSGELPSQVISK 238

Query:   278 ASKLEWLELNENHF-SGQVRIN----FNSLPN---LSKLYLGRNNLGTRTSTDLDFITLL 329
               +L++L L+ NHF S     N    F SL N   L +L L  N+LG   ++ +  +++ 
Sbjct:   239 MPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSV- 297

Query:   330 TNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGL 389
                  LV++ L  NR  G++P  I+NL   +TL+ ++ N +SG IP E+  L  L  + L
Sbjct:   298 ----NLVQIHLDQNRIHGSIPPEISNL-LNLTLLNLSSNLLSGPIPRELCKLSKLERVYL 352

Query:   390 EYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY 449
               N LTG IP  +G++  L  L +  NN+ G IPD  GNL+ L  L L  N L G++P  
Sbjct:   353 SNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQS 412

Query:   450 LGKCQNLMQLSAPNNKLNGTLPPQIFG-ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQL 508
             LGKC NL  L   +N L GT+P ++   +  L   L+LS NHLSG IPLE+  +  ++ +
Sbjct:   413 LGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSV 472

Query:   509 DISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIP 568
             D+S N  S +IP  L +C  LE+L +  N F+ ++P SL  L  +KELD+S N L+G IP
Sbjct:   473 DLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIP 532

Query:   569 IHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGP 628
                     L++LN S+N   G V  KG FS  T  S  G+   CG +  +   AC     
Sbjct:   533 PSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKK--K 588

Query:   629 RKETITLLKVVIPVIGTKLAHKLSSALLMEQQFP--IVSYAELSKATKEFSSSN 680
              K    LL V++ +I T +       L+   +F   +  YA+     +E  + N
Sbjct:   589 HKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQN 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)]

 Score = 845 (302.5 bits), Expect = 5.1e-121, Sum P(2) = 5.1e-121
 Identities = 240/674 (35%), Positives = 342/674 (50%)

Query:    24 ATVTFNMQQLHDPLGVTKSWNNSINL--CQWTGVTCGHRHQRVTKLDLESQNIGGFLSPY 81
             A   F +  LHDPLG   SW+ S     C W GV C + H RVT++ L    + G +S  
Sbjct:    31 ALTAFKLN-LHDPLGALTSWDPSTPAAPCDWRGVGCTN-H-RVTEIRLPRLQLSGRISDR 87

Query:    82 IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
             I  L  LR ++L +NSF+G IP  +    RL ++ L  NS SGK+P  +    +L  F V
Sbjct:    88 ISGLRMLRKLSLRSNSFNGTIPTSLAYCTRLLSVFLQYNSLSGKLPPAMRNLTSLEVFNV 147

Query:   142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
               N L GEI   +G    ++ L +  N  +GQ+P  + NL+ LQ  +++ N+L G IP S
Sbjct:   148 AGNRLSGEIP--VGLPSSLQFLDISSNTFSGQIPSGLANLTQLQLLNLSYNQLTGEIPAS 205

Query:   202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
             LG L++L YL    N   G  P ++ N SSL      +N   G +P   G  LPKL VL 
Sbjct:   206 LGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSASENEIGGVIPAAYGA-LPKLEVLS 264

Query:   262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVR--INFNSLPNLSKLYLGRNNLGTRT 319
             ++ NN +G +P SL   + L  ++L  N FS  VR     N    L  L L  N +  R 
Sbjct:   265 LSNNNFSGTVPFSLFCNTSLTIVQLGFNAFSDIVRPETTANCRTGLQVLDLQENRISGR- 323

Query:   320 STDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIR 379
                  F   LTN   L  L +  N F G +P  I NL     L  +A N ++G IP EI+
Sbjct:   324 -----FPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLKRLEEL-KLANNSLTGEIPVEIK 377

Query:   380 NLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGF 439
                +L+ L  E N L G IP  +G ++ L+ L L  N+  G +P  + NL  L  L LG 
Sbjct:   378 QCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQLERLNLGE 437

Query:   440 NKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV 499
             N L GS P  L    +L +L    N+ +G +P  I  ++ LS  L+LS N  SG IP  V
Sbjct:   438 NNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSISNLSNLS-FLNLSGNGFSGEIPASV 496

Query:   500 GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLS 559
             GNL  L  LD+S+ N S E+PV LS    ++ + +QGN+F+G +P+  ++L S++ ++LS
Sbjct:   497 GNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQGNNFSGVVPEGFSSLVSLRYVNLS 556

Query:   560 CNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQFCGGLGEL 618
              N+ SG+IP   G L  L  L+LS NH  G +P + G  S    + L  N      +G  
Sbjct:   557 SNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSALEVLELRSNRL----MG-- 610

Query:   619 HLPACHSVGPRKETITL----LKVVIPVIGTKLAHKLSSALLMEQQFPIV---SYAELSK 671
             H+PA  S  PR + + L    L   IP   ++ +  L+S  L       V   S++ LS 
Sbjct:   611 HIPADLSRLPRLKVLDLGQNNLSGEIPPEISQ-SSSLNSLSLDHNHLSGVIPGSFSGLSN 669

Query:   672 ATK-EFSSSNRIGK 684
              TK + S +N  G+
Sbjct:   670 LTKMDLSVNNLTGE 683

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 777 (278.6 bits), Expect = 2.2e-119, Sum P(2) = 2.2e-119
 Identities = 195/596 (32%), Positives = 309/596 (51%)

Query:    21 VKHATVTFNMQQLHDPLGVTKSWNN-SINLCQWTGVTCGHRHQ-RVTKLDLESQNIGGFL 78
             VK + VT N Q+  DPL   + WN+ +IN C WTGVTC +    RV  L+L    + G +
Sbjct:    33 VKKSLVT-NPQE-DDPL---RQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSI 87

Query:    79 SPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLID 138
             SP+ G    L  ++L++N+  G IP  +  L  LE++ L +N  +G+IP+ L    N+  
Sbjct:    88 SPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRS 147

Query:   139 FWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRI 198
               +  N LVG+I   +GN + ++ L+L   +LTG +P  +G L  +Q+  +  N L+G I
Sbjct:   148 LRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPI 207

Query:   199 PDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLT 258
             P  LG   +L     +EN  +G  P  +  + +L+   L  N   G +P  LG  + +L 
Sbjct:   208 PAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLG-EMSQLQ 266

Query:   259 VLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTR 318
              L +  N L G +P+SL++   L+ L+L+ N+ +G++   F ++  L  L L  N+L   
Sbjct:   267 YLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSG- 325

Query:   319 TSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI 378
              S      +  TN  +LV  G    +  G +P  ++   +   L  ++ N ++G+IP  +
Sbjct:   326 -SLPKSICSNNTNLEQLVLSG---TQLSGEIPVELSKCQSLKQL-DLSNNSLAGSIPEAL 380

Query:   379 RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLG 438
               L  L  L L  N L GT+ P+I  L NLQ+L L  NN+ G +P  I  L  L VL L 
Sbjct:   381 FELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLY 440

Query:   439 FNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLE 498
              N+  G IP  +G C +L  +    N   G +PP I  +  L+ LL L +N L G +P  
Sbjct:   441 ENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELN-LLHLRQNELVGGLPAS 499

Query:   499 VGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDL 558
             +GN   L  LD++ N  S  IP +      LE L++  NS  G++P SL +L+++  ++L
Sbjct:   500 LGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINL 559

Query:   559 SCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQFCG 613
             S N L+G I    G+  +L + +++ N FE ++P + G   N  R+ L G  Q  G
Sbjct:   560 SHNRLNGTIHPLCGSSSYLSF-DVTNNGFEDEIPLELGNSQNLDRLRL-GKNQLTG 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.4507	0.9619	0.9267	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	973
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-125
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-33
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-15
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	4e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	8e-05
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	8e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	9e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  404 bits (1040), Expect = e-125
 Identities = 291/954 (30%), Positives = 469/954 (49%), Gaps = 73/954 (7%)

Query: 33  LHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVIN 92
           ++DPL    +WN+S ++C W G+TC +   RV  +DL  +NI G +S  I  L +++ IN
Sbjct: 41  INDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99

Query: 93  LANNSFHGQIPKEVGRL-FRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQ 151
           L+NN   G IP ++      L  + LSNN+F+G IP         +D  +  N L GEI 
Sbjct: 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLD--LSNNMLSGEIP 157

Query: 152 AIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYL 211
             IG++  ++ L L GN L G++P S+ NL++L+   +A N+L G+IP  LGQ+++L ++
Sbjct: 158 NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217

Query: 212 GTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL 271
               N+ SG  P  +  ++SL+   L  N   G +P  LG NL  L  L + QN L+G +
Sbjct: 218 YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPI 276

Query: 272 PQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTN 331
           P S+ +  KL  L+L++N  SG++      L NL  L+L  NN   +    L      T+
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL------TS 330

Query: 332 CSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEY 391
             +L  L L  N+F G +P ++      +T++ ++ N ++G IP  + +  NL  L L  
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389

Query: 392 NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLG 451
           N L G IP ++G  R+L+ + L  N+  G +P     L L+  L +  N LQG I S   
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449

Query: 452 KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDIS 511
              +L  LS   NK  G LP   FG   L  L DLS N  SG++P ++G+L  L+QL +S
Sbjct: 450 DMPSLQMLSLARNKFFGGLP-DSFGSKRLENL-DLSRNQFSGAVPRKLGSLSELMQLKLS 507

Query: 512 RNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHL 571
            N  S EIP  LS+C  L  L +  N  +G IP S + +  + +LDLS N LSG+IP +L
Sbjct: 508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567

Query: 572 GNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKE 631
           GN+  L  +N+S+NH  G +P  G F      ++ GN   CGG     LP C  V   ++
Sbjct: 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV---RK 624

Query: 632 TITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAEL----------------SKATKE 675
           T +    +   +G  L   L +   +  +       EL                SK +K 
Sbjct: 625 TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL--ELKRVENEDGTWELQFFDSKVSKS 682

Query: 676 FS---------SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALR 726
            +           N I +G  G  YKG   ++GM   VK +N D      S +A+   + 
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MG 738

Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
            ++H N++K+I +C S   KGA    +++EY++  ++ + L + + +    +  I I +A
Sbjct: 739 KLQHPNIVKLIGLCRS--EKGA---YLIHEYIEGKNLSEVLRNLSWER---RRKIAIGIA 790

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + +LH  C P +V G+L P  +++D     H+              L  P    +  +
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-------------LSLPGLLCTDTK 837

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP 906
              +  Y+ PE     D++   D+Y FG++L+E+ T + P D  F    ++  +A+    
Sbjct: 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897

Query: 907 KKVMGI-VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
              + + +DPS+  +    S  +  +V V+   + C+   P+ R     V+K L
Sbjct: 898 DCHLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  148 bits (376), Expect = 1e-40
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNLIKIITIC 740
           +G+G FG VY     + G  VA+K++  +   +     + E E L+ + H N++K+  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVASVIEYLHNHCQPP 799
              +        +V EY + GS+ D L     KL     L I++++   +EYLH++    
Sbjct: 61  EDENHLY-----LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---G 112

Query: 800 IVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
           I+H DLKP N+LLD D     ++DFGL++ L+    L           + GT  Y+ PE 
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--------LKTIVGTPAYMAPEV 164

Query: 859 GMG-GDLSMTGDVYSFGILLLEM 880
            +G G  S   D++S G++L E+
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  144 bits (365), Expect = 1e-38
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 20/219 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+GSFG VY     + G  VA+KV+   K K   +  + E + L+ ++H N++++  + 
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQPP 799
               F+  D   +V EY + G + D L     +L E      + ++ S +EYLH+     
Sbjct: 66  ----FEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG--- 117

Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           IVH DLKP N+LLD D    ++DFGLAR L     L             GT  Y+ PE  
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---------TTFVGTPEYMAPEVL 168

Query: 860 MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
           +G       D++S G++L E+ T + P            
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK 207

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  129 bits (328), Expect = 1e-33
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 26/211 (12%)

Query: 682 IGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNL 733
           +G+G+FG VYKG L          VAVK +   K+GA+    + F+ E   ++ + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVASVIEYL 792
           ++++ +C+    +G     IV EYM  G + D+L    +KL +   L + +++A  +EYL
Sbjct: 64  VRLLGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
            +      VH DL   N L+  ++V  +SDFGL+R +    +     G       K  I 
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG------GKLPIK 169

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
           ++ PE    G  +   DV+SFG+LL E+FT 
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (323), Expect = 5e-33
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 18/213 (8%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
            F    +IGKG FG VYK      G  VA+KV+ L+ K   +  + E + L+  +H N++
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLH 793
           K      S   K  D   IV E+   GS+ D L  TN  L   ++  V  E+   +EYLH
Sbjct: 61  KYYG---SYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
           ++    I+H D+K +N+LL  D    + DFGL+  LS            +   M GT  +
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---------ARNTMVGTPYW 163

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           + PE   G       D++S GI  +E+   + P
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  128 bits (323), Expect = 6e-33
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIIT 738
           ++G GSFG VYK      G  VAVK++     K    ++   E   LR + H N++++I 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQ 797
                 F+  D   +V EY + G + D+L      L   +   I +++   +EYLH++  
Sbjct: 66  A-----FEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN-- 117

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H DLKP N+LLD + V  ++DFGLA+ L            SS     GT  Y+ PE
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--------SSSLTTFVGTPWYMAPE 168

Query: 858 -YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
               G       DV+S G++L E+ T + P
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  127 bits (321), Expect = 1e-32
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 27/211 (12%)

Query: 682 IGKGSFGFVYKG----NLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG VYKG      G+  + VAVK +  D  +   + F+ E   +R + H N++K+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNH 795
           + +C+       +   IV EYM+ G +  +L     KL +  L +  +++A  +EYL + 
Sbjct: 67  LGVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                +H DL   N L+  ++V  +SDFGL+R L    +     G       K  I ++ 
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-------KLPIRWMA 171

Query: 856 PE---YGMGGDLSMTGDVYSFGILLLEMFTR 883
           PE    G     S   DV+SFG+LL E+FT 
Sbjct: 172 PESLKEGKFTSKS---DVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  124 bits (315), Expect = 7e-32
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)

Query: 680 NRIGKGSFGFVYKGNL-GEDGMS--VAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIK 735
            ++G+G+FG VYKG L G+DG +  VAVK +  D     +  F+ E   ++ + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG---------KLNIVIEVA 786
           ++ +C+    +   +  +V EYM+ G + D+L  +                 L+  I++A
Sbjct: 61  LLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             +EYL +      VH DL   N L+  D+V  +SDFGL+R +    +     G    I 
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
                 ++ PE    G  +   DV+SFG+LL E+FT 
Sbjct: 173 ------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (314), Expect = 9e-32
 Identities = 77/289 (26%), Positives = 127/289 (43%), Gaps = 48/289 (16%)

Query: 682 IGKGSFGFVYKG----NLGEDGMSVAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIKI 736
           +G+G+FG VYKG          + VAVK +  D      + F+ E   +R + H N++K+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHN 794
           + +C+       +   IV EYM  G + D+L  +   +L +  L +  +++A  +EYL +
Sbjct: 67  LGVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                 +H DL   N L+  ++V  +SDFGL+R L    +     G       K  I ++
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-------KLPIRWM 171

Query: 855 GPE---YGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHGYAKMALPKKVM 910
            PE    G     S   DV+SFG+LL E+FT    P             Y  M+   +V+
Sbjct: 172 APESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEP-------------YPGMS-NAEVL 214

Query: 911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
                  L +     K   C   + +  + C  E P +R   + +V+ L
Sbjct: 215 -----EYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (302), Expect = 4e-30
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 26/226 (11%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRN 732
           E++    +G+GSFG VY     + G  +AVK + L        ++   E   L +++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVA 786
           +++        +    +   I  EY+  GS+   L       + GKL          ++ 
Sbjct: 61  IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLK------KFGKLPEPVIRKYTRQIL 111

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + YLH++    IVH D+K +N+L+D D V  ++DFG A+ L         E    +  
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG------DIETGEGTGS 162

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
           ++GT  ++ PE   G +     D++S G  ++EM T + P   + N
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (284), Expect = 1e-27
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 23/218 (10%)

Query: 679 SNRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNL 733
             ++G+G FG V            G  VAVK +N   +   +S F  E E LR + H N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +K   +C      G     ++ EY+  GS+ D+L    D++ + +L     ++   ++YL
Sbjct: 69  VKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 793 HN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKG 849
            +       +H DL   N+L++ + +  +SDFGLA+ L      + V   G+S       
Sbjct: 126 GSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP------ 175

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT 887
            I +  PE       S   DV+SFG+ L E+FT   P+
Sbjct: 176 -IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (280), Expect = 3e-27
 Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 19/212 (8%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           +EF+   ++G G FG V++G L ++ + VA+K++  D     + F  E +AL+ +RH++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKL-NIVIEVASVIEY 791
           I +  +CS       +   I+ E M+ GS+  +L     + L V  L ++  +VA  + Y
Sbjct: 65  ISLFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L        +H DL   N+L+  D+V  V+DFGLAR +    +L         I  K T 
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL----SSDKKIPYKWT- 171

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
               PE    G  S   DV+SFGILL EMFT 
Sbjct: 172 ---APEAASHGTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 4e-25
 Identities = 71/220 (32%), Positives = 104/220 (47%), Gaps = 32/220 (14%)

Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN 727
            ++    +  ++  IGKG FG V  G+    G  VAVK +  D   A  +F+AE   +  
Sbjct: 2   AINSKELKLGAT--IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQ-AFLAEASVMTT 56

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL-----HHTNDKLEVGKLNIV 782
           +RH NL++++ +      +G     IV EYM  GS+ D+L               +L   
Sbjct: 57  LRHPNLVQLLGVV----LQGNPL-YIVTEYMAKGSLVDYLRSRGRAVITLA---QQLGFA 108

Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
           ++V   +EYL        VH DL   NVL+  D+VA VSDFGLA+         A +GQ 
Sbjct: 109 LDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--------EASQGQD 157

Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           S    K  + +  PE       S   DV+SFGILL E+++
Sbjct: 158 SG---KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  107 bits (267), Expect = 7e-25
 Identities = 72/223 (32%), Positives = 109/223 (48%), Gaps = 24/223 (10%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRH- 730
            +    ++G+GSFG VY   L  D   VA+KV+      K    + F+ E + L ++ H 
Sbjct: 1   SYRILRKLGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVAS 787
            N++K+        F+      +V EY+  GS++D L     K    E   L I+ ++ S
Sbjct: 58  PNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
            +EYLH+     I+H D+KP N+LLD D  V  + DFGLA+ L       +     S+  
Sbjct: 113 ALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 847 MKGTIGYIGPEYGMGGDL---SMTGDVYSFGILLLEMFTRRRP 886
             GT GY+ PE  +G  L   S + D++S GI L E+ T   P
Sbjct: 170 --GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (252), Expect = 1e-23
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 18/215 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNLIKIITI 739
           +IGKG+FG VYKG L +    VAVK          K  F+ E E L+   H N++K+I +
Sbjct: 2   KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQP 798
           C            IV E +  GS+  +L    ++L V KL  + ++ A+ +EYL +    
Sbjct: 61  CVQ-----KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
             +H DL   N L+  + V  +SDFG++R       +         I +K T     PE 
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWT----APEA 166

Query: 859 GMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
              G  +   DV+S+GILL E F+    P   M N
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 48/222 (21%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIKIITIC 740
           +G+GS G VYK      G   A+K +++D      K  + E + LR+     ++K     
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63

Query: 741 SSIDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIE 790
                 GA +K    +IV EYM  GS+ D L       +VGK+       I  ++   ++
Sbjct: 64  ----CYGAFYKEGEISIVLEYMDGGSLADLLK------KVGKIPEPVLAYIARQILKGLD 113

Query: 791 YLHN--HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           YLH   H    I+H D+KPSN+L++      ++DFG+++ L             ++++  
Sbjct: 114 YLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVL------------ENTLDQC 157

Query: 849 ----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
               GT+ Y+ PE   G   S   D++S G+ LLE    + P
Sbjct: 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 68/223 (30%), Positives = 109/223 (48%), Gaps = 32/223 (14%)

Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLI 734
           IG G FG V +G L   G+  + VA+K +   K G++      F+ E   +    H N+I
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
           ++  + +    K      I+ EYM+ GS+D +L   + K  VG+L  ++  +AS ++YL 
Sbjct: 69  RLEGVVT----KSRPV-MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG---T 850
                  VH DL   N+L++ ++V  VSDFGL+R L         E   ++   KG    
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL---------EDSEATYTTKGGKIP 171

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           I +  PE       +   DV+SFGI++ E+ +   RP  +M N
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLIKIITI 739
           IGKGSFG VY      DG    +K ++L        +  + E + L+ + H N+IK    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIEYL 792
                F+      IV EY   G +         + + GK       L+  +++   ++YL
Sbjct: 67  ----SFEEKGKLCIVMEYADGGDLSQ---KIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H+     I+H D+KP N+ L  + +  + DFG+++ LS    L       + +   GT  
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-----AKTVV---GTPY 168

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Y+ PE       +   D++S G +L E+ T + P
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 29/225 (12%)

Query: 679 SNRIGKGSFGFVYKG-NLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIK 735
            N+IG G+FG VY   NL + G  +AVK + +        K    E + L  ++H NL+K
Sbjct: 5   GNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 736 IITICSSIDFKGADFK----AIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIE 790
                    + G +       I  EY   G++++ L H       V ++   +++   + 
Sbjct: 64  ---------YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLA 113

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YLH+H    IVH D+KP+N+ LDH+ V  + DFG A  L ++   +  E QS    + GT
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGT 166

Query: 851 IGYIGPEYGMGGDLSMTG---DVYSFGILLLEMFTRRRPTDNMFN 892
             Y+ PE   GG     G   D++S G ++LEM T +RP   + N
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V+ G        VAVK +   K G    ++F+ E + ++ +RH  L+++  
Sbjct: 13  KLGAGQFGEVWMG-TWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           +CS       +   IV EYM  GS+ D+L      KL + +L ++  ++A  + YL    
Sbjct: 69  VCS-----EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--- 120

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               +H DL   N+L+  ++V  ++DFGLAR       L+  +  ++    K  I +  P
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLAR-------LIEDDEYTAREGAKFPIKWTAP 173

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 24/217 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V++G L  +   VAVK +   K G    K F+AE + ++ +RH  LI++  
Sbjct: 13  KLGAGQFGEVWEG-LWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           +C+       +   IV E M+YGS+ ++L       L++ +L ++  +VAS + YL    
Sbjct: 69  VCTL-----EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ- 122

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               +H DL   NVL+  + +  V+DFGLAR +    +        +    K  I +  P
Sbjct: 123 --NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-------EAREGAKFPIKWTAP 173

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E  +    S+  DV+SFGILL E+ T  R P   M N
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 18/210 (8%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   ++ I+H NL+
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLV 65

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYL 792
           +++ +C+    +   F  I+ E+M YG++ D+L   N +    V  L +  +++S +EYL
Sbjct: 66  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
                   +H DL   N L+  + +  V+DFGL+R ++   +  A  G       K  I 
Sbjct: 121 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGA------KFPIK 170

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV++FG+LL E+ T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.3 bits (243), Expect = 5e-22
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 21/220 (9%)

Query: 662 PIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAE 721
            IVS  +  +  K      +IG+G+ G VYK      G  VA+K M L K+   +  + E
Sbjct: 10  DIVSEGDPRELYKNLE---KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINE 65

Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI 781
              +++ +H N++       S       +  +V EYM  GS+ D +     ++   ++  
Sbjct: 66  ILIMKDCKHPNIVDYY---DSYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAY 120

Query: 782 VI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           V  EV   +EYLH+     ++H D+K  N+LL  D    ++DFG A  L+        + 
Sbjct: 121 VCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--------KE 169

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           +S    + GT  ++ PE     D     D++S GI+ +EM
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 96.2 bits (239), Expect = 5e-22
 Identities = 72/214 (33%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      IGKG FG V  G+    G  VAVK +  D     ++F+AE   +  +RH NL
Sbjct: 6   KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNL 61

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEY 791
           ++++ +   ++ KG  +  IV EYM  GS+ D+L      +  G   L   ++V   +EY
Sbjct: 62  VQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L  +     VH DL   NVL+  D VA VSDFGL +           E  S+    K  +
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPV 163

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR 885
            +  PE       S   DV+SFGILL E+++  R
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 50/230 (21%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRHRN 732
            +   + IG+G+FG VYKG   E G  VA+K ++L   K+ A KS + E + L+N++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN---IVIEVASVI 789
           ++K I        + +D   I+ EY + GS+   +         G      + + V  V+
Sbjct: 61  IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKF------GPFPESLVAVYVYQVL 109

Query: 790 E---YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS--HH--------PFLV 836
           +   YLH      ++H D+K +N+L   D V  ++DFG+A  L+            P+ +
Sbjct: 110 QGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM 166

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           APE     IEM G               S   D++S G  ++E+ T   P
Sbjct: 167 APE----VIEMSG--------------ASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 28/212 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IGKG+FG V      +     A+K MN     +KG+ ++ + E   L+ + H  L+ +  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL-- 65

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL----EVGKLNIVIEVASVIEYLHN 794
              S  F+  +   +V + +  G   D  +H + K+    E  K   + E+   +EYLH+
Sbjct: 66  -WYS--FQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKF-WICEIVLALEYLHS 118

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                I+H D+KP N+LLD     H++DF +A  ++           + +    GT GY+
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT---------PDTLTTSTSGTPGYM 166

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            PE       S+  D +S G+   E    +RP
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 25/224 (11%)

Query: 674 KEFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRH 730
            E +    +G G FG V+ G   G+    VA+K++   ++GA     F+ E + +  + H
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKI--DVAIKMI---REGAMSEDDFIEEAKVMMKLSH 58

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVI 789
            NL+++  +C+    +   F  IV EYM  G + ++L     KL     L++  +V   +
Sbjct: 59  PNLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           EYL ++     +H DL   N L+  D V  VSDFGLAR+       V  +  +SS   K 
Sbjct: 114 EYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY-------VLDDQYTSSQGTKF 163

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            + +  PE       S   DV+SFG+L+ E+F+  + P +   N
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 7e-21
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 31/214 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V      + G   A+KV+    + K+   +  + E   L  I H  ++K   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
             +   F+  +   +V EY   G   +   H +   + G+ +         E+   +EYL
Sbjct: 59  HYA---FQTEEKLYLVLEYAPGG---ELFSHLS---KEGRFSEERARFYAAEIVLALEYL 109

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H+     I++ DLKP N+LLD D    ++DFGLA+ LS          ++++    GT  
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------RTNTFC--GTPE 158

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Y+ PE  +G       D +S G+LL EM T + P
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 85/283 (30%), Positives = 126/283 (44%), Gaps = 48/283 (16%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            IG+G FG V +G     G  VAVK +  D     ++F+ E   +  + H+NL++++ + 
Sbjct: 13  IIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGV- 67

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVASVIEYLHNHCQ 797
             I   G     IV E M  G++ ++L  T  +  V     L   ++VA  +EYL +   
Sbjct: 68  --ILHNGL---YIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDVAEGMEYLESK-- 119

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             +VH DL   N+L+  D VA VSDFGLAR        V   G  +S   K  + +  PE
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLAR--------VGSMGVDNS---KLPVKWTAPE 167

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
                  S   DV+S+G+LL E+F+  R P             Y KM+L K+V   V+  
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAP-------------YPKMSL-KEVKECVEKG 213

Query: 917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
             ME       E C   V     +C    P +R     + +KL
Sbjct: 214 YRMEPP-----EGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 3e-20
 Identities = 59/212 (27%), Positives = 112/212 (52%), Gaps = 24/212 (11%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKII 737
            +IG+G++G VYK    + G  VA+K + ++  K+G   + + E + L+ +RH N++++ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDW---LHHTNDKLEVGKLN-IVIEVASVIEYLH 793
            I +S   KG+ +  +V+EYM +    D    L     K    ++   + ++   ++YLH
Sbjct: 65  EIVTS-KGKGSIY--MVFEYMDH----DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
           ++    I+H D+K SN+L+++D V  ++DFGLAR  +      + +  +  I    T+ Y
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---SADYTNRVI----TLWY 167

Query: 854 IGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
             PE  +G        D++S G +L E+F  +
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.5 bits (224), Expect = 6e-20
 Identities = 67/218 (30%), Positives = 117/218 (53%), Gaps = 27/218 (12%)

Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 13  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 67

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNH 795
            + S       +   IV EYM  GS+ D+L       L + +L ++  ++AS + Y+   
Sbjct: 68  AVVSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 119

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFPIKWTA 171

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 89.9 bits (224), Expect = 1e-19
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEAL-RNIRHRNLIKII 737
           IG+GSF  V      E     A+K+++   L K+   K    E E L R   H  +IK+ 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEY 791
                  F+  +    V EY   G   + L +       G L+         E+   +EY
Sbjct: 69  YT-----FQDEENLYFVLEYAPNG---ELLQYIRK---YGSLDEKCTRFYAAEILLALEY 117

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK--- 848
           LH+     I+H DLKP N+LLD DM   ++DFG A+ L  +    + +G +++I+ +   
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 849 ---------GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                    GT  Y+ PE         + D+++ G ++ +M T + P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 23/222 (10%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRN 732
           E +    IG G FG V+ G   E    VA+K +   ++GA   + F+ E + +  + H  
Sbjct: 5   ELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPK 60

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           L+++  +C     + +    +V+E+M++G + D+L     K     L  + ++V   + Y
Sbjct: 61  LVQLYGVC----TERSPI-CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L +     ++H DL   N L+  + V  VSDFG+ RF       V  +  +SS   K  +
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF-------VLDDQYTSSTGTKFPV 165

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 42/225 (18%)

Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G+G+FG V+ G         D   VAVK +       A K F  E E L N +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTND-------KLEVGKLN------I 781
              +C+       D   +V+EYM++G ++ +L  H  D          +G+L       I
Sbjct: 73  FYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
            +++AS + YL +      VH DL   N L+ +D+V  + DFG++R +    +       
Sbjct: 128 AVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY------ 178

Query: 842 SSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                + G     I ++ PE  M    +   DV+SFG++L E+FT
Sbjct: 179 ----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 60/238 (25%), Positives = 114/238 (47%), Gaps = 40/238 (16%)

Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGATK---SFVAE 721
           E+  +   F     +G+G+FG VYKG L    E   + +V +  L +    K    F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKLEVGK- 778
            E + +++H N++ ++ +C+           +++EY+ +G + ++L  +  +  +     
Sbjct: 59  AELMSDLQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 779 -------------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 825
                        L+I I++A+ +EYL +H     VH DL   N L+   +   +SDFGL
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGL 170

Query: 826 ARFL-SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +R + S   + V    QS S+     + ++ PE  + G  +   D++SFG++L E+F+
Sbjct: 171 SRDIYSADYYRV----QSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 25/220 (11%)

Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLI 734
           IG G FG V++G L   G   ++VA+K +   K G T+     F++E   +    H N+I
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTL---KPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
           ++  + +   FK A    I+ EYM+ G++D +L   + +    +L  ++  +A+ ++YL 
Sbjct: 70  RLEGVVTK--FKPA---MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
           +      VH DL   N+L++ ++   VSDFGL+R L        PEG  ++   K  I +
Sbjct: 125 DM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD-----PEGTYTTSGGKIPIRW 176

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
             PE       +   DV+SFGI++ E+ +   RP  +M N
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 66/217 (30%), Positives = 113/217 (52%), Gaps = 25/217 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V+ G    +   VAVK +   K G  + +SF+ E + ++ +RH  L+++  
Sbjct: 13  KLGNGQFGEVWMGTWNGN-TKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKL-NIVIEVASVIEYLHNHC 796
           + S           IV EYM  GS+ D+L     + L++  L ++  +VA+ + Y+    
Sbjct: 69  VVSEEPI------YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--- 119

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +V  ++DFGLAR +  + +  A +G       K  I +  P
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGA------KFPIKWTAP 172

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 63/217 (29%), Positives = 114/217 (52%), Gaps = 25/217 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKIIT 738
           ++G+G FG V+ G        VA+K +   K G    ++F+ E + ++ +RH  L+ +  
Sbjct: 13  KLGQGCFGEVWMGTW-NGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKL-NIVIEVASVIEYLHNHC 796
           + S       +   IV E+M  GS+ D+L   + K L++ +L ++  ++A  + Y+    
Sbjct: 69  VVSE------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--- 119

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+  ++V  ++DFGLAR +  + +  A +G       K  I +  P
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGA------KFPIKWTAP 172

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIKIITI 739
           RIG+G+FG V+ G L  D   VAVK          K+ F+ E   L+   H N++++I +
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV-IEYLHN-HCQ 797
           C+    K   +  IV E +Q G    +L     +L+V +L  ++E A+  +EYL + HC 
Sbjct: 62  CTQ---KQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
              +H DL   N L+    V  +SDFG++R       + A  G    I +K T     PE
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWT----APE 166

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFT 882
               G  S   DV+SFGILL E F+
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 25/217 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V+ G        VA+K +   K+G+   ++F+AE   ++ ++H  L+++  
Sbjct: 13  KLGAGQFGEVWMG-YYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +           I+ EYM+ GS+ D+L      KL + KL ++  ++A  + ++    
Sbjct: 69  VVTQEPI------YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--- 119

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGA------KFPIKWTAP 172

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 2e-17
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 35/215 (16%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G++G VYK    + G  VA+K + LD +  G   + + E   L+ ++H N++K++ 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 739 ICSSIDFKGADFK-AIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           +  +        K  +V+EY     +  +L      L    + +I+ ++   + Y H+H 
Sbjct: 66  VIHTER------KLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG------T 850
              I+H DLKP N+L++ D V  ++DFGLAR                 I ++       T
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFG--------------IPLRTYTHEVVT 161

Query: 851 IGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
           + Y  PE  +G     T  D++S G +  EM T +
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 25/218 (11%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKS-FVAECEALRNIRHRNLIKII 737
             IGKGSFG V K     DG  +  K ++        K   V+E   LR ++H N   I+
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN---IV 62

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDW------LHHTNDKLEVGK-LNIVIEVASVIE 790
                I  +       +Y  M+Y    D              +E      I+ ++   + 
Sbjct: 63  RYYDRIIDRS---NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 791 YLHN--HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
             HN       ++H DLKP+N+ LD +    + DFGLA+ L H           + +   
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-----KTYV--- 171

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT  Y+ PE           D++S G L+ E+     P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.3 bits (206), Expect = 6e-17
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 28/219 (12%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA-ECEALRNIRHRNL 733
           E    NRIG G+ G VYK      G   A+KV+  + +   +  +  E E LR++ H N+
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           +K    C  +     + + ++ E+M  GS++    H  D+  +   ++  ++ S I YLH
Sbjct: 135 VK----CHDMFDHNGEIQ-VLLEFMDGGSLEG--THIADEQFLA--DVARQILSGIAYLH 185

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                 IVH D+KPSN+L++      ++DFG++R L+        +  +SS+   GTI Y
Sbjct: 186 RR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ-----TMDPCNSSV---GTIAY 234

Query: 854 IGPEYGMGGDLS------MTGDVYSFGILLLEMFTRRRP 886
           + PE  +  DL+        GD++S G+ +LE +  R P
Sbjct: 235 MSPER-INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 23/229 (10%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + +  + H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHE 59

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   +  IV EYM  G + ++L     + +  +L  +  +V   + 
Sbjct: 60  KLVQLYGVCTK---QRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L+D      VSDFGL+R+       V  +  +SS+  K  
Sbjct: 115 YLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY-------VLDDEYTSSVGSKFP 164

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLH 898
           + +  PE  +    S   DV++FG+L+ E+++  + P +   N      
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 7e-17
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 19/218 (8%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---------KKGATKSFVAECEALRNIRHRN 732
           IG GSFG VY G     G  +AVK + L          K+    +   E   L+ ++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
           +++ +   SS+D   AD   I  EY+  GSV   L++     E    N V ++   + YL
Sbjct: 68  IVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           HN     I+H D+K +N+L+D+     +SDFG+++ L  +       G   S++  G++ 
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ--GSVF 177

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           ++ PE       +   D++S G L++EM T + P  + 
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 42/216 (19%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITI 739
            RIG G++G VYK      G  VA+KV+ L+     +    E   L+  RH N++     
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA---- 64

Query: 740 CSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHN 794
                + G+  +     IV EY   GS+ D    T   L   ++  V  E    + YLH 
Sbjct: 65  -----YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQSSS 844
             +   +H D+K +N+LL  D    ++DFG++  L+            P+ +APE   ++
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE--VAA 174

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           +E KG  GY               D+++ GI  +E+
Sbjct: 175 VERKG--GY-----------DGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 27/218 (12%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           + F    ++G+GS+G VYK    E G  VA+KV+ ++     +  + E   L+      +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYI 60

Query: 734 IKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASV 788
           +K         + G+ FK     IV EY   GSV D +  TN  L E     I+ +    
Sbjct: 61  VK---------YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           +EYLH++     +H D+K  N+LL+ +  A ++DFG++  L+           +    + 
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--------TMAKRNTVI 160

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT  ++ PE       +   D++S GI  +EM   + P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 26/211 (12%)

Query: 682 IGKGSFGFVYKGN---LGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKII 737
           +GKG+FG V       L ++ G  VAVK +        + F  E E L++++H N++K  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI----EYLH 793
            +C S    G     +V EY+ YGS+ D+L    ++L+  KL   +  AS I    EYL 
Sbjct: 72  GVCYS---AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL---LLYASQICKGMEYLG 125

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP--FLVAPEGQSSSIEMKGTI 851
           +      VH DL   N+L++ +    + DFGL + L      + V   G+S        I
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP-------I 175

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S+  DV+SFG++L E+FT
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 57/214 (26%), Positives = 109/214 (50%), Gaps = 21/214 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMS---VAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKI 736
           +G+G FG V +G L +D  S   VAVK M LD    +  + F++E   +++  H N++K+
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 737 ITIC-SSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-----DKLEVGKL-NIVIEVASVI 789
           I +C  +   +      ++  +M++G +  +L ++      +KL +  L   ++++A  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           EYL N      +H DL   N +L  DM   V+DFGL++ +    +    +G+ + + +K 
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY--RQGRIAKMPVK- 180

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
              +I  E       +   DV++FG+ + E+ TR
Sbjct: 181 ---WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 32/224 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK----------KGATKSFVAECEALRNIRHR 731
           IGKG++G VY       G  +AVK + L            K   K+  +E E L+++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE-VASVIE 790
           N+++ +           ++ +I  EY+  GS+   L  T  + E   +    E V   + 
Sbjct: 69  NIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLR-TYGRFEEQLVRFFTEQVLEGLA 122

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YLH+     I+H DLK  N+L+D D +  +SDFG+++  S   +         ++ M+G+
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIY-----DNDQNMSMQGS 173

Query: 851 IGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           + ++ PE    Y  G   S   D++S G ++LEMF  RRP  + 
Sbjct: 174 VFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKIIT 738
             +G G+ G V K      G  +AVK + L+   A  K  + E + L       ++    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV---- 62

Query: 739 ICSSIDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE---VGKLNIVIEVASVIEY 791
                 F GA +     +I  EYM  GS+D  L     ++    +GK  I + V   + Y
Sbjct: 63  -----GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTY 115

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH   +  I+H D+KPSN+L++      + DFG++  L      V    ++      GT 
Sbjct: 116 LHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFV----GTS 163

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            Y+ PE   G D S+  D++S G+ L+E+ T R P
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNLIKIITIC 740
           +GKG+FG V+KG L +D   VAVK    D     K  F++E   L+   H N++K+I +C
Sbjct: 3   LGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHN-HCQP 798
           +           IV E +  G    +L    D+L+  +L    ++ A+ + YL + +C  
Sbjct: 62  TQ-----RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT-IGYIGPE 857
             +H DL   N L+  + V  +SDFG++R           +G  SS  +K   I +  PE
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSR--------QEDDGIYSSSGLKQIPIKWTAPE 164

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFT 882
               G  S   DV+S+GILL E F+
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 31/223 (13%)

Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLI 734
           IG G FG V  G L   G+  + VA+K +   K G T    + F++E   +    H N+I
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTL---KAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 735 K---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
               ++T    +         IV EYM+ GS+D +L   + +  V +L  ++  +AS ++
Sbjct: 69  HLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  
Sbjct: 121 YLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIP 172

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLE-MFTRRRPTDNMFN 892
           I +  PE       +   DV+S+GI++ E M    RP   M N
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 29/223 (13%)

Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLI 734
           IG G FG V +G L   G+  + VA+K +   K G T    + F++E   +    H N+I
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTL---KSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 735 K---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
               ++T    +         I+ E+M+ G++D +L   + +  V +L  ++  +A+ ++
Sbjct: 69  HLEGVVTKSRPV--------MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL    +   VH DL   N+L++ ++V  VSDFGL+RFL       +    +SS+  K  
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT---SDPTYTSSLGGKIP 174

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLE-MFTRRRPTDNMFN 892
           I +  PE       +   DV+S+GI++ E M    RP  +M N
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 33/242 (13%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL----DKKGATKSFVAECEALRNIRHR 731
           F    +IGKG F  VYK     DG  VA+K + +    D K A +  + E + L+ + H 
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK-ARQDCLKEIDLLKQLDHP 62

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT--NDKL--EVGKLNIVIEVAS 787
           N+IK +   S I+    +   IV E    G +   + H     +L  E       +++ S
Sbjct: 63  NVIKYLA--SFIE---NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            +E++H+     I+H D+KP+NV +    V  + D GL RF S           +++  +
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS--------SKTTAAHSL 166

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK 907
            GT  Y+ PE       +   D++S G LL EM   + P    + D + L      +L K
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL-----YSLCK 218

Query: 908 KV 909
           K+
Sbjct: 219 KI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 76/308 (24%), Positives = 135/308 (43%), Gaps = 61/308 (19%)

Query: 682 IGKGSFGFVYKG---NLG--EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG V+     NL   +D M VAVK +      A K F  E E L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKL------------EVG---KLN 780
             +C        D   +V+EYM++G ++ +L  H  D +            E+G    L+
Sbjct: 73  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           I  ++AS + YL +      VH DL   N L+  +++  + DFG++R +    +     G
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV--G 182

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY 900
             + + ++    ++ PE  M    +   DV+SFG++L E+FT                 Y
Sbjct: 183 GHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT-----------------Y 221

Query: 901 AKMALPKKVMGIVDPSLLMEARGPSKFEE----CLVAVVRTGVACSMESPSERMQMTAVV 956
            K    +     +  + ++E     +  E    C   V    + C    P +R+ +  + 
Sbjct: 222 GKQPWFQ-----LSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276

Query: 957 KKLCAVGE 964
           K L A+G+
Sbjct: 277 KILHALGK 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 7e-16
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 24/216 (11%)

Query: 682 IGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VYKG    +G    + VA+KV+  ++    A K  + E   + ++ H ++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHN 794
           ++ IC S          ++ + M  G + D++ +  D +     LN  +++A  + YL  
Sbjct: 74  LLGICLSSQV------QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +VH DL   NVL+       ++DFGLA+ L         E +  +   K  I ++
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD------VDEKEYHAEGGKVPIKWM 178

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDN 889
             E  +    +   DV+S+G+ + E+ T   +P + 
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 7e-16
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 29/219 (13%)

Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIR---HRNL 733
              IG+G++G VYK      G  VA+K   + L ++G   S + E   L+ +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-----LEVGKL-NIVIEVAS 787
           ++++ +C            +V+E+     VD  L     K     L    + +++ ++  
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            +++LH+H    IVH DLKP N+L+  D    ++DFGLAR  S          + +   +
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF---------EMALTSV 166

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             T+ Y  PE  +    +   D++S G +  E+F RRRP
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V+     +    VAVK M   K G  + ++F+AE   ++ ++H  L+K+  
Sbjct: 13  KLGAGQFGEVWMATYNKH-TKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ E+M  GS+ D+L      K  + KL +   ++A  + ++    
Sbjct: 69  VVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--- 119

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           Q   +H DL+ +N+L+   +V  ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGA------KFPIKWTAP 172

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E    G  ++  DV+SFGILL+E+ T  R P   M N
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.1 bits (192), Expect = 9e-16
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 41/273 (15%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V+ G    +   VAVK +   K G  + ++F+ E   ++ ++H  L+++  
Sbjct: 13  KLGAGQFGEVWMG-YYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM  GS+ D+L      K+ + KL +   ++A  + Y+    
Sbjct: 69  VVTK-----EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--- 120

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +NVL+   ++  ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGA------KFPIKWTAP 173

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E    G  ++  DV+SFGILL E+ T                 Y K+  P      V  +
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVT-----------------YGKIPYPGMSNSDVMSA 216

Query: 917 LLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
           L    R P + E C   +      C  E   ER
Sbjct: 217 LQRGYRMP-RMENCPDELYDIMKTCWKEKAEER 248

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 20/208 (9%)

Query: 681 RIGKGSFGFVYKG---NLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKI 736
           ++G GSFG V +G     G   + VAVK +  DK       F+ E   + ++ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHN 794
             +  +          +V E    GS+ D L         +  L +  +++A+ + YL  
Sbjct: 62  YGVVLTHPLM------MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE- 114

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                 +H DL   N+LL  D    + DFGL R L         +       +K    + 
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL-----PQNEDHYVMEEHLKVPFAWC 167

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            PE       S   DV+ FG+ L EMFT
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 36/228 (15%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF---VAECEALRNIRH 730
           K F+    IG GSFG VY          VA+K M+   K + + +   + E   L+ +RH
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 731 RNLIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLH-HTNDKLEVGKLNIVIEV 785
            N         +I++KG   +     +V EY   GS  D L  H     EV    I    
Sbjct: 75  PN---------TIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGA 124

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YLH+H +   +H D+K  N+LL       ++DFG A        LV+P       
Sbjct: 125 LQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS-------LVSPANS---- 170

Query: 846 EMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
              GT  ++ PE  +    G      DV+S GI  +E+  R+ P  NM
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 38/221 (17%)

Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRN 732
           +G+GSFG VY+G       GE    VA+K +N +   A+      F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHH 70

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT---NDKLEVG-------KLNIV 782
           +++++ + S     G     +V E M  G +  +L       +             + + 
Sbjct: 71  VVRLLGVVS----TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 783 IEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
            E+A  + YL         VH DL   N ++  D+   + DFG+ R +    +     G+
Sbjct: 126 AEIADGMAYLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY-RKGGK 180

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    + ++ PE    G  +   DV+SFG++L EM T
Sbjct: 181 GLL-----PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 71/285 (24%), Positives = 116/285 (40%), Gaps = 55/285 (19%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIKIITIC 740
           IG G+   VY      +   VA+K ++L+K   +      E +A+    H N++K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---LEVGKLNIVIEVASVIEYLHNHCQ 797
           S   F   D   +V  Y+  GS+ D +  +  +    E     ++ EV   +EYLH++ Q
Sbjct: 67  S---FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGYI 854
              +H D+K  N+LL  D    ++DFG++  L       A  G  +    K   GT  ++
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASL-------ADGGDRTRKVRKTFVGTPCWM 173

Query: 855 GPE-------YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK 907
            PE       Y          D++SFGI  +E+ T   P             Y+K   P 
Sbjct: 174 APEVMEQVHGYDFK------ADIWSFGITAIELATGAAP-------------YSKYP-PM 213

Query: 908 KVMGIV---DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
           KV+ +    DP  L       K+ +    ++     C  + PS+R
Sbjct: 214 KVLMLTLQNDPPSLETGADYKKYSKSFRKMISL---CLQKDPSKR 255

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 36/222 (16%)

Query: 682 IGKGSFGFVYKG---NL--GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG V+     NL   +D M VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDK--LEVGK------------LNI 781
             +C+           +V+EYM++G ++ +L  H  D   L  G+            L I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 782 VIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
             ++AS + YL + H     VH DL   N L+   +V  + DFG++R +    +     G
Sbjct: 128 ASQIASGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV--G 181

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             + + ++    ++ PE  +    +   D++SFG++L E+FT
Sbjct: 182 GRTMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 21/214 (9%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKV--MNLDKKGATKSFVAECEALRNIRHR 731
            EF   NRIG+G++G VY+      G  VA+K   M+ ++ G   S + E   L N+RH 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQY--GSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           N++++  +      K  D   +V EY +    S+ D +     + +V    +++++   +
Sbjct: 67  NIVELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK--CLMLQLLRGL 121

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           +YLH +    I+H DLK SN+LL       ++DFGLAR        + P+          
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-------- 170

Query: 850 TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFT 882
           T+ Y  PE  +G     T  D+++ G +L E+  
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVM--NLDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           +G+GS+G V K    E G  VA+K    + D K   K  + E   L+ +RH NL+ +I +
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQ 797
                F+      +V+E++ +  +DD   + N  D+  V K   + ++   IE+ H+H  
Sbjct: 69  -----FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK--YLFQILRGIEFCHSH-- 119

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H D+KP N+L+    V  + DFG AR L+      AP       +   T  Y  PE
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLA------AP--GEVYTDYVATRWYRAPE 170

Query: 858 YGMGGDLSMTG--DVYSFGILLLEMFT 882
             + GD       D+++ G L+ EM T
Sbjct: 171 L-LVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 55/212 (25%), Positives = 108/212 (50%), Gaps = 15/212 (7%)

Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
             +IG+G+FG V+K    +    VA+K  +M  +K+G   + + E + L+ ++H N++ +
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIE-VASVIEYLH 793
           I IC +       +K   Y   ++   D    L + N K  + ++  V++ + + + Y+H
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-GTIG 852
            +    I+H D+K +N+L+  D +  ++DFGLAR      F ++   + +    +  T+ 
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLAR-----AFSLSKNSKPNRYTNRVVTLW 188

Query: 853 YIGPEYGMGG-DLSMTGDVYSFGILLLEMFTR 883
           Y  PE  +G  D     D++  G ++ EM+TR
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 77.7 bits (191), Expect = 5e-15
 Identities = 103/376 (27%), Positives = 154/376 (40%), Gaps = 26/376 (6%)

Query: 266 NLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDF 325
                L  +LS+ +  E L  N  H + Q         NL  + + R  L   ++T L  
Sbjct: 3   PAENLLKSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLL 62

Query: 326 ITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLN 385
            + L+    L  L             ++ NL    +L     N++   I   +  L NL 
Sbjct: 63  PSSLSRLLSLDLLSPSGISSLDGSE-NLLNLLPLPSLDLN-LNRLRSNISE-LLELTNLT 119

Query: 386 GLGLEYNQLTGTIPPAIGEL-RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
            L L+ N +T  IPP IG L  NL+ L L  N I   +P P+ NL  L  L L FN L  
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKS 504
            +P  L    NL  L    NK++  LPP+I  ++ L + LDLS N +   +   + NLK+
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE-LDLSNNSII-ELLSSLSNLKN 233

Query: 505 LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS 564
           L  L++S NN   ++P ++   + LE L +  N    S   SL +L +++ELDLS N+LS
Sbjct: 234 LSGLELS-NNKLEDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLS 290

Query: 565 GQIPIHLG--NLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPA 622
             +P+      L  L    L             + +N                GE   P 
Sbjct: 291 NALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNI-----------LSNGETSSPE 339

Query: 623 CHSVGPRKETITLLKV 638
             S+      +  L  
Sbjct: 340 ALSILESLNNLWTLDN 355

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 78.7 bits (194), Expect = 6e-15
 Identities = 41/93 (44%), Positives = 58/93 (62%)

Query: 384 LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
           ++GLGL+   L G IP  I +LR+LQ + L GN+IRG IP  +G++T L VL L +N   
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 444 GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFG 476
           GSIP  LG+  +L  L+   N L+G +P  + G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512

Length = 623

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.7 bits (186), Expect = 8e-15
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 682 IGKGSFGFV----YKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G FG V    Y       G  VAVK +  +  +  T  +  E   L+ + H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE-VASVIEYLHNH 795
              CS    +G     ++ EY+  GS+ D+L     KL + +L +  + +   + YLH+ 
Sbjct: 72  KGCCSE---QGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKGTIGY 853
                +H DL   NVLLD+D +  + DFGLA+ +   H  + V  +G S        + +
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-------VFW 176

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
              E       S   DV+SFG+ L E+ T 
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 21/207 (10%)

Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY+G   +   + ++VAVK        +  + F+ E   +R   H +++K+I
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHC 796
            + +       +   IV E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 74  GVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK- 126

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+       + DFGL+R+L    +  A +G       K  I ++ P
Sbjct: 127 --RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-------KLPIKWMAP 177

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR 883
           E       +   DV+ FG+ + E+   
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 16/155 (10%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIIT 738
           RIG+G+ G V+K    E G +VA+K + L +   G     + E +AL+  +H  ++K++ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVASVIEYLHNH 795
           +       G+ F  +V EYM    + + L      L   +V     ++     + Y+H +
Sbjct: 67  VFP----HGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKG--VAYMHAN 118

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
               I+H DLKP+N+L+  D V  ++DFGLAR  S
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFS 150

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 22/235 (9%)

Query: 656 LMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           ++E+   IVS   +    K+++   +IG+G+ G VY       G  VA+K MNL ++   
Sbjct: 4   ILEKLRTIVS---VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK 60

Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
           +  + E   +R  +H N++  +       +   D   +V EY+  GS+ D +  T   ++
Sbjct: 61  ELIINEILVMRENKHPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV--TETCMD 113

Query: 776 VGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
            G++  V  E    +E+LH++    ++H D+K  N+LL  D    ++DFG    ++    
Sbjct: 114 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---- 166

Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
              PE QS    M GT  ++ PE           D++S GI+ +EM     P  N
Sbjct: 167 ---PE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.6 bits (187), Expect = 1e-14
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 38/219 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNL---DKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IG G++G V        G  VA+K ++    D   A K  + E + LR++RH N+I ++ 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA-KRILREIKLLRHLRHENIIGLLD 66

Query: 739 ICSSIDFKGADFKA--IVYEYMQYGSVDDWLH---HTNDKLEVGKLN-IVIEVASVIEYL 792
           I         DF    IV E M+    D  LH    +   L    +   + ++   ++YL
Sbjct: 67  I--LRPPSPEDFNDVYIVTELME---TD--LHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119

Query: 793 H--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG- 849
           H  N     ++H DLKPSN+L++ +    + DFGLAR +                 +   
Sbjct: 120 HSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE--------DEKGFLTEY 166

Query: 850 --TIGYIGPEYGMGGDLSMTG--DVYSFGILLLEMFTRR 884
             T  Y  PE  +      T   D++S G +  E+ TR+
Sbjct: 167 VVTRWYRAPEL-LLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 11/204 (5%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           I KG++G V+       G   A+KV+    + +K      + E + L   +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
             S   F+G     +V EY+  G +   L +     E      + E+   +EYLH++   
Sbjct: 60  -YS---FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN--- 112

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            I+H DLKP N+L+D +    ++DFGL++       +   + +     + GT  YI PE 
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 859 GMGGDLSMTGDVYSFGILLLEMFT 882
            +G   S T D +S G +L E   
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 56/226 (24%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK---SFVA--ECEALRNIRHRNLIKI 736
           +G+G++  VYK    E G  VA+K + L ++   K   +F A  E + L+ ++H N+I +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV-------- 788
           + +     F       +V+E+M+     D      DK      +IV+  A +        
Sbjct: 68  LDV-----FGHKSNINLVFEFMET----DLEKVIKDK------SIVLTPADIKSYMLMTL 112

Query: 789 --IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF-------LSHHPFLVAPE 839
             +EYLH++    I+H DLKP+N+L+  D V  ++DFGLAR        ++H        
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV----- 164

Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
                     T  Y  PE   G      G D++S G +  E+  R 
Sbjct: 165 ----------TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR------HRNLI 734
           +IG+G++G VYK      G  VA+K + L      +S      ALR I+      H N+I
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLR----FESEGIPKTALREIKLLKELNHPNII 61

Query: 735 KIITICSSIDFKGADFKAIVYEYMQ---YGSVDDW-LHHTNDKLEVGKLNIVIEVASVIE 790
           K++ +     F+      +V+E+M    Y  + D         ++    + + ++   + 
Sbjct: 62  KLLDV-----FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK----SYLYQLLQGLA 112

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           + H+H    I+H DLKP N+L++ + V  ++DFGLAR                      T
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY--------VVT 161

Query: 851 IGYIGPE--YGMGGDLSMTGDVYSFGILLLEMFTRR 884
             Y  PE   G  G  S   D++S G +  E+ +RR
Sbjct: 162 RWYRAPELLLGDKG-YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 74/257 (28%), Positives = 125/257 (48%), Gaps = 39/257 (15%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRN 732
           +F    +IG+G++G VYK    + G  VA+K + LD  K+G   + + E + LR + HRN
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67

Query: 733 LIKIITICS----SIDF---KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE- 784
           ++ +  I +    ++DF   KGA +  +V+EYM         H     LE G ++   + 
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMD--------HDLMGLLESGLVHFSEDH 117

Query: 785 VASVIEYLH---NHCQPP-IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           + S ++ L    N+C     +H D+K SN+LL++     ++DFGLAR  +        E 
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-------SEE 170

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG 899
                    T+ Y  PE  +G +      DV+S G +L E+FT ++P   +F     L  
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP---IFQANQEL-- 224

Query: 900 YAKMALPKKVMGIVDPS 916
            A++ L  ++ G   P+
Sbjct: 225 -AQLELISRLCGSPCPA 240

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 77/284 (27%), Positives = 117/284 (41%), Gaps = 60/284 (21%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF-VA----ECEALRNIRHRNLIKI 736
           IG+G++G VY+G     G  VA+K++NLD    T    V+    E   L  +R      I
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIE 790
                S   KG     I+ EY + GSV          ++ G +       I+ EV   ++
Sbjct: 65  TKYYGSY-LKGPRL-WIIMEYAEGGSV-------RTLMKAGPIAEKYISVIIREVLVALK 115

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+H   +  ++H D+K +N+L+ +     + DFG+A  L+        +  S      GT
Sbjct: 116 YIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN--------QNSSKRSTFVGT 164

Query: 851 IGYIGPEYGMGGDLSMT-GDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV 909
             ++ PE    G    T  D++S GI + EM T   P             Y+ +   + +
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP-------------YSDVDAFRAM 211

Query: 910 MGIVD---PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM 950
           M I     P L  E  G SK     VA      AC  E P ER+
Sbjct: 212 MLIPKSKPPRL--EDNGYSKLLREFVA------ACLDEEPKERL 247

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 22/212 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           +G+G+FG V+      D   V +K + +++  K    +   EC+ L+ + H N+I+    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE- 66

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQ 797
               +F       IV EY   G++ +++    + L  E   L+  +++   + ++H    
Sbjct: 67  ----NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121

Query: 798 PPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
             I+H DLK  N+LLD H MV  + DFG+++ LS          +S +  + GT  YI P
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---------SKSKAYTVVGTPCYISP 170

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           E   G   +   D+++ G +L E+ + +R  +
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.8 bits (181), Expect = 4e-14
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 37/220 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIR---HRNLIKI 736
           IG G++G VYK      G  VA+K + +  ++ G   S V E   L+ +    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVIE 790
           + +C++          +V+E+     VD  L    DK+    L      +++ +    ++
Sbjct: 68  MDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----PFLVAPEGQSSSIE 846
           +LH +C   IVH DLKP N+L+       ++DFGLAR  S      P +V          
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV---------- 169

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 170 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 61/235 (25%), Positives = 109/235 (46%), Gaps = 22/235 (9%)

Query: 656 LMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA++ MNL ++   
Sbjct: 5   ILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
           +  + E   +R  ++ N++  +       +   D   +V EY+  GS+ D +  T   ++
Sbjct: 62  ELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV--TETCMD 114

Query: 776 VGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
            G++  V  E    +E+LH++    ++H D+K  N+LL  D    ++DFG          
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 164

Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            + PE QS    M GT  ++ PE           D++S GI+ +EM     P  N
Sbjct: 165 QITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 23/211 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECEA----LRNIRHRNLIKI 736
           +G GSFG VY+G   +DG   AVK ++L   G T +  V + E     L  ++H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
           +           D   I  E +  GS+   L       E        ++   +EYLH+  
Sbjct: 68  LGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR- 121

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+K +N+L+D + V  ++DFG+A+ +            S +   KG+  ++ P
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV---------VEFSFAKSFKGSPYWMAP 170

Query: 857 EYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           E     G   +  D++S G  +LEM T + P
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 26/234 (11%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVK---VMNLDKKGATKSFVAECEALRNIRHRN 732
           F    +IG+G F  VY+     DG+ VA+K   + +L    A    + E + L+ + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV----IEVASV 788
           +IK         F   +   IV E    G +   + H   +  +     V    +++ S 
Sbjct: 64  VIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           +E++H+     ++H D+KP+NV +    V  + D GL RF S           +++  + 
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TTAAHSLV 167

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK 902
           GT  Y+ PE       +   D++S G LL EM   + P    + D + L+   K
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 55/210 (26%), Positives = 85/210 (40%), Gaps = 22/210 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG FG V    +   G   A K ++   L K+   +  + E + L  +  R       
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHC 796
           +  +  F+  D   +V   M  G +   +++  +    E   +    ++   +E+LH   
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR- 114

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              IV+ DLKP NVLLD      +SD GLA         V  +G        GT GY+ P
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA---------VELKGGKKIKGRAGTPGYMAP 163

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E   G     + D ++ G  L EM   R P
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 73.3 bits (181), Expect = 5e-14
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 34/208 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS---FVAECEALRNIRHRNLIKIIT 738
           +G GSFG V        G   A+K+++  K    K     + E   L++IRH  L+ +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVASVIEYL 792
                 F+      +V EY+  G +   L       + G+           +V   +EYL
Sbjct: 69  -----SFQDDSNLYLVMEYVPGGELFSHLR------KSGRFPEPVARFYAAQVVLALEYL 117

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H      IV+ DLKP N+LLD D    ++DFG A+ +    + +            GT  
Sbjct: 118 H-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----------GTPE 163

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           Y+ PE  +        D ++ GIL+ EM
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 28/213 (13%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMS---VAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIK 735
             +G G+FG V KG           VAVK +  +      K F+ E   +  + H  +++
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH 795
           +I +C     KG     +V E    G +  +L    +        +  +VA  + YL   
Sbjct: 61  LIGVC-----KGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE-- 112

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG--- 852
                VH DL   NVLL +   A +SDFG++R L          G  S      T G   
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL----------GAGSDYYRATTAGRWP 161

Query: 853 --YIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
             +  PE    G  S   DV+S+G+ L E F+ 
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 45/228 (19%)

Query: 680 NRIGKGSFGFVYKGNL------GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIR 729
           N +G G+FG VY+G        G   + VAVK +   +KGAT    K F+ E   + N  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---------LEVGKL- 779
           H N++K++ +C        + + I+ E M+ G   D L +  D          L + +L 
Sbjct: 58  HPNIVKLLGVCLL-----NEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELL 109

Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFLSHHPF 834
           +I ++VA    YL    Q   +H DL   N L+     D D V  + DFGLAR +    +
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166

Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               EG+         + ++ PE  + G  +   DV+SFG+L+ E+ T
Sbjct: 167 Y-RKEGEG-----LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.9 bits (184), Expect = 1e-13
 Identities = 38/92 (41%), Positives = 57/92 (61%)

Query: 484 LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI 543
           L L    L G IP ++  L+ L  +++S N+    IP +L + T+LE L +  NSFNGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 544 PQSLNALKSIKELDLSCNNLSGQIPIHLGNLP 575
           P+SL  L S++ L+L+ N+LSG++P  LG   
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 55/226 (24%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITIC 740
           IG+G++G VYK    + G  VA+K+M++ +    +    E   LR    H N+       
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNI------- 65

Query: 741 SSIDFKGADFKA----------IVYEYMQYGSVDDW---LHHTNDKLEVGKLN-IVIEVA 786
               F GA  K           +V E    GSV D    L     +L+   +  I+ E  
Sbjct: 66  --ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLARFLSHH----------PF 834
             + YLH +    ++H D+K  N+LL  +  A V   DFG++  L             P+
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            +APE              I  +           DV+S GI  +E+
Sbjct: 179 WMAPE-------------VIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 43/279 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMS----VAVKVMNLDKKGATKSFVAECE---AL 725
             E      +G G FG V+KG    +G S    VA+K +  D+ G  ++F    +   A+
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSG-RQTFQEITDHMLAM 63

Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIE 784
            ++ H  +++++ IC      GA  + +V +    GS+ D +    D L+  +L N  ++
Sbjct: 64  GSLDHAYIVRLLGICP-----GASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           +A  + YL  H    +VH +L   N+LL  D +  ++DFG+A  L  +P     + +   
Sbjct: 118 IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL--YP----DDKKYFY 168

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA 904
            E K  I ++  E  + G  +   DV+S+G+ + EM +                 YA M 
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS------------YGAEPYAGMR 216

Query: 905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSM 943
             +       P LL +    ++ + C + V    V C M
Sbjct: 217 PHEV------PDLLEKGERLAQPQICTIDVYMVMVKCWM 249

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD   +G   + + E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M      D    +   L + K + + ++ 
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLK----KFM------DASPLSGIPLPLIK-SYLFQLL 110

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEVV 162

Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 163 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 16/215 (7%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G+FG VYK    + G  VA+K  +M+ +K G   + + E + L+ ++H N++ +I 
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKL-NIVIEVASVIEYLH-N 794
           +      K    +  VY    Y   D    L + + KL   ++   ++++   I YLH N
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL---SHHPFLVAPEGQSSSIEMKGTI 851
           H    I+H D+K +N+L+D+  +  ++DFGLAR       +P      G      +  T 
Sbjct: 135 H----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190

Query: 852 GYIGPEYGMGGDLSMTG--DVYSFGILLLEMFTRR 884
            Y  PE  + G+   T   D++  G +  EMFTRR
Sbjct: 191 WYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 21/155 (13%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-------HRNL 733
           ++G G+FG VY     E G  VA+K M    K    S+  EC  LR ++       H N+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM----KKKFYSW-EECMNLREVKSLRKLNEHPNI 60

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +K+  +     F+  D    V+EYM+                   + +I+ ++   + ++
Sbjct: 61  VKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
           H H      H DLKP N+L+    V  ++DFGLAR
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)

Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKKGATKS---FVAECEALRNIRHRNLIKII 737
           IGKG FG VY G L   DG  +   V +L++    +    F+ E   +++  H N++ ++
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC  +  +G+    +V  YM++G + +++        V  L    ++VA  +EYL    
Sbjct: 63  GIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMAL 171

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E       +   DV+SFG+LL E+ TR  P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 20/203 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEAL-RNIRHRNLIKII 737
           IGKGSFG V       DG   AVKV+    + KK   K  +AE   L +N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
                  F+ AD    V +Y+  G +   L       E        E+AS + YLH+   
Sbjct: 62  ----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL-- 115

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I++ DLKP N+LLD      ++DFGL +        +     +S+    GT  Y+ PE
Sbjct: 116 -NIIYRDLKPENILLDSQGHVVLTDFGLCK------EGIEHSKTTST--FCGTPEYLAPE 166

Query: 858 YGMGGDLSMTGDVYSFGILLLEM 880
                    T D +  G +L EM
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.3 bits (174), Expect = 3e-13
 Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 32/219 (14%)

Query: 682 IGKGSFGFVYKG---NL--GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG V+     NL   +D + VAVK +      A K F  E E L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGK------------LNIVI 783
             +C        D   +V+EYM++G ++ +L  H  D + + +            L+I  
Sbjct: 73  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           ++A+ + YL +      VH DL   N L+  +++  + DFG++R +    +     G  +
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV--GGHT 182

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            + ++    ++ PE  M    +   DV+S G++L E+FT
Sbjct: 183 MLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 26/213 (12%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRN 732
           E +    +G G FG V+ G      + VA+K +N   +GA   + F+ E + +  + H  
Sbjct: 5   ELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPK 60

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVASVI 789
           L+++  +C+           IV E+M+ G + ++L     KL   K   L++  +V   +
Sbjct: 61  LVQLYGVCTQ-----QKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGM 113

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           EYL    +   +H DL   N L+    V  VSDFG+ R+       V  +  +SS   K 
Sbjct: 114 EYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY-------VLDDEYTSSSGAKF 163

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            + +  PE       S   DV+SFG+L+ E+FT
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 47/221 (21%), Positives = 95/221 (42%), Gaps = 34/221 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+FG VYK    E G+  A K++ ++ +   + F+ E + L   +H N++ +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY---E 69

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQPPI 800
           +  ++   +  I+ E+   G++D  +      L   ++  V  ++   + +LH+H    +
Sbjct: 70  AYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
           +H DLK  N+LL  D    ++DFG++                    ++    +IG  Y M
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKS--------------TLQKRDTFIGTPYWM 170

Query: 861 GGDLSMT-----------GDVYSFGILLLEMFTRRRPTDNM 890
             ++               D++S GI L+E+     P   +
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 48/225 (21%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           + F+    IGKGSFG VYK         VA+KV++L+            EA   I   ++
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEIE--DI 46

Query: 734 IKIITICSSID------FKGA---DFK-AIVYEYMQYGSVDDWLHHTNDKLEVGKLN--- 780
            + I   S         + G+     K  I+ EY   GS  D L       + GKL+   
Sbjct: 47  QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-------KPGKLDETY 99

Query: 781 ---IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
              I+ EV   +EYLH   +   +H D+K +N+LL  +    ++DFG++  L+       
Sbjct: 100 IAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTST----- 151

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               S      GT  ++ PE           D++S GI  +E+  
Sbjct: 152 ---MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVA---ECEALRNI 728
           E++    +GKG++G VY G L   G  +AVK + LD      A K +     E + L+++
Sbjct: 1   EWTKGEVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           +H N+++ +  C        +  +I  E++  GS+   L+      E        ++   
Sbjct: 60  KHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDG 114

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--E 846
           + YLHN+C   +VH D+K +NV+L  + +  + DFG AR L+     V   G  S++   
Sbjct: 115 VAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA----WVGLHGTHSNMLKS 167

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           M GT  ++ PE           D++S G  + EM T + P  +M
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 34/227 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMS-VAVKVMNL-------DKKGATKSF---VAECEALR-NIR 729
           +G G+FG VYK     +G + +A+K +N+       DK+   KS    V+E   ++  +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---LEVGKL-NIVIEV 785
           H N+++         F   D   IV + ++   + +  +   +K       ++ NI +++
Sbjct: 68  HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YLH   +  IVH DL P+N++L  D    ++DFGLA+          PE + +S+
Sbjct: 123 VLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-------PESKLTSV 173

Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP--TDNM 890
              GTI Y  PE           DV++FG +L +M T + P  + NM
Sbjct: 174 --VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.8 bits (170), Expect = 9e-13
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 22/235 (9%)

Query: 656 LMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           +ME+   IVS   +    K+++   +IG+G+ G V+       G  VA+K +NL K+   
Sbjct: 4   IMEKLRTIVS---IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60

Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT-NDKL 774
           +  + E   ++ +++ N++  +       F   D   +V EY+  GS+ D +  T  D+ 
Sbjct: 61  ELIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEYLAGGSLTDVVTETCMDEA 115

Query: 775 EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
           ++    +  E    +E+LH +    ++H D+K  NVLL  D    ++DFG          
Sbjct: 116 QIAA--VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA------- 163

Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            + PE QS    M GT  ++ PE           D++S GI+ +EM     P  N
Sbjct: 164 QITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.8 bits (170), Expect = 9e-13
 Identities = 61/235 (25%), Positives = 109/235 (46%), Gaps = 22/235 (9%)

Query: 656 LMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA+K MNL ++   
Sbjct: 4   ILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60

Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
           +  + E   +R  ++ N++  +       +   D   +V EY+  GS+ D +  T   ++
Sbjct: 61  ELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV--TETCMD 113

Query: 776 VGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
            G++  V  E    +++LH++    ++H D+K  N+LL  D    ++DFG          
Sbjct: 114 EGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 163

Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            + PE QS    M GT  ++ PE           D++S GI+ +EM     P  N
Sbjct: 164 QITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 20/218 (9%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRN 732
           +F   N+IGKGSFG V+K     D    A+K ++L K      +  + E   L  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK--LEVGKLNIVIEVASVIE 790
           +I+     S +D KG     IV EY + G +   L     +   E       I++   + 
Sbjct: 61  IIRYYE--SFLD-KGK--LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +LH+     I+H D+K  N+ LD      + D G+A+ LS +              + GT
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN--------TIVGT 164

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
             Y+ PE       +   DV++ G++L E  T + P D
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 39/227 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECEALRNIRHRN 732
           ++    +R+G+G+ G V K  L   GM  A+K +  D      K  + E E  ++ +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 733 LIKIITIC-----SSIDFKGADFKAIVYEYMQYGSVDDWLHH-------TNDKLEVGKLN 780
           ++K          SSI         I  EY + GS+D              +K+ +GK  
Sbjct: 61  IVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYKKVKKRGGRIGEKV-LGK-- 109

Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE- 839
           I   V   + YLH      I+H D+KPSN+LL       + DFG           V+ E 
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFG-----------VSGEL 155

Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             S +    GT  Y+ PE   G   S+T DV+S G+ LLE+   R P
Sbjct: 156 VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
             +  +IG+GS G V        G  VAVK M+L K+   +    E   +R+ +H N   
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN--- 77

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHN 794
           I+ + SS  +   D   +V E+++ G++ D + HT  ++ ++    + + V   + +LH 
Sbjct: 78  IVEMYSS--YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHA 133

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                ++H D+K  ++LL  D    +SDFG    +S       P  +S    + GT  ++
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKS----LVGTPYWM 182

Query: 855 GPE------YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
            PE      YG         D++S GI+++EM     P    FN+
Sbjct: 183 APEVISRLPYG------TEVDIWSLGIMVIEMVDGEPP---YFNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 48/232 (20%)

Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRN 732
           IG+G+FG V++         E    VAVK++   K+ A+      F  E   +    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-------------------TNDK 773
           ++K++ +C+           +++EYM YG ++++L H                     + 
Sbjct: 70  IVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 774 LEVG---KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
           L +    +L I  +VA+ + YL        VH DL   N L+  +MV  ++DFGL+R + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              +  A E  +  I       ++ PE       +   DV+++G++L E+F+
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.0 bits (174), Expect = 2e-12
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 34/230 (14%)

Query: 682 IGKGSFGFVYKGNLGED---GMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIK 735
           IGKG  G VY   L  D      VA+K +     +     K F+ E +   ++ H  ++ 
Sbjct: 10  IGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 736 IITICSSID--------FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVA 786
           + +ICS  D         +G   K+++    Q  S+   L    +K  VG  L+I  ++ 
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSIFHKIC 123

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP----FLVAPEGQS 842
           + IEY+H+     ++H DLKP N+LL       + D+G A F          +   E   
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 843 SSIEMK------GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
               M       GT  Y+ PE  +G   S + D+Y+ G++L +M T   P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 32/226 (14%)

Query: 674 KEFSSSNRIGKGSFGFVYKG-NLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIR- 729
           +++     IG+G++G V+K  +L   G  VA+K + +   ++G   S + E   LR++  
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 730 --HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-------EVGKLN 780
             H N++++  +C+           +V+E+     VD  L    DK+       E  K +
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIK-D 114

Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           ++ ++   +++LH+H    +VH DLKP N+L+       ++DFGLAR  S          
Sbjct: 115 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------- 162

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Q +   +  T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 69.2 bits (169), Expect = 3e-12
 Identities = 80/317 (25%), Positives = 121/317 (38%), Gaps = 24/317 (7%)

Query: 214 SENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQ 273
             ++   + P S+  + SLD   L       SL              +    N       
Sbjct: 54  LSSNTLLLLPSSLSRLLSLD---LLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS 110

Query: 274 SLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCS 333
            L   + L  L+L+ N+ +    +      NL +L L  N +           + L N  
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-------ESLPSPLRNLP 163

Query: 334 KLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQ 393
            L  L L FN     LP  ++NLS    L  ++GN+IS  +PPEI  L  L  L L  N 
Sbjct: 164 NLKNLDLSFNDL-SDLPKLLSNLSNLNNL-DLSGNKIS-DLPPEIELLSALEELDLSNNS 220

Query: 394 LTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKC 453
           +   +  ++  L+NL  L L  N +   +P+ IGNL+  N+  L  +  Q S  S LG  
Sbjct: 221 II-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLS--NLETLDLSNNQISSISSLGSL 276

Query: 454 QNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRN 513
            NL +L    N L+  LP     +  L  LL+L          LE+     L+  +I  N
Sbjct: 277 TNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT----LKALELKLNSILLNNNILSN 332

Query: 514 NF---SNEIPVTLSACT 527
                   + +  S   
Sbjct: 333 GETSSPEALSILESLNN 349

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 3e-12
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 28/132 (21%)

Query: 52  WTGVTCG----HRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVG 107
           W+G  C          +  L L++Q + GF+   I  L  L+ INL+ NS  G IP  +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 108 RLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYG 167
            +  LE + LS NSF+G IP +L                        G    +  L+L G
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESL------------------------GQLTSLRILNLNG 499

Query: 168 NQLTGQLPPSIG 179
           N L+G++P ++G
Sbjct: 500 NSLSGRVPAALG 511

Length = 623

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVM--NLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
            +G+G++G V K      G  VA+K    + D +   K+ + E + LR +RH N++ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG------KLNIVIEVASVIEYL 792
                  KG  +  +V+EY     V+  L    +    G      +   + ++   I Y 
Sbjct: 68  AFRR---KGRLY--LVFEY-----VERTLLELLEASPGGLPPDAVRS-YIWQLLQAIAYC 116

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
           H+H    I+H D+KP N+L+    V  + DFG AR L 
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN----LDKKGATKSFVAECEALRNIRH 730
            F    +IG+G F  VY+     D   VA+K +     +D K A +  V E + L+ + H
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK-ARQDCVKEIDLLKQLNH 61

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV----IEVA 786
            N+IK +       F   +   IV E    G +   + +   +  +     V    +++ 
Sbjct: 62  PNVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
           S +E++H+     ++H D+KP+NV +    V  + D GL RF S           +++  
Sbjct: 117 SAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TTAAHS 165

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           + GT  Y+ PE       +   D++S G LL EM   + P
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.6 bits (167), Expect = 3e-12
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 42/231 (18%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF---VAECEALRNIRH 730
           K F+    IG GSFG VY          VA+K M+   K + + +   + E + L+ I+H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASV- 788
            N         SI++KG   +    E+  +  ++  L   +D LEV K  +  +E+A++ 
Sbjct: 85  PN---------SIEYKGCYLR----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT 131

Query: 789 ------IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
                 + YLH+H    ++H D+K  N+LL       ++DFG A   S     V      
Sbjct: 132 HGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------ 182

Query: 843 SSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
                 GT  ++ PE  +    G      DV+S GI  +E+  R+ P  NM
Sbjct: 183 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 18/210 (8%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG VY     + G  +AVK +  D      K    +   E + L+N++H  +++ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
              C   D       +I  EYM  GSV D L       E        ++   +EYLH++ 
Sbjct: 70  YG-CLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN- 123

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              IVH D+K +N+L D      + DFG ++ L       +  G  S     GT  ++ P
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVT---GTPYWMSP 176

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E   G       DV+S G  ++EM T + P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 40/221 (18%)

Query: 682 IGKGSFGFVY----KGNLGEDGMS-VAVKVMN-LDKKGATKSFVAECEALRNIRHRNLIK 735
           +G+G FG V+    KG   E G + V VK +     +     F  E +  R + H+N+++
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE---------VGKLNIVIEVA 786
           ++ +C     + A+   ++ EY   G +  +L  T  K E           K+ +  ++A
Sbjct: 73  LLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL-----SHHPFLVAPEGQ 841
             +++L N      VH DL   N L+       VS   L++ +           + P   
Sbjct: 128 LGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--- 181

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    + ++ PE     D S   DV+SFG+L+ E+FT
Sbjct: 182 ---------LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 42/228 (18%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   RIGKGSFG V+KG        VA+K+++L++        AE E + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L     D+ ++  +  + E+  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM--LKEILK 112

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 113 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA-------------GQLTDTQI 156

Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           K     GT  ++ PE           D++S GI  +E+     P  +M
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRHRN 732
           +++   +IG+G++G VYKG   + G  VA+K + L  +++G   + + E   L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
           ++ +  +           ++ +Y   ++ S+D  L    D L  G+    ++   V  YL
Sbjct: 61  IVCLQDVLMQ--------ESRLYLIFEFLSMD--LKKYLDSLPKGQY---MDAELVKSYL 107

Query: 793 HN------HC-QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
           +        C    ++H DLKP N+L+D+  V  ++DFGLAR      F +     +  +
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEV 162

Query: 846 EMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRR 884
               T+ Y  PE  +G    S   D++S G +  EM T++
Sbjct: 163 V---TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.1 bits (164), Expect = 7e-12
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 67/240 (27%)

Query: 681 RIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNI-RH 730
            +G+G+FG V K          +  +VAVK++   K  AT       V+E E ++ I +H
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE------ 784
           +N+I ++ +C+    +G  +  +V EY  +G++ D+L       E    +          
Sbjct: 76  KNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 785 ----------VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
                     VA  +E+L        +H DL   NVL+  D V  ++DFGLAR + H  +
Sbjct: 131 QKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187

Query: 835 L------------VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                        +APE     +                   +   DV+SFG+LL E+FT
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRV------------------YTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.0 bits (163), Expect = 8e-12
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V    +   G  VAVK M+L K+   +    E   +R+ +H N++++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 84

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   +  LH      +
Sbjct: 85  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIAAVCLAVLKALSVLHAQ---GV 137

Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLA----------RFLSHHPFLVAPEGQSSSIEMKGT 850
           +H D+K  ++LL HD    +SDFG            + L   P+ +AP       E+   
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP-------ELISR 190

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           + Y GPE           D++S GI+++EM     P  N
Sbjct: 191 LPY-GPEV----------DIWSLGIMVIEMVDGEPPYFN 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V        G  VAVK M+L K+   +    E   +R+  H N++ +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN-- 86

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   + YLHN     +
Sbjct: 87  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIATVCLSVLRALSYLHNQ---GV 139

Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
           +H D+K  ++LL  D    +SDFG    +S       P+ +S    + GT  ++ PE   
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----VPKRKS----LVGTPYWMAPEVIS 191

Query: 861 GGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                   D++S GI+++EM     P  N
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 36/223 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMS----VAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKI 736
           +G+ +FG +YKG+L   GM     VA+K + +++       F  E   +  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-----------------L 779
           + + +           +++EY+  G + ++L   +   +VG                  L
Sbjct: 73  LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
           +I I++A+ +EYL +H     VH DL   N+L+   +   +SD GL+R +    +     
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV-- 182

Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            Q  S+     I ++ PE  M G  S   D++SFG++L E+F+
Sbjct: 183 -QPKSLL---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 55/219 (25%), Positives = 81/219 (36%), Gaps = 44/219 (20%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           I KG+FG VY       G   A+KV+   ++  K    +  AE    R I          
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESPYV 59

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSV-----------DDWLHHTNDKLEVGKLNIVIEVAS 787
                 F+  D+  +V EY+  G             +DW               + EV  
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-----------QYIAEVVL 108

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            +E LH   Q  I+H D+KP N+L+D      ++DFGL+R    +   V           
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV----------- 154

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT  Y+ PE  +G       D +S G ++ E      P
Sbjct: 155 -GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 47/226 (20%)

Query: 682 IGKGSFGFVYKGNLGEDG--MSVAVKVMN-LDKKGATKSFVAECEALRNI-RHRNLIKII 737
           IG+G+FG V +  + +DG  M+ A+K++     +   + F  E E L  +  H N+I ++
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVGKL-NI 781
             C +   +G  + AI  EY  YG++ D+L               H T   L   +L   
Sbjct: 70  GACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +VA+ ++YL    +   +H DL   NVL+  ++ + ++DFGL+R              
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-------------- 167

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-----GDVYSFGILLLEMFT 882
              + +K T+G +   +     L+ +      DV+SFG+LL E+ +
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 42/231 (18%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF---VAECEALRNIRH 730
           K FS    IG GSFG VY      +   VA+K M+   K + + +   + E   L+ +RH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASV- 788
            N         +I ++G   +    E+  +  ++  L   +D LEV K  +  +E+A+V 
Sbjct: 75  PN---------TIQYRGCYLR----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121

Query: 789 ------IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
                 + YLH+H    ++H D+K  N+LL    +  + DFG A        ++AP    
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-------IMAPANX- 170

Query: 843 SSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
                 GT  ++ PE  +    G      DV+S GI  +E+  R+ P  NM
Sbjct: 171 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 44/220 (20%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +IG+G++G VYK      G  VA+K + L+   +G   + + E   L+ + H N+++++ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 739 ICSSIDFKGADFKA-IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI------EVASVIEY 791
           +  S      + K  +V+E+     +D  L    D   +  L+  +      ++   I Y
Sbjct: 66  VVHS------ENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG-- 849
            H+H    ++H DLKP N+L+D +    ++DFGLAR              +  + ++   
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR--------------AFGVPVRTYT 157

Query: 850 ----TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
               T+ Y  PE  +G     T  D++S G +  EM  RR
Sbjct: 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 41/107 (38%), Positives = 56/107 (52%), Gaps = 5/107 (4%)

Query: 519 IPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLE 578
           IP  +S    L+ + + GNS  G+IP SL ++ S++ LDLS N+ +G IP  LG L  L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 579 YLNLSYNHFEGKVPKK--GVFSNETRISLTGNEQFCGGLGELHLPAC 623
            LNL+ N   G+VP    G   +    + T N   CG  G   L AC
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRAC 537

Length = 623

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 42/228 (18%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   RIGKGSFG VYKG        VA+K+++L++        AE E + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L      LE   +  I+ E+  
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILK 112

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 113 GLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA-------------GQLTDTQI 156

Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           K     GT  ++ PE           D++S GI  +E+     P  ++
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 20/204 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEAL-RNIRHRNLIKII 737
           IGKGSFG V       DG   AVKV+    + KK      +AE   L +N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
                  F+ A+    V +Y+  G +   L      LE        EVAS I YLH+   
Sbjct: 62  ----HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL-- 115

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I++ DLKP N+LLD      ++DFGL +        V PE  +S+    GT  Y+ PE
Sbjct: 116 -NIIYRDLKPENILLDSQGHVVLTDFGLCK------EGVEPEETTST--FCGTPEYLAPE 166

Query: 858 YGMGGDLSMTGDVYSFGILLLEMF 881
                    T D +  G +L EM 
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 42/229 (18%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF---VAECEALRNIRHRN 732
           F   + IG GSFG VY          VAVK M+   K   + +   + E + L+ ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASV--- 788
                    +I++KG   K    E+  +  ++  L   +D LEV K  +  +E+A++   
Sbjct: 83  ---------TIEYKGCYLK----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHG 129

Query: 789 ----IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
               + YLH+H    ++H D+K  N+LL       ++DFG A   S     V        
Sbjct: 130 ALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-------- 178

Query: 845 IEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
               GT  ++ PE  +    G      DV+S GI  +E+  R+ P  NM
Sbjct: 179 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 27/217 (12%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKKG--ATKSFVAECEALRNI 728
           E      +G G+FG VYKG    +G    + VA+K++N +  G  A   F+ E   + ++
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASM 66

Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEV 785
            H +L++++ +C S   +      +V + M +G + D++H   D   +G    LN  +++
Sbjct: 67  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQI 118

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
           A  + YL    +  +VH DL   NVL+       ++DFGLAR L         E + ++ 
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE------GDEKEYNAD 169

Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             K  I ++  E       +   DV+S+G+ + E+ T
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 52/217 (23%), Positives = 110/217 (50%), Gaps = 28/217 (12%)

Query: 682 IGKGSFGFVYKGNLGEDG--MSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKII 737
           +G+G FG V +G L +D   + VAVK M +    +   + F++E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 738 TIC-SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK----------LNIVIEVA 786
            +C  +++ +G     ++  +M++G +  +L ++     +G           +  + ++A
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS----RLGDCPQYLPTQMLVKFMTDIA 122

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
           S +EYL +      +H DL   N +L+ +M   V+DFGL++ + +  +    +G+ + + 
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY--RQGRIAKMP 177

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
           +K    +I  E       +   DV+SFG+ + E+ TR
Sbjct: 178 VK----WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 23/212 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG FG V    +   G   A K +N   L K+   +  + E   L  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-- 58

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK----LEVGKLNIVIEVASVIEYLHN 794
              +  F+      +V   M  G +   +++ +++     E        ++ S +E+LH 
Sbjct: 59  ---AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                I++ DLKP NVLLD+D    +SD GLA  L         +GQS +    GT G++
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK--------DGQSKTKGYAGTPGFM 164

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            PE   G +   + D ++ G+ L EM   R P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 16/210 (7%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS---FVAECEA--LRNIRHRNLIKI 736
           +G+G+FG VY     + G  +A K +  D +    S      ECE   L+N++H    +I
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---RI 66

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
           +     +  +      I  EYM  GSV D L       E        ++   + YLH++ 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              IVH D+K +N+L D      + DFG ++ L      ++  G  S   + GT  ++ P
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICMSGTGIRS---VTGTPYWMSP 178

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E   G       DV+S G  ++EM T + P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 17/207 (8%)

Query: 682 IGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKI 736
           +G+G FG V    Y       G  VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNH 795
             IC+  +  G   K I+ E++  GS+ ++L    +K+ + + L   +++   ++YL + 
Sbjct: 72  KGICT--EDGGNGIKLIM-EFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                VH DL   NVL++ +    + DFGL + +         E  +   ++   + +  
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-----KEYYTVKDDLDSPVFWYA 180

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFT 882
           PE  +     +  DV+SFG+ L E+ T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 27/222 (12%)

Query: 675 EFSSSNR---IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR 731
           E+  +     +GKG++G VY        + +A+K +        +    E      ++HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE- 790
           N+++ +   S   F    FK I  E +  GS+   L      L+  +  I+     ++E 
Sbjct: 66  NIVQYLGSDSENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120

Query: 791 --YLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
             YLH++    IVH D+K  NVL++ +  V  +SDFG ++ L+     + P  ++     
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG----INPCTET----F 169

Query: 848 KGTIGYIGPE---YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT+ Y+ PE    G  G      D++S G  ++EM T + P
Sbjct: 170 TGTLQYMAPEVIDKGPRG-YGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 12/153 (7%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +IG+GS+G V+K    E G  VA+K  V + D     K  + E   L+ ++H NL+ +I 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH-CQ 797
           +     F+      +V+EY  +  +++   +     E     I+ +    + + H H C 
Sbjct: 68  V-----FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC- 121

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
              +H D+KP N+L+       + DFG AR L+
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 56/241 (23%), Positives = 111/241 (46%), Gaps = 46/241 (19%)

Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS-FVAE 721
           E++ +T  F     +G+  FG VYKG+L     GE   +VA+K +    +G  +  F  E
Sbjct: 1   EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
                 ++H N++ ++ + +          ++++ Y  +  + ++L   +   +VG    
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 779 -------------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 825
                        ++IV ++A+ +E+L +H    +VH DL   NVL+   +   +SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 826 ARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
            R +    +           ++ G     I ++ PE  M G  S+  D++S+G++L E+F
Sbjct: 171 FREVYAADYY----------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Query: 882 T 882
           +
Sbjct: 221 S 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 46/223 (20%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           IG G++G V        G  VA+K      D     K  + E + LR+ +H N+I I  I
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 740 CSSIDFKGADFKAI--VYEYMQYGSVDDWLH---HTNDKLEVGKLNIVI-EVASVIEYLH 793
                  GADFK +  V + M+       LH   H++  L    +   + ++   ++Y+H
Sbjct: 73  LRP---PGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG---- 849
           +     ++H DLKPSN+L++ D    + DFG+AR LS           SS  E K     
Sbjct: 125 SAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS-----------SSPTEHKYFMTE 170

Query: 850 ---TIGYIGPEYGMGGDLSMTG-----DVYSFGILLLEMFTRR 884
              T  Y  PE  +   LS+       D++S G +  EM  RR
Sbjct: 171 YVATRWYRAPEL-L---LSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 37/217 (17%)

Query: 682 IGKGSFGFVYKGN---LGEDG--MSVAVKVM----NLDKKGATKSFVAECEALRNIRHRN 732
           +G G+FG V +     L +    M VAVK++    +  ++ A  S +     L N  H N
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HEN 100

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIE 790
           ++ ++  C+     G     ++ EY  YG + ++L    +     +  L+   +VA  + 
Sbjct: 101 IVNLLGACT----IGGPI-LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 791 YLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           +L + +C    +H DL   NVLL H  +  + DFGLAR + +           S+  +KG
Sbjct: 156 FLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMN----------DSNYVVKG 201

Query: 850 T----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                + ++ PE       +   DV+S+GILL E+F+
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.9 bits (155), Expect = 8e-11
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 47/226 (20%)

Query: 682 IGKGSFGFVYKGNLGEDG--MSVAVKVM-NLDKKGATKSFVAECEALRNI-RHRNLIKII 737
           IG+G+FG V K  + +DG  M  A+K M     K   + F  E E L  +  H N+I ++
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVGKL-NI 781
             C   + +G  + AI  EY  +G++ D+L               + T   L   +L + 
Sbjct: 75  GAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +VA  ++YL    Q   +H DL   N+L+  + VA ++DFGL+R            GQ
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQ 174

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-----GDVYSFGILLLEMFT 882
              + +K T+G +   +     L+ +      DV+S+G+LL E+ +
Sbjct: 175 --EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 64.3 bits (156), Expect = 8e-11
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 29/213 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG+FG V        G   A+K++  +    K      V E   L+N RH  L  +  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-- 60

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHC 796
                 F+  D    V EY   G +  + H + +++  E        E+ S +EYLH+  
Sbjct: 61  ---KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR- 114

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGY 853
              +V+ D+K  N++LD D    ++DFGL +           EG S    MK   GT  Y
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 161

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           + PE     D     D +  G+++ EM   R P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 25/210 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V        G  VAVK+M+L K+   +    E   +R+ +H+N++++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---- 83

Query: 741 SSIDFKGA---DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE-VASVIEYLHNHC 796
               +K     +   ++ E++Q G++ D +  T  +L   ++  V E V   + YLH+  
Sbjct: 84  ----YKSYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQ- 136

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              ++H D+K  ++LL  D    +SDFG    +S       P+ +S    + GT  ++ P
Sbjct: 137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----VPKRKS----LVGTPYWMAP 186

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E           D++S GI+++EM     P
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 24/206 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLI---KI 736
           ++G+GS+  VYKG    +G  VA+KV+++  ++G   + + E   L+ ++H N++    I
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
           I    ++ F        V+EYM        + H            + ++   + Y+H   
Sbjct: 72  IHTKETLTF--------VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ- 122

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              I+H DLKP N+L+ +     ++DFGLAR  S       P  Q+ S E+  T+ Y  P
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLARAKS------IP-SQTYSSEVV-TLWYRPP 172

Query: 857 EYGMGG-DLSMTGDVYSFGILLLEMF 881
           +  +G  D S   D++  G + +EM 
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVM-NLDKKGATKSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G    + VA+K +       A K  + E   + ++ 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVA 786
           + ++ +++ IC +   +      ++ + M +G + D++    D   +G    LN  +++A
Sbjct: 68  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIA 119

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + YL       +VH DL   NVL+       ++DFGLA+ L       A E +  +  
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------ADEKEYHAEG 170

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            K  I ++  E  +    +   DV+S+G+ + E+ T
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG+FG V        G   A+K++  +    K      + E   L+N RH  L  +  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-- 60

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHC 796
                 F+  D    V EY+  G +  + H + +++  E        E+ S ++YLH+  
Sbjct: 61  ---KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG- 114

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGY 853
              IV+ DLK  N++LD D    ++DFGL +           EG + +  MK   GT  Y
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGITDAATMKTFCGTPEY 161

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
           + PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.0 bits (156), Expect = 1e-10
 Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 43/239 (17%)

Query: 675 EFSSSNR-------IGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKS-------- 717
            FS S R       +G+G++G V K      G  VA+K + +       TK         
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 718 --FVA--ECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK 773
             F    E + +  I+H N++ ++ +     +   DF  +V + M      D     + K
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDV-----YVEGDFINLVMDIMAS----DLKKVVDRK 113

Query: 774 LEVGKLN---IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
           + + +     I++++ + +  LH       +H DL P+N+ ++   +  ++DFGLAR   
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170

Query: 831 HHPF---LVAPEGQSSSIEMKG---TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFT 882
           + P+   L   E      EM     T+ Y  PE  MG +      D++S G +  E+ T
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 40/156 (25%), Positives = 82/156 (52%), Gaps = 10/156 (6%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRN 732
           E+   NRI +G++G VY+    + G  VA+K + ++K+  G   + + E   L  ++H N
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++ +  +         D   +V EY+++  +   +          ++  +++++ S + +
Sbjct: 66  IVTVKEVVVG---SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
           LH++    I+H DLK SN+LL++  +  + DFGLAR
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 50/227 (22%)

Query: 682 IGKGSFGFVYKGN-LGEDG----MSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIK 735
           +G G+FG VY+G   G DG    + VAVK +        +S F+ E   +    H+N+++
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 736 IITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIE 784
           +I         G  F+     I+ E M  G +  +L     + E          L    +
Sbjct: 74  LI---------GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 785 VASVIEYLH-NHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLARFLSHHPFLVAPEG 840
           VA   +YL  NH     +H D+   N LL       VA ++DFG+AR           + 
Sbjct: 125 VAKGCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----------DI 169

Query: 841 QSSSIEMKG-----TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             +S   KG      I ++ PE  + G  +   DV+SFG+LL E+F+
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 682 IGKGSFGFVYKGNLGEDG----MSVAVKVM--NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VYKG    DG    + VA+KV+  N   K A K  + E   +  +    + +
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVCR 73

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHN 794
           ++ IC +   +      +V + M YG + D++    D++     LN  +++A  + YL  
Sbjct: 74  LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE- 126

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
             +  +VH DL   NVL+       ++DFGLAR L         E +  +   K  I ++
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD------IDETEYHADGGKVPIKWM 178

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             E  +    +   DV+S+G+ + E+ T
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 63/262 (24%), Positives = 112/262 (42%), Gaps = 44/262 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+FG VYK    E G+  A KV++   +   + ++ E + L +  H N++K++    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQPPI 800
              F   +   I+ E+   G+VD  +      L   ++ +V  +    + YLH +    I
Sbjct: 71  ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
           +H DLK  N+L   D    ++DFG++               + +I+ + +  +IG  Y M
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS------------AKNTRTIQRRDS--FIGTPYWM 170

Query: 861 GGDLSM-----------TGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV 909
             ++ M             DV+S GI L+EM     P           H    M +  K+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH----------HELNPMRVLLKI 220

Query: 910 MGIVDPSLLMEARGPSKFEECL 931
                P+L   +R  S+F++ L
Sbjct: 221 AKSEPPTLAQPSRWSSEFKDFL 242

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 48/225 (21%), Positives = 98/225 (43%), Gaps = 36/225 (16%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMS----VAVKVMNLDKKGATKS----FVAECEALRN 727
            + S+ + +G+FG ++ G L ++       V VK +   K  A++      + E   L  
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLLYG 64

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------ 781
           + H+N++ I+ +C        +   ++Y YM +G++  +L             +      
Sbjct: 65  LSHQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 782 --VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR--FLSHHPFLVA 837
              I++A  + YLH      ++H D+   N ++D ++   ++D  L+R  F   +  L  
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            E +         + ++  E  +  + S   DV+SFG+LL E+ T
Sbjct: 178 NENRP--------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 45/231 (19%)

Query: 681 RIGKGSFGFVY----KGNLGEDGMS----------VAVKVMNLD-KKGATKSFVAECEAL 725
           ++G+G FG V+    +G     G            VAVK++  D  K A   F+ E + +
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---------HTNDKLEV 776
             +++ N+I+++ +C S      D   ++ EYM+ G ++ +L          H N+   V
Sbjct: 72  SRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 777 GKLNIV---IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
              N++   +++AS ++YL        VH DL   N L+ +     ++DFG++R L    
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY--- 180

Query: 834 FLVAPEGQSSSIEMKGT--IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                 G    I+ +    I ++  E  + G  +   DV++FG+ L EMFT
Sbjct: 181 -----SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 22/216 (10%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRN 732
           F     +GKG FG V    +   G   A K +    + K+      + E + L  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK--LEVGKLNIVIEVASVIE 790
           ++ +     +  ++  D   +V   M  G +   ++H  +    E   +    E+   +E
Sbjct: 62  VVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            LH   Q  IV+ DLKP N+LLD      +SD GLA  +        PEGQ+    + GT
Sbjct: 117 DLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV--------PEGQTIKGRV-GT 164

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +GY+ PE       + + D ++ G LL EM   + P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 30/220 (13%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNL 733
           F    ++GKGS+G VYK     D    A+K ++L    +   +  V E   L ++ H N+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-------NIVIEVA 786
           I      + +D         +   M+Y    D     + + +  KL        I I++ 
Sbjct: 62  ISYKE--AFLDGN------KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             ++ LH      I+H DLK +N+LL  + +  + D G+++ L           ++ +  
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----------KNMAKT 160

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             GT  Y+ PE   G   S   D++S G LL EM T   P
Sbjct: 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 29/81 (35%), Positives = 49/81 (60%)

Query: 146 LVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQL 205
           L G I   I     ++ ++L GN + G +PPS+G++++L+  D++ N  +G IP+SLGQL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 206 RNLNYLGTSENDFSGMFPLSV 226
            +L  L  + N  SG  P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 34/85 (40%), Positives = 50/85 (58%), Gaps = 1/85 (1%)

Query: 368 NQ-ISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI 426
           NQ + G IP +I  L +L  + L  N + G IPP++G + +L+ L L  N+  G IP+ +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 427 GNLTLLNVLQLGFNKLQGSIPSYLG 451
           G LT L +L L  N L G +P+ LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 28/212 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--ECEALRNIRHRNLIKIITI 739
           +GKG+FG        ED   V  K +NL +    +   A  E   L  ++H N+I     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN- 66

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQ 797
                F   +   I  EY   G++ D +     +L  E   L  + ++ S + Y+H   +
Sbjct: 67  ----HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK----GTIGY 853
             I+H D+K  N+ L    +  + DFG+++ L             S   M     GT  Y
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL------------GSEYSMAETVVGTPYY 167

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR 885
           + PE   G   +   D+++ G +L E+ T +R
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 29/224 (12%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDKKGAT--KSFVAECEALRNIRH 730
           F+    +GKG FG V +  L  +      VAVK++  D   ++  + F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 731 RNLIKIITICSSIDFKGA-DFKAIVYEYMQYGSVDDWLHHTNDKLEVGK----------L 779
            N+IK+I +      KG      ++  +M++G +  +L  +     +G+          +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS----RIGEEPFTLPLQTLV 116

Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
             +I++AS +EYL +      +H DL   N +L+ +M   V+DFGL++ +    +    +
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY--RQ 171

Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
           G +S + +K    ++  E       +   DV++FG+ + E+ TR
Sbjct: 172 GCASKLPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 24/222 (10%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +      +G G+FG V+           A+KVM +    +    +    E   L+ + H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
            +I++    +  D     F  ++ EY+  G +  +L ++        L    E+   +EY
Sbjct: 62  FIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH+     IV+ DLKP N+LLD +    ++DFG A+ L    +            + GT 
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-----------TLCGTP 162

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP--TDNMF 891
            Y+ PE       +   D ++ GIL+ EM     P   DN F
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 5e-10
 Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 1/99 (1%)

Query: 153 IIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLG 212
             G W  I+ L L    L G +P  I  L  LQ+ +++GN + G IP SLG + +L  L 
Sbjct: 414 TKGKWF-IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD 472

Query: 213 TSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLG 251
            S N F+G  P S+  ++SL    L  N   G +P  LG
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRNIRHRNLIKIITI 739
           +GKGS+G V       DG    +K +NL      +   AE EA  L  ++H N   I+  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL---NIVIE----VASVIEYL 792
             S  ++G D   ++Y  M +    D  H    K + GKL   N V+E    +A  ++YL
Sbjct: 65  RES--WEGED--GLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H   +  I+H DLK  NV L    +  V D G+AR L +   + +         + GT  
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS--------TLIGTPY 167

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
           Y+ PE       +   DV++ G  + EM T +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 5e-10
 Identities = 65/248 (26%), Positives = 100/248 (40%), Gaps = 44/248 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           IGKG+FG VY+    +     A+KV+      + K  VA+ E    I  RN    I + +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILVRT 50

Query: 742 SID-----------FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            +D           F+      +V +YM  G +   L       E      + E+   +E
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +LH +    IV+ DLKP N+LLD      + DFGL++       L       ++    GT
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-----ANLTD---NKTTNTFCGT 159

Query: 851 IGYIGPEYGM--GGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFNDGLTLHGYAKM 903
             Y+ PE  +   G      D +S G+L+ EM     P     T  M+        + K+
Sbjct: 160 TEYLAPEVLLDEKGYTKHV-DFWSLGVLVFEMCCGWSPFYAEDTQQMYR----NIAFGKV 214

Query: 904 ALPKKVMG 911
             PK V+ 
Sbjct: 215 RFPKNVLS 222

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 33/216 (15%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIIT 738
           +IG+G++G V+K    E    VA+K + LD   +G   S + E   L+ ++H+N++++  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 739 ICSSIDFKGADFK-AIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEY 791
           +  S      D K  +V+EY      D  L    D    G ++       + ++   + +
Sbjct: 67  VLHS------DKKLTLVFEY-----CDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAF 114

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
            H+H    ++H DLKP N+L++ +    ++DFGLAR      F +     S+ +    T+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSAEVV---TL 163

Query: 852 GYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRRRP 886
            Y  P+   G  L  T  D++S G +  E+    RP
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 682 IGKGSFGFVYKG--NLGEDGMSVAVKVM-NLDKKGATK-SFVAECEALRNIRHRNLIKII 737
           +G G+FG V KG   + +   +VAVK++ N +   A K   + E   ++ + +  ++++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       E     +V +V+  ++YL     
Sbjct: 63  GICE------AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET-- 114

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
              VH DL   NVLL     A +SDFGL++ L         +        K  + +  PE
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-----KWPVKWYAPE 168

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFT 882
                  S   DV+SFG+L+ E F+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 31/220 (14%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITI 739
           ++G+G++  VYKG     G  VA+K ++LD ++G   + + E   ++ ++H N++++  +
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVIEYLH 793
             +      +   +V+EYM      D   + +     G L      +   ++   I + H
Sbjct: 67  IHT-----ENKLMLVFEYMD----KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
            +    ++H DLKP N+L++      ++DFGLAR      F +     S+ +    T+ Y
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLAR-----AFGIPVNTFSNEVV---TLWY 166

Query: 854 IGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR---RPTDN 889
             P+  +G     T  D++S G ++ EM T R     T+N
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 42/218 (19%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   +IGKGSFG V+KG        VA+K+++L++        AE E + +I+    I 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L     D+ ++    I+ E+  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILK 112

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 113 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA-------------GQLTDTQI 156

Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           K     GT  ++ PE           D++S GI  +E+
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.6 bits (149), Expect = 7e-10
 Identities = 68/229 (29%), Positives = 97/229 (42%), Gaps = 29/229 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEAL-RNIRHRNLIKII 737
           IGKGSFG V       +    AVKV+    + KK   K  ++E   L +N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
                  F+ AD    V +Y+  G +   L      LE        E+AS + YLH+   
Sbjct: 62  ----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL-- 115

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             IV+ DLKP N+LLD      ++DFGL +        +   G +S+    GT  Y+ PE
Sbjct: 116 -NIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGTTST--FCGTPEYLAPE 166

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP---------TDNMFNDGLTL 897
                    T D +  G +L EM     P          DN+ N  L L
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 215

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 16/210 (7%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS---FVAECEA--LRNIRHRNLIKI 736
           +G+G+FG VY     + G  +AVK +  D +    S      ECE   L+N+ H  +++ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
                    +     +I  E+M  GS+ D L       E        ++   + YLH++ 
Sbjct: 70  YGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              IVH D+K +N+L D      + DFG ++ L      ++  G  S   + GT  ++ P
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKS---VTGTPYWMSP 178

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E   G       D++S G  ++EM T + P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 31/220 (14%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRN 732
           ++    +IG+G++G VYK        ++A+K + L++  +G   + + E   L+ ++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 733 LIKIITICSSIDFKGADFKA-IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-----EVA 786
           ++++  +  S      + +  +V+EY+      D   H +   +  K   +I     ++ 
Sbjct: 63  IVRLQDVVHS------EKRLYLVFEYLDL----DLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEGQSSSI 845
             I Y H+H    ++H DLKP N+L+D    A  ++DFGLAR      F +     +  +
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-----AFGIPVRTFTHEV 164

Query: 846 EMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRR 884
               T+ Y  PE  +G    S   D++S G +  EM  ++
Sbjct: 165 V---TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+FG VYK    E G   A KV+    +   + ++ E E L    H  ++K++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---G 76

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQPPI 800
           +  + G  +  I+ E+   G+VD  +   +  L   ++ ++  ++   ++YLH+     I
Sbjct: 77  AFYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KI 131

Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
           +H DLK  NVLL  D    ++DFG++                 +++ + +  +IG  Y M
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS------------AKNVKTLQRRDS--FIGTPYWM 177

Query: 861 GGDLSM-----------TGDVYSFGILLLEM 880
             ++ M             D++S GI L+EM
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)

Query: 682 IGKGSFGFVYKGN-LGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G FG V     +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L                   ++L   
Sbjct: 86  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL        +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 196

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 197 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 32/215 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN----IRHRNLIKII 737
           +GKGSFG V    L   G   AVK   L K         EC  +      +   N     
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVASVIEY 791
             C+   F+  +    V E++  G   D + H  DK   G+ ++        E+   +++
Sbjct: 61  LYCT---FQTKEHLFFVMEFLNGG---DLMFHIQDK---GRFDLYRATFYAAEIVCGLQF 111

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH+     I++ DLK  NV+LD D    ++DFG+ +    + F     G + +    GT 
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVF-----GDNRASTFCGTP 160

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            YI PE   G   + + D +SFG+LL EM   + P
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 36/222 (16%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK----------PAIRNQIIREL- 54

Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNI-VIE 784
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I VI+
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 114

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
             + +   H      I+H D+KPSN+L++      + DFG++  L            S +
Sbjct: 115 GLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMA 159

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
               GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 20/203 (9%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNL-DKKGATKSFVAECEALRNIRHRNLIKIITI 739
           ++G+GS+  VYKG    +G  VA+KV+ L +++G   + + E   L+ ++H N++ +  I
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 740 CSSIDFKGADFKAIVYEYMQY-GSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
             + +     F+ +  +  QY       LH  N KL       + ++   + Y+H   Q 
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL------FLFQLLRGLSYIH---QR 122

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            I+H DLKP N+L+       ++DFGLAR  S     V     S+ +    T+ Y  P+ 
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKS-----VPSHTYSNEVV---TLWYRPPDV 174

Query: 859 GMGG-DLSMTGDVYSFGILLLEM 880
            +G  + S   D++  G + +EM
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 60/230 (26%), Positives = 113/230 (49%), Gaps = 47/230 (20%)

Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNI-R 729
           +G+G FG V +        +  +  ++VAVK++   K  AT       ++E E ++ I +
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML---KDNATDKDLADLISEMELMKLIGK 76

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH--------HTNDKLEVGK--- 778
           H+N+I ++ +C+    +G  +  ++ EY   G++ ++L         +T D  +V +   
Sbjct: 77  HKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 779 -----LNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH 832
                ++   +VA  +EYL +  C    +H DL   NVL+  D V  ++DFGLAR +   
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187

Query: 833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +      ++S+  +   + ++ PE       +   DV+SFGIL+ E+FT
Sbjct: 188 DYY----KKTSNGRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.9 bits (146), Expect = 2e-09
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 49/226 (21%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA---ECEALRNIR------- 729
            ++GKG++G V+K         VA+K          K F A     +A R  R       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62

Query: 730 ---HRNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLH---HTNDKLEVGKLNI 781
              H N++K++ +      K  + K I  V+EYM+    D  LH     N   +V K  I
Sbjct: 63  LGDHPNIVKLLNV-----IKAENDKDIYLVFEYME---TD--LHAVIRANILEDVHKRYI 112

Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
           + ++   ++Y+H+     ++H DLKPSN+LL+ D    ++DFGLAR LS        E  
Sbjct: 113 MYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL-----EENP 164

Query: 842 SSSI--EMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
            + +  +   T  Y  PE  +G      G D++S G +L EM   +
Sbjct: 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 47/226 (20%)

Query: 682 IGKGSFGFVYKGNLGEDG--MSVAVKVMN-LDKKGATKSFVAECEALRNI-RHRNLIKII 737
           IG+G+FG V K  + +DG  M  A+K M     K   + F  E E L  +  H N+I ++
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVGKL-NI 781
             C     +G  + AI  EY  +G++ D+L               + T   L   +L + 
Sbjct: 63  GACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +VA  ++YL    Q   +H DL   N+L+  + VA ++DFGL+R              
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-------------- 160

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-----GDVYSFGILLLEMFT 882
              + +K T+G +   +     L+ +      DV+S+G+LL E+ +
Sbjct: 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 34/219 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG FG V    +   G   A K ++   L KK   K  + E E L  +   N   I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY------- 791
           +  + + K      +V   M  G   D  +H  +  E G     +E+  VI Y       
Sbjct: 58  LAYAFESK--THLCLVMSLMNGG---DLKYHIYNVGERG-----LEMERVIHYSAQITCG 107

Query: 792 -LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            LH H    IV+ D+KP NVLLD      +SD GLA        +   +G++ + +  GT
Sbjct: 108 ILHLH-SMDIVYRDMKPENVLLDDQGNCRLSDLGLA--------VELKDGKTIT-QRAGT 157

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            GY+ PE       S   D ++ G  + EM   R P  +
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 3e-09
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 28/222 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG+FG V        G   A+K++  +    K      + E   L+N RH  L  +  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-- 60

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHC 796
                 F+  D    V EY   G +  + H + +++  E        E+ S ++YLH+  
Sbjct: 61  ---KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHS-- 113

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGY 853
           +  +V+ DLK  N++LD D    ++DFGL +           EG      MK   GT  Y
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKTFCGTPEY 162

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
           + PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.7 bits (144), Expect = 3e-09
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 34/222 (15%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
            +F   + +G G+ G V K      G+ +A K+++L+ K           A+RN   R L
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54

Query: 734 IKIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIE 784
            +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   
Sbjct: 55  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-- 111

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           V   + YL    Q  I+H D+KPSN+L++      + DFG++  L            S +
Sbjct: 112 VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMA 159

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
               GT  Y+ PE   G   S+  D++S G+ L+E+   R P
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 3e-09
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 17/160 (10%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           +EF     I +G+FG VY G    +    AVKV+   ++  K       AE +AL     
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA---- 59

Query: 731 RNLIK---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
             L K   I+ +  S+  + A+   +V EY+  G V   LH      E   +  + EVA 
Sbjct: 60  --LSKSPFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL 115

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
            ++YLH H    I+H DLKP N+L+ ++    ++DFGL++
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 16/210 (7%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEA--LRNIRHRNLIKI 736
           +G+G+FG VY     + G  +AVK +  D   ++ + +    ECE   L+N+RH  +++ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
                  + K     +I  EYM  GS+ D L       E        ++   + YLH++ 
Sbjct: 70  YGCLRDPEEKKL---SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              IVH D+K +N+L D      + DFG ++ +      ++  G  S   + GT  ++ P
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKS---VTGTPYWMSP 178

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E   G       DV+S    ++EM T + P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 31/85 (36%), Positives = 51/85 (60%), Gaps = 1/85 (1%)

Query: 347 GALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELR 406
           G +P+ I+ L    + I ++GN I G IPP + ++ +L  L L YN   G+IP ++G+L 
Sbjct: 432 GFIPNDISKLRHLQS-INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 407 NLQYLGLVGNNIRGIIPDPIGNLTL 431
           +L+ L L GN++ G +P  +G   L
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 54/236 (22%)

Query: 682 IGKGSFGFVYKGNL----GEDGMS-VAVKVMNLDKKGATKS----FVAECEALRNIRHRN 732
           +G+G FG V K       G  G + VAVK++   K+ A+ S     ++E   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT--------------------ND 772
           +IK+   CS     G     ++ EY +YGS+  +L  +                    N 
Sbjct: 65  VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 773 KLEVGKLNIVIEVASVI----EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
                 +  +I  A  I    +YL    +  +VH DL   NVL+       +SDFGL+R 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 829 LSHHPFLVAPEGQSSSIEMKGTI--GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +         E  S     KG I   ++  E       +   DV+SFG+LL E+ T
Sbjct: 177 VY--------EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 41/227 (18%)

Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLI 734
           +G G FG + +G L    +  + VA+  +   + G +    + F+AE   L    H N++
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 735 K---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
           +   +IT  +++         IV EYM  G++D +L     +L  G+L  ++  +AS ++
Sbjct: 70  RLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMK 848
           YL    +   VH  L    VL++ D+V  +S F               E +S +I   M 
Sbjct: 122 YL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRL-----------QEDKSEAIYTTMS 167

Query: 849 G--TIGYIGPEYGMGGDLSMTGDVYSFGILLLE-MFTRRRPTDNMFN 892
           G   + +  PE       S   DV+SFGI++ E M    RP  +M  
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 39/226 (17%)

Query: 682 IGKGSFGFVYKGN-LGED------GMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G FG V     +G D       ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH---------------TNDKLEVG 777
           +I ++  C+    +      +V EY   G++ ++L                   ++L   
Sbjct: 80  IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + +  +  
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY- 190

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 191 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.0 bits (141), Expect = 5e-09
 Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 36/216 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G G FG V    +     + A+K +      + G  +   +E E L    H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
                 FK   +  ++ EY   G +   L       + G  +       +  V    EYL
Sbjct: 61  -----TFKDKKYIYMLMEYCLGGELWTILR------DRGLFDEYTARFYIACVVLAFEYL 109

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           HN     I++ DLKP N+LLD +    + DFG A+ L              +    GT  
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---------SGQKTWTFCGTPE 157

Query: 853 YIGPE--YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Y+ PE     G D S+  D +S GILL E+ T R P
Sbjct: 158 YVAPEIILNKGYDFSV--DYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 22/156 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           IG+G++G V      E    VA+K +    D +   K  + E + LR++ H N+I I  I
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHH--------TNDKLEVGKLNIVIEVASVIEY 791
                 +  +   IVYE M     D  LH         ++D  +      + ++   ++Y
Sbjct: 73  MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQY----FLYQLLRGLKY 123

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
           +H+     ++H DLKPSN+LL+ +    + DFGLAR
Sbjct: 124 IHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 53/208 (25%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +++G+G++  V+KG        VA+K + L+ ++GA  + + E   L+N++H N++ +  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHCQ 797
           I  +          +V+EY+    +  +L +  + + +  + I + ++   + Y H    
Sbjct: 71  IIHT-----ERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-- 122

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H DLKP N+L++      ++DFGLAR  S     V  +  S+ +    T+ Y  P+
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKS-----VPTKTYSNEVV---TLWYRPPD 173

Query: 858 YGMGG-DLSMTGDVYSFGILLLEMFTRR 884
             +G  + S   D++  G +L EM T R
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 45/229 (19%)

Query: 682 IGKGSFGFVYKGN-LGED------GMSVAVKVMNLDKKGATKS----FVAECEALRNI-R 729
           +G+G FG V     LG D       ++VAVK++   K  AT+      V+E E ++ I +
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 79

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK--- 778
           H+N+I ++  C+    +      IV EY   G++ ++L         ++ D   V     
Sbjct: 80  HKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 779 -----LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
                ++   +VA  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +         +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 192 YY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 32/212 (15%)

Query: 682 IGKGSFGFVYKG--NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G G+FG V KG   + +  + VA+KV+ N ++K      + E E +  + +  ++++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI---EVASVIEYLHNH 795
           +C       A+   +V E    G ++ +L    D++ V   N+V    +V+  ++YL   
Sbjct: 63  VCE------AEALMLVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLE-- 112

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG--- 852
                VH DL   NVLL +   A +SDFGL++ L          G   S     + G   
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL----------GADDSYYKARSAGKWP 161

Query: 853 --YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             +  PE       S   DV+S+GI + E F+
Sbjct: 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 14/237 (5%)

Query: 69  LESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRL-FRLETIVLSNNSFSGKIP 127
             + N        +  L+ L  ++L NN+    IP  +G L   L+ + LS+N     +P
Sbjct: 99  DLNLNRLRSNISELLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELDLSDNKIE-SLP 156

Query: 128 TNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTF 187
           + L    NL +  +  N+L  ++  ++ N   +  L L GN+++  LPP I  LSAL+  
Sbjct: 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214

Query: 188 DIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLP 247
           D++ N +   +  SL  L+NL+ L  S N      P S+ N+S+L+   L  N+   S  
Sbjct: 215 DLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQ--ISSI 270

Query: 248 VCLGFNLPKLTVLVVAQNNLTGFLPQS----LSNASKLEWLELNENHFSGQVRINFN 300
             LG +L  L  L ++ N+L+  LP      L     L  L   +        I  N
Sbjct: 271 SSLG-SLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLN 326

Length = 394

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 21/203 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---ATKSFVAECEALRNIRHRNLIKIIT 738
           +G+G++G V K    E    VA+K    D +      ++ + E + LR ++  N++++  
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+      +V+EY++   ++      N        + + ++   I + H +   
Sbjct: 68  A-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN--- 119

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS-IEMKGTIGYIGPE 857
            IVH D+KP N+L+ H+ V  + DFG AR LS        EG +++  E   T  Y  PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLS--------EGSNANYTEYVATRWYRSPE 171

Query: 858 YGMGGDLSMTGDVYSFGILLLEM 880
             +G       D++S G +L E+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 35/212 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+ G VYK         +AVKV+ LD            E  + I     ++I+  C 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLD---------ITVELQKQIMSE--LEILYKCD 57

Query: 742 S---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
           S   I F GA F     +I  E+M  GS+D  ++    +  +G+  I + V   + YL +
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSLD--VYRKIPEHVLGR--IAVAVVKGLTYLWS 113

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                I+H D+KPSN+L++      + DFG++  L +          S +    GT  Y+
Sbjct: 114 L---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----------SIAKTYVGTNAYM 160

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            PE   G    +  DV+S GI  +E+   R P
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 25/252 (9%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGM---SVAVKVMNLDKKGATKSFVAECEALRNIRH 730
           KE+     IG G FG VY+     D         K+ NL+     ++ V E     NI  
Sbjct: 12  KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLE----NETIVMETLVYNNIYD 67

Query: 731 RNLIKIITICSSIDFKG-------ADFK--AIVYEYMQ----YGSVDDWLHHTNDKLEVG 777
            + I +     +ID  G         FK   + Y ++       +  +       K +  
Sbjct: 68  IDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL 127

Query: 778 KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
             NI+ ++ + +EY+H H    I HGD+KP N+++D +   ++ D+G+A     H   + 
Sbjct: 128 IKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIE 184

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 897
              +   +  +GT+ Y G +   G  ++  GD+ S G  +L+    + P     ++G  +
Sbjct: 185 YSKEQKDLH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243

Query: 898 HGYAKMALPKKV 909
           H  AK    K++
Sbjct: 244 HA-AKCDFIKRL 254

Length = 294

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 36/125 (28%), Positives = 64/125 (51%), Gaps = 12/125 (9%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  +++LH+     I++ DLKP N+LLD +    ++DFGL++    H        +  
Sbjct: 106 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--------EKK 154

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM-FNDGLTLHGYAK 902
           +    GT+ Y+ PE       + + D +SFG+L+ EM T   P       + +T+   AK
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214

Query: 903 MALPK 907
           + +P+
Sbjct: 215 LGMPQ 219

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 29/165 (17%)

Query: 682 IGKGSFGFVYKGNL--GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKI 736
           IG+G++G VYK     G+DG   A+K    DK+   G ++S   E   LR ++H N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 737 ITICSSIDFKGADFKA-IVYEYMQYGSVDDW----LHHTNDKLEVGKL---NIVIEVASV 788
           + +      + AD    ++++Y ++   D W     H    ++ +      +++ ++ + 
Sbjct: 68  VEVF----LEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARF 828
           + YLH N     ++H DLKP+N+L+        V  + D GLAR 
Sbjct: 121 VHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.9 bits (140), Expect = 2e-08
 Identities = 26/69 (37%), Positives = 44/69 (63%), Gaps = 1/69 (1%)

Query: 541 GSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSN 599
           G IP  ++ L+ ++ ++LS N++ G IP  LG++  LE L+LSYN F G +P+  G  ++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 600 ETRISLTGN 608
              ++L GN
Sbjct: 492 LRILNLNGN 500

Length = 623

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 37/220 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK----SFVAECEALRNIRHRNLIKII 737
           IG G FG V  G     GMS A  V+   +  AT      F+ E +  R + H N+++ +
Sbjct: 3   IGNGWFGKVLLGEA-HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 738 TIC-SSIDFKGADFKAIVYEYMQYGSVDDWL-----HHTNDKLEVGKLNIVIEVASVIEY 791
             C  SI +       +V E+   G + ++L            +     +  EVAS + +
Sbjct: 62  GQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP--FLVAPEGQSSSIEMKG 849
           LH   Q   +H DL   N  L  D+   + D+GLA  L  +P  + +  +  +  +    
Sbjct: 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR--- 167

Query: 850 TIGYIGPEYG-------MGGDLSMTGDVYSFGILLLEMFT 882
              ++ PE         +  D +   +++S G+ + E+FT
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 28/208 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN----LDKKGATKSFVAECEAL-RNIRHRNLIKI 736
           IGKGSFG V       DG   AVKV+     L++K   K  +AE   L +N++H  L+ +
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAERNVLLKNVKHPFLVGL 61

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
                   F+  +    V +++  G +   L       E        E+AS + YLH+  
Sbjct: 62  -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS-- 114

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS---SSIEMKGTIGY 853
              IV+ DLKP N+LLD      ++DFGL +           EG +   ++    GT  Y
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK-----------EGIAQSDTTTTFCGTPEY 162

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMF 881
           + PE         T D +  G +L EM 
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 40/217 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+ G V K      G+ +A K+++L+ K           A+RN   R L K++  C+
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL-KVLHECN 57

Query: 742 S---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEVASVIEYL 792
           S   + F GA +     +I  E+M  GS+D  L       E  +GK  I I V   + YL
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYL 115

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ---SSSIEMKG 849
               +  I+H D+KPSN+L++      + DFG++             GQ   S +    G
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-------------GQLIDSMANSFVG 160

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           T  Y+ PE   G   ++  D++S G+ L+EM   R P
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 42/237 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRH 730
            +F     IG+G+FG V+     + G   A+KV+    + K+       AE + L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKLEVGKLNIVIEVASV 788
             ++K+    S   F+  +   +V EYM  G + + L       + E  +  I  E+   
Sbjct: 61  PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARFYIA-ELVLA 113

Query: 789 IEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFL--SHHPFLVAPEGQSS 843
           ++ +H        +H D+KP N+L+D D   H+  +DFGL + +  +        +  + 
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 844 SIEMK-------------------GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
                                   GT  YI PE   G    +  D +S G++L EM 
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 29/214 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRNIRHRNLIKIITI 739
           IG+GSFG +Y      D     +K ++L K    +   ++ E   L  ++H N   I+T 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN---IVTF 64

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQ 797
            +S    G  F  IV EY   G +   ++     L  E   L+  ++++  ++++H+   
Sbjct: 65  FASFQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120

Query: 798 PPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK----GTIG 852
             I+H D+K  N+ L  + MVA + DFG+AR L            + S+E+     GT  
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL------------NDSMELAYTCVGTPY 167

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Y+ PE       +   D++S G +L E+ T + P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 33/216 (15%)

Query: 682 IGKGSFGFVYKG---NLGEDG----MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +G+G+F  ++KG    +G+ G      V +KV++   +  ++SF      +  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVASVIEYLH 793
               +C        D   +V EY+++GS+D +L    + + +  KL +  ++A  + +L 
Sbjct: 63  LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE 117

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL------VAPEGQSSSIEM 847
           +     + HG++   NVLL  +           R   + PF+      ++       I +
Sbjct: 118 DK---GLTHGNVCAKNVLLIREE---------DRKTGNPPFIKLSDPGISITVLPKEI-L 164

Query: 848 KGTIGYIGPE-YGMGGDLSMTGDVYSFGILLLEMFT 882
              I ++ PE      +LS+  D +SFG  L E+F+
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 48/201 (23%), Positives = 93/201 (46%), Gaps = 30/201 (14%)

Query: 696 GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV 754
           G   + VAVK++  D  K A   F+ E + +  ++  N+I+++ +C +     +D   ++
Sbjct: 43  GNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMI 97

Query: 755 YEYMQYGSVDDWL--HHTNDKLEVGK---------LNIVIEVASVIEYLHNHCQPPIVHG 803
            EYM+ G ++ +L  H   +  E            + +  ++AS ++YL +      VH 
Sbjct: 98  TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHR 154

Query: 804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IGYIGPEYGMG 861
           DL   N L+  +    ++DFG++R L          G    I+ +    I ++  E  + 
Sbjct: 155 DLATRNCLVGKNYTIKIADFGMSRNLY--------SGDYYRIQGRAVLPIRWMSWESILL 206

Query: 862 GDLSMTGDVYSFGILLLEMFT 882
           G  +   DV++FG+ L E+ T
Sbjct: 207 GKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 36/229 (15%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           ++F    RIG G++G VYK      G   A+KV+ L+          E   +++ +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           +          +   D   I  E+   GS+ D  H T    E     +  E    + YLH
Sbjct: 69  VAYFG-----SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSS 843
           +  +   +H D+K +N+LL  +    ++DFG++  ++            P+ +APE   +
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE--VA 178

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
           ++E KG  GY           +   D+++ GI  +E+   + P   MF+
Sbjct: 179 AVERKG--GY-----------NQLCDIWAVGITAIELAELQPP---MFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 3e-08
 Identities = 65/236 (27%), Positives = 95/236 (40%), Gaps = 44/236 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG  G V+   L   G   A+KV++   + K+   K  + E E L  + H     + T
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVASVIEYLHNH 795
           + +S  F+   +  +V +Y   G +   L     K    EV +     EV   +EYLH  
Sbjct: 66  LYAS--FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-YAAEVLLALEYLHLL 122

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMK----- 848
               IV+ DLKP N+LL      H+  SDF L++     P  V+   +  S         
Sbjct: 123 ---GIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 849 ----------------GTIGYIGPEY--GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                           GT  YI PE   G G   ++  D ++ GILL EM     P
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+   +E LH   +   V+ DLKP N+LLD      +SD GLA        +  PEG+S 
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA--------VKIPEGESI 158

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              + GT+GY+ PE       +++ D +  G L+ EM   + P
Sbjct: 159 RGRV-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 38/202 (18%)

Query: 702 VAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQY 760
           VAVK++  D  K A   F+ E + L  ++  N+I+++ +C        D   ++ EYM+ 
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYMEN 103

Query: 761 GSVDDWL--HHTNDKLEVGK-----------------LNIVIEVASVIEYLHNHCQPPIV 801
           G ++ +L  HH +DK E G                  L++ +++AS ++YL +      V
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160

Query: 802 HGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IGYIGPEYG 859
           H DL   N L+  ++   ++DFG++R L          G    I+ +    I ++  E  
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLY--------AGDYYRIQGRAVLPIRWMAWECI 212

Query: 860 MGGDLSMTGDVYSFGILLLEMF 881
           + G  +   DV++FG+ L E+ 
Sbjct: 213 LMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 22/212 (10%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRH 730
           K+F    ++G+G +G V+     + G  VA+K M    L K    +  + E + L   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
             L+K++       F+  ++  +  EY+  G     L++     E      + E+   ++
Sbjct: 61  EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            LH   +   +H DLKP N L+D      ++DFGL++              + +  + G+
Sbjct: 116 ALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----------GIVTYANSVVGS 161

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             Y+ PE   G     T D +S G +L E   
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 62/228 (27%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN------LDKKGATKSFVAECEALRNIRHRN--- 732
           +G G++G V      + G  VA+K ++      +  K   +    E   L+++ H N   
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENVIG 78

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVA 786
           L+ + T  SS++    DF+  VY        D  L++    ++  KL+      +V ++ 
Sbjct: 79  LLDVFTPASSLE----DFQD-VYLVTHLMGAD--LNNI---VKCQKLSDDHIQFLVYQIL 128

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             ++Y+H+     I+H DLKPSN+ ++ D    + DFGLAR                  E
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--------------E 171

Query: 847 MKG---TIGYIGPE-------YGMGGDLSMTGDVYSFGILLLEMFTRR 884
           M G   T  Y  PE       Y      + T D++S G ++ E+ T +
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 40/217 (18%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLI---KI 736
           ++G+GS+  VYKG     G  VA+K + L+ ++GA  + + E   L++++H N++    I
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 737 ITICSSIDFKGADFKAIVYEYM-----QYGSVDDW---LHHTNDKLEVGKLNIVIEVASV 788
           I    ++          V+EY+     QY  +DD    L   N +L       + ++   
Sbjct: 72  IHTKKTLTL--------VFEYLDTDLKQY--MDDCGGGLSMHNVRL------FLFQLLRG 115

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H   Q  ++H DLKP N+L+       ++DFGLAR  S     V  +  S+ +   
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKS-----VPSKTYSNEVV-- 165

Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRR 884
            T+ Y  P+  +G  + S + D++  G +  EM T R
Sbjct: 166 -TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.5 bits (134), Expect = 6e-08
 Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 17/108 (15%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+   +++LH      I++ DLK  NVLLD +    ++DFG+ +           EG   
Sbjct: 104 EIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-----------EGILG 149

Query: 844 SIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
            +      GT  YI PE           D ++ G+LL EM   + P +
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 30/214 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN------IRHRNLIK 735
           +GKGSFG V+   L       A+K   L K         EC  +          H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH--TNDKLEVGKLNI-VIEVASVIEYL 792
           +   C+   F+  +    V EY+  G   D + H  +  K ++ +      E+   +++L
Sbjct: 61  LY--CT---FQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFYAAEIICGLQFL 112

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H+     IV+ DLK  N+LLD D    ++DFG+ +       L    G + +    GT  
Sbjct: 113 HSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK----ENML----GDAKTCTFCGTPD 161

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           YI PE  +G   + + D +SFG+LL EM   + P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 39/219 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIIT--- 738
           IG+G FG VY     + G   A+K   LDKK   K    E  AL     R ++ +++   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKC--LDKK-RIKMKQGETLALN---ERIMLSLVSTGD 55

Query: 739 ----ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI---EY 791
               +C S  F   D  + + + M  G   D  +H +      +  +    A +I   E+
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQSSSIEMKGT 850
           +HN     +V+ DLKP+N+LLD      +SD GLA  F    P         +S+   GT
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HASV---GT 158

Query: 851 IGYIGPEY---GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GY+ PE    G+  D S   D +S G +L ++     P
Sbjct: 159 HGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 32/208 (15%)

Query: 702 VAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQY 760
           VAVKV+  D    A + F+ E + L  +   N+ +++ +C+           ++ EYM+ 
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMEN 103

Query: 761 GSVDDWLHH----TNDKLEVGK-------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSN 809
           G ++ +L      T+      K       L +  ++AS + YL +      VH DL   N
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160

Query: 810 VLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IGYIGPEYGMGGDLSMT 867
            L+  +    ++DFG++R L               ++ +    I ++  E  + G  +  
Sbjct: 161 CLVGKNYTIKIADFGMSRNLY--------SSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212

Query: 868 GDVYSFGILLLEMFT--RRRPTDNMFND 893
            DV++FG+ L E+ T  R +P +++ + 
Sbjct: 213 SDVWAFGVTLWEILTLCREQPYEHLTDQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 45/279 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+ G V K      G  +A KV+++  K           ++R    R L +I+  C 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK----------SSVRKQILREL-QIMHECR 61

Query: 742 S---IDFKGADFKA-----IVYEYMQYGSVDDWLHHTND-KLEV-GKLNIVIEVASVIEY 791
           S   + F GA F       +  E+M  GS+D          +E+ GK  I + V   + Y
Sbjct: 62  SPYIVSFYGA-FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTY 118

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L+N  +  I+H D+KPSN+L++      + DFG++  L +          S +    GT 
Sbjct: 119 LYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----------SIADTFVGTS 166

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG 911
            Y+ PE   GG  ++  DV+S GI ++E+   + P    F++         M +   +  
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGILDLLQQ 224

Query: 912 IV-DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
           IV +P   + +   S F E L   V    AC ++ P+ER
Sbjct: 225 IVQEPPPRLPS---SDFPEDLRDFVD---ACLLKDPTER 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNL------DKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+F   Y+    + G  +AVK +        +++   ++   E   +  + H ++I+
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH 795
                     + + F  +  E+M  GSV   L       E   +N   ++   + YLH +
Sbjct: 68  ----MLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 796 CQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               I+H D+K +N+L+D     +   ++DFG A  L+      A E Q    ++ GTI 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAK-GTGAGEFQG---QLLGTIA 173

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           ++ PE   G     + DV+S G +++EM T + P + 
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 34/215 (15%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +++G+G++  VYKG        VA+K + L+ ++GA  + + E   L++++H N++ +  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 739 ICSSIDFKGADFKAIVYEYM-----QYGSVDD---WLHHTNDKLEVGKLNIVIEVASVIE 790
           I  +          +V+EY+     QY  +DD    ++  N KL       + ++   + 
Sbjct: 72  IIHT-----EKSLTLVFEYLDKDLKQY--LDDCGNSINMHNVKL------FLFQLLRGLN 118

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y H      ++H DLKP N+L++      ++DFGLAR  S     +  +  S+ +    T
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-----IPTKTYSNEVV---T 167

Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRR 884
           + Y  P+  +G  D S   D++  G +  EM T R
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 30/213 (14%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHR 731
           +F     +G GSFG V        G   A+K +    + K    +    E   L  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVAS 787
            ++ ++  CS   F+  +    + E++  G +   L       ND   V K     E+  
Sbjct: 79  FIVNMM--CS---FQDENRVYFLLEFVVGGELFTHLRKAGRFPND---VAKF-YHAELVL 129

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
             EYLH+     I++ DLKP N+LLD+     V+DFG A+ +    F +           
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC---------- 176

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE           D ++ G+LL E 
Sbjct: 177 -GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 24/211 (11%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V    L E G   AVKV+  D   +    +  + E   L   R+   +  + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVASVIEYLHNH 795
            C    F+  D    V E++  G   D + H        E        E+ S + +LH+ 
Sbjct: 63  CC----FQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
               I++ DLK  NVLLDH+    ++DFG+ +            G+++S    GT  YI 
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-------NGKTTST-FCGTPDYIA 164

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           PE         + D ++ G+LL EM     P
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 66/241 (27%), Positives = 105/241 (43%), Gaps = 62/241 (25%)

Query: 676 FSSSN-----RIGKGSFGFVYKGNLGEDGMSVAVKVM--NLDKKGATKSFVAECEALRNI 728
           F++ +      IG+G+FG V K      G  +AVK +   +D+K   K  + + + +  +
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-EQKRLLMDLDVV--M 57

Query: 729 RHRNLIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLE-------VG 777
           R  +   I+       F GA F+     I  E M   S+D +  +  + L+       +G
Sbjct: 58  RSSDCPYIVK------FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILG 110

Query: 778 KLNIVIEVASV--IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH---- 831
           K    I VA+V  + YL    +  I+H D+KPSN+LLD +    + DFG++  L      
Sbjct: 111 K----IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164

Query: 832 ------HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR 885
                  P++ APE              I P    G D+    DV+S GI L E+ T + 
Sbjct: 165 TRDAGCRPYM-APE-------------RIDPSARDGYDVR--SDVWSLGITLYEVATGKF 208

Query: 886 P 886
           P
Sbjct: 209 P 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 35/218 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS---FVAECEALRNIRHRNLIKIIT 738
           IG G FG V  G +        V V  L    + +    F+ E +  R+++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 739 ICSS-IDFKGADFKAIVYEYMQYGSVDDWLHH-------TNDKLEVGKLNIVIEVASVIE 790
            C+    +       +V E+   G +  +L         T D   + ++    E+A  + 
Sbjct: 63  QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLL 114

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +LH +     +H DL   N LL  D+   + D+GL+       + V P+      ++   
Sbjct: 115 HLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD------QLWVP 165

Query: 851 IGYIGPE-----YG--MGGDLSMTGDVYSFGILLLEMF 881
           + +I PE     +G  +  D +   +V+S G+ + E+F
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 51/230 (22%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI-ITIC 740
           +G+G++G V K      G  +AVK +        ++ V   E     + R L+ + I++ 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--------RATVNSQE-----QKRLLMDLDISMR 55

Query: 741 SS-----IDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLE------VGKLNIVIEV 785
           S      + F GA F+     I  E M   S+D +     DK        +GK  I + +
Sbjct: 56  SVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGK--IAVSI 112

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              +EYLH+  +  ++H D+KPSNVL++ +    + DFG++ +L            S + 
Sbjct: 113 VKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV----------DSVAK 160

Query: 846 EMK-GTIGYIGPEYGMGGDLSMTG-----DVYSFGILLLEMFTRRRPTDN 889
            +  G   Y+ PE  +  +L+  G     DV+S GI ++E+ T R P D+
Sbjct: 161 TIDAGCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 35/217 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIIT--- 738
           IG+G FG VY     + G   A+K   LDKK   K    E  AL     R ++ +++   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKC--LDKK-RIKMKQGETLALN---ERIMLSLVSTGD 55

Query: 739 ----ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI---EY 791
               +C +  F   D    + + M  G   D  +H +      +  +      +I   E+
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGG---DLHYHLSQHGVFSEKEMRFYATEIILGLEH 112

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQSSSIEMKGT 850
           +HN     +V+ DLKP+N+LLD      +SD GLA  F    P         +S+   GT
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HASV---GT 158

Query: 851 IGYIGPE-YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GY+ PE    G     + D +S G +L ++     P
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 28/213 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +GKGSFG V    L       A+K   L K    +    EC  +     R ++ +     
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVE----RRVLALAWEHP 56

Query: 742 SI-----DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI---EYLH 793
            +      F+  +    V EY+  G   D + H        +       A +I   ++LH
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                 I++ DLK  NVLLD D    ++DFG+ +        +  EG++S+    GT  Y
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN------MNGEGKAST--FCGTPDY 162

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           I PE   G   + + D +SFG+LL EM   + P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 42/228 (18%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMNLDKKGATKSFVAECEALRNIRHRN 732
             + + + IG+G++G V        G+ VA+K +   + +   +  + E + LR  +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 733 LIKIITICSSIDFKGADFKA--IVYEYMQYGSVDDWLHH-------TNDKLEVGKLNIVI 783
           +I I+ I     F    F    IV E M+    D  L+        +ND ++      + 
Sbjct: 65  IIGILDIIRPPSF--ESFNDVYIVQELME---TD--LYKLIKTQHLSNDHIQY----FLY 113

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           ++   ++Y+H+     ++H DLKPSN+LL+ +    + DFGLAR       +  PE   +
Sbjct: 114 QILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR-------IADPEHDHT 163

Query: 844 S--IEMKGTIGYIGPEYGMGGDLSMTG-----DVYSFGILLLEMFTRR 884
               E   T  Y  PE  M   L+  G     D++S G +L EM + R
Sbjct: 164 GFLTEYVATRWYRAPEI-M---LNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 44/221 (19%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           IG G+FG V+      DG  VA+K M        + K    E + L   +H N++  + I
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 740 CSS--IDFKGADFKAI--VYEYMQYGSVDDWLHH--------TNDKLEVGKLNIVIEVAS 787
                ID     F+ I  V E MQ       LH         ++D ++V     + ++  
Sbjct: 68  LQPPHIDP----FEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKV----FLYQILR 114

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+     I+H D+KP N+L++ + V  + DFGLAR           E    S  M
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV----------EEPDESKHM 161

Query: 848 KG---TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
                T  Y  PE  MG     +  D++S G +  E+  RR
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 51/226 (22%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMNLDKKGA-TKSFVAECEALRNIRH 730
           T  +     +G G+FG V        G +VA+K +M         K    E + L+++RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 731 RNLIKI--ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IV 782
            N+I +  I I    D         +Y   +    D  LH     L    L        +
Sbjct: 69  ENIISLSDIFISPLED---------IYFVTELLGTD--LHRL---LTSRPLEKQFIQYFL 114

Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            ++   ++Y+H+     +VH DLKPSN+L++ +    + DFGLAR               
Sbjct: 115 YQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---------- 161

Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTG-------DVYSFGILLLEMF 881
                    GY+   Y    ++ +T        D++S G +  EM 
Sbjct: 162 -------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 31/223 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITIC 740
           +G G++G VYKG   + G   A+KVM++ +    +    E   L+    HRN+       
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 741 SSIDFKGADFKA-IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQ 797
                 G D +  +V E+   GSV D + +T  N   E     I  E+   + +LH H  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-- 140

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSSSIEM 847
             ++H D+K  NVLL  +    + DFG++  L             P+ +APE  +     
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 199

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
             T  Y               D++S GI  +EM     P  +M
Sbjct: 200 DATYDY-------------RSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 40/221 (18%)

Query: 682 IGKGSFGFVYKGNL----GEDGMSVAVKVMN----LDKKG-ATKSFVAECEALRNIRHRN 732
           +G+G+F  +YKG L      D +    +V      L      + +F      +  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVASVIEY 791
           L+K+  +C        D   +V EY+++G +D +LH   + + +  KL++  ++AS + Y
Sbjct: 63  LVKLYGVCV------RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHY 116

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-------MVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           L +     +VHG++   N+L+              +SD G+   +      V        
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------ 167

Query: 845 IEMKGTIGYIGPEYGMGGDLSMT--GDVYSFGILLLEMFTR 883
                 I +I PE    G  S+T   D +SFG  LLE+ + 
Sbjct: 168 ------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--ECEALRNIRHRNLIKIIT 738
           +IG+GSFG        EDG    +K +N+ K    +   +  E   L N++H N   I+ 
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN---IVQ 63

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHC 796
              S +  G  +  IV +Y + G +   ++     L  E   L+  +++   ++++H+  
Sbjct: 64  YQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR- 120

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK----GTIG 852
              I+H D+K  N+ L  D    + DFG+AR L            +S++E+     GT  
Sbjct: 121 --KILHRDIKSQNIFLTKDGTIKLGDFGIARVL------------NSTVELARTCIGTPY 166

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           Y+ PE       +   D+++ G +L EM T
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 58/211 (27%), Positives = 84/211 (39%), Gaps = 25/211 (11%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG+FG V        G   A+K++  +    K      + E   L+N RH  L  +  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-- 60

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+  D    V EY   G +   L       E        E+ S + YLH+    
Sbjct: 61  ---KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC--- 114

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGYIG 855
            +V+ DLK  N++LD D    ++DFGL +           EG S    MK   GT  Y+ 
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEYLA 163

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           PE     D     D +  G+++ EM   R P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 49/226 (21%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIKIITIC 740
           +GKG++G VYK      G+++A+K + L+   +     + E + L    H+ +   I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61

Query: 741 SSIDFKGADF-KAIVY---EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA-SVIEYL--- 792
             +DF GA F +  VY   EYM  GS+D  L+      E    +++  +  +V++ L   
Sbjct: 62  --VDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 793 ---HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
              HN     I+H D+KP+NVL++ +    + DFG++             G   +   K 
Sbjct: 119 KEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVS-------------GNLVASLAKT 160

Query: 850 TIG---YIGPEY----GMGGDLSMT--GDVYSFGILLLEMFTRRRP 886
            IG   Y+ PE     G   + + T   DV+S G+ +LEM   R P
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 52/239 (21%), Positives = 102/239 (42%), Gaps = 31/239 (12%)

Query: 672 ATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAECEAL 725
           A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E   +
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK------- 778
           +     ++++++ + S           ++ E M  G +  +L     ++E          
Sbjct: 64  KEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 779 ---LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
              + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +    + 
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175

Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFND 893
              +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   M N+
Sbjct: 176 --RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 40/222 (18%)

Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNLIK 735
           +G+GSFG VY+GN      GE    VAVK +N       +  F+ E   ++     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGK--------LNIVIEV 785
           ++ + S    KG     +V E M +G +  +L     + E   G+        + +  E+
Sbjct: 74  LLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
           A  + YL+       VH DL   N ++ HD    + DFG+ R +             +  
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-----------YETDY 174

Query: 846 EMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             KG  G     ++ PE    G  + + D++SFG++L E+ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNI-RHRNLIKIIT 738
           +G G++G VYKG   + G   A+KVM++  D++   K    E   L+    HRN+     
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYG 70

Query: 739 ICSSIDFKGADFKA-IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNH 795
                +  G D +  +V E+   GSV D + +T  N   E     I  E+   + +LH H
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSSSI 845
               ++H D+K  NVLL  +    + DFG++  L             P+ +APE      
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE------ 181

Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
                   I  +           D++S GI  +EM     P  +M
Sbjct: 182 -------VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 5e-07
 Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 22/152 (14%)

Query: 682 IGKGSFG----FVYKGNLGEDGMSVAVKVMNLDKKGATKSFV---AECEALRNIRHRNLI 734
           IGK         + K         VAVK +NLD   + +       E    R ++H N++
Sbjct: 6   IGKCFEDLMIVHLAKHK--PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNIL 62

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKLEVGKLNIVIEVASVIEYL 792
             +T      F       +V   M YGS +D L  H      E+    I+ +V + ++Y+
Sbjct: 63  PYVTS-----FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYI 117

Query: 793 H-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 823
           H        +H  +K S++LL  D    +S  
Sbjct: 118 HSKGF----IHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 5e-07
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 32/213 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           +G G++G V        G  VA+K +      +   K    E   L++++H N+I ++ +
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 740 CS---SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVASVIEYLHNH 795
            +   S+D +  DF    Y  M +   D      ++KL   ++  +V ++   ++Y+H  
Sbjct: 83  FTPDLSLD-RFHDF----YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH-- 135

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG---TIG 852
               I+H DLKP N+ ++ D    + DFGLAR             Q+ S EM G   T  
Sbjct: 136 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------QTDS-EMTGYVVTRW 180

Query: 853 YIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRR 884
           Y  PE  +     + T D++S G ++ EM T +
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 30/217 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IG+G+FG V    +   G   A+K++N   + K+  T  F  E + L N   R +  +  
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL-- 66

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHC 796
                 F+  +   +V +Y   G +   L    D+L  ++ +  +  E+   I+ +H   
Sbjct: 67  ---HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVH--- 119

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
           Q   VH D+KP NVLL  D   H+  +DFG    L         +G   S    GT  YI
Sbjct: 120 QLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLL-------ADGTVQSNVAVGTPDYI 170

Query: 855 GPEY--GMGGDLSMTG---DVYSFGILLLEMFTRRRP 886
            PE    M       G   D +S G+ + EM     P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 21/164 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G GS G V+     +    VAVK + L    + K  + E + +R + H N++K+  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 742 SIDFKGADFKA------------IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
                G+D               IV EYM+   + + L       E  +L  + ++   +
Sbjct: 73  P---SGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARL-FMYQLLRGL 127

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHH 832
           +Y+H+     ++H DLKP+NV ++  D+V  + DFGLAR +  H
Sbjct: 128 KYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 29/217 (13%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHR 731
           + ++S  ++G G++G V        G  VA+K ++     +   K    E   L++++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 732 NLIKIITI-CSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVI 789
           N+I ++ +  S++         +V  YMQ        H  + DK++     +V ++   +
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY----LVYQMLCGL 130

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           +Y+H      I+H DLKP N+ ++ D    + DFGLAR               +  EM G
Sbjct: 131 KYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------------HADAEMTG 173

Query: 850 ---TIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
              T  Y  PE  +     + T D++S G ++ EM T
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.0 bits (124), Expect = 9e-07
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 27/232 (11%)

Query: 657 MEQQFPIVSYAELS-KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
            + QF  V  A+ +    K +     IG G+ G V        G++VAVK ++   +  T
Sbjct: 3   EDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 62

Query: 716 --KSFVAECEALRNIRHRNLIKIITICS---SIDFKGADFKAI--VYEYMQYGSVDDWLH 768
             K    E   L+ + H+N+I ++ + +   S++    +F+ +  V E M   ++   +H
Sbjct: 63  HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE----EFQDVYLVMELMD-ANLCQVIH 117

Query: 769 HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
              D   +  L  + ++   I++LH+     I+H DLKPSN+++  D    + DFGLAR 
Sbjct: 118 MELDHERMSYL--LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 172

Query: 829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
              + F++ P           T  Y  PE  +G       D++S G ++ E+
Sbjct: 173 ACTN-FMMTP--------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 30/217 (13%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRNLI-KII 737
           +IG+G++G VYK      G  VA+K   + +D++G   + + E   L+ +     I +++
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWL-------HHTNDKLEVGKL--NIVIEVASV 788
            +    +  G     +V+EY+    +  ++               +      ++  VA  
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA-- 124

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
             + H H    ++H DLKP N+L+D    +  ++D GL R      F +  +  +  I  
Sbjct: 125 --HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-----AFSIPVKSYTHEIV- 173

Query: 848 KGTIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTR 883
             T+ Y  PE  +G    S   D++S G +  EM  +
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 11/105 (10%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+   + +LH   +  I++ DLK  NVLLD D    ++D+G+ +        + P   +S
Sbjct: 104 EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG------LGPGDTTS 154

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           +    GT  YI PE   G +   + D ++ G+L+ EM   R P D
Sbjct: 155 T--FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 9/87 (10%)

Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           IV+ DLKP N+LLD      +SD GLA        +  PEG++    + GT+GY+ PE  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA--------VQIPEGETVRGRV-GTVGYMAPEVI 173

Query: 860 MGGDLSMTGDVYSFGILLLEMFTRRRP 886
                + + D +  G L+ EM   + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.9 bits (122), Expect = 2e-06
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 682 IGKGSFGFV----YKGNLGEDGMSVAVK-VMNL-DKKGATKSFVAECEALRNIR-HRNLI 734
           +G+G++G V           +  +VA+K + N+  KK   K  + E + LR+ R H+N+ 
Sbjct: 8   LGQGAYGIVCSARNAET--SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 735 KII--TICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVGKLNIVI-EVASV 788
            +    I    +F        +Y Y +    D  LH    +   L        I ++   
Sbjct: 66  CLYDMDIVFPGNFNE------LYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           ++Y+H+     ++H DLKP N+L++ D    + DFGLAR  S +P     E      E  
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG----ENAGFMTEYV 170

Query: 849 GTIGYIGPEYGMGGDLSMTG--DVYSFGILLLEMFTRR 884
            T  Y  PE  M    S T   DV+S G +L E+  R+
Sbjct: 171 ATRWYRAPEI-MLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 682 IGKGSFGFVY---KGNLGEDGMSVAVKVMN----LDKKGATKSFVAECEALRNIRHRNLI 734
           +G G++G V+   K    + G   A+KV+     + K    +    E + L  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLH 793
             +      D K      ++ +Y+  G +   L+   +     ++ + I E+   +++LH
Sbjct: 68  VTLHYAFQTDTK----LHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLH 122

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
              Q  I++ D+K  N+LLD +    ++DFGL++           E +  +    GTI Y
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK-------EFLAEEEERAYSFCGTIEY 172

Query: 854 IGPEYGMGGDL--SMTGDVYSFGILLLEMFTRRRP 886
           + PE   GG        D +S G+L  E+ T   P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 17/108 (15%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG--- 840
           E++  + YLH   +  I++ DLK  NVLLD +    ++D+G+ +           EG   
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----------EGLRP 149

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
             ++    GT  YI PE   G D   + D ++ G+L+ EM   R P D
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 12/103 (11%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+   +E LH      IV+ DLKP N+LLD      +SD GLA        +  PEG++ 
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--------VEIPEGETI 158

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              + GT+GY+ PE       + + D +  G L+ EM   + P
Sbjct: 159 RGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 54/246 (21%)

Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +     
Sbjct: 1   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60

Query: 716 KSFVAECEALRNIRHRNLIKIITICSS-------------IDFKGADFKAIVYEYMQYGS 762
           K    E   L++++H N+I ++ + +                  GAD   IV        
Sbjct: 61  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 112

Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 113 --KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 163

Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 164 FGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209

Query: 879 EMFTRR 884
           E+ T R
Sbjct: 210 ELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 48/208 (23%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIIT 738
            ++G+G++  V+KG        VA+K + L+ ++GA  + + E   L++++H N++ +  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQ 797
           I  +          +V+EY+    +  ++    + + +  + I + ++   + Y H    
Sbjct: 72  IVHT-----DKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             ++H DLKP N+L++      ++DFGLAR  S     V  +  S+ +    T+ Y  P+
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKS-----VPTKTYSNEVV---TLWYRPPD 174

Query: 858 YGMG-GDLSMTGDVYSFGILLLEMFTRR 884
             +G  + S   D++  G +  EM + R
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 18/154 (11%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKGS+G V        G  VA+K +N   +        + E + LR +RH ++++I  I
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 740 CSSIDFKGADFKAI--VYEYMQYGSVDDWLHH---TNDKLEVGKLNIVI-EVASVIEYLH 793
                 +  +FK I  V+E M+       LH     ND L        + ++   ++Y+H
Sbjct: 68  MLPPSRR--EFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
                 + H DLKP N+L + D    + DFGLAR
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 23/120 (19%)

Query: 777 GKLNIVIEVASVIEYL---HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
           GK  + + +   + YL   H      ++H D+KPSN+LLD      + DFG++       
Sbjct: 117 GK--MTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGIS------G 163

Query: 834 FLVAPEGQSSSIEMKGTIGYIGPEY----GMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            LV  + ++ S    G   Y+ PE            +  DV+S GI L+E+ T + P  N
Sbjct: 164 RLVDSKAKTRS---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 3e-06
 Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 42/243 (17%)

Query: 667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL------DKKGATKSFVA 720
           A   +  K++  S  +G G+ G V       DG   AVKV+++      DK  A     A
Sbjct: 25  ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ----A 80

Query: 721 ECEALRNIRHRNLIKIITICSSIDFKGADFK--------AIVYEYMQYGSVDDWLHH--- 769
           E   L N    +++K    C   DF   D +        A+V +Y   G +   +     
Sbjct: 81  EVCCLLNCDFFSIVK----CHE-DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK 135

Query: 770 TNDKL---EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 826
           TN      E G L   I+V   + ++H+     ++H D+K +N+LL  + +  + DFG  
Sbjct: 136 TNRTFREHEAGLL--FIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG-- 188

Query: 827 RFLSHHPFLVAPE-GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR 885
            F   +   V+ + G++      GT  Y+ PE       S   D++S G+LL E+ T +R
Sbjct: 189 -FSKMYAATVSDDVGRT----FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Query: 886 PTD 888
           P D
Sbjct: 244 PFD 246

Length = 496

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 17/108 (15%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG--- 840
           E++  + +LH   +  I++ DLK  NVLLD +    ++D+G+ +           EG   
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-----------EGIRP 149

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
             ++    GT  YI PE   G D   + D ++ G+L+ EM   R P D
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 36/228 (15%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           ++    R+G G++G VYK      G   AVK++ L+          E   ++  +H N++
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
                     +   +   I  EY   GS+ D  H T    E+    +  E    + YLH+
Sbjct: 70  AYFG-----SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSSS 844
             +   +H D+K +N+LL  +    ++DFG+A  ++            P+ +APE   ++
Sbjct: 125 KGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE--VAA 179

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
           +E  G  GY           +   D+++ GI  +E+   + P   MF+
Sbjct: 180 VEKNG--GY-----------NQLCDIWAVGITAIELAELQPP---MFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.6 bits (118), Expect = 5e-06
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 11/105 (10%)

Query: 779 LNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
           L+   +VA  +E+L + +C    VH DL   NVLL    +  + DFGLAR + H    V+
Sbjct: 240 LSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               S+ + +K    ++ PE       +   DV+S+GILL E+F+
Sbjct: 296 K--GSTFLPVK----WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 34/220 (15%)

Query: 681 RIGKGSFGFVYKGNL--GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G++G VYK     G+D    A+K   ++  G + S   E   LR ++H N+I +  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISL-- 63

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDW----LHHTND------KLEVGKL-NIVIEVAS 787
               +    AD K  V+    Y   D W     H  +       +L  G + +++ ++  
Sbjct: 64  --QKVFLSHADRK--VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
            I YLH +    ++H DLKP+N+L+           ++D G AR L + P  + P     
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSP--LKPLADLD 173

Query: 844 SIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
            + +  T  Y  PE  +G    +   D+++ G +  E+ T
Sbjct: 174 PVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.9 bits (116), Expect = 6e-06
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 40/218 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-----RHRNLIKI 736
           IGKG++G V+K    ++G   AVK+++            E EA  NI      H N++K 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVGKLNIVIEVASV-IEYL 792
             +    D K  D   +V E    GSV D +       +++E   +  ++  A + +++L
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQS 842
           H +     +H D+K +N+LL  +    + DFG++  L+            PF +APE   
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE--- 194

Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      I  E  +        DV+S GI  +E+
Sbjct: 195 ----------VIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 15/106 (14%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR-FLSHHPFLVAPEGQS 842
           E+   +E+LH   +  IV+ D+K  N+LLD +    ++DFGL++ FLS        E + 
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--------EEKE 161

Query: 843 SSIEMKGTIGYIGPEY--GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            +    GTI Y+ PE   G GG      D +S GIL+ E+ T   P
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 50.2 bits (120), Expect = 6e-06
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 26/201 (12%)

Query: 697 EDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI 753
             G  VA+K++  D   ++     F  E      + H N++ ++    +           
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFA 56

Query: 754 VYEYMQYGSVDDWLHHTND----KLEVGKLNIVIEVASVIEYL-HNHCQPPIVHGDLKPS 808
           V+EY+   ++ + L    D      E G+L     +  V++ L   H Q  IVH DLKP 
Sbjct: 57  VFEYVPGRTLREVL--AADGALPAGETGRL-----MLQVLDALACAHNQG-IVHRDLKPQ 108

Query: 809 NVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQ-SSSIEMKGTIGYIGPEYGMGGDL 864
           N+++        A V DFG+   L       A     + + E+ GT  Y  PE   G  +
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPG--VRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 865 SMTGDVYSFGILLLEMFTRRR 885
           +   D+Y++G++ LE  T +R
Sbjct: 167 TPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 35/220 (15%)

Query: 682 IGKGSFG--FVYKGNLGED-----GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +G G++G  F+ +   G D      M V  K   + K   T+    E + L +IR    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI---EVASVIEY 791
             +      D K      ++ +Y+  G +     H + +    +  + I   E+   +E+
Sbjct: 68  VTLHYAFQTDTK----LHLILDYINGGEL---FTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH   +  I++ D+K  N+LLD +    ++DFGL++      F      ++ S    GTI
Sbjct: 121 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-----EFHEDEVERAYSF--CGTI 170

Query: 852 GYIGPEYGMGGDLSMTG-----DVYSFGILLLEMFTRRRP 886
            Y+ P+   GGD    G     D +S G+L+ E+ T   P
Sbjct: 171 EYMAPDIVRGGD---GGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.0 bits (117), Expect = 7e-06
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 21/221 (9%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHR 731
           K+F   + +G+G FG V        G   A+KVM   KK     +  V+  E  R+I   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVM---KKSVLLAQETVSFFEEERDILSI 57

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           +    I       F+  D   +V EY   G +   L+   D+ +       +  A ++  
Sbjct: 58  SNSPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL--AELVLA 114

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H+  Q   VH D+KP NVL+D      ++DFG A  L+ +  + +       +   GT 
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS----KLPV---GTP 167

Query: 852 GYIGPEY--GMGGDLSMTGDV----YSFGILLLEMFTRRRP 886
            YI PE    M GD   T  V    +S G++  EM   R P
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.4 bits (115), Expect = 7e-06
 Identities = 49/214 (22%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 682 IGKGSFGFVYKGNLG------------EDGMSVAVKVMNLDKKGATKSFVAECEALRNIR 729
           +G+G+   +Y G L             E  + V +KV++   +  + +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 730 HRNLIKIITICSSIDFKGADFKAI-VYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVAS 787
           H++++ +  +C        D + I V E++++G +D ++H  +D L    K  +  ++AS
Sbjct: 63  HKHIVLLYGVCVR------DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            + YL +     +VHG++   N+LL  + +    + G    LS     +    +   +E 
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGID--GECGPFIKLSDPGIPITVLSRQECVE- 170

Query: 848 KGTIGYIGPE-YGMGGDLSMTGDVYSFGILLLEM 880
              I +I PE      +LS+  D +SFG  L E+
Sbjct: 171 --RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.3 bits (116), Expect = 8e-06
 Identities = 33/131 (25%), Positives = 56/131 (42%), Gaps = 17/131 (12%)

Query: 769 HTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-AHVSDFGLA 826
               KL   ++  I+ ++   +  LH H    I+H D+K  NVL D      ++ D+GL 
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157

Query: 827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +            G  S     GT+ Y  PE   G +  ++ D ++ G+L  E+ T + P
Sbjct: 158 K----------IIGTPSC--YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Query: 887 TDNMFNDGLTL 897
                ++ L L
Sbjct: 206 FKEDEDEELDL 216

Length = 267

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 28/229 (12%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL--RNIRHRN 732
           +F+    +GKGSFG V            A+K+  L K    +    EC  +  R +  ++
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVA 786
               +T   S  F+  D    V EY+  G   D ++H     +VGK           E++
Sbjct: 59  KPPFLTQLHSC-FQTVDRLYFVMEYVNGG---DLMYHIQ---QVGKFKEPQAVFYAAEIS 111

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + +LH   +  I++ DLK  NV+LD +    ++DFG+ +    H      +G ++   
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMV----DGVTTRT- 160

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  YI PE         + D +++G+LL EM   + P D    D L
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+GSFG              A+K + L K   A +    E   L  ++H N   I+   
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN---IVAFK 64

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQP 798
            S  F+      IV EY   G +   +     KL  E   L   +++   ++++H   + 
Sbjct: 65  ES--FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EK 119

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            ++H D+K  N+ L  +    + DFG AR L+           + +    GT  Y+ PE 
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--------PGAYACTYVGTPYYVPPEI 171

Query: 859 GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 +   D++S G +L E+ T + P
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 39/126 (30%), Positives = 57/126 (45%), Gaps = 20/126 (15%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E++  +E+LH   Q  I++ DLKP N+LLD      ++DFGL +   H       EG  +
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-------EGTVT 157

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT---------RRRPTDNMFNDG 894
                GTI Y+ PE  M        D +S G L+ +M T         R++  D +    
Sbjct: 158 HT-FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK 216

Query: 895 LTLHGY 900
           L L  Y
Sbjct: 217 LNLPPY 222

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IG+G+FG V    +       A+K++N   + K+  T  F  E    RN+      + IT
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE----RNVLVNGDCQWIT 64

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHC 796
                 F+  ++  +V +Y   G +   L    D+L  ++ +  I  E+   I  +H   
Sbjct: 65  TLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIH--- 119

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           Q   VH D+KP NVLLD +    ++DFG    ++        +G   S    GT  YI P
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ-------DGTVQSSVAVGTPDYISP 172

Query: 857 EY------GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E       GM G      D +S G+ + EM     P
Sbjct: 173 EILQAMEDGM-GKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 28/210 (13%)

Query: 681 RIGKGSFGFVY----KGNLGEDGMSV--AVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           R+GKGSFG VY    K  + E+ + V   + V  L     T     E + L  + H  ++
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL-NPNETVQANQEAQLLSKLDHPAIV 65

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE----VASVIE 790
           K         F   D   I+ EY +   +D  L       +    N V E    +   + 
Sbjct: 66  KFHA-----SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+H   Q  I+H DLK  N+ L ++++  + DFG++R L     L        +    GT
Sbjct: 121 YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDL--------ATTFTGT 168

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
             Y+ PE           D++S G +L EM
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 20/96 (20%)

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF----LSHHPFLVAPEGQSSS 844
           I++LH+     I+H DLKPSN+++  D    + DFGLAR         P++V        
Sbjct: 131 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-------- 179

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                T  Y  PE  +G       D++S G ++ EM
Sbjct: 180 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 28/224 (12%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN-- 727
           S +TKE    N++    F F+     G  G  +     N D          + + ++   
Sbjct: 15  SDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74

Query: 728 ----IRHRNLIKIIT--ICSSI--DFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVG 777
                  R ++  I    C ++   FK   +  +V E++  G    +L   N +   +VG
Sbjct: 75  VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVG 133

Query: 778 KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
                 ++  + EYL +     IV+ DLKP N+LLD D    ++DFG A+ +        
Sbjct: 134 CF-YAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-------- 181

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
               + +  + GT  YI PE  +        D ++ GI + E+ 
Sbjct: 182 ---DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 9/99 (9%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           +VA  +E+L +      +H DL   N+LL  + V  + DFGLAR +   P  V     S+
Sbjct: 182 QVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGSA 236

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            + +K    ++ PE       +   DV+SFG+LL E+F+
Sbjct: 237 RLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 34/115 (29%), Positives = 51/115 (44%), Gaps = 22/115 (19%)

Query: 723 EALRNIRHRNLIKIITICSSIDFKGADFKA-IVYEY--------MQYGSVDDWLHHTNDK 773
           E LR  R R   +I+        + A     IVY+         M+Y  ++  L    D 
Sbjct: 39  EKLRRERTRREARILAKA-----REAGVPVPIVYDVDPDNGLIVMEY--IEGEL--LKDA 89

Query: 774 LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
           LE  + +++ EV  ++  LH      IVHGDL  SN++L    + +  DFGL  F
Sbjct: 90  LEEARPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF 140

Length = 204

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.8 bits (111), Expect = 4e-05
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 11/100 (11%)

Query: 784 EVASVIEYLHNH-CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
           +VA  +E+L +  C    +H DL   N+LL  + V  + DFGLAR +   P  V      
Sbjct: 181 QVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGD 234

Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + + +K    ++ PE       +   DV+SFG+LL E+F+
Sbjct: 235 ARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 43/217 (19%), Positives = 90/217 (41%), Gaps = 34/217 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK---SFVAECEALRNIRHRNLIKIIT 738
           IG G FG V    +  D     V V  L    ++K    F+ + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 739 IC-SSIDFKGADFKAIVYEYMQYGSV------DDWLHHTNDKLEVGKLNIVIEVASVIEY 791
            C  +I +       +V+EY + G +      + W    +  L + ++    E+A+ + +
Sbjct: 63  QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTH 114

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H H     +H DL   N  L  D+   V D+G+        ++   + +   +      
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----- 166

Query: 852 GYIGPEYG-------MGGDLSMTGDVYSFGILLLEMF 881
            ++ PE         +  + +   +V++ G+ L E+F
Sbjct: 167 -WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 5e-05
 Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 29/194 (14%)

Query: 702 VAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYG 761
           VA  VM  D++ A  +  +E   L    H  ++K        DFK  D   ++   M+YG
Sbjct: 97  VAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFD-----DFKSDDKLLLI---MEYG 147

Query: 762 SVDDWLHHTNDKL---------EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           S  D       +L         EVG L   I +A  ++ +H+     ++H DLK +N+ L
Sbjct: 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRK---MMHRDLKSANIFL 202

Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYS 872
               +  + DFG ++  S     V+ +  SS     GT  Y+ PE       S   D++S
Sbjct: 203 MPTGIIKLGDFGFSKQYSDS---VSLDVASS---FCGTPYYLAPELWERKRYSKKADMWS 256

Query: 873 FGILLLEMFTRRRP 886
            G++L E+ T  RP
Sbjct: 257 LGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 5e-05
 Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 41/240 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
            +F S   IG+G+FG V      + G   A+K +    + +K       AE + L    +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
             ++K+    S   F+  ++  ++ EY+  G +   L   +   E      + E    I+
Sbjct: 61  PWVVKLY--YS---FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAID 115

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL------------ARFLSHHPFLVAP 838
            +H       +H D+KP N+LLD      +SDFGL             R LSH       
Sbjct: 116 SIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 839 EGQSSSIEMK------------------GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           +  S  +  K                  GT  YI PE  +    +   D +S G+++ EM
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 19/109 (17%)

Query: 779 LNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
           L+   +VA  + +L + +C    +H DL   N+LL H  +  + DFGLAR + +      
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN------ 266

Query: 838 PEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                S+  +KG     + ++ PE       +   DV+S+GILL E+F+
Sbjct: 267 ----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 27/197 (13%)

Query: 693 GNLGEDG--MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF 750
                +G  + V +KV++   +    +F      +  + H +L  +  +C     +G++ 
Sbjct: 36  VEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVC----VRGSE- 90

Query: 751 KAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSN 809
             +V E++++G +D  L     ++ V  K+ +  ++AS + YL +     +VHG++   N
Sbjct: 91  NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKN 147

Query: 810 VLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQS----SSIEMKGTIGYIGPE-YGMGGD 863
           +LL        +  GLA   S  PF+ ++  G S    S  E    I +I PE    G  
Sbjct: 148 ILL--------ARLGLAEGTS--PFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNS 197

Query: 864 LSMTGDVYSFGILLLEM 880
           LS   D +SFG  LLE+
Sbjct: 198 LSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.2 bits (109), Expect = 5e-05
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 38/222 (17%)

Query: 681 RIGKGSFGFVYKGNL--GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G++G VYK     G+D    A+K   ++  G + S   E   LR ++H N+I +  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIAL-- 63

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-------------IVIEV 785
               +    +D K  V+    Y   D W  H        K N             ++ ++
Sbjct: 64  --QKVFLSHSDRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
              I YLH +    ++H DLKP+N+L+           ++D G AR L + P  + P   
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSP--LKPLAD 171

Query: 842 SSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
              + +  T  Y  PE  +G    +   D+++ G +  E+ T
Sbjct: 172 LDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 20/115 (17%)

Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGP 856
           +H D+   NVLL    VA + DFGLAR + +           S+  +KG     + ++ P
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMN----------DSNYVVKGNARLPVKWMAP 283

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDG----LTLHGYAKMALP 906
           E       ++  DV+S+GILL E+F+  + P   +  +     +   GY +M+ P
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-QMSRP 337

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 20/141 (14%)

Query: 754 VYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYLHNHCQPPIVHGDLKP 807
           +Y  M+Y +  D ++H     +VGK           E+A  + +LH+     I++ DLK 
Sbjct: 76  LYFVMEYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKL 129

Query: 808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMT 867
            NV+LD +    ++DFG+ +    + F     G  ++    GT  YI PE         +
Sbjct: 130 DNVMLDAEGHIKIADFGMCK---ENIF-----GGKTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 868 GDVYSFGILLLEMFTRRRPTD 888
            D ++FG+LL EM   + P D
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 6e-05
 Identities = 18/60 (30%), Positives = 28/60 (46%)

Query: 256 KLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL 315
            L  L ++ N LT     +      L+ L+L+ N+ +      F+ LP+L  L L  NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 7e-05
 Identities = 20/59 (33%), Positives = 28/59 (47%)

Query: 529 LEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHF 587
           L+ L +  N        +   L ++K LDLS NNL+   P     LP L  L+LS N+ 
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 9/99 (9%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           +VA  +E+L +      +H DL   N+LL  + V  + DFGLAR +   P  V      +
Sbjct: 187 QVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGDA 241

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            + +K    ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 242 RLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 44.5 bits (106), Expect = 8e-05
 Identities = 19/58 (32%), Positives = 33/58 (56%), Gaps = 4/58 (6%)

Query: 771 NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
            D +E G   ++ E+  ++  LH      IVHGDL  SN+++  D + ++ DFGL ++
Sbjct: 85  KDVIEEGNDELLREIGRLVGKLHKA---GIVHGDLTTSNIIVRDDKL-YLIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 40.4 bits (95), Expect = 8e-05
 Identities = 14/25 (56%), Positives = 16/25 (64%), Gaps = 1/25 (4%)

Query: 34 HDPLGVTKSWN-NSINLCQWTGVTC 57
           DP G   SWN +S + C WTGVTC
Sbjct: 17 GDPSGALSSWNPSSSDPCSWTGVTC 41

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 40/218 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-----RHRNLIKI 736
           IGKG++G VYK    +DG   AVK+++            E EA  NI      H N++K 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSLPNHPNVVKF 84

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDW---LHHTNDKLEVGKLNIVIEVASV-IEYL 792
             +    D        +V E    GSV +    L     +L+   ++ ++  A + +++L
Sbjct: 85  YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQS 842
           HN+    I+H D+K +N+LL  +    + DFG++  L+            PF +APE   
Sbjct: 145 HNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE--- 198

Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      I  E           DV+S GI  +E+
Sbjct: 199 ----------VIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.1 bits (107), Expect = 9e-05
 Identities = 44/211 (20%), Positives = 85/211 (40%), Gaps = 29/211 (13%)

Query: 689 FVYKGNLGEDGMSVAVKVMNLDKKGATK---SFVAECEALRNIRHRNLIKI----ITICS 741
            +YKG    +   V ++      KG          E + LR I   N++KI    I I  
Sbjct: 35  SIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIV 801
            +        +++ EY   G + + L    D     KL++ I+    +  L+ +   P  
Sbjct: 93  DLPRL-----SLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-- 145

Query: 802 HGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY--G 859
           + +L   + L+  +    +   GL + LS  PF         ++     + Y   +    
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF--------KNVNF---MVYFSYKMLND 194

Query: 860 MGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           +  + ++  D+YS G++L E+FT + P +N+
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225

Length = 283

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.8 bits (108), Expect = 9e-05
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 11/100 (11%)

Query: 784 EVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
           +VA+ +E+L + +C    VH DL   NVL+    +  + DFGLAR +      ++    S
Sbjct: 247 QVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GS 300

Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + + +K    ++ PE       +   DV+SFGILL E+FT
Sbjct: 301 TFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 12/92 (13%)

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P   +      
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRY---- 190

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               Y  PE  +G       D++S G ++ EM
Sbjct: 191 ----YRAPEVILGMGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 45.2 bits (107), Expect = 1e-04
 Identities = 31/111 (27%), Positives = 51/111 (45%), Gaps = 19/111 (17%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           EV   + +LH H    +++ DLK  N+LLD +    ++DFG+ +           EG  +
Sbjct: 104 EVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-----------EGILN 149

Query: 844 SIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP--TDN 889
            +      GT  YI PE     +   + D ++ G+L+ EM   + P   DN
Sbjct: 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 34/182 (18%)

Query: 706 VMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD------FKAIVYEYMQ 759
           V+ + +KG T   + E   L+N+ H ++I++     S             + + +Y Y  
Sbjct: 95  VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVS---GAITCMVLPHYSSDLYTY-- 146

Query: 760 YGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA 818
                  L   +  L + +  I+  ++   + YLH      I+H D+K  N+ ++     
Sbjct: 147 -------LTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQV 196

Query: 819 HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLL 878
            + D G A+F    P +VAP    + + + GT+    PE       +   D++S GI+L 
Sbjct: 197 CIGDLGAAQF----P-VVAP----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247

Query: 879 EM 880
           EM
Sbjct: 248 EM 249

Length = 357

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 42/244 (17%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F S   IG+G+FG V      + G   A+K++        K+ + E E + +IR    I
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERDI 54

Query: 735 KIITICSSI-----DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
            +    + +      F+      ++ E++  G +   L   +   E      + E    I
Sbjct: 55  LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI 114

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA------------RFLSHHP---- 833
           + +H   Q   +H D+KP N+LLD      +SDFGL             R L+H+P    
Sbjct: 115 DAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171

Query: 834 -FLVAPEGQSSSIEMK----------GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            F      + +    K          GT  YI PE  M    +   D +S G+++ EM  
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 883 RRRP 886
              P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.2 bits (105), Expect = 2e-04
 Identities = 51/226 (22%), Positives = 97/226 (42%), Gaps = 59/226 (26%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-------HRN 732
            +IG+G+F  V K    + G   A+K M    K   KS + +   LR I+       H N
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKS-LEQVNNLREIQALRRLSPHPN 59

Query: 733 LIKIITI-------CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEV 785
           ++++I +         ++ F+  D    +YE ++            +K  V   + + ++
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMN--LYELIK-----GRKRPLPEK-RVK--SYMYQL 109

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL-SHHPFLV-------- 836
              ++++H +    I H D+KP N+L+  D++  ++DFG  R + S  P+          
Sbjct: 110 LKSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYISTRWYR 165

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           APE   +        GY GP+  M        D+++ G +  E+ +
Sbjct: 166 APECLLTD-------GYYGPK--M--------DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 26/223 (11%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRH 730
           ++F     IG+G+FG V    L       A+K++N   + K+  T  F  E + L N  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASV 788
           + +  +        F+  +   +V +Y   G +   L    D+L  ++ +  +  E+   
Sbjct: 61  QWITTL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIA 114

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I+ +H   Q   VH D+KP N+L+D +    ++DFG    L         +G   S    
Sbjct: 115 IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-------DGTVQSSVAV 164

Query: 849 GTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRP 886
           GT  YI PE         G      D +S G+ + EM     P
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 43.9 bits (104), Expect = 3e-04
 Identities = 19/86 (22%), Positives = 30/86 (34%), Gaps = 15/86 (17%)

Query: 762 SVDDWLHHTND----KLEVGKLNIVIEVASVIEYLHNH-------CQPPIVHGDLKPSNV 810
              +W             V   ++   + + ++ L              I+HGDL P NV
Sbjct: 150 RRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNV 209

Query: 811 LLDHD-MVAHVSDFGLARFLSHHPFL 835
           L D D  V+   DF  A    +  F+
Sbjct: 210 LFDDDTDVSGFIDFDDAG---YGWFI 232

Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 56/210 (26%), Positives = 80/210 (38%), Gaps = 34/210 (16%)

Query: 685 GSFGFVY----KGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           GS G V+     G+  E    V VK +     G T     E + L+ I HR +I +I   
Sbjct: 103 GSEGEVFVCTKHGD--EQRKKVIVKAVT---GGKTPG--REIDILKTISHRAIINLIHAY 155

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN--IVIE--VASVIEYLHNHC 796
                    +K+ V   M     D  L    D+     L   I I+  +   + YLH   
Sbjct: 156 R--------WKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR- 204

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              I+H D+K  N+ LD    A + DFG A  L  HP      G S ++E         P
Sbjct: 205 --GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN------SP 256

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E           D++S G++L EM  +   
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 26/218 (11%)

Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR 731
             K +   N IG GSFG VY+    +    VA+K +  D +   +    E   ++N+ H 
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHI 119

Query: 732 NLIKIITICSSIDFKGAD---FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV----IE 784
           N+I +     +  FK  +   F  +V E++   +V  ++ H         L +V     +
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           +   + Y+H+     I H DLKP N+L+D +     + DFG A+ L              
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL---------AGQR 226

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEM 880
           S+    +  Y  PE  +G     T  D++S G ++ EM
Sbjct: 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 26/151 (17%)

Query: 754 VYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYLHNHCQPPIVHGDLKP 807
           +Y  M+Y +  D ++      +VG+           E+A  + +LH+     I++ DLK 
Sbjct: 76  LYFVMEYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKL 129

Query: 808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGYIGPEYGMGGDL 864
            NV+LD +    ++DFG+ +           E     +  K   GT  YI PE       
Sbjct: 130 DNVMLDSEGHIKIADFGMCK-----------ENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178

Query: 865 SMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             + D ++FG+LL EM   + P +    D L
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.8 bits (103), Expect = 4e-04
 Identities = 50/189 (26%), Positives = 75/189 (39%), Gaps = 26/189 (13%)

Query: 711 KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT 770
           K G       E   LR I H ++I++        F    F  ++    +Y +  D   + 
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKGT-----FTYNKFTCLILP--RYKT--DLYCYL 173

Query: 771 NDKLEVG---KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
             K  +     L I   V   I+YLH +    I+H D+K  N+ ++H     + DFG A 
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230

Query: 828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT 887
           F    P  +     +      GTI    PE           D++S GI+L EM T     
Sbjct: 231 F----PVDIN---ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH--- 280

Query: 888 DNMFN-DGL 895
           D++F  DGL
Sbjct: 281 DSLFEKDGL 289

Length = 391

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.2 bits (101), Expect = 4e-04
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 12/92 (13%)

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTP--------YV 179

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            T  Y  PE  +G       D++S G ++ EM
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 42/245 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRN 732
           ++F S   IG+G+FG V      + G   A+K++        K+ + E E + +IR  R+
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53

Query: 733 LI----KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           ++     +  +     F+      ++ E++  G +   L   +   E      + E    
Sbjct: 54  ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA 113

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA------------RFLSHH-PFL 835
           I+ +H   Q   +H D+KP N+LLD      +SDFGL             R L+H  P  
Sbjct: 114 IDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 836 VAPEGQSS--------------SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
              +  +S              +    GT  YI PE  M    +   D +S G+++ EM 
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 882 TRRRP 886
               P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 43.1 bits (102), Expect = 5e-04
 Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 31/215 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG------ATKSFVAE---CEALRNIRHRN 732
           +G+G FG V      + G   A+K +   KKG        +S + E    E   + RH  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKAL---KKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKLNIVIEVASVIEY 791
           L+ +   C    F+  D    V EY   G  D  +H HT+   E   +     V   ++Y
Sbjct: 64  LVNLFA-C----FQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQY 116

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH +    IV+ DLK  N+LLD +    ++DFGL +            G  +S    GT 
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-------GDRTST-FCGTP 165

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            ++ PE       +   D +  G+L+ EM     P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 31/214 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHR-NLIKIIT 738
           IGKGSFG V +    +     A+K +   +K    ++S V    A R +  + N   I+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTI---RKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVASVIEYL 792
           +  S       +  +V  ++  G +    HH   +   G+ ++        E+   +E L
Sbjct: 58  LKFSFQSPEKLY--LVLAFINGGEL---FHHLQRE---GRFDLSRARFYTAELLCALENL 109

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H      +++ DLKP N+LLD+     + DFGL +        +  +    +    GT  
Sbjct: 110 HKF---NVIYRDLKPENILLDYQGHIALCDFGLCK--------LNMKDDDKTNTFCGTPE 158

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Y+ PE  +G   +   D ++ G+LL EM T   P
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.4 bits (98), Expect = 9e-04
 Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 8/76 (10%)

Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV EY++   + D +    +   + +L +  E+  ++  LH+     I+HGDL  SN++L
Sbjct: 76  IVMEYIEGEPLKDLI----NSNGMEELELSREIGRLVGKLHSA---GIIHGDLTTSNMIL 128

Query: 813 DHDMVAHVSDFGLARF 828
               + ++ DFGLA F
Sbjct: 129 SGGKI-YLIDFGLAEF 143

Length = 211

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 18/60 (30%), Positives = 21/60 (35%)

Query: 407 NLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKL 466
           NL+ L L  N +  I       L  L VL L  N L    P       +L  L    N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 64/226 (28%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---ATKSFVAECEALRNIRHRN---LIK 735
           +G G++G V           VAVK ++   +    A +++  E   L++++H N   L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLD 81

Query: 736 IITICSSID----------FKGADFKAIVY------EYMQYGSVDDWLHHTNDKLEVGKL 779
           + T  +SI+            GAD   IV       E++Q+                   
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF------------------- 122

Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
            ++ ++   ++Y+H+     I+H DLKPSNV ++ D    + DFGLAR            
Sbjct: 123 -LIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR------------ 166

Query: 840 GQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
              +  EM G +    Y  PE  +     + T D++S G ++ E+ 
Sbjct: 167 --QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.4 bits (99), Expect = 0.001
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 25/170 (14%)

Query: 721 ECEALRNIRHRNLIKIITICSSIDF-----KGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
           E  AL  + H N++KI  I  S        +  DF   +Y +M Y    DW    +  L 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFM-YDEAFDW---KDRPLL 266

Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                I+ ++   +EY+H+     ++H D+K  N+ L+ D    + DFG A      PF 
Sbjct: 267 KQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAM-----PF- 317

Query: 836 VAPEGQSSSIEMK--GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
              E +  + +    GT+    PE   G       D++S G++LL+M + 
Sbjct: 318 ---EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 36/143 (25%), Positives = 51/143 (35%), Gaps = 48/143 (33%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL------------SH 831
           E+   IE +H       +H D+KP N+L+D D    ++DFGL                 H
Sbjct: 109 ELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165

Query: 832 H---PFLVAPE-GQSSSIEMK-------------------GTIGYIGPEYGMGGDLSMTG 868
           H       + E  +     +K                   GT  YI PE      L  TG
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV-----LLRTG 220

Query: 869 -----DVYSFGILLLEMFTRRRP 886
                D +S G++L EM   + P
Sbjct: 221 YTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 14/105 (13%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR--FLSHHPFLVAPEG- 840
           E    +EYLHN+    IVH DLKP N+L+       ++DFGL++   +S    L   EG 
Sbjct: 109 ETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY--EGH 163

Query: 841 ------QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLE 879
                 +    ++ GT  YI PE  +        D ++ GI+L E
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	973
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PLN00181	793	protein SPA1-RELATED; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.73
PRK10345	210	hypothetical protein; Provisional	99.73
smart00090	237	RIO RIO-like kinase.	99.72
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
PRK14879	211	serine/threonine protein kinase; Provisional	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
PLN03150	623	hypothetical protein; Provisional	99.61
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.5
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.36
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.35
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.34
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.27
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.24
PLN03150	623	hypothetical protein; Provisional	99.24
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
KOG1243	690	consensus Protein kinase [General function predict	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.21
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.1
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.09
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.09
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.08
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.08
COG4248	637	Uncharacterized protein with protein kinase and he	99.04
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.03
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.01
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.01
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.01
KOG3087	229	consensus Serine/threonine protein kinase [General	99.0
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.0
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.99
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.9
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.84
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.8
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.8
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.79
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.74
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.73
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.7
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.65
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.63
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.54
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.52
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.43
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.42
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.38
PRK09902	216	hypothetical protein; Provisional	98.36

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-113  Score=1091.26  Aligned_cols=909  Identities=31%  Similarity=0.502  Sum_probs=776.2

Q ss_pred             ccccchhhHHHHHHHHhhccCCCcCCCCCCCCCCCCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEc
Q 039720           14 SRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINL   93 (973)
Q Consensus        14 ~~~~~~~~~~~ll~~~~~~~~d~~~~l~sw~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L   93 (973)
                      |.+ ...++.||++||+++ .||.+.+++|+.+.+||.|.||+|++ .++|+.|||+++++.|.+++.+..+++|++|+|
T Consensus        24 ~~~-~~~~~~~l~~~~~~~-~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L  100 (968)
T PLN00113         24 SML-HAEELELLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINL  100 (968)
T ss_pred             cCC-CHHHHHHHHHHHHhC-CCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence            444 347789999999886 58888999998888999999999985 468999999999999999999999999999999


Q ss_pred             cCCCCCCCCCcccc-ccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccc
Q 039720           94 ANNSFHGQIPKEVG-RLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTG  172 (973)
Q Consensus        94 ~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~  172 (973)
                      ++|+++|.+|..+. ++++|++|+|++|.+++.+|.  +.+++|++|++++|.+.+.+|..++++++|++|+|++|.+.+
T Consensus       101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  178 (968)
T PLN00113        101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG  178 (968)
T ss_pred             CCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence            99999999998866 899999999999999998886  568999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCccccc
Q 039720          173 QLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGF  252 (973)
Q Consensus       173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~  252 (973)
                      .+|..|+++++|++|+|++|++.+.+|..++++++|++|+|++|.+++.+|..+.++++|++|++++|++.+.+|..+. 
T Consensus       179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-  257 (968)
T PLN00113        179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-  257 (968)
T ss_pred             cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998876 


Q ss_pred             CCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhccc
Q 039720          253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNC  332 (973)
Q Consensus       253 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  332 (973)
                      ++++|++|+|++|.+++.+|..+.++++|++|+|++|++++..|..+..+++|++|++++|.+.....      ..+..+
T Consensus       258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~------~~~~~l  331 (968)
T PLN00113        258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP------VALTSL  331 (968)
T ss_pred             CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC------hhHhcC
Confidence            89999999999999999999999999999999999999999999999999999999999999876432      346788


Q ss_pred             ccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEE
Q 039720          333 SKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLG  412 (973)
Q Consensus       333 ~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  412 (973)
                      ++|+.|++++|.+.+.+|..+..+ ..++.|++++|++++.+|..+..+++|+.|++++|++.+.+|.++..+++|+.|+
T Consensus       332 ~~L~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~  410 (968)
T PLN00113        332 PRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR  410 (968)
T ss_pred             CCCCEEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEE
Confidence            999999999999999999988876 6799999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCccc
Q 039720          413 LVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS  492 (973)
Q Consensus       413 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~  492 (973)
                      |++|++++.+|..|..++.|++|++++|++++.+|..+..+++|+.|++++|++.+.+|..+ ....+ +.|++++|+++
T Consensus       411 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~  488 (968)
T PLN00113        411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRL-ENLDLSRNQFS  488 (968)
T ss_pred             CcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccc-eEEECcCCccC
Confidence            99999999999999999999999999999999999999999999999999999998888754 33444 58999999999


Q ss_pred             ccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCC
Q 039720          493 GSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLG  572 (973)
Q Consensus       493 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  572 (973)
                      +.+|..+.++++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|||++|+++|.+|..+.
T Consensus       489 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  568 (968)
T PLN00113        489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG  568 (968)
T ss_pred             CccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccceEeccCCcCcCcCCCCCCCCCccccccccCccccCCCCCCCCCCCCCCCCCccccccee---------EEeeee
Q 039720          573 NLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLK---------VVIPVI  643 (973)
Q Consensus       573 ~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  643 (973)
                      .+++|+.|++++|+++|.+|..+.+.++...++.||+.+||+......|.|............+.         +++...
T Consensus       569 ~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (968)
T PLN00113        569 NVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFG  648 (968)
T ss_pred             cCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999999999876655677752211111000000         000000


Q ss_pred             hhhHhhhhh---hHHhhh-c--CCCcc-----cHHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc
Q 039720          644 GTKLAHKLS---SALLME-Q--QFPIV-----SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK  712 (973)
Q Consensus       644 ~~~~~~~~~---~~~~~~-~--~~~~~-----~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~  712 (973)
                      ....+++..   +....+ .  ....+     ...........|...+.||+|+||+||+|++..++..||||+++....
T Consensus       649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~  728 (968)
T PLN00113        649 FVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS  728 (968)
T ss_pred             HHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc
Confidence            011111100   000000 0  00000     011222334567888899999999999999988999999999864322


Q ss_pred             hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHH
Q 039720          713 GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL  792 (973)
Q Consensus       713 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~L  792 (973)
                          ....|++++++++|||||+++++|...     +..++||||+++|+|.++++.   ..+.++.+++.|+|+|++||
T Consensus       729 ----~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yL  796 (968)
T PLN00113        729 ----IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFL  796 (968)
T ss_pred             ----ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHh
Confidence                123468889999999999999998653     678999999999999999963   56677899999999999999


Q ss_pred             HhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHH
Q 039720          793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYS  872 (973)
Q Consensus       793 H~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS  872 (973)
                      |..++++|+||||||+||+++.++..++. ||.+.....            .....+|+.|+|||++.+..++.++||||
T Consensus       797 H~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S  863 (968)
T PLN00113        797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------------DTKCFISSAYVAPETRETKDITEKSDIYG  863 (968)
T ss_pred             ccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------------CCCccccccccCcccccCCCCCcccchhh
Confidence            97666799999999999999999888775 665443211            11235789999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc-cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC
Q 039720          873 FGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK-VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ  951 (973)
Q Consensus       873 lG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  951 (973)
                      |||++|||+||+.||.........+..|........ ....+++......   ....++..++.+++.+||+.||++||+
T Consensus       864 ~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt  940 (968)
T PLN00113        864 FGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPC  940 (968)
T ss_pred             HHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcC
Confidence            999999999999999766555555666665443322 2333444432211   223455667889999999999999999


Q ss_pred             HHHHHHHHHhcccc
Q 039720          952 MTAVVKKLCAVGEI  965 (973)
Q Consensus       952 ~~evl~~L~~~~~~  965 (973)
                      |+||++.|+++...
T Consensus       941 ~~evl~~L~~~~~~  954 (968)
T PLN00113        941 ANDVLKTLESASRS  954 (968)
T ss_pred             HHHHHHHHHHhhcc
Confidence            99999999988553

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.7e-61  Score=609.92  Aligned_cols=518  Identities=34%  Similarity=0.522  Sum_probs=488.6

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccc-cCCCccceEecccccccchhhhhccccccceee
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLS-RCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLS  164 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  164 (973)
                      .+++.|+|++|+++|.+|..|..+++|++|+|++|.++|.+|..+. .+++|++|++++|++.+.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            3689999999999999999999999999999999999999999876 999999999999999998886  5689999999


Q ss_pred             ccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCcccc
Q 039720          165 LYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKG  244 (973)
Q Consensus       165 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  244 (973)
                      |++|.+++.+|..|+++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChh
Q 039720          245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLD  324 (973)
Q Consensus       245 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  324 (973)
                      .+|..+. ++++|++|++++|.+++.+|..|.++++|++|+|++|++++..|..+..+++|++|+|++|.+....     
T Consensus       227 ~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-----  300 (968)
T PLN00113        227 EIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI-----  300 (968)
T ss_pred             cCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC-----
Confidence            9999887 8999999999999999999999999999999999999999999999999999999999999987532     


Q ss_pred             hhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccC
Q 039720          325 FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE  404 (973)
Q Consensus       325 ~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  404 (973)
                       +..+.++++|+.|++++|.+.+.+|..+..+ +.++.|++++|.+.+.+|..++.+++|+.|+|++|++++.+|.++..
T Consensus       301 -p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~  378 (968)
T PLN00113        301 -PELVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS  378 (968)
T ss_pred             -ChhHcCCCCCcEEECCCCccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence             3456788999999999999999999988876 57899999999999999999999999999999999999999999999


Q ss_pred             CCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccccccccccee
Q 039720          405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLL  484 (973)
Q Consensus       405 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L  484 (973)
                      +++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+..+..+. .|
T Consensus       379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L  457 (968)
T PLN00113        379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ-ML  457 (968)
T ss_pred             cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc-EE
Confidence            99999999999999999999999999999999999999999999999999999999999999999998888877775 99


Q ss_pred             eccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccc
Q 039720          485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS  564 (973)
Q Consensus       485 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  564 (973)
                      ++++|++.+.+|..+ ..++|+.|++++|++++.+|..+.++++|+.|+|++|++++.+|..+..+++|++|+|++|+++
T Consensus       458 ~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  536 (968)
T PLN00113        458 SLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS  536 (968)
T ss_pred             ECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence            999999999888876 4589999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCccceEeccCCcCcCcCCCC-CCCCCccccccccCccccCCC
Q 039720          565 GQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQFCGGL  615 (973)
Q Consensus       565 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~l~~~~N~~~cg~~  615 (973)
                      |.+|..+..+++|+.|+|++|+++|.+|.. ..+++++.+++.+|+..+.-|
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            999999999999999999999999999975 457889999999998766433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-46  Score=385.17  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=213.1

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-------GATKSFVAECEALRNIRHRNLIKIITICSSID  744 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  744 (973)
                      ..+.|.+.+.+|+|+||.|-+|..+.||+.||||+++....       .......+|+++|++++||+||++.+++.   
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~---  246 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE---  246 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee---
Confidence            34678999999999999999999999999999999975421       12234679999999999999999999854   


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC---CcEEEe
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVS  821 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~---~~~kl~  821 (973)
                        .++..||||||++||+|.+.+-..+...+...+.++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+
T Consensus       247 --~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  247 --VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             --cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence              4588899999999999999999998888888899999999999999999   99999999999999766   789999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCCCC---CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL---SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH  898 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~  898 (973)
                      |||+|+..+.         .....+.+|||.|.|||++.+..+   ..++|+||+||++|-+++|.+||.+...+.....
T Consensus       322 DFGlAK~~g~---------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e  392 (475)
T KOG0615|consen  322 DFGLAKVSGE---------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE  392 (475)
T ss_pred             ccchhhcccc---------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH
Confidence            9999998754         455667899999999999987654   4477999999999999999999987765532222


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +..++...               ..+..+....++..++|.+|+..||++|||++|++++
T Consensus       393 QI~~G~y~---------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  393 QILKGRYA---------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHhcCccc---------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            22222111               1134556667777889999999999999999999874

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=397.90  Aligned_cols=290  Identities=40%  Similarity=0.635  Sum_probs=243.0

Q ss_pred             CCCcccHHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeE
Q 039720          660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITI  739 (973)
Q Consensus       660 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  739 (973)
                      ....+++.++..+++.|...+.||+|+||.||+|... +|..||||++.........+|.+|+.++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4567899999999999999999999999999999995 669999998865443214559999999999999999999999


Q ss_pred             eeecccCCCc-eEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC
Q 039720          740 CSSIDFKGAD-FKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM  816 (973)
Q Consensus       740 ~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~  816 (973)
                      |.+.     + +.++|||||++|+|.++++...  .+++..+.+||.++|+||+|||+.+.+.||||||||+|||+|+++
T Consensus       140 C~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~  214 (361)
T KOG1187|consen  140 CLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF  214 (361)
T ss_pred             EecC-----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence            9864     3 6999999999999999998765  667899999999999999999999988999999999999999999


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CCCc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF-NDGL  895 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~-~~~~  895 (973)
                      ++||+|||+|+.....       .........||.+|+|||++..+..+.++|||||||++.|++||+.|.+... .++.
T Consensus       215 ~aKlsDFGLa~~~~~~-------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~  287 (361)
T KOG1187|consen  215 NAKLSDFGLAKLGPEG-------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL  287 (361)
T ss_pred             CEEccCccCcccCCcc-------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence            9999999999644210       0111111179999999999999999999999999999999999999887654 3344


Q ss_pred             cHhhhhhHhcCc-ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          896 TLHGYAKMALPK-KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       896 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      .+..|+...... .+.+++|+.+....   ....++...+.+++.+|++.+|++||+|.||++.|+.+...
T Consensus       288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~---~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  288 SLVEWAKPLLEEGKLREIVDPRLKEGE---YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cHHHHHHHHHHCcchhheeCCCccCCC---CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            577887666555 58888998876311   11116677799999999999999999999999999776544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=376.49  Aligned_cols=252  Identities=29%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc-eEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD-FKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~  752 (973)
                      +.+..+.||+|..|+||+|+++.+++.+|+|++.... ....+++.+|+++++...||+||.+||.+...     . ...
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~is  154 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEIS  154 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEE
Confidence            4455788999999999999999999999999996443 44568899999999999999999999986543     4 699


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||++|+|++++...+..++....+++.+|++||.|||+ .   +||||||||+|||++..|+|||||||.+..+..
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            999999999999999988889999999999999999999996 5   999999999999999999999999999987643


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                                .....++||..|||||.+.+..|+.++||||||++++|+.+|+.||........+..+...        .
T Consensus       232 ----------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~--------~  293 (364)
T KOG0581|consen  232 ----------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC--------A  293 (364)
T ss_pred             ----------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH--------H
Confidence                      2445788999999999999999999999999999999999999999876222222221111        1


Q ss_pred             ccCcccccccCCCchhH-HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFE-ECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +++.      ..+..+. .+.+++..++..|+++||.+||+++|++++
T Consensus       294 Iv~~------ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  294 IVDE------PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HhcC------CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1110      0122223 366778888889999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=372.77  Aligned_cols=204  Identities=30%  Similarity=0.545  Sum_probs=185.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ..+|...++||.|+||+||+|+++.++..||||.+...  .+...+-+..|+.+|+.++|||||.+++++..     ++.
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----DDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----CCe
Confidence            35789999999999999999999999999999999766  44556778999999999999999999998654     489


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC------CcEEEeccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD------MVAHVSDFG  824 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~------~~~kl~Dfg  824 (973)
                      .|+|||||+||+|.++++..+..++..++.++.|+|.|+++||++   +||||||||.|||++..      -.+||+|||
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            999999999999999999999999999999999999999999999   99999999999999865      468999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND  893 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~  893 (973)
                      +|+....         .......+|++.|||||+++..+|+.|+|+||+|+++|+|++|+.||...+..
T Consensus       161 fAR~L~~---------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  161 FARFLQP---------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             hhhhCCc---------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            9998764         44555788999999999999999999999999999999999999999866543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=386.23  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=214.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .+|...+.||+|||+.+|++++..+|+.||+|++...   +....+...+|+++.+.++|||||+++++     |++.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            5799999999999999999999999999999999743   45667889999999999999999999998     566799


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +|+|.|+|..++|..+....+.++|.+++.+++||+.|+.|||++   +|+|||||..|++++++.++||+|||+|..+.
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999999875


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..        +....+.+|||-|+|||++.....+..+||||+||+||-|++|++||+...-++    .+.+...     
T Consensus       170 ~~--------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----ty~~Ik~-----  232 (592)
T KOG0575|consen  170 YD--------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----TYNKIKL-----  232 (592)
T ss_pred             Cc--------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----HHHHHHh-----
Confidence            42        345567899999999999999999999999999999999999999998542211    1111111     


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                              .++..|.   ....+-.++|.++++.||.+|||+++|+..=
T Consensus       233 --------~~Y~~P~---~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  233 --------NEYSMPS---HLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             --------cCccccc---ccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                    1111122   2233345788899999999999999999753

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=383.26  Aligned_cols=257  Identities=30%  Similarity=0.456  Sum_probs=210.9

Q ss_pred             CCcCCccccccceeEEEEEECCCCcE-EEEEEeecccchh--HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..+.+.+|+|+||+||+|.+  .|+. ||||++.......  .+.|.+|+.+|.+++|||||+++|+|....    ...+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~  116 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC  116 (362)
T ss_pred             hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence            34455699999999999999  5666 9999997543222  568999999999999999999999997641    2689


Q ss_pred             EEEeeccCCCHHHHhhh--cCCCchhhHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcEEecCCC-cEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHH--TNDKLEVGKLNIVIEVASVIEYLHNHCQPP-IVHGDLKPSNVLLDHDM-VAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-ivHrDik~~NILl~~~~-~~kl~Dfg~a~~  828 (973)
                      +||||+++|+|.++++.  ...++...+.+|+.|||+||+|||+.   + |||||+||+|||++.++ ++||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999999999999988  56677788899999999999999999   7 99999999999999998 999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM--GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .....        ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||......  ++....     
T Consensus       194 ~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~~~v-----  258 (362)
T KOG0192|consen  194 KVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVASAV-----  258 (362)
T ss_pred             ecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHH-----
Confidence            54321        2233367999999999999  569999999999999999999999999976541  111110     


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFI  967 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  967 (973)
                                 .....++..+..++..+..+|.+||+.||+.||++.|++..|+.+...+.
T Consensus       259 -----------~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  259 -----------VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             -----------HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                       11122233444578889999999999999999999999999998865444

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-44  Score=353.24  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=209.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC-CCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK-GADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  750 (973)
                      .+|.+.++||+|.||+||++++..+|..||.|.+..+.  ....+....|+.+|++++|||||++++.-    |. +.+.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----f~~~~ev   94 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----FIEDNEV   94 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh----hhccchh
Confidence            46888999999999999999999999999999998553  34567899999999999999999998742    33 3344


Q ss_pred             EEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEecCCCcEEEeccc
Q 039720          751 KAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                      .++|||||.+|+|...++.    ....++..+|+++.|++.||+++|++- +.  |+||||||.||+++.+|.||++|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccch
Confidence            8999999999999998864    446678999999999999999999942 24  9999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ++++....        .......+|||+||+||.+...+|+.+|||||+||++|||+.-++||.+.    ..+.-..++.
T Consensus       174 L~r~l~s~--------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~  241 (375)
T KOG0591|consen  174 LGRFLSSK--------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIE  241 (375)
T ss_pred             hHhHhcch--------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHH
Confidence            99988653        45666789999999999999999999999999999999999999999854    1111111111


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      -             .+. .+.........+.++|..|+..||+.||+.-.++..+..
T Consensus       242 q-------------gd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  242 Q-------------GDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             c-------------CCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            0             011 112224567788899999999999999996555555543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=7.1e-47  Score=388.26  Aligned_cols=492  Identities=29%  Similarity=0.445  Sum_probs=364.3

Q ss_pred             eEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEec
Q 039720           63 RVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVH  142 (973)
Q Consensus        63 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~  142 (973)
                      ....+++++|.+. .+.+.+.+|..|.+|++++|+++ +.|++++.+..++.|+.|+|+++ .+|.+++.+.+|++++++
T Consensus        46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s  122 (565)
T KOG0472|consen   46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS  122 (565)
T ss_pred             chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence            3556788888875 56777888999999999999988 78889999999999999999988 788888888888888888


Q ss_pred             ccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccC
Q 039720          143 TNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF  222 (973)
Q Consensus       143 ~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~  222 (973)
                      +|.+. ++|+.++.+..|+.|+..+|+++ .+|+.++++.+|..|++.+|+++...|+.+ +++.|++||+..|.+. .+
T Consensus       123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tl  198 (565)
T KOG0472|consen  123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TL  198 (565)
T ss_pred             cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cC
Confidence            88876 66777778888888888888887 678888888888888888888884444444 4888888888888776 67


Q ss_pred             CccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCcc-ccCCCCCCEEEccCCcccccCcccccC
Q 039720          223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQS-LSNASKLEWLELNENHFSGQVRINFNS  301 (973)
Q Consensus       223 p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~  301 (973)
                      |..++.+.+|+.|||.+|++. .+| .+. ++..|++|.++.|+|+ .+|.. ..++.+|..|||.+|+++ ..|+.++-
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~-gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl  273 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFP-GCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL  273 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCC-ccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence            777777777777777777777 666 332 5667777777777777 34443 347777777777777776 45666666


Q ss_pred             cccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCC
Q 039720          302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL  381 (973)
Q Consensus       302 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l  381 (973)
                      +.+|.+||+++|.|+.                               +|.+++++  .++.|.+.+|.+..+ ...+-+.
T Consensus       274 LrsL~rLDlSNN~is~-------------------------------Lp~sLgnl--hL~~L~leGNPlrTi-Rr~ii~~  319 (565)
T KOG0472|consen  274 LRSLERLDLSNNDISS-------------------------------LPYSLGNL--HLKFLALEGNPLRTI-RREIISK  319 (565)
T ss_pred             hhhhhhhcccCCcccc-------------------------------CCcccccc--eeeehhhcCCchHHH-HHHHHcc
Confidence            6666677776666654                               45555555  566677777776522 2222111


Q ss_pred             C---CcCEE-------EcccccC----CCC----CCccccCCCCCCeEEccCcccCCCCCCccCCcCc---cceEEcCCC
Q 039720          382 F---NLNGL-------GLEYNQL----TGT----IPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTL---LNVLQLGFN  440 (973)
Q Consensus       382 ~---~L~~L-------~Ls~N~l----~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N  440 (973)
                      .   -|++|       .++.-+=    ++.    .......+.+.+.|++++=+++ .+|+.......   ....+++.|
T Consensus       320 gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskN  398 (565)
T KOG0472|consen  320 GTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKN  398 (565)
T ss_pred             cHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccc
Confidence            0   01111       1111100    011    1112334567889999999998 66766554443   788999999


Q ss_pred             ccccccccccccccccc-cccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccc
Q 039720          441 KLQGSIPSYLGKCQNLM-QLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEI  519 (973)
Q Consensus       441 ~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  519 (973)
                      ++. ++|..+..++.+. .+.+++|.+. .+|..+..++.+. .|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+
T Consensus       399 qL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt-~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~l  473 (565)
T KOG0472|consen  399 QLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLT-FLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-ML  473 (565)
T ss_pred             hHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcce-eeecccchhh-hcchhhhhhhhhheecccccccc-cc
Confidence            999 8998888887765 4555566665 8888888888886 8999999998 79999999999999999999999 89


Q ss_pred             cccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC-CCCC
Q 039720          520 PVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFS  598 (973)
Q Consensus       520 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~  598 (973)
                      |..+..+..|+.+-.++|++..+.|+.+.++.+|..|||.+|.|. .+|+.+++|++|++|++++|+|+ .++.. -.-+
T Consensus       474 P~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkg  551 (565)
T KOG0472|consen  474 PECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKG  551 (565)
T ss_pred             hHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHHhccC
Confidence            999999999999999999999777777999999999999999998 89999999999999999999999 33332 2234


Q ss_pred             CccccccccC
Q 039720          599 NETRISLTGN  608 (973)
Q Consensus       599 ~~~~l~~~~N  608 (973)
                      +...+++.++
T Consensus       552 T~aiL~ylrd  561 (565)
T KOG0472|consen  552 TAAILSYLRD  561 (565)
T ss_pred             hHHHHHHhcc
Confidence            4444444444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=361.17  Aligned_cols=243  Identities=28%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||.++.+.+++.+|+|++++..   ....+...+|..+|.+++||.||++.-.     |++.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence            457999999999999999999999999999999997543   3456778999999999999999999764     77889


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..|+|+||+.||.|+.++++++.+.+..++.++.+|+.||.|||++   ||||||+||+|||+|.+|+++|+|||+|+..
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999999999999999999999999999999999999   9999999999999999999999999999854


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        ......++||+.|||||++.+.+|+.++|+||+|+++|||++|.+||......     .+........ 
T Consensus       176 ~~~--------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~~k-  241 (357)
T KOG0598|consen  176 LKD--------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILKGK-  241 (357)
T ss_pred             ccC--------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhcCc-
Confidence            332        34445689999999999999999999999999999999999999999865322     1111111100 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM  950 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  950 (973)
                             .   ...+.....   +..+++.+.+..||++|.
T Consensus       242 -------~---~~~p~~ls~---~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -------L---PLPPGYLSE---EARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -------C---CCCCccCCH---HHHHHHHHHhccCHHHhc
Confidence                   0   000111223   334667799999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.8e-43  Score=347.72  Aligned_cols=268  Identities=19%  Similarity=0.284  Sum_probs=208.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      +.|+...++|+|+||+||+|+++.||+.||||++.-..  +...+-.++|+++|++++|||+|.++++|.     .....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence            46888899999999999999999999999999986433  334567899999999999999999999854     45899


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++|+|||+..-|.++-+...+.++..+.+++.|++.|+.|+|++   ++|||||||+|||++.+|.+|+||||+|+....
T Consensus        77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            99999999877777666666778888999999999999999999   999999999999999999999999999997653


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH-hhhhhHhcCccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL-HGYAKMALPKKV  909 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~  909 (973)
                      .        ...-+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|++..+-+... ....-+......
T Consensus       154 p--------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh  225 (396)
T KOG0593|consen  154 P--------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH  225 (396)
T ss_pred             C--------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence            1        333445678999999999888 689999999999999999999999887643321111 111111122222


Q ss_pred             ccccCcc----------cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          910 MGIVDPS----------LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       910 ~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ..++...          .....+.....+....-+.+++.+|++.||++|++.+|++.
T Consensus       226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2222211          10011111223344456789999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.1e-46  Score=386.99  Aligned_cols=454  Identities=29%  Similarity=0.430  Sum_probs=315.4

Q ss_pred             ccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEE
Q 039720          108 RLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTF  187 (973)
Q Consensus       108 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  187 (973)
                      .-..|+.|++++|.+. .+-+.+.++..|..|.+++|+++ .+|++++.+.+++.|+.++|.+. .+|+.++.+.+|..|
T Consensus        43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l  119 (565)
T KOG0472|consen   43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKL  119 (565)
T ss_pred             hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhh
Confidence            3345667777777776 44455566666666666666655 44555566666666666666665 566666666666666


Q ss_pred             EccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcc
Q 039720          188 DIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL  267 (973)
Q Consensus       188 ~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l  267 (973)
                      +++.|.+. .+|++++.+..|+.|+..+|+++ ..|.++.++.+|..+++.+|+++ .+|...- +++.|++||...|-+
T Consensus       120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~L  195 (565)
T KOG0472|consen  120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLDCNSNLL  195 (565)
T ss_pred             hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHH-HHHHHHhcccchhhh
Confidence            66666665 55555666666666666666665 45555555555566666666665 3333332 255556666555555


Q ss_pred             cccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccC
Q 039720          268 TGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGG  347 (973)
Q Consensus       268 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~  347 (973)
                      + .+|..++.|.+|+.|+|.+|+|... | .|.++..|++|+++.|+|..+++      ..+.+++++..|||.+|    
T Consensus       196 ~-tlP~~lg~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpa------e~~~~L~~l~vLDLRdN----  262 (565)
T KOG0472|consen  196 E-TLPPELGGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPA------EHLKHLNSLLVLDLRDN----  262 (565)
T ss_pred             h-cCChhhcchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHH------HHhcccccceeeecccc----
Confidence            5 4555555666666666666655532 2 55555555555555555544332      12334444555555555    


Q ss_pred             CCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCC------
Q 039720          348 ALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI------  421 (973)
Q Consensus       348 ~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------  421 (973)
                                           ++. ..|+.+.-+.+|++||+|+|.|+ ..|..++++ +|+.|.+.+|.++.+      
T Consensus       263 ---------------------klk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~  318 (565)
T KOG0472|consen  263 ---------------------KLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIIS  318 (565)
T ss_pred             ---------------------ccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHc
Confidence                                 444 55556666666666666666666 455556666 666666666655421      


Q ss_pred             --------------------------------CCCc---cCCcCccceEEcCCCccccccccccccccc---cccccccC
Q 039720          422 --------------------------------IPDP---IGNLTLLNVLQLGFNKLQGSIPSYLGKCQN---LMQLSAPN  463 (973)
Q Consensus       422 --------------------------------~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~l~~  463 (973)
                                                      .+..   ...+.+.+.|+++.-+++ .+|........   ....+++.
T Consensus       319 ~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~Vnfsk  397 (565)
T KOG0472|consen  319 KGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSK  397 (565)
T ss_pred             ccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEeccc
Confidence                                            0111   122456788999999999 77776665555   78999999


Q ss_pred             cccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCccccccc
Q 039720          464 NKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI  543 (973)
Q Consensus       464 N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  543 (973)
                      |++. .+|..+..+..+...+++++|.++ .+|..+..+++|..|+|++|-+. .+|..++.+..|+.|++++|+|. .+
T Consensus       398 NqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~l  473 (565)
T KOG0472|consen  398 NQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-ML  473 (565)
T ss_pred             chHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cc
Confidence            9999 999999888888878899999887 89999999999999999999988 79999999999999999999998 89


Q ss_pred             ccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCCCCCccccccccCcc
Q 039720          544 PQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQ  610 (973)
Q Consensus       544 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~l~~~~N~~  610 (973)
                      |..+..+..++.+-.++|++....|..+.+|.+|..|||.+|.+...+|..+...+++.+.+.|||.
T Consensus       474 P~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  474 PECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             hHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence            9999999999999999999986666669999999999999999999999999999999999999975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=374.65  Aligned_cols=257  Identities=29%  Similarity=0.454  Sum_probs=210.7

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .++..+.||+|-||+||.|++. ...+||+|.++.. ....+.|.+|+++|++++|++||+++++|...     +..+||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIV  279 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIV  279 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEE
Confidence            4555778999999999999994 4459999999754 33557788999999999999999999999752     469999


Q ss_pred             EeeccCCCHHHHhhh--cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          755 YEYMQYGSVDDWLHH--TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ||||+.|+|.++++.  .......+.+.++.|||+||+||+++   ++||||+.++||||+++..+||+|||+|+.....
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999999999987  33445577889999999999999999   9999999999999999999999999999965443


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .+..       .....-...|.|||.+....++.|||||||||+|||++| |+.||+.+...+.              ..
T Consensus       357 ~Y~~-------~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------------~~  415 (468)
T KOG0197|consen  357 EYTA-------SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------------LE  415 (468)
T ss_pred             ceee-------cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------------HH
Confidence            3211       111123456999999999999999999999999999999 9999987755321              11


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccccc
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFI  967 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  967 (973)
                      .+.     ++.+-..+..|+..+.++|..||+.+|++|||++.+...++++...-.
T Consensus       416 ~le-----~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  416 LLE-----RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             HHh-----ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence            111     122234456789999999999999999999999999999998866543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=368.15  Aligned_cols=261  Identities=25%  Similarity=0.359  Sum_probs=212.7

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccC
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFK  746 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  746 (973)
                      +..++|.+++.||+|+|++|++|+.+.+++.|||||+...   +....+-+..|-.+|.++ .||+|++++-.     |+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence            3456899999999999999999999999999999998543   233345577888999999 89999999876     66


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      +...+|+|+||+++|+|.+++++.+.+.+..++.++.||+.|++|||+.   |||||||||+|||+|.|++++|+|||.|
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            6799999999999999999999999999999999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCc-----cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          827 RFLSHHPFL-----VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       827 ~~~~~~~~~-----~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      +.+......     ...........++||..|.+||++.....++.+|+|+|||++|+|+.|.+||.+..+-    ....
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----liFq  297 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LIFQ  297 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HHHH
Confidence            988654322     1112222235689999999999999999999999999999999999999999864321    1111


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ++.   .    ++..+      +   +.+++...+|+.+.+..||.+|+++++|.++.
T Consensus       298 kI~---~----l~y~f------p---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  298 KIQ---A----LDYEF------P---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHH---H----hcccC------C---CCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            110   0    11111      2   22234455777799999999999999988764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-41  Score=361.33  Aligned_cols=271  Identities=25%  Similarity=0.337  Sum_probs=214.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .+.|+.+++||+|.||.||+|++..+|+.||+|.++.+.  .+......+|+.+|+++.||||+++.+...+.   ....
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence            356888899999999999999999999999999998775  55678889999999999999999999987653   3578


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .|+|+|||+. +|.-++.. .-.+.+.+++.++.|++.||+|||++   ||+|||||.+|||||.+|.+||+|||+|+++
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999999986 77777766 34678899999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....       ....+..+.|.+|+|||.+.+. .|+.++|+||.|||+.||++|++.|++..+ -.+++...+..-...
T Consensus       269 ~~~~-------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~  340 (560)
T KOG0600|consen  269 TPSG-------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPT  340 (560)
T ss_pred             cCCC-------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCC
Confidence            6543       3446677889999999998886 799999999999999999999999987543 223333333221111


Q ss_pred             cccc----------cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGI----------VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...+          +.+.-.-+....+.....+...++++..+|..||++|.||.+++..
T Consensus       341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            0001          1110000001112234455667889999999999999999998753

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-41  Score=333.20  Aligned_cols=237  Identities=24%  Similarity=0.293  Sum_probs=202.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||.|+||+|.+++.+.+|..+|+|++....   ....++..+|..+|+.+.||.++++++.+.     +...
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNSN  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCCe
Confidence            46888999999999999999999999999999997553   334567889999999999999999998754     4589


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||++||.|++++++.+++++..++.+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||+|+.+.
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999999764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .           ...+.+|||.|+|||+++..+|+.++|.|||||++|||+.|++||.+...    +..+.++...+   
T Consensus       196 ~-----------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~---  257 (355)
T KOG0616|consen  196 G-----------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGK---  257 (355)
T ss_pred             C-----------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCc---
Confidence            2           35578999999999999999999999999999999999999999986544    22233332111   


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCC
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER  949 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  949 (973)
                                .   ..+.....++.+++.+.++.|-.+|
T Consensus       258 ----------v---~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 ----------V---KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----------c---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                      1   1122233455577778888988888

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=348.23  Aligned_cols=264  Identities=22%  Similarity=0.292  Sum_probs=212.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchh-HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|+..+.||.|..++||+|+...+++.||||++..++... .+.+.+|++.|+.++||||++++..+     ..+..+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----vv~~~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-----VVDSEL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-----Eeccee
Confidence            367999999999999999999999999999999998776443 58899999999999999999998764     445899


Q ss_pred             EEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      |+||.||.+|++.+.+...  .++.+..+..|++++++||.|||.+   |.||||||+.|||++.+|.|||+|||.+..+
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999999753  3566788899999999999999999   9999999999999999999999999988766


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ..+.    .........+.||++|||||++.+  ..|+.|+||||||++..|+.+|+.||.....-...+........ .
T Consensus       177 ~~~G----~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp-~  251 (516)
T KOG0582|consen  177 FDSG----DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP-T  251 (516)
T ss_pred             cccC----ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC-C
Confidence            5432    111222256789999999999544  48999999999999999999999999877654333322222211 0


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......+         -+......+.+.+++..|+++||++||||+++++.
T Consensus       252 ~~t~~~~---------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 LLTSGLD---------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccccCC---------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            0111111         12223345578899999999999999999999863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=360.32  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=211.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ...|...++||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||.+++.+.     ..+..|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeE
Confidence            356888899999999999999999999999999999888888888999999999999999999998643     348999


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|||||+||+|.|.+... .+.+.++..|++++++||+|||.+   ||+|||||.+|||++.+|.+||+|||+|..+...
T Consensus       347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            999999999999988765 478899999999999999999999   9999999999999999999999999999877543


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                              .......+|||+|||||+.....|+++.||||||++++||+-|.+||-....    +.....++        
T Consensus       423 --------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyLIa--------  482 (550)
T KOG0578|consen  423 --------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIA--------  482 (550)
T ss_pred             --------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHHHh--------
Confidence                    3355577899999999999999999999999999999999999999864211    11111111        


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ..-..+   ...+......|.+++.+|++.||++|++|.|++++
T Consensus       483 --~ng~P~---lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  483 --TNGTPK---LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             --hcCCCC---cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence              000011   11223345567788889999999999999999975

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=353.16  Aligned_cols=269  Identities=21%  Similarity=0.258  Sum_probs=208.3

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchh-HHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIR-HRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..++|.+.++||.|+||.||+|+.+++|..||||.++..-... ...-.+|++.|+++. ||||+++.+++.+.    ..
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----Cc
Confidence            3468999999999999999999999999999999987443222 233578999999998 99999999986543    23


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .+++|||||+ .+|+++++.+. .+++..++.|+.||++||+|+|++   |+.|||+||+|||+.....+||+|||+|+.
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            8999999997 48999997654 567888999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      +..         ...-+.++.|.+|+|||++.. ..|+.+.||||+||+++|+++-++-|++..+-+. +. .....+..
T Consensus       160 v~S---------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~-KIc~VLGt  228 (538)
T KOG0661|consen  160 VRS---------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IY-KICEVLGT  228 (538)
T ss_pred             ccc---------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HH-HHHHHhCC
Confidence            765         345567789999999998654 6789999999999999999999999986533211 11 11111111


Q ss_pred             cccc----------ccCcccccc--cCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          908 KVMG----------IVDPSLLME--ARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       908 ~~~~----------~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ...+          .++-.+...  .....-...+..+..++|.+|+.+||++||||+|++++-
T Consensus       229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1111          111111100  011122234677788999999999999999999998764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.7e-40  Score=321.03  Aligned_cols=267  Identities=22%  Similarity=0.344  Sum_probs=206.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .+|...+++|+|.||.||+|++.++|+.||||.++..+  ++......+|++.|+.++|+||+.++++     |...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence            47888999999999999999999999999999998653  3345678999999999999999999998     4556889


Q ss_pred             EEEEeeccCCCHHHHhhhcCC-CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTND-KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .+|+|||+ .+|+..+++... +...+++.++.++++|++|||++   .|+||||||.|+|++.+|.+||+|||+|+.+.
T Consensus        77 ~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   77 SLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             EEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            99999997 589998876553 45577899999999999999999   99999999999999999999999999999886


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh---cC
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA---LP  906 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~---~~  906 (973)
                      ...        ...+..+-|.+|+|||.+.+. .|+..+||||.||++.||+-|.+-|++..+ -.++.......   .+
T Consensus       153 ~p~--------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~  223 (318)
T KOG0659|consen  153 SPN--------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTP  223 (318)
T ss_pred             CCC--------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCc
Confidence            532        233334789999999988774 789999999999999999988777665432 11111111111   11


Q ss_pred             cc---cccccCccccccc---CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KK---VMGIVDPSLLMEA---RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~---~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +.   +....|..-....   ........+..+..+++.+|+.+||.+|++++|++++
T Consensus       224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11   1122221111111   1112344556667899999999999999999998865

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=359.16  Aligned_cols=264  Identities=27%  Similarity=0.403  Sum_probs=209.1

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecc
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSID  744 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  744 (973)
                      .++....++..+.++||+|.||+||+|+|..   .||||+++.+..  ...+.|.+|+.++++-+|.||+-+.|||..+ 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence            3444555678889999999999999999953   699999987653  4567899999999999999999999998763 


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                           ...||+.+|+|-+|+.+++... .+...+.+.|++|||+||.|||.+   +|||||+|..||++.+++.|||+||
T Consensus       461 -----~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  461 -----PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             -----ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence                 4499999999999999998654 334466789999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      |++..-...      ..........|...|||||++..   .+|++++||||||+++|||+||..||... ..+..+...
T Consensus       533 GLatvk~~w------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmV  605 (678)
T KOG0193|consen  533 GLATVKTRW------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMV  605 (678)
T ss_pred             cceeeeeee------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEe
Confidence            999753221      11222333457888999998764   48999999999999999999999999833 222211111


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      -++....              ........|++++.+|+..||.++|++||.+.+|+..|+.+.
T Consensus       606 GrG~l~p--------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  606 GRGYLMP--------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             cccccCc--------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            1110000              001223577889999999999999999999999999888764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=346.15  Aligned_cols=262  Identities=25%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .+|...+.||+|+||+||++.+..+|...|||.+........+.+.+|+.+|++++|||||+++|.....  +. ..+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-eeeEe
Confidence            4577889999999999999999988999999999765433366789999999999999999999963321  11 37899


Q ss_pred             EEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~Dfg~a~~~~~  831 (973)
                      .|||+++|+|.+++.+.+ .+++..+..+.+||++||+|||++   |||||||||+|||++. ++.+||+|||+++....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999877 678899999999999999999999   9999999999999999 79999999999987653


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..     ..........||+.|||||++.++ ...+++||||+||++.||+||+.||......   ...........   
T Consensus       171 ~~-----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~~~---  239 (313)
T KOG0198|consen  171 KG-----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGRED---  239 (313)
T ss_pred             cc-----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhccC---
Confidence            11     112334457899999999999963 3345999999999999999999999864111   11111111000   


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                                 ..|..+...+....+++.+|+..||++||||++++.+..-..
T Consensus       240 -----------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  240 -----------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             -----------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence                       012222334445557777999999999999999998876543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=352.07  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=211.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+.++  ...+.+.+|+++++.++||||+.++++     |+...+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            578889999999999999999999999999999975543  335678999999999999999999997     5667999


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++|.||+.| +|+.++...+.++++.+..++.|+..||.|||+.   +|.|||+||.|||++..|++|+||||+|+-+..
T Consensus        77 ~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             EEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            999999987 9999999999999999999999999999999999   999999999999999999999999999997765


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .        ....+...|||.|||||+..+.+|+..+|+||+||++||+++|++||-..     .+.+..+....+.   
T Consensus       153 ~--------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~---  216 (808)
T KOG0597|consen  153 N--------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDP---  216 (808)
T ss_pred             C--------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCC---
Confidence            3        44555678999999999999999999999999999999999999999632     1222222221111   


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                  ...+.+....+..++...+.+||..|.+..+++.+
T Consensus       217 ------------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 ------------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ------------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                        11123455667788889999999999999998764

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=359.23  Aligned_cols=360  Identities=24%  Similarity=0.244  Sum_probs=218.4

Q ss_pred             eEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCc
Q 039720          139 FWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF  218 (973)
Q Consensus       139 L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l  218 (973)
                      |++++|.+...-++.|.++++|++++|..|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.||||.|.|
T Consensus        83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i  161 (873)
T KOG4194|consen   83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI  161 (873)
T ss_pred             eeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence            444444444455677778888888888888888 7888777777899999999999877778888899999999999988


Q ss_pred             cccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCccc
Q 039720          219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN  298 (973)
Q Consensus       219 ~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  298 (973)
                      +.+.-.+|..-.++++|+|++|+|+ .+..+-|.++.+|..|.|++|+|+...+..|++|++|+.|+|..|+|.-..-..
T Consensus       162 s~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt  240 (873)
T KOG4194|consen  162 SEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT  240 (873)
T ss_pred             hcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence            8554445554455555555555555 444444445555555555555555444445555555555555555554333344


Q ss_pred             ccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccc
Q 039720          299 FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI  378 (973)
Q Consensus       299 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~  378 (973)
                      |.+|++|+.|.|..|.|..                                                       .--..|
T Consensus       241 FqgL~Sl~nlklqrN~I~k-------------------------------------------------------L~DG~F  265 (873)
T KOG4194|consen  241 FQGLPSLQNLKLQRNDISK-------------------------------------------------------LDDGAF  265 (873)
T ss_pred             hcCchhhhhhhhhhcCccc-------------------------------------------------------ccCcce
Confidence            5555555555555444432                                                       223345


Q ss_pred             cCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccccccccccccccc
Q 039720          379 RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQ  458 (973)
Q Consensus       379 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  458 (973)
                      ..+.++++|+|+.|+++..-..|+.+++.|+.|+||.|.|..+-++...-.++|++|+|++|+|+...+..|..+..|++
T Consensus       266 y~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~  345 (873)
T KOG4194|consen  266 YGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEE  345 (873)
T ss_pred             eeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhh
Confidence            66667777777777777666677777777777777777777776766666677777777777777666666777777777


Q ss_pred             ccccCcccccCCCccccccccccceeeccCCcccccCCc---ccccccccceeccccCcccccccccccCccchhhhccc
Q 039720          459 LSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPL---EVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQ  535 (973)
Q Consensus       459 L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~  535 (973)
                      |.|++|++. .+.+..|...+.++.|||++|.|+..+-+   .|.++++|+.|++.+|+++.+.-.+|.+++.|+.|||.
T Consensus       346 LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~  424 (873)
T KOG4194|consen  346 LNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLG  424 (873)
T ss_pred             hcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCC
Confidence            777777766 44444443333333455555555443322   23344444444444444443333344444444444444


Q ss_pred             CcccccccccchhhhccCCeec
Q 039720          536 GNSFNGSIPQSLNALKSIKELD  557 (973)
Q Consensus       536 ~N~l~~~~p~~~~~l~~L~~L~  557 (973)
                      +|.|..+-|++|..+ .|++|-
T Consensus       425 ~NaiaSIq~nAFe~m-~Lk~Lv  445 (873)
T KOG4194|consen  425 DNAIASIQPNAFEPM-ELKELV  445 (873)
T ss_pred             CCcceeecccccccc-hhhhhh
Confidence            444444444444444 444443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=355.98  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc----cc-hhHHHHHHHHHHHHhcC-CCCceeEEeEeeecc
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD----KK-GATKSFVAECEALRNIR-HRNLIKIITICSSID  744 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  744 (973)
                      ...+.|.+.+.||+|+||+|+.|++..++..||+|++...    .. ...+.+.+|+.+++.++ ||||+++++++..  
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--   91 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--   91 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence            3456899999999999999999999999999999977643    11 23456778999999999 9999999999654  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEecc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDF  823 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~Df  823 (973)
                         ....++||||+.||+|++++.+.+.+.+.++.++++|++.|++|+|++   ||+||||||+||+++.+ +++||+||
T Consensus        92 ---~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   92 ---PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             ---CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence               467999999999999999999988889999999999999999999999   99999999999999999 99999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCC-C-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD-L-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      |++.....        ........+||+.|+|||++.+.. | +.++||||+||++|.|++|+.||.+....    ..+.
T Consensus       166 G~s~~~~~--------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~  233 (370)
T KOG0583|consen  166 GLSAISPG--------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYR  233 (370)
T ss_pred             ccccccCC--------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHH
Confidence            99986631        134455678999999999999987 8 57899999999999999999999873211    1111


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +..         .    .+...+....  ......++.+|+..||.+|+++.|++..
T Consensus       234 ki~---------~----~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  234 KIR---------K----GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             HHh---------c----CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            111         0    0011111110  4566788889999999999999999943

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-40  Score=356.66  Aligned_cols=250  Identities=22%  Similarity=0.277  Sum_probs=210.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .-|+.++.||.|+-|.|-.|++.+||+.+|||++....   ......+.+|+-+|+-+.|||++++|+++.     +..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-----~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-----NKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-----cCce
Confidence            45788899999999999999999999999999997552   223456889999999999999999999854     4589


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +|+|.||+++|.|++++-..+.+++.++++++.||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      +         +....+.+|.|.|.|||++.+.+| +.++||||+|||+|.|+||+.||++..     +........    
T Consensus       164 ~---------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLlKV~----  225 (786)
T KOG0588|consen  164 P---------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLLKVQ----  225 (786)
T ss_pred             C---------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHHHHH----
Confidence            2         445567789999999999999999 789999999999999999999998432     111111110    


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                              .+.+   +.+...+.+..+|+.+|+..||++|.|++||+++..
T Consensus       226 --------~G~f---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  226 --------RGVF---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             --------cCcc---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence                    0111   122334445568888999999999999999998754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-39  Score=348.05  Aligned_cols=262  Identities=22%  Similarity=0.295  Sum_probs=207.6

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..++|..++.||+|+||.||.|+-+.||..+|+|+++...   ....+....|..+|....+|.||+++-.     |++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence            3467999999999999999999999999999999998653   4566788999999999999999999875     6778


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +++|+||||++||++..++...+.+++..+..++.+++-|++.+|+.   |||||||||+|+|||..|++||+|||+|.-
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence            99999999999999999999999999999999999999999999999   999999999999999999999999999864


Q ss_pred             ccCCCC-------------c---cCCCCC-----c------------------ccccccccccccCcccccCCCCCcccc
Q 039720          829 LSHHPF-------------L---VAPEGQ-----S------------------SSIEMKGTIGYIGPEYGMGGDLSMTGD  869 (973)
Q Consensus       829 ~~~~~~-------------~---~~~~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~sD  869 (973)
                      ......             .   ......     .                  .....+|||.|+|||++.+.+|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            322000             0   000000     0                  122356999999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCC
Q 039720          870 VYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER  949 (973)
Q Consensus       870 vwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  949 (973)
                      +||+|||+|||+.|.+||......+    .|.+..-.....         ..+..   ..+..+-.++|.+|+. ||++|
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~----T~rkI~nwr~~l---------~fP~~---~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQE----TYRKIVNWRETL---------KFPEE---VDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhhhc---------cCCCc---CcccHHHHHHHHHHhc-CHHHh
Confidence            9999999999999999998654432    222222111100         00001   1122445688889998 99999


Q ss_pred             CC---HHHHHHH
Q 039720          950 MQ---MTAVVKK  958 (973)
Q Consensus       950 Ps---~~evl~~  958 (973)
                      ..   ++||.++
T Consensus       434 LG~~G~~EIK~H  445 (550)
T KOG0605|consen  434 LGSKGAEEIKKH  445 (550)
T ss_pred             cCcccHHHHhcC
Confidence            85   6666543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=345.74  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=212.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..|+..+.||+|+||.||+|.+..+++.||+|++..+.. ...+++.+|+.++...+++||.++|+.+..     +..++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-----g~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-----GTKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-----cccHH
Confidence            468888999999999999999999999999999987654 356789999999999999999999997544     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ++||||.||++.+.+.....+.+..+.-+++++..|+.|+|++   +.+|||||+.||++..+|.+|++|||.+......
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999999999887778888888999999999999999   9999999999999999999999999999876442


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                              ......++|||.|||||++.+..|+.|+||||||++.+||.+|.+|+.+...              ..+.-.
T Consensus       165 --------~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--------------mrvlfl  222 (467)
T KOG0201|consen  165 --------VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--------------MRVLFL  222 (467)
T ss_pred             --------hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--------------ceEEEe
Confidence                    2233678999999999999999999999999999999999999999986533              222222


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +.+...     |.....+.+.+.+++..|+.+||+.||+|.+++++
T Consensus       223 Ipk~~P-----P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  223 IPKSAP-----PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccCCCC-----CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            222221     22223566778899999999999999999999864

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=354.43  Aligned_cols=378  Identities=21%  Similarity=0.241  Sum_probs=336.9

Q ss_pred             CccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhh
Q 039720           73 NIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQA  152 (973)
Q Consensus        73 ~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~  152 (973)
                      .+.|.+|+      .-+.||+++|++...-+..|.++++|+.+++..|.++ .||...+...+|++|+|.+|.+...-.+
T Consensus        71 ~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se  143 (873)
T KOG4194|consen   71 RLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSE  143 (873)
T ss_pred             ccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHH
Confidence            34555554      4578999999999888888999999999999999998 8998777777799999999999999999


Q ss_pred             hhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCC
Q 039720          153 IIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSL  232 (973)
Q Consensus       153 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L  232 (973)
                      .+.-++.|+.||||.|.|+..--.+|..-.++++|+|++|.|+..-.+.|.+|.+|..|.|++|+++...+.+|.+|++|
T Consensus       144 ~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L  223 (873)
T KOG4194|consen  144 ELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKL  223 (873)
T ss_pred             HHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchh
Confidence            99999999999999999996666788888899999999999998888999999999999999999998888899999999


Q ss_pred             cEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceeccc
Q 039720          233 DEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR  312 (973)
Q Consensus       233 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  312 (973)
                      +.|+|..|+|. .+....|.+|++|+.|.|..|.|...-...|..|.++++|+|+.|+++..-..++-+|++|+.|+|++
T Consensus       224 ~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~  302 (873)
T KOG4194|consen  224 ESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSY  302 (873)
T ss_pred             hhhhcccccee-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccch
Confidence            99999999998 66677788999999999999999988889999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccc
Q 039720          313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYN  392 (973)
Q Consensus       313 N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N  392 (973)
                      |.|..+..+.|.+      +++|++|+|++|+++..-+.++. ...+|+.|.|++|.|...-...|..+++|+.|||++|
T Consensus       303 NaI~rih~d~Wsf------tqkL~~LdLs~N~i~~l~~~sf~-~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N  375 (873)
T KOG4194|consen  303 NAIQRIHIDSWSF------TQKLKELDLSSNRITRLDEGSFR-VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSN  375 (873)
T ss_pred             hhhheeecchhhh------cccceeEeccccccccCChhHHH-HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCC
Confidence            9999988776654      67899999999999954455544 4478999999999999777788999999999999999


Q ss_pred             cCCCCCC---ccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCccc
Q 039720          393 QLTGTIP---PAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKL  466 (973)
Q Consensus       393 ~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  466 (973)
                      .|++.+-   ..|.++++|+.|+|.+|+|+.+.-.+|.++..|+.|||.+|.|...-|.+|..+ .|++|.+..-.+
T Consensus       376 ~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  376 ELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             eEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence            9986654   457889999999999999997777899999999999999999998889999999 999988866544

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-40  Score=350.12  Aligned_cols=241  Identities=27%  Similarity=0.402  Sum_probs=205.1

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ++-+|.|+.|.||.|+.  .++.||||+++.-+       ..+++-|++++||||+.+.|+|...     ..+|||||||
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfC  194 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFC  194 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeecc
Confidence            56699999999999999  78999999885322       2468889999999999999999764     7899999999


Q ss_pred             cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCC
Q 039720          759 QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP  838 (973)
Q Consensus       759 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~  838 (973)
                      ..|-|.+.++........-...|..+||.||.|||.+   +|||||+|+-||||..+..|||+|||-++....       
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~-------  264 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD-------  264 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh-------
Confidence            9999999999988888888899999999999999999   999999999999999999999999999987643       


Q ss_pred             CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccc
Q 039720          839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLL  918 (973)
Q Consensus       839 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (973)
                        ......++||..|||||++...++++|+||||||||||||+||..||.+.....             .+..+-...+ 
T Consensus       265 --~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------------IIwGVGsNsL-  328 (904)
T KOG4721|consen  265 --KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------------IIWGVGSNSL-  328 (904)
T ss_pred             --hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------------eEEeccCCcc-
Confidence              334456889999999999999999999999999999999999999998643210             0111111111 


Q ss_pred             cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          919 MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       919 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                          ....+.+|+..|.-+++.||+..|..||++.+++.+|.-+.
T Consensus       329 ----~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  329 ----HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             ----cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence                12445788899999999999999999999999999987553

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=333.22  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=212.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchh---HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA---TKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..+|++.+.||.|.||.|-+|.....|+.||||.|+.++...   .-++.+|+++|+.++||||+.++++     |+..+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence            357889999999999999999998999999999998765433   3457899999999999999999998     56679


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ...+||||..+|.|+|++...+.+++.++..+++||.+|+.|+|++   +++|||+|.+|||+|.++++||+|||++..+
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence            9999999999999999999999999999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ..         ....++++|+|-|.+||++.+.+| ++.+|-||+||++|-++.|..||++....     ..++      
T Consensus       204 ~~---------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~lvr------  263 (668)
T KOG0611|consen  204 AD---------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----RLVR------  263 (668)
T ss_pred             cc---------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----HHHH------
Confidence            54         456678999999999999999999 78899999999999999999999864221     1111      


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                            ..-.+.++.+..+.+.    --+|++|+..+|++|.|.+||..+..
T Consensus       264 ------QIs~GaYrEP~~PSdA----~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  264 ------QISRGAYREPETPSDA----SGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ------HhhcccccCCCCCchH----HHHHHHHHhcCcccchhHHHHhhhhe
Confidence                  1111223333333332    25677999999999999999987654

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=338.15  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=208.2

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--------------chhHHHHHHHHHHHHhcCCCCceeE
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--------------KGATKSFVAECEALRNIRHRNLIKI  736 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~~  736 (973)
                      +..++|++.+.||+|.||.|-+|++..+++.||||++....              ....+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45689999999999999999999999999999999996421              1123578999999999999999999


Q ss_pred             EeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC
Q 039720          737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM  816 (973)
Q Consensus       737 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~  816 (973)
                      +++..++   ..+..|+|+|||..|.+...-.....+.+.+++++++++..||+|||.+   |||||||||+|+|++++|
T Consensus       174 iEvLDDP---~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCc---ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            9987654   4588999999999998775444433367788999999999999999999   999999999999999999


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC---CC-CcccchHHHHHHHHHHHhCCCCCCCCCC
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG---DL-SMTGDVYSFGILLLEMFTRRRPTDNMFN  892 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~  892 (973)
                      +|||+|||.+.......   ............|||.|+|||...++   .+ +.+.||||+||++|.|+.|+.||-+...
T Consensus       248 ~VKIsDFGVs~~~~~~~---~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGS---DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             cEEeeccceeeecccCC---ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            99999999998663321   12223334447899999999987773   23 7789999999999999999999975432


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      -    ..+.+         +++..+..    + ...+..+++.++|.+++++||+.|.+..||..+..-.
T Consensus       325 ~----~l~~K---------Ivn~pL~f----P-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  325 L----ELFDK---------IVNDPLEF----P-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             H----HHHHH---------HhcCcccC----C-CcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence            1    11111         12222111    1 1124566778999999999999999999988766533

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=321.68  Aligned_cols=271  Identities=23%  Similarity=0.315  Sum_probs=208.2

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..++|++.++|++|+||.||+|+++.|++.||+|.++.++  .+......+|+.+|.+.+|||||.+-.+..-.   .-+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMD  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccc
Confidence            3467999999999999999999999999999999998664  34567789999999999999999999887543   346


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..|+|||||+. +|.++++..+ .+...+++.++.|+++|++|||++   .|+|||+|++|+|+...|.+||+|||+|+.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence            79999999985 8888888765 667788899999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~  906 (973)
                      ++..        ....+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++-|++...- .++....... .|
T Consensus       227 ygsp--------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtP  297 (419)
T KOG0663|consen  227 YGSP--------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTP  297 (419)
T ss_pred             hcCC--------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCC
Confidence            8653        3345567789999999998875 6899999999999999999999998765332 1222221111 11


Q ss_pred             cc--cccccCcccccccCCCc--------hhHH--HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KK--VMGIVDPSLLMEARGPS--------KFEE--CLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~--~~~~~~~~~~~~~~~~~--------~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .+  +-+......+.....+.        .+..  ....-++++...+.+||.+|.||+|.++.
T Consensus       298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            10  11111100010000000        0001  12344678889999999999999998864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=349.86  Aligned_cols=243  Identities=22%  Similarity=0.277  Sum_probs=204.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|...+.||+|+||+|++|..+.+++.+|||+++++.   ++..+..+.|..++.... ||.++.++..     |++.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT~  441 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQTK  441 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cccC
Confidence            467999999999999999999999999999999998764   455677888988887775 9999999986     7788


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +++|+||||+.||+ .-+++..+.+++..+..++..|+.||.|||++   +|||||+|.+|||+|.+|++||+|||+++.
T Consensus       442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence            99999999999999 33445556788888999999999999999999   999999999999999999999999999985


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      --        ..+..+.+++|||.|+|||++.+..|+.++|+|||||+||||+.|..||.+..+++  +.+         
T Consensus       518 ~m--------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--~Fd---------  578 (694)
T KOG0694|consen  518 GM--------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--VFD---------  578 (694)
T ss_pred             cC--------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHH---------
Confidence            42        23456678899999999999999999999999999999999999999998654331  111         


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM  952 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  952 (973)
                        .++...       +.++....++.+.++.+++..+|++|..+
T Consensus       579 --sI~~d~-------~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  579 --SIVNDE-------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHhcCC-------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              111111       22334556677889999999999999976

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.4e-38  Score=351.02  Aligned_cols=260  Identities=23%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.++||+|+||.||+|.+.     .++..||||+++... ....+.+.+|+.++..+ +||||++++++|...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            468999999999999999999752     345789999997443 23346789999999999 899999999987532  


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------------------------------------------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------------------------------------------  771 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  771 (973)
                        ....+++|||+++|+|.+++....                                                      
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              356899999999999999987532                                                      


Q ss_pred             --------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcc
Q 039720          772 --------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS  843 (973)
Q Consensus       772 --------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  843 (973)
                              .....++..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++.......      ...
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------~~~  232 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------YVR  232 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc------hhc
Confidence                    133456678999999999999999   999999999999999999999999999986532210      111


Q ss_pred             cccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccC
Q 039720          844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEAR  922 (973)
Q Consensus       844 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (973)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |..||........ +.....    ..       ..     
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~----~~-------~~-----  295 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK----DG-------TR-----  295 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh----cC-------CC-----
Confidence            112345678999999999999999999999999999997 9999976432211 111000    00       00     


Q ss_pred             CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          923 GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       923 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                       ...+..++..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0111233456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=326.12  Aligned_cols=272  Identities=22%  Similarity=0.331  Sum_probs=213.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEee--cccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ...|...+.||+|+||.|+.|.++.+|+.||||++.  .+.....++..+|++.++.++|+||+.+.++........-..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            456666889999999999999999999999999997  666677889999999999999999999999987755556678


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .|+|+|+| +.+|...++.+..+.+..+..++.|+++|+.|+|+.   +|+|||+||+|++++.+..+||+|||+|+...
T Consensus       101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecc
Confidence            99999999 468999998888788888999999999999999999   99999999999999999999999999999775


Q ss_pred             CCCCccCCCCCcccccccccccccCccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-----
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-----  904 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-----  904 (973)
                      ..      ......+..+.|.+|+|||++. ...|+.+.||||.||++.||++|++-|++...    +++...+.     
T Consensus       177 ~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~----v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  177 KF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY----VHQLQLILELLGT  246 (359)
T ss_pred             cc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch----HHHHHHHHHhcCC
Confidence            42      1234456778999999999865 46899999999999999999999999875421    11111110     


Q ss_pred             cCcccccccC-c-------ccccccCCC--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 LPKKVMGIVD-P-------SLLMEARGP--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~-~-------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .++.....+. .       ++....+.+  ...+.....-.+++.+|+..||.+|+|++|++++
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1111111111 0       011111111  1122334456788889999999999999999875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=309.41  Aligned_cols=274  Identities=20%  Similarity=0.270  Sum_probs=215.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.+|+|||+.||.++...++..||+|++........+..++|++..++++|||++++++++....-++....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35789999999999999999999999999999999998887788899999999999999999999998776545567789


Q ss_pred             EEEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          752 AIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      |++++|...|+|.+.+...    ...++.++.+|+.+|++||++||+. -+++.||||||.||++.+++.+++.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999998753    3557788999999999999999998 3359999999999999999999999999998


Q ss_pred             hccCCCCccCC-CCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          828 FLSHHPFLVAP-EGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       828 ~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ...-....... ..-.....-..|..|+|||.+.-   ...++++|||||||++|+|+.|..||+.....+..+.     
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-----  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-----  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence            65211000000 00001112346889999998654   4669999999999999999999999986544322211     


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                            ..+....+..    +... ...+.+.+++..|++.||.+||++.|++..+..+
T Consensus       253 ------LAv~n~q~s~----P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 ------LAVQNAQISI----PNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------Eeeecccccc----CCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                  1111111110    1111 1566788999999999999999999999998765

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=374.66  Aligned_cols=480  Identities=30%  Similarity=0.395  Sum_probs=345.7

Q ss_pred             EEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCc-cccccCCCCEEeeecccCCCCCCcccccCCCccceEecccc
Q 039720           67 LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPK-EVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNN  145 (973)
Q Consensus        67 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~  145 (973)
                      +|.++.++. .||..+..-.+++.|+++.|-+- ..|- .+.+..+|+.||+|+|+++ ..|..+..+..|+.|.+++|-
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~   79 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY   79 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence            455555554 57777776667999999999876 3443 3445666999999999998 899999999999999999988


Q ss_pred             cccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCcc
Q 039720          146 LVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLS  225 (973)
Q Consensus       146 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~  225 (973)
                      +. .+|..+.++.+|+.|.|.+|.+. .+|.++..+.+|++|+++.|++. .+|..+..++.+..+..++|.....++..
T Consensus        80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~  156 (1081)
T KOG0618|consen   80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQT  156 (1081)
T ss_pred             Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccc
Confidence            76 66788999999999999999998 89999999999999999999997 89999999999999999999333233322


Q ss_pred             ccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccc
Q 039720          226 VCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNL  305 (973)
Q Consensus       226 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  305 (973)
                           .++.++|..|.+.+.++.++. .++.  .|+|++|.++   --.+.++.+|+.|..+.|++....    -..++|
T Consensus       157 -----~ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l  221 (1081)
T KOG0618|consen  157 -----SIKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSL  221 (1081)
T ss_pred             -----cchhhhhhhhhcccchhcchh-hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcch
Confidence                 288899999999988888776 4444  5999999987   235678889999999999987433    245789


Q ss_pred             cceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcC
Q 039720          306 SKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLN  385 (973)
Q Consensus       306 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~  385 (973)
                      +.|+.++|.+.+....        .--.+|+++++++|+++ .+|++++.+ ..++.+...+|+++ .+|..+...++|+
T Consensus       222 ~~L~a~~n~l~~~~~~--------p~p~nl~~~dis~n~l~-~lp~wi~~~-~nle~l~~n~N~l~-~lp~ri~~~~~L~  290 (1081)
T KOG0618|consen  222 TALYADHNPLTTLDVH--------PVPLNLQYLDISHNNLS-NLPEWIGAC-ANLEALNANHNRLV-ALPLRISRITSLV  290 (1081)
T ss_pred             heeeeccCcceeeccc--------cccccceeeecchhhhh-cchHHHHhc-ccceEecccchhHH-hhHHHHhhhhhHH
Confidence            9999999998743222        12357788888888877 455666665 45667777777774 6666777777777


Q ss_pred             EEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCcc-CCcC-ccceEEcCCCccccccc-ccccccccccccccc
Q 039720          386 GLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI-GNLT-LLNVLQLGFNKLQGSIP-SYLGKCQNLMQLSAP  462 (973)
Q Consensus       386 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~-~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~  462 (973)
                      .|+..+|.+. -+|.....++.|+.|+|..|+|. ..|+.+ .-+. .|+.|+.+.|++. ..| ..-..++.|+.|++.
T Consensus       291 ~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Lyla  367 (1081)
T KOG0618|consen  291 SLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLA  367 (1081)
T ss_pred             HHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHh
Confidence            7777777776 45666666777777777777776 344432 2222 2566666777766 333 222245567777777


Q ss_pred             CcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccc
Q 039720          463 NNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGS  542 (973)
Q Consensus       463 ~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  542 (973)
                      +|.++...-+-+-+...+ |+|+|++|+|.......+.++..|++|+||+|+|+ .+|.++.+++.|++|...+|++. .
T Consensus       368 nN~Ltd~c~p~l~~~~hL-KVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~  444 (1081)
T KOG0618|consen  368 NNHLTDSCFPVLVNFKHL-KVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-S  444 (1081)
T ss_pred             cCcccccchhhhccccce-eeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-e
Confidence            777775554444444444 47777777776444445666777777777777777 66777777777777777777776 5


Q ss_pred             cccchhhhccCCeecCCCCcccc-ccCCCCCCCCccceEeccCCc
Q 039720          543 IPQSLNALKSIKELDLSCNNLSG-QIPIHLGNLPFLEYLNLSYNH  586 (973)
Q Consensus       543 ~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~  586 (973)
                      +| .+.+++.|+.+|+|.|+|+. .+|.... .++|++|||++|.
T Consensus       445 fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  445 FP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT  487 (1081)
T ss_pred             ch-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence            66 66777777777777777764 3333322 2677777777776

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-38  Score=360.87  Aligned_cols=256  Identities=27%  Similarity=0.459  Sum_probs=213.2

Q ss_pred             CCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          676 FSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ....+.||+|+||+||+|+..     ++...||||.++..... ...+|.+|++.+..++|||||+++|+|.+.     +
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-----~  562 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-----D  562 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-----C
Confidence            344678999999999999763     24578999999876655 778999999999999999999999999864     7


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCC--------------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTND--------------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD  815 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~  815 (973)
                      -.++|+|||..|+|.+++.....              ....+...||.|||.||+||-++   .+||||+..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            89999999999999999865321              23367889999999999999999   99999999999999999


Q ss_pred             CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 039720          816 MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDG  894 (973)
Q Consensus       816 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~  894 (973)
                      ..|||+|||+++.+...+++....      ...-...|||||.+.+++|+.+||||||||++||+++ |+.||....+++
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E  713 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRG------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE  713 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccC------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence            999999999999887665433211      2223567999999999999999999999999999999 999998776542


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      .  .++..                 ..+.-+.++.|+.++.+||..||+..|.+||++.||-..|++...
T Consensus       714 V--Ie~i~-----------------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  714 V--IECIR-----------------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             H--HHHHH-----------------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            1  11111                 111134567899999999999999999999999999999998754

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.2e-40  Score=353.79  Aligned_cols=387  Identities=27%  Similarity=0.411  Sum_probs=281.9

Q ss_pred             cCCCCCCEEEccCCCCC-CCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccc
Q 039720           83 GNLSFLRVINLANNSFH-GQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIE  161 (973)
Q Consensus        83 ~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~  161 (973)
                      |-|+..+-.|+++|.|+ +.+|..+..++++++|.|...++. .+|++++.|.+|++|.+                    
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~--------------------   62 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSM--------------------   62 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhh--------------------
Confidence            34666777888888887 678888888888888888887776 56666665544444444                    


Q ss_pred             eeeccCCcccccCCCCCCCCCcccEEEccCCcCC-CCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCC
Q 039720          162 RLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLD-GRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN  240 (973)
Q Consensus       162 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  240 (973)
                          ++|++. .+...++.|+.|+.+.+.+|++. .-+|..+..|..|..||||+|++. ..|..+..-+++-.|+|+.|
T Consensus        63 ----~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N  136 (1255)
T KOG0444|consen   63 ----AHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYN  136 (1255)
T ss_pred             ----hhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccC
Confidence                444444 33444444455555555555443 123444444555555555555554 34444444444444444444


Q ss_pred             ccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCC
Q 039720          241 RFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTS  320 (973)
Q Consensus       241 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  320 (973)
                      +|. .||..+|.+|+.|-.||||+|++. .+|.....+..|++|+|++|.+...--..+..+++|+.|++++.+=+    
T Consensus       137 ~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT----  210 (1255)
T KOG0444|consen  137 NIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT----  210 (1255)
T ss_pred             ccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch----
Confidence            444 788888888888888899988888 57778888888888888888876544444455555555555543211    


Q ss_pred             CChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCc
Q 039720          321 TDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP  400 (973)
Q Consensus       321 ~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  400 (973)
                                                                        ...+|..+..+.+|..+|||.|.+. ..|+
T Consensus       211 --------------------------------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPe  239 (1255)
T KOG0444|consen  211 --------------------------------------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPE  239 (1255)
T ss_pred             --------------------------------------------------hhcCCCchhhhhhhhhccccccCCC-cchH
Confidence                                                              0157888888999999999999999 8999


Q ss_pred             cccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccc
Q 039720          401 AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTL  480 (973)
Q Consensus       401 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l  480 (973)
                      .+.++++|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|++++++++|+.|++.+|+++-            
T Consensus       240 cly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F------------  305 (1255)
T KOG0444|consen  240 CLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF------------  305 (1255)
T ss_pred             HHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc------------
Confidence            9999999999999999998 45555666789999999999999 899999999999999999998861            


Q ss_pred             cceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCC
Q 039720          481 SKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSC  560 (973)
Q Consensus       481 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  560 (973)
                                 . -+|..++.+.+|+.+..++|++. .+|+.++.|..|+.|.|++|++- .+|.++.-|+.|+.|||.+
T Consensus       306 -----------e-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre  371 (1255)
T KOG0444|consen  306 -----------E-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE  371 (1255)
T ss_pred             -----------c-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence                       1 47889999999999999999998 89999999999999999999998 8999999999999999999


Q ss_pred             CccccccCCCCCC-CCccceEec
Q 039720          561 NNLSGQIPIHLGN-LPFLEYLNL  582 (973)
Q Consensus       561 N~l~~~~p~~~~~-l~~L~~L~l  582 (973)
                      |.-- ..|+--.. -++|++-++
T Consensus       372 NpnL-VMPPKP~da~~~lefYNI  393 (1255)
T KOG0444|consen  372 NPNL-VMPPKPNDARKKLEFYNI  393 (1255)
T ss_pred             CcCc-cCCCCcchhhhcceeeec
Confidence            9654 34433222 244555444

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.2e-37  Score=335.47  Aligned_cols=251  Identities=19%  Similarity=0.278  Sum_probs=201.5

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchh---HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA---TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      ...||+|++|.||+|++  +|+.||||+++......   .+.+.+|+.++++++||||+++++++.+. ..+....++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence            36799999999999999  79999999997543322   46788999999999999999999987652 23346789999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++..........+.+++.|++.|+.|||+..  +++||||||+||+++.++.+|++|||+++.....   
T Consensus       102 Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---  176 (283)
T PHA02988        102 EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---  176 (283)
T ss_pred             EeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence            99999999999988777778888999999999999999742  7889999999999999999999999999865321   


Q ss_pred             cCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                              .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+  +..   .....      
T Consensus       177 --------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~---~i~~~------  237 (283)
T PHA02988        177 --------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYD---LIINK------  237 (283)
T ss_pred             --------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHH---HHHhc------
Confidence                    113457889999999876  688999999999999999999999998643211  111   10000      


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                        .     .....+..++..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       238 --~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        238 --N-----NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --C-----CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              0     001111234567889999999999999999999999998763

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-38  Score=324.47  Aligned_cols=266  Identities=24%  Similarity=0.326  Sum_probs=202.4

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .|...+.+|.|+||.||+|...++++.||||.+-.+++.    --+|+++|+.++|||||++.-++....-.+.-...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            567788999999999999999999999999998765542    2368999999999999999988766432223456689


Q ss_pred             EeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEeccccchhc
Q 039720          755 YEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFL  829 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~Dfg~a~~~  829 (973)
                      ||||+. +|.+.++.    ...++...++-++.||.+|+.|||+.   +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999985 88888774    45667777889999999999999998   99999999999999977 89999999999977


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-C-
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-P-  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-~-  906 (973)
                      ..         +........|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|++.... .++....+... + 
T Consensus       177 ~~---------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  177 VK---------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPT  246 (364)
T ss_pred             cc---------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCC
Confidence            54         3344567789999999998875 7899999999999999999999999874332 23333332221 1 


Q ss_pred             -cccccccC-------cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 -KKVMGIVD-------PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 -~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       +.+..+-.       +.+.......-.......+..+++.++++++|.+|.++.|++.+
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence             11111100       11111110001223455677899999999999999999998853

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-38  Score=304.03  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=209.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++++.||.|.||.||.|+.+.++-.||+|++....   .+...++.+|+++-+.++||||+++|+++.     +..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----DSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----ccc
Confidence            468999999999999999999999999999999997543   334577899999999999999999999955     458


Q ss_pred             eEEEEEeeccCCCHHHHhh--hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          750 FKAIVYEYMQYGSVDDWLH--HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ..|+++||..+|+++..++  ....+.+...+.+..|+|.|+.|+|.+   +|+||||||+|+|++..+..|++|||.+.
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9999999999999999998  555677888999999999999999999   99999999999999999999999999986


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ...          .......+||..|.+||+..+..++..+|+|++|++.||++.|.+||.....++ .   +.+...  
T Consensus       173 ~~p----------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-t---YkrI~k--  236 (281)
T KOG0580|consen  173 HAP----------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-T---YKRIRK--  236 (281)
T ss_pred             ecC----------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-H---HHHHHH--
Confidence            432          334456789999999999999999999999999999999999999998765221 1   111111  


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                        .+...         +   ........++|.+|+.++|.+|.+..|+++.-.
T Consensus       237 --~~~~~---------p---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  237 --VDLKF---------P---STISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             --ccccC---------C---cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence              11111         1   223344568888999999999999999988643

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=354.70  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=212.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeE-eeecccCC-Cce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITI-CSSIDFKG-ADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~~  750 (973)
                      .+++|.+.|.+|||+.||.|++...|..||+|++-.........+.+|+++|+.++ |||||.+++. ........ ..+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            46778889999999999999998888999999998777777788999999999997 9999999993 32221222 467


Q ss_pred             EEEEEeeccCCCHHHHhhh--cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHH--TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +++.||||.||.|-|++..  ...+.+.++++|+.|+++|+.+||.. +++|||||||.||||++.+++.||||||.|+-
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            8899999999999999974  34577899999999999999999987 77899999999999999999999999999975


Q ss_pred             ccCCCC-ccCCCCCcccccccccccccCcccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          829 LSHHPF-LVAPEGQSSSIEMKGTIGYIGPEYG---MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       829 ~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ...... ...............|+.|+|||++   .+.+.++|+|||+|||+||.|+....||+....            
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------  263 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------  263 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------------
Confidence            433210 0000000112234578999999975   567889999999999999999999999985421            


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                           .++++..+.    .| ..+.....+..||..||+.||++||++-+|+..+.++.
T Consensus       264 -----laIlng~Y~----~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 -----LAILNGNYS----FP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             -----eeEEecccc----CC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                 122222221    11 12456677889999999999999999999999998875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.8e-37  Score=334.39  Aligned_cols=250  Identities=21%  Similarity=0.264  Sum_probs=198.2

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      |+..+.||+|+||+||+|.+..+|+.||+|++....   ......+.+|+++++.++|++++++++++..     .+..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeEE
Confidence            777899999999999999999999999999987432   2233467889999999999999999988543     47899


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++...  ....+..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            999999999999887643  2456778889999999999999999   99999999999999999999999999997643


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..         .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ........ ...  
T Consensus       154 ~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~-~~~--  220 (285)
T cd05631         154 EG---------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRV-KED--  220 (285)
T ss_pred             CC---------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHh-hcc--
Confidence            21         112234689999999999999999999999999999999999999985433211 01111000 000  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                                  ...........+.+++.+||+.||++||+     ++|+++.
T Consensus       221 ------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 ------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                        01111223456778999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=339.83  Aligned_cols=246  Identities=22%  Similarity=0.287  Sum_probs=201.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     +...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence            36889999999999999999999999999999997432   223456889999999999999999988743     4578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++...+...+..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            999999999999999998887788888899999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ..  +.... ..   
T Consensus       153 ~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~--~~~i~-~~---  213 (291)
T cd05612         153 DR-----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GI--YEKIL-AG---  213 (291)
T ss_pred             CC-----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH--HHHHH-hC---
Confidence            21           12346899999999999999999999999999999999999999754221  11  10000 00   


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                           .       ...+......+.+++.+||+.||.+||+     ++|++++
T Consensus       214 -----~-------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         214 -----K-------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----C-------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 0       0011122345678889999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-36  Score=338.95  Aligned_cols=268  Identities=22%  Similarity=0.312  Sum_probs=206.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|++++++++||||+++++++..     .+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence            368999999999999999999999999999999997653 3345679999999999999999999998654     3689


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++|+|.+++......++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||++.....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            999999999999999988777788888999999999999999852  699999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .          ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  +..............
T Consensus       157 ~----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~  224 (331)
T cd06649         157 S----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEG  224 (331)
T ss_pred             c----------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccC
Confidence            1          1223468999999999999999999999999999999999999996543211  111100000000000


Q ss_pred             c---cCcc-------c-------------------ccccCCCch-hHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          912 I---VDPS-------L-------------------LMEARGPSK-FEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       912 ~---~~~~-------~-------------------~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      .   ..+.       .                   ......+.. ......++.+++.+||+.||++|||++|+++.-
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            0   0000       0                   000000000 112445788999999999999999999998875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-37  Score=319.01  Aligned_cols=259  Identities=28%  Similarity=0.337  Sum_probs=208.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +.|+..+.||+|.-|+||+|+.+.++..+|+|++....   .....+...|.+||+.++||.++.+|+.     |+.++.
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence            56788899999999999999999999999999996543   3344567889999999999999999997     566799


Q ss_pred             EEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .|+|||||+||+|..+.+++.  .+++..++.++.+|+-||+|||-.   |||+||+||+||||.++|++-|+||.++..
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence            999999999999999988654  567788999999999999999999   999999999999999999999999998865


Q ss_pred             ccCCCCcc------------------------------------------------CCCCCcccccccccccccCccccc
Q 039720          829 LSHHPFLV------------------------------------------------APEGQSSSIEMKGTIGYIGPEYGM  860 (973)
Q Consensus       829 ~~~~~~~~------------------------------------------------~~~~~~~~~~~~gt~~y~aPE~~~  860 (973)
                      ....+...                                                .+........++||-+|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            42211000                                                011223444578999999999999


Q ss_pred             CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhh
Q 039720          861 GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVA  940 (973)
Q Consensus       861 ~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  940 (973)
                      +...+.++|+|+|||++|||+.|+.||.+..++++..-             ++...+..    +. ..+......+||++
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N-------------Iv~~~l~F----p~-~~~vs~~akDLIr~  370 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN-------------IVGQPLKF----PE-EPEVSSAAKDLIRK  370 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH-------------HhcCCCcC----CC-CCcchhHHHHHHHH
Confidence            99999999999999999999999999998766543211             11111110    11 11444566789999


Q ss_pred             cCCCCCCCCCC----HHHHHHH
Q 039720          941 CSMESPSERMQ----MTAVVKK  958 (973)
Q Consensus       941 cl~~dP~~RPs----~~evl~~  958 (973)
                      .+.+||.+|..    |+||.++
T Consensus       371 LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  371 LLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HhccChhhhhccccchHHhhcC
Confidence            99999999998    8887654

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.3e-37  Score=315.69  Aligned_cols=278  Identities=22%  Similarity=0.362  Sum_probs=210.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCC-ceeEEeEeeecc-cCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRN-LIKIITICSSID-FKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-~~~~  748 (973)
                      ...|...++||+|+||+||+|+.+.+|+.||+|+++.+..  +......+|+.+++.++|+| ||.+++++.... +...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3457778889999999999999999999999999987644  46678899999999999999 999999976542 2333


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                      ...++||||++ -+|..++....    ..+...++.+++|++.|++|||++   +|+|||+||.||+++..|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence            47889999997 48898887755    344567899999999999999999   99999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      +|+...-.        ....+..++|.+|+|||++.+. .|+...||||+||+++||++++.-|++..+.+....-....
T Consensus       166 lAra~~ip--------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l  237 (323)
T KOG0594|consen  166 LARAFSIP--------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL  237 (323)
T ss_pred             hHHHhcCC--------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence            99955421        2334556789999999998887 78999999999999999999999888765422211111111


Q ss_pred             hcC--cc---cccccCcccc-cccCCCchhHH-H---HHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhc
Q 039720          904 ALP--KK---VMGIVDPSLL-MEARGPSKFEE-C---LVAVVRTGVACSMESPSERMQMTAVVKK--LCAV  962 (973)
Q Consensus       904 ~~~--~~---~~~~~~~~~~-~~~~~~~~~~~-~---~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  962 (973)
                      ..|  +.   +....+.+.. .....+..... .   .....+++.+|++++|.+|.|++.++.+  +..+
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            111  11   2222222211 11110111111 1   1367788999999999999999999986  4444

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-37  Score=342.00  Aligned_cols=243  Identities=23%  Similarity=0.269  Sum_probs=196.6

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.||+|+||.||+|++..+|+.||+|+++...   ......+.+|+.+++.++||||+++++++..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence            46999999999999999999999999997542   2334567889999999999999999987543     478999999


Q ss_pred             eccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCcc
Q 039720          757 YMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      |+.+|+|.+++.......+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~----  148 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD----  148 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----
Confidence            999999999998887888888999999999999999999   9999999999999999999999999998753221    


Q ss_pred             CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                          ........||+.|+|||++.+..++.++||||+||++|||++|+.||......     .........      +. 
T Consensus       149 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~~~~------~~-  212 (323)
T cd05571         149 ----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME------EI-  212 (323)
T ss_pred             ----CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcC------CC-
Confidence                12223456999999999999999999999999999999999999999753211     111110000      00 


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                              ..+......+.+++.+||+.||++||     ++.|++++
T Consensus       213 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         213 --------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             --------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                    01122344567888899999999999     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.9e-37  Score=342.95  Aligned_cols=274  Identities=20%  Similarity=0.269  Sum_probs=202.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||+|+||.||+|++..++..||||++...  .......+.+|+.+++.++||||+++++++......+....+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588899999999999999999999999999998643  223345688999999999999999999987654344445689


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+. ++|.+++.......+..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9999995 68999998877788888999999999999999999   9999999999999999999999999999754321


Q ss_pred             CCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH---hcCc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM---ALPK  907 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~---~~~~  907 (973)
                      .     ..........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... .+......   ..+.
T Consensus       157 ~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~  230 (338)
T cd07859         157 T-----PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPE  230 (338)
T ss_pred             c-----CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHH
Confidence            1     00111233568999999999766  678999999999999999999999997542210 00000000   0000


Q ss_pred             ccccccCc-------ccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDP-------SLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~-------~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ....+...       ........  ..........+.+++.+||+.||++||+++|+++.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000000       00000000  00111234567789999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=335.88  Aligned_cols=250  Identities=21%  Similarity=0.279  Sum_probs=209.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch--hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce-
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF-  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~-  750 (973)
                      ++|..++.+|+|+||.++.++++.++..||+|.+...+..  ......+|+.++++++|||||.+.+.+.+     ++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-----~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-----DGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc-----CCce
Confidence            5789999999999999999999999999999999876543  33468899999999999999999998543     355 


Q ss_pred             EEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .+|||+||+||++.+.+.+..  .++++.+.+|+.|++.|+.|||++   .|+|||||+.||+++.++.|||+|||+|+.
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhh
Confidence            999999999999999997654  456788999999999999999998   999999999999999999999999999998


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        ........||+.|++||++.+.+|+.|+|||||||++|||++-+++|....-.     .....     
T Consensus       156 l~~~--------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~k-----  217 (426)
T KOG0589|consen  156 LNPE--------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELILK-----  217 (426)
T ss_pred             cCCc--------hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHHH-----
Confidence            7653        23455678999999999999999999999999999999999999999864322     11110     


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         +....      ....+..+..++..++..|++.+|+.||++.+++..
T Consensus       218 ---i~~~~------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  218 ---INRGL------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---Hhhcc------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               01000      122234455677788889999999999999999986

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-37  Score=343.39  Aligned_cols=246  Identities=21%  Similarity=0.252  Sum_probs=201.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|+.++++++||||+++++++..     ++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----ENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CCE
Confidence            57999999999999999999999999999999997432   2334668899999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+.+|+|.+++...+..++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999999999998887788888889999999999999999   99999999999999999999999999997553


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..           .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+.... .    
T Consensus       170 ~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~-~----  229 (329)
T PTZ00263        170 DR-----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKIL-A----  229 (329)
T ss_pred             CC-----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHHHh-c----
Confidence            21           12346899999999999999999999999999999999999999643211    1111110 0    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                          ...       ..+......+.+++.+||+.||++||+     ++|++++
T Consensus       230 ----~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 ----GRL-------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ----CCc-------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                000       000112345668889999999999997     6887755

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-36  Score=332.42  Aligned_cols=268  Identities=21%  Similarity=0.308  Sum_probs=202.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||+||+|+++.+++.||+|+++...  ....+.+.+|+.+++.++||||+++++++..     .+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence            47999999999999999999999999999999997543  2334678899999999999999999987543     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||++++.+..+........+..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            99999999987776655555677788899999999999999999   999999999999999999999999999986533


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH--hcCccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM--ALPKKV  909 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~~  909 (973)
                      ..       ........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......  ..+...
T Consensus       153 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~  224 (287)
T cd07848         153 GS-------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQ  224 (287)
T ss_pred             cc-------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHH
Confidence            21       1122245689999999999998999999999999999999999999976432111 1111110  000000


Q ss_pred             ccc--cCccc----ccccCCC-----chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          910 MGI--VDPSL----LMEARGP-----SKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       910 ~~~--~~~~~----~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ...  .++..    .......     .........+.+++.+|++.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000  00000    0000000     001124556889999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=341.91  Aligned_cols=261  Identities=27%  Similarity=0.388  Sum_probs=208.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc---E-EEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM---S-VAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      .++-...++||+|+||.||+|+.+..+.   . ||||..+.+   ......++++|.++|++++|||||++||++...  
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--
Confidence            3455566899999999999998865432   3 899999853   355678899999999999999999999997653  


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCC-CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                         .-+++|||+|.||+|.+++++.+. .+..+...++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||
T Consensus       234 ---~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  234 ---EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             ---CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence               778999999999999999998774 77788999999999999999999   99999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhH
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      +++.-...        ........-...|+|||.+....|++++|||||||++||+++ |..||.+....  ++..+.. 
T Consensus       308 Ls~~~~~~--------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~-  376 (474)
T KOG0194|consen  308 LSRAGSQY--------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV-  376 (474)
T ss_pred             cccCCcce--------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH-
Confidence            98754311        001101123457999999999999999999999999999999 89999876433  1111110 


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccccc
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFI  967 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  967 (973)
                                     ....+...+...+..+..++.+||..||++||+|.++.+.++.+.....
T Consensus       377 ---------------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 ---------------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ---------------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                           0111122223455667788889999999999999999999999866554

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=361.72  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=210.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCC-----cEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDG-----MSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..+..+.||+|+||.||.|+...-.     ..||||.++.. ..+...+|.+|..+|++++|||||+++|+|.+     .
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence            3455678999999999999875432     34899988654 45567889999999999999999999999875     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                      ...+|++|||++|+|..++++.+       .....+...++.|||+|+.||+++   ++|||||.++|+|+++...|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence            77899999999999999998762       223366789999999999999999   99999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhh
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~  900 (973)
                      |||+|+.+...+++.....      ..-...|||||.+..+.++.|+|||||||++||++| |..||+...+.+....-.
T Consensus       845 DFGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~  918 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGE------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL  918 (1025)
T ss_pred             ccchhHhhhhchheeccCc------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence            9999997765543332211      112346999999999999999999999999999999 999999765532211110


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                                         +..+-+.+..|+..+.++|.+||+.+|++||++..+++.+.++....
T Consensus       919 -------------------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  919 -------------------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             -------------------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                               11124456788899999999999999999999999999988875443

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-37  Score=341.03  Aligned_cols=254  Identities=19%  Similarity=0.278  Sum_probs=204.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+++++.++||||+++++++..     ...
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence            36899999999999999999999999999999997542   2344668899999999999999999988654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++.......+..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            999999999999999998877788888999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .           ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.    +..........
T Consensus       153 ~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~  217 (333)
T cd05600         153 T-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET----WENLKYWKETL  217 (333)
T ss_pred             c-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH----HHHHHhccccc
Confidence            2           22345689999999999999999999999999999999999999975432110    11110000000


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ..+..      ..........+.+++.+|+..+|++||+++|+++.
T Consensus       218 --~~~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         218 --QRPVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             --cCCCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence              00000      00002334567788889999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-37  Score=303.66  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=208.9

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-----c---hhHHHHHHHHHHHHhc-CCCCceeEEeEee
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----K---GATKSFVAECEALRNI-RHRNLIKIITICS  741 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  741 (973)
                      ..-..|.-.+.+|.|..++|.++.++.+|..+|+|++....     .   ...+...+|+.+|+++ .||+|+++.+++ 
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-   92 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-   92 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-
Confidence            33456777889999999999999999999999999996432     1   1234567899999988 599999999985 


Q ss_pred             ecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       742 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                          +.+...++|+|.|+.|.|+|++...-...+....+|++|+.+|++|||.+   .|||||+||+|||+|++.++||+
T Consensus        93 ----es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   93 ----ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             ----cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence                44578999999999999999999988889999999999999999999999   99999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG------GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL  895 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~  895 (973)
                      |||+|+...+         +......+|||+|+|||.+..      ..|+..+|+|++||+||-++.|.+||....  ..
T Consensus       166 DFGFa~~l~~---------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Qm  234 (411)
T KOG0599|consen  166 DFGFACQLEP---------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QM  234 (411)
T ss_pred             ccceeeccCC---------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HH
Confidence            9999997754         445567899999999998643      478999999999999999999999996321  11


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      .+..   .. .+.       ..  + -....+.+......++|.+|++.||.+|.|++|++++-.
T Consensus       235 lMLR---~I-meG-------ky--q-F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf  285 (411)
T KOG0599|consen  235 LMLR---MI-MEG-------KY--Q-FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF  285 (411)
T ss_pred             HHHH---HH-Hhc-------cc--c-cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence            1000   00 000       00  0 113445666777889999999999999999999987543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=307.75  Aligned_cols=253  Identities=20%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .+.|.+-+.||+|.|+.||++.+..+|+.+|+|++....  ....+++.+|+.+-+.++||||+++.+.+     .....
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence            457888889999999999999999999999999996432  23567899999999999999999998864     44588


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec---CCCcEEEeccccch
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAR  827 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~---~~~~~kl~Dfg~a~  827 (973)
                      .|+|+|+|.|++|..-+-.+-...+..+..+++||++|+.|+|.+   +|||||+||+|+++-   ...-+|++|||+|.
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999999999986655544456667788999999999999999   999999999999994   34579999999999


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .+..         +.......|||+|||||++...+|+..+|||+.||++|-++.|++||.+....    .-+..+.  .
T Consensus       162 ~l~~---------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----rlye~I~--~  226 (355)
T KOG0033|consen  162 EVND---------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYEQIK--A  226 (355)
T ss_pred             EeCC---------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----HHHHHHh--c
Confidence            8762         34444678999999999999999999999999999999999999999863221    1111111  0


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...+ ++         +..++...+.-.+++++|+..||.+|.|+.|.+++
T Consensus       227 g~yd-~~---------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  227 GAYD-YP---------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             cccC-CC---------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            0000 11         11223334445578889999999999999998764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-36  Score=331.86  Aligned_cols=263  Identities=21%  Similarity=0.371  Sum_probs=198.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECC----------------CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCcee
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE----------------DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIK  735 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  735 (973)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++.... .....++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3579999999999999999998632                34579999987543 334567899999999999999999


Q ss_pred             EEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcC-------------------CCchhhHHHHHHHHHHHHHHHHhcC
Q 039720          736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-------------------DKLEVGKLNIVIEVASVIEYLHNHC  796 (973)
Q Consensus       736 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~  796 (973)
                      +++++..     .+..++||||+.+|+|.+++....                   ......+.+++.|++.|+.|||+. 
T Consensus        84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            9998754     367899999999999999986532                   123356788999999999999999 


Q ss_pred             CCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHH
Q 039720          797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL  876 (973)
Q Consensus       797 ~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~l  876 (973)
                        +|+||||||+||+++.++.+||+|||+++.......      ........++..|+|||++.+..++.++|||||||+
T Consensus       158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~  229 (304)
T cd05096         158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT  229 (304)
T ss_pred             --CccccCcchhheEEcCCccEEECCCccceecccCce------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence              999999999999999999999999999986533210      111112345778999999988899999999999999


Q ss_pred             HHHHHh--CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 039720          877 LLEMFT--RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTA  954 (973)
Q Consensus       877 l~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  954 (973)
                      +|||++  +..||......  ..................          ...+..++..+.+++.+||+.||++|||++|
T Consensus       230 l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~  297 (304)
T cd05096         230 LWEILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQVY----------LFRPPPCPQGLYELMLQCWSRDCRERPSFSD  297 (304)
T ss_pred             HHHHHHccCCCCCCcCCHH--HHHHHHHHHhhhcccccc----------ccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            999987  55677654322  111111111100000000          0111234567889999999999999999999


Q ss_pred             HHHHHHh
Q 039720          955 VVKKLCA  961 (973)
Q Consensus       955 vl~~L~~  961 (973)
                      |.+.|++
T Consensus       298 i~~~l~~  304 (304)
T cd05096         298 IHAFLTE  304 (304)
T ss_pred             HHHHHhC
Confidence            9988863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-36  Score=336.09  Aligned_cols=243  Identities=24%  Similarity=0.286  Sum_probs=195.7

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.||+|+||.||+|++..+|..||+|+++...   ......+.+|+++++.++||||+++++++..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence            46999999999999999999999999997542   2334567889999999999999999987543     478999999


Q ss_pred             eccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCcc
Q 039720          757 YMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      |+++|+|.+++.....+.+..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~----  148 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----  148 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC----
Confidence            999999999998877788888999999999999999999   9999999999999999999999999998753221    


Q ss_pred             CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                          ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ........        .
T Consensus       149 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~~~~~--------~  211 (323)
T cd05595         149 ----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILME--------E  211 (323)
T ss_pred             ----CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcC--------C
Confidence                112223568999999999999999999999999999999999999997532211     00000000        0


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                      .       ..+......+.+++.+||+.||++||     ++.++++.
T Consensus       212 ~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         212 I-------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             C-------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            0       01112345567888899999999998     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.2e-36  Score=333.94  Aligned_cols=201  Identities=26%  Similarity=0.377  Sum_probs=176.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.++||+|+||.||+|++..++..||+|++.... ......+.+|+++++.++||||+++++++..     .+..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence            368999999999999999999999999999999987543 3345678999999999999999999998765     3789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++|+|.+++...+...+..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||++.....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999999999988777777888899999999999999742  799999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~  890 (973)
                      .          ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       157 ~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         157 S----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             h----------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            1          112346889999999999889999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.9e-36  Score=329.41  Aligned_cols=267  Identities=22%  Similarity=0.328  Sum_probs=197.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|.+.+.||+|+||+||+|++..++..||+|+++... ......+.+|+++++.++||||+++++++.     .....+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence            57999999999999999999999999999999997543 223456789999999999999999999854     346899


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++ +|.+++...+ ..+...+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99999985 8998887544 356677889999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-c--Cc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-L--PK  907 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~--~~  907 (973)
                      .        ........+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. +....... .  ..
T Consensus       156 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~  226 (288)
T cd07871         156 P--------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEE  226 (288)
T ss_pred             C--------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChH
Confidence            1        111223467899999998765 5689999999999999999999999975432211 11111100 0  00


Q ss_pred             ccccccCcc-----cccccCC-C--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPS-----LLMEARG-P--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~-----~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .........     ....... +  ........+..+++.+|++.||.+|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         227 TWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             HhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000000     0000000 0  0001123456788999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=333.33  Aligned_cols=240  Identities=21%  Similarity=0.257  Sum_probs=193.3

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ||+|+||+||+|++..+++.||+|+++...   ......+.+|+.++++++||||+++++++..     .+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence            799999999999999999999999997432   2344667889999999999999999987643     47899999999


Q ss_pred             cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCC
Q 039720          759 QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP  838 (973)
Q Consensus       759 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~  838 (973)
                      ++|+|.+++...+.+.+..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....      
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------  146 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------  146 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC------
Confidence            9999999998877788888999999999999999999   9999999999999999999999999998753221      


Q ss_pred             CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccc
Q 039720          839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLL  918 (973)
Q Consensus       839 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (973)
                        ........||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..........          
T Consensus       147 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~~----------  209 (312)
T cd05585         147 --DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQEP----------  209 (312)
T ss_pred             --CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCC----------
Confidence              11223456899999999999999999999999999999999999999753211     1111111000          


Q ss_pred             cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHH
Q 039720          919 MEARGPSKFEECLVAVVRTGVACSMESPSERMQ---MTAVVK  957 (973)
Q Consensus       919 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  957 (973)
                           ...+......+.+++.+||+.||++||+   +.|++.
T Consensus       210 -----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         210 -----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                 0111223455678888999999999985   566654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-36  Score=336.05  Aligned_cols=243  Identities=23%  Similarity=0.286  Sum_probs=196.3

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.||+|+||.||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++.     ..+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999997432   234467888999999999999999998754     3578999999


Q ss_pred             eccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCcc
Q 039720          757 YMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      |+++|+|.+++.....+.+.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~----  148 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----  148 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc----
Confidence            999999999998877788888999999999999999999   9999999999999999999999999998753221    


Q ss_pred             CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                          ........||+.|+|||++.+..++.++||||+||++|+|++|+.||......     ..........      . 
T Consensus       149 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~------~-  212 (328)
T cd05593         149 ----AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMED------I-  212 (328)
T ss_pred             ----ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCC------c-
Confidence                11223356899999999999999999999999999999999999999753211     1111100000      0 


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                              ..+......+.+++.+|++.||++||     ++.|++++
T Consensus       213 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         213 --------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                    01112344567888899999999997     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-36  Score=332.86  Aligned_cols=268  Identities=21%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|.+.+.||+|+||+||+|++..+++.||||+++.... .....+.+|+.+++.++||||+++++++..     ....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence            4689999999999999999999998999999999975432 234567889999999999999999998643     4789


Q ss_pred             EEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+. +++.+++... ....+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            99999996 6777777653 4566778899999999999999999   99999999999999999999999999987542


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc-
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK-  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-  908 (973)
                      ..        ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+........... 
T Consensus       155 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (303)
T cd07869         155 VP--------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE  226 (303)
T ss_pred             CC--------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh
Confidence            21        112223468899999998765 45788999999999999999999999865332111111111100000 


Q ss_pred             --cc---c--ccCcccccccCCCchhH------HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 --VM---G--IVDPSLLMEARGPSKFE------ECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 --~~---~--~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ..   .  ..++...... .+....      .....+.+++.+|++.||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         227 DTWPGVHSLPHFKPERFTLY-SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhccchhhcccccccccccc-CCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence              00   0  0000000000 000000      112356688899999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.3e-36  Score=340.33  Aligned_cols=258  Identities=22%  Similarity=0.363  Sum_probs=199.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC-----cEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG-----MSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|.+.+.||+|+||.||+|++...|     ..||+|+++... ......+.+|+.+++.+ +||||++++++|..   
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~---  113 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH---  113 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence            457999999999999999999865433     579999997543 33456788999999999 89999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------------------------------------------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------------------------------------------  771 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  771 (973)
                        ....++||||+++|+|.+++....                                                      
T Consensus       114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence              468899999999999999985421                                                      


Q ss_pred             ----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          772 ----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       772 ----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                                      .+...++++++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++......  
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~--  266 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--  266 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc--
Confidence                            133456789999999999999999   99999999999999999999999999997653221  


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                          .........+++.|+|||++.+..++.++|||||||++|||++ |+.||........ ........          
T Consensus       267 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~----------  331 (374)
T cd05106         267 ----NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRG----------  331 (374)
T ss_pred             ----ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcc----------
Confidence                0111112235567999999998999999999999999999997 9999976433211 11111000          


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                        ..     ...+...+..+.+++.+||+.||++||+++|+++.|+++
T Consensus       332 --~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         332 --YQ-----MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             --cC-----ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              00     000011235678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-36  Score=338.94  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=199.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC-cEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG-MSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|.+.+.||+|+||.||+|++..++ ..||+|++....   ....+.+.+|+.+++.++||||+++++++..     .
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----E  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----C
Confidence            357999999999999999999876554 689999996432   2344678899999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+.+|+|.+++.......+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            78999999999999999998888888888999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....           .....||+.|+|||++.+..++.++||||+||++|||++|+.||......    ..+.....  .
T Consensus       181 ~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~i~~--~  243 (340)
T PTZ00426        181 VDTR-----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LIYQKILE--G  243 (340)
T ss_pred             cCCC-----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HHHHHHhc--C
Confidence            4321           12456899999999999989999999999999999999999999754221    11111110  0


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                             ..    ..+   ......+.+++.+|++.||++|+     +++|+++.
T Consensus       244 -------~~----~~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 -------II----YFP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CC----CCC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   00    001   11223456888899999999995     89998775

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.8e-36  Score=324.56  Aligned_cols=256  Identities=21%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             hhcCCcCCccccccceeEEEEEEC---CCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||.||+|+++   ..+..||+|+++.... .....+.+|+.++++++|||++++++++..     .
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence            357899999999999999999875   3567899999975432 334678899999999999999999998653     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +..++||||+++|+|.+++... ....+.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            7899999999999999998764 4567788899999999999999999   99999999999999999999999999876


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......       ........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+  +.....    
T Consensus       156 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~----  222 (266)
T cd05064         156 EDKSEA-------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVE----  222 (266)
T ss_pred             cccccc-------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHH----
Confidence            432111       111112235678999999999999999999999999999875 999997643221  111100    


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ..    .         ....+..++..+.+++.+||+.+|++||+++|+.+.|.++
T Consensus       223 ~~----~---------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 DG----F---------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC----C---------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            00    0         0111234556788899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.5e-36  Score=327.91  Aligned_cols=270  Identities=20%  Similarity=0.341  Sum_probs=198.2

Q ss_pred             hcCCcCCccccccceeEEEEEECC-CCcEEEEEEeeccc--chhHHHHHHHHHHHHhc---CCCCceeEEeEeeecccCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGE-DGMSVAVKVMNLDK--KGATKSFVAECEALRNI---RHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~  747 (973)
                      ++|++.+.||+|+||+||+|++.. +++.||+|+++...  ......+.+|+.+++.+   +||||++++++|.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            379999999999999999999854 46889999987543  22334566777777665   6999999999986543445


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ....++||||+. ++|.+++...  ...++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            577899999997 6899888653  2356778899999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-  904 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-  904 (973)
                      ++.....         .......||+.|+|||++.+..++.++|||||||++|||++|++||......+ .+....... 
T Consensus       157 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~  226 (290)
T cd07862         157 ARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIG  226 (290)
T ss_pred             eEeccCC---------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhC
Confidence            9755321         12234568999999999988899999999999999999999999998653321 111111110 


Q ss_pred             c--Cccccc---ccCcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          905 L--PKKVMG---IVDPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       905 ~--~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .  +.....   .....+......  ..........+.+++.+|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0  000000   000000000000  0111223456778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.2e-36  Score=339.83  Aligned_cols=257  Identities=23%  Similarity=0.361  Sum_probs=198.7

Q ss_pred             hhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||+||+|++     ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|..   
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~---  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV---  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence            35789999999999999999975     3456789999997443 33456788999999999 89999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------------------------------------------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------------------------------------------  771 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  771 (973)
                        ....++||||+++|+|.++++...                                                      
T Consensus       111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence              467899999999999999986432                                                      


Q ss_pred             ---------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          772 ---------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       772 ---------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                                           ......+.+++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                 123456778999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....      ........++..|+|||++.+..++.++|||||||++|||++ |..||........ .......      
T Consensus       266 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~------  332 (375)
T cd05104         266 NDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKE------  332 (375)
T ss_pred             Cccc------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHHHh------
Confidence            3210      011112235667999999999999999999999999999998 8999876433211 1111110      


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                            ...     ...+...+.++.+++.+||+.||++||++.||++.|++
T Consensus       333 ------~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         333 ------GYR-----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ------Ccc-----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                  000     00111123467799999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-36  Score=338.46  Aligned_cols=263  Identities=20%  Similarity=0.226  Sum_probs=199.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|+..      ...+.+|++++++++||||+++++++..     ....++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEE
Confidence            57999999999999999999999999999999753      2346789999999999999999998654     478899


Q ss_pred             EEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          754 VYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      |+|++. ++|.+++......+..+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+......
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            999985 78998888777778888999999999999999999   99999999999999999999999999997532211


Q ss_pred             CccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC------ccHhhhhhHhc--
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG------LTLHGYAKMAL--  905 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~------~~~~~~~~~~~--  905 (973)
                             ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......      ..+........  
T Consensus       237 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~  309 (391)
T PHA03212        237 -------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH  309 (391)
T ss_pred             -------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence                   122234579999999999999999999999999999999999998875332110      11111111000  


Q ss_pred             Ccc----c----c----cccCcccccccCCC--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKK----V----M----GIVDPSLLMEARGP--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~----~----~----~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +..    .    .    .............+  ......+.++.+++.+|++.||++|||++|+++.
T Consensus       310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000    0    0    00000000000001  1112345678899999999999999999999864

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.9e-36  Score=321.69  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=203.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++|||++++++++..     .+..+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEE
Confidence            3579999999999999999999988999999999976655555678899999999999999999998654     37889


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++++|.++++......+..+..++.|++.|+.|||+.   +|+|||+||+||+++.++.++|+|||++......
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            9999999999999998777778888999999999999999999   9999999999999999999999999999865321


Q ss_pred             CCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                              ........|++.|+|||.+.   ...++.++||||+||++|||++|+.||......... ..          
T Consensus       160 --------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~----------  220 (267)
T cd06646         160 --------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FL----------  220 (267)
T ss_pred             --------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-ee----------
Confidence                    11112345888999999874   345788999999999999999999998643221110 00          


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                        .........  ...........+.+++.+||+.||++||+++++++.+
T Consensus       221 --~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         221 --MSKSNFQPP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --eecCCCCCC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              000000000  0001122345677899999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=334.51  Aligned_cols=250  Identities=25%  Similarity=0.348  Sum_probs=193.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .+|...++||+|+||+||+|++..+++.||||++..... .....+.+|+++++.++|+||+++++++.     .....+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCeEE
Confidence            457778899999999999999999999999999965432 34567899999999999999999999854     347899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++|+|.+..    ...+..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       149 lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        149 VLLEFMDGGSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             EEEecCCCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999999987532    234566788999999999999999   9999999999999999999999999999865321


Q ss_pred             CCccCCCCCcccccccccccccCcccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                              ........||..|+|||++..     ...+.++|||||||++|||++|+.||......+  ...........
T Consensus       222 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~  291 (353)
T PLN00034        222 --------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMS  291 (353)
T ss_pred             --------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhcc
Confidence                    111223468999999998743     234568999999999999999999997332211  11111000000


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                                    ........+...+.+++.+||+.||++||+++|++++-
T Consensus       292 --------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        292 --------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             --------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                          00111223455678999999999999999999999863

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-35  Score=324.25  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCC-----cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDG-----MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ++|++.+.||+|+||.||+|.+...+     ..||+|+++... ......+.+|+++++.++|||++++++++..     
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-----   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----
Confidence            47889999999999999999886554     689999986443 2334668899999999999999999998653     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc----------------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT----------------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NIL  811 (973)
                      ....+++|||+++|+|.+++...                ......+++.++.|++.|+.|||+.   +++||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence            36789999999999999998764                2344567789999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 039720          812 LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM  890 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~  890 (973)
                      ++.++.++|+|||++.......      .........+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSAD------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEECCCcceeeccccc------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999997653321      0111223346788999999988899999999999999999998 99998754


Q ss_pred             CCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ...+  +...            +...     .....+..++..+.+++.+||+.||++||+++||+++|+++
T Consensus       231 ~~~~--~~~~------------i~~~-----~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         231 SNQE--VIEM------------IRSR-----QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             CHHH--HHHH------------HHcC-----CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            3221  1111            0000     00112244567788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-35  Score=318.27  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=205.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||.||+|++..+++.||||.++..   .......+.+|+++++.++|||++++++++..     .+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            4799999999999999999999999999999988642   23344678899999999999999999998654     368


Q ss_pred             EEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          751 KAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .++++||+++|+|.+++..    ....++..+..++.|++.|++|||++   +++||||||+||+++.++.++++|||.+
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            8999999999999988853    23356677899999999999999999   9999999999999999999999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......        .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||.........+......   
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---  222 (267)
T cd08228         154 RFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---  222 (267)
T ss_pred             eeccchh--------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---
Confidence            8654321        11123457889999999988889999999999999999999999986533221111111100   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                           ..        ..+.........+.+++.+||+.+|++||+++||++.+++++
T Consensus       223 -----~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         223 -----CD--------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----CC--------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 00        001112234566789999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.1e-36  Score=332.51  Aligned_cols=247  Identities=23%  Similarity=0.270  Sum_probs=195.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCC-CceeEEeEeeecccCCCce
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHR-NLIKIITICSSIDFKGADF  750 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  750 (973)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+..|.+++..+.|+ +++++++++.     ..+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            5888999999999999999999999999999997542   23446678899999999765 5777777643     3478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++.......+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            999999999999999998877788888999999999999999999   99999999999999999999999999987432


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..        ........||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..  ..... .    
T Consensus       153 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~--~~~i~-~----  215 (324)
T cd05587         153 FG--------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--EL--FQSIM-E----  215 (324)
T ss_pred             CC--------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH--HHHHH-c----
Confidence            11        11223456899999999999999999999999999999999999999754221  11  10100 0    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM-----TAVVK  957 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  957 (973)
                          ..       ...+......+.+++.+|+..||++|++.     +++.+
T Consensus       216 ----~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         216 ----HN-------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             ----CC-------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                00       00111223456788889999999999976     56554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-35  Score=323.63  Aligned_cols=270  Identities=22%  Similarity=0.322  Sum_probs=198.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhc---CCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNI---RHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +|++.+.||+|+||+||+|++..+++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999999999999999987542  22234456677766655   799999999987654444556


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ..+++|||+. +++.+++....  ..++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            7899999998 48888887543  357788899999999999999999   99999999999999999999999999997


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~  906 (973)
                      .....         .......||..|+|||++.+..++.++||||+||++|+|++|++||....... .+....... .+
T Consensus       157 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~  226 (288)
T cd07863         157 IYSCQ---------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP  226 (288)
T ss_pred             cccCc---------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCC
Confidence            65321         11223467899999999999999999999999999999999999996543221 111111100 00


Q ss_pred             c--cccccc---CcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 K--KVMGIV---DPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~--~~~~~~---~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .  ......   ..........  ..........+.+++.+|++.||++|||+.|++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0  000000   0000000000  01112344567799999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.6e-36  Score=329.41  Aligned_cols=242  Identities=24%  Similarity=0.296  Sum_probs=190.5

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHh-cCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRN-IRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+..|..++.. .+||||+++++++.     ..+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999997542   2233455667777764 48999999998854     347899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++......++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---  149 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG---  149 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---
Confidence            9999999999998877788888999999999999999999   9999999999999999999999999999754221   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+..  ... ..      . 
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~--~i~-~~------~-  212 (316)
T cd05592         150 -----EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFD--SIL-ND------R-  212 (316)
T ss_pred             -----CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHH--HHH-cC------C-
Confidence                 12223456899999999999999999999999999999999999999754221  1111  000 00      0 


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT-AVVK  957 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  957 (973)
                              +..+..+...+.+++.+||+.||++||++. ++++
T Consensus       213 --------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         213 --------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence                    111122334566888899999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.7e-35  Score=334.07  Aligned_cols=209  Identities=24%  Similarity=0.305  Sum_probs=176.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...   ......+.+|+.++..++||+|+++++++.+     ...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence            47899999999999999999999999999999997432   2234567889999999999999999988543     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++...+...+..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            999999999999999998888888889999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCccC---------------------------CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhC
Q 039720          831 HHPFLVA---------------------------PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR  883 (973)
Q Consensus       831 ~~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg  883 (973)
                      .......                           ..........+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            2110000                           0000011235799999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 039720          884 RRPTDNM  890 (973)
Q Consensus       884 ~~Pf~~~  890 (973)
                      +.||...
T Consensus       233 ~~Pf~~~  239 (363)
T cd05628         233 YPPFCSE  239 (363)
T ss_pred             CCCCCCC
Confidence            9999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-35  Score=329.22  Aligned_cols=256  Identities=22%  Similarity=0.378  Sum_probs=201.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcE----EEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMS----VAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|++.+.||+|+||+||+|++..++..    ||+|+++... ....+++.+|+.+++.++||||++++++|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            5799999999999999999998666654    8999986443 3445678899999999999999999998754      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++++||+++|+|.+++.... ......+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            35679999999999999998644 455677889999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......      ........++..|+|||++.+..++.++|||||||++|||++ |+.||......  .+......   
T Consensus       158 ~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~---  226 (316)
T cd05108         158 LLGADEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK---  226 (316)
T ss_pred             cccCCCc------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhC---
Confidence            6643210      111112234667999999999999999999999999999998 99998754221  11111100   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                       .      ..       ...+..+...+.+++.+||+.||++||++.+++..+.++.
T Consensus       227 -~------~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         227 -G------ER-------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             -C------CC-------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0      00       0111223456778999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-35  Score=329.19  Aligned_cols=237  Identities=25%  Similarity=0.289  Sum_probs=190.6

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|+++.+++.||+|+++...   ....+.+..|..++... +||||+++++++.     ..+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999997432   23445677888888876 6999999999854     347899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++.......+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~---  149 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---  149 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---
Confidence            9999999999998887888888999999999999999999   9999999999999999999999999998753221   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..........       
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~-------  212 (320)
T cd05590         150 -----GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE-------  212 (320)
T ss_pred             -----CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCC-------
Confidence                 11223456899999999999999999999999999999999999999754321     1111110000       


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM  952 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  952 (973)
                       .       ..+......+.+++.+|++.||++||++
T Consensus       213 -~-------~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 -V-------VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -C-------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence             0       0011123456788889999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.8e-35  Score=329.79  Aligned_cols=259  Identities=22%  Similarity=0.369  Sum_probs=200.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|+++... ....+.+..|+.++.++ +||||++++++|..   
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~---   82 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK---   82 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence            4579999999999999999997533     45789999987443 22345688899999999 79999999998754   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------------------------------------------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------------------------------------------  771 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  771 (973)
                       .....+++|||+++++|.+++....                                                      
T Consensus        83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence             2467889999999999999986421                                                      


Q ss_pred             -------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCccc
Q 039720          772 -------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS  844 (973)
Q Consensus       772 -------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  844 (973)
                             .++...+.+++.||+.|++|||+.   +|+||||||+||+++.++.++|+|||++..+.....      ....
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------~~~~  232 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------YVRK  232 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc------hhhc
Confidence                   334566789999999999999999   999999999999999999999999999986533210      1111


Q ss_pred             ccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCC
Q 039720          845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARG  923 (973)
Q Consensus       845 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (973)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .+....    ....    .         
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~----~~~~----~---------  294 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRL----KEGT----R---------  294 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHH----hccC----C---------
Confidence            12345678999999999999999999999999999998 999997543221 111100    0000    0         


Q ss_pred             CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          924 PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       924 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ...+......+.+++.+||+.+|++||+++|+++.|+++
T Consensus       295 ~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            001122345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-35  Score=337.69  Aligned_cols=260  Identities=22%  Similarity=0.244  Sum_probs=198.0

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .|++.+.||+|+||+||+|++..+++.||+|+++...   ......+.+|+++++.++||||+++++++.+     .+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence            5888999999999999999999999999999997532   2345678899999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++|+|.+++......++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++....
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            99999999999999998877788888889999999999999999   999999999999999999999999999864321


Q ss_pred             CCC---ccC------------------------------------CCCCcccccccccccccCcccccCCCCCcccchHH
Q 039720          832 HPF---LVA------------------------------------PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYS  872 (973)
Q Consensus       832 ~~~---~~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS  872 (973)
                      ...   ...                                    ...........||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            000   000                                    00000112357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhh--cCCCCCCCCC
Q 039720          873 FGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVA--CSMESPSERM  950 (973)
Q Consensus       873 lG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RP  950 (973)
                      |||++|||++|+.||......+..    ........       ..  ..  + .......+..+++.+  |+..+|..||
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~~----~~i~~~~~-------~~--~~--~-~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTETQ----LKVINWEN-------TL--HI--P-PQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHHH----HHHHcccc-------cc--CC--C-CCCCCCHHHHHHHHHHccCcccccCCC
Confidence            999999999999999764322111    00000000       00  00  0 001122344566666  5566777799


Q ss_pred             CHHHHHHH
Q 039720          951 QMTAVVKK  958 (973)
Q Consensus       951 s~~evl~~  958 (973)
                      +++|++++
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.3e-36  Score=333.93  Aligned_cols=243  Identities=23%  Similarity=0.278  Sum_probs=195.0

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.||+|+||.||+|++..+|+.||+|+++...   ......+..|+++++.++||||+++++++..     .+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence            46999999999999999999999999997532   2334567889999999999999999887543     478999999


Q ss_pred             eccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          757 YMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      |+++|+|.+++.......+..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---  149 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---  149 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---
Confidence            99999999999887778888899999999999999997 6   9999999999999999999999999998753221   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....+     ..........       
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~-------  212 (325)
T cd05594         150 -----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEE-------  212 (325)
T ss_pred             -----CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCC-------
Confidence                 11222456999999999999999999999999999999999999999653221     1111100000       


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                       .       ..+......+.+++.+|++.||++|+     ++++++++
T Consensus       213 -~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         213 -I-------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -C-------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             0       00112234567888899999999997     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=326.19  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=210.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch---hHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---ATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  748 (973)
                      ...|.+.+.||+|.||.||+|+.+.+|+.+|+|++......   ....+.+|+++|+++. |||||.+++++.     +.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e-----~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE-----DP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-----cC
Confidence            45788899999999999999999999999999999765432   3468999999999998 999999999854     45


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC----CcEEEeccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD----MVAHVSDFG  824 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~----~~~kl~Dfg  824 (973)
                      ...++|||++.||.|++.+... ...+..+..++.|++.|+.|||+.   ||+|||+||+|+|+...    +.+|++|||
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            7999999999999999999876 478888999999999999999998   99999999999999643    479999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      +|.....         .......+||++|+|||++.+.+|+..+||||+||++|.|++|..||..........    ...
T Consensus       185 la~~~~~---------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~  251 (382)
T KOG0032|consen  185 LAKFIKP---------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----AIL  251 (382)
T ss_pred             CceEccC---------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHH
Confidence            9987643         345556789999999999999999999999999999999999999998765432221    110


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..+.       .+     ....+........+++.+|+..||.+|+++.+++++
T Consensus       252 ~~~~-------~f-----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  252 RGDF-------DF-----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             cCCC-------CC-----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            0000       11     122334455667788889999999999999999986

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.9e-35  Score=323.11  Aligned_cols=259  Identities=24%  Similarity=0.429  Sum_probs=204.8

Q ss_pred             hcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|.+.+.||+|+||.||++..     ..++..||+|.+........+.+.+|++++++++|||++++++++..     .
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence            5788999999999999999985     23556799999876555566789999999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD  815 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~  815 (973)
                      ...++||||+++++|.+++...+             ..++..++.++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            78899999999999999987543             256678899999999999999999   99999999999999999


Q ss_pred             CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 039720          816 MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDG  894 (973)
Q Consensus       816 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~  894 (973)
                      +.++++|||+++.......      ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       157 ~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~  230 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE  230 (288)
T ss_pred             CcEEeccCCccccccCCce------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999986533210      111122335678999999998999999999999999999999 999986543211


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                        ....   .....        .      ......++..+.+++.+||+.||.+||+++|+.+.|+++...
T Consensus       231 --~~~~---i~~~~--------~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         231 --VIEC---ITQGR--------V------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             --HHHH---HHcCC--------c------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence              1000   00000        0      000112345678999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-35  Score=331.10  Aligned_cols=253  Identities=21%  Similarity=0.244  Sum_probs=197.1

Q ss_pred             cCCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK----KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFK  746 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  746 (973)
                      +|++.+.||+|+||+||+|+..   .+++.||+|++....    ....+.+..|+.+++.+ +||+|+++++++.     
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ-----   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence            4888999999999999998874   478999999996432    22345678899999999 5999999988743     


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .....++||||+++|+|.+++.....+.+..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            4578999999999999999998877788888999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +......       ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus       153 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~  224 (332)
T cd05614         153 KEFLSEE-------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRIL  224 (332)
T ss_pred             ccccccC-------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHh
Confidence            7643221       1222345699999999998765 4789999999999999999999999754322111 11111100


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                      .      .++         ..+......+.+++.+||+.||++||     +++++++.
T Consensus       225 ~------~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 K------CDP---------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             c------CCC---------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0      001         11112334567888899999999999     67787754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-35  Score=328.85  Aligned_cols=249  Identities=20%  Similarity=0.255  Sum_probs=194.9

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+..|..+++.+ +||||+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence            46999999999999999999999999997532   22345678899999888 69999999998543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++...+..++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  149 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---  149 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC---
Confidence            9999999999998877888899999999999999999999   9999999999999999999999999998743211   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC---ccHhhhhhHhcCcccccc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG---LTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~  912 (973)
                           ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.......   .....+.......     
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----  219 (329)
T cd05588         150 -----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-----  219 (329)
T ss_pred             -----CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----
Confidence                 122234578999999999999999999999999999999999999996432211   0011111100000     


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC------HHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ------MTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  958 (973)
                        ..       ...+......+.+++.+|++.||++||+      ++|+++.
T Consensus       220 --~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 --KQ-------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             --CC-------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence              00       0011123345678889999999999997      5677643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-35  Score=328.84  Aligned_cols=249  Identities=21%  Similarity=0.262  Sum_probs=194.1

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+..|..++.++ +||||+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997542   23345677888888776 79999999998644     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++......++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~---  149 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---  149 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---
Confidence            9999999999998877888888999999999999999999   9999999999999999999999999998753221   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc---cHhhhhhHhcCcccccc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL---TLHGYAKMALPKKVMGI  912 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~  912 (973)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||........   ....+.......     
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----  219 (329)
T cd05618         150 -----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----  219 (329)
T ss_pred             -----CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----
Confidence                 1122345689999999999999999999999999999999999999964322110   111111100000     


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM------TAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  958 (973)
                        ..       ...+......+.+++.+||+.||++||++      +|++++
T Consensus       220 --~~-------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 --KQ-------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             --CC-------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence              00       01112234456788889999999999984      566543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.7e-36  Score=331.24  Aligned_cols=243  Identities=23%  Similarity=0.280  Sum_probs=194.3

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+..|.+++..+ +||+|+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence            46999999999999999999999999997542   23345677888888866 79999999998643     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++.......+..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......   
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~---  149 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---  149 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC---
Confidence            9999999999998877788888899999999999999999   9999999999999999999999999998753221   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......  .  +.... ..        
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~--~~~i~-~~--------  211 (321)
T cd05591         150 -----GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--L--FESIL-HD--------  211 (321)
T ss_pred             -----CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--H--HHHHH-cC--------
Confidence                 112234568999999999999999999999999999999999999997543211  1  11110 00        


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-------CHHHHHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-------QMTAVVKK  958 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  958 (973)
                      ..       ..+......+.+++.+|++.||++||       +++++++.
T Consensus       212 ~~-------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         212 DV-------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CC-------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            00       00111234567888899999999999       77887754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-35  Score=321.10  Aligned_cols=272  Identities=22%  Similarity=0.307  Sum_probs=205.0

Q ss_pred             cC-CcCCccccccceeEEEEEE----CCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          675 EF-SSSNRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       675 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +| .+.+.||+|+||+||.+..    ..++..||+|+++.... .....+.+|++++++++|||++++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            45 8899999999999987653    35788999999975432 345678899999999999999999998754   234


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...+++|||+++++|.+++... ..++.+++.++.|++.|++|||++   +|+||||||+||+++.++.++|+|||+++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            5689999999999999998764 467788999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-Cc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-PK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~  907 (973)
                      ......     .........++..|+|||.+....++.++||||||+++|||++|+.||.................. ..
T Consensus       157 ~~~~~~-----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05080         157 VPEGHE-----YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV  231 (283)
T ss_pred             cCCcch-----hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence            543210     001111223566799999998889999999999999999999999998754432211111111000 00


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      ......+...     ....+..++..+.+++.+||+.||++||+++++++.|+++.
T Consensus       232 ~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         232 RLIELLERGM-----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhcCC-----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0111111111     01112334567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.5e-35  Score=334.14  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=201.9

Q ss_pred             HhhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeecccc-hhHHHHHHHHHHHHhcC-CCCceeEEeEeeecc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDKK-GATKSFVAECEALRNIR-HRNLIKIITICSSID  744 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  744 (973)
                      ..++|.+.+.||+|+||.||+|++..     ++..||||+++.... ...+.+.+|+++++.+. ||||++++++|..  
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            35689999999999999999998743     235799999975432 34567899999999996 9999999999754  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcC-----------------------------------------------------
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTN-----------------------------------------------------  771 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  771 (973)
                         ....++||||+++|+|.++++...                                                     
T Consensus       113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence               477999999999999999886431                                                     


Q ss_pred             -------------------------------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 039720          772 -------------------------------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPS  808 (973)
Q Consensus       772 -------------------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~  808 (973)
                                                                 .+....+..++.|++.|++|||+.   +|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence                                                       123445678999999999999999   9999999999


Q ss_pred             cEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCC
Q 039720          809 NVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPT  887 (973)
Q Consensus       809 NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf  887 (973)
                      ||+++.++.+||+|||+++......      .........+++.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~  340 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDS------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY  340 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccc------cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999998653321      0111122346778999999999999999999999999999997 99998


Q ss_pred             CCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          888 DNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      ...........   ...          ...     ....+..++..+.+++.+||+.||++||++.+|.+.|+++-
T Consensus       341 ~~~~~~~~~~~---~~~----------~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         341 PGMIVDSTFYN---KIK----------SGY-----RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             cccchhHHHHH---HHh----------cCC-----CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            76432211110   000          000     01112234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.4e-35  Score=317.82  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=202.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .+|.+.++||+|+||.||+|.+..+++.||+|++..+. ...+.+.+|+++++.++|||++++++++..     ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence            46888899999999999999998899999999987443 345678899999999999999999998654     367899


Q ss_pred             EEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +|||+++++|.+++....  ......++.++.|+++|++|||+.   +++||||||+||+++.++.+||+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            999999999999987543  356677889999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..       ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....+     ........ .  
T Consensus       157 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~~-~--  221 (263)
T cd05052         157 DT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEK-G--  221 (263)
T ss_pred             ce-------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHC-C--
Confidence            21       111111234567999999999999999999999999999998 99998753211     11111000 0  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                        ..         ...+..++..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       222 --~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 --YR---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              00         111123345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=344.68  Aligned_cols=250  Identities=18%  Similarity=0.220  Sum_probs=200.0

Q ss_pred             cCCcCCccccccceeEEEEEECCC-CcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .|.+.+.||+|+||.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++..     .+..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEEE
Confidence            489999999999999999998777 78899998866655555678889999999999999999998654     478999


Q ss_pred             EEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          754 VYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ||||+++|+|.+++..    ...+.+.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            9999999999988754    23456777889999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....      .........||+.|+|||++.+..++.++|||||||++|||++|+.||......     .......... 
T Consensus       220 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~~~-  287 (478)
T PTZ00267        220 SDSV------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLYGK-  287 (478)
T ss_pred             CCcc------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC-
Confidence            4321      111233456999999999999999999999999999999999999999643211     1000000000 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                         .          ...+..+...+.+++.+||+.||++||++++++.
T Consensus       288 ---~----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 ---Y----------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---C----------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               0          0011123456778999999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.4e-35  Score=316.59  Aligned_cols=251  Identities=24%  Similarity=0.392  Sum_probs=197.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.+.||+|+||.||+|+++ ++..+|+|.+.... ...+.+.+|+.+++.++|||++++++++..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEE
Confidence            46888999999999999999985 56789999886432 234678899999999999999999998654     467899


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ||||+++|+|.++++.. +..++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.++.....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            99999999999998754 3456777899999999999999999   9999999999999999999999999998865322


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .       ........++..|+|||++.+..++.++||||||+++|||++ |+.||......  ........  ...   
T Consensus       154 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~--~~~---  219 (256)
T cd05114         154 E-------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISR--GFR---  219 (256)
T ss_pred             c-------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC--CCC---
Confidence            1       111112235567999999988899999999999999999999 99998754321  11111100  000   


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                                  ...+...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus       220 ------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 ------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                        0001112346789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4e-35  Score=318.98  Aligned_cols=245  Identities=23%  Similarity=0.283  Sum_probs=191.9

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ||+|+||+||+|++..+++.||+|++.....   ...+.+..|+++++.++||+++++.+++.     .....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence            6999999999999999999999999964322   22356778999999999999999988754     347899999999


Q ss_pred             cCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          759 QYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       759 ~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      ++|+|.+++..    .....+..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+....... 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-  151 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-  151 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-
Confidence            99999987743    23456788899999999999999999   99999999999999999999999999997653321 


Q ss_pred             ccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......        ..
T Consensus       152 -------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~--------~~  215 (280)
T cd05608         152 -------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRI--------LN  215 (280)
T ss_pred             -------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhh--------cc
Confidence                   1222346899999999999999999999999999999999999999754322110 0000000        00


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                      ..       ...+...+..+.+++.+||+.||++||     +++|++++
T Consensus       216 ~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         216 DS-------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cC-------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            00       011123445677888999999999999     77888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-35  Score=329.51  Aligned_cols=246  Identities=21%  Similarity=0.287  Sum_probs=192.9

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHH---HhcCCCCceeEEeEeeecccCCCc
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEAL---RNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      |++.+.||+|+||.||+|++..+++.||||+++...   ....+.+..|.+++   +.++||||+++++++..     ..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence            678899999999999999999999999999997432   22345566666655   56679999999998643     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++|+|..+++. ..+.+..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            89999999999999988865 3567788999999999999999999   9999999999999999999999999998743


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        ........|++.|+|||++.+..++.++|||||||++|||++|+.||.......  ..   ....    
T Consensus       152 ~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~---~~i~----  214 (324)
T cd05589         152 MGF--------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VF---DSIV----  214 (324)
T ss_pred             CCC--------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HH---HHHH----
Confidence            221        122234568999999999999999999999999999999999999997542211  10   0000    


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                          ...       ...+......+.+++.+||+.||++||     +++++++.
T Consensus       215 ----~~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         215 ----NDE-------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----hCC-------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                000       001112345567889999999999999     56666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-35  Score=319.23  Aligned_cols=255  Identities=29%  Similarity=0.473  Sum_probs=205.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ...+|++.++||.|+||+||+|.+.. +..||+|++..........+..|+.+++.++|||++++++++..     ....
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCCe
Confidence            34679999999999999999999975 89999999986655556778999999999999999999998654     4678


Q ss_pred             EEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ++||||+++++|.+++....  ......+..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++|||.+...
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence            99999999999999997633  356677889999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        .......++..|+|||......++.++||||||+++|+|++ |+.||......+  .......     
T Consensus       155 ~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~-----  219 (261)
T cd05148         155 KEDV--------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITA-----  219 (261)
T ss_pred             CCcc--------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHh-----
Confidence            3321        11112345678999999988899999999999999999998 899997543211  1111100     


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                             ..     ....+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       220 -------~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 -------GY-----RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -------CC-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                   00     0111123445678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-35  Score=328.62  Aligned_cols=243  Identities=24%  Similarity=0.298  Sum_probs=193.6

Q ss_pred             CccccccceeEEEEEEC---CCCcEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          680 NRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK----KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +.||+|+||.||+|+..   .+++.||+|+++...    ......+.+|+.+++.++||||+++++++..     ....+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence            67999999999999863   478899999997432    2234567889999999999999999988543     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++|+|.+++...+...+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             EEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            9999999999999998887777888889999999999999999   9999999999999999999999999998753221


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                              ........||+.|+|||++.+..++.++|||||||++|||++|+.||......     .......       
T Consensus       154 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~-------  213 (323)
T cd05584         154 --------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKIL-------  213 (323)
T ss_pred             --------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHH-------
Confidence                    11222356899999999999989999999999999999999999999754221     1111000       


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                       ....       ..+......+.+++.+||+.||++||     +++++++.
T Consensus       214 -~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         214 -KGKL-------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -cCCC-------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             0000       01112234567888999999999999     78887764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=336.19  Aligned_cols=260  Identities=22%  Similarity=0.253  Sum_probs=200.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|++..+++.||||++....   ......+.+|+++++.++||||+++++++..     ...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence            47899999999999999999999999999999997532   2334567889999999999999999998543     578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+.+|+|.+++...+.+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||+++.+.
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            999999999999999998877788888999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCccCCC------------------------------CCcccccccccccccCcccccCCCCCcccchHHHHHHHHHH
Q 039720          831 HHPFLVAPE------------------------------GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM  880 (973)
Q Consensus       831 ~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~el  880 (973)
                      .........                              .........||+.|+|||++.+..++.++|||||||++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  232 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence            211000000                              00011124699999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHH
Q 039720          881 FTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ---MTAVVK  957 (973)
Q Consensus       881 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  957 (973)
                      ++|+.||.......    .........       ..+.  .  +. .......+.+++.+|+. +|.+|++   ++|+++
T Consensus       233 ~~G~~Pf~~~~~~~----~~~~i~~~~-------~~~~--~--~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         233 LVGYPPFCSDNPQE----TYRKIINWK-------ETLQ--F--PD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hcCCCCCCCCCHHH----HHHHHHcCC-------CccC--C--CC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999997543211    010100000       0000  0  00 00123355677778886 9999998   888877


Q ss_pred             H
Q 039720          958 K  958 (973)
Q Consensus       958 ~  958 (973)
                      +
T Consensus       296 h  296 (364)
T cd05599         296 H  296 (364)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=334.39  Aligned_cols=260  Identities=22%  Similarity=0.296  Sum_probs=204.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||+||+|++..+++.||||+++...   ......+.+|++++..++||||+++++++.     +...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence            47899999999999999999999999999999997542   234567889999999999999999998754     4578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++.......+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            999999999999999998887788888999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCcc---------------------CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 039720          831 HHPFLV---------------------APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN  889 (973)
Q Consensus       831 ~~~~~~---------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~  889 (973)
                      ......                     ............||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            321000                     00001122345689999999999999999999999999999999999999975


Q ss_pred             CCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHHH
Q 039720          890 MFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-MTAVVKK  958 (973)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  958 (973)
                      ....    ..+.......       ....    .+.. ...+..+.+++.+|+. ||++||+ ++|+++.
T Consensus       233 ~~~~----~~~~~i~~~~-------~~~~----~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         233 DTLQ----ETYNKIINWK-------ESLR----FPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCHH----HHHHHHhccC-------Cccc----CCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            4321    1111110000       0000    0000 1134567788889997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-35  Score=329.30  Aligned_cols=242  Identities=22%  Similarity=0.260  Sum_probs=192.9

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCce
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +|.+.+.||+|+||+||+|++..+++.||+|+++...   ......+..|..++... +|++++++++++..     .+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence            4888999999999999999999999999999997542   22334567788888777 57889988887543     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++.....+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            999999999999999998877788888999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..        ........||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+.....   ..   
T Consensus       153 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~---~~---  216 (323)
T cd05616         153 WD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIM---EH---  216 (323)
T ss_pred             CC--------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHH---hC---
Confidence            21        11223456899999999999999999999999999999999999999754321  1111000   00   


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM  952 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  952 (973)
                           .       ...+......+.+++.+|++.||++|+++
T Consensus       217 -----~-------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 -----N-------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----C-------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 0       00111233456788889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.7e-35  Score=319.23  Aligned_cols=257  Identities=22%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCc----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGM----SVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|++.+.||+|+||+||+|.+..++.    +||+|.+.... .....++..|+.+++.+.||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            578899999999999999999977776    46777765332 2234567888889999999999999998642      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++++||+++|+|.+++... ....+..+..++.||+.|++|||+.   +++||||||+||+++.++.+|++|||.++
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence            4577899999999999999764 3556778899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......      .........++..|+|||...+..++.++|||||||++||+++ |+.||.......  ..+...    
T Consensus       158 ~~~~~~------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~----  225 (279)
T cd05111         158 LLYPDD------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLE----  225 (279)
T ss_pred             eccCCC------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH----
Confidence            653221      1112223456778999999998999999999999999999998 999997543211  111100    


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                              ..     .....+..+...+.+++.+||..||++||++.|+++.|.++..
T Consensus       226 --------~~-----~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         226 --------KG-----ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             --------CC-----CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                    00     0000111233456788899999999999999999999988643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=345.70  Aligned_cols=260  Identities=21%  Similarity=0.278  Sum_probs=203.3

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC--
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK--  746 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--  746 (973)
                      ...++|.+.+.||+|+||+||+|++..+|+.||||++....  ......+.+|+..+..++|+|++++.+.+......  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            44579999999999999999999999999999999997543  33446688899999999999999988765432111  


Q ss_pred             -CCceEEEEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          747 -GADFKAIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       747 -~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                       .....++||||+++|+|.+++...    ..+.+..+..++.|++.||.|+|+.   +|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence             112468999999999999988653    3456677889999999999999999   99999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      |||+++.+....      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....
T Consensus       186 DFGls~~~~~~~------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~  254 (496)
T PTZ00283        186 DFGFSKMYAATV------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVM  254 (496)
T ss_pred             ecccCeeccccc------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence            999998654321      11222345799999999999999999999999999999999999999975321     1111


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .......    .          ...+..++..+.+++.+||+.||++||++.++++.
T Consensus       255 ~~~~~~~----~----------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTLAGR----Y----------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHhcCC----C----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111000    0          01112334567789999999999999999999864

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-35  Score=320.12  Aligned_cols=270  Identities=23%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             hcCCcCCccccccceeEEEEEE----CCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||+||+|+.    ..++..||+|++........+.+.+|+++++.++|||++++++++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            5788999999999999999974    45788999999976665566788999999999999999999998643   2345


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++|+|.+++.... ......++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            6899999999999999997643 456778899999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC-c
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP-K  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~  907 (973)
                      .......     ........++..|+|||+..+..++.++|||||||++|||++|..|+.......   ......... .
T Consensus       158 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~~~~  229 (284)
T cd05081         158 LPQDKEY-----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF---MRMMGNDKQGQ  229 (284)
T ss_pred             ccCCCcc-----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh---hhhcccccccc
Confidence            5432100     000111223456999999988899999999999999999999887764332110   000000000 0


Q ss_pred             ----ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          908 ----KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       908 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                          ...+.+..     .........++..+.+++.+||..+|++|||++||++.|+++
T Consensus       230 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         230 MIVYHLIELLKN-----NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cchHHHHHHHhc-----CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                00000100     001111233456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=312.75  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=208.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ..-|...+.||+|.|++|-+|++.-+|.+||||++...+-  ....++.+|+.-|+-++|||||++|++     ......
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence            4568888999999999999999999999999999975543  345679999999999999999999998     445689


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-cCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl-~~~~~~kl~Dfg~a~~  828 (973)
                      +|+|.|.=++|+|+|++-+. .+..+.-+.++++||+.|+.|+|+.   .+||||+||+||.+ ..-|-||+.|||++..
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence            99999999999999998654 4566777899999999999999999   99999999999877 4678999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      +.+         +......+|...|-|||++.+..| .+++||||+||++|.+++|+.||+...+.++.-          
T Consensus       169 f~P---------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----------  229 (864)
T KOG4717|consen  169 FQP---------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----------  229 (864)
T ss_pred             CCC---------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----------
Confidence            654         445567789999999999999999 567899999999999999999998665443211          


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  963 (973)
                         -++|=+    +   ..+.....+..++|..|+..||.+|.+.+||+..  |+++.
T Consensus       230 ---mImDCK----Y---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  230 ---MIMDCK----Y---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             ---hhhccc----c---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence               111111    1   1223445556688889999999999999999753  44443

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-35  Score=327.12  Aligned_cols=241  Identities=23%  Similarity=0.284  Sum_probs=191.0

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||.||+|+++.+|+.||+|+++...   .........|..++... +||+|+++++++..     .+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997542   22345567777777654 89999999998543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+.+|+|.+++.......+..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++.....   
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  149 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG---  149 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC---
Confidence            9999999999998877778888899999999999999999   9999999999999999999999999998743211   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++||||+||++|||++|+.||......  .+...  ....       . 
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~--~~~~-------~-  212 (316)
T cd05620         150 -----DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFES--IRVD-------T-  212 (316)
T ss_pred             -----CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH--HHhC-------C-
Confidence                 12223456899999999999999999999999999999999999999754221  11111  0000       0 


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT-AVV  956 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  956 (973)
                              +..+......+.+++.+|++.||++||++. ++.
T Consensus       213 --------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 --------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                    001111234567888899999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-35  Score=325.53  Aligned_cols=242  Identities=24%  Similarity=0.306  Sum_probs=191.5

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHh-cCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRN-IRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||||+++...   .........|..++.. .+||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997542   2234556777888875 489999999998654     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++.......+.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---  149 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---  149 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---
Confidence            9999999999998777778888899999999999999999   9999999999999999999999999998743211   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++||||+||++|||++|+.||......  .+......         ..+
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~---------~~~  213 (316)
T cd05619         150 -----DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRM---------DNP  213 (316)
T ss_pred             -----CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh---------CCC
Confidence                 11223456899999999999999999999999999999999999999754221  11111100         000


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT-AVVK  957 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  957 (973)
                      .         .+......+.+++.+||+.||++||++. ++.+
T Consensus       214 ~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 C---------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             C---------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            0         0111234567888899999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.4e-35  Score=316.37  Aligned_cols=254  Identities=24%  Similarity=0.425  Sum_probs=200.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++|+|++++++++.     +....+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcE
Confidence            357999999999999999999974 677899999864332 3567899999999999999999998754     347789


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++|+|.+++...  .......++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecC
Confidence            999999999999998753  3445677889999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........++..|+|||++.+..++.++|||||||++|+|++ |+.||.......  ........     
T Consensus       155 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~-----  220 (261)
T cd05072         155 DNE-------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRG-----  220 (261)
T ss_pred             CCc-------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcC-----
Confidence            321       111112335678999999988889999999999999999998 999997543221  11111000     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                         ..         ......++..+.+++.+|+..+|++||+++++.+.|+++
T Consensus       221 ---~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 ---YR---------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---CC---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               00         001122345677899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.2e-35  Score=327.03  Aligned_cols=243  Identities=23%  Similarity=0.258  Sum_probs=195.1

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||||+++...   ......+..|..+++.+ +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence            46999999999999999999999999997542   23345677888888877 69999999998543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++......++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---  149 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG---  149 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC---
Confidence            9999999999998887888889999999999999999999   9999999999999999999999999998743211   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......  .+  ..... ..        
T Consensus       150 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~--~~~i~-~~--------  211 (318)
T cd05570         150 -----GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--EL--FQSIL-ED--------  211 (318)
T ss_pred             -----CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HH--HHHHH-cC--------
Confidence                 11223346899999999999999999999999999999999999999753211  11  11100 00        


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM-----TAVVKK  958 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  958 (973)
                      .       ...+......+.+++.+||+.||++||++     .++++.
T Consensus       212 ~-------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 E-------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             C-------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0       00111234466788999999999999999     887654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.4e-35  Score=319.96  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=201.5

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|.+.+.||+|+||.||+|++.     .++..||+|+++..... ..+.+.+|+++++.++|||++++++++..    
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence            356888999999999999999874     34688999999755443 45789999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC--------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN--------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL  812 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl  812 (973)
                       ....++||||+++++|.+++...+              .+.+..+..++.|++.|+.|||++   +++||||||+||++
T Consensus        80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence             378999999999999999997543              234567789999999999999999   99999999999999


Q ss_pred             cCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 039720          813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMF  891 (973)
Q Consensus       813 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~  891 (973)
                      +.++.++|+|||.++.......      ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~  229 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS  229 (280)
T ss_pred             cCCCeEEECCcccceecccCcc------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999975432210      111122345678999999999999999999999999999998 999986543


Q ss_pred             CCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          892 NDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ...  ......    ..       ..      ...+..++..+.+++.+||+.||++||+++||++.|++
T Consensus       230 ~~~--~~~~~~----~~-------~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         230 NEE--VIECIT----QG-------RL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHH--HHHHHH----cC-------Cc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            221  111111    00       00      11112344567899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=328.10  Aligned_cols=195  Identities=25%  Similarity=0.338  Sum_probs=169.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-C-----CCceeEEeEeeecccCCC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-H-----RNLIKIITICSSIDFKGA  748 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~  748 (973)
                      +|.+.+.||+|+||.|.+|.+..|++.||||+++..+ ....+...|+.+|..++ |     -|+|++++++.     ..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----cc
Confidence            8999999999999999999999999999999997443 35567788999999997 4     38999999844     45


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC--cEEEeccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM--VAHVSDFG  824 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~--~~kl~Dfg  824 (973)
                      .+.|||+|.+. -+|+++++...  +++...++.++.||+.||.+||+.   +|||+|+||||||+.+.+  .+||+|||
T Consensus       261 ~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  261 NHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             cceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            89999999986 59999998755  445677899999999999999999   999999999999997554  79999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~  890 (973)
                      .|++...           .....+-+..|+|||++.+.+|+.+.||||||||++||++|.+-|++.
T Consensus       337 SSc~~~q-----------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  337 SSCFESQ-----------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             cccccCC-----------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            9997643           222566788999999999999999999999999999999998888754

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.8e-36  Score=320.10  Aligned_cols=249  Identities=31%  Similarity=0.532  Sum_probs=191.6

Q ss_pred             cCCccccccceeEEEEEEC----CCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          678 SSNRIGKGSFGFVYKGNLG----EDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +.+.||.|.||.||+|.+.    ..+..|+||+++.... ...+.+.+|++.+++++||||++++++|..     ....+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence            3567999999999999997    4568899999965433 346889999999999999999999999873     25589


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +|+||+++|+|.+++...  ...+...++.|+.||++||.|||++   +++||||+++||+++.++.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            999999999999999886  5667788999999999999999999   99999999999999999999999999998663


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....      ............|+|||.+.+..++.++||||||+++||+++ |+.||......  .+.......   . 
T Consensus       155 ~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~~~~~~~~---~-  222 (259)
T PF07714_consen  155 EKSK------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EIIEKLKQG---Q-  222 (259)
T ss_dssp             TSSS------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HHHHHHHTT---E-
T ss_pred             cccc------cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc---c-
Confidence            2211      112223346678999999998889999999999999999999 78998765221  111111000   0 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                                   ....+..++..+.+++.+||+.||++||+++|+++.|
T Consensus       223 -------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 -------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                         0112233456677999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.8e-35  Score=317.21  Aligned_cols=244  Identities=21%  Similarity=0.259  Sum_probs=188.9

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ||+|+||+||++++..+|+.||+|++....   ......+..|++++++++||||+++++++.     .....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence            799999999999999999999999996432   223345667999999999999999988754     347899999999


Q ss_pred             cCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCcc
Q 039720          759 QYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       759 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      ++++|.+++....  ......+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++......    
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----  148 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----  148 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----
Confidence            9999998886543  345566788999999999999999   9999999999999999999999999998765321    


Q ss_pred             CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                           .......|++.|+|||++.+..++.++||||+||++|||++|+.||......... .........        ..
T Consensus       149 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~--------~~  214 (277)
T cd05607         149 -----KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLE--------DE  214 (277)
T ss_pred             -----ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhc--------cc
Confidence                 1122345889999999999989999999999999999999999999754322111 111111000        00


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ..      .........+.+++.+||+.||++||++.|+++
T Consensus       215 ~~------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         215 VK------FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cc------cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            00      001123445678999999999999999966553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=305.02  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=208.0

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      -|.+..+||+|+||.||+|.++++|+.||||.+.++.+  .+++.+|+.+|++.+.|++|++||.|.     ....+|+|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--LQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIV  106 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--LQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIV  106 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--HHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEee
Confidence            46778899999999999999999999999999976654  677999999999999999999999743     34779999


Q ss_pred             EeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          755 YEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      ||||-.|+..|.++- +..+.+.++..+++.-++||+|||..   .=+|||||+.|||++.+|.+|++|||.|-....  
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--  181 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--  181 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh--
Confidence            999999999999875 44667888999999999999999998   789999999999999999999999999975532  


Q ss_pred             CccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                            .........|||.|||||++..-.|..++||||+|++..||..|++||.+...-              +..-++
T Consensus       182 ------TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------------RAIFMI  241 (502)
T KOG0574|consen  182 ------TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------------RAIFMI  241 (502)
T ss_pred             ------hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------------ceeEec
Confidence                  234445678999999999999999999999999999999999999999864321              111111


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...-..-   ...++.+..++-+++++|+.+.|++|-||.+++++
T Consensus       242 PT~PPPT---F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  242 PTKPPPT---FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             cCCCCCC---CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            1111111   23456677788899999999999999999988765

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-35  Score=340.34  Aligned_cols=268  Identities=21%  Similarity=0.273  Sum_probs=193.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC---CCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFK---GAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---~~~  749 (973)
                      .++|++.+.||+|+||+||+|.+..+++.||||++..+.    ....+|+.+++.++||||+++++++....+.   ...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999999999999999885432    2244799999999999999998876443222   223


Q ss_pred             eEEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFG  824 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg  824 (973)
                      ..++||||+++ ++.+++..    ....+...++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence            57799999985 67766642    34566778889999999999999999   999999999999999665 79999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      +|+.....         .......||+.|+|||++.+. .|+.++||||+||++|||++|++||......+ .+......
T Consensus       217 la~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~  286 (440)
T PTZ00036        217 SAKNLLAG---------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQV  286 (440)
T ss_pred             cchhccCC---------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            99865331         122245689999999987664 68999999999999999999999997543221 11111111


Q ss_pred             h-cCc-ccccccCcccc---cccCC-----CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 A-LPK-KVMGIVDPSLL---MEARG-----PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~-~~~-~~~~~~~~~~~---~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      . .+. .......+...   .....     ...+...+.++.+++.+||+.||.+|||+.|++++
T Consensus       287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0 000 00000000000   00000     00111234567889999999999999999999854

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.7e-35  Score=321.10  Aligned_cols=252  Identities=24%  Similarity=0.314  Sum_probs=203.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++..     ....+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            4589999999999999999999988999999999986665556778999999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++++|.+++... .....++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+......
T Consensus        94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            999999999999998654 456778899999999999999999   9999999999999999999999999998754321


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                              ........+++.|+|||...+..++.++|||||||++|+|++|+.||........ .....  .  ..    
T Consensus       170 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~--~--~~----  232 (296)
T cd06654         170 --------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIA--T--NG----  232 (296)
T ss_pred             --------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHh--c--CC----
Confidence                    1112234688899999999888899999999999999999999999975432111 00000  0  00    


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .+.       ...+......+.+++.+||..||++||++.|+++.
T Consensus       233 -~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         233 -TPE-------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -CCC-------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence             000       01112334567789999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4e-35  Score=316.95  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=202.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|.+.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++|||++++++++..     .+..+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEE
Confidence            3578888999999999999999999999999999986655555668889999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +++||+++++|.+++...+...+.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.+......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999999998887888899999999999999999999   9999999999999999999999999998755321


Q ss_pred             CCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                              ........|++.|+|||++.   ...++.++||||+||++|+|++|+.||........ ........     
T Consensus       160 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~-----  225 (267)
T cd06645         160 --------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSN-----  225 (267)
T ss_pred             --------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccC-----
Confidence                    11122346889999999874   45688999999999999999999999865432111 00000000     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ...+..       .....++..+.+++.+|++.+|++||++++++++
T Consensus       226 --~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 --FQPPKL-------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             --CCCCcc-------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence              000000       0001223456788999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=337.66  Aligned_cols=255  Identities=26%  Similarity=0.445  Sum_probs=211.5

Q ss_pred             CCcCCccccccceeEEEEEECCCC---cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..|.+.||.|.||+||+|+.+..|   ..||||.++... .....+|+.|..||.+++||||+++.|+...     ..-.
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~Pv  705 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKPV  705 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Ccee
Confidence            467789999999999999987655   579999998653 4456789999999999999999999999654     3778


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||.|||++|+|+.+++.++ .+...+...++++||.||.||-+.   ++||||+.++|||++.+-.+|++|||+++..+
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999998755 445567788999999999999998   99999999999999999999999999999775


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      +..     ........-.-...|.|||.+...+++.++||||+|++|||.++ |..||.++.+++.  ...         
T Consensus       783 dd~-----~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--Ika---------  846 (996)
T KOG0196|consen  783 DDP-----EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--IKA---------  846 (996)
T ss_pred             cCC-----CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--HHH---------
Confidence            432     11111111123457999999999999999999999999999998 9999998876521  110         


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                         +     .+..+...+.+|+..|.+||..||++|-.+||.+++|+.+|.++
T Consensus       847 ---I-----e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  847 ---I-----EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             ---H-----HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence               1     12223456689999999999999999999999999999999886

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.4e-35  Score=320.79  Aligned_cols=258  Identities=26%  Similarity=0.452  Sum_probs=204.3

Q ss_pred             hcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|.+.+.||+|+||.||+|++.     .++..||+|.+........+.+.+|++++++++|||++++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----G   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-----C
Confidence            46888899999999999999863     3456799999876555556778999999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL  812 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl  812 (973)
                      ...++||||+++++|.+++....                .+.+..++.++.|++.|++|||++   +|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            67899999999999999987542                245577899999999999999999   99999999999999


Q ss_pred             cCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 039720          813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMF  891 (973)
Q Consensus       813 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~  891 (973)
                      +.++.++|+|||+++.......      ........++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             ccCCcEEECCCCcccccCCCce------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999976543210      111223346788999999999999999999999999999999 999986543


Q ss_pred             CCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          892 NDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ...  ....  .. ..        ..      ......++..+.+++.+||+.||++||++++|++.|+++.+
T Consensus       231 ~~~--~~~~--~~-~~--------~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         231 NTE--VIEC--IT-QG--------RV------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHH--HHHH--Hh-CC--------CC------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            221  1110  00 00        00      01112234567899999999999999999999999999855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-35  Score=315.27  Aligned_cols=259  Identities=24%  Similarity=0.423  Sum_probs=200.7

Q ss_pred             CCcCCccccccceeEEEEEECCC---CcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCc
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGAD  749 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  749 (973)
                      |.+.+.||+|+||.||+|+...+   +..||+|+++.+..  .....+.+|+..++.++|||++++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999987643   47899999975432  334678999999999999999999998755322 3344


Q ss_pred             eEEEEEeeccCCCHHHHhhhc------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                      ..++++||+++|+|.+++...      ...++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence            589999999999999988543      2345677889999999999999998   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~  902 (973)
                      |.++.+.....      ........++..|+|||.+.+..++.++|||||||++|||++ |..||......  ....+..
T Consensus       158 g~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~  229 (273)
T cd05035         158 GLSKKIYSGDY------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLR  229 (273)
T ss_pred             cceeecccccc------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence            99986643221      111112234668999999988899999999999999999999 88998654321  1111111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .           ..      ....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       230 ~-----------~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 H-----------GN------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             c-----------CC------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0           00      0111223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.8e-35  Score=317.87  Aligned_cols=258  Identities=24%  Similarity=0.387  Sum_probs=203.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM----SVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++|++.++||+|+||+||+|++..++.    +||+|+++... ......+.+|+.+++.++|||++++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            3578899999999999999999877776    48999986543 3345678899999999999999999998753     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                       ...++++||+++|+|.+++... +.+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence             4577999999999999999764 4567788899999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +.......      ........+++.|+|||...+..++.++|||||||++|||++ |..||......  .+....... 
T Consensus       157 ~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~-  227 (279)
T cd05109         157 RLLDIDET------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEKG-  227 (279)
T ss_pred             eecccccc------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCC-
Confidence            86643210      111112234678999999998899999999999999999998 99998654221  111111100 


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                      .....+..+...+.+++.+||+.||++||++.|+++.++.+..
T Consensus       228 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         228 ----------------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----------------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                            0011112344567889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.5e-36  Score=332.14  Aligned_cols=253  Identities=23%  Similarity=0.258  Sum_probs=198.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||+|+++++++..     ...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence            46899999999999999999999999999999997542   2244568889999999999999999987543     478


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++|+|.+++... ..+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            99999999999999999876 5667788889999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCccccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM------GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ....       ........||+.|+|||++.      ...++.++|||||||++|||++|+.||......    ..+...
T Consensus       153 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i  221 (330)
T cd05601         153 TANK-------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNNI  221 (330)
T ss_pred             CCCC-------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----HHHHHH
Confidence            4321       11222346899999999976      456789999999999999999999999754321    111111


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......         ...  + ........+.+++.+|++ +|++||+++++++.
T Consensus       222 ~~~~~~---------~~~--~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         222 MNFQRF---------LKF--P-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HcCCCc---------cCC--C-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            100000         000  0 001233456678889997 99999999998864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.4e-35  Score=335.55  Aligned_cols=208  Identities=22%  Similarity=0.288  Sum_probs=174.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .|++.++||+|+||+||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++..     ....
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence            5889999999999999999999999999999997432   2334678899999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++|+|.+++.+.+...+..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            99999999999999998877778888889999999999999999   999999999999999999999999999853311


Q ss_pred             CCC---ccC------------------------------------CCCCcccccccccccccCcccccCCCCCcccchHH
Q 039720          832 HPF---LVA------------------------------------PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYS  872 (973)
Q Consensus       832 ~~~---~~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS  872 (973)
                      ...   ...                                    ...........||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            000   000                                    00000112346999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCC
Q 039720          873 FGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       873 lG~ll~elltg~~Pf~~~  890 (973)
                      +||++|||++|+.||...
T Consensus       234 lGvil~elltG~~Pf~~~  251 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             chHHHHHHHhCCCCCCCC
Confidence            999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6e-35  Score=347.01  Aligned_cols=264  Identities=23%  Similarity=0.300  Sum_probs=201.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.++||+|+||+||+|++..+|+.||+|+++.+.   ....+++.+|+++++.++||||+++++++..     .+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence            57999999999999999999999999999999997432   2335678999999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcC-----------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEE
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN-----------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH  819 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~k  819 (973)
                      .+++|||++||+|.+++....           ......+..++.||++||+|||+.   +|+||||||+||+++.++.++
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            899999999999999886421           112345678999999999999999   999999999999999999999


Q ss_pred             EeccccchhccCCCCccC----------CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 039720          820 VSDFGLARFLSHHPFLVA----------PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN  889 (973)
Q Consensus       820 l~Dfg~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~  889 (973)
                      |+|||+++..........          ...........||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986521110000          0001111234699999999999999999999999999999999999999975


Q ss_pred             CCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHhc
Q 039720          890 MFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-QMTAVVKKLCAV  962 (973)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~  962 (973)
                      .......  ..  ..       ...+..      .....+.+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus       234 ~~~~ki~--~~--~~-------i~~P~~------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        234 KKGRKIS--YR--DV-------ILSPIE------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             cchhhhh--hh--hh-------ccChhh------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3221110  00  00       000000      001123445677899999999999996 667777777765

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-35  Score=318.54  Aligned_cols=251  Identities=22%  Similarity=0.261  Sum_probs=198.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++..     .+..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence            4788899999999999999998899999999996432   2223457789999999999999999987543     4789


Q ss_pred             EEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ++||||+++|+|.+++...  ...++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9999999999999887653  3466788889999999999999999   9999999999999999999999999998765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....         ......|++.|+|||++.+..++.++||||+||++|||++|+.||....... .........     
T Consensus       153 ~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~-----  217 (285)
T cd05605         153 PEGE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRV-----  217 (285)
T ss_pred             CCCC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHh-----
Confidence            3211         1123468999999999998899999999999999999999999997543211 111110000     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                          ...      ....+......+.+++.+||+.||++||     +++++++.
T Consensus       218 ----~~~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         218 ----KED------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ----hhc------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                000      0111123445677899999999999999     88898664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-35  Score=312.26  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=199.5

Q ss_pred             CccccccceeEEEEEECCCC---cEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDG---MSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      ++||+|+||.||+|.+..++   ..||+|.+..... ...+.+.+|+++++.++|||++++++++..      +..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence            46999999999999876554   7899999975543 345678999999999999999999997542      4679999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++.......+..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++....... 
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~-  150 (257)
T cd05060          75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD-  150 (257)
T ss_pred             EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc-
Confidence            9999999999998877778888999999999999999999   999999999999999999999999999986643220 


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                          .........++..|+|||...+..++.++|||||||++|+|++ |+.||......  .+........         
T Consensus       151 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~---------  215 (257)
T cd05060         151 ----YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGE---------  215 (257)
T ss_pred             ----ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCC---------
Confidence                0011111223567999999998999999999999999999998 99999754321  1211111100         


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                              ....+..++..+.+++.+||..+|++||++.++++.|+++-
T Consensus       216 --------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 --------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                    01112234457789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.3e-35  Score=313.42  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=196.4

Q ss_pred             ccccccceeEEEEEE--CCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          681 RIGKGSFGFVYKGNL--GEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +||+|+||+||+|.+  ..++..||+|+++...  ....+.+.+|+.+++.++|||++++++++..      +..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            599999999999965  4578899999986443  2345678999999999999999999998642      46789999


Q ss_pred             eccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCcc
Q 039720          757 YMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      |+++|+|.+++.......+..+.+++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||.++.......  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~--  150 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN--  150 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCC--
Confidence            999999999998777778888999999999999999999   999999999999999999999999999986543210  


Q ss_pred             CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                         .........+++.|+|||.+....++.++|||||||++|||++ |+.||......  .+.....            .
T Consensus       151 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~------------~  213 (257)
T cd05116         151 ---YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIE------------S  213 (257)
T ss_pred             ---eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH------------C
Confidence               0001112234578999999988889999999999999999998 99999754321  1111110            0


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ..     ....+..++..+.+++.+||+.||++||++++|++.|+..
T Consensus       214 ~~-----~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         214 GE-----RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CC-----CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            00     0111123445677899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.1e-35  Score=341.08  Aligned_cols=286  Identities=20%  Similarity=0.217  Sum_probs=203.1

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCC------CCceeEEeE
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH------RNLIKIITI  739 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~  739 (973)
                      .+++....++|++.++||+|+||+||+|.+..+++.||||+++... ........|+++++.++|      .++++++++
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3344445688999999999999999999999899999999996432 223445667777777754      457888887


Q ss_pred             eeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCC--
Q 039720          740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDM--  816 (973)
Q Consensus       740 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~--  816 (973)
                      +..    +..+.++|||++ +++|.+++...+.+.+..+..++.||+.||+|||+ .   +||||||||+|||++.++  
T Consensus       200 ~~~----~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        200 FQN----ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEc----CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence            643    235788999987 77899998887778888899999999999999997 5   999999999999998765  


Q ss_pred             --------------cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh
Q 039720          817 --------------VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT  882 (973)
Q Consensus       817 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt  882 (973)
                                    .+||+|||.+....           .......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt  340 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDER-----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT  340 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCc-----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence                          49999999876422           12234579999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCccHhhhhhH--hcCcccc---------ccc----------CcccccccC--CCchhHHHHHHHHHHHh
Q 039720          883 RRRPTDNMFNDGLTLHGYAKM--ALPKKVM---------GIV----------DPSLLMEAR--GPSKFEECLVAVVRTGV  939 (973)
Q Consensus       883 g~~Pf~~~~~~~~~~~~~~~~--~~~~~~~---------~~~----------~~~~~~~~~--~~~~~~~~~~~l~~li~  939 (973)
                      |+.||......+ .+......  ..+..+.         ...          ++.......  ...........+.+++.
T Consensus       341 G~~pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  419 (467)
T PTZ00284        341 GKLLYDTHDNLE-HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY  419 (467)
T ss_pred             CCCCCCCCChHH-HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence            999997543211 11111100  0110000         000          000000000  00000112345779999


Q ss_pred             hcCCCCCCCCCCHHHHHH--HHHhccccccCCCCC
Q 039720          940 ACSMESPSERMQMTAVVK--KLCAVGEIFIGPPII  972 (973)
Q Consensus       940 ~cl~~dP~~RPs~~evl~--~L~~~~~~~~~~~~~  972 (973)
                      +||+.||++|||++|+++  .+..........|.|
T Consensus       420 ~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~  454 (467)
T PTZ00284        420 GLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNY  454 (467)
T ss_pred             HhCCcChhhCCCHHHHhcCccccccCCccccCCCC
Confidence            999999999999999997  444443333344444

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.5e-35  Score=318.32  Aligned_cols=257  Identities=21%  Similarity=0.382  Sum_probs=198.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|++.... .....++.+|+.+++.++||||+++++++..   
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~---   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence            45789999999999999999998742     45789999986432 2345668899999999999999999998643   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCC----------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTND----------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD  815 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~  815 (973)
                        ....++||||+++|+|.++++....          .....+..++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence              4678999999999999999875322          23456788999999999999998   99999999999999999


Q ss_pred             CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 039720          816 MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDG  894 (973)
Q Consensus       816 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~  894 (973)
                      +.++++|||+++.......      ........+++.|+|||++.+..++.++|||||||++|||++ |..||.....+.
T Consensus       156 ~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~  229 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ  229 (277)
T ss_pred             CCEEECCCCCccccCCcce------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999876543221      011112245678999999998899999999999999999999 788987543211


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                        ...   ......        .      ...+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus       230 --~~~---~~~~~~--------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         230 --VLR---FVMEGG--------L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --HHH---HHHcCC--------c------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence              111   000000        0      01112234567889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=335.53  Aligned_cols=260  Identities=20%  Similarity=0.230  Sum_probs=198.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||+||+|++..+++.||||++....   ....+.+.+|+++++.++||||+++++++.     +...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence            47899999999999999999999999999999986432   223456888999999999999999999854     3578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++.....+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            999999999999999998877788888889999999999999999   99999999999999999999999999996432


Q ss_pred             CCCCc------cCC--CC-------------------------------CcccccccccccccCcccccCCCCCcccchH
Q 039720          831 HHPFL------VAP--EG-------------------------------QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVY  871 (973)
Q Consensus       831 ~~~~~------~~~--~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw  871 (973)
                      .....      ...  ..                               ........||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  232 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence            11000      000  00                               0001124699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCC--
Q 039720          872 SFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER--  949 (973)
Q Consensus       872 SlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R--  949 (973)
                      ||||++|||++|+.||......+    .+........       .+.  .  +. .......+.+++.+|+. +|.+|  
T Consensus       233 SlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~-------~~~--~--p~-~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENSHE----TYRKIINWRE-------TLY--F--PD-DIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCHHH----HHHHHHccCC-------ccC--C--CC-CCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            99999999999999997533211    1111110000       000  0  00 01123456678889997 67765  


Q ss_pred             -CCHHHHHHH
Q 039720          950 -MQMTAVVKK  958 (973)
Q Consensus       950 -Ps~~evl~~  958 (973)
                       +++.|++.+
T Consensus       296 r~~~~~~l~h  305 (377)
T cd05629         296 RGGAHEIKSH  305 (377)
T ss_pred             CCCHHHHhcC
Confidence             599998876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-34  Score=313.20  Aligned_cols=258  Identities=24%  Similarity=0.360  Sum_probs=205.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||.||+|++..++..||||.+....   ....+++.+|+.+++.++|||++++++++..     .+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            46888999999999999999998899999999886432   2334678899999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          751 KAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .+++|||+++++|.+++..    ....++..++.++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            8999999999999998864    23456778899999999999999999   9999999999999999999999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......        .......++..|+|||++.+..++.++||||||+++|+|++|..||.....+....   ...   
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~---  219 (267)
T cd08229         154 RFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKK---  219 (267)
T ss_pred             hccccCC--------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH---hhh---
Confidence            7653321        11223458889999999988899999999999999999999999986432221111   110   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                        +.....+        +.........+.+++.+||+.||++|||+++|++.++++.
T Consensus       220 --~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 --IEQCDYP--------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --hhcCCCC--------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              0000000        1111234567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9e-35  Score=315.13  Aligned_cols=259  Identities=22%  Similarity=0.406  Sum_probs=198.4

Q ss_pred             CCcCCccccccceeEEEEEECCCCc--EEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCce
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGM--SVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGADF  750 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  750 (973)
                      |.+.+.||+|+||.||+|++..++.  .||+|.++..  .....+.+..|+++++.++||||++++++|..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567889999999999999876665  6999988654  23445678899999999999999999998754311 22345


Q ss_pred             EEEEEeeccCCCHHHHhhhc------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                      .+++|||+.+|+|.+++...      ...++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            78999999999999887432      2245677889999999999999998   99999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhH
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      +++.+.....      ........+++.|+|||...+..++.++|||||||++|||++ |+.||......  .....  .
T Consensus       158 ~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~--~  227 (272)
T cd05075         158 LSKKIYNGDY------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDY--L  227 (272)
T ss_pred             cccccCcccc------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH--H
Confidence            9986643211      011122345678999999999999999999999999999999 88998753221  11111  0


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ... .              .......++..+.+++.+||+.||++||+++|+++.|+.+
T Consensus       228 ~~~-~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQG-N--------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HcC-C--------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000 0              0011123345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.5e-35  Score=311.90  Aligned_cols=248  Identities=29%  Similarity=0.402  Sum_probs=194.8

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      +.||+|+||+||+|++..+++.||+|.+.... ......+.+|+++++.++||||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            46999999999999999899999999886433 3345678999999999999999999998654     36789999999


Q ss_pred             cCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccC
Q 039720          759 QYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA  837 (973)
Q Consensus       759 ~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~  837 (973)
                      ++++|.+++.... ...+..++.++.|++.||.|||+.   +|+||||||+||+++.++.+|++|||.+........   
T Consensus        76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---  149 (252)
T cd05084          76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY---  149 (252)
T ss_pred             cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccc---
Confidence            9999999997644 456778899999999999999999   999999999999999999999999999875432110   


Q ss_pred             CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       838 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                         .........+..|+|||.+.+..++.++|||||||++|||++ |..||.......  ......    ..    ..  
T Consensus       150 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~----~~----~~--  214 (252)
T cd05084         150 ---ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIE----QG----VR--  214 (252)
T ss_pred             ---cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHH----cC----CC--
Confidence               000011123457999999999899999999999999999998 889986543211  000000    00    00  


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                             ...+..++..+.+++.+|++.||++||+++|+.+.|+
T Consensus       215 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 -------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                   0111233456788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.2e-35  Score=325.61  Aligned_cols=238  Identities=28%  Similarity=0.305  Sum_probs=188.1

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECE-ALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+|+.||+|++....   .....++..|.. +++.++||||+++++++..     .+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997432   222344555554 4678999999999987643     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+.+|+|.+++.......+..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~---  149 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH---  149 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---
Confidence            9999999999998887788888899999999999999999   9999999999999999999999999998753221   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||......     .........        
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~--------  211 (323)
T cd05575         150 -----SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNK--------  211 (323)
T ss_pred             -----CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcC--------
Confidence                 12223456899999999999999999999999999999999999999753211     111111000        


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT  953 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  953 (973)
                      ..       .........+.+++.+|++.||++||++.
T Consensus       212 ~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 PL-------RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CC-------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            00       00011244567888899999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-35  Score=337.78  Aligned_cols=260  Identities=20%  Similarity=0.218  Sum_probs=197.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|++..+++.||||++....   ......+.+|+++++.++||||+++++++.     +++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence            36999999999999999999999999999999996432   223466889999999999999999998854     4578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++...+...+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|..+.
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence            999999999999999998877777888889999999999999999   99999999999999999999999999985331


Q ss_pred             CCCC---cc--------------------------------CCCCCcccccccccccccCcccccCCCCCcccchHHHHH
Q 039720          831 HHPF---LV--------------------------------APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGI  875 (973)
Q Consensus       831 ~~~~---~~--------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~  875 (973)
                      ....   ..                                ............||+.|+|||++.+..++.++|||||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  232 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence            1000   00                                000000112346999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC---CH
Q 039720          876 LLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM---QM  952 (973)
Q Consensus       876 ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~  952 (973)
                      ++|||++|+.||......+..    .......       ....  .  + ........+.+++.+|+ .+|++|+   ++
T Consensus       233 ilyell~G~~Pf~~~~~~~~~----~~i~~~~-------~~~~--~--~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAETQ----LKVINWE-------TTLH--I--P-SQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             eeeehhhCCCCCCCCCHHHHH----HHHhccC-------cccc--C--C-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            999999999999754322110    0000000       0000  0  0 00112334556666765 5999999   88


Q ss_pred             HHHHHH
Q 039720          953 TAVVKK  958 (973)
Q Consensus       953 ~evl~~  958 (973)
                      +|+++.
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            998866

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.4e-35  Score=312.96  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=199.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.++||+|+||+||+|++..+ ..||+|+++.... ..+.+.+|+++++.++|||++++++++.      ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence            35799999999999999999998644 5699999974332 3457889999999999999999998743      24578


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++...  ...+...+..++.|++.||+|+|+.   +++||||||+||+++.++.++|+|||.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            999999999999999763  2346677899999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........++..|+|||+..+..++.++|||||||++||+++ |+.||........    +....     
T Consensus       154 ~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----~~~~~-----  217 (262)
T cd05071         154 DNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----LDQVE-----  217 (262)
T ss_pred             ccc-------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----HHHHh-----
Confidence            322       111112345678999999988899999999999999999999 8889875432211    00000     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                       .    ..     ......+++..+.+++.+|++.||++||+++++++.|+..
T Consensus       218 -~----~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 -R----GY-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -c----CC-----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             0    00     0011234556788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-35  Score=327.52  Aligned_cols=241  Identities=27%  Similarity=0.305  Sum_probs=188.9

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECE-ALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++..     .+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence            46999999999999999999999999997432   122234444444 5678899999999987543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++.......+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~---  149 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH---  149 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC---
Confidence            9999999999998877778888889999999999999999   9999999999999999999999999998753221   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+  .  +.... ..        
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~--~~~i~-~~--------  211 (325)
T cd05602         150 -----NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--M--YDNIL-NK--------  211 (325)
T ss_pred             -----CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--H--HHHHH-hC--------
Confidence                 112234569999999999999999999999999999999999999997532211  1  11100 00        


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVV  956 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  956 (973)
                      ..       .........+.+++.+|++.||.+||++.+.+
T Consensus       212 ~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         212 PL-------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             Cc-------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            00       00112334567888899999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=317.75  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=210.0

Q ss_pred             cCCcCCccccccceeEEEEEECC----CCcEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGE----DGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .....++||+|-||.||+|....    ..-.||||+.+.+ ..+..+.|++|..+|++++||||++++|+|.+      .
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~  463 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------Q  463 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------c
Confidence            34455789999999999998742    2346889998864 34557889999999999999999999999976      5


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCC-CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTND-KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      -.|+|||.++.|.|..+++.... ++......++.||+.||.|||+.   .+|||||.++|||+....-||++|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence            78999999999999999987654 34456678899999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ++...++...       ...-..-|||||-+....++.++|||.|||.+||++. |..||....+.+...          
T Consensus       541 ~ed~~yYkaS-------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------  603 (974)
T KOG4257|consen  541 LEDDAYYKAS-------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------  603 (974)
T ss_pred             ccccchhhcc-------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------
Confidence            8765533322       1123456999999999999999999999999999998 999998765442211          


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                               ....+.+...++.|+..+..++.+||.+||.+||.+.|+...|..+.
T Consensus       604 ---------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  604 ---------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             ---------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                     01122335567889999999999999999999999999999998774

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.1e-34  Score=309.97  Aligned_cols=258  Identities=25%  Similarity=0.357  Sum_probs=205.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..   .....+.+.+|++++++++|++++++++++..     .+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            5799999999999999999999889999999998642   22345678999999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .++||||+++|+|.+++...    ....+..++.++.|++.|+.|||+.   +|+||||||+||+++.++.++++|||.+
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecccee
Confidence            89999999999999988642    3356678899999999999999999   9999999999999999999999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......        .......+++.|+|||...+..++.++|||||||++|+|++|+.||......   ........  
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~--  220 (267)
T cd08224         154 RFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI--  220 (267)
T ss_pred             eeccCCC--------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhhh--
Confidence            7553321        1122345788999999998889999999999999999999999998643211   11111100  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                             .....    .+.........+.+++.+||..+|++||++.+|++.++.++
T Consensus       221 -------~~~~~----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         221 -------EKCDY----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -------hcCCC----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                   00000    01111244556788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=317.25  Aligned_cols=263  Identities=22%  Similarity=0.365  Sum_probs=211.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +...+.++||+|-||.|.+|... .+.+||||+++.+.. ....+|.+|+++|.+++||||+.++++|...     +.++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence            46778899999999999999983 579999999986654 3458899999999999999999999999764     7899


Q ss_pred             EEEeeccCCCHHHHhhhcCCC--chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTNDK--LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +++|||++|+|.+++......  .......|+.|||.||+||.+.   .+||||+.++|+|+|.++++||+|||+++-..
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999999876322  2344678999999999999999   99999999999999999999999999999665


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT--RRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ..+++.      .....+-...|||||.+.-++++.++|||+||+++||+++  ...||....++  ++++-.....+..
T Consensus       689 sg~yy~------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~  760 (807)
T KOG1094|consen  689 SGDYYR------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQ  760 (807)
T ss_pred             cCCcee------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCC
Confidence            443211      1112234567999999999999999999999999999877  78899876554  2222222222111


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      -.          ..-...+.-|+..+.++|.+||..|-++||+++++...|++.+
T Consensus       761 ~~----------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  761 GR----------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             Cc----------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            10          1113455678889999999999999999999999999988653

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6e-35  Score=313.32  Aligned_cols=251  Identities=23%  Similarity=0.389  Sum_probs=197.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.+.||+|+||+||.|++. .+..||+|.++... ...+.+.+|+.++++++||||+++++++..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence            46889999999999999999885 45579999987433 234678999999999999999999998754     356899


Q ss_pred             EEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|||+.+|+|.+++.... ...+..++.++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||.++.....
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            999999999999987643 567788899999999999999999   9999999999999999999999999998765332


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .       ........++..|+|||...+..++.++|||||||++|+|++ |+.||.......  .......    .   
T Consensus       154 ~-------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~----~---  217 (256)
T cd05113         154 E-------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQ----G---  217 (256)
T ss_pred             c-------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhc----C---
Confidence            1       111112235667999999988889999999999999999999 999987543211  1111000    0   


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                       ..         ...+......+.+++.+||+.||++||++.++++.++
T Consensus       218 -~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 -LR---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CC---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             00         0001112456788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=312.38  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=200.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.++.... ..+.+.+|+.++++++|||++++++++..     ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCee
Confidence            457899999999999999999985 567899999875432 35678899999999999999999998654     36789


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++++|.+++....  ......+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||+++...
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            9999999999999997644  466788899999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       .........+..|+|||+..+..++.++||||||+++|||++ |+.||.......  ...  ...  .. 
T Consensus       155 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~--~~~--~~-  220 (261)
T cd05068         155 EDI-------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQ--QVD--QG-  220 (261)
T ss_pred             CCc-------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH--HHH--cC-
Confidence            221       111111223457999999998899999999999999999999 999997543211  111  000  00 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                         ..         ......++..+.+++.+|++.||++||+++++++.|+.
T Consensus       221 ---~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         221 ---YR---------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CC---------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               00         01112334567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-34  Score=317.82  Aligned_cols=265  Identities=23%  Similarity=0.292  Sum_probs=204.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|++.+.||+|+||.||+|++..++..||+|.+.... .....++.+|++++++++||||+++++++..     ++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence            36899999999999999999999999999999987543 3344668899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++++|.+++......++..+..++.|+++||.|||+.+  +++||||||+||+++.++.+|++|||++......
T Consensus        76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999999999988777788888999999999999999732  8999999999999999999999999998754321


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc-
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG-  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  911 (973)
                                ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......  .......... ..... 
T Consensus       154 ----------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~-~~~~~~  220 (308)
T cd06615         154 ----------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPV-SEGEAK  220 (308)
T ss_pred             ----------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCcc-cccccc
Confidence                      112346889999999988888999999999999999999999998643221  1111100000 00000 


Q ss_pred             ---------------------ccCcccccccCCCch-hHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          912 ---------------------IVDPSLLMEARGPSK-FEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       912 ---------------------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                                           ..+... ... .+.. ......++.+++.+||..||++||+++|+++.--
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         221 ESHRPVSGHPPDSPRPMAIFELLDYIV-NEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCcccccCCCCCccchhhHHHHHHHHh-cCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                                 000000 000 0000 0123456889999999999999999999998743

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-34  Score=310.97  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=201.6

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|.+.+.||+|++|.||+|++..+++.||+|.+...  .....+.+.+|+++++.++|||++++++++..     ....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence            477889999999999999999999999999998754  23455778899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++++|.++++..  ....+..++.++.|++.|+.|||+.   +++||||||+||+++.++.++++|||+++...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            999999999999999764  3456677889999999999999998   99999999999999999999999999988654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...        .......|++.|+|||+..+..++.++|+|||||++|+|++|+.||......  ....  ... . .  
T Consensus       153 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~--~~~-~-~--  216 (256)
T cd08529         153 DNT--------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALIL--KII-R-G--  216 (256)
T ss_pred             Ccc--------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHH--HHH-c-C--
Confidence            321        1222345788999999999999999999999999999999999999754311  1100  000 0 0  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           .      .+.........+.+++.+||+.+|++||++.|+++.
T Consensus       217 -----~------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 -----V------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -----C------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                 0      011112345677899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.7e-35  Score=331.22  Aligned_cols=271  Identities=21%  Similarity=0.280  Sum_probs=200.2

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|.+.+.||+|+||+||+|++..+++.||||++...  .....+++.+|+.+++.++||||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999889999999998643  223446788999999999999999999987654222223789


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|+||+. ++|.+.+.....+.+..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9999996 58888887777778888999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc-cc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK-VM  910 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~  910 (973)
                      .       ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||....... .+...... .... ..
T Consensus       157 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~-~g~~~~~  227 (372)
T cd07853         157 E-------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDL-LGTPSLE  227 (372)
T ss_pred             c-------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHH-cCCCCHH
Confidence            1       1122234578899999998774 57899999999999999999999997543211 11110000 0000 00


Q ss_pred             cc------cCccccccc-CCC------chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GI------VDPSLLMEA-RGP------SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~------~~~~~~~~~-~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..      ....+.... ..+      .........+.+++.+|++.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00      000000000 000      0011224567789999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=296.44  Aligned_cols=255  Identities=20%  Similarity=0.258  Sum_probs=206.4

Q ss_pred             hhcCCcC-CccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSS-NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +++|++. ++||-|-.|.|..|.++.+|+++|+|++.-.     ....+|++..-.. .|||||.+++++... +.+...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCcee
Confidence            4566665 4699999999999999999999999998532     2355677765433 699999999998875 777888


Q ss_pred             EEEEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEEEecccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGL  825 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~kl~Dfg~  825 (973)
                      +.+|||.|+||.|++.++.++.  +++.++..|+.||+.|+.|||+.   .|.|||+||+|+|...   +..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            9999999999999999998876  78899999999999999999999   9999999999999964   55799999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      |+....         .......+-||+|.|||++...+|+..+|+||+||++|-|++|.+||....+..          +
T Consensus       211 AK~t~~---------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------i  271 (400)
T KOG0604|consen  211 AKETQE---------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------I  271 (400)
T ss_pred             ccccCC---------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------C
Confidence            986543         234445678999999999999999999999999999999999999997654421          1


Q ss_pred             CcccccccCcccccccC-CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEAR-GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +..+...+...   .+. ..+.+....++..++|++++..+|.+|.|.+|+++.
T Consensus       272 spgMk~rI~~g---qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  272 SPGMKRRIRTG---QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ChhHHhHhhcc---CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            11111111111   111 134556778888999999999999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-35  Score=331.10  Aligned_cols=256  Identities=20%  Similarity=0.238  Sum_probs=197.8

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++.     +
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----D  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----c
Confidence            34578999999999999999999999999999999996422   223456788999999999999999998854     3


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ....++||||+++|+|.+++... ..++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|.
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence            57899999999999999998754 467778889999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ......       ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......    ..+...
T Consensus       191 ~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----~~~~~i  259 (370)
T cd05621         191 KMDETG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----GTYSKI  259 (370)
T ss_pred             ecccCC-------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence            654321       1122345699999999998754    3788999999999999999999999754221    111111


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE--RMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  958 (973)
                      .         +.......  + ........+.+++.+|+..+|.+  |++++|++++
T Consensus       260 ~---------~~~~~~~~--p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         260 M---------DHKNSLNF--P-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             H---------hCCcccCC--C-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1         00000000  0 01122345567777888765544  8899999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.2e-35  Score=324.00  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=192.0

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCce
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +|...+.||+|+||+||+|+++.+|+.||+|+++...   ....+.+..|..+++.+. |++++++.+++.     +.+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCE
Confidence            4677899999999999999999999999999997542   233456778888888886 567777877643     3478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++.....+.+.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            999999999999999998877888899999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..        ........||+.|+|||++.+..++.++||||+||++|||++|+.||......  ....   ......  
T Consensus       153 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~---~i~~~~--  217 (323)
T cd05615         153 VD--------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQ---SIMEHN--  217 (323)
T ss_pred             CC--------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHHhCC--
Confidence            21        11222346899999999999999999999999999999999999999754221  1111   000000  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM  952 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  952 (973)
                                   ...+......+.+++.+|++.||.+|++.
T Consensus       218 -------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -------------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -------------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                         00111223456788889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.7e-35  Score=319.36  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=200.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCc--EEEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGM--SVAVKVMNLD-KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||.||+|.+..++.  .+|+|.++.. .....+.+.+|++++.++ +|||++++++++..     ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence            578999999999999999999876664  4688888632 233456789999999999 79999999998654     36


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                      ..++++||+++|+|.++++...                ......+..++.|++.|++|||+.   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            7899999999999999997542                245567889999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFN  892 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~  892 (973)
                      .++.+||+|||++......         ........+..|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus       154 ~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~  224 (297)
T cd05089         154 ENLASKIADFGLSRGEEVY---------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC  224 (297)
T ss_pred             CCCeEEECCcCCCccccce---------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999998643211         01111123457999999998899999999999999999998 9999975432


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccC
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG  968 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  968 (973)
                      ..  ...  ..  ..        ...     ...+..+...+.+++.+||+.+|.+||+++++++.|+.+.....+
T Consensus       225 ~~--~~~--~~--~~--------~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         225 AE--LYE--KL--PQ--------GYR-----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HH--HHH--HH--hc--------CCC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            11  100  00  00        000     111123445678899999999999999999999999988654443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=310.72  Aligned_cols=253  Identities=24%  Similarity=0.312  Sum_probs=205.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|.+.+.||+|+||.||+|.+..+++.+|+|++........+.+.+|++++++++|||++++++++..     ....++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            579999999999999999999988999999999987666567889999999999999999999998644     478999


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|||+.+++|.+++... ..+.+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.+......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            99999999999998776 6677888999999999999999998   9999999999999999999999999998765331


Q ss_pred             CCccCCCCCcccccccccccccCcccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGG---DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                              ........++..|+|||...+.   .++.++|||||||++|+|++|+.||........ .......      
T Consensus       155 --------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~------  219 (262)
T cd06613         155 --------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKS------  219 (262)
T ss_pred             --------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc------
Confidence                    1112234578899999998776   889999999999999999999999975432111 0000000      


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                        ...+..      .......+..+.+++.+||..+|++||+++||+.
T Consensus       220 --~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 --NFPPPK------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cCCCcc------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              000000      1112334566889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=311.86  Aligned_cols=254  Identities=23%  Similarity=0.318  Sum_probs=202.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-----hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-----GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +.|.+.+.||+|++|.||.|.+..+++.||+|+++....     ...+.+.+|++++++++||||+++++++..     .
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence            468899999999999999999988999999999874421     123568889999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +..++++||+++++|.+++.......+..+.+++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||.++.
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            68999999999999999998877777888899999999999999999   999999999999999999999999999875


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      .....     ..........++..|+|||++.+..++.++||||+|+++||+++|+.||......    .......... 
T Consensus       154 ~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~-  223 (263)
T cd06625         154 LQTIC-----SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQP-  223 (263)
T ss_pred             ccccc-----cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHhccC-
Confidence            43211     0011112345788999999999999999999999999999999999998753211    1111110000 


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          ..         ...+..+...+.+++.+||..+|++||++.|+++.
T Consensus       224 ----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 ----TN---------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CC---------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                00         11122344567789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=312.56  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=202.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCC---CcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||+||+|++..+   ...||||+++... ......+.+|+.++++++|||++++++++..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----SR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----CC
Confidence            5799999999999999999998643   4689999987543 3345678899999999999999999998543     46


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..+++|||+++++|.+++.... .+....++.++.|++.|++|||+.   +|+||||||+||+++.++.++++|||+++.
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            7899999999999999987643 456788899999999999999998   999999999999999999999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .....      .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  .......    
T Consensus       156 ~~~~~------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~----  223 (266)
T cd05033         156 LEDSE------ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVED----  223 (266)
T ss_pred             ccccc------cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHc----
Confidence            64211      0111112234678999999999999999999999999999998 999986543221  1111100    


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .    .         ....+..++..+.+++.+||+.+|++||+++||++.|+++
T Consensus       224 ~----~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 G----Y---------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C----C---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0    0         0011123455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.5e-35  Score=330.10  Aligned_cols=255  Identities=21%  Similarity=0.240  Sum_probs=199.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     +.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            4568999999999999999999999999999999996432   223455788999999999999999998754     35


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+++|+|.+++... ..++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            7899999999999999988754 466777888999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      .....       ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||......    ..+....
T Consensus       192 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~  260 (370)
T cd05596         192 MDANG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSKIM  260 (370)
T ss_pred             ccCCC-------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHHHHHH
Confidence            53221       1122245699999999987653    4789999999999999999999999753221    1111111


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE--RMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  958 (973)
                      ....       ..  ..  + ........+.+++.+|++.+|++  ||+++|+++.
T Consensus       261 ~~~~-------~~--~~--~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         261 DHKN-------SL--TF--P-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCC-------cC--CC--C-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0000       00  00  0 01123456678888999999998  9999999765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-35  Score=328.94  Aligned_cols=239  Identities=23%  Similarity=0.295  Sum_probs=191.1

Q ss_pred             CccccccceeEEEEEE---CCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      +.||+|+||.||++++   ..+|+.||+|+++....  .....+..|++++++++||||+++++++..     ....++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence            5799999999999876   35789999999975432  233557789999999999999999988543     4789999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      |||+++|+|.+++......++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--  151 (318)
T cd05582          77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--  151 (318)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence            99999999999998877788888999999999999999999   9999999999999999999999999998754321  


Q ss_pred             ccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......     .......        
T Consensus       152 ------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~i~~--------  212 (318)
T cd05582         152 ------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----TMTMILK--------  212 (318)
T ss_pred             ------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----HHHHHHc--------
Confidence                  122234568999999999998899999999999999999999999997542211     0000000        


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTA  954 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  954 (973)
                      ...       ..+......+.+++.+||+.||++||++.+
T Consensus       213 ~~~-------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         213 AKL-------GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCC-------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            000       011123445678889999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-34  Score=322.18  Aligned_cols=243  Identities=21%  Similarity=0.270  Sum_probs=191.1

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|..++.++ +||+|+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997542   23345678899999888 69999999998543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++.....+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---  149 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---  149 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC---
Confidence            9999999999998877888899999999999999999999   9999999999999999999999999998743211   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC-ccHhhhhhHhcCcccccccC
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG-LTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  914 (973)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.......       
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  217 (327)
T cd05617         150 -----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------  217 (327)
T ss_pred             -----CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-------
Confidence                 112234569999999999999999999999999999999999999996433221 1111111110000       


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM  952 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  952 (973)
                      ..       ...+......+.+++.+|++.||++|+++
T Consensus       218 ~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         218 KP-------IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CC-------CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            00       00111223456688889999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1e-34  Score=315.57  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=199.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+    
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE----   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence            4679999999999999999999976     67899999987543 3344678999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC-------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN-------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---  816 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---  816 (973)
                       ....++||||+++++|.+++....       ...+..+.+++.||+.|++|||+.   +++||||||+||+++.++   
T Consensus        81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence             356789999999999999987653       245577889999999999999999   999999999999998755   


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGL  895 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~  895 (973)
                      .+|++|||+++.......      .........+..|+|||++.+..++.++|||||||++|||++ |+.||.....+. 
T Consensus       157 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-  229 (277)
T cd05036         157 VAKIADFGMARDIYRASY------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-  229 (277)
T ss_pred             ceEeccCccccccCCccc------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            699999999986532210      001112223567999999998999999999999999999997 999997543321 


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                       .......   ..              ....+..++..+.+++.+|++.+|++||+++||++.|+
T Consensus       230 -~~~~~~~---~~--------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         230 -VMEFVTG---GG--------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HHHHHHc---CC--------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             1111100   00              01111233456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-34  Score=315.48  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=200.2

Q ss_pred             hcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|...++||+|+||.||+|...     .++..||+|++........+.+.+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            56888999999999999999742     3567899999876555566789999999999999999999998654     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC---------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN---------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                      ...+++|||+++++|.+++...+               ......++.++.|++.|++|||+.   +++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            67899999999999999987643               245577889999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFN  892 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~  892 (973)
                      +++.+||+|||++........      ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDY------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             CCCCEEECCCCceeEcCCCce------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            999999999999875532210      111112335678999999999999999999999999999998 9999865432


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ..  ....  .....               ....+..++..+.+++.+||+.||++||+++||++.|++
T Consensus       231 ~~--~~~~--~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         231 TE--AIEC--ITQGR---------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HH--HHHH--HHcCc---------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11  1000  00000               001112334567799999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.8e-34  Score=312.38  Aligned_cols=251  Identities=25%  Similarity=0.305  Sum_probs=197.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++..+. ......+.+|++++++++|||++++++++..     .+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence            36788899999999999999999999999999997542 3344678899999999999999999998755     37789


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||++++++..+.    ..++..+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        76 lv~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          76 ICTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             EEEecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999999997652    345677889999999999999999   9999999999999999999999999999754321


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh--hhhhHhcCcccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH--GYAKMALPKKVM  910 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~--~~~~~~~~~~~~  910 (973)
                                ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........  ......     .
T Consensus       149 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----~  213 (279)
T cd06619         149 ----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-----V  213 (279)
T ss_pred             ----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-----h
Confidence                      12234688999999999999999999999999999999999999975433211110  000000     0


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ....+..        ........+.+++.+|++.||++||+++|+++.-
T Consensus       214 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         214 DEDPPVL--------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             ccCCCCC--------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            0000000        0111234567889999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.8e-34  Score=309.68  Aligned_cols=249  Identities=22%  Similarity=0.374  Sum_probs=193.9

Q ss_pred             ccccccceeEEEEEEC--CCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEee
Q 039720          681 RIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEY  757 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  757 (973)
                      .||+|+||.||+|.+.  .++..||+|++..... ...+.+.+|+.++++++|||++++++++..      +..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999774  3456799999875432 334678999999999999999999998642      468999999


Q ss_pred             ccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCcc
Q 039720          758 MQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       758 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      +++++|.+++.. ....++..+++++.|++.|+.|||++   +++||||||+||+++.++.+|++|||.+........  
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  150 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--  150 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcc--
Confidence            999999999875 34567788999999999999999999   999999999999999999999999999975533210  


Q ss_pred             CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                         .........+++.|+|||.+.+..++.++|||||||++||+++ |+.||.......  +......            
T Consensus       151 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~------------  213 (257)
T cd05115         151 ---YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQ------------  213 (257)
T ss_pred             ---ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHC------------
Confidence               0011111223568999999888889999999999999999997 999997653221  1111000            


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .     .....+..++.++.+++.+||..||++||++++|.+.|+.+
T Consensus       214 ~-----~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 G-----KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             C-----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            0     00111223456777899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-34  Score=326.94  Aligned_cols=272  Identities=20%  Similarity=0.225  Sum_probs=199.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  748 (973)
                      ..++|++.+.||+|+||.||+|++..+|..||+|++...  .......+.+|+.+++.++||||+++++++.... ....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999999999999999643  2334567889999999999999999999875432 1233


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+.+ ++.+.++.  ......+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            467999999975 56665543  356677888999999999999999   999999999999999999999999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-Cc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-PK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~  907 (973)
                      ...         ........||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .+........ +.
T Consensus       173 ~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~  242 (359)
T cd07876         173 ACT---------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPS  242 (359)
T ss_pred             ccc---------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCc
Confidence            432         112234568999999999999999999999999999999999999997542211 0000000000 00


Q ss_pred             ---------cccccc--Cccc--------ccccC---CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          908 ---------KVMGIV--DPSL--------LMEAR---GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       908 ---------~~~~~~--~~~~--------~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                               ......  .+..        .....   ...........+.+++.+|++.||++|||++|+++.-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                     000000  0000        00000   0001111235577899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-34  Score=313.91  Aligned_cols=250  Identities=21%  Similarity=0.258  Sum_probs=196.5

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      |+..+.||+|+||+||+|++..+++.||+|++....   ......+.+|+++++.++|++++++.+++.     ..+..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence            677889999999999999999999999999996442   223345788999999999999999988754     347899


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++++|.+++....  ..++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            9999999999998886533  467788899999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..         .......|+..|+|||++.+..++.++|+||+||++|||++|+.||........ ............  
T Consensus       154 ~~---------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~--  221 (285)
T cd05632         154 EG---------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETE--  221 (285)
T ss_pred             CC---------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccc--
Confidence            21         111234689999999999989999999999999999999999999975432111 111111000000  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                                   ..........+.+++.+|++.||++||+     ++|++..
T Consensus       222 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 -------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                         0011223345678888999999999999     7777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.8e-34  Score=310.52  Aligned_cols=252  Identities=26%  Similarity=0.451  Sum_probs=199.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.++||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++|++++++++++..      ...+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence            357999999999999999999885 677899999875433 34678999999999999999999987532      4578


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++++|.++++...  ..+..+++.++.|++.|+.|||+.   +|+||||||+||+++.++.++++|||.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999999999987532  356778899999999999999999   99999999999999999999999999997653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........++..|+|||++.+..++.++||||||+++|+|++ |+.||......+  ......       
T Consensus       154 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~-------  217 (260)
T cd05070         154 DNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVE-------  217 (260)
T ss_pred             Ccc-------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH-------
Confidence            321       111112235567999999988899999999999999999999 899997542211  111100       


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                           ....     ...+...+..+.+++.+|+..||++|||++++.+.|+.
T Consensus       218 -----~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         218 -----RGYR-----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----cCCC-----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 0000     11112334568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=345.21  Aligned_cols=261  Identities=20%  Similarity=0.287  Sum_probs=201.1

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ...++|.+.+.||+|+||+||+|++..++..||+|++....  ......+..|+.+++.++||||+++++++...   ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence            34568999999999999999999999999999999997542  23456789999999999999999999986532   34


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEEecCC-----
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQ----PPIVHGDLKPSNVLLDHD-----  815 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~----~~ivHrDik~~NILl~~~-----  815 (973)
                      ..+++||||+++|+|.+++...    ..+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            6789999999999999998752    456778899999999999999998521    259999999999999642     


Q ss_pred             ------------CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHH
Q 039720          816 ------------MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMF  881 (973)
Q Consensus       816 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~ell  881 (973)
                                  +.+||+|||++..+...         .......||+.|+|||++.+  ..++.++|||||||++|||+
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIE---------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             cccccccccCCCCceEEccCCcccccccc---------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence                        35899999999865321         12234568999999999854  45889999999999999999


Q ss_pred             hCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HH
Q 039720          882 TRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK--KL  959 (973)
Q Consensus       882 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L  959 (973)
                      +|+.||.....    ...........       +.+        .....+..+.++|..||+.+|++||++.|++.  .+
T Consensus       238 TGk~PF~~~~~----~~qli~~lk~~-------p~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        238 SGKTPFHKANN----FSQLISELKRG-------PDL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             HCCCCCCcCCc----HHHHHHHHhcC-------CCC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            99999974322    11111111000       000        00112356778999999999999999999984  45


Q ss_pred             Hhc
Q 039720          960 CAV  962 (973)
Q Consensus       960 ~~~  962 (973)
                      ..+
T Consensus       299 k~i  301 (1021)
T PTZ00266        299 KNV  301 (1021)
T ss_pred             hhc
Confidence            444

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.7e-35  Score=326.42  Aligned_cols=239  Identities=26%  Similarity=0.270  Sum_probs=188.5

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECE-ALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+|+.||+|++....   ......+..|.. +++.++||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence            46999999999999999999999999997432   223345555655 4678999999999987543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+.+|+|.+++.......+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~---  149 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ---  149 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---
Confidence            9999999999998887888888999999999999999999   9999999999999999999999999998743211   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||......     .........        
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~~--------  211 (325)
T cd05604         150 -----SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILHK--------  211 (325)
T ss_pred             -----CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHcC--------
Confidence                 11223456899999999999999999999999999999999999999753211     111111000        


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTA  954 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  954 (973)
                      ...       ........+.+++.+|++.||++||++.+
T Consensus       212 ~~~-------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         212 PLV-------LRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             Ccc-------CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            000       00112345668888999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-34  Score=315.34  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=198.0

Q ss_pred             hcCCcCCccccccceeEEEEEE----CCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|++.+.||+|+||+||+|++    ..++..||+|.++... ......+.+|+.+++.++|||++++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            4688889999999999999985    3466899999997433 3334678899999999999999999998543     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NIL  811 (973)
                      ...+++|||+++++|.+++....                 ..++.++..++.|++.|++|||++   +++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            67899999999999999985322                 234566788999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 039720          812 LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM  890 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~  890 (973)
                      ++.++.+|++|||+++.......      ........++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADY------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEeccccccccccCCcc------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999986543211      111223345678999999988889999999999999999999 99998653


Q ss_pred             CCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ...  .+......            ...     ...+..++..+.+++.+||+.||++||+++++.+.|.+
T Consensus       231 ~~~--~~~~~~~~------------~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         231 SNQ--EVIEMVRK------------RQL-----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CHH--HHHHHHHc------------CCc-----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            211  11111110            000     01112234567789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-34  Score=316.58  Aligned_cols=265  Identities=22%  Similarity=0.283  Sum_probs=204.4

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecc
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSID  744 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  744 (973)
                      .+.+..+.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|||++++++++....
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3445566789999999999999999999999999999999986432 2345678899999999 6999999999886544


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEE
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV  820 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl  820 (973)
                      .......++||||+++++|.+++..    .....+..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+++
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence            4556789999999999999988753    23456677888999999999999999   9999999999999999999999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL  895 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~  895 (973)
                      +|||.++......        .......|++.|+|||++..     ..++.++||||+||++|||++|+.||....... 
T Consensus       166 ~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-  236 (286)
T cd06638         166 VDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-  236 (286)
T ss_pred             ccCCceeecccCC--------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-
Confidence            9999987653211        11223458899999998753     457889999999999999999999987542211 


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      .+....     ..    ..+..       ..+..+...+.+++.+||+.||++||++.|+++..
T Consensus       237 ~~~~~~-----~~----~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         237 ALFKIP-----RN----PPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             HHhhcc-----cc----CCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            010000     00    00000       00111234677899999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=318.96  Aligned_cols=254  Identities=27%  Similarity=0.473  Sum_probs=209.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .+....++||.|-||.||.|.|+...-.||||.++.+.. ..++|++|..+|+.++|||+|+++|+|...     .-+||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYI  340 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYI  340 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEE
Confidence            356667899999999999999999999999999975543 568899999999999999999999999763     67899


Q ss_pred             EEeeccCCCHHHHhhhcCCC--chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTNDK--LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      |+|||.+|+|.+++......  +.....+++.||++||+||..+   .+||||+.++|+|+.++..||++|||+++++..
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            99999999999999876543  2344578899999999999999   999999999999999999999999999998864


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..+       .......-..-|.|||-+....++.|+|||+|||++||+.| |..||++..     +.+..         
T Consensus       418 DTY-------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSqVY---------  476 (1157)
T KOG4278|consen  418 DTY-------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVY---------  476 (1157)
T ss_pred             Cce-------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHHH---------
Confidence            321       11111112456999999999999999999999999999999 999998642     22211         


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      +.+...++     -+.++.|++.+.++|+.||++.|.+||++.|+-+.++.+
T Consensus       477 ~LLEkgyR-----M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  477 GLLEKGYR-----MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             HHHhcccc-----ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            11222222     334567888999999999999999999999999988765

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.8e-37  Score=333.55  Aligned_cols=368  Identities=26%  Similarity=0.356  Sum_probs=234.0

Q ss_pred             ceeeccCCccc-ccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC
Q 039720          161 ERLSLYGNQLT-GQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK  239 (973)
Q Consensus       161 ~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  239 (973)
                      +-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..+..++.|+.+.+..
T Consensus        10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~   87 (1255)
T KOG0444|consen   10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRD   87 (1255)
T ss_pred             ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhc
Confidence            34455555554 334555555555555555555554 45555555555555555555554 2223344444444444444


Q ss_pred             Cccc-cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCC
Q 039720          240 NRFK-GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTR  318 (973)
Q Consensus       240 N~l~-~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  318 (973)
                      |+++ .-||..+| .+..|+.||||+|+++ ..|..+...+++-.|+||+|+|..++...|-+|+.|-.||||+|++.. 
T Consensus        88 N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~-  164 (1255)
T KOG0444|consen   88 NNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM-  164 (1255)
T ss_pred             cccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh-
Confidence            4443 23666666 6667777777777776 556666666667777777777665555555555555555555555432 


Q ss_pred             CCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCC
Q 039720          319 TSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTI  398 (973)
Q Consensus       319 ~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  398 (973)
                                                                             +|+.+..+.+|+.|.|++|.+....
T Consensus       165 -------------------------------------------------------LPPQ~RRL~~LqtL~Ls~NPL~hfQ  189 (1255)
T KOG0444|consen  165 -------------------------------------------------------LPPQIRRLSMLQTLKLSNNPLNHFQ  189 (1255)
T ss_pred             -------------------------------------------------------cCHHHHHHhhhhhhhcCCChhhHHH
Confidence                                                                   3333444444444444444443222


Q ss_pred             CccccCCCCCCeEEccCcccC-CCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccccc
Q 039720          399 PPAIGELRNLQYLGLVGNNIR-GIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGI  477 (973)
Q Consensus       399 p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  477 (973)
                      -..+..+++|+.|.+++.+=+ .-+|.++..+.+|..+|+|.|.+. .+|.++.++++|+.|+|++|+|+ .+......+
T Consensus       190 LrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W  267 (1255)
T KOG0444|consen  190 LRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEW  267 (1255)
T ss_pred             HhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHH
Confidence            223333444555555544321 134455555555555555555555 55555555555555555555555 444433334


Q ss_pred             ccccceeeccCCcccccCCcccccccccceeccccCcccc-cccccccCccchhhhcccCcccccccccchhhhccCCee
Q 039720          478 TTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN-EIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKEL  556 (973)
Q Consensus       478 ~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  556 (973)
                      ..+ +.|+||.|+++ .+|..+..++.|+.|++.+|+++- -+|..++.+.+|+.+..++|.+. ..|..+..+..|+.|
T Consensus       268 ~~l-EtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL  344 (1255)
T KOG0444|consen  268 ENL-ETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKL  344 (1255)
T ss_pred             hhh-hhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHh
Confidence            444 36677777776 688899999999999999999863 38999999999999999999998 899999999999999


Q ss_pred             cCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC
Q 039720          557 DLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK  594 (973)
Q Consensus       557 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  594 (973)
                      .|++|++- .+|+.+.-|+.|+.||+..|+=-..+|..
T Consensus       345 ~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  345 KLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             ccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence            99999998 89999999999999999999977667754

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-34  Score=310.76  Aligned_cols=253  Identities=28%  Similarity=0.444  Sum_probs=201.6

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHH--HHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      |++.+.||+|+||+||+|++..+++.||+|++.........  ...+|+.+++.++||||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            67789999999999999999999999999999866543332  34569999999999999999998765     478899


Q ss_pred             EEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          754 VYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      +|||+.+++|.+++..........++.++.|+++||++||+.   +|+||||||+||+++.++.++|+|||.+.....  
T Consensus        76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--  150 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--  150 (260)
T ss_dssp             EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--
Confidence            999999999999999777888899999999999999999999   999999999999999999999999999875411  


Q ss_pred             CccCCCCCcccccccccccccCccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                            .........++..|+|||++. +..++.++||||+|+++|+|++|..||....... ............     
T Consensus       151 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~-----  218 (260)
T PF00069_consen  151 ------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-QLEIIEKILKRP-----  218 (260)
T ss_dssp             ------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-HHHHHHHHHHTH-----
T ss_pred             ------cccccccccccccccccccccccccccccccccccccccccccccccccccccchh-hhhhhhhccccc-----
Confidence                  123334556889999999988 7889999999999999999999999998651110 000110000000     


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                          .....   .........+.+++.+||+.||++||++.|+++
T Consensus       219 ----~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  219 ----LPSSS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ----HHHHT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ----ccccc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000   000111267889999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-34  Score=313.98  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=200.9

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCC-C
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKG-A  748 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~-~  748 (973)
                      .+.+.|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++++ +|||++++++++....... .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35678999999999999999999999999999999997543 3446788999999998 6999999999986542221 3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      ...+++|||+.+++|.+++....  .+.+..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            56899999999999999988633  456777889999999999999999   9999999999999999999999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ......        ........|++.|+|||++.     +..++.++||||+||++|||++|+.||......    ....
T Consensus       159 ~~~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~  226 (272)
T cd06637         159 AQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALF  226 (272)
T ss_pred             eecccc--------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHH
Confidence            754321        11223456889999999875     346788999999999999999999999643221    1111


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...  .    ...+..        ....++..+.+++.+||..||++||+++|+++.
T Consensus       227 ~~~--~----~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         227 LIP--R----NPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HHh--c----CCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            100  0    000000        011233467789999999999999999998763

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=296.97  Aligned_cols=202  Identities=28%  Similarity=0.348  Sum_probs=180.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|...+.||+|.||.|..++.+.+|+.+|+|+++.+-   +....+-..|-++|+..+||.+..+--     .|+..+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY-----sFQt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY-----SFQTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh-----hhccCc
Confidence            356888999999999999999999999999999997553   334556778999999999999887643     378889


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      +.|+||||..||.|+-++++...+.+..+..+-.+|..||.|||++   +||+||+|.+|.|+|.||++||+|||+++.-
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999999999999998899988899999999999999999   9999999999999999999999999999853


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~  890 (973)
                      ..        .......++|||.|+|||++....|+.++|+|.+||++|||++|+.||...
T Consensus       319 I~--------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  319 IK--------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             cc--------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            22        244566789999999999999999999999999999999999999999754

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=349.22  Aligned_cols=463  Identities=26%  Similarity=0.301  Sum_probs=283.5

Q ss_pred             CCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccC
Q 039720           88 LRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYG  167 (973)
Q Consensus        88 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~  167 (973)
                      |+.|||++|++. ..|..+..+.+|+.|++|.|-+. ..|.+.+++.+|++|.|..|.+. .+|+.+..+++|+.|+++.
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~  123 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF  123 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence            444555544443 44444444445555555554444 44444444444544444433332 4444444555555555555


Q ss_pred             CcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCC
Q 039720          168 NQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLP  247 (973)
Q Consensus       168 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip  247 (973)
                      |.+. .+|.-+-.++.++.+..++|.....    ++... .+.++|..|.+.+.++..+.++..  .|+|..|.+. .+ 
T Consensus       124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~-  193 (1081)
T KOG0618|consen  124 NHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VL-  193 (1081)
T ss_pred             hccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-hh-
Confidence            5444 4444444444444444444411111    11111 444444444444444444444433  3444444443 11 


Q ss_pred             cccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhh
Q 039720          248 VCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFIT  327 (973)
Q Consensus       248 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  327 (973)
                       ++ .++.+|+.|....|++....    -...+|+.|+.++|.++...+  -..-.+|+++++++|+++.++       .
T Consensus       194 -dl-s~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~lp-------~  258 (1081)
T KOG0618|consen  194 -DL-SNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSNLP-------E  258 (1081)
T ss_pred             -hh-hhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc--ccccccceeeecchhhhhcch-------H
Confidence             11 13344444444444443211    112344444444444441111  111223444444444444332       1


Q ss_pred             hhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCC
Q 039720          328 LLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRN  407 (973)
Q Consensus       328 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  407 (973)
                      ....|.+|+.+...+|++. .+|..+... +.++.|.+..|.+. .+|+....++.|+.|+|..|+|....+..|.-+..
T Consensus       259 wi~~~~nle~l~~n~N~l~-~lp~ri~~~-~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~  335 (1081)
T KOG0618|consen  259 WIGACANLEALNANHNRLV-ALPLRISRI-TSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNA  335 (1081)
T ss_pred             HHHhcccceEecccchhHH-hhHHHHhhh-hhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhH
Confidence            2334444555555555552 555555544 57888888889987 77888899999999999999999444434444443


Q ss_pred             -CCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeec
Q 039720          408 -LQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDL  486 (973)
Q Consensus       408 -L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~L  486 (973)
                       |..|+.+.|.+.......=..++.|+.|++.+|.++...-..+.++++|+.|+|++|++. .+|+..+.....++.|+|
T Consensus       336 ~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~L  414 (1081)
T KOG0618|consen  336 SLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNL  414 (1081)
T ss_pred             HHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhc
Confidence             788888999988433222234678999999999999887778899999999999999998 899888777777779999


Q ss_pred             cCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccc
Q 039720          487 SENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQ  566 (973)
Q Consensus       487 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  566 (973)
                      |+|+++ .+|..+.++..|+.|...+|++. ..| .+..++.|+.+|+|.|+|+...-..-...++|++|||++|.=.-.
T Consensus       415 SGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~  491 (1081)
T KOG0618|consen  415 SGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVF  491 (1081)
T ss_pred             ccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccccc
Confidence            999999 78999999999999999999999 788 899999999999999999854333333338999999999973223


Q ss_pred             cCCCCCCCCccceEeccCC
Q 039720          567 IPIHLGNLPFLEYLNLSYN  585 (973)
Q Consensus       567 ~p~~~~~l~~L~~L~ls~N  585 (973)
                      --..|..+.++..+++.-|
T Consensus       492 d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  492 DHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             chhhhHHhhhhhheecccC
Confidence            3455666677777777766

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=309.88  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=196.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .+|++.+.||+|+||.||+|++. ++..+|+|++.... ...+.+.+|+++++.++|||++++++++..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCceEE
Confidence            46888999999999999999985 56789999986332 234568889999999999999999998543     467899


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ||||+++++|.+++... ....+..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.++.....
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            99999999999998754 3456778899999999999999999   9999999999999999999999999998765321


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .       ........++..|+|||.+.+..++.++||||||+++|++++ |+.||......+  ...  ...      .
T Consensus       154 ~-------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~--~~~------~  216 (256)
T cd05059         154 Q-------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVS------A  216 (256)
T ss_pred             c-------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHH--HHH------c
Confidence            1       111111123457999999998999999999999999999999 899987543221  111  000      0


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ..+         ...+..++..+.+++.+||+.+|++||+++|+++.|
T Consensus       217 ~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 GYR---------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCc---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            000         011122455788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.2e-34  Score=314.66  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=203.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++..     .+..+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEE
Confidence            4689999999999999999999988999999999976655556778899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++++|.+++.+. ...+.++..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||.+......
T Consensus        93 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            999999999999998653 456678899999999999999999   9999999999999999999999999998754322


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......+++.|+|||...+..++.++|||||||++|++++|+.||.......... .            .
T Consensus       169 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~------------~  227 (297)
T cd06656         169 Q--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-L------------I  227 (297)
T ss_pred             c--------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-e------------e
Confidence            1        11223458889999999998889999999999999999999999996532211000 0            0


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..    ...+....+......+.+++.+||+.||++||+++|+++.
T Consensus       228 ~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         228 AT----NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             cc----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00    0000011122334556788899999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-34  Score=311.15  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=201.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc---EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM---SVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|+..+.||+|+||.||+|++..++.   .||+|.++... ....+.+.+|+.++++++|||++++.+++..     .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----F   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----C
Confidence            3578889999999999999999876554   79999986542 3345678999999999999999999998654     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +..++||||+++++|.+++... +.....++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence            6789999999999999999764 4556778899999999999999999   99999999999999999999999999987


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......     ...........++.|+|||++.+..++.++|||||||++||+++ |+.||......  ........   
T Consensus       156 ~~~~~~-----~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~---  225 (268)
T cd05063         156 VLEDDP-----EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAIND---  225 (268)
T ss_pred             eccccc-----ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhc---
Confidence            654321     00111111223457999999988889999999999999999998 99999654321  11111000   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                       .        .     ......+++..+.+++.+||+.||++||++++|++.|.++
T Consensus       226 -~--------~-----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 -G--------F-----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -C--------C-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0        0     0111123445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-34  Score=321.68  Aligned_cols=238  Identities=29%  Similarity=0.299  Sum_probs=187.3

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECE-ALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++..     .+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence            46999999999999999999999999996432   222344555554 5788999999999987543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+.+.......+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---  149 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---  149 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---
Confidence            9999999999998877778888899999999999999999   9999999999999999999999999998743211   


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||......     .........        
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~--------  211 (321)
T cd05603         150 -----EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYDNILHK--------  211 (321)
T ss_pred             -----CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHHHHhcC--------
Confidence                 11223456899999999999999999999999999999999999999753211     111111000        


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT  953 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  953 (973)
                      ..       ..+......+.+++.+|++.||.+||++.
T Consensus       212 ~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 PL-------QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CC-------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            00       01112234567888999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-34  Score=322.52  Aligned_cols=260  Identities=22%  Similarity=0.366  Sum_probs=198.5

Q ss_pred             hhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKK-GATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++.... .....+.+|+.++.++ +||||++++++|...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            45899999999999999999985     34678999999975432 2346788999999999 689999999987542  


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------------------------------------------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------------------------------------------  771 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  771 (973)
                        ....+++|||+++|+|.++++...                                                      
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              356789999999999999986432                                                      


Q ss_pred             -------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCC
Q 039720          772 -------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP  838 (973)
Q Consensus       772 -------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~  838 (973)
                                   ......+..++.|+++|++|||+.   +|+||||||+||+++.++.+|++|||++........    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----  234 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----  234 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc----
Confidence                         123345678899999999999999   999999999999999999999999999986532210    


Q ss_pred             CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCccc
Q 039720          839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSL  917 (973)
Q Consensus       839 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (973)
                        ........+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ......    ..        .
T Consensus       235 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~----~~--------~  299 (343)
T cd05103         235 --YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLK----EG--------T  299 (343)
T ss_pred             --hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHh----cc--------C
Confidence              011112235677999999988899999999999999999997 9999875432211 100000    00        0


Q ss_pred             ccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          918 LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       918 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .     ...+......+.+++.+||+.||++||++.|+++.|+.+-
T Consensus       300 ~-----~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         300 R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             C-----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0     0000112345789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.1e-34  Score=309.25  Aligned_cols=248  Identities=30%  Similarity=0.408  Sum_probs=198.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|.+.+.||+|+||.||+|..  .|..||+|.++.+.  ..+.+.+|+.++++++|++++++++++..    .....++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEE
Confidence            5789999999999999999987  58899999986433  35678899999999999999999987533    3467899


Q ss_pred             EEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||+++++|.++++....  ..+..++.++.|++.|++|||++   +++||||||+||+++.++.+|++|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            9999999999999876443  45677889999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .           .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......  .+......    .  
T Consensus       155 ~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~----~--  215 (256)
T cd05082         155 T-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK----G--  215 (256)
T ss_pred             c-----------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhc----C--
Confidence            1           112234567999999998899999999999999999998 99998643211  11111000    0  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                            .     .......++..+.+++.+||+.||++||+++++++.|+++
T Consensus       216 ------~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 ------Y-----KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------C-----CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  0     0111123456778999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=321.17  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=201.9

Q ss_pred             ccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccC
Q 039720          681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQY  760 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  760 (973)
                      .||+|.||+||.|++..+...+|||-+........+.+..|+...+.++|+|||+++|.|.+     +.+.-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-----nGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-----NGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-----CCeEEEEeecCCC
Confidence            59999999999999999999999999976666666778999999999999999999998543     4688899999999


Q ss_pred             CCHHHHhhhc-CCC--chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec-CCCcEEEeccccchhccCCCCcc
Q 039720          761 GSVDDWLHHT-NDK--LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       761 gsL~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~-~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      |+|.+++... +.+  .+.++..+.+||++||.|||++   .|||||||-+|||++ -.|.+||+|||-++....-    
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----  729 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----  729 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC----
Confidence            9999999763 233  3567788999999999999999   999999999999996 5789999999999876431    


Q ss_pred             CCCCCcccccccccccccCcccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGG--DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                          .....++.||..|||||++..+  .|+.++|||||||++.||.||++||-....+...+.+               
T Consensus       730 ----nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---------------  790 (1226)
T KOG4279|consen  730 ----NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---------------  790 (1226)
T ss_pred             ----CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---------------
Confidence                3344467899999999998775  6899999999999999999999999876554322211               


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..+...  -|..+.+..++...+|.+|+..||.+||+|.+++..
T Consensus       791 VGmyKv--HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  791 VGMYKV--HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             hcceec--CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            111111  144556666777788999999999999999998864

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-34  Score=319.04  Aligned_cols=266  Identities=20%  Similarity=0.298  Sum_probs=197.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|.+.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++..     ++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            57999999999999999999999899999999997543 2234567889999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++ ++.+++.... ......+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99999985 8888776544 356677888999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC--c
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP--K  907 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~--~  907 (973)
                      .        ........+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. +....... .+  .
T Consensus       157 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~  227 (309)
T cd07872         157 P--------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEE  227 (309)
T ss_pred             C--------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHH
Confidence            1        111223457889999998765 4679999999999999999999999975433211 11111100 00  0


Q ss_pred             cccccc------CcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          908 KVMGIV------DPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       908 ~~~~~~------~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ......      +.........  .........++.+++.+|++.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000      0000000000  0011123456778999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.9e-34  Score=312.90  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=199.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      +.|++.+.||+|+||.||+|++..++..+|+|.+........+.+.+|+++++.++|||++++++++..     ....++
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~   79 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   79 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence            346788899999999999999999999999999976555556778999999999999999999998654     478899


Q ss_pred             EEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      |+||+++++|.+++.. .....+..+..++.|+++||.|||+.   +++||||||+||+++.++.++++|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            9999999999998765 34567788899999999999999999   9999999999999999999999999998754321


Q ss_pred             CCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                              ........+++.|+|||++.     +..++.++||||+||++|||++|+.||....... .........   
T Consensus       157 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~---  224 (282)
T cd06643         157 --------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE---  224 (282)
T ss_pred             --------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC---
Confidence                    11122345888999999873     4467889999999999999999999987542211 111110000   


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                            .+..       ..+..++..+.+++.+||+.||++||++++++++-
T Consensus       225 ------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         225 ------PPTL-------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ------CCCC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                  0000       01112345677899999999999999999988653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-34  Score=309.55  Aligned_cols=249  Identities=19%  Similarity=0.241  Sum_probs=199.2

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      +|++.+.||+|+||.||++++..++..||+|.++... ....+.+.+|+.+++.++|||++++++++..     ....++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence            4788999999999999999999999999999987543 3345678899999999999999999998644     478999


Q ss_pred             EEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +|||+++|++.+++...  ....+..++.++.|++.|+.|||+.   +|+|+||||+||+++.++.++++|||.+.....
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            99999999999988643  2356777889999999999999999   999999999999999999999999999875532


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .        ........|++.|+|||++.+..++.++|+||||+++|+|++|+.||......     ..........   
T Consensus       153 ~--------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~---  216 (255)
T cd08219         153 P--------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVCQGS---  216 (255)
T ss_pred             c--------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHhcCC---
Confidence            1        11222346888999999999889999999999999999999999999743211     1000000000   


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .          ...+......+.+++.+||+.||++||++.|++..
T Consensus       217 -~----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -Y----------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -C----------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             0          00112233456788999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-34  Score=317.81  Aligned_cols=258  Identities=26%  Similarity=0.427  Sum_probs=201.2

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCC-----CcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGED-----GMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSID  744 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  744 (973)
                      ..++|++.+.||+|+||.||+|.+...     ...||+|++.... .....++.+|+++++++ +||||+++++++..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence            456799999999999999999988643     3789999987542 23345688999999999 79999999998654  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhc----------------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHT----------------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPS  808 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~  808 (973)
                         ....+++|||+++|+|.++++..                ....+..++.++.|++.|++|||+.   +|+||||||+
T Consensus        88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~  161 (293)
T cd05053          88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR  161 (293)
T ss_pred             ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence               36789999999999999998643                2345567889999999999999998   9999999999


Q ss_pred             cEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCC
Q 039720          809 NVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPT  887 (973)
Q Consensus       809 NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf  887 (973)
                      ||+++.++.+|++|||.++.+.....      ........++..|+|||++.+..++.++|||||||++||+++ |..||
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDY------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccc------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence            99999999999999999986543211      111112234567999999988899999999999999999998 99998


Q ss_pred             CCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          888 DNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ......  .+.....            ..     .....+..+...+.+++.+||+.||++|||++|+++.|+++
T Consensus       236 ~~~~~~--~~~~~~~------------~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         236 PGIPVE--ELFKLLK------------EG-----YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             CCCCHH--HHHHHHH------------cC-----CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            754221  1111000            00     00111223345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-34  Score=308.25  Aligned_cols=249  Identities=31%  Similarity=0.457  Sum_probs=202.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|.+.+.||+|+||.||+|..  .|+.||+|+++.... ..+++.+|+.+++.++|+|++++++++..     ....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence            45789999999999999999998  589999999975544 56789999999999999999999998643     47889


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++++|.+++....  ...+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.++...
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence            9999999999999997655  567788999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...           ....++..|+|||++....++.++||||||+++||+++ |+.||......  .+......      
T Consensus       154 ~~~-----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~------  214 (256)
T cd05039         154 QGQ-----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEK------  214 (256)
T ss_pred             ccc-----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhc------
Confidence            211           01234567999999988899999999999999999998 99998654221  11111000      


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                            ..     ....+..++..+.+++.+||..+|++||+++|+++.|+.+
T Consensus       215 ------~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 ------GY-----RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------CC-----CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                  00     0111123346678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=318.89  Aligned_cols=247  Identities=28%  Similarity=0.364  Sum_probs=201.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .|.-.+.||.|+||.||-|++..+.+.||||.+....+   ....++.+|+..|+++.|||.+.+-|+|..     +...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence            45556789999999999999999999999999976543   345689999999999999999999998654     3678


Q ss_pred             EEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      |+|||||- |+-.|++.- ..++.+.++..|+.+.+.||+|||+.   +.||||||+.|||+++.|.||++|||.|..+.
T Consensus       102 WLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  102 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC
Confidence            99999996 577777653 34567888999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                                  +...++|||+|||||++.   .+.|+-++||||+|++..|+...++|+..+..    +.....+..-+
T Consensus       178 ------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQNe  241 (948)
T KOG0577|consen  178 ------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNE  241 (948)
T ss_pred             ------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHHHhcC
Confidence                        334688999999999865   46899999999999999999999999775532    22222221111


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      .      +.        -...++...|.+++..|+++-|++|||.++++++--
T Consensus       242 s------Pt--------Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  242 S------PT--------LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             C------CC--------CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence            1      11        112456677888888999999999999999987643

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-35  Score=322.56  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=205.8

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecc----cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD----KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ...+||+|+|-+||+|.+..+|..||--.++.+    .+...+++..|+.+|+.++||||+++|.+|.+.   ......+
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in~  120 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTINF  120 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceeee
Confidence            345799999999999999999999986555432    233458899999999999999999999998764   2366889


Q ss_pred             EEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~Dfg~a~~~~~~  832 (973)
                      |+|.+..|+|..++.+.+......++.|++||++||.|||++ .|+|||||||-+||+|+. .|.|||+|.|+|..... 
T Consensus       121 iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-  198 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-  198 (632)
T ss_pred             eeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc-
Confidence            999999999999999999888888999999999999999998 789999999999999975 58999999999997643 


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                               .......|||.|||||+.. ..|++.+||||||+.+.||+|+.+||....+....+.+..++..|..+..+
T Consensus       199 ---------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  199 ---------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             ---------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc
Confidence                     2333478999999999866 899999999999999999999999998766653333333344444444433


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .|+                 .+.++|.+|+.. ..+|||+.|+++.
T Consensus       269 ~dP-----------------evr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  269 KDP-----------------EVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CCH-----------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence            333                 345888899999 9999999999874

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-34  Score=324.66  Aligned_cols=272  Identities=19%  Similarity=0.212  Sum_probs=200.1

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCC
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID-FKG  747 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~  747 (973)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....  ......+.+|+.+++.++||||+++++++.... ...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999999899999999986432  334567888999999999999999999875432 223


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ....++||||+++ ++.+.+..  ......+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            3568999999975 66666643  356677888999999999999999   99999999999999999999999999997


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh---
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA---  904 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~---  904 (973)
                      .....         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+.......   
T Consensus       168 ~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~  237 (355)
T cd07874         168 TAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTP  237 (355)
T ss_pred             cCCCc---------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            54321         12234568999999999999999999999999999999999999997532110 000000000   


Q ss_pred             -------cCccccccc----------CcccccccC---CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 -------LPKKVMGIV----------DPSLLMEAR---GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 -------~~~~~~~~~----------~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                             ........+          .+.......   ...........+.+++.+|++.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   000000000          000000000   000111223467789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-34  Score=317.59  Aligned_cols=254  Identities=25%  Similarity=0.382  Sum_probs=196.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcE--EEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMS--VAVKVMNLD-KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||.||+|++..++..  +|+|.++.. .......+.+|+.++.++ +|||++++++++..     ..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----CC
Confidence            5688899999999999999998777764  466666532 233456788999999999 89999999998643     46


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                      ..++||||+++|+|.+++....                .+...+++.++.|++.|++|||+.   +|+||||||+||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence            7999999999999999987543                345667889999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFN  892 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~  892 (973)
                      .++.+||+|||++......         .......++..|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus       159 ~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  229 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  229 (303)
T ss_pred             CCCcEEeCccccCcccchh---------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence            9999999999998632210         01111224567999999988889999999999999999998 9999864432


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .  ......    +..        ..     ...+..++..+.+++.+||+.+|++||++++++..+.++.
T Consensus       230 ~--~~~~~~----~~~--------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         230 A--ELYEKL----PQG--------YR-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             H--HHHHHH----hcC--------Cc-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1  111110    000        00     0011123446778999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-34  Score=308.94  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch---------hHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---------ATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      +|.+.+.||+|++|.||+|.+..+++.||+|++......         ..+.+.+|+.++++++|||++++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            478889999999999999999889999999988643221         22567889999999999999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                        ....++++||+++++|.+++...+..++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCC
Confidence              478899999999999999998877778888899999999999999998   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ++..........  .........|+..|+|||.+.+..++.++||||+||++|+|++|+.||......    ....... 
T Consensus       153 ~~~~~~~~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-  225 (267)
T cd06628         153 SKKLEANSLSTK--TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKIG-  225 (267)
T ss_pred             CcccccccccCC--ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHHh-
Confidence            986643211000  011112345788999999999888999999999999999999999999754221    1110000 


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                           ....         +..+...+..+.+++.+||+.||++||+++|+++
T Consensus       226 -----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 -----ENAS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----ccCC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                 0000         1112234456778889999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=321.67  Aligned_cols=255  Identities=23%  Similarity=0.255  Sum_probs=193.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|+.++..++|++|+++++++..     ...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence            4799999999999999999999999999999999742   22334568889999999999999999988543     478


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++|+|.+++.. .....+..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            9999999999999999976 44567788899999999999999999   9999999999999999999999999998755


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ....       ........||+.|+|||++..     ..++.++||||+||++|||++|+.||......    ..+....
T Consensus       153 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~----~~~~~i~  221 (331)
T cd05597         153 LADG-------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIM  221 (331)
T ss_pred             CCCC-------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH----HHHHHHH
Confidence            3321       111223468999999999863     45788999999999999999999999753211    1111111


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCC--CCCCCCCHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSME--SPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~  958 (973)
                      ......     .+      +......+..+.+++.+|+..  ++..||++++++++
T Consensus       222 ~~~~~~-----~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         222 NHKEHF-----QF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCCcc-----cC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000000     00      111111334455666676654  33448899998877

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-34  Score=310.47  Aligned_cols=256  Identities=22%  Similarity=0.360  Sum_probs=201.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCC---CcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|.+.+.||+|+||.||+|.+...   ...||||.+.... ....+.+.+|+.++++++|||++++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            5688899999999999999987543   3578999987554 3456789999999999999999999998653      4


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++|+|.+++.... ......++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            5689999999999999997644 456778889999999999999998   999999999999999999999999999976


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .....       ........++..|+|||.+....++.++||||||+++||+++ |+.||......+..  ..  .....
T Consensus       157 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~--~~~~~  225 (270)
T cd05056         157 LEDES-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GR--IENGE  225 (270)
T ss_pred             ccccc-------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH--HHcCC
Confidence            54321       111112234567999999988889999999999999999996 99999755332111  10  00000


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      .               ...+..++..+.+++.+|+..+|++||++.|+++.|+++..
T Consensus       226 ~---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 R---------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             c---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0               01112344567889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.8e-34  Score=325.22  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=199.8

Q ss_pred             HHhhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcC-CCCceeEEeEeeec
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDK-KGATKSFVAECEALRNIR-HRNLIKIITICSSI  743 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  743 (973)
                      ...++|.+.++||+|+||.||+|++.     .++..||+|+++... ....+.+.+|++++.++. ||||++++++|.. 
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence            34457888999999999999999964     345689999997543 233457889999999997 9999999998754 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCC---------------------------------------------------
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTND---------------------------------------------------  772 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------  772 (973)
                          ....++|+||+++|+|.++++..+.                                                   
T Consensus       113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                3678999999999999999875321                                                   


Q ss_pred             -----------------------------------------------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 039720          773 -----------------------------------------------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDL  805 (973)
Q Consensus       773 -----------------------------------------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDi  805 (973)
                                                                     +....+..++.|++.|++|||+.   +|+||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl  265 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL  265 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence                                                           12234677899999999999998   9999999


Q ss_pred             CCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CC
Q 039720          806 KPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RR  884 (973)
Q Consensus       806 k~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~  884 (973)
                      ||+||+++.++.+|++|||+++.......      ........+++.|+|||.+.+..++.++|||||||++|||++ |.
T Consensus       266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~  339 (401)
T cd05107         266 AARNVLICEGKLVKICDFGLARDIMRDSN------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG  339 (401)
T ss_pred             CcceEEEeCCCEEEEEecCcceecccccc------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCC
Confidence            99999999999999999999986532210      011112346788999999998889999999999999999998 89


Q ss_pred             CCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          885 RPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       885 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .||......+. ......            ....     ...+..+...+.+++.+||+.+|++||+++|+++.|+++
T Consensus       340 ~P~~~~~~~~~-~~~~~~------------~~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         340 TPYPELPMNEQ-FYNAIK------------RGYR-----MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             CCCCCCCchHH-HHHHHH------------cCCC-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            99875432211 000000            0000     111122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.1e-34  Score=314.49  Aligned_cols=258  Identities=22%  Similarity=0.375  Sum_probs=201.2

Q ss_pred             hhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|.+.+.||+|+||.||+|.+     ..++..||+|+++... ....+.+.+|+.+++++ +||||+++++++..   
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  110 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI---  110 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence            35799999999999999999975     2355689999987543 33456789999999999 79999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                        .+..+++|||+.+|+|.++++....  .+..++..++.|++.|+.|||++   +|+|+||||+||+++.++.++++||
T Consensus       111 --~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         111 --GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence              3678999999999999999976432  56788899999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~  902 (973)
                      |+++.......      ........++..|+|||.+.+..++.++||||+||++|||++ |+.||........ ......
T Consensus       186 g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~  258 (302)
T cd05055         186 GLARDIMNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIK  258 (302)
T ss_pred             cccccccCCCc------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHH
Confidence            99986533210      001112345678999999999999999999999999999998 9999875433211 101000


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                                  ....     ...+...+..+.+++.+|+..+|++||+++|+++.|++.
T Consensus       259 ------------~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 ------------EGYR-----MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------------cCCc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                        0000     000112234677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.9e-34  Score=307.89  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=197.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|.+.+.||+|++|.||+|.+.. +..||+|.+.... ...+.+.+|+++++.++|||++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            568999999999999999999864 4579999886433 23467889999999999999999998753      245789


Q ss_pred             EEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +|||+.+|+|.+++....  ......+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            999999999999997643  245677889999999999999998   999999999999999999999999999976533


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..       ........++..|+|||...+..++.++||||||+++|||++ |+.||.......  .......       
T Consensus       155 ~~-------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~-------  218 (260)
T cd05069         155 NE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVER-------  218 (260)
T ss_pred             Cc-------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-------
Confidence            21       111112335678999999998899999999999999999999 999997643221  1110000       


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                       ...         ...+...+..+.+++.+||+.||++||+++++++.|++
T Consensus       219 -~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 -GYR---------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCC---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             000         01112345667889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-34  Score=312.51  Aligned_cols=261  Identities=21%  Similarity=0.359  Sum_probs=205.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECC----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE----DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++|.+.+.||+|+||.||+|.+..    ++..||+|++.... ......+.+|+.++++++|||++++++++..    .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----D   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence            4689999999999999999999865    36889999886432 3345678899999999999999999998754    2


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc--------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEE
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT--------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH  819 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~k  819 (973)
                      ....++++||+.+|+|.+++...        ..+.+.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence            46788999999999999998754        2356677899999999999999998   999999999999999999999


Q ss_pred             EeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 039720          820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLH  898 (973)
Q Consensus       820 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~  898 (973)
                      ++|||+++.+.....      ........++..|+|||++.+..++.++|||||||++||+++ |+.||......  .+.
T Consensus       158 l~d~g~~~~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~  229 (280)
T cd05043         158 ITDNALSRDLFPMDY------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMA  229 (280)
T ss_pred             ECCCCCcccccCCce------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHH
Confidence            999999986533211      111112235667999999998899999999999999999999 99999754221  111


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      .+....        ..         ......++..+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus       230 ~~~~~~--------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         230 AYLKDG--------YR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHcC--------CC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            111100        00         001122345678999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-34  Score=315.02  Aligned_cols=255  Identities=23%  Similarity=0.380  Sum_probs=197.7

Q ss_pred             hcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .+|++.+.||+|+||+||+|++..     ++..||+|+++..... ....+.+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence            357778899999999999998753     3578999999754432 34668899999999999999999998654     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc----------------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT----------------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NIL  811 (973)
                      ....++++||+.+++|.+++...                .......+.+++.|++.|++|+|+.   +|+||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil  156 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL  156 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence            36789999999999999998532                1234566788999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 039720          812 LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM  890 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~  890 (973)
                      +++++.+||+|||+++.......      ........+++.|+|||++.+..++.++||||+||++|||++ |..||...
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADY------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             ecCCCceEecccccccccccchh------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999886533210      111122345778999999988889999999999999999998 88888653


Q ss_pred             CCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ...     ..........        .      ...+..++..+.+++.+||+.||++||+++||++.|+.
T Consensus       231 ~~~-----~~~~~i~~~~--------~------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         231 SNQ-----DVIEMIRNRQ--------V------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CHH-----HHHHHHHcCC--------c------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            221     1111110000        0      11123455667899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-34  Score=326.07  Aligned_cols=262  Identities=20%  Similarity=0.248  Sum_probs=199.9

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeee
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSS  742 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  742 (973)
                      ..++....++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++. 
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-  113 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-  113 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence            3444455689999999999999999999999999999999996422   223455788999999999999999998854 


Q ss_pred             cccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          743 IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       743 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                          +....++||||+++|+|.+++... ..++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       114 ----~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         114 ----DDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             ----cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEe
Confidence                347899999999999999998754 466777888999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH  898 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~  898 (973)
                      ||+++......       ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....    ..
T Consensus       186 fG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~  254 (371)
T cd05622         186 FGTCMKMNKEG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VG  254 (371)
T ss_pred             CCceeEcCcCC-------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HH
Confidence            99998653221       1122345699999999998654    378999999999999999999999975321    11


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHHH
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE--RMQMTAVVKKL  959 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  959 (973)
                      .+.........       .  ..  + ........+.+++.+|+..+|.+  |++++|+++..
T Consensus       255 ~~~~i~~~~~~-------~--~~--~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         255 TYSKIMNHKNS-------L--TF--P-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHHHHcCCCc-------c--cC--C-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111100000       0  00  0 01123445567888999844433  78999988864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.3e-34  Score=315.48  Aligned_cols=279  Identities=22%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|.+.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.+++.++||||+++++++..     ....+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCeEE
Confidence            57999999999999999999999899999999997543 2334567889999999999999999998653     47899


Q ss_pred             EEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+. ++|.+++... ....+..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            9999997 5888887654 3456777889999999999999999   999999999999999999999999999975432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh---cCc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA---LPK  907 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~  907 (973)
                      .        ........+++.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.......   ...
T Consensus       157 ~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~  227 (301)
T cd07873         157 P--------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEE  227 (301)
T ss_pred             C--------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChh
Confidence            1        1112233568899999987654 57889999999999999999999997543211 111100000   000


Q ss_pred             ccccccCcccccccCCC--------chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HHHhccccccCCC
Q 039720          908 KVMGIVDPSLLMEARGP--------SKFEECLVAVVRTGVACSMESPSERMQMTAVVK--KLCAVGEIFIGPP  970 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~~~~  970 (973)
                      ................+        .........+.+++.+|++.||.+|||++|+++  .++.+++.+.-.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~  300 (301)
T cd07873         228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP  300 (301)
T ss_pred             hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCC
Confidence            01111100000000000        001123445678999999999999999999998  5666666665544

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.8e-34  Score=314.80  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=203.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..+|++.+.||.|+||+||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++..     .+..+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEE
Confidence            3579999999999999999999999999999999976655556778999999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|+||+++++|.+++... ...+.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        93 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          93 VVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999999988754 467788999999999999999999   9999999999999999999999999998765332


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......+++.|+|||.+.+..++.++|||||||++|++++|+.||....... ........    .    
T Consensus       169 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~~~~~~~~----~----  231 (296)
T cd06655         169 Q--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATN----G----  231 (296)
T ss_pred             c--------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc----C----
Confidence            1        11223458889999999998889999999999999999999999997542211 01000000    0    


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .+.       ...+......+.+++.+||..||++||++.+++..
T Consensus       232 -~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         232 -TPE-------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             -Ccc-------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence             000       01112334567788999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.8e-34  Score=308.07  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      +.+.+.....||+|+||.||+|++..++..||+|.+........+.+.+|+.+++.++|+||+++++++..     .+..
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~   80 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFF   80 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEE
Confidence            34455556789999999999999988999999999876655566789999999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhc-CCC--chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEeccccch
Q 039720          752 AIVYEYMQYGSVDDWLHHT-NDK--LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLAR  827 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~Dfg~a~  827 (973)
                      ++++||+++++|.+++... ...  .+..+..++.|++.|+.|||+.   +|+||||||+||+++. ++.++|+|||.+.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999999764 333  5567788999999999999998   9999999999999986 6799999999987


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG--DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ......        .......+++.|+|||++...  .++.++||||+|+++|+|++|+.||..........  +.....
T Consensus       158 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~  227 (268)
T cd06624         158 RLAGIN--------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMF  227 (268)
T ss_pred             ecccCC--------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhh
Confidence            553211        112233578899999997664  37889999999999999999999987532211110  000000


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                     ...+..+......+.+++.+||+.+|++||++.|+++.
T Consensus       228 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ---------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                           00011223344567788999999999999999998864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=312.57  Aligned_cols=253  Identities=21%  Similarity=0.343  Sum_probs=202.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||.||+|++..++..||+|++........+.+.+|++++++++|||++++++++..     ....+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEE
Confidence            4579999999999999999999988999999999987666666789999999999999999999998654     47889


Q ss_pred             EEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++++|.+++... ..+.+..++.++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||.+.....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999998764 3567788999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .        ........+++.|+|||.+.     ...++.++||||+|+++|+|++|+.||....... .+..   ... 
T Consensus       156 ~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~-  222 (280)
T cd06611         156 T--------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLK---ILK-  222 (280)
T ss_pred             c--------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHH---Hhc-
Confidence            1        11222346889999999864     3457889999999999999999999997542211 1111   100 


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .    ..+.       ...+..+...+.+++.+||+.||++||+++++++.
T Consensus       223 -~----~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 -S----EPPT-------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -C----CCCC-------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             0    0000       01112234567788999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.2e-34  Score=307.64  Aligned_cols=252  Identities=24%  Similarity=0.420  Sum_probs=199.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|.+.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|||++++++++.      .+..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence            467999999999999999999975 778999999874433 3567889999999999999999998743      25689


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+.+++|.+++....  .....++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            9999999999999986533  456677889999999999999998   99999999999999999999999999997654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........++..|+|||++.+..++.++||||||+++||+++ |+.||.......  ........     
T Consensus       154 ~~~-------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~-----  219 (260)
T cd05067         154 DNE-------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERG-----  219 (260)
T ss_pred             CCC-------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcC-----
Confidence            221       111112235678999999998899999999999999999999 999997543211  11110000     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                         ..         ...+...+..+.+++.+||+.+|++||+++++...|+.
T Consensus       220 ---~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 ---YR---------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CC---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               00         01112234568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-34  Score=312.83  Aligned_cols=262  Identities=23%  Similarity=0.373  Sum_probs=196.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCC--------------CcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGED--------------GMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKII  737 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~  737 (973)
                      .++|++.+.||+|+||.||+|++..+              ...||+|+++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            36899999999999999999987543              2358999987542 33456789999999999999999999


Q ss_pred             eEeeecccCCCceEEEEEeeccCCCHHHHhhhcC------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 039720          738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDL  805 (973)
Q Consensus       738 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDi  805 (973)
                      +++..     ....++||||+++++|.+++....            ......++.++.|++.|++|||+.   +++||||
T Consensus        84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl  155 (295)
T cd05097          84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL  155 (295)
T ss_pred             EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence            98643     467899999999999999986532            234566788999999999999999   9999999


Q ss_pred             CCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh--C
Q 039720          806 KPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT--R  883 (973)
Q Consensus       806 k~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt--g  883 (973)
                      ||+||+++.++.+|++|||++.......      .........++..|+|||+..+..++.++|||||||++|+|++  |
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~  229 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGD------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK  229 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCc------ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence            9999999999999999999997543211      0111112234678999999988899999999999999999998  5


Q ss_pred             CCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          884 RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       884 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      ..||.....+. .+...........      ....     ......++..+.+++.+||+.||++||++++|++.|+
T Consensus       230 ~~p~~~~~~~~-~~~~~~~~~~~~~------~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         230 EQPYSLLSDEQ-VIENTGEFFRNQG------RQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCCCcccChHH-HHHHHHHhhhhcc------cccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            66776543211 1111100000000      0000     0011123457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-34  Score=312.57  Aligned_cols=266  Identities=21%  Similarity=0.263  Sum_probs=206.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++.... ....+.+.+|+++++.++|||++++++++..     ....
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEE
Confidence            357888999999999999999999899999999987543 3345778999999999999999999998654     3789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++++|.+++...+......+..++.+++.|+.|||+..  +++||||||+||+++.++.++|+|||++.....
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            999999999999999988777778888999999999999999732  899999999999999999999999999865422


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .          ......|+..|+|||++.+..++.++|||||||++|++++|+.||..............  ........
T Consensus       157 ~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~  224 (284)
T cd06620         157 S----------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM--GILDLLQQ  224 (284)
T ss_pred             h----------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh--HHHHHHHH
Confidence            1          11234688999999999888999999999999999999999999986543211000000  00000000


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .....     .......+++..+.+++.+|++.||++||+++|+++...-+
T Consensus       225 ~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         225 IVQEP-----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             Hhhcc-----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            00000     00001122456788999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.8e-34  Score=313.46  Aligned_cols=265  Identities=24%  Similarity=0.280  Sum_probs=204.6

Q ss_pred             cHHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       665 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      ...++..+.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34455566789999999999999999999999999999999986432 2345677899999998 799999999998764


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEE
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH  819 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~k  819 (973)
                      +.......++|+||+++++|.++++.    .....+..++.++.|++.|+.|||+.   +++||||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence            33344678999999999999998753    34556778899999999999999999   999999999999999999999


Q ss_pred             EeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 039720          820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG  894 (973)
Q Consensus       820 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~  894 (973)
                      |+|||.+.......        .......|+..|+|||.+...     .++.++|||||||++|||++|+.||.......
T Consensus       169 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         169 LVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             Eeecccchhccccc--------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence            99999988654321        111234578899999987543     36889999999999999999999997543211


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .+.....     .    ..+..       .........+.+++.+||+.+|++||++.|++++
T Consensus       241 -~~~~~~~-----~----~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         241 -TLFKIPR-----N----PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -HHHHHhc-----C----CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             1111100     0    00000       0012233467889999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-34  Score=312.01  Aligned_cols=253  Identities=24%  Similarity=0.307  Sum_probs=200.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .+.|++.++||+|+||.||+|++..++..||+|++........+.+.+|+.+++.++|||++++++++..     +...+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEE
Confidence            3579999999999999999999998999999999986666667788999999999999999999998654     36899


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||++++++..++.. .....+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999988764 34567788899999999999999998   999999999999999999999999998875422


Q ss_pred             CCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .        ........+++.|+|||++.     ...++.++|||||||++|||++|+.||...... .........   
T Consensus       163 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~---  230 (292)
T cd06644         163 T--------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKS---  230 (292)
T ss_pred             c--------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcC---
Confidence            1        11122345788999999874     345788999999999999999999998653211 011110000   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                            ..+.       ...+..+...+.+++.+||+.||++||+++|+++.
T Consensus       231 ------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 ------EPPT-------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ------CCcc-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                  0000       01112334467789999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-34  Score=312.32  Aligned_cols=256  Identities=22%  Similarity=0.382  Sum_probs=200.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.+.... ......+.+|+.+++.++|||++++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST----   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence            4679999999999999999998864     34789999986443 2345678899999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC----------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN----------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM  816 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~  816 (973)
                       ....++||||+++|+|.+++....          ...+..++.++.|++.|+.|||+.   +|+||||||+||+++.++
T Consensus        81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence             478899999999999999986532          234467788999999999999998   999999999999999999


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGL  895 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~  895 (973)
                      .+||+|||+++.+.....      ........++..|+|||.+.+..++.++|||||||++||+++ |..||....... 
T Consensus       157 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  229 (277)
T cd05032         157 TVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-  229 (277)
T ss_pred             CEEECCcccchhhccCcc------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-
Confidence            999999999986543221      111123346778999999988889999999999999999998 999986532211 


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                       ......           ...      ....+..++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       230 -~~~~~~-----------~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         230 -VLKFVI-----------DGG------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -HHHHHh-----------cCC------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence             111110           000      011112235678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.2e-34  Score=306.47  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=198.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|.+.+.||+|+||.||+|.+..++..||+|++....     ......+.+|+.+++.++|||++++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            36889999999999999999999899999999986432     1234568889999999999999999997643   223


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++++||+++++|.+++..........++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            67889999999999999998877777788889999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      .....     ..........++..|+|||.+.+..++.++||||+||++||+++|+.||.......    .......   
T Consensus       156 ~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~~~~~---  223 (266)
T cd06651         156 LQTIC-----MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIFKIAT---  223 (266)
T ss_pred             ccccc-----ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHHHHhc---
Confidence            53211     00111123457889999999998889999999999999999999999997542211    1100000   


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ...         .+..+....+.+..++ +||..+|++||+++|++++
T Consensus       224 --~~~---------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         224 --QPT---------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --CCC---------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence              000         0111223334455666 6888999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-34  Score=309.11  Aligned_cols=250  Identities=26%  Similarity=0.326  Sum_probs=202.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|.+.+.||.|++|.||+|++..+++.||+|++.... ......+.+|+++++.++|+|++++++++..     ....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEE
Confidence            36888999999999999999999999999999997553 3345678899999999999999999998654     37899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|+||+++++|.+++... ...+..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.++.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999999999865 667788999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......+++.|+|||+..+..++.++|||||||++|+|++|+.||.......  ...    .....    
T Consensus       152 ~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~----~~~~~----  213 (274)
T cd06609         152 M--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLF----LIPKN----  213 (274)
T ss_pred             c--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHH----Hhhhc----
Confidence            1        12223467889999999998889999999999999999999999997543111  000    00000    


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..+..      ..  ..++..+.+++.+||..||++||+++++++.
T Consensus       214 ~~~~~------~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         214 NPPSL------EG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CCCCC------cc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00000      00  0134567788999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.7e-34  Score=324.81  Aligned_cols=271  Identities=19%  Similarity=0.202  Sum_probs=199.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  748 (973)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++....  ......+.+|+.+++.++||||+++++++.... +...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999999999999999996432  334567889999999999999999998765422 2334


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+++ ++.+.+..  ......+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            568999999975 67776653  355677889999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-C-
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-P-  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-~-  906 (973)
                      ....         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ .+........ + 
T Consensus       176 ~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~  245 (364)
T cd07875         176 AGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPC  245 (364)
T ss_pred             cCCC---------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCC
Confidence            5321         12233568999999999999999999999999999999999999997543211 1111000000 0 


Q ss_pred             cccccccC----------ccc--------ccccC---CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVD----------PSL--------LMEAR---GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~----------~~~--------~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......+.          +..        .....   ...........+.+++.+|++.||.+|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000          000        00000   000111123456789999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.1e-34  Score=311.04  Aligned_cols=250  Identities=23%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.++|++++++++.+..     .+..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence            3677889999999999999999999999999986432   2223457789999999999999999988643     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ++||||+.+++|.+++....  ...+..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++...
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            99999999999999886433  456678889999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...         .......|+..|+|||++.+..++.++||||+||++|+|++|+.||......... .......  .. 
T Consensus       153 ~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~--~~-  219 (285)
T cd05630         153 PEG---------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLV--KE-  219 (285)
T ss_pred             CCC---------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhh--hh-
Confidence            321         1112346899999999999999999999999999999999999999754322100 0000000  00 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVK  957 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  957 (973)
                         ...         .....+...+.+++.+||+.||++||+     ++|+++
T Consensus       220 ---~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 ---VQE---------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---hhh---------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence               000         011223445678889999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-34  Score=310.97  Aligned_cols=268  Identities=22%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++....  ....+.+.+|+++++.++|||++++++++..     ....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence            46889999999999999999999899999999986443  2234567899999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||++++.+..+........+..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            99999999999988887766778888999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh--cCcc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA--LPKK  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~  908 (973)
                      ..        .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+... ......  ....
T Consensus       153 ~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~  223 (286)
T cd07847         153 PG--------DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPR  223 (286)
T ss_pred             Cc--------ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChH
Confidence            21        11223457788999998766 457899999999999999999999997654321111 111000  0000


Q ss_pred             cccccCccc------ccccC----CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSL------LMEAR----GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~------~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....+...      .....    ...........+.+++.+||+.||++||++.|++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            000000000      00000    000112235667899999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.6e-34  Score=316.03  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=200.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-------CCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-------DGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      .++|.+.+.||+|+||.||+|++..       ++..||+|+++... .....++..|+.+++.+ +|||++++++++.. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence            3579999999999999999998743       33579999997543 23456788899999999 79999999998754 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                          ....++||||+.+|+|.+++....                .....++.+++.|++.|++|||+.   +++||||||
T Consensus        96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence                367899999999999999997542                244567889999999999999998   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +||+++.++.+||+|||.++.......      ........+++.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccch------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999875532210      011111224567999999998889999999999999999998 8889


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      |.....+  .+......            .     .....+..+...+.+++.+||+.+|++||++.|+++.|.++..
T Consensus       243 ~~~~~~~--~~~~~~~~------------~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         243 YPGVPVE--ELFKLLKE------------G-----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             CCcCCHH--HHHHHHHc------------C-----CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            8643211  11111000            0     0011122345577789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.4e-34  Score=311.73  Aligned_cols=273  Identities=22%  Similarity=0.364  Sum_probs=202.8

Q ss_pred             hcCCcCCccccccceeEEEEEE----CCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +-|++.+.||+|+||.||.|+.    ..++..||+|.++... ......+.+|+++++.++|||++++++++...   +.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            4578899999999999999984    4578899999987443 33456789999999999999999999987542   24


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++++|.+++.... ..+..++..++.|++.|++|||++   +++||||||+||+++.++.++|+|||+++
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            56899999999999999987643 456788899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .......     .........++..|+|||+..+..++.++|||||||++|||++++.|+..........   ......+
T Consensus       158 ~~~~~~~-----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~---~~~~~~~  229 (284)
T cd05079         158 AIETDKE-----YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM---IGPTHGQ  229 (284)
T ss_pred             ccccCcc-----ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh---ccccccc
Confidence            6543210     0111123446678999999988889999999999999999999887754322110000   0000000


Q ss_pred             -ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          908 -KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       908 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                       .....+.  ..........+..++..+.+++.+||+.+|++||+++|+++.++++
T Consensus       230 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         230 MTVTRLVR--VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccHHHHHH--HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             0000000  0000000111223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6e-34  Score=307.70  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=200.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCC---cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .+|++.+.||+|+||.||+|++..++   ..||+|.++... ....+.+.+|+.+++.++||||+++++++..     .+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence            57889999999999999999886444   379999986543 2345678999999999999999999998643     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++++|.+++.... .....++..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||.+..
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            7899999999999999997653 456678899999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      +.....     .........++..|+|||.+.+..++.++|+|||||++||+++ |+.||......+  .......    
T Consensus       156 ~~~~~~-----~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~----  224 (267)
T cd05066         156 LEDDPE-----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEE----  224 (267)
T ss_pred             cccccc-----eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhC----
Confidence            643210     0111111223567999999998899999999999999999887 999987543211  1111100    


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .    ..         ......++..+.+++.+|++.+|++||+++++++.|.++
T Consensus       225 ~----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 G----YR---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C----Cc---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0    00         011122345677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.8e-34  Score=312.07  Aligned_cols=259  Identities=22%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             HhhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+.... ......+.+|+.+++.++|||++++++++..   
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK---   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence            45789999999999999999997642     35689999886443 2234567889999999999999999998643   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCC----------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTND----------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD  815 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~  815 (973)
                        ....++||||+++|+|.+++.....          .....+.+++.|++.|+.|||++   +|+||||||+||+++.+
T Consensus        81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          81 --GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             --CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence              3678999999999999999975321          12345778999999999999999   99999999999999999


Q ss_pred             CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 039720          816 MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDG  894 (973)
Q Consensus       816 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~  894 (973)
                      +.++++|||+++.......      ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....+ 
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-  228 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-  228 (288)
T ss_pred             CcEEECcCCcccccccccc------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999986543221      111112235677999999998899999999999999999999 78898653221 


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                          +......        +...      ...+..++..+.+++.+|++.||++||++.|+++.+++..
T Consensus       229 ----~~~~~~~--------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         229 ----QVLKFVM--------DGGY------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ----HHHHHHH--------cCCC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                1111110        0000      0111223457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-34  Score=314.82  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=212.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ...|.+.+.||+|.|+.|..|++.-++..||||++....-  .....+.+|+++|..+.|||||+++++..     ....
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-----t~~~  129 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-----TEAT  129 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-----ecce
Confidence            4578999999999999999999999999999999975532  23355899999999999999999999854     3489


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +|+||||+.+|.+++++.+.+...+..+..++.|+.+|++|||++   .|||||+|++|||++.+.++||+|||++.++.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            999999999999999999999988888999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      .         .......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.                
T Consensus       207 ~---------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----------------  261 (596)
T KOG0586|consen  207 Y---------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----------------  261 (596)
T ss_pred             c---------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----------------
Confidence            4         445667889999999999999888 78999999999999999999999864322                


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                       ..-++.+..+.+.+.......   .+++++++..+|.+|++++++++.-.
T Consensus       262 -~Lr~rvl~gk~rIp~~ms~dc---e~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  262 -ELRPRVLRGKYRIPFYMSCDC---EDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             -cccchheeeeecccceeechh---HHHHHHhhccCccccCCHHHhhhhcc
Confidence             111222334444443333333   36777999999999999999987543

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.9e-34  Score=315.33  Aligned_cols=263  Identities=23%  Similarity=0.380  Sum_probs=201.6

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-------CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-------EDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      ..+|.+.+.||+|+||.||+|++.       .....||+|+++... ......+.+|+.+++.+ +||||+++++++.. 
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence            357899999999999999999863       234579999987432 23456788999999999 69999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                          ....+++|||+++|+|.+++....                .....++..++.|++.|+.|||+.   +++||||||
T Consensus        90 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          90 ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             ----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence                367899999999999999997532                234566788999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +||+++.++.+||+|||.++.......      ........++..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p  236 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDY------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP  236 (314)
T ss_pred             eeEEEcCCCcEEEcccccccccccccc------ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence            999999999999999999986543210      011111224467999999998899999999999999999999 8999


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                      |......  .+......    .             .....+..++..+.+++.+||+.||++||++.|+++.|+++....
T Consensus       237 ~~~~~~~--~~~~~~~~----~-------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         237 YPGIPVE--ELFKLLRE----G-------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             CCCCCHH--HHHHHHHc----C-------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            8654221  11111100    0             001112233456778999999999999999999999999886544


Q ss_pred             cC
Q 039720          967 IG  968 (973)
Q Consensus       967 ~~  968 (973)
                      ..
T Consensus       298 ~~  299 (314)
T cd05099         298 SE  299 (314)
T ss_pred             cC
Confidence            33

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2e-34  Score=321.10  Aligned_cols=255  Identities=22%  Similarity=0.245  Sum_probs=195.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||+||+|++..+++.||+|++....   ......+.+|..++..++|++|+++++++..     .+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence            47999999999999999999999999999999996432   2234557889999999999999999988543     578


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++|+|.+++.. .....+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            9999999999999999986 34567778889999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ....       ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||......    ..+....
T Consensus       153 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~i~  221 (331)
T cd05624         153 NQDG-------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIM  221 (331)
T ss_pred             cCCC-------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----HHHHHHH
Confidence            4321       111223469999999998775     46788999999999999999999999743211    1111111


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE--RMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  958 (973)
                      ....       ..    ..+....+....+.+++.+|+..++++  |+++++++++
T Consensus       222 ~~~~-------~~----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         222 NHEE-------RF----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCC-------cc----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0000       00    001111223455667888888866554  4688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-34  Score=325.69  Aligned_cols=209  Identities=24%  Similarity=0.307  Sum_probs=176.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...   ......+..|+.++..++||+++++++++.     +...
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence            36889999999999999999999999999999997432   233466788999999999999999998754     4578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++.......+..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            999999999999999998887888888999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCccC---------------------------CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhC
Q 039720          831 HHPFLVA---------------------------PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR  883 (973)
Q Consensus       831 ~~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg  883 (973)
                      .......                           ...........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG  232 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence            2110000                           0000111235699999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 039720          884 RRPTDNM  890 (973)
Q Consensus       884 ~~Pf~~~  890 (973)
                      +.||...
T Consensus       233 ~~Pf~~~  239 (360)
T cd05627         233 YPPFCSE  239 (360)
T ss_pred             CCCCCCC
Confidence            9999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1e-33  Score=315.18  Aligned_cols=271  Identities=18%  Similarity=0.203  Sum_probs=195.4

Q ss_pred             cCCccccc--cceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          678 SSNRIGKG--SFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       678 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      +.++||+|  +|++||+++++.+|+.||+|++....  ....+.+.+|+++++.++||||+++++++..     ++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            45789999  78999999999999999999997543  2344567889999999999999999998754     378999


Q ss_pred             EEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ||||+++|+|.+++...  ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+.....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            99999999999998653  3466788899999999999999999   999999999999999999999999987654322


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...... ..........++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .....+...
T Consensus       154 ~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~  231 (327)
T cd08227         154 HGQRLR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLL  231 (327)
T ss_pred             cccccc-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccc
Confidence            110000 00111122346778999999876  46899999999999999999999999754332111111 000000000


Q ss_pred             c---------------cccCccccc------------ccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 M---------------GIVDPSLLM------------EARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~---------------~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .               ...+.....            ..............+.+++.+||+.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0               000000000            000001122345678899999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.7e-34  Score=311.85  Aligned_cols=256  Identities=23%  Similarity=0.365  Sum_probs=197.7

Q ss_pred             cCCcCCccccccceeEEEEEECC-----CCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +|++.+.||+|+||.||+|++..     ....||+|++..... .....+.+|+.+++.++||||+++++.+..     .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence            47788999999999999998743     235788898864432 334678899999999999999999998654     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC------------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN------------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGD  804 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD  804 (973)
                      +..++++||+.+|+|.+++....                        ......+..++.|++.|++|||+.   +|+|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            67899999999999999986432                        234466789999999999999998   999999


Q ss_pred             CCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-C
Q 039720          805 LKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-R  883 (973)
Q Consensus       805 ik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g  883 (973)
                      |||+||++++++.+||+|||+++.......      ........++..|+|||.+.+..++.++||||||+++|||++ |
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDS------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccc------hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            999999999999999999999976533210      011112235678999999988899999999999999999999 9


Q ss_pred             CCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          884 RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       884 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      +.||.....+  .+......            ...     ...+..+...+.+++.+||+.+|++||+++|+++.|+++-
T Consensus       227 ~~p~~~~~~~--~~~~~~~~------------~~~-----~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         227 GNPYPGIAPE--RLFNLLKT------------GYR-----MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             CCCCCCCCHH--HHHHHHhC------------CCC-----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            9998654221  11111110            000     1111233456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.4e-34  Score=305.87  Aligned_cols=255  Identities=24%  Similarity=0.354  Sum_probs=200.0

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK------GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +|++.+.||+|+||+||+|.. .+++.||+|+++....      .....+.+|+++++.++|+|++++++++.+     .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence            588899999999999999987 4889999999874421      223568889999999999999999998654     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++++||+++++|.+++.+....++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  151 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARR  151 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence            78999999999999999998777777888889999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      .......  ...........|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .......   ..
T Consensus       152 ~~~~~~~--~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~---~~  225 (265)
T cd06631         152 LAWVGLH--GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGAH---RG  225 (265)
T ss_pred             hhhcccc--ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhhc---cC
Confidence            5321100  0011122234688999999999998999999999999999999999999975422110 0000000   00


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                          ..         +..+......+.+++.+||+.+|++||++.|++.
T Consensus       226 ----~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 ----LM---------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----CC---------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                00         1111223456778899999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.8e-34  Score=308.23  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=200.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCc---EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGM---SVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .+|++.+.||+|+||.||+|++..++.   .||||++... ......++..|+.+++.++|||++++++++.     +..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence            458889999999999999999876664   6999998754 2334567999999999999999999999854     347


Q ss_pred             eEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++++|.+++... +.....+++.++.|++.|+.|||++   +++||||||+||+++.++.++++|||.+..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence            789999999999999998764 3456778899999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ........   ..........+..|+|||++.+..++.++||||+||++||+++ |..||......  ....+...    
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~----  226 (269)
T cd05065         156 LEDDTSDP---TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQ----  226 (269)
T ss_pred             cccCcccc---ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHc----
Confidence            54321000   0000001112457999999999999999999999999999887 99998754221  11111100    


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                          ...         ...+.+++..+.+++.+||+.+|++||++++++..|+++
T Consensus       227 ----~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 ----DYR---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----CCc---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                000         011123455677899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.5e-34  Score=314.79  Aligned_cols=199  Identities=21%  Similarity=0.336  Sum_probs=160.0

Q ss_pred             CCccccccceeEEEEEEC--CCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          679 SNRIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      .++||+|+||+||+|+++  .+++.||+|++....  ....+.+|+++++.++||||+++++++..   ......+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            468999999999999975  367899999986432  23457789999999999999999998653   23467899999


Q ss_pred             eccCCCHHHHhhhc---------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----cCCCcEEEecc
Q 039720          757 YMQYGSVDDWLHHT---------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF  823 (973)
Q Consensus       757 ~~~~gsL~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl----~~~~~~kl~Df  823 (973)
                      |+. +++.+++...         ...++..++.++.||+.||+|||+.   +|+||||||+|||+    +..+.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            986 5788776532         1355677889999999999999999   99999999999999    45679999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMF  891 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~  891 (973)
                      |+|+......     ..........||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus       157 G~a~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         157 GFARLFNSPL-----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CceeccCCCC-----ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            9998654321     01112234568999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-33  Score=310.78  Aligned_cols=262  Identities=21%  Similarity=0.342  Sum_probs=200.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC----------------cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCcee
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG----------------MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIK  735 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  735 (973)
                      .++|++.+.||+|+||.||+|++...+                ..||+|++.... ....+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999876433                568999987543 234567899999999999999999


Q ss_pred             EEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcC-----------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 039720          736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-----------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGD  804 (973)
Q Consensus       736 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD  804 (973)
                      +++++..     ....+++|||+.+++|.+++....           ...+..++.++.|++.|++|||+.   +|+|||
T Consensus        84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            9998654     378899999999999999987655           456778899999999999999999   999999


Q ss_pred             CCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh--
Q 039720          805 LKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT--  882 (973)
Q Consensus       805 ik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt--  882 (973)
                      |||+||+++.++.++++|||.++......      .........+++.|+|||++.+..++.++|||||||++|||++  
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSD------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCc------ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence            99999999999999999999987543221      0111123345778999999988889999999999999999998  


Q ss_pred             CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          883 RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       883 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      |..||......  ............     ......     ...+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       230 ~~~p~~~~~~~--~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         230 REQPYEHLTDQ--QVIENAGHFFRD-----DGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCCCCcChH--HHHHHHHhcccc-----cccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            67777643221  111111100000     000000     0111223457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-34  Score=313.88  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=200.4

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-------CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-------EDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      ..+|.+.+.||+|+||.||+|++.       .++..||+|++.... .....++.+|+.+++.+ +||||+++++++.. 
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence            467999999999999999999753       234579999986432 33456789999999999 89999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                          ....+++|||+++|+|.+++....                ..+..++..++.|++.|+.|||+.   +|+||||||
T Consensus        93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          93 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence                367899999999999999997642                233456788999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +||+++.++.+||+|||.++.......      ........+++.|+|||++.+..++.++||||||+++|++++ |..|
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  239 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  239 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccc------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999986643210      111112345678999999988899999999999999999998 8888


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      |......     .........              .....+..++..+.+++.+||+.+|++||++.|+++.|+++-
T Consensus       240 ~~~~~~~-----~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         240 YPGIPVE-----ELFKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             cccCCHH-----HHHHHHHcC--------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            8643211     111110000              001112234567788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-34  Score=319.89  Aligned_cols=255  Identities=21%  Similarity=0.224  Sum_probs=194.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.++||+|+||+||+++++.+++.||+|++....   ......+.+|+.++..++|++|+++++++..     ...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence            47899999999999999999999999999999996422   2234457889999999999999999988543     478


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++|+|.+++.+ .....+..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            9999999999999999976 34567778889999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ....       ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......    ..+....
T Consensus       153 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----~~~~~i~  221 (332)
T cd05623         153 MEDG-------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIM  221 (332)
T ss_pred             ccCC-------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----HHHHHHh
Confidence            3211       11222346999999999876     346789999999999999999999999753211    1111111


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE--RMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  958 (973)
                      ..         ..  ....+.....+...+.+++.+|+..+|++  |++++|++++
T Consensus       222 ~~---------~~--~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         222 NH---------KE--RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CC---------Cc--cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00         00  00001111233455667777877654444  7899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.6e-34  Score=304.08  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||.||+|++..++..||+|.+.....  .+.+.+|+++++.++|||++++++++..     ....+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~   74 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLW   74 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEE
Confidence            3679999999999999999999988899999999975433  6789999999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +++||+.+++|.+++... ...++..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.....
T Consensus        75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999998753 3456788899999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      ..        .......++..|+|||++.+..++.++||||||+++|+|++|+.||..........    ..  .     
T Consensus       152 ~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----~~--~-----  212 (256)
T cd06612         152 TM--------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----MI--P-----  212 (256)
T ss_pred             Cc--------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh----hh--c-----
Confidence            21        12223457889999999998899999999999999999999999997543211100    00  0     


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                         .....   ...........+.+++.+||+.||++||++.|+++
T Consensus       213 ---~~~~~---~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         213 ---NKPPP---TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---cCCCC---CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence               00000   01112234456788999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-33  Score=304.42  Aligned_cols=256  Identities=23%  Similarity=0.339  Sum_probs=202.6

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK------GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +|+..+.||+|++|.||+|++..+++.||+|+++....      ...+.+.+|+++++.++|||++++++++.+     .
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence            47888999999999999999999999999999975431      234678899999999999999999998643     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~  827 (973)
                      +..++|+||+++++|.+++...+...+..+..++.|++.|+.|||++   +++||||||+||+++.++ .++|+|||.+.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            78999999999999999998877778888899999999999999999   999999999999998776 69999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .......    ..........++..|+|||.+.+..++.++||||+|+++|++++|+.||........ .........  
T Consensus       153 ~~~~~~~----~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~--  225 (268)
T cd06630         153 RLAAKGT----GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIAS--  225 (268)
T ss_pred             ccccccc----cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhc--
Confidence            7643210    001112234688899999999888899999999999999999999999964322111 000000000  


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                                  ....+..+......+.+++.+|+..+|++||++.|+++
T Consensus       226 ------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                        00011222344567788999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-33  Score=306.21  Aligned_cols=249  Identities=25%  Similarity=0.331  Sum_probs=203.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..|+..+.||+|+||.||+|.+..++..||+|++.... ......+.+|+++++.+.|||++++++++..     ....+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEE
Confidence            46778899999999999999998899999999987543 3445778899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++|+|.+++... ...+.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        79 lv~e~~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEecCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999999998753 566777889999999999999998   9999999999999999999999999999765321


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......++..|+|||++.+..++.++|+|||||++|||++|..||.........     .         .
T Consensus       155 ~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~---------~  212 (277)
T cd06640         155 Q--------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----F---------L  212 (277)
T ss_pred             c--------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----h---------h
Confidence            1        1122345788899999998888999999999999999999999998754321100     0         0


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..     ....+.....++..+.+++.+||+.+|++||+++|++..
T Consensus       213 ~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 IP-----KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hh-----cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            00     000122234566778899999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=307.21  Aligned_cols=249  Identities=23%  Similarity=0.285  Sum_probs=199.9

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..+.|+.-+.||+||||.||-++.+.||+.||.|.+...   ++....-..+|-+++.+++.+.||.+--.     |++.
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTk  257 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETK  257 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCC
Confidence            346788899999999999999999999999999988533   23344567899999999999988876433     6778


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      +.+++|+..|.||+|.-++.+.+  .+++..+..++.+|+.||++||..   +||+||+||+|||+|++|+++|+|.|+|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999999887766  778888999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ..+..         .......+||.+|||||++....|+...|+||+||++|||+.|+.||........          .
T Consensus       335 vei~~---------g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------~  395 (591)
T KOG0986|consen  335 VEIPE---------GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------R  395 (591)
T ss_pred             EecCC---------CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------H
Confidence            98754         2333445899999999999999999999999999999999999999975433210          0


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT  953 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  953 (973)
                      ++    +|+......  ...+..+.++..++....++.||++|....
T Consensus       396 eE----vdrr~~~~~--~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  396 EE----VDRRTLEDP--EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HH----HHHHHhcch--hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            01    111111111  122233444555677788999999997543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-33  Score=307.84  Aligned_cols=275  Identities=24%  Similarity=0.359  Sum_probs=206.3

Q ss_pred             hcCCcCCccccccceeEEEEEEC----CCCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLG----EDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +.|.+.+.||+|+||.||+|++.    .++..||||+++..... ..+.+.+|+++++.+.|||++++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            46788899999999999999864    34789999999765443 46789999999999999999999998653   234


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...+++|||+++++|.+++.... ......+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            67899999999999999997654 456778899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ........     ........++..|+|||...+..++.++||||||+++|||++|+.|+.........+...   ....
T Consensus       158 ~~~~~~~~-----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~  229 (284)
T cd05038         158 VLPEDKDY-----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI---AQGQ  229 (284)
T ss_pred             ccccCCcc-----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc---cccc
Confidence            66422100     001111234557999999988899999999999999999999999986543322110000   0000


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .....+...+. .......+..++..+.+++.+||+.+|++||++.||++.|+++.
T Consensus       230 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         230 MIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             ccHHHHHHHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            00000000000 00001112334567889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-33  Score=304.48  Aligned_cols=255  Identities=21%  Similarity=0.258  Sum_probs=199.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|++.+.||+|+||.||.|.+..++..||+|++....     ....+.+.+|++++++++|||++++++++.+.   ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence            47889999999999999999999999999999986432     12345788899999999999999999976432   23


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...+++|||+++++|.+++.......+..+.+++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.++.
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            56889999999999999998776677788899999999999999999   999999999999999999999999999886


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      .....     ..........++..|+|||++.+..++.++|||||||++|+|++|+.||......    ......... .
T Consensus       156 ~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~  225 (265)
T cd06652         156 LQTIC-----LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQ-P  225 (265)
T ss_pred             ccccc-----ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHHhcC-C
Confidence            53211     0011122345888999999998888999999999999999999999999753211    111111000 0


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                   ..+..+......+..++.+|+. +|++||+++|+++.
T Consensus       226 -------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 -------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                         0011223344556677888884 99999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-33  Score=304.84  Aligned_cols=248  Identities=29%  Similarity=0.509  Sum_probs=201.3

Q ss_pred             CccccccceeEEEEEECCC---CcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||.||+|.+...   +..||+|+++..... ..+.+.+|++.++.++|+|++++++++..     ....+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4699999999999999765   899999999765443 36788999999999999999999998654     57899999


Q ss_pred             eeccCCCHHHHhhhc---------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          756 EYMQYGSVDDWLHHT---------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       756 e~~~~gsL~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      ||+++++|.+++...         ...++..++.++.|++.|++|||++   +++||||||+||+++.++.++++|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999875         6677888999999999999999998   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ........      ........++..|+|||.+....++.++||||+|+++|+|++ |+.||......  .+......  
T Consensus       153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~--  222 (262)
T cd00192         153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK--  222 (262)
T ss_pred             cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc--
Confidence            87654321      112233457889999999988899999999999999999999 69999765221  11111100  


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                                     ......+..++..+.+++.+||+.+|++||+++|+++.|+
T Consensus       223 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ---------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                           0001112233567889999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-33  Score=310.32  Aligned_cols=262  Identities=21%  Similarity=0.370  Sum_probs=197.3

Q ss_pred             hcCCcCCccccccceeEEEEEECC----------------CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGE----------------DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKI  736 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  736 (973)
                      ++|++.++||+|+||.||+|++..                ++..||+|+++... .....++.+|+.+++.++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            579999999999999999986532                34579999997543 3345678999999999999999999


Q ss_pred             EeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCC-----------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 039720          737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-----------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDL  805 (973)
Q Consensus       737 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDi  805 (973)
                      ++++..     .+..+++|||+++|+|.+++.....           ....++..++.|++.|++|||+.   +++||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            998654     3678999999999999999876432           23356889999999999999999   9999999


Q ss_pred             CCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh--C
Q 039720          806 KPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT--R  883 (973)
Q Consensus       806 k~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt--g  883 (973)
                      ||+||+++.++.++++|||+++.+.....      ........++..|+|||...+..++.++|||||||++|||++  |
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~  230 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDY------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK  230 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcc------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence            99999999999999999999986533210      011112234568999999888899999999999999999998  7


Q ss_pred             CCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          884 RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       884 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ..||.......  ............    .....      ...+..++..+.+++.+||+.||++||+++||++.|++
T Consensus       231 ~~p~~~~~~~~--~~~~~~~~~~~~----~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         231 EQPYSQLSDEQ--VIENTGEFFRDQ----GRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CCCccccChHH--HHHHHHHHHhhc----ccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            78886443221  111000000000    00000      01112344678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-33  Score=309.54  Aligned_cols=266  Identities=24%  Similarity=0.298  Sum_probs=209.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++|||++++++++..     .+..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            3689999999999999999999988999999999976555556778999999999999999999998654     36889


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|+||+++++|.+++.+. ......+..++.|++.|+.|||+.   +++|||+||+||+++.++.++|+|||++......
T Consensus        93 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             EEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999999999998754 356677889999999999999999   9999999999999999999999999988755332


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......+++.|+|||......++.++|||||||++|++++|+.||........ +.....          
T Consensus       169 ~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~----------  229 (293)
T cd06647         169 Q--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT----------  229 (293)
T ss_pred             c--------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhc----------
Confidence            1        122234588899999998888899999999999999999999999975432111 000000          


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhccccccCCCCC
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVGEIFIGPPII  972 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~  972 (973)
                       ..     .............+.+++.+||..+|++||++++++.+  ++..+.-.+-||++
T Consensus       230 -~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~  285 (293)
T cd06647         230 -NG-----TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLI  285 (293)
T ss_pred             -CC-----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccchH
Confidence             00     00011112234567789999999999999999999987  33444445555543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-34  Score=306.63  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=191.2

Q ss_pred             CccccccceeEEEEEECCCCc--EEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGM--SVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||.||+|++..++.  .+|+|.++... ....+.+.+|+++++++ +|||++++++++..     ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence            368999999999999987775  46888876432 33456788999999999 79999999998654     36789999


Q ss_pred             eeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEE
Q 039720          756 EYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH  819 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~k  819 (973)
                      ||+++|+|.+++....                .....++..++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            9999999999987543                245577889999999999999998   999999999999999999999


Q ss_pred             EeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 039720          820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLH  898 (973)
Q Consensus       820 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~  898 (973)
                      ++|||++......         ........+..|+|||++.+..++.++|||||||++|||++ |..||.......  . 
T Consensus       153 l~dfgl~~~~~~~---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~-  220 (270)
T cd05047         153 IADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L-  220 (270)
T ss_pred             ECCCCCccccchh---------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--H-
Confidence            9999998632210         01111223567999999988899999999999999999997 999996532211  1 


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                        .....         ....     ...+..+...+.+++.+||+.||.+||+++|+++.|.++
T Consensus       221 --~~~~~---------~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         221 --YEKLP---------QGYR-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             --HHHHh---------CCCC-----CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence              11000         0000     011122345677999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-34  Score=320.01  Aligned_cols=270  Identities=17%  Similarity=0.230  Sum_probs=197.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSID-FKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  748 (973)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++.... ....
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            35689999999999999999999999999999999864322  23456778999999999999999998764321 1223


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...+++++++ +++|.+++.. ....+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence            4578999987 7899887754 4577788999999999999999999   999999999999999999999999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC-
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP-  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~-  906 (973)
                      ...           ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+......... 
T Consensus       168 ~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~  235 (343)
T cd07878         168 ADD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTP  235 (343)
T ss_pred             cCC-----------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            432           1223468999999999876 57899999999999999999999999753221 111111110000 


Q ss_pred             -cccccccCcc----cc---cccCCC---chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 -KKVMGIVDPS----LL---MEARGP---SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 -~~~~~~~~~~----~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       ......+...    ..   ......   .........+.+++.+|++.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000000    00   000000   0001122346789999999999999999999965

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-34  Score=305.50  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=200.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|.+. ++..||||++..... ..+++.+|+.++++++|||++++++++..     ....+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceE
Confidence            468999999999999999999985 568899999875433 35678999999999999999999998543     36789


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++++|.+++....  .+....+..++.|++.|+.|||++   +++||||||+||+++.++.++++|||.++...
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence            9999999999999997643  456778899999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........++..|+|||.+.+..++.++||||+|+++|++++ |+.||....... .+.....       
T Consensus       155 ~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~-------  219 (261)
T cd05034         155 DDE-------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVER-------  219 (261)
T ss_pred             chh-------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc-------
Confidence            311       111112234567999999998899999999999999999999 999996543211 1111000       


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                        ...         ...+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       220 --~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         220 --GYR---------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              000         00111224567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-33  Score=303.62  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .|++.+.||.|++|.||+|++..+++.||+|.+....  ....+.+.+|++++++++|||++++++.+..    .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            4888999999999999999999899999999997543  2345678899999999999999999886432    235689


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++++|.+++...  ...++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            999999999999998763  3457788899999999999999999   99999999999999999999999999997653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..        ........+++.|+|||+..+..++.++||||+|+++|++++|+.||......     ..........  
T Consensus       154 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~--  218 (257)
T cd08223         154 NQ--------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIEGK--  218 (257)
T ss_pred             cc--------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcC--
Confidence            22        11222345888999999999999999999999999999999999998743211     1111100000  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        .          +.........+.+++.+|++.||++||++.|++++
T Consensus       219 --~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 --L----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --C----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              0          11112344567789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7e-34  Score=313.03  Aligned_cols=257  Identities=24%  Similarity=0.394  Sum_probs=200.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc----EEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM----SVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++|+..+.||+|+||.||+|++..+|.    .||+|++..... .....+.+|+.+++.++|||+++++++|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            3578889999999999999999877776    568888864432 334568899999999999999999998753     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                       ...++++||+++|+|.+++.... ...+..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence             34678999999999999987654 456677899999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +......      .........++..|+|||.+.+..++.++|||||||++||+++ |+.||......  ......... 
T Consensus       157 ~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~-  227 (303)
T cd05110         157 RLLEGDE------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLEKG-  227 (303)
T ss_pred             ccccCcc------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCC-
Confidence            8654321      0111112335678999999998999999999999999999998 99998654211  111111100 


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                               ..       ......+...+.+++.+||..+|++||+++|+++.++++.
T Consensus       228 ---------~~-------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         228 ---------ER-------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             ---------CC-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     00       0011123346778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=317.93  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=206.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      +.|.|+..||.|+||.||+|..+.++...|.|+|........++++-|++||...+||+||++++.|.     .+..++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEE
Confidence            45677788999999999999999999999999998877778899999999999999999999998743     2478999


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +.|||.||..+..+-.- ..+.+.++..++.|++.||.|||++   .|||||+|+.|||++.+|.++++|||.+..... 
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-  182 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-
Confidence            99999999999887653 4567788999999999999999999   999999999999999999999999998764321 


Q ss_pred             CCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                             .......+.|||+|||||+..     ..+|++++||||||+++.||.-+.+|......    +.-..+.... 
T Consensus       183 -------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKiaKS-  250 (1187)
T KOG0579|consen  183 -------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKS-  250 (1187)
T ss_pred             -------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHHhhc-
Confidence                   133445688999999999854     46899999999999999999999999654321    1111111111 


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                  +.+-...+..+...|.+++.+|+..+|..||++++++++
T Consensus       251 ------------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 ------------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ------------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                        111123445677788899999999999999999999875

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-33  Score=302.02  Aligned_cols=246  Identities=29%  Similarity=0.400  Sum_probs=192.6

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      +.||+|+||.||+|... ++..||+|+++.... .....+.+|++++++++|||++++++++..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            46999999999999874 788999999875432 334568899999999999999999998754     36789999999


Q ss_pred             cCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccC
Q 039720          759 QYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA  837 (973)
Q Consensus       759 ~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~  837 (973)
                      ++++|.+++.... ...+..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++.......    
T Consensus        75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~----  147 (250)
T cd05085          75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI----  147 (250)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc----
Confidence            9999999987543 446677899999999999999998   99999999999999999999999999987543211    


Q ss_pred             CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       838 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                         ........+++.|+|||+..+..++.++||||||+++|++++ |..||.......  ......    ..    ..  
T Consensus       148 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~----~~----~~--  212 (250)
T cd05085         148 ---YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVE----KG----YR--  212 (250)
T ss_pred             ---cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHH----cC----CC--
Confidence               011111234567999999998899999999999999999998 999997543221  111000    00    00  


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                             ...+..++..+.+++.+|+..+|++||++.|+++.|.
T Consensus       213 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 -------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                   0111223456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-33  Score=303.88  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=191.4

Q ss_pred             CccccccceeEEEEEECC---CCcEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGE---DGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||.||+|.+..   .+..||+|.+... .....+.+.+|+.+++.++|||++++++++..    .+...++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            468999999999998743   3467999988533 33445678899999999999999999997643    235678999


Q ss_pred             eeccCCCHHHHhhhcCC-CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          756 EYMQYGSVDDWLHHTND-KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      ||+.+|+|.+++..... .....+..++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||+++.......
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999999999876433 34456788999999999999998   999999999999999999999999999975532110


Q ss_pred             ccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                      ..    ........++..|+|||.+.+..++.++|||||||++|||++| .+||......  ....   ....       
T Consensus       154 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~---~~~~-------  217 (262)
T cd05058         154 YS----VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DITV---YLLQ-------  217 (262)
T ss_pred             ee----ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH---HHhc-------
Confidence            00    0111123456789999999888999999999999999999995 5566533211  1111   1000       


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                       ..      ....+..++..+.+++.+||+.+|++||++.|+++.|+++-
T Consensus       218 -~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         218 -GR------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CC------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             00      01111223456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-33  Score=305.41  Aligned_cols=252  Identities=21%  Similarity=0.334  Sum_probs=185.7

Q ss_pred             CccccccceeEEEEEEC--CCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.||+|+||.||+|++.  .++..+|+|.++.... .....+.+|+.+++.++|||++++++++.+     ....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence            46999999999999864  3456799998875442 334578889999999999999999998654     367899999


Q ss_pred             eccCCCHHHHhhhcCC-----CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          757 YMQYGSVDDWLHHTND-----KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      |+++|+|.+++.....     .....+..++.|++.|++|||+.   +++||||||+||+++.++++|++|||.++....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999999875321     23345678999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhH
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-------DLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ...      ........+++.|+|||++.+.       .++.++||||||+++|||++ |+.||......+.  ..+  .
T Consensus       153 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~--~  222 (269)
T cd05087         153 EDY------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY--T  222 (269)
T ss_pred             cce------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH--H
Confidence            210      1111234567889999987542       35789999999999999996 9999975433211  111  0


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      . ........+         +.........+.+++.+|| .+|++||+++||++.|+
T Consensus       223 ~-~~~~~~~~~---------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 V-REQQLKLPK---------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             h-hcccCCCCC---------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0 000001111         1111122334667888999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.7e-34  Score=335.05  Aligned_cols=266  Identities=23%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc----
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDF----  745 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  745 (973)
                      ....+|+..+.||+||||.||+++++-+|+.||||+|.... ...-..+.+|+..+++++|||||+++..+.+..-    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888899999999999999999999999999997654 2234568899999999999999999743322000    


Q ss_pred             --------------------------------------------------------------------------------
Q 039720          746 --------------------------------------------------------------------------------  745 (973)
Q Consensus       746 --------------------------------------------------------------------------------  745 (973)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -C-----------------------------CCceEEEEEeeccCCCHHHHhhhcCCC-chhhHHHHHHHHHHHHHHHHh
Q 039720          746 -K-----------------------------GADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKLNIVIEVASVIEYLHN  794 (973)
Q Consensus       746 -~-----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~qi~~aL~~LH~  794 (973)
                       +                             .....||-||||+..++.++++++... .....++++++|++|+.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence             0                             002457889999998888888766543 356689999999999999999


Q ss_pred             cCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc----------CCCCccCCCCCcccccccccccccCcccccCC--
Q 039720          795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS----------HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG--  862 (973)
Q Consensus       795 ~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~----------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--  862 (973)
                      .   |||||||||.||++++++.|||+|||+|+...          ..............+..+||.-|+|||++.+.  
T Consensus       716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            9   99999999999999999999999999999821          00111112223355677899999999998765  


Q ss_pred             -CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhc
Q 039720          863 -DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVAC  941 (973)
Q Consensus       863 -~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  941 (973)
                       .|+.|+|+||+||+++||+   +||....+....+....++.+|.. .              .......+.=.++|.+|
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~-~--------------~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP-A--------------DFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC-c--------------ccccccchHHHHHHHHH
Confidence             4999999999999999998   467643222111111111111111 1              11122223335788899


Q ss_pred             CCCCCCCCCCHHHHHH
Q 039720          942 SMESPSERMQMTAVVK  957 (973)
Q Consensus       942 l~~dP~~RPs~~evl~  957 (973)
                      ++.||.+||||.|++.
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999875

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.4e-34  Score=309.87  Aligned_cols=256  Identities=24%  Similarity=0.427  Sum_probs=198.8

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||.||+|++.     .++..||+|++..... .....+.+|+.++++++|||++++++++..    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV----   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence            467999999999999999999874     3678999999875432 334678899999999999999999998653    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC----------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN----------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGD  804 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrD  804 (973)
                       ++..+++|||+++|+|.+++....                      ...+..++.++.|++.||+|||+.   +++|||
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence             467899999999999999987432                      234456789999999999999999   999999


Q ss_pred             CCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-C
Q 039720          805 LKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-R  883 (973)
Q Consensus       805 ik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g  883 (973)
                      |||+||+++.++.++++|||.+..+.....      .........+..|+|||.+.+..++.++|||||||++|||++ |
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADY------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcc------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence            999999999999999999999875533210      011112234567999999998999999999999999999998 8


Q ss_pred             CCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          884 RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       884 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ..||......+     ........        ..      ...+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus       230 ~~p~~~~~~~~-----~~~~~~~~--------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         230 MQPYYGMAHEE-----VIYYVRDG--------NV------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCCCCHHH-----HHHHHhcC--------CC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            88886432211     11110000        00      00112234567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=321.92  Aligned_cols=241  Identities=23%  Similarity=0.266  Sum_probs=186.0

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhc---CCCCceeEEeEeeecccCCCceEEEEE
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNI---RHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      ||+|+||+||+|++..+++.||||++.....   ........|..++...   +||+|+++++++..     ....++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence            7999999999999999999999999964321   2233455666776655   69999999987543     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+.+|+|.+++.....+.+..+..++.||+.|++|||++   +|+||||||+|||++.++.++|+|||+++.....   
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~---  149 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD---  149 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---
Confidence            9999999999998888888888999999999999999999   9999999999999999999999999998753221   


Q ss_pred             cCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                           ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.......    .+.......       
T Consensus       150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~-------  213 (330)
T cd05586         150 -----NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGK-------  213 (330)
T ss_pred             -----CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCC-------
Confidence                 1122345699999999998754 57999999999999999999999997532110    011111000       


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC----CHHHHHH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM----QMTAVVK  957 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  957 (973)
                      ..+      +.  ......+.+++.+||+.||++||    +++|+++
T Consensus       214 ~~~------~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 VRF------PK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCC------CC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            000      00  11234556888899999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-33  Score=307.53  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=198.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|++.+.||+|+||+||+|++..++..||+|.++... ......+.+|++++++++|||++++++++..     ....+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEE
Confidence            36888999999999999999998899999999987542 2334678899999999999999999997543     47899


Q ss_pred             EEEeeccCCCHHHHhhhc---CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHT---NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      +||||+++++|.+++...   ..+.+..+..++.|++.|+.|||+.+  +|+||||||+||+++.++.++++|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999999999988763   25677888999999999999999632  8999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC------CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG------DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ...          ......+++.|+|||.+.+.      .++.++||||+||++|+|++|+.||.......  .......
T Consensus       154 ~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~  221 (286)
T cd06622         154 VAS----------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSA  221 (286)
T ss_pred             cCC----------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHH
Confidence            321          11233578899999987544      35889999999999999999999996532211  1000000


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              +.+      ...+..+..+..++.+++.+||+.+|++||++++++..
T Consensus       222 --------~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         222 --------IVD------GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             --------Hhh------cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                    000      00012223355677889999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-33  Score=306.79  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=201.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCc----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGM----SVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|++.+.||+|+||+||+|.++.+|.    .||+|++.... ......+.+|+.+++.++|||+++++++|..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            578899999999999999999876665    58999886553 3345678899999999999999999998753      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++|+||+++|+|.+++... ....+..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            5789999999999999998764 3466788899999999999999998   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......      ........++..|+|||.+....++.++|+||||+++||+++ |+.||......  .+......   
T Consensus       158 ~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~---  226 (279)
T cd05057         158 LLDVDEK------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEK---  226 (279)
T ss_pred             cccCccc------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhC---
Confidence            6543210      111111223567999999988899999999999999999999 99998754321  11111100   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      ..       .       ...+..+...+.+++.+||..||++||++.++++.|..+.
T Consensus       227 ~~-------~-------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         227 GE-------R-------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             CC-------C-------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            00       0       0111123346778899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=315.83  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=203.9

Q ss_pred             CCcCCccccccceeEEEEEECCCC---cEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ....++||+|.||.|++|.|...+   ..||||.++.+... ..++|.+|+.+|.+++|||++++||+..+      ...
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~  185 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA  185 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence            344678999999999999996532   46899999877655 66899999999999999999999998764      568


Q ss_pred             EEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ++|||.++.|+|.+.+++.  ..+.......++.|||.||.||.++   ++||||+.++|+++-....|||+|||+.+-.
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence            8999999999999999872  2333455678999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ........     ......-...|+|||.+....++.++|||+|||++|||+| |..||.+....  +            
T Consensus       263 g~ned~Yv-----m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--q------------  323 (1039)
T KOG0199|consen  263 GENEDMYV-----MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--Q------------  323 (1039)
T ss_pred             CCCCcceE-----ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--H------------
Confidence            65432111     1112223457999999999999999999999999999999 99999865331  1            


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      +...+|.     ..+...+..|++++++++..||...|++||++.+|.+.+-
T Consensus       324 IL~~iD~-----~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  324 ILKNIDA-----GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             HHHhccc-----cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            1122221     1224456788999999999999999999999999975443

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=306.91  Aligned_cols=257  Identities=23%  Similarity=0.304  Sum_probs=202.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc-CCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDF-KGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~  749 (973)
                      ++++|++.+.||+|++|.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ .|+|++++++++..... ....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            46899999999999999999999988999999999875543 346788999999999 69999999999866432 3456


Q ss_pred             eEEEEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ..++||||+++++|.+++...    ....+..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            789999999999999988653    3556778899999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      +......        ........|+..|+|||++..     ..++.++|||||||++|+|++|+.||....... .....
T Consensus       160 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~  230 (275)
T cd06608         160 SAQLDST--------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKI  230 (275)
T ss_pred             ceecccc--------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHh
Confidence            8765321        112223458889999998653     356889999999999999999999997432211 11110


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ..         ...+.       ......+...+.+++.+||..||++|||++|+++
T Consensus       231 ~~---------~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PR---------NPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hc---------cCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00         00000       0111234567789999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-33  Score=305.34  Aligned_cols=239  Identities=23%  Similarity=0.360  Sum_probs=184.8

Q ss_pred             ccccccceeEEEEEECC------------------------CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeE
Q 039720          681 RIGKGSFGFVYKGNLGE------------------------DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI  736 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  736 (973)
                      +||+|+||.||+|....                        ....||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997532                        124688999865544455678889999999999999999


Q ss_pred             EeEeeecccCCCceEEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC
Q 039720          737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD  815 (973)
Q Consensus       737 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~  815 (973)
                      +++|...     ...++||||+++|+|.+++.. .+..++..+..++.|+++||+|||++   +|+||||||+||+++..
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            9997653     678999999999999999875 44567788899999999999999998   99999999999999764


Q ss_pred             C-------cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHH-hCCCC
Q 039720          816 M-------VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMF-TRRRP  886 (973)
Q Consensus       816 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~ell-tg~~P  886 (973)
                      +       .+|++|||.+......            ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.|
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  221 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP  221 (274)
T ss_pred             CcccCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            3       4899999988643211            12346778999998765 56899999999999999985 69999


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      |......+.  .......          ...      +   ......+.+++.+||+.+|++||+++++++.|+
T Consensus       222 ~~~~~~~~~--~~~~~~~----------~~~------~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         222 LKERTPSEK--ERFYEKK----------HRL------P---EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ccccChHHH--HHHHHhc----------cCC------C---CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            875433211  1110000          000      0   111235778999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.4e-33  Score=307.54  Aligned_cols=262  Identities=24%  Similarity=0.304  Sum_probs=202.2

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecc
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSID  744 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  744 (973)
                      ..++..+.+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+..|+.+++++ +|||++++++++....
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            34444566789999999999999999999999999999999865433 345678899999988 6999999999875421


Q ss_pred             c-CCCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          745 F-KGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       745 ~-~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                      . ......+++|||+.+|+|.+++....  ...+..++.++.|++.|+.|||+.   +|+||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEe
Confidence            1 23467899999999999999987543  345666788999999999999999   99999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT  896 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~  896 (973)
                      |||.+......        ........|++.|+|||.+.     ...++.++|||||||++|||++|+.||........ 
T Consensus       164 dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-  234 (282)
T cd06636         164 DFGVSAQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-  234 (282)
T ss_pred             eCcchhhhhcc--------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-
Confidence            99998755321        11122346889999999875     35678899999999999999999999965422110 


Q ss_pred             HhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          897 LHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ...         ......+.        .....++..+.+++.+||+.||++||++.|+++
T Consensus       235 ~~~---------~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LFL---------IPRNPPPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhh---------HhhCCCCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            000         00000000        011234457889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-33  Score=321.67  Aligned_cols=268  Identities=19%  Similarity=0.176  Sum_probs=198.6

Q ss_pred             hhcCCcCCccccccceeEEEEEEC--CCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ..+|.+.+.||+|+||.||+|...  .++..||+|.+...     ....+|+++++.++||||+++++++..     ...
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-----KST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-----CCE
Confidence            357999999999999999999764  35678999988533     234679999999999999999988643     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .+++||++. +++.+++.....+.+..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+++...
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            999999986 68888887667778888999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc--cHhhhhhHhcCcc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL--TLHGYAKMALPKK  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~  908 (973)
                      ...      .........||+.|+|||++.+..++.++|||||||++|||++|+.||........  .+...........
T Consensus       237 ~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        237 AHP------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             ccc------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            321      11122345699999999999999999999999999999999999999976543211  1111111000000


Q ss_pred             c--ccc-----------cCcccccccCCCchh--HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          909 V--MGI-----------VDPSLLMEARGPSKF--EECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       909 ~--~~~-----------~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      .  ...           ...........+...  .....++.+++.+|+..||++||++.|++..-.
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~  377 (392)
T PHA03207        311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL  377 (392)
T ss_pred             cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence            0  000           000000000000000  112345678889999999999999999988643

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.1e-34  Score=307.26  Aligned_cols=240  Identities=23%  Similarity=0.367  Sum_probs=186.1

Q ss_pred             CccccccceeEEEEEECCCCc-------EEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGM-------SVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +.||+|+||.||+|.+...+.       .||+|.+........+.+.+|+.+++.++|||++++++++..     +...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence            469999999999998865544       488888865555556778899999999999999999998754     36788


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc--------EEEecc
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV--------AHVSDF  823 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~--------~kl~Df  823 (973)
                      +||||+++|+|.++++..+ ...+..++.++.||+.|++|||+.   +|+||||||+||+++.++.        ++++||
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            9999999999999997654 456677889999999999999999   9999999999999987765        699999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCC-CCCCCCCCCCccHhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRR-RPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~-~Pf~~~~~~~~~~~~~~  901 (973)
                      |.+.....            .....++..|+|||++.+. .++.++|||||||++|||++|. .||........  ....
T Consensus       153 g~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~~~  218 (258)
T cd05078         153 GISITVLP------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQFY  218 (258)
T ss_pred             ccccccCC------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HHHH
Confidence            98864422            1124578889999998874 5799999999999999999985 55543221100  0000


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      .    .        .       ...+......+.+++.+||+.||++|||++|+++.|.
T Consensus       219 ~----~--------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 E----D--------R-------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             H----c--------c-------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0    0        0       0011112245778999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-33  Score=303.45  Aligned_cols=239  Identities=21%  Similarity=0.390  Sum_probs=185.3

Q ss_pred             CccccccceeEEEEEECC------------CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          680 NRIGKGSFGFVYKGNLGE------------DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      +.||+|+||.||+|+...            ....||+|++..........+.+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            468999999999998632            233689998876555556678889999999999999999998754     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc-------EE
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-------AH  819 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~-------~k  819 (973)
                      ....+++|||+++|+|..++... ....+..+++++.||++|++|||++   +|+||||||+||+++.++.       ++
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            36778999999999999988754 4467788899999999999999999   9999999999999987664       89


Q ss_pred             EeccccchhccCCCCccCCCCCcccccccccccccCccccc-CCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCCCccH
Q 039720          820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMF-TRRRPTDNMFNDGLTL  897 (973)
Q Consensus       820 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~ll~ell-tg~~Pf~~~~~~~~~~  897 (973)
                      ++|||.+......            ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+   
T Consensus       153 l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---  217 (262)
T cd05077         153 LSDPGIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---  217 (262)
T ss_pred             eCCCCCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---
Confidence            9999998754221            1235778899999876 467899999999999999998 5888876432211   


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                        .....  ..       ...       ........+.+++.+||+.||++||++.|+++.+
T Consensus       218 --~~~~~--~~-------~~~-------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 --KERFY--EG-------QCM-------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HHHHH--hc-------Ccc-------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              00000  00       000       0011234577899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.2e-33  Score=301.27  Aligned_cols=250  Identities=21%  Similarity=0.287  Sum_probs=201.6

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|+..+.||+|+||.||.++...++..||+|.+....  .....++.+|++++++++|+|++++++++.+     .+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            5888999999999999999999999999999987543  3445678899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++|+|.+++...  ....+.++..++.|++.|+.|||+.   +++||||+|+||+++.++.+||+|||.+....
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            999999999999999765  3456678889999999999999998   99999999999999999999999999997653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...        .......+++.|+|||+..+..++.++||||||+++|+|++|+.||......     ........    
T Consensus       153 ~~~--------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~----  215 (256)
T cd08221         153 SEY--------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQ----  215 (256)
T ss_pred             ccc--------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc----
Confidence            321        1222346889999999998888899999999999999999999998653211     11111000    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                          ...      ..........+.+++.+||+.+|++||+++|+++.+
T Consensus       216 ----~~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         216 ----GNY------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CCC------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                000      011123345677888899999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-33  Score=317.73  Aligned_cols=192  Identities=21%  Similarity=0.308  Sum_probs=162.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ...+|++.+.||+|+||.||+|++..++..||+|+....      ....|+.++++++||||+++++++..     ....
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  132 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAIT  132 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-----CCee
Confidence            345799999999999999999999989999999985322      23568999999999999999998654     3678


Q ss_pred             EEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|+||+. ++|.+++.. .....+..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||.++...
T Consensus       133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99999995 588888765 34567788899999999999999999   99999999999999999999999999987432


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT  887 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf  887 (973)
                      .         ........||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       209 ~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 V---------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             c---------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            2         11222456899999999999999999999999999999999955544

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=312.11  Aligned_cols=259  Identities=25%  Similarity=0.302  Sum_probs=201.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|.+.....   ...+.+..|+++++.++||||+++++.+..     ...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCE
Confidence            368899999999999999999988999999999975432   244678899999999999999999988543     478


Q ss_pred             EEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            99999999999999998754  3456777888999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCccCC---------------------CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 039720          829 LSHHPFLVAP---------------------EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT  887 (973)
Q Consensus       829 ~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf  887 (973)
                      ..........                     ..........||..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            5332110000                     0011112346888999999999989999999999999999999999999


Q ss_pred             CCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC----HHHHHHH
Q 039720          888 DNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ----MTAVVKK  958 (973)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~  958 (973)
                      ........    +...         ......     .......+..+.+++.+||+.||++||+    ++|++..
T Consensus       233 ~~~~~~~~----~~~~---------~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         233 KGSNRDET----FSNI---------LKKEVT-----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCchHHH----HHHH---------hcCCcc-----CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            75432211    1110         000000     0001114567789999999999999999    7777774

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.8e-33  Score=303.57  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+++.+|+++++.++|||++++++++..     ....+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence            36788899999999999999999899999999987553 3345678899999999999999999998654     37899


Q ss_pred             EEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +++||+.+++|.+++... ...++..+.+++.|++.|++|+|+ .   +++||||||+||+++.++.++|+|||.+....
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            999999999999999876 566778888999999999999999 7   99999999999999999999999999987553


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...          .....++..|+|||...+..++.++||||||+++|+|++|+.||.....................  
T Consensus       153 ~~~----------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  220 (265)
T cd06605         153 NSL----------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--  220 (265)
T ss_pred             HHH----------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--
Confidence            211          11156788999999999999999999999999999999999999765322222211111111000  


Q ss_pred             cccCcccccccCCCchhHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEE-CLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         .         +..+.. ....+.++|.+||..||++||++.|++..
T Consensus       221 ---~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         221 ---P---------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---C---------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               0         111111 45667899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.9e-33  Score=302.05  Aligned_cols=249  Identities=26%  Similarity=0.400  Sum_probs=195.8

Q ss_pred             CccccccceeEEEEEECC-CC--cEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGE-DG--MSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|++|.||+|.+.. .+  ..||+|++..... ...+.+.+|+.++++++|||++++++++..      ...++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 33  3699999976655 566789999999999999999999998542      6789999


Q ss_pred             eeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          756 EYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      ||+++++|.+++....  ......++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccc
Confidence            9999999999997754  456678889999999999999999   99999999999999999999999999998764321


Q ss_pred             CccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .     .........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+  ........  .     
T Consensus       152 ~-----~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~--~-----  217 (257)
T cd05040         152 D-----HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKE--G-----  217 (257)
T ss_pred             c-----ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc--C-----
Confidence            0     0011112346778999999998899999999999999999999 999986442221  11110000  0     


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                        ..       ...+...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus       218 --~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 --ER-------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --Cc-------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              00       0111223456788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-33  Score=307.48  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=199.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +.|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++|||++++++++.     .....+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceE
Confidence            34667788999999999999998899999999987443 334567889999999999999999999854     347899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++++|.+++.. ....+..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++......
T Consensus        79 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          79 IIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            99999999999998865 3556778889999999999999998   9999999999999999999999999998765431


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......++..|+|||++.+..++.++|||||||++|||++|+.||........  ...    .       
T Consensus       155 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~----~-------  213 (277)
T cd06642         155 Q--------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL----I-------  213 (277)
T ss_pred             c--------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh----h-------
Confidence            1        111234578899999999998999999999999999999999999865432110  000    0       


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       ....     .+.....++..+.+++.+||+.+|++||++.|+++.
T Consensus       214 -~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         214 -PKNS-----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -hcCC-----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             0000     011112344567889999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-33  Score=302.11  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=200.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +|+..+.||+|+||.||+|.+..++..||+|++....     ....+.+.+|+++++.++|||++++++++..     ..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence            4778899999999999999998899999999987543     2245678899999999999999999998643     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++++||+++++|.+++.......+..+..++.|++.|+.|||+.   +|+|+||+|+||+++.++.+||+|||.+...
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceec
Confidence            8999999999999999998877677888889999999999999999   9999999999999999999999999998765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....         ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||....... ........   . 
T Consensus       153 ~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~---~-  218 (258)
T cd06632         153 VEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS---K-  218 (258)
T ss_pred             cccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc---c-
Confidence            3211         122455888999999987766 8999999999999999999999997543110 01000000   0 


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                   ..+..+......+.+++.+||+.+|++||+++|++..
T Consensus       219 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 -------------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -------------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                         0011112234566788999999999999999998753

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-33  Score=307.29  Aligned_cols=267  Identities=21%  Similarity=0.333  Sum_probs=195.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||+|++|.||+|++..++..||+|+++...  ....+.+.+|+.+++.++|||++++++++..     +...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence            4888999999999999999999899999999987543  2234678899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhc---CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHT---NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      +||||+. +++.+++...   ....+..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++...
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            9999997 6888887643   3456778889999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC-c
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP-K  907 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~  907 (973)
                      ...        ........+++.|+|||++.+. .++.++|||||||++|+|+||+.||..................+ .
T Consensus       152 ~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
T cd07861         152 GIP--------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE  223 (285)
T ss_pred             CCC--------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            321        1111223568899999987654 57889999999999999999999997543211100000000000 0


Q ss_pred             c----cccccC--cccc--cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 K----VMGIVD--PSLL--MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~----~~~~~~--~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .    .....+  ....  ..............++.+++.+||+.||++|||++|++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0    000000  0000  0000000111234566789999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-33  Score=302.83  Aligned_cols=249  Identities=21%  Similarity=0.310  Sum_probs=200.2

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||+|+||.||.+++..+|+.||+|.+....  ....+.+.+|+.++++++|||++++++++.     .....+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence            5888999999999999999999999999999997542  334467899999999999999999999853     457899


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +|+||+.+++|.+++....  ..++.++.+++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            9999999999999987643  346677889999999999999998   99999999999999999999999999997653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..        ........|++.|+|||+..+..++.++|+|||||++|+|++|+.||......     .........   
T Consensus       153 ~~--------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~---  216 (256)
T cd08218         153 ST--------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIRG---  216 (256)
T ss_pred             cc--------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhcC---
Confidence            31        11122345788999999998888999999999999999999999998643111     111110000   


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           ..      +..+......+.+++.+||+.+|++||++.||+++
T Consensus       217 -----~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         217 -----SY------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -----CC------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                 00      11122345567899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-33  Score=308.61  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=195.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++|+|++++.+++..     .+.
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCe
Confidence            3578999999999999999999998899999999996543 2334567889999999999999999998643     478


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++|+||+. +++.+++.. ........+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+++..
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999996 677766654 33456677888999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh-HhcCc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK-MALPK  907 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~  907 (973)
                      ....        .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+..... ...+.
T Consensus       154 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07870         154 SIPS--------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT  225 (291)
T ss_pred             CCCC--------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCC
Confidence            3211        111233468899999998754 5788999999999999999999999754432111111100 00000


Q ss_pred             c------------cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          908 K------------VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       908 ~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .            .........................+.+++.+|++.||.+|||++|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0            0000000000000000000011346678899999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-33  Score=308.99  Aligned_cols=267  Identities=20%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||+|+||.||+|++..+|+.||+|+++....  .....+.+|+++++.++|||++++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            48888999999999999999999999999999975422  23456788999999999999999998753     457899


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +++||+. +++.+++.. ....++..++.++.||++||.|||+.   +|+||||||+||+++.++.++|+|||+++....
T Consensus        76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            9999997 578887764 44567788899999999999999999   999999999999999999999999999975432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc--
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK--  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  908 (973)
                      .        ........+++.|+|||++.+. .++.++||||+||++|+|++|+.|+.........+...........  
T Consensus       152 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07839         152 P--------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  223 (284)
T ss_pred             C--------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence            1        1112233578899999987764 4689999999999999999999986543222111111100000000  


Q ss_pred             ----cccccCcccccccCC----CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ----VMGIVDPSLLMEARG----PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ----~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          .....+.........    ..........+.+++.+||+.||++|||++|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence                000001000000000    01112234566788999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-33  Score=314.33  Aligned_cols=257  Identities=25%  Similarity=0.382  Sum_probs=199.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCC-------CcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGED-------GMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSID  744 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  744 (973)
                      .+|++.+.||+|+||.||+|++...       +..||+|+++... ....+.+.+|+++++++ +||||++++++|..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            5799999999999999999986432       2478999887543 23456789999999999 79999999998654  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPS  808 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~  808 (973)
                         ....++++||+++|+|.+++....                .....++..++.|++.|+.|||+.   +|+||||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence               367899999999999999987532                133456778999999999999999   9999999999


Q ss_pred             cEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCC
Q 039720          809 NVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPT  887 (973)
Q Consensus       809 NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf  887 (973)
                      ||+++.++.+||+|||+++.......      ........++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccc------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999986543210      111112234567999999999999999999999999999998 88998


Q ss_pred             CCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          888 DNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .....+     ..........              ....+..+...+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       238 ~~~~~~-----~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         238 PGIPVE-----ELFKLLKEGH--------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             CCCCHH-----HHHHHHHcCC--------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            654221     1111110000              01111233456789999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.3e-33  Score=301.44  Aligned_cols=251  Identities=23%  Similarity=0.303  Sum_probs=201.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|.+.+.||.|+||.||+|.+..+++.||+|++....  ....+.+..|++++++++|||++++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            4888999999999999999999999999999987432  3345678899999999999999999987643   2346789


Q ss_pred             EEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          753 IVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLH-----NHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                      ++|||+++++|.+++...    ...++..++.++.|++.|++|||     +.   +++||||||+||+++.++.+|++||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecc
Confidence            999999999999998753    45566788999999999999999     66   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      |.+.......        .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....  ..+.+....
T Consensus       155 g~~~~~~~~~--------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~  224 (265)
T cd08217         155 GLAKILGHDS--------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKE  224 (265)
T ss_pred             cccccccCCc--------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhc
Confidence            9998654321        112234688999999999988899999999999999999999999975431  111111100


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          .    .         .+..+...+..+.+++.+|++.+|++||+++||++.
T Consensus       225 ----~----~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 ----G----K---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----C----C---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                0    0         011122345677899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=315.49  Aligned_cols=275  Identities=25%  Similarity=0.314  Sum_probs=204.3

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l  753 (973)
                      |...+.||+|+||.||+|+++.+|+.||||+++... ....+...+|+++|++++|||||+++++-.... .-......+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            445678999999999999999999999999997543 334677889999999999999999998733211 111456789


Q ss_pred             EEeeccCCCHHHHhhh---cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec--CCC--cEEEeccccc
Q 039720          754 VYEYMQYGSVDDWLHH---TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD--HDM--VAHVSDFGLA  826 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~--~~~--~~kl~Dfg~a  826 (973)
                      |||||.+|+|+..+.+   ..++++.+.+.++.+++.||.|||++   +||||||||.||++-  ++|  -.||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999975   45778899999999999999999999   999999999999994  444  4699999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH-hhhhhH-
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL-HGYAKM-  903 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~-~~~~~~-  903 (973)
                      +..++         .......+||..|++||+.. +..|+..+|.|||||++|++.||..||....+..... ..|... 
T Consensus       172 rel~d---------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  172 RELDD---------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             ccCCC---------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            98764         34667889999999999988 5899999999999999999999999998776552111 111111 


Q ss_pred             hcCcccccccCcc----cccccCCC---chhHHHHHHHHHHHhhcCCCCCCCCC--CHHHHHHHHHhc
Q 039720          904 ALPKKVMGIVDPS----LLMEARGP---SKFEECLVAVVRTGVACSMESPSERM--QMTAVVKKLCAV  962 (973)
Q Consensus       904 ~~~~~~~~~~~~~----~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~  962 (973)
                      ..+..+.....++    +......|   .........+-..+..++..+|++|.  .+.+..+.+..|
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            1122221111111    11111111   11122333455566678889999999  666666655554

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-33  Score=302.54  Aligned_cols=245  Identities=29%  Similarity=0.438  Sum_probs=195.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.+.||+|+||.||++..  +++.||+|+++.+.  ..+.+.+|+.+++.++|||++++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            5689999999999999999976  78899999986542  34678899999999999999999998643      34789


Q ss_pred             EEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +|||+.+++|.+++....  ..+...++.++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.+.....
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            999999999999997644  345677889999999999999998   999999999999999999999999999875321


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .           ......+..|+|||.+.+..++.++|||||||++|||++ |+.||......+  ......    .   
T Consensus       153 ~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----~---  212 (254)
T cd05083         153 G-----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVE----K---  212 (254)
T ss_pred             c-----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHh----C---
Confidence            1           111223567999999988899999999999999999998 999987543211  111000    0   


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                           ...     ......++..+.+++.+||+.+|++||+++++++.|+.
T Consensus       213 -----~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 -----GYR-----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----CCC-----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                 000     11112334567789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-33  Score=299.17  Aligned_cols=248  Identities=28%  Similarity=0.402  Sum_probs=194.6

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ++||+|+||.||+|.+.. ++.||+|++...... ..+.+.+|++++++++||||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence            469999999999999976 999999998754433 45678999999999999999999998654     36789999999


Q ss_pred             cCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccC
Q 039720          759 QYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA  837 (973)
Q Consensus       759 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~  837 (973)
                      .+++|.+++... .......+..++.+++.|++|||++   +++||||||+||+++.++.++|+|||.++.......   
T Consensus        75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~---  148 (251)
T cd05041          75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY---  148 (251)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---
Confidence            999999998653 3456677889999999999999999   999999999999999999999999999975532110   


Q ss_pred             CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       838 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                         ........++..|+|||.+.+..++.++|||||||++|||++ |..||.......  .......            .
T Consensus       149 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~------------~  211 (251)
T cd05041         149 ---TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIES------------G  211 (251)
T ss_pred             ---eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhc------------C
Confidence               000011223567999999988899999999999999999999 888986543211  1111000            0


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      .     ....+...+..+.+++.+||+.+|++||+++|+++.|++
T Consensus       212 ~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         212 Y-----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             C-----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            0     001112334568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.9e-33  Score=305.30  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             hcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ++|++.+.||+|+||.||+|+.+.     +.+.||+|.+...... ..+.+.+|++++++++|||++++++++.+     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-----   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence            578899999999999999999753     3567999988654433 45679999999999999999999998644     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcC---------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcE
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTN---------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA  818 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~  818 (973)
                      ....++||||+++|+|.+++....         ......+..++.|++.|+.|||+.   +|+||||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence            367899999999999999998655         466788899999999999999999   99999999999999999999


Q ss_pred             EEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccH
Q 039720          819 HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTL  897 (973)
Q Consensus       819 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~  897 (973)
                      +++|||++.......       ........++..|+|||.+.+..++.++||||||+++|++++ |..||.......  +
T Consensus       157 ~l~~~~~~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~  227 (275)
T cd05046         157 KVSLLSLSKDVYNSE-------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--V  227 (275)
T ss_pred             EEcccccccccCccc-------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--H
Confidence            999999987543211       111122346678999999888888999999999999999999 888986543221  1


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      ......   ..        ..  .   .....++..+.+++.+||+.||++||++.|+++.|.
T Consensus       228 ~~~~~~---~~--------~~--~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         228 LNRLQA---GK--------LE--L---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHc---CC--------cC--C---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111100   00        00  0   001223457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-33  Score=308.28  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch-----hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-----ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +|.+.+.||+|+||.||+|.+..+++.||||+++.....     ....+..|+++++.++|+|++++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            478889999999999999999889999999999754322     34567789999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+ +|+|.+++.... .+.+..++.++.||++||.|||+.   +|+||||||+||+++.++.++|+|||+++.
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            899999999 899999998765 667788899999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~  906 (973)
                      .....        .......+++.|+|||.+.+ ..++.++|||||||++|||++|..||......+ .+....... .+
T Consensus       152 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~  222 (298)
T cd07841         152 FGSPN--------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTP  222 (298)
T ss_pred             ccCCC--------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCC
Confidence            54321        11122346788999998754 467899999999999999999988776533211 111110000 00


Q ss_pred             --ccc---ccccCcccc---cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 --KKV---MGIVDPSLL---MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 --~~~---~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ...   ....+....   ...............+.+++.+||+.||++||+++|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              000   000000000   0000001112345678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-33  Score=320.93  Aligned_cols=266  Identities=18%  Similarity=0.202  Sum_probs=194.9

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ....|.+.+.||+|+||.||+|.+..+++.||||...      ...+.+|++++++++||||+++++++..     ....
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~  235 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLT  235 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEE
Confidence            3457999999999999999999999999999999643      2335689999999999999999998654     3678


Q ss_pred             EEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||++. ++|.+++... ..+...+++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       236 ~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        236 CLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            99999995 6888887654 3467788899999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC-C-----ccHhhhhhHh
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND-G-----LTLHGYAKMA  904 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~-~-----~~~~~~~~~~  904 (973)
                      ...      .........||+.|+|||++.+..++.++|||||||++|||++|..|+...... .     ..+.......
T Consensus       312 ~~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        312 GSW------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             ccc------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            221      111222356999999999999999999999999999999999988765332211 0     1111111110


Q ss_pred             c-C-cccccccCccc------------ccccCCC--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 L-P-KKVMGIVDPSL------------LMEARGP--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~-~-~~~~~~~~~~~------------~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      . . .........++            .......  .........+.+++.+||+.||.+|||+.|+++.
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0 0 00000000000            0000000  0001122357789999999999999999999875

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3e-33  Score=300.55  Aligned_cols=250  Identities=30%  Similarity=0.530  Sum_probs=199.5

Q ss_pred             CCcCCccccccceeEEEEEECCCC----cEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +++.+.||+|+||.||+|++..++    ..||+|+++..... ..+.+..|+.+++.++|+|++++++++..     ...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence            356788999999999999998766    89999999755433 56789999999999999999999998654     378


Q ss_pred             EEEEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .+++|||+++++|.+++.....  ..+..++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+..
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence            9999999999999999976554  67888999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .......       ......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||......  .+......   .
T Consensus       153 ~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~---~  220 (258)
T smart00219      153 LYDDDYY-------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKK---G  220 (258)
T ss_pred             ccccccc-------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhc---C
Confidence            6543210       1101236788999999988889999999999999999998 88888753221  11111100   0


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      .              ........+..+.+++.+|+..||++|||+.|+++.|
T Consensus       221 ~--------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 Y--------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C--------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0              0111122456788899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-33  Score=307.20  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=198.4

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .|.....||+|+||.||++.+..++..||||.+........+.+.+|+.+++.++|||++++++.+..     .+..++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEE
Confidence            44455779999999999999988999999999976555566778999999999999999999987543     4789999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      |||+++++|.+++... ...+.+++.++.||+.|++|||+.   +|+||||||+||+++.++.++|+|||++......  
T Consensus        98 ~e~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--  171 (292)
T cd06658          98 MEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--  171 (292)
T ss_pred             EeCCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--
Confidence            9999999999988653 466788899999999999999999   9999999999999999999999999998754321  


Q ss_pred             ccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                            ........|+..|+|||...+..++.++||||||+++|||++|+.||......  ........        ...
T Consensus       172 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~--------~~~  235 (292)
T cd06658         172 ------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRD--------NLP  235 (292)
T ss_pred             ------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh--------cCC
Confidence                  11122346889999999998888999999999999999999999998743211  00000000        011


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +...       ........+.+++.+||..||++||+++|+++.
T Consensus       236 ~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 PRVK-------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             Cccc-------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1110       011223456678889999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-33  Score=300.48  Aligned_cols=238  Identities=26%  Similarity=0.459  Sum_probs=188.1

Q ss_pred             CccccccceeEEEEEECCCC----------cEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          680 NRIGKGSFGFVYKGNLGEDG----------MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +.||+|+||.||+|.+..++          ..|++|++...... ...+.+|+.+++.++|||++++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46999999999999997666          45888887654433 6788999999999999999999998753      4


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-------cEEEe
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-------VAHVS  821 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-------~~kl~  821 (973)
                      ..++||||+++|+|.+++.... ..+...+..++.|++.||+|||+.   +|+||||||+||+++.++       .+|++
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            5689999999999999998765 567778899999999999999998   999999999999999888       79999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCC--CCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHh
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG--DLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLH  898 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~  898 (973)
                      |||++.....            .....++..|+|||++.+.  .++.++|||||||++||+++ |..||....... ...
T Consensus       151 Dfg~a~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~  217 (259)
T cd05037         151 DPGIPITVLS------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KER  217 (259)
T ss_pred             CCCccccccc------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHH
Confidence            9999985432            1123466789999998876  78999999999999999999 577776543211 000


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      .+ .   .        ..   ....+.     ...+.+++.+||..+|++||++.|+++.|.
T Consensus       218 ~~-~---~--------~~---~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 FY-Q---D--------QH---RLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HH-h---c--------CC---CCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00 0   0        00   000000     156779999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2e-33  Score=309.77  Aligned_cols=262  Identities=20%  Similarity=0.224  Sum_probs=199.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+++++.++||||+++++++.     ....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence            36889999999999999999999999999999987543   233457889999999999999999998754     3478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++++|.+++...+..++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||.++...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            899999999999999998877778888889999999999999998   99999999999999999999999999987421


Q ss_pred             CCCCc-------cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          831 HHPFL-------VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       831 ~~~~~-------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      .....       .............++..|+|||.+.+..++.++|+|||||++||+++|+.||......     .....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~  227 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQ  227 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence            11000       0000001111235788999999998889999999999999999999999999743221     11111


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      ......   ..         +......+..+.+++.+||+.||++||++.++.+.++
T Consensus       228 ~~~~~~---~~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         228 VISDDI---EW---------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHhccc---CC---------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            000000   00         1111123456778999999999999999655554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-33  Score=303.31  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=198.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc----------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK----------GATKSFVAECEALRNIRHRNLIKIITICSSID  744 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  744 (973)
                      +|.+.+.||+|+||.||+|....+|+.||+|.++....          ...+.+.+|+.+++.++|||++++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            57888999999999999999988999999999864211          112457889999999999999999998643  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                         .+..++||||+++++|.+++...+...+..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||
T Consensus        80 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          80 ---EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ---CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence               478899999999999999998877777788889999999999999998   99999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD--LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      .+.......      .........|+..|+|||......  ++.++|+||||+++|++++|..||......    .....
T Consensus       154 ~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~  223 (272)
T cd06629         154 ISKKSDDIY------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFK  223 (272)
T ss_pred             ccccccccc------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHH
Confidence            987543211      011122345788999999977654  789999999999999999999998643211    11111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ... ..    ....+.     ......++..+.+++.+||..||++||+++|+++.
T Consensus       224 ~~~-~~----~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         224 LGN-KR----SAPPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hhc-cc----cCCcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000 00    000000     01112345677788999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.7e-33  Score=299.53  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=201.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch--hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|.+.+.||+|+||.||+|.+..+++.||+|+++.....  ..+.+..|+.+++.++|+||+++++++..     .+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence            588899999999999999999889999999999765442  56789999999999999999999998543     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|+||+++++|.+++.......+..++.++.|++.|+.|||+.   +|+||||+|+||+++.++.+||+|||.+......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999999999998876677788899999999999999999   9999999999999999999999999999876432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..    ..........+++.|+|||++.+..   ++.++||||||+++|++++|+.||..........  + ....    
T Consensus       153 ~~----~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~-~~~~----  221 (264)
T cd06626         153 TT----TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--F-HVGA----  221 (264)
T ss_pred             CC----cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--H-HHhc----
Confidence            21    0011012345788999999988766   8999999999999999999999997542211110  0 0000    


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                        ...+.+      + ........+.+++.+||+.+|++||+++|++.
T Consensus       222 --~~~~~~------~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 --GHKPPI------P-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCCCC------C-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              000011      0 01122455678899999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-33  Score=308.21  Aligned_cols=268  Identities=24%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+++++.++|||++++++++.     .....
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence            468899999999999999999988899999999864322  23466889999999999999999999854     45789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++|+||++++++.++...........++.++.|++.|+.|||+.   +++|||++|+||+++.++.++++|||++.....
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            99999999999998877666677888999999999999999999   999999999999999999999999999876533


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH--hcCcc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM--ALPKK  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~  908 (973)
                      ..        .......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+ ........  .....
T Consensus       153 ~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~  223 (286)
T cd07846         153 PG--------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPR  223 (286)
T ss_pred             Cc--------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchh
Confidence            21        11223457889999998775 456889999999999999999999986432211 10010000  00000


Q ss_pred             ccccc----------CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIV----------DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....          .+...............+..+.+++.+||+.+|++||+++|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000          000000000000112345678899999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.7e-33  Score=300.22  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=197.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.++||+|+||.||+|.+. .+..||+|.++... ...+.+.+|+++++.++|+|++++++++..      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence            468999999999999999999874 66789999886432 245678899999999999999999988543      5678


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|||+++++|.+++....  ......+..++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            9999999999999997643  345567888999999999999998   99999999999999999999999999987553


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........++..|+|||++....++.++|+|||||++|++++ |+.||......  .........     
T Consensus       154 ~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~-----  219 (260)
T cd05073         154 DNE-------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERG-----  219 (260)
T ss_pred             CCC-------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCC-----
Confidence            211       111112235677999999998889999999999999999999 99999754221  111111100     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                         ..         .......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       220 ---~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 ---YR---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CC---------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               00         01112234567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4e-33  Score=302.41  Aligned_cols=259  Identities=23%  Similarity=0.381  Sum_probs=197.3

Q ss_pred             CCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC-CCc
Q 039720          676 FSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK-GAD  749 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~  749 (973)
                      |.+.+.||+|+||+||+|.+.   .++..||||++..+.  ....+++.+|+++++.++|||++++++++...... ...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            667889999999999999864   357899999997542  33456788999999999999999999987543111 112


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                      ..++++||+.+|+|.+++....      ..+...+++++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            3578999999999998875321      345567899999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~  902 (973)
                      |.++.......      ........+++.|++||......++.++|||||||++|||++ |+.||......  ....+..
T Consensus       158 g~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~  229 (273)
T cd05074         158 GLSKKIYSGDY------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI  229 (273)
T ss_pred             cccccccCCcc------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH
Confidence            99986533210      111112345678999999998899999999999999999999 88998654221  1111100


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                        ....               ......+...+.+++.+||+.+|++||+++|+++.|+++
T Consensus       230 --~~~~---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 --KGNR---------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --cCCc---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0000               001122345788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-33  Score=299.55  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=198.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|+..+.||+|+||.||+|.+..+++.+|+|++....  ......+.+|+++++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            5888999999999999999999999999999997542  234567889999999999999999998753     347899


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~~~  829 (973)
                      +||||+++++|.+++....  ..++..+++++.|++.|+.|||++   +++||||||+||+++.++ .+|++|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            9999999999999997643  356678899999999999999999   999999999999998654 6899999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...         .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......  ........   . 
T Consensus       153 ~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~---~-  217 (256)
T cd08220         153 SSK---------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIMSG---T-  217 (256)
T ss_pred             CCC---------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHHhc---C-
Confidence            432         11223457889999999998889999999999999999999999986542211  11110000   0 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                   ....+......+.+++.+||+.||++||++.|+++.
T Consensus       218 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 -------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                         001112234567789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-32  Score=300.30  Aligned_cols=261  Identities=25%  Similarity=0.299  Sum_probs=201.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|+..+.||.|++|.||+|.+..+++.||+|++..... .....+.+|+++++.++||||+++++++...   .....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence            368888999999999999999988999999999975432 3456789999999999999999999987542   345789


Q ss_pred             EEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +||||+++++|.+++..    .....+..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            99999999999988653    23456677889999999999999999   999999999999999999999999999875


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....          ......++..|+|||.+.+..++.++||||+||++|+|++|+.||.....................
T Consensus       155 ~~~~----------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         155 LVNS----------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             cccc----------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            4321          111334778899999999899999999999999999999999999765321111111111110000


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           .+.+...   ..........+.+++.+||+.+|++|||+.|+++.
T Consensus       225 -----~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         225 -----NPELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             -----chhhccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                 0000000   01011234567899999999999999999999884

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=341.16  Aligned_cols=257  Identities=26%  Similarity=0.341  Sum_probs=205.9

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .+-+|....+||.|.||.||-|.+..+|...|+|-++...  ....+...+|..++..+.|||+|++||+-.+     .+
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Re 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----RE 1307 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----HH
Confidence            4457888899999999999999999999999999887543  2334668899999999999999999998443     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..+|-||||++|+|.+.++..+-..+.....+..|++.|+.|||++   |||||||||.||+++.+|.+|++|||.|..+
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            7889999999999999998876666665677889999999999999   9999999999999999999999999999988


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG---DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ..+.    ...........||+.|||||++.+.   +-..++||||+|||+.||+||+.||.....+-..+...+.+.. 
T Consensus      1385 ~~~~----~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1385 KNNA----QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK- 1459 (1509)
T ss_pred             cCch----hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC-
Confidence            6542    1112344467899999999998874   4577899999999999999999999876655333322222221 


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                       |+.+.....+=.+++..|+..||++|.++.|+++.
T Consensus      1460 -----------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -----------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                             22223233344466679999999999999887764

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.5e-33  Score=305.86  Aligned_cols=269  Identities=22%  Similarity=0.285  Sum_probs=191.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCC---CcEEEEEEeecccchhH-----------HHHHHHHHHHHhcCCCCceeEEe
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDKKGAT-----------KSFVAECEALRNIRHRNLIKIIT  738 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~  738 (973)
                      .++|.+.+.||+|+||+||+|++..+   +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999999777   66788887644332111           11223344556678999999998


Q ss_pred             EeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcE
Q 039720          739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA  818 (973)
Q Consensus       739 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~  818 (973)
                      ++... .......+++++++. .++.+.+......++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+
T Consensus        91 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFK-RCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEe-cCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence            75442 122234567788764 36666666554456677889999999999999999   99999999999999999999


Q ss_pred             EEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh
Q 039720          819 HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH  898 (973)
Q Consensus       819 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~  898 (973)
                      +|+|||+|+.+....... ...........||+.|+|||+..+..++.++||||+||++|||++|+.||...........
T Consensus       166 ~l~DFGla~~~~~~~~~~-~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHI-EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCccc-ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999998664321100 0011112234699999999999999999999999999999999999999986633322221


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ......    ...+.....        ....+++.+.+++..||..+|++||+++++++.+
T Consensus       245 ~~~~~~----~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDF----IKRLHEGKI--------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHH----HHHhhhhhh--------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            111100    000011110        1122356678899999999999999999999876

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.4e-33  Score=298.21  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=206.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|.+.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|+.++..++|+|++++++++..     ....+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEE
Confidence            368889999999999999999998999999999976543 456789999999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++++|.+++.......+..++.++.|+++|++|||+ .   +++||||+|+||+++.++.++++|||.+.....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999999887777888899999999999999999 8   999999999999999999999999999886543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      ..        .......++..|+|||.+....++.++|+||||+++|+|++|+.||.......  .........     .
T Consensus       153 ~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~-----~  217 (264)
T cd06623         153 TL--------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAIC-----D  217 (264)
T ss_pred             CC--------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHh-----c
Confidence            21        11123457889999999998899999999999999999999999997654211  111111000     0


Q ss_pred             ccCcccccccCCCchhHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEE-CLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...         +..... ++..+.+++.+|++.+|++||++.|+++.
T Consensus       218 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 GPP---------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCC---------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000         111122 45678899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-33  Score=302.20  Aligned_cols=248  Identities=23%  Similarity=0.288  Sum_probs=201.4

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      +|.+.+.||+|+||.||+|++..++..||+|++....   ....+.+.+|++++++++|||++++++++     .+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            4788999999999999999998899999999997543   23457889999999999999999998874     445789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++|+||+.+++|.+++.......+..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999999999998777778888999999999999999999   999999999999999999999999999876533


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      ..         ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......  ..........     
T Consensus       153 ~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~-----  216 (258)
T cd05578         153 DT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQET-----  216 (258)
T ss_pred             Cc---------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhcc-----
Confidence            21         1223457889999999988889999999999999999999999998654321  1111111000     


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH--HHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM--TAVV  956 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  956 (973)
                                .....+...+..+.+++.+||+.||++||++  +|++
T Consensus       217 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                      0011122334677789999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.4e-33  Score=303.80  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=191.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHH-HHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEA-LRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||.||+|++..+|+.||+|+++.... .....+..|+.. ++..+|||++++++++..     ....
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence            468899999999999999999999999999999975432 233455556664 667789999999998754     3678


Q ss_pred             EEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          752 AIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +++|||++ |+|.+++..    ....++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||.+.
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999997 688777654    234567788999999999999999853  89999999999999999999999999987


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      .....         .......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.........+......
T Consensus       153 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (283)
T cd06617         153 YLVDS---------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE  223 (283)
T ss_pred             ccccc---------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence            65321         11123457889999998764    456889999999999999999999996533221111111100


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                               ..+...        ...++..+.+++.+||..||++||+++|+++.
T Consensus       224 ---------~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         224 ---------PSPQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ---------CCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     000110        11234567889999999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.6e-33  Score=301.98  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=184.2

Q ss_pred             CccccccceeEEEEEECC--CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLGE--DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.||+|+||+||+|+...  ....+|+|.+.... ......+.+|+.+++.++||||+++++++..     ....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence            369999999999997532  34578888775433 2334568899999999999999999998653     477899999


Q ss_pred             eccCCCHHHHhhhcCC-----CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          757 YMQYGSVDDWLHHTND-----KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      |+++|+|.+++.....     ..+..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccccc
Confidence            9999999999876432     23456788999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCccccc-------CCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhH
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGM-------GGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ...      ........+++.|+|||+..       ...++.++|||||||++|||++ |..||......+ .+.   ..
T Consensus       153 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~---~~  222 (269)
T cd05042         153 EDY------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLK---QV  222 (269)
T ss_pred             chh------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHH---HH
Confidence            110      01112234567899999864       3456889999999999999999 888887543221 010   00


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      . ........+         +.........+.+++..|| .||++||+++||++.|.
T Consensus       223 ~-~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         223 V-REQDIKLPK---------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             h-hccCccCCC---------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0 000000111         1112233455667788898 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-33  Score=308.65  Aligned_cols=198  Identities=21%  Similarity=0.345  Sum_probs=158.6

Q ss_pred             CCccccccceeEEEEEECC--CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          679 SNRIGKGSFGFVYKGNLGE--DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      .++||+|+||+||+|++..  ++..||+|.+....  ....+.+|+++++.++|||++++++++..   ......++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence            3579999999999999753  56899999986432  33467889999999999999999998753   23467899999


Q ss_pred             eccCCCHHHHhhhc---------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----cCCCcEEEecc
Q 039720          757 YMQYGSVDDWLHHT---------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF  823 (973)
Q Consensus       757 ~~~~gsL~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl----~~~~~~kl~Df  823 (973)
                      |+.+ ++.+++...         ...++..+..++.|++.||.|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9874 777776421         1245567889999999999999999   99999999999999    56679999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~  890 (973)
                      |+++......     ..........||+.|+|||++.+ ..++.++||||+||++|||+||++||...
T Consensus       157 G~a~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPL-----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCc-----ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9998664321     01112234568999999999876 45799999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.7e-33  Score=305.42  Aligned_cols=245  Identities=24%  Similarity=0.281  Sum_probs=200.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|++++++++||||+++++++..     ...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence            46889999999999999999999999999999997432   2345678899999999999999999998643     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.+||+|||++....
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            999999999999999998888888888999999999999999998   99999999999999999999999999987653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..           .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......    .......      
T Consensus       153 ~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~------  211 (290)
T cd05580         153 GR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKIL------  211 (290)
T ss_pred             CC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh------
Confidence            21           22345889999999998888899999999999999999999998754311    0011110      


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVK  957 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  957 (973)
                         ...       ...+......+.+++.+||..||++||     +++|+++
T Consensus       212 ---~~~-------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         212 ---EGK-------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---cCC-------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               000       001112245667888999999999999     7777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.2e-33  Score=300.55  Aligned_cols=243  Identities=22%  Similarity=0.263  Sum_probs=187.4

Q ss_pred             ccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHH---hcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALR---NIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .||+|+||.||+|.+..+++.||+|++.....   .....+.+|..+++   ..+||+++.+++++..     .+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            48999999999999998999999999864321   12233444544443   3479999999887543     4688999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      |||+++|+|.+++...+...+..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||++......  
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--  150 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--  150 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--
Confidence            99999999999998877788888999999999999999999   9999999999999999999999999998754321  


Q ss_pred             ccCCCCCcccccccccccccCccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                              ......|++.|+|||... +..++.++||||+||++|+|++|+.||.........  .......      ..
T Consensus       151 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~------~~  214 (279)
T cd05633         151 --------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTL------TV  214 (279)
T ss_pred             --------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhh------cC
Confidence                    112345899999999876 456899999999999999999999999754332111  1111100      00


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                      +         ...+......+.+++.+|++.||++||     +++|++++
T Consensus       215 ~---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 N---------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             C---------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0         111123345677888999999999999     69999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-33  Score=299.67  Aligned_cols=250  Identities=25%  Similarity=0.436  Sum_probs=196.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|+++... .....+.+|++++++++||+++++++++..     ....++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCceEE
Confidence            46888999999999999999985 57789999886432 234678899999999999999999998543     467899


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|||+.+++|.+++... +...+..++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++.....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            99999999999998764 3456777889999999999999999   9999999999999999999999999998765332


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .       ........++..|+|||...+..++.++||||||+++|||++ |+.||.......  +..   .. ...   
T Consensus       154 ~-------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~---~~-~~~---  217 (256)
T cd05112         154 Q-------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE---TI-NAG---  217 (256)
T ss_pred             c-------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH---HH-hCC---
Confidence            1       111112234568999999998899999999999999999998 999987533211  111   00 000   


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                       ..         ...+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus       218 -~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         218 -FR---------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -CC---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             00         000111235678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.6e-33  Score=299.07  Aligned_cols=259  Identities=24%  Similarity=0.314  Sum_probs=203.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|++.+.||.|+||+||+|.+..++..||+|++.... ....+.+.+|+++++.++|+|++++++.+..     .+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence            47899999999999999999998899999999997543 2345778999999999999999999987644     47899


Q ss_pred             EEEeeccCCCHHHHhhhc---CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHT---NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      +++||+++++|.+++...   ....+..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||++...
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999764   3456777889999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ......    .........|+..|+|||++... .++.++|+|||||++|+|++|+.||........ .......     
T Consensus       153 ~~~~~~----~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~-----  222 (267)
T cd06610         153 ADGGDR----TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN-----  222 (267)
T ss_pred             ccCccc----cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC-----
Confidence            543210    00122344688899999998776 789999999999999999999999975433211 1111100     


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          ..+...    ........+..+.+++.+||+.||++||+++|+++.
T Consensus       223 ----~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         223 ----DPPSLE----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ----CCCCcC----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                000000    000112345667899999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.5e-33  Score=306.32  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=198.2

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .|....+||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++..     .+..+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEE
Confidence            34445679999999999999988999999999976555556778899999999999999999998543     4789999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      +||+++++|.+++.. ..+.+..++.++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++......  
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--  170 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--  170 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc--
Confidence            999999999997755 3567788899999999999999999   9999999999999999999999999998754321  


Q ss_pred             ccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                            ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+   ..... ..     .
T Consensus       171 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~---~~~~~-~~-----~  234 (297)
T cd06659         171 ------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAM---KRLRD-SP-----P  234 (297)
T ss_pred             ------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH---HHHhc-cC-----C
Confidence                  11122356889999999999889999999999999999999999998743211 111   01000 00     0


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..       ..........+.+++.+||+.+|++||+++|+++.
T Consensus       235 ~~-------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 PK-------LKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CC-------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00       00011223456788899999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-32  Score=297.45  Aligned_cols=250  Identities=20%  Similarity=0.277  Sum_probs=194.9

Q ss_pred             HHHHHHhhcCCcCCcc--ccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          667 AELSKATKEFSSSNRI--GKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      .+.....++|++.+.+  |+|+||.||+++.+.++..+|+|++........     |+.....+ +|||++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec-
Confidence            3444455678888877  999999999999999999999999864322111     22222222 69999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEec
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSD  822 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~D  822 (973)
                          .+..++||||+++++|.+++.......+..+..++.|+++|+.|||+.   +++||||||+||+++.++ .++++|
T Consensus        81 ----~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 ----LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             ----CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence                368999999999999999998877778899999999999999999999   999999999999999998 999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      ||.++.....            ....++..|+|||++.+..++.++||||+|+++|+|++|+.||.....+......+..
T Consensus       154 fg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T PHA03390        154 YGLCKIIGTP------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK  221 (267)
T ss_pred             CccceecCCC------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH
Confidence            9998754321            1235788999999999999999999999999999999999999855443322222221


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-MTAVVK  957 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  957 (973)
                      .. ..               ...........+.+++.+||+.||++||+ ++|+++
T Consensus       222 ~~-~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 RQ-QK---------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hh-cc---------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11 00               01111234556778889999999999996 588874

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.8e-33  Score=303.98  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=199.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||+|+||.||+|++..+|+.||+|++....  ....+.+.+|+.++++++|||++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence            5888999999999999999998899999999997554  3345678999999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +|+||+ +++|.+++... ....+.+++.++.|+++|++|||+.   +++|+||||+||+++.++.++++|||.+.....
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            999999 99999998653 4467788999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cCcc-
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LPKK-  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~-  908 (973)
                      ..       ........++..|+|||++.+. .++.++||||+|+++|||++|.+||....... .+....... .+.. 
T Consensus       152 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~  223 (286)
T cd07832         152 EE-------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEE  223 (286)
T ss_pred             CC-------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChH
Confidence            21       1122234688899999987654 46899999999999999999988876433211 111100000 0000 


Q ss_pred             ----cccccCcc---cccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ----VMGIVDPS---LLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ----~~~~~~~~---~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          ..+..+..   .......  .....+....+.+++.+|++.||++||++++++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                00000000   0000000  01112334678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.9e-33  Score=301.03  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .|...+.||+|++|.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++..     .+..+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            45556899999999999999988999999999876555556678999999999999999999998543     4788999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      +||+++++|.+++.. .......+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+......  
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--  168 (285)
T cd06648          95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--  168 (285)
T ss_pred             EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC--
Confidence            999999999999887 4567778899999999999999999   9999999999999999999999999988754321  


Q ss_pred             ccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                            ........|++.|+|||...+..++.++|||||||++|+|++|+.||.....    ..........      ..
T Consensus       169 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~~~~~------~~  232 (285)
T cd06648         169 ------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKRIRDN------LP  232 (285)
T ss_pred             ------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHhc------CC
Confidence                  1111234588999999999888899999999999999999999999864321    1111111000      00


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      +..       ......+..+.+++.+||+.+|++||++.|+++
T Consensus       233 ~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         233 PKL-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCC-------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            000       011123456789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.2e-33  Score=302.45  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=192.6

Q ss_pred             CccccccceeEEEEEECCCC------cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDG------MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +.||+|+||.||+|++....      ..||+|.+.... ......+.+|+++++.++||||+++++++..     .+..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36999999999999986433      689999886432 2345678899999999999999999998643     36789


Q ss_pred             EEEeeccCCCHHHHhhhc-------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-----cEEE
Q 039720          753 IVYEYMQYGSVDDWLHHT-------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-----VAHV  820 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-----~~kl  820 (973)
                      +||||+++++|.+++...       ......++..++.|++.|+.|||+.   +++|+||||+||+++.++     .+++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            999999999999998753       2234577889999999999999998   999999999999999877     8999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhh
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHG  899 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~  899 (973)
                      +|||++........      ........++..|+|||++.+..++.++|||||||++|||++ |+.||......  ....
T Consensus       153 ~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~  224 (269)
T cd05044         153 GDFGLARDIYKSDY------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQ  224 (269)
T ss_pred             CCcccccccccccc------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHH
Confidence            99999976533211      111112245678999999999999999999999999999998 99998744221  1111


Q ss_pred             hhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          900 YAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ...            ...     ....+...+..+.+++.+||..+|++||++++|++.|++
T Consensus       225 ~~~------------~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         225 HVT------------AGG-----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHh------------cCC-----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            100            000     011122345677899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=282.60  Aligned_cols=285  Identities=18%  Similarity=0.269  Sum_probs=216.5

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecc
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSID  744 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  744 (973)
                      +.++.+.+.     +.||+|+|+.|--|....+|..||||++.+.......+..+|++++.+.+ |+||+.++++     
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----  144 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----  144 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence            455555553     56999999999999999999999999998776677889999999999885 9999999998     


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---cEEEe
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---VAHVS  821 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---~~kl~  821 (973)
                      |+++...|+|||.|.||+|..++++...+.+.++.++.++|+.||+|||++   ||.|||+||+|||.....   -+|||
T Consensus       145 FEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  145 FEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             hcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence            666799999999999999999999999999999999999999999999999   999999999999997655   58999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG--  894 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~--  894 (973)
                      ||.+..-+....... ..........+|+..|||||+..     ...|+.++|.||+||++|-|+.|++||.++=+++  
T Consensus       222 DfDLgSg~k~~~~~s-pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCS-PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             ccccccccccCCCCC-CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            999886543322111 22233444567899999999743     2368999999999999999999999998664432  


Q ss_pred             ----ccHhhhhhHhcCcccccccCcccccccCCC-chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhc--ccc
Q 039720          895 ----LTLHGYAKMALPKKVMGIVDPSLLMEARGP-SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAV--GEI  965 (973)
Q Consensus       895 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~--~~~  965 (973)
                          .....+......     -+   -.+.+.-| ..+.....+-.+++...+..|+..|.++.+++.+  .+.+  .+.
T Consensus       301 WdrGe~Cr~CQ~~LFe-----sI---QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka  372 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFE-----SI---QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA  372 (463)
T ss_pred             ccCCCccHHHHHHHHH-----HH---hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence                111111111100     00   00111111 1223444555677778888999999999999873  2222  377


Q ss_pred             ccCCCCC
Q 039720          966 FIGPPII  972 (973)
Q Consensus       966 ~~~~~~~  972 (973)
                      +.+|+|+
T Consensus       373 lptp~v~  379 (463)
T KOG0607|consen  373 LPTPQVL  379 (463)
T ss_pred             CCCCccc
Confidence            7788775

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=305.79  Aligned_cols=268  Identities=22%  Similarity=0.342  Sum_probs=202.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|+++++.++|+||+++++++..     .+..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence            36889999999999999999999899999999986432  3345778999999999999999999998754     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +++|||++++.+..+........+..++.++.||+.|+.|||+.   +++|||++|+||+++.++.+||+|||.+.....
T Consensus        76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            99999999888877776666677888999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH--hcCcc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM--ALPKK  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~  908 (973)
                      ..       ........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. +......  ..+..
T Consensus       153 ~~-------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~  224 (288)
T cd07833         153 RP-------ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPS  224 (288)
T ss_pred             Cc-------cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence            21       1122335678899999998888 889999999999999999999999975432111 0000000  00000


Q ss_pred             cccc--cCccccc----ccCCCc-----hhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          909 VMGI--VDPSLLM----EARGPS-----KFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       909 ~~~~--~~~~~~~----~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ....  .++....    +...+.     ....++..+.+++.+||..+|++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000  0000000    000000     01123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=312.67  Aligned_cols=280  Identities=21%  Similarity=0.276  Sum_probs=205.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|++... .......+.+|+.+++.++|||++++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999999999999999998643 23345668889999999999999999998776555555678


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++++||+. +++.+.+.. ..+.+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            99999997 488877754 3567788899999999999999999   999999999999999999999999999876533


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh---cCc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA---LPK  907 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~  907 (973)
                      ..     ..........||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||....... .........   .++
T Consensus       159 ~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~  232 (336)
T cd07849         159 EH-----DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQE  232 (336)
T ss_pred             cc-----cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHH
Confidence            21     11112233568899999998654 568999999999999999999999996532110 000000000   000


Q ss_pred             ccccccCccc-------ccccCCC--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcc
Q 039720          908 KVMGIVDPSL-------LMEARGP--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~-------~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  963 (973)
                      ....+.+...       ......+  .........+.+++.+||+.||++||+++|++++  ++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            1111111000       0000000  0011234567899999999999999999999987  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=279.32  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=195.9

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc-cchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..++...+..||.|+.|.||+++.+.+|...|||.++.. .....+++...++++..-+ +|.||+.+||+..     +.
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-----n~  164 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-----NT  164 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-----Cc
Confidence            345556677899999999999999999999999999754 4455678888888877665 8999999999654     46


Q ss_pred             eEEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .++++||.|. .-++.++.. .+..++.-+-++...+.+||.||.+++  +|+|||+||+|||+|+.|++|+||||++-.
T Consensus       165 dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  165 DVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             hHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccce
Confidence            7888999874 234444433 334566666788889999999999875  999999999999999999999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +..         ....+...|.+.|||||.+.-   ..|+-++||||||++++|+.||+.||+....+.+.+..... ..
T Consensus       242 lvd---------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~e  311 (391)
T KOG0983|consen  242 LVD---------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EE  311 (391)
T ss_pred             eec---------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cC
Confidence            644         234445679999999998764   47888999999999999999999999976555433322211 11


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              .+.+...       ..+...+.+++..|+..|+.+||...+++++
T Consensus       312 --------PP~L~~~-------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  312 --------PPLLPGH-------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             --------CCCCCcc-------cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                    1122111       1245667788889999999999999998764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=328.63  Aligned_cols=276  Identities=22%  Similarity=0.253  Sum_probs=213.7

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeee
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSS  742 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  742 (973)
                      ..++....++|.+.+.||+|+||.|..++++.+++.||+|++...   +.....-|..|.++|..-..+=|+.+.-    
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy----  142 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY----  142 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH----
Confidence            344555667899999999999999999999999999999999753   3455677999999998888887887653    


Q ss_pred             cccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          743 IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       743 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                       .|+++.++|+|||||+||+|-.++.+.+..++..++.++.+|.-||+-+|+.   |+|||||||+|||+|..|++||+|
T Consensus       143 -AFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  143 -AFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             -HhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence             4888999999999999999999999988889999999999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      ||.|-.+...+       .......+|||.|++||++..     +.|++.+|+||+||++|||+.|..||...    ..+
T Consensus       219 FGsClkm~~dG-------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slv  287 (1317)
T KOG0612|consen  219 FGSCLKMDADG-------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLV  287 (1317)
T ss_pred             chhHHhcCCCC-------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHH
Confidence            99998776432       444555689999999998653     57899999999999999999999999642    223


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHHHHHhcccc-----ccCC
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ---MTAVVKKLCAVGEI-----FIGP  969 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~~~~~-----~~~~  969 (973)
                      ..|.++.-.+......            ...+.++...++|.+.+ -+|+.|..   .+|+..+-...+..     -.-|
T Consensus       288 eTY~KIm~hk~~l~FP------------~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~p  354 (1317)
T KOG0612|consen  288 ETYGKIMNHKESLSFP------------DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVP  354 (1317)
T ss_pred             HHHHHHhchhhhcCCC------------cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCC
Confidence            3333332221111111            00112333445555544 67888988   88887765433321     2346


Q ss_pred             CCCC
Q 039720          970 PIIG  973 (973)
Q Consensus       970 ~~~~  973 (973)
                      |++|
T Consensus       355 P~vP  358 (1317)
T KOG0612|consen  355 PVVP  358 (1317)
T ss_pred             CCCC
Confidence            6665

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-33  Score=311.76  Aligned_cols=281  Identities=21%  Similarity=0.259  Sum_probs=207.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|.+.+.||+|+||+||+|++..+++.||||.+...  .......+.+|+.+++.++|||++++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46899999999999999999999999999999998643  2333456788999999999999999999876543333356


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++++||+. ++|.+++...+...+..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            899999996 68999988777788888999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc--cHhhhhhHhcCc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL--TLHGYAKMALPK  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~  907 (973)
                      ...        .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||........  ..........++
T Consensus       160 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         160 EKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE  231 (337)
T ss_pred             CCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            221        12223457889999998765 4689999999999999999999999965321100  000000000000


Q ss_pred             ccccccCcccc------cccCC---CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcccc
Q 039720          908 KVMGIVDPSLL------MEARG---PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVGEI  965 (973)
Q Consensus       908 ~~~~~~~~~~~------~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~  965 (973)
                      ......+....      .....   ......+...+.+++.+||+.||++||+++|+++.  ++.+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            00000000000      00000   01112345667899999999999999999999987  6665433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-32  Score=310.45  Aligned_cols=270  Identities=19%  Similarity=0.217  Sum_probs=200.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  748 (973)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  .....+.+.+|+.+++.++|||++++++++.... +.+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999999999999998642  2334456788999999999999999999865321 2334


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+. ++|.+.+...  .....+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            56899999996 5888877654  66777889999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-c-C
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-L-P  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~-~  906 (973)
                      ....         .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ......... . +
T Consensus       168 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~  237 (353)
T cd07850         168 AGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPS  237 (353)
T ss_pred             CCCC---------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCC
Confidence            5321         11223457889999999999999999999999999999999999997542110 000000000 0 0


Q ss_pred             cccc-----------------------cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVM-----------------------GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ....                       ........ ..............+.+++.+|++.||++||+++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLF-PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHHhhhhhhHHhhcCCCCCCcchhhhCccccc-CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000                       00000000 000000011234567789999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-33  Score=302.45  Aligned_cols=268  Identities=21%  Similarity=0.343  Sum_probs=195.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|++|+||+|++..+++.||+|.+..... .....+.+|+++++.++||||+++++++..     .+..
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeE
Confidence            3579999999999999999999988999999999875432 233557789999999999999999998643     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+.+ +|.+++.... ...+..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||.++...
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            999999985 8999887643 456678899999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-c--C
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-L--P  906 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~--~  906 (973)
                      ..        ........++..|+|||+..+ ..++.++||||+|+++|+|++|+.||.........+....... .  +
T Consensus       155 ~~--------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (291)
T cd07844         155 VP--------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE  226 (291)
T ss_pred             CC--------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCCh
Confidence            21        111112346788999998765 4678999999999999999999999975432111111111000 0  0


Q ss_pred             cccccccC-ccc---ccccCCCc----hhHHH--HHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          907 KKVMGIVD-PSL---LMEARGPS----KFEEC--LVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       907 ~~~~~~~~-~~~---~~~~~~~~----~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      +....... ...   ........    .....  ...+.+++.+|++.+|++||+++|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000000 000   00000000    00011  156678999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-32  Score=299.88  Aligned_cols=253  Identities=25%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..+.|++.+.||+|++|.||+|.+..++..||+|++..... ..+.+.+|+++++.++|+|++++++++..     ....
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEE
Confidence            45678889999999999999999988899999999976544 45678899999999999999999998655     3789


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++++||+++++|.+++.... ..+...+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+|||.+....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999999998876 677788899999999999999998   99999999999999999999999999987553


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...        .......++..|+|||++.+..++.++|||||||++|+|++|+.||.......    ...... .... 
T Consensus       168 ~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----~~~~~~-~~~~-  233 (286)
T cd06614         168 KEK--------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----ALFLIT-TKGI-  233 (286)
T ss_pred             cch--------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH-hcCC-
Confidence            211        11123347889999999988889999999999999999999999987432210    000000 0000 


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                 ........++..+.+++.+||+.+|.+||++.++++.
T Consensus       234 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 -----------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -----------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                       0001112245677889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-32  Score=297.51  Aligned_cols=243  Identities=23%  Similarity=0.279  Sum_probs=191.2

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ||+|+||+||+|.+..+|+.||+|++....   ......+..|+++++.++|||++++++++..     .+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence            689999999999999999999999996432   2234456789999999999999999987543     47899999999


Q ss_pred             cCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCcc
Q 039720          759 QYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV  836 (973)
Q Consensus       759 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~  836 (973)
                      ++++|.+++....  ...+..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.+......    
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----  148 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----  148 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC----
Confidence            9999999997655  567788889999999999999999   9999999999999999999999999998765321    


Q ss_pred             CCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcc
Q 039720          837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS  916 (973)
Q Consensus       837 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (973)
                           .......++..|+|||++.+..++.++||||+||++|+|++|+.||........ ........        ... 
T Consensus       149 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~--------~~~-  213 (277)
T cd05577         149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRT--------LEM-  213 (277)
T ss_pred             -----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhcc--------ccc-
Confidence                 111234577899999999888899999999999999999999999975433111 00000000        000 


Q ss_pred             cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 039720          917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVK  957 (973)
Q Consensus       917 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  957 (973)
                            ....+......+.+++.+||+.||++||     ++.+++.
T Consensus       214 ------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 ------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                  0111122345677889999999999999     7777875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-33  Score=300.10  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=196.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  749 (973)
                      ...|++.++||+||.+.||++.. ++.+.||+|.+...  .......|.+|+..|.+++ |.+||.+++|-.     ++.
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~d~  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----TDG  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----cCc
Confidence            35799999999999999999988 46677788776533  2345578999999999996 899999999843     468


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCch-hhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..||||||=+ .+|..++++...... ..++.+..|++.|+.++|..   ||||.|+||.|+|+ -.|.+||+|||+|.-
T Consensus       434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            9999999754 589999987765544 56788999999999999999   99999999999998 568999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCC-----------CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-----------DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      +..+..      .-.....+||+-||+||.+...           +.++++||||+||++|+|+.|+.||.....     
T Consensus       509 I~~DTT------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----  577 (677)
T KOG0596|consen  509 IQPDTT------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----  577 (677)
T ss_pred             cCcccc------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----
Confidence            755431      1122345799999999987653           256889999999999999999999985422     


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .|++      +..+.++....+++......    +++++|..|++.||.+||+..|+++.
T Consensus       578 -~~aK------l~aI~~P~~~Iefp~~~~~~----~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 -QIAK------LHAITDPNHEIEFPDIPEND----ELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHH------HHhhcCCCccccccCCCCch----HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             1222      23344443333332121111    27889999999999999999999864

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-32  Score=301.02  Aligned_cols=266  Identities=23%  Similarity=0.364  Sum_probs=195.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||.|++|.||+|++..+++.||||+++.+.  ....+.+.+|++++++++|||++++++++.     +.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            4788999999999999999999899999999987543  223457889999999999999999999854     357899


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+. ++|.+++...  ....+..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+....
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999996 6898888653  3456778899999999999999999   99999999999999999999999999987653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH-hcCcc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM-ALPKK  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~  908 (973)
                      ...        .......+++.|+|||+..+.. ++.++|||||||++|||+||+.||....... ...+.... ..+..
T Consensus       152 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~  222 (284)
T cd07860         152 VPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDE  222 (284)
T ss_pred             cCc--------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence            321        1112234678899999877644 5889999999999999999999997543211 11111110 00000


Q ss_pred             -c----ccccC--cccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 -V----MGIVD--PSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 -~----~~~~~--~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .    .....  ..+......  ..........+.+++.+||+.||++||+++|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         223 VVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence             0    00000  000000000  00011233456789999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=297.77  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=197.0

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcC---CCCceeEEeEeeecccCCCce
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIR---HRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++... ....+++.+|+.+++.++   |||++++++++..     ...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence            4778889999999999999999999999999987542 334567888999999986   9999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++++|.+++... ...+..++.++.|++.|+.|||+.   +|+||||+|+||+++.++.++++|||.+....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            89999999999999998664 566788899999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        .......|+..|+|||...+ ..++.++|||||||++|+|++|+.||.......     ....     .
T Consensus       153 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~-----~  214 (277)
T cd06917         153 QNS--------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMML-----I  214 (277)
T ss_pred             CCc--------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhc-----c
Confidence            321        11223458889999998765 456899999999999999999999997542211     0000     0


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....+.+.        .......+.+++.+||+.||++||++.|+++.
T Consensus       215 ~~~~~~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         215 PKSKPPRLE--------DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ccCCCCCCC--------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            000001110        01134567889999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=294.75  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=199.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|++.+.||+|+||.||+|++..++..||+|++....     ......+.+|++++++++|||++++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            46899999999999999999999999999999985431     23345788999999999999999999986432   23


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++++||+++++|.+++.......+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.++.
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            56889999999999999998776677788899999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      .....     ..........++..|+|||.+.+..++.++|+|||||++|++++|+.||....... .+.+   .. ...
T Consensus       156 ~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~-~~~  225 (264)
T cd06653         156 IQTIC-----MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFK---IA-TQP  225 (264)
T ss_pred             ccccc-----ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHH---HH-cCC
Confidence            53211     00111223458889999999988889999999999999999999999997542111 1111   00 000


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                          .         .+..+......+.+++.+||+ +|..||++.+++.
T Consensus       226 ----~---------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 ----T---------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ----C---------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                0         011223344567788889998 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.9e-32  Score=302.25  Aligned_cols=248  Identities=27%  Similarity=0.334  Sum_probs=195.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +.|.+.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|+.+++.++|||++++.++|..     .+.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence            56889999999999999999998899999999986432   2234568899999999999999999998765     367


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++|+||+. |++.+.+.. .....+..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence            899999997 577776653 34567788889999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ...            ....+++.|+|||++.   ...++.++||||||+++|||++|+.||........    ..... .
T Consensus       166 ~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----~~~~~-~  228 (307)
T cd06607         166 SPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIA-Q  228 (307)
T ss_pred             CCC------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----HHHHh-c
Confidence            321            1245788999999874   45688999999999999999999999865321110    00000 0


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      .     ..+        ......+...+.+++.+||+.||++||++.+++....
T Consensus       229 ~-----~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         229 N-----DSP--------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             C-----CCC--------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            0     000        0111234567889999999999999999999987544

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-32  Score=296.97  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=195.7

Q ss_pred             cCCcCCccccccceeEEEEEECC-CCcEEEEEEeeccc----------chhHHHHHHHHHHHHh-cCCCCceeEEeEeee
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGE-DGMSVAVKVMNLDK----------KGATKSFVAECEALRN-IRHRNLIKIITICSS  742 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  742 (973)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....          .....++.+|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999977 67899999886321          2233557788888865 799999999998643


Q ss_pred             cccCCCceEEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCc
Q 039720          743 IDFKGADFKAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMV  817 (973)
Q Consensus       743 ~~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~  817 (973)
                           ....+++|||+++++|.+++..    .....+..++.++.|++.|+.|||+ .   +++||||||+||+++.++.
T Consensus        81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCc
Confidence                 4789999999999999988743    2345667889999999999999996 5   8999999999999999999


Q ss_pred             EEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      ++++|||.+.......         ......|+..|+|||...+..++.++||||||+++|+|++|+.||......    
T Consensus       153 ~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----  219 (269)
T cd08528         153 VTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----  219 (269)
T ss_pred             EEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----
Confidence            9999999997653311         223456888999999999888999999999999999999999998643211    


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                       .......        +....     +.........+.+++.+||+.||++||++.|+.++++
T Consensus       220 -~~~~~~~--------~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         220 -SLATKIV--------EAVYE-----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -HHHHHHh--------hccCC-----cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             1000000        00000     0001123456778999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.9e-32  Score=300.77  Aligned_cols=273  Identities=20%  Similarity=0.290  Sum_probs=196.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++....  .....+.+|+.+++.++ |||++++++++..........
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            368899999999999999999999999999999865432  23456888999999995 699999999876543333345


Q ss_pred             EEEEEeeccCCCHHHHhhhcC-----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEeccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN-----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFG  824 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~Dfg  824 (973)
                      .++||||+++ ++.+++....     .+.+..++.++.||+.||.|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 7888876432     346788899999999999999999   9999999999999998 8899999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      .+......        ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||................
T Consensus       157 ~~~~~~~~--------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  228 (295)
T cd07837         157 LGRAFSIP--------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL  228 (295)
T ss_pred             cceecCCC--------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            98754321        111122346788999998765 457899999999999999999999997543211111100000


Q ss_pred             hcCcc--cccccCcccccccC--CC----chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 ALPKK--VMGIVDPSLLMEAR--GP----SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~--~~~~~~~~~~~~~~--~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..+..  ..............  .+    .........+.+++.+||+.||++||+++|++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000  00000000000000  00    0012245667899999999999999999998753

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.7e-33  Score=308.72  Aligned_cols=275  Identities=23%  Similarity=0.290  Sum_probs=204.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++... ......
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP-GADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc-CCCCce
Confidence            368999999999999999999999999999999987542  23456778899999999999999999876543 234467


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+. ++|.+++.....+.+..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||.+....
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            899999996 68999998777788888999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc-
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK-  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-  908 (973)
                      ....    ..........++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+ .......... 
T Consensus       159 ~~~~----~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~-~~~~~~~g~~~  232 (334)
T cd07855         159 SSPT----EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QL-KLILSVLGSPS  232 (334)
T ss_pred             ccCc----CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HH-HHHHHHhCCCh
Confidence            3210    11122234468889999998765 468999999999999999999999997542211 11 1100000000 


Q ss_pred             --ccccc-Ccc-------cccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 --VMGIV-DPS-------LLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 --~~~~~-~~~-------~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ..... ...       .......  .......+..+.+++.+|++.||++||+++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              00000 000       0000000  00112345678899999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.4e-32  Score=301.63  Aligned_cols=253  Identities=26%  Similarity=0.319  Sum_probs=197.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .|...+.||+|+||.||+|++..++..||+|++....   ......+.+|+++++.++|||++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            4777889999999999999998899999999986432   2234578899999999999999999998754     3678


Q ss_pred             EEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+. |++.+.+.. .....+.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++....
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            99999997 477777654 44456788889999999999999999   99999999999999999999999999886432


Q ss_pred             CCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .            .....|++.|+|||++.   ...++.++|||||||++|||++|+.||....... ..........  
T Consensus       177 ~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~--  241 (317)
T cd06635         177 P------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES--  241 (317)
T ss_pred             C------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhccC--
Confidence            2            12345788999999873   4568899999999999999999999986532111 0111110000  


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                                     .......+...+.+++.+||+.+|++||++.|+++.........
T Consensus       242 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         242 ---------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ---------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                           01111233456778999999999999999999998776554433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-32  Score=296.98  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=199.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +-|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+..+++++|||++++++++..     ....+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~   78 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   78 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEE
Confidence            35778899999999999999998899999999986433 2344678899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++++|.+++... ......+..++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||++......
T Consensus        79 lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          79 IIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEEEeCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            999999999999998753 456777889999999999999998   9999999999999999999999999998755321


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......++..|+|||...+..++.++|+|||||++|+|++|..||.......  ...   .. ...    
T Consensus       155 ~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~---~~-~~~----  216 (277)
T cd06641         155 Q--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLF---LI-PKN----  216 (277)
T ss_pred             h--------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHH---HH-hcC----
Confidence            1        11123457889999999988888999999999999999999999986532210  000   00 000    


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                               ..+......+..+.+++.+||+.+|++||+++|++++
T Consensus       217 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 ---------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                     0011112334567788999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=299.78  Aligned_cols=265  Identities=23%  Similarity=0.362  Sum_probs=196.3

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      |++.+.||.|++|.||+|.+..+|..||+|++....  ......+.+|+++++.++|||++++++++..     ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence            677899999999999999999999999999997543  2234678889999999999999999998643     478999


Q ss_pred             EEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +|||+. ++|.+++....  ...+..++.++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||.+.....
T Consensus        76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            999995 68999987765  567788899999999999999998   999999999999999999999999999975532


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH-hcCcc-
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM-ALPKK-  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~-  908 (973)
                      .        ........+++.|+|||++.+. .++.++||||||+++|+|++|+.||........ ....... ..+.. 
T Consensus       152 ~--------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~  222 (283)
T cd07835         152 P--------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDED  222 (283)
T ss_pred             C--------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChH
Confidence            1        1111223467889999987664 568899999999999999999999975422111 1111100 00000 


Q ss_pred             ----cccccC--ccccccc--CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ----VMGIVD--PSLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ----~~~~~~--~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          .....+  ..+....  ............+.+++.+|++.||++||+++|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                000000  0000000  0001112233567789999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4e-32  Score=293.55  Aligned_cols=252  Identities=20%  Similarity=0.341  Sum_probs=182.3

Q ss_pred             CccccccceeEEEEEECCC--CcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLGED--GMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.||+|+||+||+|+...+  ...+++|.++... ....+.+.+|+.+++.++|||+++++++|..     ....++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence            3699999999999976422  2356677665433 3345789999999999999999999998654     367899999


Q ss_pred             eccCCCHHHHhhhcC----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          757 YMQYGSVDDWLHHTN----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      |+++|+|.++++...    ......+..++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            999999999997642    223455678999999999999998   9999999999999999999999999998643211


Q ss_pred             CCccCCCCCcccccccccccccCcccccC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHh
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMG-------GDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      .      .........++..|+|||++..       ..++.++|||||||++|||++ |..||......+ .+..    .
T Consensus       153 ~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~----~  221 (268)
T cd05086         153 D------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNH----V  221 (268)
T ss_pred             h------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH----H
Confidence            1      0111123457889999998743       245789999999999999997 577876432211 1111    1


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      .........++...         ......+.+++..|| .+|++||+++||++.|.
T Consensus       222 ~~~~~~~~~~~~~~---------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         222 IKDQQVKLFKPQLE---------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HhhcccccCCCccC---------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11111111222211         113345667888999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-32  Score=300.06  Aligned_cols=269  Identities=22%  Similarity=0.312  Sum_probs=197.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||.||+|++..+++.||+|.++....  .....+.+|+.++++++|||++++++++...   +....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            578999999999999999999998999999999975432  2334577899999999999999999987542   23789


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++|+||+. ++|.+++.... .+.+..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||.++...
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99999997 49998887644 367788999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc---C
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL---P  906 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~---~  906 (973)
                      ...        .......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||........ .........   +
T Consensus       158 ~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~  228 (293)
T cd07843         158 SPL--------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTE  228 (293)
T ss_pred             CCc--------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCch
Confidence            321        111234578889999987664 468899999999999999999999975432110 000000000   0


Q ss_pred             cc---cccccCc--ccccccC---CCchhHH--HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KK---VMGIVDP--SLLMEAR---GPSKFEE--CLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~---~~~~~~~--~~~~~~~---~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..   .......  .......   .......  ....+.+++.+||+.||++||++.|++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00   0000000  0000000   0000111  25567789999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-32  Score=295.71  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=197.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|.+.+.||+|+||.||+|.+..+|..||+|.+....  ....+.+.+|+++++.++|+|++++++++..     ....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence            4788899999999999999999999999999997542  2344678899999999999999999998543     47899


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~~~  829 (973)
                      +++||+++++|.+++....  ...+..+..++.|+++|+.|||+.   +++|+||||+||+++.++ .++++|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            9999999999999987644  346677899999999999999999   999999999999999886 4699999998765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        ........|++.|+|||+..+..++.++|+||||+++|||++|+.||......     .......... 
T Consensus       153 ~~~--------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~-  218 (257)
T cd08225         153 NDS--------MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQGY-  218 (257)
T ss_pred             cCC--------cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhccc-
Confidence            432        11122345888999999998888999999999999999999999998643211     1111111100 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         .          ..........+.+++.+||..+|++||+++|+++.
T Consensus       219 ---~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ---F----------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---C----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               0          00011223457788899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-32  Score=300.52  Aligned_cols=272  Identities=19%  Similarity=0.247  Sum_probs=196.5

Q ss_pred             cCCcCCccccccceeEEEEEECC--CCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGE--DGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|++....   ......+.+|+.+++.++|||++++++++.+.   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            47888999999999999999988  79999999997633   33456778899999999999999999987542   236


Q ss_pred             eEEEEEeeccCCCHHHHhhhc-----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC----CCcEEE
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT-----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH----DMVAHV  820 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~----~~~~kl  820 (973)
                      ..++||||+.+ ++.+++...     ..+.+..++.++.|++.|++|||+.   +|+||||||+||+++.    ++.+|+
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEE
Confidence            79999999975 677666432     2456677889999999999999999   9999999999999999    899999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc---
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT---  896 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~---  896 (973)
                      +|||++........     .........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....+...   
T Consensus       154 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         154 GDLGLARLFNAPLK-----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             CCCccccccCCCcc-----cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            99999986543210     0111223457889999998766 45789999999999999999999999765443200   


Q ss_pred             -----HhhhhhHh------------cCcccccccCcccccccCCCchhH------HHHHHHHHHHhhcCCCCCCCCCCHH
Q 039720          897 -----LHGYAKMA------------LPKKVMGIVDPSLLMEARGPSKFE------ECLVAVVRTGVACSMESPSERMQMT  953 (973)
Q Consensus       897 -----~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~  953 (973)
                           +.......            .........+..............      .....+.+++.+|++.||++|||++
T Consensus       229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                 00000000            000000000000000000000000      2335678999999999999999999


Q ss_pred             HHHHH
Q 039720          954 AVVKK  958 (973)
Q Consensus       954 evl~~  958 (973)
                      |++++
T Consensus       309 eil~~  313 (316)
T cd07842         309 EALEH  313 (316)
T ss_pred             HHhcC
Confidence            98763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.7e-32  Score=295.80  Aligned_cols=265  Identities=21%  Similarity=0.333  Sum_probs=197.0

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      +|++.++||+|++|.||+|++..+|..||||+++.... ...+.+.+|+.+++.++|||++++++++..     .+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            48889999999999999999999999999999976532 234667889999999999999999998654     377899


Q ss_pred             EEeeccCCCHHHHhhhcC---CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          754 VYEYMQYGSVDDWLHHTN---DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ||||+.+ ++.+++....   ...+..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9999985 8888876543   456788899999999999999998   99999999999999999999999999997553


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC--
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP--  906 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~--  906 (973)
                      ...        .......++..|+|||++.+. .++.++||||+||++|+|++|+.||......+. ........ .+  
T Consensus       152 ~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~  222 (284)
T cd07836         152 IPV--------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTE  222 (284)
T ss_pred             CCc--------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCh
Confidence            211        111233568889999987654 568899999999999999999999975433211 11100000 00  


Q ss_pred             cccccccCc-cccccc------CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          907 KKVMGIVDP-SLLMEA------RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       907 ~~~~~~~~~-~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ......... ......      .........+..+.+++.+|++.||++||+++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000 000000      001111234566789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.2e-32  Score=300.24  Aligned_cols=278  Identities=21%  Similarity=0.314  Sum_probs=198.0

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc---C
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDF---K  746 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~  746 (973)
                      ..++|++.++||+|+||.||+|++..+++.||||++....  ......+.+|++++++++|||+++++++|.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999986442  2234456789999999999999999998865421   1


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      .....++||||+. +++.+.+.... ...+.+++.++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence            2356799999997 47887776543 567788999999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH-
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM-  903 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~-  903 (973)
                      +........    ..........++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ......... 
T Consensus       166 ~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~  240 (310)
T cd07865         166 ARAFSLSKN----SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLC  240 (310)
T ss_pred             cccccCCcc----cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence            986643221    001112234577889999987664 4688999999999999999999998754321 111100000 


Q ss_pred             -hcCcccc-cccCcccccccCCCc----h------hHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 -ALPKKVM-GIVDPSLLMEARGPS----K------FEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 -~~~~~~~-~~~~~~~~~~~~~~~----~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       ..+.... ...+.........+.    .      .......+.+++.+||+.||++||+++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence             0000000 000000000000000    0      00112456689999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.5e-32  Score=292.23  Aligned_cols=243  Identities=24%  Similarity=0.307  Sum_probs=195.6

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ||.|++|.||+|++..+++.||+|++....   ....+.+.+|+++++.++|||++++++++.+     +...++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence            699999999999998889999999997433   2345678999999999999999999998543     47899999999


Q ss_pred             cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCC
Q 039720          759 QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP  838 (973)
Q Consensus       759 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~  838 (973)
                      ++++|.+++.+....+...+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++++|||.+.......     
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----  147 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----  147 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----
Confidence            9999999998877778888899999999999999998   99999999999999999999999999998654321     


Q ss_pred             CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccc
Q 039720          839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLL  918 (973)
Q Consensus       839 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (973)
                          ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.....+......  ...         +..  
T Consensus       148 ----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~---------~~~--  210 (262)
T cd05572         148 ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN--DIL---------KGN--  210 (262)
T ss_pred             ----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH--HHh---------ccC--
Confidence                122345788999999988888999999999999999999999999765432111111  100         000  


Q ss_pred             cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 039720          919 MEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVK  957 (973)
Q Consensus       919 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  957 (973)
                         .....+......+.+++.+||+.+|++||+     ++|+++
T Consensus       211 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 ---GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence               001111222557789999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.8e-32  Score=301.24  Aligned_cols=270  Identities=19%  Similarity=0.263  Sum_probs=192.9

Q ss_pred             Cccccc--cceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKG--SFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      ..||+|  +||+||+|++..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..     ++..++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence            356666  99999999999999999999987543  2334678899999999999999999998654     47889999


Q ss_pred             eeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          756 EYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      ||+.++++.+++....  ..++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+.......
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            9999999999987643  356677889999999999999998   99999999999999999999999998665432211


Q ss_pred             CccCCCCCcccccccccccccCcccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc---
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGG--DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK---  908 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---  908 (973)
                      .... ..........++..|+|||++.+.  .++.++||||+||++|||++|+.||.....................   
T Consensus       156 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         156 QKAK-VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             cccc-ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            0000 000011112345679999998764  5789999999999999999999999765432211111100000000   


Q ss_pred             -------------------ccccc-Cc----ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 -------------------VMGIV-DP----SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 -------------------~~~~~-~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                         +.+.. ..    ..............+...+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                               00000 00    0000000112234566788999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.2e-32  Score=299.96  Aligned_cols=273  Identities=24%  Similarity=0.315  Sum_probs=199.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|+++....  .....+.+|+.++++++|+|++++++++...   ..+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            4679999999999999999999999999999999975432  2234567899999999999999999986532   2356


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+.+ +|.+++... ..+.+.+++.++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.+...
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            8999999974 788887653 4566788899999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+...... ....
T Consensus       159 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~-~~~~  228 (309)
T cd07845         159 GLPA--------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQL-LGTP  228 (309)
T ss_pred             CCcc--------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCC
Confidence            4321        11122345778999998765 467899999999999999999999997543221 11111110 0000


Q ss_pred             cccc---c---C--cccccccCCCc----hhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          909 VMGI---V---D--PSLLMEARGPS----KFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       909 ~~~~---~---~--~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ....   .   .  ...........    ......+.+.+++.+|++.||++||+++|++++-.-.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            0000   0   0  00000000000    0111345667899999999999999999999765443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-32  Score=294.10  Aligned_cols=269  Identities=22%  Similarity=0.304  Sum_probs=197.3

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhc---CCCCceeEEeEeeecccCCCce
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNI---RHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      |++.+.||+|+||.||+|++..+++.||+|+++....  .....+.+|+.+++++   .|||++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6778899999999999999988899999999974432  2234566787777666   5999999999987653333445


Q ss_pred             EEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .+++|||+.+ ++.+++....  .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999974 8988887643  367788999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-Cc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-PK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~  907 (973)
                      .....         ......++..|+|||++.+..++.++|||||||++|||++|+.||......+ .+........ +.
T Consensus       157 ~~~~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~  226 (287)
T cd07838         157 YSFEM---------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPS  226 (287)
T ss_pred             ccCCc---------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCC
Confidence            53321         1122347888999999999999999999999999999999999987543221 1111111100 00


Q ss_pred             ccccccC-----cccccccC--CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVD-----PSLLMEAR--GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~-----~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .......     ........  ......+....+.+++.+||+.||++||+++|++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0000000     00000000  011122345677899999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-32  Score=290.49  Aligned_cols=248  Identities=27%  Similarity=0.392  Sum_probs=202.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||+|++|.||+|++..+++.||+|.+.....  ...+.+.+|++++++++|||++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence            47889999999999999999988999999999976543  455779999999999999999999998654     37899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ++|||+++++|.+++......++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||.+......
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999999999998877778888999999999999999999   9999999999999999999999999999866432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      .        .......++..|+|||...+..++.++||||+|+++|+|++|+.||......    ........  .    
T Consensus       153 ~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~~--~----  214 (254)
T cd06627         153 S--------KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIVQ--D----  214 (254)
T ss_pred             c--------ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhc--c----
Confidence            1        1122345788999999988888899999999999999999999998754311    11111100  0    


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ..         +..+......+.+++.+|+..+|++||++.|++.
T Consensus       215 ~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 DH---------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CC---------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            00         0111223456678888999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.4e-32  Score=290.19  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++.....  ...+.+.+|++++++++|||++++++++...   .....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence            47788999999999999999988999999999975542  4567889999999999999999999986542   136889


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +++||+++++|.+++.......+..++.++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+|||.+......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999999998877778888999999999999999998   9999999999999999999999999999876442


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                      ..      ........++..|+|||...+..++.++||||||+++|+|++|+.||..........   ...         
T Consensus       155 ~~------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~---------  216 (260)
T cd06606         155 ET------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL---YKI---------  216 (260)
T ss_pred             cc------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---Hhc---------
Confidence            10      011234568889999999988889999999999999999999999997654111100   000         


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ....     .....+......+.+++.+|++.||++||++.|+++.
T Consensus       217 ~~~~-----~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         217 GSSG-----EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cccC-----CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            0000     0011222335678899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.2e-32  Score=288.52  Aligned_cols=250  Identities=28%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      +|...+.||+|++|.||+|.+..+++.||+|++........+.+.+|+.+++.++||+++++++++..     ....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence            47888999999999999999988999999999976655566789999999999999999999998654     3789999


Q ss_pred             EeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          755 YEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      +||+++++|.+++... ....+..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999999998776 4667788899999999999999998   99999999999999999999999999998654321


Q ss_pred             CccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                               ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ . .....   ...    
T Consensus       153 ---------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~-~~~~~---~~~----  214 (253)
T cd05122         153 ---------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-L-FKIAT---NGP----  214 (253)
T ss_pred             ---------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-H-HHHHh---cCC----
Confidence                     02345688899999999888899999999999999999999999875421110 0 00000   000    


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       +..       .........+.+++.+||+.||++||++.|+++.
T Consensus       215 -~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         215 -PGL-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -CCc-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             000       0011124567889999999999999999998763

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.2e-32  Score=297.83  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=191.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|...+.||+|+||+||++++..+++.||+|++.... ......+.+|+.++.++. ||||+++++++..     +...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            4556778999999999999999999999999987543 234567889999999996 9999999998643     46788


Q ss_pred             EEEeeccCCCHHHHhh-----hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          753 IVYEYMQYGSVDDWLH-----HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ++|||+. +++.++..     .....++..+.+++.|++.|++|||+..  +|+||||||+||+++.++.++|+|||+++
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            9999986 45554332     2345677888999999999999999742  89999999999999999999999999997


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG---DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      .....         .......|+..|+|||++.+.   .++.++||||+||++|+|++|+.||.....    ........
T Consensus       157 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~  223 (288)
T cd06616         157 QLVDS---------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQV  223 (288)
T ss_pred             HhccC---------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhh
Confidence            65321         111233578899999998776   689999999999999999999999975421    10110000


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...     ..+...     ......+...+.+++.+||+.||++||+++||++.
T Consensus       224 ~~~-----~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         224 VKG-----DPPILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCC-----CCCcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000     001110     11112345678899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-32  Score=304.04  Aligned_cols=278  Identities=21%  Similarity=0.242  Sum_probs=207.3

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.+.||+|++|.||+|++..+++.||+|++....  ....+.+.+|+.+++.++|||++++++++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999998889999999987543  34456789999999999999999999987654222334789


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ++|||+. ++|.+++.....+.+..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999998 58999988777778888999999999999999999   9999999999999999999999999999866432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC----c
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP----K  907 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~----~  907 (973)
                      ..     .........++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+. . ........    +
T Consensus       157 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~-~~i~~~~~~~~~~  229 (330)
T cd07834         157 ED-----EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-L-NLIVEVLGTPSEE  229 (330)
T ss_pred             cc-----ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-H-HHHHHhcCCCChh
Confidence            10     01122334578899999998887 889999999999999999999999976532110 0 00000000    0


Q ss_pred             ccccccCccc-------cc--ccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcc
Q 039720          908 KVMGIVDPSL-------LM--EARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~-------~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  963 (973)
                      ..........       ..  ...........+..+.+++.+||+.||++||++++++..  ++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            0000000000       00  000001112245667899999999999999999999985  55554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-32  Score=295.95  Aligned_cols=268  Identities=23%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      |.+.+.||+|+||.||+|++..+++.||+|++....  ......+.+|+++++.++|||++++++++...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            677889999999999999999899999999998653  33456788999999999999999999987542   1368999


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      |+||+++ +|.+++... ..+.+..++.++.|+++|++|||+.   +++|+||||+||++++++.++++|||.+......
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9999974 888888765 4567788899999999999999999   9999999999999999999999999999866432


Q ss_pred             CCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc---Ccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL---PKK  908 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~---~~~  908 (973)
                      .       ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+........   ...
T Consensus       154 ~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~  225 (287)
T cd07840         154 N-------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDEN  225 (287)
T ss_pred             C-------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhh
Confidence            1       111223356788999997665 467899999999999999999999997543211 1111111000   000


Q ss_pred             cccccC----cccccccCCC----chhHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVD----PSLLMEARGP----SKFEE-CLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~----~~~~~~~~~~----~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....+    ..........    ..... +...+.+++.+||+.+|++||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000000    0000000000    01111 25678899999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.6e-32  Score=295.32  Aligned_cols=247  Identities=24%  Similarity=0.349  Sum_probs=195.8

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEee
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEY  757 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  757 (973)
                      ...+||+|+||.||+|....++..||||++..........+.+|+.+++.++|+|++++++++..     .+..+++|||
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   98 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEF   98 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEEec
Confidence            34679999999999999999999999999875555556778999999999999999999998654     4789999999


Q ss_pred             ccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccC
Q 039720          758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA  837 (973)
Q Consensus       758 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~  837 (973)
                      +++++|.+++... ...+..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+......     
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-----  169 (292)
T cd06657          99 LEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----  169 (292)
T ss_pred             CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc-----
Confidence            9999999987543 467778889999999999999999   9999999999999999999999999988754321     


Q ss_pred             CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCccc
Q 039720          838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSL  917 (973)
Q Consensus       838 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (973)
                         ........|++.|+|||...+..++.++|+||+|+++|+|++|+.||......  ..........+        ...
T Consensus       170 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~--------~~~  236 (292)
T cd06657         170 ---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP--------PKL  236 (292)
T ss_pred             ---cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCC--------ccc
Confidence               11122345888999999988888899999999999999999999998743211  11111111111        000


Q ss_pred             ccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          918 LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       918 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                             .........+.+++.+||+.||.+||++.|+++.
T Consensus       237 -------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         237 -------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             -------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence                   0111233456788889999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=5.1e-32  Score=290.61  Aligned_cols=247  Identities=24%  Similarity=0.322  Sum_probs=199.9

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|++.++||+|+||.||++++..+++.+|+|++....  ......+.+|+++++.++||||+++.+++.     +....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence            4788999999999999999999999999999997542  334567788999999999999999998754     348899


Q ss_pred             EEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +|+||+++++|.+++..    .....+..++.++.|++.|+.|||+.   +++||||+|+||+++.++.+|++|||.+..
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            99999999999999876    23456677889999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....          ......+++.|+|||...+..++.++|+||+|+++|+|++|+.||......  .+......     
T Consensus       153 ~~~~----------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-----  215 (256)
T cd08530         153 LKKN----------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR-----  215 (256)
T ss_pred             hccC----------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-----
Confidence            5431          112235788999999999989999999999999999999999999754321  11110000     


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                  ...+.........+.+++.+|++.+|++||++.|+++.
T Consensus       216 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         216 ------------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ------------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                        00011122445668899999999999999999998864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-33  Score=296.72  Aligned_cols=244  Identities=23%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      .+.||+|-||+||-|+++.+|+.||||+|.+.+  ......+.+|+.+|++++||.||.+.-.     +++.+..++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence            367999999999999999999999999996432  3345789999999999999999998654     566799999999


Q ss_pred             eccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC---CcEEEeccccchhccCC
Q 039720          757 YMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHH  832 (973)
Q Consensus       757 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~---~~~kl~Dfg~a~~~~~~  832 (973)
                      .+.|.-|.-.+.. .+++++...+.+..||+.||.|||.+   +|+|+|+||+|||+...   .++||||||+|+.+++ 
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-  719 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-  719 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-
Confidence            9976555555544 45666777778889999999999999   99999999999999654   3899999999998875 


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                              .......+|||.|+|||++....|...-|+||.||++|.-++|..||....    ++.+-..          
T Consensus       720 --------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQ----------  777 (888)
T KOG4236|consen  720 --------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQ----------  777 (888)
T ss_pred             --------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhh----------
Confidence                    344556789999999999999999999999999999999999999986432    2211111          


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                       +..   ....+..+.+....-+++|...++..-.+|.+.+..+.
T Consensus       778 -NAa---FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  778 -NAA---FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             -ccc---cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence             001   11224445666667778888999999999998876543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=6.7e-32  Score=294.29  Aligned_cols=264  Identities=18%  Similarity=0.232  Sum_probs=193.1

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      |++.++||+|+||.||+|++..+++.||+|+++... ........+|+.+++++. |||++++++++.+.   ..+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            677889999999999999999999999999987532 222334567888898885 99999999987542   2367899


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      |+||+. |++.+.+... ....+.+++.++.|++.||+|||+.   +++||||||+||+++. +.+||+|||.++.....
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            999997 5788877653 4567788999999999999999999   9999999999999999 99999999999865332


Q ss_pred             CCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc---
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK---  908 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---  908 (973)
                               .......++..|+|||++.. ..++.++||||+||++|||++|+.||......+  ............   
T Consensus       153 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~  221 (282)
T cd07831         153 ---------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAE  221 (282)
T ss_pred             ---------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHH
Confidence                     11123457889999997654 456889999999999999999999997543211  111111111000   


Q ss_pred             cccccCc------cccccc--CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDP------SLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~------~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +......      ......  .........+..+.+++.+||+.+|++||+++|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000      000000  0000112346778899999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.1e-31  Score=291.70  Aligned_cols=243  Identities=21%  Similarity=0.248  Sum_probs=186.8

Q ss_pred             ccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHH---HHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECE---ALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .||+|+||.||+|++..+++.||+|++.....   .....+..|..   .++...||+++++++++..     .+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence            48999999999999988999999999864321   11222334433   4445579999999887543     4789999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      |||+.+|+|.+++...+...+..++.++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++......  
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--  150 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--  150 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence            99999999999998777778889999999999999999998   9999999999999999999999999998754321  


Q ss_pred             ccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                              ......|+..|+|||++.+. .++.++||||+||++|||++|+.||..........  ......      ..
T Consensus       151 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~------~~  214 (278)
T cd05606         151 --------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTL------TM  214 (278)
T ss_pred             --------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--HHHHhh------cc
Confidence                    11234689999999998754 68999999999999999999999997653321110  000000      00


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                      +         ...+......+.+++.+|+..+|++||     +++|+++.
T Consensus       215 ~---------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 A---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             C---------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            0         111112345677888899999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=7.8e-32  Score=296.92  Aligned_cols=276  Identities=23%  Similarity=0.319  Sum_probs=199.4

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc----
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID----  744 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  744 (973)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|+++...  ......+.+|+++++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999999899999999997543  233456788999999999999999999876532    


Q ss_pred             -cCCCceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          745 -FKGADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       745 -~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                       ..+....++|+||+++ ++.+.+... ..+.+..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence             1223478999999986 666666543 3567788999999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ||.+.......       ........++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+....
T Consensus       160 fg~~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~  231 (302)
T cd07864         160 FGLARLYNSEE-------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELIS  231 (302)
T ss_pred             ccccccccCCc-------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence            99998654321       111122345778999998765 45688999999999999999999999753221 1111111


Q ss_pred             hHh---cCcccccccCcccc--------cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMA---LPKKVMGIVDPSLL--------MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~---~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...   .+.....+......        ............+..+.+++.+||+.||++||++++++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            110   00000000000000        0000001111235678899999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=6.7e-32  Score=289.89  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=201.7

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|.+.+.||.|+||.||+|.+..++..||+|++.....  ...+.+.+|+++++.++|||++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            57888999999999999999988999999999976533  456778899999999999999999998543     37899


Q ss_pred             EEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +++||+++++|.+++...    ...+...+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceee
Confidence            999999999999998764    5566788899999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      .....        .......|++.|+|||...+..++.++|+||+|+++|+|++|+.||......     ..........
T Consensus       153 ~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~  219 (258)
T cd08215         153 LSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILKGQ  219 (258)
T ss_pred             cccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhcCC
Confidence            54321        1222346888999999998888999999999999999999999998644211     1111110000


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              .      ...+..+...+.+++.+||..+|++||++.|+++.
T Consensus       220 --------~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 --------Y------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --------C------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    0      01111334567789999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=1.6e-31  Score=296.19  Aligned_cols=267  Identities=19%  Similarity=0.208  Sum_probs=190.5

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      .+.+|.|  |.||.++...+++.||||++...  .....+.+.+|+++++.++||||+++++++..     .+..+++||
T Consensus         7 ~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e   79 (314)
T cd08216           7 GKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSP   79 (314)
T ss_pred             hHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEe
Confidence            3444444  44555555569999999999755  23345679999999999999999999998543     478899999


Q ss_pred             eccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCC
Q 039720          757 YMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF  834 (973)
Q Consensus       757 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~  834 (973)
                      |+++|++.+++...  ...++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|++|||.+........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            99999999999763  3456777889999999999999999   999999999999999999999999998875533221


Q ss_pred             ccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc-
Q 039720          835 LVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG-  911 (973)
Q Consensus       835 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  911 (973)
                      ... ..........++..|+|||++..  ..++.++||||+||++|||++|+.||............ .....+..... 
T Consensus       157 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~  234 (314)
T cd08216         157 RQR-VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKS  234 (314)
T ss_pred             ccc-ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccC
Confidence            110 01112233457788999999866  35889999999999999999999999864332211111 11111000000 


Q ss_pred             ---------------ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          912 ---------------IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       912 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                     ..++.. ...............+.+++.+||+.||++||+++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNN-RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             chhhhcCCcCcccccccccch-hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                           000000 0000111222345677889999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=1e-31  Score=300.67  Aligned_cols=275  Identities=20%  Similarity=0.272  Sum_probs=200.1

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++++ +||||+++++++..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            356899999999999999999999889999999988532  223345677899999999 99999999998653   234


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+. ++|.+++... ...+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            56899999997 5999988765 556677888999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-c-
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-L-  905 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~-  905 (973)
                      .......   ..........|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ........ . 
T Consensus       157 ~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~  232 (337)
T cd07852         157 LSELEEN---PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPP  232 (337)
T ss_pred             ccccccc---ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence            5432110   01122234568899999998755 4678899999999999999999999965332110 10000000 0 


Q ss_pred             Cc---------ccccccCccccccc-CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PK---------KVMGIVDPSLLMEA-RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~---------~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..         ......+....... .........+..+.+++.+||+.||++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00         00000000000000 0001111245678899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.3e-32  Score=289.39  Aligned_cols=242  Identities=23%  Similarity=0.307  Sum_probs=187.0

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHH-HhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEAL-RNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||.||+|.+..+++.||+|+++....   .....+..|..++ ...+|||++++++++..     .+..++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence            569999999999999998999999999864322   1223344555444 45589999999998643     47899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++++|.+++...+..++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....    
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            9999999999998877778888999999999999999999   999999999999999999999999999874321    


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                              .....+++.|+|||...+..++.++||||+|+++|+|++|..||......  ..  +..... .    ..+ 
T Consensus       150 --------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~--~~~~~~-~----~~~-  211 (260)
T cd05611         150 --------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AV--FDNILS-R----RIN-  211 (260)
T ss_pred             --------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HH--HHHHHh-c----ccC-
Confidence                    12335788999999998888999999999999999999999999754221  11  111000 0    000 


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                       .     .......++..+.+++.+||+.+|++||++.++.+
T Consensus       212 -~-----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         212 -W-----PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             -C-----CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence             0     01111234566789999999999999997754443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=5.6e-34  Score=276.17  Aligned_cols=280  Identities=21%  Similarity=0.313  Sum_probs=205.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeec--ccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC---CC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFK---GA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---~~  748 (973)
                      ..|....+||+|.||+||+|+.+.+|++||+|++-.  ++.+......+|++++..++|+|++.++++|......   +.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            467778899999999999999999999999987644  3455678899999999999999999999998764432   23


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||++|+. +|.-++... ..+...++.+++.++.+||.|+|..   .|+|||+||.|+|++.+|.+||+|||+|+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            458899999975 788877765 4667788999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh--
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA--  904 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~--  904 (973)
                      .+...+..    ....-+..+.|.+|++||.+.+ ..|+++.|||.-||++.||+||.+-+...++... ++......  
T Consensus       173 ~fs~~~n~----~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~Is~LcGs  247 (376)
T KOG0669|consen  173 AFSTSKNV----VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHLISQLCGS  247 (376)
T ss_pred             ceeccccc----CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHHHHHHhcc
Confidence            76554321    1223445667999999998776 4789999999999999999999998876654321 11111100  


Q ss_pred             c-CcccccccCcccccccC---CC----chhHHHH------HHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          905 L-PKKVMGIVDPSLLMEAR---GP----SKFEECL------VAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       905 ~-~~~~~~~~~~~~~~~~~---~~----~~~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      + ++.+-.+.+-.+.....   .+    ....+..      .+-.+++.+++..||.+|+.+++++.+---.
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            0 00000000000000000   00    0011111      1345777799999999999999998765433

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=7.3e-32  Score=295.85  Aligned_cols=268  Identities=21%  Similarity=0.321  Sum_probs=193.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|++|+||+|++..+++.||+|++.....  ...+.+.+|+++++.++|||++++++++..     ....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence            478999999999999999999988999999999864432  234668899999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCC--chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDK--LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~Dfg~a~~  828 (973)
                      ++||||++ +++.+++......  .+..+..++.||+.||+|||++   +++||||+|+||+++. ++.+|++|||++..
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            99999996 5788877654433  4566778999999999999999   9999999999999985 56799999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC-
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP-  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~-  906 (973)
                      ....        ........+++.|+|||++.+ ..++.++||||+||++|+|+||+.||......+...........+ 
T Consensus       153 ~~~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  224 (294)
T PLN00009        153 FGIP--------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN  224 (294)
T ss_pred             cCCC--------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            4321        111123356889999998766 457899999999999999999999997543221111000000000 


Q ss_pred             cc-cc---cccCccc-ccccCCC---chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KK-VM---GIVDPSL-LMEARGP---SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~-~~---~~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .. ..   ...+... .......   .........+.+++.+|++.+|++||+++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 00   0000000 0000000   0011234457789999999999999999999863

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=4.5e-32  Score=292.58  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=194.6

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ||+|+||.||+|++..+|+.||+|++.....   ...+.+.+|++++++++|||++++++.+.     .....++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence            6899999999999988899999999975433   34567889999999999999999988643     457899999999


Q ss_pred             cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCC
Q 039720          759 QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP  838 (973)
Q Consensus       759 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~  838 (973)
                      ++++|.+++.+.+...+..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            9999999998877778888999999999999999999   9999999999999999999999999998754332100000


Q ss_pred             CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccc
Q 039720          839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLL  918 (973)
Q Consensus       839 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (973)
                      ..........++..|+|||......++.++||||||+++|++++|+.||.......     ........        .. 
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~--------~~-  218 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNILNG--------KI-  218 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcC--------Cc-
Confidence            00112223457888999999988889999999999999999999999997543211     00000000        00 


Q ss_pred             cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          919 MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       919 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                         ..+. ....+..+.+++.+||+.+|++||++.++.+.++
T Consensus       219 ---~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 ---EWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ---CCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence               0000 0012456778999999999999999955544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=5e-33  Score=286.67  Aligned_cols=265  Identities=23%  Similarity=0.275  Sum_probs=201.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCC--CC----ceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH--RN----LIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~~~~~~~~~~~~  746 (973)
                      .++|.+...+|+|.||.|-++.+.+++..||||+++.-. ...+..+-|+++++++.+  |+    +|.+.+|     |+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            679999999999999999999999999999999997433 245667889999999942  22    4555554     45


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC----------
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH----------  814 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~----------  814 (973)
                      ...+.|+|+|.+ |-++++++..+.  .++...+..++.|++++++|||+.   +++|.|+||+|||+..          
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence            568999999987 559999998754  455688999999999999999999   9999999999999932          


Q ss_pred             ----------CCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCC
Q 039720          815 ----------DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR  884 (973)
Q Consensus       815 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~  884 (973)
                                +..++++|||.|++-.+.           ....+.|..|+|||++.+-+++.++||||+||+++|++||.
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccC-----------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence                      236899999999865432           24567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCC-ccHhhhhhHhcCccccccc-----------C---ccccc------ccCCC-----chhHHHHHHHHHHH
Q 039720          885 RPTDNMFNDG-LTLHGYAKMALPKKVMGIV-----------D---PSLLM------EARGP-----SKFEECLVAVVRTG  938 (973)
Q Consensus       885 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~-----------~---~~~~~------~~~~~-----~~~~~~~~~l~~li  938 (973)
                      .-|+...+.+ ..+.+..-+.+|..+....           |   .....      +...+     .....+...|++++
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            9998765432 1222333333332222211           0   00000      00000     11235567799999


Q ss_pred             hhcCCCCCCCCCCHHHHHHH
Q 039720          939 VACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       939 ~~cl~~dP~~RPs~~evl~~  958 (973)
                      .+|+.+||.+|+|+.|++.+
T Consensus       387 ~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHccCccccccHHHHhcC
Confidence            99999999999999999864

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=4.3e-32  Score=303.92  Aligned_cols=276  Identities=19%  Similarity=0.277  Sum_probs=197.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc--------
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSID--------  744 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  744 (973)
                      ..+|.+.+.||+|+||+||+|.+..+|+.||+|++........+.+.+|+++++.++|||++++++++....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999999999999999997666556677899999999999999999988754321        


Q ss_pred             -cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEec
Q 039720          745 -FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSD  822 (973)
Q Consensus       745 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~D  822 (973)
                       +.+....++||||+. ++|.+++... .+.+..++.++.|+++|+.|||+.   +|+||||||+||+++. ++.++++|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence             112246789999997 5888887643 567788899999999999999999   9999999999999984 55789999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ||.++......     ..........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..............
T Consensus       159 fg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         159 FGLARIVDPHY-----SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             cccceecCCcc-----ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99987553211     00111123357889999997654 5678899999999999999999999975432111000000


Q ss_pred             hHhcCc-----ccccccCcccccccC---CC--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPK-----KVMGIVDPSLLMEAR---GP--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~-----~~~~~~~~~~~~~~~---~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......     ...............   .+  ........++.+++.+|++.||++||+++|++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000000     000000000000000   00  0011234567789999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=4.6e-32  Score=317.08  Aligned_cols=270  Identities=19%  Similarity=0.224  Sum_probs=184.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC-cEEEEEEee-----------------cccchhHHHHHHHHHHHHhcCCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG-MSVAVKVMN-----------------LDKKGATKSFVAECEALRNIRHRNLI  734 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~niv  734 (973)
                      .++|++.+.||+|+||+||+|..+... ..+++|.+.                 .........+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998764322 222222110                 01112345678999999999999999


Q ss_pred             eEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcC-----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 039720          735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSN  809 (973)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~N  809 (973)
                      ++++++..     .+..++|++++. +++.+++....     ......+..++.|++.||+|||++   +||||||||+|
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~N  297 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLEN  297 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            99998654     367899999985 56777664322     122355778999999999999999   99999999999


Q ss_pred             EEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCC-CC
Q 039720          810 VLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-TD  888 (973)
Q Consensus       810 ILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~P-f~  888 (973)
                      ||++.++.+||+|||+++.+....       ........||+.|+|||++.+..++.++|||||||++|||++|..| +.
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~  370 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKER-------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG  370 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCccc-------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence            999999999999999998654321       1122235699999999999999999999999999999999998754 44


Q ss_pred             CCCCC-CccHhhhhhHh------cCcc---cccccCcccccccC--CCchh--HHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 039720          889 NMFND-GLTLHGYAKMA------LPKK---VMGIVDPSLLMEAR--GPSKF--EECLVAVVRTGVACSMESPSERMQMTA  954 (973)
Q Consensus       889 ~~~~~-~~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~e  954 (973)
                      ..... ...+.......      .+..   ..+.++........  .+...  ......+.+++.+|++.||++|||+.|
T Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e  450 (501)
T PHA03210        371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE  450 (501)
T ss_pred             CCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH
Confidence            33221 11111111100      0000   00000000000000  00000  012345667888999999999999999


Q ss_pred             HHHH
Q 039720          955 VVKK  958 (973)
Q Consensus       955 vl~~  958 (973)
                      +++.
T Consensus       451 lL~h  454 (501)
T PHA03210        451 LLAL  454 (501)
T ss_pred             HhhC
Confidence            9875

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=1.3e-31  Score=295.55  Aligned_cols=251  Identities=26%  Similarity=0.340  Sum_probs=195.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +.|...+.||+|+||.||+|++..++..||+|.+...   ......++.+|+++++.++|+|++++.+++..     ...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence            4577778899999999999999989999999998643   22334568889999999999999999998754     378


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+. |++.+.+.. ...+.+.++..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||++...
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            899999997 578777654 33456788889999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ...            ....+++.|+|||.+.   ...++.++|||||||++|+|++|+.||....... .......... 
T Consensus       166 ~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~-  231 (308)
T cd06634         166 APA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES-  231 (308)
T ss_pred             cCc------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCC-
Confidence            321            1345788999999864   3567889999999999999999999986532211 0111110000 


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                              +        ......+...+.+++.+||+.+|++||+++++++.-.-..
T Consensus       232 --------~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         232 --------P--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             --------C--------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                    0        0011234456778999999999999999999998755443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=2.4e-31  Score=291.12  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=194.9

Q ss_pred             cCCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK----KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFK  746 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  746 (973)
                      .|++.+.||+|+||.||.|++.   .+|..||+|+++...    ....+.+.+|+++++++ +|++|+++++++.     
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-----   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence            4788899999999999999874   478999999997432    22346678899999999 5899999988754     


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .....++||||+++++|.+++.......+..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence            3478899999999999999998877777888888999999999999998   9999999999999999999999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG--DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      .......       ........|+..|+|||.....  .++.++||||||+++|+|++|+.||....... .........
T Consensus       153 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~  224 (290)
T cd05613         153 KEFHEDE-------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRI  224 (290)
T ss_pred             eeccccc-------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHh
Confidence            7653321       1122234588899999997653  46889999999999999999999986432211 111111111


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                      ...      .         +..+......+.+++.+||+.||++||     ++++++..
T Consensus       225 ~~~------~---------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         225 LKS------E---------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             hcc------C---------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            000      0         111122345677888999999999997     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=1.3e-31  Score=299.52  Aligned_cols=276  Identities=20%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             hhcCCc-CCccccccceeEEEEEECCCCcEEEEEEeecccchh--------------HHHHHHHHHHHHhcCCCCceeEE
Q 039720          673 TKEFSS-SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--------------TKSFVAECEALRNIRHRNLIKII  737 (973)
Q Consensus       673 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~  737 (973)
                      .++|.. .+.||+|+||+||+|.+..+++.||||+++......              ...+.+|+++++.++|||+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            456764 567999999999999999899999999986432211              12577899999999999999999


Q ss_pred             eEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc
Q 039720          738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV  817 (973)
Q Consensus       738 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~  817 (973)
                      +++..     .+..++||||+. |+|.+++.......+..+..++.|++.|++|||+.   +|+||||+|+||+++.++.
T Consensus        87 ~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         87 DVYVE-----GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             EEEec-----CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence            98653     478999999997 68999998777778888999999999999999998   9999999999999999999


Q ss_pred             EEEeccccchhccCCCCccC------CCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCC
Q 039720          818 AHVSDFGLARFLSHHPFLVA------PEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~  890 (973)
                      ++++|||.+...........      ...........+++.|+|||.+.+. .++.++||||+||++|+|++|+.||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999976542110000      0001112223467889999988764 4689999999999999999999999755


Q ss_pred             CCCCccHhhhhhHh-cCcc--cccccC-ccc-ccccCCC----chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          891 FNDGLTLHGYAKMA-LPKK--VMGIVD-PSL-LMEARGP----SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       891 ~~~~~~~~~~~~~~-~~~~--~~~~~~-~~~-~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...+. +....... .+..  ...... +.. ......+    .....+...+.+++.+|++.||++||+++|++..
T Consensus       238 ~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        238 NEIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CHHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            33211 11100000 0000  000000 000 0000000    0111234567789999999999999999999874

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=1.4e-31  Score=292.65  Aligned_cols=256  Identities=20%  Similarity=0.251  Sum_probs=196.6

Q ss_pred             cCCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK----KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFK  746 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  746 (973)
                      +|.+.+.||+|+||.||+|++.   .+++.||||+++...    ....+.+.+|+++++++ +||+++++.+++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4778899999999999999864   467899999987432    22345688999999999 599999998874     3


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .....++||||+.+|+|.+++.....+.+..+..++.|+++||+|||+.   +++||||||+||+++.++.++++|||++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccc
Confidence            4578899999999999999998776677788889999999999999998   9999999999999999999999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD--LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      +......       ........|+..|+|||...+..  .+.++||||||+++|||++|+.||....... .........
T Consensus       153 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~  224 (288)
T cd05583         153 KEFLAEE-------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRI  224 (288)
T ss_pred             ccccccc-------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHH
Confidence            7653321       11122345788999999987654  7889999999999999999999996432111 111111110


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ...      .         ...+......+.+++.+||+.||++|||+.++.+.+..
T Consensus       225 ~~~------~---------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         225 LKS------K---------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             Hcc------C---------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            000      0         11112234566788999999999999998887766654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.5e-33  Score=293.52  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=214.6

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++.++..||-||||.|=+++.+.....+|+|+++..   .....+++..|-.+|...+.|.||++|..     |.+..+.
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchhh
Confidence            455667799999999999999766666899988643   33456778999999999999999999986     5566899


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      |+.||-|-||.++..+.+.+.+.+.++..++..+.+|++|||++   +||+||+||+|.+++.+|-+||.|||+|+.+..
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999998865


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                               .....+++|||.|.|||++.....+.++|.||+|+++||+++|.+||....    .+..|..+.......+
T Consensus       573 ---------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d----pmktYn~ILkGid~i~  639 (732)
T KOG0614|consen  573 ---------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD----PMKTYNLILKGIDKIE  639 (732)
T ss_pred             ---------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc----hHHHHHHHHhhhhhhh
Confidence                     445667899999999999999999999999999999999999999998642    2333433332222111


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHHH-------HhccccccCCCCCC
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKKL-------CAVGEIFIGPPIIG  973 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L-------~~~~~~~~~~~~~~  973 (973)
                      .              +....+.-.++|.+.....|.+|..     ..||.++-       ++++..--.||++|
T Consensus       640 ~--------------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~  699 (732)
T KOG0614|consen  640 F--------------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIP  699 (732)
T ss_pred             c--------------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccc
Confidence            1              1222334457777888999999986     56666653       34456666777764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=306.30  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=208.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCc----EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGM----SVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +.+..++||+|+||+||+|.|...|+    +||||++... .....+++.+|+-+|.+++|||+++++++|..      .
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s  770 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------S  770 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------c
Confidence            45667899999999999999976664    6888888643 34567889999999999999999999999875      3


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCC-chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDK-LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...+|++|+++|+|.|+++.++.. .......|..|||+||.|||++   ++|||||.++||||....++|+.|||+|+.
T Consensus       771 ~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  771 TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            488999999999999999876543 3466789999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .....      .+.......-.+-|||=|.+....|+.++|||||||++||++| |..||.....++.            
T Consensus       848 l~~d~------~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------------  909 (1177)
T KOG1025|consen  848 LAPDE------KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------------  909 (1177)
T ss_pred             cCccc------ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------------
Confidence            75533      1212222223456999999999999999999999999999999 9999986643311            


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                        .     .+.....+...++.|..++..++.+||..|++.||+++++...+.+..
T Consensus       910 --~-----dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  910 --P-----DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             --h-----HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence              1     111222224556788899999999999999999999999999998775

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=1.2e-31  Score=296.67  Aligned_cols=280  Identities=22%  Similarity=0.316  Sum_probs=198.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc---CC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDF---KG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  747 (973)
                      .++|++.++||+|+||.||+|++..+++.||+|++.....  .....+.+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4689999999999999999999999999999999864432  223567889999999999999999987654321   22


Q ss_pred             CceEEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      ....++|+||+.+ ++.+.+.. ...+++.++..++.|+++||+|||+.   +|+||||||+||+++.++.++++|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence            4567999999875 66666654 34677788999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCC---CCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          827 RFLSHHPFLVAPE---GQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       827 ~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      .............   .........+++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            8654322100000   11122334678889999987654 57899999999999999999999997543211 0111000


Q ss_pred             Hh---cCcc------cccccCcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          903 MA---LPKK------VMGIVDPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       903 ~~---~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ..   .+..      .....+.........  ..........+.+++.+|++.||++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00   0000      000000000000000  0011122356789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-33  Score=284.71  Aligned_cols=243  Identities=23%  Similarity=0.276  Sum_probs=194.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  749 (973)
                      .+|..+..||.|+||.|-+|..+.+.+.+|||+++.+-   ....+--+.|-++|.-.. -|.++.+..+     |++-+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTmD  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTMD  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhhh
Confidence            46888999999999999999999999999999998653   222333456666666553 5677777665     66679


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .+|+||||+.||+|--+++.-+.+.+..+..+|.+||-||-|||++   ||++||+|.+|||+|.+|++||+|||+++.-
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999999999999999999999999999999999999999   9999999999999999999999999999853


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..        .......++|||.|+|||++.+.+|+.++|+||+||++|||+.|++||++..+++  +.+..        
T Consensus       501 i~--------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~aI--------  562 (683)
T KOG0696|consen  501 IF--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQAI--------  562 (683)
T ss_pred             cc--------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH--------
Confidence            22        2445567899999999999999999999999999999999999999998653321  11110        


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM  952 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  952 (973)
                         .+..       ..++....++-+.+....+.+.|.+|..+
T Consensus       563 ---~ehn-------vsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  563 ---MEHN-------VSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             ---HHcc-------CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence               0000       12223334455667777888888888643

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.8e-31  Score=297.81  Aligned_cols=274  Identities=20%  Similarity=0.271  Sum_probs=197.4

Q ss_pred             cCCcCCccccccceeEEEEEECCC--CcEEEEEEeecc--cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGED--GMSVAVKVMNLD--KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +|++.+.||+|+||.||+|++..+  +..||+|++...  .....+.+.+|+.+++++ +||||+++++++... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            478889999999999999999877  899999998643  223356788899999999 599999999875432 13335


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++++||+. ++|.+++.......+..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.++..
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            6788888886 68999998777778888999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH--hcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM--ALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~--~~~  906 (973)
                      ......    .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+......  ..+
T Consensus       156 ~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~  230 (332)
T cd07857         156 SENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPD  230 (332)
T ss_pred             cccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCC
Confidence            432210    1111223568999999998765 568999999999999999999999987532110 00000000  000


Q ss_pred             cc-cccccCcc-------c--ccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KK-VMGIVDPS-------L--LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~-~~~~~~~~-------~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .. .....++.       .  ................+.+++.+|++.||++||+++|++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00 00000000       0  00000000011124567899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-31  Score=299.53  Aligned_cols=274  Identities=21%  Similarity=0.257  Sum_probs=198.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  749 (973)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|++....  ......+.+|+++++.++||||+++++++.... .....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999998899999999986432  223456889999999999999999999875432 12234


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++|+||+. .++.++..  ....+..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++..
T Consensus        94 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             eEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            5789999986 47776543  3466778889999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC-
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP-  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~-  906 (973)
                      ..           ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+....... .+ 
T Consensus       168 ~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~  235 (342)
T cd07879         168 DA-----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPG  235 (342)
T ss_pred             CC-----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCC
Confidence            21           1123457888999998766 468899999999999999999999997532110 111100000 00 


Q ss_pred             cccccccCc--------ccc--cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhccc
Q 039720          907 KKVMGIVDP--------SLL--MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~  964 (973)
                      .........        ...  ...............+.+++.+||+.||++||+++|++..  ++.++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000000        000  0000000011234567799999999999999999999955  666653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1e-31  Score=292.41  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=202.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+..|+++++++. ||||+++++++     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            47889999999999999999999999999999996532   233467888999999998 99999998874     3457


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++++|.+++...+......++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+...
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            8999999999999999998887788889999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCccC------------CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          830 SHHPFLVA------------PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       830 ~~~~~~~~------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      ........            ...........++..|+|||+.....++.++||||+|++++++++|+.||......    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----  228 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----  228 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence            44221000            00012223445788999999988888999999999999999999999999854311    


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH----HHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM----TAVVK  957 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  957 (973)
                      .......         +.    .   ...+...++.+.+++.+||+.||++||++    +|+++
T Consensus       229 ~~~~~~~---------~~----~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTFQKIL---------KL----E---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHH---------hc----C---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0000000         00    0   01112224567789999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.9e-31  Score=292.78  Aligned_cols=254  Identities=23%  Similarity=0.317  Sum_probs=191.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||.||+|++..+++.||||+++... ......+..|+.++.+.. |||++++++++..     ...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence            357889999999999999999998889999999997543 233455667777776665 9999999998754     368


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .+++|||+. +++.+++.. ....++..+..++.|++.|+.|||+..  +|+||||+|+||+++.++.+||+|||.+...
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999999985 577777655 334566778899999999999999732  8999999999999999999999999998765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD----LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ....         ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.........+.   ... 
T Consensus       166 ~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~-  232 (296)
T cd06618         166 VDSK---------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT---KIL-  232 (296)
T ss_pred             cCCC---------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH---HHh-
Confidence            3211         112234778899999987553    78899999999999999999999965322111111   100 


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ...     .+..       .....+..++.+++.+||+.||++||+++++++.-
T Consensus       233 ~~~-----~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         233 QEE-----PPSL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             cCC-----CCCC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            000     0000       00012345678899999999999999999998753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=4.6e-31  Score=291.85  Aligned_cols=244  Identities=28%  Similarity=0.361  Sum_probs=190.5

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      |...++||+|+||+||+|++..+++.||+|++.....   .....+.+|+++++.++|||++++++++.+     ....+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence            6667889999999999999998999999999874322   234568889999999999999999998765     37889


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+. |++.+++.. .....+.+++.++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            9999996 577777754 33456778889999999999999999   999999999999999999999999998864221


Q ss_pred             CCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                                  .....|+..|+|||++.   ...++.++|||||||++|+|++|+.||....... ..   ..... ..
T Consensus       174 ------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~---~~~~~-~~  236 (313)
T cd06633         174 ------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL---YHIAQ-ND  236 (313)
T ss_pred             ------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HH---HHHHh-cC
Confidence                        12345888999999874   4568889999999999999999999986542211 01   00000 00


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           .+.        .........+.+++.+||+.+|++||++.|+++.
T Consensus       237 -----~~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 -----SPT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----CCC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000        0011223457788899999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.7e-31  Score=296.89  Aligned_cols=268  Identities=21%  Similarity=0.276  Sum_probs=197.9

Q ss_pred             HHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       670 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ...+++|.+.+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+++++.++|||++++.+++..    .
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~   81 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----P   81 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----C
Confidence            34678899999999999999999999999999999988542  22345678899999999999999999998643    2


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ....++++||+ +++|.+++... ...+..+..++.|+++|+.|||+.   +|+||||+|+||+++.++.++++|||.+.
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            35688999998 56898887643 456667788999999999999999   99999999999999999999999999987


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH--h
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM--A  904 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~--~  904 (973)
                      ....           ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||........ .......  .
T Consensus       157 ~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~~~~~~~~~~  224 (328)
T cd07856         157 IQDP-----------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-FSIITDLLGT  224 (328)
T ss_pred             ccCC-----------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence            5422           1123356888999998766 5789999999999999999999999975432110 0000000  0


Q ss_pred             cCcc-cccccCc---ccccccC--CC----chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 LPKK-VMGIVDP---SLLMEAR--GP----SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~-~~~~~~~---~~~~~~~--~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .++. .....+.   .+.....  .+    .........+.+++.+|++.+|++||++++++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000 0000000   0000000  00    0111234678899999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8e-32  Score=284.38  Aligned_cols=276  Identities=24%  Similarity=0.295  Sum_probs=199.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHH--hcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALR--NIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .....+.||+|.||.||+|+.  +++.||||++...   ..+.+.+|.++.+  .++|+||++++++-..... ....++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCc-ccccee
Confidence            345567899999999999999  6799999999633   4566777777765  5589999999987544322 255889


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      +|++|.+.|+|.+++... ........+++.-+++||+|||+..      .|+|+|||||+.||||..|+++.|+|||+|
T Consensus       285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999999999876 4566778999999999999999863      468999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCC-C-----CcccchHHHHHHHHHHHhCCCCCC-CCCCCCc-cHh
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD-L-----SMTGDVYSFGILLLEMFTRRRPTD-NMFNDGL-TLH  898 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDvwSlG~ll~elltg~~Pf~-~~~~~~~-~~~  898 (973)
                      ..+....      ........+||..|||||++.+.. +     -.+.||||+|.++||+++...-+. +...+.. .+.
T Consensus       364 l~~~p~~------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  364 LRLEPGK------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             EEecCCC------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9876432      233344478999999999987642 1     235899999999999999765443 1111111 011


Q ss_pred             hhhhHhc-Ccc-cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          899 GYAKMAL-PKK-VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       899 ~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      ....... -++ -.-++..+.+...+........+..+-+.+..||..||+.|.|+.=|.+++.++.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            0110000 000 0111222222222212222244566788899999999999999999998888775

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=298.13  Aligned_cols=243  Identities=21%  Similarity=0.240  Sum_probs=193.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHh-cCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN-IRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ...|.....+|.|+|++|-.+.+..+++..++|++....    .+..+|+.++.. -+|||++++.+.+.+     ..+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~-----~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED-----GKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC-----Ccee
Confidence            457888888999999999999999999999999996542    223356655444 479999999998654     5899


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-cCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl-~~~~~~kl~Dfg~a~~~~  830 (973)
                      |+|||.+.|+-+.+.+....... .++.+|+++|+.|++|||++   ||||||+||+|||+ +..++++|+|||.++...
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999999999988887665544 66778999999999999999   99999999999999 689999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..           ....+-|..|.|||+.....|++++||||||+++|+|++|+.||.....+ ..+..  ....     
T Consensus       468 ~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~--~i~~-----  528 (612)
T KOG0603|consen  468 RS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT--RIQM-----  528 (612)
T ss_pred             hh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH--hhcC-----
Confidence            31           22335678899999999999999999999999999999999999876655 11111  1111     


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                                   +...........+++.+|++.||.+||+|+++...=.
T Consensus       529 -------------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  529 -------------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             -------------CccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence                         1111233344557777999999999999999876543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=279.03  Aligned_cols=273  Identities=25%  Similarity=0.382  Sum_probs=206.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHh--cCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN--IRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++....+.||+|.||+||+|+|  .|+.||||++....   ++...+|.++.+.  ++|+||+.+++.-. .+.....+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~-~~~gs~TQ  283 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADN-KDNGSWTQ  283 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccc-cCCCceEE
Confidence            45677789999999999999999  79999999996443   3445667777654  49999999998622 22334467


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH-----CQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      +++|++|.+.|+|+|++... ........+++.-+|.||+|||..     ..|.|.|||||+.||||..++...|+|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            89999999999999999884 556677899999999999999964     367899999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCC----CC--CcccchHHHHHHHHHHHhC----------CCCCCC
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG----DL--SMTGDVYSFGILLLEMFTR----------RRPTDN  889 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~--~~~sDvwSlG~ll~elltg----------~~Pf~~  889 (973)
                      |....+.....    .-.....+||..|||||++...    .+  -..+||||||.++||+...          +.||.+
T Consensus       363 Av~h~~~t~~i----di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  363 AVRHDSDTDTI----DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eEEecccCCcc----cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            98766542111    2233356799999999986542    11  2348999999999998753          257766


Q ss_pred             CCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          890 MFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ....+....+..+..    ..+    +++...+..+...++...+.++|+.||..+|.-|.||-.+.++|.++.+
T Consensus       439 ~Vp~DPs~eeMrkVV----Cv~----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVV----CVQ----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCCCHHHHhcce----eec----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            655444433322211    122    2222223344556788899999999999999999999999999988753

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.7e-31  Score=297.74  Aligned_cols=276  Identities=18%  Similarity=0.238  Sum_probs=200.4

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID  744 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  744 (973)
                      .++....++|.+.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            344556789999999999999999999998899999999986432  223456788999999999999999999875432


Q ss_pred             -cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          745 -FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       745 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                       +......+++++++ +++|.+++... ...+..++.++.|++.|+.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~df  164 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  164 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecc
Confidence             22334567888876 78998887654 467788899999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      |+++....           ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ..+.....
T Consensus       165 g~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~  232 (345)
T cd07877         165 GLARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR  232 (345)
T ss_pred             cccccccc-----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            99875422           1123457889999998766 56788999999999999999999999653221 11111111


Q ss_pred             Hh--cCcccccccCcccc----c---ccCC---CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          903 MA--LPKKVMGIVDPSLL----M---EARG---PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       903 ~~--~~~~~~~~~~~~~~----~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ..  .+......+.....    .   ....   ..........+.+++.+|++.||++||++.+++..=
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            00  00000000000000    0   0000   000011244577999999999999999999988753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-33  Score=274.50  Aligned_cols=250  Identities=25%  Similarity=0.275  Sum_probs=188.8

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHH-hcCCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALR-NIRHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      ...||.|+||+|++..++.+|+..|||.|+.... ...+++..|.++.. .-+.|+||++||++..     +...||+||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeHH
Confidence            4569999999999999999999999999986654 45577888888654 4469999999998644     366889999


Q ss_pred             eccCCCHHHHhh-----hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          757 YMQYGSVDDWLH-----HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       757 ~~~~gsL~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      .|+ .+++.+..     .....++.-.-+|......||+||.+..  .|||||+||+|||++..|.+|+||||++-....
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            986 56665543     2334555556677888899999998764  899999999999999999999999999976543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG--DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                               .-..+...|...|||||.+...  .|+-+|||||+|+++||+.||..||.....-..++.+.+....+   
T Consensus       221 ---------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp---  288 (361)
T KOG1006|consen  221 ---------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP---  288 (361)
T ss_pred             ---------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC---
Confidence                     2233345688899999987653  58999999999999999999999998654322222222221111   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                            .+..    .....+....+.+++.-|+.+|-..||..+++.++
T Consensus       289 ------~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  289 ------ILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ------eecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                  1111    11113345567788889999999999999997654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.3e-31  Score=320.75  Aligned_cols=148  Identities=32%  Similarity=0.449  Sum_probs=132.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|.+.++||+|+||+||+|.+..+++.||||+++...   ......+..|+.+++.++||||+++++++..     ..
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----AN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CC
Confidence            357999999999999999999999899999999997432   2234678899999999999999999987644     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+.+++|.+++...+...+..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            8999999999999999998777777888899999999999999998   999999999999999999999999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=5e-31  Score=287.53  Aligned_cols=265  Identities=23%  Similarity=0.334  Sum_probs=198.4

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      |.+.+.||+|++|.||+|.+..+++.+|+|+++....  .....+.+|+++++.++|++++++++++..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            6778899999999999999988999999999875432  345678899999999999999999998543     478999


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ++||+.+ ++.+++... ....+..+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||.+......
T Consensus        76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            9999975 888887664 4567788899999999999999999   9999999999999999999999999999765432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc---Ccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL---PKK  908 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~---~~~  908 (973)
                      .        .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ .+........   +..
T Consensus       152 ~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~  222 (283)
T cd05118         152 V--------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEV  222 (283)
T ss_pred             c--------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHh
Confidence            1        111223577889999998776 78999999999999999999999996543211 1111000000   000


Q ss_pred             cccccC---c---cccccc--CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVD---P---SLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~---~---~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....+   .   ......  ............+.+++.+||+.||++||++.|++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            000000   0   000000  0011123456778899999999999999999998763

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-31  Score=288.46  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=194.5

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      |.+.+.||+|++|+||+|+...+++.||||++..... .......+|+..+++++ |||++++++++..     .+..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            6778899999999999999988899999999864322 22334567899999999 9999999998543     578999


Q ss_pred             EEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          754 VYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ||||+ +|++.+.+....  ...+..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            99999 789999887654  567788899999999999999999   999999999999999999999999999976543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh---cC-
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA---LP-  906 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~---~~-  906 (973)
                      .         .......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||........ +.......   .. 
T Consensus       152 ~---------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~  221 (283)
T cd07830         152 R---------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQ  221 (283)
T ss_pred             C---------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChh
Confidence            2         11223457889999998754 4678999999999999999999999975532211 10000000   00 


Q ss_pred             -----cccccccCccccccc--CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 -----KKVMGIVDPSLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 -----~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           .......+.......  ............+.+++.+||+.||++||+++|++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence                 000000000000000  0000111124568899999999999999999998763

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=4.5e-32  Score=270.75  Aligned_cols=205  Identities=24%  Similarity=0.373  Sum_probs=168.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc----EEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM----SVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      -..|+....||+|.||.||+|....+..    .+|+|.++..++  +......+|+..++.++|||++.+..++...   
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence            3479999999999999999996654433    789999975533  3446688999999999999999999886542   


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC-----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC----Cc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN-----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD----MV  817 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~----~~  817 (973)
                       +..+++++||.+. +|...++...     ..+...++.|+.||+.|+.|||++   =|+|||+||.|||+..+    |.
T Consensus       100 -d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen  100 -DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             -CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence             5889999999985 7888876432     345567789999999999999999   89999999999999877    89


Q ss_pred             EEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCC
Q 039720          818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~  890 (973)
                      |||+|+|+|+.+...-     ..-......+.|.+|+|||.+.+. .|+.+.|||+.||++.||+|-++-|...
T Consensus       175 VKIaDlGlaR~~~~pl-----kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPL-----KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             eEeecccHHHHhhccc-----cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999999999875431     112233356789999999998885 6899999999999999999999888654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=245.04  Aligned_cols=266  Identities=20%  Similarity=0.312  Sum_probs=196.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +|...++||+|.||+||+|+..++++.||+|.++.+.  .+......+|+-+++.++|+|||+++++...     +....
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence            5777889999999999999999999999999998664  3456789999999999999999999998554     47889


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +|+|||.. +|..+... .+.+....+..++.|+++|+.|+|++   .+.|||+||.|.+++.+|+.|++|||+|+-++-
T Consensus        78 lvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   78 LVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             EeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            99999974 67777765 34455566788999999999999999   999999999999999999999999999986642


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHh-cC--
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMA-LP--  906 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~-~~--  906 (973)
                      .        .......+.|.+|++|.++.+. -|+.+.|+||-||++.|+.. |++.|++..-.+ ++....... .+  
T Consensus       154 p--------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~e  224 (292)
T KOG0662|consen  154 P--------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTE  224 (292)
T ss_pred             c--------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCcc
Confidence            1        1222334578899999998886 46889999999999999998 777776543222 111111111 11  


Q ss_pred             c---ccccccCcccccccCCCchhHHHHHH----HHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 K---KVMGIVDPSLLMEARGPSKFEECLVA----VVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~----l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +   .+....|.....-++......+..+.    =.+++++.+.-+|..|.++++.++.
T Consensus       225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1   12222333222222111112222222    1356667888899999999988764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.6e-31  Score=287.66  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=198.1

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      |+..+.||+|++|.||+|+...+++.||+|++....  ....+.+..|+.+++.++|+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            567788999999999999999899999999997653  3345678889999999999999999998543     478999


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      |+||+. ++|.+++... ....+..+.+++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||.+......
T Consensus        76 v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             EecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            999998 5899999876 4677888999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh---cCcc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA---LPKK  908 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~~  908 (973)
                      .        .......++..|+|||.+.+. .++.++|||||||++||+++|+.||......+. +.......   .+..
T Consensus       152 ~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  222 (282)
T cd07829         152 L--------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEES  222 (282)
T ss_pred             c--------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHH
Confidence            1        112223457789999998776 789999999999999999999999965432110 00000000   0000


Q ss_pred             ---cccc--cCccccccc--CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ---VMGI--VDPSLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ---~~~~--~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         ....  .+.......  ............+.+++.+||..||++||+++|++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence               0000  000000000  0001111225678899999999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.9e-31  Score=296.17  Aligned_cols=275  Identities=19%  Similarity=0.230  Sum_probs=200.3

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~  748 (973)
                      ..++|++.+.||+|+||.||+|.+..++..||||++....  ....+.+.+|+++++.++||||+++++++.... ....
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999999999999999985432  223456889999999999999999999865421 1122


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+ +++|.+++.. ...++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||++..
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            3568999998 7799888764 4567788899999999999999999   999999999999999999999999999875


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc--
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL--  905 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~--  905 (973)
                      ....           .....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||....... ..........  
T Consensus       168 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  235 (343)
T cd07880         168 TDSE-----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTP  235 (343)
T ss_pred             cccC-----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence            4321           123357889999998776 457899999999999999999999997543211 0111000000  


Q ss_pred             CcccccccCcc----ccc---ccCC---CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHH--HHHHhcc
Q 039720          906 PKKVMGIVDPS----LLM---EARG---PSKFEECLVAVVRTGVACSMESPSERMQMTAVV--KKLCAVG  963 (973)
Q Consensus       906 ~~~~~~~~~~~----~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~~~  963 (973)
                      +......+...    ...   ....   ..........+.+++.+|++.||++||++.+++  ..++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            00000000000    000   0000   001122345678999999999999999999998  4455543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-32  Score=281.76  Aligned_cols=266  Identities=22%  Similarity=0.337  Sum_probs=206.2

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-------chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-------KGATKSFVAECEALRNIRHRNLIKIITICSSID  744 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  744 (973)
                      ..++|.....||+|||+.||+|.+....+.||||+-...+       ....+...+|.++.+.+.||.||++|+|+.-  
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl--  538 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL--  538 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee--
Confidence            3467999999999999999999999999999999875432       1223567889999999999999999999753  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec---CCCcEEEe
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVS  821 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~---~~~~~kl~  821 (973)
                        +.+.+|-|.|||+|.+|+-++.....+.+.++..|+.||+.||.||.+. .++|||-|+||.|||+.   ..|.+||+
T Consensus       539 --DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  539 --DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             --ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence              3578899999999999999999999999999999999999999999998 67899999999999995   45789999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      |||+++.++...+. ...+........||++|++||.+.-+    ..+.++||||+||++|+++.|+.||....... ++
T Consensus       616 DFGLSKIMdddSy~-~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dI  693 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYN-SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DI  693 (775)
T ss_pred             ecchhhhccCCccC-cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HH
Confidence            99999998765432 22334455567899999999976433    56889999999999999999999998654332 22


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .++..+....+      ..+..   .+    ....+-..+|++|+++--++|....++..
T Consensus       694 LqeNTIlkAtE------VqFP~---KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  694 LQENTILKATE------VQFPP---KP----VVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             Hhhhchhccee------ccCCC---CC----ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            22221111111      01110   01    11223346777999999999988777643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=4.7e-31  Score=283.94  Aligned_cols=248  Identities=22%  Similarity=0.269  Sum_probs=192.7

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecc-----cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-----KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      +|.+.+.||+|+||.||+|++..++..+++|+.+..     ......++..|+.+++.++|||++++++++.     +..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            588899999999999999999877777777776532     1223456778999999999999999998754     346


Q ss_pred             eEEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ..++|+||+++++|.+++..    .....+..++.++.|++.|+.|||+.   +++|+||||+||+++. +.++++|||.
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCc
Confidence            78999999999999998864    33456788899999999999999999   9999999999999975 5699999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +.......        .......|++.|+|||...+..++.++|+||||+++|+|++|..||.....     ........
T Consensus       152 ~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~  218 (260)
T cd08222         152 SRLLMGSC--------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIV  218 (260)
T ss_pred             eeecCCCc--------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHH
Confidence            87653321        112234578899999998888889999999999999999999999864211     11111100


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .              ...+..+..+...+.+++.+||+.+|++||++.|+++.
T Consensus       219 ~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 E--------------GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             c--------------CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            0              00011123445677889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=267.60  Aligned_cols=202  Identities=23%  Similarity=0.332  Sum_probs=180.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  748 (973)
                      -++|+..+.||+|+|+.|..++.+.+.+.||+|+++..   ..+..+....|-.+..+. +||.+|.+..+     |+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence            46799999999999999999999999999999999743   344556677777777665 59999998775     6778


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..+++|.||++||+|--++++...++++.+..+..+|+-||.|||++   ||++||+|.+|||+|.+|++|++|||+++.
T Consensus       324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence            99999999999999999999999999999999999999999999999   999999999999999999999999999985


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM  890 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~  890 (973)
                      --.        ......+++|||.|.|||++.+..|+.++|+|++||+++||+.|+.||+..
T Consensus       401 ~l~--------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  401 GLG--------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             CCC--------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            322        244556789999999999999999999999999999999999999999744

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7.4e-31  Score=277.91  Aligned_cols=221  Identities=16%  Similarity=0.083  Sum_probs=175.8

Q ss_pred             ccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccCCCHH
Q 039720          685 GSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVD  764 (973)
Q Consensus       685 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  764 (973)
                      |.+|.||+|+++.+++.||+|+++....     ...|...+....|||++++++++.     +.+..+++|||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence            8999999999999999999999965432     234455555667999999999754     347899999999999999


Q ss_pred             HHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCccc
Q 039720          765 DWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS  844 (973)
Q Consensus       765 ~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  844 (973)
                      +++......++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++++|||.+......           .
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----------~  139 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----------C  139 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------c
Confidence            9998777778888999999999999999998   9999999999999999999999999987654321           1


Q ss_pred             ccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCC
Q 039720          845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGP  924 (973)
Q Consensus       845 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (973)
                      ....++..|+|||...+..++.++||||+|+++|||++|+.|+.......               .....         .
T Consensus       140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~---------~  195 (237)
T cd05576         140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTT---------L  195 (237)
T ss_pred             ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccc---------c
Confidence            12335677999999988889999999999999999999998875321110               00000         0


Q ss_pred             chhHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 039720          925 SKFEECLVAVVRTGVACSMESPSERMQMT  953 (973)
Q Consensus       925 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~  953 (973)
                      ..+......+.+++.+|++.||++||++.
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            01112345567889999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4e-31  Score=296.23  Aligned_cols=270  Identities=19%  Similarity=0.257  Sum_probs=197.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~  748 (973)
                      ..++|.+.+.||+|++|.||+|++..+++.||+|++....  ....+.+.+|+.++++++|||++++.+++..... ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999999899999999986432  2234567789999999999999999886543211 222


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++|+||+ +++|.+++.. ..+.+..++.++.|+++|+.|||+.   +|+||||||+||+++.++.++|+|||.+..
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            3589999998 5799998875 3567788999999999999999999   999999999999999999999999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh--c
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA--L  905 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~--~  905 (973)
                      ....           .....++..|+|||.+.+ ..++.++||||+||++|++++|+.||....... .+.......  .
T Consensus       168 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~  235 (343)
T cd07851         168 TDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTP  235 (343)
T ss_pred             cccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCC
Confidence            4321           223457888999998765 467899999999999999999999997543211 111100000  0


Q ss_pred             Cccc-ccccCc-------ccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKV-MGIVDP-------SLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~-~~~~~~-------~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +... ......       ......+.  ..........+.+++.+|++.||++|||++|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0000 000000       00000000  00111235678899999999999999999999863

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=277.00  Aligned_cols=237  Identities=27%  Similarity=0.307  Sum_probs=190.8

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      ||+|+||.||+|.+..+++.||+|+++....   ...+.+..|++++++++|||++++++.+.     .....+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence            6999999999999988899999999875432   24567889999999999999999998743     457899999999


Q ss_pred             cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCC
Q 039720          759 QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP  838 (973)
Q Consensus       759 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~  838 (973)
                      .+++|.+++.......+..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+.......     
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----  147 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-----  147 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-----
Confidence            9999999998877778888999999999999999998   99999999999999999999999999987654321     


Q ss_pred             CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccc
Q 039720          839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLL  918 (973)
Q Consensus       839 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (973)
                         .......++..|+|||...+..++.++|+||||+++|++++|+.||.....     .........        ..  
T Consensus       148 ---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~--------~~--  209 (250)
T cd05123         148 ---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILK--------DP--  209 (250)
T ss_pred             ---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc--------CC--
Confidence               122344578899999999888889999999999999999999999964322     111111000        00  


Q ss_pred             cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 039720          919 MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTA  954 (973)
Q Consensus       919 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  954 (973)
                           ...+...+..+.+++.+||..||++||++.+
T Consensus       210 -----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 -----LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                 0111112456678899999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=293.04  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=213.5

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      +.+...+..|++.+.||.|.+|.||+++.+.+++.+|+|+...+.. ..+++..|..+++.. .|||++.+++++.-..-
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3344456789999999999999999999999999999999875543 345677788888877 59999999999877666


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                      ..++.+|+|||||.+|+..|++....  .+.+..+..|++.++.|+.+||.+   .++|||||-.|||++.++.||++||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence            78899999999999999999998644  445677889999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH  898 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~  898 (973)
                      |.+......        ........|||.|||||++...     .|+..+|+||+|++..||--|.+|+.++..--.   
T Consensus       168 GvSaQldsT--------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---  236 (953)
T KOG0587|consen  168 GVSAQLDST--------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---  236 (953)
T ss_pred             eeeeeeecc--------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---
Confidence            999876532        3444567899999999997643     578889999999999999999999886643210   


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         -..        +.+.   ..+....+..+.+.+.++|..|+.+|-+.||++.+++++
T Consensus       237 ---LF~--------IpRN---PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 ---LFL--------IPRN---PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---hcc--------CCCC---CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               000        1000   011123356677888899999999999999999998764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-30  Score=273.20  Aligned_cols=134  Identities=22%  Similarity=0.345  Sum_probs=117.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-----C---CCceeEEeEeeeccc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-----H---RNLIKIITICSSIDF  745 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~~~~  745 (973)
                      .+|.+.++||-|.|++||+|.+.+..+.||+|+.+.. ....+..+.|+++|++++     |   .+||++++.+... .
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-G  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-G  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-C
Confidence            6899999999999999999999999999999999754 346678899999999884     3   4699999987764 5


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhh--cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHH--TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL  812 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl  812 (973)
                      ..+.++|||+|++ |.+|..+|..  .++++...+++|++||+.||+|||..|  ||||.||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            6778999999998 6788888875  345677889999999999999999999  99999999999999

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=306.56  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=205.1

Q ss_pred             hcCCcCCccccccceeEEEEEECC-------CCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGE-------DGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSID  744 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  744 (973)
                      ++..+.+.+|+|.||.|++|....       ....||||..+... ....+.+..|+++|+.+ +|+|++.++|+|..  
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence            344566799999999999997431       25689999987443 34567899999999988 59999999999875  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPS  808 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~  808 (973)
                         ....++|+||+..|+|.+++...+                .....+...++.|||.|++||++.   ++||||+.++
T Consensus       374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence               478999999999999999998765                144466789999999999999999   9999999999


Q ss_pred             cEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccc--cccccCcccccCCCCCcccchHHHHHHHHHHHh-CCC
Q 039720          809 NVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG--TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRR  885 (973)
Q Consensus       809 NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~  885 (973)
                      |||+..+..+||+|||+|+.......+..       ....|  ...|||||.+....|+.++|||||||++||++| |..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~-------~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~  520 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRT-------KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT  520 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEe-------cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence            99999999999999999997654432211       11112  234999999999999999999999999999999 999


Q ss_pred             CCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          886 PTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       886 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                      ||++..... .+.+                 ...++.+.+.+..|..++.++|..||+.+|++||++.|+.+.+..
T Consensus       521 PYp~~~~~~-~l~~-----------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  521 PYPGIPPTE-ELLE-----------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CCCCCCcHH-HHHH-----------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            998632111 1111                 122333455667778889999999999999999999999999987

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-31  Score=247.39  Aligned_cols=214  Identities=23%  Similarity=0.331  Sum_probs=172.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHH-HhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEAL-RNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      +.......||+|++|.|-+.++..+|+..|+|.++..- ....++...|+++. +...+|.+|++||.+.     .....
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-----regdv  120 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-----REGDV  120 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----ccccE
Confidence            34445667999999999999999999999999997543 33456778888875 4557999999999643     34789


Q ss_pred             EEEEeeccCCCHHHHh----hhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          752 AIVYEYMQYGSVDDWL----HHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ++.||.|+ .+|+.+.    ...+..++.-.-+|+.-+..||.|||++.  .++|||+||+|||++.+|++|+||||++-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999986 4777554    34556677778899999999999999985  89999999999999999999999999997


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ....+         -..+-..|...|+|||.+..    ..|+-++||||+|++++||.+++.||+....+.+++.+.+..
T Consensus       198 ~L~dS---------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  198 YLVDS---------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             eehhh---------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            66432         12223468889999998654    479999999999999999999999999877776666555444


Q ss_pred             h
Q 039720          904 A  904 (973)
Q Consensus       904 ~  904 (973)
                      .
T Consensus       269 p  269 (282)
T KOG0984|consen  269 P  269 (282)
T ss_pred             C
Confidence            3

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.3e-30  Score=279.74  Aligned_cols=216  Identities=22%  Similarity=0.285  Sum_probs=181.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .-|..++.||-|+||+|.+++-..|...||+|.+++..   +........|.+||...+.+=||++|-.     |++++.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            44788899999999999999998999999999997543   3345678899999999999999999865     677899


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +|+||+|++||++-.++.+.+-+.+.-+..++.++..|+++.|+.   |+|||||||+|||||.+|++||+|||+|.-+.
T Consensus       704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence            999999999999999999999888888999999999999999998   99999999999999999999999999986431


Q ss_pred             C---CCCccCCCCCc-------------------------------ccccccccccccCcccccCCCCCcccchHHHHHH
Q 039720          831 H---HPFLVAPEGQS-------------------------------SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL  876 (973)
Q Consensus       831 ~---~~~~~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~l  876 (973)
                      .   ..++-.....+                               .....+||+.|+|||++....|+..+|+||.||+
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence            1   11110000000                               1112459999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCccH
Q 039720          877 LLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       877 l~elltg~~Pf~~~~~~~~~~  897 (973)
                      +|||+.|++||-+.+..+++.
T Consensus       861 l~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             HHHHhhCCCCccCCCCCccee
Confidence            999999999998877766543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.3e-30  Score=249.47  Aligned_cols=266  Identities=19%  Similarity=0.277  Sum_probs=199.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCce
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ..++|++.+++|+|.|++||.|....+.++++||+++.   ...+.+.+|+++|+.+. ||||++++++..++   ....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence            35689999999999999999999988999999999964   34577899999999997 99999999998764   3466


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~Dfg~a~~~  829 (973)
                      ..+++||+++.+...+..   .+...++..++.+++.||+|+|+.   ||+|||+||.|+|+|.. ...+++|+|+|.++
T Consensus       110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence            789999999877766543   345567889999999999999999   99999999999999965 47999999999988


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh----
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA----  904 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~----  904 (973)
                      .+..         .-.-.+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||-.......++...++..    
T Consensus       184 Hp~~---------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e  254 (338)
T KOG0668|consen  184 HPGK---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE  254 (338)
T ss_pred             CCCc---------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence            6532         1112235667889998765 4678999999999999999999999865544444444433322    


Q ss_pred             -----------cCcccccccC---cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 -----------LPKKVMGIVD---PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 -----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                 ++....+++.   +..|......+...-...+..+++.+.+.+|-++|+||+|.+++
T Consensus       255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                       1111222111   11111111111111122455678889999999999999998864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.6e-30  Score=303.33  Aligned_cols=264  Identities=20%  Similarity=0.222  Sum_probs=171.2

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCC----CcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEe-eecccC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGED----GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC-SSIDFK  746 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~  746 (973)
                      ..++|.+.+.||+|+||.||+|++..+    +..||+|++.....  .+....|  .++...+.++..++..+ ......
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999888    89999998753221  1111111  11222222222222111 111113


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCC--------------------chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDK--------------------LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLK  806 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik  806 (973)
                      .....++|+||+.+++|.++++.....                    ....+..++.|++.||+|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            457899999999999999998754211                    1123457899999999999999   99999999


Q ss_pred             CCcEEecC-CCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC----------------------C
Q 039720          807 PSNVLLDH-DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG----------------------D  863 (973)
Q Consensus       807 ~~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~  863 (973)
                      |+|||++. ++.+||+|||+|+......       ........+++.|+|||.+...                      .
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            99999986 5799999999998653221       2223346789999999964322                      2


Q ss_pred             CCcccchHHHHHHHHHHHhCCCCCCCCCCC--------CccHhhhhhHhcCcccccccCcccccccC-CCchhHHHHHHH
Q 039720          864 LSMTGDVYSFGILLLEMFTRRRPTDNMFND--------GLTLHGYAKMALPKKVMGIVDPSLLMEAR-GPSKFEECLVAV  934 (973)
Q Consensus       864 ~~~~sDvwSlG~ll~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  934 (973)
                      ++.++||||+||++|||+++..|+......        ..+...|...         ..+....+.. ............
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~  426 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL---------VEPRASPDLRRGFEVLDLDGGAG  426 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh---------hccccchhhhhhhhhccccchHH
Confidence            345679999999999999977765432100        0011111111         1111000000 000011122345


Q ss_pred             HHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          935 VRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       935 ~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .+++.+|++.||++|||++|++++
T Consensus       427 ~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        427 WELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHHHccCCcccCCCHHHHhCC
Confidence            588999999999999999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=266.45  Aligned_cols=269  Identities=20%  Similarity=0.309  Sum_probs=213.1

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCC-----cEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeE
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDG-----MSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITI  739 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~  739 (973)
                      .+++.....+++....+.+|.||+||.|.|++..     +.|-+|.++.. .+.....+..|.-.+..++|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3455555667888888999999999999886543     34556666433 23345678889989999999999999999


Q ss_pred             eeecccCCCceEEEEEeeccCCCHHHHhhhcCC--------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 039720          740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND--------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       740 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NIL  811 (973)
                      +.+    +.+..++++.++..|+|..+++..+.        ....+...++.|++.|++|||+.   +|||.||.++|.+
T Consensus       356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv  428 (563)
T KOG1024|consen  356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV  428 (563)
T ss_pred             Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence            865    45788999999999999999983321        12244567899999999999999   9999999999999


Q ss_pred             ecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 039720          812 LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM  890 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~  890 (973)
                      +|+.-++||+|=.+++...+.++..-++      .-.....||+||.+....|+.++|||||||++|||+| |+.||.+.
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGD------nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI  502 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGD------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI  502 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCC------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence            9999999999999999876655433222      2235567999999999999999999999999999999 99999865


Q ss_pred             CCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                      ...++  ..+                 ..++.+-..+..|+.+++.+|.-||..+|++||++++++.-|.++..++
T Consensus       503 DPfEm--~~y-----------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  503 DPFEM--EHY-----------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             CHHHH--HHH-----------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            33221  111                 1222334556789999999999999999999999999999999887654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.1e-28  Score=261.99  Aligned_cols=239  Identities=27%  Similarity=0.357  Sum_probs=191.9

Q ss_pred             cceeEEEEEECCCCcEEEEEEeecccchh-HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccCCCHH
Q 039720          686 SFGFVYKGNLGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVD  764 (973)
Q Consensus       686 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  764 (973)
                      +||.||+|++..+++.||+|++....... .+.+.+|++.+++++|+|++++++++..     ....++++||+.+++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            58999999998889999999997655444 6789999999999999999999998654     37889999999999999


Q ss_pred             HHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCccc
Q 039720          765 DWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS  844 (973)
Q Consensus       765 ~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  844 (973)
                      +++..........+..++.+++.++.|||+.   +++|+||+|+||+++.++.++++|||.+.......         ..
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------~~  143 (244)
T smart00220       76 DLLKKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------LL  143 (244)
T ss_pred             HHHHhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---------cc
Confidence            9998766567788899999999999999999   99999999999999999999999999998664321         22


Q ss_pred             ccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCC
Q 039720          845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGP  924 (973)
Q Consensus       845 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (973)
                      ....++..|++||......++.++||||+|+++|++++|..||....... .........            .   ....
T Consensus       144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~------------~---~~~~  207 (244)
T smart00220      144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKP------------K---PPFP  207 (244)
T ss_pred             ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhcc------------C---CCCc
Confidence            34457889999999988888999999999999999999999987532211 111110000            0   0000


Q ss_pred             chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          925 SKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       925 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ......+..+.+++.+|+..+|++||++.++++
T Consensus       208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            000014457788999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.1e-28  Score=277.96  Aligned_cols=269  Identities=19%  Similarity=0.210  Sum_probs=178.4

Q ss_pred             hhcCCcCCccccccceeEEEEEEC----------------CCCcEEEEEEeecccchhHHHH--------------HHHH
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG----------------EDGMSVAVKVMNLDKKGATKSF--------------VAEC  722 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e~  722 (973)
                      .++|++.++||+|+||+||+|.+.                ..++.||||.+........+++              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            568999999999999999999752                2456899999976544333333              3466


Q ss_pred             HHHHhcCCCCc-----eeEEeEeeecc---cCCCceEEEEEeeccCCCHHHHhhhcCC----------------------
Q 039720          723 EALRNIRHRNL-----IKIITICSSID---FKGADFKAIVYEYMQYGSVDDWLHHTND----------------------  772 (973)
Q Consensus       723 ~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------  772 (973)
                      .++.+++|.++     ++++++|....   .......++||||+.+++|.++++....                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766544     66777765421   1123568999999999999999874311                      


Q ss_pred             --CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCccccccccc
Q 039720          773 --KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT  850 (973)
Q Consensus       773 --~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt  850 (973)
                        .....+..++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||++.......       ........+|
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-------~~~~~~g~~t  373 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-------NFNPLYGMLD  373 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-------ccCccccCCC
Confidence              11234678899999999999999   99999999999999999999999999997543211       1111122357


Q ss_pred             ccccCcccccCCC--------------------C--CcccchHHHHHHHHHHHhCCC-CCCCCCCCCccHhhhhhHhcCc
Q 039720          851 IGYIGPEYGMGGD--------------------L--SMTGDVYSFGILLLEMFTRRR-PTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       851 ~~y~aPE~~~~~~--------------------~--~~~sDvwSlG~ll~elltg~~-Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      +.|+|||.+....                    |  ..+.||||+||++|+|++|.. ||.....-......+..... .
T Consensus       374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~-~  452 (507)
T PLN03224        374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN-R  452 (507)
T ss_pred             cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH-H
Confidence            8999999865432                    1  234799999999999999875 66532111111100000000 0


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCC---CCCCCHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESP---SERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~  958 (973)
                       .........     .............+++.+++..+|   .+|+|++|++++
T Consensus       453 -~r~~~~~~~-----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        453 -WRMYKGQKY-----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -HHhhcccCC-----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence             000000000     011112234556678888998766   689999999875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=253.31  Aligned_cols=271  Identities=20%  Similarity=0.241  Sum_probs=195.6

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .+-.+.||.|+||.||.+++..+|+.||.|++...  .-...+++.+|.+++..++|.|++..+++.......--.+.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44467899999999999999999999999988532  2335678999999999999999999888765433222345678


Q ss_pred             EEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          754 VYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      ++|.|. .+|...+-.......+.++-++.||++||.|||+.   +|.||||||.|.|++.+...||||||+|+..+..+
T Consensus       135 ~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence            888875 47777777776777788888999999999999999   99999999999999999999999999998654432


Q ss_pred             CccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc---
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV---  909 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---  909 (973)
                             ....+..+-|.+|+|||++++. .|+.+.||||.||++.|++..+..|.....- .++. ..........   
T Consensus       211 -------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~-lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  211 -------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQ-MIIDLLGTPSQEA  281 (449)
T ss_pred             -------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-HHHH-HHHHHhCCCcHHH
Confidence                   2333445678899999998885 7899999999999999999988888643221 1111 0000000000   


Q ss_pred             ---------ccccC-----cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          910 ---------MGIVD-----PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       910 ---------~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                               ..+.+     +++..-+.. ..+.+....-+.+.++++..||++|.+.++.+..+-
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtl-sS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKI-ASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeee-cCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence                     00000     111111111 111122223456777899999999999998876543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-29  Score=269.21  Aligned_cols=198  Identities=23%  Similarity=0.366  Sum_probs=174.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch---h-----HHHHHHHHHHHHhcC---CCCceeEEeEee
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---A-----TKSFVAECEALRNIR---HRNLIKIITICS  741 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~  741 (973)
                      ..+|...+.+|+|+||.|+.|.+++....|+||.|.+++--   +     -.....|+++|..++   |+||++++++  
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf--  637 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF--  637 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence            45699999999999999999999999999999999755321   1     123567999999997   9999999998  


Q ss_pred             ecccCCCceEEEEEeec-cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEE
Q 039720          742 SIDFKGADFKAIVYEYM-QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV  820 (973)
Q Consensus       742 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl  820 (973)
                         |++.+++|++||.. ++.+|++++.....+.+.++..|++||+.|+++||++   ||||||||-+||.++.+|-+||
T Consensus       638 ---FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  638 ---FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             ---eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence               56679999999985 4569999999999999999999999999999999999   9999999999999999999999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCC
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTD  888 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~  888 (973)
                      +|||.|.+..          ......++||..|.|||++.+.+| +...|||++|+++|.++...-||.
T Consensus       712 idfgsaa~~k----------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTK----------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhc----------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999998764          344557889999999999999998 667899999999999998888875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-29  Score=280.18  Aligned_cols=241  Identities=25%  Similarity=0.342  Sum_probs=183.1

Q ss_pred             CCcccccccee-EEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEEEEEe
Q 039720          679 SNRIGKGSFGF-VYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       679 ~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      .+.+|.|+.|+ ||+|..  .|+.||||.+-   .+..+.+.+|++.++.- .|||||++++.     ..+..+.||+.|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE  583 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE  583 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence            35688999885 899999  88999999884   23445678899999887 59999999875     345689999999


Q ss_pred             eccCCCHHHHhhhcCCCch----hhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---C--CcEEEeccccch
Q 039720          757 YMQYGSVDDWLHHTNDKLE----VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---D--MVAHVSDFGLAR  827 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~~~~----~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~--~~~kl~Dfg~a~  827 (973)
                      .|. -+|.|++...+.-.+    ...+..+.|+++|+++||+.   +|||||+||.||||+.   +  ..++|+|||+++
T Consensus       584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            997 599999987411111    33478899999999999998   9999999999999976   3  478999999999


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .+.....     .-.......||.+|+|||++....-+.++||||+||++|+.++ |.+||++....+..+..      .
T Consensus       660 kl~~~~s-----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~  728 (903)
T KOG1027|consen  660 KLAGGKS-----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------G  728 (903)
T ss_pred             ccCCCcc-----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------C
Confidence            8865431     1122345679999999999999888889999999999999999 59999876443322211      0


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ...       + ...   ....++  .-.++|.+|++.||..||+|.+|+.
T Consensus       729 ~~~-------L-~~L---~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  729 NYT-------L-VHL---EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ccc-------e-eee---ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            000       0 000   000111  4457888999999999999999974

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=9e-29  Score=262.45  Aligned_cols=268  Identities=21%  Similarity=0.285  Sum_probs=202.5

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC------CCCceeEEeEeeecc
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR------HRNLIKIITICSSID  744 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~  744 (973)
                      ....+|.+....|+|-|++|..|.+...|..||||+|+... ..-+.=..|+++|+++.      --|+++++..     
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----  502 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----  502 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----
Confidence            45578999999999999999999999999999999997443 23345568999999995      2367777664     


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCC---CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEE
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHV  820 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl  820 (973)
                      |....++|+|||.+. -+|.+.+.+.+.   +....+..++.|+.-||..|...   +|+|.||||+||||++.. .+||
T Consensus       503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence            556799999999875 589999987654   33466788999999999999988   999999999999998765 5799


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc-Hhh
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT-LHG  899 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~-~~~  899 (973)
                      ||||.|.++....          .+.+..+..|.|||++.+-+|+...|+||+||++||++||+..|++.++..+. ++.
T Consensus       579 CDfGSA~~~~ene----------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  579 CDFGSASFASENE----------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             ccCcccccccccc----------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            9999998876432          22344566899999999999999999999999999999999999877654221 111


Q ss_pred             hhhHhcCcc---------------------------------cccccCc------ccccccCCCchhHHHHHHHHHHHhh
Q 039720          900 YAKMALPKK---------------------------------VMGIVDP------SLLMEARGPSKFEECLVAVVRTGVA  940 (973)
Q Consensus       900 ~~~~~~~~~---------------------------------~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~  940 (973)
                      -.++.+|..                                 ++..+.|      .+....+.+.........|.+|+.+
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            111111110                                 1111111      0111112233344556778899999


Q ss_pred             cCCCCCCCCCCHHHHHHH
Q 039720          941 CSMESPSERMQMTAVVKK  958 (973)
Q Consensus       941 cl~~dP~~RPs~~evl~~  958 (973)
                      |+..||++|.|..+++++
T Consensus       729 ml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKH  746 (752)
T ss_pred             HhccChhhcCCHHHHhcC
Confidence            999999999999998764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-28  Score=239.15  Aligned_cols=252  Identities=20%  Similarity=0.299  Sum_probs=190.2

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +.|.+.+.+|+|-||.+-+|+++++.+.+|+|.++.. .....+|.+|...--.+ .|.||+.-|++    .|+..+.++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v----aFqt~d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEV----AFQTSDAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHH----HhhcCceEE
Confidence            5799999999999999999999999999999998643 23456788887654444 48999998876    477788999


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec--CCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~--~~~~~kl~Dfg~a~~~~  830 (973)
                      +++||++.|+|.+-+... +..+...++++.|+++|++|||++   .+||||||.+||||-  +...+|+||||..+..+
T Consensus        99 F~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             EeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999999999988764 456677889999999999999999   999999999999994  33489999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ..           ......+..|.+||.....     ...+.+|+|.||+++|.++||+.||+...-.+.....|.....
T Consensus       175 ~t-----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~  243 (378)
T KOG1345|consen  175 TT-----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK  243 (378)
T ss_pred             ce-----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence            31           1122345569999974432     3477899999999999999999999865554444444433221


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ...      +.+      |.......+...++.++-+..+|++|.-..++.+
T Consensus       244 rk~------~~~------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  244 RKN------PAL------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             ccC------ccC------chhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            111      111      2223334455667777899999999955544443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-28  Score=243.81  Aligned_cols=263  Identities=19%  Similarity=0.218  Sum_probs=198.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  749 (973)
                      ..+|...+.+|.|.- .|..|.+.-.++.||+|.....  .....++..+|...+..+.|+|+++++.++....+ ..-.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357888899999999 8888888889999999987533  33456788999999999999999999998754322 2234


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..|+|||+|. .+|...++..  ..-+++..++.|++.|+.|+|+.   ||+|||+||+||++..++.+||.|||+|+..
T Consensus        95 e~y~v~e~m~-~nl~~vi~~e--lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILME--LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHHh--cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhccc
Confidence            5789999996 5888887732  23466789999999999999999   9999999999999999999999999999854


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc-
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK-  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-  908 (973)
                      ..         ....+..+.|..|+|||++.+..|.+.+||||+||++.||++|+.-|.+    ...+.+|.+....-+ 
T Consensus       169 ~~---------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~~lgt  235 (369)
T KOG0665|consen  169 DT---------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIEQLGT  235 (369)
T ss_pred             Cc---------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHHHhcC
Confidence            32         2344567789999999999999999999999999999999999999873    334455554431100 


Q ss_pred             ---------------------------cccccCccc-ccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ---------------------------VMGIVDPSL-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ---------------------------~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                                 ..+.+.... .......   .-.....-.++.+|+..||++|.++++++++
T Consensus       236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~---~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS---KLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC---ccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                                       001111111 1111101   0112223466779999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-28  Score=268.80  Aligned_cols=254  Identities=22%  Similarity=0.315  Sum_probs=206.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|.....+|.|+||.||+|+++.+++..|+|+++.+.........+|+-+++..+|||||.+++.+..     .+..+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcCcE
Confidence            4578999999999999999999999999999999998887777888899999999999999999997544     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ++||||.+|+|.+..+-.+...+.++...+++..+|++|||+.   |=+|||||-.||++++.|.+|++|||.+..+...
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999999999999999999999999999999999999999   8899999999999999999999999998766432


Q ss_pred             CCccCCCCCcccccccccccccCcccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYG---MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                              -.....+.||++|||||+.   ..+.|...+|||++|++..|+---++|..+...       .....+.  .
T Consensus       166 --------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~Lm--T  228 (829)
T KOG0576|consen  166 --------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLM--T  228 (829)
T ss_pred             --------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHh--h
Confidence                    2344567899999999975   356889999999999999999887777433211       1100000  0


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ...+++--.      .....+.+.|.++++.|+..+|.+||+++.++.
T Consensus       229 kS~~qpp~l------kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  229 KSGFQPPTL------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccCCCCCcc------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            011111111      111244566778888999999999999987654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-28  Score=251.33  Aligned_cols=392  Identities=21%  Similarity=0.231  Sum_probs=221.5

Q ss_pred             EEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC-CccccCCCcccccCCCCCcEEEccC
Q 039720          186 TFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK-NRFKGSLPVCLGFNLPKLTVLVVAQ  264 (973)
Q Consensus       186 ~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~ip~~~~~~l~~L~~L~Ls~  264 (973)
                      .++|..|+|+...|.+|+.+++|+.||||+|.|+.+-|.+|.++.+|..|-+.+ |+|+ .+|.+.|.+|..|+.|.+.-
T Consensus        71 eirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNa  149 (498)
T KOG4237|consen   71 EIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNA  149 (498)
T ss_pred             EEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcCh
Confidence            344444444433334444444444444444444444444444444444444433 4444 44444444444455555444


Q ss_pred             CcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCC------hhhhhhhcccccceee
Q 039720          265 NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTD------LDFITLLTNCSKLVKL  338 (973)
Q Consensus       265 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------~~~~~~l~~l~~L~~L  338 (973)
                      |++.-+..+.|..+++|..|.|.+|.+..+....|..+.+++.+++..|.+-..-.-.      -.....++...-..-.
T Consensus       150 n~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~  229 (498)
T KOG4237|consen  150 NHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPY  229 (498)
T ss_pred             hhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchH
Confidence            4444444444555555555555555554444444555555555555554421110000      0001112222223333


Q ss_pred             ccccccccCCCChhhhhhhhhhhHhhhcCCccccCCC-ccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcc
Q 039720          339 GLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIP-PEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNN  417 (973)
Q Consensus       339 ~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  417 (973)
                      .+.++++...-+..+......+..-..+.+...+..| ..|..+++|+.|+|++|+|+.+-+.+|.++.+++.|.|..|+
T Consensus       230 rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~  309 (498)
T KOG4237|consen  230 RLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNK  309 (498)
T ss_pred             HHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcch
Confidence            4444444433333332222222222233343444444 468999999999999999999999999999999999999999


Q ss_pred             cCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCC-cccc--------------ccccccc
Q 039720          418 IRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLP-PQIF--------------GITTLSK  482 (973)
Q Consensus       418 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~--------------~~~~l~~  482 (973)
                      |..+-...|.++..|+.|+|.+|+|+..-|.+|..+..|.+|++-.|.+...-- .++.              .-+...+
T Consensus       310 l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~  389 (498)
T KOG4237|consen  310 LEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVR  389 (498)
T ss_pred             HHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhc
Confidence            997777889999999999999999998999999999999999999998762211 0111              1111222


Q ss_pred             eeeccCCcccc---cCCccccc---------ccccce-eccccCcccccccccccCccchhhhcccCcccccccccchhh
Q 039720          483 LLDLSENHLSG---SIPLEVGN---------LKSLVQ-LDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA  549 (973)
Q Consensus       483 ~L~Ls~N~l~~---~~p~~~~~---------l~~L~~-L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  549 (973)
                      .++++.+.+..   ..|++.+.         .+-+.. ...|++.++ .+|..+.  ..-..|++.+|.++ .+|..  .
T Consensus       390 ~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~  463 (498)
T KOG4237|consen  390 QIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--L  463 (498)
T ss_pred             cccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--H
Confidence            34444333321   11211111         111221 223333333 4444332  24567888888888 67766  5


Q ss_pred             hccCCeecCCCCccccccCCCCCCCCccceEeccCC
Q 039720          550 LKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN  585 (973)
Q Consensus       550 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  585 (973)
                      +..| .+|||+|+++..--..|.+|+.|.+|-||+|
T Consensus       464 ~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  464 LRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             Hhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            6777 7888888888655667888888888888876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=2.1e-25  Score=231.01  Aligned_cols=210  Identities=29%  Similarity=0.510  Sum_probs=180.5

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccC
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQY  760 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  760 (973)
                      ||+|++|.||+++...+++.+++|++...... ..+.+.+|++.++.++|++++++++++..     ....++++||+.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            68999999999999877999999999755432 35779999999999999999999998654     3789999999999


Q ss_pred             CCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEeccccchhccCCCCccCC
Q 039720          761 GSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLSHHPFLVAP  838 (973)
Q Consensus       761 gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~  838 (973)
                      ++|.+++... .......+..++.++++++.+||+.   +++|+||+|.||+++. ++.++++|||.+.......     
T Consensus        76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~-----  147 (215)
T cd00180          76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-----  147 (215)
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc-----
Confidence            9999998875 3566778899999999999999999   9999999999999999 8999999999998654321     


Q ss_pred             CCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCccc
Q 039720          839 EGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSL  917 (973)
Q Consensus       839 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (973)
                         .......+...|++||..... .++.++|+|++|++++++                                     
T Consensus       148 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------  187 (215)
T cd00180         148 ---SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------  187 (215)
T ss_pred             ---chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence               012234577889999998877 788999999999999998                                     


Q ss_pred             ccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          918 LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       918 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                    ..+.+++.+|++.+|++||+++++++.
T Consensus       188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                          356688889999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.9e-26  Score=241.85  Aligned_cols=277  Identities=23%  Similarity=0.288  Sum_probs=200.7

Q ss_pred             HHHHhhcCCcCCccccccceeEEEEEECC---CCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecc
Q 039720          669 LSKATKEFSSSNRIGKGSFGFVYKGNLGE---DGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSID  744 (973)
Q Consensus       669 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  744 (973)
                      +....+.|..+++||+|.|++||+|.+..   .+..||+|.+....  ...++.+|+++|..+. +.||+++.++     
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~-----  103 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC-----  103 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----
Confidence            33455789999999999999999999877   78999999986433  3567899999999985 8899999887     


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEecc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDF  823 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~Df  823 (973)
                      +...+...+|+||++.....++...-   ...++..+++.+..||.++|++   |||||||||.|++.+.. +.-.|+||
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~l---~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRSL---SLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhcC---CHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence            45568999999999999988887654   3567889999999999999999   99999999999999854 57899999


Q ss_pred             ccchhccCCC----------------------------------Ccc--CCCCCcccccccccccccCcccccCC-CCCc
Q 039720          824 GLARFLSHHP----------------------------------FLV--APEGQSSSIEMKGTIGYIGPEYGMGG-DLSM  866 (973)
Q Consensus       824 g~a~~~~~~~----------------------------------~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~  866 (973)
                      |+|...+...                                  +..  ............||++|+|||++... ..+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9998321100                                  000  00111122234699999999997765 4588


Q ss_pred             ccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc---cccccCc-------------ccc--------cccC
Q 039720          867 TGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK---VMGIVDP-------------SLL--------MEAR  922 (973)
Q Consensus       867 ~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-------------~~~--------~~~~  922 (973)
                      ++||||.||++.-++++++||-....+...+.+.+...-+..   +....+.             +..        ...+
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            999999999999999999999766655443333332221111   0000000             000        0000


Q ss_pred             -------CCchhHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          923 -------GPSKFEE-CLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       923 -------~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                             ......+ .+...++++.+|+..||.+|.||+|.+++
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                   0111222 23478899999999999999999998864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=5.4e-25  Score=230.85  Aligned_cols=199  Identities=31%  Similarity=0.506  Sum_probs=172.3

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      |.+.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            56778899999999999999888999999999866544 56789999999999999999999998654     3678999


Q ss_pred             EeeccCCCHHHHhhhcCC-CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          755 YEYMQYGSVDDWLHHTND-KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      +||+++++|.+++..... ..+.....++.+++.++.+||+.   +++|+|++|+||+++.++.++++|||.+.......
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            999999999999987665 67788899999999999999999   99999999999999999999999999998664321


Q ss_pred             CccCCCCCcccccccccccccCcccc-cCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYG-MGGDLSMTGDVYSFGILLLEMFTRRRPTDN  889 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~ll~elltg~~Pf~~  889 (973)
                             ........++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus       153 -------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 -------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                   0122334577889999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=5.3e-27  Score=242.25  Aligned_cols=416  Identities=18%  Similarity=0.186  Sum_probs=252.6

Q ss_pred             ecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccC-CcCCC
Q 039720          118 SNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAG-NKLDG  196 (973)
Q Consensus       118 s~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~  196 (973)
                      ++-.++ ++|.++..  +-++++|..|.++...|.+|+.+++|++|||++|+|+..-|+.|.+|.+|.+|-+.+ |+|+.
T Consensus        54 r~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~  130 (498)
T KOG4237|consen   54 RGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD  130 (498)
T ss_pred             cCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence            333344 45554432  224456666666666666666666666666666666655566666666655555544 56653


Q ss_pred             CCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCcccc
Q 039720          197 RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLS  276 (973)
Q Consensus       197 ~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  276 (973)
                      ...+.|++|..|+.|.+.-|++..+..++|..+++|..|.+.+|.+. .++...+..+..++.+.+..|.+.     ...
T Consensus       131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~i-----cdC  204 (498)
T KOG4237|consen  131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFI-----CDC  204 (498)
T ss_pred             hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccc-----ccc
Confidence            33355666666666666666665555555555555555555555555 455544445555555555554421     011


Q ss_pred             CCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhh
Q 039720          277 NASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANL  356 (973)
Q Consensus       277 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l  356 (973)
                      +++.|..       +....+..+++..-..-..|.++++..+.+..+.     ..+..+..--.+.....+..|..-+.-
T Consensus       205 nL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~-----c~~esl~s~~~~~d~~d~~cP~~cf~~  272 (498)
T KOG4237|consen  205 NLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFL-----CSLESLPSRLSSEDFPDSICPAKCFKK  272 (498)
T ss_pred             ccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhh-----hhHHhHHHhhccccCcCCcChHHHHhh
Confidence            1111111       2223334455555555566666666554443221     111122111122223344555544555


Q ss_pred             hhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEE
Q 039720          357 STTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQ  436 (973)
Q Consensus       357 ~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  436 (973)
                      .+.|+.|++++|+|+++-+.+|..+..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+..|.+|+
T Consensus       273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~  352 (498)
T KOG4237|consen  273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN  352 (498)
T ss_pred             cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence            56788888888888888888999999999999999999877778889999999999999999988899999999999999


Q ss_pred             cCCCccccc-----ccccc-----------ccccccccccccCccccc---CCCcccc---------ccccccceeeccC
Q 039720          437 LGFNKLQGS-----IPSYL-----------GKCQNLMQLSAPNNKLNG---TLPPQIF---------GITTLSKLLDLSE  488 (973)
Q Consensus       437 Ls~N~l~~~-----~p~~~-----------~~l~~L~~L~l~~N~l~~---~~p~~~~---------~~~~l~~~L~Ls~  488 (973)
                      |-.|.+.-.     +-+|+           .+-..++.+.++.+.+..   .-|++..         ..+-+..+...|+
T Consensus       353 l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSn  432 (498)
T KOG4237|consen  353 LLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSN  432 (498)
T ss_pred             hccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcc
Confidence            888876410     01111           111235666666665541   1222211         1112223455566


Q ss_pred             CcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCC
Q 039720          489 NHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN  561 (973)
Q Consensus       489 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  561 (973)
                      +.++ .+|..+-  ..-++|++.+|.++ .+|..  .+.+| .+|+++|++.-.--..|.++++|.+|-||+|
T Consensus       433 k~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  433 KLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             cchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            6665 5555442  45678999999999 77877  67788 9999999999666778899999999999887

>PLN03210 Resistant to P

Probab=99.91  E-value=3.4e-23  Score=263.96  Aligned_cols=128  Identities=24%  Similarity=0.364  Sum_probs=66.7

Q ss_pred             cccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEc
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYL  237 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  237 (973)
                      .+|++|+|.+|++. .+|..+..+++|+.|+|++|...+.+|+ ++.+++|+.|+|++|.....+|.++.++++|+.|++
T Consensus       611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            45555566655555 4555555566666666665543334443 555566666666655544455555555555555555


Q ss_pred             cCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCccc
Q 039720          238 FKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS  292 (973)
Q Consensus       238 ~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  292 (973)
                      ++|...+.+|..+  ++++|+.|++++|.....+|..   .++|++|+|++|.++
T Consensus       689 ~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~  738 (1153)
T PLN03210        689 SRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE  738 (1153)
T ss_pred             CCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence            5543333555443  3555555555555433333321   234455555555544

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.90  E-value=5.3e-23  Score=262.24  Aligned_cols=320  Identities=20%  Similarity=0.256  Sum_probs=226.1

Q ss_pred             CCCcCCCCCCEEEccCCC------CCCCCCccccccC-CCCEEeeecccCCCCCCcccccCCCccceEecccccccchhh
Q 039720           80 PYIGNLSFLRVINLANNS------FHGQIPKEVGRLF-RLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQA  152 (973)
Q Consensus        80 ~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~  152 (973)
                      ..+..++.|+.|.+..+.      +...+|..|..++ +|+.|++.++.+. .+|..+ ...+|++|++.+|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            347789999999997654      3446788887765 5999999999987 889888 5789999999999876 5778


Q ss_pred             hhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCC
Q 039720          153 IIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSL  232 (973)
Q Consensus       153 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L  232 (973)
                      .+..+++|+.|+|+++...+.+|. ++.+++|++|+|++|.....+|..++++++|++|++++|...+.+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            889999999999999875557774 8899999999999998777899999999999999999986666777766 89999


Q ss_pred             cEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceeccc
Q 039720          233 DEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR  312 (973)
Q Consensus       233 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  312 (973)
                      +.|++++|...+.+|..    .++|+.|++++|.++ .+|..+ .+++|++|++.++...... ..+..           
T Consensus       707 ~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~-~~~~~-----------  768 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLW-ERVQP-----------  768 (1153)
T ss_pred             CEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccchhhcc-ccccc-----------
Confidence            99999999776677743    468999999999998 456654 5677777777664432110 00000           


Q ss_pred             ccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccc
Q 039720          313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYN  392 (973)
Q Consensus       313 N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N  392 (973)
                                                          ++......+..|+.|++++|...+.+|..++++++|+.|+|++|
T Consensus       769 ------------------------------------l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C  812 (1153)
T PLN03210        769 ------------------------------------LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENC  812 (1153)
T ss_pred             ------------------------------------cchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCC
Confidence                                                00000111123444444444444456666666677777777765


Q ss_pred             cCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccC
Q 039720          393 QLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPN  463 (973)
Q Consensus       393 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  463 (973)
                      ..-+.+|..+ .+++|+.|+|++|..-..+|..   .++|++|+|++|.++ .+|..+..+++|+.|++++
T Consensus       813 ~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~  878 (1153)
T PLN03210        813 INLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG  878 (1153)
T ss_pred             CCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence            4333555554 5666777777766543344432   245666666666666 5666666666666666655

syringae 6; Provisional

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=2.6e-23  Score=209.31  Aligned_cols=166  Identities=19%  Similarity=0.205  Sum_probs=126.5

Q ss_pred             CCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCC
Q 039720          761 GSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE  839 (973)
Q Consensus       761 gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~  839 (973)
                      |+|.++++.. ..+++.+++.++.|++.||+|||+.   +      ||+||+++.++.+|+  ||.++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999864 4578899999999999999999998   5      999999999999999  9998765321       


Q ss_pred             CCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCccccc
Q 039720          840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLM  919 (973)
Q Consensus       840 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  919 (973)
                            ...||+.|+|||++.+..++.++|||||||++|||++|+.||.........+...........         . 
T Consensus        63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~-  126 (176)
T smart00750       63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---------P-  126 (176)
T ss_pred             ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---------c-
Confidence                  125889999999999999999999999999999999999999654332222222111111000         0 


Q ss_pred             ccCCCchhHHHHH--HHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          920 EARGPSKFEECLV--AVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       920 ~~~~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ..  .........  .+.+++.+||..||++||++.|+++++..+
T Consensus       127 ~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      127 RD--RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             cc--cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            00  011122222  688999999999999999999999998765

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=4e-23  Score=243.61  Aligned_cols=262  Identities=26%  Similarity=0.359  Sum_probs=135.7

Q ss_pred             CCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceec
Q 039720          231 SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYL  310 (973)
Q Consensus       231 ~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  310 (973)
                      .-..|+|+.|.++ ++|..+.   ++|+.|++++|+|+. +|.   .+++|++|+|++|+|+.++ .   ..++|+.|+|
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP-~---lp~sL~~L~L  269 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLP-V---LPPGLLELSI  269 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCccc-C---cccccceeec
Confidence            3456777777776 6776654   367777777777773 443   2456677777777766442 2   1345666666


Q ss_pred             ccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcc
Q 039720          311 GRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLE  390 (973)
Q Consensus       311 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls  390 (973)
                      ++|.++.++.                                   ++..++.|++++|+++ .+|.   .+++|+.|+|+
T Consensus       270 s~N~L~~Lp~-----------------------------------lp~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS  310 (788)
T PRK15387        270 FSNPLTHLPA-----------------------------------LPSGLCKLWIFGNQLT-SLPV---LPPGLQELSVS  310 (788)
T ss_pred             cCCchhhhhh-----------------------------------chhhcCEEECcCCccc-cccc---cccccceeECC
Confidence            6665543221                                   0112222333333333 2222   12345555666


Q ss_pred             cccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCC
Q 039720          391 YNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTL  470 (973)
Q Consensus       391 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  470 (973)
                      +|+|++ +|..   ..+|+.|++++|+|++ +|..   ..+|++|+|++|+|+ .+|..   .++|+.            
T Consensus       311 ~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~------------  366 (788)
T PRK15387        311 DNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYK------------  366 (788)
T ss_pred             CCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCC---Ccccce------------
Confidence            665553 2321   1234555555555552 3321   134555555555555 23322   123444            


Q ss_pred             CccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhh
Q 039720          471 PPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNAL  550 (973)
Q Consensus       471 p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  550 (973)
                                   |++++|+|++ +|..   ..+|+.|++++|+|++ +|...   ++|+.|++++|+|+ .+|..+   
T Consensus       367 -------------L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---  421 (788)
T PRK15387        367 -------------LWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---  421 (788)
T ss_pred             -------------ehhhcccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---
Confidence                         4445555542 3322   2345566666666652 44322   35566666666665 345432   


Q ss_pred             ccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCC
Q 039720          551 KSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       551 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  593 (973)
                      .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|.
T Consensus       422 ~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        422 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            34556666666666 5666666666677777777777665554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=8.4e-23  Score=223.67  Aligned_cols=174  Identities=20%  Similarity=0.183  Sum_probs=132.9

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECC-CCcEEEEEEeecc-----cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGE-DGMSVAVKVMNLD-----KKGATKSFVAECEALRNIRHRNLIKIITICSSID  744 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  744 (973)
                      ....+|.+.+.||+|+||+||+|++.. +++.||||++...     .......+.+|+++++.++|+|+++.+..+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            345689999999999999999999876 6788899987532     122356689999999999999998533211    


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEecCCCcEEEecc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDL-KPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDi-k~~NILl~~~~~~kl~Df  823 (973)
                          ...++||||++|++|... ...      ....++.|+++|++|||+.   ||+|||| ||+|||++.++.+||+||
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-RPH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-Ccc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence                357999999999999732 111      1256889999999999999   9999999 999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCC
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG  862 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  862 (973)
                      |+|+.+...................+++.|+|||++...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999977543211111111222456788899999987643

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=1.3e-22  Score=239.34  Aligned_cols=262  Identities=26%  Similarity=0.347  Sum_probs=121.7

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCC
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN  168 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  168 (973)
                      ..|+|++|+|+ .+|..+.  ++|+.|++++|+++ .+|..   .++|++|++++|+++. +|..   .++|+.|+|++|
T Consensus       204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N  272 (788)
T PRK15387        204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSN  272 (788)
T ss_pred             cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccCC
Confidence            34444444444 3444443  24444455444444 23321   2334444444443332 2211   134445555555


Q ss_pred             cccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCc
Q 039720          169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPV  248 (973)
Q Consensus       169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~  248 (973)
                      .++ .+|..+   ++|+.|++++|+++ .+|..   +++|++|+|++|+|++ +|..   ..+|+.|++++|+++ .+|.
T Consensus       273 ~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~-~LP~  339 (788)
T PRK15387        273 PLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPT  339 (788)
T ss_pred             chh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCccc-cccc
Confidence            554 233321   33445555555554 33331   2445555555555543 2221   123444445555554 3442


Q ss_pred             ccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhh
Q 039720          249 CLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITL  328 (973)
Q Consensus       249 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  328 (973)
                      .    ..+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+.+ |..   ..+|+.|+|++|+|+.++..       
T Consensus       340 l----p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~LP~l-------  400 (788)
T PRK15387        340 L----PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTSLPVL-------  400 (788)
T ss_pred             c----ccccceEecCCCccCC-CCCC---CcccceehhhccccccC-ccc---ccccceEEecCCcccCCCCc-------
Confidence            1    1245555555555552 2322   13444455555555532 211   13455555555555433211       


Q ss_pred             hcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCC
Q 039720          329 LTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNL  408 (973)
Q Consensus       329 l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  408 (973)
                         .++|+.                         |++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..+.++++|
T Consensus       401 ---~s~L~~-------------------------LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L  447 (788)
T PRK15387        401 ---PSELKE-------------------------LMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSE  447 (788)
T ss_pred             ---ccCCCE-------------------------EEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCC
Confidence               123333                         4444444442 3332   234566777777777 567777777777


Q ss_pred             CeEEccCcccCCCCCCcc
Q 039720          409 QYLGLVGNNIRGIIPDPI  426 (973)
Q Consensus       409 ~~L~L~~N~l~~~~p~~~  426 (973)
                      +.|+|++|+|++..+..+
T Consensus       448 ~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        448 TTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CeEECCCCCCCchHHHHH
Confidence            788888887777666554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.88  E-value=2.5e-23  Score=257.68  Aligned_cols=206  Identities=16%  Similarity=0.174  Sum_probs=135.4

Q ss_pred             cCC-CCceeEEeEeeecc--cCCCceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 039720          728 IRH-RNLIKIITICSSID--FKGADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG  803 (973)
Q Consensus       728 l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  803 (973)
                      ++| +||+.+++++....  ...++..+.++||+ +++|.+++... ..+++.+++.++.||++||+|||++   +|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            344 46777777652211  12234567788877 56999999753 3467788999999999999999999   99999


Q ss_pred             CCCCCcEEecCCCcE-------------------EEeccccchhccCCCC--c---cCCC---CCcccccccccccccCc
Q 039720          804 DLKPSNVLLDHDMVA-------------------HVSDFGLARFLSHHPF--L---VAPE---GQSSSIEMKGTIGYIGP  856 (973)
Q Consensus       804 Dik~~NILl~~~~~~-------------------kl~Dfg~a~~~~~~~~--~---~~~~---~~~~~~~~~gt~~y~aP  856 (973)
                      ||||+|||++..+.+                   |++|||+++.......  .   ....   .........||+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999655544                   4555555543211000  0   0000   00011123588999999


Q ss_pred             ccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHH
Q 039720          857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVR  936 (973)
Q Consensus       857 E~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  936 (973)
                      |++.+..|+.++|||||||++|||++|..|+.....   .+.......        ..+          ...........
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~--------~~~----------~~~~~~~~~~~  243 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRV--------LPP----------QILLNWPKEAS  243 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhh--------cCh----------hhhhcCHHHHH
Confidence            999999999999999999999999999888653211   111111000        000          00111223457


Q ss_pred             HHhhcCCCCCCCCCCHHHHHHH
Q 039720          937 TGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       937 li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ++.+||+.||.+||++.|+++.
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhc
Confidence            7788999999999999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-23  Score=205.26  Aligned_cols=245  Identities=22%  Similarity=0.313  Sum_probs=185.6

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecccchh--HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      ..-+|.+...|+.|+|+|  .|..+++|++.......  ..+|..|+-.++.+.||||.++++.|..+     ....++.
T Consensus       194 l~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~is  266 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIIS  266 (448)
T ss_pred             hhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEee
Confidence            345789999999999999  67788889887654322  35688999999999999999999998765     7899999


Q ss_pred             eeccCCCHHHHhhhcCCC--chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe--ccccchhccC
Q 039720          756 EYMQYGSVDDWLHHTNDK--LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLARFLSH  831 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~--Dfg~a~~~~~  831 (973)
                      .||+.|+|+..++.....  ...++.+++.++|+|++|||+.. +-|.---+.+..+++|++.+++|.  |-.++...  
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe--  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec--
Confidence            999999999999987654  34678899999999999999983 334444689999999999988774  43333210  


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCC---CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL---SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                                   ....-.|.|++||.++..+-   -+++|+|||++++||+.|...||.+...-+.-+           
T Consensus       344 -------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----------  399 (448)
T KOG0195|consen  344 -------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----------  399 (448)
T ss_pred             -------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----------
Confidence                         11234678999999887654   457999999999999999999998764432111           


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                        .+.-..+     +...++.....+.++|.-|+..||.+||.++.|+-.|++..
T Consensus       400 --kialegl-----rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  400 --KIALEGL-----RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --hhhhccc-----cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              0010111     12223344556668888899999999999999999998763

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=5.4e-22  Score=236.05  Aligned_cols=316  Identities=23%  Similarity=0.336  Sum_probs=150.1

Q ss_pred             cccccchhhHHHHHHHHhhccCCCcCCCCC----CCCCCCCCceee----------------eEeeCCCCeEEEEEeecc
Q 039720           13 YSRHATSHVKHATVTFNMQQLHDPLGVTKS----WNNSINLCQWTG----------------VTCGHRHQRVTKLDLESQ   72 (973)
Q Consensus        13 ~~~~~~~~~~~~ll~~~~~~~~d~~~~l~s----w~~~~~~c~w~g----------------v~C~~~~~~v~~l~l~~~   72 (973)
                      |+...+.++-+.+++..+...+.  +++.+    |++.++.|-=..                |.|..  ..|+.+..-+.
T Consensus        56 ~~~~~~~~~~~~~~~~~~~l~~p--~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~  131 (754)
T PRK15370         56 PPETASPEEIKSKFECLRMLAFP--AYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTES  131 (754)
T ss_pred             CCCCCCHHHHHHHHHHHHHhcCC--chhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--Ccccccccccc
Confidence            44455566667777777655333  35666    998889996544                67754  35666654442


Q ss_pred             CccccccC--CC-------------------------------cCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeec
Q 039720           73 NIGGFLSP--YI-------------------------------GNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSN  119 (973)
Q Consensus        73 ~l~g~~~~--~l-------------------------------~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~  119 (973)
                      ........  ..                               +-......|+|++++++ .+|..+.  ++|+.|+|++
T Consensus       132 ~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~  208 (754)
T PRK15370        132 EQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDN  208 (754)
T ss_pred             cccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecC
Confidence            11111000  00                               11123455666666665 4555442  3566666666


Q ss_pred             ccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCC
Q 039720          120 NSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIP  199 (973)
Q Consensus       120 n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  199 (973)
                      |.++ .+|..+.  .+|++|++++|++. .+|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|++++|+|+ .+|
T Consensus       209 N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP  278 (754)
T PRK15370        209 NELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLP  278 (754)
T ss_pred             CCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccc
Confidence            6665 4554443  35555555555544 2333332  24555555555554 3444432  34555555555554 344


Q ss_pred             CcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCC
Q 039720          200 DSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNAS  279 (973)
Q Consensus       200 ~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  279 (973)
                      +.+.  ++|++|++++|+|+                         .+|..+.   ++|+.|++++|.++. +|..+.  +
T Consensus       279 ~~l~--~sL~~L~Ls~N~Lt-------------------------~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~  325 (754)
T PRK15370        279 ENLP--EELRYLSVYDNSIR-------------------------TLPAHLP---SGITHLNVQSNSLTA-LPETLP--P  325 (754)
T ss_pred             cccC--CCCcEEECCCCccc-------------------------cCcccch---hhHHHHHhcCCcccc-CCcccc--c
Confidence            4332  24555555555554                         3333221   234445555555542 232221  3


Q ss_pred             CCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhh
Q 039720          280 KLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTT  359 (973)
Q Consensus       280 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~  359 (973)
                      +|++|++++|.++++ |..+.  ++|+.|+|++|+|+.++..       +  .++|+.|++++|++. .+|..+.   ..
T Consensus       326 sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~L~~LP~~-------l--p~~L~~LdLs~N~Lt-~LP~~l~---~s  389 (754)
T PRK15370        326 GLKTLEAGENALTSL-PASLP--PELQVLDVSKNQITVLPET-------L--PPTITTLDVSRNALT-NLPENLP---AA  389 (754)
T ss_pred             cceeccccCCccccC-Chhhc--CcccEEECCCCCCCcCChh-------h--cCCcCEEECCCCcCC-CCCHhHH---HH
Confidence            455555555555432 22221  3555555555555433221       0  124555555555554 3444332   24


Q ss_pred             hhHhhhcCCccccCCCccc----cCCCCcCEEEcccccCC
Q 039720          360 MTLIAMAGNQISGTIPPEI----RNLFNLNGLGLEYNQLT  395 (973)
Q Consensus       360 l~~L~l~~n~l~~~~p~~~----~~l~~L~~L~Ls~N~l~  395 (973)
                      ++.|++++|+|+ .+|..+    ..++++..|+|.+|.++
T Consensus       390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            556666666655 333322    22344445555555444

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=3.4e-21  Score=212.73  Aligned_cols=265  Identities=18%  Similarity=0.190  Sum_probs=191.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCC-cEEEEEEeecccchhHHHHHHHHHHHHhcCC----CCceeEEeEeeecccCCCc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDG-MSVAVKVMNLDKKGATKSFVAECEALRNIRH----RNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~  749 (973)
                      +|.+.++||+|+||.||.|.+..++ ..+|+|+...........+..|+.++..+..    +++..+++...    ..+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999997664 6789998876543333367888888888862    57888877642    3457


Q ss_pred             eEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-----CcEEEec
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-----MVAHVSD  822 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-----~~~kl~D  822 (973)
                      ..++||+.+ |.+|.++....  +.+...++..++.|++.+|+++|+.   |++||||||.|+++...     ..+.+.|
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            889999976 78999987544  4567788999999999999999999   99999999999999865     4689999


Q ss_pred             cccchhcc--CCCCccCCCCCcc-cccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhh
Q 039720          823 FGLARFLS--HHPFLVAPEGQSS-SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG  899 (973)
Q Consensus       823 fg~a~~~~--~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~  899 (973)
                      ||+|+.+.  ...... ...... ...+.||..|.++++..+...+++.|+||++.++.|++.|..||........ ...
T Consensus       171 fGlar~~~~~~~~~~~-~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~  248 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGN-LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK  248 (322)
T ss_pred             cCCCccccccCCCCcc-cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH
Confidence            99998332  111000 001111 2346699999999999999999999999999999999999999965543211 111


Q ss_pred             hhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          900 YAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      ............              .....+..+.++...+-..+..++|....+...+++..
T Consensus       249 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  249 FEKDPRKLLTDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             HHHHhhhhcccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            111110000000              01112233445555555689999999999998887663

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-20  Score=190.04  Aligned_cols=264  Identities=17%  Similarity=0.220  Sum_probs=190.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      .|++.++||+|+||+++.|+..-+++.||||.-....  ...++..|....+.+. .++|..++-+     .+++.+..+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~NiL  101 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNIL  101 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhhh
Confidence            6999999999999999999999999999999875332  3445777888887775 6888887765     344567789


Q ss_pred             EEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-----cEEEeccccch
Q 039720          754 VYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-----VAHVSDFGLAR  827 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-----~~kl~Dfg~a~  827 (973)
                      |+|.+ |.+|+|+..- ...+...++..+|.|++.-++|+|++   ..|+|||||+|+||...+     .+.++|||+|+
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            99977 7899998874 44567788999999999999999999   999999999999997544     58999999999


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .+-.... ..-..-+......||..||+-....+...++..|+-|+|-++.+.+-|..||.+...+. .-..+.++..-.
T Consensus       178 ~YrDp~T-kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-nK~kYeKIGe~K  255 (449)
T KOG1165|consen  178 EYRDPKT-KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-NKEKYEKIGETK  255 (449)
T ss_pred             hhcCccc-cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-hHHHHHHhcccc
Confidence            8754331 00011223334569999999999999999999999999999999999999998764431 112222221110


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .   ....+        +-....+.++.+-+.-.-..|-++-|..+=+...+.++
T Consensus       256 r---~T~i~--------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  256 R---STPIE--------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             c---cCCHH--------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            0   00000        11112233444444444457778888877665555444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=6e-21  Score=227.15  Aligned_cols=223  Identities=26%  Similarity=0.392  Sum_probs=116.0

Q ss_pred             ccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEcc
Q 039720          159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLF  238 (973)
Q Consensus       159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  238 (973)
                      +...|+++++.++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|++++|+|+                   
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-------------------  233 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-------------------  233 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-------------------
Confidence            4556666666666 4555443  35666666666666 4454433  35666666666555                   


Q ss_pred             CCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCC
Q 039720          239 KNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTR  318 (973)
Q Consensus       239 ~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  318 (973)
                            .+|..+.   ++|+.|+|++|.++ .+|..+.  ++|++|+|++|+|+. +|..+.  ++|+.|+|++|+|+.+
T Consensus       234 ------sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L  298 (754)
T PRK15370        234 ------SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTL  298 (754)
T ss_pred             ------cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccC
Confidence                  3333322   24555555555555 3344432  356666666666653 233332  3566666666655432


Q ss_pred             CCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCC
Q 039720          319 TSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTI  398 (973)
Q Consensus       319 ~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  398 (973)
                      +.                               .+   +..++.|++++|+++. +|..+.  ++|+.|++++|.+++ +
T Consensus       299 P~-------------------------------~l---p~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-L  340 (754)
T PRK15370        299 PA-------------------------------HL---PSGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-L  340 (754)
T ss_pred             cc-------------------------------cc---hhhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-C
Confidence            21                               10   1234455555555552 333222  467777777777763 5


Q ss_pred             CccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccc
Q 039720          399 PPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN  467 (973)
Q Consensus       399 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  467 (973)
                      |..+.  ++|+.|+|++|+|+ .+|..+.  +.|++|+|++|+|+ .+|..+.  .+|+.|++++|+|.
T Consensus       341 P~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~  401 (754)
T PRK15370        341 PASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV  401 (754)
T ss_pred             Chhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence            55443  56677777777666 3444332  45666666666665 3443332  23444444444444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.1e-21  Score=186.95  Aligned_cols=209  Identities=22%  Similarity=0.288  Sum_probs=165.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCC-CCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH-RNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ...|+++++||+|+||.+|.|....+|..||||+-+....  ..++.-|.++.+.+++ ..|..+..|     ..+..+.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccccccc
Confidence            4689999999999999999999999999999999864432  3456778888888875 556666555     3345778


Q ss_pred             EEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC---CcEEEeccccch
Q 039720          752 AIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLAR  827 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~---~~~kl~Dfg~a~  827 (973)
                      .+||+.+ |.+|+++..- ...+.-.++.-++-|++.-++|+|.+   ++|||||||+|+|+.-+   ..+.++|||+|+
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            8999987 7899998874 34556677888999999999999999   99999999999999744   468999999999


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND  893 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~  893 (973)
                      .+-..... .-..........||..|.+-....+...+...|+-|+|.++.++--|..||++....
T Consensus       163 ky~d~~t~-~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  163 KYRDIRTR-QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             hhcccccc-ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            77443210 001122333457999999988888888899999999999999999999999977543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.5e-21  Score=225.17  Aligned_cols=257  Identities=18%  Similarity=0.208  Sum_probs=187.9

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecc--cc----hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KK----GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..+.+|.|++|.|+.+.........+.|.++..  ..    .....+..|+-+-..++|||++..+..+.+.     ...
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence            356799999999998888777776777765421  11    1112256677777888999998876654332     233


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      .-.||||++ +|+.++...+.+...++..++.|+..|+.|+|+.   ||.|||+|++|++++.+|.+||+|||.+.....
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            334999999 9999998877777788899999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLS-MTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..    +.........+|...|+|||+..+..|. +..||||.|++++.|.+|+.||......+...   .......+..
T Consensus       473 ~~----e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~  545 (601)
T KOG0590|consen  473 PW----EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRN  545 (601)
T ss_pred             Cc----chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccccccc
Confidence            11    1112344567899999999999999995 45899999999999999999998665543322   0000000000


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              ............+.+-..+|.+|++.||.+|.|+++|++.
T Consensus       546 --------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  546 --------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             --------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence                    0000011223455666788889999999999999999863

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=3.7e-19  Score=198.68  Aligned_cols=261  Identities=27%  Similarity=0.377  Sum_probs=193.9

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccch---hHHHHHHHHHHHHhcCCC-CceeEEeEeeecccCCCceE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---ATKSFVAECEALRNIRHR-NLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  751 (973)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+......   ....+.+|..+++.+.|+ +++++.+++.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            677889999999999999996   88999999755432   367799999999999988 7999998863     23457


Q ss_pred             EEEEeeccCCCHHHHhhhcC---CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccch
Q 039720          752 AIVYEYMQYGSVDDWLHHTN---DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAR  827 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~  827 (973)
                      +++++++.++++.+++....   .........++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            99999999999997777664   567788899999999999999999   999999999999999998 79999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCC--CccHhhhhh
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFND--GLTLHGYAK  902 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~--~~~~~~~~~  902 (973)
                      ...........  ........||..|+|||.+.+   ..+....|+||+|++++++++|..||......  .........
T Consensus       151 ~~~~~~~~~~~--~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  228 (384)
T COG0515         151 LLPDPGSTSSI--PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL  228 (384)
T ss_pred             ecCCCCccccc--cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence            54332100000  013356679999999999887   57899999999999999999999997654431  111111111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....    .........     ........+.+++..|+..+|..|.++.+....
T Consensus       229 ~~~~~----~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 ELPTP----SLASPLSPS-----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hcCCc----ccccccCcc-----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11100    000000000     002223456788889999999999999887764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=9.2e-21  Score=218.75  Aligned_cols=252  Identities=20%  Similarity=0.254  Sum_probs=178.5

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch-hH---HHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-AT---KSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +|...+-+|++.|=+|.+|++. .|. |+||++-...+. .-   .+...|++ ...++|||++++.-+     ......
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence            5677888999999999999995 454 999999644322 22   33444444 556689999998654     233466


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .|+|-+|+. -+|+|.+..+......+.+.|+.|++.|+..+|+.   ||+|||||.+|||++.-..+.|+||..-+-. 
T Consensus        96 AylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPt-  170 (1431)
T KOG1240|consen   96 AYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPT-  170 (1431)
T ss_pred             HHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCc-
Confidence            778888886 48999998776666778889999999999999999   9999999999999999999999999865432 


Q ss_pred             CCCCccCCCCCcccccc----cccccccCcccccC----------CC-CCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 039720          831 HHPFLVAPEGQSSSIEM----KGTIGYIGPEYGMG----------GD-LSMTGDVYSFGILLLEMFT-RRRPTDNMFNDG  894 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~----~gt~~y~aPE~~~~----------~~-~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~  894 (973)
                          +..++.......+    ..-.+|+|||.+..          .+ .+++.||||+||+++|+++ |++||.-.    
T Consensus       171 ----YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----  242 (1431)
T KOG1240|consen  171 ----YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----  242 (1431)
T ss_pred             ----cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence                2222223222222    23347999997543          23 6788999999999999999 88888621    


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                       ++-.|..+.       ..+++...+.     .+  ...+.+++..|++.||++|.+|++.++.-+++
T Consensus       243 -QL~aYr~~~-------~~~~e~~Le~-----Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  243 -QLLAYRSGN-------ADDPEQLLEK-----IE--DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -HHHhHhccC-------ccCHHHHHHh-----Cc--CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             222222221       0111111000     00  11355788899999999999999999876554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=1.2e-19  Score=183.15  Aligned_cols=139  Identities=17%  Similarity=0.135  Sum_probs=109.0

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchh--------------------------HHHHHHHHHHHHhcCCCC
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--------------------------TKSFVAECEALRNIRHRN  732 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~n  732 (973)
                      ...||+|+||.||+|.+. +|+.||||+++......                          ......|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999996 89999999997542210                          112345999999998887


Q ss_pred             ceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEE
Q 039720          733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       733 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~ivHrDik~~NIL  811 (973)
                      +.....+..       ...++||||+.++++.........++..++..++.|++.++.|+ |+.   ||+||||||+||+
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl  150 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL  150 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence            644332211       22379999999987765544445667778899999999999999 688   9999999999999


Q ss_pred             ecCCCcEEEeccccchhc
Q 039720          812 LDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~  829 (973)
                      ++ ++.++++|||+|...
T Consensus       151 i~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         151 YH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EE-CCcEEEEEccccccC
Confidence            98 578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=7.7e-20  Score=185.75  Aligned_cols=176  Identities=15%  Similarity=0.152  Sum_probs=134.1

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHH---H------HHHHHHHHHhcCCCCceeEEeEeee
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK---S------FVAECEALRNIRHRNLIKIITICSS  742 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~e~~~l~~l~h~niv~~~~~~~~  742 (973)
                      ..++|+..+.+|.|+||.||.+..  ++..+|+|+++........   .      +.+|+..+.++.||++..+.++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            457899999999999999999766  5778999999744322222   2      6789999999999999999887543


Q ss_pred             ccc---CCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEE
Q 039720          743 IDF---KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH  819 (973)
Q Consensus       743 ~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~k  819 (973)
                      ...   ......+++|||++|.+|.++..    ..    .....+++.++..+|+.   |++|||+||+||+++.++ ++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~----~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----IS----EDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----cc----HHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence            211   12356889999999999988732    11    13466999999999999   999999999999999988 99


Q ss_pred             EeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHH
Q 039720          820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF  881 (973)
Q Consensus       820 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ell  881 (973)
                      ++|||.........         ..           ..+.....|..++|+|+||+++....
T Consensus       175 liDfg~~~~~~e~~---------a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRK---------AK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchh---------hH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999876442211         00           01334455677999999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=5.4e-19  Score=175.23  Aligned_cols=194  Identities=16%  Similarity=0.069  Sum_probs=141.2

Q ss_pred             CcCCccccccceeEEEEEECCCCcEEEEEEeecccc----hhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceE
Q 039720          677 SSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK----GATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       677 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .+...|++|+||+||.+..  .+.+++.+.+.....    .....+.+|+++|+++. |+++++++++         ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            3467899999999997766  788888887764433    11235789999999995 5889999886         346


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDL-KPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDi-k~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +++|||+.|.+|......       ....++.|++.+++++|+.   ||+|||| ||+|||++.++.++|+|||+|....
T Consensus        74 ~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             EEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            899999999998754321       1245788999999999999   9999999 7999999999999999999998554


Q ss_pred             CCCCcc-----CCCCCcccccccccccccCcccccCC-CCC-cccchHHHHHHHHHHHhCCCCCCCCC
Q 039720          831 HHPFLV-----APEGQSSSIEMKGTIGYIGPEYGMGG-DLS-MTGDVYSFGILLLEMFTRRRPTDNMF  891 (973)
Q Consensus       831 ~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~ll~elltg~~Pf~~~~  891 (973)
                      ....+.     .+...-.......++.|++|+...-- ..+ ...+.++.|+.+|.++|++.|+....
T Consensus       144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            322100     00000001112357788888753321 222 56788999999999999999976543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.3e-18  Score=176.61  Aligned_cols=140  Identities=21%  Similarity=0.170  Sum_probs=110.2

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchh--------------------------HHHHHHHHHHHHhcCCCC
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--------------------------TKSFVAECEALRNIRHRN  732 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~n  732 (973)
                      ...||+|++|.||+|++. +|+.||||+++......                          ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999986 89999999997542110                          122457899999999998


Q ss_pred             ceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEE
Q 039720          733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       733 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NIL  811 (973)
                      +.....+..       ...++||||++|+++..........+..+..+++.|++.++.++|+ .   ||+||||||+||+
T Consensus        81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceEEEe-------cCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence            754444321       1247999999988654432233445567788999999999999999 8   9999999999999


Q ss_pred             ecCCCcEEEeccccchhcc
Q 039720          812 LDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++ ++.++++|||+|+...
T Consensus       151 l~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EE-CCCEEEEEcccceecC
Confidence            99 8999999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=7e-21  Score=174.97  Aligned_cols=176  Identities=27%  Similarity=0.432  Sum_probs=95.4

Q ss_pred             CCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceee
Q 039720          406 RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLD  485 (973)
Q Consensus       406 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~  485 (973)
                      .+.+.|.||+|+++ .+|..++.+.+|++|++++|+++ .+|..++.+++|+.|+++-|++.                  
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~------------------   92 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN------------------   92 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh------------------
Confidence            33444444444444 33334444444444444444444 44444444444444444433333                  


Q ss_pred             ccCCcccccCCcccccccccceeccccCcccc-cccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccc
Q 039720          486 LSENHLSGSIPLEVGNLKSLVQLDISRNNFSN-EIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS  564 (973)
Q Consensus       486 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  564 (973)
                              ..|..|+.++.|+.|||+.|++.. .+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+..|.+-
T Consensus        93 --------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll  163 (264)
T KOG0617|consen   93 --------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL  163 (264)
T ss_pred             --------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence                    344445555555555555555532 35555666666666666666665 56666666666666666666665


Q ss_pred             cccCCCCCCCCccceEeccCCcCcCcCCCCCCC---CCccccccccCccc
Q 039720          565 GQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVF---SNETRISLTGNEQF  611 (973)
Q Consensus       565 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~---~~~~~l~~~~N~~~  611 (973)
                       .+|..++.++.|+.|.+.+|+++-.+|+.+.+   .+-....++.|||.
T Consensus       164 -~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  164 -SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             -hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence             56666666666666666666666666655432   22344566777774

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=2.3e-20  Score=171.60  Aligned_cols=166  Identities=35%  Similarity=0.573  Sum_probs=132.8

Q ss_pred             cccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccccccccccccc
Q 039720          377 EIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNL  456 (973)
Q Consensus       377 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  456 (973)
                      .+.++.+.+.|.||+|+++ .+|..++.+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            3456677888999999998 77888999999999999999998 78889999999999999999998 899999999999


Q ss_pred             ccccccCcccc-cCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhccc
Q 039720          457 MQLSAPNNKLN-GTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQ  535 (973)
Q Consensus       457 ~~L~l~~N~l~-~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~  535 (973)
                      +.|||..|.+. ..+|..||.+..+. .|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|+.|+++
T Consensus       105 evldltynnl~e~~lpgnff~m~tlr-alyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq  181 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFYMTTLR-ALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ  181 (264)
T ss_pred             hhhhccccccccccCCcchhHHHHHH-HHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence            99999999887 35677777776664 6777777776 67777777777777777777776 567777777777777777


Q ss_pred             Ccccccccccchhh
Q 039720          536 GNSFNGSIPQSLNA  549 (973)
Q Consensus       536 ~N~l~~~~p~~~~~  549 (973)
                      +|+++ .+|..+++
T Consensus       182 gnrl~-vlppel~~  194 (264)
T KOG0617|consen  182 GNRLT-VLPPELAN  194 (264)
T ss_pred             cceee-ecChhhhh
Confidence            77776 56655544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=1.1e-18  Score=182.78  Aligned_cols=236  Identities=20%  Similarity=0.272  Sum_probs=146.2

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcC----------CCCceeEEeEee
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIR----------HRNLIKIITICS  741 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~----------h~niv~~~~~~~  741 (973)
                      .+...+.||.|+++.||.+++.++++++|+|++.....   ...+++.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45567789999999999999999999999999975542   22345555554433322          212222222222


Q ss_pred             ecc----c---CCCc-----eEEEEEeeccCCCHHHHhh---hcCCCc----hhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 039720          742 SID----F---KGAD-----FKAIVYEYMQYGSVDDWLH---HTNDKL----EVGKLNIVIEVASVIEYLHNHCQPPIVH  802 (973)
Q Consensus       742 ~~~----~---~~~~-----~~~lv~e~~~~gsL~~~l~---~~~~~~----~~~~~~i~~qi~~aL~~LH~~~~~~ivH  802 (973)
                      ...    +   .+..     ..+++|+-+. ++|.+++.   ......    ...+..+..|+++.+++||+.   |+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence            100    0   0011     2356777664 68887754   222221    123456678999999999999   9999


Q ss_pred             cCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC--------CCCCcccchHHHH
Q 039720          803 GDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--------GDLSMTGDVYSFG  874 (973)
Q Consensus       803 rDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG  874 (973)
                      +||||+|++++.+|.+.|+||+.....+.           .......+..|.+||....        -.++.+.|.|++|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG  237 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT-----------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG  237 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE-----------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc-----------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence            99999999999999999999998775432           1111334567999997533        2578899999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCC
Q 039720          875 ILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER  949 (973)
Q Consensus       875 ~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  949 (973)
                      +++|.|++|+.||.....+.....                     .....   .+.++.+..+|..+++.+|++|
T Consensus       238 ~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C---~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  238 ITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRC---RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTS---S---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHccCCCCCCCccccccc---------------------cchhc---CCcCHHHHHHHHHHccCCcccC
Confidence            999999999999986533211100                     11101   1556778899999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.8e-18  Score=177.84  Aligned_cols=206  Identities=20%  Similarity=0.252  Sum_probs=141.9

Q ss_pred             CCCCceeEEeEeeecc----------------------cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHH
Q 039720          729 RHRNLIKIITICSSID----------------------FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA  786 (973)
Q Consensus       729 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~  786 (973)
                      +|||||.+.+++.+.-                      ..++...|+||..++. +|..++-.... ......-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~-s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR-SYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC-chHHHHHHHHHHH
Confidence            5999999987654311                      2234567899988764 88888865533 3345677889999


Q ss_pred             HHHHHHHhcCCCCeEecCCCCCcEEec--CCC--cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC
Q 039720          787 SVIEYLHNHCQPPIVHGDLKPSNVLLD--HDM--VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG  862 (973)
Q Consensus       787 ~aL~~LH~~~~~~ivHrDik~~NILl~--~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  862 (973)
                      +|+.|||++   ||.|||+|++|||+.  +|+  ...++|||.+---+...  ............-|.-.-||||+.+..
T Consensus       352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG--lqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG--LQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccc--cccccccccccCCCcceecchhhhhcC
Confidence            999999999   999999999999994  333  67899999875332211  111111122223366678999987654


Q ss_pred             CC------CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHH
Q 039720          863 DL------SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVR  936 (973)
Q Consensus       863 ~~------~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  936 (973)
                      +-      -.++|.|+.|.+.||+++..-||....+  +.+                +.....+...+..++.++..+.+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L----------------~~r~Yqe~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLL----------------DTRTYQESQLPALPSRVPPVARQ  488 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccch--hee----------------chhhhhhhhCCCCcccCChHHHH
Confidence            21      3579999999999999999999975222  111                11111222334555667777889


Q ss_pred             HHhhcCCCCCCCCCCHHHHHHHH
Q 039720          937 TGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       937 li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ++...++.||.+|+++.-....+
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHH
Confidence            99999999999999987555443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=3.1e-18  Score=203.22  Aligned_cols=201  Identities=22%  Similarity=0.286  Sum_probs=159.8

Q ss_pred             HHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC---CCCceeEEeEeeecc
Q 039720          668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR---HRNLIKIITICSSID  744 (973)
Q Consensus       668 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  744 (973)
                      ++......|.|.+.||+|+||+||.|.... |+.||+|+-+...   .-+|+--.+++.+++   -+.|.++..+     
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a-----  762 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSA-----  762 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHH-----
Confidence            334455789999999999999999999964 9999999976432   223334445555555   2333333332     


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-------CCc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-------DMV  817 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-------~~~  817 (973)
                      +...+.-++|+||.+.|+|.+++...+.+.+.-++.+..|++..+++||..   +|||+||||+|.|+..       ...
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence            222366789999999999999999888888888899999999999999999   9999999999999942       346


Q ss_pred             EEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 039720          818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP  886 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~P  886 (973)
                      ++|+|||.+-.+.-..      .+..+...++|-.+-.+|+..+.+|++++|.|.++.+++-|+.|++-
T Consensus       840 l~lIDfG~siDm~lfp------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFP------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eEEEecccceeeeEcC------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            8999999998764322      23466678899999999999999999999999999999999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.74  E-value=5.2e-19  Score=195.76  Aligned_cols=225  Identities=22%  Similarity=0.227  Sum_probs=175.2

Q ss_pred             cccccceeEEEEEE---CCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceEEEEE
Q 039720          682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       682 lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +|+|+||.|+.++-   ...|..+|+|+.+....  ........|..++...+ ||.+|++...     ++.+...+++.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHhh
Confidence            79999999997532   34678899998864421  12225667888888887 9999998654     56678899999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      +|..+|.+...+.....+.+.....+...++-|++++|+.   +|+|||+|++||+++.+|++++.|||.++..-...  
T Consensus        77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            9999999999998888888888888899999999999999   99999999999999999999999999998754321  


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                                ..+||..|||||++.  ....++|.||||++++||+||..||...     .+...            ...
T Consensus       152 ----------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-----~~~~I------------l~~  202 (612)
T KOG0603|consen  152 ----------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-----TMKRI------------LKA  202 (612)
T ss_pred             ----------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-----HHHHH------------hhh
Confidence                      117999999999988  5677899999999999999999999851     01000            000


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM  952 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  952 (973)
                      +       ...+.+......+++..+...+|..|.-.
T Consensus       203 ~-------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 E-------LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             c-------cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            1       12223334444566667888888888865

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=1.1e-19  Score=201.98  Aligned_cols=261  Identities=23%  Similarity=0.260  Sum_probs=143.3

Q ss_pred             EEeeccCcc-ccccCCCcCCCCCCEEEccCCCCCC----CCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEe
Q 039720           67 LDLESQNIG-GFLSPYIGNLSFLRVINLANNSFHG----QIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV  141 (973)
Q Consensus        67 l~l~~~~l~-g~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l  141 (973)
                      |+|.+++++ +.....+..++.|++|+++++.++.    .++..+...++|++|+++++.+.+ .|..            
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~------------   69 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRG------------   69 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchH------------
Confidence            455555554 2333344555667777777776642    244455566667777776666542 1111            


Q ss_pred             cccccccchhhhhccccccceeeccCCcccccCCCCCCCCCc---ccEEEccCCcCCC----CCCCcccCC-Cccceecc
Q 039720          142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA---LQTFDIAGNKLDG----RIPDSLGQL-RNLNYLGT  213 (973)
Q Consensus       142 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~L-~~L~~L~L  213 (973)
                           ...++..+..+++|+.|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++
T Consensus        70 -----~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L  144 (319)
T cd00116          70 -----LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL  144 (319)
T ss_pred             -----HHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEc
Confidence                 0223444555556666666666655444444444443   6666666666542    122334444 56666666


Q ss_pred             CCCCcccc----CCccccCCCCCcEEEccCCccccC----CCcccccCCCCCcEEEccCCccccc----CCccccCCCCC
Q 039720          214 SENDFSGM----FPLSVCNISSLDEAYLFKNRFKGS----LPVCLGFNLPKLTVLVVAQNNLTGF----LPQSLSNASKL  281 (973)
Q Consensus       214 s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----ip~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L  281 (973)
                      ++|.+++.    ++..+..+.+|++|++++|.+++.    ++..+. .+++|++|+|++|.+++.    +...+..+++|
T Consensus       145 ~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~-~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L  223 (319)
T cd00116         145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLK-ANCNLEVLDLNNNGLTDEGASALAETLASLKSL  223 (319)
T ss_pred             CCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHH-hCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence            66666521    233445555666666666666532    122222 345777777777776532    33445667777


Q ss_pred             CEEEccCCcccccCccccc-----CcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCC
Q 039720          282 EWLELNENHFSGQVRINFN-----SLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGA  348 (973)
Q Consensus       282 ~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~  348 (973)
                      ++|++++|.+++.....+.     ..+.|++|++++|.++...  .......+..+++|+.+++++|.++..
T Consensus       224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~--~~~l~~~~~~~~~L~~l~l~~N~l~~~  293 (319)
T cd00116         224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDG--AKDLAEVLAEKESLLELDLRGNKFGEE  293 (319)
T ss_pred             CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHH--HHHHHHHHhcCCCccEEECCCCCCcHH
Confidence            8888877777653222221     2367778888877775321  223344556667777777777776633

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.73  E-value=1e-19  Score=202.06  Aligned_cols=254  Identities=20%  Similarity=0.216  Sum_probs=153.2

Q ss_pred             eEEEEEeeccCccc----cccCCCcCCCCCCEEEccCCCCCC------CCCccccccCCCCEEeeecccCCCCCCccccc
Q 039720           63 RVTKLDLESQNIGG----FLSPYIGNLSFLRVINLANNSFHG------QIPKEVGRLFRLETIVLSNNSFSGKIPTNLSR  132 (973)
Q Consensus        63 ~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~  132 (973)
                      .++.++++++.+++    .+++.+...+.|+.|+++++.+.+      .++..+..+++|++|+|++|.+.+..+..+..
T Consensus        24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~  103 (319)
T cd00116          24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES  103 (319)
T ss_pred             hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence            38889999998844    356677888999999999998862      34456778889999999999998766766666


Q ss_pred             CCC---ccceEeccccccc----chhhhhccc-cccceeeccCCcccc----cCCCCCCCCCcccEEEccCCcCCCC---
Q 039720          133 CFN---LIDFWVHTNNLVG----EIQAIIGNW-LKIERLSLYGNQLTG----QLPPSIGNLSALQTFDIAGNKLDGR---  197 (973)
Q Consensus       133 l~~---L~~L~l~~n~~~~----~~~~~~~~l-~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~---  197 (973)
                      +.+   |++|++++|++.+    .+...+..+ ++|+.|+|++|.+++    .++..+..+.+|++|++++|.+++.   
T Consensus       104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  183 (319)
T cd00116         104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR  183 (319)
T ss_pred             HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence            665   7888888777763    333445555 677777777777663    2333455556677777777766532   


Q ss_pred             -CCCcccCCCccceeccCCCCccccC----CccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCC
Q 039720          198 -IPDSLGQLRNLNYLGTSENDFSGMF----PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLP  272 (973)
Q Consensus       198 -~p~~~~~L~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p  272 (973)
                       ++..+..+++|++|++++|.+++..    +..+.                         .+++|++|++++|.+++...
T Consensus       184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~-------------------------~~~~L~~L~ls~n~l~~~~~  238 (319)
T cd00116         184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLA-------------------------SLKSLEVLNLGDNNLTDAGA  238 (319)
T ss_pred             HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhc-------------------------ccCCCCEEecCCCcCchHHH
Confidence             2223444456666666666665321    12223                         34555555555555553222


Q ss_pred             cccc-----CCCCCCEEEccCCcccc----cCcccccCcccccceecccccCCCCCCCChhhhhhhccc-ccceeecccc
Q 039720          273 QSLS-----NASKLEWLELNENHFSG----QVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNC-SKLVKLGLVF  342 (973)
Q Consensus       273 ~~~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l-~~L~~L~l~~  342 (973)
                      ..+.     ..+.|++|++++|.++.    .....+..+++|+++++++|.++....  ......+... +.|+++++.+
T Consensus       239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~~~~~~~  316 (319)
T cd00116         239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGA--QLLAESLLEPGNELESLWVKD  316 (319)
T ss_pred             HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHH--HHHHHHHhhcCCchhhcccCC
Confidence            2221     23566666666666651    122334455666677777766654321  1222233333 4555555555


Q ss_pred             c
Q 039720          343 N  343 (973)
Q Consensus       343 N  343 (973)
                      |
T Consensus       317 ~  317 (319)
T cd00116         317 D  317 (319)
T ss_pred             C
Confidence            4

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=4.4e-17  Score=165.71  Aligned_cols=139  Identities=17%  Similarity=0.262  Sum_probs=107.7

Q ss_pred             CcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-----CCCCceeEEeEeeecccCCCce-
Q 039720          677 SSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-----RHRNLIKIITICSSIDFKGADF-  750 (973)
Q Consensus       677 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-  750 (973)
                      .-.+.||+|+||.||.  +..++.. +||++........+.+.+|+++++.+     .||||+++++++...  .+... 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence            3457899999999995  6667666 69999766555667899999999999     579999999987542  11123 


Q ss_pred             EEEEEee--ccCCCHHHHhhhcCCCchhhHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEecC----CCcEEEecc
Q 039720          751 KAIVYEY--MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI-EYLHNHCQPPIVHGDLKPSNVLLDH----DMVAHVSDF  823 (973)
Q Consensus       751 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~~~~ivHrDik~~NILl~~----~~~~kl~Df  823 (973)
                      +.+|+||  +.+|+|.+++.+. .+.+.  ..++.|++.++ +|||++   +|+||||||+||+++.    ++.++|+||
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            3478999  5679999999764 33333  35677888777 999999   9999999999999974    348999995


Q ss_pred             ccc
Q 039720          824 GLA  826 (973)
Q Consensus       824 g~a  826 (973)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=4.2e-17  Score=170.36  Aligned_cols=144  Identities=18%  Similarity=0.159  Sum_probs=113.1

Q ss_pred             hcCCcCCccccccceeEEEEE-ECCCCcEEEEEEeecccch------------------------hHHHHHHHHHHHHhc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKG------------------------ATKSFVAECEALRNI  728 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  728 (973)
                      .-|.+.+.||+|+||.||+|. +..+|+.||+|+++.....                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358889999999999999998 6679999999999754210                        112356899999999


Q ss_pred             CCCC--ceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCC-eEecCC
Q 039720          729 RHRN--LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP-IVHGDL  805 (973)
Q Consensus       729 ~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-ivHrDi  805 (973)
                      .+..  +.+++++         ...++||||+.++++.............+...++.|++.++.+||+.   + |+||||
T Consensus       108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di  175 (237)
T smart00090      108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDL  175 (237)
T ss_pred             HhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence            7533  3444442         23479999999988877654434444455678999999999999999   9 999999


Q ss_pred             CCCcEEecCCCcEEEeccccchhcc
Q 039720          806 KPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       806 k~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ||+||+++ ++.++++|||.|....
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999 8899999999987543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.71  E-value=4e-17  Score=181.72  Aligned_cols=218  Identities=27%  Similarity=0.361  Sum_probs=158.3

Q ss_pred             HHhcCCCCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCe-Ee
Q 039720          725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPI-VH  802 (973)
Q Consensus       725 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~i-vH  802 (973)
                      |+.+.|.|+.+++|.+.+.     ...++|.+||..|+|.|.+.... .....-...+.++++.||.|+|..   .| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence            3567899999999998763     78899999999999999998743 333444567889999999999987   44 99


Q ss_pred             cCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCC-------CCcccchHHHHH
Q 039720          803 GDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD-------LSMTGDVYSFGI  875 (973)
Q Consensus       803 rDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlG~  875 (973)
                      +.+++.|.++|....+|++|||+.......      ..........-..-|.|||.+....       .+.++||||||+
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~------~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i  146 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEET------AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI  146 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhccccccc------ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence            999999999999999999999998765320      0011111222445699999877641       466799999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 039720          876 LLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAV  955 (973)
Q Consensus       876 ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  955 (973)
                      +++|+++.+.||......... .+.+..... .-...+.+.+...       .+...++..++.+||..+|++||++++|
T Consensus       147 i~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~~rPs~~~i  217 (484)
T KOG1023|consen  147 IMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIELL-------NELPPELLLLVARCWEEIPEKRPSIEQI  217 (484)
T ss_pred             HHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCcchhhh-------hhcchHHHHHHHHhcccChhhCccHHHH
Confidence            999999999999875444332 111111110 1111122222111       1334478899999999999999999999


Q ss_pred             HHHHHhcccc
Q 039720          956 VKKLCAVGEI  965 (973)
Q Consensus       956 l~~L~~~~~~  965 (973)
                      -..++.+...
T Consensus       218 ~~~~~~~~~~  227 (484)
T KOG1023|consen  218 RSKLLTINKG  227 (484)
T ss_pred             Hhhhhhhccc
Confidence            9998877553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=1.6e-17  Score=192.50  Aligned_cols=219  Identities=23%  Similarity=0.245  Sum_probs=147.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..+|..++.|..|+||.||.++++.+.+.+|+|+ ..+.-           +++     ||..+.           +..+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----------ilR-----nilt~a-----------~npf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----------ILR-----NILTFA-----------GNPF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----------hhh-----cccccc-----------CCcc
Confidence            3578999999999999999999999999999943 22211           111     122221           1222


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|      |+-.+.+...+..+..        ++.+++|+|+.   ||+|||+||+|.+|+.-|++|++|||+++.....
T Consensus       134 vv------gDc~tllk~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ee------chhhhhcccCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence            22      3444444444443322        27899999999   9999999999999999999999999998764321


Q ss_pred             CCc-------cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          833 PFL-------VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       833 ~~~-------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      -..       .....+......+||+.|+|||++....|+..+|+|++|+++||.+.|+.||...+.++. +...+... 
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~-  274 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDD-  274 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhh-
Confidence            100       000111122345899999999999999999999999999999999999999987654321 11111111 


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT  953 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  953 (973)
                                ..+.+     ..+..+.+...++.+.++..|..|--..
T Consensus       275 ----------i~wpE-----~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  275 ----------IEWPE-----EDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ----------ccccc-----cCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                      11111     1122233455677788889999997444

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=9.9e-16  Score=156.89  Aligned_cols=143  Identities=26%  Similarity=0.231  Sum_probs=112.0

Q ss_pred             HHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch----------------------hHHHHHHHHHHH
Q 039720          668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG----------------------ATKSFVAECEAL  725 (973)
Q Consensus       668 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l  725 (973)
                      ++......|.+.+.||+|+||.||+|.+. +|+.||||+++.....                      ....+..|..++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            33344445888899999999999999885 8999999998653211                      112356788889


Q ss_pred             HhcCCCC--ceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 039720          726 RNIRHRN--LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG  803 (973)
Q Consensus       726 ~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  803 (973)
                      ..+.|++  +...++.         ...++||||++++++.+....      .....++.+++.++.++|+.   +|+||
T Consensus        88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~  149 (198)
T cd05144          88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHG  149 (198)
T ss_pred             HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence            8888774  4444432         345899999999998775431      34567899999999999998   99999


Q ss_pred             CCCCCcEEecCCCcEEEeccccchhc
Q 039720          804 DLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       804 Dik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ||||+||+++.++.++|+|||.+...
T Consensus       150 Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         150 DLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcccEEEcCCCcEEEEECCccccC
Confidence            99999999999999999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=1.9e-15  Score=156.80  Aligned_cols=134  Identities=23%  Similarity=0.333  Sum_probs=111.2

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      +.||+|++|.||+|.+  .|..|++|+......        .....+.+|+.++..+.|+++.....++..     ....
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCC
Confidence            5799999999999998  788899998753221        112457889999999999988776665433     2567


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +++|||++|++|.+++.....    ....++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            899999999999999865432    6788999999999999999   999999999999999 78999999998863

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=5.2e-17  Score=176.63  Aligned_cols=126  Identities=27%  Similarity=0.478  Sum_probs=106.2

Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCC---chhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDK---LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      .+.+|.|++|...+|.+|+......   .......++.|++.|++|   +   +.+|||+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4678999999999999999754433   235578999999999999   6   899999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT  882 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt  882 (973)
                      ........  .........+...||..||+||.+.+..|+.++||||||++++|+++
T Consensus       403 ~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCC--cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            98765533  11122335556789999999999999999999999999999999997

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=1.8e-15  Score=155.30  Aligned_cols=130  Identities=27%  Similarity=0.412  Sum_probs=104.4

Q ss_pred             ccccccceeEEEEEECCCCcEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .||+|+||+||+|.+  ++..|++|+......        ....++.+|+++++.+.|+++.....++..     ....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence            389999999999996  678999998653211        113567789999999998875544443322     24568


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +||||++|++|.+++.....       .++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999988754321       7899999999999999   999999999999999 89999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.61  E-value=1.5e-15  Score=180.90  Aligned_cols=137  Identities=31%  Similarity=0.502  Sum_probs=103.6

Q ss_pred             cccchhhHHHHHHHHhhccCCCcCCCCCCCCCCCCC----ceeeeEeeCC--C--CeEEEEEeeccCccccccCCCcCCC
Q 039720           15 RHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLC----QWTGVTCGHR--H--QRVTKLDLESQNIGGFLSPYIGNLS   86 (973)
Q Consensus        15 ~~~~~~~~~~ll~~~~~~~~d~~~~l~sw~~~~~~c----~w~gv~C~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l~   86 (973)
                      ......+.+||+.||++. .++..  .+|++ ..||    .|.||+|+..  .  ..|+.|+|+++++.|.+|+.++.|+
T Consensus       367 ~~t~~~~~~aL~~~k~~~-~~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~  442 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSL-GLPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR  442 (623)
T ss_pred             cccCchHHHHHHHHHHhc-CCccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence            334556789999999875 45432  48974 3443    7999999632  2  2588899999999888888888899


Q ss_pred             CCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhc
Q 039720           87 FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIG  155 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~  155 (973)
                      +|+.|+|++|+++|.+|..++.+++|++|+|++|+++|.+|..++++++|+.|++++|++.+.+|..++
T Consensus       443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~  511 (623)
T PLN03150        443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG  511 (623)
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHh
Confidence            999999999998888888888888999999988888888888777776666555555555555555544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.59  E-value=6.3e-15  Score=174.13  Aligned_cols=137  Identities=28%  Similarity=0.377  Sum_probs=109.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--c------chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--K------KGATKSFVAECEALRNIRHRNLIKIITICSSID  744 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  744 (973)
                      ...|...+.||+|+||+||+|.+.  +..+++|+....  .      ....+++.+|+++++.++|++++....++..  
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--  407 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--  407 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence            345567889999999999999884  444555543211  1      1123568899999999999999887666443  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                         ....++||||+++++|.+++.        ....++.|++.++.|||+.   +++|||+||+||++ .++.++++|||
T Consensus       408 ---~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        408 ---PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             ---CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence               245789999999999999875        3567899999999999999   99999999999999 67899999999


Q ss_pred             cchh
Q 039720          825 LARF  828 (973)
Q Consensus       825 ~a~~  828 (973)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=1.6e-14  Score=146.75  Aligned_cols=135  Identities=24%  Similarity=0.276  Sum_probs=97.8

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchh--HHH----------------------HHHHHHHHHhcCCCC--
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKS----------------------FVAECEALRNIRHRN--  732 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--  732 (973)
                      .+.||+|+||+||+|.+. +|+.||||+++......  ...                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999986 89999999987542211  111                      134566666664432  


Q ss_pred             ceeEEeEeeecccCCCceEEEEEeeccCCCHHHH-hhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcE
Q 039720          733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDW-LHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNV  810 (973)
Q Consensus       733 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NI  810 (973)
                      +.+++++         ...++||||++++.+... +.... . ..++..++.+++.++.++|. .   +|+||||||+||
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni  146 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNI  146 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence            4444442         245899999998543211 11111 0 15578899999999999999 7   999999999999


Q ss_pred             EecCCCcEEEeccccchhc
Q 039720          811 LLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       811 Ll~~~~~~kl~Dfg~a~~~  829 (973)
                      +++ ++.++++|||.+...
T Consensus       147 li~-~~~~~liDfg~a~~~  164 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EEE-CCcEEEEECcccccc
Confidence            999 999999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.52  E-value=7.5e-14  Score=136.34  Aligned_cols=135  Identities=20%  Similarity=0.268  Sum_probs=110.5

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCC--CCceeEEeEeeecccCCCceEEEEE
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH--RNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.+.||+|.++.||++...  +..+++|+......  ...+.+|+.+++.++|  ..+++++.+..     ..+..++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEE
Confidence            4577999999999999984  47899999865433  5678899999999976  48888877643     236789999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ||+.++.+..+       .......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99998877654       3345667899999999999986434799999999999999999999999999863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.5e-15  Score=178.07  Aligned_cols=257  Identities=22%  Similarity=0.262  Sum_probs=190.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-CCcEEEEEEeeccc--chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-DGMSVAVKVMNLDK--KGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  748 (973)
                      ...|...+.||+|+|+.|-.+.... ....+|+|.+....  ....++...|..+-+... |+|++++++...     ..
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-----~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-----SP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-----CC
Confidence            3467778889999999999887732 34556667665443  223445556777777776 999999998743     45


Q ss_pred             ceEEEEEeeccCCCHHHHh-hhcC-CCchhhHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEecCCC-cEEEeccc
Q 039720          749 DFKAIVYEYMQYGSVDDWL-HHTN-DKLEVGKLNIVIEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFG  824 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l-~~~~-~~~~~~~~~i~~qi~~aL~~LH-~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg  824 (973)
                      +..++..+|..++++++.+ +... .........++.|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++|||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence            8889999999999999988 5544 5566778899999999999999 77   999999999999999999 99999999


Q ss_pred             cchhccCCCCccCCCCCcccccccc-cccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKG-TIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      +|..+...     ..........+| ++.|.|||...+. ...+..|+||.|+++.-+++|..|+............|..
T Consensus       171 ~At~~~~~-----~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~  245 (601)
T KOG0590|consen  171 LATAYRNK-----NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS  245 (601)
T ss_pred             hhcccccc-----CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence            99876541     122344445567 9999999998885 4477899999999999999999998866554433333222


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ...      ....         ..+........+++.+++..+|..|.+.+++..
T Consensus       246 ~~~------~~~~---------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  246 NKG------RFTQ---------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccc------cccc---------CccccCChhhhhcccccccCCchhccccccccc
Confidence            210      0000         111222334457777899999999999887654

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.50  E-value=1.4e-15  Score=165.14  Aligned_cols=191  Identities=28%  Similarity=0.453  Sum_probs=143.4

Q ss_pred             CCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccccccccccee
Q 039720          405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLL  484 (973)
Q Consensus       405 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L  484 (973)
                      +.--...||+.|++. .+|..++.+..|+.+.|..|.+. .+|.+++++..|+.||++.|+++ .+|..++.+.  ++.|
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp--Lkvl  148 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP--LKVL  148 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc--ceeE
Confidence            444456677777776 66777777777777777777777 67777777777777777777777 7777776654  2467


Q ss_pred             eccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccc
Q 039720          485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS  564 (973)
Q Consensus       485 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  564 (973)
                      -+++|+++ .+|..++.+..|..||.|.|.+. .+|..++++.+|+.|++..|++. .+|..+..| .|..||+|+|+++
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis  224 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS  224 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence            78888887 67888888888888888888888 67888888888888888888887 677777755 4778888888888


Q ss_pred             cccCCCCCCCCccceEeccCCcCcCcCCCC---CCCCCcccccc
Q 039720          565 GQIPIHLGNLPFLEYLNLSYNHFEGKVPKK---GVFSNETRISL  605 (973)
Q Consensus       565 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~---~~~~~~~~l~~  605 (973)
                       .+|..|.+|..|++|-|.+|+|+.++-+.   |...-+++|+.
T Consensus       225 -~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~  267 (722)
T KOG0532|consen  225 -YLPVDFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLST  267 (722)
T ss_pred             -ecchhhhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecc
Confidence             88888888888888888888888655443   34444455544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.48  E-value=3.8e-13  Score=140.95  Aligned_cols=139  Identities=17%  Similarity=0.151  Sum_probs=105.6

Q ss_pred             CCccc-cccceeEEEEEECCCCcEEEEEEeeccc-------------chhHHHHHHHHHHHHhcCCCCc--eeEEeEeee
Q 039720          679 SNRIG-KGSFGFVYKGNLGEDGMSVAVKVMNLDK-------------KGATKSFVAECEALRNIRHRNL--IKIITICSS  742 (973)
Q Consensus       679 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~  742 (973)
                      ...|| .||.|+||.+..  .+..+|||.+....             ......+.+|+.++..+.|+++  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 899999999988  57889999885321             1223567889999999998875  666665332


Q ss_pred             cccCCCceEEEEEeeccC-CCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          743 IDFKGADFKAIVYEYMQY-GSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       743 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                      . .......++||||++| .+|.+++... ...+    ..+.+++.++.+||+.   ||+||||||+|||++.++.++++
T Consensus       114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        114 R-HGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             e-cCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence            1 1111234599999997 6899887653 2222    3467899999999999   99999999999999999999999


Q ss_pred             ccccchh
Q 039720          822 DFGLARF  828 (973)
Q Consensus       822 Dfg~a~~  828 (973)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998864

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.45  E-value=2.1e-15  Score=163.79  Aligned_cols=192  Identities=30%  Similarity=0.429  Sum_probs=129.3

Q ss_pred             cCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccC
Q 039720          384 LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPN  463 (973)
Q Consensus       384 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  463 (973)
                      -...||+.|++. .+|..++.+..|+.+.|.+|.|. .+|..++++..|.+|||+.|+++ ..|..++.|+ |+.|-+++
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN  152 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN  152 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence            345566666666 66666666666777777777776 56666777777777777777776 6666666664 66777777


Q ss_pred             cccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCccccccc
Q 039720          464 NKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI  543 (973)
Q Consensus       464 N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  543 (973)
                      |+++ .+|..+.....+. .||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..+.. -.|..||+|.|++. .+
T Consensus       153 Nkl~-~lp~~ig~~~tl~-~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~i  226 (722)
T KOG0532|consen  153 NKLT-SLPEEIGLLPTLA-HLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YL  226 (722)
T ss_pred             Cccc-cCCcccccchhHH-Hhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ec
Confidence            7776 6777776444443 6777777776 56777777777777777777777 56666663 35677777777777 67


Q ss_pred             ccchhhhccCCeecCCCCccccccCCCCCCCCc---cceEeccCCc
Q 039720          544 PQSLNALKSIKELDLSCNNLSGQIPIHLGNLPF---LEYLNLSYNH  586 (973)
Q Consensus       544 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~ls~N~  586 (973)
                      |-.|..|+.|++|-|.+|.|. ..|..++..-.   -++|+..-++
T Consensus       227 Pv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  227 PVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             chhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            777777777777777777776 55655544333   3555555553

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.36  E-value=1.2e-12  Score=149.53  Aligned_cols=183  Identities=33%  Similarity=0.440  Sum_probs=113.1

Q ss_pred             cccceeeccCCcccccCCCCCCCCC-cccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEE
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLS-ALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY  236 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  236 (973)
                      +.++.|++.+|+++ .+|+....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.++.|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            55666666666666 4555555553 6666666666666 55555666666666666666666 3444444566666666


Q ss_pred             ccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       237 L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      +++|++. .+|..+. .+..|++|.+++|.+. ..+..+.++.++..|.+.+|++... +..+..+++|++|++++|.++
T Consensus       193 ls~N~i~-~l~~~~~-~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~  268 (394)
T COG4886         193 LSGNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS  268 (394)
T ss_pred             ccCCccc-cCchhhh-hhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cchhccccccceecccccccc
Confidence            6666666 5665542 2344777777777433 3556666777777777777776632 455666667777777777776


Q ss_pred             CCCCCChhhhhhhcccccceeeccccccccCCCChhhhh
Q 039720          317 TRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIAN  355 (973)
Q Consensus       317 ~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~  355 (973)
                      .++.        +..+.+++.|++++|.+...+|.....
T Consensus       269 ~i~~--------~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         269 SISS--------LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             cccc--------ccccCccCEEeccCccccccchhhhcc
Confidence            5432        455667777777777766555554433

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.35  E-value=8.3e-13  Score=151.00  Aligned_cols=199  Identities=37%  Similarity=0.490  Sum_probs=150.2

Q ss_pred             EEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcC-ccceEEcCCCccccccccccccccccccccccCc
Q 039720          386 GLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLT-LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN  464 (973)
Q Consensus       386 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  464 (973)
                      .++++.|.+. .....+..++.++.|++.+|++. .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            5677777764 23344455577777777777777 4555556664 7788888888877 66667777888888888888


Q ss_pred             ccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccc
Q 039720          465 KLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP  544 (973)
Q Consensus       465 ~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  544 (973)
                      ++. .+|........+ +.|++++|+++ .+|...+....|+.|++++|++. ..+..+.++.++..|.+.+|++. .++
T Consensus       174 ~l~-~l~~~~~~~~~L-~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~  248 (394)
T COG4886         174 DLS-DLPKLLSNLSNL-NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP  248 (394)
T ss_pred             hhh-hhhhhhhhhhhh-hheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence            877 666654444444 36888888887 67766666777999999999655 57778888889999999999987 557


Q ss_pred             cchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC
Q 039720          545 QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK  594 (973)
Q Consensus       545 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  594 (973)
                      ..+..++.++.|++++|+++ .++. +..+.+++.|++++|.+....|..
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             chhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence            78888889999999999998 5555 888999999999999998887765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.34  E-value=9.7e-12  Score=141.81  Aligned_cols=142  Identities=18%  Similarity=0.238  Sum_probs=100.3

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhH----------------------------------------HHH
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT----------------------------------------KSF  718 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  718 (973)
                      .+.||.|++|.||+|+.+ +|+.||||+.+..-....                                        -++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            467999999999999985 899999999864311000                                        023


Q ss_pred             HHHHHHHHhc----CCCCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHH-HHHHHH
Q 039720          719 VAECEALRNI----RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS-VIEYLH  793 (973)
Q Consensus       719 ~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~-aL~~LH  793 (973)
                      .+|...+.++    +|.+-+.+-.++.+.    ....++||||++|+++.+........  ....+++.+++. .+..+|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~--~~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAG--LDRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcC--CCHHHHHHHHHHHHHHHHH
Confidence            4455555444    233344444443321    24578999999999998876532111  134566666666 468889


Q ss_pred             hcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       794 ~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ..   |++|+|+||.||+++.++.++++|||++..+.
T Consensus       275 ~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            88   99999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=9.9e-12  Score=126.96  Aligned_cols=243  Identities=19%  Similarity=0.282  Sum_probs=155.1

Q ss_pred             EEEEEECCCCcEEEEEEeec----ccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccCCCHHH
Q 039720          690 VYKGNLGEDGMSVAVKVMNL----DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDD  765 (973)
Q Consensus       690 V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~  765 (973)
                      ||.+.+.+.|.+|+---+..    +.....+....-++-+-++.|.|+|++..|+.+..+.+..+..++.|||.-|++..
T Consensus        82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~  161 (458)
T KOG1266|consen   82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ  161 (458)
T ss_pred             HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence            55555555565554322211    11112222233344455667999999999998877777888899999999999999


Q ss_pred             HhhhcC----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCC
Q 039720          766 WLHHTN----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ  841 (973)
Q Consensus       766 ~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  841 (973)
                      ++++..    ......-.+|+.||..||.|||+. .|.|+|+++.-+-|++..+|-+|+. -+.-.......   .....
T Consensus       162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~---~~~~~  236 (458)
T KOG1266|consen  162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSV---NSTRE  236 (458)
T ss_pred             HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEec-ccCccccchhh---hhhhH
Confidence            998643    233455678999999999999985 8899999999999999999988874 22111111100   00001


Q ss_pred             cccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCccccccc
Q 039720          842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEA  921 (973)
Q Consensus       842 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (973)
                      .......+-++|.|||.=.....+.++|||+||+...+|..+..--......  ...+...   ...+...-+.      
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~--~~~ee~i---a~~i~~len~------  305 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESK--VEVEENI---ANVIIGLENG------  305 (458)
T ss_pred             hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcce--eehhhhh---hhheeeccCc------
Confidence            1111234678899999866666788999999999999999887643221111  0000000   0000000000      


Q ss_pred             CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          922 RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       922 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                              ..   ...+.+|++..|..||+|.+++.+.
T Consensus       306 --------lq---r~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  306 --------LQ---RGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             --------cc---cCcCcccccCCCCCCcchhhhhcCc
Confidence                    00   1456689999999999999987654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.24  E-value=5.3e-11  Score=136.96  Aligned_cols=146  Identities=18%  Similarity=0.222  Sum_probs=95.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch----------------------------------hHH---
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG----------------------------------ATK---  716 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~---  716 (973)
                      .+|+. +.||+|++|.||+|+.+.+|+.||||+.+..-..                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 7899999999999999877999999999743110                                  011   


Q ss_pred             ---HHHHHHHHHHhc----CCCCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHh--hhcCCCchhhHHHHHHHHHH
Q 039720          717 ---SFVAECEALRNI----RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKLEVGKLNIVIEVAS  787 (973)
Q Consensus       717 ---~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~i~~qi~~  787 (973)
                         ++.+|...+.++    .+...+.+-.++.+.    ....++||||++|+++.+..  ...+ ..   ...++...+.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g-~d---~~~la~~~v~  270 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAG-TD---MKLLAERGVE  270 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcC-CC---HHHHHHHHHH
Confidence               133444444444    244445444443322    35678999999999998742  2222 11   1122222111


Q ss_pred             -HHHHHHhcCCCCeEecCCCCCcEEecCCC----cEEEeccccchhccC
Q 039720          788 -VIEYLHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSDFGLARFLSH  831 (973)
Q Consensus       788 -aL~~LH~~~~~~ivHrDik~~NILl~~~~----~~kl~Dfg~a~~~~~  831 (973)
                       -+..+...   |++|+|+||.||+++.++    .++++|||++.....
T Consensus       271 ~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 VFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence             12223445   999999999999999988    999999999876643

>PLN03150 hypothetical protein; Provisional

Probab=99.24  E-value=5.2e-12  Score=150.84  Aligned_cols=118  Identities=36%  Similarity=0.590  Sum_probs=102.9

Q ss_pred             ccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEecc
Q 039720          504 SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS  583 (973)
Q Consensus       504 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  583 (973)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..+..+++|+.|||++|+++|.+|..+++|++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCcCcCCCC--CCCCCccccccccCccccCCCCCCCCCCCC
Q 039720          584 YNHFEGKVPKK--GVFSNETRISLTGNEQFCGGLGELHLPACH  624 (973)
Q Consensus       584 ~N~l~~~~p~~--~~~~~~~~l~~~~N~~~cg~~~~~~~~~~~  624 (973)
                      +|+++|.+|..  ..+.++..+++.+|+.+||.+.   ++.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence            99999999975  2234556788999999999654   35675

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=7.7e-12  Score=139.67  Aligned_cols=252  Identities=23%  Similarity=0.282  Sum_probs=179.2

Q ss_pred             hcCCcCCcccc--ccceeEEEEEE--CCCCcEEEEEEee--cccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccC
Q 039720          674 KEFSSSNRIGK--GSFGFVYKGNL--GEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFK  746 (973)
Q Consensus       674 ~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  746 (973)
                      ..|-+.+.+|.  |.+|.||.+..  ..++..+|+|.-+  .........-++|+...++++ |++.++.+..     +.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WE  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cc
Confidence            45667788999  99999999988  8899999999844  333344455567777777774 8999985554     45


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCC-CchhhHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEE
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKLNIVIEVAS----VIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHV  820 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~----aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl  820 (973)
                      +.+..++-+|++. .++.++.+.... +++...+..+.+..+    |+.++|+.   .++|-|+||.||+...+ ...++
T Consensus       189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence            6688899999886 688888776555 566778888888888    99999999   99999999999999999 88999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      +|||+...++...+...   ........|..-|++||. ...-++.++|+|++|.+..+..++..+.......  .   |
T Consensus       265 ~df~~v~~i~~~~~~~~---~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~---W  335 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSV---FKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--S---W  335 (524)
T ss_pred             CCcceeEEccCCccccc---eeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCC--C---c
Confidence            99999988766442111   111122246678999998 4556688999999999999998877765432111  0   1


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ....          ...    ...+....-..++...+..|++.+|-.|++++++.+
T Consensus       336 ~~~r----------~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 SQLR----------QGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccc----------ccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1110          000    000111111223344777899999999999987543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.21  E-value=1.2e-10  Score=130.96  Aligned_cols=172  Identities=17%  Similarity=0.265  Sum_probs=133.2

Q ss_pred             EE-EEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhh
Q 039720          690 VY-KGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH  768 (973)
Q Consensus       690 V~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  768 (973)
                      +| .|..+.++.+|.|.+++.......+...+-++.|+.++||+|+++++..     +.+...|+|+|.+.  .|..++.
T Consensus        27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~--Pl~~~lk   99 (690)
T KOG1243|consen   27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVR--PLETVLK   99 (690)
T ss_pred             cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeeccc--cHHHHHH
Confidence            44 4677789999999999866655566788889999999999999999874     44578999999985  6777776


Q ss_pred             hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCccccccc
Q 039720          769 HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK  848 (973)
Q Consensus       769 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~  848 (973)
                      ..+   .......+.||+.||.|||+.|  +++|+++.-..|+|+..|..||++|-++.......        ......+
T Consensus       100 ~l~---~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~--------~~~~~~~  166 (690)
T KOG1243|consen  100 ELG---KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN--------APAKSLY  166 (690)
T ss_pred             HhH---HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC--------cccccch
Confidence            654   4456677899999999999776  89999999999999999999999999887553321        0111122


Q ss_pred             ccccccCcccccCCCCCcccchHHHHHHHHHHHhC
Q 039720          849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR  883 (973)
Q Consensus       849 gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg  883 (973)
                      --..|..|+.+....  -..|.|.|||++++++.|
T Consensus       167 ~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  167 LIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            223466777544333  246999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.21  E-value=4.8e-11  Score=119.01  Aligned_cols=130  Identities=15%  Similarity=0.160  Sum_probs=96.1

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCcee-EEeEeeecccCCCceEEEEEee
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK-IITICSSIDFKGADFKAIVYEY  757 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~e~  757 (973)
                      .+.++.|.++.||+++.  .+..|++|+...... ....+..|+.+++.+.+.++++ ++.+.       ....++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence            35689999999999997  588999999864432 2234678899998887655544 43321       1235799999


Q ss_pred             ccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC--QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       758 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ++|.++.+.        ......++.++++++..||+..  ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus        73 i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999887653        0112346789999999999882  11259999999999999 6789999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=3.2e-10  Score=113.19  Aligned_cols=138  Identities=19%  Similarity=0.189  Sum_probs=99.2

Q ss_pred             CCccccccceeEEEEEECC------CCcEEEEEEeeccc------------c----------hhHH----HHHHHHHHHH
Q 039720          679 SNRIGKGSFGFVYKGNLGE------DGMSVAVKVMNLDK------------K----------GATK----SFVAECEALR  726 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~------------~----------~~~~----~~~~e~~~l~  726 (973)
                      ...||.|--+.||.|....      .+..+|||+++...            +          ...+    ...+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3469999999999998642      35799999986421            0          0111    2347999999


Q ss_pred             hcCC--CCceeEEeEeeecccCCCceEEEEEeeccCCCHHH-HhhhcCCCchhhHHHHHHHHHHHHHHH-HhcCCCCeEe
Q 039720          727 NIRH--RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDD-WLHHTNDKLEVGKLNIVIEVASVIEYL-HNHCQPPIVH  802 (973)
Q Consensus       727 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH  802 (973)
                      ++..  -++..++++         ...++||||+.++.+.. .+.+ ......+...+..+++.++..+ |+.   ++||
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~---glVH  148 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVH  148 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            8853  456666654         46789999997653322 1221 1223345567789999999999 777   9999


Q ss_pred             cCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          803 GDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       803 rDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ||+++.||+++ ++.++++|||.|...+
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999999997 5789999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=1.3e-11  Score=124.19  Aligned_cols=211  Identities=24%  Similarity=0.223  Sum_probs=136.2

Q ss_pred             CCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCC-Cccccccccccc
Q 039720          373 TIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGF-NKLQGSIPSYLG  451 (973)
Q Consensus       373 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~  451 (973)
                      .+|-.+.-+.+|..+.+|.+.-.. +.+-...-+.|+.+...+.-++ ..| .+-..+.+....-+. .-.+|..-..+.
T Consensus       205 ~l~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~-~~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~d  281 (490)
T KOG1259|consen  205 RLSFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQ-DVP-SLLPETILADPSGSEPSTSNGSALVSAD  281 (490)
T ss_pred             ccccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeeccccc-ccc-cccchhhhcCccCCCCCccCCceEEecc
Confidence            344445556677777777665432 2222233467777777665554 222 111122222111111 112233334444


Q ss_pred             cccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhh
Q 039720          452 KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEY  531 (973)
Q Consensus       452 ~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  531 (973)
                      .++.|+++||++|.|+ .+.++..-.+.. +.|++|+|.|+. + ..+..+.+|+.||||+|.++ .+-.+-..+.+.+.
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pki-r~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKL-RRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccce-eEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            5677888888888887 555544433333 588999998873 2 23778889999999999988 55666667788899


Q ss_pred             hcccCcccccccccchhhhccCCeecCCCCccccc-cCCCCCCCCccceEeccCCcCcCcCCC
Q 039720          532 LLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQ-IPIHLGNLPFLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       532 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~  593 (973)
                      |.|+.|.|.  .-..++.|-+|..||+++|+|... --..+++||-|+.+.|.+|++.+.+..
T Consensus       357 L~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY  417 (490)
T KOG1259|consen  357 LKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY  417 (490)
T ss_pred             eehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence            999999986  234577888899999999998741 124688899999999999999876553

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.10  E-value=2.1e-11  Score=122.65  Aligned_cols=132  Identities=23%  Similarity=0.261  Sum_probs=79.6

Q ss_pred             cccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEc
Q 039720          183 ALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVV  262 (973)
Q Consensus       183 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L  262 (973)
                      .|++||||+|.|+ .+.+++.-++.++.|++|.|.|..+  +.++.+++|++|+|++|.++ ++-. +-..|-+.+.|.|
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~G-wh~KLGNIKtL~L  359 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVG-WHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhh-hHhhhcCEeeeeh
Confidence            3444444444444 3444444444444444444444421  11444445555555555444 2221 1125678888888


Q ss_pred             cCCcccccCCccccCCCCCCEEEccCCcccccC-cccccCcccccceecccccCCCCCCC
Q 039720          263 AQNNLTGFLPQSLSNASKLEWLELNENHFSGQV-RINFNSLPNLSKLYLGRNNLGTRTST  321 (973)
Q Consensus       263 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~  321 (973)
                      +.|.|...  ..+.++-+|..||+++|+|.... ...+++||-|++|.|.+|.+..++..
T Consensus       360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY  417 (490)
T KOG1259|consen  360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY  417 (490)
T ss_pred             hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence            88888732  56778888999999999987543 24588899999999999998776543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.09  E-value=2.9e-11  Score=138.40  Aligned_cols=130  Identities=24%  Similarity=0.345  Sum_probs=75.6

Q ss_pred             cccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEE
Q 039720          156 NWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEA  235 (973)
Q Consensus       156 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  235 (973)
                      .+..++.+.+..|.+.. +-..++.+++|+.|++.+|+|. .+...+..+++|++|++++|.|+.+.+  +..       
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~-------  138 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LST-------  138 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhh-------
Confidence            34556666677776663 3344667777888888888877 444446777788888888887764332  222       


Q ss_pred             EccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCc-ccccCcccccceeccccc
Q 039720          236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVR-INFNSLPNLSKLYLGRNN  314 (973)
Q Consensus       236 ~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~  314 (973)
                                        ++.|+.|++++|.|+.+  ..+..+..|+.+++++|++..+.+ . ...+.+|+.+++++|.
T Consensus       139 ------------------l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~  197 (414)
T KOG0531|consen  139 ------------------LTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNS  197 (414)
T ss_pred             ------------------ccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCc
Confidence                              23344444444444421  233445556666666666554433 2 3555666666666666


Q ss_pred             CCC
Q 039720          315 LGT  317 (973)
Q Consensus       315 l~~  317 (973)
                      +..
T Consensus       198 i~~  200 (414)
T KOG0531|consen  198 IRE  200 (414)
T ss_pred             hhc
Confidence            544

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.09  E-value=1.8e-11  Score=129.86  Aligned_cols=211  Identities=21%  Similarity=0.188  Sum_probs=151.9

Q ss_pred             cccCCCCEEeeecccCCCCCC--cccccCCCccceEeccccccc--chhhhhccccccceeeccCCcccccCCCCC-CCC
Q 039720          107 GRLFRLETIVLSNNSFSGKIP--TNLSRCFNLIDFWVHTNNLVG--EIQAIIGNWLKIERLSLYGNQLTGQLPPSI-GNL  181 (973)
Q Consensus       107 ~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~l~~n~~~~--~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l  181 (973)
                      .++.+|+...|.+.... ..+  .....|++.++|++++|-+..  .+-.....|++|+.|+|+.|.+.-...... ..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            46778888888877665 333  356678888888888887663  455677889999999999999873332222 256


Q ss_pred             CcccEEEccCCcCCCCC-CCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCc-ccccCCCCCcE
Q 039720          182 SALQTFDIAGNKLDGRI-PDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPV-CLGFNLPKLTV  259 (973)
Q Consensus       182 ~~L~~L~L~~N~l~~~~-p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~  259 (973)
                      ++|+.|.|+.|.|+..- -..+..+++|+.|+|+.|....+...+...++.|++|+|++|.+. ..+. ..-..++.|+.
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence            88999999999997322 123456899999999999654455556677889999999999987 3331 22237888999


Q ss_pred             EEccCCccccc-CCcc-----ccCCCCCCEEEccCCcccccC-cccccCcccccceecccccCCCCC
Q 039720          260 LVVAQNNLTGF-LPQS-----LSNASKLEWLELNENHFSGQV-RINFNSLPNLSKLYLGRNNLGTRT  319 (973)
Q Consensus       260 L~Ls~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~  319 (973)
                      |.++.+.|+.+ .|+.     ...+++|++|+++.|+|.... -..+..+++|+.|....|.++.-.
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e~  342 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKET  342 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccccc
Confidence            99999988753 2333     356788999999999986322 234666788888888888887643

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.08  E-value=6.1e-12  Score=130.07  Aligned_cols=139  Identities=23%  Similarity=0.231  Sum_probs=75.8

Q ss_pred             CCccceeccCCCCcccc----CCccccCCCCCcEEEccCCccccC---CCcccccCCCCCcEEEccCCcccc----cCCc
Q 039720          205 LRNLNYLGTSENDFSGM----FPLSVCNISSLDEAYLFKNRFKGS---LPVCLGFNLPKLTVLVVAQNNLTG----FLPQ  273 (973)
Q Consensus       205 L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~---ip~~~~~~l~~L~~L~Ls~N~l~~----~~p~  273 (973)
                      -+.|+++..++|++..-    +...|...+.|+++.++.|.|...   +-...+..+++|++|||.+|-++.    .+..
T Consensus       156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak  235 (382)
T KOG1909|consen  156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK  235 (382)
T ss_pred             CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence            45566666666666421    122344456666666666666411   111112356677777777776652    2344


Q ss_pred             cccCCCCCCEEEccCCcccccCcccc-----cCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccc
Q 039720          274 SLSNASKLEWLELNENHFSGQVRINF-----NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRF  345 (973)
Q Consensus       274 ~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l  345 (973)
                      .+..+++|+.|+++++.+......+|     ...|+|+.|.|.+|.|+.....  .........+.|+.|+|++|++
T Consensus       236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~--~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL--ALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH--HHHHHHhcchhhHHhcCCcccc
Confidence            55666677777777777764433332     3356777777777776542211  1122333455666666666666

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.08  E-value=3.6e-11  Score=140.55  Aligned_cols=257  Identities=20%  Similarity=0.205  Sum_probs=172.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchh---HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA---TKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..+.+.+.+.+.+|.++.++.++-..+|...++|+........   .+....+-.++-..++|-++....-     +.-.
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence            4566778889999999999999888888777777664332111   1112222222222334555543322     3334


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .-.+++++|..+++|...++..+....+.+......+..+.+|||..   .+.|||++|.|++...+++.++.|||....
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            66789999999999999999877655555566677888999999998   799999999999999999999999984433


Q ss_pred             ccCC---------------------CCccCCC--CCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCC
Q 039720          829 LSHH---------------------PFLVAPE--GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR  885 (973)
Q Consensus       829 ~~~~---------------------~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~  885 (973)
                      .+-.                     .......  .........||+.|.+||...+......+|+|+.|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            2111                     0000000  0012334568999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 039720          886 PTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT  953 (973)
Q Consensus       886 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  953 (973)
                      ||...+.+..                 ++....+...-+..+.+......+++...+..+|.+|-.|.
T Consensus      1034 p~na~tpq~~-----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI-----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhh-----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9987654311                 11111111111222333333445666677788888888765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.04  E-value=6.2e-09  Score=110.41  Aligned_cols=267  Identities=14%  Similarity=0.071  Sum_probs=158.9

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeec--ccCCCceEEEE
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSI--DFKGADFKAIV  754 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~~~~~~lv  754 (973)
                      ..+.||+|+.+.+|-.-.   -...+.|++.........+.   +..|.+. .||-+-.-+.+=...  .-.......++
T Consensus        15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecch---hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            356799999999997533   23455799876554333322   2223322 455433211111000  01122335567


Q ss_pred             EeeccCC-CHHHHh---hhcCC---CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          755 YEYMQYG-SVDDWL---HHTND---KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       755 ~e~~~~g-sL~~~l---~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      |..+.+. ...++.   ++...   ..+.-..+.++.++.+.+.||+.   |.+-+|+.++|+|+++++.++++|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            7776653 122222   11222   23355678899999999999999   99999999999999999999998755332


Q ss_pred             hccCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCc----cH
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGL----TL  897 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg-~~Pf~~~~~~~~----~~  897 (973)
                      ...         ........+|..+|.+||...     +..-+...|-|.+|+++++++.| ++||.+......    .-
T Consensus       166 i~~---------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E  236 (637)
T COG4248         166 INA---------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE  236 (637)
T ss_pred             ecc---------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence            221         133444567889999999755     33557789999999999999995 999976542210    00


Q ss_pred             hhhhhHhcCcccccccCccc-ccccCCCchhHHHHHHHHHHHhhcCCCC--CCCCCCHHHHHHHHHhccccc
Q 039720          898 HGYAKMALPKKVMGIVDPSL-LMEARGPSKFEECLVAVVRTGVACSMES--PSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~~  966 (973)
                      ...+....    ....+... ....+......-.+.++..+..+|+...  |.-||+++.++..|.+++..+
T Consensus       237 ~~Ia~g~f----~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         237 TDIAHGRF----AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             hhhhccee----eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            01111111    00011110 0111112222333455566666787653  678999999999999887654

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.04  E-value=4.1e-11  Score=127.26  Aligned_cols=203  Identities=22%  Similarity=0.219  Sum_probs=115.4

Q ss_pred             cCCCCcCEEEcccccCCCCCC--ccccCCCCCCeEEccCcccCCCCC--CccCCcCccceEEcCCCcccccccccccccc
Q 039720          379 RNLFNLNGLGLEYNQLTGTIP--PAIGELRNLQYLGLVGNNIRGIIP--DPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQ  454 (973)
Q Consensus       379 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  454 (973)
                      +++.+|+.+.|.+.... ..+  .....+++++.|||++|-+....+  .....+++|+.|+|+.|++.           
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~-----------  185 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS-----------  185 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc-----------
Confidence            34555666666665554 222  244455666666666665543221  12233445555555555544           


Q ss_pred             ccccccccCcccccCCCccccccccccceeeccCCcccc-cCCcccccccccceeccccCcccccccccccCccchhhhc
Q 039720          455 NLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSG-SIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLL  533 (973)
Q Consensus       455 ~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~  533 (973)
                                   .......-...+.++.|.|+.|.++. .+-.....+++|+.|+|..|...+.......-+..|+.||
T Consensus       186 -------------~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld  252 (505)
T KOG3207|consen  186 -------------NFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD  252 (505)
T ss_pred             -------------CCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence                         22222222222333466666666652 1122234567888888888853334344455567888888


Q ss_pred             ccCcccccccc--cchhhhccCCeecCCCCcccc-ccCCC-----CCCCCccceEeccCCcCcCcCCCC---CCCCCccc
Q 039720          534 MQGNSFNGSIP--QSLNALKSIKELDLSCNNLSG-QIPIH-----LGNLPFLEYLNLSYNHFEGKVPKK---GVFSNETR  602 (973)
Q Consensus       534 L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~-~~p~~-----~~~l~~L~~L~ls~N~l~~~~p~~---~~~~~~~~  602 (973)
                      |++|++- ..+  ...+.++.|+.|+++.+.++. ..|+.     ...+++|++|+++.|++.. .+..   ..+.+++.
T Consensus       253 Ls~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~  330 (505)
T KOG3207|consen  253 LSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKH  330 (505)
T ss_pred             ccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchhhh
Confidence            8888887 344  456778888888888888875 33444     4567889999999998852 2222   22345555


Q ss_pred             cccccC
Q 039720          603 ISLTGN  608 (973)
Q Consensus       603 l~~~~N  608 (973)
                      +.+.+|
T Consensus       331 l~~~~n  336 (505)
T KOG3207|consen  331 LRITLN  336 (505)
T ss_pred             hhcccc
Confidence            555555

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.03  E-value=1.3e-10  Score=113.55  Aligned_cols=106  Identities=28%  Similarity=0.415  Sum_probs=23.0

Q ss_pred             CcccEEEccCCcCCCCCCCccc-CCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEE
Q 039720          182 SALQTFDIAGNKLDGRIPDSLG-QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVL  260 (973)
Q Consensus       182 ~~L~~L~L~~N~l~~~~p~~~~-~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L  260 (973)
                      ..+++|+|.+|+|+ .+. .++ .+.+|+.|+|++|.|+...  .+..++.|++|++++|+++ .++..+...+++|++|
T Consensus        19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            34455555555554 222 233 3445555555555554211  2233333334444444443 3332222234455555


Q ss_pred             EccCCcccccC-CccccCCCCCCEEEccCCccc
Q 039720          261 VVAQNNLTGFL-PQSLSNASKLEWLELNENHFS  292 (973)
Q Consensus       261 ~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~  292 (973)
                      +|++|+|...- -..+..+++|++|+|.+|.++
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            55555554211 123445555555555555554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.01  E-value=1.4e-10  Score=132.63  Aligned_cols=213  Identities=30%  Similarity=0.347  Sum_probs=131.7

Q ss_pred             hHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCC
Q 039720          361 TLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN  440 (973)
Q Consensus       361 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  440 (973)
                      ..+.+..|.|. .+-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|.|+.+  ..+..++.|+.|++++|
T Consensus        75 ~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N  150 (414)
T KOG0531|consen   75 KELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGN  150 (414)
T ss_pred             Hhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhheeccC
Confidence            33334444444 233446677778888888888873 333367778888888888888754  23566667888888888


Q ss_pred             ccccccccccccccccccccccCcccccCCCcc-ccccccccceeeccCCcccccCCcccccccccceeccccCcccccc
Q 039720          441 KLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQ-IFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEI  519 (973)
Q Consensus       441 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  519 (973)
                      .|+ .+. .+..+++|+.+++++|++. .+... ...+..+ +.+++.+|.+.  ....+..+..+..+++..|.++-.-
T Consensus       151 ~i~-~~~-~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l-~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~  224 (414)
T KOG0531|consen  151 LIS-DIS-GLESLKSLKLLDLSYNRIV-DIENDELSELISL-EELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLE  224 (414)
T ss_pred             cch-hcc-CCccchhhhcccCCcchhh-hhhhhhhhhccch-HHHhccCCchh--cccchHHHHHHHHhhcccccceecc
Confidence            887 333 3445777778888888777 33331 2233333 35677777775  2333445555666677777776332


Q ss_pred             cccccCcc--chhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCc
Q 039720          520 PVTLSACT--TLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE  588 (973)
Q Consensus       520 p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  588 (973)
                      +  +..+.  .|+.+++++|++. ..+..+..+..+..|++++|++...  ..+...+.+..+....|.+.
T Consensus       225 ~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  225 G--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             C--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence            2  22222  3777888888777 4445666777777788887777632  23445566666777777665

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.01  E-value=2.4e-11  Score=125.73  Aligned_cols=243  Identities=24%  Similarity=0.294  Sum_probs=155.2

Q ss_pred             CeEEEEEeeccCccc----cccCCCcCCCCCCEEEccCC---CCCCCCCcc-------ccccCCCCEEeeecccCCCCCC
Q 039720           62 QRVTKLDLESQNIGG----FLSPYIGNLSFLRVINLANN---SFHGQIPKE-------VGRLFRLETIVLSNNSFSGKIP  127 (973)
Q Consensus        62 ~~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~Ls~n~l~~~~p  127 (973)
                      ..++.++|+||.++.    .+.+.|.+.+.|+.-++|+-   +....+|+.       +-..++|++||||.|.|.-.-+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            468899999998865    34456778889999999864   233355543       4556689999999999875545


Q ss_pred             ccc----ccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCC----
Q 039720          128 TNL----SRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIP----  199 (973)
Q Consensus       128 ~~~----~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----  199 (973)
                      ..|    .++++|++|++.+|.+...-...++.  .|.+|.  .|       .-++.-+.|+++...+|++. ..+    
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrle-n~ga~~~  177 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLE-NGGATAL  177 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccCCCcceEEEEeeccccc-cccHHHH
Confidence            443    34555666666665554322222211  112211  11       11233457788888888775 222    


Q ss_pred             -CcccCCCccceeccCCCCccc----cCCccccCCCCCcEEEccCCccccCCCcc---cccCCCCCcEEEccCCcccccC
Q 039720          200 -DSLGQLRNLNYLGTSENDFSG----MFPLSVCNISSLDEAYLFKNRFKGSLPVC---LGFNLPKLTVLVVAQNNLTGFL  271 (973)
Q Consensus       200 -~~~~~L~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~ip~~---~~~~l~~L~~L~Ls~N~l~~~~  271 (973)
                       ..|...+.|+.+.++.|.|..    ....+|..+++|+.|+|.+|-|+..-...   ....+++|+.|++++|.+...-
T Consensus       178 A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~G  257 (382)
T KOG1909|consen  178 AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEG  257 (382)
T ss_pred             HHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccccc
Confidence             346666788888888887742    12345677788888888888776321111   1225678888888888887543


Q ss_pred             Cccc-----cCCCCCCEEEccCCcccc----cCcccccCcccccceecccccCC
Q 039720          272 PQSL-----SNASKLEWLELNENHFSG----QVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       272 p~~~-----~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      ..+|     ...++|+.|.|.+|.|+.    .+..++...+.|..|+|++|.+.
T Consensus       258 a~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  258 AIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            3332     246789999999998873    22334566888999999999985

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.01  E-value=2e-10  Score=112.29  Aligned_cols=127  Identities=24%  Similarity=0.305  Sum_probs=37.4

Q ss_pred             CcCCCCCCEEEccCCCCCCCCCcccc-ccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcccccc
Q 039720           82 IGNLSFLRVINLANNSFHGQIPKEVG-RLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKI  160 (973)
Q Consensus        82 l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L  160 (973)
                      +.+...+++|+|++|+|+ .|. .++ .+.+|+.||||+|.++ .++ .+..+++|++|++++|.+....+.....+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence            445566788888888887 443 465 5778888888888887 333 35566666666666666654322222345666


Q ss_pred             ceeeccCCcccccC-CCCCCCCCcccEEEccCCcCCCCCCC----cccCCCccceecc
Q 039720          161 ERLSLYGNQLTGQL-PPSIGNLSALQTFDIAGNKLDGRIPD----SLGQLRNLNYLGT  213 (973)
Q Consensus       161 ~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~L~~L~~L~L  213 (973)
                      ++|+|++|+|...- -..+..+++|++|+|.+|.++ ..+.    .+..+++|+.||-
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEETT
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeCC
Confidence            66666666665211 123445566666666666665 2232    2445555655553

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.00  E-value=3.5e-09  Score=100.53  Aligned_cols=140  Identities=26%  Similarity=0.324  Sum_probs=103.8

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecc--------cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--------KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ....+.||+-+.|+++.+  .|+.++||.-...        ..-..++..+|.+.+.+..--.|....-++.+     ..
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-----~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-----TY   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-----cC
Confidence            567899999999999999  7888888854321        12234678889999988864444433333322     25


Q ss_pred             eEEEEEeeccC-CCHHHHhhhcCCCc-h-hhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---cEEEecc
Q 039720          750 FKAIVYEYMQY-GSVDDWLHHTNDKL-E-VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---VAHVSDF  823 (973)
Q Consensus       750 ~~~lv~e~~~~-gsL~~~l~~~~~~~-~-~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---~~kl~Df  823 (973)
                      .-.++|||++| .++.+++....... + ......+.+|-+.+.-||..   +|||+|+..+||++..++   .+.++||
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEee
Confidence            66789999986 47788876543222 2 22368899999999999999   999999999999997665   4589999


Q ss_pred             ccch
Q 039720          824 GLAR  827 (973)
Q Consensus       824 g~a~  827 (973)
                      |++.
T Consensus       161 gls~  164 (229)
T KOG3087|consen  161 GLSS  164 (229)
T ss_pred             cchh
Confidence            9986

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.00  E-value=3.7e-10  Score=137.51  Aligned_cols=272  Identities=22%  Similarity=0.250  Sum_probs=139.1

Q ss_pred             ccceEecccc--cccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceecc
Q 039720          136 LIDFWVHTNN--LVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGT  213 (973)
Q Consensus       136 L~~L~l~~n~--~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L  213 (973)
                      |..|.+..|.  +.....+.|..++.|++|||++|.=-+.+|+++++|-+|++|+|++..++ .+|..+++|+.|.+|++
T Consensus       547 L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl  625 (889)
T KOG4658|consen  547 LRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNL  625 (889)
T ss_pred             cceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecc
Confidence            4444444443  23333445666777777777776655577777777777777777777777 67777777777777777


Q ss_pred             CCCCccccCCccccCCCCCcEEEccCCccc--cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCC----EEEcc
Q 039720          214 SENDFSGMFPLSVCNISSLDEAYLFKNRFK--GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLE----WLELN  287 (973)
Q Consensus       214 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls  287 (973)
                      ..+.....+|.....+++|++|.+......  ...-..+ .++.+|+.+.......  .+-..+..+..|.    .+.+.
T Consensus       626 ~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el-~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~  702 (889)
T KOG4658|consen  626 EVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKEL-ENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE  702 (889)
T ss_pred             ccccccccccchhhhcccccEEEeeccccccchhhHHhh-hcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence            777665556666666777777776554311  0111111 2444455544433322  0111122222222    22222


Q ss_pred             CCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcC
Q 039720          288 ENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAG  367 (973)
Q Consensus       288 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~  367 (973)
                      .+... .....+..+.+|+.|.+.++.+.++.....         ...+.++            .+    ..+..+...+
T Consensus       703 ~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~---------~~~~~~~------------~f----~~l~~~~~~~  756 (889)
T KOG4658|consen  703 GCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWE---------ESLIVLL------------CF----PNLSKVSILN  756 (889)
T ss_pred             ccccc-eeecccccccCcceEEEEcCCCchhhcccc---------cccchhh------------hH----HHHHHHHhhc
Confidence            21111 233455666666666666666543221100         0000000            00    0111111112


Q ss_pred             CccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCC-CCCccCCcCccceEEcC
Q 039720          368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI-IPDPIGNLTLLNVLQLG  438 (973)
Q Consensus       368 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls  438 (973)
                      +... ..+.+.--.++|+.|++..+.....+.+....+..+..+-+..+.+.+. .-...+.++++..+.++
T Consensus       757 ~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~  827 (889)
T KOG4658|consen  757 CHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLS  827 (889)
T ss_pred             cccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccC
Confidence            1111 2333344557888888888777666666666677777666666666654 23334444444444333

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=5e-09  Score=100.34  Aligned_cols=131  Identities=27%  Similarity=0.363  Sum_probs=98.7

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeecc--------cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--------KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..+++|+-+.+|.+.+  -|..+++|.-...        ..-...+..+|..++.+++--.|...+-+..     +++..
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-----D~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-----DPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-----cCCCC
Confidence            3588999999999987  4556767754221        1122356788999998887555444333322     23677


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .|+|||++|..|.+.+...       ...++..+-.-+.-||..   ||||+|+.++||++..+. +.++|||++.+
T Consensus        75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            8999999999999888765       246778888888999999   999999999999997765 89999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=4e-10  Score=126.13  Aligned_cols=249  Identities=17%  Similarity=0.120  Sum_probs=169.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEEC-CCCcEEEEEEeecccchhH--HHHHHHHHHHHhc-CCCCceeEEeEeeecccCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLG-EDGMSVAVKVMNLDKKGAT--KSFVAECEALRNI-RHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  747 (973)
                      ...+|..+..||.|.|+.|+.+.-. .++..|++|-.........  ..-..|+.+...+ .|.+++.++..+..     
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----
Confidence            3456778889999999999998755 6888999997754332222  2234566666555 47788876665433     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~Dfg~a  826 (973)
                      .+..++--|||++++......-...+.+..++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||.+
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            356678899999999887765444556677889999999999999988   99999999999999886 78899999988


Q ss_pred             hhccCCCCccCCCCCcccccccccccc-cCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGY-IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ..+.-          .......++..| .+|+......+..++|++|||..+.+..++.+--... ..      |..   
T Consensus       415 t~~~~----------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~------~~~---  474 (524)
T KOG0601|consen  415 TRLAF----------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ------SLT---  474 (524)
T ss_pred             cccce----------ecccccccccccccchhhccccccccccccccccccccccccCcccCccc-cc------cee---
Confidence            63211          111111123334 3666666778899999999999999999876542211 10      000   


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                             +....   .  +.. ......+..+...+...|+..||.+.+.......
T Consensus       475 -------i~~~~---~--p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  475 -------IRSGD---T--PNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             -------eeccc---c--cCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                   00000   0  111 1111445566667889999999999887665443

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.90  E-value=1.1e-09  Score=80.31  Aligned_cols=40  Identities=40%  Similarity=0.832  Sum_probs=31.0

Q ss_pred             hhhHHHHHHHHhhccCCCcCCCCCCCCC--CCCCceeeeEee
Q 039720           19 SHVKHATVTFNMQQLHDPLGVTKSWNNS--INLCQWTGVTCG   58 (973)
Q Consensus        19 ~~~~~~ll~~~~~~~~d~~~~l~sw~~~--~~~c~w~gv~C~   58 (973)
                      ..|++||++||+++..||.+.+++|+.+  ++||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            4689999999998877888999999976  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.84  E-value=2.3e-08  Score=104.44  Aligned_cols=144  Identities=20%  Similarity=0.273  Sum_probs=105.6

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCC--CceeEEeEeeecccCCCceEEEEEe
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHR--NLIKIITICSSIDFKGADFKAIVYE  756 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e  756 (973)
                      +.++.|.++.||+++.. +|..+++|+...... .....+..|+++++.+.+.  .+.+++.+.....  .....++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999874 468999999864432 1345688999999999764  3566666643211  1135689999


Q ss_pred             eccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 039720          757 YMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC----------------------------------------  796 (973)
Q Consensus       757 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----------------------------------------  796 (973)
                      |++|.++.+.+.. ......+...++.++++++.+||+..                                        
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888775532 23344556677888888888888521                                        


Q ss_pred             -------------CCCeEecCCCCCcEEecC--CCcEEEeccccch
Q 039720          797 -------------QPPIVHGDLKPSNVLLDH--DMVAHVSDFGLAR  827 (973)
Q Consensus       797 -------------~~~ivHrDik~~NILl~~--~~~~kl~Dfg~a~  827 (973)
                                   ...++|+|+++.||+++.  ++.+.++||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         236799999999999998  6678999999886

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.80  E-value=3.8e-08  Score=98.06  Aligned_cols=125  Identities=25%  Similarity=0.244  Sum_probs=83.5

Q ss_pred             eEEEEEECCCCcEEEEEEeeccc--------------c------------hhHHHHHHHHHHHHhcCCC--CceeEEeEe
Q 039720          689 FVYKGNLGEDGMSVAVKVMNLDK--------------K------------GATKSFVAECEALRNIRHR--NLIKIITIC  740 (973)
Q Consensus       689 ~V~~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--niv~~~~~~  740 (973)
                      .||.|.. .+|..+|||+.+...              .            .......+|++.|.++...  ++.+++++ 
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            3899988 478899999986421              0            0123567899999999866  45666654 


Q ss_pred             eecccCCCceEEEEEeecc--CCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEecCCCc
Q 039720          741 SSIDFKGADFKAIVYEYMQ--YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMV  817 (973)
Q Consensus       741 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~ivHrDik~~NILl~~~~~  817 (973)
                              ...++||||+.  |..+..+....  ........++.+++..+..+ |+.   ||+|+|+.+.||+++++ .
T Consensus        79 --------~~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   79 --------NRNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             --------ETTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred             --------eCCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence                    34679999998  65554433221  11344667888888866664 677   99999999999999887 9


Q ss_pred             EEEeccccchhc
Q 039720          818 AHVSDFGLARFL  829 (973)
Q Consensus       818 ~kl~Dfg~a~~~  829 (973)
                      +.++|||.+...
T Consensus       145 ~~iIDf~qav~~  156 (188)
T PF01163_consen  145 VYIIDFGQAVDS  156 (188)
T ss_dssp             EEE--GTTEEET
T ss_pred             EEEEecCcceec
Confidence            999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.80  E-value=3.5e-09  Score=85.09  Aligned_cols=61  Identities=41%  Similarity=0.568  Sum_probs=45.7

Q ss_pred             CCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccC
Q 039720          255 PKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       255 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      ++|++|++++|+|+.+.+..|.++++|++|++++|+++.+.+..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4577777777777766666777777777777777777777777777777777777777764

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.79  E-value=3.7e-08  Score=100.16  Aligned_cols=138  Identities=25%  Similarity=0.202  Sum_probs=102.9

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc----------------------hhHHHHHHHHHHHHhcCCC-
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK----------------------GATKSFVAECEALRNIRHR-  731 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~-  731 (973)
                      -+.+..+||.|--+.||.|.+. .|.++|||.-+....                      .......+|+++|..+.-. 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3566789999999999999995 899999997642210                      1123467899999999755 


Q ss_pred             -CceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 039720          732 -NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNV  810 (973)
Q Consensus       732 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NI  810 (973)
                       .+.+.+++         +...+||||++|-.|...--     .......++..|+.-+.-.-..   ||||+|+++-||
T Consensus       171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNI  233 (304)
T COG0478         171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNI  233 (304)
T ss_pred             CCCCCcccc---------ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---CccccCCchheE
Confidence             67777765         77889999999977765431     1223344555555555555566   999999999999


Q ss_pred             EecCCCcEEEeccccchhcc
Q 039720          811 LLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       811 Ll~~~~~~kl~Dfg~a~~~~  830 (973)
                      +++++|.+.++||-.+...+
T Consensus       234 lV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             EEecCCCEEEEeCcccccCC
Confidence            99999999999999876543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.74  E-value=1.1e-08  Score=125.01  Aligned_cols=206  Identities=21%  Similarity=0.227  Sum_probs=106.6

Q ss_pred             CcccEEEccCCcCCCCCCCcccCCCccceeccCCCC--ccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcE
Q 039720          182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEND--FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTV  259 (973)
Q Consensus       182 ~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~  259 (973)
                      ...+...+.+|++. .++....+ ++|+.|-+..|.  +.......|..++.|..|+|++|.=-+.+|..++ +|-+|++
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~-~Li~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG-ELVHLRY  599 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh-hhhhhhc
Confidence            45555666666554 34443332 256666666654  3323333355566666666666555556666666 6677777


Q ss_pred             EEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeec
Q 039720          260 LVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLG  339 (973)
Q Consensus       260 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~  339 (973)
                      |+|++..++ .+|..+.++.+|.+|++..+.-...++.....|.+|++|.+..-..    ..+......+.++.+|+.+.
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~----~~~~~~l~el~~Le~L~~ls  674 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSAL----SNDKLLLKELENLEHLENLS  674 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecccc----ccchhhHHhhhcccchhhhe
Confidence            777777776 5677777777777777776665545566666677777777665441    11122223334444444443


Q ss_pred             ccccccc-CCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCC
Q 039720          340 LVFNRFG-GALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG  396 (973)
Q Consensus       340 l~~N~l~-~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  396 (973)
                      ....... ..-......+.+....+.+.++... ..+..+..+.+|+.|.+.++.+..
T Consensus       675 ~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e  731 (889)
T KOG4658|consen  675 ITISSVLLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE  731 (889)
T ss_pred             eecchhHhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence            3221110 0000111222222333333222222 344455666666666666666653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.73  E-value=8.3e-09  Score=82.89  Aligned_cols=61  Identities=41%  Similarity=0.533  Sum_probs=40.4

Q ss_pred             CCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcc
Q 039720          382 FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL  442 (973)
Q Consensus       382 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  442 (973)
                      ++|++|++++|+++.+.+.+|.++++|++|++++|+|+.+.|+.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566666666666655556666666666666666666666666666666666666666654

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.70  E-value=2.6e-07  Score=97.88  Aligned_cols=142  Identities=18%  Similarity=0.103  Sum_probs=97.0

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeecccch-----------hHHHHHHHHHHHHhcCCCC--ceeEEeEeeecccCCC
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-----------ATKSFVAECEALRNIRHRN--LIKIITICSSIDFKGA  748 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~  748 (973)
                      +-......|+++..  .|+.|.||........           ....+.+|...+..+...+  ..+++++.........
T Consensus        30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            33333344667766  6789999977432211           1124778888888774333  3333444322111113


Q ss_pred             ceEEEEEeeccCC-CHHHHhhh--cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-------CCcE
Q 039720          749 DFKAIVYEYMQYG-SVDDWLHH--TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-------DMVA  818 (973)
Q Consensus       749 ~~~~lv~e~~~~g-sL~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-------~~~~  818 (973)
                      ...++|+|++++. +|.+++..  ...........++.+++..+.-||..   ||+|+|++++|||++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence            4578999999986 89888753  22233455678999999999999999   9999999999999975       4689


Q ss_pred             EEeccccchh
Q 039720          819 HVSDFGLARF  828 (973)
Q Consensus       819 kl~Dfg~a~~  828 (973)
                      .++||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998863

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.65  E-value=1.3e-06  Score=95.67  Aligned_cols=172  Identities=19%  Similarity=0.231  Sum_probs=131.0

Q ss_pred             cceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeeccC-CCHH
Q 039720          686 SFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQY-GSVD  764 (973)
Q Consensus       686 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~  764 (973)
                      -..+.|+|....+|..|++|.++.++.........-+++.+++.|+|+|++.+++.-. -.++...++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHH
Confidence            4568999999999999999999766554554556678889999999999999887633 2345778999999875 4666


Q ss_pred             HHhhh---------------cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          765 DWLHH---------------TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       765 ~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      +.--.               ....++...|.++.|+..||.++|+.   |...+-+.+.+|+++.+.+++|+..|..-.+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            65321               11234567899999999999999999   9999999999999999999999888876543


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP  886 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~P  886 (973)
                      ...+               +       |.+.+   -.+-|.=.||.++..|.||..-
T Consensus       444 ~~d~---------------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDP---------------T-------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCC---------------C-------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3211               0       11111   1256888999999999999654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.63  E-value=1.2e-09  Score=122.49  Aligned_cols=124  Identities=27%  Similarity=0.307  Sum_probs=63.0

Q ss_pred             eeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCccccccccc-chhhhccCCeecCCCC
Q 039720          483 LLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ-SLNALKSIKELDLSCN  561 (973)
Q Consensus       483 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N  561 (973)
                      ..+.++|.++ .+..++.-++.|+.|||++|+++..  +.+..|+.|+.|||++|+++ .+|. ....+. |..|.|++|
T Consensus       168 ~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN  242 (1096)
T KOG1859|consen  168 TASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNN  242 (1096)
T ss_pred             hhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeeccc
Confidence            3455555554 3444455555566666666666532  14555566666666666665 3332 222322 556666666


Q ss_pred             ccccccCCCCCCCCccceEeccCCcCcCcCCCC--CCCCCccccccccCccccC
Q 039720          562 NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK--GVFSNETRISLTGNEQFCG  613 (973)
Q Consensus       562 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--~~~~~~~~l~~~~N~~~cg  613 (973)
                      .++..  ..+.+|.+|+.||+++|-|++.-.-.  +.+..+..+.++|||.-|.
T Consensus       243 ~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  243 ALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             HHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            55521  23445555666666666554432211  2334455566666655553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.54  E-value=2.9e-08  Score=112.67  Aligned_cols=157  Identities=12%  Similarity=0.194  Sum_probs=103.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC-CccCCCCCcccccccccccccCccccc
Q 039720          782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP-FLVAPEGQSSSIEMKGTIGYIGPEYGM  860 (973)
Q Consensus       782 ~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~  860 (973)
                      +.+++.|+.|+|...  ++||++|.|++|.++..+..|++.|+++....... +..................|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345559999999875  99999999999999999999999999887654421 111122222222233456799999999


Q ss_pred             CCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHh
Q 039720          861 GGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGV  939 (973)
Q Consensus       861 ~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  939 (973)
                      ....+.++|+||+||++|.++. |+.-+.........-....           .+..     ...-.....+.++.+-+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-----------~~~~-----~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-----------LLNA-----GAFGYSNNLPSELRESLK  246 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-----------cccc-----ccccccccCcHHHHHHHH
Confidence            9888999999999999999995 4444433222111000000           0000     001111344556667777


Q ss_pred             hcCCCCCCCCCCHHHHH
Q 039720          940 ACSMESPSERMQMTAVV  956 (973)
Q Consensus       940 ~cl~~dP~~RPs~~evl  956 (973)
                      +++..++..||++.++.
T Consensus       247 k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHhcCCcccCcchhhhh
Confidence            89999999999777654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.52  E-value=3.5e-09  Score=118.82  Aligned_cols=128  Identities=27%  Similarity=0.273  Sum_probs=87.3

Q ss_pred             cccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEc
Q 039720          183 ALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVV  262 (973)
Q Consensus       183 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L  262 (973)
                      .|.+.+.+.|.+. ....++.-++.|+.|+|++|+++...  .+..++.|++|+|+.|++. .+|.---.++ +|..|.+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence            4556666666665 55566666666666666666666332  4555666666666666666 5554332233 3889999


Q ss_pred             cCCcccccCCccccCCCCCCEEEccCCcccccC-cccccCcccccceecccccCCC
Q 039720          263 AQNNLTGFLPQSLSNASKLEWLELNENHFSGQV-RINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       263 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      ++|.++..  ..+.+|.+|+.|||+.|-|.+-- -..+..|..|+.|+|.+|.+-.
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            99988843  45788999999999999887532 2346678889999999998854

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.43  E-value=1.9e-08  Score=90.39  Aligned_cols=106  Identities=22%  Similarity=0.333  Sum_probs=57.4

Q ss_pred             eeccCCcccccCCccc-ccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCc
Q 039720          484 LDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNN  562 (973)
Q Consensus       484 L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  562 (973)
                      .+|++|.+.. .|..| ...+.++.|+|++|.++ .+|..+..++.|+.|+++.|.|. ..|..+..|.++-.||..+|.
T Consensus        58 i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na  134 (177)
T KOG4579|consen   58 ISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENA  134 (177)
T ss_pred             Eecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCc
Confidence            3444444442 22222 22345666666666666 56666666666666666666666 566666666666666666666


Q ss_pred             cccccCCCCCCCCccceEeccCCcCcCcCCC
Q 039720          563 LSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       563 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  593 (973)
                      +. .+|..+-.-+..-..++.++++.+..+.
T Consensus       135 ~~-eid~dl~~s~~~al~~lgnepl~~~~~~  164 (177)
T KOG4579|consen  135 RA-EIDVDLFYSSLPALIKLGNEPLGDETKK  164 (177)
T ss_pred             cc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence            65 4444432222223334455555544443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.42  E-value=2.4e-06  Score=87.65  Aligned_cols=110  Identities=23%  Similarity=0.278  Sum_probs=83.8

Q ss_pred             HHHHHHHHHHHHhcCCC--CceeEEeEeeecccCCCceEEEEEeeccCC-CHHHHhhhcCCCchhhHHHHHHHHHHHHHH
Q 039720          715 TKSFVAECEALRNIRHR--NLIKIITICSSIDFKGADFKAIVYEYMQYG-SVDDWLHHTNDKLEVGKLNIVIEVASVIEY  791 (973)
Q Consensus       715 ~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~qi~~aL~~  791 (973)
                      .....+|...+..+...  .+.+.+++..... ......++|+|++++. +|.+++.............++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            34677888877777432  3445555544321 1224568999999874 799998874444556678899999999999


Q ss_pred             HHhcCCCCeEecCCCCCcEEecCCC---cEEEeccccchh
Q 039720          792 LHNHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLARF  828 (973)
Q Consensus       792 LH~~~~~~ivHrDik~~NILl~~~~---~~kl~Dfg~a~~  828 (973)
                      ||+.   ||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999   999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.38  E-value=4.8e-06  Score=84.24  Aligned_cols=154  Identities=19%  Similarity=0.169  Sum_probs=104.4

Q ss_pred             cccHHHHHHHhhcCCcCCc---cccccceeEEEEEECCCCcEEEEEEeecccch------------------------hH
Q 039720          663 IVSYAELSKATKEFSSSNR---IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG------------------------AT  715 (973)
Q Consensus       663 ~~~~~~~~~~~~~y~~~~~---lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------~~  715 (973)
                      ..++..+....++..+...   |+.|--+.||+|.. .++..+|||+++.....                        ..
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3455666666666666655   45566678999987 47899999999753211                        01


Q ss_pred             HHHHHHHHHHHhcC--CCCceeEEeEeeecccCCCceEEEEEeeccCCCH-HHHhhhcCCCchhhHHHHHHHHHHHHHHH
Q 039720          716 KSFVAECEALRNIR--HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSV-DDWLHHTNDKLEVGKLNIVIEVASVIEYL  792 (973)
Q Consensus       716 ~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~i~~qi~~aL~~L  792 (973)
                      ....+|+.-|+++.  +-.+.+.+++         ....+||||+..... .=.+..-+ ....+...+..++++.+.-|
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~LkDv~-~e~~e~~~~~~~~v~~~~~l  182 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRLKDVP-LELEEAEGLYEDVVEYMRRL  182 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCcccCC-cCchhHHHHHHHHHHHHHHH
Confidence            23567888888774  4445555554         456799999854311 11111111 11125667788888888888


Q ss_pred             HhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       793 H~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      -..+  ++||+|++.-|||+. ++.+.++|||.|....
T Consensus       183 ~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         183 YKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7743  999999999999999 8999999999987554

>PRK09902 hypothetical protein; Provisional

Probab=98.36  E-value=9.3e-06  Score=81.33  Aligned_cols=141  Identities=17%  Similarity=0.173  Sum_probs=102.3

Q ss_pred             cccccceeEEEEEECCCCcEEEEEEeecc-----c-chhHHHHHHHHHHHHhcCCC--CceeEEeEeeecccCCCceEEE
Q 039720          682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD-----K-KGATKSFVAECEALRNIRHR--NLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       682 lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      -|+||.+.|+....  .|..+-+|.-.-.     . +-....|.+|+..+..+...  .+.+++ ++...........++
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46789999999877  4556778875411     1 33457799999999888532  244444 332222233456789


Q ss_pred             EEeeccC-CCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc--EEEeccccchh
Q 039720          754 VYEYMQY-GSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV--AHVSDFGLARF  828 (973)
Q Consensus       754 v~e~~~~-gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~--~kl~Dfg~a~~  828 (973)
                      |+|.+.+ -+|.+++....  ..+......+..+++.++.-||+.   |+.|+|+.+.||+++.++.  ++++||--++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997764 48888876533  234455678999999999999999   9999999999999986666  99999987764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	973
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-51
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-28
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-51
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-27
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-34
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-22
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-14
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-14
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		1e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		2e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-14
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		5e-14
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		5e-14
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		5e-14
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		5e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-08
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		7e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		3e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		4e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-05
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		6e-05
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		6e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-05
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		7e-05
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		7e-05
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		3e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-04
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		2e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-04
3a79_B	562	Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len		2e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		3e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-04
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		4e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-04
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		5e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		6e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-04
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		6e-04
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		6e-04
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		6e-04
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		6e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-04
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		8e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  201 bits (510), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 193/624 (30%), Positives = 277/624 (44%), Gaps = 74/624 (11%)
Query: 55  VTCGHRHQRVTKLDLESQNIGG------FLSPYIGNLSFLRVINLANNSFHGQIPKEVGR 108
           V+ G +   +  LDL + +I G       LS   G L  L +   + N   G +  +V R
Sbjct: 141 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI---SGNKISGDV--DVSR 195
Query: 109 LFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN 168
              LE + +S+N+FS  IP  L  C  L    +  N L G+    I    +++ L++  N
Sbjct: 196 CVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 254
Query: 169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSL-GQLRNLNYLGTSENDFSGMFPLSVC 227
           Q  G +PP    L +LQ   +A NK  G IPD L G    L  L  S N F G  P    
Sbjct: 255 QFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 312
Query: 228 NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN-ASKLEWLEL 286
           + S L+   L  N F G LP+     +  L VL ++ N  +G LP+SL+N ++ L  L+L
Sbjct: 313 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 372
Query: 287 NENHFSGQVRINFNSLPN--LSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR 344
           + N+FSG +  N    P   L +LYL  N    +    L      +NCS+LV L L FN 
Sbjct: 373 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL------SNCSELVSLHLSFNY 426
Query: 345 FGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE 404
             G +P S+ +LS    L  +  N + G IP E+  +  L  L L++N LTG IP  +  
Sbjct: 427 LSGTIPSSLGSLSKLRDL-KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 485
Query: 405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
             NL ++ L  N + G IP  IG L  L +L+L  N   G+IP+ LG C++L+ L    N
Sbjct: 486 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 545
Query: 465 KLNGTLPPQIF-----------------------------GITTLSKLLDLSE---NHLS 492
             NGT+P  +F                             G   L +   +     N LS
Sbjct: 546 LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 605
Query: 493 GSIPLEV-------------GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSF 539
              P  +              N  S++ LD+S N  S  IP  + +   L  L +  N  
Sbjct: 606 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 665
Query: 540 NGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
           +GSIP  +  L+ +  LDLS N L G+IP  +  L  L  ++LS N+  G +P+ G F  
Sbjct: 666 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 725
Query: 600 ETRISLTGNEQFCGGLGELHLPAC 623
                   N   CG      LP C
Sbjct: 726 FPPAKFLNNPGLCG----YPLPRC 745

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  122 bits (307), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 140/502 (27%), Positives = 229/502 (45%), Gaps = 28/502 (5%)
Query: 182 SALQTFDIAGNKLDGRIPD--SLGQLRNLNYLGTSEN--DFSGMFPLSVCNISSLDEAYL 237
           ++L + D++ N L G +    SLG    L +L  S N  DF G     +  ++SL+   L
Sbjct: 97  ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL-KLNSLEVLDL 155
Query: 238 FKNRFKGSLPV--CLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQV 295
             N   G+  V   L     +L  L ++ N ++G +   +S    LE+L+++ N+FS  +
Sbjct: 156 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGI 213
Query: 296 RINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIAN 355
                    L  L +  N L        DF   ++ C++L  L +  N+F G +P     
Sbjct: 214 PF-LGDCSALQHLDISGNKLSG------DFSRAISTCTELKLLNISSNQFVGPIPPLPL- 265
Query: 356 LSTTMTLIAMAGNQISGTIPPEIRNLFN-LNGLGLEYNQLTGTIPPAIGELRNLQYLGLV 414
              ++  +++A N+ +G IP  +    + L GL L  N   G +PP  G    L+ L L 
Sbjct: 266 --KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 323
Query: 415 GNNIRGIIP-DPIGNLTLLNVLQLGFNKLQGSIPSYLGK-CQNLMQLSAPNNKLNGTLPP 472
            NN  G +P D +  +  L VL L FN+  G +P  L     +L+ L   +N  +G + P
Sbjct: 324 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 383
Query: 473 QIFG--ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLE 530
            +      TL +L  L  N  +G IP  + N   LV L +S N  S  IP +L + + L 
Sbjct: 384 NLCQNPKNTLQELY-LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 442
Query: 531 YLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGK 590
            L +  N   G IPQ L  +K+++ L L  N+L+G+IP  L N   L +++LS N   G+
Sbjct: 443 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 502
Query: 591 VPKK-GVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAH 649
           +PK  G   N   + L+ N  F G +    L  C S+        L    IP    K + 
Sbjct: 503 IPKWIGRLENLAILKLS-NNSFSGNI-PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 560
Query: 650 KLSSALLMEQQFPIVSYAELSK 671
           K+++  +  +++  +    + K
Sbjct: 561 KIAANFIAGKRYVYIKNDGMKK 582

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  200 bits (509), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 193/625 (30%), Positives = 277/625 (44%), Gaps = 74/625 (11%)
Query: 55  VTCGHRHQRVTKLDLESQNIGG------FLSPYIGNLSFLRVINLANNSFHGQIPKEVGR 108
           V+ G +   +  LDL + +I G       LS   G L  L +   + N   G +  +V R
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI---SGNKISGDV--DVSR 198
Query: 109 LFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN 168
              LE + +S+N+FS  IP  L  C  L    +  N L G+    I    +++ L++  N
Sbjct: 199 CVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSL-GQLRNLNYLGTSENDFSGMFPLSVC 227
           Q  G +PP    L +LQ   +A NK  G IPD L G    L  L  S N F G  P    
Sbjct: 258 QFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 228 NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN-ASKLEWLEL 286
           + S L+   L  N F G LP+     +  L VL ++ N  +G LP+SL+N ++ L  L+L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 287 NENHFSGQVRINFNSLP--NLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR 344
           + N+FSG +  N    P   L +LYL  N    +    L      +NCS+LV L L FN 
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL------SNCSELVSLHLSFNY 429
Query: 345 FGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE 404
             G +P S+ +LS    L  +  N + G IP E+  +  L  L L++N LTG IP  +  
Sbjct: 430 LSGTIPSSLGSLSKLRDL-KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
             NL ++ L  N + G IP  IG L  L +L+L  N   G+IP+ LG C++L+ L    N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 465 KLNGTLPPQIF-----------------------------GITTLSKLLDLSE---NHLS 492
             NGT+P  +F                             G   L +   +     N LS
Sbjct: 549 LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 493 GSIPLEV-------------GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSF 539
              P  +              N  S++ LD+S N  S  IP  + +   L  L +  N  
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 540 NGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
           +GSIP  +  L+ +  LDLS N L G+IP  +  L  L  ++LS N+  G +P+ G F  
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728
Query: 600 ETRISLTGNEQFCGGLGELHLPACH 624
                   N   CG      LP C 
Sbjct: 729 FPPAKFLNNPGLCG----YPLPRCD 749

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  122 bits (306), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 139/492 (28%), Positives = 226/492 (45%), Gaps = 28/492 (5%)
Query: 182 SALQTFDIAGNKLDGRIPD--SLGQLRNLNYLGTSEN--DFSGMFPLSVCNISSLDEAYL 237
           ++L + D++ N L G +    SLG    L +L  S N  DF G     +  ++SL+   L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL-KLNSLEVLDL 158
Query: 238 FKNRFKGSLPV--CLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQV 295
             N   G+  V   L     +L  L ++ N ++G +   +S    LE+L+++ N+FS  +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGI 216
Query: 296 RINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIAN 355
                    L  L +  N L        DF   ++ C++L  L +  N+F G +P     
Sbjct: 217 PF-LGDCSALQHLDISGNKLSG------DFSRAISTCTELKLLNISSNQFVGPIPPLPL- 268
Query: 356 LSTTMTLIAMAGNQISGTIPPEIRNLFN-LNGLGLEYNQLTGTIPPAIGELRNLQYLGLV 414
              ++  +++A N+ +G IP  +    + L GL L  N   G +PP  G    L+ L L 
Sbjct: 269 --KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 415 GNNIRGIIP-DPIGNLTLLNVLQLGFNKLQGSIPSYLGK-CQNLMQLSAPNNKLNGTLPP 472
            NN  G +P D +  +  L VL L FN+  G +P  L     +L+ L   +N  +G + P
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 473 QIFG--ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLE 530
            +      TL +L  L  N  +G IP  + N   LV L +S N  S  IP +L + + L 
Sbjct: 387 NLCQNPKNTLQELY-LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
Query: 531 YLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGK 590
            L +  N   G IPQ L  +K+++ L L  N+L+G+IP  L N   L +++LS N   G+
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 591 VPKK-GVFSNETRISLTGNEQFCGGLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAH 649
           +PK  G   N   + L+ N  F G +    L  C S+        L    IP    K + 
Sbjct: 506 IPKWIGRLENLAILKLS-NNSFSGNI-PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563
Query: 650 KLSSALLMEQQF 661
           K+++  +  +++
Sbjct: 564 KIAANFIAGKRY 575

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  145 bits (367), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 108/313 (34%), Positives = 160/313 (51%), Gaps = 27/313 (8%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSF 718
           Q    S  EL  A+  FS+ N +G+G FG VYKG L  DG  VAVK +  ++ +G    F
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERXQGGELQF 82
Query: 719 VAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---LE 775
             E E +    HRNL+++   C +        + +VY YM  GSV   L    +    L+
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 776 VGKLN-IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
             K   I +  A  + YLH+HC P I+H D+K +N+LLD +  A V DFGLA+ + +   
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 197
Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF--- 891
            V          ++GTIG+I PEY   G  S   DV+ +G++LLE+ T +R  D      
Sbjct: 198 HV-------XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 250
Query: 892 NDGLTLHGYAKMAL-PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM 950
           +D + L  + K  L  KK+  +VD  L    +G  K EE +  +++  + C+  SP ER 
Sbjct: 251 DDDVMLLDWVKGLLKEKKLEALVDVDL----QGNYKDEE-VEQLIQVALLCTQSSPMERP 305
Query: 951 QMTAVVKKLCAVG 963
           +M+ VV+ L   G
Sbjct: 306 KMSEVVRMLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  142 bits (359), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 106/313 (33%), Positives = 158/313 (50%), Gaps = 27/313 (8%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSF 718
           Q    S  EL  A+  F + N +G+G FG VYKG L  DG  VAVK +  ++ +G    F
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLA-DGXLVAVKRLKEERTQGGELQF 74
Query: 719 VAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---LE 775
             E E +    HRNL+++   C +        + +VY YM  GSV   L    +    L+
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 776 VGKLN-IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
             K   I +  A  + YLH+HC P I+H D+K +N+LLD +  A V DFGLA+ + +   
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF--- 891
            V          ++G IG+I PEY   G  S   DV+ +G++LLE+ T +R  D      
Sbjct: 190 HV-------XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 892 NDGLTLHGYAKMAL-PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM 950
           +D + L  + K  L  KK+  +VD  L    +G  K EE +  +++  + C+  SP ER 
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDL----QGNYKDEE-VEQLIQVALLCTQSSPMERP 297
Query: 951 QMTAVVKKLCAVG 963
           +M+ VV+ L   G
Sbjct: 298 KMSEVVRMLEGDG 310

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 122/251 (48%), Gaps = 7/251 (2%)
Query: 374 IPPEIRNLFNLNGLGLE-YNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
           IP  + NL  LN L +   N L G IPPAI +L  L YL +   N+ G IPD +  +  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 433 NVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS 492
             L   +N L G++P  +    NL+ ++   N+++G +P      + L   + +S N L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 493 GSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKS 552
           G IP    NL +L  +D+SRN    +  V   +    + + +  NS    + + +   K+
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKN 245
Query: 553 IKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFC 612
           +  LDL  N + G +P  L  L FL  LN+S+N+  G++P+ G        +   N+  C
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
Query: 613 GGLGELHLPAC 623
           G      LPAC
Sbjct: 306 GS----PLPAC 312

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 99/322 (30%), Positives = 148/322 (45%), Gaps = 40/322 (12%)
Query: 651 LSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD 710
           LSS+ L+  +   V   +L +AT  F     IG G FG VYKG L  DG  VA+K    +
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE 74
Query: 711 KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT 770
                + F  E E L   RH +L+ +I  C        +   ++Y+YM+ G++   L+ +
Sbjct: 75  SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGS 129
Query: 771 N----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 826
           +          +L I I  A  + YLH      I+H D+K  N+LLD + V  ++DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186
Query: 827 RFLSHHPFLVAPEGQSS-SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR- 884
           +  +         GQ+     +KGT+GYI PEY + G L+   DVYSFG++L E+   R 
Sbjct: 187 KKGTEL-------GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 885 -------RPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRT 937
                  R   N+    +  H   ++        IVDP+L  + R      E L     T
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLE------QIVDPNLADKIR-----PESLRKFGDT 288
Query: 938 GVACSMESPSERMQMTAVVKKL 959
            V C   S  +R  M  V+ KL
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKL 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 147/323 (45%), Gaps = 42/323 (13%)
Query: 651 LSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD 710
           LSS+ L+  +   V   +L +AT  F     IG G FG VYKG L  DG  VA+K    +
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE 74
Query: 711 KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT 770
                + F  E E L   RH +L+ +I  C        +   ++Y+YM+ G++   L+ +
Sbjct: 75  SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGS 129
Query: 771 N----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 826
           +          +L I I  A  + YLH      I+H D+K  N+LLD + V  ++DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186
Query: 827 RFLSHHPFLVAPEGQSSSIE--MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
           +           E   + +   +KGT+GYI PEY + G L+   DVYSFG++L E+   R
Sbjct: 187 K--------KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 885 --------RPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVR 936
                   R   N+    +  H   ++        IVDP+L  + R      E L     
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLE------QIVDPNLADKIR-----PESLRKFGD 287
Query: 937 TGVACSMESPSERMQMTAVVKKL 959
           T V C   S  +R  M  V+ KL
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 29/219 (13%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           +IG GSFG V++      G  VAVK++      A +   F+ E   ++ +RH N++    
Sbjct: 44  KIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL--- 98
Query: 739 ICSSIDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVG---KLNIVIEVASVIEY 791
                 F GA  +    +IV EY+  GS+   LH +  + ++    +L++  +VA  + Y
Sbjct: 99  ------FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LHN   PPIVH +LK  N+L+D      V DFGL+R L    FL       SS    GT 
Sbjct: 153 LHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFL-------SSKSAAGTP 203
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
            ++ PE       +   DVYSFG++L E+ T ++P  N+
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 109/221 (49%), Gaps = 29/221 (13%)
Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKI 736
             +IG GSFG V++      G  VAVK++      A +   F+ E   ++ +RH N++  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL- 98
Query: 737 ITICSSIDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVG---KLNIVIEVASVI 789
                   F GA  +    +IV EY+  GS+   LH +  + ++    +L++  +VA  +
Sbjct: 99  --------FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            YLHN   PPIVH DLK  N+L+D      V DFGL+R L    FL        S    G
Sbjct: 151 NYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFL-------XSKXAAG 201
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           T  ++ PE       +   DVYSFG++L E+ T ++P  N+
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 108/224 (48%), Gaps = 24/224 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   ++         AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 66  ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH      I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I
Sbjct: 120 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSI 170
Query: 852 GYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 110/228 (48%), Gaps = 32/228 (14%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   ++         AIV ++ +  S+   LH +  K E+ KL +I  + A  ++Y
Sbjct: 82  ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----RFLSHHPFLVAPEGQSSSIEM 847
           LH      I+H DLK +N+ L  D    + DFGLA    R+   H F           ++
Sbjct: 136 LHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----------QL 182
Query: 848 KGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            G+I ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      IGKG FG V  G+    G  VAVK +  D     ++F+AE   +  +RH NL
Sbjct: 12  KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNL 67
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEY 791
           ++++ +   ++ KG  +  IV EYM  GS+ D+L      +  G   L   ++V   +EY
Sbjct: 68  VQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 123
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L  +     VH DL   NVL+  D VA VSDFGL +           E  S+    K  +
Sbjct: 124 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPV 169
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR 885
            +  PE       S   DV+SFGILL E+++  R
Sbjct: 170 KWTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH      I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I
Sbjct: 120 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSI 170
Query: 852 GYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH +  K E+ KL +I  + A  ++Y
Sbjct: 82  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----RFLSHHPFLVAPEGQSSSIEM 847
           LH      I+H DLK +N+ L  D    + DFGLA    R+   H F           ++
Sbjct: 136 LHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----------QL 182
Query: 848 KGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            G+I ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 71  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH      I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I
Sbjct: 125 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSI 175
Query: 852 GYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 13  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 69
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH +  K E+ KL +I  + A  ++Y
Sbjct: 70  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 123
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----RFLSHHPFLVAPEGQSSSIEM 847
           LH      I+H DLK +N+ L  D    + DFGLA    R+   H F           ++
Sbjct: 124 LHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE----------QL 170
Query: 848 KGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            G+I ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 171 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 218

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      IGKG FG V  G+    G  VAVK +  D     ++F+AE   +  +RH NL
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNL 61
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEY 791
           ++++ +   ++ KG  +  IV EYM  GS+ D+L      +  G   L   ++V   +EY
Sbjct: 62  VQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L  +     VH DL   NVL+  D VA VSDFGL +           E  S+    K  +
Sbjct: 118 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPV 163
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S   DV+SFGILL E+++
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 67
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 68  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 121
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH      I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I
Sbjct: 122 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSI 172
Query: 852 GYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 71  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH      I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I
Sbjct: 125 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSI 175
Query: 852 GYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      IGKG FG V  G+    G  VAVK +  D     ++F+AE   +  +RH NL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNL 248
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEY 791
           ++++ +   ++ KG  +  IV EYM  GS+ D+L      +  G   L   ++V   +EY
Sbjct: 249 VQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L  +     VH DL   NVL+  D VA VSDFGL +           E  S+    K  +
Sbjct: 305 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPV 350
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S   DV+SFGILL E+++
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----RFLSHHPFLVAPEGQSSSIEM 847
           LH      I+H DLK +N+ L  D+   + DFGLA    R+   H F           ++
Sbjct: 120 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----------QL 166
Query: 848 KGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            G+I ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      IGKG FG V  G+    G  VAVK +  D     ++F+AE   +  +RH NL
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNL 76
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEY 791
           ++++ +   ++ KG  +  IV EYM  GS+ D+L      +  G   L   ++V   +EY
Sbjct: 77  VQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L  +     VH DL   NVL+  D VA VSDFGL +           E  S+    K  +
Sbjct: 133 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPV 178
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S   DV+SFGILL E+++
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 29  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 85
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 86  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 139
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----RFLSHHPFLVAPEGQSSSIEM 847
           LH      I+H DLK +N+ L  D+   + DFGLA    R+   H F           ++
Sbjct: 140 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----------QL 186
Query: 848 KGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            G+I ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 187 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 63
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 64  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 117
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +  AP G 
Sbjct: 118 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAPAGA 173
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                 K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 174 ------KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 64
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 118
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +  AP G 
Sbjct: 119 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAPAGA 174
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                 K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 175 ------KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 94  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----RFLSHHPFLVAPEGQSSSIEM 847
           LH      I+H DLK +N+ L  D+   + DFGLA    R+   H F           ++
Sbjct: 148 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----------QL 194
Query: 848 KGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            G+I ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 36  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 92
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 93  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 146
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH      I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I
Sbjct: 147 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSI 197
Query: 852 GYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 241

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRN 732
           + +   RIG GSFG VYKG    D   VAVK++N+      +  +F  E   LR  RH N
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++  +   +          AIV ++ +  S+   LH    K E+ KL +I  + A  ++Y
Sbjct: 94  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           LH      I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I
Sbjct: 148 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSI 198
Query: 852 GYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            ++ PE     D    S   DVY+FGI+L E+ T + P  N+ N
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G FG V+ G        VA+K +   K G  + ++F+ E + ++ +RH  L+++  
Sbjct: 274 KLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + S           IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+    
Sbjct: 330 VVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  P
Sbjct: 384 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG------AKFPIKWTAP 433
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G FG V+ G        VA+K +   K G  + ++F+ E + ++ +RH  L+++  
Sbjct: 191 KLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + S           IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+    
Sbjct: 247 VVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  P
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG------AKFPIKWTAP 350
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 121/242 (50%), Gaps = 38/242 (15%)
Query: 658 EQQFPIVSYAELSKATKEFSSS------NRIGKGSFGFVYKGNLGEDGMSVAVK----VM 707
           + +F   S+ EL   T  F         N++G+G FG VYKG +  +  +VAVK    ++
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 708 NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL 767
           ++  +   + F  E + +   +H NL++++   S     G D   +VY YM  GS+ D L
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD----GDDL-CLVYVYMPNGSLLDRL 121
Query: 768 HHTNDKLEVG---KLNIVIEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 823
              +    +    +  I    A+ I +LH NH     +H D+K +N+LLD    A +SDF
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDF 177
Query: 824 GLARFLSHHPFLVAPEGQSSSI---EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           GLAR         A E  + ++    + GT  Y+ PE  + G+++   D+YSFG++LLE+
Sbjct: 178 GLAR---------ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEI 227
Query: 881 FT 882
            T
Sbjct: 228 IT 229

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G FG V+ G        VA+K +   K G  + ++F+ E + ++ +RH  L+++  
Sbjct: 191 KLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + S           IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+    
Sbjct: 247 VVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  P
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG------AKFPIKWTAP 350
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 121/242 (50%), Gaps = 38/242 (15%)
Query: 658 EQQFPIVSYAELSKATKEFSSS------NRIGKGSFGFVYKGNLGEDGMSVAVK----VM 707
           + +F   S+ EL   T  F         N++G+G FG VYKG +  +  +VAVK    ++
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 708 NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL 767
           ++  +   + F  E + +   +H NL++++   S     G D   +VY YM  GS+ D L
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD----GDDL-CLVYVYMPNGSLLDRL 121
Query: 768 HHTNDKLEVG---KLNIVIEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 823
              +    +    +  I    A+ I +LH NH     +H D+K +N+LLD    A +SDF
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDF 177
Query: 824 GLARFLSHHPFLVAPEGQSSSI---EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           GLAR         A E  + ++    + GT  Y+ PE  + G+++   D+YSFG++LLE+
Sbjct: 178 GLAR---------ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEI 227
Query: 881 FT 882
            T
Sbjct: 228 IT 229

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G FG V+ G        VA+K +   K G  + ++F+ E + ++ +RH  L+++  
Sbjct: 191 KLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + S           IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+    
Sbjct: 247 VVSEEPI------YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  P
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG------AKFPIKWTAP 350
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 120/242 (49%), Gaps = 38/242 (15%)
Query: 658 EQQFPIVSYAELSKATKEFSSS------NRIGKGSFGFVYKGNLGEDGMSVAVK----VM 707
           + +F   S+ EL   T  F         N++G+G FG VYKG +  +  +VAVK    ++
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 60
Query: 708 NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL 767
           ++  +   + F  E + +   +H NL++++   S     G D   +VY YM  GS+ D L
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD----GDDL-CLVYVYMPNGSLLDRL 115
Query: 768 HHTNDKLEVG---KLNIVIEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 823
              +    +    +  I    A+ I +LH NH     +H D+K +N+LLD    A +SDF
Sbjct: 116 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDF 171
Query: 824 GLARFLSHHPFLVAPEGQSSSI---EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           GLAR         A E  +  +    + GT  Y+ PE  + G+++   D+YSFG++LLE+
Sbjct: 172 GLAR---------ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEI 221
Query: 881 FT 882
            T
Sbjct: 222 IT 223

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   ++ I+H NL+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLV 70
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVASVIEY 791
           +++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +  +++S +EY
Sbjct: 71  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEY 124
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L    +   +H DL   N L+  + +  V+DFGL+R ++   F       ++    K  I
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF-------TAHAGAKFPI 174
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S+  DV++FG+LL E+ T
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 60/224 (26%), Positives = 114/224 (50%), Gaps = 20/224 (8%)
Query: 662 PIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAE 721
           P  +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKE 63
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     
Sbjct: 64  AAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVL 117
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
           L +  +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +    
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---- 170
Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 171 ---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 70/223 (31%), Positives = 119/223 (53%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ IRH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKIRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 61/224 (27%), Positives = 114/224 (50%), Gaps = 20/224 (8%)
Query: 662 PIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAE 721
           P  +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKE 60
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     
Sbjct: 61  AAVMKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECN-RQEVNAVVL 114
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
           L +  +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R       L+  
Sbjct: 115 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR-------LMTG 164
Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 165 DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           + +  +++G G FG VY+G   +  ++VAVK +  D     + F+ E   ++ I+H NL+
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLV 70
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVASVIEY 791
           +++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +  +++S +EY
Sbjct: 71  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEY 124
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L    +   +H DL   N L+  + +  V+DFGL+R       L+  +  ++    K  I
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR-------LMTGDTXTAHAGAKFPI 174
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S+  DV++FG+LL E+ T
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 35/222 (15%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G FG V+ G        VA+K +   K G  + ++F+ E + ++ +RH  L+++  
Sbjct: 192 KLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGNMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIEY 791
           + S           IV EYM  GS+ D+L     K E+GK       +++  ++AS + Y
Sbjct: 248 VVSEEPI------YIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +        VH DL+ +N+L+  ++V  V+DFGL R +  + +  A +G       K  I
Sbjct: 297 VERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY-TARQG------AKFPI 346
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 347 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 388

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 62
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYM 116
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 166
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 62
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYM 116
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 166
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 67
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECN-RQEVNAVVLLYM 121
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 171
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 62
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYM 116
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 166
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 62
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYM 116
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 166
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 67
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYM 121
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 171
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/223 (30%), Positives = 119/223 (53%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVIEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 67
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 121
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 171
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 75
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 76  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 129
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 130 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 179
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 180 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 67
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 121
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 171
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 62
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 116
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 166
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 62
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 116
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 166
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 64
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 118
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 119 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 168
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 169 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 64
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 118
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R ++   +       
Sbjct: 119 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------- 168
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 169 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 27/218 (12%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 18  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 72
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNH 795
            + S       +   IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+   
Sbjct: 73  AVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 124
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  
Sbjct: 125 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFPIKWTA 176
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 214

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/223 (30%), Positives = 119/223 (53%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 14  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 68
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 69  AVVSE------EPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 117
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 118 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 167
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 168 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/223 (30%), Positives = 119/223 (53%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 16  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 70
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 71  AVVSE------EPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 119
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 120 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 169
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 170 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 212

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/223 (30%), Positives = 119/223 (53%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           + +  +++G G +G VY G   +  ++VAVK +  D     + F+ E   ++ I+H NL+
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLV 91
Query: 735 KIITICS-SIDFKGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEY 791
           +++ +C+    F       IV EYM YG++ D+L   N  +   V  L +  +++S +EY
Sbjct: 92  QLLGVCTLEPPF------YIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEY 145
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L    +   +H DL   N L+  + V  V+DFGL+R ++   +       ++    K  I
Sbjct: 146 LE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY-------TAHAGAKFPI 195
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S+  DV++FG+LL E+ T
Sbjct: 196 KWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 60/221 (27%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA 724
           +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAV 67
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           ++ I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYM 121
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +++S +EYL    +   +H DL   N L+  + +  V+DFGL+R       L+  +  
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR-------LMTGDTX 171
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   ++ I+H NL+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLV 70
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVASVIEY 791
           +++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L +  +++S +EY
Sbjct: 71  QLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEY 124
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L    +   +H DL   N L+  + +  V+DFGL+R       L+  +  ++    K  I
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR-------LMTGDTXTAHAGAKFPI 174
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE       S+  DV++FG+LL E+ T
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 69/223 (30%), Positives = 119/223 (53%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVCEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 27/218 (12%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 22  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNH 795
            + S       +   IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+   
Sbjct: 77  AVVSE------EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE-- 128
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFPIKWTA 180
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 218

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 112/220 (50%), Gaps = 20/220 (9%)
Query: 666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL 725
           Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVM 270
Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIV 782
           + I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L + 
Sbjct: 271 KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMA 324
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            +++S +EYL    +   +H +L   N L+  + +  V+DFGL+R ++   +       +
Sbjct: 325 TQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-------T 374
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 68/218 (31%), Positives = 117/218 (53%), Gaps = 27/218 (12%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 15  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 69
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNH 795
            + S       +   IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+   
Sbjct: 70  AVVSE------EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 121
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            +   VH DL+ +N+L+  ++V  V+DFGLAR +  +    A +G       K  I +  
Sbjct: 122 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-XTARQGA------KFPIKWTA 173
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 174 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 211

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 112/220 (50%), Gaps = 20/220 (9%)
Query: 666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL 725
           Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     + F+ E   +
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVM 309
Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIV 782
           + I+H NL++++ +C+    +   F  I+ E+M YG++ D+L   N + EV     L + 
Sbjct: 310 KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMA 363
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            +++S +EYL    +   +H +L   N L+  + +  V+DFGL+R ++   +       +
Sbjct: 364 TQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-------T 413
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +    K  I +  PE       S+  DV++FG+LL E+ T
Sbjct: 414 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL  +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 129 YVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 27/218 (12%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 22  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVIEYLHNH 795
            + S       +   IV EYM  GS+ D+L   T   L + +L ++  ++AS + Y+   
Sbjct: 77  AVVSE------EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE-- 128
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  I +  
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW-TARQGA------KFPIKWTA 180
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 218

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  GS+ D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVIEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  +    A +G       K  
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-XTARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 68/223 (30%), Positives = 118/223 (52%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  G + D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVMEYMSKGCLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 112/215 (52%), Gaps = 24/215 (11%)
Query: 682 IGKGSFGFVYKGNLG-EDGMS--VAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G FG V +GNL  EDG S  VAVK M LD   +   + F++E   +++  H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--------LNIVIEVASV 788
           + +C  +  +G     ++  +M+YG +  +L ++  +LE G         L  ++++A  
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS--RLETGPKHIPLQTLLKFMVDIALG 159
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           +EYL N      +H DL   N +L  DM   V+DFGL++ +    +    +G+ + + +K
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY--RQGRIAKMPVK 214
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
               +I  E       +   DV++FG+ + E+ TR
Sbjct: 215 ----WIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 68/223 (30%), Positives = 118/223 (52%), Gaps = 37/223 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMS-VAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
           ++G+G FG V+ G    +G + VA+K +   K G  + ++F+ E + ++ +RH  L+++ 
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIE 790
            + S       +   IV EYM  G + D+L     K E+GK       +++  ++AS + 
Sbjct: 80  AVVSE------EPIYIVTEYMSKGCLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y+    +   VH DL+ +N+L+  ++V  V+DFGLAR +  + +  A +G       K  
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA------KFP 178
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           I +  PE  + G  ++  DV+SFGILL E+ T+ R P   M N
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 660 QFPIVSYAELSKATKEFSSS------NRIGKGSFGFVYKGNLGEDGMSVAVK----VMNL 709
           +F   S+ EL   T  F         N+ G+G FG VYKG +  +  +VAVK    ++++
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDI 59
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
             +   + F  E +     +H NL++++   S     G D   +VY Y   GS+ D L  
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSD----GDDL-CLVYVYXPNGSLLDRLSC 114
Query: 770 TNDKLEVG---KLNIVIEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 825
            +    +    +  I    A+ I +LH NH     +H D+K +N+LLD    A +SDFGL
Sbjct: 115 LDGTPPLSWHXRCKIAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGL 170
Query: 826 ARFLSHHPFLVAPEGQSSSI---EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           AR         A E  +  +    + GT  Y  PE  + G+++   D+YSFG++LLE+ T
Sbjct: 171 AR---------ASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIIT 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 76  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP--FLVAPEGQSSSIEMKGTIG 852
                 +H DL   N+L++++    + DFGL + L      F V   G+S        I 
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP-------IF 182
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 76/303 (25%), Positives = 126/303 (41%), Gaps = 51/303 (16%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      +G+G+FG V K         VA+K   ++ +   K+F+ E   L  + H N+
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNI 64
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEVASVIE 790
           +K+   C        +   +V EY + GS+ + LH             ++  ++ +  + 
Sbjct: 65  VKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 117
Query: 791 YLHNHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           YLH+     ++H DLKP N+LL     V  + DFG            A + Q+     KG
Sbjct: 118 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----------TACDIQTHMTNNKG 166
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM----FNDGLTLHGYAKMAL 905
           +  ++ PE   G + S   DV+S+GI+L E+ TRR+P D +    F     +H   +  L
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 226
Query: 906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI 965
            K +              P   E  +         C  + PS+R  M  +VK +  +   
Sbjct: 227 IKNL--------------PKPIESLM-------TRCWSKDPSQRPSMEEIVKIMTHLMRY 265
Query: 966 FIG 968
           F G
Sbjct: 266 FPG 268

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 76/303 (25%), Positives = 126/303 (41%), Gaps = 51/303 (16%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      +G+G+FG V K         VA+K   ++ +   K+F+ E   L  + H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNI 63
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEVASVIE 790
           +K+   C        +   +V EY + GS+ + LH             ++  ++ +  + 
Sbjct: 64  VKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 791 YLHNHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           YLH+     ++H DLKP N+LL     V  + DFG            A + Q+     KG
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----------TACDIQTHMTNNKG 165
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM----FNDGLTLHGYAKMAL 905
           +  ++ PE   G + S   DV+S+GI+L E+ TRR+P D +    F     +H   +  L
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225
Query: 906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI 965
            K +              P   E  +         C  + PS+R  M  +VK +  +   
Sbjct: 226 IKNL--------------PKPIESLM-------TRCWSKDPSQRPSMEEIVKIMTHLMRY 264
Query: 966 FIG 968
           F G
Sbjct: 265 FPG 267

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 131/275 (47%), Gaps = 44/275 (16%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKII 737
            R+G G FG V+ G    +   VA+K +   K G  + +SF+ E + ++ ++H  L+++ 
Sbjct: 15  KRLGNGQFGEVWMGTWNGN-TKVAIKTL---KPGTMSPESFLEEAQIMKKLKHDKLVQLY 70
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKL-NIVIEVASVIEYLHNH 795
            + S           IV EYM  GS+ D+L     + L++  L ++  +VA+ + Y+   
Sbjct: 71  AVVSEEPI------YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                +H DL+ +N+L+ + ++  ++DFGLAR +  +    A +G       K  I +  
Sbjct: 125 N---YIHRDLRSANILVGNGLICKIADFGLARLIEDNE-XTARQG------AKFPIKWTA 174
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHGYAKMALPKKVMGIVD 914
           PE  + G  ++  DV+SFGILL E+ T+ R P   M N              ++V+  V+
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------------REVLEQVE 220
Query: 915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
               M        ++C +++    + C  + P ER
Sbjct: 221 RGYRMPCP-----QDCPISLHELMIHCWKKDPEER 250

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 27/224 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHR 731
           E +    IG G FG V+ G  L +D   VA+K +   ++GA   + F+ E E +  + H 
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 60
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVI 789
            L+++  +C     + A    +V+E+M++G + D+L  T   L   +  L + ++V   +
Sbjct: 61  KLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM 114
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            YL   C   ++H DL   N L+  + V  VSDFG+ RF       V  +  +SS   K 
Sbjct: 115 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGTKF 164
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            + +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 27/224 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHR 731
           E +    IG G FG V+ G  L +D   VA+K +   ++GA   + F+ E E +  + H 
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 62
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVI 789
            L+++  +C     + A    +V+E+M++G + D+L  T   L   +  L + ++V   +
Sbjct: 63  KLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM 116
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            YL   C   ++H DL   N L+  + V  VSDFG+ RF       V  +  +SS   K 
Sbjct: 117 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGTKF 166
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            + +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 167 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 109/239 (45%), Gaps = 28/239 (11%)
Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKI 736
           S RIG GSFG VYKG    D   VAVK++ +      +  +F  E   LR  RH N++  
Sbjct: 41  STRIGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLF 97
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNH 795
           +       +   D  AIV ++ +  S+   LH    K ++ +L +I  + A  ++YLH  
Sbjct: 98  M------GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
               I+H D+K +N+ L   +   + DFGLA   S         G     +  G++ ++ 
Sbjct: 152 N---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW------SGSQQVEQPTGSVLWMA 202
Query: 856 PEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL----HGYAKMALPK 907
           PE     D    S   DVYS+GI+L E+ T   P  ++ N    +     GYA   L K
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 27/224 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHR 731
           E +    IG G FG V+ G  L +D   VA+K +   ++GA   + F+ E E +  + H 
Sbjct: 11  ELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 65
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVI 789
            L+++  +C     + A    +V+E+M++G + D+L  T   L   +  L + ++V   +
Sbjct: 66  KLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM 119
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            YL   C   ++H DL   N L+  + V  VSDFG+ RF       V  +  +SS   K 
Sbjct: 120 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGTKF 169
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            + +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 170 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 682 IGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATK----SFVAECEALRNIRHRNL 733
           IG G FG VYKG L    G+  + VA+K +   K G T+     F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           I++  + S   +K      I+ EYM+ G++D +L   + +  V +L  ++  +A+ ++YL
Sbjct: 109 IRLEGVISK--YKPM---MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
            N      VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I 
Sbjct: 164 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATYTTSGGKIPIR 215
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       +   DV+SFGI++ E+ T
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           E +    IG G FG V+ G  L +D   VA+K +  +   +   F+ E E +  + H  L
Sbjct: 28  ELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKL 84
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEY 791
           +++  +C     + A    +V+E+M++G + D+L  T   L   +  L + ++V   + Y
Sbjct: 85  VQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAY 138
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L   C   ++H DL   N L+  + V  VSDFG+ RF       V  +  +SS   K  +
Sbjct: 139 LEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGTKFPV 188
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 189 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 230

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIKIIT 738
            +IG+G+FG V+ G L  D   VAVK          K+ F+ E   L+   H N++++I 
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQ 797
           +C+    K   +  IV E +Q G    +L     +L V   L +V + A+ +EYL + C 
Sbjct: 180 VCTQ---KQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
              +H DL   N L+    V  +SDFG++R       + A  G    + +K T     PE
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWT----APE 285
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFT 882
               G  S   DV+SFGILL E F+
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIKIIT 738
            +IG+G+FG V+ G L  D   VAVK          K+ F+ E   L+   H N++++I 
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQ 797
           +C+    K   +  IV E +Q G    +L     +L V   L +V + A+ +EYL + C 
Sbjct: 180 VCTQ---KQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
              +H DL   N L+    V  +SDFG++R       + A  G    + +K T     PE
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWT----APE 285
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFT 882
               G  S   DV+SFGILL E F+
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN--IRHRNLIKIITI 739
           IG+G +G VYKG+L  D   VAVKV +   +   ++F+ E    R   + H N+ + I  
Sbjct: 21  IGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKLNIVIEVASVIEYLH----- 793
              +   G     +V EY   GS+  +L  HT+D   V    +   V   + YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW--VSSCRLAHSVTRGLAYLHTELPR 133
Query: 794 -NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
            +H +P I H DL   NVL+ +D    +SDFGL+  L+ +  +   E  +++I   GTI 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 853 YIGPEYGMGGDLSMTG--------DVYSFGILLLEMFTR 883
           Y+ PE  + G +++          D+Y+ G++  E+F R
Sbjct: 194 YMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 80  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 137 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 186
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 107 YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 213
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 76  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 182
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 76  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 182
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 75  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 132 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 181
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 74  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 131 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 180
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 94  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKGTIG 852
                 +H DL   N+L++++    + DFGL + L        V   G+S        I 
Sbjct: 151 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP-------IF 200
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 83  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKGTIG 852
                 +H DL   N+L++++    + DFGL + L        V   G+S        I 
Sbjct: 140 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP-------IF 189
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 79  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 185
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 94  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKGTIG 852
                 +H DL   N+L++++    + DFGL + L        V   G+S        I 
Sbjct: 151 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP-------IF 200
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 81  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 138 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 187
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 82  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 139 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 188
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 77  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP--FLVAPEGQSSSIEMKGTIG 852
                 +H +L   N+L++++    + DFGL + L      + V   G+S        I 
Sbjct: 134 K---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP-------IF 183
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 184 WYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 25/218 (11%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKII 737
            R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++ 
Sbjct: 14  ERLGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLY 69
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNH 795
            + +           I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++   
Sbjct: 70  AVVTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                +H DL+ +N+L+   +   ++DFGLAR +  + +  A EG       K  I +  
Sbjct: 124 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREG------AKFPIKWTA 173
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           PE    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 27/224 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHR 731
           E +    IG G FG V+ G  L +D   VA+K +   ++GA   + F+ E E +  + H 
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 63
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVI 789
            L+++  +C     + A    +V E+M++G + D+L  T   L   +  L + ++V   +
Sbjct: 64  KLVQLYGVC----LEQAPI-CLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM 117
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            YL   C   ++H DL   N L+  + V  VSDFG+ RF       V  +  +SS   K 
Sbjct: 118 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGTKF 167
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            + +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 26  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 82  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 132
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGA------KFPIKWTAP 185
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 222

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 30  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 86  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 136
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGA------KFPIKWTAP 189
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 190 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGA------KFPIKWTAP 179
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 25  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 81  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 131
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGA------KFPIKWTAP 184
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 185 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 221

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 27/224 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGN-LGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHR 731
           E +    IG G FG V+ G  L +D   VA+K +   ++GA   + F+ E E +  + H 
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 62
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVI 789
            L+++  +C     + A    +V+E+M++G + D+L  T   L   +  L + ++V   +
Sbjct: 63  KLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM 116
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            YL    +  ++H DL   N L+  + V  VSDFG+ RF       V  +  +SS   K 
Sbjct: 117 AYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGTKF 166
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            + +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 167 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 680 NRIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHN 794
              +C S    G     ++ EY+ YGS+ D+L    ++++ +  L    ++   +EYL  
Sbjct: 79  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IG 852
                 +H DL   N+L++++    + DFGL + L         + +   ++  G   I 
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIF 185
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S+  DV+SFG++L E+FT
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 133/309 (43%), Gaps = 56/309 (18%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL-DKKGAT------KSFVAECEA 724
           A  E     +IGKG FG V+KG L +D   VA+K + L D +G T      + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE----VGKLN 780
           + N+ H N++K+  +  +          +V E++  G   D  H   DK        KL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSVKLR 126
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFLSHHPFL 835
           +++++A  IEY+ N   PPIVH DL+  N+ L     +  + A V+DFGL++   H    
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---- 181
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMT--GDVYSFGILLLEMFTRRRPTDNMFND 893
                  S   + G   ++ PE     + S T   D YSF ++L  + T   P D     
Sbjct: 182 -------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---- 230
Query: 894 GLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT 953
               + Y K+    K + ++      E   P+  E+C   +      C    P +R   +
Sbjct: 231 ----YSYGKI----KFINMIRE----EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 954 AVVKKLCAV 962
            +VK+L  +
Sbjct: 279 YIVKELSEL 287

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+GSFG V        G  VA+K++N   L K         E   LR +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           +      K  D   +V EY     + D++   +   E        ++ S +EY H H   
Sbjct: 82  V-----IKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH--- 132
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGP 856
            IVH DLKP N+LLD  +   ++DFGL+  ++   FL    G    ++ E+     Y GP
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           E           DV+S G++L  M  RR P D+
Sbjct: 193 EV----------DVWSCGVILYVMLCRRLPFDD 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 25/218 (11%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKII 737
            R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++ 
Sbjct: 15  ERLGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLY 70
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNH 795
            + +           I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++   
Sbjct: 71  AVVTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                +H +L+ +N+L+   +   ++DFGLAR +  + +  A EG       K  I +  
Sbjct: 125 N---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREG------AKFPIKWTA 174
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           PE    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 29/218 (13%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMN------LDKKGATKSFVAECEALRNIRHRNL 733
           + +G G+FG V  G     G  VAVK++N      LD  G  K    E + L+  RH ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR---EIQNLKLFRHPHI 73
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           IK+  + S+      DF  +V EY+  G + D++       E+    +  ++ S ++Y H
Sbjct: 74  IKLYQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTI 851
            H    +VH DLKP NVLLD  M A ++DFGL+  +S   FL    G    ++ E+    
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            Y GPE           D++S G++L  +     P D+
Sbjct: 186 LYAGPEV----------DIWSCGVILYALLCGTLPFDD 213

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSV--AVKVMN-LDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +  AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 116 GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 224
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 265
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 266 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 318

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 100/294 (34%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L NL+++    N L     TD   IT L N +KLV + +  N+     P  +ANL T +T
Sbjct: 62  LNNLTQINFSNNQL-----TD---ITPLKNLTKLVDILMNNNQIADITP--LANL-TNLT 110
Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  NQI+   P  ++NL NLN L L  N ++     A+  L +LQ L    N +  +
Sbjct: 111 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDL 166
Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
              P+ NLT L  L +  NK+  S  S L K  NL  L A NN        QI  IT L 
Sbjct: 167 --KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN--------QISDITPLG 214
Query: 482 KLLDLSENHLSGSIPLEVGNLKS---LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            L +L E  L+G+   ++G L S   L  LD++ N  SN  P  LS  T L  L +  N 
Sbjct: 215 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 272
Query: 539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   P  L  L ++  L+L+ N L    PI   NL  L YL L +N+     P
Sbjct: 273 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP 322

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+GSFG V        G  VA+K++N   L K         E   LR +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           +      K  D   +V EY     + D++   +   E        ++ S +EY H H   
Sbjct: 72  V-----IKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH--- 122
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGP 856
            IVH DLKP N+LLD  +   ++DFGL+  ++   FL    G    ++ E+     Y GP
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           E           DV+S G++L  M  RR P D+
Sbjct: 183 EV----------DVWSCGVILYVMLCRRLPFDD 205

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 206
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 247
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 248 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 300

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+GSFG V        G  VA+K++N   L K         E   LR +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           +      K  D   +V EY     + D++   +   E        ++ S +EY H H   
Sbjct: 81  V-----IKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH--- 131
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGP 856
            IVH DLKP N+LLD  +   ++DFGL+  ++   FL    G    ++ E+     Y GP
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           E           DV+S G++L  M  RR P D+
Sbjct: 192 EV----------DVWSCGVILYVMLCRRLPFDD 214

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  +    A EG       K  I +  P
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGA------KFPIKWTAP 179
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 117 GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 225
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 266
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 267 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 319

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 21  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 77  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 127
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  +    A EG       K  I +  P
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGA------KFPIKWTAP 180
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 217

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 29  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 85  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 135
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  +    A EG       K  I +  P
Sbjct: 136 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGA------KFPIKWTAP 188
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 225

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 100/294 (34%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L NL+++    N L     TD   IT L N +KLV + +  N+     P  +ANL T +T
Sbjct: 62  LNNLTQINFSNNQL-----TD---ITPLKNLTKLVDILMNNNQIADITP--LANL-TNLT 110
Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  NQI+   P  ++NL NLN L L  N ++     A+  L +LQ L    N +  +
Sbjct: 111 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDL 166
Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
              P+ NLT L  L +  NK+  S  S L K  NL  L A NN        QI  IT L 
Sbjct: 167 --KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN--------QISDITPLG 214
Query: 482 KLLDLSENHLSGSIPLEVGNLKS---LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            L +L E  L+G+   ++G L S   L  LD++ N  SN  P  LS  T L  L +  N 
Sbjct: 215 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 272
Query: 539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   P  L  L ++  L+L+ N L    PI   NL  L YL L +N+     P
Sbjct: 273 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP 322

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 22  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 78  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 128
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  +    A EG       K  I +  P
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGA------KFPIKWTAP 181
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 218

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  +    A EG       K  I +  P
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGA------KFPIKWTAP 179
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 26  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 82  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 132
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  +    A EG       K  I +  P
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGA------KFPIKWTAP 185
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 222

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 28  RLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 84  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 134
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +  +    A EG       K  I +  P
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGA------KFPIKWTAP 187
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 224

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+GSFG V        G  VA+K++N   L K         E   LR +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           +      K  D   +V EY     + D++   +   E        ++ S +EY H H   
Sbjct: 76  V-----IKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH--- 126
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGP 856
            IVH DLKP N+LLD  +   ++DFGL+  ++   FL    G    ++ E+     Y GP
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           E           DV+S G++L  M  RR P D+
Sbjct: 187 EV----------DVWSCGVILYVMLCRRLPFDD 209

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 100/294 (34%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L NL+++    N L     TD   IT L N +KLV + +  N+     P  +ANL T +T
Sbjct: 62  LNNLTQINFSNNQL-----TD---ITPLKNLTKLVDILMNNNQIADITP--LANL-TNLT 110
Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  NQI+   P  ++NL NLN L L  N ++     A+  L +LQ L    N +  +
Sbjct: 111 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL 166
Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
              P+ NLT L  L +  NK+  S  S L K  NL  L A NN        QI  IT L 
Sbjct: 167 --KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN--------QISDITPLG 214
Query: 482 KLLDLSENHLSGSIPLEVGNLKS---LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            L +L E  L+G+   ++G L S   L  LD++ N  SN  P  LS  T L  L +  N 
Sbjct: 215 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 272
Query: 539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   P  L  L ++  L+L+ N L    PI   NL  L YL L +N+     P
Sbjct: 273 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP 322

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMN------LDKKGATKSFVAECEALRNIRHRNL 733
           + +G G+FG V  G     G  VAVK++N      LD  G  K    E + L+  RH ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR---EIQNLKLFRHPHI 73
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           IK+  + S+      DF  +V EY+  G + D++       E+    +  ++ S ++Y H
Sbjct: 74  IKLYQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---------VAPEGQSSS 844
            H    +VH DLKP NVLLD  M A ++DFGL+  +S   FL          APE  S  
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGR 185
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           +       Y GPE           D++S G++L  +     P D+
Sbjct: 186 L-------YAGPEV----------DIWSCGVILYALLCGTLPFDD 213

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 90  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 198
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 239
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 240 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 97  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 205
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 246
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 247 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 299

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 96  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 204
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 245
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 246 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 298

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 93  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 201
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 242
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 243 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 206
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 247
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 248 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 300

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 95  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    +        + + +K    ++  
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 203
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 244
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 245 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGLAR L        PE   ++   K  I +  P
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLARVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 681 RIGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
           ++GKG+FG V    Y       G  VAVK +    +   + F  E E L++++H N++K 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASVIEYLHNH 795
             +C S    G     ++ E++ YGS+ ++L    ++++ +  L    ++   +EYL   
Sbjct: 80  KGVCYSA---GRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT--IGY 853
                +H DL   N+L++++    + DFGL + L         + +   ++  G   I +
Sbjct: 137 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEXXKVKEPGESPIFW 186
Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             PE       S+  DV+SFG++L E+FT
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 118/249 (47%), Gaps = 40/249 (16%)
Query: 665 SYAELSKATKEFSSS---------NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKK 712
           ++ + ++A +EF+             IG G FG V  G L   G+  + VA+K +   K 
Sbjct: 11  TFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL---KA 67
Query: 713 GAT----KSFVAECEALRNIRHRNLIK---IITICSSIDFKGADFKAIVYEYMQYGSVDD 765
           G T    + F++E   +    H N+I    ++T C  +         I+ EYM+ GS+D 
Sbjct: 68  GYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDA 119
Query: 766 WLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 824
           +L   + +  V +L  ++  + S ++YL +      VH DL   N+L++ ++V  VSDFG
Sbjct: 120 FLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFG 176
Query: 825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR- 883
           ++R L        PE   ++   K  I +  PE       +   DV+S+GI++ E+ +  
Sbjct: 177 MSRVLEDD-----PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 231
Query: 884 RRPTDNMFN 892
            RP  +M N
Sbjct: 232 ERPYWDMSN 240

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 135/308 (43%), Gaps = 55/308 (17%)
Query: 679 SNRIGKGSFGFVYKG---NLG--EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
              +G+G+FG V+     NL   +D M VAVK +      A K F  E E L N++H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKL------------EVG--- 777
           +K   +C        D   +V+EYM++G ++ +L  H  D +            E+G   
Sbjct: 80  VKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 778 KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
            L+I  ++AS + YL +      VH DL   N L+  +++  + DFG++R +    +   
Sbjct: 135 MLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLT 896
             G  + + ++    ++ PE  M    +   DV+SFG++L E+FT  ++P   + N  + 
Sbjct: 192 --GGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 897 LHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVV 956
                                + + R   +   C   V    + C    P +R+ +  + 
Sbjct: 246 -------------------ECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIY 286
Query: 957 KKLCAVGE 964
           K L A+G+
Sbjct: 287 KILHALGK 294

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 56/309 (18%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL-DKKGAT------KSFVAECEA 724
           A  E     +IGKG FG V+KG L +D   VA+K + L D +G T      + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE----VGKLN 780
           + N+ H N++K+  +  +          +V E++  G   D  H   DK        KL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSVKLR 126
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFLSHHPFL 835
           +++++A  IEY+ N   PPIVH DL+  N+ L     +  + A V+DFG ++   H    
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---- 181
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMT--GDVYSFGILLLEMFTRRRPTDNMFND 893
                  S   + G   ++ PE     + S T   D YSF ++L  + T   P D     
Sbjct: 182 -------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---- 230
Query: 894 GLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT 953
               + Y K+    K + ++      E   P+  E+C   +      C    P +R   +
Sbjct: 231 ----YSYGKI----KFINMIRE----EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 954 AVVKKLCAV 962
            +VK+L  +
Sbjct: 279 YIVKELSEL 287

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  +++L    
Sbjct: 103 GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    F    +   +    K  + ++  
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMAL 211
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 252
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 253 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 305

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  +++L    
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    F    +   +    K  + ++  
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMAL 206
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 247
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 248 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 300

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  +++L    
Sbjct: 96  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    F    +   +    K  + ++  
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMAL 204
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 245
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 246 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 298

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 56/309 (18%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL-DKKGAT------KSFVAECEA 724
           A  E     +IGKG FG V+KG L +D   VA+K + L D +G T      + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE----VGKLN 780
           + N+ H N++K+  +  +          +V E++  G   D  H   DK        KL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSVKLR 126
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFLSHHPFL 835
           +++++A  IEY+ N   PPIVH DL+  N+ L     +  + A V+DF L++   H    
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---- 181
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMT--GDVYSFGILLLEMFTRRRPTDNMFND 893
                  S   + G   ++ PE     + S T   D YSF ++L  + T   P D     
Sbjct: 182 -------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---- 230
Query: 894 GLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT 953
               + Y K+    K + ++      E   P+  E+C   +      C    P +R   +
Sbjct: 231 ----YSYGKI----KFINMIRE----EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 954 AVVKKLCAV 962
            +VK+L  +
Sbjct: 279 YIVKELSEL 287

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  +++L    
Sbjct: 98  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    F    +   +    K  + ++  
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMAL 206
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 247
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 248 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 300

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  +++L    
Sbjct: 99  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    F    +   +    K  + ++  
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMAL 207
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 248
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 249 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 301

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 665 SYAELSKATKEFS---SSNRI------GKGSFGFVYKGNL---GEDGMSVAVKVMNLDKK 712
           +Y E  +A + F+    ++RI      G G  G V  G L   G+  + VA+K +   K 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KA 87
Query: 713 GAT----KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH 768
           G T    + F++E   +    H N+I++  + +           IV EYM+ GS+D +L 
Sbjct: 88  GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFLR 142
Query: 769 HTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
             + +  + +L  ++  V + + YL +      VH DL   NVL+D ++V  VSDFGL+R
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRP 886
            L        P+   ++   K  I +  PE       S   DV+SFG+++ E+     RP
Sbjct: 200 VLEDD-----PDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
Query: 887 TDNMFN 892
             NM N
Sbjct: 255 YWNMTN 260

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 101 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 156 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 207
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 244

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V+     +    VAVK M   K G+   ++F+AE   ++ ++H  L+K+  
Sbjct: 22  KLGAGQFGEVWMATYNKH-TKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 77
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ E+M  GS+ D+L      K  + KL +   ++A  + ++    
Sbjct: 78  VVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--- 128
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           Q   +H DL+ +N+L+   +V  ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGA------KFPIKWTAP 181
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL+E+ T  R P   M N
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 218

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSV--AVKVMN-LDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +  AVK +N +   G    F+ E   +++  H N++ ++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  +++L    
Sbjct: 157 GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    F    +   +    K  + ++  
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMAL 265
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 306
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 84  GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM- 137
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 138 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 190
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 168 ---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  ++YL    
Sbjct: 97  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +             + + +K    ++  
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK----WMAL 205
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 246
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 247 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 299

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 101/294 (34%), Positives = 139/294 (47%), Gaps = 37/294 (12%)
Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L NL+++    N L     TD   IT L N +KLV + +  N+     P  +ANL T +T
Sbjct: 67  LNNLTQINFSNNQL-----TD---ITPLKNLTKLVDILMNNNQIADITP--LANL-TNLT 115
Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  NQI+   P  ++NL NLN L L  N ++     A+  L +LQ L   GN +  +
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSF-GNQVTDL 170
Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
              P+ NLT L  L +  NK+  S  S L K  NL  L A NN        QI  IT L 
Sbjct: 171 --KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN--------QISDITPLG 218
Query: 482 KLLDLSENHLSGSIPLEVGNLKS---LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            L +L E  L+G+   ++G L S   L  LD++ N  SN  P  LS  T L  L +  N 
Sbjct: 219 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276
Query: 539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   P  L  L ++  L+L+ N L    PI   NL  L YL L +N+     P
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP 326

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 101/294 (34%), Positives = 139/294 (47%), Gaps = 37/294 (12%)
Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L NL+++    N L     TD   IT L N +KLV + +  N+     P  +ANL T +T
Sbjct: 62  LNNLTQINFSNNQL-----TD---ITPLKNLTKLVDILMNNNQIADITP--LANL-TNLT 110
Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  NQI+   P  ++NL NLN L L  N ++     A+  L +LQ L   GN +  +
Sbjct: 111 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNF-GNQVTDL 165
Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
              P+ NLT L  L +  NK+  S  S L K  NL  L A NN        QI  IT L 
Sbjct: 166 --KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN--------QISDITPLG 213
Query: 482 KLLDLSENHLSGSIPLEVGNLKS---LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            L +L E  L+G+   ++G L S   L  LD++ N  SN  P  LS  T L  L +  N 
Sbjct: 214 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 271
Query: 539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   P  L  L ++  L+L+ N L    PI   NL  L YL L +N+     P
Sbjct: 272 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP 321

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 101/294 (34%), Positives = 139/294 (47%), Gaps = 37/294 (12%)
Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L NL+++    N L     TD   IT L N +KLV + +  N+     P  +ANL T +T
Sbjct: 62  LNNLTQINFSNNQL-----TD---ITPLKNLTKLVDILMNNNQIADITP--LANL-TNLT 110
Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  NQI+   P  ++NL NLN L L  N ++     A+  L +LQ L   GN +  +
Sbjct: 111 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNF-GNQVTDL 165
Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
              P+ NLT L  L +  NK+  S  S L K  NL  L A NN        QI  IT L 
Sbjct: 166 --KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN--------QISDITPLG 213
Query: 482 KLLDLSENHLSGSIPLEVGNLKS---LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            L +L E  L+G+   ++G L S   L  LD++ N  SN  P  LS  T L  L +  N 
Sbjct: 214 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 271
Query: 539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   P  L  L ++  L+L+ N L    PI   NL  L YL L +N+     P
Sbjct: 272 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP 321

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 101/294 (34%), Positives = 139/294 (47%), Gaps = 37/294 (12%)
Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L NL+++    N L     TD   IT L N +KLV + +  N+     P  +ANL T +T
Sbjct: 66  LNNLTQINFSNNQL-----TD---ITPLKNLTKLVDILMNNNQIADITP--LANL-TNLT 114
Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  NQI+   P  ++NL NLN L L  N ++     A+  L +LQ L   GN +  +
Sbjct: 115 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSF-GNQVTDL 169
Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
              P+ NLT L  L +  NK+  S  S L K  NL  L A NN        QI  IT L 
Sbjct: 170 --KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNN--------QISDITPLG 217
Query: 482 KLLDLSENHLSGSIPLEVGNLKS---LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            L +L E  L+G+   ++G L S   L  LD++ N  SN  P  LS  T L  L +  N 
Sbjct: 218 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 275
Query: 539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   P  L  L ++  L+L+ N L    PI   NL  L YL L +N+     P
Sbjct: 276 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP 325

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 36/293 (12%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG VY G L   DG  +   V +L++    G    F+ E   +++  H N++ ++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            IC     +      +V  YM++G + +++ +      V  L    ++VA  +++L    
Sbjct: 99  GIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N +LD      V+DFGLAR +    F    +   +    K  + ++  
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF----DSVHNKTGAKLPVKWMAL 207
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+SFG+LL E+ TR  P                   P   +   D +
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDIT 248
Query: 917 L-LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG 968
           + L++ R   + E C   +    + C       R   + +V ++ A+   FIG
Sbjct: 249 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 301

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLIKI 736
             ++G G FG V+     +    VAVK M   K G+   ++F+AE   ++ ++H  L+K+
Sbjct: 193 EKKLGAGQFGEVWMATYNKH-TKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKL-NIVIEVASVIEYLHN 794
             + +           I+ E+M  GS+ D+L      K  + KL +   ++A  + ++  
Sbjct: 249 HAVVTKEPI------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 301
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
             Q   +H DL+ +N+L+   +V  ++DFGLAR +  + +  A EG       K  I + 
Sbjct: 302 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREG------AKFPIKWT 352
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            PE    G  ++  DV+SFGILL+E+ T  R P   M N
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLI 734
           IG G FG V  G L   G+  + VA+K +   K G T    + F++E   +    H N+I
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTL---KAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 735 K---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
               ++T C  +         I+ EYM+ GS+D +L   + +  V +L  ++  + S ++
Sbjct: 79  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      VH DL   N+L++ ++V  VSDFG++R L        PE   ++   K  
Sbjct: 131 YLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-----PEAAYTTRGGKIP 182
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           I +  PE       +   DV+S+GI++ E+ +   RP  +M N
Sbjct: 183 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 225

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + + N+ H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   F  I+ EYM  G + ++L     + +  +L  +  +V   +E
Sbjct: 80  KLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L++   V  VSDFGL+R+       V  + ++SS+  K  
Sbjct: 135 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEETSSVGSKFP 184
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +  PE  M    S   D+++FG+L+ E+++
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 665 SYAELSKATKEFS---SSNRI------GKGSFGFVYKGNL---GEDGMSVAVKVMNLDKK 712
           +Y E  +A + F+    ++RI      G G  G V  G L   G+  + VA+K +   K 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KA 87
Query: 713 GAT----KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH 768
           G T    + F++E   +    H N+I++  + +           IV EYM+ GS+D +L 
Sbjct: 88  GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFLR 142
Query: 769 HTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
             + +  + +L  ++  V + + YL +      VH DL   NVL+D ++V  VSDFGL+R
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRP 886
            L        P+   ++   K  I +  PE       S   DV+SFG+++ E+     RP
Sbjct: 200 VLEDD-----PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
Query: 887 TDNMFN 892
             NM N
Sbjct: 255 YWNMTN 260

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 112/236 (47%), Gaps = 22/236 (9%)
Query: 652 SSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK 711
           S   ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA++ MNL +
Sbjct: 1   SDEEILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 712 KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN 771
           +   +  + E   +R  ++ N++  +       +   D   +V EY+  GS+ D +  T 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 772 DKLEVGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
             ++ G++  V  E    +E+LH++    ++H D+K  N+LL  D    ++DFG   F +
Sbjct: 113 --MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCA 164
Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                + PE QS   EM GT  ++ PE           D++S GI+ +EM     P
Sbjct: 165 Q----ITPE-QSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 111 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 166 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 217
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 254

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLI 734
           IG G FG V  G L   G+  + VA+K +   K G T    + F++E   +    H N+I
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTL---KAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 735 K---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
               ++T C  +         I+ EYM+ GS+D +L   + +  V +L  ++  + S ++
Sbjct: 73  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      VH DL   N+L++ ++V  VSDFG++R L        PE   ++   K  
Sbjct: 125 YLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-----PEAAYTTRGGKIP 176
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           I +  PE       +   DV+S+GI++ E+ +   RP  +M N
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 219

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL R L        PE   ++   K  I +  P
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + + N+ H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   F  I+ EYM  G + ++L     + +  +L  +  +V   +E
Sbjct: 80  KLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L++   V  VSDFGL+R+       V  +  +SS+  K  
Sbjct: 135 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFP 184
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +  PE  M    S   D+++FG+L+ E+++
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 122/249 (48%), Gaps = 38/249 (15%)
Query: 665 SYAELSKATKEFSSS---------NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKK 712
           ++ + ++A +EF+             IG G FG V  G+L   G+  + VA+K +   K 
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL---KS 71
Query: 713 GAT----KSFVAECEALRNIRHRNLIK---IITICSSIDFKGADFKAIVYEYMQYGSVDD 765
           G T    + F++E   +    H N+I    ++T  + +         I+ E+M+ GS+D 
Sbjct: 72  GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV--------MIITEFMENGSLDS 123
Query: 766 WLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 824
           +L   + +  V +L  ++  +A+ ++YL +      VH DL   N+L++ ++V  VSDFG
Sbjct: 124 FLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG 180
Query: 825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR- 883
           L+RFL       +    +S++  K  I +  PE       +   DV+S+GI++ E+ +  
Sbjct: 181 LSRFLEDD---TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 237
Query: 884 RRPTDNMFN 892
            RP  +M N
Sbjct: 238 ERPYWDMTN 246

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 41/273 (15%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           R+G G FG V+ G    +   VAVK +   K G  + ++F+ E   ++ ++H  L+++  
Sbjct: 20  RLGAGQFGEVWMGYY-NNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM  GS+ D+L      K+ + KL +   ++A  + Y+    
Sbjct: 76  VVTR-----EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--- 127
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +NVL+   ++  ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 128 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGA------KFPIKWTAP 180
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E    G  ++  DV+SFGILL E+ T                 Y K+  P +    V  +
Sbjct: 181 EAINFGCFTIKSDVWSFGILLYEIVT-----------------YGKIPYPGRTNADVMTA 223
Query: 917 LLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
           L    R P + E C   +      C  E   ER
Sbjct: 224 LSQGYRMP-RVENCPDELYDIMKMCWKEKAEER 255

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLIKII 737
           IG G FG V +G L   G   +   +   K G T    + F++E   +    H N+I++ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + ++     +    I+ E+M+ G++D +L   + +  V +L  ++  +AS + YL    
Sbjct: 84  GVVTN-----SMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---A 135
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   VH DL   N+L++ ++V  VSDFGL+RFL  +    +   ++SS+  K  I +  P
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS---SDPTETSSLGGKIPIRWTAP 192
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGL 895
           E       +   D +S+GI++ E+ +   RP  +M N  +
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDV 232

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 112/237 (47%), Gaps = 22/237 (9%)
Query: 651 LSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD 710
           +S   ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA++ MNL 
Sbjct: 1   MSDEEILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 57
Query: 711 KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT 770
           ++   +  + E   +R  ++ N++  +       +   D   +V EY+  GS+ D +  T
Sbjct: 58  QQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTET 112
Query: 771 NDKLEVGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
              ++ G++  V  E    +E+LH++    ++H D+K  N+LL  D    ++DFG   F 
Sbjct: 113 C--MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FC 164
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +     + PE QS    M GT  ++ PE           D++S GI+ +EM     P
Sbjct: 165 AQ----ITPE-QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK--SFVAECEALRNIRHRNLIKIIT 738
           R+G G  G V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++  
Sbjct: 20  RLGAGQAGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++    
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +N+L+   +   ++DFGLAR +       A EG       K  I +  P
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAE-XTAREGA------KFPIKWTAP 179
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
           E    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + + N+ H 
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 70
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   F  I+ EYM  G + ++L     + +  +L  +  +V   +E
Sbjct: 71  KLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 125
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L++   V  VSDFGL+R+       V  +  +SS+  K  
Sbjct: 126 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFP 175
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +  PE  M    S   D+++FG+L+ E+++
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + + N+ H 
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 63
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   F  I+ EYM  G + ++L     + +  +L  +  +V   +E
Sbjct: 64  KLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 118
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L++   V  VSDFGL+R+       V  +  +SS+  K  
Sbjct: 119 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFP 168
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +  PE  M    S   D+++FG+L+ E+++
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + + N+ H 
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 64
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   F  I+ EYM  G + ++L     + +  +L  +  +V   +E
Sbjct: 65  KLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L++   V  VSDFGL+R+       V  +  +SS+  K  
Sbjct: 120 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFP 169
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +  PE  M    S   D+++FG+L+ E+++
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + + N+ H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 59
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   F  I+ EYM  G + ++L     + +  +L  +  +V   +E
Sbjct: 60  KLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L++   V  VSDFGL+R+       V  +  +SS+  K  
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFP 164
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +  PE  M    S   D+++FG+L+ E+++
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 111/236 (47%), Gaps = 22/236 (9%)
Query: 652 SSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK 711
           S   ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA++ MNL +
Sbjct: 1   SDEEILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 712 KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN 771
           +   +  + E   +R  ++ N++  +       +   D   +V EY+  GS+ D +  T 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 772 DKLEVGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
             ++ G++  V  E    +E+LH++    ++H D+K  N+LL  D    ++DFG   F +
Sbjct: 113 --MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCA 164
Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                + PE QS    M GT  ++ PE           D++S GI+ +EM     P
Sbjct: 165 Q----ITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 111/236 (47%), Gaps = 22/236 (9%)
Query: 652 SSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK 711
           S   ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA++ MNL +
Sbjct: 1   SDEEILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 712 KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN 771
           +   +  + E   +R  ++ N++  +       +   D   +V EY+  GS+ D +  T 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 772 DKLEVGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
             ++ G++  V  E    +E+LH++    ++H D+K  N+LL  D    ++DFG   F +
Sbjct: 113 --MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCA 164
Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                + PE QS    M GT  ++ PE           D++S GI+ +EM     P
Sbjct: 165 Q----ITPE-QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV E M+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 84  GVVTK-----SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM- 137
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 138 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 190
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 114/243 (46%), Gaps = 28/243 (11%)
Query: 665 SYAELSKATKEFSSS---------NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-K 711
           +Y + ++A  EF+             IG G FG V  G L   G+  + VA+K + +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 712 KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN 771
           +   + F+ E   +    H N+I +  + +      +    IV EYM+ GS+D +L   +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTK-----SKPVMIVTEYMENGSLDTFLKKND 118
Query: 772 DKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
            +  V +L  ++  +++ ++YL +      VH DL   N+L++ ++V  VSDFGL+R L 
Sbjct: 119 GQFTVIQLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE 175
Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDN 889
                  PE   ++   K  I +  PE       +   DV+S+GI++ E+ +   RP   
Sbjct: 176 DD-----PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWE 230
Query: 890 MFN 892
           M N
Sbjct: 231 MTN 233

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLIKII 737
           IG G FG V +G L   G   +   +   K G T    + F++E   +    H N+I++ 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + ++     +    I+ E+M+ G++D +L   + +  V +L  ++  +AS + YL    
Sbjct: 82  GVVTN-----SMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS 136
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+RFL  +    +    +SS+  K  I +  P
Sbjct: 137 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS---SDPTYTSSLGGKIPIRWTAP 190
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGL 895
           E       +   D +S+GI++ E+ +   RP  +M N  +
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDV 230

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV E M+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 168 A---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S   E+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRTELC 167
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 26/234 (11%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVA---VKVMNLDKKGATKSFVAECEALRNIRHRN 732
           F    +IG+G F  VY+     DG+ VA   V++ +L    A    + E + L+ + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL----EVGKLNIVIEVASV 788
           +IK         F   +   IV E    G +   + H   +     E       +++ S 
Sbjct: 94  VIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           +E++H+     ++H D+KP+NV +    V  + D GL RF S           +++  + 
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS--------SKTTAAHSLV 197
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK 902
           GT  Y+ PE       +   D++S G LL EM   + P    + D + L+   K
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 248

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           +E +    +G G FG V  G   +    VAVK++   K+G+     F  E + +  + H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHP 63
Query: 732 NLIKIITICSSIDFKGADFKA-IVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVI 789
            L+K   +CS       ++   IV EY+  G + ++L      LE  +L  +  +V   +
Sbjct: 64  KLVKFYGVCSK------EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            +L +H     +H DL   N L+D D+   VSDFG+ R++    ++       SS+  K 
Sbjct: 118 AFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-------SSVGTKF 167
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTL 897
            + +  PE       S   DV++FGIL+ E+F+  + P D   N  + L
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           +G G FG V  G L    +  +SVA+K + +   +   + F+ E   +    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +      +    IV E M+ GS+D +L   + +  V +L  ++  +AS ++YL +  
Sbjct: 113 GVVTK-----SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I +  P
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAYTTRGGKIPIRWTSP 219
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 32/231 (13%)
Query: 669 LSKATKEFSSSNRIGKGSFGFVYKG-NLGEDGMSVAVKVMNLD--KKGATKSFVAECEAL 725
           L +A +++     IG+G++G V+K  +L   G  VA+K + +   ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 726 RNIR---HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-------E 775
           R++    H N++++  +C+           +V+E+     VD  L    DK+       E
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTE 120
Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
             K +++ ++   +++LH+H    +VH DLKP N+L+       ++DFGLAR  S     
Sbjct: 121 TIK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---- 172
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                Q +   +  T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 173 -----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 29/226 (12%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIR 729
           AT  +     IG G++G VYK      G  VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 730 ---HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------N 780
              H N+++++ +C++          +V+E+     VD  L    DK     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKD 116
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           ++ +    +++LH +C   IVH DLKP N+L+       ++DFGLAR  S+         
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--------- 164
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Q +   +  T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 29/226 (12%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIR 729
           AT  +     IG G++G VYK      G  VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 730 ---HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------N 780
              H N+++++ +C++          +V+E+     VD  L    DK     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKD 116
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           ++ +    +++LH +C   IVH DLKP N+L+       ++DFGLAR  S+    +AP  
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALAP-- 170
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 +  T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 171 ------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNI 728
           ++ +++ +   +G+GS+G V K    + G  VA+K  + + D K   K  + E + L+ +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVA 786
           RH NL+ ++ +C     K      +V+E++ +  +DD     N  D   V K   + ++ 
Sbjct: 82  RHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY--LFQII 134
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
           + I + H+H    I+H D+KP N+L+    V  + DFG AR L+      AP G+    E
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA------AP-GEVYDDE 184
Query: 847 MKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
           +  T  Y  PE  +G        DV++ G L+ EMF
Sbjct: 185 V-ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMN------LDKKGATKSFVAECEALRNIRHRNL 733
           + +G G+FG V  G     G  VAVK++N      LD  G  +    E + L+  RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR---EIQNLKLFRHPHI 78
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           IK+  + S+     +D   +V EY+  G + D++       E     +  ++ S ++Y H
Sbjct: 79  IKLYQVIST----PSDI-FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG- 852
            H    +VH DLKP NVLLD  M A ++DFGL+  +S   FL    G  +    +   G 
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGR 190
Query: 853 -YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            Y GPE           D++S G++L  +     P D+
Sbjct: 191 LYAGPEV----------DIWSSGVILYALLCGTLPFDD 218

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLIKI 736
             ++G G FG V+     +    VAVK M   K G+   ++F+AE   ++ ++H  L+K+
Sbjct: 187 EKKLGAGQFGEVWMATYNKH-TKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKL 242
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKL-NIVIEVASVIEYLHN 794
             + +           I+ E+M  GS+ D+L      K  + KL +   ++A  + ++  
Sbjct: 243 HAVVTKEPI------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 295
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
             Q   +H DL+ +N+L+   +V  ++DFGLAR  +  P                 I + 
Sbjct: 296 --QRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFP-----------------IKWT 336
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFTRRR-PTDNMFN 892
            PE    G  ++  DV+SFGILL+E+ T  R P   M N
Sbjct: 337 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 375

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 31/245 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRN 732
           E +    IG G FG VY+     D ++V     + D+      ++   E +    ++H N
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
           +I +  +C     K  +   +V E+ + G ++  L       ++  +N  +++A  + YL
Sbjct: 68  IIALRGVC----LKEPNL-CLVMEFARGGPLNRVLSGKRIPPDI-LVNWAVQIARGMNYL 121
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDM--------VAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           H+    PI+H DLK SN+L+   +        +  ++DFGLAR    H        +++ 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWH--------RTTK 171
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL-HGYA-- 901
           +   G   ++ PE       S   DV+S+G+LL E+ T   P   +  DGL + +G A  
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAYGVAMN 229
Query: 902 KMALP 906
           K+ALP
Sbjct: 230 KLALP 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHR 731
           + +F   + +G+G++G V        G  VA+K +   DK       + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASV 788
           N+I I  I     F+  +   I+ E MQ       LH       +   +I   + +    
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQSSS-IE 846
           ++ LH      ++H DLKPSN+L++ +    V DFGLAR +         P GQ S  +E
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 847 MKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMFTRR 884
              T  Y  PE  +     S   DV+S G +L E+F RR
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 15/216 (6%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRN 732
           ++    +IG+G+FG V+K    + G  VA+K  +M  +K+G   + + E + L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVA-SVI 789
           ++ +I IC +        KA +Y    +   D    L +   K  + ++  V+++  + +
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
            Y+H +    I+H D+K +NVL+  D V  ++DFGLAR      F +A   Q +    + 
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR-----AFSLAKNSQPNRYXNRV 190
Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTR 883
            T+ Y  PE  +G  D     D++  G ++ EM+TR
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 112/237 (47%), Gaps = 22/237 (9%)
Query: 651 LSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD 710
           +S   ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA++ MNL 
Sbjct: 1   MSDEEILEKLRIIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 57
Query: 711 KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT 770
           ++   +  + E   +R  ++ N++  +       +   D   +V EY+  GS+ D +  T
Sbjct: 58  QQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTET 112
Query: 771 NDKLEVGKLNIVI-EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
              ++ G++  V  E    +E+LH++    ++H ++K  N+LL  D    ++DFG   F 
Sbjct: 113 C--MDEGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFG---FC 164
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +     + PE QS    M GT  ++ PE           D++S GI+ +EM     P
Sbjct: 165 AQ----ITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 193
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S   ++ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRTDLC 167
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 679 SNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
              +G+G+FG V+          +D + VAVK +      A K F  E E L N++H ++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGK------------LN 780
           +K   +C        D   +V+EYM++G ++ +L  H  D + + +            L+
Sbjct: 78  VKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           I  ++A+ + YL +      VH DL   N L+  +++  + DFG++R +    +     G
Sbjct: 133 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV--G 187
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             + + ++    ++ PE  M    +   DV+S G++L E+FT
Sbjct: 188 GHTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S   ++ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRTDLC 167
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL-DKKGATKSFVAECEALRNIRHRNL 733
           +F     +G+G FG V++     D  + A+K + L +++ A +  + E +AL  + H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 734 IKIITIC----SSIDFKGADFKAIVYEYMQY---GSVDDWLH---HTNDKLEVGKLNIVI 783
           ++         ++   + +  K  +Y  MQ     ++ DW++      ++     L+I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPE 839
           ++A  +E+LH+     ++H DLKPSN+    D V  V DFGL   +         L    
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
             +      GT  Y+ PE   G   S   D++S G++L E+
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 682 IGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKI 736
           +G+G FG V    Y       G  VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNH 795
             IC+     G +   ++ E++  GS+ ++L    +K+ + + L   +++   ++YL + 
Sbjct: 77  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                VH DL   NVL++ +    + DFGL + +         E  +   +    + +  
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE-----TDKEXXTVKDDRDSPVFWYA 185
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFT 882
           PE  M     +  DV+SFG+ L E+ T
Sbjct: 186 PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS---CHAP-------SSRRTTLS 168
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +    +G G FG V  G        VA+K++   K+G+     F+ E + + N+ H 
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 64
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C+    +   F  I+ EYM  G + ++L     + +  +L  +  +V   +E
Sbjct: 65  KLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      +H DL   N L++   V  VSDFGL+R+       V  +  +SS   K  
Sbjct: 120 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSRGSKFP 169
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +  PE  M    S   D+++FG+L+ E+++
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 682 IGKGSFGFV----YKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKI 736
           +G+G FG V    Y       G  VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNH 795
             IC+     G +   ++ E++  GS+ ++L    +K+ + + L   +++   ++YL + 
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                VH DL   NVL++ +    + DFGL + +         E  +   +    + +  
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE-----TDKEXXTVKDDRDSPVFWYA 197
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFT 882
           PE  M     +  DV+SFG+ L E+ T
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIR 729
           AT  +     IG G++G VYK      G  VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 730 ---HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------N 780
              H N+++++ +C++          +V+E+     VD  L    DK     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKD 116
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----PFLV 836
           ++ +    +++LH +C   IVH DLKP N+L+       ++DFGLAR  S+     P +V
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                        T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 174 -------------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S   ++ 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRTDLC 172
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S   ++ 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRTDLC 168
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S   ++ 
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRDDLC 193
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 170
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHR 731
           + +F   + +G+G++G V        G  VA+K +   DK       + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASV 788
           N+I I  I     F+  +   I+ E MQ       LH       +   +I   + +    
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQSSSI-E 846
           ++ LH      ++H DLKPSN+L++ +    V DFGLAR +         P GQ S + E
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 847 MKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMFTRR 884
              T  Y  PE  +     S   DV+S G +L E+F RR
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 167
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRAA--LC 170
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 172
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 29/223 (13%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNLI 734
           IG G FG V  G+L   G+  + VA+K +   K G T    + F++E   +    H N+I
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTL---KSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 735 K---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
               ++T  + +         I+ E+M+ GS+D +L   + +  V +L  ++  +A+ ++
Sbjct: 72  HLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YL +      VH  L   N+L++ ++V  VSDFGL+RFL       +    +S++  K  
Sbjct: 124 YLADM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDD---TSDPTYTSALGGKIP 177
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           I +  PE       +   DV+S+GI++ E+ +   RP  +M N
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 220

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 83  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 137
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 138 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 184
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 15/216 (6%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRN 732
           ++    +IG+G+FG V+K    + G  VA+K  +M  +K+G   + + E + L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVA-SVI 789
           ++ +I IC +        K  +Y    +   D    L +   K  + ++  V+++  + +
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
            Y+H +    I+H D+K +NVL+  D V  ++DFGLAR      F +A   Q +    + 
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR-----AFSLAKNSQPNRYXNRV 190
Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTR 883
            T+ Y  PE  +G  D     D++  G ++ EM+TR
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 116/234 (49%), Gaps = 16/234 (6%)
Query: 657 MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGA 714
           M +Q+  V      + +K +    +IG+G+FG V+K    + G  VA+K  +M  +K+G 
Sbjct: 1   MAKQYDSVECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59
Query: 715 TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTND 772
             + + E + L+ ++H N++ +I IC +        K  +Y    +   D    L +   
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 119
Query: 773 KLEVGKLNIVIEVA-SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
           K  + ++  V+++  + + Y+H +    I+H D+K +NVL+  D V  ++DFGLAR    
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR---- 172
Query: 832 HPFLVAPEGQSSSIEMK-GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTR 883
             F +A   Q +    +  T+ Y  PE  +G  D     D++  G ++ EM+TR
Sbjct: 173 -AFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHR 731
           + +F   + +G+G++G V        G  VA+K +   DK       + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASV 788
           N+I I  I     F+  +   I+ E MQ       LH       +   +I   + +    
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQSSSI-E 846
           ++ LH      ++H DLKPSN+L++ +    V DFGLAR +         P GQ S + E
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 847 MKGTIGYIGPEYGM-GGDLSMTGDVYSFGILLLEMFTRR 884
              T  Y  PE  +     S   DV+S G +L E+F RR
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S   ++ 
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRDDLC 170
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G V   L   +   E      + E+A+ 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRXXLX 172
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 119
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 120 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 166
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 41/273 (15%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNLIKIIT 738
           ++G G FG V+ G    +   VAVK +   K G  + ++F+ E   ++ ++H  L+++  
Sbjct: 19  KLGAGQFGEVWMGYY-NNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKL-NIVIEVASVIEYLHNHC 796
           + +       +   I+ E+M  GS+ D+L      K+ + KL +   ++A  + Y+    
Sbjct: 75  VVTK-----EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--- 126
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           +   +H DL+ +NVL+   ++  ++DFGLAR +  + +  A EG       K  I +  P
Sbjct: 127 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGA------KFPIKWTAP 179
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E    G  ++  +V+SFGILL E+ T                 Y K+  P +    V  +
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVT-----------------YGKIPYPGRTNADVMSA 222
Query: 917 LLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
           L    R P + E C   +      C  E   ER
Sbjct: 223 LSQGYRMP-RMENCPDELYDIMKMCWKEKAEER 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G V   L   +   E      + E+A+ 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 172
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 23/242 (9%)
Query: 651 LSSALLMEQQFPIVSYAELSKATKEFSSSNR-IGKGSFGFVYKG---NLGEDGMSVAVKV 706
           L SALL E +  ++ +  +       + S+R IGKG FG VY G   +  ++ +  A+K 
Sbjct: 3   LDSALLAEVKDVLIPHERV------VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS 56
Query: 707 MN-LDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDD 765
           ++ + +    ++F+ E   +R + H N++ +I I             ++  YM +G +  
Sbjct: 57  LSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM----LPPEGLPHVLLPYMCHGDLLQ 112
Query: 766 WLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 824
           ++        V  L +  ++VA  +EYL    +   VH DL   N +LD      V+DFG
Sbjct: 113 FIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFG 169
Query: 825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
           LAR +    +    + + + + +K T      E       +   DV+SFG+LL E+ TR 
Sbjct: 170 LARDILDREYYSVQQHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRG 225
Query: 885 RP 886
            P
Sbjct: 226 AP 227

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 118 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 164
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 125 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 171
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRTXLC 167
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           GT+ Y+ PE   G       D++S G+L  E    + P +
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRXXLC 169
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + ++  + 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTT--LC 170
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +        + AP  +  +  + 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRDT--LC 168
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRTTLC 172
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRXXLC 167
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           GT+ Y+ PE   G       D++S G+L  E    + P +
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 15/216 (6%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRN 732
           ++    +IG+G+FG V+K    + G  VA+K  +M  +K+G   + + E + L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVA-SVI 789
           ++ +I IC +        K  +Y    +   D    L +   K  + ++  V+++  + +
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
            Y+H +    I+H D+K +NVL+  D V  ++DFGLAR      F +A   Q +    + 
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR-----AFSLAKNSQPNRYXNRV 190
Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTR 883
            T+ Y  PE  +G  D     D++  G ++ EM+TR
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 102/231 (44%), Gaps = 22/231 (9%)
Query: 667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECE 723
           A+   A ++F     +GKG FG VY          +A+KV+    L+K G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 724 ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI 783
              ++RH N++++        F  +    ++ EY   G+V   L   +   E      + 
Sbjct: 61  IQSHLRHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A+ + Y H+     ++H D+KP N+LL       ++DFG +        + AP  + +
Sbjct: 116 ELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--------VHAPSSRRA 164
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD-NMFND 893
           +  + GT+ Y+ PE   G       D++S G+L  E    + P + N + D
Sbjct: 165 A--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQD 213

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHR 731
           +++    ++G+G++G VYK    + G  VA+K + LD   +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIE 790
           N++ +I +  S          +V+E+M+   +   L      L+  ++ I + ++   + 
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           + H H    I+H DLKP N+L++ D    ++DFGLAR      F +     +  +    T
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-----AFGIPVRSYTHEV---VT 182
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
           + Y  P+  MG    S + D++S G +  EM T
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 680 NRIGKGSFGFVYKGNLGED---GMSVAVKVMNL---DKKGATKSFVAECEALRNIRHRNL 733
           +++G G    VY   L ED    + VA+K + +   +K+   K F  E      + H+N+
Sbjct: 17  DKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYL 792
           + +I +         D   +V EY++  ++ +++  ++  L V   +N   ++   I++ 
Sbjct: 74  VSMIDVDEE-----DDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHA 127
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H+     IVH D+KP N+L+D +    + DFG+A+ LS           + +  + GT+ 
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-------TQTNHVLGTVQ 177
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Y  PE   G       D+YS GI+L EM     P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRXXLC 170
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           GT+ Y+ PE   G       D++S G+L  E    + P +
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 32/231 (13%)
Query: 669 LSKATKEFSSSNRIGKGSFGFVYKG-NLGEDGMSVAVKVMNLD--KKGATKSFVAECEAL 725
           L +A +++     IG+G++G V+K  +L   G  VA+K + +   ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 726 RNIR---HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-------E 775
           R++    H N++++  +C+           +V+E+     VD  L    DK+       E
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTE 120
Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
             K +++ ++   +++LH+H    +VH DLKP N+L+       ++DFGLAR  S     
Sbjct: 121 TIK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---- 172
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                Q +   +  T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 173 -----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 32/231 (13%)
Query: 669 LSKATKEFSSSNRIGKGSFGFVYKG-NLGEDGMSVAVKVMNLD--KKGATKSFVAECEAL 725
           L +A +++     IG+G++G V+K  +L   G  VA+K + +   ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 726 RNIR---HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-------E 775
           R++    H N++++  +C+           +V+E+     VD  L    DK+       E
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTE 120
Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
             K +++ ++   +++LH+H    +VH DLKP N+L+       ++DFGLAR  S     
Sbjct: 121 TIK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---- 172
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                Q +   +  T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 173 -----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 682 IGKGSFG----FVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIKI 736
           +G+G FG    + Y       G  VAVK +  D     +S +  E + LR + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE---YLH 793
              C      GA    +V EY+  GS+ D+L     +  +G   +++    + E   YLH
Sbjct: 99  KGCCED---AGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKGTI 851
                  +H DL   NVLLD+D +  + DFGLA+ +   H  + V  +G S        +
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP-------V 201
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE           DV+SFG+ L E+ T
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHR 731
           +++    ++G+G++G VYK    + G  VA+K + LD   +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIE 790
           N++ +I +  S          +V+E+M+   +   L      L+  ++ I + ++   + 
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           + H H    I+H DLKP N+L++ D    ++DFGLAR      F +     +  +    T
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-----AFGIPVRSYTHEV---VT 182
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
           + Y  P+  MG    S + D++S G +  EM T
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 111/292 (38%), Gaps = 44/292 (15%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMNLD---KKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +  D   +  A   F+ E  A+ +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L+   ++VA
Sbjct: 72  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI- 845
             + YL +      +H DL   N+LL    +  + DFGL R L        P+     + 
Sbjct: 126 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHYVM 174
Query: 846 --EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM 903
               K    +  PE       S   D + FG+ L EMFT  +      N    LH   K 
Sbjct: 175 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK- 233
Query: 904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAV 955
                           E     + E+C   +    V C    P +R    A+
Sbjct: 234 ----------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 20/219 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLI 734
           +    R+G G FG+V +    + G  VA+K    +     +  +  E + ++ + H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 735 KIITICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVI-EVASVIE 790
               +   +      D   +  EY + G +  +L+   +   L+ G +  ++ +++S + 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 791 YLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
           YLH +    I+H DLKP N++L      ++  + D G A+ L                E 
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---------EF 184
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT+ Y+ PE       ++T D +SFG L  E  T  RP
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 20/219 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLI 734
           +    R+G G FG+V +    + G  VA+K    +     +  +  E + ++ + H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 735 KIITICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVI-EVASVIE 790
               +   +      D   +  EY + G +  +L+   +   L+ G +  ++ +++S + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 791 YLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
           YLH +    I+H DLKP N++L      ++  + D G A+ L                E 
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---------EF 183
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT+ Y+ PE       ++T D +SFG L  E  T  RP
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 120
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 121 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 171
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 172 --VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK-----SFVAECEA 724
           S AT  +     IG G++G VYK      G  VA+K + +   G        S V E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 725 LRNIR---HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-- 779
           LR +    H N+++++ +C++          +V+E+     VD  L    DK     L  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPA 119
Query: 780 ----NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
               +++ +    +++LH +C   IVH DLKP N+L+       ++DFGLAR  S+    
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---- 172
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                Q +   +  T+ Y  PE  +    +   D++S G +  EMF RR+P
Sbjct: 173 -----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 217

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG V+          +D M VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKLEVGK-------------LNI 781
             +C+    +G     +V+EYM++G ++ +L  H  + KL  G              L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 782 VIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
             +VA+ + YL   H     VH DL   N L+   +V  + DFG++R +    +     G
Sbjct: 164 ASQVAAGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV--G 217
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             + + ++    ++ PE  +    +   DV+SFG++L E+FT
Sbjct: 218 GRTMLPIR----WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ + 
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y H+     ++H D+KP N+LL  +    ++DFG +        + AP  + ++  + GT
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS--------VHAPSSRRTT--LCGT 173
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
           + Y+ PE   G       D++S G+L  E  
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 114 QGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
           +K++ +  +      +   +V+E++     D  D    T   L + K + + ++   + +
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK-SYLFQLLQGLAF 118
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
            H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        +    T+
Sbjct: 119 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV---VTL 167
Query: 852 GYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
            Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
           +K++ +  +      +   +V+E++     D  D    T   L + K + + ++   + +
Sbjct: 68  VKLLDVIHT-----ENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK-SYLFQLLQGLAF 121
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
            H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        +    T+
Sbjct: 122 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV---VTL 170
Query: 852 GYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
            Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 112
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 163
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 164 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 112
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 163
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 164 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 120
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 121 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 171
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 172 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       ++DFG +    H P        S    + 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAP-------SSRRAALC 167
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 114
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 115 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 166 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       +++FG +        + AP  + ++  + 
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--------VHAPSSRRTT--LC 169
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT+ Y+ PE   G       D++S G+L  E    + P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 117
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 118 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 168
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 169 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
           +K++ +  +      +   +V+E++     D  D    T   L + K + + ++   + +
Sbjct: 67  VKLLDVIHT-----ENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK-SYLFQLLQGLAF 120
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
            H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        +    T+
Sbjct: 121 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV---VTL 169
Query: 852 GYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
            Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNI 728
           A ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           RH N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H+     ++H D+KP N+LL       +++FG +        + AP  + ++  + 
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS--------VHAPSSRRTT--LC 170
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           GT+ Y+ PE   G       D++S G+L  E    + P +
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 682 IGKGSFGFVYKGNL---GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKII 737
           IG G FG V  G L   G+  ++VA+K + +   +   + F+ E   +    H N++ + 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            + +    +G     IV E+M+ G++D +L   + +  V +L  ++  +A+ + YL +  
Sbjct: 111 GVVT----RGKPV-MIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM- 164
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH DL   N+L++ ++V  VSDFGL+R +        PE   ++   K  + +  P
Sbjct: 165 --GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD-----PEAVYTTTGGKIPVRWTAP 217
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           E       +   DV+S+GI++ E+ +   RP  +M N
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 254

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 116
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 117 QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 167
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 168 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 114
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 115 QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 166 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 116
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 117 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 167
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 168 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 115
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 116 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 166
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 167 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 117
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 118 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVV 169
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 170 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++++        F  A    ++ EY   G+V   L   +   E      + E+A+ + 
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y H+     ++H D+KP N+LL  +    ++DFG +        + AP  +  +  + GT
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS--------VHAPSSRRDT--LCGT 173
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
           + Y+ PE   G       D++S G+L  E  
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 682 IGKGSFGFVYKG---NL--GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG V+     NL   +D M VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKLEVGK-------------LNI 781
             +C+    +G     +V+EYM++G ++ +L  H  + KL  G              L +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 782 VIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
             +VA+ + YL   H     VH DL   N L+   +V  + DFG++R +    +     G
Sbjct: 141 ASQVAAGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV--G 194
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             + + ++    ++ PE  +    +   DV+SFG++L E+FT
Sbjct: 195 GRTMLPIR----WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 682 IGKGSFGFVYKG---NL--GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKI 736
           +G+G+FG V+     NL   +D M VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKLEVGK-------------LNI 781
             +C+    +G     +V+EYM++G ++ +L  H  + KL  G              L +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 782 VIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
             +VA+ + YL   H     VH DL   N L+   +V  + DFG++R +    +     G
Sbjct: 135 ASQVAAGMVYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV--G 188
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             + + ++    ++ PE  +    +   DV+SFG++L E+FT
Sbjct: 189 GRTMLPIR----WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 112
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 163
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 164 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 114
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 115 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 166 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 116
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 117 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVV 168
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 115
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 116 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 166
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 167 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 112
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 163
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 164 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 669 LSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEAL 725
           + +  ++F   N +GKGSF  VY+      G+ VA+K+++   + K G  +    E +  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIE 784
             ++H +++++        F+ +++  +V E    G ++ +L +      E    + + +
Sbjct: 66  CQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           + + + YLH+H    I+H DL  SN+LL  +M   ++DFGLA  L        P  +  +
Sbjct: 121 IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK------MPHEKHYT 171
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
             + GT  YI PE        +  DV+S G +   +   R P D
Sbjct: 172 --LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 115
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 116 QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 166
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 167 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 114
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 115 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 166 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 114
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 115 QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 166 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K     +M   ++      T   L + K + + ++ 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKT----FMDASAL------TGIPLPLIK-SYLFQLL 116
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 117 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVV 168
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+GSFG V      +    VA+K ++   L K         E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           + ++      D   +V EY   G + D++       E        ++   IEY H H   
Sbjct: 77  VITT----PTDI-VMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH--- 127
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGP 856
            IVH DLKP N+LLD ++   ++DFGL+  ++   FL    G    ++ E+     Y GP
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF 891
           E           DV+S GI+L  M   R P D+ F
Sbjct: 188 EV----------DVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           +K++ +  +      +   +V+E++     +  D    T   L + K + + ++   + +
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEHVHQDLKTFMDASALTGIPLPLIK-SYLFQLLQGLAF 117
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
            H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  +    T+
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV---VTL 166
Query: 852 GYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
            Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRH 730
           ++ +F    ++G G++  VYKG     G+ VA+K + LD ++G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG------KLNIV-- 782
            N++++  +  +      +   +V+E+M     D+ L    D   VG      +LN+V  
Sbjct: 63  ENIVRLYDVIHT-----ENKLTLVFEFM-----DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 783 --IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
              ++   + + H +    I+H DLKP N+L++      + DFGLAR      F +    
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-----AFGIPVNT 164
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFT 882
            SS +    T+ Y  P+  MG     T  D++S G +L EM T
Sbjct: 165 FSSEVV---TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD +  G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVAS 787
           +K++ +  + +            Y+ +  VD  L    D   +  + +      + ++  
Sbjct: 68  VKLLDVIHTEN----------KLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V        +  
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYXHEVV- 168
Query: 848 KGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
             T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V        G  VAVK M+L K+   +    E   +R+  H N++ + +  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS-- 109
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   + YLHN     +
Sbjct: 110 ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIATVCLSVLRALSYLHNQG---V 162
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
           +H D+K  ++LL  D    +SDFG    +S       P+ +     + GT  ++ PE   
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----VPKRKX----LVGTPYWMAPEVIS 214
Query: 861 GGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                   D++S GI+++EM     P  N
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEPPYFN 243

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 117/257 (45%), Gaps = 44/257 (17%)
Query: 643 IGTKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLG-EDG-- 699
           I  +L  KL   L+ EQQF +                  +GKG FG V +  L  EDG  
Sbjct: 7   ISDELKEKLEDVLIPEQQFTL---------------GRMLGKGEFGSVREAQLKQEDGSF 51
Query: 700 MSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKIITICSSIDFKGA-DFKAIVYE 756
           + VAVK++  D   ++  + F+ E   ++   H ++ K++ +      KG      ++  
Sbjct: 52  VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 757 YMQYGSVDDWLHHTNDKLEVGK----------LNIVIEVASVIEYLHNHCQPPIVHGDLK 806
           +M++G +  +L  +     +G+          +  ++++A  +EYL +      +H DL 
Sbjct: 112 FMKHGDLHAFLLASR----IGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLA 164
Query: 807 PSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSM 866
             N +L  DM   V+DFGL+R +    +    +G +S + +K    ++  E       ++
Sbjct: 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYY--RQGCASKLPVK----WLALESLADNLYTV 218
Query: 867 TGDVYSFGILLLEMFTR 883
             DV++FG+ + E+ TR
Sbjct: 219 HSDVWAFGVTMWEIMTR 235

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+  + LD +  G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 113
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 164
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 165 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+  + LD +  G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 734 IKIITICSS-------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
           +K++ +  +        +F   D K    ++M   ++      T   L + K + + ++ 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASAL------TGIPLPLIK-SYLFQLL 112
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + + H+H    ++H DLKP N+L++ +    ++DFGLAR      F V     +  + 
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 163
Query: 847 MKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  PE  +G     T  D++S G +  EM TRR
Sbjct: 164 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +    L +  A   F+ E  A+ +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L+   ++VA
Sbjct: 78  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI- 845
             + YL +      +H DL   N+LL    +  + DFGL R L        P+     + 
Sbjct: 132 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHXVM 180
Query: 846 --EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               K    +  PE       S   D + FG+ L EMFT
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +    L +  A   F+ E  A+ +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L+   ++VA
Sbjct: 68  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI- 845
             + YL +      +H DL   N+LL    +  + DFGL R L        P+     + 
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHXVM 170
Query: 846 --EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               K    +  PE       S   D + FG+ L EMFT
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +    L +  A   F+ E  A+ +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L+   ++VA
Sbjct: 72  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI- 845
             + YL +      +H DL   N+LL    +  + DFGL R L        P+     + 
Sbjct: 126 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHYVM 174
Query: 846 --EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               K    +  PE       S   D + FG+ L EMFT
Sbjct: 175 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +    L +  A   F+ E  A+ +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L+   ++VA
Sbjct: 68  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI- 845
             + YL +      +H DL   N+LL    +  + DFGL R L        P+     + 
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHYVM 170
Query: 846 --EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               K    +  PE       S   D + FG+ L EMFT
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +    L +  A   F+ E  A+ +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L+   ++VA
Sbjct: 78  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI- 845
             + YL +      +H DL   N+LL    +  + DFGL R L        P+     + 
Sbjct: 132 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHYVM 180
Query: 846 --EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               K    +  PE       S   D + FG+ L EMFT
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 682 IGKGSFG----FVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIKI 736
           +G+G FG    + Y       G  VAVK +  D     +S +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE---YLH 793
              C     +G     +V EY+  GS+ D+L     +  +G   +++    + E   YLH
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKGTI 851
           +      +H +L   NVLLD+D +  + DFGLA+ +   H  + V  +G S        +
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-------V 184
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE           DV+SFG+ L E+ T
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +    L +  A   F+ E  A+ +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN-IVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L+   ++VA
Sbjct: 68  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI- 845
             + YL +      +H DL   N+LL    +  + DFGL R L        P+     + 
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHYVM 170
Query: 846 --EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               K    +  PE       S   D + FG+ L EMFT
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMN-LDKKGATKSFVAECEALRNIR 729
           E      +G G+FG VYKG    +G    + VA+K++N      A   F+ E   + ++ 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVA 786
           H +L++++ +C S   +      +V + M +G + +++H   D   +G    LN  +++A
Sbjct: 76  HPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIA 127
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + YL       +VH DL   NVL+       ++DFGLAR L         E + ++  
Sbjct: 128 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE------GDEKEYNADG 178
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            K  I ++  E       +   DV+S+G+ + E+ T
Sbjct: 179 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 680 NRIGKGSFGFV---YKGNLGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           +++GKG+FG V       LG++ G  VAVK +        + F  E + L+ + H + I 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 86
Query: 736 IITICSSIDFKGADFKA------IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASV 788
                  + ++G  +        +V EY+  G + D+L     +L+  +L +   ++   
Sbjct: 87  -------VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF--LSHHPFLVAPEGQSSSIE 846
           +EYL +      VH DL   N+L++ +    ++DFGLA+   L    ++V   GQS    
Sbjct: 140 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---- 192
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               I +  PE       S   DV+SFG++L E+FT
Sbjct: 193 ---PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 37/210 (17%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V    +   G  VAVK M+L K+   +    E   +R+ +H N++++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 215
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   +  LH      +
Sbjct: 216 ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIAAVCLAVLQALSVLHAQG---V 268
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQSSSIEMKGT 850
           +H D+K  ++LL HD    +SDFG    +S            P+ +AP       E+   
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP-------ELISR 321
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + Y GPE           D++S GI+++EM
Sbjct: 322 LPY-GPEV----------DIWSLGIMVIEM 340

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 37/210 (17%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V    +   G  VAVK M+L K+   +    E   +R+ +H N++++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 95
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   +  LH      +
Sbjct: 96  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIAAVCLAVLQALSVLHAQG---V 148
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQSSSIEMKGT 850
           +H D+K  ++LL HD    +SDFG    +S            P+ +AP       E+   
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP-------ELISR 201
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + Y GPE           D++S GI+++EM
Sbjct: 202 LPY-GPEV----------DIWSLGIMVIEM 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 41/221 (18%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V    +   G  VAVK M+L K+   +    E   +R+ +H N++++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 93
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQP 798
               +   D   +V E+++ G++ D + HT  N++        V++  SV+     H Q 
Sbjct: 94  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVL-----HAQ- 144
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQSSSIEMK 848
            ++H D+K  ++LL HD    +SDFG    +S            P+ +AP       E+ 
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP-------ELI 197
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
             + Y GPE           D++S GI+++EM     P  N
Sbjct: 198 SRLPY-GPEV----------DIWSLGIMVIEMVDGEPPYFN 227

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 122/271 (45%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V  ++ + AT     K  + E   + ++ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +     LN  +++A  
Sbjct: 110 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 163
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 164 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 214
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 215 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 274
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 275 PPICTIDVYMIMVKCWMIDADSRPKFRELII 305

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 37/210 (17%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V    +   G  VAVK M+L K+   +    E   +R+ +H N++++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 138
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   +  LH      +
Sbjct: 139 ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIAAVCLAVLQALSVLHAQG---V 191
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQSSSIEMKGT 850
           +H D+K  ++LL HD    +SDFG    +S            P+ +AP       E+   
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP-------ELISR 244
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + Y GPE           D++S GI+++EM
Sbjct: 245 LPY-GPEV----------DIWSLGIMVIEM 263

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V    +   G  VAVK M+L K+   +    E   +R+ +H N++++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 84
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   +  LH      +
Sbjct: 85  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIAAVCLAVLQALSVLHAQG---V 137
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQSSSIEMKGT 850
           +H D+K  ++LL HD    +SDFG    +S            P+ +AP       E+   
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP-------ELISR 190
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           + Y GPE           D++S GI+++EM     P  N
Sbjct: 191 LPY-GPEV----------DIWSLGIMVIEMVDGEPPYFN 218

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V    +   G  VAVK M+L K+   +    E   +R+ +H N++++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 88
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +   D   +V E+++ G++ D + HT    E     + + V   +  LH      +
Sbjct: 89  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIAAVCLAVLQALSVLHAQG---V 141
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVAPEGQSSSIEMKGT 850
           +H D+K  ++LL HD    +SDFG    +S            P+ +AP       E+   
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP-------ELISR 194
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           + Y GPE           D++S GI+++EM     P  N
Sbjct: 195 LPY-GPEV----------DIWSLGIMVIEMVDGEPPYFN 222

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEAL-RNIRHRNLIKII 737
           IGKGSFG V       + +  AVKV+    + KK   K  ++E   L +N++H  L+ + 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 104
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
                  F+ AD    V +Y+  G +   L      LE        E+AS + YLH+   
Sbjct: 105 ----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN- 159
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             IV+ DLKP N+LLD      ++DFGL +    H         S++    GT  Y+ PE
Sbjct: 160 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--------NSTTSTFCGTPEYLAPE 209
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP---------TDNMFNDGLTL 897
                    T D +  G +L EM     P          DN+ N  L L
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 258

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 682 IGKGSFG----FVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIKI 736
           +G+G FG    + Y       G  VAVK +  D     +S +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE---YLH 793
              C     +G     +V EY+  GS+ D+L     +  +G   +++    + E   YLH
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEMKGTI 851
                  +H +L   NVLLD+D +  + DFGLA+ +   H  + V  +G S        +
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-------V 184
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            +  PE           DV+SFG+ L E+ T
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 683 GKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSS 742
            +G FG V+K  L  D   VAVK+  L  K + +S   E  +   ++H NL++ I    +
Sbjct: 24  ARGRFGCVWKAQLMND--FVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFI----A 76
Query: 743 IDFKGADFKA---IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV-IEYLHNHC-- 796
            + +G++ +    ++  +   GS+ D+L    + +   +L  V E  S  + YLH     
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 797 ------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQSSSIEMKG 849
                 +P I H D K  NVLL  D+ A ++DFGLA RF    P    P      +   G
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKP----PGDTHGQV---G 187
Query: 850 TIGYIGPEYGMGG-----DLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           T  Y+ PE   G      D  +  D+Y+ G++L E+ +R +  D   ++
Sbjct: 188 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKKG--ATKSFVAECEALRNI 728
           E      +G G+FG VYKG    +G    + VA+K++N +  G  A   F+ E   + ++
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASM 97
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEV 785
            H +L++++ +C S   +      +V + M +G + +++H   D   +G    LN  +++
Sbjct: 98  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQI 149
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
           A  + YL    +  +VH DL   NVL+       ++DFGLAR L         E + ++ 
Sbjct: 150 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE------GDEKEYNAD 200
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             K  I ++  E       +   DV+S+G+ + E+ T
Sbjct: 201 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 81  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 136 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 191
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 192 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKGSFG V K          AVKV+N    K   T + + E E L+ + H N++K+  I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
                   + F  IV E    G + D +       E     I+ +V S I Y+H H    
Sbjct: 90  LED----SSSF-YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 800 IVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---Y 853
           IVH DLKP N+LL   + D    + DFGL+     +             +MK  IG   Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT------------KMKDRIGTAYY 189
Query: 854 IGPEYGMGGDLSMTGDVYSFGILL 877
           I PE  + G      DV+S G++L
Sbjct: 190 IAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 137 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL        +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 247
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 248 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +GKG FG   K    E G  + +K +    +   ++F+ E + +R + H N++K I +  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL- 76
Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVASVIEYLHNHCQPPI 800
              +K      I  EY++ G++   +   + +     +++   ++AS + YLH+     I
Sbjct: 77  ---YKDKRLNFIT-EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG--------QSSSIEMKGTIG 852
           +H DL   N L+  +    V+DFGLAR +        PEG        +     + G   
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEK--TQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
           ++ PE   G       DV+SFGI+L E+  R
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           IGKG FG V++G     G  VAVK+ +  ++   +S+  E E  + +  RH N++  I  
Sbjct: 37  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
            +  +        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH      
Sbjct: 92  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIVGT 149
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-----G 849
             +P I H DLK  N+L+  +    ++D GLA         V  +  + +I++      G
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHRVG 200
Query: 850 TIGYIGPEYGMGGDLSMT-------GDVYSFGILLLEMFTR 883
           T  Y+ PE  +   ++M         D+Y+ G++  E+  R
Sbjct: 201 TKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 206
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 207 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 89  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 144 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 199
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 200 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H     
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 203
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             +    +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 204 --DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 85  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 140 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 195
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 196 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 88  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 143 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 198
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 199 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 206
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 207 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFG-FVYKGNLGEDG------MSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG  V    +G D         VAVK++  D      S  ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L               H+  ++L   
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   +VA  +EYL +      +H DL   NVL+  D V  ++DFGLAR + H  +  
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 206
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+LL E+FT
Sbjct: 207 -----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           IGKG FG V++G     G  VAVK+ +  ++   +S+  E E  + +  RH N++  I  
Sbjct: 50  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
            +  +        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH      
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIVGT 162
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-----G 849
             +P I H DLK  N+L+  +    ++D GLA         V  +  + +I++      G
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHRVG 213
Query: 850 TIGYIGPEYGMGGDLSMT-------GDVYSFGILLLEMFTR 883
           T  Y+ PE  +   ++M         D+Y+ G++  E+  R
Sbjct: 214 TKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 60/252 (23%), Positives = 122/252 (48%), Gaps = 46/252 (18%)
Query: 660 QFPIVSYAELSKATKEFSSS-----NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNL 709
           + P+++  + +K  KE S S       +G+  FG VYKG+L     GE   +VA+K +  
Sbjct: 8   EMPLINQHKQAK-LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 710 DKKGATKS-FVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH 768
             +G  +  F  E      ++H N++ ++ + +          ++++ Y  +G + ++L 
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLV 121
Query: 769 HTNDKLEVGK----------------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
             +   +VG                 +++V ++A+ +EYL +H    +VH DL   NVL+
Sbjct: 122 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178
Query: 813 DHDMVAHVSDFGLAR--FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDV 870
              +   +SD GL R  + + +  L+     +S + ++    ++ PE  M G  S+  D+
Sbjct: 179 YDKLNVKISDLGLFREVYAADYYKLLG----NSLLPIR----WMAPEAIMYGKFSIDSDI 230
Query: 871 YSFGILLLEMFT 882
           +S+G++L E+F+
Sbjct: 231 WSYGVVLWEVFS 242

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 76  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 180
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELII 271

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 44/271 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            +G G+FG VYK    E  +  A KV++   +   + ++ E + L +  H N++K++   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA- 102
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQPP 799
               F   +   I+ E+   G+VD  +      L   ++ +V  +    + YLH++    
Sbjct: 103 ----FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---K 155
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           I+H DLK  N+L   D    ++DFG++               + +I+ + +  +IG  Y 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA------------KNTRTIQRRDS--FIGTPYW 201
Query: 860 MGGDLSM-----------TGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK 908
           M  ++ M             DV+S GI L+EM     P           H    M +  K
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH----------HELNPMRVLLK 251
Query: 909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGV 939
           +     P+L   +R  S F++ L   +   V
Sbjct: 252 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNV 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF---VAECEALRNIRH 730
           K FS    IG GSFG VY      +   VA+K M+   K + + +   + E   L+ +RH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASV- 788
            N         +I ++G   +    E+  +  ++  L   +D LEV K  +  +E+A+V 
Sbjct: 114 PN---------TIQYRGCYLR----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 160
Query: 789 ------IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
                 + YLH+H    ++H D+K  N+LL    +  + DFG A  ++     V      
Sbjct: 161 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------ 211
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTG---DVYSFGILLLEMFTRRRPTDNM 890
                 GT  ++ PE  +  D        DV+S GI  +E+  R+ P  NM
Sbjct: 212 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 80  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 133
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 184
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 244
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSRPKFRELII 275

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 77  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 130
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 181
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 241
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELII 272

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V        G   AVKV++   + +K   +S + E + L+ + H N++K+  
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+   +  +V E    G + D +       EV    I+ +V S I Y+H +   
Sbjct: 100 F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--- 151
Query: 799 PIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG--- 852
            IVH DLKP N+LL+    D    + DFGL+                +S +MK  IG   
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF------------EASKKMKDKIGTAY 199
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILL 877
           YI PE  + G      DV+S G++L
Sbjct: 200 YIAPEV-LHGTYDEKCDVWSTGVIL 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 180
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELII 271

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 180
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 241 PPICTIDVYMIMRKCWMIDADSRPKFRELII 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 182
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELII 273

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIIT 738
           IGKGSFG V      +     A+K MN  K   +   ++   E + ++ + H  L+ +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
                 F+  +   +V + +  G +   L    + K E  KL  + E+   ++YL N   
Sbjct: 82  ----YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALDYLQNQ-- 134
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H D+KP N+LLD     H++DF +A  L         E Q ++  M GT  Y+ PE
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-------ETQITT--MAGTKPYMAPE 184
Query: 858 Y---GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 G   S   D +S G+   E+   RRP
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKGSFG V K          AVKV+N    K   T + + E E L+ + H N++K+  I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
                 + +    IV E    G + D +       E     I+ +V S I Y+H H    
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 800 IVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---Y 853
           IVH DLKP N+LL   + D    + DFGL+                 + +MK  IG   Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------------NTKMKDRIGTAYY 189
Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           I PE  + G      DV+S G++L  + +   P
Sbjct: 190 IAPEV-LRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 78  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 182
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELII 273

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 79  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 183
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELII 274

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKGSFG V K          AVKV+N    K   T + + E E L+ + H N++K+  I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
                   + F  IV E    G + D +       E     I+ +V S I Y+H H    
Sbjct: 90  LED----SSSF-YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 800 IVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---Y 853
           IVH DLKP N+LL   + D    + DFGL+                 + +MK  IG   Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------------NTKMKDRIGTAYY 189
Query: 854 IGPEYGMGGDLSMTGDVYSFGILL 877
           I PE  + G      DV+S G++L
Sbjct: 190 IAPEV-LRGTYDEKCDVWSAGVIL 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 77  NPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG 130
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 181
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 241
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELII 272

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 680 NRIGKGSFGFV---YKGNLGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           +++GKG+FG V       LG++ G  VAVK +        + F  E + L+ + H + I 
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 73
Query: 736 IITICSSIDFKGADFKA------IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASV 788
                  + ++G  +        +V EY+  G + D+L     +L+  +L +   ++   
Sbjct: 74  -------VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 789 IEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF--LSHHPFLVAPEGQSSSI 845
           +EYL    C    VH DL   N+L++ +    ++DFGLA+   L    ++V   GQS   
Sbjct: 127 MEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP-- 180
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                I +  PE       S   DV+SFG++L E+FT
Sbjct: 181 -----IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 680 NRIGKGSFGFV---YKGNLGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           +++GKG+FG V       LG++ G  VAVK +        + F  E + L+ + H + I 
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 74
Query: 736 IITICSSIDFKGADFKA------IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASV 788
                  + ++G  +        +V EY+  G + D+L     +L+  +L +   ++   
Sbjct: 75  -------VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 789 IEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF--LSHHPFLVAPEGQSSSI 845
           +EYL    C    VH DL   N+L++ +    ++DFGLA+   L    ++V   GQS   
Sbjct: 128 MEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP-- 181
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                I +  PE       S   DV+SFG++L E+FT
Sbjct: 182 -----IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 66  FLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           EYLH+     +V+ D+K  N++LD D    ++DFGL +           EG S    MK 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKT 164
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF---VAECEALRNIRH 730
           K FS    IG GSFG VY      +   VA+K M+   K + + +   + E   L+ +RH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASV- 788
            N         +I ++G   +    E+  +  ++  L   +D LEV K  +  +E+A+V 
Sbjct: 75  PN---------TIQYRGCYLR----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 789 ------IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
                 + YLH+H    ++H D+K  N+LL    +  + DFG A  ++     V      
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------ 172
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTG---DVYSFGILLLEMFTRRRPTDNM 890
                 GT  ++ PE  +  D        DV+S GI  +E+  R+ P  NM
Sbjct: 173 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 180
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELII 271

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 82  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 135
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 136 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 187 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 246
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 247 PPICTIDVYMIMVKCWMIDADSRPKFRELII 277

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL-----DKKGATKSFVAEC 722
           ++    K +   + +G+G F  VYK         VA+K + L      K G  ++ + E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 723 EALRNIRHRNLIKIIT-------ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
           + L+ + H N+I ++        I    DF   D + I+         D+ L  T   ++
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK--------DNSLVLTPSHIK 115
Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                 ++     +EYLH H    I+H DLKP+N+LLD + V  ++DFGLA+        
Sbjct: 116 A----YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----- 163
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTR 883
                  +      T  Y  PE   G  +   G D+++ G +L E+  R
Sbjct: 164 ---SPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 183
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELII 274

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 187
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELII 278

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 183
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 244 PPICTIDVYMIMRKCWMIDADSRPKFRELII 274

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 183
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELII 274

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 101 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 154
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 155 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 205
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 206 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 265
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 266 PPICTIDVYMIMVKCWMIDADSRPKFRELII 296

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 186
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 661 FPIVSYA--ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKG 713
           FP   Y   E   + ++ +    +G+GSFG VY+GN      GE    VAVK +N     
Sbjct: 2   FPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 714 ATK-SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
             +  F+ E   ++     ++++++ + S    KG     +V E M +G +  +L     
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRP 116
Query: 773 KLE--VGK--------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
           + E   G+        + +  E+A  + YL+       VH DL   N ++ HD    + D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILL 877
           FG+ R +             +    KG  G     ++ PE    G  + + D++SFG++L
Sbjct: 174 FGMTRDIXE-----------TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222
Query: 878 LEM 880
            E+
Sbjct: 223 WEI 225

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 86  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 139
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 140 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 190
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 250
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 251 PPICTIDVYMIMRKCWMIDADSRPKFRELII 281

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 658 EQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS 717
           E + P   +A   +  +++   + IG+G    V +      G   AVK+M +  +  +  
Sbjct: 80  EDELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE 137
Query: 718 FVAEC-EALRNIRH--RNLIKIITICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTNDK 773
            + E  EA R   H  R +     I + ID ++ + F  +V++ M+ G + D+L      
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL 197
Query: 774 LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
            E    +I+  +   + +LH +    IVH DLKP N+LLD +M   +SDFG +  L    
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL---- 250
Query: 834 FLVAPEGQSSSIEMKGTIGYIGPEY----------GMGGDLSMTGDVYSFGILLLEMFT 882
                E      E+ GT GY+ PE           G G ++    D+++ G++L  +  
Sbjct: 251 -----EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLLA 300

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 66  FLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           EYLH+     +V+ D+K  N++LD D    ++DFGL +           EG S    MK 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKX 164
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 69  FLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 121
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           EYLH+     +V+ D+K  N++LD D    ++DFGL +           EG S    MK 
Sbjct: 122 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKT 167
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 66  FLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           EYLH+     +V+ D+K  N++LD D    ++DFGL +           EG S    MK 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKX 164
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 186
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 78
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 139 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 187
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 188 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 186
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 73  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEG 126
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 177
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 237
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 238 PPICTIDVYMIMVKCWMIDADSRPKFRELII 268

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 44/271 (16%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            +G G+FG VYK    E  +  A KV++   +   + ++ E + L +  H N++K++   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA- 102
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQPP 799
               F   +   I+ E+   G+VD  +      L   ++ +V  +    + YLH++    
Sbjct: 103 ----FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---K 155
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           I+H DLK  N+L   D    ++DFG++               +  I+ + +  +IG  Y 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA------------KNTRXIQRRDS--FIGTPYW 201
Query: 860 MGGDLSM-----------TGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK 908
           M  ++ M             DV+S GI L+EM     P           H    M +  K
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH----------HELNPMRVLLK 251
Query: 909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGV 939
           +     P+L   +R  S F++ L   +   V
Sbjct: 252 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNV 282

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 70  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 174
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELII 265

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNL 733
             +G+GSFG VY+GN      GE    VAVK +N       +  F+ E   ++     ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGK--------LNIVI 783
           ++++ + S    KG     +V E M +G +  +L     + E   G+        + +  
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  + YL+       VH DL   N ++ HD    + DFG+ R +             +
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-----------T 183
Query: 844 SIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               KG  G     ++ PE    G  + + D++SFG++L E+
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 54/225 (24%), Positives = 110/225 (48%), Gaps = 40/225 (17%)
Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIK 735
           +G+  FG VYKG+L     GE   +VA+K +    +G  +  F  E      ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK----------------L 779
           ++ + +          ++++ Y  +G + ++L   +   +VG                 +
Sbjct: 77  LLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR--FLSHHPFLVA 837
           ++V ++A+ +EYL +H    +VH DL   NVL+   +   +SD GL R  + + +  L+ 
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               +S + ++    ++ PE  M G  S+  D++S+G++L E+F+
Sbjct: 189 ----NSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 81
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 142 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 190
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 191 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKG--NLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIR 729
           +++    +IG+G++G VYK   N GE   + A+K + L+K+  G   + + E   L+ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELK 58
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASV 788
           H N++K+  +  +          +V+E++    +   L      LE V   + ++++ + 
Sbjct: 59  HSNIVKLYDVIHT-----KKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I Y H+     ++H DLKP N+L++ +    ++DFGLAR      F +     +  I   
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-----AFGIPVRKYTHEI--- 161
Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEM 880
            T+ Y  P+  MG    S T D++S G +  EM
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 85
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 146 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 194
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 195 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 96
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 157 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 205
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 206 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM--NLDKKGATKSFVAECEALRNIRHRN 732
           E+     IG G++G V        G  VA+K +    D     K  + E + L++ +H N
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVGKLNIVI-EVASV 788
           +I I  I       G +FK++   Y+    ++  LH   H++  L +  +   + ++   
Sbjct: 116 IIAIKDILRPTVPYG-EFKSV---YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           ++Y+H+     ++H DLKPSN+L++ +    + DFG+AR L   P     E Q    E  
Sbjct: 172 LKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA----EHQYFMTEYV 224
Query: 849 GTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRR 885
            T  Y  PE  +   + +   D++S G +  EM  RR+
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 36/238 (15%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN- 732
           ++F     +G GSFG V+      +G   A+KV+        K  V     L+ + H N 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVR---LKQVEHTND 55
Query: 733 ---LIKIIT----ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEV 785
              ++ I+T    I     F+ A    ++ +Y++ G +   L  +             EV
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              +EYLH+     I++ DLKP N+LLD +    ++DFG A+++    + +         
Sbjct: 116 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-------- 164
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM 903
              GT  YI PE       + + D +SFGIL+ EM     P    F D  T+  Y K+
Sbjct: 165 ---GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKI 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 42/233 (18%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     IG G FG V+K     DG +  ++ +  + + A +    E +AL  + H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 735 KIITICSSIDF---------KGADFKA---------------IVYEYMQYGSVDDWLH-H 769
                    D+         + +D+                 I  E+   G+++ W+   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 770 TNDKLE-VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
             +KL+ V  L +  ++   ++Y+H+     ++H DLKPSN+ L       + DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
           L +       +G+ +    KGT+ Y+ PE     D     D+Y+ G++L E+ 
Sbjct: 186 LKN-------DGKRT--RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNL 733
             +G+GSFG VY+GN      GE    VAVK +N       +  F+ E   ++     ++
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGK--------LNIVI 783
           ++++ + S    KG     +V E M +G +  +L     + E   G+        + +  
Sbjct: 80  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  + YL+       VH DL   N ++ HD    + DFG+ R +             +
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-----------T 180
Query: 844 SIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               KG  G     ++ PE    G  + + D++SFG++L E+
Sbjct: 181 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 135/322 (41%), Gaps = 56/322 (17%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RH 730
            K+     +IGKG +G V+ G     G  VAVKV    ++    S+  E E  + +  RH
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRH 90
Query: 731 RNLIKIITICSSIDFKGADFKAIVY---EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
            N++  I    + D KG      +Y   +Y + GS+ D+L  T    +   L +     S
Sbjct: 91  ENILGFI----AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAK-SMLKLAYSSVS 145
Query: 788 VIEYLHNHC-----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQ 841
            + +LH        +P I H DLK  N+L+  +    ++D GLA +F+S    +  P   
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLS-------MTGDVYSFGILLLEMFTR----------R 884
                  GT  Y+ PE  +   L+       +  D+YSFG++L E+  R          +
Sbjct: 206 RV-----GTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 885 RPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKF--EECLVAVVRTGVACS 942
            P  ++     +     ++   KK+     PS       P+++  +ECL  + +    C 
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLR----PSF------PNRWSSDECLRQMGKLMTECW 309
Query: 943 MESPSERMQMTAVVKKLCAVGE 964
             +P+ R+    V K L  + E
Sbjct: 310 AHNPASRLTALRVKKTLAKMSE 331

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 66  FLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           EYLH+     +V+ D+K  N++LD D    ++DFGL +           EG S    MK 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKX 164
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 186
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 198
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 199 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 71  FLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 123
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           EYLH+     +V+ D+K  N++LD D    ++DFGL +           EG S    MK 
Sbjct: 124 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKX 169
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 218

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 198
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 199 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 90
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 151 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 199
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 200 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 109/269 (40%), Gaps = 40/269 (14%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            +G G+FG VYK    E  +  A KV++   +   + ++ E + L +  H N++K++   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA- 102
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQPP 799
               F   +   I+ E+   G+VD  +      L   ++ +V  +    + YLH++    
Sbjct: 103 ----FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---K 155
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLA----RFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
           I+H DLK  N+L   D    ++DFG++    R +      +            GT  ++ 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------------GTPYWMA 203
Query: 856 PEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM 910
           PE  M             DV+S GI L+EM     P           H    M +  K+ 
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH----------HELNPMRVLLKIA 253
Query: 911 GIVDPSLLMEARGPSKFEECLVAVVRTGV 939
               P+L   +R  S F++ L   +   V
Sbjct: 254 KSEPPTLAQPSRWSSNFKDFLKKCLEKNV 282

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM--NLDKKGATKSFVAECEALRNIRHRN 732
           E+     IG G++G V        G  VA+K +    D     K  + E + L++ +H N
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVGKLNIVI-EVASV 788
           +I I  I       G +FK++   Y+    ++  LH   H++  L +  +   + ++   
Sbjct: 115 IIAIKDILRPTVPYG-EFKSV---YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           ++Y+H+     ++H DLKPSN+L++ +    + DFG+AR L   P     E Q    E  
Sbjct: 171 LKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP----AEHQYFMTEYV 223
Query: 849 GTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRR 885
            T  Y  PE  +   + +   D++S G +  EM  RR+
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 220
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 221 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 82
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 143 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 191
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 192 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNL 733
           ++     IG G+   V           VA+K +NL+K + +    + E +A+    H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGKLN------IVIEV 785
           +   T      F   D   +V + +  GSV D + H   K E   G L+      I+ EV
Sbjct: 71  VSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              +EYLH + Q   +H D+K  N+LL  D    ++DFG++ FL+    +   + + + +
Sbjct: 126 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 846 EMKGTIGYIGPEYG---MGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  ++ PE      G D     D++SFGI  +E+ T   P
Sbjct: 183 ---GTPCWMAPEVMEQVRGYDFK--ADIWSFGITAIELATGAAP 221

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 680 NRIGKGSFGFV---YKGNLGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           +++GKG+FG V       LG++ G  VAVK +        + F  E + L+ + H + I 
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 70
Query: 736 IITICSSIDFKGADFKA------IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASV 788
                  + ++G  +        +V EY+  G + D+L     +L+  +L +   ++   
Sbjct: 71  -------VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 789 IEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF--LSHHPFLVAPEGQSSSI 845
           +EYL    C    VH DL   N+L++ +    ++DFGLA+   L     +V   GQS   
Sbjct: 124 MEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP-- 177
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                I +  PE       S   DV+SFG++L E+FT
Sbjct: 178 -----IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKG--NLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIR 729
           +++    +IG+G++G VYK   N GE   + A+K + L+K+  G   + + E   L+ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELK 58
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASV 788
           H N++K+  +  +          +V+E++    +   L      LE V   + ++++ + 
Sbjct: 59  HSNIVKLYDVIHT-----KKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I Y H+     ++H DLKP N+L++ +    ++DFGLAR      F +     +  +   
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-----AFGIPVRKYTHEV--- 161
Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEM 880
            T+ Y  P+  MG    S T D++S G +  EM
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITIC 740
           IG G+   V           VA+K +NL+K + +    + E +A+    H N++   T  
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-- 80
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGKLN------IVIEVASVIEYL 792
               F   D   +V + +  GSV D + H   K E   G L+      I+ EV   +EYL
Sbjct: 81  ---SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H + Q   +H D+K  N+LL  D    ++DFG++ FL+    +   + + + +   GT  
Sbjct: 138 HKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV---GTPC 191
Query: 853 YIGPEYG---MGGDLSMTGDVYSFGILLLEMFTRRRP 886
           ++ PE      G D     D++SFGI  +E+ T   P
Sbjct: 192 WMAPEVMEQVRGYDFK--ADIWSFGITAIELATGAAP 226

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKG--NLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIR 729
           +++    +IG+G++G VYK   N GE   + A+K + L+K+  G   + + E   L+ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELK 58
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-VGKLNIVIEVASV 788
           H N++K+  +  +          +V+E++    +   L      LE V   + ++++ + 
Sbjct: 59  HSNIVKLYDVIHT-----KKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I Y H+     ++H DLKP N+L++ +    ++DFGLAR      F +     +  +   
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-----AFGIPVRKYTHEV--- 161
Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEM 880
            T+ Y  P+  MG    S T D++S G +  EM
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNL 733
             +G+GSFG VY+GN      GE    VAVK +N       +  F+ E   ++     ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGK--------LNIVI 783
           ++++ + S    KG     +V E M +G +  +L     + E   G+        + +  
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  + YL+       VH DL   N ++ HD    + DFG+ R +    +         
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYY-------- 186
Query: 844 SIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               KG  G     ++ PE    G  + + D++SFG++L E+
Sbjct: 187 ---RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     IG G FG V+K     DG +  +K +  + + A +    E +AL  + H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 735 KIITICSSIDFKGADFKA-----------IVYEYMQYGSVDDWLH-HTNDKLE-VGKLNI 781
                    D+                  I  E+   G+++ W+     +KL+ V  L +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             ++   ++Y+H+     +++ DLKPSN+ L       + DFGL   L +          
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN---------D 175
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
                 KGT+ Y+ PE     D     D+Y+ G++L E+ 
Sbjct: 176 GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 66  FLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           EYLH+     +V+ D+K  N++LD D    ++DFGL +           EG S    MK 
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKT 164
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
             GT  Y+ PE     D     D +  G+++ EM   R P  N
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 34/227 (14%)
Query: 669 LSKATKE-FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN 727
           L+K  +E F    ++G+GS+G VYK    E G  VA+K + ++     +  + E      
Sbjct: 23  LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKE------ 74
Query: 728 IRHRNLIKIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVGKLN 780
                 I I+  C S   + + G+ FK     IV EY   GSV D +   N  L   ++ 
Sbjct: 75  ------ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 781 IVIEVA-SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
            +++     +EYLH   +   +H D+K  N+LL+ +  A ++DFG+A  L+        +
Sbjct: 129 TILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT--------D 177
Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             +    + GT  ++ PE       +   D++S GI  +EM   + P
Sbjct: 178 XMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 34/225 (15%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 58
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEV 785
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   V
Sbjct: 59  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--V 116
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YL    +  I+H D+KPSN+L++      + DFG++  L              + 
Sbjct: 117 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DEMAN 164
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           E  GT  Y+ PE   G   S+  D++S G+ L+EM   R P   M
Sbjct: 165 EFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V        G   AVKV++   + +K   +S + E + L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+   +  +V E    G + D +       EV    I+ +V S I Y+H +   
Sbjct: 94  F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--- 145
Query: 799 PIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG--- 852
            IVH DLKP N+LL+    D    + DFGL+                +S +MK  IG   
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF------------EASKKMKDKIGTAY 193
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILL 877
           YI PE  + G      DV+S G++L
Sbjct: 194 YIAPEV-LHGTYDEKCDVWSTGVIL 217

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 105
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 166 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 214
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 215 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 220
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 221 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 113
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 174 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 222
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 223 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 42/228 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   RIGKGSFG V+KG        VA+K+++L           E         +  I 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-----------EEAEDEIEDIQQEIT 73
Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L     D+ ++    ++ E+  
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEILK 131
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA-------------GQLTDTQI 175
Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           K     GT  ++ PE           D++S GI  +E+     P  +M
Sbjct: 176 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V        G   AVKV++   + +K   +S + E + L+ + H N++K+  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+   +  +V E    G + D +       EV    I+ +V S I Y+H +   
Sbjct: 118 F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--- 169
Query: 799 PIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG--- 852
            IVH DLKP N+LL+    D    + DFGL+                +S +MK  IG   
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF------------EASKKMKDKIGTAY 217
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILL 877
           YI PE  + G      DV+S G++L
Sbjct: 218 YIAPEV-LHGTYDEKCDVWSTGVIL 241

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANSF 194
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE       S + D+++ G ++ ++
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQL 227

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 156
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 265
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 266 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V        G   AVKV++   + +K   +S + E + L+ + H N++K+  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+   +  +V E    G + D +       EV    I+ +V S I Y+H +   
Sbjct: 117 F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--- 168
Query: 799 PIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG--- 852
            IVH DLKP N+LL+    D    + DFGL+                +S +MK  IG   
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF------------EASKKMKDKIGTAY 216
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILL 877
           YI PE  + G      DV+S G++L
Sbjct: 217 YIAPEV-LHGTYDEKCDVWSTGVIL 240

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 115
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 176 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 224
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 225 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNL 733
             +G+GSFG VY+GN      GE    VAVK +N       +  F+ E   ++     ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGK--------LNIVI 783
           ++++ + S    KG     +V E M +G +  +L     + E   G+        + +  
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  + YL+       VH DL   N ++ HD    + DFG+ R +    +         
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-------- 186
Query: 844 SIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               KG  G     ++ PE    G  + + D++SFG++L E+
Sbjct: 187 ---RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAECEALRNIRHRNL 733
             +G+GSFG VY+GN      GE    VAVK +N       +  F+ E   ++     ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE--VGK--------LNIVI 783
           ++++ + S    KG     +V E M +G +  +L     + E   G+        + +  
Sbjct: 82  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  + YL+       VH DL   N ++ HD    + DFG+ R +    +    +G   
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR--KGGKG 191
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            + ++    ++ PE    G  + + D++SFG++L E+
Sbjct: 192 LLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 47/226 (20%)
Query: 682 IGKGSFGFVYKGNLGEDG--MSVAVKVMN-LDKKGATKSFVAECEALRNI-RHRNLIKII 737
           IG+G+FG V K  + +DG  M  A+K M     K   + F  E E L  +  H N+I ++
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-----HTNDKLEVGK-----------LNI 781
             C   + +G  + AI  EY  +G++ D+L       T+    +             L+ 
Sbjct: 83  GAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +VA  ++YL    Q   +H DL   N+L+  + VA ++DFGL+R            GQ
Sbjct: 138 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQ 182
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-----GDVYSFGILLLEMFT 882
              + +K T+G +   +     L+ +      DV+S+G+LL E+ +
Sbjct: 183 --EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 117
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEV 785
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   V
Sbjct: 118 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--V 175
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YL    +  I+H D+KPSN+L++      + DFG++  L            S + 
Sbjct: 176 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMAN 223
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 224 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +     LN  +++A  
Sbjct: 80  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 133
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFG A+ L       A E +  +   K
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG------AEEKEYHAEGGK 184
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 244
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSRPKFRELII 275

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 19/207 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IG GS+G   K     DG  +  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP- 798
              ID        IV EY + G +   +     + +      V+ V + +      C   
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 799 -----PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                 ++H DLKP+NV LD      + DFGLAR L+H         +  + E  GT  Y
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--------DEDFAKEFVGTPYY 182
Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + PE       +   D++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 47/226 (20%)
Query: 682 IGKGSFGFVYKGNLGEDG--MSVAVKVMN-LDKKGATKSFVAECEALRNI-RHRNLIKII 737
           IG+G+FG V K  + +DG  M  A+K M     K   + F  E E L  +  H N+I ++
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-----HTNDKLEVGK-----------LNI 781
             C   + +G  + AI  EY  +G++ D+L       T+    +             L+ 
Sbjct: 93  GAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +VA  ++YL    Q   +H DL   N+L+  + VA ++DFGL+R            GQ
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQ 192
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-----GDVYSFGILLLEMFT 882
              + +K T+G +   +     L+ +      DV+S+G+LL E+ +
Sbjct: 193 --EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +     LN  +++A  
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFG A+ L       A E +  +   K
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG------AEEKEYHAEGGK 182
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 243 PPICTIDVYMIMRKCWMIDADSRPKFRELII 273

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +     LN  +++A  
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFG A+ L       A E +  +   K
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG------AEEKEYHAEGGK 180
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELII 271

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +  G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 180
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELII 271

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKV--MNLDKKGATKSFVAECE- 723
           A + K T E      +G G FG V+KG    +G S+ + V    ++ K   +SF A  + 
Sbjct: 7   ARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 724 --ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
             A+ ++ H ++++++ +C     +      +V +Y+  GS+ D  H    +  +G    
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLD--HVRQHRGALGPQLL 117
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
           LN  +++A  + YL  H    +VH +L   NVLL       V+DFG+A  L         
Sbjct: 118 LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP------PD 168
Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + Q    E K  I ++  E    G  +   DV+S+G+ + E+ T
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +     LN  +++A  
Sbjct: 78  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFG A+ L       A E +  +   K
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG------AEEKEYHAEGGK 182
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 243 PPICTIDVYMIMRKCWMIDADSRPKFRELII 273

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 63/272 (23%)
Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL-DKKGATKSFVAECEALRNI 728
           S+   +F     +G+G FG V++     D  + A+K + L +++ A +  + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 729 RHRNLIKI-----------------------------ITICSSIDFKGADFKAI------ 753
            H  +++                              ++  S +D      + +      
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 754 ------------VYEYMQYG-----SVDDWLHHT---NDKLEVGKLNIVIEVASVIEYLH 793
                       VY Y+Q       ++ DW++      D+     L+I I++A  +E+LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKG 849
           +     ++H DLKPSN+    D V  V DFGL   +         L      ++     G
Sbjct: 182 SKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVG 238
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
           T  Y+ PE   G + S   D++S G++L E+ 
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +     LN  +++A  
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFG A+ L       A E +  +   K
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG------AEEKEYHAEGGK 182
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELII 273

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKV--MNLDKKGATKSFVAECE- 723
           A + K T E      +G G FG V+KG    +G S+ + V    ++ K   +SF A  + 
Sbjct: 25  ARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 83
Query: 724 --ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
             A+ ++ H ++++++ +C     +      +V +Y+  GS+ D  H    +  +G    
Sbjct: 84  MLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLD--HVRQHRGALGPQLL 135
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
           LN  +++A  + YL  H    +VH +L   NVLL       V+DFG+A  L         
Sbjct: 136 LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP------PD 186
Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + Q    E K  I ++  E    G  +   DV+S+G+ + E+ T
Sbjct: 187 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 107/233 (45%), Gaps = 48/233 (20%)
Query: 682 IGKGSFGFVYKGN---LGEDGMSVAVKVMNLDKKGAT---KSFVAECEALRNI-RHRNLI 734
           +G G+FG V       + + G+S+ V V  L +K  +   ++ ++E + +  +  H N++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--------------EVGKLN 780
            ++  C+     G  +  +++EY  YG + ++L    +K               E   LN
Sbjct: 113 NLLGACT---LSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 781 IV---------IEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR-FL 829
           ++          +VA  +E+L    C    VH DL   NVL+ H  V  + DFGLAR  +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           S   ++V           +  + ++ PE    G  ++  DV+S+GILL E+F+
Sbjct: 224 SDSNYVVRGNA-------RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +  G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 83  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 187
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELII 278

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +  G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  +++A  
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L       A E +  +   K
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEYHAEGGK 187
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELII 278

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-----KSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V   + + AT     K  + E   + ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++    D +     LN  +++A  
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFG A+ L       A E +  +   K
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG------AEEKEYHAEGGK 187
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK 907
             I ++  E  +    +   DV+S+G+ + E+ T   +P D +    ++        LP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 908 KVMGIVDPSLLM------EARGPSKFEECLV 932
             +  +D  ++M      +A    KF E ++
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELII 278

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 682 IGKGSFG----FVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA----ECEALRNIRHRNL 733
           +G+G FG    + Y       G  VAVK +   K+G      +    E E LR + H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL-HHTNDKLEVGKLNIVIEVASVIE-- 790
           +K    C     +G     +V EY+  GS+ D+L  H      VG   +++    + E  
Sbjct: 73  VKYKGCCED---QGEKSVQLVMEYVPLGSLRDYLPRHC-----VGLAQLLLFAQQICEGM 124
Query: 791 -YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEM 847
            YLH       +H  L   NVLLD+D +  + DFGLA+ +   H  + V  +G S     
Sbjct: 125 AYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP---- 177
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              + +  PE           DV+SFG+ L E+ T
Sbjct: 178 ---VFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 682 IGKGSFG----FVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA----ECEALRNIRHRNL 733
           +G+G FG    + Y       G  VAVK +   K+G      +    E E LR + H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL-HHTNDKLEVGKLNIVIEVASVIE-- 790
           +K    C     +G     +V EY+  GS+ D+L  H      VG   +++    + E  
Sbjct: 74  VKYKGCCED---QGEKSVQLVMEYVPLGSLRDYLPRHC-----VGLAQLLLFAQQICEGM 125
Query: 791 -YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL--SHHPFLVAPEGQSSSIEM 847
            YLH       +H  L   NVLLD+D +  + DFGLA+ +   H  + V  +G S     
Sbjct: 126 AYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP---- 178
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              + +  PE           DV+SFG+ L E+ T
Sbjct: 179 ---VFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           ++ S +E+LH   Q  I++ DLKP NVLLD D    +SD GLA  L          GQ+ 
Sbjct: 297 QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTK 345
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +    GT G++ PE  +G +   + D ++ G+ L EM   R P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           IGKG FG V++G     G  VAVK+ +  ++   +S+  E E  + +  RH N++  I  
Sbjct: 12  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 65
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
             + D        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH      
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIVGT 124
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-----G 849
             +P I H DLK  N+L+  +    ++D GLA         V  +  + +I++      G
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHRVG 175
Query: 850 TIGYIGPEYGMGGDLSMT-------GDVYSFGILLLEMFTR 883
           T  Y+ PE  +   ++M         D+Y+ G++  E+  R
Sbjct: 176 TKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           IGKG FG V++G     G  VAVK+ +  ++   +S+  E E  + +  RH N++  I  
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 64
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
             + D        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH      
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIVGT 123
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-----G 849
             +P I H DLK  N+L+  +    ++D GLA         V  +  + +I++      G
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHRVG 174
Query: 850 TIGYIGPEYGMGGDLSMT-------GDVYSFGILLLEMFTR 883
           T  Y+ PE  +   ++M         D+Y+ G++  E+  R
Sbjct: 175 TKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           IGKG FG V++G     G  VAVK+ +  ++   +S+  E E  + +  RH N++  I  
Sbjct: 17  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 70
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
             + D        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH      
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIVGT 129
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-----G 849
             +P I H DLK  N+L+  +    ++D GLA         V  +  + +I++      G
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHRVG 180
Query: 850 TIGYIGPEYGMGGDLSMT-------GDVYSFGILLLEMFTR 883
           T  Y+ PE  +   ++M         D+Y+ G++  E+  R
Sbjct: 181 TKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           IGKG FG V++G     G  VAVK+ +  ++   +S+  E E  + +  RH N++  I  
Sbjct: 14  IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 67
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
             + D        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH      
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIVGT 126
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-----G 849
             +P I H DLK  N+L+  +    ++D GLA         V  +  + +I++      G
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHRVG 177
Query: 850 TIGYIGPEYGMGGDLSMT-------GDVYSFGILLLEMFTR 883
           T  Y+ PE  +   ++M         D+Y+ G++  E+  R
Sbjct: 178 TKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 55
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E     + I V  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            + YL    +  I+H D+KPSN+L++      + DFG++  L            S +   
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMANSF 163
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 55
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E     + I V  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            + YL    +  I+H D+KPSN+L++      + DFG++  L            S +   
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMANSF 163
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           ++ S +E+LH   Q  I++ DLKP NVLLD D    +SD GLA  L          GQ+ 
Sbjct: 297 QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTK 345
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +    GT G++ PE  +G +   + D ++ G+ L EM   R P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           ++ S +E+LH   Q  I++ DLKP NVLLD D    +SD GLA  L          GQ+ 
Sbjct: 297 QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTK 345
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +    GT G++ PE  +G +   + D ++ G+ L EM   R P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           ++ S +E+LH   Q  I++ DLKP NVLLD D    +SD GLA  L          GQ+ 
Sbjct: 297 QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTK 345
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +    GT G++ PE  +G +   + D ++ G+ L EM   R P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 55
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E     + I V  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            + YL    +  I+H D+KPSN+L++      + DFG++  L            S +   
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMANSF 163
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 82
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEV 785
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   V
Sbjct: 83  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--V 140
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YL    +  I+H D+KPSN+L++      + DFG++  L            S + 
Sbjct: 141 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMAN 188
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 26/249 (10%)
Query: 654 ALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG 713
            +L+ ++   V Y E  +     +   R+G+GSFG V++    + G   AVK + L+   
Sbjct: 39  GVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF- 96
Query: 714 ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK 773
             +  VA C  L + R      I+ +  ++  +   +  I  E ++ GS+   +      
Sbjct: 97  RVEELVA-CAGLSSPR------IVPLYGAV--REGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 774 LEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHH 832
            E   L  + +    +EYLH      I+HGD+K  NVLL  D   A + DFG       H
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG-------H 197
Query: 833 PFLVAPEGQSSSI----EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
              + P+G   S+     + GT  ++ PE  MG       D++S   ++L M     P  
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
Query: 889 NMFNDGLTL 897
             F   L L
Sbjct: 258 QYFRGPLCL 266

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 40/227 (17%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+  +RIGKGSFG VYKG        VA+K+++L++       + +            I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE-----------IT 69
Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           +++ C S     + G+  K+    I+ EY+  GS  D L       E     I+ E+   
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKG 128
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++K
Sbjct: 129 LDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA-------------GQLTDTQIK 172
Query: 849 -----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
                GT  ++ PE           D++S GI  +E+     P  ++
Sbjct: 173 RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           EF     +GKG+FG V        G   A+K++  +    K      + E   L+N RH 
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 209 FLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           +YLH+  +  +V+ DLK  N++LD D    ++DFGL +           EG      MK 
Sbjct: 262 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKT 308
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 105/250 (42%), Gaps = 26/250 (10%)
Query: 653 SALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
             +L+ ++   V Y E  +     +   R+G+GSFG V++    + G   AVK + L+  
Sbjct: 54  EGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF 112
Query: 713 GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
              +  VA C  L + R      I+ +  ++  +   +  I  E ++ GS+   +     
Sbjct: 113 -RVEELVA-CAGLSSPR------IVPLYGAV--REGPWVNIFMELLEGGSLGQLIKQMGC 162
Query: 773 KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSH 831
             E   L  + +    +EYLH      I+HGD+K  NVLL  D   A + DFG       
Sbjct: 163 LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG------- 212
Query: 832 HPFLVAPEGQSSSI----EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT 887
           H   + P+G   S+     + GT  ++ PE  MG       D++S   ++L M     P 
Sbjct: 213 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 272
Query: 888 DNMFNDGLTL 897
              F   L L
Sbjct: 273 TQYFRGPLCL 282

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 661 FPIVSYA--ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKG 713
           FP   Y   E   + ++ +    +G+GSFG VY+GN      GE    VAVK +N     
Sbjct: 3   FPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 62
Query: 714 ATK-SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
             +  F+ E   ++     ++++++ + S    KG     +V E M +G +  +L     
Sbjct: 63  RERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRP 117
Query: 773 KLE--VGK--------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
           + E   G+        + +  E+A  + YL+       VH +L   N ++ HD    + D
Sbjct: 118 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGD 174
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILL 877
           FG+ R +    +             KG  G     ++ PE    G  + + D++SFG++L
Sbjct: 175 FGMTRDIYETDYY-----------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 223
Query: 878 LEM 880
            E+
Sbjct: 224 WEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 661 FPIVSYA--ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKG 713
           FP   Y   E   + ++ +    +G+GSFG VY+GN      GE    VAVK +N     
Sbjct: 2   FPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 714 ATK-SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
             +  F+ E   ++     ++++++ + S    KG     +V E M +G +  +L     
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRP 116
Query: 773 KLE--VGK--------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
           + E   G+        + +  E+A  + YL+       VH +L   N ++ HD    + D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGD 173
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILL 877
           FG+ R +    +             KG  G     ++ PE    G  + + D++SFG++L
Sbjct: 174 FGMTRDIYETDYY-----------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222
Query: 878 LEM 880
            E+
Sbjct: 223 WEI 225

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 95  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 147
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 148 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 197
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 93  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 145
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANSF 195
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 194
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           EF     +GKG+FG V        G   A+K++  +    K      + E   L+N RH 
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 212 FLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 264
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           +YLH+  +  +V+ DLK  N++LD D    ++DFGL +           EG      MK 
Sbjct: 265 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKT 311
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 360

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 192
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 194
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 93  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 145
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 195
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 14/209 (6%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G    V+      D   VAVKV+  D       ++      +N    N   I+ +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 742 S--IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
           +   +        IV EY+   ++ D +H          + ++ +    + + H   Q  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNG 136
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGPE 857
           I+H D+KP+N+L+       V DFG+AR        +A  G S   +  + GT  Y+ PE
Sbjct: 137 IIHRDVKPANILISATNAVKVVDFGIAR-------AIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              G  +    DVYS G +L E+ T   P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLIK 735
           IG+G+FG V++         E    VAVK++  +     ++ F  E   +    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLH----HTNDKLE---------------- 775
           ++ +C+           +++EYM YG ++++L     HT   L                 
Sbjct: 115 LLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 776 ----VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                 +L I  +VA+ + YL        VH DL   N L+  +MV  ++DFGL+R +  
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             +  A +G  +       I ++ PE       +   DV+++G++L E+F+
Sbjct: 227 ADYYKA-DGNDAI-----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 74
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEV 785
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   V
Sbjct: 75  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--V 132
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YL    +  I+H D+KPSN+L++      + DFG++  L            S + 
Sbjct: 133 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMAN 180
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 181 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 55
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEV 785
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   V
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--V 113
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YL    +  I+H D+KPSN+L++      + DFG++  L            S + 
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMAN 161
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V+K +    G+ +A K+++L+ K           A+RN   R L 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----------PAIRNQIIREL- 55
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEV 785
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   V
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--V 113
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YL    +  I+H D+KPSN+L++      + DFG++  L            S + 
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMAN 161
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 192
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 89  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 141
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANSF 191
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 224

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 194
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 105/250 (42%), Gaps = 26/250 (10%)
Query: 653 SALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
             +L+ ++   V Y E  +     +   R+G+GSFG V++    + G   AVK + L+  
Sbjct: 52  EGVLLTEKLKPVDY-EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF 110
Query: 713 GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
              +  VA C  L + R      I+ +  ++  +   +  I  E ++ GS+   +     
Sbjct: 111 -RVEELVA-CAGLSSPR------IVPLYGAV--REGPWVNIFMELLEGGSLGQLIKQMGC 160
Query: 773 KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSH 831
             E   L  + +    +EYLH      I+HGD+K  NVLL  D   A + DFG       
Sbjct: 161 LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG------- 210
Query: 832 HPFLVAPEGQSSSI----EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT 887
           H   + P+G   S+     + GT  ++ PE  MG       D++S   ++L M     P 
Sbjct: 211 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 270
Query: 888 DNMFNDGLTL 897
              F   L L
Sbjct: 271 TQYFRGPLCL 280

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     M+VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 181
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           EF     +GKG+FG V        G   A+K++  +    K      + E   L+N RH 
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 69  FLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 121
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           +YLH+  +  +V+ DLK  N++LD D    ++DFGL +           EG      MK 
Sbjct: 122 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKX 168
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 217

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 89  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 141
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 191
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 224

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 47/226 (20%)
Query: 682 IGKGSFGFVYKGNLGEDG--MSVAVKVMN-LDKKGATKSFVAECEALRNI-RHRNLIKII 737
           IG+G+FG V K  + +DG  M  A+K M     K   + F  E E L  +  H N+I ++
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLH-----HTNDKLEVGK-----------LNI 781
             C   + +G  + AI  EY  +G++ D+L       T+    +             L+ 
Sbjct: 90  GAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             +VA  ++YL    Q   +H +L   N+L+  + VA ++DFGL+R            GQ
Sbjct: 145 AADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR------------GQ 189
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-----GDVYSFGILLLEMFT 882
              + +K T+G +   +     L+ +      DV+S+G+LL E+ +
Sbjct: 190 --EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 731 RNLIKIITICSSIDFKGADFKAIVY---EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
              +K+   C   D K       +Y    Y + G +  ++       E        E+ S
Sbjct: 97  PFFVKLY-FCFQDDEK-------LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 148
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIE 846
            +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +  
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANX 198
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
             GT  Y+ PE         + D+++ G ++ ++
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 232

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRN 727
           K  ++F     +G+GSF  V            A+K++   ++ K+        E + +  
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEV 785
           + H   +K+        F   D + + +   Y + G +  ++       E        E+
Sbjct: 64  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSS 844
            S +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +
Sbjct: 117 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARA 166
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               GT  Y+ PE         + D+++ G ++ ++
Sbjct: 167 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 202

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRN 727
           K  ++F     +G+GSF  V            A+K++   ++ K+        E + +  
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEV 785
           + H   +K+        F   D + + +   Y + G +  ++       E        E+
Sbjct: 66  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSS 844
            S +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +
Sbjct: 119 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARA 168
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               GT  Y+ PE         + D+++ G ++ ++
Sbjct: 169 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 204

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRN 727
           K  ++F     +G+GSF  V            A+K++   ++ K+        E + +  
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEV 785
           + H   +K+        F   D + + +   Y + G +  ++       E        E+
Sbjct: 67  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSS 844
            S +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +
Sbjct: 120 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARA 169
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               GT  Y+ PE         + D+++ G ++ ++
Sbjct: 170 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRN 727
           K  ++F     +G+GSF  V            A+K++   ++ K+        E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEV 785
           + H   +K+        F   D + + +   Y + G +  ++       E        E+
Sbjct: 65  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSS 844
            S +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +
Sbjct: 118 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARA 167
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               GT  Y+ PE         + D+++ G ++ ++
Sbjct: 168 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 203

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           EF     +GKG+FG V        G   A+K++  +    K      + E   L+N RH 
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 71  FLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 123
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           +YLH+  +  +V+ DLK  N++LD D    ++DFGL +           EG      MK 
Sbjct: 124 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKX 170
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 219

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 194
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQL 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF  V            A+K++   ++ K+        E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 194
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--ECEALRNI 728
           ++ +++    +IG+GSFG        EDG    +K +N+ +  + +   +  E   L N+
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVA 786
           +H N   I+    S +  G+ +  IV +Y + G +   ++     L  E   L+  +++ 
Sbjct: 81  KHPN---IVQYRESFEENGSLY--IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             ++++H+     I+H D+K  N+ L  D    + DFG+AR L            +S++E
Sbjct: 136 LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL------------NSTVE 180
Query: 847 MK----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +     GT  Y+ PE       +   D+++ G +L E+ T
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHR 731
           EF     +GKG+FG V        G   A+K++  +    K      + E   L+N RH 
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVI 789
            L  +        F+  D    V EY   G +  + H + +++  E        E+ S +
Sbjct: 70  FLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 122
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           +YLH+  +  +V+ DLK  N++LD D    ++DFGL +           EG      MK 
Sbjct: 123 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKX 169
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
             GT  Y+ PE     D     D +  G+++ EM   R P  N  ++ L
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 218

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V        G   AVKV++   + +K   +S + E + L+ + H N+ K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+   +  +V E    G + D +       EV    I+ +V S I Y H +   
Sbjct: 94  F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN--- 145
Query: 799 PIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            IVH DLKP N+LL+    D    + DFGL+            E      +  GT  YI 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---------EASKKXKDKIGTAYYIA 196
Query: 856 PEYGMGGDLSMTGDVYSFGILL 877
           PE  + G      DV+S G++L
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 19/207 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IG GS+G   K     DG  +  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP- 798
              ID        IV EY + G +   +     + +      V+ V + +      C   
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 799 -----PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                 ++H DLKP+NV LD      + DFGLAR L+H          S +    GT  Y
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--------DTSFAKTFVGTPYY 182
Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + PE       +   D++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 19/207 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IG GS+G   K     DG  +  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP- 798
              ID        IV EY + G +   +     + +      V+ V + +      C   
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 799 -----PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                 ++H DLKP+NV LD      + DFGLAR L+H          S +    GT  Y
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--------DTSFAKAFVGTPYY 182
Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + PE       +   D++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F   + +G G+ G V K      G+ +A K+++L+ K           A+RN   R L 
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIK----------PAIRNQIIREL- 65
Query: 735 KIITICSS---IDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLE--VGKLNIVIEV 785
           +++  C+S   + F GA +     +I  E+M  GS+D  L       E  +GK++I   V
Sbjct: 66  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--V 123
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + YL    Q  I+H D+KPSN+L++      + DFG++  L            S + 
Sbjct: 124 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMAN 171
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  Y+ PE   G   S+  D++S G+ L+E+   R P
Sbjct: 172 SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 14/209 (6%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G    V+      D   VAVKV+  D       ++      +N    N   I+ +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 742 S--IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
           +   +        IV EY+   ++ D +H          + ++ +    + + H   Q  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNG 136
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGPE 857
           I+H D+KP+N+++       V DFG+AR        +A  G S   +  + GT  Y+ PE
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIAR-------AIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              G  +    DVYS G +L E+ T   P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 14/209 (6%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G    V+      D   VAVKV+  D       ++      +N    N   I+ +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 742 S--IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
           +   +        IV EY+   ++ D +H          + ++ +    + + H   Q  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNG 136
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGPE 857
           I+H D+KP+N+++       V DFG+AR        +A  G S   +  + GT  Y+ PE
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIAR-------AIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              G  +    DVYS G +L E+ T   P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV EY+   ++ D +H          + ++ +    + + H   Q  I+H D+KP+N+++
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMI 149
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGPEYGMGGDLSMTGDV 870
                  V DFG+AR        +A  G S   +  + GT  Y+ PE   G  +    DV
Sbjct: 150 SATNAVKVMDFGIAR-------AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 871 YSFGILLLEMFTRRRP 886
           YS G +L E+ T   P
Sbjct: 203 YSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV EY+   ++ D +H          + ++ +    + + H   Q  I+H D+KP+N+++
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMI 166
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGPEYGMGGDLSMTGDV 870
                  V DFG+AR        +A  G S   +  + GT  Y+ PE   G  +    DV
Sbjct: 167 SATNAVKVMDFGIAR-------AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 219
Query: 871 YSFGILLLEMFTRRRP 886
           YS G +L E+ T   P
Sbjct: 220 YSLGCVLYEVLTGEPP 235

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV EY+   ++ D +H          + ++ +    + + H   Q  I+H D+KP+N+++
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMI 149
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQS--SSIEMKGTIGYIGPEYGMGGDLSMTGDV 870
                  V DFG+AR        +A  G S   +  + GT  Y+ PE   G  +    DV
Sbjct: 150 SATNAVKVMDFGIAR-------AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 871 YSFGILLLEMFTRRRP 886
           YS G +L E+ T   P
Sbjct: 203 YSLGCVLYEVLTGEPP 218

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 24/231 (10%)
Query: 665 SYAELSK---ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSF 718
           + AE+ K      +F     +GKG FG VY     ++   +A+KV+    L+K+G     
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 62
Query: 719 VAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK 778
             E E   ++RH N++++        F       ++ E+   G +   L       E   
Sbjct: 63  RREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 117
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
              + E+A  + Y H   +  ++H D+KP N+L+ +     ++DFG +    H P L   
Sbjct: 118 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSL--- 168
Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                   M GT+ Y+ PE   G       D++  G+L  E      P D+
Sbjct: 169 ----RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QS 842
           E+ S +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+
Sbjct: 122 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQA 171
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            +    GT  Y+ PE         + D+++ G ++ ++
Sbjct: 172 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 209

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QS 842
           E+ S +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQA 187
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            +    GT  Y+ PE         + D+++ G ++ ++
Sbjct: 188 RANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     M+VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK- 130
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+       + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 131 --RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 181
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           +GKG +G V++G+    G +VAVK+ +   +   KS+  E E    +  RH N++  I  
Sbjct: 45  VGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 99
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
             +          I + Y + GS+ D+L  T     V  L IV+ +AS + +LH      
Sbjct: 100 DMTSRHSSTQLWLITH-YHEMGSLYDYLQLTTLD-TVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
             +P I H DLK  N+L+  +    ++D GLA   S     +   G +  +   GT  Y+
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL-DVGNNPRV---GTKRYM 213
Query: 855 GPEYGMGG------DLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
            PE           D     D+++FG++L E+  RR  ++ +  D
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV-ARRMVSNGIVED 257

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAVK+++  +    + +    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKF 133
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKGTIGYIG 855
           IVH DLK  N+LLD DM   ++DFG +   +       F  AP    ++ E+     Y G
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAP--PYAAPELFQGKKYDG 191
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           PE           DV+S G++L  + +   P D
Sbjct: 192 PEV----------DVWSLGVILYTLVSGSLPFD 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VA+K+++  +   T  +    E   ++ + H N++K+  +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          ++ EY   G V D+L       E    +   ++ S ++Y H   Q  
Sbjct: 83  IET-----EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKR 134
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKGTIGYIG 855
           IVH DLK  N+LLD DM   ++DFG +   +       F  AP    ++ E+     Y G
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP--PYAAPELFQGKKYDG 192
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           PE           DV+S G++L  + +   P D
Sbjct: 193 PEV----------DVWSLGVILYTLVSGSLPFD 215

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHR 731
           +++    +IG+G++G V+K    E    VA+K + LD   +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 732 NLIKIITICSSIDFKGADFK-AIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASV 788
           N++++  +  S      D K  +V+E+     +  +    N  L  E+ K + + ++   
Sbjct: 62  NIVRLHDVLHS------DKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVK-SFLFQLLKG 113
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + + H+     ++H DLKP N+L++ +    ++DFGLAR      F +     S+ +   
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLAR-----AFGIPVRCYSAEV--- 162
Query: 849 GTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRRRP 886
            T+ Y  P+   G  L  T  D++S G +  E+    RP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK------------L 779
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K            +
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
               +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V   
Sbjct: 148 XYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYV--- 201
Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                 + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 202 ---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG+GS G V        G  VAVK+M+L K+   +    E   +R+ +H N++++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-- 109
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE-VASVIEYLHNHCQPP 799
               +   +   ++ E++Q G++ D +     +L   ++  V E V   + YLH      
Sbjct: 110 ---SYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ---G 161
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           ++H D+K  ++LL  D    +SDFG    +S       P+ +     + GT  ++ PE  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----VPKRKX----LVGTPYWMAPEVI 213
Query: 860 MGGDLSMTGDVYSFGILLLEMFTRRRP 886
                +   D++S GI+++EM     P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +   K    +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVR 77
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSXICSR-- 186
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     ++VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 106 GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 158
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 159 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 209
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 210 ESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 24/231 (10%)
Query: 665 SYAELSK---ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSF 718
           + AE+ K      +F     +GKG FG VY     ++   +A+KV+    L+K+G     
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 719 VAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK 778
             E E   ++RH N++++        F       ++ E+   G +   L       E   
Sbjct: 62  RREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
              + E+A  + Y H   +  ++H D+KP N+L+ +     ++DFG +    H P L   
Sbjct: 117 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSL--- 167
Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                   M GT+ Y+ PE   G       D++  G+L  E      P D+
Sbjct: 168 ----RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           ++F     +GKGSFG V+     +     A+K +  D          EC  +        
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--VECTMVEK------ 69
Query: 734 IKIITICSSIDFKGADF-----KAIVYEYMQYGSVDDWLHHTND--KLEVGKLNI-VIEV 785
            +++++     F    F     K  ++  M+Y +  D ++H     K ++ +      E+
Sbjct: 70  -RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              +++LH+     IV+ DLK  N+LLD D    ++DFG+ +            G + + 
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--------ENMLGDAKTN 177
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E  GT  YI PE  +G   + + D +SFG+LL EM   + P
Sbjct: 178 EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     ++VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 181
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRH 730
           ++F     +G+GSF               A+K++   ++ K+        E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 731 RNLIKIITICSSIDFKGADFKAIVY--EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
              +K+        F   D + + +   Y + G +  ++       E        E+ S 
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEM 847
           +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS       PE  Q+ +   
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-------PESKQARANXF 192
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  Y+ PE         + D+++ G ++ ++
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     M+VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 561
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           +GKG +G V++G+    G +VAVK+ +   +   KS+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
             +          I + Y + GS+ D+L  T     V  L IV+ +AS + +LH      
Sbjct: 71  DMTSRHSSTQLWLITH-YHEMGSLYDYLQLTTLD-TVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
             +P I H DLK  N+L+  +    ++D GLA   S     +   G +  +   GT  Y+
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV-GNNPRV---GTKRYM 184
Query: 855 GPEYGMGG------DLSMTGDVYSFGILLLEMFTR 883
            PE           D     D+++FG++L E+  R
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VA+K+++  +   T  +    E   ++ + H N++K+  +
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          ++ EY   G V D+L       E    +   ++ S ++Y H   Q  
Sbjct: 80  IET-----EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKR 131
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           IVH DLK  N+LLD DM   ++DFG +     + F V  +  +      G+  Y  PE  
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFS-----NEFTVGGKLDTFC----GSPPYAAPELF 182
Query: 860 MGGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
            G        DV+S G++L  + +   P D
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     ++VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 80  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 132
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 133 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 183
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           +GKG +G V++G+    G +VAVK+ +   +   KS+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-----N 794
             +          I + Y + GS+ D+L  T     V  L IV+ +AS + +LH      
Sbjct: 71  DMTSRHSSTQLWLITH-YHEMGSLYDYLQLTTLD-TVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
             +P I H DLK  N+L+  +    ++D GLA   S     +   G +  +   GT  Y+
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV-GNNPRV---GTKRYM 184
Query: 855 GPEYGMGG------DLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
            PE           D     D+++FG++L E+  RR  ++ +  D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV-ARRMVSNGIVED 228

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK------------L 779
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K            +
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
               +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V   
Sbjct: 148 CYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--- 201
Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                 + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 202 ---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     ++VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 81  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 133
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 134 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 184
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 67/245 (27%), Positives = 105/245 (42%), Gaps = 39/245 (15%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLIKII 737
           IG+GSF  VYKG   E   +V V    L  +  TKS    F  E E L+ ++H N+++  
Sbjct: 34  IGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI----EVASVIEYLH 793
               S   KG     +V E    G++  +L     + +V K+ ++     ++   +++LH
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYLK----RFKVXKIKVLRSWCRQILKGLQFLH 146
Query: 794 NHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               PPI+H DLK  N+ +        + D GLA            +  S +  + GT  
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----------KRASFAKAVIGTPE 195
Query: 853 YIGPE-YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN---------DGLTLHGYAK 902
           +  PE Y    D S+  DVY+FG   LE  T   P     N          G+    + K
Sbjct: 196 FXAPEXYEEKYDESV--DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253
Query: 903 MALPK 907
           +A+P+
Sbjct: 254 VAIPE 258

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     M+VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK- 130
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++       A +G       K  I ++ P
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG-------KLPIKWMAP 181
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 32/251 (12%)
Query: 655 LLMEQQFPIVSYA---ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK 711
           +L+ ++   V Y    E+  AT +     R+G+GSFG V++    + G   AVK + L+ 
Sbjct: 75  VLLTEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV 130
Query: 712 KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN 771
             A +  +  C  L + R      I+ +  ++  +   +  I  E ++ GS+   +    
Sbjct: 131 FRAEE--LMACAGLTSPR------IVPLYGAV--REGPWVNIFMELLEGGSLGQLVKEQG 180
Query: 772 DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-AHVSDFGLARFLS 830
              E   L  + +    +EYLH+     I+HGD+K  NVLL  D   A + DFG      
Sbjct: 181 CLPEDRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFG------ 231
Query: 831 HHPFLVAPEGQSSSI----EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            H   + P+G   S+     + GT  ++ PE  +G       DV+S   ++L M     P
Sbjct: 232 -HAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290
Query: 887 TDNMFNDGLTL 897
               F   L L
Sbjct: 291 WTQFFRGPLCL 301

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 40/225 (17%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 93
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK------------- 778
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K             
Sbjct: 94  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 779 -LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
            +    +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V 
Sbjct: 150 LIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV- 205
Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                   + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 206 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     ++VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 75  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 127
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 178
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     ++VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 83  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 186
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 40/258 (15%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNR--------IGKGSFGFVYKGNLG----- 696
           KL ++ +M    P  S+A  + +  +     R        +G G+FG VY+G +      
Sbjct: 5   KLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 64
Query: 697 EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY 755
              + VAVK +  +  +     F+ E   +    H+N+++    C  +  +    + I+ 
Sbjct: 65  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR----CIGVSLQSLP-RFILL 119
Query: 756 EYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASVIEYLH-NHCQPPIVHGDLKP 807
           E M  G +  +L  T  +         +  L++  ++A   +YL  NH     +H D+  
Sbjct: 120 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAA 175
Query: 808 SNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL 864
            N LL       VA + DFG+AR +    +    +G  + + +K    ++ PE  M G  
Sbjct: 176 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAMLPVK----WMPPEAFMEGIF 229
Query: 865 SMTGDVYSFGILLLEMFT 882
           +   D +SFG+LL E+F+
Sbjct: 230 TSKTDTWSFGVLLWEIFS 247

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKK-GATKSFVAECEALRNIR 729
           E      +G G+FG VYKG    DG    + VA+KV+  +    A K  + E   +  + 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASV 788
              + +++ IC +   +      +V + M YG + D +     +L     LN  +++A  
Sbjct: 78  SPYVSRLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKG 131
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLAR L         E +  +   K
Sbjct: 132 MSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD------IDETEYHADGGK 182
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             I ++  E  +    +   DV+S+G+ + E+ T
Sbjct: 183 VPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +   K    +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVR 77
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 186
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 41/226 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 92
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK------------- 778
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K             
Sbjct: 93  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             +    +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 206 ------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +   K    +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVR 77
Query: 736 I-ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI---VIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K  +  + +   + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+       LV  E   S I  +  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGEPNVSYICSR-- 186
Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
             Y  PE   G  D + + DV+S G +L E+ 
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K+            
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 205 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 683 GKGSFGFVYKGNLGEDGMSVAVKVMNL-DKKGATKSFVAECEALRNIRHRNLIKIITICS 741
            +G FG V+K  L  +   VAVK+  + DK+     +  E  +L  ++H N+++ I    
Sbjct: 33  ARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEK 88
Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV----IEYLHNHC- 796
                  D   ++  + + GS+ D+L     K  V   N +  +A      + YLH    
Sbjct: 89  RGTSVDVDL-WLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIP 142
Query: 797 ------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
                 +P I H D+K  NVLL +++ A ++DFGLA         +  E   S+ +  G 
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA---------LKFEAGKSAGDTHGQ 193
Query: 851 IG---YIGPEYGMGG-----DLSMTGDVYSFGILLLEMFTRRRPTD 888
           +G   Y+ PE   G      D  +  D+Y+ G++L E+ +R    D
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   +IGKGSFG V+KG        VA+K+++L++       +           +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L     D+ ++    I+ E+  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILK 115
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 116 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA-------------GQLTDTQI 159
Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           K     GT  ++ PE           D++S GI  +E+
Sbjct: 160 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 197

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K+            
Sbjct: 83  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 196 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAVK+++  +   T  +    E   ++ + H N++K+  +
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 83  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKY 134
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           IVH DLK  N+LLD DM   ++DFG +     + F V  +  +      G+  Y  PE  
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFS-----NEFTVGNKLDTFC----GSPPYAAPELF 185
Query: 860 MGGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
            G        DV+S G++L  + +   P D
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   +IGKGSFG V+KG        VA+K+++L++       +           +  I 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 72
Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L     D+ ++    I+ E+  
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILK 130
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 131 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA-------------GQLTDTQI 174
Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           K     GT  ++ PE           D++S GI  +E+
Sbjct: 175 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 94/235 (40%), Gaps = 30/235 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFV-AECEALRNIRHRNLI 734
           F   + +G+G+   VY+          A+KV+   KK   K  V  E   L  + H N+I
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL---KKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
           K+  I     F+     ++V E +  G + D +       E    + V ++   + YLH 
Sbjct: 112 KLKEI-----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 795 HCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +    IVH DLKP N+L      D    ++DFGL++ + H   +           + GT 
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---------VCGTP 214
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILL------LEMFTRRRPTDNMFNDGLTLHGY 900
           GY  PE   G       D++S GI+        E F   R    MF   L    Y
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY 269

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   +IGKGSFG V+KG        VA+K+++L++       +           +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L     D+ ++    I+ E+  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILK 115
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 116 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA-------------GQLTDTQI 159
Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           K     GT  ++ PE           D++S GI  +E+
Sbjct: 160 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 197

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 149 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 204 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 259
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 260 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 40/258 (15%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNR--------IGKGSFGFVYKGNLG----- 696
           KL ++ +M    P  S+A  + +  +     R        +G G+FG VY+G +      
Sbjct: 25  KLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 84
Query: 697 EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY 755
              + VAVK +  +  +     F+ E   +    H+N+++    C  +  +    + I+ 
Sbjct: 85  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR----CIGVSLQSLP-RFILL 139
Query: 756 EYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASVIEYLH-NHCQPPIVHGDLKP 807
           E M  G +  +L  T  +         +  L++  ++A   +YL  NH     +H D+  
Sbjct: 140 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAA 195
Query: 808 SNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL 864
            N LL       VA + DFG+AR +    +    +G  + + +K    ++ PE  M G  
Sbjct: 196 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAMLPVK----WMPPEAFMEGIF 249
Query: 865 SMTGDVYSFGILLLEMFT 882
           +   D +SFG+LL E+F+
Sbjct: 250 TSKTDTWSFGVLLWEIFS 267

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 42/224 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           F+   +IGKGSFG V+KG        VA+K+++L           E         +  I 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----------EEAEDEIEDIQQEIT 77
Query: 736 IITICSS---IDFKGADFKA----IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVAS 787
           +++ C S     + G+  K     I+ EY+  GS  D L     D+ ++    I+ E+  
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILK 135
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++YLH+  +   +H D+K +NVLL       ++DFG+A             GQ +  ++
Sbjct: 136 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA-------------GQLTDTQI 179
Query: 848 K-----GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           K     GT  ++ PE           D++S GI  +E+     P
Sbjct: 180 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +FS    IG+G FG VY     + G   A+K   LDKK      + + E L  +  R ++
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIK---MKQGETL-ALNERIML 242
Query: 735 KIIT-------ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
            +++       +C S  F   D  + + + M  G   D  +H +      + ++    A 
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAE 299
Query: 788 VI---EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQSS 843
           +I   E++HN     +V+ DLKP+N+LLD      +SD GLA  F    P         +
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HA 348
Query: 844 SIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEM------FTRRRPTDNMFNDGLT 896
           S+   GT GY+ PE    G     + D +S G +L ++      F + +  D    D +T
Sbjct: 349 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 405
Query: 897 L 897
           L
Sbjct: 406 L 406

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 682 IGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKII 737
           IG+G FG V++G   +     M+VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI-VIEVASVIEYLHNHC 796
            + +       +   I+ E    G +  +L      L++  L +   ++++ + YL +  
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+       + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 511 --RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 561
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMF 881
           E       +   DV+ FG+ + E+ 
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 128
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K+            
Sbjct: 129 NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 184
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 185 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 242 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +FS    IG+G FG VY     + G   A+K   LDKK      + + E L  +  R ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIK---MKQGETL-ALNERIML 243
Query: 735 KIIT-------ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
            +++       +C S  F   D  + + + M  G   D  +H +      + ++    A 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAE 300
Query: 788 VI---EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQSS 843
           +I   E++HN     +V+ DLKP+N+LLD      +SD GLA  F    P         +
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HA 349
Query: 844 SIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEM------FTRRRPTDNMFNDGLT 896
           S+   GT GY+ PE    G     + D +S G +L ++      F + +  D    D +T
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 897 L 897
           L
Sbjct: 407 L 407

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 680 NRI-GKGSFGFVYKG---NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLI 734
           NRI G+G FG VY+G   N   + ++VAVK    D     K  F++E   ++N+ H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASVIEYLH 793
           K+I I         +   I+ E   YG +  +L    + L+V  L +  +++   + YL 
Sbjct: 89  KLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 794 N-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           + +C    VH D+   N+L+       + DFGL+R++    +  A      S+  +  I 
Sbjct: 143 SINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA------SV-TRLPIK 191
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           ++ PE       +   DV+ F + + E+ +
Sbjct: 192 WMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +FS    IG+G FG VY     + G   A+K   LDKK      + + E L  +  R ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIK---MKQGETL-ALNERIML 243
Query: 735 KIIT-------ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
            +++       +C S  F   D  + + + M  G   D  +H +      + ++    A 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAE 300
Query: 788 VI---EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQSS 843
           +I   E++HN     +V+ DLKP+N+LLD      +SD GLA  F    P         +
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HA 349
Query: 844 SIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEM------FTRRRPTDNMFNDGLT 896
           S+   GT GY+ PE    G     + D +S G +L ++      F + +  D    D +T
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 897 L 897
           L
Sbjct: 407 L 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +FS    IG+G FG VY     + G   A+K   LDKK      + + E L  +  R ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIK---MKQGETL-ALNERIML 243
Query: 735 KIIT-------ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
            +++       +C S  F   D  + + + M  G   D  +H +      + ++    A 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAE 300
Query: 788 VI---EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLSHHPFLVAPEGQSS 843
           +I   E++HN     +V+ DLKP+N+LLD      +SD GLA  F    P         +
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HA 349
Query: 844 SIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEM------FTRRRPTDNMFNDGLT 896
           S+   GT GY+ PE    G     + D +S G +L ++      F + +  D    D +T
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 897 L 897
           L
Sbjct: 407 L 407

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRHR 731
           +F     +GKG FG VY     +    VA+KV+    ++K+G       E E   ++ H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           N++++        F       ++ EY   G +   L  +    E     I+ E+A  + Y
Sbjct: 84  NILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
            H      ++H D+KP N+LL       ++DFG +        + AP  +  +  M GT+
Sbjct: 139 CHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--------VHAPSLRRKT--MCGTL 185
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            Y+ PE   G   +   D++  G+L  E+  
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLV 216

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAVK+++  +    + +    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKF 133
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKGTIGYIG 855
           IVH DLK  N+LLD DM   ++DFG +   +       F  +P    ++ E+     Y G
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP--PYAAPELFQGKKYDG 191
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           PE           DV+S G++L  + +   P D
Sbjct: 192 PEV----------DVWSLGVILYTLVSGSLPFD 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K+            
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 205 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+     G     IV E+ ++G++  +L    ++    K+            
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 205 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAVK+++  +    + +    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKF 133
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKGTIGYIG 855
           IVH DLK  N+LLD DM   ++DFG +   +       F  +P    ++ E+     Y G
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP--PYAAPELFQGKKYDG 191
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           PE           DV+S G++L  + +   P D
Sbjct: 192 PEV----------DVWSLGVILYTLVSGSLPFD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAV++++  +    + +    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKF 133
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           IVH DLK  N+LLD DM   ++DFG +   +    L          E  G+  Y  PE  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---------DEFCGSPPYAAPELF 184
Query: 860 MGGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
            G        DV+S G++L  + +   P D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+    K      ++ E+ ++G++  +L    ++    K+            
Sbjct: 83  NVVNLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 196 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++     
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI---- 210
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             +    +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 211 --DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLI 734
           F    ++G G+FG V+       G+   +K +N D+     +   AE E L+++ H N+I
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---LEVGKL-NIVIEVASVIE 790
           KI  +     F+      IV E  + G + + +     +   L  G +  ++ ++ + + 
Sbjct: 84  KIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLARFLSHHPFLVAPEGQSSSIE 846
           Y H+     +VH DLKP N+L   D   H    + DFGLA            +    S  
Sbjct: 139 YFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELF---------KSDEHSTN 185
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             GT  Y+ PE     D++   D++S G+++  + T
Sbjct: 186 AAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLT 220

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNR--------IGKGSFGFVYKGNLG----- 696
           KL ++ +M    P   +A  + +  +     R        +G G+FG VY+G +      
Sbjct: 15  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 74
Query: 697 EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY 755
              + VAVK +  +  +     F+ E   +    H+N+++    C  +  +    + I+ 
Sbjct: 75  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR----CIGVSLQSLP-RFILL 129
Query: 756 EYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASVIEYLH-NHCQPPIVHGDLKP 807
           E M  G +  +L  T  +         +  L++  ++A   +YL  NH     +H D+  
Sbjct: 130 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAA 185
Query: 808 SNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL 864
            N LL       VA + DFG+AR +    +    +G  + + +K    ++ PE  M G  
Sbjct: 186 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAMLPVK----WMPPEAFMEGIF 239
Query: 865 SMTGDVYSFGILLLEMFT 882
           +   D +SFG+LL E+F+
Sbjct: 240 TSKTDTWSFGVLLWEIFS 257

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 154 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 207
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 208 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHR 731
           +++    +IG+GS+G V+K    + G  VA+K  + + D     K  + E   L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-----LNIVIEVA 786
           NL+ ++ +     F+      +V+EY      D  + H  D+ + G       +I  +  
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTL 112
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
             + + H H     +H D+KP N+L+    V  + DFG AR L+
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 168 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 221
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 222 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+    K      ++ E+ ++G++  +L    ++    K+            
Sbjct: 83  NVVNLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 196 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGMS----VAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D  +    VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------- 780
           N++ ++  C+    K      ++ E+ ++G++  +L    ++    K+            
Sbjct: 83  NVVNLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                   +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V         + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 196 V------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 26/248 (10%)
Query: 655 LLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           +L+ ++   V Y E  +     +   R+G+GSFG V++    + G   AVK + L+   A
Sbjct: 56  VLLTEKLKPVDY-EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA 114
Query: 715 TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL 774
            +  +  C  L + R      I+ +  ++  +   +  I  E ++ GS+   +       
Sbjct: 115 EE--LMACAGLTSPR------IVPLYGAV--REGPWVNIFMELLEGGSLGQLVKEQGCLP 164
Query: 775 EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-AHVSDFGLARFLSHHP 833
           E   L  + +    +EYLH+     I+HGD+K  NVLL  D   A + DFG       H 
Sbjct: 165 EDRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFG-------HA 214
Query: 834 FLVAPEGQSSSI----EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
             + P+G    +     + GT  ++ PE  +G       DV+S   ++L M     P   
Sbjct: 215 VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 274
Query: 890 MFNDGLTL 897
            F   L L
Sbjct: 275 FFRGPLCL 282

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAV++++  +    + +    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKF 133
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKGTIGYIG 855
           IVH DLK  N+LLD DM   ++DFG +   +       F  +P    ++ E+     Y G
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP--PYAAPELFQGKKYDG 191
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           PE           DV+S G++L  + +   P D
Sbjct: 192 PEV----------DVWSLGVILYTLVSGSLPFD 214

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 106/226 (46%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT---------------NDKLEVG 777
           +I ++  C+     G  +  ++ EY   G++ ++L                   +++   
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
            L +   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++     
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI---- 210
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             +    +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 211 --DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 110/245 (44%), Gaps = 39/245 (15%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGN---LGEDG--MSVAVKVMNLDKKGA 714
           Q P     E  +   +F  +  +G G+FG V +     LG++   + VAVK++       
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 715 TK-SFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
            K + ++E + + ++ +H N++ ++  C+     G     ++ EY  YG + ++L   + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKSR 146
Query: 773 KLEVG-KLNIVIEVASVIEYLHNHCQPP----------IVHGDLKPSNVLLDHDMVAHVS 821
            LE      I    AS  + LH   Q             +H D+   NVLL +  VA + 
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 822 DFGLARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILL 877
           DFGLAR + +           S+  +KG     + ++ PE       ++  DV+S+GILL
Sbjct: 207 DFGLARDIMN----------DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 878 LEMFT 882
            E+F+
Sbjct: 257 WEIFS 261

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 32/232 (13%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMNLDKKGATKSFVAECEALRNIR 729
           +   +F     +G+G+FG V K     D    A+K + + ++K +T   ++E   L ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVMLLASLN 60
Query: 730 H-------------RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLE 775
           H             RN +K +T   ++  K   F  I  EY + G++ D +H  N ++  
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMT---AVKKKSTLF--IQMEYCENGTLYDLIHSENLNQQR 115
Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                +  ++   + Y+H+     I+H DLKP N+ +D      + DFGLA+ +     +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 836 VAPEGQS---SSIEMKGTIG---YIGPEYGMG-GDLSMTGDVYSFGILLLEM 880
           +  + Q+   SS  +   IG   Y+  E   G G  +   D+YS GI+  EM
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 682 IGKGSFGFVYKGN-LGEDGM----SVAVKVMNLDKKGAT----KSFVAECEALRNI-RHR 731
           +G+G+FG V + +  G D      +VAVK++   K+GAT    ++ ++E + L +I  H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 93
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--------EVGKLNIVI 783
           N++ ++  C+     G     IV E+ ++G++  +L    ++         ++ K  + +
Sbjct: 94  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTL 149
Query: 784 E--------VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
           E        VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  
Sbjct: 150 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           V      + + +K    ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 207 V--RKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 45/235 (19%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR---- 729
           +++    ++GKG++G V+K      G  VAVK +         +F    +A R  R    
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMI 61
Query: 730 ------HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVGKLN 780
                 H N++ ++ +        AD    VY    Y   D  LH     N    V K  
Sbjct: 62  LTELSGHENIVNLLNVLR------ADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQY 113
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-------RFLSHHP 833
           +V ++  VI+YLH+     ++H D+KPSN+LL+ +    V+DFGL+       R  ++ P
Sbjct: 114 VVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 834 FLVAP------EGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMF 881
             +        + Q    +   T  Y  PE  +G      G D++S G +L E+ 
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 90  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 145 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 198
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 199 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +   ++ +   G ++KG     G  + VKV+ +      KS  F  EC  LR   H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGK-LNIVIEVASVI 789
           N++ ++  C S     A    ++  +M YGS+ + LH  TN  ++  + +   +++A  +
Sbjct: 68  NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLARFLS----HHPFLVAPEGQSS 843
            +LH   +P I    L   +V++D DM A +S  D   + F S    + P  VAPE    
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFS-FQSPGRMYAPAWVAPEALQK 182
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
             E                    + D++SF +LL E+ TR  P  ++ N
Sbjct: 183 KPEDTN---------------RRSADMWSFAVLLWELVTREVPFADLSN 216

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 42/240 (17%)
Query: 682 IGKGSFGFVYK------GNLGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +GKG +G V++       N G+   M V  K M +     T    AE   L  ++H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            +I       F+      ++ EY+  G +   L      +E      + E++  + +LH 
Sbjct: 85  DLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH- 138
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH-----HPFLVAPEGQSSSIEMKG 849
             Q  I++ DLKP N++L+H     ++DFGL +   H     H F              G
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-------------G 183
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT---------RRRPTDNMFNDGLTLHGY 900
           TI Y+ PE  M    +   D +S G L+ +M T         R++  D +    L L  Y
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 98  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 153 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 206
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 207 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAVK+++  +    + +    E   ++ + H N++K+  +
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 75  IET-----EKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH---QKF 126
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKGTIGYIG 855
           IVH DLK  N+LLD DM   ++DFG +   +       F  +P    ++ E+     Y G
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP--PYAAPELFQGKKYDG 184
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           PE           DV+S G++L  + +   P D
Sbjct: 185 PEV----------DVWSLGVILYTLVSGSLPFD 207

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 680 NRI-GKGSFGFVYKG---NLGEDGMSVAVKVM----NLDKKGATKSFVAECEALRNIRHR 731
           NRI G+G FG VY+G   N   + ++VAVK       LD K   + F++E   ++N+ H 
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHP 69
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASVIE 790
           +++K+I I         +   I+ E   YG +  +L    + L+V  L +  +++   + 
Sbjct: 70  HIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 123
Query: 791 YLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           YL + +C    VH D+   N+L+       + DFGL+R++    +  A          + 
Sbjct: 124 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VTRL 172
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            I ++ PE       +   DV+ F + + E+ +
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 680 NRI-GKGSFGFVYKG---NLGEDGMSVAVKVM----NLDKKGATKSFVAECEALRNIRHR 731
           NRI G+G FG VY+G   N   + ++VAVK       LD K   + F++E   ++N+ H 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHP 73
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV-IEVASVIE 790
           +++K+I I         +   I+ E   YG +  +L    + L+V  L +  +++   + 
Sbjct: 74  HIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 791 YLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           YL + +C    VH D+   N+L+       + DFGL+R++    +  A          + 
Sbjct: 128 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VTRL 176
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            I ++ PE       +   DV+ F + + E+ +
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 98  ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 153 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 206
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 207 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNR--------IGKGSFGFVYKGNLG----- 696
           KL ++ +M    P   +A  + +  +     R        +G G+FG VY+G +      
Sbjct: 39  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 98
Query: 697 EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY 755
              + VAVK +  +  +     F+ E   +    H+N+++    C  +  +    + I+ 
Sbjct: 99  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR----CIGVSLQSLP-RFILL 153
Query: 756 EYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASVIEYLH-NHCQPPIVHGDLKP 807
           E M  G +  +L  T  +         +  L++  ++A   +YL  NH     +H D+  
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAA 209
Query: 808 SNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL 864
            N LL       VA + DFG+AR +    +    +G  + + +K    ++ PE  M G  
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR--KGGCAMLPVK----WMPPEAFMEGIF 263
Query: 865 SMTGDVYSFGILLLEMFT 882
           +   D +SFG+LL E+F+
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V    + E G   AVKV+  D   +    +  + E   L   R+   +  + 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
            C    F+  D    V E++  G +   +  +    E        E+ S + +LH+    
Sbjct: 91  CC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG-- 144
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGYIG 855
            I++ DLK  NVLLDH+    ++DFG+ +           EG  + +      GT  YI 
Sbjct: 145 -IIYRDLKLDNVLLDHEGHCKLADFGMCK-----------EGICNGVTTATFCGTPDYIA 192
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
           PE           D ++ G+LL EM     P +    D L
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 154 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 207
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 208 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-----FVAECEALRNIRH 730
           +    ++G G++G V    L  D ++   + + + +K +  +      + E   L+ + H
Sbjct: 39  YQRVKKLGSGAYGEVL---LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++K+        F+      +V E  + G + D + H     EV    I+ +V S + 
Sbjct: 96  PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 791 YLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
           YLH H    IVH DLKP N+LL   + D +  + DFGL+            E Q    E 
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---------ENQKKMKER 198
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLL 878
            GT  YI PE  +        DV+S G++L 
Sbjct: 199 LGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 113 ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 168 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 221
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 222 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNR--------IGKGSFGFVYKGNLG----- 696
           KL ++ +M    P   +A  + +  +     R        +G G+FG VY+G +      
Sbjct: 16  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 75
Query: 697 EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY 755
              + VAVK +  +  +     F+ E   +    H+N+++    C  +  +    + I+ 
Sbjct: 76  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR----CIGVSLQSLP-RFILL 130
Query: 756 EYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASVIEYLH-NHCQPPIVHGDLKP 807
           E M  G +  +L  T  +         +  L++  ++A   +YL  NH     +H D+  
Sbjct: 131 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----FIHRDIAA 186
Query: 808 SNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL 864
            N LL       VA + DFG+AR +    +    +G  + + +K    ++ PE  M G  
Sbjct: 187 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR--KGGCAMLPVK----WMPPEAFMEGIF 240
Query: 865 SMTGDVYSFGILLLEMFT 882
           +   D +SFG+LL E+F+
Sbjct: 241 TSKTDTWSFGVLLWEIFS 258

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 42/240 (17%)
Query: 682 IGKGSFGFVYK------GNLGED-GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +GKG +G V++       N G+   M V  K M +     T    AE   L  ++H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            +I       F+      ++ EY+  G +   L      +E      + E++  + +LH 
Sbjct: 85  DLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH- 138
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH-----HPFLVAPEGQSSSIEMKG 849
             Q  I++ DLKP N++L+H     ++DFGL +   H     H F              G
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC-------------G 183
Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT---------RRRPTDNMFNDGLTLHGY 900
           TI Y+ PE  M    +   D +S G L+ +M T         R++  D +    L L  Y
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 54/256 (21%)
Query: 652 SSALLMEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM 707
           S  L M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK +
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 708 NLDKKGA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKA 752
           +   +     K    E   L++++H N   L+ + T   S++            GAD   
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV               T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ +
Sbjct: 122 IV----------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAV 164
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTG 868
           + D    + DFGLAR               +  EM G +    Y  PE  +     + T 
Sbjct: 165 NEDCELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 869 DVYSFGILLLEMFTRR 884
           D++S G ++ E+ T R
Sbjct: 211 DIWSVGCIMAELLTGR 226

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+FG VYK    E G   A KV+    +   + ++ E E L    H  ++K++    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 74
Query: 742 SIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHC 796
                GA +      I+ E+   G+VD  +   +  L   ++ +V  ++   + +LH+  
Sbjct: 75  -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK- 128
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              I+H DLK  NVL+  +    ++DFG++        L   + + S I   GT  ++ P
Sbjct: 129 --RIIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFI---GTPYWMAP 178
Query: 857 EYGMGGDLSMT-----GDVYSFGILLLEM 880
           E  M   +  T      D++S GI L+EM
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+FG VYK    E G   A KV+    +   + ++ E E L    H  ++K++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 82
Query: 742 SIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHC 796
                GA +      I+ E+   G+VD  +   +  L   ++ +V  ++   + +LH+  
Sbjct: 83  -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              I+H DLK  NVL+  +    ++DFG++        L   + + S I   GT  ++ P
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFI---GTPYWMAP 186
Query: 857 EYGMGGDLSMT-----GDVYSFGILLLEM 880
           E  M   +  T      D++S GI L+EM
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHR 731
           +++    +IG+G++G V+K    E    VA+K + LD   +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 732 NLIKIITICSSIDFKGADFK-AIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASV 788
           N++++  +  S      D K  +V+E+     +  +    N  L  E+ K + + ++   
Sbjct: 62  NIVRLHDVLHS------DKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVK-SFLFQLLKG 113
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + + H+     ++H DLKP N+L++ +    +++FGLAR      F +     S+ +   
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVRCYSAEV--- 162
Query: 849 GTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRRRP 886
            T+ Y  P+   G  L  T  D++S G +  E+    RP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 133/293 (45%), Gaps = 28/293 (9%)
Query: 205 LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQ 264
           L NL YL  + N  + + PLS  N+  L   Y+  N+      +    NL  L  L + +
Sbjct: 65  LTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKITD---ISALQNLTNLRELYLNE 119
Query: 265 NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLD 324
           +N++   P  L+N +K   L L  NH       N + L  LS    G N L T T + + 
Sbjct: 120 DNISDISP--LANLTKXYSLNLGANH-------NLSDLSPLSNXT-GLNYL-TVTESKVK 168
Query: 325 FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNL 384
            +T + N + L  L L +N+     P  +A+L++     A   NQI+   P  + N   L
Sbjct: 169 DVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV-NQITDITP--VANXTRL 223
Query: 385 NGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
           N L +  N++T   P  +  L  L +L +  N I  I  + + +LT L  L +G N++  
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKXLNVGSNQI-- 277
Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPL 497
           S  S L     L  L   NN+L       I G+T L+ L  LS+NH++   PL
Sbjct: 278 SDISVLNNLSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLF-LSQNHITDIRPL 329

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+AR +    +    +G  + 
Sbjct: 168 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 221
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 222 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 54/256 (21%)
Query: 652 SSALLMEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM 707
           S  L M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK +
Sbjct: 1   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 60
Query: 708 NLDKKGA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKA 752
           +   +     K    E   L++++H N+I    + T   S++            GAD   
Sbjct: 61  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 120
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV               T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ +
Sbjct: 121 IV----------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAV 163
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTG 868
           + D    + DFGLAR               +  EM G +    Y  PE  +     + T 
Sbjct: 164 NEDCELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 869 DVYSFGILLLEMFTRR 884
           D++S G ++ E+ T R
Sbjct: 210 DIWSVGCIMAELLTGR 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 54/256 (21%)
Query: 652 SSALLMEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM 707
           S  L M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK +
Sbjct: 19  SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 78
Query: 708 NLDKKGA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKA 752
           +   +     K    E   L++++H N   L+ + T   S++            GAD   
Sbjct: 79  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 138
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV               T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ +
Sbjct: 139 IV----------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAV 181
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTG 868
           + D    + DFGLAR               +  EM G +    Y  PE  +     + T 
Sbjct: 182 NEDCELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 869 DVYSFGILLLEMFTRR 884
           D++S G ++ E+ T R
Sbjct: 228 DIWSVGCIMAELLTGR 243

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE------ 775
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 776 ----VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 832 HPFLVAPEGQSSSIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             +             KG  G     ++ PE    G  +   DV+SFG++L E+ T
Sbjct: 213 TDYY-----------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +GKG++G VY G    + + +A+K +       ++    E    ++++H+N+++ +    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG--- 86
Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE---YLHNHCQP 798
              F    F  I  E +  GS+   L      L+  +  I      ++E   YLH++   
Sbjct: 87  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 799 PIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
            IVH D+K  NVL++ +  V  +SDFG ++ L+     + P  ++      GT+ Y+ PE
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG----INPCTET----FTGTLQYMAPE 193
Query: 858 YGMGG--DLSMTGDVYSFGILLLEMFTRRRP 886
               G        D++S G  ++EM T + P
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IGKG+F  V        G  VAVK+++  +    + +    E    + + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             +          +V EY   G V D+L       E        ++ S ++Y H   Q  
Sbjct: 82  IET-----EKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH---QKF 133
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKGTIGYIG 855
           IVH DLK  N+LLD D    ++DFG +   +       F  AP    ++ E+     Y G
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAP--PYAAPELFQGKKYDG 191
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           PE           DV+S G++L  + +   P D
Sbjct: 192 PEV----------DVWSLGVILYTLVSGSLPFD 214

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 109/226 (48%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                 ++   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 214 -----KNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 54/256 (21%)
Query: 652 SSALLMEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM 707
           S  L M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK +
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 708 NLDKKGA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKA 752
           +   +     K    E   L++++H N   L+ + T   S++            GAD   
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           IV               T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ +
Sbjct: 122 IV----------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAV 164
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTG 868
           + D    + DFGLAR               +  EM G +    Y  PE  +     + T 
Sbjct: 165 NEDSELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 869 DVYSFGILLLEMFTRR 884
           D++S G ++ E+ T R
Sbjct: 211 DIWSVGCIMAELLTGR 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 121 KL----------TDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +GKG++G VY G    + + +A+K +       ++    E    ++++H+N+++ +    
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG--- 72
Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE---YLHNHCQP 798
              F    F  I  E +  GS+   L      L+  +  I      ++E   YLH++   
Sbjct: 73  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 127
Query: 799 PIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE-MKGTIGYIGP 856
            IVH D+K  NVL++ +  V  +SDFG ++ L+         G +   E   GT+ Y+ P
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---------GINPCTETFTGTLQYMAP 178
Query: 857 EYGMGG--DLSMTGDVYSFGILLLEMFTRRRP 886
           E    G        D++S G  ++EM T + P
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           ++F     +GKGSFG V+     +     A+K +  D          EC  +        
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--VECTMVEK------ 68
Query: 734 IKIITICSSIDFKGADF-----KAIVYEYMQYGSVDDWLHHTND--KLEVGKLNI-VIEV 785
            +++++     F    F     K  ++  M+Y +  D ++H     K ++ +      E+
Sbjct: 69  -RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              +++LH+     IV+ DLK  N+LLD D    ++DFG+ +            G + + 
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--------ENMLGDAKTN 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              GT  YI PE  +G   + + D +SFG+LL EM   + P
Sbjct: 177 XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYY- 213
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 214 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +++G+G++  VYKG        VA+K + L+ ++GA  + + E   L++++H N++ +  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQ 797
           I  +          +V+EY+    +  +L    + + +  + + + ++   + Y H    
Sbjct: 68  IIHT-----EKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             ++H DLKP N+L++      ++DFGLAR  S     +  +   + +    T+ Y  P+
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLARAKS-----IPTKTYDNEV---VTLWYRPPD 170
Query: 858 YGMGG-DLSMTGDVYSFGILLLEMFTRR 884
             +G  D S   D++  G +  EM T R
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI----CYFLYQILRGLKY 143
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 193
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 121 KL----------TDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+   +E LH      IV+ DLKP N+LLD      +SD GLA        +  PEGQ+ 
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTI 342
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              + GT+GY+ PE       + + D ++ G LL EM   + P
Sbjct: 343 KGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 139
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 189
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 36/125 (28%), Positives = 64/125 (51%), Gaps = 12/125 (9%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  +++LH+     I++ DLKP N+LLD +    ++DFGL++    H        +  
Sbjct: 135 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--------EKK 183
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM-FNDGLTLHGYAK 902
           +    GT+ Y+ PE       + + D +SFG+L+ EM T   P       + +T+   AK
Sbjct: 184 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 243
Query: 903 MALPK 907
           + +P+
Sbjct: 244 LGMPQ 248

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 36/125 (28%), Positives = 64/125 (51%), Gaps = 12/125 (9%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  +++LH+     I++ DLKP N+LLD +    ++DFGL++    H        +  
Sbjct: 134 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--------EKK 182
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM-FNDGLTLHGYAK 902
           +    GT+ Y+ PE       + + D +SFG+L+ EM T   P       + +T+   AK
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 903 MALPK 907
           + +P+
Sbjct: 243 LGMPQ 247

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 214 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 139
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLAR-------VADPDHDHTGFLTEYVA 189
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 12/112 (10%)
Query: 775 EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
           E   +    E+   +E LH      IV+ DLKP N+LLD      +SD GLA        
Sbjct: 285 EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA-------- 333
Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +  PEGQ+    + GT+GY+ PE       + + D ++ G LL EM   + P
Sbjct: 334 VHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 119
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 120 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 165
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 166 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 211
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 212 GCIMAELLTGR 222

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 103 IITLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 214 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 141
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 191
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)
Query: 668 ELSKATKEFSSSNR----IGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAE 721
           E++K   E  +  R    +G G++G V     G  G  VA+K +      +   K    E
Sbjct: 15  EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN- 780
              L+++RH N+I ++ + +  D    DF    Y  M +   D      ++KL   ++  
Sbjct: 75  LRLLKHMRHENVIGLLDVFTP-DETLDDFTDF-YLVMPFMGTDLGKLMKHEKLGEDRIQF 132
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           +V ++   + Y+H      I+H DLKP N+ ++ D    + DFGLAR             
Sbjct: 133 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------------- 176
Query: 841 QSSSIEMKGTI---GYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
           Q+ S EM G +    Y  PE  +     + T D++S G ++ EM T
Sbjct: 177 QADS-EMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 103 IIHLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 214 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 159
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 160 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 209
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 79
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 136
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 137 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 182
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 183 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 228
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 229 GCIMAELLTGR 239

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 137
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 138 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 187
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLI 734
           +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+I
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
            I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y+
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKYI 148
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKGT 850
           H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   T
Sbjct: 149 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVAT 198
Query: 851 IGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
             Y  PE  +     + + D++S G +L EM + R
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLI 734
           +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
            I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKYI 140
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKGT 850
           H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   T
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVAT 190
Query: 851 IGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
             Y  PE  +     + + D++S G +L EM + R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLI 734
           +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+I
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
            I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y+
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKYI 138
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKGT 850
           H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   T
Sbjct: 139 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVAT 188
Query: 851 IGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
             Y  PE  +     + + D++S G +L EM + R
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 143
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLXEXVA 193
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 144
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 145 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLXEXVA 194
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLI 734
           +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
            I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKYI 140
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKGT 850
           H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   T
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLAR-------VADPDHDHTGFLTEYVAT 190
Query: 851 IGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
             Y  PE  +     + + D++S G +L EM + R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 143
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLAR-------VADPDHDHTGFLTEYVA 193
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 80
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 137
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 138 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 183
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 184 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 229
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 230 GCIMAELLTGR 240

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 144
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 145 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 194
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 145
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 146 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 195
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 136
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 137 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 186
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 143
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 193
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 119
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 120 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 165
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 166 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 211
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 212 GCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 128
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 129 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 174
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 175 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 220
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 221 GCIMAELLTGR 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 37/125 (29%), Positives = 64/125 (51%), Gaps = 12/125 (9%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  +++LH+     I++ DLKP N+LLD +    ++DFGL++    H        +  
Sbjct: 138 ELALGLDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDH--------EKK 186
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM-FNDGLTLHGYAK 902
           +    GT+ Y+ PE       S + D +S+G+L+ EM T   P       + +TL   AK
Sbjct: 187 AYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK 246
Query: 903 MALPK 907
           + +P+
Sbjct: 247 LGMPQ 251

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 129
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 130 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 175
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 176 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 221
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 222 GCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 129
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 130 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 175
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 176 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 221
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 222 GCIMAELLTGR 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLI 734
           +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
            I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKYI 144
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKGT 850
           H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   T
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLAR-------VADPDHDHTGFLTEYVAT 194
Query: 851 IGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
             Y  PE  +     + + D++S G +L EM + R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 128
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 129 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXE 174
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 175 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 220
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 221 GCIMAELLTGR 231

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAV-KVMNLDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+ K+   + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 143
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 193
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLI 734
           +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
            I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKYI 140
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKGT 850
           H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   T
Sbjct: 141 HS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-------VADPDHDHTGFLTEYVAT 190
Query: 851 IGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
             Y  PE  +     + + D++S G +L EM + R
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 114/268 (42%), Gaps = 58/268 (21%)
Query: 644 GTKLAHKLSSA----LLMEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNL 695
            T L  K  SA     +  ++ P     EL+K   E    + + + +G G++G V     
Sbjct: 13  STSLYKKAGSAAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYD 72
Query: 696 GEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHRNLI---KIITICSSID------ 744
            + G+ +AVK ++   +     K    E   L++++H N+I    + T  +S++      
Sbjct: 73  VKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVY 132
Query: 745 ----FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                 GAD   IV               T+D ++     ++ ++   ++Y+H+     I
Sbjct: 133 LVTHLMGADLNNIV----------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADI 175
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPE 857
           +H DLKPSN+ ++ D    + DFGLAR               +  EM G +    Y  PE
Sbjct: 176 IHRDLKPSNLAVNEDCELKILDFGLAR--------------HTDDEMTGYVATRWYRAPE 221
Query: 858 YGMGG-DLSMTGDVYSFGILLLEMFTRR 884
             +     +MT D++S G ++ E+ T R
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +A           GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLA-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 682 IGKGSFGFVYKGNL-GEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IGKG FG VY G   GE    VA++++++  D +   K+F  E  A R  RH N++  + 
Sbjct: 41  IGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQ 797
            C S         AI+    +  ++   +      L+V K   I  E+   + YLH    
Sbjct: 97  ACMS-----PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG- 150
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H DLK  NV  D+  V  ++DFGL    S    L A   +       G + ++ PE
Sbjct: 151 --ILHKDLKSKNVFYDNGKVV-ITDFGL---FSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 858 --YGMGGD-------LSMTGDVYSFGILLLEMFTRRRP 886
               +  D        S   DV++ G +  E+  R  P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ 72
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 129
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 130 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 175
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 176 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 221
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 222 GCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 119
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 120 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSE 165
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 166 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 211
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 212 GCIMAELLTGR 222

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 682 IGKGSFGFVYKGNLG-----EDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIK 735
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASV 788
               C  +  +    + I+ E M  G +  +L  T  +         +  L++  ++A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 789 IEYLH-NHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            +YL  NH     +H D+   N LL       VA + DFG+A+ +    +    +G  + 
Sbjct: 154 CQYLEENH----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR--KGGCAM 207
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           + +K    ++ PE  M G  +   D +SFG+LL E+F+
Sbjct: 208 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 90  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 145 DLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYY- 200
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 201 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 141
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 191
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 95  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 150 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 205
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 206 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 54/226 (23%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++ EY   G++ ++L         ++ D   V +      
Sbjct: 92  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 147 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 202
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 203 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 109/245 (44%), Gaps = 39/245 (15%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGN---LGEDG--MSVAVKVMNLDKKGA 714
           Q P     E  +   +F  +  +G G+FG V +     LG++   + VAVK++       
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 715 TK-SFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
            K + ++E + + ++ +H N++ ++  C+     G     ++ EY  YG + ++L   + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKSR 146
Query: 773 KLEVG-KLNIVIEVASVIEYLHNHCQPP----------IVHGDLKPSNVLLDHDMVAHVS 821
            LE      I     S  + LH   Q             +H D+   NVLL +  VA + 
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 822 DFGLARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILL 877
           DFGLAR + +           S+  +KG     + ++ PE       ++  DV+S+GILL
Sbjct: 207 DFGLARDIMN----------DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 878 LEMFT 882
            E+F+
Sbjct: 257 WEIFS 261

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA-- 724
           A  ++ T ++     +GKG+F  V +          A K++N  K  A      E EA  
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE 784
            R ++H N++++     SI  +G  F  +V++ +  G + + +       E    + + +
Sbjct: 84  CRLLKHPNIVRLH---DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQ 138
Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHHPFLVAPEG- 840
           +   + ++H H    IVH DLKP N+LL          ++DFGLA         +  +G 
Sbjct: 139 ILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA---------IEVQGE 186
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
           Q +     GT GY+ PE           D+++ G++L
Sbjct: 187 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNL 733
               +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           +++I IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL 
Sbjct: 433 VRMIGICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 486
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIG 852
              +   VH DL   NVLL     A +SDFGL++ L       A E    +    K  + 
Sbjct: 487 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVK 537
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S   DV+SFG+L+ E F+
Sbjct: 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHR 731
           T  +     IG GS+    +       M  AVK+++  K+  T+    E E L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           N+I +  +     +    +  +V E M+ G + D +       E     ++  +   +EY
Sbjct: 77  NIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSDFGLARFL-SHHPFLVAPEGQSSSIE 846
           LH      +VH DLKPSN+L   +        + DFG A+ L + +  L+ P        
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-------- 180
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
              T  ++ PE           D++S G+LL  M T   P  N  +D
Sbjct: 181 -CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/243 (21%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 182 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 235
Query: 891 FND 893
            N+
Sbjct: 236 SNE 238

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/243 (21%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 177
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 178 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 231
Query: 891 FND 893
            N+
Sbjct: 232 SNE 234

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/243 (21%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 184 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 891 FND 893
            N+
Sbjct: 238 SNE 240

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/243 (21%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 184 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 891 FND 893
            N+
Sbjct: 238 SNE 240

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/243 (21%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 191 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 891 FND 893
            N+
Sbjct: 245 SNE 247

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/243 (21%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 185 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 238
Query: 891 FND 893
            N+
Sbjct: 239 SNE 241

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYG--SVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      IV + M+     +    H +ND +       + ++   ++Y
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----CYFLYQILRGLKY 141
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLAR-------VADPDHDHTGFLTEYVA 191
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 119/294 (40%), Gaps = 35/294 (11%)
Query: 644 GTKLAHKLSSALLMEQQFPIV-SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSV 702
            ++LA     A  ++   PIV    E+     +F     IG+G+F  V    + + G   
Sbjct: 30  ASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVY 89
Query: 703 AVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQ 759
           A+K+MN   + K+G    F  E + L N   R + ++        F+  ++  +V EY  
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL-----HFAFQDENYLYLVMEYYV 144
Query: 760 YGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
            G +   L    +++  E+ +  +  E+   I+ +H       VH D+KP N+LLD    
Sbjct: 145 GGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH 200
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-------DV 870
             ++DFG    L         +G   S+   GT  Y+ PE                  D 
Sbjct: 201 IRLADFGSCLKLR-------ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW 253
Query: 871 YSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG--IVDPSLLMEAR 922
           ++ G+   EMF  + P    F    T   Y K+   K+ +   +VD  +  EAR
Sbjct: 254 WALGVFAYEMFYGQTP----FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNL 733
               +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           +++I IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL 
Sbjct: 434 VRMIGICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 487
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIG 852
              +   VH DL   NVLL     A +SDFGL++ L       A E    +    K  + 
Sbjct: 488 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVK 538
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           +  PE       S   DV+SFG+L+ E F+
Sbjct: 539 WYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 54/248 (21%), Positives = 101/248 (40%), Gaps = 41/248 (16%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175
Query: 832 HPFLVAPEGQSSSIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRR 885
                      +    KG  G     ++ PE    G  +   DV+SFG++L E+ T   +
Sbjct: 176 -----------TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 224
Query: 886 PTDNMFND 893
           P   + N+
Sbjct: 225 PYQGLSNE 232

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 54/248 (21%), Positives = 101/248 (40%), Gaps = 41/248 (16%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 832 HPFLVAPEGQSSSIEMKGTIG-----YIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRR 885
                      +    KG  G     ++ PE    G  +   DV+SFG++L E+ T   +
Sbjct: 185 -----------TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 233
Query: 886 PTDNMFND 893
           P   + N+
Sbjct: 234 PYQGLSNE 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 32/232 (13%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMNLDKKGATKSFVAECEALRNIR 729
           +   +F     +G+G+FG V K     D    A+K + + ++K +T   ++E   L ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVMLLASLN 60
Query: 730 H-------------RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLE 775
           H             RN +K +T   ++  K   F  I  EY +  ++ D +H  N ++  
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMT---AVKKKSTLF--IQMEYCENRTLYDLIHSENLNQQR 115
Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                +  ++   + Y+H+     I+H DLKP N+ +D      + DFGLA+ +     +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 836 VAPEGQS---SSIEMKGTIG---YIGPEYGMG-GDLSMTGDVYSFGILLLEM 880
           +  + Q+   SS  +   IG   Y+  E   G G  +   D+YS GI+  EM
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 -----------KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + IG G++G V      + G+ VAVK ++   +  
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 122
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 123 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELK 170
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 171 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 216
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 217 IMAELLTGR 225

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 42  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 97
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 98  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 155
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 156 IGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 213 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 42  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 97
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 98  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 155
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 156 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      + ++  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 213 -----------KGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 80
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 137
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 138 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 183
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 184 LKILDFGLAR--------------HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSV 229
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 230 GCIMAELLTGR 240

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     IG GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EYM  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEFS--FKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     IG GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EYM  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEFS--FKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 16  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 71
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 72  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 129
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 130 IGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 186
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 187 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 226

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + D+GLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDYGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRN 732
           K F     +G G+F  V        G   AVK +     KG   S   E   LR I+H N
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHEN 81
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
           ++ +  I     ++  +   +V + +  G + D +       E     ++ +V   + YL
Sbjct: 82  IVALEDI-----YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYL 136
Query: 793 HNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK- 848
           H   +  IVH DLKP N+L    D +    +SDFGL++           EG+   +    
Sbjct: 137 H---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----------EGKGDVMSTAC 183
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
           GT GY+ PE       S   D +S G++
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 715 --TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N   L+ + T   S++            GAD   IV     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 124
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 125 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 172
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               ++ EM G +    Y  PE  +     + T D++S G 
Sbjct: 173 ILDFGLAR--------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 219 IMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 124
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 125 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 172
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               ++ EM G +    Y  PE  +     + T D++S G 
Sbjct: 173 ILDFGLAR--------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 219 IMAELLTGR 227

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 80
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 137
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 138 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 183
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 184 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 229
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 230 GCIMAELLTGR 240

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 53/233 (22%)
Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVM----NLDKKGATKSFVAECEALRNIRHRN 732
           +G G+FG V +         +  M+VAVK++    +L ++ A  S +     L N  H N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMN 111
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI--------- 783
           ++ ++  C+     G     ++ EY  YG + ++L    D     K +  I         
Sbjct: 112 IVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 784 ---------EVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
                    +VA  + +L + +C    +H DL   N+LL H  +  + DFGLAR + +  
Sbjct: 167 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKN-- 220
Query: 834 FLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    S+  +KG     + ++ PE       +   DV+S+GI L E+F+
Sbjct: 221 --------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 21/160 (13%)
Query: 721 ECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN 780
           E   L+++ H N+IK+  +     F+   +  +V E+ + G + + + + +   E    N
Sbjct: 96  EISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHHPFLVA 837
           I+ ++ S I YLH H    IVH D+KP N+LL++    +   + DFGL+ F S    L  
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR- 206
Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
                   +  GT  YI PE  +    +   DV+S G+++
Sbjct: 207 --------DRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 124
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 125 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 172
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               ++ EM G +    Y  PE  +     + T D++S G 
Sbjct: 173 ILDFGLAR--------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 219 IMAELLTGR 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 79
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 136
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 137 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 182
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 183 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 228
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 229 GCIMAELLTGR 239

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 64/125 (51%), Gaps = 12/125 (9%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+A  +++LH+     I++ DLKP N+LLD +    ++DFGL++    H        +  
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--------EKK 182
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM-FNDGLTLHGYAK 902
           +    GT+ Y+ PE       + + D +SFG+L+ EM T   P       + +T+   AK
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 903 MALPK 907
           + +P+
Sbjct: 243 LGMPQ 247

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 53/233 (22%)
Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVM----NLDKKGATKSFVAECEALRNIRHRN 732
           +G G+FG V +         +  M+VAVK++    +L ++ A  S +     L N  H N
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMN 104
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI--------- 783
           ++ ++  C+     G     ++ EY  YG + ++L    D     K +  I         
Sbjct: 105 IVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 159
Query: 784 ---------EVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
                    +VA  + +L + +C    +H DL   N+LL H  +  + DFGLAR + +  
Sbjct: 160 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN-- 213
Query: 834 FLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    S+  +KG     + ++ PE       +   DV+S+GI L E+F+
Sbjct: 214 --------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           +++   IG GSFG V++  L E    VA+K +  DK+   +    E + +R ++H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVD 96
Query: 736 IITI-CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
           +     S+ D K   F  +V EY+         H+   K  +  L I + +  ++  L  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 795 HCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                I H D+KP N+LLD    V  + DFG A+       L+A E   S I    +  Y
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNVSXI---CSRYY 207
Query: 854 IGPEYGMGGDLSMTG-DVYSFGILLLEMF 881
             PE   G     T  D++S G ++ E+ 
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 79  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 129
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ-SSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENXYKAQTHGKWPVKWYAP 183
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 8   KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 63
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 64  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 121
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 122 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV 178
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 179 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 122
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 123 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELK 170
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 171 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 216
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 217 IMAELLTGR 225

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 22  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 77
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 78  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 135
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 193 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 14  KAKEDFLKKWESPAQNTAHLD----QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK 69
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 70  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVPGGEMFSHLRR 127
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 128 IGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 185 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA------TKSFVAECEALR 726
           +  +    ++G G++G V    L +D ++ A + + + KK +      + + + E   L+
Sbjct: 20  SDRYQRVKKLGSGAYGEVL---LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA 786
            + H N++K+        F+      +V E  + G + D +       EV    I+ +V 
Sbjct: 77  QLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVL 131
Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           S   YLH H    IVH DLKP N+LL+    D +  + DFGL+   +H  F V  + +  
Sbjct: 132 SGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS---AH--FEVGGKMK-- 181
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
             E  GT  YI PE  +        DV+S G++L
Sbjct: 182 --ERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 212

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 124
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 125 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 172
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 173 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 219 IMAELLTGR 227

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 55/243 (22%), Positives = 104/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH------TNDKLE 775
              ++     ++++++ + S           ++ E M  G +  +L         N  L 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 776 VGKLNIVI----EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
              L+ +I    E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 191 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 891 FND 893
            N+
Sbjct: 245 SNE 247

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 55/243 (22%), Positives = 104/243 (42%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH------TNDKLE 775
              ++     ++++++ + S           ++ E M  G +  +L         N  L 
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 776 VGKLNIVI----EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
              L+ +I    E+A  + YL+ +     VH DL   N ++  D    + DFG+ R +  
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 181 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 234
Query: 891 FND 893
            N+
Sbjct: 235 SNE 237

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 140
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 141 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 188
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 189 ILDFGLAR--------------HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 234
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 235 IMAELLTGR 243

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITIC 740
           + +G F FVY+      G   A+K +  +++   ++ + E   ++ +  H N+++  +  
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 741 S----SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG---KLNIVIEVASVIEYLH 793
           S      D   A+F  ++   +  G + ++L     +  +     L I  +    ++++H
Sbjct: 96  SIGKEESDTGQAEF--LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK----G 849
              +PPI+H DLK  N+LL +     + DFG A  +SH+P       + + +E +     
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 850 TIGYIGPE---YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
           T  Y  PE         +    D+++ G +L  +  R+ P    F DG  L 
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 117
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 118 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 165
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 166 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 212 IMAELLTGR 220

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DFGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFGLAR--------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/226 (23%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++  Y   G++ ++L         ++ D   V +      
Sbjct: 103 IINLLGACTQ---DGPLY--VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 214 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 73  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 123
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVKWYAP 177
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 178 ECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 85  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVKWYAP 189
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 79  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 129
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVKWYAP 183
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 95  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 145
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVKWYAP 199
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 95  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 145
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVKWYAP 199
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 122
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 123 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 170
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 171 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 216
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 217 IMAELLTGR 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 75  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVKWYAP 179
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 2   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 62  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 116
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 117 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 164
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 165 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 210
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 211 IMAELLTGR 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 715 --TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N   L+ + T   S++            GAD   IV     
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 119
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 120 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 167
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 168 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 213
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 214 IMAELLTGR 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF----VAECEALRNIRHRNLIKII 737
           +G G+FG V KG      +   V V  L  +    +     +AE   ++ + +  ++++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC       A+   +V E  + G ++ +L       +   + +V +V+  ++YL    +
Sbjct: 93  GICE------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---E 143
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIGP 856
              VH DL   NVLL     A +SDFGL++ L       A E    +    K  + +  P
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWPVKWYAP 197
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E       S   DV+SFG+L+ E F+
Sbjct: 198 ECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 53/233 (22%)
Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVM----NLDKKGATKSFVAECEALRNIRHRN 732
           +G G+FG V +         +  M+VAVK++    +L ++ A  S +     L N  H N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMN 88
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI--------- 783
           ++ ++  C+     G     ++ EY  YG + ++L    D     K +  I         
Sbjct: 89  IVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 784 ---------EVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
                    +VA  + +L + +C    +H DL   N+LL H  +  + DFGLAR + +  
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN-- 197
Query: 834 FLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    S+  +KG     + ++ PE       +   DV+S+GI L E+F+
Sbjct: 198 --------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 29/203 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMS---VAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKII 737
           +G G+F  V    L ED  +   VA+K +  +  +G   S   E   L  I+H N++ + 
Sbjct: 26  LGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            I     ++      ++ + +  G + D +       E     ++ +V   ++YLH+   
Sbjct: 83  DI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 798 PPIVHGDLKPSNVL---LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-GTIGY 853
             IVH DLKP N+L   LD D    +SDFGL++           E   S +    GT GY
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLSTACGTPGY 184
Query: 854 IGPEYGMGGDLSMTGDVYSFGIL 876
           + PE       S   D +S G++
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 29/203 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMS---VAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKII 737
           +G G+F  V    L ED  +   VA+K +  +  +G   S   E   L  I+H N++ + 
Sbjct: 26  LGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            I     ++      ++ + +  G + D +       E     ++ +V   ++YLH+   
Sbjct: 83  DI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 798 PPIVHGDLKPSNVL---LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-GTIGY 853
             IVH DLKP N+L   LD D    +SDFGL++           E   S +    GT GY
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLSTACGTPGY 184
Query: 854 IGPEYGMGGDLSMTGDVYSFGIL 876
           + PE       S   D +S G++
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 29/203 (14%)
Query: 682 IGKGSFGFVYKGNLGEDGMS---VAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKII 737
           +G G+F  V    L ED  +   VA+K +  +  +G   S   E   L  I+H N++ + 
Sbjct: 26  LGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            I     ++      ++ + +  G + D +       E     ++ +V   ++YLH+   
Sbjct: 83  DI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 798 PPIVHGDLKPSNVL---LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-GTIGY 853
             IVH DLKP N+L   LD D    +SDFGL++           E   S +    GT GY
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLSTACGTPGY 184
Query: 854 IGPEYGMGGDLSMTGDVYSFGIL 876
           + PE       S   D +S G++
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 715 --TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N   L+ + T   S++            GAD   IV     
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 123
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 124 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 171
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 172 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 217
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 218 IMAELLTGR 226

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 52/243 (21%), Positives = 102/243 (41%), Gaps = 31/243 (12%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATK-SFVAE 721
           E   A ++ + S  +G+GSFG VY+G        E    VA+K +N       +  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--- 778
              ++     ++++++ + S           ++ E M  G +  +L     ++E      
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 779 -------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                  + +  E+A  + YL+ +     VH DL   N  +  D    + DFG+ R +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM 890
             +    +G    + ++    ++ PE    G  +   DV+SFG++L E+ T   +P   +
Sbjct: 178 TDYY--RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 231
Query: 891 FND 893
            N+
Sbjct: 232 SNE 234

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 53/233 (22%)
Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVM----NLDKKGATKSFVAECEALRNIRHRN 732
           +G G+FG V +         +  M+VAVK++    +L ++ A  S +     L N  H N
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMN 106
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI--------- 783
           ++ ++  C+     G     ++ EY  YG + ++L    D     K +  I         
Sbjct: 107 IVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 161
Query: 784 ---------EVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
                    +VA  + +L + +C    +H DL   N+LL H  +  + DFGLAR + +  
Sbjct: 162 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN-- 215
Query: 834 FLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    S+  +KG     + ++ PE       +   DV+S+GI L E+F+
Sbjct: 216 --------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 53/233 (22%)
Query: 682 IGKGSFGFVYKGNL-----GEDGMSVAVKVM----NLDKKGATKSFVAECEALRNIRHRN 732
           +G G+FG V +         +  M+VAVK++    +L ++ A  S +     L N  H N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMN 111
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI--------- 783
           ++ ++  C+     G     ++ EY  YG + ++L    D     K +  I         
Sbjct: 112 IVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 784 ---------EVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
                    +VA  + +L + +C    +H DL   N+LL H  +  + DFGLAR + +  
Sbjct: 167 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN-- 220
Query: 834 FLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                    S+  +KG     + ++ PE       +   DV+S+GI L E+F+
Sbjct: 221 --------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEYS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNI-RHRNLIKIIT 738
           +G G++G VYKG   + G   A+KVM++  D++   K    E   L+    HRN+     
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYG 88
Query: 739 ICSSIDFKGADFK-AIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNH 795
                +  G D +  +V E+   GSV D + +T  N   E     I  E+   + +LH H
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSSSI 845
               ++H D+K  NVLL  +    + DFG++  L             P+ +APE      
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE------ 199
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                   I  +           D++S GI  +EM
Sbjct: 200 -------VIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 104/233 (44%), Gaps = 29/233 (12%)
Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLIKII 737
           S+ +G+G+   V++G   + G   A+KV N +         + E E L+ + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            I      +    K ++ E+   GS+   L   ++   + +   +I +  V+  +++  +
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 798 PPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
             IVH ++KP N++     D   V  ++DFG AR L         E     + + GT  Y
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---------EDDEQFVSLYGTEEY 181
Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP 906
           + P            D+Y   +L  +   +   T ++++ G+T +  A  +LP
Sbjct: 182 LHP------------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 14  KAKEDFLKKWESPAQNTAHLD----QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK 69
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +  S  FK      +V EY+  G +   L  
Sbjct: 70  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS--FKDNSNLYMVMEYVPGGEMFSHLRR 127
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 128 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 185 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEYS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 53/226 (23%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 682 IGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNI-RHRN 732
           +G+G+FG V          +  ++ ++VAVK++  D      S  V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------HHTNDKLEVGK------ 778
           +I ++  C+     G  +  ++  Y   G++ ++L         ++ D   V +      
Sbjct: 103 IINLLGACTQ---DGPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 779 --LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             ++   ++A  +EYL +      +H DL   NVL+  + V  ++DFGLAR +++  +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  +   +  + ++ PE       +   DV+SFG+L+ E+FT
Sbjct: 214 -----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 104/233 (44%), Gaps = 29/233 (12%)
Query: 679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLIKII 737
           S+ +G+G+   V++G   + G   A+KV N +         + E E L+ + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            I      +    K ++ E+   GS+   L   ++   + +   +I +  V+  +++  +
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 798 PPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
             IVH ++KP N++     D   V  ++DFG AR L         E     + + GT  Y
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---------EDDEQFVXLYGTEEY 181
Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP 906
           + P            D+Y   +L  +   +   T ++++ G+T +  A  +LP
Sbjct: 182 LHP------------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEYS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 42  KAKEDFLKKWESPAQNTAHLD----QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK 97
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 98  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRR 155
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 156 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 213 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 22  KAKEDFLKKWESPAQNTAHLD----QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK 77
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 78  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRR 135
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 193 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 103 FLVKLEFS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 206
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLI 734
           ++    IG+G++G V           VA+K ++  + +   +  + E + L   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
            I  I  +   +      IV + M+    D +    + +L    +   + ++   ++Y+H
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLME---TDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKGTI 851
           +     ++H DLKPSN+L++      + DFGLAR       +  PE   +    E   T 
Sbjct: 162 SAN---VLHRDLKPSNLLINTTCDLKICDFGLAR-------IADPEHDHTGFLTEXVATR 211
Query: 852 GYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
            Y  PE  +     + + D++S G +L EM + R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 22  KAKEDFLKKWESPAQNTAHLD----QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK 77
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 78  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRR 135
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 193 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 115/245 (46%), Gaps = 43/245 (17%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGN---LGEDG--MSVAVKVMNLDKKGA 714
           Q P     E  +   +F  +  +G G+FG V +     LG++   + VAVK++       
Sbjct: 26  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 715 TK-SFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
            K + ++E + + ++ +H N++ ++  C+     G     ++ EY  YG + ++L    +
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKAE 138
Query: 773 ---KLEVGK-------LNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVS 821
                E G+       L+   +VA  + +L + +C    +H D+   NVLL +  VA + 
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 194
Query: 822 DFGLARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILL 877
           DFGLAR + +           S+  +KG     + ++ PE       ++  DV+S+GILL
Sbjct: 195 DFGLARDIMN----------DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 244
Query: 878 LEMFT 882
            E+F+
Sbjct: 245 WEIFS 249

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEFS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 22  KAKEDFLKKWESPAQNTAHLD----QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK 77
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 78  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRR 135
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 193 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     IG GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEFS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA------TKSFVAECEALRNIR 729
           +    ++G G++G V    L +D ++ A + + + KK +      + + + E   L+ + 
Sbjct: 6   YQRVKKLGSGAYGEVL---LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N++K+        F+      +V E  + G + D +       EV    I+ +V S  
Sbjct: 63  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
            YLH H    IVH DLKP N+LL+    D +  + DFGL+   +H  F V  + +    E
Sbjct: 118 TYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS---AH--FEVGGKMK----E 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
             GT  YI PE  +        DV+S G++L
Sbjct: 166 RLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 195

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 715 --TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N   L+ + T   S++            GAD   IV     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 123 ----------TDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELK 165
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGL R               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 166 ILDFGLCR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 212 IMAELLTGR 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITI 739
           +GKG +G V++G     G SVAVK+ +   +   +S+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGLW--HGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIA- 69
Query: 740 CSSIDFKGADFK-AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH----- 793
            S +  + +  +  ++  Y ++GS+ D+L     +  +  L + +  A  + +LH     
Sbjct: 70  -SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA-LRLAVSAACGLAHLHVEIFG 127
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
              +P I H D K  NVL+  ++   ++D GLA   S     +   G +  +   GT  Y
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDI-GNNPRV---GTKRY 183
Query: 854 IGPEY---GMGGDLSMT---GDVYSFGILLLEMFTR 883
           + PE     +  D   +    D+++FG++L E+  R
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+++D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIIISKGYNKAVDWWALGVLIYEM 231

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ PE  +    +   D ++ G+L+ +M
Sbjct: 192 KGRTWXLC-----------GTPEYLAPEIILSKGYNKAVDWWALGVLIYQM 231

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 41/226 (18%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL-IKIITI 739
            +G+G++G V K      G  +AVK +        ++ V   E  R +   ++ ++ +  
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRI--------RATVNSQEQKRLLMDLDISMRTVDC 109
Query: 740 CSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA-SVIEYL-H 793
             ++ F GA F+     I  E M   S+D +     DK +    +I+ ++A S+++ L H
Sbjct: 110 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 168
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSS 843
            H +  ++H D+KPSNVL++      + DFG++ +L             P++ APE    
Sbjct: 169 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM-APE---- 223
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                     I PE    G  S+  D++S GI ++E+   R P D+
Sbjct: 224 ---------RINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDS 259

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 115/245 (46%), Gaps = 43/245 (17%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGN---LGEDG--MSVAVKVMNLDKKGA 714
           Q P     E  +   +F  +  +G G+FG V +     LG++   + VAVK++       
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 715 TK-SFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
            K + ++E + + ++ +H N++ ++  C+     G     ++ EY  YG + ++L    +
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKAE 146
Query: 773 ---KLEVGK-------LNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVS 821
                E G+       L+   +VA  + +L + +C    +H D+   NVLL +  VA + 
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 202
Query: 822 DFGLARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVYSFGILL 877
           DFGLAR + +           S+  +KG     + ++ PE       ++  DV+S+GILL
Sbjct: 203 DFGLARDIMN----------DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 252
Query: 878 LEMFT 882
            E+F+
Sbjct: 253 WEIFS 257

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNL 733
            +++ + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 734 IKIITICSSIDFKGADFKAIVYEYM--QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           I I  I  +   +      +V   M      +    H +ND +       + ++   ++Y
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI----CYFLYQILRGLKY 159
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI--EMKG 849
           +H+     ++H DLKPSN+LL+      + DFGLAR       +  P+   +    E   
Sbjct: 160 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLAR-------VADPDHDHTGFLTEYVA 209
Query: 850 TIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRR 884
           T  Y  PE  +     + + D++S G +L EM + R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 87
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 88  FLVKLEFS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 146 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWTLCGTPEYL 191
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEM 217

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 103 FLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 206
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             +  FGLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILGFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 103 FLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +    + +            GT  Y+
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----------GTPEYL 206
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + D GLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDAGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +  S  FK      +V EY+  G +   L       E        ++    EYLH+
Sbjct: 102 FLVKLEFS--FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+L+D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY   G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+++D      V+DFGLA+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 31/226 (13%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--------KGATKSFVAECEA 724
           ++++S+ + +G G+FGFV+     E    V VK +  +K                 E   
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNI 781
           L  + H N+IK++ I     F+   F  +V E  ++GS  D     +    + +     I
Sbjct: 83  LSRVEHANIIKVLDI-----FENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
             ++ S + YL       I+H D+K  N+++  D    + DFG A +L            
Sbjct: 136 FRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---- 188
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRRRP 886
                  GTI Y  PE  MG        +++S G+ L  +     P
Sbjct: 189 -----FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + D GLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDRGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG- 713
           Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +  
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 714 -ATKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 123
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 124 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 171
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 172 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 217
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 218 IMAELLTGR 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 54/246 (21%)
Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +     
Sbjct: 4   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 63
Query: 716 KSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEYMQYGS 762
           K    E   L++++H N   L+ + T   S++            GAD   IV        
Sbjct: 64  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 115
Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 116 --KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 166
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 167 FGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 212
Query: 879 EMFTRR 884
           E+ T R
Sbjct: 213 ELLTGR 218

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRNIRH 730
           T E+     +GKG+F  V +      G   A K++N  K  A      E EA   R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++++     SI  +G  F  +V++ +  G + + +       E    + + ++   + 
Sbjct: 63  PNIVRLH---DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESV- 116
Query: 791 YLHNHCQ-PPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
              NHC    IVH DLKP N+LL          ++DFGLA        +     Q +   
Sbjct: 117 ---NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--------IEVQGDQQAWFG 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
             GT GY+ PE           D+++ G++L
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 26/146 (17%)
Query: 753 IVYEYMQYGSV---DDWLHHTNDK------LEVGKLNIVIEVASVIEYLHNHCQPPIVHG 803
           I+YEYM+  S+   D++    +        ++V K  I+  V +   Y+HN  +  I H 
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC-IIKSVLNSFSYIHN--EKNICHR 176
Query: 804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD 863
           D+KPSN+L+D +    +SDFG         ++V  + + S    +GT  ++ PE+    +
Sbjct: 177 DVKPSNILMDKNGRVKLSDFG------ESEYMVDKKIKGS----RGTYEFMPPEF-FSNE 225
Query: 864 LSMTG---DVYSFGILLLEMFTRRRP 886
            S  G   D++S GI L  MF    P
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 54/246 (21%)
Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +     
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 716 KSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEYMQYGS 762
           K    E   L++++H N   L+ + T   S++            GAD   IV        
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 114
Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 115 --KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 165
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 166 FGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 879 EMFTRR 884
           E+ T R
Sbjct: 212 ELLTGR 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 54/246 (21%)
Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +     
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 716 KSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEYMQYGS 762
           K    E   L++++H N   L+ + T   S++            GAD   IV        
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 114
Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 115 --KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 165
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 166 FGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 879 EMFTRR 884
           E+ T R
Sbjct: 212 ELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 54/246 (21%)
Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 716 KSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQYGS 762
           K    E   L++++H N+I    + T   S++            GAD   IV        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 113
Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 114 --KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 164
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 165 FGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 879 EMFTRR 884
           E+ T R
Sbjct: 211 ELLTGR 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 54/249 (21%)
Query: 659 QQFPIVSYAELSKATKEFSSSNR----IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA 714
           Q+ P     EL+K   E     +    +G G++G V      + G  VAVK ++   +  
Sbjct: 13  QERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 72
Query: 715 --TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQ 759
              K    E   L++++H N+I    + T   S++            GAD   IV     
Sbjct: 73  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----- 127
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                     T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    
Sbjct: 128 -----KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 175
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGI 875
           + DFGLAR               +  EM G +    Y  PE  +     + T D++S G 
Sbjct: 176 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 221
Query: 876 LLLEMFTRR 884
           ++ E+ T R
Sbjct: 222 IMAELLTGR 230

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRNIRH 730
           T E+     +GKG+F  V +      G   A K++N  K  A      E EA   R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N+++   +  SI  +G  F  +V++ +  G + + +       E    + + ++   + 
Sbjct: 63  PNIVR---LHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESV- 116
Query: 791 YLHNHCQ-PPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
              NHC    IVH DLKP N+LL          ++DFGLA        +     Q +   
Sbjct: 117 ---NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--------IEVQGDQQAWFG 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
             GT GY+ PE           D+++ G++L
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY   G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+++D      V+DFGLA+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 106/251 (42%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G+ VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N+I    + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + D GLAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDGGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 41/226 (18%)
Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL-IKIITI 739
            +G+G++G V K      G  +AVK +        ++ V   E  R +   ++ ++ +  
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI--------RATVNSQEQKRLLMDLDISMRTVDC 65
Query: 740 CSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA-SVIEYL-H 793
             ++ F GA F+     I  E M   S+D +     DK +    +I+ ++A S+++ L H
Sbjct: 66  PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSS 843
            H +  ++H D+KPSNVL++      + DFG++ +L             P++ APE    
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM-APE---- 179
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                     I PE    G  S+  D++S GI ++E+   R P D+
Sbjct: 180 ---------RINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDS 215

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 106/250 (42%), Gaps = 29/250 (11%)
Query: 629 RKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFG 688
           + +  + L V IP       H++ +A    +Q  + S+  +SK       +  +G G FG
Sbjct: 55  KSKRTSALAVDIPAPPAPFDHRIVTA----KQGAVNSFYTVSK-------TEILGGGRFG 103
Query: 689 FVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA 748
            V+K      G+ +A K++        +    E   +  + H NLI++        F+  
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-----FESK 158
Query: 749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPS 808
           +   +V EY+  G + D +   ++   + +L+ ++ +  + E + +  Q  I+H DLKP 
Sbjct: 159 NDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 809 NVLLDHDMVAHVS--DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSM 866
           N+L  +     +   DFGLAR       L             GT  ++ PE      +S 
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVN---------FGTPEFLAPEVVNYDFVSF 267
Query: 867 TGDVYSFGIL 876
             D++S G++
Sbjct: 268 PTDMWSVGVI 277

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT  Y+ P   +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEYLAPAIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH---- 730
           +F     +G GSFG V      E G   A+K+  LDK+   K        L+ I H    
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDKQKVVK--------LKQIEHTLNE 92
Query: 731 RNLIKIITI--CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IV 782
           + +++ +     + ++F   D  + +Y  M+Y    +   H      +G+ +        
Sbjct: 93  KRILQAVNFPFLTKLEFSFKD-NSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYA 148
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            ++    EYLH+     +++ DLKP N+++D      V+DFG A+ +           + 
Sbjct: 149 AQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----------KG 194
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 116/251 (46%), Gaps = 49/251 (19%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGN---LGEDG--MSVAVKVMNLDKKGA 714
           Q P     E  +   +F  +  +G G+FG V +     LG++   + VAVK++       
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 715 TK-SFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL----- 767
            K + ++E + + ++ +H N++ ++  C+     G     ++ EY  YG + ++L     
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKRP 146
Query: 768 ----------HHTNDKLEVGKL-NIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHD 815
                     H+  ++L    L +   +VA  + +L + +C    +H D+   NVLL + 
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNG 202
Query: 816 MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDLSMTGDVY 871
            VA + DFGLAR + +           S+  +KG     + ++ PE       ++  DV+
Sbjct: 203 HVAKIGDFGLARDIMN----------DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 252
Query: 872 SFGILLLEMFT 882
           S+GILL E+F+
Sbjct: 253 SYGILLWEIFS 263

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH---- 730
           +F     +G GSFG V      E G   A+K+  LDK+   K        L+ I H    
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDKQKVVK--------LKQIEHTLNE 92
Query: 731 RNLIKIITI--CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IV 782
           + +++ +     + ++F   D  + +Y  M+Y    +   H      +G+ +        
Sbjct: 93  KRILQAVNFPFLTKLEFSFKD-NSNLYMVMEYAPGGEMFSHLR---RIGRFSEPHARFYA 148
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            ++    EYLH+     +++ DLKP N+++D      V+DFG A+ +           + 
Sbjct: 149 AQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----------KG 194
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY   G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+++D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 33/210 (15%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNL 733
             +G G F  V K      G+  A K +   +  A++  V+      E   LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           I +  +     ++      ++ E +  G + D+L       E    + + ++   + YLH
Sbjct: 78  ITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 794 NHCQPPIVHGDLKPSNV-LLDHDM-VAHVS--DFGLARFLSHHPFLVAPEGQSSSIEMK- 848
                 I H DLKP N+ LLD ++ + H+   DFGLA  +               +E K 
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------------EDGVEFKN 177
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
             GT  ++ PE      L +  D++S G++
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 33/210 (15%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNL 733
             +G G F  V K      G+  A K +   +  A++  V+      E   LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           I +  +     ++      ++ E +  G + D+L       E    + + ++   + YLH
Sbjct: 78  ITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 794 NHCQPPIVHGDLKPSNV-LLDHDM-VAHVS--DFGLARFLSHHPFLVAPEGQSSSIEMK- 848
                 I H DLKP N+ LLD ++ + H+   DFGLA  +               +E K 
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------------EDGVEFKN 177
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
             GT  ++ PE      L +  D++S G++
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 33/210 (15%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNL 733
             +G G F  V K      G+  A K +   +  A++  V+      E   LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           I +  +     ++      ++ E +  G + D+L       E    + + ++   + YLH
Sbjct: 78  ITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 794 NHCQPPIVHGDLKPSNV-LLDHDM-VAHVS--DFGLARFLSHHPFLVAPEGQSSSIEMK- 848
                 I H DLKP N+ LLD ++ + H+   DFGLA  +               +E K 
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------------EDGVEFKN 177
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
             GT  ++ PE      L +  D++S G++
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 33/210 (15%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNL 733
             +G G F  V K      G+  A K +   +  A++  V+      E   LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           I +  +     ++      ++ E +  G + D+L       E    + + ++   + YLH
Sbjct: 78  ITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 794 NHCQPPIVHGDLKPSNV-LLDHDM-VAHVS--DFGLARFLSHHPFLVAPEGQSSSIEMK- 848
                 I H DLKP N+ LLD ++ + H+   DFGLA  +               +E K 
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------------EDGVEFKN 177
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
             GT  ++ PE      L +  D++S G++
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY   G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+++D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 54/251 (21%)
Query: 657 MEQQFPIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK 712
           M Q+ P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 713 GA--TKSFVAECEALRNIRHRN---LIKIITICSSID----------FKGADFKAIVYEY 757
                K    E   L++++H N   L+ + T   S++            GAD   IV   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--- 117
Query: 758 MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
                       T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D  
Sbjct: 118 -------KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 163
Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSF 873
             + DF LAR               +  EM G +    Y  PE  +     + T D++S 
Sbjct: 164 LKILDFYLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 209
Query: 874 GILLLEMFTRR 884
           G ++ E+ T R
Sbjct: 210 GCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 103/246 (41%), Gaps = 54/246 (21%)
Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +     
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 716 KSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQYGS 762
           K    E   L++++H N+I    + T   S++            GAD   IV        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 113
Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 114 --KCAKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 164
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 165 FGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 879 EMFTRR 884
           E+ T R
Sbjct: 211 ELLTGR 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRN 727
           +K +  +     +GKG+F  V +      G+  A K++N  K  A   +    E    R 
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           ++H N++++         +   F  +V++ +  G + + +       E    + + ++  
Sbjct: 85  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            I Y H++    IVH +LKP N+LL          ++DFGLA         +      + 
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEVNDSEAW 187
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
               GT GY+ PE       S   D+++ G++L
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 22  KAKEDFLKKWESPAQNTAHLD----QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK 77
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY   G +   L  
Sbjct: 78  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYAPGGEMFSHLRR 135
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+++D      V+DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 193 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALR 726
           E+  S  +G G+ G V      +    VA+K+++  K     +  A        E E L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EV 785
            + H  +IKI     + D+       IV E M+ G + D +   N +L+     +   ++
Sbjct: 71  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQM 123
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
              ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++ L          G++
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GET 170
Query: 843 SSIE-MKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLL 878
           S +  + GT  Y+ PE     G  G  +   D +S G++L 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALR 726
           E+  S  +G G+ G V      +    VA+K+++  K     +  A        E E L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EV 785
            + H  +IKI     + D+       IV E M+ G + D +   N +L+     +   ++
Sbjct: 71  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQM 123
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
              ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++ L          G++
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GET 170
Query: 843 SSIE-MKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLL 878
           S +  + GT  Y+ PE     G  G  +   D +S G++L 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALR 726
           E+  S  +G G+ G V      +    VA+K+++  K     +  A        E E L+
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EV 785
            + H  +IKI     + D+       IV E M+ G + D +   N +L+     +   ++
Sbjct: 77  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQM 129
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
              ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++ L          G++
Sbjct: 130 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GET 176
Query: 843 SSIE-MKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLL 878
           S +  + GT  Y+ PE     G  G  +   D +S G++L 
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 216

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALR 726
           E+  S  +G G+ G V      +    VA+K+++  K     +  A        E E L+
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EV 785
            + H  +IKI     + D+       IV E M+ G + D +   N +L+     +   ++
Sbjct: 70  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQM 122
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
              ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++ L          G++
Sbjct: 123 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GET 169
Query: 843 SSIE-MKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLL 878
           S +  + GT  Y+ PE     G  G  +   D +S G++L 
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALR 726
           E+  S  +G G+ G V      +    VA+K+++  K     +  A        E E L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EV 785
            + H  +IKI     + D+       IV E M+ G + D +   N +L+     +   ++
Sbjct: 71  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQM 123
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
              ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++ L          G++
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GET 170
Query: 843 SSIE-MKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLL 878
           S +  + GT  Y+ PE     G  G  +   D +S G++L 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 33/208 (15%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNLIK 735
           +G G F  V K      G+  A K +   +  A++  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH 795
           +  +     ++      ++ E +  G + D+L       E    + + ++   + YLH  
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 796 CQPPIVHGDLKPSNV-LLDHDM-VAHVS--DFGLARFLSHHPFLVAPEGQSSSIEMK--- 848
               I H DLKP N+ LLD ++ + H+   DFGLA  +               +E K   
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------------EDGVEFKNIF 179
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
           GT  ++ PE      L +  D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 40/218 (18%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH---- 730
           +F     +G GSFG V      E G   A+K+  LDK+   K        L+ I H    
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDKQKVVK--------LKQIEHTLNE 92
Query: 731 RNLIKIITI--CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IV 782
           + +++ +     + ++F   D  + +Y  M+Y    +   H      +G+          
Sbjct: 93  KRILQAVNFPFLTKLEFSFKD-NSNLYMVMEYAPGGEMFSHLR---RIGRFXEPHARFYA 148
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            ++    EYLH+     +++ DLKP N+++D      V+DFG A+ +           + 
Sbjct: 149 AQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----------KG 194
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 16/206 (7%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +F     +G GSFG V      E G   A+K+++  K    K         R ++  N  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++ +     FK      +V EY   G +   L       E        ++    EYLH+
Sbjct: 102 FLVKL--EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                +++ DLKP N+++D      V+DFG A+ +           +  +  + GT  Y+
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----------KGRTWXLCGTPEYL 205
Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEM 880
            PE  +    +   D ++ G+L+ EM
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 33/210 (15%)
Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNL 733
             +G G F  V K      G+  A K +   +  A++  V+      E   LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           I +  +     ++      ++ E +  G + D+L       E    + + ++   + YLH
Sbjct: 78  ITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 794 NHCQPPIVHGDLKPSNV-LLDHDM-VAHVS--DFGLARFLSHHPFLVAPEGQSSSIEMK- 848
                 I H DLKP N+ LLD ++ + H+   DFGLA  +               +E K 
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------------EDGVEFKN 177
Query: 849 --GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
             GT  ++ PE      L +  D++S G++
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 103/246 (41%), Gaps = 54/246 (21%)
Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 716 KSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQYGS 762
           K    E   L++++H N+I    + T   S++            GAD   IV        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 113
Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 114 --KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 164
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 165 FGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 879 EMFTRR 884
           E+ T R
Sbjct: 211 ELLTGR 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMNLDKKGATKSFVAECEALRNIR 729
           +   +F     +G+G+FG V K     D    A+K + + ++K +T   ++E   L ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVXLLASLN 60
Query: 730 H-------------RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEV 776
           H             RN +K  T   ++  K   F  I  EY +  ++ D +H  N   + 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXT---AVKKKSTLF--IQXEYCENRTLYDLIHSENLNQQR 115
Query: 777 GKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
            +   +  ++   + Y+H+     I+H +LKP N+ +D      + DFGLA+ +     +
Sbjct: 116 DEYWRLFRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 836 VAPEGQS---SSIEMKGTIG---YIGPEYGMG-GDLSMTGDVYSFGILLLE 879
           +  + Q+   SS  +   IG   Y+  E   G G  +   D YS GI+  E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A+L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 21  KAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R ++  N   ++ +     FK      +V EY+  G +   L  
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
               + +            GT   + PE  +    +   D ++ G+L+ EM
Sbjct: 192 KGRTWXLC-----------GTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 57/244 (23%), Positives = 108/244 (44%), Gaps = 33/244 (13%)
Query: 682 IGKGSFGFVYKG--NLGEDGMSVAVKVMNL-DKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G G+FG V +G   + +  + VA+KV+    +K  T+  + E + +  + +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQ 797
           +C       A+   +V E    G +  +L    +++ V  +  ++ +V+  ++YL    +
Sbjct: 78  VCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---E 128
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
              VH DL   NVLL +   A +SDFGL++ L                  K  + +  PE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-----KWPLKWYAPE 183
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
                  S   DV+S+G+ + E  +  ++P             Y KM  P +VM  ++  
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP-------------YKKMKGP-EVMAFIEQG 229
Query: 917 LLME 920
             ME
Sbjct: 230 KRME 233

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 90/231 (38%), Gaps = 20/231 (8%)
Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           K     L + + P  + A L     +F     +G GSFG V      E G   A+K+++ 
Sbjct: 22  KAKEDFLKKWESPAQNTAHLD----QFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK 77
Query: 710 DKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH 769
            K    K         R  +  N   ++ +     FK      +V EY   G +   L  
Sbjct: 78  QKVVKLKQIEHTLNEKRIQQAVNFPFLVKL--EFSFKDNSNLYMVLEYAPGGEMFSHLRR 135
Query: 770 TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                E        ++    EYLH+     +++ DLKP N+L+D      V+DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 192
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                      +  +  + GT  Y+ PE  +    +   D ++ G+L+ EM
Sbjct: 193 -----------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNL 733
           +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 71
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
            KII +    D++  D    +Y  M+ G++D   WL     K  +          +++E 
Sbjct: 72  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEA 123
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q       GT+
Sbjct: 124 VHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV------GTV 176
Query: 852 GYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
            Y+ PE     D+S +              DV+S G +L  M   + P   + N    LH
Sbjct: 177 NYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 234
Query: 899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM 952
                        I+DP+   E   P   E+ L  V++    C    P +R+ +
Sbjct: 235 ------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISI 271

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 116/258 (44%), Gaps = 56/258 (21%)
Query: 660 QFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGN---LGEDG--MSVAVKVMNLDKKGA 714
           Q P     E  +   +F  +  +G G+FG V +     LG++   + VAVK++       
Sbjct: 19  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 76
Query: 715 TK-SFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
            K + ++E + + ++ +H N++ ++  C+     G     ++ EY  YG + ++L    +
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAE 131
Query: 773 KL----------------EVGK-------LNIVIEVASVIEYLHN-HCQPPIVHGDLKPS 808
            +                E G+       L+   +VA  + +L + +C    +H D+   
Sbjct: 132 AMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAAR 187
Query: 809 NVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT----IGYIGPEYGMGGDL 864
           NVLL +  VA + DFGLAR + +           S+  +KG     + ++ PE       
Sbjct: 188 NVLLTNGHVAKIGDFGLARDIMN----------DSNYIVKGNARLPVKWMAPESIFDCVY 237
Query: 865 SMTGDVYSFGILLLEMFT 882
           ++  DV+S+GILL E+F+
Sbjct: 238 TVQSDVWSYGILLWEIFS 255

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 48/233 (20%)
Query: 682 IGKGSFGFVYKGNL----GEDGMS-VAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIK 735
           +G+G FG V K       G  G + VAVK++  +   +  +  ++E   L+ + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWL-----------------------HHTND 772
           +   CS     G     ++ EY +YGS+  +L                       H    
Sbjct: 91  LYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 773 KLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
            L +G L +   +++  ++YL    +  +VH DL   N+L+       +SDFGL+R +  
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY- 201
Query: 832 HPFLVAPEGQSSSIEMKGTI--GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  E  S     +G I   ++  E       +   DV+SFG+LL E+ T
Sbjct: 202 -------EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 48/233 (20%)
Query: 682 IGKGSFGFVYKGNL----GEDGMS-VAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIK 735
           +G+G FG V K       G  G + VAVK++  +   +  +  ++E   L+ + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWL-----------------------HHTND 772
           +   CS     G     ++ EY +YGS+  +L                       H    
Sbjct: 91  LYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 773 KLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
            L +G L +   +++  ++YL    +  +VH DL   N+L+       +SDFGL+R +  
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY- 201
Query: 832 HPFLVAPEGQSSSIEMKGTI--GYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  E  S     +G I   ++  E       +   DV+SFG+LL E+ T
Sbjct: 202 -------EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHR 731
           K + S   +G G++G V        G  VA+K ++     +   K    E   L++++H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 732 NLI---KIITICSSIDFKGADFKAIVYEYMQYGSVDDW-LHHTNDKLEVGKLNIVIEVAS 787
           N+I    + T  SS+     DF  +V  +MQ        L  + +K++     +V ++  
Sbjct: 84  NVIGLLDVFTPASSLR-NFYDF-YLVMPFMQTDLQKIMGLKFSEEKIQY----LVYQMLK 137
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++Y+H+     +VH DLKP N+ ++ D    + DFGLAR               +  EM
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR--------------HADAEM 180
Query: 848 KG---TIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
            G   T  Y  PE  +     + T D++S G ++ EM T
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 103/246 (41%), Gaps = 54/246 (21%)
Query: 662 PIVSYAELSKATKE----FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--T 715
           P     EL+K   E    + + + +G G++G V      + G  VAVK ++   +     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 716 KSFVAECEALRNIRHRNLI---KIITICSSID----------FKGADFKAIVYEYMQYGS 762
           K    E   L++++H N+I    + T   S++            GAD   IV        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 113
Query: 763 VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                  T+D ++     ++ ++   ++Y+H+     I+H DLKPSN+ ++ D    + D
Sbjct: 114 --KCQKLTDDHVQF----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 164
Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLL 878
           FGLAR               +  EM G +    Y  PE  +     + T D++S G ++ 
Sbjct: 165 FGLAR--------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 879 EMFTRR 884
           E+ T R
Sbjct: 211 ELLTGR 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNL 733
           +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
            KII +    D++  D    +Y  M+ G++D   WL     K  +          +++E 
Sbjct: 69  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEA 120
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q       GT+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV------GTV 173
Query: 852 GYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
            Y+ PE     D+S +              DV+S G +L  M   + P   + N    LH
Sbjct: 174 NYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231
Query: 899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM 952
                        I+DP+   E   P   E+ L  V++    C    P +R+ +
Sbjct: 232 ------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISI 268

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
           ++   +VA  +E+L +      +H DL   N+LL  + V  + DFGLAR +  +P  V  
Sbjct: 202 ISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYV-- 256
Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  + +  + ++ PE       S   DV+S+G+LL E+F+
Sbjct: 257 ----RKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 99/232 (42%), Gaps = 46/232 (19%)
Query: 682 IGKGSFGFVYKGNL----GEDGMS-VAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIK 735
           +G+G FG V K       G  G + VAVK++  +   +  +  ++E   L+ + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWL-----------------------HHTND 772
           +   CS     G     ++ EY +YGS+  +L                       H    
Sbjct: 91  LYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 773 KLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR-FLS 830
            L +G L +   +++  ++YL    +  +VH DL   N+L+       +SDFGL+R    
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              ++   +G+         + ++  E       +   DV+SFG+LL E+ T
Sbjct: 203 EDSYVKRSQGRIP-------VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 657 MEQQFPIVSYAELS-KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKG 713
           M+ QF  V  A+ +    K +     IG G+ G V        G++VAVK ++     + 
Sbjct: 4   MDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 63
Query: 714 ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHHTN 771
             K    E   L+ + H+N+I ++ + +       +F+ +  V E M   ++   +H   
Sbjct: 64  HAKRAYRELVLLKCVNHKNIISLLNVFTP-QKTLEEFQDVYLVMELMD-ANLCQVIHMEL 121
Query: 772 DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
           D   +  L  + ++   I++LH+     I+H DLKPSN+++  D    + DFGLAR  S 
Sbjct: 122 DHERMSYL--LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAST 176
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + F++ P           T  Y  PE  +G       D++S G ++ E+
Sbjct: 177 N-FMMTP--------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRN 727
           +K +  +     +GKG+F  V +      G+  A K++N  K  A   +    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           ++H N++++         +   F  +V++ +  G + + +       E    + + ++  
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            I Y H++    IVH +LKP N+LL          ++DFGLA         +      + 
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEVNDSEAW 164
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
               GT GY+ PE       S   D+++ G++L
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRN 727
           +K +  +     +GKG+F  V +      G+  A K++N  K  A   +    E    R 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           ++H N++++         +   F  +V++ +  G + + +       E    + + ++  
Sbjct: 61  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 115
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            I Y H++    IVH +LKP N+LL          ++DFGLA         +      + 
Sbjct: 116 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEVNDSEAW 163
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
               GT GY+ PE       S   D+++ G++L
Sbjct: 164 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRN 727
           +K +  +     +GKG+F  V +      G+  A K++N  K  A   +    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           ++H N++++         +   F  +V++ +  G + + +       E    + + ++  
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
            I Y H++    IVH +LKP N+LL          ++DFGLA         +      + 
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEVNDSEAW 164
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
               GT GY+ PE       S   D+++ G++L
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRNIRH 730
           T E+     IGKG+F  V +      G   A K++N  K  A      E EA   R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++++     SI  +G  F  +V++ +  G + + +       E    + + ++   + 
Sbjct: 63  SNIVRL---HDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV- 116
Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLARFLSHHPFLVAPEG-QSSSIE 846
            LH H Q  +VH DLKP N+LL          ++DFGLA         +  +G Q +   
Sbjct: 117 -LHCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLA---------IEVQGDQQAWFG 165
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
             GT GY+ PE           D+++ G++L
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNL 733
           +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 67
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
            KII +    D++  D    +Y  M+ G++D   WL     K  +          +++E 
Sbjct: 68  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEA 119
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q       GT+
Sbjct: 120 VHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV------GTV 172
Query: 852 GYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
            Y+ PE     D+S +              DV+S G +L  M   + P   + N    LH
Sbjct: 173 NYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 230
Query: 899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM 952
                        I+DP+   E   P   E+ L  V++    C    P +R+ +
Sbjct: 231 ------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISI 267

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHR 731
           K + S   +G G++G V        G  VA+K ++     +   K    E   L++++H 
Sbjct: 42  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 732 N---LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDW-LHHTNDKLEVGKLNIVIEVAS 787
           N   L+ + T  SS+     DF  +V  +MQ        +  + +K++     +V ++  
Sbjct: 102 NVIGLLDVFTPASSLR-NFYDF-YLVMPFMQTDLQKIMGMEFSEEKIQY----LVYQMLK 155
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            ++Y+H+     +VH DLKP N+ ++ D    + DFGLAR               +  EM
Sbjct: 156 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR--------------HADAEM 198
Query: 848 KG---TIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFT 882
            G   T  Y  PE  +     + T D++S G ++ EM T
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALR 726
           E+  S  +G G+ G V      +    VA+++++  K     +  A        E E L+
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EV 785
            + H  +IKI     + D+       IV E M+ G + D +   N +L+     +   ++
Sbjct: 210 KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQM 262
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
              ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++ L          G++
Sbjct: 263 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GET 309
Query: 843 SSIE-MKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLL 878
           S +  + GT  Y+ PE     G  G  +   D +S G++L 
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 349

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E++  + YLH      I++ DLK  NVLLD +    ++D+G+ +     P      G ++
Sbjct: 129 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRP------GDTT 178
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           S    GT  YI PE   G D   + D ++ G+L+ EM   R P D
Sbjct: 179 SX-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E++  + YLH      I++ DLK  NVLLD +    ++D+G+ +     P      G ++
Sbjct: 161 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRP------GDTT 210
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
           S    GT  YI PE   G D   + D ++ G+L+ EM   R P D
Sbjct: 211 ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALR 726
           E+  S  +G G+ G V      +    VA+++++  K     +  A        E E L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EV 785
            + H  +IKI     + D+       IV E M+ G + D +   N +L+     +   ++
Sbjct: 196 KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQM 248
Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
              ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++ L          G++
Sbjct: 249 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GET 295
Query: 843 SSIE-MKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLL 878
           S +  + GT  Y+ PE     G  G  +   D +S G++L 
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 335

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 682 IGKGSFGFVYKGNLGEDG-------MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +G+G+F  ++KG   E G         V +KV++   +  ++SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEV-GKLNIVIEVASVIEYLH 793
               +C        D   +V E++++GS+D +L    + + +  KL +  ++A+ + +L 
Sbjct: 76  LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQSSSIEMKG--- 849
            +    ++HG++   N+LL  +           R   + PF+ ++  G S ++  K    
Sbjct: 131 ENT---LIHGNVCAKNILLIREE---------DRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 850 -TIGYIGPE-YGMGGDLSMTGDVYSFGILLLEM 880
             I ++ PE      +L++  D +SFG  L E+
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMS---VAVKVMNLDK-KGATKSFVAECEALRNIRHR 731
           +   + +G G+F  V    L ED  +   VA+K +     +G   S   E   L  I+H 
Sbjct: 20  YDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 76
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           N++ +  I     ++      ++ + +  G + D +       E     ++ +V   ++Y
Sbjct: 77  NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 792 LHNHCQPPIVHGDLKPSNVL---LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           LH+     IVH DLKP N+L   LD D    +SDFGL++           E   S +   
Sbjct: 132 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLSTA 178
Query: 849 -GTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            GT GY+ PE       S   D +S G++
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 664 VSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAE 721
           VS A  + +   +    ++G+G++G VYK        +VA+K + L  +++G   + + E
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 722 CEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI 781
              L+ ++HRN+I++ ++             +++EY +           ND  +    N 
Sbjct: 84  VSLLKELQHRNIIELKSVIHH-----NHRLHLIFEYAE-----------NDLKKYMDKNP 127
Query: 782 VIEVASVIEYLH------NHCQP-PIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFL 829
            + +  +  +L+      N C     +H DLKP N+LL         V  + DFGLAR  
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-- 185
Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTR 883
               F +     +  I    T+ Y  PE  +G    S + D++S   +  EM  +
Sbjct: 186 ---AFGIPIRQFTHEI---ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 30/228 (13%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS--FVAECEALRNIRHR 731
           K+ +   ++ +   G ++KG     G  + VKV+ +      KS  F  EC  LR   H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGK-LNIVIEVASVI 789
           N++ ++  C S     A    ++  +  YGS+ + LH  TN  ++  + +   ++ A   
Sbjct: 68  NVLPVLGACQS---PPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGX 124
Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-RFLS----HHPFLVAPEGQSSS 844
            +LH   +P I    L   +V +D D  A +S   +   F S    + P  VAPE     
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKK 183
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
            E                    + D +SF +LL E+ TR  P  ++ N
Sbjct: 184 PEDTN---------------RRSADXWSFAVLLWELVTREVPFADLSN 216

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 17/108 (15%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG--- 840
           E++  + YLH      I++ DLK  NVLLD +    ++D+G+ +           EG   
Sbjct: 114 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----------EGLRP 159
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
             ++    GT  YI PE   G D   + D ++ G+L+ EM   R P D
Sbjct: 160 GDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 40/248 (16%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           ++    ++G+G +  V++     +   V VK++   KK   K    E + L N+R     
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLR--GGP 92
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            IIT+   +    +   A+V+E++        L+ T    ++     + E+   ++Y H+
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIR--FYMYEILKALDYCHS 149
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                I+H D+KP NV++DH+     + D+GLA F  +HP      GQ  ++ +  +  +
Sbjct: 150 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------GQEYNVRV-ASRYF 197
Query: 854 IGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG---YAKMALP 906
            GPE    Y M  D S+  D++S G +L  M  R+ P           HG   Y ++   
Sbjct: 198 KGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------FFHGHDNYDQLVRI 245
Query: 907 KKVMGIVD 914
            KV+G  D
Sbjct: 246 AKVLGTED 253

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 17/108 (15%)
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG--- 840
           E++  + YLH      I++ DLK  NVLLD +    ++D+G+ +           EG   
Sbjct: 118 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----------EGLRP 163
Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
             ++    GT  YI PE   G D   + D ++ G+L+ EM   R P D
Sbjct: 164 GDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 682 IGKGSFGFVYKG--NLGEDGMSVAVKVMNL-DKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G G+FG V +G   + +  + VA+KV+    +K  T+  + E + +  + +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQ 797
           +C       A+   +V E    G +  +L    +++ V  +  ++ +V+  ++YL    +
Sbjct: 404 VCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---E 454
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL-SHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              VH +L   NVLL +   A +SDFGL++ L +   +  A   +S+    K  + +  P
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA---RSAG---KWPLKWYAP 508
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNM 890
           E       S   DV+S+G+ + E  +  ++P   M
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSFG V   +        A+K++  D   +    +  + E   L  +     +  + 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
            C    F+  D    V EY+  G   D ++H     +VGK           E++  + +L
Sbjct: 87  SC----FQTVDRLYFVMEYVNGG---DLMYHIQ---QVGKFKEPQAVFYAAEISIGLFFL 136
Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H      I++ DLK  NV+LD +    ++DFG+ +    H      +G ++  E  GT  
Sbjct: 137 HKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMM----DGVTTR-EFCGTPD 185
Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL 895
           YI PE         + D +++G+LL EM   + P D    D L
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V      
Sbjct: 200 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV------ 250
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V      
Sbjct: 205 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV------ 255
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 256 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 682 IGKGSFG--FVYKGNLGED-----GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +G G++G  F+ +   G D      M V  K   + K   T+    E + L +IR    +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
             +T+  +  F+      ++ +Y+  G +     H + +    +  + I V  ++  L +
Sbjct: 122 --VTLHYA--FQTETKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
             +  I++ D+K  N+LLD +    ++DFGL++        VA E +  + +  GTI Y+
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETE-RAYDFCGTIEYM 227
Query: 855 GPEYGMGGD--LSMTGDVYSFGILLLEMFTRRRP 886
            P+   GGD       D +S G+L+ E+ T   P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V      
Sbjct: 198 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV------ 248
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 249 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P  V      
Sbjct: 207 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV------ 257
Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              + +  + ++ PE       ++  DV+SFG+LL E+F+
Sbjct: 258 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           K F     +G G+F  V+       G   A+K +         S   E   L+ I+H N+
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           + +  I     ++      +V + +  G + D +       E     ++ +V S ++YLH
Sbjct: 69  VTLEDI-----YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123
Query: 794 NHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            +    IVH DLKP N+L    + +    ++DFGL++   +     A           GT
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----------GT 170
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGIL 876
            GY+ PE       S   D +S G++
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 695 LGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKIITICSSID--------- 744
           LG+ G +   ++ ++D K       V +   L+  +   +   I I  S+D         
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 745 -FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG 803
            F+  DF  +V E  +  S+ +         E      + +    ++YLHN+    ++H 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHR 166
Query: 804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD 863
           DLK  N+ L+ DM   + DFGLA  +         +G+    ++ GT  YI PE      
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEF-------DGERKK-DLCGTPNYIAPEVLCKKG 218
Query: 864 LSMTGDVYSFGILLLEMFTRRRP 886
            S   D++S G +L  +   + P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 695 LGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKIITICSSID--------- 744
           LG+ G +   ++ ++D K       V +   L+  +   +   I I  S+D         
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 745 -FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG 803
            F+  DF  +V E  +  S+ +         E      + +    ++YLHN+    ++H 
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHR 150
Query: 804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD 863
           DLK  N+ L+ DM   + DFGLA  +         +G+    ++ GT  YI PE      
Sbjct: 151 DLKLGNLFLNDDMDVKIGDFGLATKIEF-------DGERKK-DLCGTPNYIAPEVLCKKG 202
Query: 864 LSMTGDVYSFGILLLEMFTRRRP 886
            S   D++S G +L  +   + P
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPP 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 27/241 (11%)
Query: 657 MEQQFPIVSYAELSKATKE-FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKK 712
           +E   P  S  +  +  +E F     IG+G+FG V    L       A+K++N   + K+
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 713 GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
             T  F  E + L N   + +  +        F+  +   +V +Y   G +   L    D
Sbjct: 116 AETACFREERDVLVNGDSKWITTL-----HYAFQDDNNLYLVMDYYVGGDLLTLLSKFED 170
Query: 773 KL--EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
           +L  E+ +  +  E+   I+ +H   Q   VH D+KP N+L+D +    ++DFG      
Sbjct: 171 RLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC---- 222
Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEY-----GMGGDLSMTGDVYSFGILLLEMFTRRR 885
                +  +G   S    GT  YI PE      G  G      D +S G+ + EM     
Sbjct: 223 ---LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 886 P 886
           P
Sbjct: 280 P 280

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 682 IGKGSFGFVYKGNLGEDG-------MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
           +G+G+F  ++KG   E G         V +KV++   +  ++SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEV-GKLNIVIEVASVIEYLH 793
               +C    F G D   +V E++++GS+D +L    + + +  KL +  ++A  + +L 
Sbjct: 76  LNYGVC----FCG-DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLE 130
Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQSSSIEMKG--- 849
            +    ++HG++   N+LL  +           R   + PF+ ++  G S ++  K    
Sbjct: 131 ENT---LIHGNVCAKNILLIREE---------DRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 850 -TIGYIGPE-YGMGGDLSMTGDVYSFGILLLEM 880
             I ++ PE      +L++  D +SFG  L E+
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRN 727
           ++ T+E+     +GKG+F  V +      G   A  ++N  K  A      E EA   R 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           ++H N++++     SI  +G  +  ++++ +  G + + +       E    + + ++  
Sbjct: 67  LKHPNIVRL---HDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLARFLSHHPFLVAPEG-QSS 843
            +  LH H Q  +VH +LKP N+LL   +      ++DFGLA         +  EG Q +
Sbjct: 122 AV--LHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA---------IEVEGEQQA 169
Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
                GT GY+ PE           D+++ G++L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNL 733
           +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
            KII +    D++  D    +Y  M+ G++D   WL     K  +          +++E 
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEA 167
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q       GT+
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV------GTV 220
Query: 852 GYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
            Y+ PE     D+S +              DV+S G +L  M   + P   + N    LH
Sbjct: 221 NYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM 952
                        I+DP+   E   P   E+ L  V++    C    P +R+ +
Sbjct: 279 ------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISI 315

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHRNLIKIITIC 740
           IG GS+    +       M  AVKV++  K+  ++    E E L R  +H N+I +  + 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE----EIEILLRYGQHPNIITLKDV- 89
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +       +V E M+ G + D +       E     ++  +   +EYLH+     +
Sbjct: 90  ----YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---V 142
Query: 801 VHGDLKPSNVLLDHDM----VAHVSDFGLARFL-SHHPFLVAPEGQSSSIEMKGTIGYIG 855
           VH DLKPSN+L   +        + DFG A+ L + +  L+ P           T  ++ 
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP---------CYTANFVA 193
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           PE           D++S GILL  M     P  N  +D
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNL 733
           +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
            KII +    D++  D    +Y  M+ G++D   WL     K  +          +++E 
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEA 167
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q       GT+
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV------GTV 220
Query: 852 GYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
            Y+ PE     D+S +              DV+S G +L  M   + P   + N    LH
Sbjct: 221 NYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM 952
                        I+DP+   E   P   E+ L  V++    C    P +R+ +
Sbjct: 279 ------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISI 315

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 51/187 (27%)
Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK----------------------- 711
           +++  + IGKGS+G V       D    A+KV++  K                       
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 712 ---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH 768
              +G  +    E   L+ + H N++K++ +   +D    D   +V+E +  G V     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPV----- 125
Query: 769 HTNDKLEVGKLNIVIEVASV---------IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
                +EV  L  + E  +          IEYLH      I+H D+KPSN+L+  D    
Sbjct: 126 -----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIK 177
Query: 820 VSDFGLA 826
           ++DFG++
Sbjct: 178 IADFGVS 184

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 22/203 (10%)
Query: 695 LGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKIITICSSID--------- 744
           LG+ G +   ++ ++D K       V +   L+  +   +   I I  S+D         
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 745 -FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG 803
            F+  DF  +V E  +  S+ +         E      + +    ++YLHN+    ++H 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHR 166
Query: 804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD 863
           DLK  N+ L+ DM   + DFGLA  +         +G+     + GT  YI PE      
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEF-------DGERKKT-LCGTPNYIAPEVLCKKG 218
Query: 864 LSMTGDVYSFGILLLEMFTRRRP 886
            S   D++S G +L  +   + P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 22/203 (10%)
Query: 695 LGEDGMSVAVKVMNLDKKGA-TKSFVAECEALRNIRHRNLIKIITICSSID--------- 744
           LG+ G +   ++ ++D K       V +   L+  +   +   I I  S+D         
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 745 -FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG 803
            F+  DF  +V E  +  S+ +         E      + +    ++YLHN+    ++H 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHR 166
Query: 804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD 863
           DLK  N+ L+ DM   + DFGLA  +         +G+     + GT  YI PE      
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEF-------DGERKK-XLCGTPNYIAPEVLCKKG 218
Query: 864 LSMTGDVYSFGILLLEMFTRRRP 886
            S   D++S G +L  +   + P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 4/178 (2%)
Query: 337 KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLT 395
           KL L  N+   +LP    +  T + L+ +  N++  T+P  I + L NL  L +  N+L 
Sbjct: 41  KLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98
Query: 396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQN 455
                   +L NL  L L  N ++ + P    +LT L  L LG+N+LQ        K  +
Sbjct: 99  ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS 158
Query: 456 LMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRN 513
           L +L   NN+L   +P   F   T  K L L  N L         +L+ L  L +  N
Sbjct: 159 LKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           +     +G G F  V K      G   A K +   +  +++  V+      E   LR IR
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  I     F+      ++ E +  G + D+L       E      + ++   +
Sbjct: 74  HPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDM---VAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFG+A     H      E ++   
Sbjct: 129 HYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKN--- 177
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEA 724
           E+    ++F     IG+G+FG V    +       A+K++N   + K+  T  F  E + 
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI- 783
           L N       + IT      F+  +   +V +Y   G +   L    DKL        I 
Sbjct: 128 LVN----GDCQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 182
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+   I+ +H   Q   VH D+KP NVLLD +    ++DFG           +  +G   
Sbjct: 183 EMVLAIDSIH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSC-------LKMNDDGTVQ 232
Query: 844 SIEMKGTIGYIGPEY------GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           S    GT  YI PE       GMG       D +S G+ + EM     P
Sbjct: 233 SSVAVGTPDYISPEILQAMEDGMGK-YGPECDWWSLGVCMYEMLYGETP 280

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           +     +G G F  V K      G   A K +   +  +++  V+      E   LR IR
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  I     F+      ++ E +  G + D+L       E      + ++   +
Sbjct: 67  HPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDM---VAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFG+A     H      E ++   
Sbjct: 122 HYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKN--- 170
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 171 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 53/304 (17%)
Query: 666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECE 723
           +  +S   + +S   +IG G    V++  L E     A+K +NL++       S+  E  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 724 ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNI 781
            L  ++  +  KII +    D++  D    +Y  M+ G++D   WL     K  +     
Sbjct: 79  YLNKLQQHS-DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWER 129
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
                +++E +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQ 188
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTD 888
                  GT+ Y+ PE     D+S +              DV+S G +L  M   + P  
Sbjct: 189 V------GTVNYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 889 NMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE 948
            + N    LH             I+DP+   E   P   E+ L  V++    C    P +
Sbjct: 241 QIINQISKLH------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQ 283
Query: 949 RMQM 952
           R+ +
Sbjct: 284 RISI 287

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEA 724
           E+    ++F     IG+G+FG V    +       A+K++N   + K+  T  F  E + 
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI- 783
           L N       + IT      F+  +   +V +Y   G +   L    DKL        I 
Sbjct: 144 LVN----GDCQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 198
Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           E+   I+ +H   Q   VH D+KP NVLLD +    ++DFG           +  +G   
Sbjct: 199 EMVLAIDSIH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSC-------LKMNDDGTVQ 248
Query: 844 SIEMKGTIGYIGPEY------GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           S    GT  YI PE       GMG       D +S G+ + EM     P
Sbjct: 249 SSVAVGTPDYISPEILQAMEDGMGK-YGPECDWWSLGVCMYEMLYGETP 296

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHRNLIKIITIC 740
           IG GS+    +       M  AVKV++  K+  ++    E E L R  +H N+I +  + 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE----EIEILLRYGQHPNIITLKDV- 89
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
               +       +V E M+ G + D +       E     ++  +   +EYLH+     +
Sbjct: 90  ----YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---V 142
Query: 801 VHGDLKPSNVLLDHDM----VAHVSDFGLARFL-SHHPFLVAPEGQSSSIEMKGTIGYIG 855
           VH DLKPSN+L   +        + DFG A+ L + +  L+ P           T  ++ 
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP---------CYTANFVA 193
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           PE           D++S GILL  M     P  N  +D
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 657 MEQQFPIVSYAELS-KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKG 713
           ++ QF  V  A+ +    K +     IG G+ G V        G++VAVK ++     + 
Sbjct: 6   VDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 65
Query: 714 ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHHTN 771
             K    E   L+ + H+N+I ++ + +       +F+ +  V E M   ++   +H   
Sbjct: 66  HAKRAYRELVLLKCVNHKNIISLLNVFTP-QKTLEEFQDVYLVMELMD-ANLCQVIHMEL 123
Query: 772 DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
           D   +  L  + ++   I++LH+     I+H DLKPSN+++  D    + DFGLAR    
Sbjct: 124 DHERMSYL--LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 178
Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           + F++ P           T  Y  PE  +G   +   D++S G ++ E+
Sbjct: 179 N-FMMTP--------YVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMXGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMXGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL-----DKKGATKSFVA-ECEALRNIR 729
           +     +G G F  V K      G   A K +        ++G ++  +  E   LR IR
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  I     F+      ++ E +  G + D+L       E      + ++   +
Sbjct: 88  HPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDM---VAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFG+A     H      E ++   
Sbjct: 143 HYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKN--- 191
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 192 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 28/198 (14%)
Query: 417 NIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN--GTLPPQI 474
           N +G+   P G  +    L+L  NKLQ        K   L +LS  +N L+  G      
Sbjct: 15  NSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSD 74
Query: 475 FGITTLSKLLDLSENHL----SGSIPLE--------------------VGNLKSLVQLDI 510
           FG T+L K LDLS N +    S  + LE                      +L++L+ LDI
Sbjct: 75  FGTTSL-KYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 133
Query: 511 SRNNFSNEIPVTLSACTTLEYLLMQGNSFNGS-IPQSLNALKSIKELDLSCNNLSGQIPI 569
           S  +         +  ++LE L M GNSF  + +P     L+++  LDLS   L    P 
Sbjct: 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 193
Query: 570 HLGNLPFLEYLNLSYNHF 587
              +L  L+ LN+S+N+F
Sbjct: 194 AFNSLSSLQVLNMSHNNF 211

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 49/202 (24%), Positives = 75/202 (37%), Gaps = 26/202 (12%)
Query: 113 ETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTG 172
           + I L  N  S     +   C NL   W+H+N L     A       +E+L L  N    
Sbjct: 34  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 93
Query: 173 QLPPS-------------------------IGNLSALQTFDIAGNKLDGRIPDSLGQLRN 207
            + P+                            L+ALQ   +  N L     D+   L N
Sbjct: 94  SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 153
Query: 208 LNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL 267
           L +L    N  S +   +   + SLD   L +NR     P     +L +L  L +  NNL
Sbjct: 154 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNL 212
Query: 268 TGFLPQSLSNASKLEWLELNEN 289
           +    ++L+    L++L LN+N
Sbjct: 213 SALPTEALAPLRALQYLRLNDN 234

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           K +    ++G+G F +V       DG   A+K +   ++   +    E +  R   H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 734 IKIITICSSIDFKGADFKA-IVYEYMQYGSVDDWLHHTNDK----LEVGKLNIVIEVASV 788
           ++++  C  +  +GA  +A ++  + + G++ + +    DK     E   L +++ +   
Sbjct: 89  LRLVAYC--LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           +E +H        H DLKP+N+LL  +    + D G     S +   +  EG   ++ ++
Sbjct: 147 LEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLG-----SMNQACIHVEGSRQALTLQ 198
Query: 849 G------TIGYIGPE-YGMGGD--LSMTGDVYSFGILLLEMFTRRRPTDNMFNDG 894
                  TI Y  PE + +     +    DV+S G +L  M     P D +F  G
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 29/183 (15%)
Query: 721 ECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN 780
           E + LR +RH+N+I+++ +  + +      K  +Y  M+Y      +    D +   +  
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEE------KQKMYMVMEYCVCG--MQEMLDSVPEKRFP 107
Query: 781 IV------IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
           +        ++   +EYLH+     IVH D+KP N+LL       +S  G+A  L  HPF
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPF 162
Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG---DVYSFGILLLEMFTRRRP--TDN 889
                 ++S    +G+  +  PE   G D + +G   D++S G+ L  + T   P   DN
Sbjct: 163 AADDTCRTS----QGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 890 MFN 892
           ++ 
Sbjct: 218 IYK 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G  G V+     +    VA+K + L    + K  + E + +R + H N++K+  I  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 742 SIDFKGADFKA---------IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
               +  D            IV EYM+    +  +      LE      + ++   ++Y+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLAN--VLEQGPLLEEHARLFMYQLLRGLKYI 136
Query: 793 HNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHH 832
           H+     ++H DLKP+N+ ++  D+V  + DFGLAR +  H
Sbjct: 137 HS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTDN 889
             +      DV+S GI+L  M     P D 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 49/202 (24%), Positives = 75/202 (37%), Gaps = 26/202 (12%)
Query: 113 ETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTG 172
           + I L  N  S     +   C NL   W+H+N L     A       +E+L L  N    
Sbjct: 35  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 173 QLPPS-------------------------IGNLSALQTFDIAGNKLDGRIPDSLGQLRN 207
            + P+                            L+ALQ   +  N L     D+   L N
Sbjct: 95  SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
Query: 208 LNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL 267
           L +L    N  S +   +   + SLD   L +NR     P     +L +L  L +  NNL
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNL 213
Query: 268 TGFLPQSLSNASKLEWLELNEN 289
           +    ++L+    L++L LN+N
Sbjct: 214 SALPTEALAPLRALQYLRLNDN 235

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 121/307 (39%), Gaps = 47/307 (15%)
Query: 271 LPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN----NLGTRTSTDLDFI 326
           LP  +   + L+ L LN N F    +IN  S P+L  LY+  N    +LGTR       +
Sbjct: 292 LPSGIEGMNSLKKLVLNANSFDQLCQINAASFPSLRDLYIKGNMRKLDLGTRC------L 345
Query: 327 TLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNG 386
             L N  KL             L HS    S    L              +++NL +L  
Sbjct: 346 EKLENLQKL------------DLSHSDIEASDCCNL--------------QLKNLRHLQY 379
Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIP-DPIGNLTLLNVLQLGFNKLQGS 445
           L L YN+  G    A  E   L+ L +   ++    P  P  NL LL VL L    L  S
Sbjct: 380 LNLSYNEPLGLEDQAFKECPQLELLDVAFTHLHVKAPHSPFQNLHLLRVLNLSHCLLDTS 439
Query: 446 IPSYLGKCQNLMQLSAPNNKL-NGTLPP-QIFGITTLSKLLDLSENHLSGSIPLEVGNLK 503
               L   Q+L  L+   N   +G++    +  +    ++L LS  +L          L+
Sbjct: 440 NQHLLAGLQDLRHLNLQGNSFQDGSISKTNLLQMVGSLEILILSSCNLLSIDQQAFHGLR 499
Query: 504 SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALK-------SIKEL 556
           ++  LD+S N+ + +    LS    L YL M  N+     P  L AL        S   L
Sbjct: 500 NVNHLDLSHNSLTGDSMDALSHLKGL-YLNMASNNIRIIPPHLLPALSQQSIINLSHNPL 558
Query: 557 DLSCNNL 563
           D +C+N+
Sbjct: 559 DCTCSNI 565

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 24/294 (8%)
Query: 333 SKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGN-----QISGTIPPEIRNLF---NL 384
           +++ +L L      G LP  I  +++   L+  A +     QI+    P +R+L+   N+
Sbjct: 277 TRVQELDLTAAHLNG-LPSGIEGMNSLKKLVLNANSFDQLCQINAASFPSLRDLYIKGNM 335
Query: 385 NGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRG--IIPDPIGNLTLLNVLQLGFNKL 442
             L L      GT    + +L NLQ L L  ++I         + NL  L  L L +N+ 
Sbjct: 336 RKLDL------GT--RCLEKLENLQKLDLSHSDIEASDCCNLQLKNLRHLQYLNLSYNEP 387
Query: 443 QGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNL 502
            G       +C  L  L      L+   P   F    L ++L+LS   L  S    +  L
Sbjct: 388 LGLEDQAFKECPQLELLDVAFTHLHVKAPHSPFQNLHLLRVLNLSHCLLDTSNQHLLAGL 447
Query: 503 KSLVQLDISRNNFSN-EIPVT--LSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLS 559
           + L  L++  N+F +  I  T  L    +LE L++   +      Q+ + L+++  LDLS
Sbjct: 448 QDLRHLNLQGNSFQDGSISKTNLLQMVGSLEILILSSCNLLSIDQQAFHGLRNVNHLDLS 507
Query: 560 CNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK-KGVFSNETRISLTGNEQFC 612
            N+L+G     L +L  L YLN++ N+     P      S ++ I+L+ N   C
Sbjct: 508 HNSLTGDSMDALSHLKGL-YLNMASNNIRIIPPHLLPALSQQSIINLSHNPLDC 560

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPAFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 64/226 (28%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---ATKSFVAECEALRNIRHRNLI---K 735
           +G G++G V           VAVK ++   +    A +++  E   L++++H N+I    
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 86
Query: 736 IITICSSI-DFK---------GADFKAIVY------EYMQYGSVDDWLHHTNDKLEVGKL 779
           + T  +SI DF          GAD   IV       E++Q+                   
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF------------------- 127
Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
            +V ++   ++Y+H+     I+H DLKPSNV ++ D    + DFGLAR            
Sbjct: 128 -LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR------------ 171
Query: 840 GQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
              +  EM G +    Y  PE  +     + T D++S G ++ E+ 
Sbjct: 172 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 53/304 (17%)
Query: 666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECE 723
           +  +S   + +S   +IG G    V++  L E     A+K +NL++       S+  E  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 724 ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNI 781
            L  ++  +  KII +    D++  D    +Y  M+ G++D   WL     K  +     
Sbjct: 79  YLNKLQQHS-DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWER 129
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
                +++E +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 188
Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTD 888
                  GT+ Y+ PE     D+S +              DV+S G +L  M   + P  
Sbjct: 189 V------GTVNYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 889 NMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE 948
            + N    LH             I+DP+   E   P   E+ L  V++    C    P +
Sbjct: 241 QIINQISKLH------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQ 283
Query: 949 RMQM 952
           R+ +
Sbjct: 284 RISI 287

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 27/227 (11%)
Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHR 731
           T  +     IG GS+    +          AVK+++  K+  T+    E E L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76
Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           N+I +  +     +    +  +V E  + G + D +       E     ++  +   +EY
Sbjct: 77  NIITLKDV-----YDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSDFGLARFL-SHHPFLVAPEGQSSSIE 846
           LH      +VH DLKPSN+L   +        + DFG A+ L + +  L  P        
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP-------- 180
Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
              T  ++ PE           D++S G+LL    T   P  N  +D
Sbjct: 181 -CYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDD 226

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTDN 889
             +      DV+S GI+L  M     P D 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTDN 889
             +      DV+S GI+L  M     P D 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTDN 889
             +      DV+S GI+L  M     P D 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTDN 889
             +      DV+S GI+L  M     P D 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G+G++G V K      G   AVK +        ++ V   E  R +   ++      C 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI--------RATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 742 -SIDFKGADFK---AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA-SVIEYL-HNH 795
            ++ F GA F+     +   +   S+D +     DK +    +I+ ++A S+++ L H H
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 153
Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----------HPFLVAPEGQSSSI 845
            +  ++H D+KPSNVL++        DFG++ +L             P+  APE      
Sbjct: 154 SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPY-XAPE------ 206
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                   I PE    G  S+  D++S GI  +E+   R P D+
Sbjct: 207 -------RINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDS 242

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 64/226 (28%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---ATKSFVAECEALRNIRHRNLI---K 735
           +G G++G V           VAVK ++   +    A +++  E   L++++H N+I    
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 94
Query: 736 IITICSSI-DFK---------GADFKAIVY------EYMQYGSVDDWLHHTNDKLEVGKL 779
           + T  +SI DF          GAD   IV       E++Q+                   
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF------------------- 135
Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
            +V ++   ++Y+H+     I+H DLKPSNV ++ D    + DFGLAR            
Sbjct: 136 -LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR------------ 179
Query: 840 GQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
              +  EM G +    Y  PE  +     + T D++S G ++ E+ 
Sbjct: 180 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRNIRHRNLIKIITI 739
           +GKG+F  V +      G   A K++N  K  A      E EA   R ++H N++++   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL--- 86
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
             SI  +G  +  ++++ +  G + + +       E    + + ++   +  LH H Q  
Sbjct: 87  HDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV--LHCH-QMG 141
Query: 800 IVHGDLKPSNVLLDHDM---VAHVSDFGLARFLSHHPFLVAPEG-QSSSIEMKGTIGYIG 855
           +VH DLKP N+LL   +      ++DFGLA         +  EG Q +     GT GY+ 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA---------IEVEGEQQAWFGFAGTPGYLS 192
Query: 856 PEYGMGGDLSMTGDVYSFGILL 877
           PE           D+++ G++L
Sbjct: 193 PEVLRKDPYGKPVDLWACGVIL 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 64/226 (28%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG---ATKSFVAECEALRNIRHRNLI---K 735
           +G G++G V           VAVK ++   +    A +++  E   L++++H N+I    
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 94
Query: 736 IITICSSI-DFK---------GADFKAIVY------EYMQYGSVDDWLHHTNDKLEVGKL 779
           + T  +SI DF          GAD   IV       E++Q+                   
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF------------------- 135
Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
            +V ++   ++Y+H+     I+H DLKPSNV ++ D    + DFGLAR            
Sbjct: 136 -LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR------------ 179
Query: 840 GQSSSIEMKGTIG---YIGPEYGMGG-DLSMTGDVYSFGILLLEMF 881
              +  EM G +    Y  PE  +     + T D++S G ++ E+ 
Sbjct: 180 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+  DF  +V E  +  S+ +         E      + ++    +YLH +   
Sbjct: 109 F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 160
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            ++H DLK  N+ L+ D+   + DFGLA  + +       +G+   + + GT  YI PE 
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-------DGERKKV-LCGTPNYIAPEV 212
Query: 859 GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 S   DV+S G ++  +   + P
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+  DF  +V E  +  S+ +         E      + ++    +YLH +   
Sbjct: 107 F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 158
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            ++H DLK  N+ L+ D+   + DFGLA  + +       +G+   + + GT  YI PE 
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-------DGERKKV-LCGTPNYIAPEV 210
Query: 859 GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 S   DV+S G ++  +   + P
Sbjct: 211 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 53/294 (18%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG--ATKSFVAECEALRNIRHRNL 733
           +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASVIEY 791
            KII +    D++  D    +Y  M+ G++D   WL     K  +          +++E 
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEA 167
Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +H   Q  IVH DLKP+N L+   M+  + DFG+A  +      V  + Q       G +
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV------GAV 220
Query: 852 GYIGPEYGMGGDLSMT-------------GDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 898
            Y+ PE     D+S +              DV+S G +L  M   + P   + N    LH
Sbjct: 221 NYMPPE--AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM 952
                        I+DP+   E   P   E+ L  V++    C    P +R+ +
Sbjct: 279 ------------AIIDPN--HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISI 315

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMXGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMXGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 20/155 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           IG+GS+G+VY         +VA+K +N   +     K  + E   L  ++   +I++  +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC--- 796
               D    D   IV E              +D  ++ K  I +    +   L+N     
Sbjct: 94  IIPDDLLKFDELYIVLEIAD-----------SDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 797 ----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
               +  I+H DLKP+N LL+ D    V DFGLAR
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 33/185 (17%)
Query: 703 AVKVMNLDKKGA---------TKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKA 752
           AVK++++   G+          ++ + E + LR +  H N+I++        ++   F  
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 87
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           +V++ M+ G + D+L       E     I+  +  VI  LH   +  IVH DLKP N+LL
Sbjct: 88  LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL 144
Query: 813 DHDMVAHVSDFGLA---------RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD 863
           D DM   ++DFG +         R +   P  +APE    S+          P YG   D
Sbjct: 145 DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN------HPGYGKEVD 198
Query: 864 LSMTG 868
           +  TG
Sbjct: 199 MWSTG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMXGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQ 797
                 F+  DF  +V E  +  S+ + LH     L E      + ++    +YLH +  
Sbjct: 83  F-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN-- 134
Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             ++H DLK  N+ L+ D+   + DFGLA  + +       +G+   + + GT  YI PE
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-------DGERKKV-LCGTPNYIAPE 185
Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                  S   DV+S G ++  +   + P + 
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 12/96 (12%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ PE         
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEV-------- 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
            T  Y  PE  +G       D++S G ++ EM   +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 45/283 (15%)
Query: 640 IPVIGTKLAHKLSSALL-MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNL--- 695
           +P +    A + SSA   + +QF +        A KE+     IG+G FG +Y  ++   
Sbjct: 1   MPRVKAAQAGRQSSAKRHLAEQFAVGEII-TDMAKKEWKVGLPIGQGGFGCIYLADMNSS 59
Query: 696 ---GEDGMSVAVKVMNLD-----------KKGATKSFVAECEALRNIRHRNLIKIITICS 741
              G D   V VKV   D           ++ A    + +    R +++  + K      
Sbjct: 60  ESVGSDAPCV-VKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG-SG 117
Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEYLHNHCQPP 799
             D  G  ++ ++ +  ++GS    ++  N K    K  L + + +  ++EY+H H    
Sbjct: 118 LHDKNGKSYRFMIMD--RFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---E 172
Query: 800 IVHGDLKPSNVLLDH---DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE------MKGT 850
            VHGD+K SN+LL++   D V ++ D+GLA       +   PEG     +        GT
Sbjct: 173 YVHGDIKASNLLLNYKNPDQV-YLVDYGLA-------YRYCPEGVHKEYKEDPKRCHDGT 224
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           I +   +   G   S  GD+   G  +++  T   P ++   D
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAE---CEALRNIRHRNLIKIIT 738
           +G+GSF    K    +   + AVK+++   +  T+  +     CE      H N++K+  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-----HPNIVKLHE 73
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           +     F       +V E +  G + + +       E     I+ ++ S + ++H+    
Sbjct: 74  V-----FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 799 PIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            +VH DLKP N+L    + ++   + DFG AR       L  P+ Q        T+ Y  
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR-------LKPPDNQPLKTPC-FTLHYAA 177
Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           PE         + D++S G++L  M + + P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ PE         
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPEV-------- 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            T  Y  PE  +G       D++S G ++ EM
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/192 (26%), Positives = 75/192 (39%), Gaps = 8/192 (4%)
Query: 102 IPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIE 161
           IP    R+F      L  N  S     +   C NL   W+H+N L G   A       +E
Sbjct: 29  IPASSQRIF------LHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLE 82
Query: 162 RLSLYGN-QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG 220
           +L L  N QL    P +   L  L T  +    L    P     L  L YL   +N+   
Sbjct: 83  QLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQA 142
Query: 221 MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASK 280
           +   +  ++ +L   +L  NR   S+P      L  L  L++ QN++    P +  +  +
Sbjct: 143 LPDNTFRDLGNLTHLFLHGNRIP-SVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGR 201
Query: 281 LEWLELNENHFS 292
           L  L L  N+ S
Sbjct: 202 LMTLYLFANNLS 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 56/123 (45%), Gaps = 18/123 (14%)
Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
           +GK+ + I     + YL    +  ++H D+KPSN+LLD      + DFG++        L
Sbjct: 126 LGKMTVAI--VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS------GRL 175
Query: 836 VAPEGQSSSIEMKGTIGYIGPEY-----GMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           V  + +  S    G   Y+ PE          D  +  DV+S GI L+E+ T + P  N 
Sbjct: 176 VDDKAKDRSA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232
Query: 891 FND 893
             D
Sbjct: 233 KTD 235

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 45/283 (15%)
Query: 640 IPVIGTKLAHKLSSALL-MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNL--- 695
           +P +    A + SSA   + +QF +        A KE+     IG+G FG +Y  ++   
Sbjct: 1   MPRVKAAQAGRQSSAKRHLAEQFAVGEII-TDMAKKEWKVGLPIGQGGFGCIYLADMNSS 59
Query: 696 ---GEDGMSVAVKVMNLD-----------KKGATKSFVAECEALRNIRHRNLIKIITICS 741
              G D   V VKV   D           ++ A    + +    R +++  + K      
Sbjct: 60  ESVGSDAPCV-VKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG-SG 117
Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEYLHNHCQPP 799
             D  G  ++ ++ +  ++GS    ++  N K    K  L + + +  ++EY+H H    
Sbjct: 118 LHDKNGKSYRFMIMD--RFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---E 172
Query: 800 IVHGDLKPSNVLLDH---DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE------MKGT 850
            VHGD+K SN+LL++   D V ++ D+GLA       +   PEG     +        GT
Sbjct: 173 YVHGDIKASNLLLNYKNPDQV-YLVDYGLA-------YRYCPEGVHKEYKEDPKRCHDGT 224
Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           I +   +   G   S  GD+   G  +++  T   P ++   D
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF--VAECEALRNIRHRNLIKIITI 739
           IGKGSFG V K    +    VA+K++  +K+   ++   +   E LR     N + +I +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA-SVIEYLHNHCQP 798
             +  F+  +   + +E +   S++ +     +K +   L +V + A S+++ L    + 
Sbjct: 165 LENFTFR--NHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 799 PIVHGDLKPSNVLLDHDMVA--HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
            I+H DLKP N+LL     +   V DFG + +          E Q     ++    Y  P
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----------EHQRVYTXIQSRF-YRAP 268
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E  +G    M  D++S G +L E+ T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 703 AVKVMNLDKKGA---------TKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKA 752
           AVK++++   G+          ++ + E + LR +  H N+I++        ++   F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 100
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           +V++ M+ G + D+L       E     I+  +  VI  LH   +  IVH DLKP N+LL
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL 157
Query: 813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
           D DM   ++DFG +  L          G+    E+ GT  Y+ PE
Sbjct: 158 DDDMNIKLTDFGFSCQLD--------PGEKLR-EVCGTPSYLAPE 193

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 33/185 (17%)
Query: 703 AVKVMNLDKKGA---------TKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKA 752
           AVK++++   G+          ++ + E + LR +  H N+I++        ++   F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 100
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           +V++ M+ G + D+L       E     I+  +  VI  LH   +  IVH DLKP N+LL
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL 157
Query: 813 DHDMVAHVSDFGLA---------RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD 863
           D DM   ++DFG +         R +   P  +APE    S+          P YG   D
Sbjct: 158 DDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDN------HPGYGKEVD 211
Query: 864 LSMTG 868
           +  TG
Sbjct: 212 MWSTG 216

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF--VAECEALRNIRHRNLIKIITI 739
           IGKGSFG V K    +    VA+K++  +K+   ++   +   E LR     N + +I +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA-SVIEYLHNHCQP 798
             +  F+  +   + +E +   S++ +     +K +   L +V + A S+++ L    + 
Sbjct: 165 LENFTFR--NHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 799 PIVHGDLKPSNVLLDHDMVA--HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
            I+H DLKP N+LL     +   V DFG + +          E Q     ++    Y  P
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----------EHQRVYTXIQSRF-YRAP 268
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E  +G    M  D++S G +L E+ T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNI 728
           K    +   + IG+GS+G+VY         +VA+K +N   +     K  + E   L  +
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           +   +I++  +    D    D   IV E              +D  ++ K  I +    V
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIAD-----------SDLKKLFKTPIFLTEQHV 133
Query: 789 IEYLHNHC-------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
              L+N         +  I+H DLKP+N LL+ D    + DFGLAR
Sbjct: 134 KTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/224 (20%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 656 LMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           + +Q +P     +       +     +G G+FG V++      G + A K +    +   
Sbjct: 139 IWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL- 774
           ++   E + +  +RH  L+ +        F+  +   ++YE+M  G + + +   ++K+ 
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMS 253
Query: 775 EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLARFLSHH 832
           E   +  + +V   + ++H +     VH DLKP N++        +   DFGL   L   
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--- 307
Query: 833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
                 + + S     GT  +  PE   G  +    D++S G+L
Sbjct: 308 ------DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 72  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 175
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 176 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 110/275 (40%), Gaps = 21/275 (7%)
Query: 171 TGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNIS 230
           TG   P+  + S   +  I   +    +P S+    N  YL   EN    +   +  ++ 
Sbjct: 2   TGTSCPAACSCSNQASRVICTRRELAEVPASIPV--NTRYLNLQENSIQVIRTDTFKHLR 59
Query: 231 SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH 290
            L+   L KN  +  + V     LP L  L +  N LT    Q+    SKL  L L  N 
Sbjct: 60  HLEILQLSKNLVR-KIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNP 118
Query: 291 FSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRF---GG 347
                   FN +P+L +L LG           L++I      S+    GLV  R+   G 
Sbjct: 119 IESIPSYAFNRVPSLRRLDLGE-------LKRLEYI------SEAAFEGLVNLRYLNLGM 165
Query: 348 ALPHSIANLSTTMTL--IAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGEL 405
                I NL+  + L  + ++GN++    P   + L +L  L L + Q+      A  +L
Sbjct: 166 CNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDDL 225
Query: 406 RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN 440
           ++L+ L L  NN+  +  D    L  L  + L  N
Sbjct: 226 KSLEELNLSHNNLMSLPHDLFTPLHRLERVHLNHN 260

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 72  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 175
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 176 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+  DF  +V E  +  S+ +         E      + ++    +YLH +   
Sbjct: 85  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 136
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            ++H DLK  N+ L+ D+   + DFGLA  + +       +G+     + GT  YI PE 
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-------DGERKKT-LCGTPNYIAPEV 188
Query: 859 GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 S   DV+S G ++  +   + P
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+  DF  +V E  +  S+ +         E      + ++    +YLH +   
Sbjct: 89  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 140
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            ++H DLK  N+ L+ D+   + DFGLA  + +       +G+     + GT  YI PE 
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-------DGERKKT-LCGTPNYIAPEV 192
Query: 859 GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 S   DV+S G ++  +   + P
Sbjct: 193 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI--GNLTLLNVLQLGFNKLQG 444
           L    N  T ++      L+ LQ L L  N ++      +   N++ L  L +  N L  
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417
Query: 445 SIPSYLGKC---QNLMQLSAPNNKLNGT----LPPQIFGITTLSKLLDLSENHLSGSIPL 497
              +Y   C   ++++ L+  +N L G+    LPP++       K+LDL  N +  SIP 
Sbjct: 418 H--AYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV-------KVLDLHNNRI-MSIPK 467
Query: 498 EVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP 544
           +V +L++L +L+++ N   +         T+L+Y+ +  N ++ + P
Sbjct: 468 DVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/244 (22%), Positives = 103/244 (42%), Gaps = 33/244 (13%)
Query: 657 MEQQFPIVSYAELSKATKEFSSSN-RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           M+  F +   +E  +    F     ++G+G++G VYK    +        +  ++  G +
Sbjct: 3   MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62
Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDW----LHHTN 771
            S   E   LR ++H N+I +  +  S     AD K  V+    Y   D W     H  +
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLS----HADRK--VWLLFDYAEHDLWHIIKFHRAS 116
Query: 772 D------KLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHV 820
                  +L  G + +++ ++   I YLH +    ++H DLKP+N+L+           +
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173
Query: 821 SDFGLARFLSHHPFLVAPEGQSSSIE-MKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLL 878
           +D G AR  +      +P    + ++ +  T  Y  PE  +G    +   D+++ G +  
Sbjct: 174 ADMGFARLFN------SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227
Query: 879 EMFT 882
           E+ T
Sbjct: 228 ELLT 231

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                 F+  DF  +V E  +  S+ +         E      + ++    +YLH +   
Sbjct: 85  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 136
Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            ++H DLK  N+ L+ D+   + DFGLA  + +       +G+     + GT  YI PE 
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-------DGERKKT-LCGTPNYIAPEV 188
Query: 859 GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 S   DV+S G ++  +   + P
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 70
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 71  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 178
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 179
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 9/85 (10%)
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           I+H DLKPSN+++  D    + DFGLAR  +   F++ PE          T  Y  PE  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEV--------VTRYYRAPEVI 197
Query: 860 MGGDLSMTGDVYSFGILLLEMFTRR 884
           +G       D++S G ++ EM   +
Sbjct: 198 LGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/224 (20%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 656 LMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           + +Q +P     +       +     +G G+FG V++      G + A K +    +   
Sbjct: 33  IWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 92
Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL- 774
           ++   E + +  +RH  L+ +        F+  +   ++YE+M  G + + +   ++K+ 
Sbjct: 93  ETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMS 147
Query: 775 EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLARFLSHH 832
           E   +  + +V   + ++H +     VH DLKP N++        +   DFGL   L   
Sbjct: 148 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--- 201
Query: 833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
                 + + S     GT  +  PE   G  +    D++S G+L
Sbjct: 202 ------DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 63/154 (40%), Gaps = 3/154 (1%)
Query: 345 FGGALPHSIANLS--TTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI 402
            GG   H I+ L   T +T + + GNQ+          L NL  L L  NQL        
Sbjct: 70  LGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 403 GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAP 462
            +L NL YL L  N ++ +       LT L  L L +N+LQ        K   L  L   
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLY 189
Query: 463 NNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIP 496
            N+L  ++P  +F   T  + + L +N    + P
Sbjct: 190 QNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 222

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTP--------YV 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            T  Y  PE  +G       D++S G+++ EM
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NVL+DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVLIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTP--------YV 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            T  Y  PE  +G       D++S G+++ EM
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 58/269 (21%), Positives = 108/269 (40%), Gaps = 44/269 (16%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITIC 740
           +G+G FG V++        +   K + +  KG  +  V +  ++ NI RHRN++ +    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHE-- 68
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI---EVASVIEYLHNHCQ 797
               F+  +   +++E++    +D +        E+ +  IV    +V   +++LH+H  
Sbjct: 69  ---SFESMEELVMIFEFIS--GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-- 121
Query: 798 PPIVHGDLKPSNVLLD--HDMVAHVSDFGLARFL----SHHPFLVAPEGQSSSIEMKGTI 851
             I H D++P N++          + +FG AR L    +      APE            
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE------------ 168
Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMF---------TRRRPTDNMFNDGLTLHGYAK 902
            Y  PE      +S   D++S G L+  +          T ++  +N+ N   T    A 
Sbjct: 169 -YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
Query: 903 MALPKKVMGIVDPSLLMEARGPSKFEECL 931
             +  + M  VD  L+ E +      E L
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEAL 256

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 131 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 179
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +  +  + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 180 KEYNVRV-ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 132 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 180
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 181 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 226

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 131 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 179
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 180 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 133 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 181
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 182 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 227

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 132 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 180
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 181 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 226

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 110/275 (40%), Gaps = 21/275 (7%)
Query: 171 TGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNIS 230
           TG   P+  + S   +  I   +    +P S+    N  YL   EN    +   +  ++ 
Sbjct: 2   TGTSCPAACSCSNQASRVICTRRELAEVPASIPV--NTRYLNLQENSIQVIRTDTFKHLR 59
Query: 231 SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH 290
            L+   L KN  +  + V     LP L  L +  N LT    Q+    SKL  L L  N 
Sbjct: 60  HLEILQLSKNLVR-KIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNP 118
Query: 291 FSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRF---GG 347
                   FN +P+L +L LG           L++I      S+    GLV  R+   G 
Sbjct: 119 IESIPSYAFNRVPSLRRLDLGE-------LKRLEYI------SEAAFEGLVNLRYLNLGM 165
Query: 348 ALPHSIANLSTTMTL--IAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGEL 405
                I NL+  + L  + ++GN++    P   + L +L  L L + Q+      A  +L
Sbjct: 166 CNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDDL 225
Query: 406 RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN 440
           ++L+ L L  NN+  +  D    L  L  + L  N
Sbjct: 226 KSLEELNLSHNNLMSLPHDLFTPLHRLERVHLNHN 260

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 131 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 179
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 180 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 131 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 179
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 180 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 131 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 179
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 180 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 131 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 179
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 180 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH++    + D+GLA F  +HP      G
Sbjct: 152 IYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF--YHP------G 200
Query: 841 QSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
           +  ++ +     + GPE  +   D   + D++S G +   M  R+ P
Sbjct: 201 KEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 246

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIR 729
           + +   +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I +  +     ++      ++ E +  G + D+L       E      + ++ + +
Sbjct: 73  HPNVITLHEV-----YENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 790 EYLHNHCQPPIVHGDLKPSNV-LLDHDMVA---HVSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N+ LLD ++      + DFGLA     H      E ++   
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNEFKN--- 176
Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGIL 876
            + GT  ++ PE      L +  D++S G++
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 57/124 (45%), Gaps = 20/124 (16%)
Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLARFLSHHPFL 835
           L + + +  ++EY+H H     VHGD+K SN+LL++   D V ++ D+GLA       + 
Sbjct: 155 LQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQV-YLVDYGLA-------YR 203
Query: 836 VAPEGQSSSIEM------KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
             PEG   +          GTI +   +   G   S  GD+   G  +++  T   P ++
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263
Query: 890 MFND 893
              D
Sbjct: 264 NLKD 267

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 136 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 184
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +  +  + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 185 QEYNVRV-ASRYFKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 231
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 232 FHGHDNYDQLVRIAKVLGTED 252

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           IG+G++G V K      G  +AVK +        +S V E E  + +   +++   + C 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI--------RSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 742 SI-DFKGADFKA----IVYEYMQ--YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            I  F GA F+     I  E M   +     +++   D +   ++   I +A+V    H 
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----------RFLSHHPFLVAPEGQSSS 844
                I+H D+KPSN+LLD      + DFG++          R     P++ APE    S
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYM-APERIDPS 200
Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              +G                +  DV+S GI L E+ T R P
Sbjct: 201 ASRQG--------------YDVRSDVWSLGITLYELATGRFP 228

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 6/76 (7%)
Query: 753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL 812
           +V+E M+ GS+   +H      E+    +V +VAS +++LHN     I H DLKP N+L 
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILC 144
Query: 813 DH-DMVA--HVSDFGL 825
           +H + V+   + DFGL
Sbjct: 145 EHPNQVSPVKICDFGL 160

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 137 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 185
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 186 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 232
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 233 FHGHDNYDQLVRIAKVLGTED 253

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 142 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 190
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 191 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 237
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 238 FHGHDNYDQLVRIAKVLGTED 258

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 136 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 184
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 185 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 231
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 232 FHGHDNYDQLVRIAKVLGTED 252

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 32/141 (22%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F  +HP      G
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------G 183
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT 896
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  R+ P          
Sbjct: 184 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRKEP---------F 230
Query: 897 LHG---YAKMALPKKVMGIVD 914
            HG   Y ++    KV+G  D
Sbjct: 231 FHGHDNYDQLVRIAKVLGTED 251

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 14/234 (5%)
Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI 446
           L L+ N++T         L+NL  L L+ N I  I P     L  L  L L  N+L+  +
Sbjct: 57  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 115
Query: 447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLV 506
           P  + K   L +L    N++         G+  +  +++L  N L  S  +E G  + + 
Sbjct: 116 PEKMPKT--LQELRVHENEITKVRKSVFNGLNQMI-VVELGTNPLKSS-GIENGAFQGMK 171
Query: 507 QLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQ 566
           +L   R   +N   +      +L  L + GN        SL  L ++ +L LS N++S  
Sbjct: 172 KLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 567 IPIHLGNLPFLEYLNLSYNHFEGKVPK--------KGVFSNETRISLTGNEQFC 612
               L N P L  L+L+ N    KVP         + V+ +   IS  G+  FC
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 60/105 (57%), Gaps = 4/105 (3%)
Query: 484 LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI 543
           LDL+  HLS  +P  +  L +L +L +S N F N   ++ S   +L +L ++GN+    +
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 544 PQ-SLNALKSIKELDLSCNNL--SGQIPIHLGNLPFLEYLNLSYN 585
               L  L++++ELDLS +++  S    + L NL  L+ LNLSYN
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 63/142 (44%), Gaps = 4/142 (2%)
Query: 345 FGGALPHSIANLS--TTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI 402
            GG   H I+ L   T +T + + GNQ+          L NL  L L  NQL        
Sbjct: 70  LGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 403 GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAP 462
            +L NL YL L  N ++ +       LT L  L L  N+LQ        K   L QLS  
Sbjct: 130 DKLTNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQSLPEGVFDKLTQLKQLSLN 189
Query: 463 NNKLNGTLPPQIFG-ITTLSKL 483
           +N+L  ++P  +F  +T+L+ +
Sbjct: 190 DNQLK-SVPDGVFDRLTSLTHI 210

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 14/234 (5%)
Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI 446
           L L+ N++T         L+NL  L L+ N I  I P     L  L  L L  N+L+  +
Sbjct: 57  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 115
Query: 447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLV 506
           P  + K   L +L    N++         G+  +  +++L  N L  S  +E G  + + 
Sbjct: 116 PEKMPKT--LQELRVHENEITKVRKSVFNGLNQMI-VVELGTNPLKSS-GIENGAFQGMK 171
Query: 507 QLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQ 566
           +L   R   +N   +      +L  L + GN        SL  L ++ +L LS N++S  
Sbjct: 172 KLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 567 IPIHLGNLPFLEYLNLSYNHFEGKVPK--------KGVFSNETRISLTGNEQFC 612
               L N P L  L+L+ N    KVP         + V+ +   IS  G+  FC
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIRHRNLIKIITI 739
           IG GS+G V +     +   VA+K  +   +     K  + E   L  + H +++K++ I
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV---IEYLHNHC 796
               D +  D   +V E        D+       + + +L+I   + ++   ++Y+H+  
Sbjct: 121 VIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS-- 174
Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
              I+H DLKP+N L++ D    V DFGLAR + +
Sbjct: 175 -AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTP--------YV 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
            T  Y  PE  +G       D++S G ++ EM   +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 177 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTP--------YV 224
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
            T  Y  PE  +G       D++S G ++ EM   +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 12/93 (12%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 141 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMVP--------FV 188
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF 881
            T  Y  PE  +G       D++S G ++ EM 
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 45/227 (19%)
Query: 678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-----------ATKSFVAECEALR 726
           +S  +G+G F  V +      G   A K +   ++G           A       C  + 
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 727 NIR--HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE 784
           N+   + N  +II I       G  F   + E  +  S +D             + ++ +
Sbjct: 93  NLHEVYENTSEIILILEYAA-GGEIFSLCLPELAEMVSEND------------VIRLIKQ 139
Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDH-----DMVAHVSDFGLARFLSHHPFLVAPE 839
           +   + YLH   Q  IVH DLKP N+LL       D+   + DFG++R + H   L    
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI--KIVDFGMSRKIGHACELR--- 191
Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 E+ GT  Y+ PE      ++   D+++ GI+   + T   P
Sbjct: 192 ------EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 16/209 (7%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +     ++   E      + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG-- 72
Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                +  + + +  EY   G + D +       E        ++ + + YLH      I
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM 860
            H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ Y+ PE   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLK 180
Query: 861 GGDLSMTG-DVYSFGILLLEMFTRRRPTD 888
             +      DV+S GI+L  M     P D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF--VAECEALRNIRHRNLIKIITI 739
           IGKG FG V K    +    VA+K++  +K+   ++   +   E LR     N + +I +
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA-SVIEYLHNHCQP 798
             +  F+  +   + +E +   S++ +     +K +   L +V + A S+++ L    + 
Sbjct: 165 LENFTFR--NHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 799 PIVHGDLKPSNVLLDHDMVA--HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
            I+H DLKP N+LL     +   V DFG + +          E Q     ++    Y  P
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----------EHQRVYXXIQSRF-YRAP 268
Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFT 882
           E  +G    M  D++S G +L E+ T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 16/190 (8%)
Query: 701 SVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQ 759
           +VAVK++++ +     ++   E    + + H N++K          +  + + +  EY  
Sbjct: 33  AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-----HRREGNIQYLFLEYCS 87
Query: 760 YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH 819
            G + D +       E        ++ + + YLH      I H D+KP N+LLD      
Sbjct: 88  GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLK 144
Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLL 878
           +SDFGLA    ++        +    +M GT+ Y+ PE     +      DV+S GI+L 
Sbjct: 145 ISDFGLATVFRYN------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 879 EMFTRRRPTD 888
            M     P D
Sbjct: 199 AMLAGELPWD 208

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 118/299 (39%), Gaps = 18/299 (6%)
Query: 185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKG 244
           +  D+  N++     D      +L  L  +EN  S + P +  N+ +L    L  NR K 
Sbjct: 35  RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK- 93
Query: 245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPN 304
            +P+ +   L  LT L +++N +   L     +   L+ LE+ +N         F+ L +
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153
Query: 305 LSKLYLGRNNLGTRTSTDLDFITLLT---------------NCSKLVKLGLVFNRFGGAL 349
           L +L L + NL +  +  L  +  L                +  +L +L ++       L
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 350 PHSIANLSTTMTLIAMAGNQISGTIPP--EIRNLFNLNGLGLEYNQLTGTIPPAIGELRN 407
                N    + L +++    + T  P   +R+L  L  L L YN ++      + EL  
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR 273
Query: 408 LQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKL 466
           LQ + LVG  +  + P     L  L VL +  N+L     S      NL  L   +N L
Sbjct: 274 LQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           I+H DLKPSN+++  D    + DFGLAR  +   F++ P           T  Y  PE  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTP--------YVVTRYYRAPEVI 197
Query: 860 MGGDLSMTGDVYSFGILLLEMFTRR 884
           +G       D++S G ++ EM   +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 20/110 (18%)
Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLSHHPFLVAPEG 840
           + E+   ++Y H+     I+H D+KP NV++DH      + D+GLA F  +HP       
Sbjct: 138 MYELLKALDYCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEF--YHP------A 186
Query: 841 QSSSIEMKGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Q  ++ +     + GPE    Y M  D S+  D++S G +L  M  RR P
Sbjct: 187 QEYNVRVASRY-FKGPELLVDYQM-YDYSL--DMWSLGCMLASMIFRREP 232

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 32/225 (14%)
Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH 730
           K    F      G+G+FG V  G     GMSVA+K +  D +   +      + L  + H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHH 78
Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEV-- 785
            N++++ +   ++   G   +  +Y  +    V D LH       + +V    I+I+V  
Sbjct: 79  PNIVQLQSYFYTL---GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 786 ---ASVIEYLH----NHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLSHHPFLVA 837
                 I  LH    N C     H D+KP NVL++  D    + DFG A+ LS       
Sbjct: 136 FQLIRSIGCLHLPSVNVC-----HRDIKPHNVLVNEADGTLKLCDFGSAKKLS------- 183
Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMF 881
                 ++    +  Y  PE   G     T  D++S G +  EM 
Sbjct: 184 --PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTP--------YV 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
            T  Y  PE  +G       D++S G ++ EM   +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           I+H DLKPSN+++  D    + DFGLAR  +   F++ P           T  Y  PE  
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTP--------YVVTRYYRAPEVI 196
Query: 860 MGGDLSMTGDVYSFGILLLEMFTRR 884
           +G       D++S G ++ EM   +
Sbjct: 197 LGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P          
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTP--------YV 186
Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
            T  Y  PE  +G       D++S G ++ EM   +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           I+H DLKPSN+++  D    + DFGLAR  +   F++ P           T  Y  PE  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTP--------YVVTRYYRAPEVI 197
Query: 860 MGGDLSMTGDVYSFGILLLEMFTRR 884
           +G       D++S G ++ EM   +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHR 731
           K + +   IG G+ G V          +VA+K ++   +  T  K    E   ++ + H+
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 732 NLIKIITICSSI----DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           N+I ++ + +      +F+      +V E M   ++   +    D   +  L  + ++  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDV---YLVMELMD-ANLXQVIQMELDHERMSYL--LYQMLX 137
Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            I++LH+     I+H DLKPSN+++  D    + DFGLAR  +   F++ P         
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTP--------Y 185
Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
             T  Y  PE  +G       D++S G ++ EM   +
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           I+H DLKPSN+++  D    + DFGLAR  +   F++ P           T  Y  PE  
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTP--------YVVTRYYRAPEVI 198
Query: 860 MGGDLSMTGDVYSFGILLLEMFTRR 884
           +G       D++S G ++ EM   +
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHK 223
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	973
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-159
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-143
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-100
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-71
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-40
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-97
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-31
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-89
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-87
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-83
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-87
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-70
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-65
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-39
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-87
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-54
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-52
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-33
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-81
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-75
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-56
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-54
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-33
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-25
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-20
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-72
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-65
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-59
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-56
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-32
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-51
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-29
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-13
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-40
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-46
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-32
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-21
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-04
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-45
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-06
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-15
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-42
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-40
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-37
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-24
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-37
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-30
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-22
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-06
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-22
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-29
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-10
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-09
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-06
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-07
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-06
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-22
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-05
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-11
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-09
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	7e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	7e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	6e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-04
4fev_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	4e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	4e-04
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  485 bits (1250), Expect = e-159
 Identities = 165/568 (29%), Positives = 253/568 (44%), Gaps = 27/568 (4%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG 124
             LD+ S N    + P++G+ S L+ ++++ N   G   + +     L+ + +S+N F G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261

Query: 125 KIPTNLSRCFNLIDFWVHTNNLVGEI-QAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
            IP       +L    +  N   GEI   + G    +  L L GN   G +PP  G+ S 
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319

Query: 184 LQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSENDFSGMFPLSVCNIS-SLDEAYLFKNR 241
           L++  ++ N   G +P D+L ++R L  L  S N+FSG  P S+ N+S SL    L  N 
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379

Query: 242 FKGSLPVCLGFN-LPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFN 300
           F G +   L  N    L  L +  N  TG +P +LSN S+L  L L+ N+ SG +  +  
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439

Query: 301 SLPNLSKLYLGRNNL-GTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTT 359
           SL  L  L L  N L G            L     L  L L FN   G +P  ++N  T 
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQE-------LMYVKTLETLILDFNDLTGEIPSGLSNC-TN 491

Query: 360 MTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIR 419
           +  I+++ N+++G IP  I  L NL  L L  N  +G IP  +G+ R+L +L L  N   
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551

Query: 420 GIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN--KLNGTLPPQIFGI 477
           G IP  +   +      +  N + G    Y+       +     N  +  G    Q+  +
Sbjct: 552 GTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607

Query: 478 TTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGN 537
           +T +   +++     G       N  S++ LD+S N  S  IP  + +   L  L +  N
Sbjct: 608 STRNPC-NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666

Query: 538 SFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVF 597
             +GSIP  +  L+ +  LDLS N L G+IP  +  L  L  ++LS N+  G +P+ G F
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726

Query: 598 SNETRISLTGNEQFCGGLGELHLPACHS 625
                     N   CG      LP C  
Sbjct: 727 ETFPPAKFLNNPGLCG----YPLPRCDP 750

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  443 bits (1143), Expect = e-143
 Identities = 160/576 (27%), Positives = 255/576 (44%), Gaps = 54/576 (9%)

Query: 31  QQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNI---GGFLSPYIGNLSF 87
             L D   +   W+++ N C + GVTC  R  +VT +DL S+ +      +S  + +L+ 
Sbjct: 22  DVLPDK-NLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78

Query: 88  LRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPT--NLSRCFNLIDFWVHTNN 145
           L  + L+N+  +G +         L ++ LS NS SG + T  +L  C  L    V +N 
Sbjct: 79  LESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNT 137

Query: 146 LVGEIQA-IIGNWLKIERLSLYGNQLTGQLPPSI---GNLSALQTFDIAGNKLDGRIPDS 201
           L    +         +E L L  N ++G              L+   I+GNK+ G +   
Sbjct: 138 LDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-- 195

Query: 202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
           + +  NL +L  S N+FS   P  + + S+L    +  N+  G     +     +L +L 
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS-TCTELKLLN 253

Query: 262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
           ++ N   G +P        L++L L EN F+G        +P+                 
Sbjct: 254 ISSNQFVGPIPP--LPLKSLQYLSLAENKFTG-------EIPD----------------- 287

Query: 322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPE-IRN 380
                 L   C  L  L L  N F GA+P    + S  +  +A++ N  SG +P + +  
Sbjct: 288 -----FLSGACDTLTGLDLSGNHFYGAVPPFFGSCS-LLESLALSSNNFSGELPMDTLLK 341

Query: 381 LFNLNGLGLEYNQLTGTIPPAIGELR-NLQYLGLVGNNIRGIIPDPIGNLTL--LNVLQL 437
           +  L  L L +N+ +G +P ++  L  +L  L L  NN  G I   +       L  L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401

Query: 438 GFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPL 497
             N   G IP  L  C  L+ L    N L+GT+P  +  ++ L   L L  N L G IP 
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-DLKLWLNMLEGEIPQ 460

Query: 498 EVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELD 557
           E+  +K+L  L +  N+ + EIP  LS CT L ++ +  N   G IP+ +  L+++  L 
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520

Query: 558 LSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK 593
           LS N+ SG IP  LG+   L +L+L+ N F G +P 
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  143 bits (362), Expect = 3e-35
 Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 14/190 (7%)

Query: 427 GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--L 484
             +T +++     N    ++ S L     L  L   N+ +NG++          + L  L
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG----FKCSASLTSL 105

Query: 485 DLSENHLSGSIP--LEVGNLKSLVQLDISRNNFSNEIPVTLSA-CTTLEYLLMQGNSFNG 541
           DLS N LSG +     +G+   L  L++S N       V+      +LE L +  NS +G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165

Query: 542 SIPQSL---NALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFS 598
           +        +    +K L +S N +SG + +       LE+L++S N+F   +P  G  S
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPFLGDCS 223

Query: 599 NETRISLTGN 608
               + ++GN
Sbjct: 224 ALQHLDISGN 233

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  104 bits (261), Expect = 6e-23
 Identities = 37/146 (25%), Positives = 61/146 (41%), Gaps = 25/146 (17%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
               ++ S+  GG  SP   N   +  ++++ N   G IPKE+G +  L  + L +N  S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
           G IP  +              +L             +  L L  N+L G++P ++  L+ 
Sbjct: 670 GSIPDEVG-------------DLR-----------GLNILDLSSNKLDGRIPQAMSALTM 705

Query: 184 LQTFDIAGNKLDGRIPDSLGQLRNLN 209
           L   D++ N L G IP+  GQ     
Sbjct: 706 LTEIDLSNNNLSGPIPEM-GQFETFP 730

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  327 bits (841), Expect = e-100
 Identities = 99/576 (17%), Positives = 187/576 (32%), Gaps = 82/576 (14%)

Query: 42  SWNNSINLCQWT---GVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSF 98
           +WN +  L  W    GV+    + RVT L LE     G +   IG L+ L V+ L ++  
Sbjct: 59  NWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117

Query: 99  HGQ----IPKEVGRLFRLETIVLSNNSFSGKIPTNLSR--CFNLIDFWVHTNNLVGEIQA 152
                   PK +      E        +         R    +LI   ++++     I+ 
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177

Query: 153 IIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLG 212
                LK  ++    N +T  +  ++  L+ L+ F +  +           +  N  Y  
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236

Query: 213 TSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGF-- 270
             +        L   N+  L +  ++       LP  L   LP++ ++ VA N       
Sbjct: 237 QYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQ 290

Query: 271 ------LPQSLSNASKLEWLELNENHF-SGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL 323
                          K++ + +  N+  +  V  +   +  L  L    N L        
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG------ 344

Query: 324 DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPP--EIRNL 381
             +    +  KL  L L +N+    +P +    +  +  ++ A N++   IP   + +++
Sbjct: 345 -KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSV 401

Query: 382 FNLNGLGLEYNQLTG-------TIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNV 434
             ++ +   YN++          + P   +  N+  + L  N I     +     + L+ 
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461

Query: 435 LQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGS 494
           + L  N L   IP                                L+ + DL  N L+  
Sbjct: 462 INLMGNMLTE-IPKNSL----------------KDENENFKNTYLLTSI-DLRFNKLTKL 503

Query: 495 IP-LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSI 553
                   L  LV +D+S N+FS + P      +TL+   ++                  
Sbjct: 504 SDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQ---------------- 546

Query: 554 KELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG 589
              D   N    + P  +   P L  L +  N    
Sbjct: 547 --RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  247 bits (632), Expect = 6e-71
 Identities = 73/481 (15%), Positives = 148/481 (30%), Gaps = 41/481 (8%)

Query: 63  RVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSF 122
            + K  + S      +            I   +N+    + K V RL +L    + N+ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLS 182
             +         N                    N   +  + +Y      +LP  +  L 
Sbjct: 219 VAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273

Query: 183 ALQTFDIAGNKL--------DGRIPDSLGQLRNLNYLGTSENDF-SGMFPLSVCNISSLD 233
            +Q  ++A N+         D +          +  +    N+  +     S+  +  L 
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333

Query: 234 EAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSG 293
                 N+ +G LP   G +  KL  L +A N +T           ++E L    N    
Sbjct: 334 MLECLYNQLEGKLP-AFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391

Query: 294 -QVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFI-TLLTNCSKLVKLGLVFNRFGGALPH 351
                +  S+  +S +    N +G+    + D +         +  + L  N+       
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451

Query: 352 SIANLSTTMTLIAMAGNQISG-------TIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-- 402
             +   + ++ I + GN ++              +N + L  + L +N+LT  +      
Sbjct: 452 LFSTG-SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRA 509

Query: 403 GELRNLQYLGLVGNNIRGIIPDPIGNLT------LLNVLQLGFNKLQGSIPSYLGKCQNL 456
             L  L  + L  N+     P    N +      + N      N+     P  +  C +L
Sbjct: 510 TTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568

Query: 457 MQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS 516
            QL   +N +   +  +I     +  +LD+ +N         V          +  +   
Sbjct: 569 TQLQIGSNDIR-KVNEKIT--PNI-SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

Query: 517 N 517
           +
Sbjct: 625 D 625

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  157 bits (399), Expect = 3e-40
 Identities = 37/238 (15%), Positives = 80/238 (33%), Gaps = 13/238 (5%)

Query: 377 EIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRG----IIPDPIGNLTLL 432
            + +   + GL LE    +G +P AIG+L  L+ L L  +  +       P  I      
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 433 NVLQLGFNKLQGSIPSYLGKCQ--NLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENH 490
              Q      Q +   Y  +    +L++    ++    ++          +++     N+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI-GQLSNN 194

Query: 491 LSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNAL 550
           ++  +   V  L  L Q  +  + F  E           EY          +     + L
Sbjct: 195 IT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNL 248

Query: 551 KSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGN 608
           K + ++++       ++P  L  LP ++ +N++ N        K  +       +   
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  307 bits (789), Expect = 3e-97
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 14/308 (4%)

Query: 323 LDFITLLTNCSKLV----KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGT--IPP 376
           L     L N + L             + G L  +    +  +  + ++G  +     IP 
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70

Query: 377 EIRNLFNLNGLGL-EYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVL 435
            + NL  LN L +   N L G IPPAI +L  L YL +   N+ G IPD +  +  L  L
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 436 QLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSI 495
              +N L G++P  +    NL+ ++   N+++G +P      + L   + +S N L+G I
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 496 PLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKE 555
           P    NL +L  +D+SRN    +  V   +    + + +  NS    +   +   K++  
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248

Query: 556 LDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGL 615
           LDL  N + G +P  L  L FL  LN+S+N+  G++P+ G        +   N+  CG  
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307

Query: 616 GELHLPAC 623
               LPAC
Sbjct: 308 ---PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  238 bits (611), Expect = 1e-71
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 13/292 (4%)

Query: 31  QQLHDPLGVTKSWNNSINLCQ--WTGVTCGHRHQ--RVTKLDLESQNIGG--FLSPYIGN 84
           + L +P     SW  + + C   W GV C    Q  RV  LDL   N+     +   + N
Sbjct: 16  KDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74

Query: 85  LSFLRVINLAN-NSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHT 143
           L +L  + +   N+  G IP  + +L +L  + +++ + SG IP  LS+   L+      
Sbjct: 75  LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134

Query: 144 NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTF-DIAGNKLDGRIPDSL 202
           N L G +   I +   +  ++  GN+++G +P S G+ S L T   I+ N+L G+IP + 
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF 194

Query: 203 GQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVV 262
             L NL ++  S N   G   +   +  +  + +L KN     L   +G     L  L +
Sbjct: 195 ANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VG-LSKNLNGLDL 251

Query: 263 AQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNN 314
             N + G LPQ L+    L  L ++ N+  G++    N L          N 
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  123 bits (310), Expect = 7e-31
 Identities = 38/164 (23%), Positives = 63/164 (38%), Gaps = 4/164 (2%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFL-RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
             +  +   I G +    G+ S L   + ++ N   G+IP     L  L  + LS N   
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE 210

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
           G          N     +  N+L  ++  + G    +  L L  N++ G LP  +  L  
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

Query: 184 LQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC 227
           L + +++ N L G IP   G L+  +    + N      PL  C
Sbjct: 270 LHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPAC 312

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  297 bits (763), Expect = 6e-89
 Identities = 114/577 (19%), Positives = 199/577 (34%), Gaps = 30/577 (5%)

Query: 59  HRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLS 118
            R+ ++T LD+    I          L  L+V+NL +N       K       L  + L 
Sbjct: 46  TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105

Query: 119 NNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP-- 176
           +NS          +  NLI   +  N L             ++ L L  N++        
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165

Query: 177 SIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC---NISSLD 233
            I   S+L+  +++ N++    P     +  L  L  +           +C     +S+ 
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225

Query: 234 EAYLFKNRFKGSLPVCL-GFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS 292
              L  ++   +      G     LT+L ++ NNL      S +   +LE+  L  N+  
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285

Query: 293 GQVRINFNSLPNLSKLYLGRNNLGTRTS----TDLDFITLLTNCSKLVKLGLVFNRFGGA 348
                + + L N+  L L R+      S      +D  +       L  L +  N   G 
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS-FQWLKCLEHLNMEDNDIPGI 344

Query: 349 LPHSIANLSTTMTLIAMAGNQISGTIPPEI--RNLFN--LNGLGLEYNQLTGTIPPAIGE 404
             +    L   +  ++++ +  S          +L +  L+ L L  N+++     A   
Sbjct: 345 KSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403

Query: 405 LRNLQYLGLVGNNIRGIIP-DPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPN 463
           L +L+ L L  N I   +       L  +  + L +NK      +      +L +L    
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463

Query: 464 NKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS----- 516
             L   +         L  L  LDLS N+++      +  L+ L  LD+  NN +     
Sbjct: 464 VALKN-VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH 522

Query: 517 ---NEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGN 573
                    L   + L  L ++ N F+    +    L  +K +DL  NNL+        N
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582

Query: 574 LPFLEYLNLSYNHFEGKVPK--KGVFSNETRISLTGN 608
              L+ LNL  N       K     F N T + +  N
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  293 bits (753), Expect = 2e-87
 Identities = 114/550 (20%), Positives = 185/550 (33%), Gaps = 26/550 (4%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
           +T L+L    +    +      S L  +++  N+     P+   +L  L+ + L +N  S
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
                  + C NL +  + +N++             +  L L  N L+     +   L  
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 184 LQTFDIAGNKLDGRIPDSLG--QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
           LQ   ++ NK+     + L      +L  L  S N      P     I  L   +L   +
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206

Query: 242 FKGSLP--VCLGFNLPKLTVLVVAQNNLTGFLPQSLSN--ASKLEWLELNENHFSGQVRI 297
              SL   +CL      +  L ++ + L+     +      + L  L+L+ N+ +     
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266

Query: 298 NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTN---CSKLVKLGLVFNRFGGALPHSIA 354
           +F  LP L   +L  NN+    S  L  +  +          K  +           S  
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326

Query: 355 NLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIG----ELRNLQY 410
            L     L  M  N I G        L NL  L L  +  +                L  
Sbjct: 327 WLKCLEHLN-MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 411 LGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGT 469
           L L  N I  I  D    L  L VL LG N++   +        +N+ ++    NK    
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ- 444

Query: 470 LPPQIFGITTLSKLLDLSENHLSG--SIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACT 527
           L    F +    + L L    L    S P     L++L  LD+S NN +N     L    
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504

Query: 528 TLEYLLMQGN--------SFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEY 579
            LE L +Q N        +  G     L  L  +  L+L  N           +L  L+ 
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564

Query: 580 LNLSYNHFEG 589
           ++L  N+   
Sbjct: 565 IDLGLNNLNT 574

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  283 bits (726), Expect = 1e-83
 Identities = 95/497 (19%), Positives = 170/497 (34%), Gaps = 25/497 (5%)

Query: 111 RLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQL 170
             E    S+   + ++P +L    N+    +  N L     A    + ++  L +  N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 171 TGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNIS 230
           +   P     L  L+  ++  N+L      +     NL  L    N    +         
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 231 SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA--SKLEWLELNE 288
           +L    L  N    +        L  L  L+++ N +     + L     S L+ LEL+ 
Sbjct: 122 NLITLDLSHNGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 289 NHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGA 348
           N         F+++  L  L+L    L     +  + + L    + +  L L  ++    
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQL---GPSLTEKLCLELANTSIRNLSLSNSQLSTT 237

Query: 349 LPHSIANLS-TTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRN 407
              +   L  T +T++ ++ N ++         L  L    LEYN +      ++  L N
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297

Query: 408 LQYLGL---------VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQ 458
           ++YL L            ++  I       L  L  L +  N + G   +      NL  
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357

Query: 459 LSAPNNKLN-GTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNF 515
           LS  N+  +  TL  + F     S L  L+L++N +S         L  L  LD+  N  
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417

Query: 516 SNEIPV-TLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSG--QIPIHLG 572
             E+          +  + +  N +      S   + S++ L L    L      P    
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477

Query: 573 NLPFLEYLNLSYNHFEG 589
            L  L  L+LS N+   
Sbjct: 478 PLRNLTILDLSNNNIAN 494

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  279 bits (715), Expect = 4e-82
 Identities = 114/571 (19%), Positives = 191/571 (33%), Gaps = 52/571 (9%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLF--RLETIVLSNNSF 122
             LDL    +          L  L+ + L+NN       +E+       L+ + LS+N  
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL---KIERLSLYGNQLTGQLPPSIG 179
               P        L   +++   L   +   +   L    I  LSL  +QL+     +  
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 180 NL--SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYL 237
            L  + L   D++ N L+    DS   L  L Y     N+   +F  S+  + ++    L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 238 FKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI 297
            ++  K S+                   +L      S      LE L + +N   G    
Sbjct: 304 KRSFTKQSIS----------------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347

Query: 298 NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLS 357
            F  L NL  L L  +    RT T+  F++L    S L  L L  N+       + + L 
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKIESDAFSWL- 404

Query: 358 TTMTLIAMAGNQISGTIPP-EIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGN 416
             + ++ +  N+I   +   E R L N+  + L YN+       +   + +LQ L L   
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464

Query: 417 NIRGI--IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQI 474
            ++ +   P P   L  L +L L  N +       L   + L  L   +N L        
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA------- 517

Query: 475 FGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLM 534
                      L ++   G     +  L  L  L++  N F             L+ + +
Sbjct: 518 ----------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567

Query: 535 QGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLG-NLPFLEYLNLSYNHFEGKVPK 593
             N+ N       N   S+K L+L  N ++       G     L  L++ +N F+     
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

Query: 594 KGVF-----SNETRISLTGNEQFCGGLGELH 619
              F        T I    +   C      H
Sbjct: 628 IAWFVNWINETHTNIPELSSHYLCNTPPHYH 658

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (254), Expect = 3e-22
 Identities = 31/149 (20%), Positives = 52/149 (34%), Gaps = 9/149 (6%)

Query: 463 NNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVT 522
           + KL   +P  +   T +  +L+L+ N L             L  LD+  N  S   P  
Sbjct: 13  HLKLT-QVPDDLP--TNI-TVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 523 LSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNL 582
                 L+ L +Q N  +    ++     ++ EL L  N++             L  L+L
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128

Query: 583 SYNHFEGKVPKKGVFSNETR---ISLTGN 608
           S+N       K G          + L+ N
Sbjct: 129 SHNGLSS--TKLGTQVQLENLQELLLSNN 155

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  291 bits (746), Expect = 3e-87
 Identities = 104/555 (18%), Positives = 186/555 (33%), Gaps = 41/555 (7%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
              LDL    +    S    +   L+V++L+              L  L T++L+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTG-QLPPSIGNLS 182
                  S   +L        NL       IG+   ++ L++  N +   +LP    NL+
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 183 ALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRF 242
            L+  D++ NK+       L  L  +  L  S +                    L  N  
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD--------------------LSLNPM 189

Query: 243 KGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQ-SLSNASKLEWLELNENHFSGQVRI---N 298
               P    F   +L  L +  N  +  + +  +   + LE   L    F  +  +   +
Sbjct: 190 NFIQPGA--FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 299 FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLST 358
            ++L  L  L +    L        D I L    + +    LV          S    + 
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNF 304

Query: 359 TMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNI 418
               + +   +       ++++L  L      +    G    +  +L +L++L L  N +
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGL 359

Query: 419 --RGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFG 476
             +G         T L  L L FN +   + S     + L  L   ++ L       +F 
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 477 ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEI-PVTLSACTTLEYLLMQ 535
                  LD+S  H   +       L SL  L ++ N+F     P   +    L +L + 
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 536 GNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK-- 593
                   P + N+L S++ L++S NN           L  L+ L+ S NH      +  
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538

Query: 594 KGVFSNETRISLTGN 608
           +   S+   ++LT N
Sbjct: 539 QHFPSSLAFLNLTQN 553

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  243 bits (621), Expect = 8e-70
 Identities = 109/531 (20%), Positives = 188/531 (35%), Gaps = 45/531 (8%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHG-QIPKEVGRLFRLETIVLSNNSFS 123
            KL     N+    +  IG+L  L+ +N+A+N     ++P+    L  LE + LS+N   
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 124 GKIPTNLSRCFNLIDFWVH---TNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP-SIG 179
               T+L     +    +    + N +  IQ      +++ +L+L  N  +  +    I 
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 180 NLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK 239
            L+ L+   +            LG+ RN   L   + D S +  L    I     AYL  
Sbjct: 223 GLAGLEVHRL-----------VLGEFRNEGNL--EKFDKSALEGLCNLTIEEFRLAYL-- 267

Query: 240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINF 299
           + +   +       L  ++   +    +        S     + LEL    F        
Sbjct: 268 DYYLDDIIDLFN-CLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ---FPT 321

Query: 300 NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR--FGGALPHSIANLS 357
             L +L +L    N  G   S          +   L  L L  N   F G    S    +
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFS--------EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 358 TTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGN 416
           +   L  ++ N +  T+      L  L  L  +++ L           LRNL YL +   
Sbjct: 374 SLKYLD-LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 417 NIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIF 475
           + R         L+ L VL++  N  Q +       + +NL  L     +L   L P  F
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAF 490

Query: 476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSAC-TTLEYLLM 534
              +  ++L++S N+           L SL  LD S N+        L    ++L +L +
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550

Query: 535 QGNSFNGSIPQS--LNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS 583
             N F  +      L  +K  ++L +    +    P     +P L  LN++
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-LNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  229 bits (586), Expect = 5e-65
 Identities = 91/493 (18%), Positives = 159/493 (32%), Gaps = 34/493 (6%)

Query: 117 LSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP 176
               +F  KIP NL    +  +  +  N L         ++ +++ L L   ++      
Sbjct: 14  CMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 177 SIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY 236
           +  +LS L T  + GN +      +   L +L  L   E + + +    + ++ +L E  
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLE----WLELNENHFS 292
           +  N  +         NL  L  L ++ N +       L    ++      L+L+ N  +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 293 GQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGA--LP 350
                 F  +  L KL L  N               +   + L    LV   F     L 
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKT-----CIQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 351 HSIANLSTTMTLIAMAGNQIS------GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE 404
               +    +  + +   +++        I      L N++   L    +          
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSY 302

Query: 405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
               Q+L LV           + +L  L      F   +G          +L  L    N
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRN 357

Query: 465 KLN--GTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPV- 521
            L+  G      FG T+L K LDLS N +   +      L+ L  LD   +N        
Sbjct: 358 GLSFKGCCSQSDFGTTSL-KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415

Query: 522 TLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQI-PIHLGNLPFLEYL 580
              +   L YL +       +     N L S++ L ++ N+      P     L  L +L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475

Query: 581 NLSYNHFEGKVPK 593
           +LS    E   P 
Sbjct: 476 DLSQCQLEQLSPT 488

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  152 bits (387), Expect = 8e-39
 Identities = 50/288 (17%), Positives = 95/288 (32%), Gaps = 23/288 (7%)

Query: 355 NLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLV 414
           NL  +   + ++ N +         +   L  L L   ++      A   L +L  L L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 415 GNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQI 474
           GN I+ +       L+ L  L      L       +G  + L +L+  +N +     P+ 
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 475 FGITTLSKLLDLSENHLSGSIPLEVGNLKSL----VQLDISRNNFSNEIPVTLSACTTLE 530
           F   T  + LDLS N +      ++  L  +    + LD+S N  +   P        L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLH 203

Query: 531 YLLMQGNSFNGSIPQ-SLNALKSIKELDLSCNNLSGQIPI------HLGNLPFLEYLNLS 583
            L ++ N  + ++ +  +  L  ++   L       +  +       L  L  L      
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 584 YNHFEGKVPK-KGVFSNET----------RISLTGNEQFCGGLGELHL 620
             + +  +     +F+  T           I    +  +  G   L L
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  296 bits (760), Expect = 7e-87
 Identities = 99/593 (16%), Positives = 185/593 (31%), Gaps = 79/593 (13%)

Query: 30  MQQLHDPLGVTKSWNNSINLCQW---TGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLS 86
                +    + +WN +  L  W    GV   + + RVT L L      G +   IG L+
Sbjct: 289 YSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQLT 347

Query: 87  FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLS------RCFNLIDFW 140
            L+V++   +S               +      +                    +L+   
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407

Query: 141 VHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPD 200
           ++ N  +  I+      LK  ++    N++T  +  +I  L+ LQ    A +        
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIA 466

Query: 201 SLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVL 260
              +  N +Y             LS  N+  L +  L+       LP  L  +LP+L  L
Sbjct: 467 VDWEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY-DLPELQSL 520

Query: 261 VVAQNNLTGF---------LPQSLSNASKLEWLELNENHFSG-QVRINFNSLPNLSKLYL 310
            +A N              L        K++   +  N+        +   +  L  L  
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580

Query: 311 GRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQI 370
             N +          +       KL  L L +N+    +P      +  +  +  + N++
Sbjct: 581 VHNKVRH--------LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKL 631

Query: 371 SGTIPP--EIRNLFNLNGLGLEYNQLTGTIPPAIG------ELRNLQYLGLVGNNIRGII 422
              IP     ++++ +  +   YN++       I       +  N   + L  N I+   
Sbjct: 632 K-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFP 689

Query: 423 PDPIGNLTLLNVLQLGFNKLQ-------GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF 475
            +     + ++ + L  N +                    L  +    NKL  +L     
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDF- 747

Query: 476 GITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLL 533
             TTL  L  +D+S N  S S P +  N   L    I                       
Sbjct: 748 RATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ------------------RD 788

Query: 534 MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
            +GN      P  +    S+ +L +  N++   +   L   P L  L+++ N 
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNP 838

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  202 bits (516), Expect = 4e-54
 Identities = 69/477 (14%), Positives = 133/477 (27%), Gaps = 79/477 (16%)

Query: 168 NQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC 227
           +    Q    + N   +    +AG    GR+PD++GQL  L  L    +  +    L   
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 228 NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELN 287
              + D +   K+R +            +L +  + Q+ +       +    K   + L 
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLK 426

Query: 288 ENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGG 347
           +           N +  +SK                     +   +KL  +    + F  
Sbjct: 427 DTQIGN----LTNRITFISKA--------------------IQRLTKLQIIYFANSPFTY 462

Query: 348 ALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRN 407
               ++               +          NL +L  + L        +P  + +L  
Sbjct: 463 -DNIAVDWEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516

Query: 408 LQYLGLVGNNIRGI---------IPDPIGNLTLLNVLQLGFNKLQGSIPSY-LGKCQNLM 457
           LQ L +  N              + D       + +  +G+N L+    S  L K   L 
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLG 576

Query: 458 QLSAPNNKLNG---------------------TLPPQIFGITTLSKLLDLSENHLSGSIP 496
            L   +NK+                        +P      T   + L  S N L   IP
Sbjct: 577 LLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIP 635

Query: 497 --LEVGNLKSLVQLDISRNNFSNEIPVTLSA-----CTTLEYLLMQGNSFNGSIPQSLNA 549
                 ++  +  +D S N   +E      +           + +  N       +    
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695

Query: 550 LKSIKELDLSCNNLS-------GQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
              I  + LS N ++            +  N   L  ++L +N     +      + 
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATT 751

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  195 bits (497), Expect = 9e-52
 Identities = 67/450 (14%), Positives = 128/450 (28%), Gaps = 67/450 (14%)

Query: 67  LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKI 126
            + +             NL  L  + L N     Q+P  +  L  L+++ ++ N      
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-A 530

Query: 127 PTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPS--IGNLSAL 184
               +    L D                    KI+   +  N L    P S  +  +  L
Sbjct: 531 AQLKADWTRLAD--------------DEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKL 575

Query: 185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC-NISSLDEAYLFKNRFK 243
              D   NK+  R  ++ G    L  L    N      P   C     ++      N+ K
Sbjct: 576 GLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK 632

Query: 244 GSLPVCLGF-NLPKLTVLVVAQNNLTG-----FLPQSLSNASKLEWLELNENHFSGQVRI 297
             +P      ++  +  +  + N +                     + L+ N        
Sbjct: 633 -YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE 691

Query: 298 NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLS 357
            F +   +S + L  N + +                       +          +  N  
Sbjct: 692 LFATGSPISTIILSNNLMTS-----------------------IPENSLKPKDGNYKNT- 727

Query: 358 TTMTLIAMAGNQISGTIPPEIR--NLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGL-- 413
             +T I +  N+++ ++  + R   L  L+ + + YN  + + P        L+  G+  
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRH 785

Query: 414 ----VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKL-NG 468
                GN I    P  I     L  LQ+G N ++  +   L     L  L   +N   + 
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISI 842

Query: 469 TLPPQIFGITTLSKLLDLSENHLSGSIPLE 498
            +      I     +L   +          
Sbjct: 843 DVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  138 bits (350), Expect = 1e-33
 Identities = 41/260 (15%), Positives = 90/260 (34%), Gaps = 20/260 (7%)

Query: 368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG 427
           +        ++ N   + GL L      G +P AIG+L  L+ L    ++          
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 428 NLTLLNVLQLGFNKLQGSIPS-YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--- 483
                ++ +   ++++      +L   Q L       + +N    P++  I   S++   
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426

Query: 484 ---LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN 540
              +    N ++  I   +  L  L  +  + + F+ +           E          
Sbjct: 427 DTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQY 480

Query: 541 GSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNE 600
            +   S + LK + +++L       Q+P  L +LP L+ LN++ N        K  ++  
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR- 539

Query: 601 TRISLTGNEQFCGGLGELHL 620
               L  +E     +   ++
Sbjct: 540 ----LADDEDTGPKIQIFYM 555

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  266 bits (683), Expect = 1e-81
 Identities = 100/306 (32%), Positives = 153/306 (50%), Gaps = 31/306 (10%)

Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECE 723
           S  EL  A+  FS+ N +G+G FG VYKG L  DG  VAVK +  +  +G    F  E E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 724 ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEV----GKL 779
            +    HRNL+++   C +        + +VY YM  GSV   L    +         + 
Sbjct: 80  MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
            I +  A  + YLH+HC P I+H D+K +N+LLD +  A V DFGLA+ +          
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--------DY 186

Query: 840 GQSS-SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF---NDGL 895
             +  +  ++GTIG+I PEY   G  S   DV+ +G++LLE+ T +R  D      +D +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 896 TLHGYAKMALP-KKVMGIVDPSLLMEARGPSKF-EECLVAVVRTGVACSMESPSERMQMT 953
            L  + K  L  KK+  +VD  L         + +E +  +++  + C+  SP ER +M+
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDL------QGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 954 AVVKKL 959
            VV+ L
Sbjct: 301 EVVRML 306

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  258 bits (662), Expect = 2e-75
 Identities = 103/540 (19%), Positives = 186/540 (34%), Gaps = 27/540 (5%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
              L+     +    +     L  L  ++L     +           RL+T+VL+ N   
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
               T LS    L   +     +       + N   +E L L  N ++    P       
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154

Query: 184 LQTFDIAGNKLDGRIPDSLGQLRNLN--YLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
           L+  D   N +     + +  L+      L  + ND +G       + +          +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQ 213

Query: 242 FKGSLPVCLGFN-LPKLTVLVVAQNNLTGFLPQSLSN--ASKLEWLELNENHFSGQVRIN 298
               +   L  + +  L +      +     P          +E + L +++F       
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273

Query: 299 FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLST 358
           F+    L +L L   +L    S        L   S L KL L  N+F      S +N   
Sbjct: 274 FHCFSGLQELDLTATHLSELPSG-------LVGLSTLKKLVLSANKFENLCQISASNF-P 325

Query: 359 TMTLIAMAGNQISGTIPPE-IRNLFNLNGLGLEYNQLT--GTIPPAIGELRNLQYLGLVG 415
           ++T +++ GN     +    + NL NL  L L ++ +         +  L +LQ L L  
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385

Query: 416 NNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP-SYLGKCQNLMQLSAPNNKLNGTLPPQI 474
           N    +  +       L +L L F +L+     S       L  L+  ++ L+     Q+
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQL 444

Query: 475 FGITTLSKL--LDLSENHLSGSIPLEVG---NLKSLVQLDISRNNFSNEIPVTLSACTTL 529
           F    L  L  L+L  NH       +      L  L  L +S  + S+      ++   +
Sbjct: 445 FD--GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502

Query: 530 EYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG 589
            ++ +  N    S  ++L+ LK I  L+L+ N++S  +P  L  L     +NL  N  + 
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  215 bits (549), Expect = 7e-60
 Identities = 91/518 (17%), Positives = 169/518 (32%), Gaps = 40/518 (7%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG 124
             L      I       + N   L  + L +N        +     +L+ +   NN+   
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

Query: 125 KIPTNLSRCFNLIDFWVH-TNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGN--L 181
               ++S      +  ++   N +  I+    +    + L+  G Q    +   + N  +
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLN--YLGTSENDFSGMFPLSVCNISSLDEAYLFK 239
            +L          +   P     L  ++   +   ++ F  +   +    S L E  L  
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287

Query: 240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN- 298
                 LP  L   L  L  LV++ N        S SN   L  L +  N    ++    
Sbjct: 288 THLS-ELPSGL-VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345

Query: 299 FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLST 358
             +L NL +L L  +++ T    +L       N S L  L L +N        +      
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401

Query: 359 TMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNN 417
              L  +A  ++         +NL  L  L L ++ L  +       L  LQ+L L GN+
Sbjct: 402 LELLD-LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460

Query: 418 IRGIIPDPIG---NLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQI 474
                         L  L +L L F  L           + +  +   +N+L  +   + 
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEA 519

Query: 475 FGITTLSKL-LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACT-TLEYL 532
                L  + L+L+ NH+S  +P  +  L     +++ +N            CT +  Y 
Sbjct: 520 LS--HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLD---------CTCSNIYF 568

Query: 533 LMQGNSFNGSIPQSLNAL---------KSIKELDLSCN 561
           L         +  + + L           + ++ LSC+
Sbjct: 569 LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLSCS 606

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  205 bits (523), Expect = 2e-56
 Identities = 90/457 (19%), Positives = 155/457 (33%), Gaps = 49/457 (10%)

Query: 163 LSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF 222
            +     L  ++P ++   ++ +  + + N L      +  +L NL +L     D +   
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL-----DLTR-- 66

Query: 223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLE 282
               C I  + E   F++               +L  LV+  N L      +LS    L+
Sbjct: 67  ----CQIYWIHED-TFQS-------------QHRLDTLVLTANPLIFMAETALSGPKALK 108

Query: 283 WLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVF 342
            L   +   S    I  ++   L  LYLG N++   +S  L          KL  L    
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI---SSIKLP---KGFPTEKLKVLDFQN 162

Query: 343 NRFGGALPHSIANL-STTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPA 401
           N         +++L   T   + + GN I+  I P   +      L     Q    I   
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221

Query: 402 IG--ELRNLQYLGLVGNNIRGIIPDPIGNLTLLNV--LQLGFNKLQGSIPSYLGKCQNLM 457
           +    +++L        +   I P     L  ++V  + L  +       +       L 
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ 281

Query: 458 QLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN 517
           +L      L+  LP  + G++TL K L LS N       +   N  SL  L I  N    
Sbjct: 282 ELDLTATHLS-ELPSGLVGLSTL-KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339

Query: 518 EI-PVTLSACTTLEYLLMQGNSFNGS--IPQSLNALKSIKELDLSCNNLSGQIPIHLGNL 574
           E+    L     L  L +  +    S      L  L  ++ L+LS N             
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399

Query: 575 PFLEYLNLSYNHFEGKVPKKGVFSNETR---ISLTGN 608
           P LE L+L++   +     +  F N      ++L+ +
Sbjct: 400 PQLELLDLAFTRLKV-KDAQSPFQNLHLLKVLNLSHS 435

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  199 bits (508), Expect = 2e-54
 Identities = 98/534 (18%), Positives = 165/534 (30%), Gaps = 87/534 (16%)

Query: 62  QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS 121
           + +  L L S +I     P       L+V++  NN+ H    +++  L +   + L+ N 
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN- 187

Query: 122 FSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGN- 180
                                  N +  I+    +    + L+  G Q    +   + N 
Sbjct: 188 ----------------------GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225

Query: 181 -LSALQTFDIAGNKLDGRIPDSLGQLRNLN--YLGTSENDFSGMFPLSVCNISSLDEAYL 237
            + +L          +   P     L  ++   +   ++ F  +   +    S L E  L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285

Query: 238 FKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI 297
                   LP  L   L  L  LV++ N        S SN   L  L +  N    ++  
Sbjct: 286 TATHLS-ELPSGL-VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 298 N-FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANL 356
               +L NL +L L  +++ T    +L       N S L  L                NL
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSL----------------NL 383

Query: 357 STTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVG 415
           S          N+         +    L  L L + +L           L  L+ L L  
Sbjct: 384 S---------YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434

Query: 416 NNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF 475
           + +          L  L  L L  N             Q L +L                
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL---------------- 478

Query: 476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQ 535
                 ++L LS   LS        +LK +  +D+S N  ++     LS    + YL + 
Sbjct: 479 ------EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLA 531

Query: 536 GNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG 589
            N  +  +P  L  L   + ++L  N L         N+ FLE+   +    E 
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQKLED 581

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  135 bits (342), Expect = 4e-33
 Identities = 67/393 (17%), Positives = 127/393 (32%), Gaps = 67/393 (17%)

Query: 58  GHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVL 117
           G     V  ++L+        S      S L+ ++L       ++P  +  L  L+ +VL
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308

Query: 118 SNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQA-IIGNWLKIERLSLYGNQLT--GQL 174
           S N F      + S   +L    +  N    E+    + N   +  L L  + +      
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368

Query: 175 PPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDE 234
              + NLS LQ+ +++ N+      ++  +   L  L     D +         +   D 
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL-----DLAF------TRLKVKDA 417

Query: 235 AYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQ 294
              F+             NL  L VL ++ + L     Q       L+ L L  NHF   
Sbjct: 418 QSPFQ-------------NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464

Query: 295 VRI---NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPH 351
                 +  +L  L  L L   +L +            T+   +  +             
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQ------HAFTSLKMMNHV------------- 505

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYL 411
              +LS          N+++ +    + +L  +  L L  N ++  +P  +  L   + +
Sbjct: 506 ---DLS---------HNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTI 552

Query: 412 GLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
            L  N +         N+  L   +    KL+ 
Sbjct: 553 NLRQNPLDCT----CSNIYFLEWYKENMQKLED 581

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  110 bits (278), Expect = 3e-25
 Identities = 38/223 (17%), Positives = 62/223 (27%), Gaps = 30/223 (13%)

Query: 389 LEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPS 448
            E   L   IP  +    + + L    N +  I       L  L  L L   ++      
Sbjct: 19  CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75

Query: 449 YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQL 508
                  L                           L L+ N L       +   K+L  L
Sbjct: 76  TFQSQHRL-------------------------DTLVLTANPLIFMAETALSGPKALKHL 110

Query: 509 DISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIP 568
              +   S+   + L    TLE L +  N  +          + +K LD   N +     
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170

Query: 569 IHLGNLPFLE--YLNLSYNHFEGKVPKKGVFSNETRISLTGNE 609
             + +L       LNL+ N   G  P     +    ++  G +
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.9 bits (234), Expect = 6e-20
 Identities = 28/157 (17%), Positives = 46/157 (29%), Gaps = 4/157 (2%)

Query: 433 NVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS 492
                    L   IP  L    +   L    N L  T+    F        LDL+   + 
Sbjct: 15  KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIY 70

Query: 493 GSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKS 552
                   +   L  L ++ N         LS    L++L       +      L+  K+
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 553 IKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG 589
           ++ L L  N++S            L+ L+   N    
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  241 bits (617), Expect = 2e-72
 Identities = 98/324 (30%), Positives = 147/324 (45%), Gaps = 32/324 (9%)

Query: 645 TKLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAV 704
             +   LSS+ L+  +   V   +L +AT  F     IG G FG VYKG L  DG  VA+
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVAL 68

Query: 705 KVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVD 764
           K    +     + F  E E L   RH +L+ +I  C        +   ++Y+YM+ G++ 
Sbjct: 69  KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLK 123

Query: 765 DWLHHTNDKLEV----GKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV 820
             L+ ++          +L I I  A  + YLH      I+H D+K  N+LLD + V  +
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKI 180

Query: 821 SDFGLARFLSHHPFLVAPEGQSS--SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLL 878
           +DFG+++           E   +  S  +KGT+GYI PEY + G L+   DVYSFG++L 
Sbjct: 181 TDFGISK--------KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 879 EMFTRRRPTDNMFNDG-LTLHGYAKMALPK-KVMGIVDPSLLMEARGPSKF-EECLVAVV 935
           E+   R           + L  +A  +    ++  IVDP+L        K   E L    
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL------ADKIRPESLRKFG 286

Query: 936 RTGVACSMESPSERMQMTAVVKKL 959
            T V C   S  +R  M  V+ KL
Sbjct: 287 DTAVKCLALSSEDRPSMGDVLWKL 310

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  229 bits (587), Expect = 4e-65
 Identities = 98/563 (17%), Positives = 172/563 (30%), Gaps = 59/563 (10%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
              +DL    +    S    N S L+ ++L+         K    L  L  ++L+ N   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
              P + S   +L                        E L     +L       IG L  
Sbjct: 94  SFSPGSFSGLTSL------------------------ENLVAVETKLASLESFPIGQLIT 129

Query: 184 LQTFDIAGNKLDG-RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEA----YLF 238
           L+  ++A N +   ++P     L NL ++  S N    +    +  +    +      + 
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189

Query: 239 KNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQ-SLSNASKLEWLELNENHFSGQVRI 297
            N           F   KL  L +  N  +  + +  L N + L    L    F  +  +
Sbjct: 190 LNPIDFIQDQA--FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247

Query: 298 N------FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPH 351
                     L +++            +   + F       + +  + L           
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF----HCLANVSAMSLAGVSIKY--LE 301

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYL 411
            +       +L  +   Q+    P    +L  L  L L  N+   +I      L +L YL
Sbjct: 302 DVPKHFKWQSLS-IIRCQLK-QFPTL--DLPFLKSLTLTMNKG--SISFKKVALPSLSYL 355

Query: 412 GLVGNNIRGIIPDPIGNLTL--LNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGT 469
            L  N +         +L    L  L L FN     + +     + L  L   ++ L   
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRV 414

Query: 470 LPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPV-TLSACTT 528
                F        LD+S  +           L SL  L ++ N+F +       +  T 
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474

Query: 529 LEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
           L +L +             + L  ++ L++S NNL      H   L  L  L+ S+N  E
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534

Query: 589 GKVPKKGVFSNETRIS---LTGN 608
               K  +      ++   LT N
Sbjct: 535 T--SKGILQHFPKSLAFFNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  213 bits (544), Expect = 3e-59
 Identities = 93/543 (17%), Positives = 163/543 (30%), Gaps = 40/543 (7%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG 124
             LDL    I          L  L  + L  N      P     L  LE +V      + 
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 125 KIPTNLSRCFNLIDFWVHTNNLVG-EIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
                + +   L    V  N +   ++ A   N   +  + L  N +       +  L  
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178

Query: 184 L----QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG-MFPLSVCNISSLDEAYLF 238
                 + D++ N +D  I D   Q   L+ L    N  S  +    + N++ L    L 
Sbjct: 179 NPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237

Query: 239 KNRFKG-----SLPVCLGFNLPKLTVLVV--AQNNLTGFLPQSLSNASKLEWLELNENHF 291
              FK           +   L  +T+        N            + +  + L     
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297

Query: 292 SGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPH 351
                +          L + R  L    + DL           L  L L  N+  G++  
Sbjct: 298 KYLEDVPK--HFKWQSLSIIRCQLKQFPTLDL---------PFLKSLTLTMNK--GSISF 344

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLF--NLNGLGLEYNQLTGTIPPAIGELRNLQ 409
               L +   L  ++ N +S +      +L   +L  L L +N     +      L  LQ
Sbjct: 345 KKVALPSLSYLD-LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ 402

Query: 410 YLGLVGNNIRGIIP-DPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNG 468
           +L    + ++ +       +L  L  L + +   +           +L  L    N    
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462

Query: 469 TLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSAC 526
                +F     + L  LDLS+  L          L  L  L++S NN         +  
Sbjct: 463 NTLSNVFA--NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520

Query: 527 TTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
            +L  L    N    S     +  KS+   +L+ N+++  I     +  FL+++      
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC-IC---EHQKFLQWVKEQKQF 576

Query: 587 FEG 589
              
Sbjct: 577 LVN 579

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  203 bits (519), Expect = 6e-56
 Identities = 85/506 (16%), Positives = 157/506 (31%), Gaps = 36/506 (7%)

Query: 100 GQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLK 159
           G +   +  +  + T    +   S K+P ++    +  +  +  N L         N+ +
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
           ++ L L   ++      +   L  L    + GN +    P S   L +L  L   E   +
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 220 GMFPLSVCNISSLDEAYLFKNRFKG-SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
            +    +  + +L +  +  N      LP     NL  L  + ++ N +       L   
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS-NLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 279 SKLEW----LELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSK 334
            +       L+++ N     ++        L +L L  N       +     T L N + 
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFN-----SSNIMKTCLQNLAG 230

Query: 335 LVKLGLVFNRFGGALPHSIANLSTTMTL-------IAMAGNQISGTIPPEIRNLFNLNGL 387
           L    L+   F       I   S    L         +           +   L N++ +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290

Query: 388 GLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP 447
            L    +       + +    Q L ++   ++     P  +L  L  L L  NK   SI 
Sbjct: 291 SLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKG--SIS 343

Query: 448 SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSL 505
                  +L  L    N L+       +     + L  LDLS N     +      L+ L
Sbjct: 344 FKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL 401

Query: 506 VQLDISRNNFSNEIPV-TLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS 564
             LD   +            +   L YL +   +           L S+  L ++ N+  
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461

Query: 565 GQIPIH-LGNLPFLEYLNLSYNHFEG 589
                +   N   L +L+LS    E 
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQ 487

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  128 bits (325), Expect = 4e-31
 Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 19/271 (7%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGL 413
            ++ ++   I ++ N +         N   L  L L   ++      A   L +L  L L
Sbjct: 28  DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLIL 87

Query: 414 VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQ 473
            GN I+   P     LT L  L     KL       +G+   L +L+  +N ++    P 
Sbjct: 88  TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147

Query: 474 IFGITTLSKL--LDLSENHLSGSIPLEVGNLK----SLVQLDISRNNFSNEIPVTLSACT 527
            F    L+ L  +DLS N++      ++  L+      + LD+S N     I        
Sbjct: 148 YFS--NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI 204

Query: 528 TLEYLLMQGNSFNGSIPQ-SLNALKSIKELDLSCNNLSGQIPI------HLGNLPFLEYL 580
            L  L ++GN  + +I +  L  L  +    L       +  +       +  L  +   
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 581 NLSYNHFEGKVPKKGVFSNETR---ISLTGN 608
                +          F        +SL G 
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  119 bits (300), Expect = 5e-28
 Identities = 54/360 (15%), Positives = 111/360 (30%), Gaps = 66/360 (18%)

Query: 63  RVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSF 122
            + +  L   N           L+ +  ++LA  S   +  ++V + F+ +++ +     
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLS 182
                 +L                             ++ L+L  N+ +  +      L 
Sbjct: 320 KQFPTLDLPF---------------------------LKSLTLTMNKGS--ISFKKVALP 350

Query: 183 ALQTFDIAGNKLDGRIPDSLGQL--RNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN 240
           +L   D++ N L      S   L   +L +L  S N    M   +   +  L       +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHS 409

Query: 241 RFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN-F 299
             K         +L KL  L ++  N            + L  L++  N F      N F
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469

Query: 300 NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTT 359
            +  NL+ L L +  L       + +  +     +L  L                N+S  
Sbjct: 470 ANTTNLTFLDLSKCQL-----EQISW-GVFDTLHRLQLL----------------NMS-- 505

Query: 360 MTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIR 419
                   N +          L++L+ L   +N++  +        ++L +  L  N++ 
Sbjct: 506 -------HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 16/85 (18%), Positives = 32/85 (37%)

Query: 62  QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS 121
             +T LDL    +          L  L+++N+++N+          +L+ L T+  S N 
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532

Query: 122 FSGKIPTNLSRCFNLIDFWVHTNNL 146
                        +L  F +  N++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  220 bits (564), Expect = 4e-65
 Identities = 80/312 (25%), Positives = 132/312 (42%), Gaps = 43/312 (13%)

Query: 665 SYAELSKATKEFSS------SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--- 715
           S+ EL   T  F         N++G+G FG VYKG +  +  +VAVK +       T   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73

Query: 716 -KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK- 773
            + F  E + +   +H NL++++   S       D   +VY YM  GS+ D L   +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 774 -LEVGK-LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
            L       I    A+ I +LH +     +H D+K +N+LLD    A +SDFGLAR    
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA--- 182

Query: 832 HPFLVAPEGQSS--SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
                + +   +  +  + GT  Y+ PE  + G+++   D+YSFG++LLE+ T     D 
Sbjct: 183 -----SEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 890 MFNDGLTLHGYAKMAL--PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPS 947
                  L    +      K +   +D  +       +     + A+      C  E  +
Sbjct: 237 HREPQ-LLLDIKEEIEDEEKTIEDYIDKKM-----NDADSTS-VEAMYSVASQCLHEKKN 289

Query: 948 ERMQMTAVVKKL 959
           +R  +  V + L
Sbjct: 290 KRPDIKKVQQLL 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  190 bits (485), Expect = 5e-54
 Identities = 72/323 (22%), Positives = 123/323 (38%), Gaps = 41/323 (12%)

Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECE- 723
           + +E S           IG+G +G VYKG+L  D   VAVKV         ++F+ E   
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVF---SFANRQNFINEKNI 58

Query: 724 -ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV 782
             +  + H N+ + I     +   G     +V EY   GS+  +L             + 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV-SSCRLA 117

Query: 783 IEVASVIEYLHN------HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             V   + YLH       H +P I H DL   NVL+ +D    +SDFGL+  L+ +  + 
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMG-------GDLSMTGDVYSFGILLLEMFTRRRPTDN 889
             E  +++I   GTI Y+ PE   G              D+Y+ G++  E+F R   TD 
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDL 235

Query: 890 MFNDGLTLHGYAKMALPKKVMGIVDPSL-------LMEARGPS------KFEECLVAVVR 936
              + +      +  +  +      P+          E + P       +    + ++  
Sbjct: 236 FPGESVP-----EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 937 TGVACSMESPSERMQMTAVVKKL 959
           T   C  +    R+      +++
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERM 313

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  196 bits (501), Expect = 8e-54
 Identities = 99/532 (18%), Positives = 177/532 (33%), Gaps = 39/532 (7%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
              LDL    +    S    +   L+V++L+              L  L T++L+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLT-GQLPPSIGNLS 182
                  S   +L        NL       IG+   ++ L++  N +   +LP    NL+
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 183 ALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRF 242
            L+  D++ NK+       L  L  +  L  S +       LS+  ++ +          
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD-------LSLNPMNFIQP-------- 194

Query: 243 KGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQ-SLSNASKLEWLELNENHFSGQVRI---N 298
                    F   +L  L +  N  +  + +  +   + LE   L    F  +  +   +
Sbjct: 195 -------GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 299 FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLST 358
            ++L  L  L +    L        D I L    + +    LV          S      
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307

Query: 359 TMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNI 418
            + L+     Q           L +L  L    N+       +  +L +L++L L  N +
Sbjct: 308 HLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGL 359

Query: 419 R--GIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFG 476
              G         T L  L L FN +  ++ S     + L  L   ++ L       +F 
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 477 ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEI-PVTLSACTTLEYLLMQ 535
                  LD+S  H   +       L SL  L ++ N+F     P   +    L +L + 
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 536 GNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHF 587
                   P + N+L S++ L+++ N L          L  L+ + L  N +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  157 bits (400), Expect = 1e-40
 Identities = 79/450 (17%), Positives = 147/450 (32%), Gaps = 59/450 (13%)

Query: 165 LYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPL 224
                   ++P ++    + +  D++ N L      S      L  L            L
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLD-----------L 59

Query: 225 SVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWL 284
           S C I ++ E   +++             L  L+ L++  N +      + S  S L+ L
Sbjct: 60  SRCEIQTI-EDGAYQS-------------LSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105

Query: 285 ELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR 344
              E + +         L  L +L +  N +              +N + L  L L  N+
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLI-----QSFKLPEYFSNLTNLEHLDLSSNK 160

Query: 345 FGGALPHSIA---NLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP- 400
                   +     +      + ++ N ++  I P       L+ L L  N  +  +   
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219

Query: 401 AIGELRNLQYLGLVG------NNIRGIIPDPIGNLTLLNVLQLGFNKLQGS---IPSYLG 451
            I  L  L+   LV        N+       +  L  L + +     L      I     
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279

Query: 452 KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDIS 511
              N+   S  +  +               +L++                LKSL +L  +
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFT 333

Query: 512 RNNFSNEIPVTLSACTTLEYLLMQGN--SFNGSIPQSLNALKSIKELDLSCNNLSGQIPI 569
            N   N    +     +LE+L +  N  SF G   QS     S+K LDLS N +   +  
Sbjct: 334 SNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS 390

Query: 570 HLGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
           +   L  LE+L+  +++ + ++ +  VF +
Sbjct: 391 NFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  130 bits (330), Expect = 8e-32
 Identities = 81/405 (20%), Positives = 141/405 (34%), Gaps = 37/405 (9%)

Query: 63  RVTKLDLESQNIGGFLSPYIGNLSFLRV----INLANNSFHGQIPKEVGRLFRLETIVLS 118
            +  LDL S  I       +  L  + +    ++L+ N  +  I     +  RL  + L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208

Query: 119 NNSFSGKIP-------TNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLT 171
           NN  S  +          L     ++  + +  NL    ++ +     +         L 
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 172 G---QLPPSIGNLSALQTFDIAGNKLDGRIPDS--LGQLRNLNYLGTSENDFSGMFPLSV 226
                +      L+ + +F +    ++ R+ D       ++L  +      F  +     
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTL----- 322

Query: 227 CNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLT--GFLPQSLSNASKLEWL 284
             + SL       N+   +       +LP L  L +++N L+  G   QS    + L++L
Sbjct: 323 -KLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 285 ELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR 344
           +L+ N     +  NF  L  L  L    +NL       +   ++  +   L+ L +    
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-----KQMSEFSVFLSLRNLIYLDISHTH 432

Query: 345 FGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAIG 403
              A       LS+   L  MAGN       P+I   L NL  L L   QL    P A  
Sbjct: 433 TRVAFNGIFNGLSSLEVLK-MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 404 ELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPS 448
            L +LQ L +  N ++ +       LT L  + L  N    S P 
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  107 bits (270), Expect = 2e-24
 Identities = 52/289 (17%), Positives = 95/289 (32%), Gaps = 23/289 (7%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGL 413
            NL  +   + ++ N +         +   L  L L   ++      A   L +L  L L
Sbjct: 24  DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83

Query: 414 VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQ 473
            GN I+ +       L+ L  L      L       +G  + L +L+  +N +     P+
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143

Query: 474 IFGITTLSKLLDLSENHLSGSIPLEVGNLKSL----VQLDISRNNFSNEIPVTLSACTTL 529
            F   T  + LDLS N +      ++  L  +    + LD+S N   N I         L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRL 202

Query: 530 EYLLMQGNSFNGSIPQ-SLNALKSIKELDL------SCNNLSGQIPIHLGNLPFLEYLNL 582
             L ++ N  + ++ +  +  L  ++   L      +  NL       L  L  L     
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

Query: 583 SYNHFEGKVPK-KGVFSN----------ETRISLTGNEQFCGGLGELHL 620
              + +  +     +F+              I    +  +  G   L L
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  187 bits (477), Expect = 5e-53
 Identities = 67/317 (21%), Positives = 119/317 (37%), Gaps = 40/317 (12%)

Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECE- 723
               L   +          +G FG V+K  L      VAVK+         +S+  E E 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIF---PIQDKQSWQNEYEV 69

Query: 724 -ALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIV 782
            +L  ++H N+++ I           D   ++  + + GS+ D+L            +I 
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANVVSWNE-LCHIA 127

Query: 783 IEVASVIEYLHNH-------CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
             +A  + YLH          +P I H D+K  NVLL +++ A ++DFGLA         
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF------ 181

Query: 836 VAPEGQSSSIEMK---GTIGYIGPEYGMGG-----DLSMTGDVYSFGILLLEMFTRRRPT 887
              E   S+ +     GT  Y+ PE   G      D  +  D+Y+ G++L E+ +R    
Sbjct: 182 ---EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 888 DNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPS-----KFEECLVAVVRTGVACS 942
           D    D   L    ++     +  + +  +  + R P      +    +  +  T   C 
Sbjct: 239 DGP-VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-PVLRDYWQKHAGMAMLCETIEECW 296

Query: 943 MESPSERMQMTAVVKKL 959
                 R+    V +++
Sbjct: 297 DHDAEARLSAGCVGERI 313

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  190 bits (486), Expect = 1e-52
 Identities = 112/513 (21%), Positives = 174/513 (33%), Gaps = 73/513 (14%)

Query: 82  IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
              L+      L   +    + +    L ++ T+              +    NL     
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75

Query: 142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
             N L       + N  K+  + +  NQ+       + NL+ L    +  N++     D 
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI--TDIDP 129

Query: 202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
           L  L NLN L  S N  S +  LS   ++SL +     N+     P+    NL  L  L 
Sbjct: 130 LKNLTNLNRLELSSNTISDISALS--GLTSLQQLSF-GNQVTDLKPLA---NLTTLERLD 183

Query: 262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
           ++ N ++      L+  + LE L    N  S         L NL +L L  N L      
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGNQLKD---- 235

Query: 322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
               I  L + + L  L L                         A NQIS   P  +  L
Sbjct: 236 ----IGTLASLTNLTDLDL-------------------------ANNQISNLAP--LSGL 264

Query: 382 FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
             L  L L  NQ++   P  +  L  L  L L  N +  I P  I NL  L  L L FN 
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320

Query: 442 LQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEV 499
           +    P  +     L +L   NNK++      +  +  L+ +  L    N +S   PL  
Sbjct: 321 ISDISP--VSSLTKLQRLFFYNNKVSD-----VSSLANLTNINWLSAGHNQISDLTPL-- 371

Query: 500 GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLS 559
            NL  + QL ++   ++N  PV   A  ++   +          P +++   S  E D++
Sbjct: 372 ANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTG-ALIAPATISDGGSYTEPDIT 429

Query: 560 CNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            N  S               +      F G V 
Sbjct: 430 WNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  185 bits (473), Expect = 5e-51
 Identities = 111/488 (22%), Positives = 190/488 (38%), Gaps = 49/488 (10%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
             K  L   N+    +    +L  +  +         +    V  L  L  I  SNN  +
Sbjct: 26  KMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 81

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
              P  L     L+D  ++ N +       + N   +  L+L+ NQ+T      + NL+ 
Sbjct: 82  DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTN 135

Query: 184 LQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK 243
           L   +++ N +      +L  L +L  L    N  + + PL+  N+++L+   +  N+  
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKPLA--NLTTLERLDISSNKVS 190

Query: 244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLP 303
               +     L  L  L+   N ++   P  L   + L+ L LN N           SL 
Sbjct: 191 DISVLA---KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG--TLASLT 243

Query: 304 NLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLI 363
           NL+ L L  N +     ++L     L+  +KL +L L  N+     P  +A L T +T +
Sbjct: 244 NLTDLDLANNQI-----SNLAP---LSGLTKLTELKLGANQISNISP--LAGL-TALTNL 292

Query: 364 AMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIP 423
            +  NQ+    P  I NL NL  L L +N ++   P  +  L  LQ L    N +  +  
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-- 346

Query: 424 DPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL 483
             + NLT +N L  G N++    P  L     + QL   +       P       ++   
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNT 403

Query: 484 LDLSENHLSGSIPLEVGNLKSLVQLDISRNN--FSNEIPVTLSACTTLEYLLMQGNSFNG 541
           +      L    P  + +  S  + DI+ N   ++NE+  T S   T+        +F+G
Sbjct: 404 VKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKG---TTTFSG 458

Query: 542 SIPQSLNA 549
           ++ Q L A
Sbjct: 459 TVTQPLKA 466

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  123 bits (310), Expect = 1e-29
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 25/240 (10%)

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYL 411
           +   L+  M    +    ++ T+     +L  +  L  +   +       +  L NL  +
Sbjct: 19  TDTALAEKMKT-VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73

Query: 412 GLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLP 471
               N +  I   P+ NLT L  + +  N++    P  L    NL  L+  NN++     
Sbjct: 74  NFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--- 126

Query: 472 PQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTL 529
             I  +  L+ L  L+LS N +S    L    L SL QL    N  ++  P  L+  TTL
Sbjct: 127 --IDPLKNLTNLNRLELSSNTISDISAL--SGLTSLQQLSFG-NQVTDLKP--LANLTTL 179

Query: 530 EYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG 589
           E L +  N    S    L  L +++ L  + N +S   P  LG L  L+ L+L+ N  + 
Sbjct: 180 ERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 72.7 bits (179), Expect = 2e-13
 Identities = 38/165 (23%), Positives = 56/165 (33%), Gaps = 19/165 (11%)

Query: 427 GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--L 484
           G L    + Q     +              M+       +  T+       T L ++  L
Sbjct: 1   GPLGSATITQD--TPINQIFT--DTALAEKMKTVLGKTNVTDTVS-----QTDLDQVTTL 51

Query: 485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP 544
                 +  SI   V  L +L Q++ S N  ++  P  L   T L  +LM  N      P
Sbjct: 52  QADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107

Query: 545 QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG 589
             L  L ++  L L  N ++   P  L NL  L  L LS N    
Sbjct: 108 --LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  177 bits (451), Expect = 8e-50
 Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 55/307 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      +G+G+FG V K         VA+K +  + +   K+F+ E   L  + H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNI 63

Query: 734 IKIITICSSIDFKGADFKA--IVYEYMQYGSVDDWLHHTNDKLEVG---KLNIVIEVASV 788
           +K           GA      +V EY + GS+ + LH             ++  ++ +  
Sbjct: 64  VK---------LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
           + YLH+     ++H DLKP N+LL     V  + DFG A  +           Q+     
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----------QTHMTNN 163

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK 907
           KG+  ++ PE   G + S   DV+S+GI+L E+ TRR+P D +                 
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------------PAF 211

Query: 908 KVMGIVD----PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG 963
           ++M  V     P L           + + +++     C  + PS+R  M  +VK +  + 
Sbjct: 212 RIMWAVHNGTRPPL------IKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLM 262

Query: 964 EIFIGPP 970
             F G  
Sbjct: 263 RYFPGAD 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  172 bits (437), Expect = 4e-48
 Identities = 65/252 (25%), Positives = 103/252 (40%), Gaps = 40/252 (15%)

Query: 656 LMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT 715
           +   +FP      L+    E     +IGKG FG V+KG L +D   VA+K + L      
Sbjct: 3   MGGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60

Query: 716 -------KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA--IVYEYMQYGSVDDW 766
                  + F  E   + N+ H N++K           G       +V E++  G +   
Sbjct: 61  TEMIEKFQEFQREVFIMSNLNHPNIVK---------LYGLMHNPPRMVMEFVPCGDLYHR 111

Query: 767 LHHTNDKLEVG-KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-----HDMVAHV 820
           L      ++   KL +++++A  IEY+ N   PPIVH DL+  N+ L        + A V
Sbjct: 112 LLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

Query: 821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE--YGMGGDLSMTGDVYSFGILLL 878
           +DFGL++   H           S   + G   ++ PE         +   D YSF ++L 
Sbjct: 171 ADFGLSQQSVH-----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219

Query: 879 EMFTRRRPTDNM 890
            + T   P D  
Sbjct: 220 TILTGEGPFDEY 231

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  172 bits (438), Expect = 2e-47
 Identities = 94/423 (22%), Positives = 151/423 (35%), Gaps = 87/423 (20%)

Query: 144 NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLG 203
              + +I     +  +  R  L    +T     +   L ++    +AG K+       + 
Sbjct: 9   PAPINQIFPD-ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIE 63

Query: 204 QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVA 263
            L NL YL  + N  + + PLS                           NL KLT L + 
Sbjct: 64  YLTNLEYLNLNGNQITDISPLS---------------------------NLVKLTNLYIG 96

Query: 264 QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL 323
            N +T     +L N + L  L LNE++ S        +L  +  L LG N+  +      
Sbjct: 97  TNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS------ 146

Query: 324 DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN 383
             ++ L+N + L  L +                           +++       I NL +
Sbjct: 147 -DLSPLSNMTGLNYLTVT-------------------------ESKVKD--VTPIANLTD 178

Query: 384 LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
           L  L L YNQ+       +  L +L Y     N I  I P  + N+T LN L++G NK+ 
Sbjct: 179 LYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234

Query: 444 GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGN 501
              P  L     L  L    N+++      I  +  L+KL  L++  N +S    L   N
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISD-----INAVKDLTKLKMLNVGSNQISDISVL--NN 285

Query: 502 LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
           L  L  L ++ N   NE    +   T L  L +  N      P  L +L  +   D +  
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343

Query: 562 NLS 564
            + 
Sbjct: 344 VIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  170 bits (433), Expect = 8e-47
 Identities = 93/404 (23%), Positives = 151/404 (37%), Gaps = 63/404 (15%)

Query: 208 LNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL 267
              L T     + +FP +  +++    A L K      +       L  +T LVVA   +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56

Query: 268 TGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFIT 327
                Q +   + LE+L LN N  +       ++L  L+ LY+G N +     TD+  + 
Sbjct: 57  ASI--QGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKI-----TDISALQ 107

Query: 328 LLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGL 387
            LTN   L +L                 L+          + IS      + NL  +  L
Sbjct: 108 NLTN---LREL----------------YLN---------EDNISD--ISPLANLTKMYSL 137

Query: 388 GLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP 447
            L  N    +    +  +  L YL +  + ++ + P  I NLT L  L L +N+++   P
Sbjct: 138 NLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194

Query: 448 SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSL 505
             L    +L   +A  N++       I  +  +++L  L +  N ++   PL   NL  L
Sbjct: 195 --LASLTSLHYFTAYVNQITD-----ITPVANMTRLNSLKIGNNKITDLSPL--ANLSQL 245

Query: 506 VQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSG 565
             L+I  N  S+ I   +   T L+ L +  N  +      LN L  +  L L+ N L  
Sbjct: 246 TWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN 301

Query: 566 QIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNE 609
           +    +G L  L  L LS NH     P     S           
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRPLAS-LSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  153 bits (390), Expect = 4e-41
 Identities = 78/379 (20%), Positives = 147/379 (38%), Gaps = 35/379 (9%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG 124
             L      I   + P   +L+      L   S    + +E   L  +  +V++    + 
Sbjct: 3   ATLATLPAPINQ-IFP-DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA- 57

Query: 125 KIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSAL 184
            I   +    NL    ++ N +       + N +K+  L +  N++T     ++ NL+ L
Sbjct: 58  SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNL 112

Query: 185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKG 244
           +   +  + +       L  L  +  L    N         + N++ L+   + +++ K 
Sbjct: 113 RELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD 169

Query: 245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPN 304
             P+    NL  L  L +  N +    P  L++ + L +     N  +        ++  
Sbjct: 170 VTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTR 222

Query: 305 LSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIA 364
           L+ L +G N +     TDL     L N S+L  L +  N+      +++ +L T + ++ 
Sbjct: 223 LNSLKIGNNKI-----TDLSP---LANLSQLTWLEIGTNQISD--INAVKDL-TKLKMLN 271

Query: 365 MAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPD 424
           +  NQIS      + NL  LN L L  NQL       IG L NL  L L  N+I  I   
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR-- 327

Query: 425 PIGNLTLLNVLQLGFNKLQ 443
           P+ +L+ ++        ++
Sbjct: 328 PLASLSKMDSADFANQVIK 346

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  170 bits (434), Expect = 2e-47
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 21/216 (9%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKII 737
            +IG GSFG V++      G  VAVK++            F+ E   ++ +RH N++  +
Sbjct: 43  EKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG---KLNIVIEVASVIEYLHN 794
              +          +IV EY+  GS+   LH +  + ++    +L++  +VA  + YLHN
Sbjct: 101 GAVTQ-----PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
              PPIVH +LK  N+L+D      V DFGL+R  +            SS    GT  ++
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--------TFLSSKSAAGTPEWM 206

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
            PE       +   DVYSFG++L E+ T ++P  N+
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  175 bits (445), Expect = 2e-47
 Identities = 91/522 (17%), Positives = 175/522 (33%), Gaps = 84/522 (16%)

Query: 77  FLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNL 136
           F++P   + +FL+     +++   ++P E   +        + + +    P         
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGE---- 56

Query: 137 IDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDG 196
                     V  ++  +    +   L L    L+  LP    +L   ++   + N L  
Sbjct: 57  -----QREMAVSRLRDCLDR--QAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT- 104

Query: 197 RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPK 256
            +P+    L++L     +    S            L+   +  N+ +  LP     N   
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLE-KLPEL--QNSSF 154

Query: 257 LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG 316
           L ++ V  N+L   LP    +   LE++    N           +LP L+ +Y   N+L 
Sbjct: 155 LKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 208

Query: 317 T------------RTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIA 364
                          +  L+ +  L N   L  +    N     LP    +L      + 
Sbjct: 209 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA----LN 263

Query: 365 MAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPD 424
           +  N ++  +P   ++L  L+     ++ L+   P       NL YL    N IR +  D
Sbjct: 264 VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRSL-CD 314

Query: 425 PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLL 484
              +L  LN   +  NKL   +P+       L +L A  N L   +P     +  L    
Sbjct: 315 LPPSLEELN---VSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQL---- 362

Query: 485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP 544
            +  N L    P    +++ L       N+   E+P        L+ L ++ N      P
Sbjct: 363 HVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVP---ELPQNLKQLHVETNPLR-EFP 412

Query: 545 QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
               +++   +L ++   +             LE     ++H
Sbjct: 413 DIPESVE---DLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  165 bits (419), Expect = 6e-44
 Identities = 94/431 (21%), Positives = 152/431 (35%), Gaps = 71/431 (16%)

Query: 158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEND 217
             ++    + + LT ++P    N+ +   +  A ++ +   P   G+ R +         
Sbjct: 11  TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS------ 63

Query: 218 FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN 277
                 L  C      E  L       SLP       P L  LV + N+LT  LP+   +
Sbjct: 64  -----RLRDCLDRQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPELPQS 112

Query: 278 ASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVK 337
              L     N    S       +  P L  L +  N L          +  L N S L  
Sbjct: 113 LKSLLVDNNNLKALS-------DLPPLLEYLGVSNNQLEK--------LPELQNSSFLKI 157

Query: 338 LGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT 397
           + +  N     LP    +L      IA   NQ+     PE++NL  L  +  + N L   
Sbjct: 158 IDVDNNSL-KKLPDLPPSL----EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-K 209

Query: 398 IPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLM 457
           +P       +L+ +    N +       + NL  L  +    N L+ ++P       +L 
Sbjct: 210 LPD---LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLE 260

Query: 458 QLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN 517
            L+  +N L   LP     +T     LD+SEN  S  +     NL     L+ S N    
Sbjct: 261 ALNVRDNYLT-DLPELPQSLTF----LDVSENIFS-GLSELPPNLYY---LNASSNEI-R 310

Query: 518 EIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFL 577
            +        +LE L +  N     +P     L   + L  S N+L+ ++P    N   L
Sbjct: 311 SLCDLP---PSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQN---L 359

Query: 578 EYLNLSYNHFE 588
           + L++ YN   
Sbjct: 360 KQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  140 bits (354), Expect = 1e-35
 Identities = 88/485 (18%), Positives = 146/485 (30%), Gaps = 93/485 (19%)

Query: 62  QRVTKLDLESQNIGGFLSPYIGNLSF-------------LRVINLANNSFHGQIPKEVGR 108
           +  T+             P  G                    + L N      +P+    
Sbjct: 34  KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--- 89

Query: 109 LFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN 168
              LE++V S NS + ++P       +L+    +   L             +E L +  N
Sbjct: 90  PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNN 141

Query: 169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCN 228
           QL     P + N S L+  D+  N L  ++PD    L  +       N    +  L   N
Sbjct: 142 QLEK--LPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLEELPELQ--N 193

Query: 229 ISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNE 288
           +  L   Y   N  K  LP         L  +V   N L   LP  L N   L  +  + 
Sbjct: 194 LPFLTAIYADNNSLK-KLPDLPL----SLESIVAGNNILE-ELP-ELQNLPFLTTIYADN 246

Query: 289 NHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGA 348
           N          +  P+L  L +  N L            L  + + L     +F+     
Sbjct: 247 NLLKTL----PDLPPSLEALNVRDNYLTD-------LPELPQSLTFLDVSENIFSG---- 291

Query: 349 LPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNL 408
           L     NL      +  + N+I  ++     +L  LN   +  N+L   +P        L
Sbjct: 292 LSELPPNLYY----LNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPALPP---RL 339

Query: 409 QYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGK---------------- 452
           + L    N++  + P+   NL  L+   + +N L+   P                     
Sbjct: 340 ERLIASFNHLAEV-PELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRMNSHLAEVPEL 394

Query: 453 CQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISR 512
            QNL QL    N L    P     +  L     ++   +             L       
Sbjct: 395 PQNLKQLHVETNPLR-EFPDIPESVEDL----RMNSERVVDPYEFAHETTDKLEDDVFEH 449

Query: 513 NNFSN 517
           ++  +
Sbjct: 450 HHHHH 454

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  120 bits (303), Expect = 6e-29
 Identities = 56/342 (16%), Positives = 117/342 (34%), Gaps = 51/342 (14%)

Query: 252 FNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG 311
            +   L   +   +NLT  +P    N           + +             ++   L 
Sbjct: 8   VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
                                 +  +L L       +LP    +L +    +  + N ++
Sbjct: 67  DCL-----------------DRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT 104

Query: 372 GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTL 431
             +P   ++L +L         L+   P        L+YLG+  N +  +    + N + 
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSF 154

Query: 432 LNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHL 491
           L ++ +  N L+  +P       +L  ++A NN+L     P++  +  L+ +     N L
Sbjct: 155 LKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQL--EELPELQNLPFLTAI-YADNNSL 207

Query: 492 SGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALK 551
              +P    +L+S+       N    E+P  L     L  +    N    ++P    +L+
Sbjct: 208 K-KLPDLPLSLESI---VAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLE 260

Query: 552 SIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK 593
           +   L++  N L+  +P    +L FL+     ++      P 
Sbjct: 261 A---LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN 298

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  113 bits (286), Expect = 9e-27
 Identities = 52/271 (19%), Positives = 99/271 (36%), Gaps = 40/271 (14%)

Query: 350 PHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQ 409
           P +++N  T +       + ++  +P E  N+ +       +++     PP  GE R + 
Sbjct: 5   PRNVSN--TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 410 YLGLVGNNIRGI------------IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLM 457
              L     R              +P+   +L  L       N L   +P      ++L+
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLL 117

Query: 458 QLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN 517
             +     L+  LPP +       + L +S N L   +P E+ N   L  +D+  N+   
Sbjct: 118 VDNNNLKALSD-LPPLL-------EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK- 166

Query: 518 EIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFL 577
           ++P       +LE++    N     +P  L  L  +  +    N+L  ++P    +   L
Sbjct: 167 KLPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---L 217

Query: 578 EYLNLSYNHFEGKVPKKGVFSNETRISLTGN 608
           E +    N  E ++P+       T I    N
Sbjct: 218 ESIVAGNNILE-ELPELQNLPFLTTIYADNN 247

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  175 bits (445), Expect = 1e-46
 Identities = 92/513 (17%), Positives = 176/513 (34%), Gaps = 38/513 (7%)

Query: 117 LSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP 176
             + SF+  IP+ L+    +    +  N +       +     ++ L L  +++   +  
Sbjct: 12  GRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67

Query: 177 SI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC-NISSLDE 234
               +L +L+  D++ N L        G L +L YL    N +  +   S+  N+++L  
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 235 AYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQ 294
             +        +       L  L  L +   +L  +  QSL +   +  L L+ +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 295 VRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIA 354
           + I  + L ++  L L   NL     + L    + +   KL   G V           + 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 355 NLSTTMTLIAMAGNQISG--TIPPEIRNLF---------NLNGLGLEYNQLTGTIPPAIG 403
                ++ +      ++G     P   ++           +  L +    L   +     
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307

Query: 404 ELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI---PSYLGKCQNLMQLS 460
            L  ++ + +  + +  +      +L  L  L L  N +        +  G   +L  L 
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367

Query: 461 APNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNE 518
              N L  ++      + TL  L  LD+S N     +P      + +  L++S       
Sbjct: 368 LSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV- 424

Query: 519 IPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLE 578
             V      TLE L +  N+ + S    L  L   +EL +S N L   +P      P L 
Sbjct: 425 --VKTCIPQTLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLK-TLP-DASLFPVLL 476

Query: 579 YLNLSYNHFEGKVPKKGVFSNETRIS---LTGN 608
            + +S N    K    G+F   T +    L  N
Sbjct: 477 VMKISRNQL--KSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  156 bits (396), Expect = 3e-40
 Identities = 91/520 (17%), Positives = 175/520 (33%), Gaps = 58/520 (11%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSF 122
           +  LDL    I       +   + L+V+ L ++  +  I  +    L  LE + LS+N  
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL 86

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNLVG-EIQAIIGNWLKIERLSLYGNQLTGQLPP-SIGN 180
           S    +      +L    +  N      + ++  N   ++ L +   +   ++       
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146

Query: 181 LSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN 240
           L++L   +I    L      SL  +R++++L    ++ +                     
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA--------------------- 185

Query: 241 RFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFN 300
                L       L  +  L +   NL  F    L        ++      S     +FN
Sbjct: 186 ----FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 301 SLPNLSKLY----------LGRNNLGTRTSTDLDFITLLTN--CSKLVKLGLVFNRFGGA 348
            L  L +               N LG    ++ D ++ L       + +L +        
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301

Query: 349 LPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP---AIGEL 405
           L    + L   +  I +  +++        ++L +L  L L  N +           G  
Sbjct: 302 LSTVYSLL-EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360

Query: 406 RNLQYLGLVGNNIRGI--IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPN 463
            +LQ L L  N++R +    + +  L  L  L +  N     +P      + +  L+  +
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419

Query: 464 NKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTL 523
             +   +   I    TL ++LD+S N+L  S  L    L  L +L ISRN     +P   
Sbjct: 420 TGIR-VVKTCIP--QTL-EVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDA- 469

Query: 524 SACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNL 563
           S    L  + +  N          + L S++++ L  N  
Sbjct: 470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  122 bits (309), Expect = 2e-29
 Identities = 55/407 (13%), Positives = 128/407 (31%), Gaps = 26/407 (6%)

Query: 65  TKLDLESQNIGGFLSP-YIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
             L + +      +       L+ L  + +   S      + +  +  +  + L  +  +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
             +        ++    +   NL     + +        +     + +     S   L  
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 184 LQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK 243
           L  + +  +++                   + ++   +  L      ++   ++ +    
Sbjct: 246 LLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299

Query: 244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN---FN 300
             L       L K+  + V  + +         +   LE+L+L+EN    +   N     
Sbjct: 300 YDLSTVYS-LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358

Query: 301 SLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTM 360
           + P+L  L L +N+L +   T    +TL      L  L +  N F   +P S        
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTL----KNLTSLDISRNTF-HPMPDSCQWPEKMR 413

Query: 361 TLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRG 420
            L  ++   I   +   I     L  L +  N L  +       L  LQ L +  N ++ 
Sbjct: 414 FLN-LSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKT 465

Query: 421 IIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN 467
           +         +L V+++  N+L+        +  +L ++    N  +
Sbjct: 466 L--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  177 bits (450), Expect = 6e-46
 Identities = 109/550 (19%), Positives = 183/550 (33%), Gaps = 53/550 (9%)

Query: 92  NLANNSFHG--QIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGE 149
            +A   F    Q+P+    L   E ++LS N       ++      L    + +      
Sbjct: 7   RIAFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 150 IQA-IIGNWLKIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRI--PDSLGQL 205
           I      N   +  L L  +++   L P     L  L    +    L   +        L
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122

Query: 206 RNLNYLGTSENDFSGM-FPLSVCNISSLDEAYLFKNRFKGSLPVCL-GFNLPKLTVLVVA 263
           + L  L  S+N    +    S   ++SL       N+        L       L+   +A
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182

Query: 264 QNNLTGFLPQSLSNASK------LEWLELNENHFSGQVRINFNS------------LPNL 305
            N+L   +               LE L+++ N ++  +  NF++              ++
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242

Query: 306 SKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAM 365
                G +N+      D +    L   S +  L L               L     L  +
Sbjct: 243 MGAGFGFHNI---KDPDQNTFAGLARSS-VRHLDLSHGFVFSLNSRVFETLKDLKVLN-L 297

Query: 366 AGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDP 425
           A N+I+         L NL  L L YN L          L  + Y+ L  N+I  I    
Sbjct: 298 AYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357

Query: 426 IGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLD 485
              L  L  L L  N L     + +    ++  +    NKL  TLP         + L+ 
Sbjct: 358 FKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLT----ANLIH 407

Query: 486 LSENHLSG-SIPLEVGNLKSLVQLDISRNNFSN-EIPVTLSACTTLEYLLMQGNSFNGSI 543
           LSEN L    I   +  +  L  L +++N FS+     T S   +LE L +  N    + 
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467

Query: 544 PQSLNA-----LKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFS 598
              L       L  ++ L L+ N L+   P    +L  L  L+L+ N     +    + +
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526

Query: 599 NETRISLTGN 608
           N   + ++ N
Sbjct: 527 NLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  160 bits (407), Expect = 1e-40
 Identities = 101/558 (18%), Positives = 188/558 (33%), Gaps = 58/558 (10%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSF 122
             +L L    I    +     L  L+++ L +      I KE    L  L  + L ++  
Sbjct: 26  TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLK----IERLSLYGNQLTG-QLPPS 177
               P      F+L +  ++   L      +   + +    + RL L  NQ+    L PS
Sbjct: 86  YFLHPDAFQGLFHLFELRLYFCGL--SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143

Query: 178 IGNLSALQTFDIAGNKLDGRIPDSLGQLR--NLNYLGTSENDFSGMFPLSVCNIS----- 230
            G L++L++ D + N++       L  L+   L++   + N       +           
Sbjct: 144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203

Query: 231 -SLDEAYLFKNRFK-----------GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN- 277
             L+   +  N +                         +       +N+      + +  
Sbjct: 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263

Query: 278 -ASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLV 336
             S +  L+L+           F +L +L  L L  N +       +           L 
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI-----NKIA-DEAFYGLDNLQ 317

Query: 337 KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLT 395
            L L +N  G     +   L   +  I +  N I+  I  +  + L  L  L L  N LT
Sbjct: 318 VLNLSYNLLGELYSSNFYGL-PKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT 375

Query: 396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG-SIPSYLGKCQ 454
                 I  + ++  + L GN +  +    +      N++ L  N+L+   I  +L +  
Sbjct: 376 -----TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVP 426

Query: 455 NLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-----GNLKSLVQLD 509
           +L  L    N+ +     Q        + L L EN L  +   E+       L  L  L 
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486

Query: 510 ISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPI 569
           ++ N  ++  P   S  T L  L +  N     +  +     +++ LD+S N L      
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL-PANLEILDISRNQLLA---P 541

Query: 570 HLGNLPFLEYLNLSYNHF 587
           +      L  L++++N F
Sbjct: 542 NPDVFVSLSVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  135 bits (342), Expect = 1e-32
 Identities = 95/516 (18%), Positives = 177/516 (34%), Gaps = 43/516 (8%)

Query: 62  QRVTKLDLESQNIGGF-LSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFR---LETIVL 117
           + +T+LDL    I    L P  G L+ L+ I+ ++N     + +      +   L    L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSL 181

Query: 118 SNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPS 177
           + NS   ++  +  +C N         N+V EI  + GN   ++    + N ++     S
Sbjct: 182 AANSLYSRVSVDWGKCMNPF------RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235

Query: 178 IGNLSALQTFDIAGNKLDGRIPDSLGQLR--NLNYLGTSENDFSGMFPLSVCNISSLDEA 235
           +     +       + +     ++   L   ++ +L  S      +       +  L   
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295

Query: 236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQV 295
            L  N+    +     + L  L VL ++ N L      +     K+ +++L +NH +   
Sbjct: 296 NLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354

Query: 296 RINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIAN 355
              F  L  L  L L  N            +T +     +  + L  N+       ++  
Sbjct: 355 DQTFKFLEKLQTLDLRDNA-----------LTTIHFIPSIPDIFLSGNKL-----VTLPK 398

Query: 356 LSTTMTLIAMAGNQISG-TIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLGL 413
           ++ T  LI ++ N++    I   +  + +L  L L  N+ +         E  +L+ L L
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458

Query: 414 VGNNIR-----GIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNG 468
             N ++      +  D    L+ L VL L  N L    P        L  LS  +N+L  
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT- 517

Query: 469 TLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTT 528
            L           ++LD+S N L            SL  LDI+ N F  E  ++      
Sbjct: 518 VLSHNDL--PANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKFICECELSTFINWL 572

Query: 529 LEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS 564
               +              ++   +    LS     
Sbjct: 573 NHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCD 608

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 99.5 bits (248), Expect = 2e-21
 Identities = 71/309 (22%), Positives = 105/309 (33%), Gaps = 23/309 (7%)

Query: 58  GHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVL 117
           G     V  LDL    +    S     L  L+V+NLA N  +    +    L  L+ + L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321

Query: 118 SNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPS 177
           S N       +N      +    +  N++            K++ L L  N LT     +
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----T 376

Query: 178 IGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSV-CNISSLDEAY 236
           I  + ++    ++GNKL      +L      N +  SEN    +  L     +  L    
Sbjct: 377 IHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILI 432

Query: 237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL-----TGFLPQSLSNASKLEWLELNENHF 291
           L +NRF            P L  L + +N L     T          S L+ L LN N+ 
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492

Query: 292 SGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPH 351
           +      F+ L  L  L L  N L     T L    L  N   L  L +  N+     P 
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRL-----TVLSHNDLPAN---LEILDISRNQLLAPNPD 544

Query: 352 SIANLSTTM 360
              +LS   
Sbjct: 545 VFVSLSVLD 553

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.9 bits (101), Expect = 5e-04
 Identities = 22/98 (22%), Positives = 32/98 (32%), Gaps = 18/98 (18%)

Query: 537 NSFNG--SIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK 594
             F     +PQ LN   + + L LS N +          L  L+ L L   +    +  K
Sbjct: 11  YRFCNLTQVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID-K 66

Query: 595 GVFSNET---RISLTGNE---------QFCGGLGELHL 620
             F N      + L  ++         Q    L EL L
Sbjct: 67  EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRL 104

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  163 bits (416), Expect = 2e-45
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 30/223 (13%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNL----DKKGATKSFVAECEALRNIRHRNLIK 735
             IG G FG VY+      G  VAVK        D     ++   E +    ++H N+I 
Sbjct: 13  EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH 795
           +  +C     K  +   +V E+ + G ++  L       ++  +N  +++A  + YLH+ 
Sbjct: 71  LRGVCL----KEPNL-CLVMEFARGGPLNRVLSGKRIPPDI-LVNWAVQIARGMNYLHDE 124

Query: 796 CQPPIVHGDLKPSNVLLD--------HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
              PI+H DLK SN+L+          + +  ++DFGLAR             +++ +  
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----------RTTKMSA 174

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
            G   ++ PE       S   DV+S+G+LL E+ T   P   +
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  162 bits (413), Expect = 7e-45
 Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 38/286 (13%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKII 737
            RIG GSFG VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +
Sbjct: 30  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHC 796
              ++         AIV ++ +  S+   LH +  K E+ K ++I  + A  ++YLH   
Sbjct: 87  GYSTAPQL------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              I+H DLK +N+ L  D    + DFGLA   S         G     ++ G+I ++ P
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW------SGSHQFEQLSGSILWMAP 191

Query: 857 E---YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV 913
           E          S   DVY+FGI+L E+ T + P             Y+ +    +++ +V
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQIIEMV 238

Query: 914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
               L           C   + R    C  +   ER     ++ ++
Sbjct: 239 GRGSLSP-DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  163 bits (416), Expect = 7e-45
 Identities = 55/333 (16%), Positives = 105/333 (31%), Gaps = 31/333 (9%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
           +      L    +         LS   +    + N  H +           N +   +  
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAW-------RQANSNNPQIET 62

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
              G       D +   T     V L L         P     LS    +  +    +  
Sbjct: 63  RT-GRALKATADLLEDATQ-PGRVALELRSVPLP-QFPDQAFRLSHLQHMT-IDAAGLM- 117

Query: 373 TIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
            +P  ++    L  L L  N L   +P +I  L  L+ L +        +P+P+ +    
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA- 175

Query: 433 NVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS 492
                                 NL  L      +  +LP  I  +  L K L +  + LS
Sbjct: 176 --------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLS 219

Query: 493 GSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKS 552
            ++   + +L  L +LD+         P        L+ L+++  S   ++P  ++ L  
Sbjct: 220 -ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278

Query: 553 IKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN 585
           +++LDL       ++P  +  LP    + +  +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  147 bits (374), Expect = 3e-39
 Identities = 65/359 (18%), Positives = 116/359 (32%), Gaps = 39/359 (10%)

Query: 172 GQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISS 231
           G       + S  +     G+       D L Q +       +    +        N ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 232 LDEAYLFKNRFKGSLPVCLGF-NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH 290
                      K +    L     P    L +    L    P      S L+ + ++   
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 291 FSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALP 350
              ++         L  L L RN L    ++       + + ++L +L +        LP
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRALPAS-------IASLNRLRELSIRACPELTELP 167

Query: 351 HSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQY 410
             +A+                     E + L NL  L LE+  +  ++P +I  L+NL+ 
Sbjct: 168 EPLASTD----------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210

Query: 411 LGLVGNNIRGIIPDPIGNLTLLNVLQL-GFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGT 469
           L +  + +   +   I +L  L  L L G   L+ + P   G    L +L   +     T
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKDCSNLLT 268

Query: 470 LPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN---EIPVTLSA 525
           LP  I  +T L K LDL        +P  +  L +   + +  +  +      PV   A
Sbjct: 269 LPLDIHRLTQLEK-LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  145 bits (368), Expect = 2e-38
 Identities = 58/326 (17%), Positives = 106/326 (32%), Gaps = 37/326 (11%)

Query: 271 LPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLT 330
                 ++S  E L       S  +R   + L    + Y    N                
Sbjct: 4   SHHHHHHSSGRENLYFQG---STALRPYHDVLSQWQRHYNADRNR-------WHSAWRQA 53

Query: 331 NCSKLVKLGLVFNRFGGALPHSIANL-STTMTLIAMAGNQISGTIPPEIRNLFNLNGLGL 389
           N +              A    + +        + +    +    P +   L +L  + +
Sbjct: 54  NSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTI 111

Query: 390 EYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQL-GFNKLQGSIPS 448
           +   L   +P  + +   L+ L L  N +R  +P  I +L  L  L +    +L   +P 
Sbjct: 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPE 168

Query: 449 YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQL 508
            L                      +  G+  L  L  L    +  S+P  + NL++L  L
Sbjct: 169 PLASTD---------------ASGEHQGLVNLQSL-RLEWTGIR-SLPASIANLQNLKSL 211

Query: 509 DISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLS-CNNLSGQI 567
            I  +  S  +   +     LE L ++G +   + P        +K L L  C+NL   +
Sbjct: 212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TL 269

Query: 568 PIHLGNLPFLEYLNLSYNHFEGKVPK 593
           P+ +  L  LE L+L       ++P 
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPS 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  125 bits (316), Expect = 1e-31
 Identities = 40/253 (15%), Positives = 85/253 (33%), Gaps = 15/253 (5%)

Query: 60  RHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSN 119
                  L+L S  +          LS L+ + +       ++P  + +   LET+ L+ 
Sbjct: 79  TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136

Query: 120 NSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL---------KIERLSLYGNQL 170
           N     +P +++    L +  +     + E+   + +            ++ L L    +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195

Query: 171 TGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNIS 230
              LP SI NL  L++  I  + L   +  ++  L  L  L          +P      +
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253

Query: 231 SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH 290
            L    L       +LP+ +   L +L  L +        LP  ++       + +  + 
Sbjct: 254 PLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312

Query: 291 FSGQVRINFNSLP 303
            +   +    + P
Sbjct: 313 QAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  119 bits (301), Expect = 1e-29
 Identities = 55/359 (15%), Positives = 104/359 (28%), Gaps = 81/359 (22%)

Query: 69  LESQNIGGFLSPY-IGNLSFLRVINLANNSFHGQIPKEVGRL--FRLETIVLSNNSFSGK 125
             + +   + S +   N +  ++      +        +          + L +     +
Sbjct: 38  HYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-Q 95

Query: 126 IPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQ 185
            P    R  +L    +    L+ E+   +  +  +E L+L  N L   LP SI +L+ L+
Sbjct: 96  FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153

Query: 186 TFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGS 245
              I        +P+ L                          + +L    L     + S
Sbjct: 154 ELSIRACPELTELPEPLASTDA---------------SGEHQGLVNLQSLRLEWTGIR-S 197

Query: 246 LPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNL 305
           LP  +  NL  L  L +  + L+  L  ++ +  KLE L+                    
Sbjct: 198 LPASIA-NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD-------------------- 235

Query: 306 SKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAM 365
                                  L  C+ L              P      +    LI  
Sbjct: 236 -----------------------LRGCTALRN-----------YPPIFGGRAPLKRLILK 261

Query: 366 AGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPD 424
             + +  T+P +I  L  L  L L        +P  I +L     + LV  +++  +  
Sbjct: 262 DCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII-LVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 27/169 (15%), Positives = 48/169 (28%), Gaps = 7/169 (4%)

Query: 42  SWNNSI-----NLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANN 96
                +      L              +  L LE   I   L   I NL  L+ + + N+
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 97  SFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGN 156
                +   +  L +LE + L   +     P        L    +   + +  +   I  
Sbjct: 217 PLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR 275

Query: 157 WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQL 205
             ++E+L L G     +LP  I  L A     +  +             
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 15/117 (12%), Positives = 24/117 (20%), Gaps = 22/117 (18%)

Query: 493 GSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ------- 545
           GS      +      L    +         LS                            
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 546 --SLNALKSI------------KELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
             +  ALK+               L+L    L  Q P     L  L+++ +      
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  161 bits (410), Expect = 1e-44
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 26/224 (11%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHR 731
           K+ +   ++ +   G ++KG     G  + VKV+ +       ++ F  EC  LR   H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGK-LNIVIEVASVI 789
           N++ ++  C S     A    ++  +M YGS+ + LH  TN  ++  + +   +++A  +
Sbjct: 68  NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            +LH   +P I    L   +V++D DM A +S   +                  S     
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------------QSPGRMY 170

Query: 850 TIGYIGPEYGMGGDLSMTG---DVYSFGILLLEMFTRRRPTDNM 890
              ++ PE              D++SF +LL E+ TR  P  ++
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  160 bits (407), Expect = 8e-44
 Identities = 54/227 (23%), Positives = 87/227 (38%), Gaps = 35/227 (15%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKII 737
             IGKG FG VY G    +   VA++++++++  +   K+F  E  A R  RH N++   
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL-- 93

Query: 738 TICSSIDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYL 792
                  F GA       AI+    +  ++   +      L+V K   I  E+   + YL
Sbjct: 94  -------FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H      I+H DLK  NV  D+  V  ++DFGL             +         G + 
Sbjct: 147 H---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN---GWLC 199

Query: 853 YIGPEYGMGGDLSMTG---------DVYSFGILLLEMFTRRRPTDNM 890
           ++ PE                    DV++ G +  E+  R  P    
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  162 bits (412), Expect = 7e-43
 Identities = 66/444 (14%), Positives = 122/444 (27%), Gaps = 59/444 (13%)

Query: 150 IQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLN 209
           I  I  N  + +   +  + L   L     +   ++  D++GN L       L     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 210 YLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTG 269
            L  S N       L   ++S+L    L  N  +  L        P +  L  A NN++ 
Sbjct: 62  LLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISR 113

Query: 270 FLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLL 329
                       + + L  N  +    ++      +  L L  N +       ++F  L 
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELA 165

Query: 330 TNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGL 389
            +   L  L L                           N I   +  ++     L  L L
Sbjct: 166 ASSDTLEHLNL-------------------------QYNFIY-DVKGQV-VFAKLKTLDL 198

Query: 390 EYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ-GSIPS 448
             N+L   + P       + ++ L  N +  +I   +     L    L  N    G++  
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 449 YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQL 508
           +  K Q +  ++    K    L  Q     T+  L             L       L+ L
Sbjct: 257 FFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCE---DLPAPFADRLIAL 310

Query: 509 DISRN-------NFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
               +       + +  +            +      +   I Q     ++   L+    
Sbjct: 311 KRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370

Query: 562 NLSGQIPIHLGNLPFLEYLNLSYN 585
            L  Q+         L+       
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAV 394

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  147 bits (372), Expect = 1e-37
 Identities = 64/504 (12%), Positives = 140/504 (27%), Gaps = 79/504 (15%)

Query: 82  IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
             N +  ++  + ++S    +       + ++ + LS N  S     +L+    L     
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL----- 60

Query: 142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
                              E L+L  N L       + +LS L+T D+  N +       
Sbjct: 61  -------------------ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QE 94

Query: 202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
           L    ++  L  + N           NIS +  +                        + 
Sbjct: 95  LLVGPSIETLHAANN-----------NISRVSCS-----------------RGQGKKNIY 126

Query: 262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSG-QVRINFNSLPNLSKLYLGRNNLGTRTS 320
           +A N +T          S++++L+L  N            S   L  L L  N +     
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD--- 183

Query: 321 TDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRN 380
                +      +KL  L L  N+    +     + +    +  +  N++   I   +R 
Sbjct: 184 -----VKGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWIS-LRNNKLV-LIEKALRF 235

Query: 381 LFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN 440
             NL    L  N             +N +   +    ++ +        T+  +   G  
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294

Query: 441 KLQGSIPSYLGKCQNLMQLSAPNNKLNG----TLPPQIFGITTLSKLLDLSENHLSGSIP 496
             +     +  +   L +         G     L  +        + +D  +      I 
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ-REIDALKEQYRTVID 353

Query: 497 LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNG--SIPQSLNALKSIK 554
                 ++ + L+  +     ++     A   L+  L Q           +  + L+ ++
Sbjct: 354 QVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLR 413

Query: 555 ELDLSCNNLSGQIPIHLGNLPFLE 578
            +      +  +      N     
Sbjct: 414 AIVKRYEEMYVEQQSVQNNAIRDW 437

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  144 bits (366), Expect = 7e-37
 Identities = 52/342 (15%), Positives = 108/342 (31%), Gaps = 52/342 (15%)

Query: 250 LGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLY 309
           +  N  +  +  V  ++L   L     +A  ++ L+L+ N  S     +      L  L 
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 310 LGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQ 369
           L  N L      +   +  L+    L  L                +L+          N 
Sbjct: 65  LSSNVL-----YETLDLESLST---LRTL----------------DLN---------NNY 91

Query: 370 ISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNL 429
           +      E+    ++  L    N ++  +  +    +  + + L  N I  +     G  
Sbjct: 92  VQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCR 143

Query: 430 TLLNVLQLGFNKLQG-SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDL 486
           + +  L L  N++   +          L  L+   N +   +  Q+      +KL  LDL
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV----FAKLKTLDL 198

Query: 487 SENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
           S N L+  +  E  +   +  + +  N     I   L     LE+  ++GN F+    + 
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 547 LNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
               K+ +   ++   +      +          +      E
Sbjct: 257 FF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  123 bits (309), Expect = 1e-29
 Identities = 49/303 (16%), Positives = 95/303 (31%), Gaps = 26/303 (8%)

Query: 328 LLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGL 387
           +  N ++     +  +    AL     +      L  ++GN +S     ++     L  L
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELD-LSGNPLSQISAADLAPFTKLELL 63

Query: 388 GLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP 447
            L  N L       +  L  L+ L L  N ++ +          +  L    N +   + 
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQEL-----LVGPSIETLHAANNNIS-RVS 115

Query: 448 SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSG-SIPLEVGNLKSLV 506
               + Q    +   NNK+   L     G  +  + LDL  N +   +      +  +L 
Sbjct: 116 C--SRGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172

Query: 507 QLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQ 566
            L++  N    ++   +     L+ L +  N     +     +   +  + L  N L   
Sbjct: 173 HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 567 IPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGN---------EQFCGGLGE 617
           I   L     LE+ +L  N F     +     N+   ++            E+ C     
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

Query: 618 LHL 620
            H 
Sbjct: 289 GHY 291

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 83.4 bits (206), Expect = 9e-17
 Identities = 42/254 (16%), Positives = 73/254 (28%), Gaps = 7/254 (2%)

Query: 65  TKLDLESQNIGGFLSP-YIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
             LDL+   I          +   L  +NL  N  +  +  +V    +L+T+ LS+N  +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA 204

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQL-TGQLPPSIGNLS 182
             +         +    +  N LV  I+  +     +E   L GN    G L        
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 183 ALQTFDIAGNK-LDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
            +QT      K L G+  +        +Y      D    F   +  +   + A L    
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
            +     C   N  +   +   +      + Q          LE  +     QV     +
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA 382

Query: 302 LPNLSKLYLGRNNL 315
              L          
Sbjct: 383 HAELDGTLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 79.9 bits (197), Expect = 1e-15
 Identities = 32/203 (15%), Positives = 64/203 (31%), Gaps = 32/203 (15%)

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKS 504
           +I                ++ L       +       K LDLS N LS     ++     
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 505 LVQLDISRNNFSNEIPV-----------------TLSACTTLEYLLMQGNSFNGSIPQSL 547
           L  L++S N     + +                  L    ++E L    N+ +  +    
Sbjct: 60  LELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVS--C 116

Query: 548 NALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETR---IS 604
           +  +  K + L+ N ++    +  G    ++YL+L  N  +  V    + ++      ++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLN 175

Query: 605 LTGN-------EQFCGGLGELHL 620
           L  N       +     L  L L
Sbjct: 176 LQYNFIYDVKGQVVFAKLKTLDL 198

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  156 bits (397), Expect = 2e-42
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 15/218 (6%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITI 739
             +GKG FG   K    E G  + +K +    +   ++F+ E + +R + H N++K I +
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHCQP 798
                 K       + EY++ G++   +   + +    +  +   ++AS + YLH+    
Sbjct: 76  LY----KDKRL-NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM--- 127

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG--- 855
            I+H DL   N L+  +    V+DFGLAR +                + K     +G   
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 856 ---PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
              PE   G       DV+SFGI+L E+  R     + 
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  154 bits (390), Expect = 1e-41
 Identities = 70/313 (22%), Positives = 125/313 (39%), Gaps = 48/313 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECE--ALRNIRH 730
            ++ +    +GKG +G V++G+    G +VAVK+ +   +   KS+  E E      +RH
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRETELYNTVMLRH 61

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++  I    +          ++  Y + GS+ D+L  T        L IV+ +AS + 
Sbjct: 62  ENILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTTLDTVS-CLRIVLSIASGLA 119

Query: 791 YLH-----NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
           +LH        +P I H DLK  N+L+  +    ++D GLA   S        +    + 
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST----NQLDVGNN 175

Query: 846 EMKGTIGYIGPE------YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG 899
              GT  Y+ PE           D     D+++FG++L E+  R      +         
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--------- 226

Query: 900 YAKMALPKKVMGIVDPSLLMEARG-----------PSKF--EECLVAVVRTGVACSMESP 946
                 P   +   DPS   + R            P+++  +  L ++ +    C  ++P
Sbjct: 227 -EDYKPPFYDVVPNDPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284

Query: 947 SERMQMTAVVKKL 959
           S R+    + K L
Sbjct: 285 SARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  152 bits (387), Expect = 7e-41
 Identities = 70/296 (23%), Positives = 111/296 (37%), Gaps = 28/296 (9%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECE--ALRNIRHRNLIKII 737
            +IGKG +G V+ G     G  VAVKV    ++    S+  E E      +RH N++  I
Sbjct: 43  KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH---- 793
                          ++ +Y + GS+ D+L  T    +   L +     S + +LH    
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYLKSTTLDAKS-MLKLAYSSVSGLCHLHTEIF 155

Query: 794 -NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               +P I H DLK  N+L+  +    ++D GLA            E         GT  
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNTRVGTKR 211

Query: 853 YIGPEYGMGGDLSMTG-------DVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL 905
           Y+ PE  +   L+          D+YSFG++L E+  R      +    L  H       
Sbjct: 212 YMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 906 PKKVM--GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
             + M   +    L          +ECL  + +    C   +P+ R+    V K L
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  150 bits (380), Expect = 6e-40
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 26/225 (11%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECE--ALRNIRHRNLIKII 737
             IGKG FG V++G     G  VAVK+ +  ++   +S+  E E      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH---- 793
              +  +        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH    
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIV 160

Query: 794 -NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               +P I H DLK  N+L+  +    ++D GLA                +     GT  
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT----DTIDIAPNHRVGTKR 216

Query: 853 YIGPEYGMGGDLSMTG-------DVYSFGILLLEMFTRRRPTDNM 890
           Y+ PE  +   ++M         D+Y+ G++  E+  R       
Sbjct: 217 YMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  147 bits (373), Expect = 1e-38
 Identities = 72/374 (19%), Positives = 134/374 (35%), Gaps = 31/374 (8%)

Query: 252 FNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG 311
             L    ++    + +       L +  ++E L LN+          F     + KLY+G
Sbjct: 42  ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
            N +       L    +  N   L  L L  N    +LP  I + +  +T ++M+ N + 
Sbjct: 102 FNAI-----RYLPP-HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154

Query: 372 GTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLT 430
             I  +  +   +L  L L  N+LT  +      + +L +  +  N +  +         
Sbjct: 155 -RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLSTL-----AIPI 205

Query: 431 LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENH 490
            +  L    N +   +         L  L   +N L  T    +     L   +DLS N 
Sbjct: 206 AVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNYPGL-VEVDLSYNE 259

Query: 491 LSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA 549
           L   I       ++ L +L IS N     + +      TL+ L +  N     + ++   
Sbjct: 260 LE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316

Query: 550 LKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNE 609
              ++ L L  N++     + L     L+ L LS+N ++     + +F N  R ++   +
Sbjct: 317 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDAD 372

Query: 610 QFCGGLGELHLPAC 623
           Q C    +L    C
Sbjct: 373 QHCKIDYQLEHGLC 386

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  142 bits (360), Expect = 9e-37
 Identities = 66/359 (18%), Positives = 124/359 (34%), Gaps = 32/359 (8%)

Query: 163 LSLYGNQLTGQ-----LPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEND 217
              Y   +  Q            L+  +      + +       L   R +  L  ++  
Sbjct: 21  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80

Query: 218 FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN 277
              +   +     ++ + Y+  N  +  LP  +  N+P LTVLV+ +N+L+        N
Sbjct: 81  IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 139

Query: 278 ASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVK 337
             KL  L ++ N+        F +  +L  L L  N L     T +D   +      L  
Sbjct: 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-----THVDLSLI----PSLFH 190

Query: 338 LGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT 397
             + +N        ++A     +  +  + N I+  +   +     L  L L++N LT  
Sbjct: 191 ANVSYNLL-----STLAIP-IAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD- 240

Query: 398 IPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLM 457
               +     L  + L  N +  I+  P   +  L  L +  N+L  ++  Y      L 
Sbjct: 241 -TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 298

Query: 458 QLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS 516
            L   +N L   +         L   L L  N +  ++ L      +L  L +S N++ 
Sbjct: 299 VLDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  129 bits (326), Expect = 2e-32
 Identities = 71/413 (17%), Positives = 147/413 (35%), Gaps = 62/413 (15%)

Query: 67  LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSFSGK 125
           + ++ Q    +       L+  +++   N++   ++P  +     ++E + L++     +
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83

Query: 126 IPTN-LSRCFNLIDFWVHTNNLVGEIQAIIGNWL-KIERLSLYGNQLTGQLPPSI-GNLS 182
           I T   +    +   ++  N +   +   +   +  +  L L  N L+  LP  I  N  
Sbjct: 84  IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 141

Query: 183 ALQTFDIAGNKLDGRIPDSLGQ-LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
            L T  ++ N L+ RI D   Q   +L  L            LS   ++ +D +      
Sbjct: 142 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ-----------LSSNRLTHVDLS------ 183

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
                       +P L    V+ N L+     +L+    +E L+ + N  +    +    
Sbjct: 184 -----------LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPV 224

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
              L+ L L  NNL             L N   LV++ L +N     + H    +     
Sbjct: 225 NVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276

Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
           L  ++ N++   +    + +  L  L L +N L   +     +   L+ L L  N+I  +
Sbjct: 277 LY-ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 333

Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQI 474
               +     L  L L  N    +    L   +N+ + +  +   +  +  Q+
Sbjct: 334 ---KLSTHHTLKNLTLSHNDWDCNSLRALF--RNVARPAVDDADQHCKIDYQL 381

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  114 bits (287), Expect = 2e-27
 Identities = 70/289 (24%), Positives = 106/289 (36%), Gaps = 27/289 (9%)

Query: 327 TLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLN 385
            L  +C     + +               L+    +     + +   +P  +  +   + 
Sbjct: 16  NLQYDCV-FYDVHIDMQTQDVYFGFEDITLNNQKIVT-FKNSTMR-KLPAALLDSFRQVE 72

Query: 386 GLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
            L L   Q+   I   A      +Q L +  N IR + P    N+ LL VL L  N L  
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 445 SIPSYL-GKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLK 503
           S+P  +      L  LS  NN L   +    F  TT  + L LS N L+  + L    + 
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIP 186

Query: 504 SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNL 563
           SL   ++S N  S     TL+    +E L    NS N  +         +  L L  NNL
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238

Query: 564 SGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETR---ISLTGNE 609
           +      L N P L  ++LSYN  E K+     F    R   + ++ N 
Sbjct: 239 T-DTAW-LLNYPGLVEVDLSYNELE-KIM-YHPFVKMQRLERLYISNNR 283

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  104 bits (261), Expect = 6e-24
 Identities = 52/256 (20%), Positives = 91/256 (35%), Gaps = 20/256 (7%)

Query: 373 TIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
            I   ++       + ++              L N + +    + +R +    + +   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 433 NVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS 492
            +L L   +++            + +L    N +   LPP +F    L  +L L  N LS
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 493 GSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALK 551
            S+P  +  N   L  L +S NN       T  A T+L+ L +  N     +   L+ + 
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186

Query: 552 SIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNE-- 609
           S+   ++S N LS      L     +E L+ S+N     V    V    T + L  N   
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHNNLT 239

Query: 610 -----QFCGGLGELHL 620
                    GL E+ L
Sbjct: 240 DTAWLLNYPGLVEVDL 255

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  146 bits (371), Expect = 5e-37
 Identities = 76/390 (19%), Positives = 136/390 (34%), Gaps = 33/390 (8%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
            L    ++    + +       L +  ++E L LN+          F     + KLY+G 
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSI-ANLSTTMTLIAMAGNQIS 371
           N +       L    +  N   L  L L  N    +LP  I  N     TL  M+ N + 
Sbjct: 109 NAI-----RYLPP-HVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLS-MSNNNLE 160

Query: 372 GTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLT 430
             I  +  +   +L  L L  N+LT  +      + +L +  +  N +       +    
Sbjct: 161 -RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLST-----LAIPI 211

Query: 431 LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENH 490
            +  L    N +   +         L  L   +N L  T    +     L   +DLS N 
Sbjct: 212 AVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNYPGL-VEVDLSYNE 265

Query: 491 LSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA 549
           L   I       ++ L +L IS N     + +      TL+ L +  N     + ++   
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322

Query: 550 LKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNE 609
              ++ L L  N++     + L     L+ L LS+N ++     + +F N  R ++   +
Sbjct: 323 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDAD 378

Query: 610 QFCGGLGELHLPACHSVGPRKETITLLKVV 639
           Q C    +L    C     +     LL+ +
Sbjct: 379 QHCKIDYQLEHGLCCKESDKPYLDRLLQYI 408

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  140 bits (354), Expect = 7e-35
 Identities = 76/447 (17%), Positives = 145/447 (32%), Gaps = 37/447 (8%)

Query: 163 LSLYGNQLTGQLP-----PSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEND 217
              Y   +  Q            L+  +      + +       L   R +  L  ++  
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86

Query: 218 FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN 277
              +   +     ++ + Y+  N  +  LP  +  N+P LTVLV+ +N+L+        N
Sbjct: 87  IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 145

Query: 278 ASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVK 337
             KL  L ++ N+        F +  +L  L L  N L     T +D   +      L  
Sbjct: 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-----THVDLSLI----PSLFH 196

Query: 338 LGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT 397
             + +N        ++A     +  +  + N I+  +   +     L  L L++N LT  
Sbjct: 197 ANVSYNLL-----STLAIP-IAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD- 246

Query: 398 IPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLM 457
               +     L  + L  N +  I+  P   +  L  L +  N+L  ++  Y      L 
Sbjct: 247 -TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 304

Query: 458 QLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN 517
            L   +N L   +         L   L L  N +  ++ L      +L  L +S N++  
Sbjct: 305 VLDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDC 359

Query: 518 EIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFL 577
                L     +    +     +  I   L      KE D        ++  ++     +
Sbjct: 360 NSLRALF--RNVARPAVDDADQHCKIDYQLEHGLCCKESD---KPYLDRLLQYIALTSVV 414

Query: 578 EYLNLSYNHFEGKVPKKGVFSNETRIS 604
           E +  +            V S    I+
Sbjct: 415 EKVQRAQGRCSATDTINSVQSLSHYIT 441

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  133 bits (336), Expect = 2e-32
 Identities = 78/507 (15%), Positives = 169/507 (33%), Gaps = 71/507 (14%)

Query: 67  LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSFSGK 125
           + ++ Q    +       L+  +++   N++   ++P  +     ++E + L++     +
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89

Query: 126 IPTN-LSRCFNLIDFWVHTNNLVGEIQAIIGNWL-KIERLSLYGNQLTGQLPPSI-GNLS 182
           I T   +    +   ++  N +   +   +   +  +  L L  N L+  LP  I  N  
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 147

Query: 183 ALQTFDIAGNKLDGRIPDSLGQ-LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
            L T  ++ N L+ RI D   Q   +L  L            LS   ++ +D +      
Sbjct: 148 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ-----------LSSNRLTHVDLS------ 189

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
                       +P L    V+ N L+     +L+    +E L+ + N  +    +    
Sbjct: 190 -----------LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPV 230

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
              L+ L L  NNL             L N   LV++ L +N     + H    +   + 
Sbjct: 231 NVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLE 281

Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + ++ N++   +    + +  L  L L +N L   +     +   L+ L L  N+I  +
Sbjct: 282 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 339

Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
               +     L  L L  N    +    L   +N+ + +  +   +  +  Q+       
Sbjct: 340 ---KLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCK 394

Query: 482 ---------KLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYL 532
                     L  ++   +   +    G   +   ++  ++                E L
Sbjct: 395 ESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQL 454

Query: 533 LMQGNSFNGSIPQSLNALKSIKELDLS 559
             + N     + Q  N     ++L   
Sbjct: 455 EAEVNELRAEVQQLTNEQIQQEQLLQG 481

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  105 bits (263), Expect = 2e-23
 Identities = 57/320 (17%), Positives = 102/320 (31%), Gaps = 51/320 (15%)

Query: 270 FLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLL 329
            +  +L        + ++             +L N   +    + +       L    LL
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-----RKLP-AALL 71

Query: 330 TNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLG 388
            +  ++  L                NL+           QI   I          +  L 
Sbjct: 72  DSFRQVELL----------------NLN---------DLQIE-EIDTYAFAYAHTIQKLY 105

Query: 389 LEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP 447
           + +N +   +PP     +  L  L L  N++  +      N   L  L +  N L+    
Sbjct: 106 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 164

Query: 448 SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQ 507
                  +L  L   +N+L   +   +    +L    ++S N LS      +    ++ +
Sbjct: 165 DTFQATTSLQNLQLSSNRLT-HVDLSLI--PSLFH-ANVSYNLLS-----TLAIPIAVEE 215

Query: 508 LDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQI 567
           LD S N+ +    V       L  L +Q N+        L     + E+DLS N L  +I
Sbjct: 216 LDASHNSINV---VRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KI 269

Query: 568 PIH-LGNLPFLEYLNLSYNH 586
             H    +  LE L +S N 
Sbjct: 270 MYHPFVKMQRLERLYISNNR 289

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (352), Expect = 2e-36
 Identities = 48/338 (14%), Positives = 101/338 (29%), Gaps = 76/338 (22%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
           N  +  +  V  ++L   L     +A  ++ L+L+ N  S     +      L  L L  
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
           N L      +   +  L+    L                   +L+          N +  
Sbjct: 68  NVL-----YETLDLESLSTLRTL-------------------DLN---------NNYVQ- 93

Query: 373 TIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
               E+    ++  L    N ++  +  +    +  + + L  N I  +     G  + +
Sbjct: 94  ----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 433 NVLQLGFNKLQG-SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSEN 489
             L L  N++   +          L  L+   N +   +  Q+      +KL  LDLS N
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV----FAKLKTLDLSSN 201

Query: 490 HLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA 549
            L+  +  E  +   +  + +  N                             I ++L  
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLV-------------------------LIEKALRF 235

Query: 550 LKSIKELDLSCNNLS-GQIPIHLGNLPFLEYLNLSYNH 586
            ++++  DL  N    G +         ++ +      
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (352), Expect = 2e-36
 Identities = 57/348 (16%), Positives = 111/348 (31%), Gaps = 38/348 (10%)

Query: 150 IQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLN 209
           I  I  N  + +   +  + L   L     +   ++  D++GN L       L     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 210 YLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTG 269
            L  S N       L   ++S+L    L  N  +  L        P +  L  A NN++ 
Sbjct: 62  LLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISR 113

Query: 270 FLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLL 329
                       + + L  N  +    ++      +  L L  N +       ++F  L 
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELA 165

Query: 330 TNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIA-----MAGNQISGTIPPEIRNLFNL 384
            +   L  L L +N         I ++   +         ++ N+++  + PE ++   +
Sbjct: 166 ASSDTLEHLNLQYNF--------IYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216

Query: 385 NGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
             + L  N+L   I  A+   +NL++  L GN                 V  +    ++ 
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK- 273

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS 492
            +     +   +  L          LP          +L+ L  +H  
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPA-----PFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (322), Expect = 2e-32
 Identities = 52/275 (18%), Positives = 99/275 (36%), Gaps = 18/275 (6%)

Query: 348 ALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRN 407
           A+     N +       +  + +   +    ++ +N+  L L  N L+      +     
Sbjct: 1   AIHEIKQNGNRYKIEK-VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 408 LQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN 467
           L+ L L  N +   +   + +L+ L  L L  N +       L    ++  L A NN ++
Sbjct: 60  LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

Query: 468 GTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN-EIPVTLSAC 526
             +           K + L+ N ++    L+ G    +  LD+  N           ++ 
Sbjct: 113 -RVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 527 TTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
            TLE+L +Q N     +   +     +K LDLS N L+  +     +   + +++L  N 
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 587 FEGKVPKK-GVFSNETRISLTGNEQFCGGLGELHL 620
               + K      N     L GN   CG L +   
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  125 bits (317), Expect = 8e-32
 Identities = 50/287 (17%), Positives = 93/287 (32%), Gaps = 22/287 (7%)

Query: 328 LLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGL 387
           +  N ++     +  +    AL     +      L  ++GN +S     ++     L  L
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELD-LSGNPLSQISAADLAPFTKLELL 63

Query: 388 GLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP 447
            L  N L       +  L  L+ L L  N ++ +          +  L    N +   + 
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQEL-----LVGPSIETLHAANNNIS-RVS 115

Query: 448 SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSG-SIPLEVGNLKS 504
              G  Q    +   NNK+   L     G    S++  LDL  N +   +      +  +
Sbjct: 116 CSRG--QGKKNIYLANNKIT-MLRDLDEG--CRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 505 LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS 564
           L  L++  N    ++   +     L+ L +  N     +     +   +  + L  N L 
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 565 GQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQF 611
             I   L     LE+ +L  N F      +  FS   R+     +  
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTV 272

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  142 bits (360), Expect = 6e-36
 Identities = 91/471 (19%), Positives = 169/471 (35%), Gaps = 37/471 (7%)

Query: 160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
              L++  N ++      I +LS L+   I+ N++           + L YL  S N   
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 220 GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGF-NLPKLTVLVVAQNNLTGFLPQSLSNA 278
               +S     +L    L  N F  +LP+C  F N+ +L  L ++  +L       +++ 
Sbjct: 83  K---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 279 SKLE-WLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVK 337
           +  +  L L E +     + +   L + +   L       +    +  +++ T  + L  
Sbjct: 139 NISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT-VANLEL 194

Query: 338 LGLVFNRFGGALPHSIANLSTTMTLIAM-----AGNQISGTIPPEIRNL--------FNL 384
             +          + ++ L+   T   +        + +      I  L        F++
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254

Query: 385 NGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
           + + L+          +   L+ L    +V +             + +N+     +  + 
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVG---N 501
                  K    + L   NN L      +  G  T  + L L  N L   +         
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLL-TDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQ 372

Query: 502 LKSLVQLDISRNNFSNEIP-VTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSC 560
           +KSL QLDIS+N+ S +      S   +L  L M  N    +I + L     IK LDL  
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430

Query: 561 NNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVF---SNETRISLTGN 608
           N +   IP  +  L  L+ LN++ N  +  VP  G+F   ++  +I L  N
Sbjct: 431 NKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  125 bits (316), Expect = 3e-30
 Identities = 78/472 (16%), Positives = 156/472 (33%), Gaps = 34/472 (7%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSF 122
            T L++    I    +  I +LS LR++ +++N     +   V      LE + LS+N  
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL 81

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNL-VGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNL 181
                       NL    +  N      I    GN  +++ L L    L       I +L
Sbjct: 82  VKISCHPTV---NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEND-------------FSGMFPLSVCN 228
           +  +   + G        +    L++ N                        +  L + N
Sbjct: 139 NISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196

Query: 229 ISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNE 288
           I  + E             +     L  LT+  +     +      L   + + +  ++ 
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256

Query: 289 NHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGA 348
               GQ+          S   L  + + +          +    S +       +     
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY-IYEIFSNMNIKNFTVSGTRMV 315

Query: 349 LPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIG---EL 405
                + +S  + L   + N ++ T+     +L  L  L L+ NQL   +        ++
Sbjct: 316 HMLCPSKISPFLHLD-FSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373

Query: 406 RNLQYLGLVGNNIRGIIPDPI-GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
           ++LQ L +  N++              L  L +  N L  +I   L     +  L   +N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431

Query: 465 KLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNF 515
           K+  ++P Q+  +  L + L+++ N L  S+P  +   L SL ++ +  N +
Sbjct: 432 KIK-SIPKQVVKLEAL-QELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 98.4 bits (245), Expect = 2e-21
 Identities = 61/370 (16%), Positives = 117/370 (31%), Gaps = 34/370 (9%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG 311
           +L +  T+L ++QN ++      + + SKL  L ++ N         F     L  L L 
Sbjct: 18  DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHS--IANLSTTMTLIAMAGNQ 369
            N L       +           L  L L FN F  ALP      N+ + +  + ++   
Sbjct: 78  HNKL-----VKISCHPT----VNLKHLDLSFNAF-DALPICKEFGNM-SQLKFLGLSTTH 126

Query: 370 ISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNL 429
           +  +    I +L     L +          P    L++     L            I ++
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDV 184

Query: 430 TLLNVLQLGFNKLQG-----------SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGIT 478
           ++  V  L  + ++            SI + L     L  L+  N +       +I  + 
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244

Query: 479 TLSKL--LDLSENHLSGSIPLEVG-----NLKSLVQLDISRNNFSNEIPVTLSACTTLEY 531
             + +    +S   L G +          +LK+L    +  + F           + +  
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304

Query: 532 LLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKV 591
                +          + +     LD S N L+  +  + G+L  LE L L  N  +   
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364

Query: 592 PKKGVFSNET 601
               + +   
Sbjct: 365 KIAEMTTQMK 374

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 17/250 (6%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGL 413
            +LS   T++ ++ N IS     +I +L  L  L + +N++           + L+YL L
Sbjct: 17  KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76

Query: 414 VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP--SYLGKCQNLMQLSAPNNKLNGTLP 471
             N +  I   P  NL  L+   L FN    ++P     G    L  L      L  +  
Sbjct: 77  SHNKLVKISCHPTVNLKHLD---LSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSV 132

Query: 472 PQIFGITTLSKLLDLSENHLSGSIP--LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTL 529
             I  +     LL L E +     P  L+  N +SL  +  +   F   + V++     L
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192

Query: 530 EYLLMQGNSFNG------SIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLP---FLEYL 580
           E   ++    +       SI   L     +  L L+    +    I +  L     + Y 
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252

Query: 581 NLSYNHFEGK 590
           ++S    +G+
Sbjct: 253 SISNVKLQGQ 262

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 72.2 bits (177), Expect = 4e-13
 Identities = 48/314 (15%), Positives = 95/314 (30%), Gaps = 21/314 (6%)

Query: 44  NNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLS--PYIGNLSFLRVINLANNSFHGQ 101
                +   +  T  +      K  LE      FLS    +     L  + L N      
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235

Query: 102 IPKEVGRLFR---LETIVLSNNSFSGKIPTNLSRCFNL----IDFWVHTNNLVGEIQAII 154
               + +L     +    +SN    G++              +      +++ G  Q+ I
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295

Query: 155 GNWL-KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGT 213
                 +   +   +            +S     D + N L   + ++ G L  L  L  
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355

Query: 214 SENDFSGMFPLSVC--NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL 271
             N    +  ++     + SL +  + +N                L  L ++ N LT  +
Sbjct: 356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415

Query: 272 PQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTN 331
            + L    +++ L+L+ N     +      L  L +L +  N L +      D       
Sbjct: 416 FRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFD------R 466

Query: 332 CSKLVKLGLVFNRF 345
            + L K+ L  N +
Sbjct: 467 LTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 62.6 bits (152), Expect = 4e-10
 Identities = 31/163 (19%), Positives = 52/163 (31%), Gaps = 9/163 (5%)

Query: 425 PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLL 484
           P        +L +  N +     S +     L  L   +N++   L   +F      + L
Sbjct: 16  PKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYL 74

Query: 485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVT--LSACTTLEYLLMQGNSFNGS 542
           DLS N L   I        +L  LD+S N F + +P+       + L++L +       S
Sbjct: 75  DLSHNKLV-KISC--HPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKS 130

Query: 543 IPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN 585
               +  L   K L +               L      +L   
Sbjct: 131 SVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIV 171

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.0 bits (148), Expect = 1e-09
 Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 11/168 (6%)

Query: 476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQ 535
            ++  + +L++S+N++S     ++ +L  L  L IS N               LEYL + 
Sbjct: 18  DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 536 GNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH--LGNLPFLEYLNLSYNHFEGKVPK 593
            N     I    +   ++K LDLS N     +PI    GN+  L++L LS  H E     
Sbjct: 78  HNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133

Query: 594 KGVFSNETRISLTGNEQFC-----GGLGELHLPACHSVGPRKETITLL 636
                N +++ L   E +       GL + +  + H V P  +    +
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  138 bits (348), Expect = 6e-34
 Identities = 79/416 (18%), Positives = 131/416 (31%), Gaps = 86/416 (20%)

Query: 181 LSALQTFDIAGNKLDGRIPDSLGQ-LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK 239
            +     ++  + L   +PD L   +  L               +   N++SL       
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLPAHITTLV--------------IPDNNLTSLPA----- 78

Query: 240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINF 299
                          P+L  L V+ N LT  LP       +L        H         
Sbjct: 79  -------------LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP------- 117

Query: 300 NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTT 359
                L KL++  N L     T L    L      L +L +  N+   +LP   + L   
Sbjct: 118 ALPSGLCKLWIFGNQL-----TSLP--VLPPG---LQELSVSDNQLA-SLPALPSELCK- 165

Query: 360 MTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIR 419
              +    NQ++ ++P     L  L+   +  NQL  ++P    EL  L       N + 
Sbjct: 166 ---LWAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPTLPSELYKLWAYN---NRLT 214

Query: 420 GIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITT 479
            + P     L     L +  N+L  S+P        L +L    N+L  +LP    G+ +
Sbjct: 215 SL-PALPSGLK---ELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLS 265

Query: 480 LSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSF 539
           L     +  N L+  +P  + +L S   +++  N  S      L   T+          F
Sbjct: 266 L----SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRF 320

Query: 540 N---GSIPQSLNALKSIKELDLSCNNLSGQIPI----HLGNLPFLEYLNLSYNHFE 588
           +    S P+   AL       L         P       G     +  +L  +   
Sbjct: 321 DMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  138 bits (348), Expect = 7e-34
 Identities = 84/449 (18%), Positives = 150/449 (33%), Gaps = 90/449 (20%)

Query: 88  LRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLV 147
             V+N+  +     +P  +     + T+V+ +N+ +  +P                    
Sbjct: 42  NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---------------- 81

Query: 148 GEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRN 207
                      ++  L + GNQLT  LP     L  L  F      L    P     L  
Sbjct: 82  -----------ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCK 125

Query: 208 LNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL 267
           L       N  +   P+    +  L    +  N+   SLP        +L  L    N L
Sbjct: 126 LW---IFGNQLTS-LPVLPPGLQELS---VSDNQLA-SLPALPS----ELCKLWAYNNQL 173

Query: 268 TGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLP----NLSKLYLGRNNLGTRTSTDL 323
           T  LP   S    L+ L +++N  +        SLP     L KL+   N L        
Sbjct: 174 T-SLPMLPSG---LQELSVSDNQLA--------SLPTLPSELYKLWAYNNRL-------- 213

Query: 324 DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN 383
              +L    S L +L +  NR   +LP   + L      + ++GN+++ ++P     L +
Sbjct: 214 --TSLPALPSGLKELIVSGNRLT-SLPVLPSEL----KELMVSGNRLT-SLPMLPSGLLS 265

Query: 384 LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
           L+   +  NQLT  +P ++  L +   + L GN +       +  +T          +  
Sbjct: 266 LS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321

Query: 444 GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLK 503
            +  S   + + L   +A     +  +P +        +     +   + +  L +  L 
Sbjct: 322 MAGASAPRETRALHLAAA-----DWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

Query: 504 SLVQLDISRNNFSNEIPVTLSACTTLEYL 532
                 I    F  +I   L+     E L
Sbjct: 377 ETEN-FIKDAGFKAQISSWLAQLAEDEAL 404

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  123 bits (309), Expect = 4e-29
 Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 62/310 (20%)

Query: 296 RINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIAN 355
           ++        + L +G + L     T L    L  +   +  L +  N    +LP     
Sbjct: 33  KMRACLNNGNAVLNVGESGL-----TTLP-DCLPAH---ITTLVIPDNNL-TSLPALPPE 82

Query: 356 LSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVG 415
           L  T+ +   +GNQ++ ++P     L  L+        L             L  L + G
Sbjct: 83  L-RTLEV---SGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFG 130

Query: 416 NNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF 475
           N +   +P     L  L+   +  N+L  S+P+       L +L A NN+L  +LP    
Sbjct: 131 NQLTS-LPVLPPGLQELS---VSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPS 181

Query: 476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQ 535
           G+      L +S+N L+ S+P     L  L       NN    +P   S    L+ L++ 
Sbjct: 182 GLQE----LSVSDNQLA-SLPTLPSELYKLWAY----NNRLTSLPALPSG---LKELIVS 229

Query: 536 GNSFNGSIPQSLNALKSI-----------------KELDLSCNNLSGQIPIHLGNLPFLE 578
           GN    S+P   + LK +                   L +  N L+ ++P  L +L    
Sbjct: 230 GNRLT-SLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSET 287

Query: 579 YLNLSYNHFE 588
            +NL  N   
Sbjct: 288 TVNLEGNPLS 297

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  135 bits (341), Expect = 8e-34
 Identities = 81/502 (16%), Positives = 157/502 (31%), Gaps = 70/502 (13%)

Query: 198 IPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKL 257
            PD      N      +  +      +S   +++L       +       +     L  L
Sbjct: 15  FPDD-----NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIE---KLTGL 66

Query: 258 TVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT 317
           T L+   NN+T      LS  + L +L  + N  +    ++   L  L+ L    N L  
Sbjct: 67  TKLICTSNNITTL---DLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKL-- 118

Query: 318 RTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPE 377
              T LD     +    L  L    N        +  ++S    L  +  +        +
Sbjct: 119 ---TKLDV----SQNPLLTYLNCARNTL------TEIDVSHNTQLTELDCHLNKKITKLD 165

Query: 378 IRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQL 437
           +     L  L   +N++T  +   + + + L  L    NNI  +    +     L  L  
Sbjct: 166 VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC 219

Query: 438 GFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSI 495
             NKL   I   +     L       N L   L      ++TLSKL  L   +  L    
Sbjct: 220 SSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD-----VSTLSKLTTLHCIQTDLLE-- 268

Query: 496 PLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKE 555
            +++ +   L+           E+   ++  T L  L  Q       +   L+    +  
Sbjct: 269 -IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY 322

Query: 556 LDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGL 615
           L L+   L+    + + +   L+ L+    H +      G             +      
Sbjct: 323 LYLNNTELTE---LDVSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQT----- 373

Query: 616 GELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKATKE 675
             + +P   ++     TI +   ++   G  +  +     + +Q    +++  LS     
Sbjct: 374 --ITMPKE-TLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430

Query: 676 ----FSSSNRIGKGSFGFVYKG 693
               F+S N    G+    ++ 
Sbjct: 431 VTYTFTSENGAIVGTVTTPFEA 452

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  134 bits (339), Expect = 2e-33
 Identities = 78/464 (16%), Positives = 143/464 (30%), Gaps = 61/464 (13%)

Query: 112 LETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLT 171
             + V +          +  +   L     H +++  ++  I      + +L    N +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT 77

Query: 172 GQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISS 231
             L   +   + L       NKL   +   +  L  L YL    N  +    L V     
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128

Query: 232 LDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHF 291
           L      +N     + V    +  +LT L    N     L   ++  ++L  L+ + N  
Sbjct: 129 LTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182

Query: 292 SGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPH 351
           +    ++ +    L++L    NN+     T LD         +L  L    N+    +  
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNI-----TKLDL----NQNIQLTFLDCSSNKL-TEID- 228

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYL 411
            +  L+        + N ++  +      L  L  L      L   I   +     L Y 
Sbjct: 229 -VTPLTQLTYFD-CSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYF 280

Query: 412 GLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLP 471
              G     I    + + T L +L      +   +   L +   L+ L   N +L   L 
Sbjct: 281 QAEGCRK--IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD 334

Query: 472 PQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSA---- 525
                ++  +KL  L     H+       VG + +L     +          TL+     
Sbjct: 335 -----VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLT 387

Query: 526 -CTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIP 568
              + + L   GN  N  I      +       ++  NLS   P
Sbjct: 388 IAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  132 bits (333), Expect = 7e-33
 Identities = 81/499 (16%), Positives = 164/499 (32%), Gaps = 89/499 (17%)

Query: 62  QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS 121
             +T LD  + +I       I  L+ L  +   +N+       ++ +   L  +   +N 
Sbjct: 42  ATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNK 96

Query: 122 FSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNL 181
            +     +++    L      TN L    +  +     +  L+   N LT ++   + + 
Sbjct: 97  LTN---LDVTPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLT-EID--VSHN 147

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
           + L   D   NK   ++   +     L  L  S N  +    L V     L+      N 
Sbjct: 148 TQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNN 202

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
               L +       +LT L  + N LT      ++  ++L + + + N  +    ++ ++
Sbjct: 203 IT-KLDLN---QNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT---ELDVST 252

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L  L+ L+  + +L      ++D    LT+ ++L+                         
Sbjct: 253 LSKLTTLHCIQTDL-----LEID----LTHNTQLIYFQA--------------------- 282

Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
                          ++ +   L  L  +   +T  +   + +   L YL L    +  +
Sbjct: 283 ------EGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTEL 333

Query: 422 IPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLS 481
               + + T L  L      +Q    S +GK   L        +   T+P +     +L+
Sbjct: 334 ---DVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLT 387

Query: 482 -----KLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQG 536
                 LLD   N +  +I    G +       I+  N S + P        + Y     
Sbjct: 388 IAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENLSTDNP-------AVTYTFTSE 438

Query: 537 NS-FNGSIPQSLNALKSIK 554
           N    G++     A + IK
Sbjct: 439 NGAIVGTVTTPFEAPQPIK 457

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 40/224 (17%), Positives = 68/224 (30%), Gaps = 44/224 (19%)

Query: 368 NQISGTIPPEIRNLF---NLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPD 424
           N +         + F   N         ++  T   +  +L  L  L    ++I  +   
Sbjct: 1   NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--T 58

Query: 425 PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLL 484
            I  LT L  L    N +  ++   L +  NL                           L
Sbjct: 59  GIEKLTGLTKLICTSNNIT-TLD--LSQNTNL-------------------------TYL 90

Query: 485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP 544
               N L+    L+V  L  L  L+   N  +    + +S    L YL    N+    I 
Sbjct: 91  ACDSNKLTN---LDVTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTLT-EID 143

Query: 545 QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
             ++    + ELD   N    ++ +       L  L+ S+N   
Sbjct: 144 --VSHNTQLTELDCHLNKKITKLDV--TPQTQLTTLDCSFNKIT 183

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  133 bits (337), Expect = 3e-33
 Identities = 76/332 (22%), Positives = 129/332 (38%), Gaps = 16/332 (4%)

Query: 163 LSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF 222
           +  +  +    +P  I   +  +  D+  N++     D      +L  L  +EN  S + 
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLE 282
           P +  N+ +L    L  NR K  +P+ +   L  LT L +++N +   L     +   L+
Sbjct: 73  PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131

Query: 283 WLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVF 342
            LE+ +N         F+ L +L +L L + NL     T +     L++   L+ L L  
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL-----TSIPT-EALSHLHGLIVLRLRH 185

Query: 343 NRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP-A 401
                   +S   L     L  ++      T+ P      NL  L + +  LT  +P  A
Sbjct: 186 LNINAIRDYSFKRLYRLKVLE-ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243

Query: 402 IGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLS 460
           +  L  L++L L  N I  I    +  L  L  +QL   +L   +  Y       L  L+
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLN 302

Query: 461 APNNKLNGTLPPQIFGITTLSKLLDLSENHLS 492
              N+L  TL   +F      + L L  N L+
Sbjct: 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  131 bits (331), Expect = 2e-32
 Identities = 77/340 (22%), Positives = 130/340 (38%), Gaps = 41/340 (12%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG 311
            +P    +L + +N +        ++   LE LELNEN  S      FN+L NL  L L 
Sbjct: 29  GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
            N L       +  + + T  S L KL +                         + N+I 
Sbjct: 89  SNRL-----KLIP-LGVFTGLSNLTKLDI-------------------------SENKIV 117

Query: 372 GTIPPEI-RNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNL 429
             +   + ++L+NL  L +  N L   I   A   L +L+ L L   N+  I  + + +L
Sbjct: 118 -ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL 175

Query: 430 TLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSE 488
             L VL+L    +  +I  Y   +   L  L   +     T+ P       L+ L  ++ 
Sbjct: 176 HGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL-SITH 233

Query: 489 NHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSL 547
            +L+ ++P     +L  L  L++S N  S      L     L+ + + G       P + 
Sbjct: 234 CNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292

Query: 548 NALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHF 587
             L  ++ L++S N L+        ++  LE L L  N  
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  118 bits (297), Expect = 4e-28
 Identities = 70/350 (20%), Positives = 125/350 (35%), Gaps = 46/350 (13%)

Query: 265 NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLD 324
                 +P+ +   ++   L+L +N      +  F S P+L +L L  N +     + ++
Sbjct: 21  KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-----SAVE 72

Query: 325 FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFN 383
                 N   L  LGL                           N++   IP  +   L N
Sbjct: 73  PGAF-NNLFNLRTLGL-------------------------RSNRLK-LIPLGVFTGLSN 105

Query: 384 LNGLGLEYNQLTGTIPPAI-GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL 442
           L  L +  N++   +   +  +L NL+ L +  N++  I       L  L  L L    L
Sbjct: 106 LTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164

Query: 443 QGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN 501
             SIP+  L     L+ L   +  +N  +    F      K+L++S      ++      
Sbjct: 165 T-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222

Query: 502 LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
             +L  L I+  N +    + +     L +L +  N  +      L+ L  ++E+ L   
Sbjct: 223 GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282

Query: 562 NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFS---NETRISLTGN 608
            L+   P     L +L  LN+S N     +  + VF    N   + L  N
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  111 bits (280), Expect = 5e-26
 Identities = 72/361 (19%), Positives = 118/361 (32%), Gaps = 62/361 (17%)

Query: 86  SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNN 145
           +  R+++L  N        E      LE + L+ N  S  +       FN      +  N
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVE---PGAFN------NLFN 81

Query: 146 LVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQ 204
           L                L L  N+L   +P  +   LS L   DI+ NK+   +      
Sbjct: 82  L--------------RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126

Query: 205 LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQ 264
           L NL  L   +N           ++  +         F G         L  L  L + +
Sbjct: 127 LYNLKSLEVGDN-----------DLVYISH-----RAFSG---------LNSLEQLTLEK 161

Query: 265 NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLD 324
            NLT    ++LS+   L  L L   + +     +F  L  L  L +         + +  
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN-- 219

Query: 325 FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFN 383
                     L  L +           ++ +L   +  + ++ N IS TI   +   L  
Sbjct: 220 ----CLYGLNLTSLSITHCNLTAVPYLAVRHL-VYLRFLNLSYNPIS-TIEGSMLHELLR 273

Query: 384 LNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL 442
           L  + L   QL   + P A   L  L+ L + GN +  +      ++  L  L L  N L
Sbjct: 274 LQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

Query: 443 Q 443
            
Sbjct: 333 A 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  105 bits (263), Expect = 8e-24
 Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 18/242 (7%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLN 433
           IP E R L       L  N++            +L+ L L  N +  + P    NL  L 
Sbjct: 30  IPTETRLLD------LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83

Query: 434 VLQLGFNKLQGSIPS-YLGKCQNLMQLSAPNNKLNGTLPPQIF-GITTLSKLLDLSENHL 491
            L L  N+L+  IP        NL +L    NK+   L   +F  +  L K L++ +N L
Sbjct: 84  TLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNL-KSLEVGDNDL 140

Query: 492 SGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNAL 550
              I       L SL QL + + N ++     LS    L  L ++  + N     S   L
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199

Query: 551 KSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETR---ISLTG 607
             +K L++S       +  +      L  L++++ +    VP      +      ++L+ 
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP-YLAVRHLVYLRFLNLSY 257

Query: 608 NE 609
           N 
Sbjct: 258 NP 259

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 90.2 bits (224), Expect = 7e-19
 Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 7/256 (2%)

Query: 65  TKLDLESQNIGGFLSPYI-GNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSF 122
            +L+L ++NI   + P    NL  LR + L +N     IP  V   L  L  + +S N  
Sbjct: 59  EELEL-NENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI 116

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNLVGEIQA-IIGNWLKIERLSLYGNQLTGQLPPSIGNL 181
              +       +NL    V  N+LV  I          +E+L+L    LT     ++ +L
Sbjct: 117 VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL 175

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
             L    +    ++     S  +L  L  L  S   +      +     +L    +    
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
              ++P     +L  L  L ++ N ++      L    +L+ ++L     +      F  
Sbjct: 236 LT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294

Query: 302 LPNLSKLYLGRNNLGT 317
           L  L  L +  N L T
Sbjct: 295 LNYLRVLNVSGNQLTT 310

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 28/137 (20%), Positives = 53/137 (38%), Gaps = 8/137 (5%)

Query: 62  QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNN 120
            R+  L++        ++P       L  +++ + +    +P      L  L  + LS N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258

Query: 121 SFSGKIPTN-LSRCFNLIDFWVHTNNLVGEIQAIIGNWL-KIERLSLYGNQLTGQLPPSI 178
             S  I  + L     L +  +    L   ++      L  +  L++ GNQLT  L  S+
Sbjct: 259 PIS-TIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLEESV 315

Query: 179 -GNLSALQTFDIAGNKL 194
             ++  L+T  +  N L
Sbjct: 316 FHSVGNLETLILDSNPL 332

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (316), Expect = 5e-32
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 16/209 (7%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIIT 738
            IG+GSF  VYKG   E  + VA   +   K  K   + F  E E L+ ++H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
                  KG     +V E M  G++  +L            +   ++   +++LH    P
Sbjct: 93  -SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TP 150

Query: 799 PIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
           PI+H DLK  N+ +        + D GLA               S +  + GT  ++ PE
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----------ASFAKAVIGTPEFMAPE 200

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                    + DVY+FG+ +LEM T   P
Sbjct: 201 MYEEKY-DESVDVYAFGMCMLEMATSEYP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  129 bits (326), Expect = 1e-31
 Identities = 55/224 (24%), Positives = 110/224 (49%), Gaps = 23/224 (10%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHR 731
            + +  +++G G +G VY+G   +  ++VAVK +   K+     + F+ E   ++ I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 276

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKL-NIVIEVASVI 789
           NL++++ +C+    +   F  I+ E+M YG++ D+L      ++    L  +  +++S +
Sbjct: 277 NLVQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           EYL        +H +L   N L+  + +  V+DFGL+R ++   +       ++    K 
Sbjct: 332 EYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-------TAHAGAKF 381

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            I +  PE       S+  DV++FG+LL E+ T    P   +  
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  128 bits (324), Expect = 4e-31
 Identities = 96/469 (20%), Positives = 162/469 (34%), Gaps = 35/469 (7%)

Query: 160 IERLSLYGNQLTGQLPPS-IGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
            + LSL  N ++ +L    I  LS L+   ++ N++           ++L YL  S N  
Sbjct: 54  TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112

Query: 219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGF-NLPKLTVLVVAQNNLTGFLPQSLSN 277
                +S C ++SL    L  N F   LPVC  F NL KLT L ++           +++
Sbjct: 113 QN---ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168

Query: 278 AS-KLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLV 336
                  L+L   H  G    +     N + L+L  +     +      +  L    +L 
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALG-HLQLS 226

Query: 337 KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEY----- 391
            + L        L   ++ L+   TL+ +    I  T    ++         +EY     
Sbjct: 227 NIKLNDENCQR-LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285

Query: 392 NQLTGTIPPAIG-----ELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI 446
             +T  I           L++L    +                  +N+  L  +      
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345

Query: 447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVG---NLK 503
                   +   L+   N        Q        + L L  N L  +         N+ 
Sbjct: 346 MVCPPSPSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMS 403

Query: 504 SLVQLDISRNNFSNEIPVTL-SACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNN 562
           SL  LD+S N+ ++       +   ++  L +  N   GS+ + L     +K LDL  N 
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNR 461

Query: 563 LSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNE---TRISLTGN 608
           +   IP  + +L  L+ LN++ N  +  VP  GVF        I L  N
Sbjct: 462 IM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  111 bits (278), Expect = 2e-25
 Identities = 77/484 (15%), Positives = 158/484 (32%), Gaps = 46/484 (9%)

Query: 117 LSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP 176
           LS NS S     ++S    L    +  N +      +      +E L +  N+L   +  
Sbjct: 59  LSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISC 117

Query: 177 SIGNLSALQTFDIAGNKLDGRIPDS--LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDE 234
               +++L+  D++ N  D  +P     G L  L +LG S   F     L +  ++ L  
Sbjct: 118 --CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHL 171

Query: 235 AYLFKNRFKGSLPVC--LGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS 292
           + +  +     +         +P  TVL +  +  + F  Q   + + L  L+L+    +
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231

Query: 293 GQVRINFNSLPNLSKLYLGRNNLGTR----TSTDLDFITLLTNCSKLVKLGLVFNRFGGA 348
            +      +  +         N+  +    T      +        +  L +        
Sbjct: 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITER 291

Query: 349 LPHSIANLSTT----MTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE 404
           +       S T    + +  +       +          +N   L  +            
Sbjct: 292 IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS 351

Query: 405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
             +  +L    N     +      L  L  L L  N L+ +        +N+  L   + 
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDV 410

Query: 465 KLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLS 524
            LN +L    +  T                        +S++ L++S N  +  +   L 
Sbjct: 411 SLN-SLNSHAYDRTC--------------------AWAESILVLNLSSNMLTGSVFRCLP 449

Query: 525 ACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPI-HLGNLPFLEYLNLS 583
               ++ L +  N    SIP+ +  L++++EL+++ N L   +P      L  L+Y+ L 
Sbjct: 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLH 505

Query: 584 YNHF 587
            N +
Sbjct: 506 DNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  108 bits (271), Expect = 1e-24
 Identities = 79/469 (16%), Positives = 158/469 (33%), Gaps = 30/469 (6%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSF 122
              L L   +I     P I  LS LRV+ L++N     +   V      LE + +S+N  
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112

Query: 123 SGKIPT-NLSRCFNLIDFWVHTNNL-VGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGN 180
              I    ++   +L    +  N+  V  +    GN  K+  L L   +        + +
Sbjct: 113 Q-NISCCPMA---SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168

Query: 181 LSALQTF-DIAGNKLDGRIPDSL--GQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYL 237
           L       D+    + G   +SL       L+ +    + FS    +SV  +  L  + +
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228

Query: 238 FKNRF------KGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHF 291
             N             +  G  L  +T+  +                  +E+L +     
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288

Query: 292 SGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPH 351
           + ++     +    +   L   ++  +         L +  +++    L  +     +  
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKE-ALYSVFAEMNIKMLSISDTP-FIHM 346

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYL 411
                 ++ T +    N  + ++      L  L  L L+ N L           +N+  L
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL 405

Query: 412 GLVGNNIRGIIPDPIGNLT----LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN 467
             +  ++  +              + VL L  N L GS+   L     +  L   NN++ 
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463

Query: 468 GTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNF 515
            ++P  +  +  L + L+++ N L  S+P  V   L SL  + +  N +
Sbjct: 464 -SIPKDVTHLQAL-QELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 46/281 (16%), Positives = 83/281 (29%), Gaps = 33/281 (11%)

Query: 43  WNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNL---SFLRVINLANNSFH 99
            N+       T ++   R   +  + L+        S  +        +  +N+ N +  
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289

Query: 100 GQIPKEVGRLFRLETIVL-----SNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAII 154
            +I +E           L      N  F       L   F  ++  + + +    I  + 
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFIHMVC 348

Query: 155 GNWL-KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLD--GRIPDSLGQLRNLNYL 211
                    L+   N  T  +      L  LQT  +  N L    ++      + +L  L
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408

Query: 212 GTSENDF-SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFN----------------- 253
             S N   S  +  +     S+    L  N   GS+  CL                    
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKD 468

Query: 254 ---LPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHF 291
              L  L  L VA N L           + L+++ L++N +
Sbjct: 469 VTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  126 bits (319), Expect = 5e-31
 Identities = 71/382 (18%), Positives = 123/382 (32%), Gaps = 32/382 (8%)

Query: 160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSENDF 218
           +  + L  N +      S   L  LQ   +        I  ++   L +L  L    N F
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 219 SGMFPLSVCNISSLDEAYLFKNRFKGS-LPVCLGFNLPKLTVLVVAQNNLTGFLPQSL-S 276
             +   +   +++L+   L +    G+ L       L  L +LV+  NN+    P S   
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151

Query: 277 NASKLEWLELNENHFSGQVRINFNSLP--NLSKLYLGRNNLGT--RTSTDLDFITLLTNC 332
           N  +   L+L  N        +  +    + + L L    L          +        
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211

Query: 333 SKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLF---------- 382
           + +  L L  N F  ++     +      + ++  +             F          
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

Query: 383 ----NLNGLGLEYNQLTGTIPPAI-GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQL 437
                +    L  +++   +  ++     +L+ L L  N I  I  +    LT L  L L
Sbjct: 272 LEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNL 330

Query: 438 GFNKLQGSIPSYL-GKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGS 494
             N L  SI S +      L  L    N +   L  Q F    L  L  L L  N L  S
Sbjct: 331 SQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSF--LGLPNLKELALDTNQLK-S 385

Query: 495 IPLEV-GNLKSLVQLDISRNNF 515
           +P  +   L SL ++ +  N +
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  108 bits (272), Expect = 4e-25
 Identities = 74/389 (19%), Positives = 124/389 (31%), Gaps = 67/389 (17%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN-FNSLPNLSKLYL 310
            LP  +  + ++ N++      S S    L++L++ +      +R N F  L +L  L L
Sbjct: 27  ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86

Query: 311 GRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQI 370
             N         L+        + L  L L                             +
Sbjct: 87  DYNQF-----LQLE-TGAFNGLANLEVLTL-------------------------TQCNL 115

Query: 371 -SGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP--AIGELRNLQYLGLVGNNIRGIIPDPI 426
               +     + L +L  L L  N +   I P      +R    L L  N ++ I  + +
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDL 174

Query: 427 GNLTLLNV--LQLGFNKLQGSIPSYLG--------KCQNLMQLSAPNNKLNGTLPPQIFG 476
            N    +   L+L    LQ     +LG        K  ++  L    N    ++  + F 
Sbjct: 175 LNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234

Query: 477 ITTLSKLLDLSENHLSGSI-PLEVGNLKSLVQ-------------LDISRNNFSNEIPVT 522
               +K+  L  ++           N K                  D+S++     +   
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSV 294

Query: 523 LSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNL 582
            S  T LE L +  N  N     +   L  + +L+LS N L         NL  LE L+L
Sbjct: 295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354

Query: 583 SYNHFEGKVPKKGVFSNETR---ISLTGN 608
           SYNH    +     F        ++L  N
Sbjct: 355 SYNHIRA-LG-DQSFLGLPNLKELALDTN 381

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  100 bits (251), Expect = 2e-22
 Identities = 76/422 (18%), Positives = 128/422 (30%), Gaps = 51/422 (12%)

Query: 50  CQWTGVTCGHRH--------QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQ 101
                  C +R           V  +DL   +I          L  L+ + +   +    
Sbjct: 10  VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69

Query: 102 IPKEV-GRLFRLETIVLSNNSFSGKIPTN-LSRCFNLIDFWVHTNNLVGEI--QAIIGNW 157
           I       L  L  + L  N F  ++ T   +   NL    +   NL G +         
Sbjct: 70  IRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128

Query: 158 LKIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEN 216
             +E L L  N +    P S   N+      D+  NK+   I                E 
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SIC---------------EE 172

Query: 217 DFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGF-NLPKLTVLVVAQNNLTGFLPQSL 275
           D           +          N +      C        +T L ++ N     + +  
Sbjct: 173 DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232

Query: 276 SNASKLE-----WLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDF--ITL 328
            +A          L  + N  S     NF    N +   L  + +    + DL    I  
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV---KTCDLSKSKIFA 289

Query: 329 L-----TNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLF 382
           L     ++ + L +L L  N       ++   L T +  + ++ N +  +I   +  NL 
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL-THLLKLNLSQNFLG-SIDSRMFENLD 347

Query: 383 NLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
            L  L L YN +   +   +   L NL+ L L  N ++ +       LT L  + L  N 
Sbjct: 348 KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 406

Query: 442 LQ 443
             
Sbjct: 407 WD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.7 bits (233), Expect = 4e-20
 Identities = 57/293 (19%), Positives = 98/293 (33%), Gaps = 39/293 (13%)

Query: 351 HSIANLSTTMTLIAMAGNQISGTIPPE-IRNLFNLNGLGLEYNQLTGTIPP-AIGELRNL 408
           H +  L   +  + ++ N I+  +       L +L  L +E       I       L +L
Sbjct: 23  HQVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 409 QYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI--PSYLGKCQNLMQLSAPNNKL 466
             L L  N    +       L  L VL L    L G++   ++     +L  L   +N +
Sbjct: 82  IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 467 NGTLPPQIFGITTLSKL--LDLSENHLS----------GSIPLEVGNLKSLVQLDISRNN 514
               P   F    + +   LDL+ N +                 +  L S+   D++   
Sbjct: 142 KKIQPASFF--LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199

Query: 515 FSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ---SLNALKSIKELDLSCNN-----LSGQ 566
              E        T++  L + GN F  S+ +      A   I+ L LS +          
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259

Query: 567 IPIHLGNLPF-------LEYLNLSYNHFEGKVPKKGVFSNETR---ISLTGNE 609
                 N  F       ++  +LS +     +  K VFS+ T    ++L  NE
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL-KSVFSHFTDLEQLTLAQNE 310

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  123 bits (310), Expect = 8e-31
 Identities = 51/229 (22%), Positives = 103/229 (44%), Gaps = 28/229 (12%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKKGATKS----FVAECEAL 725
            EF     +G G+FG VYKG    +G    + VA+K +   ++  +       + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVM 71

Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIE 784
            ++ + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  ++
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           +A  + YL +     +VH DL   NVL+       ++DFGLA+ L         E +  +
Sbjct: 126 IAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHA 176

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
              K  I ++  E  +    +   DV+S+G+ + E+ T   +P D +  
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  122 bits (307), Expect = 8e-31
 Identities = 50/236 (21%), Positives = 91/236 (38%), Gaps = 29/236 (12%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR 729
            +   +F     IG G FG V+K     DG +  +K +  + + A +    E +AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 730 HRNLIK-----------IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EV 776
           H N++              T   +          I  E+   G+++ W+     +   +V
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 777 GKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
             L +  ++   ++Y+H+     +++ DLKPSN+ L       + DFGL   L +     
Sbjct: 123 LALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
                      KGT+ Y+ PE     D     D+Y+ G++L E+            
Sbjct: 180 R---------SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  121 bits (306), Expect = 2e-30
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 18/217 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIIT- 738
            +G+G FG V++     D  + A+K + L  +  A +  + E +AL  + H  +++    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 739 ------ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVASVI 789
                            +  I  +  +  ++ DW++      E  +   L+I +++A  +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSI 845
           E+LH+     ++H DLKPSN+    D V  V DFGL   +         L      +   
Sbjct: 132 EFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              GT  Y+ PE   G   S   D++S G++L E+  
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  121 bits (305), Expect = 2e-30
 Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 30/232 (12%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR 729
            +   +F     +G+G+FG V K     D    A+K +   ++    + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLN 60

Query: 730 HRNLIKIITICSSIDFKGADFKA--------IVYEYMQYGSVDDWLHHTNDKLEVGK-LN 780
           H+ +++                A        I  EY + G++ D +H  N   +  +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           +  ++   + Y+H+     I+H DLKP N+ +D      + DFGLA+ +     ++  + 
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 841 QSSSIE------MKGTIGYIGPEYGMGGDLSMTG------DVYSFGILLLEM 880
           Q+            GT  Y+  E      L  TG      D+YS GI+  EM
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEM 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  122 bits (309), Expect = 3e-30
 Identities = 74/290 (25%), Positives = 115/290 (39%), Gaps = 52/290 (17%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLIKI 736
           +IG+G+FG V+ G L  D   VAVK     ++         F+ E   L+   H N++++
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNH 795
           I +C+           IV E +Q G    +L     +L V  L  +V + A+ +EYL + 
Sbjct: 178 IGVCT-----QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI- 854
                +H DL   N L+    V  +SDFG++R                     G +  + 
Sbjct: 233 ---CCIHRDLAARNCLVTEKNVLKISDFGMSREE-----------ADGVYAASGGLRQVP 278

Query: 855 ----GPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHGYAKMALPKKV 909
                PE    G  S   DV+SFGILL E F+    P  N+ N              ++ 
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------------QQT 324

Query: 910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
              V+    +    P   E C  AV R    C    P +R   + + ++L
Sbjct: 325 REFVEKGGRLPC--P---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (303), Expect = 4e-30
 Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 26/239 (10%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNL---GEDGMSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +    L +  A   F+ E  A+ +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L    ++VA
Sbjct: 78  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + YL +      +H DL   N+LL    +  + DFGL R L  +      +       
Sbjct: 132 EGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-----DDHYVMQEH 183

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN----DGLTLHGY 900
            K    +  PE       S   D + FG+ L EMFT  + P   +        +   G 
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  123 bits (311), Expect = 5e-30
 Identities = 76/255 (29%), Positives = 110/255 (43%), Gaps = 34/255 (13%)

Query: 647 LAHKLSSALLMEQQFPIVSYAELSKATKEFSSS-----NRIGKGSFGFVYKGNLGEDGMS 701
           L  +L    +ME         E  ++    +         IGKG FG V  G+    G  
Sbjct: 163 LCTRLIKPKVMEGTVAAQD--EFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNK 218

Query: 702 VAVKVMNLDKKGAT-KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQY 760
           VAVK +   K  AT ++F+AE   +  +RH NL++++ +      +      IV EYM  
Sbjct: 219 VAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAK 271

Query: 761 GSVDDWL-HHTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA 818
           GS+ D+L       L    L    ++V   +EYL  +     VH DL   NVL+  D VA
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 328

Query: 819 HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLL 878
            VSDFGL +           E  S+    K  + +  PE       S   DV+SFGILL 
Sbjct: 329 KVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 377

Query: 879 EMFTR-RRPTDNMFN 892
           E+++  R P   +  
Sbjct: 378 EIYSFGRVPYPRIPL 392

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  119 bits (300), Expect = 8e-30
 Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 21/233 (9%)

Query: 680 NRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V            G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHN 794
              +C S   +      ++ EY+ YGS+ D+L    ++++  KL     ++   +EYL  
Sbjct: 76  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQSSSIEMKGTIGY 853
                 +H DL   N+L++++    + DFGL + L          E   S I        
Sbjct: 133 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI--FWY--- 184

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG---YAKM 903
             PE       S+  DV+SFG++L E+FT    + +   + + + G     +M
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (308), Expect = 1e-29
 Identities = 67/251 (26%), Positives = 114/251 (45%), Gaps = 25/251 (9%)

Query: 647 LAHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKV 706
           L  KLS   +  +              +      ++G G FG V+          VAVK 
Sbjct: 161 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKT 219

Query: 707 MNLDKKGAT--KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVD 764
           M   K G+   ++F+AE   ++ ++H  L+K+  + +       +   I+ E+M  GS+ 
Sbjct: 220 M---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLL 270

Query: 765 DWL-HHTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
           D+L      K  + KL +   ++A  + ++        +H DL+ +N+L+   +V  ++D
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 327

Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           FGLAR +  + +  A EG       K  I +  PE    G  ++  DV+SFGILL+E+ T
Sbjct: 328 FGLARVIEDNEY-TAREG------AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

Query: 883 R-RRPTDNMFN 892
             R P   M N
Sbjct: 381 YGRIPYPGMSN 391

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  118 bits (299), Expect = 1e-29
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 25/217 (11%)

Query: 680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRN 732
             IGKG FG VY G      ++ +  A+K +    +       ++F+ E   +R + H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++ +I I      +G     ++  YM +G +  ++        V  L +  ++VA  +EY
Sbjct: 84  VLALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 792 L-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           L         VH DL   N +LD      V+DFGLAR +    +    + + + + +K T
Sbjct: 140 LAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRP 886
                 E       +   DV+SFG+LL E+ TR   P
Sbjct: 196 ----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  122 bits (307), Expect = 2e-29
 Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 34/256 (13%)

Query: 647 LAHKLSSALLMEQQFPIVSYAELSKATKEFSSS-----NRIGKGSFGFVYKGNLGEDGMS 701
           L H+L++     +         L+K   E          ++G+G FG V+ G        
Sbjct: 156 LCHRLTTVCPTSKPQTQ----GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTR 210

Query: 702 VAVKVMNLDKKGATKS--FVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQ 759
           VA+K +   K G      F+ E + ++ +RH  L+++  + S           IV EYM 
Sbjct: 211 VAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIVTEYMS 261

Query: 760 YGSVDDWL-HHTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
            GS+ D+L   T   L + +L ++  ++AS + Y+        VH DL+ +N+L+  ++V
Sbjct: 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLV 318

Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
             V+DFGLAR +  + +       ++    K  I +  PE  + G  ++  DV+SFGILL
Sbjct: 319 CKVADFGLARLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371

Query: 878 LEMFTR-RRPTDNMFN 892
            E+ T+ R P   M N
Sbjct: 372 TELTTKGRVPYPGMVN 387

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 2e-29
 Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 21/233 (9%)

Query: 680 NRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
            ++GKG+FG V            G  VAVK +    +   + F  E E L++++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHN 794
              +C S   +      ++ EY+ YGS+ D+L    ++++  KL     ++   +EYL  
Sbjct: 107 YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL-VAPEGQSSSIEMKGTIGY 853
                 +H DL   N+L++++    + DFGL + L          E   S I        
Sbjct: 164 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI--FWY--- 215

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG---YAKM 903
             PE       S+  DV+SFG++L E+FT    + +   + + + G     +M
Sbjct: 216 -APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  119 bits (300), Expect = 2e-29
 Identities = 51/229 (22%), Positives = 103/229 (44%), Gaps = 28/229 (12%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKKGATKS----FVAECEAL 725
            EF     +G G+FG VYKG    +G    + VA+K +   ++  +       + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVM 71

Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIE 784
            ++ + ++ +++ IC +   +      ++ + M +G + D++    D +    L N  ++
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           +A  + YL +     +VH DL   NVL+       ++DFGLA+ L         E +  +
Sbjct: 126 IAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHA 176

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
              K  I ++  E  +    +   DV+S+G+ + E+ T   +P D +  
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (300), Expect = 3e-29
 Identities = 29/292 (9%), Positives = 73/292 (25%), Gaps = 46/292 (15%)

Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
           +  +A +  Q       + LS+  ++      +  G    V+     E     A+KV  +
Sbjct: 38  EAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM 97

Query: 710 DKK---GATKSFVAECEALRNIRHRNLI---------------------KIITICSSIDF 745
             +      +       A   +   +                           +    D 
Sbjct: 98  GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157

Query: 746 KGADFKAIVYEYMQ------YGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
                  ++           + ++D       D+  +    +  ++  +   L +     
Sbjct: 158 YAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214

Query: 800 IVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
           +VHG   P N+ +  D    + D                 G          + Y   E+ 
Sbjct: 215 LVHGHFTPDNLFIMPDGRLMLGDVSALW----------KVGTRGP-ASSVPVTYAPREFL 263

Query: 860 MGGDLSMTG--DVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV 909
                + T   + +  G+ +  ++    P   +            + +P   
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  119 bits (300), Expect = 4e-29
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 25/222 (11%)

Query: 680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRN 732
             +G G FG V  G L    +  +SVA+K +   K G T    + F+ E   +    H N
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHPN 107

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           +I++  + +      +    IV EYM+ GS+D +L   + +  V +L  ++  +AS ++Y
Sbjct: 108 IIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L +      VH DL   N+L++ ++V  VSDFGL R L        PE   ++   K  I
Sbjct: 163 LSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAYTTRGGKIPI 214

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            +  PE       +   DV+S+GI+L E+ +   RP   M N
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  118 bits (297), Expect = 4e-29
 Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 28/229 (12%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDKKGAT----KSFVAECEAL 725
            E      +G G FG V+KG    +G    + V +KV+   +  +     ++      A+
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQSFQAVTDHMLAI 69

Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIE 784
            ++ H ++++++ +C     +      +V +Y+  GS+ D +      L    L N  ++
Sbjct: 70  GSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           +A  + YL  H    +VH +L   NVLL       V+DFG+A  L         + Q   
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD------DKQLLY 174

Query: 845 IEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            E K  I ++  E    G  +   DV+S+G+ + E+ T    P   +  
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  116 bits (293), Expect = 8e-29
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)

Query: 680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRN 732
             IG+G FG VY G L       +  AVK +    +         F+ E   +++  H N
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++ ++ IC     +G+    +V  YM++G + +++ +      V  L    ++VA  ++Y
Sbjct: 88  VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143

Query: 792 LH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           L         VH DL   N +LD      V+DFGLAR +    +        + + +K  
Sbjct: 144 LASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRP 886
                 E       +   DV+SFG+LL E+ TR   P
Sbjct: 200 ----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  121 bits (304), Expect = 9e-29
 Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 34/256 (13%)

Query: 647 LAHKLSSALLMEQQFPIVSYAELSKATKEFSSS-----NRIGKGSFGFVYKGNLGEDGMS 701
           L H+L++     +         L+K   E          ++G+G FG V+ G        
Sbjct: 239 LCHRLTTVCPTSKPQTQ----GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTR 293

Query: 702 VAVKVMNLDKKGATKS--FVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQ 759
           VA+K +   K G      F+ E + ++ +RH  L+++  + S           IV EYM 
Sbjct: 294 VAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIVTEYMS 344

Query: 760 YGSVDDWL-HHTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV 817
            GS+ D+L   T   L + +L ++  ++AS + Y+        VH DL+ +N+L+  ++V
Sbjct: 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLV 401

Query: 818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
             V+DFGLAR +  + +       ++    K  I +  PE  + G  ++  DV+SFGILL
Sbjct: 402 CKVADFGLARLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454

Query: 878 LEMFTR-RRPTDNMFN 892
            E+ T+ R P   M N
Sbjct: 455 TELTTKGRVPYPGMVN 470

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  116 bits (292), Expect = 9e-29
 Identities = 57/218 (26%), Positives = 109/218 (50%), Gaps = 23/218 (10%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKII 737
           +++G G +G VY+G   +  ++VAVK +   K+     + F+ E   ++ I+H NL++++
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKL-NIVIEVASVIEYLHNH 795
            +C+    +   F  I+ E+M YG++ D+L   N + +    L  +  +++S +EYL   
Sbjct: 76  GVCT----REPPF-YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                +H DL   N L+  + +  V+DFGL+R ++   +       ++    K  I +  
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-------TAHAGAKFPIKWTA 180

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           PE       S+  DV++FG+LL E+ T    P   +  
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  116 bits (292), Expect = 9e-29
 Identities = 50/220 (22%), Positives = 99/220 (45%), Gaps = 25/220 (11%)

Query: 681 RIGKGSFGFVYKG--NLGEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLI 734
            +G G+FG V +G   + +  + VA+KV+   K+G  K+     + E + +  + +  ++
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
           ++I +C +          +V E    G +  +L    +++ V  +  ++ +V+  ++YL 
Sbjct: 74  RLIGVCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                  VH DL   NVLL +   A +SDFGL++ L            ++    K  + +
Sbjct: 128 EKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-----DSYYTARSAGKWPLKW 179

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
             PE       S   DV+S+G+ + E  +  ++P   M  
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (293), Expect = 1e-28
 Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 34/222 (15%)

Query: 680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRN 732
             +G+G FG V +GNL       + VAVK M LD   +++     F++E   +++  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD--NSSQREIEEFLSEAACMKDFSHPN 97

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVA 786
           +I+++ +C  +  +G     ++  +M+YG +  +L ++  +     +        ++++A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             +EYL N      +H DL   N +L  DM   V+DFGL++ +            S    
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKI-----------YSGDYY 203

Query: 847 MKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
            +G I  +       E       +   DV++FG+ + E+ TR
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  117 bits (296), Expect = 1e-28
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 25/223 (11%)

Query: 680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRN 732
             IG+G FG VY G L       +  AVK +    +         F+ E   +++  H N
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           ++ ++ IC     +G+    +V  YM++G + +++ +      V  L    ++VA  +++
Sbjct: 152 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 207

Query: 792 L-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           L         VH DL   N +LD      V+DFGLAR +    F        + + +K  
Sbjct: 208 LASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
                 E       +   DV+SFG+LL E+ TR   P  ++  
Sbjct: 264 ----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  116 bits (293), Expect = 1e-28
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 25/222 (11%)

Query: 680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRN 732
             IG G  G V  G L   G+  + VA+K +   K G T    + F++E   +    H N
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           +I++  + +    +G     IV EYM+ GS+D +L   + +  + +L  ++  V + + Y
Sbjct: 112 IIRLEGVVT----RGRLA-MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L +      VH DL   NVL+D ++V  VSDFGL+R L        P+   ++   K  I
Sbjct: 167 LSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAAYTTTGGKIPI 218

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            +  PE       S   DV+SFG+++ E+     RP  NM N
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  115 bits (291), Expect = 1e-28
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 25/213 (11%)

Query: 680 NRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHR 731
             +G+G FG V            G  VAVK +   K  +  +       E E LRN+ H 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEILRNLYHE 83

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
           N++K   IC+     G +   ++ E++  GS+ ++L    +K+ + +     +++   ++
Sbjct: 84  NIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL-SHHPFLVAPEGQSSSIEMKG 849
           YL +      VH DL   NVL++ +    + DFGL + + +   +    + + S +    
Sbjct: 141 YLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV--FW 195

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                 PE  M     +  DV+SFG+ L E+ T
Sbjct: 196 Y----APECLMQSKFYIASDVWSFGVTLHELLT 224

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (305), Expect = 2e-28
 Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 31/213 (14%)

Query: 681 RIGKGSFGFVYKG---NLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKI 736
            I  G  G++Y     N+  +G  V +K +       A    +AE + L  + H ++++I
Sbjct: 87  CIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNH 795
                  D  G     IV EY+   S+         KL V + +  ++E+   + YLH+ 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSI 201

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
               +V+ DLKP N++L  + +  + D G    +               +   GT G+  
Sbjct: 202 ---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----------NSFGYL--YGTPGFQA 245

Query: 856 PEYGMGG--DLSMTGDVYSFGILLLEMFTRRRP 886
           PE    G    +   D+Y+ G  L  +      
Sbjct: 246 PEIVRTGPTVAT---DIYTVGRTLAALTLDLPT 275

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  114 bits (289), Expect = 2e-28
 Identities = 72/240 (30%), Positives = 106/240 (44%), Gaps = 32/240 (13%)

Query: 662 PIVSYAELSKATKEFSSS-----NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT- 715
            + +  E  ++    +         IGKG FG V  G+    G  VAVK +   K  AT 
Sbjct: 4   SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATA 58

Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKL 774
           ++F+AE   +  +RH NL++++ +      +      IV EYM  GS+ D+L       L
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114

Query: 775 EVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP 833
               L    ++V   +EYL  +     VH DL   NVL+  D VA VSDFGL +      
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK------ 165

Query: 834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
                E  S+    K  + +  PE       S   DV+SFGILL E+++  R P   +  
Sbjct: 166 -----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  116 bits (292), Expect = 2e-28
 Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 26/222 (11%)

Query: 681 RIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRN 732
            IG G FG VYKG L    G+  + VA+K +   K G T      F+ E   +    H N
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEY 791
           +I++  + S           I+ EYM+ G++D +L   + +  V +L  ++  +A+ ++Y
Sbjct: 108 IIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L N      VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K  I
Sbjct: 163 LANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATYTTSGGKIPI 214

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            +  PE       +   DV+SFGI++ E+ T   RP   + N
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  115 bits (291), Expect = 2e-28
 Identities = 46/229 (20%), Positives = 94/229 (41%), Gaps = 20/229 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           ++G+G F +V       DG   A+K +   ++   +    E +  R   H N+++++   
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA-- 93

Query: 741 SSIDFKGADFKA-IVYEYMQYGSVDDWL---HHTNDKLEVGK-LNIVIEVASVIEYLHNH 795
             +  +GA  +A ++  + + G++ + +       + L   + L +++ +   +E +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP-EGQSSSIEMKGTIGYI 854
                 H DLKP+N+LL  +    + D G       H                + TI Y 
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 855 GPE------YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 897
            PE      + +  + +   DV+S G +L  M     P D +F  G ++
Sbjct: 211 APELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  115 bits (289), Expect = 2e-28
 Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 27/241 (11%)

Query: 664 VSYAELSKATKEFSSSN------RIGKGSFGFVYKG--NLGEDGMSVAVKVM--NLDKKG 713
           ++  E+                  +G G+FG V KG   + +   +VAVK++    +   
Sbjct: 1   MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60

Query: 714 ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK 773
                +AE   ++ + +  ++++I IC +  +       +V E  + G ++ +L   N  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKYLQQ-NRH 113

Query: 774 LEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH 832
           ++   +  +V +V+  ++YL        VH DL   NVLL     A +SDFGL++ L   
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170

Query: 833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMF 891
                     +    K  + +  PE       S   DV+SFG+L+ E F+  ++P   M 
Sbjct: 171 -----ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

Query: 892 N 892
            
Sbjct: 226 G 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  114 bits (287), Expect = 3e-28
 Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 28/221 (12%)

Query: 681 RIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNIRHRNL 733
            IG+G FG V++G         ++VA+K     K   +    + F+ E   +R   H ++
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +K+I + +       +   I+ E    G +  +L      L++  L     ++++ + YL
Sbjct: 79  VKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
            +      VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I 
Sbjct: 133 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIK 182

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           ++ PE       +   DV+ FG+ + E+     +P   + N
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  115 bits (289), Expect = 5e-28
 Identities = 53/235 (22%), Positives = 99/235 (42%), Gaps = 30/235 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITIC 740
           + +G F FVY+      G   A+K +  +++   ++ + E   ++ +  H N   I+  C
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN---IVQFC 92

Query: 741 SSIDFKGADFKAIVYEY---MQY--GSVDDWLHHTNDKL-----EVGKLNIVIEVASVIE 790
           S+      +      E+    +   G + ++L     +       V  L I  +    ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV--LKIFYQTCRAVQ 150

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK-- 848
           ++H   +PPI+H DLK  N+LL +     + DFG A  +SH+P       + + +E +  
Sbjct: 151 HMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 849 --GTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 897
              T  Y  PE    Y     +    D+++ G +L  +  R+ P    F DG  L
Sbjct: 210 RNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  113 bits (286), Expect = 5e-28
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 30/238 (12%)

Query: 665 SYAELSKATKEFSSSN-----RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KS 717
           S A L   + E    +      +G G FG V  G        VA+K++   K+G+     
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDE 65

Query: 718 FVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG 777
           F+ E + + N+ H  L+++  +C+           I+ EYM  G + ++L     + +  
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMRHRFQTQ 120

Query: 778 KL-NIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
           +L  +  +V   +EYL         +H DL   N L++   V  VSDFGL+R++    + 
Sbjct: 121 QLLEMCKDVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175

Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
                 +SS+  K  + +  PE  M    S   D+++FG+L+ E+++  + P +   N
Sbjct: 176 ------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  115 bits (289), Expect = 5e-28
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)

Query: 680 NRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           +++GKG+FG V            G  VAVK +        + F  E + L+ +    ++K
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHN 794
              +       G     +V EY+  G + D+L     +L+  +L     ++   +EYL +
Sbjct: 89  YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP-FLVAPEGQSSSIEMKGTIGY 853
                 VH DL   N+L++ +    ++DFGLA+ L     + V  E   S I        
Sbjct: 146 RR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI--FWY--- 197

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             PE       S   DV+SFG++L E+FT
Sbjct: 198 -APESLSDNIFSRQSDVWSFGVVLYELFT 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  113 bits (285), Expect = 6e-28
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 25/217 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIIT 738
            IG GS+G   K     DG  +  K ++     +   +  V+E   LR ++H N   I+ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIEY 791
               I  +      IV EY + G   D         +  +       L ++ ++   ++ 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGG---DLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 792 LH--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            H  +     ++H DLKP+NV LD      + DFGLAR L+H         ++      G
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF----AKT----FVG 178

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           T  Y+ PE       +   D++S G LL E+     P
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  119 bits (300), Expect = 6e-28
 Identities = 53/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)

Query: 665 SYAELSKATKEFSSSN-----RIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDKKGATK 716
           +Y   S    E           IG+G FG V++G         M+VA+K     K   + 
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSD 432

Query: 717 S----FVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND 772
           S    F+ E   +R   H +++K+I + +       +   I+ E    G +  +L     
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVRKF 486

Query: 773 KLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
            L++  L     ++++ + YL +      VH D+   NVL+  +    + DFGL+R++  
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543

Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNM 890
             +  A +G+   + +K       PE       +   DV+ FG+ + E+     +P   +
Sbjct: 544 STYYKASKGK---LPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

Query: 891 FN 892
            N
Sbjct: 597 KN 598

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  112 bits (283), Expect = 8e-28
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 25/224 (11%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHR 731
            E +    IG G FG V+ G    +   VA+K +   ++GA   + F+ E E +  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 63

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+++  +C            +V E+M++G + D+L           L  + ++V   + 
Sbjct: 64  KLVQLYGVCLE-----QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118

Query: 791 YL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           YL         +H DL   N L+  + V  VSDFG+ RF+    +       +SS   K 
Sbjct: 119 YLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKF 167

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
            + +  PE       S   DV+SFG+L+ E+F+  + P +N  N
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  113 bits (286), Expect = 1e-27
 Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 33/222 (14%)

Query: 680 NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLI 734
             +GKG FG V +  L       + VAVK++  D       + F+ E   ++   H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 735 KIITICSSIDFKGADFKA-IVYEYMQYGSVDDWL-----HHTNDKLEVGKL-NIVIEVAS 787
           K++ +      KG      ++  +M++G +  +L           L +  L   ++++A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 788 VIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
            +EYL   +     +H DL   N +L  DM   V+DFGL+R +            S    
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKI-----------YSGDYY 193

Query: 847 MKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
            +G    +       E       ++  DV++FG+ + E+ TR
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  112 bits (282), Expect = 1e-27
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 23/223 (10%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHR 731
           +E +    +G G FG V  G   +    VAVK++   K+G+     F  E + +  + H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHP 63

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIE 790
            L+K   +CS    K      IV EY+  G + ++L      LE  +L  +  +V   + 
Sbjct: 64  KLVKFYGVCS----KEYPI-YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +L +H     +H DL   N L+D D+   VSDFG+ R++    +        SS+  K  
Sbjct: 119 FLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-------VSSVGTKFP 168

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           + +  PE       S   DV++FGIL+ E+F+  + P D   N
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (282), Expect = 1e-27
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 28/221 (12%)

Query: 681 RIGKGSFGFVYKG---NLGEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNL 733
            +G+G FG VY+G   N   + ++VAVK     KK  T      F++E   ++N+ H ++
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +K+I I         +   I+ E   YG +  +L    + L+V  L    +++   + YL
Sbjct: 76  VKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
            +      VH D+   N+L+       + DFGL+R++    +  A   +   + +K    
Sbjct: 130 ESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR---LPIKWM-- 181

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
              PE       +   DV+ F + + E+ +  ++P   + N
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  112 bits (282), Expect = 2e-27
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 25/218 (11%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRNIRHRNLIKII 737
            R+G G FG V+ G        VAVK +   K+G+    +F+AE   ++ ++H+ L+++ 
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWL-HHTNDKLEVGKL-NIVIEVASVIEYLHNH 795
            + +       +   I+ EYM+ GS+ D+L   +  KL + KL ++  ++A  + ++   
Sbjct: 75  AVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                +H DL+ +N+L+   +   ++DFGLAR +  + +       ++    K  I +  
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIKWTA 178

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
           PE    G  ++  DV+SFGILL E+ T  R P   M N
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  111 bits (281), Expect = 2e-27
 Identities = 45/231 (19%), Positives = 98/231 (42%), Gaps = 40/231 (17%)

Query: 681 RIGKGSFGFVYKGNLGEDG-------MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
            +G+G+F  ++KG   E G         V +KV++   +  ++SF      +  + H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +    +C        D   +V E++++GS+D +L    + + +     +  ++A+ + +L
Sbjct: 75  VLNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 793 -HNHCQPPIVHGDLKPSNVLLDHD--------MVAHVSDFGLARFLSHHPFLVAPEGQSS 843
             N      +HG++   N+LL  +            +SD G++  +     L        
Sbjct: 130 EENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER----- 180

Query: 844 SIEMKGTIGYIGPE-YGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
                  I ++ PE      +L++  D +SFG  L E+ +   +P   + +
Sbjct: 181 -------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  117 bits (294), Expect = 3e-27
 Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 25/220 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDG--MSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLI 734
            +G G+FG V +G        + VA+KV+   K+G  K+     + E + +  + +  ++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
           ++I +C +          +V E    G +  +L    +++ V  +  ++ +V+  ++YL 
Sbjct: 400 RLIGVCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 453

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                  VH +L   NVLL +   A +SDFGL++ L            ++    K  + +
Sbjct: 454 EKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-----DSYYTARSAGKWPLKW 505

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFN 892
             PE       S   DV+S+G+ + E  +  ++P   M  
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (281), Expect = 4e-27
 Identities = 49/225 (21%), Positives = 83/225 (36%), Gaps = 31/225 (13%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRN 727
           S   + F   +R+G GS+G V+K    EDG   AVK      +G       +AE  +   
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 728 I-RHRNLIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKL-EVGKLNI 781
           + +H   ++          + A  +     +  E     S+          L E      
Sbjct: 113 VGQHPCCVR---------LEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGY 162

Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
           + +    + +LH+     +VH D+KP+N+ L       + DFGL   L            
Sbjct: 163 LRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---------A 210

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            +    +G   Y+ PE  + G      DV+S G+ +LE+      
Sbjct: 211 GAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVACNMEL 254

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (281), Expect = 4e-27
 Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 31/233 (13%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI 728
           S +   +  S+ +G+G+   V++G   + G   A+KV N           + E E L+ +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKL--EVGKLNIVIEV 785
            H+N++K+  I    +      K ++ E+   GS+   L   +N     E   L ++ +V
Sbjct: 65  NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
              + +L  +    IVH ++KP N++     D   V  ++DFG AR L      V     
Sbjct: 122 VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV----- 173

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTG--------DVYSFGILLLEMFTRRRP 886
                + GT  Y+ P+      L            D++S G+      T   P
Sbjct: 174 ----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  114 bits (286), Expect = 5e-27
 Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 36/226 (15%)

Query: 675 EFSSSNRIGKGSFG-FVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHR 731
            F   + +G G+ G  VY+G    D   VAVK +  +    A +    E + LR    H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR----EVQLLRESDEHP 78

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEY 791
           N+I+    C+    K   F+ I  E       +         L +  + ++ +  S + +
Sbjct: 79  NVIRYF--CT---EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133

Query: 792 LHNHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
           LH+     IVH DLKP N+L+        + A +SDFGL + L+         G+ S   
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA--------VGRHSFSR 182

Query: 847 MK---GTIGYIGPEY---GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                GT G+I PE        + + T D++S G +   + +    
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (281), Expect = 6e-27
 Identities = 63/278 (22%), Positives = 102/278 (36%), Gaps = 28/278 (10%)

Query: 614 GLGELHLPACHSVGPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELSKAT 673
           G G +     HS+    +T +     +  +G +        L  + +     Y E     
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EV 57

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
              +   R+G+GSFG V++    + G   AVK + L+        V E  A   +    +
Sbjct: 58  HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRI 112

Query: 734 IKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           +            GA  +     I  E ++ GS+   +       E   L  + +    +
Sbjct: 113 VP---------LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGL 163

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           EYLH      I+HGD+K  NVLL  D   A + DFG A  L       +         + 
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IP 217

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT  ++ PE  MG       D++S   ++L M     P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  111 bits (280), Expect = 6e-27
 Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 25/235 (10%)

Query: 680 NRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHRNLI 734
             +G+G FG V            G  VAVK +  D     +S +  E + LR + H ++I
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
           K    C      GA    +V EY+  GS+ D+L      + + +L     ++   + YLH
Sbjct: 97  KYKGCCED---AGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLH 151

Query: 794 -NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP-FLVAPEGQSSSIEMKGTI 851
             H     +H DL   NVLLD+D +  + DFGLA+ +     +    E   S +      
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY- 204

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG--YAKMA 904
               PE           DV+SFG+ L E+ T    + +     L L G    +M 
Sbjct: 205 ---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (277), Expect = 2e-26
 Identities = 66/343 (19%), Positives = 105/343 (30%), Gaps = 72/343 (20%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG 311
           +LP    +L +  N +T        N   L  L L  N  S      F  L  L +LYL 
Sbjct: 49  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
           +N L      +L                         +P ++  L        +  N+I+
Sbjct: 109 KNQL-----KELP----------------------EKMPKTLQELR-------VHENEIT 134

Query: 372 GTIPPEI-RNLFNLNGLGLEYNQLT-GTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGN 428
             +   +   L  +  + L  N L    I   A   ++ L Y+ +   NI  I   P G 
Sbjct: 135 -KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI---PQGL 190

Query: 429 LTLLNVLQLGFNKLQGSIPS-YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LD 485
              L  L L  NK+   + +  L    NL +L    N ++  +            L  L 
Sbjct: 191 PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSL--ANTPHLRELH 246

Query: 486 LSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ 545
           L+ N L   +P  + + K +  + +  NN S  I                 N F    P 
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS---------------NDFCP--PG 287

Query: 546 SLNALKSIKELDLSCNNLSGQIPIHLG---NLPFLEYLNLSYN 585
                 S   + L  N +     I       +     + L   
Sbjct: 288 YNTKKASYSGVSLFSNPVQ-YWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (271), Expect = 1e-25
 Identities = 62/275 (22%), Positives = 101/275 (36%), Gaps = 21/275 (7%)

Query: 335 LVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQ 393
              L L  N+          NL    TLI +  N+IS  I P     L  L  L L  NQ
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLI-LINNKIS-KISPGAFAPLVKLERLYLSKNQ 111

Query: 394 LTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI--PSYLG 451
           L   +P      + LQ L +  N I  +       L  + V++LG N L+ S        
Sbjct: 112 LK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 452 KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDI 510
             + L  +   +  +  T+P  +    +L++L  L  N ++  +       L +L +L +
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGLP--PSLTEL-HLDGNKIT-KVDAASLKGLNNLAKLGL 223

Query: 511 SRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSG----- 565
           S N+ S     +L+    L  L +  N     +P  L   K I+ + L  NN+S      
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282

Query: 566 -QIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
              P +         ++L  N  +    +   F  
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  107 bits (269), Expect = 2e-25
 Identities = 64/321 (19%), Positives = 109/321 (33%), Gaps = 59/321 (18%)

Query: 160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
              L L  N++T        NL  L T  +  NK+    P +   L  L  L  S+N   
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 220 ----GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL--PQ 273
                M         +L E  + +N     +   +   L ++ V+ +  N L        
Sbjct: 114 ELPEKMPK-------TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 274 SLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCS 333
           +     KL ++ + + + +    I     P+L++L+L  N +     T +D  +L    +
Sbjct: 166 AFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKI-----TKVDAASL-KGLN 216

Query: 334 KLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYN 392
            L KLGL                         + N IS  +      N  +L  L L  N
Sbjct: 217 NLAKLGL-------------------------SFNSIS-AVDNGSLANTPHLRELHLNNN 250

Query: 393 QLTGTIPPAIGELRNLQYLGLVGNNIRGI------IPDPIGNLTLLNVLQLGFNKLQ-GS 445
           +L   +P  + + + +Q + L  NNI  I       P         + + L  N +Q   
Sbjct: 251 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309

Query: 446 IPSYLGKC-QNLMQLSAPNNK 465
           I     +C      +   N K
Sbjct: 310 IQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (257), Expect = 7e-24
 Identities = 61/269 (22%), Positives = 105/269 (39%), Gaps = 49/269 (18%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
           +PP+   L       L+ N++T  I       L+NL  L L+ N I  I P     L  L
Sbjct: 50  LPPDTALLD------LQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 433 NVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENH 490
             L L  N+L+  +P  + K   L +L    N++   +   +F    L+++  ++L  N 
Sbjct: 103 ERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVF--NGLNQMIVVELGTNP 156

Query: 491 LSGSIPLEVG---NLKSLVQLDISRNNFS-----------------NEI----PVTLSAC 526
           L  S  +E G    +K L  + I+  N +                 N+I      +L   
Sbjct: 157 LK-SSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGL 215

Query: 527 TTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
             L  L +  NS +     SL     ++EL L+ N L  ++P  L +  +++ + L  N+
Sbjct: 216 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 274

Query: 587 FE----GKVPKKGVFSNETR---ISLTGN 608
                       G  + +     +SL  N
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSN 303

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 65/311 (20%), Positives = 99/311 (31%), Gaps = 53/311 (17%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHG 100
           C    V C                  LDL++  I         NL  L  + L NN    
Sbjct: 31  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89

Query: 101 QIPKEVGR-LFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL- 158
           +I       L +LE + LS N    ++P  + +   L +  VH N     I  +  +   
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENE----ITKVRKSVFN 142

Query: 159 ---KIERLSLYGNQLT-GQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGT 213
              ++  + L  N L    +       +  L    IA   +   IP  L    +L  L  
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 199

Query: 214 SENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQ 273
             N            I+ +D A       KG         L  L  L ++ N+++     
Sbjct: 200 DGN-----------KITKVDAAS-----LKG---------LNNLAKLGLSFNSISAVDNG 234

Query: 274 SLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCS 333
           SL+N   L  L LN N    +V         +  +YL  NN+    S D       T  +
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 293

Query: 334 KLVKLGLVFNR 344
               + L  N 
Sbjct: 294 SYSGVSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 30/133 (22%), Positives = 52/133 (39%), Gaps = 10/133 (7%)

Query: 469 TLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACT 527
            +P  +   T L   LDL  N ++  I      NLK+L  L +  N  S   P   +   
Sbjct: 45  KVPKDLPPDTAL---LDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 100

Query: 528 TLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNH 586
            LE L +  N     +P+     K+++EL +  N ++ ++       L  +  + L  N 
Sbjct: 101 KLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNP 156

Query: 587 FEGKVPKKGVFSN 599
            +    + G F  
Sbjct: 157 LKSSGIENGAFQG 169

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (280), Expect = 2e-26
 Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 31/233 (13%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI 728
           S +   +  S+ +G+G+   V++G   + G   A+KV N           + E E L+ +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKL-EVGKLNIVIEV 785
            H+N++K+  I    +      K ++ E+   GS+   L        L E   L ++ +V
Sbjct: 65  NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
              + +L  +    IVH ++KP N++     D   V  ++DFG AR L      V     
Sbjct: 122 VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV----- 173

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTG--------DVYSFGILLLEMFTRRRP 886
                + GT  Y+ P+      L            D++S G+      T   P
Sbjct: 174 ----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 2e-26
 Identities = 44/276 (15%), Positives = 89/276 (32%), Gaps = 47/276 (17%)

Query: 648 AHKLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM 707
           A  L S  L     P    +EL +  +       +G+       +    E G S  V V 
Sbjct: 47  ADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVP 106

Query: 708 NLDKKGA------TKSFVAECEALRNIRH-------------RNLIKIITICSSIDFKGA 748
              ++         K  V     LR I++              +L+K       I  +  
Sbjct: 107 YFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 166

Query: 749 DFKA------IVYEYMQ--YGSVDDWLHHTNDK----LEVGKLNIVIEVASVIEYLHNHC 796
           +          +Y  MQ    +  + L   +      +   +L + ++V  ++  LH++ 
Sbjct: 167 ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH------HPFLVAPEGQSSSIEMKGT 850
              +VH  L+P +++LD      ++ F                    PE        + T
Sbjct: 227 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPE----LEARRAT 279

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           I Y          ++ + D ++ G+++  ++    P
Sbjct: 280 ISYHRDR---RTLMTFSFDAWALGLVIYWIWCADLP 312

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  110 bits (276), Expect = 3e-26
 Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 20/209 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           IG+GSFG        EDG    +K +N+ +      +    E   L N++H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE- 90

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQ 797
                F+      IV +Y + G +   ++     L  E   L+  +++   ++++H+   
Sbjct: 91  ----SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-- 144

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H D+K  N+ L  D    + DFG+AR L+           + +    GT  Y+ PE
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST------VELARA--CIGTPYYLSPE 195

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                  +   D+++ G +L E+ T +  
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  108 bits (273), Expect = 3e-26
 Identities = 48/221 (21%), Positives = 96/221 (43%), Gaps = 30/221 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +GKG++G VY G    + + +A+K +       ++    E    ++++H+N+++      
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ------ 83

Query: 742 SIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKL---NIVIEVASVIEYLHN 794
              + G+  +     I  E +  GS+   L      L+  +        ++   ++YLH+
Sbjct: 84  ---YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 795 HCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
           +    IVH D+K  NVL++ +  V  +SDFG ++ L+             +    GT+ Y
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--------GINPCTETFTGTLQY 189

Query: 854 IGPE--YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
           + PE             D++S G  ++EM T + P   +  
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  108 bits (273), Expect = 4e-26
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 23/212 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK---SFVAECEALRNIRHRNLIKIIT 738
           IG+G F  VY+     DG+ VA+K + +      K     + E + L+ + H N   +I 
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN---VIK 96

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL----EVGKLNIVIEVASVIEYLHN 794
             +S  F   +   IV E    G +   + H   +     E       +++ S +E++H+
Sbjct: 97  YYAS--FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                ++H D+KP+NV +    V  + D GL RF S           + S  + GT  Y+
Sbjct: 155 RR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TTAAHS--LVGTPYYM 203

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            PE       +   D++S G LL EM   + P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  109 bits (275), Expect = 4e-26
 Identities = 59/275 (21%), Positives = 96/275 (34%), Gaps = 22/275 (8%)

Query: 335 LVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQ 393
              L L  N            L     L+ +  N+IS  I  +    L  L  L +  N 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALV-LVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113

Query: 394 LTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ-GSIPSYLGK 452
           L   IPP +    +L  L +  N IR +       L  +N +++G N L+          
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 453 CQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDIS 511
              L  L     KL   +P  +    TL++L  L  N +  +I LE       L +L + 
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDLP--ETLNEL-HLDHNKIQ-AIELEDLLRYSKLYRLGLG 225

Query: 512 RNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIP--- 568
            N        +LS   TL  L +  N  +  +P  L  LK ++ + L  NN++ ++    
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVND 283

Query: 569 ----IHLGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
                      +   ++L  N       +   F  
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  108 bits (271), Expect = 1e-25
 Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 15/239 (6%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPE-IRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYL 411
             +S   TL+ +  N IS  +  +  + L +L  L L  N+++  I   A   LR LQ L
Sbjct: 50  KEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKL 107

Query: 412 GLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKL-NGT 469
            +  N++  I   P    + L  L++  N+++  +P       +N+  +    N L N  
Sbjct: 108 YISKNHLVEI---PPNLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSG 163

Query: 470 LPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTL 529
             P  F    L   L +SE  L+  IP      ++L +L +  N         L   + L
Sbjct: 164 FEPGAFDGLKL-NYLRISEAKLT-GIP--KDLPETLNELHLDHNKIQAIELEDLLRYSKL 219

Query: 530 EYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
             L +  N        SL+ L +++EL L  N LS ++P  L +L  L+ + L  N+  
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  103 bits (258), Expect = 7e-24
 Identities = 49/271 (18%), Positives = 95/271 (35%), Gaps = 26/271 (9%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
            L  L  LV+  N ++    ++ S   KL+ L +++NH      I  N   +L +L +  
Sbjct: 76  GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV---EIPPNLPSSLVELRIHD 132

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
           N +  +         + +    +  + +  N    +     A     +  + ++  +++ 
Sbjct: 133 NRI-RKVPKG-----VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT- 185

Query: 373 TIPPEIRNLF-NLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLT 430
            IP    +L   LN L L++N++   I    +     L  LGL  N IR I    +  L 
Sbjct: 186 GIPK---DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241

Query: 431 LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF-GITTLSKLLDLSEN 489
            L  L L  NKL   +P+ L   + L  +    N +   +    F  +    K    +  
Sbjct: 242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGI 299

Query: 490 HLSG------SIPLEV-GNLKSLVQLDISRN 513
            L         +       +   + +     
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  102 bits (257), Expect = 9e-24
 Identities = 62/320 (19%), Positives = 105/320 (32%), Gaps = 58/320 (18%)

Query: 160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
              L L  N ++         L  L    +  NK+      +   LR L  L  S+N   
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 220 ----GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLT-GFLPQS 274
                +         SL E  +  NR +  +P  +   L  +  + +  N L        
Sbjct: 116 EIPPNLPS-------SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 275 LSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSK 334
             +  KL +L ++E   +    I  +    L++L+L  N +  +     D        SK
Sbjct: 168 AFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKI--QAIELEDL----LRYSK 218

Query: 335 LVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQ 393
           L +LGL                           NQI   I       L  L  L L+ N+
Sbjct: 219 LYRLGL-------------------------GHNQIR-MIENGSLSFLPTLRELHLDNNK 252

Query: 394 LTGTIPPAIGELRNLQYLGLVGNNIRGIIPD------PIGNLTLLNVLQLGFNKLQ-GSI 446
           L+  +P  + +L+ LQ + L  NNI  +  +              N + L  N +    +
Sbjct: 253 LS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311

Query: 447 PSYLGKC-QNLMQLSAPNNK 465
                +C  + + +   N K
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 61/311 (19%), Positives = 104/311 (33%), Gaps = 54/311 (17%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHG 100
           C    V C                T LDL++ +I          L  L  + L NN    
Sbjct: 33  CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91

Query: 101 QIPKEV-GRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLK 159
           +I ++    L +L+ + +S N    +IP NL                             
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--------------------------S 124

Query: 160 IERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKL-DGRIPDSLGQLRNLNYLGTSEND 217
           +  L ++ N++  ++P  +   L  +   ++ GN L +            LNYL  SE  
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183

Query: 218 FS----GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQ 273
            +     +         +L+E +L  N+ + ++ +       KL  L +  N +      
Sbjct: 184 LTGIPKDLP-------ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENG 235

Query: 274 SLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCS 333
           SLS    L  L L+ N  S +V      L  L  +YL  NN+      D   +      +
Sbjct: 236 SLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294

Query: 334 KLVKLGLVFNR 344
               + L  N 
Sbjct: 295 YYNGISLFNNP 305

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 46/243 (18%), Positives = 83/243 (34%), Gaps = 25/243 (10%)

Query: 84  NLSFLRVINLANNSFHGQIPKEVGRLFR-LETIVLSNNSFSGKIPTN-LSRCFNLIDFWV 141
            L  L+ + ++ N    +IP     L   L  + + +N    K+P    S   N+    +
Sbjct: 100 PLRKLQKLYISKNHLV-EIPPN---LPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEM 154

Query: 142 HTNNL-VGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPD 200
             N L     +    + LK+  L +   +LT  +P        L    +  NK+   I  
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIEL 210

Query: 201 -SLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTV 259
             L +   L  LG   N    +   S+  + +L E +L  N+    +P  L  +L  L V
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL-PDLKLLQV 268

Query: 260 LVVAQNNLTGFLPQSLS------NASKLEWLELNENHFSGQVRIN---FNSLPNLSKLYL 310
           + +  NN+T                +    + L  N       +    F  + +   +  
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP-YWEVQPATFRCVTDRLAIQF 327

Query: 311 GRN 313
           G  
Sbjct: 328 GNY 330

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (277), Expect = 6e-26
 Identities = 39/279 (13%), Positives = 77/279 (27%), Gaps = 58/279 (20%)

Query: 650 KLSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL 709
            L S  L     P    +EL +  +       +G+       +    E G S  V V   
Sbjct: 54  SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 113

Query: 710 DKK---GATKSFVAECEALRNIRH----------------RNLIKIITICSSIDFKGADF 750
            ++    A K    E   LR +R                  +L+K       I  +  + 
Sbjct: 114 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 173

Query: 751 KAIVYEY-----MQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIEYLHNHCQP 798
              V            ++  +           K       L + ++V  ++  LH++   
Sbjct: 174 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH------HPFLVAPEGQSSSIEMKGTIG 852
            +VH  L+P +++LD      ++ F                    PE             
Sbjct: 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPE------------- 277

Query: 853 YIGPE-----YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                           ++   D ++ G+ +  ++    P
Sbjct: 278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (271), Expect = 7e-26
 Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 20/247 (8%)

Query: 373 TIPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNI--RGIIPDPIGNL 429
           ++P  I    +   L LE N+L  ++P     +L  L  L L  N +  +G         
Sbjct: 21  SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77

Query: 430 TLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLS 487
           T L  L L FN +  ++ S     + L  L   ++ L       +F   +L  L  LD+S
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF--LSLRNLIYLDIS 134

Query: 488 ENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEI-PVTLSACTTLEYLLMQGNSFNGSIPQ 545
             H        +   L SL  L ++ N+F     P   +    L +L +        +  
Sbjct: 135 HTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 192

Query: 546 -SLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK---KGVFSNET 601
            + N+L S++ L++S NN           L  L+ L+ S NH      K   +   S+  
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLA 251

Query: 602 RISLTGN 608
            ++LT N
Sbjct: 252 FLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (259), Expect = 2e-24
 Identities = 57/328 (17%), Positives = 102/328 (31%), Gaps = 66/328 (20%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQ--VRINFNSLPNLSKLY 309
            +P   T L +  N L           ++L  L L+ N  S +     +     +L  L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 310 LGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSI-ANLSTTMTLIAMAGN 368
           L  N + T +S             +L  L    +        S+  +L   +  + ++  
Sbjct: 85  LSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHT 136

Query: 369 QISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPI 426
                    I   L +L  L +  N       P    ELRNL +L L    +  + P   
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195

Query: 427 GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--L 484
            +L+ L VL +  N                            +L    +    L+ L  L
Sbjct: 196 NSLSSLQVLNMSHNNFF-------------------------SLDTFPY--KCLNSLQVL 228

Query: 485 DLSENHLSGSIPLEV--GNLKSLVQLDISRNNFSNEIPVTLSACT-TLEYLLMQGNSFNG 541
           D S NH+  +   +       SL  L++++N+F+         CT   +  L        
Sbjct: 229 DYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA---------CTCEHQSFLQWIKDQRQ 278

Query: 542 SIPQSLNAL---------KSIKELDLSC 560
            + +                +  L+++C
Sbjct: 279 LLVEVERMECATPSDKQGMPVLSLNITC 306

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (251), Expect = 3e-23
 Identities = 53/243 (21%), Positives = 102/243 (41%), Gaps = 15/243 (6%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLT--GTIPPAIGELRNLQY 410
             + ++ T + +  N++  ++P  +   L  L  L L  N L+  G    +     +L+Y
Sbjct: 24  TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82

Query: 411 LGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY--LGKCQNLMQLSAPNNKLNG 468
           L L  N +   +      L  L  L    + L+  +  +      +NL+ L   +     
Sbjct: 83  LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR- 139

Query: 469 TLPPQIF-GITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSAC 526
                IF G+++L ++L ++ N    +   ++   L++L  LD+S+     ++  T    
Sbjct: 140 VAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197

Query: 527 TT-LEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLP-FLEYLNLSY 584
            + L+ L M  N+F          L S++ LD S N++       L + P  L +LNL+ 
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257

Query: 585 NHF 587
           N F
Sbjct: 258 NDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 45/203 (22%), Positives = 71/203 (34%), Gaps = 31/203 (15%)

Query: 389 LEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL--QGSI 446
                LT ++P  I    +   L L  N ++ +       LT L  L L  N L  +G  
Sbjct: 14  CNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70

Query: 447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSL 505
                   +L  L    N +  T+     G+  L + LD   ++L       V  +L++L
Sbjct: 71  SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNL 128

Query: 506 VQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSG 565
           + LDIS  +         +  ++LE L M GNSF  +    +                  
Sbjct: 129 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI------------------ 170

Query: 566 QIPIHLGNLPFLEYLNLSYNHFE 588
                   L  L +L+LS    E
Sbjct: 171 -----FTELRNLTFLDLSQCQLE 188

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 54/281 (19%), Positives = 94/281 (33%), Gaps = 42/281 (14%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNIGGFLSPYI-GNLSFLRVINLANN--S 97
           C  T + C  +             T+L+LES  +   L   +   L+ L  ++L++N  S
Sbjct: 7   CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 98  FHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNW 157
           F G   +       L+ + LS N     + +N      L                     
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL--------------------- 103

Query: 158 LKIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEN 216
              E L    + L      S+  +L  L   DI+              L +L  L  + N
Sbjct: 104 ---EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160

Query: 217 DFSGMFPLSV-CNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSL 275
            F   F   +   + +L    L + + +  L      +L  L VL ++ NN         
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219

Query: 276 SNASKLEWLELNENHFSGQVRINFNSLP-NLSKLYLGRNNL 315
              + L+ L+ + NH     +      P +L+ L L +N+ 
Sbjct: 220 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (281), Expect = 1e-25
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 20/220 (9%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKII-T 738
           R+G G FG+V +    + G  VA+K    +      + +  E + ++ + H N++     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWL--HHTNDKL-EVGKLNIVIEVASVIEYLHNH 795
                     D   +  EY + G +  +L        L E     ++ +++S + YLH +
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 796 CQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               I+H DLKP N++L      ++  + D G A+ L                E  GT+ 
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---------EFVGTLQ 188

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
           Y+ PE       ++T D +SFG L  E  T  RP    + 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  107 bits (268), Expect = 2e-25
 Identities = 53/283 (18%), Positives = 98/283 (34%), Gaps = 63/283 (22%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNI 728
           S+   +F     +G+G FG V++     D  + A+K + L  +  A +  + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 729 RHRNLIKIITICSSIDFKGADFKA------------------------------------ 752
            H  +++          +    +                                     
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 753 ----------------IVYEYMQYGSVDDWLHHTNDKLEVGK---LNIVIEVASVIEYLH 793
                           I  +  +  ++ DW++      +      L+I I++A  +E+LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH----HPFLVAPEGQSSSIEMKG 849
           +     ++H DLKPSN+    D V  V DFGL   +         L      ++     G
Sbjct: 182 SKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
           T  Y+ PE   G + S   D++S G++L E+            
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (277), Expect = 3e-25
 Identities = 62/404 (15%), Positives = 124/404 (30%), Gaps = 59/404 (14%)

Query: 154 IGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAG---NKLDGRIPDSLGQLRNLNY 210
           I N   + + S Y N ++G            +   + G   N+    + + L  +   + 
Sbjct: 7   INNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSE 63

Query: 211 LGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGF 270
           L  +  + S   P ++     +    + +N    SLP         L  L    N L+  
Sbjct: 64  LQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELPA----SLEYLDACDNRLS-T 114

Query: 271 LPQSLSNASKLEWLELNENHFSGQVRINFNSLP----NLSKLYLGRNNLGTRTSTDLDFI 326
           LP+  ++   L+ L+++ N  +         LP     L  +    N L           
Sbjct: 115 LPELPAS---LKHLDVDNNQLT--------MLPELPALLEYINADNNQLTM--------- 154

Query: 327 TLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNL-- 384
            L    + L  L +  N+    LP    +L      + ++ N +  ++P       +   
Sbjct: 155 -LPELPTSLEVLSVRNNQLT-FLPELPESL----EALDVSTNLLE-SLPAVPVRNHHSEE 207

Query: 385 --NGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL 442
                    N++T  IP  I  L     + L  N +   I + +   T            
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

Query: 443 QGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNL 502
                S     QN +     +         +   ++ +    +  E+  + S  L+   L
Sbjct: 267 -----SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLD--RL 319

Query: 503 KSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
              V    + + F  ++   L   +    L  Q  +      +S
Sbjct: 320 SDTVSA-RNTSGFREQVAAWLEKLSASAELRQQSFAVAADATES 362

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  106 bits (267), Expect = 4e-24
 Identities = 64/337 (18%), Positives = 109/337 (32%), Gaps = 79/337 (23%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLEL-NENHFSGQVRINFNSLPNLSKLYLG 311
           N   L+      N ++G      S   K E   L  EN       +    +   S+L L 
Sbjct: 9   NNFSLSQNS-FYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLN 67

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
           R NL +                               LP ++    T + +     N + 
Sbjct: 68  RLNLSS-------------------------------LPDNLPPQITVLEI---TQNALI 93

Query: 372 GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTL 431
            ++P    +L  L+      N+L+ T+P       +L++L +  N +  ++P+    L  
Sbjct: 94  -SLPELPASLEYLD---ACDNRLS-TLPELPA---SLKHLDVDNNQLT-MLPELPALLEY 144

Query: 432 LNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHL 491
           +N      N+L   +P       +L  LS  NN+L   LP     +  L    D+S N L
Sbjct: 145 IN---ADNNQLT-MLPE---LPTSLEVLSVRNNQLT-FLPELPESLEAL----DVSTNLL 192

Query: 492 SGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALK 551
             S+P          + +I      N I                       IP+++ +L 
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT---------------------HIPENILSLD 230

Query: 552 SIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
               + L  N LS +I   L         +    +F 
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  106 bits (266), Expect = 3e-25
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 681 RIGKGSFGFVYKGN---LGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLI 734
           ++G G    VY      L      VA+K + +    K+   K F  E      + H+N++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 735 KIITICSSIDFKGADFKA--IVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEY 791
            +I      D    +     +V EY++  ++ +++  ++  L V   +N   ++   I++
Sbjct: 75  SMI------DV-DEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKH 126

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
            H+     IVH D+KP N+L+D +    + DFG+A+ LS          Q++ + + GT+
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-----TSLTQTNHV-L-GTV 176

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            Y  PE   G       D+YS GI+L EM     P
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (267), Expect = 3e-25
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 49/233 (21%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRH 730
             +G G+FG VY+G +         + VAVK +    +  ++     F+ E   +    H
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNH 92

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVI 783
           +N+++ I +      +      I+ E M  G +  +L  T  +            L++  
Sbjct: 93  QNIVRCIGVSL----QSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 784 EVASVIEYL-HNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPE 839
           ++A   +YL  NH     +H D+   N LL       VA + DFG+AR +          
Sbjct: 148 DIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI---------- 193

Query: 840 GQSSSIEMKGTIGYIG-----PEYGMGGDLSMTGDVYSFGILLLEMFTR-RRP 886
              +S   KG    +      PE  M G  +   D +SFG+LL E+F+    P
Sbjct: 194 -YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  105 bits (265), Expect = 6e-25
 Identities = 49/229 (21%), Positives = 88/229 (38%), Gaps = 48/229 (20%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRH 730
             +G+GSFG VY+G        E    VA+K +    + A+      F+ E   ++    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNC 87

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK----------LN 780
            ++++++ + S           ++ E M  G +  +L      +              + 
Sbjct: 88  HHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 781 IVIEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
           +  E+A  + YL+ N      VH DL   N ++  D    + DFG+ R +          
Sbjct: 143 MAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDI---------- 188

Query: 840 GQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
              +    KG  G +      PE    G  +   DV+SFG++L E+ T 
Sbjct: 189 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  105 bits (264), Expect = 6e-25
 Identities = 52/233 (22%), Positives = 91/233 (39%), Gaps = 40/233 (17%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
            + +     +G G+FG VYK    E G   A KV+    +   + ++ E E L    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 733 LIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVAS 787
           ++K           GA +      I+ E+   G+VD  +   +  L   ++ +V  ++  
Sbjct: 78  IVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH----------PFLVA 837
            + +LH+     I+H DLK  NVL+  +    ++DFG++                P+ +A
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
           PE              +  E           D++S GI L+EM     P   +
Sbjct: 186 PE-------------VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (265), Expect = 1e-24
 Identities = 62/267 (23%), Positives = 106/267 (39%), Gaps = 56/267 (20%)

Query: 649 HKLSSALLMEQQFPIVSYAELSKAT---KEFSSSN-----RIGKGSFGFVYKGNL----- 695
            KL ++ +M    P   +A  + +    KE    N      +G G+FG VY+G +     
Sbjct: 38  SKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN 97

Query: 696 GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLIKIITICSSIDFKGADFK 751
               + VAVK +    +  ++     F+ E   +    H+N+++ I +      +     
Sbjct: 98  DPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----QSLPR- 149

Query: 752 AIVYEYMQYGSVDDWLHHTNDKLEVGK-------LNIVIEVASVIEYL-HNHCQPPIVHG 803
            I+ E M  G +  +L  T  +            L++  ++A   +YL  NH     +H 
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF----IHR 205

Query: 804 DLKPSNVLLD---HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG----- 855
           D+   N LL       VA + DFG+AR +             +    KG    +      
Sbjct: 206 DIAARNCLLTCPGPGRVAKIGDFGMARDI-----------YRAGYYRKGGCAMLPVKWMP 254

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFT 882
           PE  M G  +   D +SFG+LL E+F+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  104 bits (261), Expect = 1e-24
 Identities = 56/245 (22%), Positives = 94/245 (38%), Gaps = 42/245 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHR 731
           + +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  
Sbjct: 28  RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 732 NLIKIITICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIE 784
           +  KII +    D      +  +V E      ++ WL       +   ++          
Sbjct: 87  S-DKIIRL---YDYEITDQYIYMVMECGN-IDLNSWLK------KKKSIDPWERKSYWKN 135

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           +   +  +H H    IVH DLKP+N L+   M+  + DFG+A  +      V  + Q   
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ--- 188

Query: 845 IEMKGTIGYIGPE------YGMGGDLSMTG-----DVYSFGILLLEMFTRRRPTDNMFND 893
               GT+ Y+ PE             S +      DV+S G +L  M   + P   + N 
Sbjct: 189 ---VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245

Query: 894 GLTLH 898
              LH
Sbjct: 246 ISKLH 250

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  104 bits (262), Expect = 2e-24
 Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 42/245 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHR 731
           + +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  
Sbjct: 9   RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 732 NLIKIITICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIE 784
           +  KII +    D      +  +V E      ++ WL       +   ++          
Sbjct: 68  S-DKIIRL---YDYEITDQYIYMVMECGN-IDLNSWLK------KKKSIDPWERKSYWKN 116

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           +   +  +H H    IVH DLKP+N L+   M+  + DFG+A  +      V  + Q   
Sbjct: 117 MLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ--- 169

Query: 845 IEMKGTIGYIGPE--YGMGGDLSMTG---------DVYSFGILLLEMFTRRRPTDNMFND 893
               GT+ Y+ PE    M                 DV+S G +L  M   + P   + N 
Sbjct: 170 ---VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226

Query: 894 GLTLH 898
              LH
Sbjct: 227 ISKLH 231

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (260), Expect = 2e-24
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 20/213 (9%)

Query: 681 RIGKGSFGFVYKGN---LGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLI 734
            +G G    V+         D   VAVKV+  D          F  E +    + H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLH 793
            +     + +        IV EY+   ++ D +H T   +   + + ++ +    + + H
Sbjct: 76  AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSH 133

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
            +    I+H D+KP+N+++       V DFG+AR ++          Q++++ + GT  Y
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAAV-I-GTAQY 185

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           + PE   G  +    DVYS G +L E+ T   P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (262), Expect = 2e-24
 Identities = 49/297 (16%), Positives = 99/297 (33%), Gaps = 51/297 (17%)

Query: 627 GPRKETITLLKVVIPVIGTKLAHKLSSALLMEQQFPIVSYAELS---------KATKEFS 677
            P+  ++  +     ++G     KL   LL     P+ SY             K   EF 
Sbjct: 2   SPQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQ 61

Query: 678 SSNR-------IGKGSFGFVYKG-----NLGEDGMSVAVKVMNLDKKGATKSFVAECEAL 725
             ++       +G+G+F  VY+      N  ++     +KV                E L
Sbjct: 62  LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL 121

Query: 726 RNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH---TNDKL--EVGKLN 780
           +       +K  +          +   +V E   YG++ + ++    T +K+  +   ++
Sbjct: 122 KPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH-----------VSDFGLARFL 829
             + +  +IE +H+     I+HGD+KP N +L +  +             + D G +  +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                   P+G   +     T G+   E       +   D +     +  M      
Sbjct: 234 KLF-----PKGTIFT-AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (261), Expect = 3e-24
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECEALRNIRHRN 732
            +F   + +G G+ G V+K +    G+ +A K+++L+ K A     + E + L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 733 LIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
           ++          F GA +      I  E+M  GS+D  L       E     + I V   
Sbjct: 93  IVG---------FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL    +  I+H D+KPSN+L++      + DFG++  L            S +    
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----------DSMANSFV 191

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (260), Expect = 4e-24
 Identities = 51/272 (18%), Positives = 108/272 (39%), Gaps = 25/272 (9%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYL 411
           + L+  +  + ++ N+I+  I     +   NL  L L  N +  TI   +   L +L++L
Sbjct: 48  SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHL 105

Query: 412 GLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP--SYLGKCQNLMQLSAPNNKLNGT 469
            L  N +  +       L+ L  L L  N  + ++   S       L  L   N      
Sbjct: 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTK 164

Query: 470 LPPQIF-GITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACT 527
           +  + F G+T L + L++  + L  S   +   +++++  L +        + + +   +
Sbjct: 165 IQRKDFAGLTFL-EELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222

Query: 528 TLEYLLMQGNSFNG----SIP----QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEY 579
           ++E L ++    +      +      SL    + + + ++  +L  Q+   L  +  L  
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281

Query: 580 LNLSYNHFEGKVPKKGVF---SNETRISLTGN 608
           L  S N  +  VP  G+F   ++  +I L  N
Sbjct: 282 LEFSRNQLKS-VP-DGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 52/274 (18%), Positives = 101/274 (36%), Gaps = 25/274 (9%)

Query: 255 PKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN---FNSLPNLSKLYLG 311
             +  L ++ N +T      L     L+ L L  N  +    I    F+SL +L  L L 
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN---TIEEDSFSSLGSLEHLDLS 108

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
            N L     ++L   +     S L  L L+ N +      S+ +  T + ++ +      
Sbjct: 109 YNYL-----SNLS-SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162

Query: 372 GTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLT 430
             I  +    L  L  L ++ + L    P ++  ++N+ +L L       ++   +   +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222

Query: 431 LLNVLQLGFNKLQG----SIPS----YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSK 482
            +  L+L    L       + +     L K      +   +  L   +   +  I+ L  
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL-L 280

Query: 483 LLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNF 515
            L+ S N L  S+P  +   L SL ++ +  N +
Sbjct: 281 ELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 97.1 bits (242), Expect = 1e-21
 Identities = 58/300 (19%), Positives = 103/300 (34%), Gaps = 53/300 (17%)

Query: 303 PNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTL 362
             +  L L  N +   +++DL        C  L  L L                      
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQ------RCVNLQALVL---------------------- 83

Query: 363 IAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRG 420
                N I+ TI  +   +L +L  L L YN L+  +       L +L +L L+GN  + 
Sbjct: 84  ---TSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT 138

Query: 421 IIPDPI-GNLTLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIF-GI 477
           +    +  +LT L +L++G       I          L +L    + L  +  P+    I
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSI 197

Query: 478 TTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFS----NEIPV----TLSACTT 528
             +S L  L        +         S+  L++   +      +E+      +L    T
Sbjct: 198 QNVSHL-ILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255

Query: 529 LEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNHF 587
              + +   S    + + LN +  + EL+ S N L   +P      L  L+ + L  N +
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 90.9 bits (226), Expect = 9e-20
 Identities = 53/290 (18%), Positives = 97/290 (33%), Gaps = 35/290 (12%)

Query: 160 IERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
           ++ L L  N++T  +  S       LQ   +  N ++    DS   L +L +L  S N  
Sbjct: 54  VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112

Query: 219 S----GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLP-Q 273
           S      F      +SSL    L  N +K      L  +L KL +L V   +    +  +
Sbjct: 113 SNLSSSWFK----PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

Query: 274 SLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCS 333
             +  + LE LE++ +        +  S+ N+S L L              F+ + ++  
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH---ILLLEIFVDVTSS-- 223

Query: 334 KLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQ 393
            +  L L                     L     +++S      +   F    + +    
Sbjct: 224 -VECLELRDTD-----------------LDTFHFSELSTGETNSLIKKFTFRNVKITDES 265

Query: 394 LTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
           L   +   + ++  L  L    N ++ +       LT L  + L  N   
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 12/192 (6%)

Query: 425 PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF-GITTLSKL 483
           P G    +  L L  N++     S L +C NL  L   +N +N T+    F  + +L + 
Sbjct: 47  PSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL-EH 104

Query: 484 LDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTL-SACTTLEYLLMQGNSFNG 541
           LDLS N+LS ++       L SL  L++  N +      +L S  T L+ L +       
Sbjct: 105 LDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163

Query: 542 SIP-QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVF--- 597
            I  +    L  ++EL++  ++L    P  L ++  + +L L        +  +      
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL-EIFVDVT 221

Query: 598 SNETRISLTGNE 609
           S+   + L   +
Sbjct: 222 SSVECLELRDTD 233

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 30/219 (13%), Positives = 66/219 (30%), Gaps = 14/219 (6%)

Query: 84  NLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSFSGKIPTNL-SRCFNLIDFWV 141
           +L  L  ++L+ N     +       L  L  + L  N +     T+L S    L    V
Sbjct: 98  SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156

Query: 142 HTNNLVGEIQA-IIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPD 200
              +   +IQ         +E L +  + L    P S+ ++  +    +   +    +  
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI 216

Query: 201 SLGQLRNLNYLGTSENDFSGMFPLSVCNIS--------SLDEAYLFKNRFKGSLPVCLGF 252
            +    ++  L   + D        +            +     +        +   L  
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK--LLN 274

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHF 291
            +  L  L  ++N L           + L+ + L+ N +
Sbjct: 275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  104 bits (261), Expect = 5e-24
 Identities = 55/245 (22%), Positives = 92/245 (37%), Gaps = 42/245 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHR 731
           + +S   +IG G    V++  L E     A+K +NL++       S+  E   L  ++  
Sbjct: 56  RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 732 NLIKIITICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIE 784
           +  KII +    D      +  +V E      ++ WL       +   ++          
Sbjct: 115 S-DKIIRL---YDYEITDQYIYMVMECGN-IDLNSWLK------KKKSIDPWERKSYWKN 163

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
           +   +  +H H    IVH DLKP+N L+   M+  + DFG+A  +      V  + Q   
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ--- 216

Query: 845 IEMKGTIGYIGPE--YGMGGDLSMTG---------DVYSFGILLLEMFTRRRPTDNMFND 893
               G + Y+ PE    M                 DV+S G +L  M   + P   + N 
Sbjct: 217 ---VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273

Query: 894 GLTLH 898
              LH
Sbjct: 274 ISKLH 278

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  101 bits (254), Expect = 2e-23
 Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 54/235 (22%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNI-R 729
             +G+G+FG V + +           +VAVK++   K+GAT S     ++E + L +I  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGH 89

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKL 774
           H N++ ++  C+           ++ E+ ++G++  +L                   D L
Sbjct: 90  HLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 775 EVGKL-NIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH 832
            +  L     +VA  +E+L    C    +H DL   N+LL    V  + DFGLAR +   
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDI--- 198

Query: 833 PFLVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                         ++     +      PE       ++  DV+SFG+LL E+F+
Sbjct: 199 --------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (253), Expect = 2e-23
 Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 28/214 (13%)

Query: 681 RIGKGSFGFVYKGNLGED---GMSVAVKVMNLDKKGATKSFVA----ECEALRNIRHRNL 733
            +G+G  G VY     ED      VA+K+M+     +   F      E      ++  + 
Sbjct: 41  LVGRGGMGDVY---EAEDTVRERIVALKLMSETL-SSDPVFRTRMQREARTAGRLQEPH- 95

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYL 792
             ++ I    +  G  +  +    +    +   L      L   + + IV ++ S ++  
Sbjct: 96  --VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAA 150

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H        H D+KP N+L+  D  A++ DFG+A            E  +      GT+ 
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIAS-------ATTDEKLTQLGNTVGTLY 200

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           Y+ PE       +   D+Y+   +L E  T   P
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  100 bits (252), Expect = 2e-23
 Identities = 56/258 (21%), Positives = 101/258 (39%), Gaps = 24/258 (9%)

Query: 326 ITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLN 385
           I      +  +K+    +        + A+L   +T ++  G  ++ TI   ++ L NL 
Sbjct: 12  IFPDPALANAIKIAAGKSNVTD--TVTQADL-DGITTLSAFGTGVT-TIEG-VQYLNNLI 66

Query: 386 GLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGS 445
           GL L+ NQ+T  + P +  L  +  L L GN ++ +    I  L  +  L L   ++   
Sbjct: 67  GLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV 122

Query: 446 IPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLK 503
            P  L    NL  L    N++       I  +  L+ L  L +    +S   PL   NL 
Sbjct: 123 TP--LAGLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQVSDLTPLA--NLS 173

Query: 504 SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNL 563
            L  L    N  S+  P  L++   L  + ++ N  +   P  L    ++  + L+   +
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229

Query: 564 SGQIPIHLGNLPFLEYLN 581
           + Q   +  NL     + 
Sbjct: 230 TNQPVFYNNNLVVPNVVK 247

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 99.4 bits (248), Expect = 7e-23
 Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 23/220 (10%)

Query: 368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG 427
           + ++ T+     +L  +  L      +T TI   +  L NL  L L  N I  +   P+ 
Sbjct: 29  SNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDL--APLK 82

Query: 428 NLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LD 485
           NLT +  L+L  N L     S +   Q++  L   + ++       +  +  LS L  L 
Sbjct: 83  NLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT-----DVTPLAGLSNLQVLY 135

Query: 486 LSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ 545
           L  N ++   PL    L +L  L I     S+  P  L+  + L  L    N  +  I  
Sbjct: 136 LDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS- 189

Query: 546 SLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN 585
            L +L ++ E+ L  N +S   P  L N   L  + L+  
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQ 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 62/362 (17%), Positives = 118/362 (32%), Gaps = 86/362 (23%)

Query: 159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
              +++   + +T     +  +L  + T    G  +     + +  L NL  L   +N  
Sbjct: 20  NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQI 75

Query: 219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
           + + PL                            NL K+T L ++ N L      +++  
Sbjct: 76  TDLAPLK---------------------------NLTKITELELSGNPLKNV--SAIAGL 106

Query: 279 SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKL 338
             ++ L+L     +         L NL  LYL  N +     T++     L   + L  L
Sbjct: 107 QSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQI-----TNISP---LAGLTNLQYL 156

Query: 339 GLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTI 398
            +                            Q+S  + P + NL  L  L  + N+++  I
Sbjct: 157 SI-------------------------GNAQVS-DLTP-LANLSKLTTLKADDNKIS-DI 188

Query: 399 PPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQ 458
            P +  L NL  + L  N I  +   P+ N + L ++ L    +      Y     NL+ 
Sbjct: 189 SP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYN---NNLVV 242

Query: 459 LSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNL----KSLVQLDISRNN 514
            +         + P      T+S     +  +L+ ++   + N+       V    +   
Sbjct: 243 PNVVKGPSGAPIAP-----ATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVP 297

Query: 515 FS 516
           FS
Sbjct: 298 FS 299

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 66/315 (20%), Positives = 113/315 (35%), Gaps = 58/315 (18%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYLG 311
            L     +   ++N+T  +    ++   +  L       +    I     L NL  L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT---TIEGVQYLNNLIGLELK 71

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
            N +     TDL  +  LT  ++L                    LS         GN + 
Sbjct: 72  DNQI-----TDLAPLKNLTKITEL-------------------ELS---------GNPLK 98

Query: 372 GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTL 431
             +   I  L ++  L L   Q+T   P  +  L NLQ L L  N I  I   P+  LT 
Sbjct: 99  -NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTN 152

Query: 432 LNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSEN 489
           L  L +G  ++   +   L     L  L A +NK++      I  + +L  L  + L  N
Sbjct: 153 LQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-----DISPLASLPNLIEVHLKNN 205

Query: 490 HLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA 549
            +S   PL   N  +L  + ++    +N+     +        +++G S     P +++ 
Sbjct: 206 QISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISD 261

Query: 550 LKSIKELDLSCNNLS 564
             +    +L+ N  S
Sbjct: 262 NGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 46/244 (18%), Positives = 78/244 (31%), Gaps = 46/244 (18%)

Query: 368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG 427
             I+   P     L N   +    + +T T+     +L  +  L   G  +  I  + + 
Sbjct: 7   TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQ 60

Query: 428 NLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LD 485
            L  L  L+L  N++   +   L     + +L    N L       +  I  L  +  LD
Sbjct: 61  YLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-----NVSAIAGLQSIKTLD 113

Query: 486 LSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ 545
           L+   ++   PL    L +L  L +  N  +N  P                         
Sbjct: 114 LTSTQITDVTPLA--GLSNLQVLYLDLNQITNISP------------------------- 146

Query: 546 SLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISL 605
            L  L +++ L +    +S   P  L NL  L  L    N     +       N   + L
Sbjct: 147 -LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DISPLASLPNLIEVHL 202

Query: 606 TGNE 609
             N+
Sbjct: 203 KNNQ 206

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 57/294 (19%), Positives = 105/294 (35%), Gaps = 33/294 (11%)

Query: 112 LETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLT 171
              I    ++ +       +    +          V  I+ +      +  L L  NQ+T
Sbjct: 21  AIKIAAGKSNVTD--TVTQADLDGITTLSAF-GTGVTTIEGV-QYLNNLIGLELKDNQIT 76

Query: 172 GQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISS 231
             L P + NL+ +   +++GN L  +   ++  L+++  L  +    + + PL+   +S+
Sbjct: 77  -DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPLA--GLSN 130

Query: 232 LDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHF 291
           L   YL  N+     P+     L  L  L +    ++      L+N SKL  L+ ++N  
Sbjct: 131 LQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185

Query: 292 SGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPH 351
           S        SLPNL +++L  N +     +D+     L N S L  + L           
Sbjct: 186 SDIS--PLASLPNLIEVHLKNNQI-----SDVSP---LANTSNLFIVTLTNQT------- 228

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGEL 405
            I N         +  N + G     I      +        LT  +   I  +
Sbjct: 229 -ITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNV 281

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 57/248 (22%), Positives = 95/248 (38%), Gaps = 19/248 (7%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG 124
             L+L+   I   L+P + NL+ +  + L+ N    +    +  L  ++T+ L++   + 
Sbjct: 66  IGLELKDNQITD-LAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121

Query: 125 KIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSAL 184
              T L+   NL   ++  N +   I  +      ++ LS+   Q++  L P + NLS L
Sbjct: 122 --VTPLAGLSNLQVLYLDLNQIT-NISPL-AGLTNLQYLSIGNAQVS-DLTP-LANLSKL 175

Query: 185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKG 244
            T     NK+   I   L  L NL  +    N  S + PL+  N S+L    L       
Sbjct: 176 TTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTIT- 230

Query: 245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLEL--NENHFSGQVRINFNSL 302
           + PV    NL      VV   +     P ++S+        L  N   F   V   FN  
Sbjct: 231 NQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQS 288

Query: 303 PNLSKLYL 310
                  +
Sbjct: 289 VTFKNTTV 296

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  100 bits (251), Expect = 2e-23
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 59/245 (24%)

Query: 674 KEFSSSN-----RIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FV 719
           KE S S       +G+  FG VYKG+L     GE   +VA+K +   K  A       F 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFR 60

Query: 720 AECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL------------ 767
            E      ++H N++ ++ + +    K     ++++ Y  +G + ++L            
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGST 115

Query: 768 ---HHTNDKLEVGKL-NIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSD 822
                    LE     ++V ++A+ +EYL  +H     VH DL   NVL+   +   +SD
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISD 171

Query: 823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILL 877
            GL R +            ++          +      PE  M G  S+  D++S+G++L
Sbjct: 172 LGLFREV-----------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220

Query: 878 LEMFT 882
            E+F+
Sbjct: 221 WEVFS 225

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  100 bits (251), Expect = 2e-23
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
            K+++   +IG+G+ G VY       G  VA++ MNL ++   +  + E   +R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 733 LIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVAS 787
           ++          +  +        +V EY+  GS+ D +  T   ++ G++  V  E   
Sbjct: 79  IVN---------YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQ 127

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            +E+LH++    ++H D+K  N+LL  D    ++DFG    ++          QS    M
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--------QSKRSTM 176

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  ++ PE           D++S GI+ +EM
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (253), Expect = 3e-23
 Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 60/239 (25%)

Query: 680 NRIGKGSFGFVYKGNLGEDG--MSVAVKVMNLDKKGATKS----FVAECEALRNI-RHRN 732
           + IG+G+FG V K  + +DG  M  A+K M   K+ A+K     F  E E L  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVG 777
           +I ++  C     +G  +  +  EY  +G++ D+L               + T   L   
Sbjct: 88  IINLLGACEH---RGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 778 KL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLV 836
           +L +   +VA  ++YL        +H DL   N+L+  + VA ++DFGL+R         
Sbjct: 143 QLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--------- 190

Query: 837 APEGQSSSIEMKGTIGYI-----GPE---YGMGGDLSMTGDVYSFGILLLEMFTR-RRP 886
                   + +K T+G +       E   Y +    +   DV+S+G+LL E+ +    P
Sbjct: 191 -----GQEVYVKKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTP 241

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  100 bits (252), Expect = 3e-23
 Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 53/233 (22%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNI-R 729
             +G G+FG V +         +  + VAVK++   K  A        ++E + + ++ +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQ 108

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK----------- 778
           H N++ ++  C+     G     ++ EY  YG + ++L   +  LE              
Sbjct: 109 HENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 779 ---LNIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
              L+   +VA  + +L   +C    +H D+   NVLL +  VA + DFGLAR +     
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI----- 214

Query: 835 LVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                  + S  +      +      PE       ++  DV+S+GILL E+F+
Sbjct: 215 ------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (251), Expect = 4e-23
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
                S  +IG+GS G V        G  VAVK+M+L K+   +    E   +R+ +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 733 LIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVAS 787
           +++            +        ++ E++Q G++ D +     +L   ++  V   V  
Sbjct: 104 VVE---------MYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQ 152

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            + YLH      ++H D+K  ++LL  D    +SDFG    +S        +       +
Sbjct: 153 ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--------KDVPKRKSL 201

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  ++ PE       +   D++S GI+++EM
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (251), Expect = 5e-23
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 44/228 (19%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
             +G+G+FG V+          +D M VAVK +    + A + F  E E L  ++H++++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWL--------------HHTNDKLEVGKL- 779
           +   +C+    +G     +V+EYM++G ++ +L                    L +G+L 
Sbjct: 107 RFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 780 NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE 839
            +  +VA+ + YL        VH DL   N L+   +V  + DFG++R +          
Sbjct: 162 AVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI---------- 208

Query: 840 GQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
             S+     G    +      PE  +    +   DV+SFG++L E+FT
Sbjct: 209 -YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 27/213 (12%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
            + F    ++G+GS+G VYK    E G  VA+K + ++     +  + E   ++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 733 LIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVAS 787
           ++K         + G+ FK     IV EY   GSV D +   N  L   ++  ++     
Sbjct: 86  VVK---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            +EYLH       +H D+K  N+LL+ +  A ++DFG+A  L+        +  +    +
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--------DTMAKRNTV 185

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
            GT  ++ PE       +   D++S GI  +EM
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  103 bits (258), Expect = 6e-23
 Identities = 63/344 (18%), Positives = 116/344 (33%), Gaps = 58/344 (16%)

Query: 257 LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG 316
           +   +     +    P      ++     L +   +    +  N L ++ ++    +++ 
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI- 55

Query: 317 TRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPP 376
                 +  I  L N   + KL L                          GN+++  I P
Sbjct: 56  ----KSVQGIQYLPN---VTKLFL-------------------------NGNKLT-DIKP 82

Query: 377 EIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQ 436
            + NL NL  L L+ N++   +   + +L+ L+ L L  N I  I  + + +L  L  L 
Sbjct: 83  -LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 137

Query: 437 LGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGS 494
           LG NK+  +  + L +   L  LS  +N+++      I  +  L+KL  L LS+NH+S  
Sbjct: 138 LGNNKI--TDITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKNHISDL 190

Query: 495 IPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNG----SIPQSLNAL 550
             L    LK+L  L++      N+     S       +     S       S        
Sbjct: 191 RALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 248

Query: 551 KSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK 594
                L    N +S      +         +        +V   
Sbjct: 249 NVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTV 292

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.6 bits (224), Expect = 7e-19
 Identities = 60/298 (20%), Positives = 98/298 (32%), Gaps = 76/298 (25%)

Query: 149 EIQAIIG--NWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLR 206
            I+ I     + +  + +L    +T     +   L+++       + +   +   +  L 
Sbjct: 10  PIKQIFPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLP 65

Query: 207 NLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNN 266
           N+  L  + N  + + PL+                           NL  L  L + +N 
Sbjct: 66  NVTKLFLNGNKLTDIKPLT---------------------------NLKNLGWLFLDENK 98

Query: 267 LTGFLPQSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYLGRNNLGTRTSTDLDF 325
           +      SL +  KL+ L L  N  S    I     LP L  LYLG N +     TD+  
Sbjct: 99  IKDL--SSLKDLKKLKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKI-----TDITV 148

Query: 326 ITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLN 385
              L+  +KL  L L                           NQIS  I P +  L  L 
Sbjct: 149 ---LSRLTKLDTLSL-------------------------EDNQIS-DIVP-LAGLTKLQ 178

Query: 386 GLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
            L L  N ++  +   +  L+NL  L L          +   NL + N ++     L 
Sbjct: 179 NLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 73.2 bits (179), Expect = 2e-13
 Identities = 60/399 (15%), Positives = 132/399 (33%), Gaps = 31/399 (7%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPK--EVGRLFRLETIVLSNNS 121
             K +L+ +++          L+ +  I   N+     I     +  L  +  + L+ N 
Sbjct: 23  TIKDNLKKKSVTDA--VTQNELNSIDQIIANNS----DIKSVQGIQYLPNVTKLFLNGNK 76

Query: 122 FSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNL 181
            +  I   L+   NL   ++   N + ++ ++  +  K++ LSL  N ++  +   + +L
Sbjct: 77  LT-DI-KPLTNLKNLGWLFLD-ENKIKDLSSL-KDLKKLKSLSLEHNGIS-DING-LVHL 130

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
             L++  +  NK+       L +L  L+ L   +N  S + PL+   ++ L   YL KN 
Sbjct: 131 PQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNH 186

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
                 +     L  L VL +             SN      ++  +        I+ + 
Sbjct: 187 ISDLRALA---GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD- 242

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
             +  K  +  +           F   +T      +      +    +     ++  T+ 
Sbjct: 243 -GDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVI 301

Query: 362 LIAMAGNQISGTIPPEIRNLFNLN------GLGLEYNQLTGTIPPAIGELRNLQYLGLVG 415
              +          P  +  +           G E+N  T  +      L  +       
Sbjct: 302 KTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAVFKAETTE 361

Query: 416 N--NIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGK 452
              N+   +    GN  +  + +   +  QG++ S+  K
Sbjct: 362 KTVNLTRYVKYIRGNAGIYKLPREDNSLKQGTLASHRCK 400

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 99.2 bits (248), Expect = 9e-23
 Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 62/242 (25%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRH 730
             +G+G FG V K             +VAVK++   K+ A+ S     ++E   L+ + H
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNH 85

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL----------------------- 767
            ++IK+   CS    +      ++ EY +YGS+  +L                       
Sbjct: 86  PHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 768 HHTNDKLEVGKL-NIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 825
           H     L +G L +   +++  ++YL         VH DL   N+L+       +SDFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGL 196

Query: 826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEM 880
           +R +                 +K + G I       E       +   DV+SFG+LL E+
Sbjct: 197 SRDV-----------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

Query: 881 FT 882
            T
Sbjct: 246 VT 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 57/237 (24%)

Query: 680 NRIGKGSFGFVYKGNL-------GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNI 728
             +G+G+FG V             ++ ++VAVK++   K  AT+      V+E E ++ I
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMI 97

Query: 729 -RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTND 772
            +H+N+I ++  C+     G  +  ++ EY   G++ ++L                   +
Sbjct: 98  GKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 773 KLEVGKL-NIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
           ++    L +   ++A  +EYL    C    +H DL   NVL+  + V  ++DFGLAR + 
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI- 207

Query: 831 HHPFLVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                      +     K T G +      PE       +   DV+SFG+L+ E+FT
Sbjct: 208 ----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 57/237 (24%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNI-R 729
             +G G+FG V +         +  M+VAVK++   K  A  +     ++E + L  +  
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGN 85

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK----------- 778
           H N++ ++  C+     G     ++ EY  YG + ++L    D     K           
Sbjct: 86  HMNIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 779 -------LNIVIEVASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
                  L+   +VA  + +L   +C    +H DL   N+LL H  +  + DFGLAR + 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI- 195

Query: 831 HHPFLVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                     ++ S  +      +      PE       +   DV+S+GI L E+F+
Sbjct: 196 ----------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  100 bits (251), Expect = 2e-22
 Identities = 68/245 (27%), Positives = 105/245 (42%), Gaps = 27/245 (11%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
           I    R L       L  NQ+   I   +   LR+L+ L L  N+IR I       L  L
Sbjct: 62  ISTNTRLLN------LHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 433 NVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSE- 488
           N L+L  N+L  +IP+        L +L   NN +  ++P   F    +  L  LDL E 
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF--NRIPSLRRLDLGEL 170

Query: 489 NHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSL 547
             LS  I       L +L  L+++  N   EIP  L+    L+ L + GN  +   P S 
Sbjct: 171 KRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSF 227

Query: 548 NALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNHFEGKVPKKGVFS---NETRI 603
             L  +++L +  + +   I  +   NL  L  +NL++N+    +P   +F+   +  RI
Sbjct: 228 QGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLP-HDLFTPLHHLERI 284

Query: 604 SLTGN 608
            L  N
Sbjct: 285 HLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 92.9 bits (231), Expect = 5e-20
 Identities = 63/263 (23%), Positives = 89/263 (33%), Gaps = 39/263 (14%)

Query: 160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
              L+L+ NQ+      S  +L  L+   ++ N +      +   L NLN L        
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL-------- 117

Query: 220 GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNAS 279
                            LF NR   ++P      L KL  L +  N +      + +   
Sbjct: 118 ----------------ELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIP 160

Query: 280 KLEWLELNENHFSGQVRIN-FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKL 338
            L  L+L E      +    F  L NL  L L   N        L  I  LT   KL +L
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN--------LREIPNLTPLIKLDEL 212

Query: 339 GLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPE-IRNLFNLNGLGLEYNQLTGT 397
            L  N      P S   L     L  M  +QI   I      NL +L  + L +N LT  
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLW-MIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-L 269

Query: 398 IPP-AIGELRNLQYLGLVGNNIR 419
           +P      L +L+ + L  N   
Sbjct: 270 LPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 92.5 bits (230), Expect = 8e-20
 Identities = 50/231 (21%), Positives = 89/231 (38%), Gaps = 13/231 (5%)

Query: 236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQV 295
            L +N+ +  + V    +L  L +L +++N++      + +  + L  LEL +N  +   
Sbjct: 70  NLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIP 128

Query: 296 RINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLV-FNRFGGALPHSIA 354
              F  L  L +L+L  N + +  S              L +L L    R       +  
Sbjct: 129 NGAFVYLSKLKELWLRNNPIESIPSY------AFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 355 NLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGL 413
            LS    L  +A   +     P +  L  L+ L L  N L+  I P +   L +LQ L +
Sbjct: 183 GLSNLRYLN-LAMCNL--REIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWM 238

Query: 414 VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
           + + I+ I  +   NL  L  + L  N L            +L ++   +N
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 5/159 (3%)

Query: 84  NLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSFSGKIPTN-LSRCFNLIDFWV 141
            LS L+ + L NN     IP     R+  L  + L        I         NL    +
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192

Query: 142 HTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS 201
              NL  EI  +    +K++ L L GN L+   P S   L  LQ   +  +++     ++
Sbjct: 193 AMCNLR-EIPNLTPL-IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250

Query: 202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN 240
              L++L  +  + N+ + +       +  L+  +L  N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 57/237 (24%)

Query: 680 NRIGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDKKGATKS----FVAECEALRNI 728
             +G+G+FG V          +       VAVK++   K  AT+      ++E E ++ I
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMI 131

Query: 729 -RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTND 772
            +H+N+I ++  C+    +      IV EY   G++ ++L               H+  +
Sbjct: 132 GKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 773 KLEVGKL-NIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
           +L    L +   +VA  +EYL    C    +H DL   NVL+  D V  ++DFGLAR + 
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDI- 241

Query: 831 HHPFLVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                            K T G +      PE       +   DV+SFG+LL E+FT
Sbjct: 242 ----------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 62/276 (22%)

Query: 646 KLAHKLSSALLMEQQFPIVSYAELSKATKEFSSSN-----RIGKGSFGFVYKGNL----- 695
           ++  +LSS         +  Y        EF          +G+G FG V          
Sbjct: 48  RITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK 107

Query: 696 --GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNI-RHRNLIKIITICSSIDFKGA 748
              ++ ++VAVK++   K  AT+      V+E E ++ I +H+N+I ++  C+    +  
Sbjct: 108 DKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDG 160

Query: 749 DFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVGKL-NIVIEVASVIEYL 792
               ++ EY   G++ ++L                   +++    L +   ++A  +EYL
Sbjct: 161 PL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219

Query: 793 -HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
               C    +H DL   NVL+  + V  ++DFGLAR +            +     K T 
Sbjct: 220 ASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI-----------NNIDYYKKTTN 264

Query: 852 GYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           G +      PE       +   DV+SFG+L+ E+FT
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  100 bits (250), Expect = 2e-22
 Identities = 55/245 (22%), Positives = 93/245 (37%), Gaps = 53/245 (21%)

Query: 674 KEFSSSNRIGKGSFG-FVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALR-NIRHR 731
               S   +G GS G  V++G+    G  VAVK M +D        + E + L  +  H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHP 69

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-------NIVIE 784
           N+I+              F  I  E     ++ D +   N   E  KL       +++ +
Sbjct: 70  NVIRYYCS-----ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDH-------------DMVAHVSDFGLARFLSH 831
           +AS + +LH+     I+H DLKP N+L+               ++   +SDFGL + L  
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD- 179

Query: 832 HPFLVAPEGQSSSIEMK---GTIGYIGPEYGMGGDLSMTG-------DVYSFGILLLEMF 881
                     S    +    GT G+  PE     +   T        D++S G +   + 
Sbjct: 180 ------SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 882 TRRRP 886
           ++ + 
Sbjct: 234 SKGKH 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 57/217 (26%), Positives = 83/217 (38%), Gaps = 16/217 (7%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLN 433
           IP   + +F      L  N+++     +    RNL  L L  N +  I       L LL 
Sbjct: 30  IPAASQRIF------LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 434 VLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENH 490
            L L  N    S+          L  L      L   L P +F    L+ L  L L +N 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF--RGLAALQYLYLQDNA 140

Query: 491 LSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA 549
           L  ++P +   +L +L  L +  N  S+          +L+ LL+  N      P +   
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199

Query: 550 LKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYN 585
           L  +  L L  NNLS  +P   L  L  L+YL L+ N
Sbjct: 200 LGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 47/241 (19%), Positives = 76/241 (31%), Gaps = 38/241 (15%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG 311
            +P     + +  N ++     S      L  L L+ N  +      F  L  L +L L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSI-ANLSTTMTLIAMAGNQI 370
            N                    +L  L L        L   +   L+    L  +  N +
Sbjct: 89  DNAQLRSVDPAT-----FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY-LQDNAL 141

Query: 371 SGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGN 428
              +P +  R+L NL  L L  N+++ ++P  A   L +L  L L  N +  + P    +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199

Query: 429 LTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSE 488
           L  L  L L  N L                           LP +        + L L++
Sbjct: 200 LGRLMTLYLFANNLS-------------------------ALPTEALAPLRALQYLRLND 234

Query: 489 N 489
           N
Sbjct: 235 N 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 57/281 (20%), Positives = 95/281 (33%), Gaps = 68/281 (24%)

Query: 265 NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLD 324
             L   +P  +   +  + + L+ N  S     +F +  NL+ L+L  N L         
Sbjct: 21  QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL--ARIDAAA 75

Query: 325 FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFN 383
           F  L    + L +L L  N                         Q+  ++ P     L  
Sbjct: 76  FTGL----ALLEQLDLSDN------------------------AQLR-SVDPATFHGLGR 106

Query: 384 LNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL 442
           L+ L L+   L   + P     L  LQYL L  N ++ +  D   +L  L  L L  N++
Sbjct: 107 LHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165

Query: 443 QGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEV- 499
                                     ++P + F    L  L  L L +N ++  +     
Sbjct: 166 S-------------------------SVPERAF--RGLHSLDRLLLHQNRVA-HVHPHAF 197

Query: 500 GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN 540
            +L  L+ L +  NN S      L+    L+YL +  N + 
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 55/255 (21%), Positives = 89/255 (34%), Gaps = 44/255 (17%)

Query: 167 GNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSV 226
              L   +P  I   +A Q   + GN++      S    RNL  L    N  + +   + 
Sbjct: 20  QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76

Query: 227 CNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLEL 286
             ++ L++  L  N    S+       L +L  L + +  L    P      + L++L L
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136

Query: 287 NENHFSGQVRIN---FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFN 343
            +N       +    F  L NL+ L+L  N + +                 L +L L   
Sbjct: 137 QDNALQ---ALPDDTFRDLGNLTHLFLHGNRI-SSVPER-----AFRGLHSLDRLLL--- 184

Query: 344 RFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP-A 401
                                   N+++  + P   R+L  L  L L  N L+  +P  A
Sbjct: 185 ----------------------HQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEA 220

Query: 402 IGELRNLQYLGLVGN 416
           +  LR LQYL L  N
Sbjct: 221 LAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 45/213 (21%), Positives = 66/213 (30%), Gaps = 35/213 (16%)

Query: 390 EYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY 449
               L   +P  I      Q + L GN I  +          L +L L  N L       
Sbjct: 19  PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA------ 69

Query: 450 LGKCQNLMQLSAPNNKLNGTLPPQIF-GITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQ 507
                               +    F G+  L + LDLS+N    S+       L  L  
Sbjct: 70  -------------------RIDAAAFTGLALL-EQLDLSDNAQLRSVDPATFHGLGRLHT 109

Query: 508 LDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP-QSLNALKSIKELDLSCNNLSGQ 566
           L + R       P        L+YL +Q N+   ++P  +   L ++  L L  N +S  
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSV 168

Query: 567 IPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
                  L  L+ L L  N     V     F +
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVA-HVH-PHAFRD 199

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 47/232 (20%), Positives = 74/232 (31%), Gaps = 32/232 (13%)

Query: 88  LRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTN-LSRCFNLIDFWVHTNNL 146
            + I L  N               L  + L +N  + +I     +    L    +  N  
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92

Query: 147 VGEIQA-IIGNWLKIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPD-SLG 203
           +  +         ++  L L    L  +L P +   L+ALQ   +  N L   +PD +  
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150

Query: 204 QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVA 263
            L NL +L    N            ISS+     F+              L  L  L++ 
Sbjct: 151 DLGNLTHLFLHGN-----------RISSV-PERAFR-------------GLHSLDRLLLH 185

Query: 264 QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL 315
           QN +    P +  +  +L  L L  N+ S         L  L  L L  N  
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 36/171 (21%), Positives = 59/171 (34%), Gaps = 15/171 (8%)

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLK 503
           ++P  +       ++    N+++  +P   F       +L L  N L+  I       L 
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80

Query: 504 SLVQLDISRNNFSNEIPV-TLSACTTLEYLLMQGNSFNGSIPQ-SLNALKSIKELDLSCN 561
            L QLD+S N     +   T      L  L +        +       L +++ L L  N
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139

Query: 562 NLSGQIPIH-LGNLPFLEYLNLSYNHFEGKVPKKGVFSNET---RISLTGN 608
            L   +P     +L  L +L L  N     VP +  F       R+ L  N
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVP-ERAFRGLHSLDRLLLHQN 187

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 21/120 (17%), Positives = 43/120 (35%), Gaps = 6/120 (5%)

Query: 481 SKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN 540
                  +  L  ++P+ +    +  ++ +  N  S+    +  AC  L  L +  N   
Sbjct: 13  KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69

Query: 541 GSIPQSLNALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNHFEGKVPKKGVFSN 599
                +   L  +++LDLS N     +       L  L  L+L     + ++   G+F  
Sbjct: 70  RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG-PGLFRG 127

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 97.2 bits (243), Expect = 3e-22
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKGSF  VY+      G+ VA+K+++   + K G  +    E +    ++H +++++  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQ 797
                 F+ +++  +V E    G ++ +L +      E    + + ++ + + YLH+H  
Sbjct: 79  Y-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG- 132

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE-MKGTIGYIGP 856
             I+H DL  SN+LL  +M   ++DFGLA            +        + GT  YI P
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLA---------TQLKMPHEKHYTLCGTPNYISP 181

Query: 857 EYGMGGDLSMTGDVYSFGILLLEM 880
           E        +  DV+S G +   +
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTL 205

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 47/230 (20%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
             +G+G+FG V+          +D M VAVK +      A K F  E E L N++H +++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWL---------------HHTNDKLEVGKL 779
           K   +C      G     +V+EYM++G ++ +L                    +L + ++
Sbjct: 81  KFYGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 780 -NIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
            +I  ++AS + YL   H     VH DL   N L+  +++  + DFG++R +        
Sbjct: 136 LHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDV-------- 183

Query: 838 PEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
               S+     G    +      PE  M    +   DV+SFG++L E+FT
Sbjct: 184 ---YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 99.8 bits (249), Expect = 3e-22
 Identities = 69/245 (28%), Positives = 99/245 (40%), Gaps = 27/245 (11%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
           IP   R L       L  N +   I       L +L+ L L  N+IR I       L  L
Sbjct: 73  IPSNTRYLN------LMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 433 NVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSE- 488
           N L+L  N L   IPS        L +L   NN +  ++P   F    +  L  LDL E 
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF--NRVPSLMRLDLGEL 181

Query: 489 NHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSL 547
             L   I       L +L  L++   N  + +P  L+    LE L M GN F    P S 
Sbjct: 182 KKLE-YISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSF 238

Query: 548 NALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNHFEGKVPKKGVFS---NETRI 603
           + L S+K+L +  + +S  I  +    L  L  LNL++N+    +P   +F+       +
Sbjct: 239 HGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLP-HDLFTPLRYLVEL 295

Query: 604 SLTGN 608
            L  N
Sbjct: 296 HLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 61/335 (18%), Positives = 92/335 (27%), Gaps = 93/335 (27%)

Query: 159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
           +  ++      L+ ++P  I   S  +  ++  N +     D+   L +L  L    N  
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN-- 109

Query: 219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
                    +I  + E   F               L  L  L +  N LT     +    
Sbjct: 110 ---------SIRQI-EVGAFNG-------------LASLNTLELFDNWLTVIPSGAFEYL 146

Query: 279 SKLEWLELNENHFSGQVRIN---FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKL 335
           SKL  L L  N       I    FN +P+L +L LG        S              L
Sbjct: 147 SKLRELWLRNNPIE---SIPSYAFNRVPSLMRLDLGELKKLEYISEGA-----FEGLFNL 198

Query: 336 VKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT 395
             L L                             I     P +  L  L  L +  N   
Sbjct: 199 KYLNL-------------------------GMCNI--KDMPNLTPLVGLEELEMSGNHFP 231

Query: 396 GTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQ 454
             I P +   L +L+ L ++ + +  I  +    L  L  L L  N L            
Sbjct: 232 -EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS----------- 279

Query: 455 NLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSEN 489
                         +LP  +F        L L  N
Sbjct: 280 --------------SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 49.7 bits (119), Expect = 4e-06
 Identities = 28/155 (18%), Positives = 56/155 (36%), Gaps = 7/155 (4%)

Query: 65  TKLDLESQNIGGFLSPYI-GNLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSF 122
            +L L +  I   +  Y    +  L  ++L        I +     LF L+ + L   + 
Sbjct: 150 RELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208

Query: 123 SGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP-SIGNL 181
              +P  L+    L +  +  N+              +++L +  +Q++  +   +   L
Sbjct: 209 K-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGL 265

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEN 216
           ++L   ++A N L     D    LR L  L    N
Sbjct: 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.2 bits (245), Expect = 4e-22
 Identities = 62/284 (21%), Positives = 110/284 (38%), Gaps = 73/284 (25%)

Query: 649 HKLSSALLMEQQFPIVSYAELSKATK------EFSSSN-----RIGKGSFGFVYKGNL-- 695
             L S LL+++  P   Y  +           E+  +N      IG+G+FG V++     
Sbjct: 11  TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 696 ---GEDGMSVAVKVMNLDKKGATKS----FVAECEALRNIRHRNLIKIITICSSIDFKGA 748
               E    VAVK++   K+ A+      F  E   +    + N++K++ +C+     G 
Sbjct: 71  LLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----VGK 123

Query: 749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGK------------------------LNIVIE 784
               +++EYM YG ++++L   +                               L I  +
Sbjct: 124 PM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182

Query: 785 VASVIEYLH-NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSS 843
           VA+ + YL         VH DL   N L+  +MV  ++DFGL+R +            S+
Sbjct: 183 VAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRNI-----------YSA 227

Query: 844 SIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                     I      PE       +   DV+++G++L E+F+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 39/218 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
                 F+  DF  +V E  +  S+ +             L        + ++    +YL
Sbjct: 83  F-----FEDNDFVFVVLELCRRRSLLELH------KRRKALTEPEARYYLRQIVLGCQYL 131

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---- 848
           H +    ++H DLK  N+ L+ D+   + DFGLA  +  +             E K    
Sbjct: 132 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDG-----------ERKKVLC 176

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT  YI PE       S   DV+S G ++  +   + P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 60/248 (24%), Positives = 99/248 (39%), Gaps = 52/248 (20%)

Query: 657 MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK 716
           M +    + +   S    ++     IG G+   V           VA+K +NL+K   + 
Sbjct: 1   MSEDSSALPW---SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57

Query: 717 S-FVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT--NDK 773
              + E +A+    H N++      S   F   D   +V + +  GSV D + H     +
Sbjct: 58  DELLKEIQAMSQCHHPNIVSY--YTS---FVVKDELWLVMKLLSGGSVLDIIKHIVAKGE 112

Query: 774 LEVGKLN------IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
            + G L+      I+ EV   +EYLH + Q   +H D+K  N+LL  D    ++DFG++ 
Sbjct: 113 HKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSA 169

Query: 828 FLSHH---------------PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYS 872
           FL+                 P  +APE       M+   GY               D++S
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPE------VMEQVRGY-----------DFKADIWS 212

Query: 873 FGILLLEM 880
           FGI  +E+
Sbjct: 213 FGITAIEL 220

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 44/241 (18%), Positives = 89/241 (36%), Gaps = 35/241 (14%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT--KSFVAECEALRN 727
           S+ T EF    +IG G FG V+K     DG   A+K       G+   ++ + E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 728 I-RHRNLIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKL----EVGK 778
           + +H ++++         +  A  +     I  EY   GS+ D +      +    E   
Sbjct: 67  LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
            +++++V   + Y+H+     +VH D+KPSN+ +    + + +             ++  
Sbjct: 118 KDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 839 EG-------QSSSIEMKGTIGYIGPE---YGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
            G        SS    +G   ++  E              D+++  + ++          
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKA--DIFALALTVVCAAGAEPLPR 232

Query: 889 N 889
           N
Sbjct: 233 N 233

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 7e-22
 Identities = 58/245 (23%), Positives = 90/245 (36%), Gaps = 57/245 (23%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHR 731
              F     +G G++G VYKG   + G   A+KVM++      +    E   L+    HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHR 81

Query: 732 NLIKIITICSSIDFKGADFKA----------IVYEYMQYGSVDDWLHHTNDKLEVGKLN- 780
           N+           + GA  K           +V E+   GSV D + +T        L  
Sbjct: 82  NIAT---------YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKE 128

Query: 781 -----IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH--- 832
                I  E+   + +LH H    ++H D+K  NVLL  +    + DFG++  L      
Sbjct: 129 EWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185

Query: 833 -------PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR 885
                  P+ +APE              I  +           D++S GI  +EM     
Sbjct: 186 RNTFIGTPYWMAPE-------------VIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

Query: 886 PTDNM 890
           P  +M
Sbjct: 233 PLCDM 237

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 39/218 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG F   ++ +  +     A K++    L K    +    E    R++ H++++    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
                 F+  DF  +V E  +  S+ +             L        + ++    +YL
Sbjct: 109 F-----FEDNDFVFVVLELCRRRSLLELH------KRRKALTEPEARYYLRQIVLGCQYL 157

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---- 848
           H +    ++H DLK  N+ L+ D+   + DFGLA  +  +             E K    
Sbjct: 158 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDG-----------ERKKVLC 202

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GT  YI PE       S   DV+S G ++  +   + P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 42/222 (18%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT---KSFVAECEALRNIR 729
            K FS    IG GSFG VY      +   VA+K M+   K +    +  + E   L+ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 730 HRNLIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-E 784
           H N I+         ++G   +     +V EY   GS  D L      L+  ++  V   
Sbjct: 113 HPNTIQ---------YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH------PFLVAP 838
               + YLH+H    ++H D+K  N+LL    +  + DFG A  ++        P+ +AP
Sbjct: 163 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAP 219

Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           E     I       Y               DV+S GI  +E+
Sbjct: 220 E----VILAMDEGQY-----------DGKVDVWSLGITCIEL 246

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 96.5 bits (240), Expect = 2e-21
 Identities = 43/231 (18%), Positives = 76/231 (32%), Gaps = 47/231 (20%)

Query: 673 TKEFSSSNRIGKG--SFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNI 728
              +     IGKG      V        G  V V+ +NL+            E    +  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWL-HHTNDKLEVGKLNIVI-EVA 786
            H N++      +   F   +   +V  +M YGS  D +  H  D +    +  ++  V 
Sbjct: 84  NHPNIVPY--RAT---FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH-------------- 832
             ++Y+H+      VH  +K S++L+  D   ++S       +  H              
Sbjct: 139 KALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 833 ---PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEM 880
                 ++PE     +  +   GY               D+YS GI   E+
Sbjct: 196 VKVLPWLSPE-----VLQQNLQGY-----------DAKSDIYSVGITACEL 230

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 50/258 (19%), Positives = 79/258 (30%), Gaps = 23/258 (8%)

Query: 350 PHSIANLSTTMTL--IAMAGNQISGTIPPEIRNLFNLNG---LGLEYNQLTGTIPPAIGE 404
                ++  +++L  + +   +I   I      +  ++G   L LE  ++TGT PP + E
Sbjct: 58  LGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117

Query: 405 L--RNLQYLGLVGNNIRGIIPD----PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQ 458
               +L  L L   +                  L VL +            +     L  
Sbjct: 118 ATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177

Query: 459 LSAPNNKLNGTLP-PQIFGITTLSKL--LDLSENH---LSGSIPLEVGNLKSLVQLDISR 512
           L   +N   G               L  L L        SG           L  LD+S 
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237

Query: 513 NNFSNEIPVTL-SACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHL 571
           N+  +          + L  L +        +P+ L     +  LDLS N L    P   
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSPD 293

Query: 572 GNLPFLEYLNLSYNHFEG 589
             LP +  L+L  N F  
Sbjct: 294 E-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.5 bits (227), Expect = 4e-20
 Identities = 48/290 (16%), Positives = 84/290 (28%), Gaps = 21/290 (7%)

Query: 263 AQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYLGRNNLGTRTST 321
           A N L     +       LE+L    +  +   +  +     +L +L +    +    S 
Sbjct: 27  AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARI---PSR 83

Query: 322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLS-TTMTLIAMAGNQISG--TIPPEI 378
            L     +   S L +L L      G  P  +   +   + ++ +     +       E+
Sbjct: 84  ILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAEL 143

Query: 379 RNLF--NLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRG-------IIPDPIGNL 429
           +      L  L +            +     L  L L  N   G       + P     L
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203

Query: 430 TLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSEN 489
            +L +   G     G   +       L  L   +N L            +    L+LS  
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263

Query: 490 HLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSF 539
            L   +P  +     L  LD+S N      P        +  L ++GN F
Sbjct: 264 GLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.0 bits (218), Expect = 5e-19
 Identities = 43/240 (17%), Positives = 79/240 (32%), Gaps = 32/240 (13%)

Query: 361 TLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRN---LQYLGLVGNN 417
            L+     +       +I    +L  L +   ++   I      +     LQ L L    
Sbjct: 47  YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106

Query: 418 IRGIIPDPIGNLTLLNVLQLGFNKLQGS-IPSYLGKCQNLMQLSAPNNKLNGTLPPQIFG 476
           + G  P P+   T  ++  L    +  +   ++L + Q  ++                  
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG---------------- 150

Query: 477 ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSAC----TTLEYL 532
                K+L +++ H       +V    +L  LD+S N    E  +  + C     TL+ L
Sbjct: 151 ----LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206

Query: 533 LMQGNSFN---GSIPQSLNALKSIKELDLSCNNLSGQIP-IHLGNLPFLEYLNLSYNHFE 588
            ++        G       A   ++ LDLS N+L              L  LNLS+   +
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.9 bits (210), Expect = 6e-18
 Identities = 47/271 (17%), Positives = 92/271 (33%), Gaps = 36/271 (13%)

Query: 158 LKIERLSLYGNQLTGQLPPS---IGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTS 214
           L ++RL++   ++  ++      +  +S LQ   +   ++ G  P  L +    +     
Sbjct: 68  LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD----- 122

Query: 215 ENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQS 274
                         ++ L+   +        L     +  P L VL +AQ +   F  + 
Sbjct: 123 --------------LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 275 LSNASKLEWLELNENHFSGQVRIN----FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLT 330
           +     L  L+L++N   G+  +         P L  L L    +    +       L  
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM---ETPSGVCSALAA 225

Query: 331 NCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGL 389
              +L  L L  N    A      +  + +  + ++   +   +P  +   L  L+   L
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLD---L 281

Query: 390 EYNQLTGTIPPAIGELRNLQYLGLVGNNIRG 420
            YN+L     P+  EL  +  L L GN    
Sbjct: 282 SYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 37/219 (16%), Positives = 66/219 (30%), Gaps = 36/219 (16%)

Query: 60  RHQRVTKLDLESQNIGGFLSPYIGNLSF-----LRVINLANNSFHGQIPKEVGRLFRLET 114
               +  L+L + +     + ++  L       L+V+++A         ++V     L T
Sbjct: 119 TGPDLNILNLRNVSWATRDA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177

Query: 115 IVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLT--- 171
           + LS+N   G+     + C                       +  ++ L+L    +    
Sbjct: 178 LDLSDNPELGERGLISALCP--------------------LKFPTLQVLALRNAGMETPS 217

Query: 172 GQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQ-LRNLNYLGTSENDFSGMFPLSVCNIS 230
           G           LQ  D++ N L              LN L  S      +       +S
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS 277

Query: 231 SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTG 269
            LD   L  NR     P      LP++  L +  N    
Sbjct: 278 VLD---LSYNRLD-RNPSPDE--LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 11/123 (8%)

Query: 476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSA---CTTLEYL 532
           G  +L  LL   +         ++    SL +L +      + I          + L+ L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 533 LMQGNSFNGSIPQSL--NALKSIKELDLSCNNLSGQIPIHLGNLPF-----LEYLNLSYN 585
            ++     G+ P  L       +  L+L  N         L  L       L+ L+++  
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLR-NVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 586 HFE 588
           H  
Sbjct: 160 HSL 162

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 28/224 (12%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-FVAECEALRNIRHR 731
            + F+   +IGKGSFG V+KG        VA+K+++L++          E   L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 732 NLIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVA 786
            + K         + G+  K     I+ EY+  GS  D L      L+  ++  ++ E+ 
Sbjct: 81  YVTK---------YYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREIL 129

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             ++YLH+      +H D+K +NVLL       ++DFG+A  L+        + Q     
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--------DTQIKRNT 178

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
             GT  ++ PE           D++S GI  +E+     P   +
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 49/241 (20%), Positives = 87/241 (36%), Gaps = 54/241 (22%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVA--------------ECEA 724
           + +G F  +      +D    A+K      L+KK                      E + 
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 725 LRNIRHRNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWL--HHTNDKLEVGKL- 779
           + +I++   +    I         ++  +  +YEYM+  S+  +       DK     + 
Sbjct: 97  ITDIKNEYCLTCEGII-------TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 780 -----NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
                 I+  V +   Y+HN     I H D+KPSN+L+D +    +SDFG + +      
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY------ 201

Query: 835 LVAPEGQSSSIEMKGTIGYIGPE--YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN 892
               + +      +GT  ++ PE             D++S GI L  MF    P    F+
Sbjct: 202 --MVDKKIKG--SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FS 253

Query: 893 D 893
            
Sbjct: 254 L 254

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 62/242 (25%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNI-R 729
             +G G+FG V              + VAVK++   K+ A     ++ ++E + +  +  
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGS 107

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK----------- 778
           H N++ ++  C+     G  +  +++EY  YG + ++L    +K    +           
Sbjct: 108 HENIVNLLGACTL---SGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 779 ------------LNIVIEVASVIEYL-HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 825
                       L    +VA  +E+L    C    VH DL   NVL+ H  V  + DFGL
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGL 218

Query: 826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEM 880
           AR +            S S  +      +      PE    G  ++  DV+S+GILL E+
Sbjct: 219 ARDI-----------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

Query: 881 FT 882
           F+
Sbjct: 268 FS 269

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 33/208 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG FG VY     +    +A+KV+    L+K G       E E   ++RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
                 F  A    ++ EY   G+V   L          K +       + E+A+ + Y 
Sbjct: 77  Y-----FHDATRVYLILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYC 125

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H+     ++H D+KP N+LL       ++DFG +               S   ++ GT+ 
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWS----------VHAPSSRRTDLCGTLD 172

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           Y+ PE   G       D++S G+L  E 
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 33/208 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG FG VY     ++   +A+KV+    L+K+G       E E   ++RH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
                 F       ++ E+   G +   L         G+ +       + E+A  + Y 
Sbjct: 82  Y-----FHDRKRIYLMLEFAPRGELYKELQKH------GRFDEQRSATFMEELADALHYC 130

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H      ++H D+KP N+L+ +     ++DFG +          AP  +  +  M GT+ 
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVH--------APSLRRRT--MCGTLD 177

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEM 880
           Y+ PE   G       D++  G+L  E 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEF 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 37/209 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+F  V+       G   A+K +         S   E   L+ I+H N++ +  I  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVIEYLHNH 795
              ++      +V + +  G + D +      LE G         ++ +V S ++YLH +
Sbjct: 75  ---YESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 796 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               IVH DLKP N+L    + +    ++DFGL++   +                 GT G
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS----------TACGTPG 172

Query: 853 YIGPEYGMGGDLSMTGDVYSFG----ILL 877
           Y+ PE       S   D +S G    ILL
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 46/229 (20%), Positives = 81/229 (35%), Gaps = 41/229 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECEAL-RNIRHR 731
            +  +   +G G+ G V+K    + G  +AVK M         K  + + + + ++    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 732 NLIKIITICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVA 786
            +++           G         I  E M     +         +    L  + + + 
Sbjct: 85  YIVQ---------CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIV 134

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH---------PFLVA 837
             + YL       ++H D+KPSN+LLD      + DFG++  L               +A
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           PE              I P      D  +  DV+S GI L+E+ T + P
Sbjct: 193 PE-------------RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 39/230 (16%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECE-ALRNIRHRNLIKII 737
             +G+G++G V K      G  +AVK +         K  + + + ++R +     +   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT-- 70

Query: 738 TICSSIDFKGADFK----AIVYEYMQYGSVDDWLHHTNDKL------EVGKLNIVIEVAS 787
                  F GA F+     I  E M   S+D +     DK        +GK  I + +  
Sbjct: 71  -------FYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVK 120

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            +E+LH+     ++H D+KPSNVL++      + DFG++       +LV    +      
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG------YLVDDVAKDIDA-- 170

Query: 848 KGTIGYIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
            G   Y+ PE           S+  D++S GI ++E+   R P D+    
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 50/225 (22%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IGKG+F  V        G  VA+K+++   L+     K F  E   ++ + H N++K+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYL 792
           +   I+ +   +  ++ EY   G V D+L      +  G++          ++ S ++Y 
Sbjct: 82  V---IETEKTLY--LIMEYASGGEVFDYL------VAHGRMKEKEARSKFRQIVSAVQYC 130

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---------VAPEGQSS 843
           H      IVH DLK  N+LLD DM   ++DFG +   +    L          APE    
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE---- 183

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
             + K    Y GPE           DV+S G++L  + +   P D
Sbjct: 184 LFQGK---KYDGPEV----------DVWSLGVILYTLVSGSLPFD 215

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 47/233 (20%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-KSFVAECE-ALRNIRHRNLIKIIT 738
            IG+G++G V K      G  +AVK +         K  + + +  +R+     +++   
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ--- 85

Query: 739 ICSSIDFKGADFKA----IVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASV 788
                 F GA F+     I  E M   S D +  +    L+   +       I +     
Sbjct: 86  ------FYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD-DVIPEEILGKITLATVKA 137

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + +L  + +  I+H D+KPSN+LLD      + DFG++  L              SI   
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL------------VDSIAKT 183

Query: 849 GTIG---YIGPE----YGMGGDLSMTGDVYSFGILLLEMFTRRRP---TDNMF 891
              G   Y+ PE            +  DV+S GI L E+ T R P    +++F
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 14/209 (6%)

Query: 337 KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLT 395
            L L FN       +S  +    + ++ ++  +I  TI     ++L +L+ L L  N + 
Sbjct: 32  NLDLSFNPLRHLGSYSFFSF-PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 396 GTIPPAI-GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPS--YLGK 452
            ++       L +LQ L  V  N+  +   PIG+L  L  L +  N +Q S     Y   
Sbjct: 90  -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147

Query: 453 CQNLMQLSAPNNKLNGTLPPQIF----GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQL 508
             NL  L   +NK+  ++          +  L+  LDLS N ++  I         L +L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205

Query: 509 DISRNNFSNEIPVTLSACTTLEYLLMQGN 537
            +  N   +         T+L+ + +  N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 52/221 (23%), Positives = 78/221 (35%), Gaps = 21/221 (9%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
           +P   +NL       L +N L   +   +      LQ L L    I+ I      +L+ L
Sbjct: 26  LPFSTKNLD------LSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 433 NVLQLGFNKLQGSIPS-YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHL 491
           + L L  N +Q S+         +L +L A    L  +L     G     K L+++ N +
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136

Query: 492 SGSIPLEVG---NLKSLVQLDISRNNFSNEIPVTLSACTTLEY----LLMQGNSFNGSIP 544
             S  L      NL +L  LD+S N   +     L     +      L +  N  N  I 
Sbjct: 137 Q-SFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193

Query: 545 QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN 585
                   +KEL L  N L          L  L+ + L  N
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 52/261 (19%), Positives = 85/261 (32%), Gaps = 60/261 (22%)

Query: 160 IERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSL-GQLRNLNYLGTSEND 217
            + L L  N L   L      +   LQ  D++  ++   I D     L +L+ L      
Sbjct: 30  TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL------ 81

Query: 218 FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN 277
                              L  N  + SL +     L  L  LV  + NL       + +
Sbjct: 82  ------------------ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 278 ASKLEWLELNENHF-SGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLV 336
              L+ L +  N   S ++   F++L NL  L L  N + +   TDL  +          
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH--------- 173

Query: 337 KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG 396
                              +      + ++ N ++  I P       L  L L+ NQL  
Sbjct: 174 ------------------QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK- 213

Query: 397 TIPP-AIGELRNLQYLGLVGN 416
           ++P      L +LQ + L  N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 45/282 (15%), Positives = 89/282 (31%), Gaps = 72/282 (25%)

Query: 50  CQWTGVTC-GHRHQRV--------TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHG 100
                  C      ++          LDL    +    S    +   L+V++L+      
Sbjct: 7   VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65

Query: 101 QIPKEV-GRLFRLETIVLSNN---SFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGN 156
            I       L  L T++L+ N   S +    + LS                         
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS------------------------- 100

Query: 157 WLKIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSE 215
              +++L      L   L     G+L  L+  ++A N            +++        
Sbjct: 101 --SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN-----------LIQSFKLPEY-- 144

Query: 216 NDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTV----LVVAQNNLTGFL 271
             FS +        ++L+   L  N+ + S+       L ++ +    L ++ N +  F+
Sbjct: 145 --FSNL--------TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 272 PQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN 313
                   +L+ L L+ N         F+ L +L K++L  N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 32/129 (24%), Positives = 53/129 (41%), Gaps = 11/129 (8%)

Query: 476 GITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPV-TLSACTTLEYLL 533
            +   +K LDLS N L   +      +   L  LD+SR      I      + + L  L+
Sbjct: 25  NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLI 82

Query: 534 MQGN---SFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGK 590
           + GN   S        L++L+   +L     NL+      +G+L  L+ LN+++N  +  
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQ---KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-S 138

Query: 591 VPKKGVFSN 599
                 FSN
Sbjct: 139 FKLPEYFSN 147

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 57/236 (24%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA----ECEALRNIRHRNLIKII 737
           +G+GS+G V +    E     AVK++   K     +  A    E + LR +RH+N+I+++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVA--------SVI 789
            +   +  +      +V EY   G  +  +    D +   +  +    A          +
Sbjct: 73  DV---LYNEEKQKMYMVMEYCVCGMQE--ML---DSVPEKRFPV--CQAHGYFCQLIDGL 122

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH------------PFLVA 837
           EYLH+     IVH D+KP N+LL       +S  G+A  L               P    
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           PE         G   + G +           D++S G+ L  + T   P    F  
Sbjct: 180 PE------IANGLDTFSGFK----------VDIWSAGVTLYNITTGLYP----FEG 215

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 90.1 bits (224), Expect = 7e-20
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 21/220 (9%)

Query: 368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG 427
             ++  +      L +++ +    + +  ++   I  L N+  L L GN +  I   P+ 
Sbjct: 34  KSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDI--KPLA 87

Query: 428 NLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LD 485
           NL  L  L L  NK++  + S L   + L  LS  +N ++      I G+  L +L  L 
Sbjct: 88  NLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-----DINGLVHLPQLESLY 140

Query: 486 LSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ 545
           L  N ++    L    L  L  L +  N  S+ +P  L+  T L+ L +  N  + S  +
Sbjct: 141 LGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN--HISDLR 194

Query: 546 SLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN 585
           +L  LK++  L+L       +   H  NL     +  +  
Sbjct: 195 ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 55/293 (18%), Positives = 99/293 (33%), Gaps = 40/293 (13%)

Query: 213 TSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLP 272
           T       +F       +   +  L K     ++       L  +  ++   +++     
Sbjct: 9   TVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV-- 61

Query: 273 QSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTN 331
           Q +     +  L LN N  +    I    +L NL  L+L  N +      DL     L +
Sbjct: 62  QGIQYLPNVTKLFLNGNKLT---DIKPLANLKNLGWLFLDENKV-----KDLSS---LKD 110

Query: 332 CSKLVKLGLVFNRFGGALPHSIANLS--TTMTLIAMAGNQISGTIPPEIRNLFNLNGLGL 389
             KL  L L  N         I  L     +  + +  N+I+  I   +  L  L+ L L
Sbjct: 111 LKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSL 163

Query: 390 EYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY 449
           E NQ++  I P +  L  LQ L L  N+I  +    +  L  L+VL+L   +      ++
Sbjct: 164 EDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINH 219

Query: 450 LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNL 502
                    +   +  L             +S   D  + ++   +P     +
Sbjct: 220 QSNLVVPNTVKNTDGSLV--------TPEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 47/221 (21%), Positives = 72/221 (32%), Gaps = 45/221 (20%)

Query: 368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG 427
             I                  L+   +T  +     EL ++  +    ++I+ +    I 
Sbjct: 12  TPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQ 65

Query: 428 NLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LD 485
            L  +  L L  NKL   I   L   +NL  L    NK+       +  +  L KL  L 
Sbjct: 66  YLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLS 118

Query: 486 LSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ 545
           L  N +S    L   +L  L  L +  N  ++                            
Sbjct: 119 LEHNGISDINGLV--HLPQLESLYLGNNKITD--------------------------IT 150

Query: 546 SLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
            L+ L  +  L L  N +S  +P  L  L  L+ L LS NH
Sbjct: 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 55/254 (21%), Positives = 92/254 (36%), Gaps = 32/254 (12%)

Query: 192 NKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLG 251
             +     D              +   +     +   ++S+D+     +  K    +   
Sbjct: 12  TPIKQIFSDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ-- 65

Query: 252 FNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYL 310
             LP +T L +  N LT   P  L+N   L WL L+EN       + +   L  L  L L
Sbjct: 66  -YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK---DLSSLKDLKKLKSLSL 119

Query: 311 GRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLS--TTMTLIAMAGN 368
             N +     +D++    L +  +L  L L  N+        I  LS  T +  +++  N
Sbjct: 120 EHNGI-----SDING---LVHLPQLESLYLGNNKI-----TDITVLSRLTKLDTLSLEDN 166

Query: 369 QISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGN 428
           QIS  I P +  L  L  L L  N ++  +   +  L+NL  L L          +   N
Sbjct: 167 QIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSN 222

Query: 429 LTLLNVLQLGFNKL 442
           L + N ++     L
Sbjct: 223 LVVPNTVKNTDGSL 236

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.5 bits (230), Expect = 1e-19
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 23/219 (10%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRH 730
           ++ +    ++G G++G V         +  A+K++        +    + E   L+ + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++K+        F+      +V E  + G + D + H     EV    I+ +V S + 
Sbjct: 96  PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150

Query: 791 YLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
           YLH H    IVH DLKP N+LL   + D +  + DFGL+    +   +          E 
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---------ER 198

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT  YI PE  +        DV+S G++L  +     P
Sbjct: 199 LGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 49/225 (21%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G G+FG V  G     G  VAVK++N   +           E + L+  RH ++IK+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI------EVASVIEYL 792
           +   I      F  +V EY+  G + D++       + G++  +       ++ S ++Y 
Sbjct: 79  V---ISTPTDFF--MVMEYVSGGELFDYI------CKHGRVEEMEARRLFQQILSAVDYC 127

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---------VAPEGQSS 843
           H H    +VH DLKP NVLLD  M A ++DFGL+  +S   FL          APE    
Sbjct: 128 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE---- 180

Query: 844 SIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
            I  +    Y GPE           D++S G++L  +     P D
Sbjct: 181 VISGR---LYAGPE----------VDIWSCGVILYALLCGTLPFD 212

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 43/208 (20%)

Query: 670 SKATKEFSS----SNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---------LDKKGATK 716
           S +T  F         +G+G    V +          AVK+++          + +   +
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 717 SFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
           + + E + LR +  H N+I++        ++   F  +V++ M+ G + D+L       E
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TE 117

Query: 776 VGKL------NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
              L       I+  +  VI  LH      IVH DLKP N+LLD DM   ++DFG +  L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
                L          E+ GT  Y+ PE
Sbjct: 175 DPGEKLR---------EVCGTPSYLAPE 193

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 56/256 (21%), Positives = 88/256 (34%), Gaps = 78/256 (30%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------------------- 720
           IGKGS+G V       D    A+KV++  K      F                       
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 721 -----ECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
                E   L+ + H N++K++ +   +D    D   +V+E +  G V +          
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTL------ 131

Query: 776 VGKLNIVIEVA--------SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL-A 826
              L+   + A          IEYLH      I+H D+KPSN+L+  D    ++DFG+  
Sbjct: 132 -KPLSE--DQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 827 RFLSHHPFL---------VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
            F      L         +APE        +    + G             DV++ G+ L
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPE-----SLSETRKIFSGKA----------LDVWAMGVTL 230

Query: 878 LEMFTRRRPTDNMFND 893
                 + P    F D
Sbjct: 231 YCFVFGQCP----FMD 242

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 31/169 (18%), Positives = 63/169 (37%), Gaps = 13/169 (7%)

Query: 352 SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYL 411
           + A +  ++T I +A   ++      I    N+  L +     T   P  I  L NL+ L
Sbjct: 39  TEAQM-NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERL 93

Query: 412 GLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLP 471
            ++G ++       +  LT L +L +  +    SI + +     +  +    N     + 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153

Query: 472 PQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNE 518
           P    + TL +L  L++  + +     +E  +   L QL         +
Sbjct: 154 P----LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 29/206 (14%), Positives = 57/206 (27%), Gaps = 36/206 (17%)

Query: 383 NLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL 442
                       + T      ++ +L Y+ L   N+  +    I     +  L +     
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHA 78

Query: 443 QGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVG 500
                                             I+ LS L  L +    ++      + 
Sbjct: 79  TN-----------------------------YNPISGLSNLERLRIMGKDVTSDKIPNLS 109

Query: 501 NLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSC 560
            L SL  LDIS +   + I   ++    +  + +  N     I   L  L  +K L++  
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168

Query: 561 NNLSGQIPIHLGNLPFLEYLNLSYNH 586
           + +       + + P L  L      
Sbjct: 169 DGVHDYRG--IEDFPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 36/173 (20%), Positives = 68/173 (39%), Gaps = 15/173 (8%)

Query: 416 NNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF 475
           +     IPD            LG +       + +    +L  ++  N  +       + 
Sbjct: 11  SQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-----DLT 60

Query: 476 GITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLL 533
           GI     +  L ++  H +   P+    L +L +L I   + +++    LS  T+L  L 
Sbjct: 61  GIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118

Query: 534 MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
           +  ++ + SI   +N L  +  +DLS N     I   L  LP L+ LN+ ++ 
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG 170

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 37/191 (19%), Positives = 67/191 (35%), Gaps = 16/191 (8%)

Query: 279 SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKL 338
           S  +         S    I    + +L+ + L   N+     TDL  I    N   +  L
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-----TDLTGIEYAHN---IKDL 71

Query: 339 GLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTI 398
            +         P  I+ L + +  + + G  ++    P +  L +L  L + ++    +I
Sbjct: 72  TINNIHATNYNP--ISGL-SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 399 PPAIGELRNLQYLGLVGNN-IRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLM 457
              I  L  +  + L  N  I  I   P+  L  L  L + F+ +       +     L 
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDI--MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLN 184

Query: 458 QLSAPNNKLNG 468
           QL A +  + G
Sbjct: 185 QLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 32/169 (18%), Positives = 64/169 (37%), Gaps = 14/169 (8%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
            +  LT + +A  N+T      +  A  ++ L +N  H +       + L NL +L +  
Sbjct: 42  QMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMG 97

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
            ++ +      D I  L+  + L  L +  +    ++   I  L   +  I ++ N    
Sbjct: 98  KDVTS------DKIPNLSGLTSLTLLDISHSAHDDSILTKINTL-PKVNSIDLSYNGAIT 150

Query: 373 TIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            I P ++ L  L  L ++++ +       I +   L  L      I G 
Sbjct: 151 DIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 29/219 (13%), Positives = 63/219 (28%), Gaps = 46/219 (21%)

Query: 156 NWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPD--SLGQLRNLNYLGT 213
            +       L  +        +   +++L    +A       + D   +    N+  L  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN----VTDLTGIEYAHNIKDLTI 73

Query: 214 SENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQ 273
           +    +   P+S                            L  L  L +   ++T     
Sbjct: 74  NNIHATNYNPIS---------------------------GLSNLERLRIMGKDVTSDKIP 106

Query: 274 SLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCS 333
           +LS  + L  L+++ +     +    N+LP ++ + L  N         +  I  L    
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA-------ITDIMPLKTLP 159

Query: 334 KLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
           +L  L + F+         I +    +  +      I G
Sbjct: 160 ELKSLNIQFDGVHDYRG--IEDF-PKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.8 bits (143), Expect = 5e-10
 Identities = 16/130 (12%), Positives = 44/130 (33%), Gaps = 5/130 (3%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG 124
             L + + +     +P I  LS L  + +            +  L  L  + +S+++   
Sbjct: 69  KDLTINNIHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126

Query: 125 KIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSAL 184
            I T ++    +    +  N  + +I   +    +++ L++  + +       I +   L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183

Query: 185 QTFDIAGNKL 194
                    +
Sbjct: 184 NQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 21/152 (13%), Positives = 54/152 (35%), Gaps = 6/152 (3%)

Query: 460 SAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEI 519
           +A    L  +        +T    L+      S +  +    + SL  + ++  N ++  
Sbjct: 2   AAEQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTA-NITEAQMNSLTYITLANINVTDLT 60

Query: 520 PVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEY 579
              +     ++ L +         P  ++ L +++ L +   +++     +L  L  L  
Sbjct: 61  G--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116

Query: 580 LNLSYNHFEGKVPKK-GVFSNETRISLTGNEQ 610
           L++S++  +  +  K         I L+ N  
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 88.2 bits (219), Expect = 7e-19
 Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 53/219 (24%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVA-----ECEALRNIRHRNL 733
           +G G+FGFV+     E    V VK +    + +    +         E   L  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVAS 787
           IK++ I     F+   F  +V E   +GS  D     +      +L+      I  ++ S
Sbjct: 92  IKVLDI-----FENQGFFQLVMEK--HGSGLDLFAFIDRH---PRLDEPLASYIFRQLVS 141

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---------VAP 838
            + YL       I+H D+K  N+++  D    + DFG A +L                AP
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198

Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
           E     +       Y GPE           +++S G+ L
Sbjct: 199 E----VLMGN---PYRGPEL----------EMWSLGVTL 220

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.9 bits (216), Expect = 8e-19
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 26/204 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITIC 740
           +G G+FG V+       G+   +K +N D+ +   +   AE E L+++ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL----EVGKLNIVIEVASVIEYLHNHC 796
               F+      IV E  + G + + +     +     E     ++ ++ + + Y H+  
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143

Query: 797 QPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
              +VH DLKP N+L           + DFGLA              + S+    GT  Y
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--------SDEHST-NAAGTALY 192

Query: 854 IGPEYGMGGDLSMTGDVYSFGILL 877
           + PE     D++   D++S G+++
Sbjct: 193 MAPEV-FKRDVTFKCDIWSAGVVM 215

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 89.8 bits (223), Expect = 8e-19
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 24/220 (10%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIR 729
           +  +     +GKGSFG V        G   AVKV++   + +K   +S + E + L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N++K+        F+   +  +V E    G + D +       EV    I+ +V S I
Sbjct: 85  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139

Query: 790 EYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
            Y+H +    IVH DLKP N+LL     D    + DFGL+        +          +
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---------D 187

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             GT  YI PE  + G      DV+S G++L  + +   P
Sbjct: 188 KIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.0 bits (221), Expect = 1e-18
 Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 48/241 (19%)

Query: 661 FPIVSYAELSKATKEFSS----SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK----- 711
           F  ++  + S   K        S  +G G+ G V      +    VA+++++  K     
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177

Query: 712 ---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH 768
                   +   E E L+ + H  +IKI     + D+       IV E M+ G + D + 
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV- 230

Query: 769 HTNDKLEVGKLN------IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAH 819
                +   +L          ++   ++YLH +    I+H DLKP NVLL   + D +  
Sbjct: 231 -----VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282

Query: 820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG---DVYSFGIL 876
           ++DFG ++ L     +           + GT  Y+ PE  +    +      D +S G++
Sbjct: 283 ITDFGHSKILGETSLMR---------TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

Query: 877 L 877
           L
Sbjct: 334 L 334

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 38/191 (19%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA--------ECEALRNIR-HRN 732
           IG+G    V +      G   AVK+M +  +  +   +         E   LR +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVA 786
           +I +I    S     + F  +V++ M+ G + D+L       E   L      +I+  + 
Sbjct: 162 IITLIDSYES-----SSFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLL 210

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + +LH +    IVH DLKP N+LLD +M   +SDFG +  L     L          E
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---------E 258

Query: 847 MKGTIGYIGPE 857
           + GT GY+ PE
Sbjct: 259 LCGTPGYLAPE 269

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 47/214 (21%), Positives = 74/214 (34%), Gaps = 47/214 (21%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           IG+GS+G V         +  A K +          F  E E ++++ H N+I++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYLHNH 795
              F+      +V E    G + + +      +            I+ +V S + Y H  
Sbjct: 75  ---FEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 796 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               + H DLKP N L      D    + DFGLA        +             GT  
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---------TKVGTPY 173

Query: 853 YIGPE-----YGMGGDLSMTGDVYSFG----ILL 877
           Y+ P+     YG         D +S G    +LL
Sbjct: 174 YVSPQVLEGLYG------PECDEWSAGVMMYVLL 201

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 46/235 (19%), Positives = 84/235 (35%), Gaps = 62/235 (26%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA-ECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------IVIEVASVIE 790
                   + + +  EY   G + D +           +           ++    + + 
Sbjct: 75  RE-----GNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLM----AGVV 119

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH------------PFLVAP 838
           YLH      I H D+KP N+LLD      +SDFGLA    ++               VAP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           E     ++ +    +               DV+S GI+L  M     P    ++ 
Sbjct: 177 E----LLKRR---EFHAEP----------VDVWSCGIVLTAMLAGELP----WDQ 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 31/204 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA-ECEALRNIRHRNLIKIITIC 740
           +G+G FG V++        +   K +    KG  +  V  E   L   RHRN++ +    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHES- 69

Query: 741 SSIDFKGADFKAIVYEYMQYGS-----VDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH 795
               F+  +   +++E++                     E   ++ V +V   +++LH+H
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVHQVCEALQFLHSH 121

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
               I H D++P N++      + +   +FG AR L          G +    +     Y
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--------PGDNFR-LLFTAPEY 169

Query: 854 IGPEYGMGGDLSMTGDVYSFGILL 877
             PE      +S   D++S G L+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 48/233 (20%)

Query: 669 LSKATKEFSS----SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--------KGATK 716
           +S   K        S  +G G+ G V      +    VA+K+++  K             
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 717 SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEV 776
           +   E E L+ + H  +IKI     + D+       IV E M+ G + D +      +  
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV------VGN 108

Query: 777 GKL------NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAR 827
            +L          ++   ++YLH +    I+H DLKP NVLL   + D +  ++DFG ++
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165

Query: 828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG---DVYSFGILL 877
            L     +           + GT  Y+ PE  +    +      D +S G++L
Sbjct: 166 ILGETSLMR---------TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 41/199 (20%), Positives = 79/199 (39%), Gaps = 20/199 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+FG V++      G     K +N        +   E   +  + H  LI +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQPPI 800
              F+      ++ E++  G + D +   + K+ E   +N + +    ++++H H    I
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 170

Query: 801 VHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
           VH D+KP N++ +    + V   DFGLA  L+    +              T  +  PE 
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---------VTTATAEFAAPEI 221

Query: 859 GMGGDLSMTGDVYSFGILL 877
                +    D+++ G+L 
Sbjct: 222 VDREPVGFYTDMWAIGVLG 240

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.9 bits (218), Expect = 3e-18
 Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 39/220 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G G+FG V  G     G  VAVK++N   +           E + L+  RH ++IK+  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQ 797
           +   I      F  +V EY+  G + D++   N +L E     +  ++ S ++Y H H  
Sbjct: 84  V---ISTPSDIF--MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM- 136

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---------VAPEGQSSSIEMK 848
             +VH DLKP NVLLD  M A ++DFGL+  +S   FL          APE     I  +
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE----VISGR 190

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
               Y GPE           D++S G++L  +     P D
Sbjct: 191 ---LYAGPE----------VDIWSSGVILYALLCGTLPFD 217

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 49/247 (19%), Positives = 80/247 (32%), Gaps = 16/247 (6%)

Query: 373 TIPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIP-DPIGNLT 430
            IP ++    N   L     +L   I   A     +L+ + +  N++  +I  D   NL 
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79

Query: 431 LLNVLQL-GFNKLQGSIPS-YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSE 488
            L+ +++   N L   I         NL  L   N  +   LP      +    LLD+ +
Sbjct: 80  KLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQD 137

Query: 489 NHLSGSIPLEV--GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
           N    +I      G     V L +++N          +     E  L   N+        
Sbjct: 138 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDV 197

Query: 547 LNALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISL 605
            +       LD+S   +   +P + L NL  L   +        K+P           SL
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASL 253

Query: 606 TGNEQFC 612
           T     C
Sbjct: 254 TYPSHCC 260

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 85.6 bits (212), Expect = 5e-18
 Identities = 48/233 (20%), Positives = 82/233 (35%), Gaps = 14/233 (6%)

Query: 335 LVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLE-YN 392
            ++L  V  +       + +     +  I ++ N +   I  ++  NL  L+ + +E  N
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGF-GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 393 QLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYL- 450
            L   I P A   L NLQYL +    I+ +      +     +L +  N    +I     
Sbjct: 91  NLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149

Query: 451 -GKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQL 508
            G     + L    N +   +    F  T L +L     N+L   +P +V       V L
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVIL 207

Query: 509 DISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
           DISR    +     L     L             +P +L  L ++ E  L+  
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRAR---STYNLKKLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.9 bits (210), Expect = 9e-18
 Identities = 54/246 (21%), Positives = 87/246 (35%), Gaps = 24/246 (9%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN-FNSLPNLSKLYL 310
           +LP+    L      L      + S    LE +E+++N     +  + F++LP L ++ +
Sbjct: 27  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86

Query: 311 GRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQI 370
            + N     + +        N   L  L +        LP      S    L+ +  N  
Sbjct: 87  EKANNLLYINPE-----AFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNIN 140

Query: 371 SGTIPPE-IRNL-FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNN-IRGIIPDPIG 427
             TI       L F    L L  N +   I  +      L  L L  NN +  +  D   
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199

Query: 428 NLTLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDL 486
             +   +L +   ++  S+PSY L   + L   S  N K    LP        L KL+ L
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-------LEKLVAL 248

Query: 487 SENHLS 492
            E  L+
Sbjct: 249 MEASLT 254

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 79.5 bits (196), Expect = 5e-16
 Identities = 39/228 (17%), Positives = 70/228 (30%), Gaps = 12/228 (5%)

Query: 389 LEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPS 448
            + +++T  IP  +   RN   L  V   +R I          L  +++  N +   I +
Sbjct: 16  CQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72

Query: 449 Y-LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLV 506
                   L ++          + P+ F      + L +S   +   +P     +    V
Sbjct: 73  DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKV 131

Query: 507 QLDISRNNFSNEIPVTLSA--CTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS 564
            LDI  N   + I              L +  N     I  S      + EL+LS NN  
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNL 190

Query: 565 GQIPIH-LGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQF 611
            ++P            L++S       +P      N  ++        
Sbjct: 191 EELPNDVFHGASGPVILDISRTRIH-SLP-SYGLENLKKLRARSTYNL 236

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 38/287 (13%), Positives = 85/287 (29%), Gaps = 68/287 (23%)

Query: 160 IERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSEND 217
              L     +L   +          L+  +I+ N +   I  D    L  L+ +   + +
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 218 FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN 277
                     N+  ++    F+N             LP L  L+++   +         +
Sbjct: 91  ----------NLLYINPE-AFQN-------------LPNLQYLLISNTGIKHLPDVHKIH 126

Query: 278 ASKLEWLELNENHFSGQVRIN-FNSLPNLSK-LYLGRNNLGTRTSTDLDFITLLTNCSKL 335
           + +   L++ +N     +  N F  L   S  L+L +N +                    
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE------------------ 168

Query: 336 VKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQL 394
                        + +S  N +    L     N +   +P ++         L +   ++
Sbjct: 169 -------------IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 214

Query: 395 TGTIPPAI-GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN 440
             ++P      L+ L+       N++ +    +  L  L    L + 
Sbjct: 215 H-SLPSYGLENLKKLRARST--YNLKKL--PTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 45/312 (14%), Positives = 77/312 (24%), Gaps = 80/312 (25%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNI-----GGFLSPYIGNLSFLRVINLAN 95
           C      C             +   +L      +     G F          L  I ++ 
Sbjct: 9   CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAF-----SGFGDLEKIEISQ 63

Query: 96  NSFHGQIPKEV-GRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAII 154
           N     I  +V   L +L  I +   +    I     +         +  NL        
Sbjct: 64  NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQ---------NLPNL-------- 106

Query: 155 GNWLKIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGT 213
                 + L +    +   LP     +       DI  N            +  +     
Sbjct: 107 ------QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI----------NIHTI----- 144

Query: 214 SENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNN-LTGFLP 272
             N F G+              +L KN  +  +     FN  +L  L ++ NN L     
Sbjct: 145 ERNSFVGLSFE-------SVILWLNKNGIQ-EIHNSA-FNGTQLDELNLSDNNNLEELPN 195

Query: 273 QSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNC 332
                AS    L+++             +L  L        NL          +  L   
Sbjct: 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK--------LPTLEKL 245

Query: 333 SKLVKLGLVFNR 344
             L++  L +  
Sbjct: 246 VALMEASLTYPS 257

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 54/244 (22%), Positives = 83/244 (34%), Gaps = 63/244 (25%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA-ECEALRNIRHRNLIKIITIC 740
           IG G+FG             VAVK   +++  A    V  E    R++RH N+++   + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------IVIEVASVIE 790
            +         AI+ EY   G + + +         G+ +          ++    S + 
Sbjct: 86  LT-----PTHLAIIMEYASGGELYERI------CNAGRFSEDEARFFFQQLL----SGVS 130

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLARFLSHHPFL---------VAPE 839
           Y H+     I H DLK  N LLD        + DFG ++    H            +APE
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187

Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG 899
                +  +    Y G             DV+S G+ L  M     P    F D      
Sbjct: 188 ----VLLRQ---EYDGKI----------ADVWSCGVTLYVMLVGAYP----FEDPEEPRD 226

Query: 900 YAKM 903
           Y K 
Sbjct: 227 YRKT 230

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 34/187 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKGSFG V K          AVKV+N        T + + E E L+ + H N++K+  I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYLH 793
                 + +    IV E    G + D +      ++  + +      I+ +V S I Y+H
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 794 NHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            H    IVH DLKP N+LL   + D    + DFGL+            +      +  GT
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--------QNTKMK-DRIGT 186

Query: 851 IGYIGPE 857
             YI PE
Sbjct: 187 AYYIAPE 193

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.0 bits (218), Expect = 5e-18
 Identities = 42/199 (21%), Positives = 83/199 (41%), Gaps = 20/199 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G G+FG V++      G + A K +    +   ++   E + +  +RH  L+ +     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQPPI 800
              F+  +   ++YE+M  G + + +   ++K+ E   +  + +V   + ++H +     
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NY 276

Query: 801 VHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
           VH DLKP N++        +   DFGL   L     +             GT  +  PE 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---------VTTGTAEFAAPEV 327

Query: 859 GMGGDLSMTGDVYSFGILL 877
             G  +    D++S G+L 
Sbjct: 328 AEGKPVGYYTDMWSVGVLS 346

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 36/214 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITIC 740
           +G+G+   V            AVK++             E E L   + HRN++++I   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF- 79

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYLHN 794
               F+  D   +V+E M+ GS+   +H      +    N      +V +VAS +++LHN
Sbjct: 80  ----FEEEDRFYLVFEKMRGGSILSHIH------KRRHFNELEASVVVQDVASALDFLHN 129

Query: 795 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK--- 848
                I H DLKP N+L    +      + DF L   +  +             E+    
Sbjct: 130 KG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP----ELLTPC 182

Query: 849 GTIGYIGPEYGMGGDLSMTG-----DVYSFGILL 877
           G+  Y+ PE         +      D++S G++L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.4 bits (212), Expect = 6e-18
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 44/222 (19%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+GSFG V      +    VA+K ++   L K         E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 739 ICSSIDFKGADFKAIVYEYMQY--GSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNH 795
           + ++           +   ++Y  G + D++     ++ E        ++   IEY H H
Sbjct: 77  VITT--------PTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---------VAPEGQSSSIE 846
               IVH DLKP N+LLD ++   ++DFGL+  ++   FL          APE     I 
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE----VIN 180

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTD 888
            K    Y GPE           DV+S GI+L  M   R P D
Sbjct: 181 GK---LYAGPE----------VDVWSCGIVLYVMLVGRLPFD 209

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 87.1 bits (216), Expect = 7e-18
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 34/221 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-------------KGATKSFVAECEALRNI 728
           +G G++G V            A+KV+   +             +   +    E   L+++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
            H N+IK+  +     F+   +  +V E+ + G + + + + +   E    NI+ ++ S 
Sbjct: 104 DHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
           I YLH H    IVH D+KP N+LL   +  +   + DFGL+ F S    L          
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR--------- 206

Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           +  GT  YI PE  +    +   DV+S G+++  +     P
Sbjct: 207 DRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.7 bits (210), Expect = 9e-18
 Identities = 47/235 (20%), Positives = 85/235 (36%), Gaps = 62/235 (26%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA-ECEALRNIRHRNLIKIITIC 740
           +G+G++G V          +VAVK++++ +       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN----------IVIEVASVIE 790
                   + + +  EY   G + D +           +           ++    + + 
Sbjct: 75  RE-----GNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLM----AGVV 119

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP---FL---------VAP 838
           YLH      I H D+KP N+LLD      +SDFGLA    ++     L         VAP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 839 EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND 893
           E     ++ +    +               DV+S GI+L  M     P    ++ 
Sbjct: 177 E----LLKRR---EFHAEP----------VDVWSCGIVLTAMLAGELP----WDQ 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 38/209 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICS 741
           +G+G+   VY+          A+KV  L K    K    E   L  + H N+IK+  I  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI-- 116

Query: 742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVIEYLHNH 795
              F+     ++V E +  G + D +      +E G        + V ++   + YLH +
Sbjct: 117 ---FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHEN 167

Query: 796 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
               IVH DLKP N+L      D    ++DFGL++ + H   +           + GT G
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---------TVCGTPG 215

Query: 853 YIGPEYGMGGDLSMTGDVYSFG----ILL 877
           Y  PE   G       D++S G    ILL
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILL 244

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLI 734
             S +  +G G FG V+K      G+ +A K++        +    E   +  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLH 793
           ++        F+  +   +V EY+  G + D +   +  L E+  +  + ++   I ++H
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
                 I+H DLKP N+L  +     +   DFGLAR       L             GT 
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---------VNFGTP 252

Query: 852 GYIGPEYGMGGDLSMTGDVYSFG----ILL 877
            ++ PE      +S   D++S G    +LL
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 53/203 (26%), Positives = 79/203 (38%), Gaps = 18/203 (8%)

Query: 247 PVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLS 306
           P+C    +     +   + NLT  LP  L        L L+EN               L+
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 307 KLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMA 366
           +L L R  L     T L     L     L  L L  N+   +LP     L     L  ++
Sbjct: 59  QLNLDRAEL-----TKLQVDGTLPV---LGTLDLSHNQL-QSLPLLGQTLPALTVL-DVS 108

Query: 367 GNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLGLVGNNIRGIIPD 424
            N+++ ++P    R L  L  L L+ N+L  T+PP +      L+ L L  NN+  +   
Sbjct: 109 FNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAG 166

Query: 425 PIGNLTLLNVLQLGFNKLQGSIP 447
            +  L  L+ L L  N L  +IP
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIP 188

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 12/209 (5%)

Query: 379 RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLG 438
             + +   +  +   LT  +PP +   ++   L L  N +       +   T L  L L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 439 FNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLE 498
             +L   +    G    L  L   +N+L  +LP     +  L+  LD+S N L+ S+PL 
Sbjct: 64  RAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTV-LDVSFNRLT-SLPLG 118

Query: 499 V-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSL-NALKSIKEL 556
               L  L +L +  N      P  L+    LE L +  N+    +P  L N L+++  L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 557 DLSCNNLSGQIPIHLGNLPFLEYLNLSYN 585
            L  N+L   IP        L +  L  N
Sbjct: 178 LLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 45/180 (25%), Positives = 66/180 (36%), Gaps = 12/180 (6%)

Query: 337 KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG 396
            L L  N        +     T +T + +   ++  T       L  L  L L +NQL  
Sbjct: 35  ILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ- 90

Query: 397 TIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPS-YLGKCQN 455
           ++P     L  L  L +  N +  +    +  L  L  L L  N+L+ ++P   L     
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149

Query: 456 LMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRN 513
           L +LS  NN L   LP  +     L  L  L L EN L  +IP        L    +  N
Sbjct: 150 LEKLSLANNNLT-ELPAGLL--NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 41/154 (26%), Positives = 59/154 (38%), Gaps = 9/154 (5%)

Query: 163 LSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF 222
           ++     LT  LPP +          ++ N L      +L     L  L     + + + 
Sbjct: 15  VNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71

Query: 223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLE 282
                 +  L    L  N+ + SLP+ LG  LP LTVL V+ N LT     +L    +L+
Sbjct: 72  VDG--TLPVLGTLDLSHNQLQ-SLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127

Query: 283 WLELNENHFSG-QVRINFNSLPNLSKLYLGRNNL 315
            L L  N        +     P L KL L  NNL
Sbjct: 128 ELYLKGNELKTLPPGL-LTPTPKLEKLSLANNNL 160

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 45/192 (23%), Positives = 68/192 (35%), Gaps = 19/192 (9%)

Query: 102 IPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIE 161
           +PK+   L       LS N         L     L    +    L  ++Q   G    + 
Sbjct: 29  LPKDTTILH------LSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLG 80

Query: 162 RLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS-- 219
            L L  NQL   LP     L AL   D++ N+L      +L  L  L  L    N+    
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139

Query: 220 --GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSN 277
             G+          L++  L  N     LP  L   L  L  L++ +N+L   +P+    
Sbjct: 140 PPGLLT----PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFG 193

Query: 278 ASKLEWLELNEN 289
           +  L +  L+ N
Sbjct: 194 SHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 47/212 (22%), Positives = 70/212 (33%), Gaps = 33/212 (15%)

Query: 48  NLCQWTGVTC-GHRHQRV--------TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSF 98
            +     V C       +        T L L    +  F    +   + L  +NL     
Sbjct: 8   KVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 99  HGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL 158
                +  G L  L T+ LS+N     +P        L    V  N     + ++    L
Sbjct: 68  --TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN----RLTSLPLGAL 120

Query: 159 ----KIERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSL-GQLRNLNYLG 212
               +++ L L GN+L   LPP +      L+   +A N L   +P  L   L NL+ L 
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLL 178

Query: 213 TSENDFS----GMFPLSVCNISSLDEAYLFKN 240
             EN       G F         L  A+L  N
Sbjct: 179 LQENSLYTIPKGFFGS-----HLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 30/128 (23%), Positives = 48/128 (37%), Gaps = 11/128 (8%)

Query: 484 LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI 543
           ++  + +L+ ++P      K    L +S N        TL   T L  L +        +
Sbjct: 15  VNCDKRNLT-ALP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KL 70

Query: 544 PQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVF---SNE 600
                 L  +  LDLS N L   +P+    LP L  L++S+N     +P  G        
Sbjct: 71  Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLP-LGALRGLGEL 126

Query: 601 TRISLTGN 608
             + L GN
Sbjct: 127 QELYLKGN 134

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 84.6 bits (210), Expect = 1e-17
 Identities = 59/238 (24%), Positives = 116/238 (48%), Gaps = 22/238 (9%)

Query: 657 MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGA 714
           M +Q+  V      + +K +    +IG+G+FG V+K    + G  VA+K + ++  K+G 
Sbjct: 1   MAKQYDSVECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

Query: 715 TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY---EYMQYGSVDD---WLH 768
             + + E + L+ ++H N++ +I IC +        K  +Y   ++ ++    D    L 
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLS 115

Query: 769 HTNDKLEVGKL-NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 827
           +   K  + ++  ++  + + + Y+H +    I+H D+K +NVL+  D V  ++DFGLAR
Sbjct: 116 NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172

Query: 828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
             S       P   ++ +    T+ Y  PE  +G        D++  G ++ EM+TR 
Sbjct: 173 AFS-LAKNSQPNRYTNRVV---TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 48/231 (20%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
              ++ +  IG GSFG VY+  L + G  VA+K +  DK+   +    E + +R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 733 LIKII-TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE------- 784
           ++++     SS + K   +  +V +Y+      + ++         K  + +        
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 785 -VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLV------ 836
            +   + Y+H+     I H D+KP N+LLD D  V  + DFG A+ L      V      
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220

Query: 837 ---APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
              APE       + G   Y           + + DV+S G +L E+   +
Sbjct: 221 YYRAPE------LIFGATDY-----------TSSIDVWSAGCVLAELLLGQ 254

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 85.5 bits (212), Expect = 2e-17
 Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKGSFG V K          AVKV+N        T + + E E L+ + H N++K+  I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP 799
                 + +    IV E    G + D +       E     I+ +V S I Y+H H    
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141

Query: 800 IVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           IVH DLKP N+LL   + D    + DFGL+     +  +          +  GT  YI P
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---------DRIGTAYYIAP 192

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E  + G      DV+S G++L  + +   P
Sbjct: 193 EV-LRGTYDEKCDVWSAGVILYILLSGTPP 221

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 40/187 (21%), Positives = 75/187 (40%), Gaps = 34/187 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKG+F  V +      G+  A K++N  K      +    E    R ++H N++++   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVIEYLH 793
                 +   F  +V++ +  G + + +      +           + + ++   I Y H
Sbjct: 74  -----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 122

Query: 794 NHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           ++    IVH +LKP N+LL          ++DFGLA  ++                  GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---------GFAGT 170

Query: 851 IGYIGPE 857
            GY+ PE
Sbjct: 171 PGYLSPE 177

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 82.7 bits (205), Expect = 1e-16
 Identities = 43/217 (19%), Positives = 81/217 (37%), Gaps = 49/217 (22%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKG+F  V +      G   A  ++N  K      +    E    R ++H N++++   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVIEYLH 793
            S           ++++ +  G + + +      +           + + ++   + + H
Sbjct: 79  ISE-----EGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCH 127

Query: 794 NHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
                 +VH +LKP N+LL          ++DFGLA  +           Q +     GT
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--------EGEQQAWFGFAGT 176

Query: 851 IGYIGPE------YGMGGDLSMTGDVYSFG----ILL 877
            GY+ PE      YG         D+++ G    ILL
Sbjct: 177 PGYLSPEVLRKDPYG------KPVDLWACGVILYILL 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 44/208 (21%), Positives = 85/208 (40%), Gaps = 28/208 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKI 736
           IGKG F  V +    E G   AVK++++ K       +T+    E      ++H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSV-DDWLHHTNDKL---EVGKLNIVIEVASVIEYL 792
           +   SS          +V+E+M    +  + +   +      E    + + ++   + Y 
Sbjct: 92  LETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 793 HNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
           H++    I+H D+KP  VLL   ++     +  FG+A  L         E    +    G
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--------GESGLVAGGRVG 195

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILL 877
           T  ++ PE           DV+  G++L
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 80.6 bits (200), Expect = 1e-16
 Identities = 50/220 (22%), Positives = 98/220 (44%), Gaps = 39/220 (17%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKII 737
            +IG+G++G V+K    E    VA+K + LD   +G   S + E   L+ ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDD---WLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
            +  S          +V+E+       D   +    N  L+   + + + ++   + + H
Sbjct: 68  DVLHS---DKKLT--LVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG---- 849
           +     ++H DLKP N+L++ +    +++FGLAR                 I ++     
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAF--------------GIPVRCYSAE 161

Query: 850 --TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRRRP 886
             T+ Y  P+   G  L  T  D++S G +  E+    RP
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 82.7 bits (205), Expect = 1e-16
 Identities = 86/463 (18%), Positives = 149/463 (32%), Gaps = 87/463 (18%)

Query: 184 LQTFDIAGNKL-DGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRF 242
           +Q+ DI   +L D R  + L  L+    +            L  C ++      +     
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVR-----------LDDCGLTEARCKDISS--- 50

Query: 243 KGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA-----SKLEWLELNENHFSGQ--- 294
                  L  N P L  L +  N L       +         K++ L L     +G    
Sbjct: 51  ------ALRVN-PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103

Query: 295 -VRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSI 353
            +     +LP L +L+L  N LG      L    LL    +L KL L +     A    +
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLL-CEGLLDPQCRLEKLQLEYCSLSAASCEPL 162

Query: 354 ANL---STTMTLIAMAGNQISGTIPPEI-----RNLFNLNGLGLEYNQLT----GTIPPA 401
           A++         + ++ N I+      +      +   L  L LE   +T      +   
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222

Query: 402 IGELRNLQYLGLVGNNI-----RGIIPDPIGNLTLLNVLQLGFNKLQ----GSIPSYLGK 452
           +    +L+ L L  N +       + P  +   + L  L +    +     G +   L  
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282

Query: 453 CQNLMQLSAPNNKLNGTLPPQIFGITTLSKL----------LDLSENHLSG----SIPLE 498
            ++L +LS   N+L         G   L +           L +     +          
Sbjct: 283 KESLKELSLAGNELGDE------GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336

Query: 499 VGNLKSLVQLDISRNNFSNEIPVTLSA-----CTTLEYLLMQGNSFN----GSIPQSLNA 549
           +   + L++L IS N   +     L        + L  L +     +     S+  +L A
Sbjct: 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 396

Query: 550 LKSIKELDLSCNNLSGQIPIHLG-----NLPFLEYLNLSYNHF 587
             S++ELDLS N L     + L          LE L L   ++
Sbjct: 397 NHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 74.6 bits (184), Expect = 6e-14
 Identities = 57/345 (16%), Positives = 102/345 (29%), Gaps = 58/345 (16%)

Query: 279 SKLEWLELNENHFSGQ-VRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVK 337
             ++ L++     S          L     + L    L      D+     L     L +
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS--ALRVNPALAE 60

Query: 338 LGLVFNRFGG----ALPHSIANLSTTMTLIAMAGNQISGT----IPPEIRNLFNLNGLGL 389
           L L  N  G      +   +   S  +  +++    ++G     +   +R L  L  L L
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 390 EYNQLTGTIPPAIGELR-----NLQYLGLVGNNIRGIIPDPIG----NLTLLNVLQLGFN 440
             N L       + E        L+ L L   ++     +P+            L +  N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 441 KLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS----GSIP 496
            +  +    L +      L     +L               + L L    ++      + 
Sbjct: 181 DINEAGVRVLCQG-----LKDSPCQL---------------EALKLESCGVTSDNCRDLC 220

Query: 497 LEVGNLKSLVQLDISRNNFSNE-----IPVTLSACTTLEYLLMQGNSFN----GSIPQSL 547
             V +  SL +L +  N   +       P  L   + L  L +          G + + L
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280

Query: 548 NALKSIKELDLSCNNLSGQIPIHLGNL-----PFLEYLNLSYNHF 587
            A +S+KEL L+ N L  +    L          LE L +    F
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 74.2 bits (183), Expect = 7e-14
 Identities = 65/394 (16%), Positives = 111/394 (28%), Gaps = 77/394 (19%)

Query: 230 SSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLT----GFLPQSLSNASKLEWLE 285
             +    +       +    L   L +  V+ +    LT      +  +L     L  L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 286 LNENHFSGQ-VRINFNSL----PNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGL 340
           L  N      V      L      + KL L    L       L   + L     L +L L
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQELHL 120

Query: 341 VFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP 400
             N  G A    +  L   +                 +     L  L LEY  L+     
Sbjct: 121 SDNLLGDA---GLQLLCEGL-----------------LDPQCRLEKLQLEYCSLSAASCE 160

Query: 401 AIGEL----RNLQYLGLVGNNI-----RGIIPDPIGNLTLLNVLQLGFNKLQ----GSIP 447
            +  +     + + L +  N+I     R +      +   L  L+L    +       + 
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220

Query: 448 SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQ 507
             +    +L +L+  +NKL         G+  L   L L  +               L  
Sbjct: 221 GIVASKASLRELALGSNKLGDV------GMAELCPGL-LHPS-------------SRLRT 260

Query: 508 LDISRNNFSNE----IPVTLSACTTLEYLLMQGNSFNGSIPQSL-----NALKSIKELDL 558
           L I     + +    +   L A  +L+ L + GN       + L          ++ L +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320

Query: 559 SCNNLSGQ----IPIHLGNLPFLEYLNLSYNHFE 588
              + +          L    FL  L +S N  E
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.8 bits (161), Expect = 3e-11
 Identities = 66/363 (18%), Positives = 116/363 (31%), Gaps = 54/363 (14%)

Query: 59  HRHQRVTKLDLESQNIG----GFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFR--- 111
               ++ KL L++  +     G LS  +  L  L+ ++L++N       + +        
Sbjct: 82  TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141

Query: 112 --LETIVLSNNSFSGK----IPTNLSRCFNLIDFWVHTNNL----VGEI-QAIIGNWLKI 160
             LE + L   S S      + + L    +  +  V  N++    V  + Q +  +  ++
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201

Query: 161 ERLSLYGNQLTGQ----LPPSIGNLSALQTFDIAGNKLDGR-----IPDSLGQLRNLNYL 211
           E L L    +T      L   + + ++L+   +  NKL         P  L     L  L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261

Query: 212 GTSENDFS--GMFPLS--VCNISSLDEAYLFKNRFKGS----LPVCLGFNLPKLTVLVVA 263
              E   +  G   L   +    SL E  L  N         L   L     +L  L V 
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321

Query: 264 QNNLTG----FLPQSLSNASKLEWLELNENHFS-------GQVRINFNSLPNLSKLYLGR 312
             + T          L+    L  L+++ N           Q      S   L  L+L  
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS--VLRVLWLAD 379

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGG----ALPHSIANLSTTMTLIAMAGN 368
            ++   + + L     L     L +L L  N  G      L  S+      +  + +   
Sbjct: 380 CDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437

Query: 369 QIS 371
             S
Sbjct: 438 YWS 440

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 43/243 (17%), Positives = 76/243 (31%), Gaps = 57/243 (23%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKI 736
           IG+GS+G V      +     A+K+MN +K         +    E   ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 737 ITICSS-------------------IDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG 777
             +                      ++    D        +    +        + +   
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 778 KL----------------NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV- 820
                             NI+ ++ S + YLHN     I H D+KP N L   +    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 821 -SDFGLARFLSHHPFLVAPEGQSSSIEMK---GTIGYIGPE--YGMGGDLSMTGDVYSFG 874
             DFGL++                   M    GT  ++ PE             D +S G
Sbjct: 211 LVDFGLSKEFY-------KLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263

Query: 875 ILL 877
           +LL
Sbjct: 264 VLL 266

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 38/211 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITI 739
           +GKG+F  V +      G+  A K++N  K      +    E    R ++H N++++   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVIEYLH 793
                 +   F  +V++ +  G + + +      +           + + ++   I Y H
Sbjct: 97  -----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 145

Query: 794 NHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           ++    IVH +LKP N+LL          ++DFGLA  +         + ++      GT
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--------NDSEAWH-GFAGT 193

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFG----ILL 877
            GY+ PE       S   D+++ G    ILL
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 31/215 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           IGKGSFG V      +     A+K MN     ++   ++   E + ++ + H  L+ +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL----EVGKLNIVIEVASVIEYLHN 794
             S   F+  +   +V + +  G   D  +H    +    E  KL I  E+   ++YL N
Sbjct: 82  -YS---FQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQN 133

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
                I+H D+KP N+LLD     H++DF +A        ++  E Q ++  M GT  Y+
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAA-------MLPRETQITT--MAGTKPYM 181

Query: 855 GPE---YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            PE      G   S   D +S G+   E+   RRP
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 46/232 (19%), Positives = 80/232 (34%), Gaps = 55/232 (23%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHR--NL 733
           +G G FG VY G    D + VA+K +  D+               E   L+ +      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQ-YGSVDDWLHHTNDKLEVGKLN------IVIEVA 786
           I+++      +   +    ++ E  +    + D++       E G L          +V 
Sbjct: 111 IRLLDW---FERPDSFV--LILERPEPVQDLFDFI------TERGALQEELARSFFWQVL 159

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFL--------VA 837
             + + HN     ++H D+K  N+L+D +     + DFG    L    +           
Sbjct: 160 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP 216

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
           PE     I       Y G              V+S GILL +M     P ++
Sbjct: 217 PE----WIRYH---RYHGRS----------AAVWSLGILLYDMVCGDIPFEH 251

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 43/222 (19%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIIT 738
            ++G G++  VYKG     G+ VA+K + LD + G   + + E   ++ ++H N++++  
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKLNIVIEVASV-------I 789
           +  +   +      +V+E+M     D   ++           L +   V          +
Sbjct: 71  VIHT---ENKLT--LVFEFMDN---DLKKYMDSRTVGNTPRGLELN-LVKYFQWQLLQGL 121

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            + H +    I+H DLKP N+L++      + DFGLAR                 I +  
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF--------------GIPVNT 164

Query: 850 ------TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
                 T+ Y  P+  MG     T  D++S G +L EM T +
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.2 bits (196), Expect = 6e-16
 Identities = 51/223 (22%), Positives = 100/223 (44%), Gaps = 38/223 (17%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRN 732
           + +   +++G+G++  VYKG        VA+K + L+ + GA  + + E   L++++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDD---WLHHTNDKLEVGKL-NIVIEVASV 788
           ++ +  I  +   + +    +V+EY+      D   +L    + + +  +   + ++   
Sbjct: 62  IVTLHDIIHT---EKSLT--LVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRG 112

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + Y H      ++H DLKP N+L++      ++DFGLAR                SI  K
Sbjct: 113 LAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK--------------SIPTK 155

Query: 849 G------TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
                  T+ Y  P+  +G     T  D++  G +  EM T R
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.8 bits (195), Expect = 7e-16
 Identities = 47/210 (22%), Positives = 89/210 (42%), Gaps = 29/210 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+GSF  V            A+K++      K+        E + +  + H   +K+  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI------EVASVIEYL 792
             +   F+  +       Y + G   + L +     ++G  +         E+ S +EYL
Sbjct: 97  -FT---FQDDEKLYFGLSYAKNG---ELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 146

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H      I+H DLKP N+LL+ DM   ++DFG A+ LS      + + +++S    GT  
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP----ESKQARANS--FVGTAQ 197

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
           Y+ PE         + D+++ G ++ ++  
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 39/179 (21%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHRNLIKIITIC 740
           IG GS+    +       M  AVK+++  K+  T+    E E L R  +H N+I +  + 
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDV- 84

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYLHN 794
               +    +  +V E M+ G + D +      L     +      ++  +   +EYLH 
Sbjct: 85  ----YDDGKYVYVVTELMKGGELLDKI------LRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 795 HCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHH----------PFLVAPE 839
                +VH DLKPSN+L      +     + DFG A+ L                VAPE
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 22/213 (10%), Positives = 52/213 (24%), Gaps = 56/213 (26%)

Query: 681 RIGKGSFGFVYKG---NLGEDGMSVAVKVMNLDKKGATKS---FVAECEALRNIRHRNLI 734
             G       ++     L      VA+  ++             ++    L  I    + 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQ---VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 735 KIITICSSIDF-KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           +++      D         +V E+++ GS+ +    +   +    +  +  +A+  +  H
Sbjct: 95  RVL------DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA--IRAMQSLAAAADAAH 146

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
                 +      PS V +  D    ++                                
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYPATM----------PDANPQD---------- 183

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                          D+   G  L  +   R P
Sbjct: 184 ---------------DIRGIGASLYALLVNRWP 201

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 53/235 (22%), Positives = 87/235 (37%), Gaps = 44/235 (18%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR 729
            K    F      G+G+FG V  G     GMSVA+K +  D +   +  +   + L  + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77

Query: 730 HRNLIKIITICSSIDFKGAD--FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           H N++++ +   ++  +     +  +V EY+      D LH         ++     +  
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIK 132

Query: 788 V--------IEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLV-- 836
           V        I  LH      + H D+KP NVL++  D    + DFG A+ LS     V  
Sbjct: 133 VFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191

Query: 837 -------APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
                  APE       + G   Y           +   D++S G +  EM    
Sbjct: 192 ICSRYYRAPE------LIFGNQHY-----------TTAVDIWSVGCIFAEMMLGE 229

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 35/210 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNLIK 735
           +G G F  V K      G+  A K +   +  A++  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWL----HHTNDKLEVGKLNIVIEVASVIEY 791
           +  +     ++      ++ E +  G + D+L      +    E    + + ++   + Y
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLS----EEEATSFIKQILDGVNY 130

Query: 792 LHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
           LH      I H DLKP N++L           + DFGLA  +                 +
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---------NI 178

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
            GT  ++ PE      L +  D++S G++ 
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKII- 737
            ++G+G +  V++     +   V VK++   KK   K    E + L N+R   N+I +  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLAD 98

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHC 796
            +   +        A+V+E++   + D         L    +   + E+   ++Y H+  
Sbjct: 99  IVKDPVSRT----PALVFEHVN--NTD--FKQLYQTLTDYDIRFYMYEILKALDYCHSMG 150

Query: 797 QPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
              I+H D+KP NV++DH+     + D+GLA F  +HP      GQ  ++ +  +  + G
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHP------GQEYNVRV-ASRYFKG 198

Query: 856 PEYGMGG---DLSMTGDVYSFGILLLEMFTRRRP 886
           PE  +     D S+  D++S G +L  M  R+ P
Sbjct: 199 PELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP 230

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 39/216 (18%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           IG+G+FG V            A+K+++     K+  +  F  E + +       ++++  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVASVIEYL 792
             +   F+   +  +V EYM  G   D ++     +    +          EV   ++ +
Sbjct: 136 -YA---FQDDRYLYMVMEYMPGG---DLVNL----MSNYDVPEKWARFYTAEVVLALDAI 184

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           H+      +H D+KP N+LLD     H+  +DFG    ++        EG        GT
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMN-------KEGMVRCDTAVGT 232

Query: 851 IGYIGPE--YGMGGDLSMTGDV--YSFGILLLEMFT 882
             YI PE     GGD     +   +S G+ L EM  
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.8 bits (197), Expect = 2e-15
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 32/215 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG FG V    +   G   A K +      K+      + E + L  +  R    +++
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF---VVS 248

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVI----EVASVIEYLH 793
           +  +  ++  D   +V   M  G   D   H     + G      +    E+   +E LH
Sbjct: 249 LAYA--YETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
                 IV+ DLKP N+LLD     H+  SD GLA  +        PEGQ+      GT+
Sbjct: 304 RER---IVYRDLKPENILLDDH--GHIRISDLGLAVHV--------PEGQTIK-GRVGTV 349

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           GY+ PE       + + D ++ G LL EM   + P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 39/172 (22%), Positives = 74/172 (43%), Gaps = 23/172 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHRNLIKIITIC 740
           +G G  G V +      G   A+K++  D   A +    E +   +     +++ I+ + 
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVY 91

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQP 798
            ++         I+ E M+ G +   +    D+   E     I+ ++ + I++LH+H   
Sbjct: 92  ENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-- 148

Query: 799 PIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFL--------VAPE 839
            I H D+KP N+L    + D V  ++DFG A+  + +           VAPE
Sbjct: 149 -IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE 199

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 45/206 (21%), Positives = 80/206 (38%), Gaps = 27/206 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNLIK 735
           +G G F  V K      G+  A K +   +  A++  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH 795
           +  +     ++      ++ E +  G + D+L       E    + + ++   + YLH  
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 796 CQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
               I H DLKP N++L           + DFGLA  +                 + GT 
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---------NIFGTP 182

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILL 877
            ++ PE      L +  D++S G++ 
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVIT 208

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 12/154 (7%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRHRNLIKII 737
             +G+GS+G V K    + G  VA+K      D K   K  + E + L+ +RH NL+ ++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            +C     K   +  +V+E++ + ++ D L    + L+   +   + ++ + I + H+H 
Sbjct: 91  EVCKK---KKRWY--LVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
              I+H D+KP N+L+    V  + DFG AR L+
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IG+G+F  V    + + G   A+K+MN   + K+G    F  E + L N   R + ++  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQ 797
             +   F+  ++  +V EY   G +   L    +++        + E+   I+ +H    
Sbjct: 128 -FA---FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG- 182

Query: 798 PPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
              VH D+KP N+LLD     H+  +DFG    L         +G   S+   GT  Y+ 
Sbjct: 183 --YVHRDIKPDNILLDRC--GHIRLADFGSCLKLR-------ADGTVRSLVAVGTPDYLS 231

Query: 856 PE--YGMGGDLSMTG-----DVYSFGILLLEMFT 882
           PE    +GG           D ++ G+   EMF 
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 48/229 (20%)

Query: 681 RIGKGSFGFVYKG--NLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           ++G+G++G VYK     G+D    A+K +     G + S   E   LR ++H N+I +  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQK 85

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDW-LHHTNDKLEVGKLNIVIEVASV--------- 788
           +  S          ++++Y ++   D W +   +   +  K  + +    V         
Sbjct: 86  VFLS---HADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 789 -IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLARF-------LSHHPFLV 836
            I YLH +    ++H DLKP+N+L+  +        ++D G AR        L+    +V
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
                        T  Y  PE  +G        D+++ G +  E+ T  
Sbjct: 197 V------------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 49/236 (20%), Positives = 97/236 (41%), Gaps = 47/236 (19%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKG-NLGEDGMSVAVKVMNLDKKGATKSFVAECE----- 723
            +A +++     IG+G++G V+K  +L   G  VA+K + +             E     
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLS 57

Query: 724 ALRNI---------RHRNLIKIITICSSIDFKGADFKAIVYEYMQY---GSVDDWLHHTN 771
            +R +          H N++++  +C+           +V+E++       +D       
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117

Query: 772 DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR-FLS 830
               +  +  + ++   +++LH+H    +VH DLKP N+L+       ++DFGLAR +  
Sbjct: 118 PTETIKDM--MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172

Query: 831 HHPF--LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
                 +V             T+ Y  PE  +    +   D++S G +  EMF R+
Sbjct: 173 QMALTSVVV------------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 41/189 (21%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITIC 740
           +G+GSF    K    +   + AVK+++   +  T+    E  AL+    H N++K+  + 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN------IVIEVASVIEYLHN 794
               F       +V E +  G + + +       +    +      I+ ++ S + ++H+
Sbjct: 75  ----FHDQLHTFLVMELLNGGELFERI------KKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 795 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK--- 848
                +VH DLKP N+L    + ++   + DFG AR          P+ Q     +K   
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-------PDNQ----PLKTPC 170

Query: 849 GTIGYIGPE 857
            T+ Y  PE
Sbjct: 171 FTLHYAAPE 179

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 11/168 (6%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEI--RNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQY 410
            +L +   L+ ++ N +S  +  E     L NL+ L L +N L   I   A   + NL+Y
Sbjct: 35  QSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRY 92

Query: 411 LGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY-LGKCQNLMQLSAPNNKLNGT 469
           L L  N++  +      +L  L VL L  N +   +          L +L    N+++  
Sbjct: 93  LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-R 150

Query: 470 LPPQIF-GITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNN 514
            P ++      L KL  LDLS N L      ++  L + V+  +  +N
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 49/201 (24%), Positives = 70/201 (34%), Gaps = 34/201 (16%)

Query: 391 YNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI-GNLTLLNVLQLGFNKLQGSIPSY 449
             QL   +P ++        L L  NN+  +  +     LT L+ L L  N L   I S 
Sbjct: 27  KQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82

Query: 450 -LGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEV-GNLKSL 505
                 NL  L   +N L+ TL   +F  + L  L  L L  NH+   +      ++  L
Sbjct: 83  AFVPVPNLRYLDLSSNHLH-TLDEFLF--SDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138

Query: 506 VQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSG 565
            +L +S+N  S   PV                          N L  +  LDLS N L  
Sbjct: 139 QKLYLSQNQISR-FPV---------------ELIKD-----GNKLPKLMLLDLSSNKLKK 177

Query: 566 QIPIHLGNLPFLEYLNLSYNH 586
                L  LP      L  ++
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 46/257 (17%), Positives = 84/257 (32%), Gaps = 40/257 (15%)

Query: 184 LQTFDIAGNKLDGRIP--DSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
               D++ N L  R+    +  +L NL+ L            LS  +++ +  +  F   
Sbjct: 41  TALLDLSHNNL-SRLRAEWTPTRLTNLHSLL-----------LSHNHLNFI-SSEAFVP- 86

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
                       +P L  L ++ N+L        S+   LE L L  NH     R  F  
Sbjct: 87  ------------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           +  L KLYL +N +   +   ++ I       KL+ L L  N+        +  L   + 
Sbjct: 135 MAQLQKLYLSQNQI---SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191

Query: 362 L-IAMAGNQISGTIPPEIRNLF------NLNGLGLEYNQLTGTIPPAIGELRNLQYLGLV 414
             + +  N +      ++  LF       L+ +      L       +  + +L +    
Sbjct: 192 NGLYLHNNPL--ECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCS 249

Query: 415 GNNIRGIIPDPIGNLTL 431
                         LT+
Sbjct: 250 EYKESAWEAHLGDTLTI 266

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 13/190 (6%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYL 411
           +N+      + +  N++S ++P +    L  L  L L  N+L  T+P  I  EL+NL+ L
Sbjct: 33  SNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90

Query: 412 GLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYL-GKCQNLMQLSAPNNKLNGTL 470
            +  N ++ +       L  L  L+L  N+L+ S+P  +      L  LS   N+L  +L
Sbjct: 91  WVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SL 148

Query: 471 PPQIFGITTLSKL--LDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACT 527
           P  +F    L+ L  L L  N L   +P      L  L  L +  N           +  
Sbjct: 149 PKGVF--DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205

Query: 528 TLEYLLMQGN 537
            L+ L +Q N
Sbjct: 206 KLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 21/195 (10%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLN 433
           IP + + L       L+ N+L+     A   L  L+ L L  N ++ +       L  L 
Sbjct: 35  IPADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88

Query: 434 VLQLGFNKLQGSIPS----YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLS 487
            L +  NKLQ ++P      L    NL +L    N+L  +LPP++F   +L+KL  L L 
Sbjct: 89  TLWVTDNKLQ-ALPIGVFDQLV---NLAELRLDRNQLK-SLPPRVF--DSLTKLTYLSLG 141

Query: 488 ENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
            N L  S+P  V   L SL +L +  N             T L+ L +  N        +
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200

Query: 547 LNALKSIKELDLSCN 561
            ++L+ +K L L  N
Sbjct: 201 FDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 54/258 (20%), Positives = 85/258 (32%), Gaps = 84/258 (32%)

Query: 161 ERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
           ++L L  N+L+  LP      L+ L+   +  NKL         +L+NL  L        
Sbjct: 40  KKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL-------- 90

Query: 220 GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNAS 279
                           ++  N+ + +LP+ +   L  L  L + +N L   LP  +    
Sbjct: 91  ----------------WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV---- 128

Query: 280 KLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLG 339
                              F+SL  L+ L LG N L    S                   
Sbjct: 129 -------------------FDSLTKLTYLSLGYNEL---QS------------------- 147

Query: 340 LVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTI 398
                    LP  + +  T++  + +  NQ+   +P      L  L  L L+ NQL    
Sbjct: 148 ---------LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVP 197

Query: 399 PPAIGELRNLQYLGLVGN 416
             A   L  L+ L L  N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 49/195 (25%), Positives = 76/195 (38%), Gaps = 21/195 (10%)

Query: 126 IPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL-KIERLSLYGNQLTGQLPPSI-GNLSA 183
           IP +  +        + +N L   + +   + L K+  L L  N+L   LP  I   L  
Sbjct: 35  IPADTKK------LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 184 LQTFDIAGNKLDGRIPDSL-GQLRNLNYLGTSENDFS----GMFPLSVCNISSLDEAYLF 238
           L+T  +  NKL   +P  +  QL NL  L    N        +F     +++ L    L 
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD----SLTKLTYLSLG 141

Query: 239 KNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN 298
            N  + SLP  +   L  L  L +  N L      +    ++L+ L+L+ N         
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200

Query: 299 FNSLPNLSKLYLGRN 313
           F+SL  L  L L  N
Sbjct: 201 FDSLEKLKMLQLQEN 215

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 35/210 (16%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNLIK 735
           +G G F  V K      G+  A K +   +  +++  V+      E   L+ I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWL----HHTNDKLEVGKLNIVIEVASVIEY 791
           +  +     ++      ++ E +  G + D+L      T    E      + ++ + + Y
Sbjct: 79  LHEV-----YENKTDVILILELVAGGELFDFLAEKESLT----EEEATEFLKQILNGVYY 129

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLARFLSHHPFLVAPEGQSSSIEM 847
           LH+     I H DLKP N++L    V      + DFGLA  +                 +
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---------NI 177

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILL 877
            GT  ++ PE      L +  D++S G++ 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 43/216 (19%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVA------ECEALRNIRHRNLIK 735
           +G G F  V K      G   A K +   +  +++  V+      E   LR IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL------NIVIEVASVI 789
           +  I     F+      ++ E +  G + D+L       E   L        + ++   +
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLKQILDGV 121

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLARFLSHHPFLVAPEGQSSSI 845
            YLH+     I H DLKP N++L    V +    + DFG+A  +                
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--------- 169

Query: 846 EMKGTIGYIGPEYGMGGDLSMTGDVYSFG----ILL 877
            + GT  ++ PE      L +  D++S G    ILL
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 12/154 (7%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRHRNLIKII 737
            +IG+GS+G V+K    + G  VA+K      D     K  + E   L+ ++H NL+ ++
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYLHNHC 796
            +      K      +V+EY  + +V   L      +    + +I  +    + + H H 
Sbjct: 69  EVFRR---KRRLH--LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
               +H D+KP N+L+    V  + DFG AR L+
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 53/231 (22%), Positives = 94/231 (40%), Gaps = 35/231 (15%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI 728
           S AT  +     IG G++G VYK      G  VA+K + +    G           +R +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--PISTVREV 62

Query: 729 ---------RHRNLIKIITICSSIDFKGADFKAIVYEYMQY---GSVDDWLHHTNDKLEV 776
                     H N+++++ +C++          +V+E++       +D           +
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122

Query: 777 GKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR-FLSHHPF- 834
             L  + +    +++LH +C   IVH DLKP N+L+       ++DFGLAR +       
Sbjct: 123 KDL--MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177

Query: 835 -LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
            +V             T+ Y  PE  +    +   D++S G +  EMF R+
Sbjct: 178 PVVV------------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 53/224 (23%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKII-TIC 740
           IG GSFG V++  L E    VA+K +  DK+   +    E + +R ++H N++ +     
Sbjct: 48  IGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFY 102

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV----------IE 790
           S+ D K   F  +V EY+      + ++  +      KL   + +  +          + 
Sbjct: 103 SNGDKKDEVFLNLVLEYV-----PETVYRASRHY--AKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFLV---------APEG 840
           Y+H+     I H D+KP N+LLD    V  + DFG A+ L      V         APE 
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPE- 211

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
                 + G   Y           +   D++S G ++ E+   +
Sbjct: 212 -----LIFGATNY-----------TTNIDIWSTGCVMAELMQGQ 239

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.9 bits (192), Expect = 5e-15
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G+G FG V+   +   G   A K +N     K+   +  + E + L  +  R ++ +  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI----EVASVIEYLHN 794
             +   F+      +V   M  G +   +++ ++     +    I    ++ S +E+LH 
Sbjct: 252 -YA---FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
                I++ DLKP NVLLD D   +V  SD GLA             GQ+ +    GT G
Sbjct: 308 RN---IIYRDLKPENVLLDDD--GNVRISDLGLAV--------ELKAGQTKTKGYAGTPG 354

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           ++ PE  +G +   + D ++ G+ L EM   R P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 6e-15
 Identities = 51/248 (20%), Positives = 89/248 (35%), Gaps = 44/248 (17%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRHRNLIKIIT 738
            IG GS+G V +     +   VA+K +    +     K  + E   L  + H +++K++ 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119

Query: 739 ICSSIDFKGADFKAI--VYEYMQYGSVDDWLH---HTNDKL-EVGKLNIVIEVASVIEYL 792
           I    D +   F  +  V E        D       T   L E+    ++  +   ++Y+
Sbjct: 120 IVIPKDVE--KFDELYVVLEIADS----D-FKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H+     I+H DLKP+N L++ D    V DFGLAR + +         Q      +  + 
Sbjct: 173 HSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE---NGNSQLPISPREDDMN 226

Query: 853 YIGPEYGMGGDLSMTG-----------------------DVYSFGILLLEMFTRRRPTDN 889
            +   +       +TG                       DV+S G +  E+    +    
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286

Query: 890 MFNDGLTL 897
              D   L
Sbjct: 287 YHADRGPL 294

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 25/197 (12%)

Query: 326 ITLLTNCSKLVKLGLVFNRFGGALPHSIANLS--TTMTLIAMAGNQISGTIPPEIRNLFN 383
           +      +  VK  L            + +    + +       + I  ++   ++   N
Sbjct: 12  VFPDPGLANAVKQNLGKQSV-----TDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTN 64

Query: 384 LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
           L  L L +NQ++  + P + +L  L+ L +  N ++ +  + I +   L+ L L  N+L 
Sbjct: 65  LKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNL--NGIPSAC-LSRLFLDNNEL- 118

Query: 444 GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGN 501
                 L   +NL  LS  NNKL       I  +  LSKL  LDL  N ++ +  L    
Sbjct: 119 -RDTDSLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNTGGLT--R 170

Query: 502 LKSLVQLDISRNNFSNE 518
           LK +  +D++     NE
Sbjct: 171 LKKVNWIDLTGQKCVNE 187

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 42/174 (24%), Positives = 66/174 (37%), Gaps = 20/174 (11%)

Query: 415 GNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQI 474
              I  + PDP   L       LG   +  +      +   +   +  N+ +       +
Sbjct: 6   PTPINQVFPDP--GLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-----SL 56

Query: 475 FGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYL 532
            G+   + L  L LS N +S   PL+  +L  L +L ++RN   N   +       L  L
Sbjct: 57  AGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLKN---LNGIPSACLSRL 111

Query: 533 LMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNH 586
            +  N        SL  LK+++ L +  N L   I   LG L  LE L+L  N 
Sbjct: 112 FLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNE 161

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 38/241 (15%), Positives = 73/241 (30%), Gaps = 47/241 (19%)

Query: 202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLV 261
              L N       +   + +       +S +       +  +    +        L  L 
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAGMQ---FFTNLKELH 69

Query: 262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST 321
           ++ N ++      L + +KLE L +N N       +N      LS+L+L  N L      
Sbjct: 70  LSHNQISDL--SPLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNEL-----R 119

Query: 322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
           D D    L +   L  L +                           N++  +I   +  L
Sbjct: 120 DTDS---LIHLKNLEILSI-------------------------RNNKLK-SIVM-LGFL 149

Query: 382 FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNK 441
             L  L L  N++T      +  L+ + ++ L G             L + N ++    +
Sbjct: 150 SKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR 207

Query: 442 L 442
            
Sbjct: 208 W 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 42/205 (20%), Positives = 73/205 (35%), Gaps = 31/205 (15%)

Query: 144 NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLG 203
              + ++           + +L    +T     S   LS +Q F+   + +  +    + 
Sbjct: 6   PTPINQVFPD-PGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI--QSLAGMQ 60

Query: 204 QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVA 263
              NL  L  S N  S + PL   +++ L+E  + +NR K +L    G     L+ L + 
Sbjct: 61  FFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLK-NLN---GIPSACLSRLFLD 114

Query: 264 QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI----NFNSLPNLSKLYLGRNNLGTRT 319
            N L      SL +   LE L +  N      ++        L  L  L L  N +    
Sbjct: 115 NNELRDT--DSLIHLKNLEILSIRNN------KLKSIVMLGFLSKLEVLDLHGNEI---- 162

Query: 320 STDLDFITLLTNCSKLVKLGLVFNR 344
            T+      LT   K+  + L   +
Sbjct: 163 -TNTGG---LTRLKKVNWIDLTGQK 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 51/250 (20%), Positives = 93/250 (37%), Gaps = 22/250 (8%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
             K +L  Q++   +S     LS ++  N  N++   Q    +     L+ + LS+N  S
Sbjct: 21  AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQIS 76

Query: 124 GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSA 183
             + + L     L +  V+ N L   +  I      + RL L  N+L      S+ +L  
Sbjct: 77  -DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRD--TDSLIHLKN 129

Query: 184 LQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK 243
           L+   I  NKL  +    LG L  L  L    N+ +    L+   +  ++   L   +  
Sbjct: 130 LEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCV 185

Query: 244 GSLPVCLGFNLPKLTVL-VVAQNNLTGFLPQSLSNASKLEWLEL--NENHFSGQVRINFN 300
            + PV      P+L +   V   +     P  +SN        +      ++ +V   F+
Sbjct: 186 -NEPVK---YQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFS 241

Query: 301 SLPNLSKLYL 310
              N+ +   
Sbjct: 242 EYINVGETEA 251

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 75.7 bits (187), Expect = 6e-15
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 40/218 (18%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKII 737
            ++G+G++G VYK      G  VA+K + LD   +G   + + E   L+ + H N++ +I
Sbjct: 27  EKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDD---WLHHTNDKLEVGKL-NIVIEVASVIEYLH 793
            +  S   +      +V+E+M+     D    L      L+  ++   + ++   + + H
Sbjct: 86  DVIHS---ERCLT--LVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG---- 849
            H    I+H DLKP N+L++ D    ++DFGLAR                 I ++     
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLARAF--------------GIPVRSYTHE 179

Query: 850 --TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
             T+ Y  P+  MG     T  D++S G +  EM T +
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 51/234 (21%), Positives = 83/234 (35%), Gaps = 57/234 (24%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVA---ECEALRNIR----HR 731
           +GKG FG V+ G+   D + VA+KV+    +         V    E   L  +     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 732 NLIKIITICSSIDFKGADFKAIVYEYMQYGS-VDDWLHHTNDKLEVGKL------NIVIE 784
            +I+++      + +      +V E       + D++       E G L          +
Sbjct: 99  GVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYI------TEKGPLGEGPSRCFFGQ 147

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSHHPFL-------- 835
           V + I++ H+     +VH D+K  N+L+D     A + DFG    L   P+         
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVY 204

Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
             PE     I       Y                V+S GILL +M     P + 
Sbjct: 205 SPPE----WISRH---QYHALP----------ATVWSLGILLYDMVCGDIPFER 241

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 76.3 bits (188), Expect = 9e-15
 Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 38/225 (16%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKKGATKSFVAECEALRNIRH 730
            K + +   IG G+ G V          +VA+K ++     +   K    E   ++ + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 731 RNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHH------TNDKLEVGKLNIV 782
           +N+I ++ + +       +F+ +  V E M     +  L         ++++      ++
Sbjct: 84  KNIIGLLNVFTP-QKSLEEFQDVYIVMELMD---AN--LCQVIQMELDHERMSY----LL 133

Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---VAPE 839
            ++   I++LH+     I+H DLKPSN+++  D    + DFGLAR       +   V   
Sbjct: 134 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-- 188

Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
                     T  Y  PE  +G       D++S G ++ EM    
Sbjct: 189 ----------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.9 bits (187), Expect = 2e-14
 Identities = 54/247 (21%), Positives = 93/247 (37%), Gaps = 35/247 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           IG+G+FG V    L       A+K++N     K+  T  F  E + L N   + +  +  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVI-EVASVIEYLHNHCQ 797
             +   F+  +   +V +Y   G +   L    D+L        + E+   I+ +H    
Sbjct: 141 -YA---FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH- 195

Query: 798 PPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
              VH D+KP N+L+D +   H+  +DFG           +  +G   S    GT  YI 
Sbjct: 196 --YVHRDIKPDNILMDMN--GHIRLADFGSCL-------KLMEDGTVQSSVAVGTPDYIS 244

Query: 856 PEYGMGGDLSMTG-----DVYSFGILLLEMFTRRRP-----TDNMFNDGLTLHGYAKMAL 905
           PE     +          D +S G+ + EM     P         +     ++   +   
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--KIMNHKERFQF 302

Query: 906 PKKVMGI 912
           P +V  +
Sbjct: 303 PTQVTDV 309

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 48/255 (18%), Positives = 96/255 (37%), Gaps = 64/255 (25%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
           +K++S    +G GSFG V +    E G   A+K +  D +   +    E + ++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-----LNIVIE--- 784
           +IK++    +   +         ++ + G  ++ +++ +  + V       LN+++E   
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 785 --VASVIEYLHNHCQPP-----------------------IVHGDLKPSNVLLD-HDMVA 818
             +  V++      +                         I H D+KP N+L++  D   
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181

Query: 819 HVSDFGLARFLSHHPFLV---------APEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGD 869
            + DFG A+ L      V         APE       M G   Y           + + D
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPE------LMLGATEY-----------TPSID 224

Query: 870 VYSFGILLLEMFTRR 884
           ++S G +  E+   +
Sbjct: 225 LWSIGCVFGELILGK 239

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 72.5 bits (179), Expect = 5e-14
 Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 42/219 (19%)

Query: 680 NRIGKGSFGFVYKG--NLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIK 735
            +IG+G++G VYK   N GE   + A+K + L+   +G   + + E   L+ ++H N++K
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVD--DWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +  +  +   K      +V+E++     D    L      LE     + ++++ + I Y 
Sbjct: 65  LYDVIHT---KKRLV--LVFEHLDQ---DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG--- 849
           H+     ++H DLKP N+L++ +    ++DFGLAR                 I ++    
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAF--------------GIPVRKYTH 159

Query: 850 ---TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
              T+ Y  P+  MG     T  D++S G +  EM    
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.1 bits (182), Expect = 7e-14
 Identities = 49/225 (21%), Positives = 91/225 (40%), Gaps = 38/225 (16%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMN-LDKKGATKSFVAECEALRNIRH 730
            K + +   IG G+ G V          +VA+K +      +   K    E   ++ + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 731 RNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHH------TNDKLEVGKLNIV 782
           +N+I ++ + +       +F+ +  V E M     D  L         ++++      ++
Sbjct: 121 KNIISLLNVFTP-QKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY----LL 170

Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL---VAPE 839
            ++   I++LH+     I+H DLKPSN+++  D    + DFGLAR       +   V   
Sbjct: 171 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-- 225

Query: 840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR 884
                     T  Y  PE  +G       D++S G ++ EM   +
Sbjct: 226 ----------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 43/207 (20%), Positives = 81/207 (39%), Gaps = 31/207 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA--TKSFVAECEALRNIRHR-NLIKIIT 738
           +G+G F  V +      G   A K +   ++G       + E   L   +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 739 ICSSIDFKGADFKAIVYEYMQYGS-----VDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           +     ++      ++ EY   G      + +     +   E   + ++ ++   + YLH
Sbjct: 97  V-----YENTSEIILILEYAAGGEIFSLCLPELAEMVS---ENDVIRLIKQILEGVYYLH 148

Query: 794 NHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            +    IVH DLKP N+LL          + DFG++R + H   L          E+ GT
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---------EIMGT 196

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILL 877
             Y+ PE      ++   D+++ GI+ 
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIA 223

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 74.2 bits (182), Expect = 1e-13
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 27/213 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           IG+G FG VY     + G   A+K ++   +  K      + E   L  +   +   I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           +  +  F   D  + + + M  G +   L       E        E+   +E++HN    
Sbjct: 257 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-- 312

Query: 799 PIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
            +V+ DLKP+N+LLD     HV  SD GLA            + +  +    GT GY+ P
Sbjct: 313 -VVYRDLKPANILLDEH--GHVRISDLGLACDF--------SKKKPHA--SVGTHGYMAP 359

Query: 857 E---YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           E    G+  D S   D +S G +L ++     P
Sbjct: 360 EVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 36/216 (16%), Positives = 75/216 (34%), Gaps = 14/216 (6%)

Query: 254 LPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN-FNSLPNLSKLYLGR 312
            P    L + + +L      + SN   +  + ++ +    Q+  + F +L  ++ + +  
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
               T    D      L     L  LG+           +    +    ++ +  N    
Sbjct: 90  TRNLTYIDPD-----ALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMT 144

Query: 373 TIPPEI-RNLFN-LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNN-IRGIIPDPIGNL 429
           +IP    + L N    L L  N  T ++         L  + L  N  +  I  D  G +
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203

Query: 430 -TLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
            +  ++L +    +  ++PS     ++L +L A N 
Sbjct: 204 YSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 33/189 (17%), Positives = 62/189 (32%), Gaps = 11/189 (5%)

Query: 405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYL-GKCQNLMQLSAPN 463
             + Q L L+  ++R I      NL  ++ + +  +     + S+       +  +   N
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 464 NKLNGTLPPQIF-GITTLSKLLDLSENHLSGSIP--LEVGNLKSLVQLDISRNNFSNEIP 520
            +    + P     +  L K L +    L    P   +V +      L+I+ N +   IP
Sbjct: 90  TRNLTYIDPDALKELPLL-KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 521 VTL--SACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHL--GNLPF 576
           V      C     L +  N F  S+         +  + L+ N     I      G    
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206

Query: 577 LEYLNLSYN 585
              L++S  
Sbjct: 207 PSLLDVSQT 215

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 37/235 (15%), Positives = 80/235 (34%), Gaps = 40/235 (17%)

Query: 160 IERLSLYGNQLTGQLPP-SIGNLSALQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSEND 217
            + L L    L   +P  +  NL  +    ++ +    ++   S   L  + ++      
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT- 90

Query: 218 FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQS-LS 276
                     N++ +D     K              LP L  L +    L  F   + + 
Sbjct: 91  ---------RNLTYIDPD-ALKE-------------LPLLKFLGIFNTGLKMFPDLTKVY 127

Query: 277 NASKLEWLELNENHFSGQVRIN-FNSLPNLSK-LYLGRNNLGTRTSTDLDFITLLTNCSK 334
           +      LE+ +N +   + +N F  L N +  L L  N     +     F     N +K
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF--TSVQGYAF-----NGTK 180

Query: 335 LVKLGLVFNRFGGALP-HSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGL 387
           L  + L  N++   +   +   + +  +L+ ++   ++  +P +   +L  L   
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 41.1 bits (97), Expect = 8e-04
 Identities = 28/143 (19%), Positives = 44/143 (30%), Gaps = 9/143 (6%)

Query: 84  NLSFLRVINLANNSFHGQIPKEV-GRLFRLETIVLSNNSFSGKIP--TNLSRCFNLIDFW 140
           NLS +  I + N      I  +    L  L+ + + N       P  T +          
Sbjct: 78  NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILE 136

Query: 141 VHTNNLVGEIQ--AIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRI 198
           +  N  +  I   A  G   +   L LY N  T  +     N + L    +  NK    I
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVI 195

Query: 199 PDSL--GQLRNLNYLGTSENDFS 219
                 G     + L  S+   +
Sbjct: 196 DKDAFGGVYSGPSLLDVSQTSVT 218

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 35/229 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHR 731
           + +F   + +G+G++G V        G  VA+K +   DK       + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69

Query: 732 NLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHH-------TNDKLEVGKLNIV 782
           N+I I  I     F+  +F  +  + E MQ     D LH        ++D ++      +
Sbjct: 70  NIITIFNIQRPDSFE--NFNEVYIIQELMQT----D-LHRVISTQMLSDDHIQY----FI 118

Query: 783 IEVASVIEYLH--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
            +    ++ LH  N     ++H DLKPSN+L++ +    V DFGLAR +         E 
Sbjct: 119 YQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA-ADNSEP 172

Query: 841 QSSSIEMKG---TIGYIGPEYGMGGDLSMTG--DVYSFGILLLEMFTRR 884
                 M     T  Y  PE  M      +   DV+S G +L E+F RR
Sbjct: 173 TGQQSGMVEFVATRWYRAPEV-MLTSAKYSRAMDVWSCGCILAELFLRR 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 51/267 (19%), Positives = 99/267 (37%), Gaps = 40/267 (14%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR--------HRNL 733
           +G G F  V+      +   VA+K++  DK   T++   E + L+ +             
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 734 IKIITICSSIDFKGADFK--AIVYEYMQYGSVDDWLHHTNDK---LEVGKLNIVIEVASV 788
             I+ +    + KG +     +V+E +   ++   +     +   L   K  I  ++   
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVK-QISKQLLLG 143

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAH------VSDFGLARFLSHHPFLVAPEGQS 842
           ++Y+H  C   I+H D+KP NVL++            ++D G A +   H        Q+
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQT 198

Query: 843 SSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR--PTDNMFNDGLTLHGY 900
                     Y  PE  +G       D++S   L+ E+ T       D   +        
Sbjct: 199 RE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250

Query: 901 AKMALPKKVMGIVDPSLLMEARGPSKF 927
           A++    +++G +   LL   +    F
Sbjct: 251 AQII---ELLGELPSYLLRNGKYTRTF 274

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 44/234 (18%)

Query: 668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-----KKGATKSFVAEC 722
           ++    K +   + +G+G F  VYK         VA+K + L      K G  ++ + E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 723 EALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDD---WLHHTNDKLEVGKL 779
           + L+ + H N+I ++        K      +V+++M+     D    +   +  L    +
Sbjct: 64  KLLQELSHPNIIGLLDAFGH---KSNIS--LVFDFMET----DLEVIIKDNSLVLTPSHI 114

Query: 780 -NIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF-------LSH 831
              ++     +EYLH H    I+H DLKP+N+LLD + V  ++DFGLA+         +H
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
               V             T  Y  PE   G  +   G D+++ G +L E+  R 
Sbjct: 172 ---QVV------------TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 24/173 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITIC 740
           +G G  G V +          A+K++  D   A +    E E      +  ++++I+ + 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQP 798
            +  + G     IV E +  G +   +    D+   E     I+  +   I+YLH+    
Sbjct: 125 EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 181

Query: 799 PIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLSHH---------PFLVAPE 839
            I H D+KP N+L      + +  ++DFG A+  + H         P+ VAPE
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 47/222 (21%), Positives = 95/222 (42%), Gaps = 43/222 (19%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKII 737
            ++G+G++G VYK        +VA+K + L+  ++G   + + E   L+ ++HRN+I++ 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDD--WLHHTNDKLEVGKL-NIVIEVASVIEYLHN 794
           ++             +++EY +     D       N  + +  + + + ++ + + + H+
Sbjct: 100 SVIHH---NHRLH--LIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAH-----VSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
                 +H DLKP N+LL     +      + DFGLAR                 I ++ 
Sbjct: 151 RR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--------------GIPIRQ 193

Query: 850 ------TIGYIGPEYGMGGDLSMTG-DVYSFGILLLEMFTRR 884
                 T+ Y  PE  +G     T  D++S   +  EM  + 
Sbjct: 194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.7 bits (175), Expect = 5e-13
 Identities = 45/341 (13%), Positives = 102/341 (29%), Gaps = 28/341 (8%)

Query: 204 QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVA 263
            +    ++   E   S  F   +   S +    L  +    S+         + + + + 
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302

Query: 264 QNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL 323
                    Q   +  ++ W   +       ++         S                 
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362

Query: 324 DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN 383
              + L +C +L +L            +    L+  + + A+               L  
Sbjct: 363 VLQSELESCKELQELEPE---------NKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413

Query: 384 LNGLGLEY-----NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLG 438
           ++ +   Y     ++          E  +++ L L   ++  +    +  L L+  L L 
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLS 471

Query: 439 FNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSG-SI 495
            N+L+ ++P  L   + L  L A +N L       + G+  L +L  L L  N L   + 
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE-----NVDGVANLPRLQELLLCNNRLQQSAA 525

Query: 496 PLEVGNLKSLVQLDISRNNFS---NEIPVTLSACTTLEYLL 533
              + +   LV L++  N+                ++  +L
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 68.2 bits (166), Expect = 6e-12
 Identities = 41/256 (16%), Positives = 78/256 (30%), Gaps = 29/256 (11%)

Query: 376 PEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVL 435
           P    L +L    L       T         + +   L+ +       D       L   
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRD-SATDEQLFRC 354

Query: 436 QLGFNKLQGSIPSYLGKCQNLMQLSAPN----------NKLNGTLPPQIFGITTLSKLLD 485
           +L   K    + S L  C+ L +L   N           +    L  +   +   S L  
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413

Query: 486 LSENHLSG----------SIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQ 535
           +     +              +       +  L ++  + +  +   L     + +L + 
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLS 471

Query: 536 GNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG--KVPK 593
            N    ++P +L AL+ ++ L  S N L   +   + NLP L+ L L  N  +    +  
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQP 528

Query: 594 KGVFSNETRISLTGNE 609
                    ++L GN 
Sbjct: 529 LVSCPRLVLLNLQGNS 544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.3 bits (161), Expect = 3e-11
 Identities = 42/225 (18%), Positives = 77/225 (34%), Gaps = 29/225 (12%)

Query: 368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG 427
            + S  +  E+ +   L  L  E      TI   I  +R L  L      ++        
Sbjct: 358 VEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQ-----YFS 409

Query: 428 NLTLLNVLQLGFNKLQGSI-----PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSK 482
            L  ++ ++  +     S           +  ++  L   +  L       +  +  L  
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-----VLCHLEQLLL 464

Query: 483 L--LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN 540
           +  LDLS N L  ++P  +  L+ L  L  S N   N +   ++    L+ LL+  N   
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ 521

Query: 541 G-SIPQSLNALKSIKELDLSCNNLSGQIPIHLGN----LPFLEYL 580
             +  Q L +   +  L+L  N+L  Q           LP +  +
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.5 bits (151), Expect = 4e-10
 Identities = 40/260 (15%), Positives = 77/260 (29%), Gaps = 43/260 (16%)

Query: 199 PDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLT 258
                    L     S    S +    + +   L E          ++ + +      L 
Sbjct: 342 CRDSATDEQLFRCELSVE-KSTVLQSELESCKELQELEPENKWCLLTIILLM----RALD 396

Query: 259 VLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTR 318
            L+  +  L  F      +  +  +L+   + F  +  +      ++  L+L   +L   
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--- 453

Query: 319 TSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI 378
             T L  +  L   + L                   +LS          N++   +PP +
Sbjct: 454 --TVLCHLEQLLLVTHL-------------------DLS---------HNRLR-ALPPAL 482

Query: 379 RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI-IPDPIGNLTLLNVLQL 437
             L  L  L    N L   +   +  L  LQ L L  N ++      P+ +   L +L L
Sbjct: 483 AALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540

Query: 438 GFNKLQGSIPSYLGKCQNLM 457
             N L         +   ++
Sbjct: 541 QGNSLC-QEEGIQERLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.4 bits (117), Expect = 5e-06
 Identities = 35/206 (16%), Positives = 69/206 (33%), Gaps = 25/206 (12%)

Query: 67  LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKI 126
            +LE +N    L+  +   +   ++       +    K V  + R   +    + F  + 
Sbjct: 375 QELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM-RAAYLDDLRSKFLLEN 433

Query: 127 PTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQT 186
                   ++    +   +L   +  +    L +  L L  N+L   LPP++  L  L+ 
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCHL-EQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490

Query: 187 FDIAGNKLDGRIPDSLGQLRNLNYLGTSEN---DFSGMFPLSVCNISSLDEAYLFKNRFK 243
              + N L+  +   +  L  L  L    N     + + PL  C    L    L  N   
Sbjct: 491 LQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSC--PRLVLLNLQGN--- 543

Query: 244 GSLPVC--------LGFNLPKLTVLV 261
               +C        L   LP ++ ++
Sbjct: 544 ---SLCQEEGIQERLAEMLPSVSSIL 566

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 35/230 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN 732
              +     +G G  G V+     +    VA+K + L    + K  + E + +R + H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 733 LIKIITI-------CSSIDFKGADFKAI--VYEYMQYGSVDDWLH---HTNDKLEVGKLN 780
           ++K+  I        +       +  ++  V EYM+    D  L         LE     
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME---TD--LANVLEQGPLLEEHARL 124

Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPE 839
            + ++   ++Y+H+     ++H DLKP+N+ ++  D+V  + DFGLAR +  H       
Sbjct: 125 FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH------- 174

Query: 840 GQSSSIEMKG---TIGYIGPEYGMGGDLSMTG--DVYSFGILLLEMFTRR 884
             S    +     T  Y  P   +    + T   D+++ G +  EM T +
Sbjct: 175 -YSHKGHLSEGLVTKWYRSPRL-LLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 70.0 bits (172), Expect = 8e-13
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 28/211 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G GSFG V      E G   A+K+++     K    +  + E   L+ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVASVIEYLHNH 795
             S   FK      +V EY+  G +  + H            +     ++    EYLH+ 
Sbjct: 108 -FS---FKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSL 160

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
               +++ DLKP N+L+D      V+DFG A+             +  +  + GT   + 
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----------RVKGRTWTLCGTPEALA 206

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           PE  +    +   D ++ G+L+ EM     P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 34/225 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMNLDKKGATKSFVAECEALRNIRHR 731
              +++ + IG+G++G V       + + VA+K +   + +   +  + E + L   RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 732 NLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLH---HTNDKLEVGKLNIVIEVA 786
           N+I I  I  +   +    K +  V + M+     D L+    T           + ++ 
Sbjct: 86  NIIGINDIIRAPTIE--QMKDVYIVQDLMET----D-LYKLLKTQHLSNDHICYFLYQIL 138

Query: 787 SVIEYLH--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSS 844
             ++Y+H  N     ++H DLKPSN+LL+      + DFGLAR        VA      +
Sbjct: 139 RGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLAR--------VADPDHDHT 185

Query: 845 IEMKG---TIGYIGPEYGMGGDLSMTG--DVYSFGILLLEMFTRR 884
             +     T  Y  PE  M      T   D++S G +L EM + R
Sbjct: 186 GFLTEYVATRWYRAPEI-MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.1 bits (172), Expect = 1e-12
 Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 41/228 (17%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVM---NLDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG+FG V        G   A+K++    +  K      + E   L+N RH  L  +  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVASVIEYL 792
             S   F+  D    V EY   G   +   H +        +         E+ S ++YL
Sbjct: 215 -YS---FQTHDRLCFVMEYANGG---ELFFHLS---RERVFSEDRARFYGAEIVSALDYL 264

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK---G 849
           H+     +V+ DLK  N++LD D    ++DFGL +           EG      MK   G
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKTFCG 311

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
           T  Y+ PE     D     D +  G+++ EM   R P      + +F 
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 41/226 (18%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMN-LDKKGATKSFVAECEALRNIRH 730
            K + S   +G G++G V        G  VA+K +      +   K    E   L++++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 731 RNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHH------TNDKLEVGKLNIV 782
            N+I ++ + +       +F     V  +MQ    D  L        + +K++     +V
Sbjct: 83  ENVIGLLDVFTP-ASSLRNFYDFYLVMPFMQ---TD--LQKIMGLKFSEEKIQY----LV 132

Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQS 842
            ++   ++Y+H+     +VH DLKP N+ ++ D    + DFGLAR               
Sbjct: 133 YQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR--------------H 175

Query: 843 SSIEMKG---TIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRR 884
           +  EM G   T  Y  PE  +     + T D++S G ++ EM T +
Sbjct: 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 34/223 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNL--DKKGATKSFVAECEALRNIRH 730
            + + + + +G G++G V      + G+ VAVK ++         K    E   L++++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 731 RNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLH---HTNDKLEVGKLNIVIEV 785
            N+I ++ + +       +F  +  V   M     D  L+         +     ++ ++
Sbjct: 88  ENVIGLLDVFTP-ARSLEEFNDVYLVTHLMG---AD--LNNIVKCQKLTDDHVQFLIYQI 141

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              ++Y+H+     I+H DLKPSN+ ++ D    + DFGLAR               ++ 
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--------------HTAD 184

Query: 846 EMKG---TIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRR 884
           EM G   T  Y  PE  +     + T D++S G ++ E+ T R
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 46/200 (23%), Positives = 73/200 (36%), Gaps = 30/200 (15%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVK-VMNL-DKKGATKSFVAECEALRNIRHRNLIKIIT 738
            IG+GS+G+VY         +VA+K V  + +     K  + E   L  ++   +I++  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92

Query: 739 ICSSIDFKGADFKAI--VYEYMQYGSVDDWLH---HTNDKL-EVGKLNIVIEVASVIEYL 792
           +    D     F  +  V E        D L     T   L E     I+  +     ++
Sbjct: 93  LIIPDDLL--KFDELYIVLEIADS----D-LKKLFKTPIFLTEEHIKTILYNLLLGENFI 145

Query: 793 H--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           H        I+H DLKP+N LL+ D    V DFGLAR             + ++I     
Sbjct: 146 HESG-----IIHRDLKPANCLLNQDCSVKVCDFGLAR--------TINSEKDTNIVNDLE 192

Query: 851 IGYIGPEYGMGGDLSMTGDV 870
                  +       +T  V
Sbjct: 193 ENEEPGPHNKNLKKQLTSHV 212

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 37/170 (21%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLL 432
           +P  I  +       LE N +   IPP A    + L+ + L  N I  + PD    L  L
Sbjct: 30  LPETITEIR------LEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 433 NVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF-GITTLSKLLDLSENHL 491
           N L L  NK+                           LP  +F G+ +L +LL L+ N +
Sbjct: 83  NSLVLYGNKIT-------------------------ELPKSLFEGLFSL-QLLLLNANKI 116

Query: 492 SGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN 540
           +  + ++   +L +L  L +  N        T S    ++ + +  N F 
Sbjct: 117 N-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 31/154 (20%), Positives = 56/154 (36%), Gaps = 27/154 (17%)

Query: 161 ERLSLYGNQLTGQLPPSI-GNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
             + L  N +   +PP        L+  D++ N++    PD+   LR+LN L        
Sbjct: 35  TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL-------- 85

Query: 220 GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNAS 279
                            L+ N+    LP  L   L  L +L++  N +      +  +  
Sbjct: 86  ----------------VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLH 128

Query: 280 KLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN 313
            L  L L +N      +  F+ L  +  ++L +N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 34/160 (21%), Positives = 57/160 (35%), Gaps = 33/160 (20%)

Query: 258 TVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT 317
           T + + QN +    P + S   KL  ++L+ N  S      F  L +L+ L L  N +  
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94

Query: 318 RTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPE 377
              +  +          L  L                       L+ +  N+I+  +  +
Sbjct: 95  LPKSLFE---------GLFSL----------------------QLLLLNANKIN-CLRVD 122

Query: 378 I-RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGN 416
             ++L NLN L L  N+L          LR +Q + L  N
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 13/157 (8%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHG 100
           C    V C  +          + +T++ LE   I             LR I+L+NN    
Sbjct: 11  CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69

Query: 101 QIPKEV-GRLFRLETIVLSNNSFSGKIPTNL-SRCFNLIDFWVHTNNLVGEIQAIIGNWL 158
           ++  +    L  L ++VL  N  + ++P +L    F+L    ++ N +         +  
Sbjct: 70  ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLH 128

Query: 159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLD 195
            +  LSLY N+L      +   L A+QT  +A N   
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 25/165 (15%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFV--------AECEALRNIRHRN 732
           +IG G FG +Y           A  V+ ++ +     F         A+ + ++    R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 733 LIKIITI-----CSSIDFKGADFKAIVYEYMQYG-SVDDWLHHTNDKLEVGK--LNIVIE 784
            +  + I         +FKG  ++ +V E    G  +   +   N   +     L + I 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQK-ISGQNGTFKK-STVLQLGIR 159

Query: 785 VASVIEYLHNHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLAR 827
           +  V+EY+H +     VHGD+K +N+LL   +    +++D+GL+ 
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 67.3 bits (165), Expect = 6e-12
 Identities = 47/240 (19%), Positives = 79/240 (32%), Gaps = 57/240 (23%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK--VMNLDKKGATKSFVAECEALRNIR- 729
              ++    I  GS+G V  G +  +G+ VA+K     +                R +R 
Sbjct: 21  QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 730 --------HRNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHH---------T 770
                   H N++ +  I    +        +  V E M+     D L           +
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEP--AMHKLYLVTELMRT----D-LAQVIHDQRIVIS 132

Query: 771 NDKLEVGKLNIVIEVASVIEYLH--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
              ++      +  +   +  LH        +VH DL P N+LL  +    + DF LAR 
Sbjct: 133 PQHIQY----FMYHILLGLHVLHEAG-----VVHRDLHPGNILLADNNDITICDFNLARE 183

Query: 829 LSHHPFL---VAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRR 884
            +        V                Y  PE  M     +   D++S G ++ EMF R+
Sbjct: 184 DTADANKTHYVT------------HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 66.9 bits (164), Expect = 8e-12
 Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 46/230 (20%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +GKG+FG V        G   A+K++  +    K      V E   L+N RH  L  +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVASVIEYL 792
             +   F+  D    V EY   G   +   H +                  E+ S +EYL
Sbjct: 72  -YA---FQTHDRLCFVMEYANGG---ELFFHLS---RERVFTEERARFYGAEIVSALEYL 121

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMK-- 848
           H+     +V+ D+K  N++LD D   H+  +DFGL +           EG S    MK  
Sbjct: 122 HSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK-----------EGISDGATMKTF 165

Query: 849 -GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
            GT  Y+ PE     D     D +  G+++ EM   R P      + +F 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 34/223 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVK-VMN-LDKKGATKSFVAECEALRNIRH 730
              +     +G G++G V     G  G  VA+K +      +   K    E   L+++RH
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 731 RNLIKIITICSSIDFKGADFKAI--VYEYMQYGSVDDWLHH--TNDKLEVGKLN-IVIEV 785
            N+I ++ + +  D    DF     V  +M      D L     ++KL   ++  +V ++
Sbjct: 84  ENVIGLLDVFTP-DETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQM 137

Query: 786 ASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSI 845
              + Y+H      I+H DLKP N+ ++ D    + DFGLAR               +  
Sbjct: 138 LKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------------QADS 180

Query: 846 EMKG---TIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRR 884
           EM G   T  Y  PE  +     + T D++S G ++ EM T +
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 33/151 (21%), Positives = 61/151 (40%), Gaps = 15/151 (9%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITIC 740
           +G G  G V +          A+K++  D   A +    E E      +  ++++I+ + 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80

Query: 741 SSIDFKGADFKAIVYEYMQYGSV-DDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQP 798
            +  + G     IV E +  G +        +    E     I+  +   I+YLH+    
Sbjct: 81  EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 137

Query: 799 PIVHGDLKPSNVLL---DHDMVAHVSDFGLA 826
            I H D+KP N+L      + +  ++DFG A
Sbjct: 138 -IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 52/275 (18%), Positives = 103/275 (37%), Gaps = 31/275 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKS-----------FVAECEALRNIR 729
            IG+G FG +Y  ++     SV      + K   + +             A+ E ++   
Sbjct: 42  PIGQGGFGCIYLADM-NSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYM---QYG-SVDDWLHHTNDKLEVGK--LNIVI 783
               +K + +         D     Y +M   ++G  +         +    K  L + +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSR-KTVLQLSL 159

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLA-RFLSHHPFLVAPEG 840
            +  ++EY+H H     VHGD+K SN+LL+  +    ++ D+GLA R+            
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY 900
                +  GTI +   +   G   S  GD+   G  +++  T   P ++   D   +   
Sbjct: 217 PKRCHD--GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR-D 273

Query: 901 AKMALPKKVMGIVDPSLLMEARG-PSKFEECLVAV 934
           +K+   + +  ++D      A   P +  + +  V
Sbjct: 274 SKIRYRENIASLMD--KCFPAANAPGEIAKYMETV 306

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 55/250 (22%), Positives = 99/250 (39%), Gaps = 67/250 (26%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR--- 729
            +++    ++GKG++G V+K      G  VAVK +         +F    +A R  R   
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIM 60

Query: 730 -------HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH---HTNDKLEVGKL 779
                  H N++ ++ +  + + +  D   +V++YM+     D LH     N    V K 
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDR--DV-YLVFDYMET----D-LHAVIRANILEPVHKQ 112

Query: 780 NIVIEVASVIEYLH--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
            +V ++  VI+YLH        ++H D+KPSN+LL+ +    V+DFGL+R   +   +  
Sbjct: 113 YVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTG-----------------------DVYSFG 874
               S +            E        +T                        D++S G
Sbjct: 168 NIPLSIN---------ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

Query: 875 ILLLEMFTRR 884
            +L E+   +
Sbjct: 219 CILGEILCGK 228

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 26/142 (18%), Positives = 52/142 (36%), Gaps = 12/142 (8%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPE--IRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQY 410
            ++      + +  N+ +  +      + L  L  +    N++T  I   A      +  
Sbjct: 28  EHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNE 85

Query: 411 LGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYL-GKCQNLMQLSAPNNKLNGT 469
           + L  N +  +       L  L  L L  N++   + +       ++  LS  +N++  T
Sbjct: 86  ILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-T 143

Query: 470 LPPQIFGITTLSKL--LDLSEN 489
           + P  F   TL  L  L+L  N
Sbjct: 144 VAPGAF--DTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 28/137 (20%), Positives = 45/137 (32%), Gaps = 12/137 (8%)

Query: 161 ERLSLYGNQLTGQLPPSIG--NLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
             L L  N+ T  L  +     L  L+  + + NK+      +      +N +  + N  
Sbjct: 35  AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93

Query: 219 ----SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQS 274
                 MF      + SL    L  NR    +       L  + +L +  N +T   P +
Sbjct: 94  ENVQHKMFK----GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGA 148

Query: 275 LSNASKLEWLELNENHF 291
                 L  L L  N F
Sbjct: 149 FDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 2/81 (2%)

Query: 236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSG-Q 294
            L  N F       +   LP+L  +  + N +T     +   AS +  + L  N     Q
Sbjct: 38  RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQ 97

Query: 295 VRINFNSLPNLSKLYLGRNNL 315
            ++ F  L +L  L L  N +
Sbjct: 98  HKM-FKGLESLKTLMLRSNRI 117

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 32/213 (15%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G GSFG V+      +G   A+KV+  +   +    +    E   L  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVASVIEYLHNH 795
             +   F+ A    ++ +Y++ G  + +      +     V K     EV   +EYLH+ 
Sbjct: 73  -GT---FQDAQQIFMIMDYIEGG--ELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHSK 125

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
               I++ DLKP N+LLD +   H+  +DFG A+                +  + GT  Y
Sbjct: 126 ---DIIYRDLKPENILLDKN--GHIKITDFGFAK-----------YVPDVTYTLCGTPDY 169

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           I PE       + + D +SFGIL+ EM     P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 11/167 (6%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLG 412
           + +      + +    ++       R L  L  L L+YNQL  T+   +  +L  L  LG
Sbjct: 31  SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89

Query: 413 LVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLG---KCQNLMQLSAPNNKLNGT 469
           L  N +  +      +LT L+ L LG N+L+ S+PS  G   +   L +L    N+L  +
Sbjct: 90  LANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFDRLTKLKELRLNTNQLQ-S 145

Query: 470 LPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNF 515
           +P   F   T  + L LS N L  S+P      L  L  + +  N F
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 11/161 (6%)

Query: 282 EWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLV 341
           E L+L     +      F  L  L+ L L  N L T ++   D +T L        LGL 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG------TLGLA 91

Query: 342 FNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP 400
            N+   +LP  + +  T +  + + GNQ+  ++P  +   L  L  L L  NQL  +IP 
Sbjct: 92  NNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148

Query: 401 -AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN 440
            A  +L NLQ L L  N ++ +       L  L  + L  N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 38/154 (24%), Positives = 61/154 (39%), Gaps = 3/154 (1%)

Query: 161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG 220
           E+L L    L      +   L+ L   ++  N+L          L  L  LG + N  + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 221 MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA-S 279
           +      +++ LD+ YL  N+ K SLP  +   L KL  L +  N L   +P    +  +
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLT 155

Query: 280 KLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN 313
            L+ L L+ N         F+ L  L  + L  N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 38/185 (20%), Positives = 63/185 (34%), Gaps = 37/185 (20%)

Query: 113 ETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL-KIERLSLYGNQLT 171
           E + L +   +            L    +  N L   + A + + L ++  L L  NQL 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 172 GQLPPSI-GNLSALQTFDIAGNKLDGRIP----DSLGQLRNLNYLGTSENDFSGMFPLSV 226
             LP  +  +L+ L    + GN+L   +P    D L +L+ L                  
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL------------------ 136

Query: 227 CNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLEL 286
                     L  N+ + S+P      L  L  L ++ N L      +     KL+ + L
Sbjct: 137 ---------RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186

Query: 287 NENHF 291
             N F
Sbjct: 187 FGNQF 191

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 64.1 bits (157), Expect = 6e-11
 Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 44/231 (19%)

Query: 682 IGKGSFGFVY---KGNLGEDGMSVAVKVMN----LDKKGATKSFVAECEALRNIRHRNLI 734
           +GKG +G V+   K      G   A+KV+     +     T    AE   L  ++H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNI------VIEVASV 788
            +I   +   F+      ++ EY+  G   +           G          + E++  
Sbjct: 85  DLI--YA---FQTGGKLYLILEYLSGG---ELFMQLE---REGIFMEDTACFYLAEISMA 133

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIE 846
           + +LH      I++ DLKP N++L+H    HV  +DFGL +        +     + +  
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK------ESIHDGTVTHT-- 180

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
             GTI Y+ PE  M    +   D +S G L+ +M T   P          +
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 64.5 bits (157), Expect = 6e-11
 Identities = 55/310 (17%), Positives = 108/310 (34%), Gaps = 86/310 (27%)

Query: 682 IGKGSFGFVYKGNLGEDGMS---VAVKVMNLDKKGATKSFVAECEALRNIR-----HRNL 733
           +G G F  V+   L  D      VA+KV+   +   T++ + E   L+++R       N 
Sbjct: 45  LGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHY-TETALDEIRLLKSVRNSDPNDPNR 100

Query: 734 IKIITICSSIDFKGADFK--AIVYEYMQYGSVDDWLHHTNDK---LEVGKLNIVIEVASV 788
             ++ +       G +     +V+E + +  +  W+  +N +   L   K  I+ +V   
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVK-KIIQQVLQG 158

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLL------------------------------------ 812
           ++YLH  C+  I+H D+KP N+LL                                    
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 813 -------------DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG 859
                           +   ++D G A ++  H         +  I    T  Y   E  
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--------TEDI---QTRQYRSLEVL 265

Query: 860 MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY--AKMALPKKVMGIVDPSL 917
           +G   +   D++S   +  E+ T     +    +  T      A +    +++G V   L
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII---ELLGKVPRKL 322

Query: 918 LMEARGPSKF 927
           ++  +   +F
Sbjct: 323 IVAGKYSKEF 332

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 63.3 bits (155), Expect = 8e-11
 Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 20/116 (17%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E+A  +++LH+     I++ DLKP N+LLD +   H+  +DFGL++        +  E +
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK------ESIDHEKK 182

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
           + S    GT+ Y+ PE       + + D +SFG+L+ EM T   P           
Sbjct: 183 AYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 1e-10
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 25/208 (12%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR---NLIKIIT 738
           IGKGSFG V K    +    VA+K++  ++K   +    E   L ++R +   N + +I 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKL-NIVIEVASVIEYLHNHC 796
           +  +  F+      + +E +   ++ + +     +   +  +      +   ++ LH + 
Sbjct: 164 MLENFTFRN--HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220

Query: 797 QPPIVHGDLKPSNVLLDHDMVAH--VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
              I+H DLKP N+LL     +   V DFG + +     +      QS          Y 
Sbjct: 221 ---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI---QSRF--------YR 266

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            PE  +G    M  D++S G +L E+ T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLT 294

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 36/119 (30%), Positives = 50/119 (42%), Gaps = 26/119 (21%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E+AS + YLH+     IV+ DLKP N+LLD     H+  +DFGL +           E  
Sbjct: 147 EIASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK-----------ENI 190

Query: 842 SSSIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
             +       GT  Y+ PE         T D +  G +L EM     P     T  M++
Sbjct: 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 26/119 (21%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E+   +++LH+     IV+ DLK  N+LLD D   H+  +DFG+ +           E  
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK-----------ENM 169

Query: 842 SSSIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
               +     GT  YI PE  +G   + + D +SFG+LL EM   + P      + +F+
Sbjct: 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 33/119 (27%), Positives = 52/119 (43%), Gaps = 26/119 (21%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E+A  + +L +     I++ DLK  NV+LD +   H+  +DFG+ +           E  
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK-----------ENI 172

Query: 842 SSSIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
              +  K   GT  YI PE         + D ++FG+LL EM   + P      D +F 
Sbjct: 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 63.5 bits (154), Expect = 2e-10
 Identities = 31/116 (26%), Positives = 52/116 (44%), Gaps = 20/116 (17%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E+A  + +L +     I++ DLK  NV+LD +   H+  +DFG+ +        +     
Sbjct: 450 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK------ENIWDGVT 498

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
           + +    GT  YI PE         + D ++FG+LL EM   + P      D +F 
Sbjct: 499 TKT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 47/288 (16%), Positives = 82/288 (28%), Gaps = 66/288 (22%)

Query: 382 FNLNGLGLEYNQLTG----TIPPAIGELRNLQYLGLVGNNI--RGI--IPDPIGNLTLLN 433
           F++ G  L+ + +T     ++   + E  +++ + L GN I       + + I +   L 
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 434 VLQLGFNKLQ----------GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL 483
           + +                   +   L KC  L  +   +N    T          L   
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT------AQEPLIDF 117

Query: 484 ---------LDLSENHLS-------------GSIPLEVGNLKSLVQLDISRNNFSNE--- 518
                    L L  N L               ++  +  N   L  +   RN   N    
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177

Query: 519 -IPVTLSACTTLEYLLMQGNSFN-----GSIPQSLNALKSIKELDLSCNNLSGQ----IP 568
               T  +   L  + M  N          + + L   + +K LDL  N  +      + 
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237

Query: 569 IHLGNLPFLEYLNLSYNHFE-------GKVPKKGVFSNETRISLTGNE 609
           I L + P L  L L+                 K        + L  NE
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 45/334 (13%), Positives = 93/334 (27%), Gaps = 75/334 (22%)

Query: 305 LSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFG--GALPHSIANL---STT 359
           +    L  + + T     +    +L     + ++ L  N  G   A    ++        
Sbjct: 6   IEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAA--RWLSENIASKKD 61

Query: 360 MTLIAMAGNQIS----------GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGEL---- 405
           + +   +                 +   +     L+ + L  N    T    + +     
Sbjct: 62  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121

Query: 406 RNLQYLGLVGNNI-------------RGIIPDPIGNLTLLNVLQLGFNKLQG----SIPS 448
             L++L L  N +                +     N   L  +  G N+L+         
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181

Query: 449 YLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQL 508
                + L  +    N +         GI  L     L+               + L  L
Sbjct: 182 TFQSHRLLHTVKMVQNGIRPE------GIEHLLLEG-LAYC-------------QELKVL 221

Query: 509 DISRNNFSNE----IPVTLSACTTLEYLLMQGNSFNGSIPQSL-NALK-----SIKELDL 558
           D+  N F++     + + L +   L  L +     +     ++ +A        ++ L L
Sbjct: 222 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281

Query: 559 SCNNLSGQIPIHLG-----NLPFLEYLNLSYNHF 587
             N +       L       +P L +L L+ N F
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 49/319 (15%), Positives = 95/319 (29%), Gaps = 63/319 (19%)

Query: 257 LTVLVVAQNNLTG----FLPQSLSNASKLEWLELNENHFS--GQVRIN--FNSLPNLSKL 308
           +    +  + +T      +   L     ++ + L+ N         ++    S  +L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 309 YLGRNNLGTRTSTDLD----FITLLTNCSKLVKLGLVFNRFGGALPHSIANL---STTMT 361
                  G       +     +  L  C KL  + L  N FG      + +     T + 
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 362 LIAMAGNQIS-------------GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGEL--- 405
            + +  N +                +  + +N   L  +    N+L         +    
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185

Query: 406 -RNLQYLGLVGNNIR-----GIIPDPIGNLTLLNVLQLGFNKL--QG--SIPSYLGKCQN 455
            R L  + +V N IR      ++ + +     L VL L  N     G  ++   L    N
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245

Query: 456 LMQLSAPNNKLNGTLPPQIFGITTLSKL-----------LDLSENHLS--GSIPLE---V 499
           L +L   +  L+        G   +              L L  N +       L+    
Sbjct: 246 LRELGLNDCLLSAR------GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299

Query: 500 GNLKSLVQLDISRNNFSNE 518
             +  L+ L+++ N FS E
Sbjct: 300 EKMPDLLFLELNGNRFSEE 318

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 21/134 (15%), Positives = 42/134 (31%), Gaps = 23/134 (17%)

Query: 476 GITTLSKLLDLSENHLSG----SIPLEVGNLKSLVQLDISRNNFSNE----IPVTLSACT 527
              ++     L  + ++     S+   +    S+ ++ +S N    E    +   +++  
Sbjct: 2   ARFSIEGK-SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 528 TLEYLLMQGNSFN----------GSIPQSLNALKSIKELDLSCNNLS--GQIPI--HLGN 573
            LE                      + Q+L     +  + LS N      Q P+   L  
Sbjct: 61  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120

Query: 574 LPFLEYLNLSYNHF 587
              LE+L L  N  
Sbjct: 121 HTPLEHLYLHNNGL 134

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 8e-04
 Identities = 42/281 (14%), Positives = 75/281 (26%), Gaps = 70/281 (24%)

Query: 60  RHQRVTKLDLESQNIG----------GFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRL 109
             + +   +      G            L   +     L  + L++N+F     + +   
Sbjct: 58  SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117

Query: 110 FR----LETIVLSNNSFS-------------GKIPTNLSRCFNLIDFWVHTNNLVGEIQA 152
                 LE + L NN                  +         L       N L      
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177

Query: 153 IIGNWLK----IERLSLYGNQLTGQ-----LPPSIGNLSALQTFDIAGNKLDGR----IP 199
                 +    +  + +  N +  +     L   +     L+  D+  N         + 
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237

Query: 200 DSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNL---PK 256
            +L    NL  LG           L+ C +S+           +G+  V   F+      
Sbjct: 238 IALKSWPNLRELG-----------LNDCLLSA-----------RGAAAVVDAFSKLENIG 275

Query: 257 LTVLVVAQNNLTG----FLPQSL-SNASKLEWLELNENHFS 292
           L  L +  N +       L   +      L +LELN N FS
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 35/215 (16%), Positives = 76/215 (35%), Gaps = 41/215 (19%)

Query: 680 NRIGKGSFGFVYKG--------NLGEDGMSVAVKVMNLDKKGATKSFV----AECEALRN 727
           +   + + G +Y+         + G      ++K+   D +   +       A+   +  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 728 IRHRNLIKIITICSSIDF--KGADFKAIVYEYMQYG-SVDDWLHHTNDKLEVGK--LNIV 782
            +      ++ I + + F      ++ +V      G S+   L  +   +   +  L + 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSVLQVA 165

Query: 783 IEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLA-RFL---SHHPFL 835
             +   +E+LH +     VHG++   N+ +   D   V  ++ +G A R+     H  + 
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKHVAY- 220

Query: 836 VAPEGQSSSIEMKGTIGYI------GPEYGMGGDL 864
              EG  S  E  G + +I      G       DL
Sbjct: 221 --VEGSRSPHE--GDLEFISMDLHKGCGPSRRSDL 251

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 18/153 (11%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG GSFG +Y G     G  VA+K+  +  K        E +  + ++       + I 
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ-----GGVGIP 68

Query: 741 SSIDF-KGADFKAIVYEYMQYG-SVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQ 797
           +        D+  +V E +  G S++D  +  + K  +   L +  ++ S IEY+H+   
Sbjct: 69  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125

Query: 798 PPIVHGDLKPSNVLL---DHDMVAHVSDFGLAR 827
              +H D+KP N L+       + ++ DFGLA+
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 19/109 (17%)

Query: 779 LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
           +    +VA  +E+L        +H DL   N+LL    V  + DFGLAR +         
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI--------- 243

Query: 839 EGQSSSIEMKGTIGYI-----GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
                   ++     +      PE       ++  DV+SFG+LL E+F+
Sbjct: 244 --YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 33/169 (19%), Positives = 68/169 (40%), Gaps = 24/169 (14%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKKGAT----KSFVAECEALRNI-R 729
             +G+G+FG V + +           +VAVK++   K+GAT    ++ ++E + L +I  
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGH 84

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N++ ++  C+    K      ++ E+ ++G++  +L    ++    K           
Sbjct: 85  HLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA------- 133

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP 838
            +         +  DLK     +     +  S F   + LS      AP
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 31/114 (27%), Positives = 48/114 (42%), Gaps = 3/114 (2%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLG 412
           A + T   ++ +  NQI+   P    +L NL  L L  NQL   +P  +   L  L  L 
Sbjct: 36  AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94

Query: 413 LVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKL 466
           L  N +  +       L  L  L +  NKL   +P  + +  +L  L+   N+L
Sbjct: 95  LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 39/157 (24%), Positives = 58/157 (36%), Gaps = 34/157 (21%)

Query: 161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKL----DGRIPDSLGQLRNLNYLGTSEN 216
           + L L+ NQ+T   P    +L  L+   +  N+L     G + DSL QL  L        
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLTVL-------- 93

Query: 217 DFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLS 276
                               L  N+    LP  +   L  L  L +  N LT  LP+ + 
Sbjct: 94  -------------------DLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIE 132

Query: 277 NASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN 313
             + L  L L++N         F+ L +L+  YL  N
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 33/127 (25%), Positives = 46/127 (36%), Gaps = 26/127 (20%)

Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI 446
           L L  NQ+T   P     L NL+ L L  N +  +      +LT L VL LG N+L    
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT--- 101

Query: 447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLV 506
                                  LP  +F      K L +  N L+  +P  +  L  L 
Sbjct: 102 ----------------------VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT 138

Query: 507 QLDISRN 513
            L + +N
Sbjct: 139 HLALDQN 145

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 41/135 (30%), Positives = 62/135 (45%), Gaps = 8/135 (5%)

Query: 282 EWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLV 341
           + L L++N  +      F+SL NL +LYLG N LG       D +T LT       L L 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT------VLDLG 96

Query: 342 FNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPA 401
            N+    LP ++ +    +  + M  N+++  +P  I  L +L  L L+ NQL      A
Sbjct: 97  TNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA 154

Query: 402 IGELRNLQYLGLVGN 416
              L +L +  L GN
Sbjct: 155 FDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 40/139 (28%), Positives = 60/139 (43%), Gaps = 6/139 (4%)

Query: 425 PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLL 484
           P G  T   +L L  N++    P       NL +L   +N+L   LP  +F   T   +L
Sbjct: 35  PAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVL 93

Query: 485 DLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI 543
           DL  N L+  +P  V   L  L +L +  N  + E+P  +   T L +L +  N    SI
Sbjct: 94  DLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SI 150

Query: 544 PQ-SLNALKSIKELDLSCN 561
           P  + + L S+    L  N
Sbjct: 151 PHGAFDRLSSLTHAYLFGN 169

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 62.2 bits (151), Expect = 5e-10
 Identities = 66/479 (13%), Positives = 154/479 (32%), Gaps = 58/479 (12%)

Query: 129 NLSRCFNLIDFWVHTNNLVGE----IQAIIGNWLKIERLSLYGNQLTGQLPPSIG-NLSA 183
            L    +  DF +  +   G     I+A+  ++  +E + L    +T      I  +   
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131

Query: 184 LQTFDIAGNKL--DGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
            +   ++  +      +       RNL  L            L   ++  +   +L    
Sbjct: 132 FKVLVLSSCEGFSTDGLAAIAATCRNLKELD-----------LRESDVDDVSGHWL---- 176

Query: 242 FKGSLPVCLGFNLPKLTVLVVA--QNNLT-GFLPQSLSNASKLEWLELNENHFSGQVRIN 298
                          L  L ++   + ++   L + ++    L+ L+LN      ++   
Sbjct: 177 ------SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATL 230

Query: 299 FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLST 358
               P L +L  G      R          L+ C +L  L   ++     LP  + ++ +
Sbjct: 231 LQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA-VYSVCS 289

Query: 359 TMTLIAMAGNQISGT-IPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE-LRNLQYLGLVGN 416
            +T + ++   +    +   +     L  L +  + +       +    ++L+ L +   
Sbjct: 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRV--F 346

Query: 417 NIRGIIPDPIGNLTLLNVLQL--GFNKLQGSIPSYLGKCQN-----LMQLSAPNNKLNGT 469
                + +P   LT   ++ +  G  KL+    S L  C+      L+ ++     +   
Sbjct: 347 PSEPFVMEPNVALTEQGLVSVSMGCPKLE----SVLYFCRQMTNAALITIARNRPNM--- 399

Query: 470 LPPQIFGITTLSKLLD--LSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACT 527
                F +  +       L+   L       V + K L +L +S            +   
Sbjct: 400 ---TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAK 456

Query: 528 TLEYLLMQGNSF-NGSIPQSLNALKSIKELDLS-CNNLSGQIPIHLGNLPFLEYLNLSY 584
            +E L +      +  +   L+   S+++L++  C      +  +   L  +  L +S 
Sbjct: 457 KMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 61.1 bits (149), Expect = 6e-10
 Identities = 35/119 (29%), Positives = 52/119 (43%), Gaps = 26/119 (21%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E+ S + +LH+     I++ DLK  NVLLDH+   H   +DFG+ +           EG 
Sbjct: 132 EIISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK-----------EGI 175

Query: 842 SSSIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-----TDNMFN 892
            + +      GT  YI PE           D ++ G+LL EM     P      D++F 
Sbjct: 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 60.7 bits (148), Expect = 7e-10
 Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 21/108 (19%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E++  + YLH      I++ DLK  NVLLD +   H+  +D+G+ +           EG 
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-----------EGL 161

Query: 842 SSSIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                     GT  YI PE   G D   + D ++ G+L+ EM   R P
Sbjct: 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.2 bits (149), Expect = 7e-10
 Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 21/108 (19%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E++  + YLH      I++ DLK  NVLLD +   H+  +D+G+ +           EG 
Sbjct: 161 EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-----------EGL 204

Query: 842 SSSIEMK---GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                     GT  YI PE   G D   + D ++ G+L+ EM   R P
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 20/155 (12%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG G+FG +  G        VA+K+  +  +        E         + L     I 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFY-----KQLGSGDGIP 68

Query: 741 SSIDF-KGADFKAIVYEYMQYG-SVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQ 797
               F     + A+V E +  G S++D     +    +   L I I++ S +EY+H+   
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125

Query: 798 PPIVHGDLKPSNVLLDHDM-----VAHVSDFGLAR 827
             +++ D+KP N L+         V H+ DF LA+
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 16/103 (15%)

Query: 784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQ 841
           E+   +E+LH      I++ D+K  N+LLD +   HV  +DFGL++      F+     +
Sbjct: 167 EIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSK-----EFVADETER 216

Query: 842 SSSIEMKGTIGYIGPEYGMGGDL--SMTGDVYSFGILLLEMFT 882
           +      GTI Y+ P+   GGD       D +S G+L+ E+ T
Sbjct: 217 AYD--FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 49/331 (14%), Positives = 103/331 (31%), Gaps = 67/331 (20%)

Query: 276 SNASKLEWLELNENHFS-------GQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITL 328
           +  + +  L L+ N           Q+     +  N++ L L  N L  ++S +L   TL
Sbjct: 48  NTPASVTSLNLSGNSLGFKNSDELVQILAAIPA--NVTSLNLSGNFLSYKSSDEL-VKTL 104

Query: 329 LTNCSKLVKLGLVFNRFGG----ALPHSIANLSTTMTLIAMAGNQISGT----IPPEIRN 380
                 +  L L +N F          + +NL  ++T + + GN +       +   +  
Sbjct: 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAA 164

Query: 381 L-FNLNGLGLEYNQLTGTIPPAIGEL-----RNLQYLGLVGNNI-----RGIIPDPIGNL 429
           +  N+N L L  N L       + +       ++  L L  N +       +        
Sbjct: 165 IPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIP 224

Query: 430 TLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSEN 489
             +  L L  N L G         +NL  L      L               + + L  +
Sbjct: 225 NHVVSLNLCLNCLHGPS------LENLKLLKDSLKHL---------------QTVYLDYD 263

Query: 490 HLSG-------SIPLEVGNLKSLVQLDISRNNFSNEIPVTLSA-----CTTLEYLLMQGN 537
            +         ++     N++ ++ +D +         + +S          +   +   
Sbjct: 264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323

Query: 538 SF-----NGSIPQSLNALKSIKELDLSCNNL 563
                  + +  + LN    ++E   +C  L
Sbjct: 324 CLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 50/300 (16%), Positives = 95/300 (31%), Gaps = 62/300 (20%)

Query: 303 PNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFG----GALPHSIANLST 358
             ++ L L  NNL + ++ +L         + +  L L  N  G      L   +A +  
Sbjct: 22  HGVTSLDLSLNNLYSISTVEL-IQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80

Query: 359 TMTLIAMAGNQISGTIPPEI-----RNLFNLNGLGLEYNQLTGTIPPAIGEL-----RNL 408
            +T + ++GN +S     E+        F +  L L +N  +        +       ++
Sbjct: 81  NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140

Query: 409 QYLGLVGNNIR--------GIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLS 460
             L L GN++          I+     N+  LN   L  N L     + L K      L+
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLN---LRGNNLASKNCAELAKF-----LA 192

Query: 461 APNNKLNGTLPPQIFGITTLSKLLDLSENHL--SGSIPLE---VGNLKSLVQLDISRNNF 515
           +    +                 LDLS N L       L          +V L++  N  
Sbjct: 193 SIPASV---------------TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237

Query: 516 SNE----IPVTLSACTTLEYLLMQGNSFNGSIPQSLNAL-------KSIKELDLSCNNLS 564
                  + +   +   L+ + +  +       +   AL       + I  +D +   + 
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 56/369 (15%), Positives = 116/369 (31%), Gaps = 86/369 (23%)

Query: 151 QAIIGNWLKIERLSLYGNQLTGQLPPSIG-----NLSALQTFDIAGNKLDGRIPDSLGQ- 204
           QA       +  L+L GN L  +    +        + + + +++GN L  +  D L + 
Sbjct: 44  QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103

Query: 205 LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRF--KGSLPVC--LGFNLPKLTVL 260
           L  +                    I+ LD   L  N F  K S             +T L
Sbjct: 104 LAAIP-----------------FTITVLD---LGWNDFSSKSSSEFKQAFSNLPASITSL 143

Query: 261 VVAQNNLTGFLPQSLSNA-----SKLEWLELNENHFS-------GQVRINFNSLPNLSKL 308
            +  N+L       L        + +  L L  N+ +        +   +  +  +++ L
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA--SVTSL 201

Query: 309 YLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANL---STTMTLIAM 365
            L  N LG ++  +L +I   +  + +V L L  N   G    ++  L      +  + +
Sbjct: 202 DLSANLLGLKSYAELAYI-FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260

Query: 366 AGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDP 425
             + +      + + L                   A   ++ +  +   G  I      P
Sbjct: 261 DYDIVKNMSKEQCKALGA-----------------AFPNIQKIILVDKNGKEI-----HP 298

Query: 426 IGNLTLLNVLQLGFNKLQGSIPSYLGKCQNL---MQLSAPNNKLNGTLPPQIFGITTLSK 482
             ++ + N+++    K    +PS L +C       Q +  +  +   L           +
Sbjct: 299 SHSIPISNLIRELSGKAD--VPSLLNQCLIFAQKHQTNIEDLNIPDEL-----------R 345

Query: 483 LLDLSENHL 491
               +   L
Sbjct: 346 ESIQTCKPL 354

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 46/228 (20%), Positives = 83/228 (36%), Gaps = 54/228 (23%)

Query: 228 NIS-SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLEL 286
           +      +A L K              L  +  ++   +++   +   +     + +L L
Sbjct: 16  DAFAETIKANLKKKSVT-DAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLAL 70

Query: 287 NENHFS--GQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR 344
             N              L NL+ L L  N L                             
Sbjct: 71  GGNKLHDISA----LKELTNLTYLILTGNQL----------------------------- 97

Query: 345 FGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRN-LFNLNGLGLEYNQLTGTIPPAI- 402
              +LP+ + +  T +  + +  NQ+  ++P  + + L NL  L L +NQL  ++P  + 
Sbjct: 98  --QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVF 153

Query: 403 GELRNLQYLGLVGNNIRGIIPDPIG---NLTLLNVLQLGFNKLQGSIP 447
            +L NL  L L  N ++ +   P G    LT L  L+L  N+L+ S+P
Sbjct: 154 DKLTNLTELDLSYNQLQSL---PEGVFDKLTQLKDLRLYQNQLK-SVP 197

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 54/216 (25%)

Query: 299 FNSLPNLSKLYLGRNNLGTRTS----TDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIA 354
            N L ++ ++    +++ +        ++ ++ L  N  KL  +                
Sbjct: 37  QNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGN--KLHDIS-ALKE---------- 83

Query: 355 NLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLGL 413
                                     L NL  L L  NQL  ++P  +  +L NL+ L L
Sbjct: 84  --------------------------LTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVL 116

Query: 414 VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLG---KCQNLMQLSAPNNKLNGTL 470
           V N ++ +       LT L  L L  N+LQ S+P   G   K  NL +L    N+L  +L
Sbjct: 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSYNQLQ-SL 172

Query: 471 PPQIFGITTLSKLLDLSENHLSGSIPLEV-GNLKSL 505
           P  +F   T  K L L +N L  S+P  V   L SL
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSL 207

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 11/179 (6%)

Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI 446
             L+   +T         L ++  +    ++I+ +    I  L  +  L LG NKL   I
Sbjct: 24  ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH-DI 78

Query: 447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN-LKSL 505
            +   +  NL  L    N+L  +LP  +F   T  K L L EN L  S+P  V + L +L
Sbjct: 79  SAL-KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNL 135

Query: 506 VQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSL-NALKSIKELDLSCNNL 563
             L+++ N   +         T L  L +  N    S+P+ + + L  +K+L L  N L
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 27/167 (16%)

Query: 159 KIERLSLYGNQLTGQLPPSIG---NLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSE 215
            +  L+L GN+L       I     L+ L    + GN+L         +L NL  L   E
Sbjct: 64  NVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118

Query: 216 NDF----SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL 271
           N       G+F      +++L    L  N+ + SLP  +   L  LT L ++ N L    
Sbjct: 119 NQLQSLPDGVFD----KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL---- 169

Query: 272 PQSLSNA-----SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN 313
            QSL        ++L+ L L +N         F+ L +L  ++L  N
Sbjct: 170 -QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 13/158 (8%)

Query: 161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSENDFS 219
            + +L    +T         L+++       + +        L  +R L  LG ++    
Sbjct: 22  IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQYLPNVRYL-ALGGNKLHDI 78

Query: 220 GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA- 278
                    +++L    L  N+ + SLP  +   L  L  LV+ +N L   LP  + +  
Sbjct: 79  SALK----ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132

Query: 279 SKLEWLELNENHF-SGQVRINFNSLPNLSKLYLGRNNL 315
           + L +L L  N   S    + F+ L NL++L L  N L
Sbjct: 133 TNLTYLNLAHNQLQSLPKGV-FDKLTNLTELDLSYNQL 169

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 28/154 (18%), Positives = 53/154 (34%), Gaps = 36/154 (23%)

Query: 435 LQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLS 492
           L      ++  + + L   +    L+   N +      +I  ++ +  L  L L  N + 
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK 83

Query: 493 GSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKS 552
               L+     +L +L IS N  +           +L                 +  L +
Sbjct: 84  KIENLD-AVADTLEELWISYNQIA-----------SLS---------------GIEKLVN 116

Query: 553 IKELDLSCNNLSGQIPI-HLGNLPFLEYLNLSYN 585
           ++ L +S N ++    I  L  L  LE L L+ N
Sbjct: 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 39/155 (25%), Positives = 61/155 (39%), Gaps = 22/155 (14%)

Query: 368 NQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG 427
             I   +   +  L     L L  N +   I   +  + NL+ L L  N I+ I  + + 
Sbjct: 35  PPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIKKI--ENLD 89

Query: 428 NLT-LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--L 484
            +   L  L + +N++  S+ S + K  NL  L   NNK+  T   +I  +  L KL  L
Sbjct: 90  AVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKI--TNWGEIDKLAALDKLEDL 145

Query: 485 DLSENHLSGSIPLE----------VGNLKSLVQLD 509
            L+ N L                 V  L +L +LD
Sbjct: 146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 4/84 (4%)

Query: 505 LVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS 564
            V+L          +  TLS     ++L +  N+    I  SL+ +++++ L L  N + 
Sbjct: 27  KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK 83

Query: 565 GQIPIHLGNLPFLEYLNLSYNHFE 588
            +I         LE L +SYN   
Sbjct: 84  -KIENLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 31/148 (20%), Positives = 51/148 (34%), Gaps = 37/148 (25%)

Query: 197 RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPK 256
           ++  +L  L+   +L  S N+           ISSL                     +  
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE--------KISSLS-------------------GMEN 71

Query: 257 LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYLGRNNL 315
           L +L + +N +   +    + A  LE L ++ N  +    +     L NL  LY+  N +
Sbjct: 72  LRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA---SLSGIEKLVNLRVLYMSNNKI 127

Query: 316 GTRTSTDLDFITLLTNCSKLVKLGLVFN 343
                T+   I  L    KL  L L  N
Sbjct: 128 -----TNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 34/157 (21%), Positives = 60/157 (38%), Gaps = 33/157 (21%)

Query: 271 LPQSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLL 329
           +  +LS     + L L+ N+     +I + + + NL  L LGRN +       ++   L 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNLI-----KKIE--NLD 89

Query: 330 TNCSKLVKLGLVFNRFGGALPHSIANLSTTMTL--IAMAGNQISGTIPPEI---RNLFNL 384
                L +L + +N+       S++ +   + L  + M+ N+I+     EI     L  L
Sbjct: 90  AVADTLEELWISYNQI-----ASLSGIEKLVNLRVLYMSNNKITN--WGEIDKLAALDKL 142

Query: 385 NGLGLEYNQLTGTIPPA----------IGELRNLQYL 411
             L L  N L                 +  L NL+ L
Sbjct: 143 EDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 20/97 (20%), Positives = 34/97 (35%), Gaps = 20/97 (20%)

Query: 526 CTTLEYLLMQGNSFNG--SIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS 583
            T  E + +          +  +L+ LK+ K L LS NN+  +I   L  +  L  L+L 
Sbjct: 22  ATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLG 78

Query: 584 YNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHL 620
            N  +                +   +     L EL +
Sbjct: 79  RNLIK---------------KIENLDAVADTLEELWI 100

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 25/110 (22%), Positives = 47/110 (42%), Gaps = 7/110 (6%)

Query: 102 IPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIE 161
           +   +  L   + + LS N+   KI ++LS   NL    +  N +  +I+ +      +E
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 162 RLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYL 211
            L +  NQ+   L   I  L  L+   ++ NK+       + +L  L+ L
Sbjct: 97  ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAALDKL 142

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 33/155 (21%), Positives = 62/155 (40%), Gaps = 20/155 (12%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           RIG+GSFG +++G    +   VA+K               E         + L     I 
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY-----KLLAGCTGIP 69

Query: 741 SSIDF-KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--LNIVIEVASVIEYLHNHCQ 797
           +   F +      +V + +   S++D L     K  V K       ++ + ++ +H    
Sbjct: 70  NVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSV-KTVAMAAKQMLARVQSIHEKS- 126

Query: 798 PPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAR 827
             +V+ D+KP N L+      +  + +V DFG+ +
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.2 bits (137), Expect = 1e-08
 Identities = 28/197 (14%), Positives = 59/197 (29%), Gaps = 45/197 (22%)

Query: 672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM--------NLDKKGATKSFVAECE 723
            T++     +IG+G FG V++     D   VA+K++        N   +   +  + E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 724 ALR---NIRHRNLIKIITICSSIDF---KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG 777
             +    +      +             +G+    ++  +  Y S     +   D  +  
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 778 KLNIVIE---------------------------VASVIEYLHNHCQPPIVHGDLKPSNV 810
           +L IV+E                           + + +       +    H DL   NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 811 LLDHDMVAHVSDFGLAR 827
           LL    +  +      +
Sbjct: 194 LLKKTSLKKLHYTLNGK 210

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 31/117 (26%), Positives = 48/117 (41%), Gaps = 8/117 (6%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLG 412
             +    T + +  N +          L +L  L L  N+L  ++P  +  +L +L YL 
Sbjct: 24  TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82

Query: 413 LVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLG---KCQNLMQLSAPNNKL 466
           L  N ++ +       LT L  L L  N+LQ S+P   G   K   L  L    N+L
Sbjct: 83  LSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPD--GVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 43/123 (34%), Positives = 57/123 (46%), Gaps = 9/123 (7%)

Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI 446
           L LE N L         EL +L  L L GN ++ +       LT L  L L  N+LQ S+
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91

Query: 447 PSYLG---KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV-GNL 502
           P+  G   K   L +L+   N+L  +LP  +F   T  K L L +N L  S+P  V   L
Sbjct: 92  PN--GVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 147

Query: 503 KSL 505
            SL
Sbjct: 148 TSL 150

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 9/136 (6%)

Query: 282 EWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLV 341
            +L+L  N         F+ L +L++LYLG N L +  +   + +T LT       L L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT------YLNLS 84

Query: 342 FNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPP 400
            N+   +LP+ + +  T +  +A+  NQ+  ++P  +   L  L  L L  NQL      
Sbjct: 85  TNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142

Query: 401 AIGELRNLQYLGLVGN 416
               L +LQY+ L  N
Sbjct: 143 VFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 36/158 (22%), Positives = 55/158 (34%), Gaps = 35/158 (22%)

Query: 161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG 220
             L L  N L          L++L    + GNKL         +L +L YL         
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL--------- 81

Query: 221 MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA-- 278
                           L  N+ + SLP  +   L +L  L +  N L     QSL +   
Sbjct: 82  ---------------NLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-----QSLPDGVF 120

Query: 279 ---SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN 313
              ++L+ L L +N         F+ L +L  ++L  N
Sbjct: 121 DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 23/208 (11%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR---NLIKIIT 738
           IGKGSFG V K     +   VA+K++  +KK        E   L  +          I+ 
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK-LEVGKL-NIVIEVASVIEYLHNHC 796
           +     F+      +V+E + Y ++ D L +TN + + +        ++ + + +L    
Sbjct: 121 LKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP- 176

Query: 797 QPPIVHGDLKPSNVLLDHDMVAH--VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
           +  I+H DLKP N+LL +   +   + DFG +  L    +      QS          Y 
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI---QSRF--------YR 225

Query: 855 GPEYGMGGDLSMTGDVYSFGILLLEMFT 882
            PE  +G    +  D++S G +L+EM T
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 36/142 (25%)

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLN 433
           IP ++  L+      L+ NQ T  +P  +   ++L  + L  N I  +      N+T L 
Sbjct: 29  IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 434 VLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF-GITTLSKLLDLSENHLS 492
            L L +N+L+                          +PP+ F G+ +L +LL L  N +S
Sbjct: 82  TLILSYNRLR-------------------------CIPPRTFDGLKSL-RLLSLHGNDIS 115

Query: 493 GSIPLEV-GNLKSLVQLDISRN 513
             +P     +L +L  L I  N
Sbjct: 116 -VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 24/95 (25%), Positives = 42/95 (44%), Gaps = 4/95 (4%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLG 412
             +   +T + + GNQ +  +P E+ N  +L  + L  N+++ T+       +  L  L 
Sbjct: 27  KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLI 84

Query: 413 LVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIP 447
           L  N +R I P     L  L +L L  N +   +P
Sbjct: 85  LSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVP 118

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 16/152 (10%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG GSFG +Y G   +    VA+K+ N+  K      + E +  R      L     I 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRI-----LQGGTGIP 66

Query: 741 SSIDF-KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQP 798
           +   F    D+  +V + +   S++D  +  + KL +   L +  ++ + +E++H+    
Sbjct: 67  NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123

Query: 799 PIVHGDLKPSNVLLDHDMVAH---VSDFGLAR 827
             +H D+KP N L+     A+   + DFGLA+
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.1 bits (129), Expect = 2e-07
 Identities = 80/557 (14%), Positives = 166/557 (29%), Gaps = 171/557 (30%)

Query: 11  WLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKL--- 67
           +L S   T   + + +T    +  D L     +N++    ++  V+   R Q   KL   
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRL-----YNDNQVFAKYN-VS---RLQPYLKLRQA 143

Query: 68  --DLES-QNI-----GGFLSPYIGNLSFLRVINLANNSFHGQIPKEV-----GRLFRLET 114
             +L   +N+      G      G  +++ +    +     ++  ++           ET
Sbjct: 144 LLELRPAKNVLIDGVLGS-----GK-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197

Query: 115 IVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQL 174
           ++        +I  N +   +  D   H++N+   I     + ++ E   L  ++     
Sbjct: 198 VLEMLQKLLYQIDPNWT---SRSD---HSSNIKLRI-----HSIQAELRRLLKSK---PY 243

Query: 175 PPS------IGNLSALQTFDIAGNKL-----DGRIPDSLG-------------------Q 204
                    + N  A   F++   K+       ++ D L                    +
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNL-SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 205 LRNL--NYLGTSENDFSGMFPLSVCNIS----SLDEAYL--FKNRFKGSLPVCLGFNLPK 256
           +++L   YL     D     P  V   +    S+    +      +     V    N  K
Sbjct: 303 VKSLLLKYLDCRPQD----LPREVLTTNPRRLSIIAESIRDGLATWDNWKHV----NCDK 354

Query: 257 L-TVLVVAQNNLT-----------GFLPQSLSNASK-LE--WLELNENHFSGQVRINFNS 301
           L T++  + N L               P S    +  L   W ++ ++     V +  N 
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS----DVMVVVNK 410

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L   S L   +    T +   +    L         L            H         +
Sbjct: 411 LHKYS-LVEKQPKESTISIPSIYL-ELKVKLENEYAL------------HR--------S 448

Query: 362 LI----AMAGNQISGTIPPEIRNLFNLNGLG--LEYNQLTGTIPPAIGELRNLQYLGL-- 413
           ++              IPP +   F  + +G  L+  +    +       R + +L    
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYF-YSHIGHHLKNIEHPERMT----LFRMV-FLDFRF 502

Query: 414 VGNNIRGIIPDPIGNLTLLNVLQ-------------LGFNKLQGSIPSYL---------G 451
           +   IR        + ++LN LQ               + +L  +I  +L          
Sbjct: 503 LEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS 562

Query: 452 KCQNLMQ--LSAPNNKL 466
           K  +L++  L A +  +
Sbjct: 563 KYTDLLRIALMAEDEAI 579

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 1e-05
 Identities = 93/747 (12%), Positives = 197/747 (26%), Gaps = 248/747 (33%)

Query: 59  HRHQ---RVTKLDLESQNI-GGFLSPYIGNLSFLRVINLANNSFHG-------QIPKEVG 107
           H H       +   + ++I   F   ++ N     V ++  +                V 
Sbjct: 3   HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62

Query: 108 RLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYG 167
              RL   +LS           + + F            V E+  I   +L +  +    
Sbjct: 63  GTLRLFWTLLSK-------QEEMVQKF------------VEEVLRINYKFL-MSPIKTEQ 102

Query: 168 NQLTGQLPPSIGNLSALQT-------FDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG 220
            Q +      I     L         ++++  +   ++  +L +LR    +        G
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL-----IDG 157

Query: 221 MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASK 280
           +                      GS     G    K T + +              +   
Sbjct: 158 V---------------------LGS-----G----K-TWVAL----------DVCLSYKV 176

Query: 281 LEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGL 340
                  +     ++   F         +L   NL    S +     L     ++     
Sbjct: 177 -------QCKMDFKI---F---------WL---NLKNCNSPETVLEMLQKLLYQIDPNWT 214

Query: 341 VFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP 400
             +     +   I ++                    E+R L         Y         
Sbjct: 215 SRSDHSSNIKLRIHSIQA------------------ELRRLLKSK----PYE-------- 244

Query: 401 AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLM--- 457
                  L            ++   + N    N     FN            C+ L+   
Sbjct: 245 -----NCL------------LVLLNVQNAKAWNA----FN----------LSCKILLTTR 273

Query: 458 ------QLSAPNNK-------LNGTLPPQIFGITTLSKLL-----DLSENHLSGSIPLEV 499
                  LSA                P ++  +  L K L     DL    L+ + P  +
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL--LLKYLDCRPQDLPREVLTTN-PRRL 330

Query: 500 GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKS--IKEL- 556
             +   ++  ++  +                +  +  +     I  SLN L+    +++ 
Sbjct: 331 SIIAESIRDGLATWDN---------------WKHVNCDKLTTIIESSLNVLEPAEYRKMF 375

Query: 557 -DLSCNNLSGQIPIHLGNLPFLEYL--NLSYN---HFEGKVPKKGVF---SNETRISLTG 607
             LS    S  IP  L     L  +  ++  +       K+ K  +      E+ IS+  
Sbjct: 376 DRLSVFPPSAHIPTIL-----LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS 430

Query: 608 ----NEQFCGGLGELH--LPACHSVGPRKETITLLKVVIPV-IGTKLAHKLSSALLMEQ- 659
                +        LH  +   +++    ++  L+   +     + + H L +    E+ 
Sbjct: 431 IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM 490

Query: 660 -QFPIVSYAELS--KATKEFSSSNRIGKGSFGFV------YKGNLGEDGMSVAVKVMNLD 710
             F +V + +    +      S+     GS          YK  + ++       V  + 
Sbjct: 491 TLFRMV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI- 548

Query: 711 KKGATKSFVAECEA-LRNIRHRNLIKI 736
                  F+ + E  L   ++ +L++I
Sbjct: 549 -----LDFLPKIEENLICSKYTDLLRI 570

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 20/127 (15%), Positives = 40/127 (31%), Gaps = 7/127 (5%)

Query: 484 LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI 543
           + L+   +  +      N     +LD+ R      I    +     + +    N     +
Sbjct: 2   VKLTAELIEQAAQYT--NAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIR-KL 57

Query: 544 PQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE--GKVPKKGVFSNET 601
                 L+ +K L ++ N +          LP L  L L+ N     G +       + T
Sbjct: 58  -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 602 RISLTGN 608
            + +  N
Sbjct: 117 YLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 7/94 (7%)

Query: 250 LGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLY 309
           LG  L +   +  + N +            +L+ L +N N           +LP+L++L 
Sbjct: 37  LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94

Query: 310 LGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFN 343
           L  N+L      +L  +  L +   L  L ++ N
Sbjct: 95  LTNNSL-----VELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 30/160 (18%), Positives = 47/160 (29%), Gaps = 30/160 (18%)

Query: 376 PEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVL 435
            +  N      L L   ++   I      L     +    N IR +  D    L  L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69

Query: 436 QLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSI 495
            +  N++            +L +L   NN            +  L  L  L+        
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNS-----------LVELGDLDPLA-------- 110

Query: 496 PLEVGNLKSLVQLDISRNNFSNEI---PVTLSACTTLEYL 532
                +LKSL  L I RN  +N+       +     +  L
Sbjct: 111 -----SLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 23/100 (23%), Positives = 34/100 (34%), Gaps = 6/100 (6%)

Query: 367 GNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI 426
           G +I   I      L   + +    N++   +      LR L+ L +  N I  I     
Sbjct: 28  GYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLD 84

Query: 427 GNLTLLNVLQLGFNKLQ--GSIPSYLGKCQNLMQLSAPNN 464
             L  L  L L  N L   G +   L   ++L  L    N
Sbjct: 85  QALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 20/98 (20%), Positives = 31/98 (31%), Gaps = 5/98 (5%)

Query: 348 ALPHSIANLSTTMTLIAMAGNQISGTIPPE-IRNLFNLNGLGLEYNQLTGTIPP-AIGEL 405
              H +        L  +   Q    +    +R L  L  L +  + L   + P A    
Sbjct: 22  DSLHHLPGAENLTELY-IENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT 79

Query: 406 RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
             L  L L  N +  +    +  L+ L  L L  N L 
Sbjct: 80  PRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.9 bits (108), Expect = 4e-05
 Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 2/95 (2%)

Query: 494 SIPLEVGNLKSLVQLDISRNNFSNEIP-VTLSACTTLEYLLMQGNSFNGSIPQSLNALKS 552
                +   ++L +L I        +    L     L  L +  +      P + +    
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 553 IKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHF 587
           +  L+LS N L       +  L  L+ L LS N  
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 18/98 (18%), Positives = 38/98 (38%), Gaps = 5/98 (5%)

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF-GITTLSKLLDLSENHLSGSIPLEV-GNL 502
               +L   +NL +L   N +    L  +   G+  L  L  + ++ L   +  +     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL-TIVKSGLR-FVAPDAFHFT 79

Query: 503 KSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN 540
             L +L++S N     +        +L+ L++ GN  +
Sbjct: 80  PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 12/71 (16%), Positives = 23/71 (32%), Gaps = 6/71 (8%)

Query: 542 SIPQSLNALKSIKELDLSCNNLSGQIP-IHLGNLPFLEYLNLSYNHFEGKVPKKGVFS-- 598
                L   +++ EL +        +    L  L  L  L +  +     V     F   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-PDAFHFT 79

Query: 599 -NETRISLTGN 608
              +R++L+ N
Sbjct: 80  PRLSRLNLSFN 90

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 32/137 (23%), Positives = 49/137 (35%), Gaps = 12/137 (8%)

Query: 428 NLTLLNVLQLGFNKLQ-GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--L 484
               +  L L   K   G I     +  NL  LS  N  L       +  +  L KL  L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76

Query: 485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVT-LSACTTLEYLLMQGN---SFN 540
           +LSEN + G + +    L +L  L++S N   +   +  L     L+ L +      + N
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136

Query: 541 GSIPQSLNALKSIKELD 557
                    L  +  LD
Sbjct: 137 DYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.4 bits (118), Expect = 6e-07
 Identities = 29/120 (24%), Positives = 42/120 (35%), Gaps = 7/120 (5%)

Query: 224 LSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEW 283
           L     +++ E  L   +        L      L  L +    L      +L    KL+ 
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKK 75

Query: 284 LELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFN 343
           LEL+EN   G + +    LPNL+ L L  N L      D+  +  L     L  L L   
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 4/88 (4%)

Query: 501 NLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSC 560
            ++ LV LD  ++N   +I    +    LE+L +       S+  +L  L  +K+L+LS 
Sbjct: 25  AVRELV-LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80

Query: 561 NNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
           N + G + +    LP L +LNLS N  +
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 33/137 (24%), Positives = 51/137 (37%), Gaps = 10/137 (7%)

Query: 379 RNLFNLNGLGLEYNQLT-GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQL 437
           R    +  L L+  +   G I     E  NL++L L+   +  +    +  L  L  L+L
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLEL 78

Query: 438 GFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSEN---HLS 492
             N++ G +     K  NL  L+   NKL       +  +  L  L  LDL      +L+
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVTNLN 136

Query: 493 GSIPLEVGNLKSLVQLD 509
                    L  L  LD
Sbjct: 137 DYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 4/103 (3%)

Query: 484 LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSI 543
           LD  +++  G I        +L  L +        +   L     L+ L +  N   G +
Sbjct: 31  LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGL 87

Query: 544 PQSLNALKSIKELDLSCNNLSGQIPI-HLGNLPFLEYLNLSYN 585
                 L ++  L+LS N L     +  L  L  L+ L+L   
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 4/107 (3%)

Query: 112 LETIVLSNNSFS-GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQL 170
           +  +VL N   + GKI    +   NL    +  N  +  + + +    K+++L L  N++
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISV-SNLPKLPKLKKLELSENRI 83

Query: 171 TGQLPPSIGNLSALQTFDIAGNKL-DGRIPDSLGQLRNLNYLGTSEN 216
            G L      L  L   +++GNKL D    + L +L  L  L     
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.3 bits (118), Expect = 4e-07
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 4/88 (4%)

Query: 501 NLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSC 560
           ++K LV LD SR+N   ++         LE+L         SI  +L  L  +K+L+LS 
Sbjct: 18  DVKELV-LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73

Query: 561 NNLSGQIPIHLGNLPFLEYLNLSYNHFE 588
           N +SG + +     P L +LNLS N  +
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 31/116 (26%), Positives = 43/116 (37%), Gaps = 7/116 (6%)

Query: 228 NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELN 287
             S + E  L  +R        L     +L  L      LT     +L   +KL+ LEL+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 288 ENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFN 343
           +N  SG + +     PNL+ L L  N +      DL  I  L     L  L L   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 29/133 (21%), Positives = 50/133 (37%), Gaps = 12/133 (9%)

Query: 432 LNVLQLGFNKLQ-GSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSE 488
           +  L L  ++   G +     + + L  LS  N  L       I  +  L+KL  L+LS+
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELSD 73

Query: 489 NHLSGSIPLEVGNLKSLVQLDISRNNFSN-EIPVTLSACTTLEYLLMQGN---SFNGSIP 544
           N +SG + +      +L  L++S N   +      L     L+ L +      + N    
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRE 133

Query: 545 QSLNALKSIKELD 557
                L  +  LD
Sbjct: 134 NVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 22/106 (20%), Positives = 37/106 (34%), Gaps = 4/106 (3%)

Query: 482 KLLDLSENHLS-GSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN 540
           K L L  +  + G +       + L  L       +  I   L     L+ L +  N  +
Sbjct: 20  KELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVS 77

Query: 541 GSIPQSLNALKSIKELDLSCNNLSGQIPI-HLGNLPFLEYLNLSYN 585
           G +        ++  L+LS N +     I  L  L  L+ L+L   
Sbjct: 78  GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 7/114 (6%)

Query: 379 RNLFNLNGLGLEYNQLT-GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQL 437
           R   ++  L L+ ++   G +     E   L++L  +   +  I    +  L  L  L+L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLEL 71

Query: 438 GFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSEN 489
             N++ G +     KC NL  L+   NK+       I  +  L  L  LDL   
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 25/107 (23%), Positives = 45/107 (42%), Gaps = 4/107 (3%)

Query: 112 LETIVLSNNSFS-GKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQL 170
           ++ +VL N+  + GK+         L       N  +  I A +    K+++L L  N++
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLST-INVGLTSI-ANLPKLNKLKKLELSDNRV 76

Query: 171 TGQLPPSIGNLSALQTFDIAGNKL-DGRIPDSLGQLRNLNYLGTSEN 216
           +G L         L   +++GNK+ D    + L +L NL  L     
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 32/195 (16%), Positives = 71/195 (36%), Gaps = 20/195 (10%)

Query: 406 RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNK 465
           + +       + +   + +      + ++          ++   L +C  L  LS    +
Sbjct: 70  QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 129

Query: 466 LNGTLPPQIFGITTLSKLLDLSENHLSG-------SIPLEVGNLKSLVQLDISR-NNFSN 517
           L+         + TL+K  +L   +LSG       ++   + +   L +L++S   +F+ 
Sbjct: 130 LSDP------IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183

Query: 518 EIPVTLSA--CTTLEYLLMQGNSFN---GSIPQSLNALKSIKELDLS-CNNLSGQIPIHL 571
           +      A    T+  L + G   N     +   +    ++  LDLS    L        
Sbjct: 184 KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF 243

Query: 572 GNLPFLEYLNLSYNH 586
             L +L++L+LS  +
Sbjct: 244 FQLNYLQHLSLSRCY 258

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 44.9 bits (106), Expect = 8e-05
 Identities = 42/217 (19%), Positives = 83/217 (38%), Gaps = 32/217 (14%)

Query: 377 EIRNLFNLNGLGLEYNQLT-GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVL 435
           E  + F +  + L  + +   T+   + +   LQ L L G  +   I + +   + L  L
Sbjct: 88  EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147

Query: 436 QLGFNKL--QGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSG 493
            L       + ++ + L  C  L +L+                   LS   D +E H+  
Sbjct: 148 NLSGCSGFSEFALQTLLSSCSRLDELN-------------------LSWCFDFTEKHVQV 188

Query: 494 SIPLEVGNLKSLVQLDIS--RNNFSNE-IPVTLSACTTLEYLLMQGNSF--NGSIPQSLN 548
           ++       +++ QL++S  R N     +   +  C  L +L +  +    N    Q   
Sbjct: 189 AVA---HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF-QEFF 244

Query: 549 ALKSIKELDLS-CNNLSGQIPIHLGNLPFLEYLNLSY 584
            L  ++ L LS C ++  +  + LG +P L+ L +  
Sbjct: 245 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 27/149 (18%), Positives = 51/149 (34%), Gaps = 15/149 (10%)

Query: 479 TLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
           +L + LDL+  +L   +   + +   +      R+     +    S    ++++ +  + 
Sbjct: 47  SLWQTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFS-PFRVQHMDLSNSV 104

Query: 539 FN-GSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVF 597
               ++   L+    ++ L L    LS  I   L     L  LNLS              
Sbjct: 105 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC------------ 152

Query: 598 SNETRISLTGNEQFCGGLGELHLPACHSV 626
           S  +  +L      C  L EL+L  C   
Sbjct: 153 SGFSEFALQTLLSSCSRLDELNLSWCFDF 181

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 26/99 (26%), Positives = 47/99 (47%), Gaps = 11/99 (11%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYL 411
             + ++ T + +  N++  ++P  +   L  L  L L  NQ+  ++P  +  +L  L  L
Sbjct: 24  TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTIL 81

Query: 412 GLVGNNIRGIIPDPIG---NLTLLNVLQLGFNKLQGSIP 447
            L  N ++ +   P G    LT L  L L  N+L+ S+P
Sbjct: 82  YLHENKLQSL---PNGVFDKLTQLKELALDTNQLK-SVP 116

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 30/86 (34%), Positives = 40/86 (46%), Gaps = 12/86 (13%)

Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG---NLTLLNVLQLGFNKLQ 443
           L LE N+L         +L  L  L L  N I+ +   P G    LT L +L L  NKLQ
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL---PDGVFDKLTKLTILYLHENKLQ 89

Query: 444 GSIPSYLG---KCQNLMQLSAPNNKL 466
            S+P+  G   K   L +L+   N+L
Sbjct: 90  -SLPN--GVFDKLTQLKELALDTNQL 112

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 12/109 (11%)

Query: 387 LGLEYNQLTGTIPPAI-GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGS 445
           L L  N+L       + G L +L  L L  N + GI P+     + +  LQLG NK++  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92

Query: 446 IPSYLG---KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSEN 489
           I +          L  L+  +N+++  + P  F    L+ L  L+L+ N
Sbjct: 93  ISN--KMFLGLHQLKTLNLYDNQIS-CVMPGSF--EHLNSLTSLNLASN 136

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 45/351 (12%), Positives = 104/351 (29%), Gaps = 61/351 (17%)

Query: 250 LGFNLPKLTVLVVAQNNLT--GFLPQSLSNASKLEWLELNE-NHFSGQ-VRINFNSLPNL 305
           +  NL +L  +   +  ++       + + A  LE L+L++ + F+   +         +
Sbjct: 107 ISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKI 166

Query: 306 SKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAM 365
             L +  ++   +         L  + + L  L      F    P  +  ++        
Sbjct: 167 KTLLMEESSFSEKD--GKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIA-------- 216

Query: 366 AGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDP 425
                        RN  +L  + +   ++   +        NL+       N    +P+ 
Sbjct: 217 -------------RNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEK 262

Query: 426 IGNLT-LLNVLQLGFNKL-QGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL 483
             NL     + +LG + +    +P        + +L      L           T + K 
Sbjct: 263 YMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETED-----HCTLIQKC 317

Query: 484 LDLSENHLSGSIPLE-----VGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS 538
            +L        I            K L +L I R                 + +  +   
Sbjct: 318 PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER-------------GADEQGMEDEEGL 364

Query: 539 FNGSIPQSLNAL----KSIKELDLSCNNLSGQIPIHLG-NLPFLEYLNLSY 584
            +    + L AL    + ++ + +  ++++ +    +G  L  L    L  
Sbjct: 365 VS---QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL 412

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 41/316 (12%), Positives = 80/316 (25%), Gaps = 31/316 (9%)

Query: 84  NLSFLRVINLANNSF--HGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV 141
           N   L  + + +          K    L       L+ +    +   NL     L    +
Sbjct: 218 NCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL 277

Query: 142 HTNNLVGEIQAIIGNWLKIERLSL-YGNQLTGQLPPSIGNLSALQTFDIAGNKLD---GR 197
                   +  +     +I +L L Y    T      I     L+  +      D     
Sbjct: 278 SYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336

Query: 198 IPDSLGQLRNLNYLGTSENDFSGMFPLSVCNIS---------SLDEAYLFKNRFKGSLPV 248
           +     QL+ L     ++          V              L+   ++ +        
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396

Query: 249 CLGFNLPKLTVL----VVAQNNLTGF-----LPQSLSNASKLEWLELNENHFSGQVRINF 299
            +G  L  L       +  +  +T       +   L    KL            Q  +  
Sbjct: 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFY----LRQGGLTD 452

Query: 300 NSLPNLSKL--YLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLS 357
             L  + +    +    LG    +D   +     C  L KL +    F      +     
Sbjct: 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKL 512

Query: 358 TTMTLIAMAGNQISGT 373
            ++  + + G + S T
Sbjct: 513 PSLRYLWVQGYRASMT 528

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 1e-05
 Identities = 18/124 (14%), Positives = 51/124 (41%), Gaps = 18/124 (14%)

Query: 482 KLLDLSENHLSGSIPLEVG--NLKSLVQLDIS--RNNFSNEIPVTL-------SACTTLE 530
           K L++    L  S+  ++   +L +L +L +     ++  +  + +            L+
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255

Query: 531 YLLMQGNSFNGSIPQSL---NALKSIKELDLSCNNLSG----QIPIHLGNLPFLEYLNLS 583
           +L +        + +     + L  ++ +D+S   L+      +  H+  +  L+++N+ 
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315

Query: 584 YNHF 587
           YN+ 
Sbjct: 316 YNYL 319

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 47/230 (20%), Positives = 88/230 (38%), Gaps = 51/230 (22%)

Query: 682 IGKGSFGFVYKG-NLGEDGMSVAVKVM-NLDK--KGATKSFVAECEALRNIRHR---NLI 734
           +G+G+FG V +  +       VA+K++ N+ K  + A      E   L+ I+ +   N  
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKDKENKF 82

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---LEVGKLNIVIEVASVIEY 791
             + +    +F G     I +E +   +  ++L   N +   L   + ++  ++   + +
Sbjct: 83  LCVLMSDWFNFHG--HMCIAFELLGK-NTFEFLKENNFQPYPLPHVR-HMAYQLCHALRF 138

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAH-------------------VSDFGLARFLSHH 832
           LH +    + H DLKP N+L  +                        V+DFG A F   H
Sbjct: 139 LHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195

Query: 833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT 882
              +     +          Y  PE  +    +   DV+S G +L E + 
Sbjct: 196 HTTIV---ATRH--------YRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 17/97 (17%), Positives = 39/97 (40%), Gaps = 6/97 (6%)

Query: 494 SIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQG-----NSFNGSIPQSLN 548
            +P    +   +  +D + +   +     +     +E + +       +     + Q  N
Sbjct: 52  HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLEN 111

Query: 549 ALKSIKELDLS-CNNLSGQIPIHLGNLPFLEYLNLSY 584
             KS+ E+++  C N++ +  I L +   L+YL LS 
Sbjct: 112 LQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSD 148

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 31/222 (13%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR--NLIKIITI 739
           +G G+FG V      ++    AVKV+  + K  T+S   E + L+ I++   N   I+  
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDK---LEVGKLNIVIEVASVIEYLHNHC 796
                +       +++E +   S+ + +   N     +E  K    IE+   + YL    
Sbjct: 102 HGKFMYYD--HMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK-LYCIEILKALNYLRKMS 157

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ--------SSSIEMK 848
              + H DLKP N+LLD                     +   +           ++ +  
Sbjct: 158 ---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214

Query: 849 GTIGYI------GPE--YGMGGDLSMTGDVYSFGILLLEMFT 882
                I       PE    +G D+S   D++SFG +L E++T
Sbjct: 215 YHGSIINTRQYRAPEVILNLGWDVSS--DMWSFGCVLAELYT 254

>4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 7/32 (21%), Positives = 11/32 (34%)

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
              + HGD    N++ D   +    D G    
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.6 bits (101), Expect = 4e-04
 Identities = 43/224 (19%), Positives = 90/224 (40%), Gaps = 39/224 (17%)

Query: 682 IGKGSFGFVYKG-NLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR---NLIKII 737
           +G+G+FG V +  +    G  VAVK++    +    +   E + L ++      +  + +
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-EIQVLEHLNTTDPNSTFRCV 80

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG-KLNIVIEVA----SVIEYL 792
            +    +  G     IV+E +   S  D++        +  +L+ + ++A      + +L
Sbjct: 81  QMLEWFEHHG--HICIVFELLGL-STYDFIKENG---FLPFRLDHIRKMAYQICKSVNFL 134

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE------GQSSSIE 846
           H++    + H DLKP N+L          +  + R       L+ P+      G S++ +
Sbjct: 135 HSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT---LINPDIKVVDFG-SATYD 187

Query: 847 MKGTIGYI------GPE--YGMGGDLSMTGDVYSFGILLLEMFT 882
            +     +       PE    +G       DV+S G +L+E + 
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYL 229

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 64/400 (16%), Positives = 109/400 (27%), Gaps = 79/400 (19%)

Query: 163 LSLYGNQ-LTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGM 221
           L    N+ +  QL   I NL AL+       KL       L     L+            
Sbjct: 6   LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLD------------ 53

Query: 222 FPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSL-----S 276
                 +    ++ +  +              L  L  L +A   +T      +     S
Sbjct: 54  --HLFFHYEFQNQRFSAEV-------------LSSLRQLNLAGVRMTPVKCTVVAAVLGS 98

Query: 277 NASKLEWLELNENHFSGQVRINF-NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKL 335
               L+ + L                     KL L  N+LG     DL  + LL +  ++
Sbjct: 99  GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL-LLHDQCQI 157

Query: 336 VKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT 395
             L L  N    A    +           +AGN              ++  L L +  L 
Sbjct: 158 TTLRLSNNPLTAAGVAVLME--------GLAGNT-------------SVTHLSLLHTGLG 196

Query: 396 GT----IPPAIGELRNLQYLGLVGNNIRG----IIPDPIGNLTLLNVLQLGFNKLQGS-- 445
                 +   +   R LQ L +  N         +         L +L L FN+L     
Sbjct: 197 DEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGR 256

Query: 446 --IPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLK 503
             +    G  +   ++     +         +    LS++      +L+      V    
Sbjct: 257 QVLRDLGGAAEGGARVVVSLTEGTAV---SEYWSVILSEVQ----RNLNSWDRARVQRHL 309

Query: 504 SLVQLDISRNNFSNE----IPVTLSACTTLEYLLMQGNSF 539
            L+  D+  +  +          L     +  LL Q  S 
Sbjct: 310 ELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 10/48 (20%), Positives = 19/48 (39%), Gaps = 3/48 (6%)

Query: 784 EVASVIEYLHNH---CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 828
           +   + ++L       +    HGDL  SN+ +    V+   D G +  
Sbjct: 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	973
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.87
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.74
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.72
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.69
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.61
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.6
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.59
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.59
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.58
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.57
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.52
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.51
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.51
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.5
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.49
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.44
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.41
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.39
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.37
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.24
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.19
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.19
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.18
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.18
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.18
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.87
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.86
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.86
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.85
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.84
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.81
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.73
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.65
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.34
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.3
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.29
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.16
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.15
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.05
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.98
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.91
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.68
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.65
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.55
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.4
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.39
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.1
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.04
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.95
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.86
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.79
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.71
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.67
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.51
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.32
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.26
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.25
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.17
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.16
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.01
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.94
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.7
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.97
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.78
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.21
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.79

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=7.3e-83  Score=789.90  Aligned_cols=598  Identities=29%  Similarity=0.430  Sum_probs=449.7

Q ss_pred             ccccchhhHHHHHHHHhhccCCCcCCCCCCCCCCCCCceeeeEeeCCCCeEEEEEeeccCcccc---cc-----------
Q 039720           14 SRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGF---LS-----------   79 (973)
Q Consensus        14 ~~~~~~~~~~~ll~~~~~~~~d~~~~l~sw~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~---~~-----------   79 (973)
                      +..+...|++|||+||+++. ||. +++||+.++|||.|.||+|+  +++|+.|||+++++.|.   +|           
T Consensus         6 ~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~   81 (768)
T 3rgz_A            6 PSQSLYREIHQLISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES   81 (768)
T ss_dssp             --CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred             cccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence            34556778999999999875 888 99999988899999999998  68999999999999887   54           


Q ss_pred             ------------CCCcCCCCCCEEEccCCCCCCCCCc--cccccCCCCEEeeecccCCCCCCccc-ccCCCccceEeccc
Q 039720           80 ------------PYIGNLSFLRVINLANNSFHGQIPK--EVGRLFRLETIVLSNNSFSGKIPTNL-SRCFNLIDFWVHTN  144 (973)
Q Consensus        80 ------------~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~l~~n  144 (973)
                                  +.++.+++|++|||++|.++|.+|.  .++++++|++|+|++|.+++.+|..+ +++++|++|++++|
T Consensus        82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n  161 (768)
T 3rgz_A           82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN  161 (768)
T ss_dssp             EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred             cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence                        4788889999999999999999998  99999999999999999999888877 78999999999999


Q ss_pred             ccccchhhh---hccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCcccc
Q 039720          145 NLVGEIQAI---IGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGM  221 (973)
Q Consensus       145 ~~~~~~~~~---~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~  221 (973)
                      ++.+..|..   +.++++|++|++++|.+++..|.  +++++|++|+|++|++++.+|. ++++++|++|++++|++++.
T Consensus       162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~  238 (768)
T 3rgz_A          162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD  238 (768)
T ss_dssp             CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred             ccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence            999888876   66666666666666655543332  4445555555555555444444 44455555555555554444


Q ss_pred             CCccccC----------------------CCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCC
Q 039720          222 FPLSVCN----------------------ISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNAS  279 (973)
Q Consensus       222 ~p~~~~~----------------------l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  279 (973)
                      +|..+.+                      +++|++|+|++|++++.+|..++..+++|++|+|++|.+++.+|..|++++
T Consensus       239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~  318 (768)
T 3rgz_A          239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS  318 (768)
T ss_dssp             HHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred             ccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence            4444444                      445555555555555566666654447777777777777777777777777


Q ss_pred             CCCEEEccCCcccccCccc-ccCcccccceecccccCCCCCCCChhhhh-------------------hhcc--ccccee
Q 039720          280 KLEWLELNENHFSGQVRIN-FNSLPNLSKLYLGRNNLGTRTSTDLDFIT-------------------LLTN--CSKLVK  337 (973)
Q Consensus       280 ~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-------------------~l~~--l~~L~~  337 (973)
                      +|++|+|++|++++.+|.. |..+++|++|+|++|+++......+....                   .+..  +++|++
T Consensus       319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~  398 (768)
T 3rgz_A          319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE  398 (768)
T ss_dssp             TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred             CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence            7777777777777555544 67777777777777776532222111110                   0111  345566


Q ss_pred             eccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcc
Q 039720          338 LGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNN  417 (973)
Q Consensus       338 L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  417 (973)
                      |++++|++.+.+|..+..+ ..++.|++++|++++.+|..+..+++|+.|+|++|++++.+|..+..+++|++|+|++|+
T Consensus       399 L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~  477 (768)
T 3rgz_A          399 LYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND  477 (768)
T ss_dssp             EECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             EECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence            6666666666666665554 456667777777777777777777777777777777777777777777777777777777


Q ss_pred             cCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCc
Q 039720          418 IRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPL  497 (973)
Q Consensus       418 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~  497 (973)
                      +++.+|..+.++++|++|+|++|++++.+|.+++.+++|++|++++|++.|.+|..+..+..+. .|++++|+++|.+|.
T Consensus       478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~g~ip~  556 (768)
T 3rgz_A          478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI-WLDLNTNLFNGTIPA  556 (768)
T ss_dssp             CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCC-EEECCSSEEESBCCG
T ss_pred             ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCC-EEECCCCccCCcCCh
Confidence            7777777777777777777777777777777777777777777777777777777776666654 677777777766664


Q ss_pred             c----------------------------------------------------------------------cccccccce
Q 039720          498 E----------------------------------------------------------------------VGNLKSLVQ  507 (973)
Q Consensus       498 ~----------------------------------------------------------------------~~~l~~L~~  507 (973)
                      .                                                                      ++.+++|+.
T Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~  636 (768)
T 3rgz_A          557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF  636 (768)
T ss_dssp             GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred             HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence            3                                                                      444678999


Q ss_pred             eccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcC
Q 039720          508 LDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHF  587 (973)
Q Consensus       508 L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  587 (973)
                      |||++|+++|.+|..++++++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..+++|++|||++|++
T Consensus       637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l  716 (768)
T 3rgz_A          637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL  716 (768)
T ss_dssp             EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred             EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCCCCCCCCccccccccCccccCCCCCCCCCCCC
Q 039720          588 EGKVPKKGVFSNETRISLTGNEQFCGGLGELHLPACH  624 (973)
Q Consensus       588 ~~~~p~~~~~~~~~~l~~~~N~~~cg~~~~~~~~~~~  624 (973)
                      +|.+|..++|.++...++.|||++||.++    +.|.
T Consensus       717 ~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C~  749 (768)
T 3rgz_A          717 SGPIPEMGQFETFPPAKFLNNPGLCGYPL----PRCD  749 (768)
T ss_dssp             EEECCSSSSGGGSCGGGGCSCTEEESTTS----CCCC
T ss_pred             cccCCCchhhccCCHHHhcCCchhcCCCC----cCCC
Confidence            99999999999999999999999999875    3675

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.4e-65  Score=630.75  Aligned_cols=518  Identities=34%  Similarity=0.527  Sum_probs=437.5

Q ss_pred             CeEEEEEeeccCccccccC--CCcCCCCCCEEEccCCCCCCCCCccc-c-------------------------------
Q 039720           62 QRVTKLDLESQNIGGFLSP--YIGNLSFLRVINLANNSFHGQIPKEV-G-------------------------------  107 (973)
Q Consensus        62 ~~v~~l~l~~~~l~g~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~~-~-------------------------------  107 (973)
                      .+++.|||+++.+.|.+|+  .++++++|++|+|++|.+++.+|..+ +                               
T Consensus       100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~  179 (768)
T 3rgz_A          100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE  179 (768)
T ss_dssp             TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred             CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence            4677888888888888887  78888888888888888777766543 3                               


Q ss_pred             ------------------ccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCc
Q 039720          108 ------------------RLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQ  169 (973)
Q Consensus       108 ------------------~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~  169 (973)
                                        ++++|++|+|++|.+++.+|. ++++++|++|++++|++.+.+|..++++++|++|+|++|+
T Consensus       180 L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~  258 (768)
T 3rgz_A          180 LKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ  258 (768)
T ss_dssp             CCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSC
T ss_pred             CCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCc
Confidence                              344455555555555555555 6777777777777777777777777777777777777777


Q ss_pred             ccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCC-CccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCc
Q 039720          170 LTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQL-RNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPV  248 (973)
Q Consensus       170 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~  248 (973)
                      +++.+|..  .+++|++|++++|++++.+|..+.++ ++|++|+|++|.+++.+|..|+++++|++|+|++|+++|.+|.
T Consensus       259 l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~  336 (768)
T 3rgz_A          259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM  336 (768)
T ss_dssp             CEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCH
T ss_pred             ccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCH
Confidence            77766664  67777777777777777788777765 8888888888888888888888888888888888888888887


Q ss_pred             ccccCCCCCcEEEccCCcccccCCccccCCC-CCCEEEccCCcccccCcccccC--cccccceecccccCCCCCCCChhh
Q 039720          249 CLGFNLPKLTVLVVAQNNLTGFLPQSLSNAS-KLEWLELNENHFSGQVRINFNS--LPNLSKLYLGRNNLGTRTSTDLDF  325 (973)
Q Consensus       249 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~  325 (973)
                      ..+.++++|++|+|++|.+++.+|..+.+++ +|++|+|++|++++..+..+..  +++|++|+|++|+++...      
T Consensus       337 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------  410 (768)
T 3rgz_A          337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI------  410 (768)
T ss_dssp             HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC------
T ss_pred             HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc------
Confidence            7555788888888888888888888888877 8888888888888777777766  778888888888886432      


Q ss_pred             hhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCC
Q 039720          326 ITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGEL  405 (973)
Q Consensus       326 ~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  405 (973)
                      +..+.++++|+.|++++|++.+.+|..+..+ +.++.|++++|++++.+|..+..+++|++|+|++|++++.+|.++..+
T Consensus       411 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  489 (768)
T 3rgz_A          411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC  489 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             CHHHhcCCCCCEEECcCCcccCcccHHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcC
Confidence            2456789999999999999999999999887 579999999999999999999999999999999999999999999999


Q ss_pred             CCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccc-------
Q 039720          406 RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGIT-------  478 (973)
Q Consensus       406 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~-------  478 (973)
                      ++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..++.+++|+.|++++|+++|.+|..++...       
T Consensus       490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~  569 (768)
T 3rgz_A          490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF  569 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred             CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence            9999999999999999999999999999999999999999999999999999999999999999998765421       


Q ss_pred             --------------------------------------------------------------cccceeeccCCcccccCC
Q 039720          479 --------------------------------------------------------------TLSKLLDLSENHLSGSIP  496 (973)
Q Consensus       479 --------------------------------------------------------------~l~~~L~Ls~N~l~~~~p  496 (973)
                                                                                    ..++.|||++|+++|.+|
T Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip  649 (768)
T 3rgz_A          570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP  649 (768)
T ss_dssp             TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence                                                                          223579999999999999


Q ss_pred             cccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCc
Q 039720          497 LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPF  576 (973)
Q Consensus       497 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  576 (973)
                      ..++++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..++.|++|||++|+++|.+|.. +.+..
T Consensus       650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~  728 (768)
T 3rgz_A          650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFET  728 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGG
T ss_pred             HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999975 45566


Q ss_pred             cceEeccCCc-CcCc
Q 039720          577 LEYLNLSYNH-FEGK  590 (973)
Q Consensus       577 L~~L~ls~N~-l~~~  590 (973)
                      +....+.+|+ ++|.
T Consensus       729 ~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          729 FPPAKFLNNPGLCGY  743 (768)
T ss_dssp             SCGGGGCSCTEEEST
T ss_pred             CCHHHhcCCchhcCC
Confidence            6667788886 6664

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=9e-61  Score=586.93  Aligned_cols=564  Identities=21%  Similarity=0.201  Sum_probs=477.7

Q ss_pred             CceeeeEeeCC---------CCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecc
Q 039720           50 CQWTGVTCGHR---------HQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNN  120 (973)
Q Consensus        50 c~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n  120 (973)
                      |.++-|.|+..         ..+++.|+|+++.+.+..+..++++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   83 (680)
T 1ziw_A            4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN   83 (680)
T ss_dssp             CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred             eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence            45566777642         247899999999999877778999999999999999999988999999999999999999


Q ss_pred             cCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCC
Q 039720          121 SFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPD  200 (973)
Q Consensus       121 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  200 (973)
                      .+++..+..|+++++|++|++++|++.+..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|++++..+.
T Consensus        84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  163 (680)
T 1ziw_A           84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE  163 (680)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred             ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence            99954445799999999999999999988889999999999999999999998899999999999999999999987777


Q ss_pred             ccc--CCCccceeccCCCCccccCCccccCC---------------------------CCCcEEEccCCccccCCCcccc
Q 039720          201 SLG--QLRNLNYLGTSENDFSGMFPLSVCNI---------------------------SSLDEAYLFKNRFKGSLPVCLG  251 (973)
Q Consensus       201 ~~~--~L~~L~~L~Ls~N~l~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~ip~~~~  251 (973)
                      .+.  .+++|++|++++|.+++..|..+..+                           ++|+.|++++|++++..|..+.
T Consensus       164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~  243 (680)
T 1ziw_A          164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL  243 (680)
T ss_dssp             HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred             HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence            654  56899999999999999888877655                           4567777788888766565554


Q ss_pred             cCCC--CCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCC-CChhh--h
Q 039720          252 FNLP--KLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTS-TDLDF--I  326 (973)
Q Consensus       252 ~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~--~  326 (973)
                       +++  +|++|+|++|.+++..|..|..+++|++|+|++|++++..+..|.++++|++|++++|....... ..+..  .
T Consensus       244 -~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~  322 (680)
T 1ziw_A          244 -GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD  322 (680)
T ss_dssp             -GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred             -ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence             454  49999999999988888889999999999999999998888889999999999998875432100 00000  0


Q ss_pred             hhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccC--CCccccCC--CCcCEEEcccccCCCCCCccc
Q 039720          327 TLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGT--IPPEIRNL--FNLNGLGLEYNQLTGTIPPAI  402 (973)
Q Consensus       327 ~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~--~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~  402 (973)
                      ..+..+++|++|++++|++.+..|..+..+ ..++.|++++|.+.+.  ....|..+  ++|+.|++++|++++..|.+|
T Consensus       323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~  401 (680)
T 1ziw_A          323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF  401 (680)
T ss_dssp             TTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTT
T ss_pred             hhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhh
Confidence            145678899999999999998777777665 5789999999875432  23334433  589999999999999999999


Q ss_pred             cCCCCCCeEEccCcccCCCCC-CccCCcCccceEEcCCCccccccccccccccccccccccCcccc--cCCCcccccccc
Q 039720          403 GELRNLQYLGLVGNNIRGIIP-DPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN--GTLPPQIFGITT  479 (973)
Q Consensus       403 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~~~~  479 (973)
                      ..+++|++|+|++|++.+.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.+.  +.+|..+..+..
T Consensus       402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~  481 (680)
T 1ziw_A          402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN  481 (680)
T ss_dssp             TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred             hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence            999999999999999987666 68999999999999999999888999999999999999999987  577888887777


Q ss_pred             ccceeeccCCcccccCCcccccccccceeccccCccccccc--------ccccCccchhhhcccCcccccccccchhhhc
Q 039720          480 LSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIP--------VTLSACTTLEYLLMQGNSFNGSIPQSLNALK  551 (973)
Q Consensus       480 l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  551 (973)
                      +. .|++++|++++..|..|..+++|+.|++++|++++..+        ..|.++++|+.|+|++|+++...+..|..++
T Consensus       482 L~-~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~  560 (680)
T 1ziw_A          482 LT-ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF  560 (680)
T ss_dssp             CC-EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CC-EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence            75 99999999998888889999999999999999986422        2378999999999999999955555799999


Q ss_pred             cCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCC--CCCCccccccccCccccCCCC
Q 039720          552 SIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKG--VFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       552 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~~~~~l~~~~N~~~cg~~~  616 (973)
                      +|+.|+|++|+|++..+..|..+++|+.|+|++|++++.+|...  .+++++.+++.+|||.|+|..
T Consensus       561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            99999999999997666778999999999999999999887642  478899999999999999864

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.3e-60  Score=577.30  Aligned_cols=501  Identities=20%  Similarity=0.244  Sum_probs=359.7

Q ss_pred             cccchhhHHHHHHHHhhccCCCcC-------CCCCCCCCCCCCce---eeeEeeCCCCeEEEEEeeccCccccccCCCcC
Q 039720           15 RHATSHVKHATVTFNMQQLHDPLG-------VTKSWNNSINLCQW---TGVTCGHRHQRVTKLDLESQNIGGFLSPYIGN   84 (973)
Q Consensus        15 ~~~~~~~~~~ll~~~~~~~~d~~~-------~l~sw~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~   84 (973)
                      .++...|++||.+|+.+...+.+.       ..++|+.+++||.|   .||+|+.. ++|+.|+|+++++.|.+|+++++
T Consensus        25 ~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~  103 (636)
T 4eco_A           25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQ  103 (636)
T ss_dssp             CCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGG
T ss_pred             hhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhc
Confidence            344457899999999876433332       34589988999999   99999865 89999999999999999999999


Q ss_pred             CCCCCEEEccCCCC------CC------CCCccccccCCCCEEeeecccCCCCCCcccccC-CCccceEecccccccchh
Q 039720           85 LSFLRVINLANNSF------HG------QIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRC-FNLIDFWVHTNNLVGEIQ  151 (973)
Q Consensus        85 l~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~l~~n~~~~~~~  151 (973)
                      |++|++|+|++|.+      .|      .+|.+.  +.+|+ +++++|.+.+.+|..++.+ ..+..+++....+..   
T Consensus       104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~---  177 (636)
T 4eco_A          104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK---  177 (636)
T ss_dssp             CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC---
T ss_pred             CccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc---
Confidence            99999999999987      33      566555  67788 9999999999888877642 222222222211110   


Q ss_pred             hhhccccccceeecc--CCcccccCCCCCCCCCcccEEEccCCcCCCC-----------------CCCccc--CCCccce
Q 039720          152 AIIGNWLKIERLSLY--GNQLTGQLPPSIGNLSALQTFDIAGNKLDGR-----------------IPDSLG--QLRNLNY  210 (973)
Q Consensus       152 ~~~~~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~L~~L~~  210 (973)
                         .....++.+.+.  +|++++ +|.+|+++++|++|+|++|++++.                 +|..++  ++++|++
T Consensus       178 ---~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~  253 (636)
T 4eco_A          178 ---SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTD  253 (636)
T ss_dssp             ---CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred             ---ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCE
Confidence               111223333333  466776 677777777777777777777764                 777777  7777777


Q ss_pred             eccCCCCccccCCccccCCCCCcEEEccCCc-ccc-CCCcccccCC------CCCcEEEccCCcccccCCc--cccCCCC
Q 039720          211 LGTSENDFSGMFPLSVCNISSLDEAYLFKNR-FKG-SLPVCLGFNL------PKLTVLVVAQNNLTGFLPQ--SLSNASK  280 (973)
Q Consensus       211 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~ip~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~  280 (973)
                      |+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++ ++      ++|++|+|++|.++ .+|.  .|+++++
T Consensus       254 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~-~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~  331 (636)
T 4eco_A          254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ-ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKK  331 (636)
T ss_dssp             EEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH-HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTT
T ss_pred             EEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH-hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCC
Confidence            7777777777777777777777777777776 666 6776665 33      78888888888888 6777  7888888


Q ss_pred             CCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhh
Q 039720          281 LEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTM  360 (973)
Q Consensus       281 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l  360 (973)
                      |++|+|++|+++|.+| .|..+++|++|+|++|+++                                            
T Consensus       332 L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~--------------------------------------------  366 (636)
T 4eco_A          332 LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT--------------------------------------------  366 (636)
T ss_dssp             CCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE--------------------------------------------
T ss_pred             CCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc--------------------------------------------
Confidence            8888888888887677 7777777777777777653                                            


Q ss_pred             hHhhhcCCccccCCCccccCCCC-cCEEEcccccCCCCCCccccCCC--CCCeEEccCcccCCCCCCccC-------CcC
Q 039720          361 TLIAMAGNQISGTIPPEIRNLFN-LNGLGLEYNQLTGTIPPAIGELR--NLQYLGLVGNNIRGIIPDPIG-------NLT  430 (973)
Q Consensus       361 ~~L~l~~n~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~  430 (973)
                                  .+|..+..+++ |++|+|++|+++ .+|..+..++  +|++|++++|++.+..|..|.       .++
T Consensus       367 ------------~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~  433 (636)
T 4eco_A          367 ------------EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI  433 (636)
T ss_dssp             ------------ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCC
T ss_pred             ------------cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCC
Confidence                        23444555666 666666666666 5566665543  667777777777666666666       566


Q ss_pred             ccceEEcCCCccccccccccccccccccccccCcccccCCCcccccccc-------ccceeeccCCcccccCCcccc--c
Q 039720          431 LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITT-------LSKLLDLSENHLSGSIPLEVG--N  501 (973)
Q Consensus       431 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~-------l~~~L~Ls~N~l~~~~p~~~~--~  501 (973)
                      +|++|+|++|+++...+..+..+++|+.|++++|+++ .+|...+....       .++.|+|++|+++ .+|..+.  .
T Consensus       434 ~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~  511 (636)
T 4eco_A          434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATT  511 (636)
T ss_dssp             CEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTT
T ss_pred             CCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhcc
Confidence            7777777777777332333445677777777777776 66666555431       3347777777777 5676665  7


Q ss_pred             ccccceeccccCcccccccccccCccchhhhcc------cCcccccccccchhhhccCCeecCCCCccccccCCCCCCCC
Q 039720          502 LKSLVQLDISRNNFSNEIPVTLSACTTLEYLLM------QGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLP  575 (973)
Q Consensus       502 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  575 (973)
                      +++|+.|+|++|++++ +|..+.++++|+.|+|      ++|++.+.+|..+..+++|++|+|++|+| +.+|..+.  +
T Consensus       512 l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~  587 (636)
T 4eco_A          512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--P  587 (636)
T ss_dssp             CTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--T
T ss_pred             CCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--C
Confidence            7788888888888875 7777777888888877      56888889999999999999999999999 58888876  7


Q ss_pred             ccceEeccCCcCcCcCC
Q 039720          576 FLEYLNLSYNHFEGKVP  592 (973)
Q Consensus       576 ~L~~L~ls~N~l~~~~p  592 (973)
                      +|+.|+|++|++....+
T Consensus       588 ~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          588 NISVLDIKDNPNISIDL  604 (636)
T ss_dssp             TCCEEECCSCTTCEEEC
T ss_pred             cCCEEECcCCCCccccH
Confidence            89999999998876544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.5e-57  Score=547.55  Aligned_cols=494  Identities=19%  Similarity=0.197  Sum_probs=361.1

Q ss_pred             CCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeecc
Q 039720           87 FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLY  166 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~  166 (973)
                      .+++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|++.+..|..|+++++|++|+|+
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            45666666666665556666666666666666666665556666666666666666666666666666666666666666


Q ss_pred             CCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCc--EEEccCCcccc
Q 039720          167 GNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLD--EAYLFKNRFKG  244 (973)
Q Consensus       167 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~--~L~L~~N~l~~  244 (973)
                      +|++++..|..|+++++|++|++++|++++..+..+..+++|++|++++|.+++..|..|..+++|+  .|++++|++++
T Consensus       114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~  193 (606)
T 3t6q_A          114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG  193 (606)
T ss_dssp             TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred             ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence            6666655556666666666666666666643333334466666666666666666666666666666  66666666664


Q ss_pred             CCCcccccCCCCCcEEEccCCcc--------------------------cccCCccccCCC--CCCEEEccCCcccccCc
Q 039720          245 SLPVCLGFNLPKLTVLVVAQNNL--------------------------TGFLPQSLSNAS--KLEWLELNENHFSGQVR  296 (973)
Q Consensus       245 ~ip~~~~~~l~~L~~L~Ls~N~l--------------------------~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~  296 (973)
                      ..|.. + ...+|+.|++++|..                          ....+..|..+.  +|++|++++|++++..+
T Consensus       194 ~~~~~-~-~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~  271 (606)
T 3t6q_A          194 IEPGA-F-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS  271 (606)
T ss_dssp             ECTTT-T-TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred             cChhH-h-hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence            33333 2 345566666665531                          111222333333  78999999999999888


Q ss_pred             ccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCc
Q 039720          297 INFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPP  376 (973)
Q Consensus       297 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~  376 (973)
                      ..|..+++|++|+|++|+++.++..       +..+++|++|++++|++.                         +..|.
T Consensus       272 ~~~~~l~~L~~L~l~~n~l~~lp~~-------l~~l~~L~~L~l~~n~l~-------------------------~~~~~  319 (606)
T 3t6q_A          272 NTFHCFSGLQELDLTATHLSELPSG-------LVGLSTLKKLVLSANKFE-------------------------NLCQI  319 (606)
T ss_dssp             TTTTTCTTCSEEECTTSCCSCCCSS-------CCSCTTCCEEECTTCCCS-------------------------BGGGG
T ss_pred             HHhccccCCCEEeccCCccCCCChh-------hcccccCCEEECccCCcC-------------------------cCchh
Confidence            8899999999999999998865542       456667777777666555                         34455


Q ss_pred             cccCCCCcCEEEcccccCCCCCCc-cccCCCCCCeEEccCcccCCCC--CCccCCcCccceEEcCCCccccccccccccc
Q 039720          377 EIRNLFNLNGLGLEYNQLTGTIPP-AIGELRNLQYLGLVGNNIRGII--PDPIGNLTLLNVLQLGFNKLQGSIPSYLGKC  453 (973)
Q Consensus       377 ~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  453 (973)
                      .+..+++|++|++++|.+.+.+|. .+..+++|++|++++|++.+..  +..+..+++|++|++++|++++..|..+..+
T Consensus       320 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  399 (606)
T 3t6q_A          320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC  399 (606)
T ss_dssp             CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTC
T ss_pred             hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCC
Confidence            667778888888888888755554 4888888888888888888665  7778888888888888888887778888888


Q ss_pred             cccccccccCcccccCCCcccc-ccccccceeeccCCcccccCCcccccccccceeccccCccccc---ccccccCccch
Q 039720          454 QNLMQLSAPNNKLNGTLPPQIF-GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNE---IPVTLSACTTL  529 (973)
Q Consensus       454 ~~L~~L~l~~N~l~~~~p~~~~-~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~---~p~~~~~l~~L  529 (973)
                      ++|+.|++++|++.+..|...+ .+..+ +.|++++|.+++..|..++.+++|+.|++++|++++.   .+..+..+++|
T Consensus       400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L  478 (606)
T 3t6q_A          400 PQLELLDLAFTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL  478 (606)
T ss_dssp             TTCSEEECTTCCEECCTTCCTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred             ccCCeEECCCCcCCCcccchhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence            8888888888888876666533 44444 5888999988888888888899999999999998863   33568888999


Q ss_pred             hhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC-CCCCCccccccccC
Q 039720          530 EYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGN  608 (973)
Q Consensus       530 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~l~~~~N  608 (973)
                      ++|++++|++++..|..+..+++|++|+|++|++++..|..+..++.| .|++++|++++.+|.. ..+++++.+++.+|
T Consensus       479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  557 (606)
T 3t6q_A          479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN  557 (606)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTC
T ss_pred             cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCC
Confidence            999999999998888889999999999999999998888899999999 9999999999887764 45678888999999


Q ss_pred             ccccCCCC
Q 039720          609 EQFCGGLG  616 (973)
Q Consensus       609 ~~~cg~~~  616 (973)
                      ||.|+|..
T Consensus       558 ~~~c~c~~  565 (606)
T 3t6q_A          558 PLDCTCSN  565 (606)
T ss_dssp             CEECSGGG
T ss_pred             CccccCCc
Confidence            99998753

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=6.3e-56  Score=543.90  Aligned_cols=533  Identities=21%  Similarity=0.191  Sum_probs=456.9

Q ss_pred             EEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccc
Q 039720           66 KLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNN  145 (973)
Q Consensus        66 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~  145 (973)
                      .+|.++++++ .+|..+.  +++++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|+
T Consensus         8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   84 (680)
T 1ziw_A            8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE   84 (680)
T ss_dssp             EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred             eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence            5799999986 5787665  799999999999998777789999999999999999999889999999999999999999


Q ss_pred             cccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCcc
Q 039720          146 LVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLS  225 (973)
Q Consensus       146 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~  225 (973)
                      +.+..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+++..+..
T Consensus        85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  164 (680)
T 1ziw_A           85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE  164 (680)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred             cCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHH
Confidence            99877778999999999999999999877889999999999999999999999999999999999999999999887776


Q ss_pred             cc--CCCCCcEEEccCCccccCCCccccc--------------------------CCCCCcEEEccCCcccccCCccccC
Q 039720          226 VC--NISSLDEAYLFKNRFKGSLPVCLGF--------------------------NLPKLTVLVVAQNNLTGFLPQSLSN  277 (973)
Q Consensus       226 ~~--~l~~L~~L~L~~N~l~~~ip~~~~~--------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~  277 (973)
                      +.  .+++|++|++++|++++..|..+..                          ..++|+.|++++|.+++..|..|.+
T Consensus       165 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~  244 (680)
T 1ziw_A          165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG  244 (680)
T ss_dssp             HGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGG
T ss_pred             hhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhc
Confidence            54  5689999999999999666654331                          1267888999999999988999988


Q ss_pred             CCC--CCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCC-----CC
Q 039720          278 ASK--LEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGA-----LP  350 (973)
Q Consensus       278 l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~-----~p  350 (973)
                      ++.  |++|+|++|++++..+..|..+++|++|+|++|++..+...      .+..+++|+.|++++|...+.     +|
T Consensus       245 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~~~~~~~~~~~~lp  318 (680)
T 1ziw_A          245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH------SLHGLFNVRYLNLKRSFTKQSISLASLP  318 (680)
T ss_dssp             GGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTT------TTTTCTTCCEEECTTCBCCC------CC
T ss_pred             cCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChh------hhcCCCCccEEeccchhhhccccccccc
Confidence            865  99999999999998889999999999999999999875443      456788999999998776653     33


Q ss_pred             h----hhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCC--CCCccccCC--CCCCeEEccCcccCCCC
Q 039720          351 H----SIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG--TIPPAIGEL--RNLQYLGLVGNNIRGII  422 (973)
Q Consensus       351 ~----~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l--~~L~~L~L~~N~l~~~~  422 (973)
                      .    .+.. ...++.|++++|++++..+..|..+++|++|+|++|.+..  ..+..|..+  ++|+.|++++|++++..
T Consensus       319 ~i~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~  397 (680)
T 1ziw_A          319 KIDDFSFQW-LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE  397 (680)
T ss_dssp             EECTTTTTT-CTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred             ccChhhccc-CCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence            2    3333 3678999999999999888899999999999999998543  233344443  58999999999999999


Q ss_pred             CCccCCcCccceEEcCCCccccccc-cccccccccccccccCcccccCCCccccccccccceeeccCCccc--ccCCccc
Q 039720          423 PDPIGNLTLLNVLQLGFNKLQGSIP-SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLS--GSIPLEV  499 (973)
Q Consensus       423 p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~--~~~p~~~  499 (973)
                      |..|..+++|++|++++|++++.+| ..+..+++|++|++++|++.+..+..+..+..+ +.|++++|.++  +.+|..+
T Consensus       398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L-~~L~l~~n~l~~~~~~p~~~  476 (680)
T 1ziw_A          398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL-QRLMLRRVALKNVDSSPSPF  476 (680)
T ss_dssp             TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTC-CEEECTTSCCBCTTCSSCTT
T ss_pred             hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCccc-ccchhccccccccccCCccc
Confidence            9999999999999999999987766 688999999999999999986555566555555 58999999987  5788999


Q ss_pred             ccccccceeccccCcccccccccccCccchhhhcccCcccccccc--------cchhhhccCCeecCCCCccccccCCCC
Q 039720          500 GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP--------QSLNALKSIKELDLSCNNLSGQIPIHL  571 (973)
Q Consensus       500 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~  571 (973)
                      ..+++|+.|++++|++++..|..|.++++|++|+|++|++++..+        ..+..+++|++|+|++|+++...+..|
T Consensus       477 ~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~  556 (680)
T 1ziw_A          477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF  556 (680)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             ccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHc
Confidence            999999999999999998888889999999999999999986432        237889999999999999994444568


Q ss_pred             CCCCccceEeccCCcCcCcCCCC-CCCCCccccccccCc
Q 039720          572 GNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNE  609 (973)
Q Consensus       572 ~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~l~~~~N~  609 (973)
                      ..+++|+.|+|++|++++.++.. ..+++++.+++.+|.
T Consensus       557 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~  595 (680)
T 1ziw_A          557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL  595 (680)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCc
Confidence            99999999999999999877764 457889999999984

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.4e-57  Score=553.98  Aligned_cols=487  Identities=18%  Similarity=0.221  Sum_probs=359.5

Q ss_pred             hhhcccccchhhHHHHHHHHhhccCCCcCCCCCCCCCC-----CC--Cce------------eeeEeeCCCCeEEEEEee
Q 039720           10 FWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSI-----NL--CQW------------TGVTCGHRHQRVTKLDLE   70 (973)
Q Consensus        10 ~~~~~~~~~~~~~~~ll~~~~~~~~d~~~~l~sw~~~~-----~~--c~w------------~gv~C~~~~~~v~~l~l~   70 (973)
                      ..+...++...|++||++||++. .||     +|+.+.     +|  |.|            .||+|+. +++|+.|+|+
T Consensus       259 ~~~~~~~~~~~d~~ALl~~k~~l-~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls  331 (876)
T 4ecn_A          259 IQLKETAEYIKDYKALKAIWEAL-DGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLA  331 (876)
T ss_dssp             ECCCCCCHHHHHHHHHHHHHHHT-TGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECT
T ss_pred             eeccccccchHHHHHHHHHHHHc-CCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECc
Confidence            34444555667899999999976 566     897544     55  999            9999986 6899999999


Q ss_pred             ccCccccccCCCcCCCCCCEEEc-cCCCCCCCCCccc-------------------------------------------
Q 039720           71 SQNIGGFLSPYIGNLSFLRVINL-ANNSFHGQIPKEV-------------------------------------------  106 (973)
Q Consensus        71 ~~~l~g~~~~~l~~l~~L~~L~L-~~n~l~~~~p~~~-------------------------------------------  106 (973)
                      ++++.|.+|+++++|++|++|+| ++|.++|..|...                                           
T Consensus       332 ~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~  411 (876)
T 4ecn_A          332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN  411 (876)
T ss_dssp             TTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTC
T ss_pred             cCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhC
Confidence            99999999999999999999999 8998887644221                                           


Q ss_pred             --------cccCCCCEEeee--cccCCCCCCcccccCCCccceEeccccccc-----------------chhhhhc--cc
Q 039720          107 --------GRLFRLETIVLS--NNSFSGKIPTNLSRCFNLIDFWVHTNNLVG-----------------EIQAIIG--NW  157 (973)
Q Consensus       107 --------~~l~~L~~L~Ls--~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~-----------------~~~~~~~--~l  157 (973)
                              .....++.+.+.  +|.+++ +|..|+++++|+.|++++|++.+                 .+|..++  ++
T Consensus       412 ~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L  490 (876)
T 4ecn_A          412 PEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNL  490 (876)
T ss_dssp             TTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGC
T ss_pred             ccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccC
Confidence                    112234444444  388887 99999999999999999999998                 3899987  99


Q ss_pred             cccceeeccCCcccccCCCCCCCCCcccEEEccCCc-CCC-CCCCcccCCC-------ccceeccCCCCccccCCc--cc
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNK-LDG-RIPDSLGQLR-------NLNYLGTSENDFSGMFPL--SV  226 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~L~-------~L~~L~Ls~N~l~~~~p~--~~  226 (973)
                      ++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++       +|++|+|++|+++ .+|.  .+
T Consensus       491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l  569 (876)
T 4ecn_A          491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL  569 (876)
T ss_dssp             TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred             CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence            999999999999999999999999999999999998 988 7888777666       9999999999999 7888  89


Q ss_pred             cCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCC-CCEEEccCCcccccCcccccCccc-
Q 039720          227 CNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASK-LEWLELNENHFSGQVRINFNSLPN-  304 (973)
Q Consensus       227 ~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~-  304 (973)
                      +++++|++|+|++|+++ .+| .+ .++++|+.|+|++|.++ .+|..+.++++ |++|+|++|+++ .+|..+..++. 
T Consensus       570 ~~L~~L~~L~Ls~N~l~-~lp-~~-~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~  644 (876)
T 4ecn_A          570 QKMVKLGLLDCVHNKVR-HLE-AF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY  644 (876)
T ss_dssp             TTCTTCCEEECTTSCCC-BCC-CC-CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSS
T ss_pred             hcCCCCCEEECCCCCcc-cch-hh-cCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccC
Confidence            99999999999999999 899 44 48999999999999999 78989999999 999999999999 56777877755 


Q ss_pred             -ccceecccccCCCCCCCChhhhhhhc--ccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCcc-ccC
Q 039720          305 -LSKLYLGRNNLGTRTSTDLDFITLLT--NCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPE-IRN  380 (973)
Q Consensus       305 -L~~L~L~~N~l~~~~~~~~~~~~~l~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~-~~~  380 (973)
                       |+.|+|++|++....+.-.   ..+.  .+.+|+.|++++|++.                          .+|.. +..
T Consensus       645 ~L~~L~Ls~N~l~g~ip~l~---~~l~~~~~~~L~~L~Ls~N~L~--------------------------~lp~~~~~~  695 (876)
T 4ecn_A          645 VMGSVDFSYNKIGSEGRNIS---CSMDDYKGINASTVTLSYNEIQ--------------------------KFPTELFAT  695 (876)
T ss_dssp             CEEEEECCSSCTTTTSSSCS---SCTTTCCCCCEEEEECCSSCCC--------------------------SCCHHHHHT
T ss_pred             CCCEEECcCCcCCCccccch---hhhccccCCCcCEEEccCCcCC--------------------------ccCHHHHcc
Confidence             9999999999865322100   0000  1223444444433333                          22222 224


Q ss_pred             CCCcCEEEcccccCCCCCCccccCC--------CCCCeEEccCcccCCCCCCccC--CcCccceEEcCCCcccccccccc
Q 039720          381 LFNLNGLGLEYNQLTGTIPPAIGEL--------RNLQYLGLVGNNIRGIIPDPIG--NLTLLNVLQLGFNKLQGSIPSYL  450 (973)
Q Consensus       381 l~~L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~  450 (973)
                      +++|+.|+|++|+|+ .+|..+...        ++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++++ +|..+
T Consensus       696 l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l  772 (876)
T 4ecn_A          696 GSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQP  772 (876)
T ss_dssp             TCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGG
T ss_pred             CCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhh
Confidence            555666666666665 333332221        25666666666665 4555554  55666666666666654 55555


Q ss_pred             ccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchh
Q 039720          451 GKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLE  530 (973)
Q Consensus       451 ~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  530 (973)
                      ..+++|+.|++++|+                   ++++|++.+.+|..+..+++|+.|+|++|++ +.+|..+.  ++|+
T Consensus       773 ~~L~~L~~L~Ls~N~-------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~  830 (876)
T 4ecn_A          773 LNSSQLKAFGIRHQR-------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLY  830 (876)
T ss_dssp             GGCTTCCEEECCCCB-------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSC
T ss_pred             hcCCCCCEEECCCCC-------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCC
Confidence            566666666665554                   3455777777777777777777777777777 46676655  4777


Q ss_pred             hhcccCcccccccccchhhhccCCeecCCCCccc
Q 039720          531 YLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLS  564 (973)
Q Consensus       531 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  564 (973)
                      .|+|++|++....+..+.....+..+.|.+|++.
T Consensus       831 ~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             EEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred             EEECCCCCCCccChHHccccccchheeecCCCcc
Confidence            7777777777666666666666666666666654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.9e-56  Score=541.10  Aligned_cols=529  Identities=18%  Similarity=0.141  Sum_probs=415.1

Q ss_pred             EEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEeccccc
Q 039720           67 LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNL  146 (973)
Q Consensus        67 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~  146 (973)
                      ++.++++++ .+|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|.+
T Consensus        16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l   92 (606)
T 3vq2_A           16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI   92 (606)
T ss_dssp             EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence            455556664 4666554  7888888888888877777888888888888888888877788888888888888888888


Q ss_pred             ccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCC-CCCCcccCCCccceeccCCCCccccCCcc
Q 039720          147 VGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDG-RIPDSLGQLRNLNYLGTSENDFSGMFPLS  225 (973)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~  225 (973)
                      .+..|..|+++++|++|+|++|++++..|..|+++++|++|++++|++++ .+|..|+++++|++|++++|++++..|..
T Consensus        93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~  172 (606)
T 3vq2_A           93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND  172 (606)
T ss_dssp             CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred             cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence            88888888888888888888888887777888888888888888888875 56888888888888888888888888887


Q ss_pred             ccCCCCCc----EEEccCCccccCCCcccccCCCCCcEEEccCCccc-ccCCccccCCCCCCEEEccCCcccc------c
Q 039720          226 VCNISSLD----EAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLT-GFLPQSLSNASKLEWLELNENHFSG------Q  294 (973)
Q Consensus       226 ~~~l~~L~----~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~------~  294 (973)
                      +..+++|+    +|++++|+++ .+|...+ ...+|+.|++++|.++ +..|..+.+++.|+.+++..+.+.+      .
T Consensus       173 ~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~-~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~  250 (606)
T 3vq2_A          173 LQFLRENPQVNLSLDMSLNPID-FIQDQAF-QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF  250 (606)
T ss_dssp             THHHHHCTTCCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             hhhhhccccccceeeccCCCcc-eeCcccc-cCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence            77776665    7888888887 5666666 3448888888888886 4667778888888888875544432      1


Q ss_pred             CcccccCccc--ccceec-ccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccc
Q 039720          295 VRINFNSLPN--LSKLYL-GRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS  371 (973)
Q Consensus       295 ~~~~~~~l~~--L~~L~L-~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~  371 (973)
                      .+..+.++..  ++.+++ ..|.+....       ..+..+++|+.|++++|.+. .+| .+..+ ..++.|++++|++ 
T Consensus       251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~-------~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~-~~L~~L~l~~n~l-  319 (606)
T 3vq2_A          251 EPSIMEGLCDVTIDEFRLTYTNDFSDDI-------VKFHCLANVSAMSLAGVSIK-YLE-DVPKH-FKWQSLSIIRCQL-  319 (606)
T ss_dssp             CGGGGTTGGGSEEEEEEECCCTTCCGGG-------GSCGGGTTCSEEEEESCCCC-CCC-CCCTT-CCCSEEEEESCCC-
T ss_pred             ChHHhhhhhhccHhheeccccccccccc-------cccccCCCCCEEEecCccch-hhh-hcccc-ccCCEEEcccccC-
Confidence            1222222222  333444 333333211       11556667777777777664 344 33332 4677777777777 


Q ss_pred             cCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCC--CCCccCCcCccceEEcCCCccccccccc
Q 039720          372 GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI--IPDPIGNLTLLNVLQLGFNKLQGSIPSY  449 (973)
Q Consensus       372 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  449 (973)
                      +.+| .+ .+++|+.|++++|+..+.+  .+..+++|++|++++|++++.  .|..+..+++|++|++++|.++ .+|..
T Consensus       320 ~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~  394 (606)
T 3vq2_A          320 KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSAN  394 (606)
T ss_dssp             SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCC
T ss_pred             cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhh
Confidence            5777 45 8899999999999655433  677889999999999998866  3778888999999999999988 47788


Q ss_pred             cccccccccccccCcccccCCC-ccccccccccceeeccCCcccccCCcccccccccceeccccCcccc-cccccccCcc
Q 039720          450 LGKCQNLMQLSAPNNKLNGTLP-PQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN-EIPVTLSACT  527 (973)
Q Consensus       450 ~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~  527 (973)
                      +..+++|+.|++++|++.+..| ..+..+..+ +.|++++|.+++..|..++.+++|+.|++++|++++ .+|..|+.++
T Consensus       395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  473 (606)
T 3vq2_A          395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT  473 (606)
T ss_dssp             CTTCTTCCEEECTTSEEESTTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred             ccCCCCCCeeECCCCccCCccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCC
Confidence            8999999999999999987766 345555555 589999999998889999999999999999999987 4788899999


Q ss_pred             chhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCCCC-Cccccccc
Q 039720          528 TLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFS-NETRISLT  606 (973)
Q Consensus       528 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-~~~~l~~~  606 (973)
                      +|+.|+|++|++++..|..+..+++|++|+|++|++++.+|..+..+++|++|++++|++++.++....++ +++.+++.
T Consensus       474 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~  553 (606)
T 3vq2_A          474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT  553 (606)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECC
T ss_pred             CCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEcc
Confidence            99999999999998888899999999999999999998889999999999999999999997666555565 58899999


Q ss_pred             cCccccCCCCC
Q 039720          607 GNEQFCGGLGE  617 (973)
Q Consensus       607 ~N~~~cg~~~~  617 (973)
                      +|||.|++...
T Consensus       554 ~N~~~c~c~~~  564 (606)
T 3vq2_A          554 NNSVACICEHQ  564 (606)
T ss_dssp             SCCCCCSSTTH
T ss_pred             CCCcccCCccH
Confidence            99999988753

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.1e-55  Score=534.44  Aligned_cols=527  Identities=20%  Similarity=0.191  Sum_probs=453.6

Q ss_pred             CCCce----eeeEeeCC---------CCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCE
Q 039720           48 NLCQW----TGVTCGHR---------HQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLET  114 (973)
Q Consensus        48 ~~c~w----~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  114 (973)
                      +.|.|    ..|.|...         ..+++.|+|+++.+.+..+..+.++++|++|+|++|++++..|..|+++++|++
T Consensus         5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~   84 (606)
T 3vq2_A            5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN   84 (606)
T ss_dssp             -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred             CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence            34655    35778642         246899999999999888889999999999999999999888889999999999


Q ss_pred             EeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccc-cCCCCCCCCCcccEEEccCCc
Q 039720          115 IVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTG-QLPPSIGNLSALQTFDIAGNK  193 (973)
Q Consensus       115 L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~  193 (973)
                      |+|++|.+++..|..|+++++|++|++++|.+.+..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|+
T Consensus        85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~  164 (606)
T 3vq2_A           85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY  164 (606)
T ss_dssp             EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred             eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence            9999999998889999999999999999999999888899999999999999999986 579999999999999999999


Q ss_pred             CCCCCCCcccCCCccc----eeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccc
Q 039720          194 LDGRIPDSLGQLRNLN----YLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTG  269 (973)
Q Consensus       194 l~~~~p~~~~~L~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~  269 (973)
                      +++..|..|+.+++|+    +|++++|.+++..+..+... +|++|++++|.+.+......+.+++.|+.+++..+.+.+
T Consensus       165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~  243 (606)
T 3vq2_A          165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD  243 (606)
T ss_dssp             CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred             ceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence            9988899999888876    79999999998777777665 999999999999754433344589999999886554432


Q ss_pred             ------cCCccccCCC--CCCEEEc-cCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeecc
Q 039720          270 ------FLPQSLSNAS--KLEWLEL-NENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGL  340 (973)
Q Consensus       270 ------~~p~~~~~l~--~L~~L~L-s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l  340 (973)
                            ..+..+.++.  .++.+++ ..|.+++..+. |..+++|+.|++++|.+..++        .+..+++|+.|++
T Consensus       244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l  314 (606)
T 3vq2_A          244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSI  314 (606)
T ss_dssp             SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEE
T ss_pred             CCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEc
Confidence                  1122222222  4566666 67778877776 888888888888888887654        3566788888888


Q ss_pred             ccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCC--CCccccCCCCCCeEEccCccc
Q 039720          341 VFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT--IPPAIGELRNLQYLGLVGNNI  418 (973)
Q Consensus       341 ~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l  418 (973)
                      ++|++ +.+|. +  ..+.++.|++++|...+..  .+..+++|++|+|++|++++.  +|..+..+++|++|++++|.+
T Consensus       315 ~~n~l-~~lp~-~--~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  388 (606)
T 3vq2_A          315 IRCQL-KQFPT-L--DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA  388 (606)
T ss_dssp             ESCCC-SSCCC-C--CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSE
T ss_pred             ccccC-ccccc-C--CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcc
Confidence            88888 67773 3  3467888888888655444  677999999999999999876  488999999999999999999


Q ss_pred             CCCCCCccCCcCccceEEcCCCccccccc-cccccccccccccccCcccccCCCccccccccccceeeccCCcccc-cCC
Q 039720          419 RGIIPDPIGNLTLLNVLQLGFNKLQGSIP-SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSG-SIP  496 (973)
Q Consensus       419 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~-~~p  496 (973)
                      .+ +|..+..+++|++|++++|++.+..| ..+..+++|+.|++++|++.+..|..+..+..+. .|++++|++++ .+|
T Consensus       389 ~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~  466 (606)
T 3vq2_A          389 II-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN-TLKMAGNSFKDNTLS  466 (606)
T ss_dssp             EE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC-EEECTTCEEGGGEEC
T ss_pred             cc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC-EEECCCCcCCCcchH
Confidence            85 66889999999999999999998877 7899999999999999999988888887777775 99999999998 479


Q ss_pred             cccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCC-
Q 039720          497 LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLP-  575 (973)
Q Consensus       497 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-  575 (973)
                      ..++.+++|+.|++++|++++..|..|.++++|+.|+|++|++++.+|..+..+++|++|||++|+|+ .+|..+..++ 
T Consensus       467 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~  545 (606)
T 3vq2_A          467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPK  545 (606)
T ss_dssp             SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCT
T ss_pred             HhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999 7888899997 


Q ss_pred             ccceEeccCCcCcCcCCC
Q 039720          576 FLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       576 ~L~~L~ls~N~l~~~~p~  593 (973)
                      +|++|++++|++.+..+.
T Consensus       546 ~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          546 SLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             TCCEEECCSCCCCCSSTT
T ss_pred             cCcEEEccCCCcccCCcc
Confidence            599999999999987774

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-55  Score=546.43  Aligned_cols=519  Identities=19%  Similarity=0.213  Sum_probs=374.3

Q ss_pred             CceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCC-CccccccCCCCEEeeecccCCCCCCc
Q 039720           50 CQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQI-PKEVGRLFRLETIVLSNNSFSGKIPT  128 (973)
Q Consensus        50 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p~  128 (973)
                      |.|..|-+  ...+++.|||++|.+.+..+..+.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|.
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            45666655  3346777777777777666667777777777777777655555 56677777777777777777766677


Q ss_pred             ccccCCCccceEecccccccchhhh--hccccccceeeccCCcccccCC-CCCCCCCcccEEEccCCcCCCCCCCcccCC
Q 039720          129 NLSRCFNLIDFWVHTNNLVGEIQAI--IGNWLKIERLSLYGNQLTGQLP-PSIGNLSALQTFDIAGNKLDGRIPDSLGQL  205 (973)
Q Consensus       129 ~~~~l~~L~~L~l~~n~~~~~~~~~--~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L  205 (973)
                      .|+++++|++|++++|.+.+.+|..  ++++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++..+..+..+
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            7777777777777777777655554  6777777777777777765543 456777777777777777776667777666


Q ss_pred             --CccceeccCCCCccccCCccccCCCC------CcEEEccCCccccCCCcccccC--CCCCcEEEccC---------Cc
Q 039720          206 --RNLNYLGTSENDFSGMFPLSVCNISS------LDEAYLFKNRFKGSLPVCLGFN--LPKLTVLVVAQ---------NN  266 (973)
Q Consensus       206 --~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~ip~~~~~~--l~~L~~L~Ls~---------N~  266 (973)
                        ++|+.|+++.|.+.+..|..+..+.+      |+.|++++|++++.+|..+...  .++++.|.++.         |.
T Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~  251 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN  251 (844)
T ss_dssp             HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred             cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence              67777777777777666666555554      7777777777766666555432  24566666652         23


Q ss_pred             ccccCCccccCC--CCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeecccccc
Q 039720          267 LTGFLPQSLSNA--SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR  344 (973)
Q Consensus       267 l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~  344 (973)
                      +.+..+..|.++  ++|++|+|++|.+++..+..|..+++|+.|+|++|+++.+...      .+..+++|++|++    
T Consensus       252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~------~~~~l~~L~~L~L----  321 (844)
T 3j0a_A          252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE------AFYGLDNLQVLNL----  321 (844)
T ss_dssp             STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT------TTTTCSSCCEEEE----
T ss_pred             cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH------HhcCCCCCCEEEC----
Confidence            333334445444  5677777777777766666677777777777777766654332      2334445555555    


Q ss_pred             ccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCC
Q 039720          345 FGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPD  424 (973)
Q Consensus       345 l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  424 (973)
                                           ++|++++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|.+++.   
T Consensus       322 ---------------------s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i---  377 (844)
T 3j0a_A          322 ---------------------SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI---  377 (844)
T ss_dssp             ---------------------ESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC---
T ss_pred             ---------------------CCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc---
Confidence                                 45555556677888888999999999999888888888899999999999988743   


Q ss_pred             ccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcc--ccccccccceeeccCCcccccCCc-cccc
Q 039720          425 PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQ--IFGITTLSKLLDLSENHLSGSIPL-EVGN  501 (973)
Q Consensus       425 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~~~l~~~L~Ls~N~l~~~~p~-~~~~  501 (973)
                        ..+++|+.|++++|+++ .+|..   ..+++.|++++|++.+ ++..  +..+..+ +.|+|++|++++..+. .+..
T Consensus       378 --~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~-l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~  449 (844)
T 3j0a_A          378 --HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLEN-LDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSE  449 (844)
T ss_dssp             --SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCS-STTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCS
T ss_pred             --cCCCCcchhccCCCCcc-ccccc---ccccceeecccCcccc-CchhhhhhcCCcc-ceeeCCCCccccccccccccc
Confidence              23778889999999988 55644   4578888999998884 3322  2244444 4899999999865443 3566


Q ss_pred             ccccceeccccCccc-----ccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCc
Q 039720          502 LKSLVQLDISRNNFS-----NEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPF  576 (973)
Q Consensus       502 l~~L~~L~ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  576 (973)
                      +++|+.|+|++|.++     +..|..|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+.  ++
T Consensus       450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~  527 (844)
T 3j0a_A          450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN  527 (844)
T ss_dssp             CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred             CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence            789999999999987     44556788999999999999999988888899999999999999999976666665  88


Q ss_pred             cceEeccCCcCcCcCCCCCCCCCccccccccCccccCCCC
Q 039720          577 LEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       577 L~~L~ls~N~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~~  616 (973)
                      |+.|+|++|++++.+|..  |.+++.+++.+|||.|+|..
T Consensus       528 L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          528 LEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSC
T ss_pred             ccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccccc
Confidence            999999999999998865  77889999999999998864

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=8.6e-53  Score=509.05  Aligned_cols=478  Identities=19%  Similarity=0.171  Sum_probs=402.4

Q ss_pred             cCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCccccc
Q 039720           94 ANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQ  173 (973)
Q Consensus        94 ~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  173 (973)
                      ++..++ .+|..+..  ++++|+|++|.+++..|..|+++++|++|++++|++.+..|..|.++++|++|+|++|++++.
T Consensus        20 ~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~   96 (606)
T 3t6q_A           20 ENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM   96 (606)
T ss_dssp             TTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEE
T ss_pred             CCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccccc
Confidence            334444 56766643  799999999999988899999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccC
Q 039720          174 LPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFN  253 (973)
Q Consensus       174 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~  253 (973)
                      .|..|+++++|++|++++|++++..|..|+++++|++|++++|++++..+..+..+++|++|++++|++++..|..+. .
T Consensus        97 ~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~  175 (606)
T 3t6q_A           97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS-S  175 (606)
T ss_dssp             CTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHH-T
T ss_pred             ChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhh-h
Confidence            999999999999999999999977788999999999999999999986656666699999999999999955555554 8


Q ss_pred             CCCCc--EEEccCCcccccCCccccCCCCCCEEEccCCccc--------------------------ccCcccccCcc--
Q 039720          254 LPKLT--VLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS--------------------------GQVRINFNSLP--  303 (973)
Q Consensus       254 l~~L~--~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--------------------------~~~~~~~~~l~--  303 (973)
                      +++|+  .|++++|.+++..|..|.. .+|++|++++|...                          .+.+..|.++.  
T Consensus       176 l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~  254 (606)
T 3t6q_A          176 LQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM  254 (606)
T ss_dssp             TTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGS
T ss_pred             hcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcC
Confidence            99999  9999999999888877655 68999999988611                          11122222222  


Q ss_pred             cccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCC
Q 039720          304 NLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN  383 (973)
Q Consensus       304 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~  383 (973)
                      +|+.|++++|.++.++...      +.++++                         ++.|++++|+++ .+|..+..+++
T Consensus       255 ~L~~L~l~~n~l~~~~~~~------~~~l~~-------------------------L~~L~l~~n~l~-~lp~~l~~l~~  302 (606)
T 3t6q_A          255 SVESINLQKHYFFNISSNT------FHCFSG-------------------------LQELDLTATHLS-ELPSGLVGLST  302 (606)
T ss_dssp             EEEEEECTTCCCSSCCTTT------TTTCTT-------------------------CSEEECTTSCCS-CCCSSCCSCTT
T ss_pred             ceeEEEeecCccCccCHHH------hccccC-------------------------CCEEeccCCccC-CCChhhccccc
Confidence            4555555555555443321      233444                         455555555555 67888999999


Q ss_pred             cCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCC-ccCCcCccceEEcCCCcccccc--cccccccccccccc
Q 039720          384 LNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPD-PIGNLTLLNVLQLGFNKLQGSI--PSYLGKCQNLMQLS  460 (973)
Q Consensus       384 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~  460 (973)
                      |++|++++|++++..|..+..+++|++|++++|.+.+.+|. .+..+++|++|++++|++++..  |..+..+++|++|+
T Consensus       303 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~  382 (606)
T 3t6q_A          303 LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN  382 (606)
T ss_dssp             CCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEE
T ss_pred             CCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEE
Confidence            99999999999988899999999999999999999876665 5999999999999999999766  78899999999999


Q ss_pred             ccCcccccCCCccccccccccceeeccCCcccccCCcc-cccccccceeccccCcccccccccccCccchhhhcccCccc
Q 039720          461 APNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLE-VGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSF  539 (973)
Q Consensus       461 l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  539 (973)
                      +++|++.+..|..+..+..+ +.|++++|++++..|.. +..+++|+.|++++|.+++..|..+.++++|++|++++|++
T Consensus       383 l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  461 (606)
T 3t6q_A          383 LSYNEPLSLKTEAFKECPQL-ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF  461 (606)
T ss_dssp             CCSCSCEEECTTTTTTCTTC-SEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBC
T ss_pred             CCCCcCCcCCHHHhcCCccC-CeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCC
Confidence            99999997777777777766 49999999999876654 89999999999999999999999999999999999999999


Q ss_pred             ccc---cccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC-CCCCCccccccccCcc
Q 039720          540 NGS---IPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQ  610 (973)
Q Consensus       540 ~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~l~~~~N~~  610 (973)
                      ++.   .+..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++.+|.. ..++++ .+++.+|..
T Consensus       462 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l  535 (606)
T 3t6q_A          462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI  535 (606)
T ss_dssp             GGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred             CccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence            873   2367899999999999999999988999999999999999999999988854 446666 788888854

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.6e-52  Score=500.56  Aligned_cols=498  Identities=17%  Similarity=0.182  Sum_probs=391.9

Q ss_pred             CCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCc
Q 039720           49 LCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPT  128 (973)
Q Consensus        49 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~  128 (973)
                      .|.|.|| |+.          ++++++ .+|+.+.  ++|++|+|++|++++..|..|+++++|++|+|++|.+++..|.
T Consensus         3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999999 964          334554 5777664  7999999999999988889999999999999999999988889


Q ss_pred             ccccCCCccceEecccccccchhhhhccccccceeeccCCcccc-cCCCCCCCCCcccEEEccCCcCCCCCC-CcccCCC
Q 039720          129 NLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTG-QLPPSIGNLSALQTFDIAGNKLDGRIP-DSLGQLR  206 (973)
Q Consensus       129 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~L~  206 (973)
                      .|+++++|++|++++|.+.+..|..|+++++|++|+|++|.+++ ..|..|+++++|++|++++|++.+.+| ..|.+++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~  148 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT  148 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence            99999999999999999999999999999999999999999986 467889999999999999999544555 6899999


Q ss_pred             ccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccC--C-ccccCCCCCCE
Q 039720          207 NLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL--P-QSLSNASKLEW  283 (973)
Q Consensus       207 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~  283 (973)
                      +|++|++++|++++..|..+..+++|++|+++.|.+. .+|..++..+++|++|++++|.+++..  | .....+++|++
T Consensus       149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~  227 (549)
T 2z81_A          149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK  227 (549)
T ss_dssp             EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred             ccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence            9999999999999999999999999999999999987 777777667999999999999999752  2 23456889999


Q ss_pred             EEccCCcccccCcc----cccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhh
Q 039720          284 LELNENHFSGQVRI----NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTT  359 (973)
Q Consensus       284 L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~  359 (973)
                      |++++|.+++..+.    .+..+++|+.|++++|.+..+..........+..+.+|+.|.+..+.+....    .     
T Consensus       228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~----~-----  298 (549)
T 2z81_A          228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY----L-----  298 (549)
T ss_dssp             EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGG----G-----
T ss_pred             eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhh----h-----
Confidence            99999999865443    3567789999999999887654332222334556677777777776543210    0     


Q ss_pred             hhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccc-cCCCCCCeEEccCcccCCCCC---CccCCcCccceE
Q 039720          360 MTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRNLQYLGLVGNNIRGIIP---DPIGNLTLLNVL  435 (973)
Q Consensus       360 l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L  435 (973)
                                 ...++..+....+|+.|++++|+++ .+|..+ ..+++|++|+|++|++.+.+|   ..++.+++|++|
T Consensus       299 -----------~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L  366 (549)
T 2z81_A          299 -----------FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL  366 (549)
T ss_dssp             -----------SCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEE
T ss_pred             -----------cccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEE
Confidence                       0112223344567888888888887 566655 568888888888888887653   346778888888


Q ss_pred             EcCCCccccccc--cccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccC
Q 039720          436 QLGFNKLQGSIP--SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRN  513 (973)
Q Consensus       436 ~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  513 (973)
                      ++++|++++..+  ..+..+++|++|++++|+++ .+|..+..+..+ +.|++++|+++ .+|..+  .++|+.|++++|
T Consensus       367 ~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N  441 (549)
T 2z81_A          367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN  441 (549)
T ss_dssp             ECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCS-CCCTTS--CTTCSEEECCSS
T ss_pred             EccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCcc-cccchh--cCCceEEECCCC
Confidence            888888875432  45778888888888888887 677766665555 47888888877 344333  257888888888


Q ss_pred             cccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCC
Q 039720          514 NFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       514 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  593 (973)
                      ++++.+    .++++|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|..+..+++|+.|++++|++.+..|.
T Consensus       442 ~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          442 NLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             CCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             Chhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            887542    46778888888888887 5665 45678888888888888877777788888888888888888777663

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-51  Score=510.38  Aligned_cols=498  Identities=21%  Similarity=0.175  Sum_probs=403.8

Q ss_pred             EEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCC-CcccccCCCccceEecccc
Q 039720           67 LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKI-PTNLSRCFNLIDFWVHTNN  145 (973)
Q Consensus        67 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~l~~n~  145 (973)
                      .|.++++++. +|.   ..++|++|||++|++++..|..|+++++|++|+|++|.+.+.+ |..|+++++|++|++++|+
T Consensus         9 ~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~   84 (844)
T 3j0a_A            9 AFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK   84 (844)
T ss_dssp             EEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred             EEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence            4566777764 565   5588999999999999888999999999999999999777777 7889999999999999999


Q ss_pred             cccchhhhhccccccceeeccCCcccccCCCC--CCCCCcccEEEccCCcCCCCCC-CcccCCCccceeccCCCCccccC
Q 039720          146 LVGEIQAIIGNWLKIERLSLYGNQLTGQLPPS--IGNLSALQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSENDFSGMF  222 (973)
Q Consensus       146 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~L~~L~~L~Ls~N~l~~~~  222 (973)
                      +.+..|..|.++++|++|+|++|.+++.+|..  |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..
T Consensus        85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~  164 (844)
T 3j0a_A           85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC  164 (844)
T ss_dssp             CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred             CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence            99888999999999999999999998766665  8899999999999999987655 57899999999999999998888


Q ss_pred             CccccCC--CCCcEEEccCCccccCCCcccccCCC------CCcEEEccCCcccccCCccccCC---CCCCEEEccCCc-
Q 039720          223 PLSVCNI--SSLDEAYLFKNRFKGSLPVCLGFNLP------KLTVLVVAQNNLTGFLPQSLSNA---SKLEWLELNENH-  290 (973)
Q Consensus       223 p~~~~~l--~~L~~L~L~~N~l~~~ip~~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~-  290 (973)
                      +..+..+  ++|+.|+++.|.+.+.+|..+. .++      +|+.|++++|.+++..+..+...   ++++.|+++++. 
T Consensus       165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~  243 (844)
T 3j0a_A          165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM  243 (844)
T ss_dssp             SGGGHHHHHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred             HHHcccccCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence            8888877  8888899999988877776554 333      38888888888887777766543   567777776433 


Q ss_pred             --------ccccCcccccCc--ccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhh
Q 039720          291 --------FSGQVRINFNSL--PNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTM  360 (973)
Q Consensus       291 --------l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l  360 (973)
                              +.+.....|.++  ++|+.|+|++|.+.                              +..|..+..+ ..+
T Consensus       244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~------------------------------~~~~~~~~~l-~~L  292 (844)
T 3j0a_A          244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF------------------------------SLNSRVFETL-KDL  292 (844)
T ss_dssp             BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCC------------------------------EECSCCSSSC-CCC
T ss_pred             cccccccccCCCChhhhhccccCCccEEECCCCccc------------------------------ccChhhhhcC-CCC
Confidence                    222333334333  34555555555544                              3333333332 345


Q ss_pred             hHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCC
Q 039720          361 TLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN  440 (973)
Q Consensus       361 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  440 (973)
                      +.|++++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++.+..+..|..+++|++|+|++|
T Consensus       293 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N  372 (844)
T 3j0a_A          293 KVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN  372 (844)
T ss_dssp             CEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETC
T ss_pred             CEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCC
Confidence            55666666777777888999999999999999999999999999999999999999999888889999999999999999


Q ss_pred             ccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccC-CcccccccccceeccccCcccccc
Q 039720          441 KLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSI-PLEVGNLKSLVQLDISRNNFSNEI  519 (973)
Q Consensus       441 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~  519 (973)
                      .+++ ++    .+++|+.|++++|++. .+|....    .++.|++++|++++.. +..+..+++|+.|+|++|++++..
T Consensus       373 ~l~~-i~----~~~~L~~L~l~~N~l~-~l~~~~~----~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~  442 (844)
T 3j0a_A          373 ALTT-IH----FIPSIPDIFLSGNKLV-TLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS  442 (844)
T ss_dssp             CSCC-CS----SCCSCSEEEEESCCCC-CCCCCCT----TCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCC
T ss_pred             CCCc-cc----CCCCcchhccCCCCcc-ccccccc----ccceeecccCccccCchhhhhhcCCccceeeCCCCcccccc
Confidence            9983 33    3889999999999998 7776532    2358999999999642 234568999999999999999655


Q ss_pred             cc-cccCccchhhhcccCcccc-----cccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCC
Q 039720          520 PV-TLSACTTLEYLLMQGNSFN-----GSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       520 p~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  593 (973)
                      +. .+..+++|+.|+|++|.++     +..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++.+|.
T Consensus       443 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~  522 (844)
T 3j0a_A          443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN  522 (844)
T ss_dssp             SSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCC
T ss_pred             cccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChh
Confidence            43 4667899999999999997     44556788999999999999999999899999999999999999999998876


Q ss_pred             CCCCCCccccccccCccc
Q 039720          594 KGVFSNETRISLTGNEQF  611 (973)
Q Consensus       594 ~~~~~~~~~l~~~~N~~~  611 (973)
                      ... ++++.+++.+|...
T Consensus       523 ~~~-~~L~~L~Ls~N~l~  539 (844)
T 3j0a_A          523 DLP-ANLEILDISRNQLL  539 (844)
T ss_dssp             CCC-SCCCEEEEEEECCC
T ss_pred             hhh-ccccEEECCCCcCC
Confidence            544 78999999999653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=486.24  Aligned_cols=506  Identities=17%  Similarity=0.174  Sum_probs=362.7

Q ss_pred             EeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccc
Q 039720           68 DLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLV  147 (973)
Q Consensus        68 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~  147 (973)
                      +.++.+++ .+|..+.  +++++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|++++|++.
T Consensus        13 ~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~   89 (570)
T 2z63_A           13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ   89 (570)
T ss_dssp             ECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             EeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC
Confidence            33334443 3555442  46888888888888777778888888888888888888766778888888888888888888


Q ss_pred             cchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCC-CCCCcccCCCccceeccCCCCccccCCccc
Q 039720          148 GEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDG-RIPDSLGQLRNLNYLGTSENDFSGMFPLSV  226 (973)
Q Consensus       148 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~  226 (973)
                      +..|..|..+++|++|++++|++++..+..|+++++|++|++++|++++ .+|..|+++++|++|++++|++++..|..+
T Consensus        90 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~  169 (570)
T 2z63_A           90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  169 (570)
T ss_dssp             EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGG
T ss_pred             ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHc
Confidence            8888888888888999998888886555578888889999998888876 468888888889999999888888878888


Q ss_pred             cCCCCC----cEEEccCCccccCCCcccccCCCCCcEEEccCCccc-ccCCccccCCCCCCEEEccCCcc------cccC
Q 039720          227 CNISSL----DEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLT-GFLPQSLSNASKLEWLELNENHF------SGQV  295 (973)
Q Consensus       227 ~~l~~L----~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l------~~~~  295 (973)
                      ..+++|    +.+++++|.+++..| ..+ ...+|+.|++++|... ..++..+.+++.++.+.+..+.+      ....
T Consensus       170 ~~l~~L~~~~~~L~l~~n~l~~~~~-~~~-~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  247 (570)
T 2z63_A          170 RVLHQMPLLNLSLDLSLNPMNFIQP-GAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  247 (570)
T ss_dssp             HHHHTCTTCCCEEECTTCCCCEECT-TTT-TTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECC
T ss_pred             cchhccchhhhhcccCCCCceecCH-HHh-ccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcc
Confidence            888888    788888888884444 444 2347888888887543 23455666777776666543322      2223


Q ss_pred             cccccCccc--ccceecccc-cCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCcccc
Q 039720          296 RINFNSLPN--LSKLYLGRN-NLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG  372 (973)
Q Consensus       296 ~~~~~~l~~--L~~L~L~~N-~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~  372 (973)
                      ...|.++++  ++.+++++| .+....      ...+..+++|+.|++++|.+. .+|..+...  .++.|++++|.+. 
T Consensus       248 ~~~~~~l~~l~l~~l~l~~~~~~~~~~------~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-  317 (570)
T 2z63_A          248 KSALEGLCNLTIEEFRLAYLDYYLDDI------IDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-  317 (570)
T ss_dssp             TTTTGGGGGSEEEEEEEEETTEEESCS------TTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-
T ss_pred             hhhhccccccchhhhhhhcchhhhhhc------hhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc-
Confidence            334444443  344555554 332221      123456677777777777666 355555444  5666666666666 


Q ss_pred             CCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCC--CCccCCcCccceEEcCCCcccccccccc
Q 039720          373 TIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGII--PDPIGNLTLLNVLQLGFNKLQGSIPSYL  450 (973)
Q Consensus       373 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  450 (973)
                      .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|++++..  |..+..+++|++|++++|++++..+ .+
T Consensus       318 ~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~  392 (570)
T 2z63_A          318 QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NF  392 (570)
T ss_dssp             SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EE
T ss_pred             ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cc
Confidence            4444  4667788888888877765554  66778888888888777543  5667777888888888888774443 37


Q ss_pred             ccccccccccccCcccccCCCcc-ccccccccceeeccCCcccccCCcccccccccceeccccCccc-ccccccccCccc
Q 039720          451 GKCQNLMQLSAPNNKLNGTLPPQ-IFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS-NEIPVTLSACTT  528 (973)
Q Consensus       451 ~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~  528 (973)
                      ..+++|+.|++++|.+.+..|.. +..+..+ +.|++++|.+++..|..+..+++|+.|++++|+++ +.+|..+..+++
T Consensus       393 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~  471 (570)
T 2z63_A          393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN  471 (570)
T ss_dssp             ETCTTCCEEECTTSEEESCTTSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             cccCCCCEEEccCCccccccchhhhhcCCCC-CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence            77888888888888877655533 3334444 47888888887777777777888888888888876 467777788888


Q ss_pred             hhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC
Q 039720          529 LEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK  594 (973)
Q Consensus       529 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  594 (973)
                      |++|++++|++++..|..+..+++|++|+|++|++++..|..+..+++|+.|++++|++++.+|..
T Consensus       472 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            888888888888777777777888888888888887766677777888888888888888777754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-50  Score=482.86  Aligned_cols=510  Identities=20%  Similarity=0.207  Sum_probs=435.0

Q ss_pred             CCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccC
Q 039720           88 LRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYG  167 (973)
Q Consensus        88 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~  167 (973)
                      .+.++.++.+++ .+|..+.  +++++|+|++|.+++..|..|.++++|++|++++|++.+..+..|.++++|++|+|++
T Consensus         9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~   85 (570)
T 2z63_A            9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG   85 (570)
T ss_dssp             TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence            456888888888 7887664  5799999999999987788999999999999999999988889999999999999999


Q ss_pred             CcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCcccc-CCccccCCCCCcEEEccCCccccCC
Q 039720          168 NQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGM-FPLSVCNISSLDEAYLFKNRFKGSL  246 (973)
Q Consensus       168 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~i  246 (973)
                      |++++..|..|+++++|++|++++|++++..+..|+++++|++|++++|.+++. +|..|+++++|++|++++|++++..
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~  165 (570)
T 2z63_A           86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (570)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred             CcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence            999988889999999999999999999966666899999999999999999873 6899999999999999999998554


Q ss_pred             CcccccCCCCC----cEEEccCCcccccCCccccCCCCCCEEEccCCcccc-cCcccccCcccccceecccccCC-----
Q 039720          247 PVCLGFNLPKL----TVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSG-QVRINFNSLPNLSKLYLGRNNLG-----  316 (973)
Q Consensus       247 p~~~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~-----  316 (973)
                      |..+. .+++|    +.|++++|.+++..|..|..+ +|++|++++|.... ..+..+..+++++.+.+..+.+.     
T Consensus       166 ~~~~~-~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l  243 (570)
T 2z63_A          166 CTDLR-VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL  243 (570)
T ss_dssp             GGGGH-HHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSC
T ss_pred             HHHcc-chhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhh
Confidence            54444 67777    899999999998888888776 79999999985442 33455677777777666544332     


Q ss_pred             -CCCCCChhhhhhhcccccceeeccccc-cccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccC
Q 039720          317 -TRTSTDLDFITLLTNCSKLVKLGLVFN-RFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQL  394 (973)
Q Consensus       317 -~~~~~~~~~~~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  394 (973)
                       .+....+   ..+.++ .++.++++.+ .+.+.+|..+..+ ..++.|++++|.+. .+|..+..+ +|+.|++++|++
T Consensus       244 ~~~~~~~~---~~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~  316 (570)
T 2z63_A          244 EKFDKSAL---EGLCNL-TIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKF  316 (570)
T ss_dssp             EECCTTTT---GGGGGS-EEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBC
T ss_pred             hhcchhhh---cccccc-chhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccEEeeccCcc
Confidence             2222222   222222 3677888888 7788888887765 67999999999998 688889999 999999999999


Q ss_pred             CCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccc--ccccccccccccccccCcccccCCCc
Q 039720          395 TGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI--PSYLGKCQNLMQLSAPNNKLNGTLPP  472 (973)
Q Consensus       395 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~  472 (973)
                      + .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|++++..  |..+..+++|+.|++++|.+. .+|.
T Consensus       317 ~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~  390 (570)
T 2z63_A          317 G-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS  390 (570)
T ss_dssp             S-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE-EEEE
T ss_pred             c-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccc-cccc
Confidence            9 5665  5789999999999999877665  78999999999999999654  788999999999999999999 4565


Q ss_pred             cccccccccceeeccCCcccccCC-cccccccccceeccccCcccccccccccCccchhhhcccCcccc-cccccchhhh
Q 039720          473 QIFGITTLSKLLDLSENHLSGSIP-LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN-GSIPQSLNAL  550 (973)
Q Consensus       473 ~~~~~~~l~~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l  550 (973)
                      .+..+..+ +.|++++|.+++..| ..+..+++|+.|++++|.+++..|..|.++++|+.|++++|+++ +.+|..+..+
T Consensus       391 ~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l  469 (570)
T 2z63_A          391 NFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL  469 (570)
T ss_dssp             EEETCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred             cccccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcc
Confidence            56666666 499999999998766 57899999999999999999999999999999999999999998 6799999999


Q ss_pred             ccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC-CCCCCccccccccCccccCCCC
Q 039720          551 KSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       551 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~l~~~~N~~~cg~~~  616 (973)
                      ++|++|+|++|++++..|..+..+++|++|++++|++++.+|.. ..+++++.+++.+||+.|+++.
T Consensus       470 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             cCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            99999999999999888999999999999999999999988864 5688999999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=442.61  Aligned_cols=263  Identities=25%  Similarity=0.408  Sum_probs=206.8

Q ss_pred             hcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|.+.++||+|+||+||+|+++     .+++.||||+++.......++|.+|+++|++++|||||+++++|.+     .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            46788899999999999999875     3688999999987666667889999999999999999999999764     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC---------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN---------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                      ...++|||||++|+|.++++...               .+++.++..|+.|||+||+|||++   +||||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            77999999999999999997642               356678899999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFN  892 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~  892 (973)
                      .++.+||+|||+|+......      .........||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~  266 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTD------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN  266 (329)
T ss_dssp             TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred             CCCcEEEcccccceeccCCC------cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999998764322      1222334579999999999999999999999999999999999 9999986532


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPII  972 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~  972 (973)
                      .  .+......                 ......+..++..+.+++.+||+.||++||||+||++.|+++.   ..||+|
T Consensus       267 ~--~~~~~i~~-----------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~---~~pp~~  324 (329)
T 4aoj_A          267 T--EAIDCITQ-----------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA---QAPPVY  324 (329)
T ss_dssp             H--HHHHHHHH-----------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH---HSCC--
T ss_pred             H--HHHHHHHc-----------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh---hCCccc
Confidence            2  11111110                 0012223345667889999999999999999999999999874   458875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-50  Score=438.67  Aligned_cols=258  Identities=24%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             hcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|.+.++||+|+||+||+|++.     .++..||||+++.......++|.+|+++|++++|||||+++++|.+     +
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence            57888999999999999999874     3688999999987666667889999999999999999999999764     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD  815 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~  815 (973)
                      +..++|||||++|+|.++++..+             .+++.++..++.|||+||+|||++   +||||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            78999999999999999997642             466788999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 039720          816 MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDG  894 (973)
Q Consensus       816 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~  894 (973)
                      +.+||+|||+|+......      .........||+.|||||++.+..|+.++|||||||++|||+| |+.||...... 
T Consensus       165 ~~~Ki~DFGla~~~~~~~------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-  237 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTD------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-  237 (299)
T ss_dssp             GCEEECCCSCHHHHTGGG------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred             CcEEECCcccceecCCCC------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            999999999998764321      1122233568999999999999999999999999999999999 99999865322 


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                       .+......                 ...+..+..++..+.+++.+||+.||++|||++||.+.|+++.+
T Consensus       238 -~~~~~i~~-----------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          238 -EVIECITQ-----------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             -HHHHHHHH-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHc-----------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             11111110                 00112233456678899999999999999999999999998754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-49  Score=435.57  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=210.2

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      +.|++.++||+|+||+||+|+++.+|+.||||++........+.+.+|+++|+.++|||||++++++..     .+..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            569999999999999999999999999999999987666666778999999999999999999998655     478999


Q ss_pred             EEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          754 VYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      |||||+||+|.+++.+ ..+++.+++.++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+.+... 
T Consensus       149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  223 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-  223 (346)
T ss_dssp             EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence            9999999999999876 4678899999999999999999999   9999999999999999999999999999876432 


Q ss_pred             CccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                             .......+||+.|||||++.+..|+.++||||+||++|||++|+.||......  .........        .
T Consensus       224 -------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~--------~  286 (346)
T 4fih_A          224 -------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDN--------L  286 (346)
T ss_dssp             -------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS--------S
T ss_pred             -------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcC--------C
Confidence                   22334568999999999999999999999999999999999999999753221  111111110        0


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .+.       ...+..+..++.+++.+||+.||++|||++|++++
T Consensus       287 ~~~-------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          287 PPR-------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCC-------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC-------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            001       11123344567789999999999999999999874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.5e-49  Score=487.38  Aligned_cols=462  Identities=19%  Similarity=0.247  Sum_probs=320.0

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEee-ecccCCCCCCcccccCC-Ccc-----ce----------Eeccccccc
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVL-SNNSFSGKIPTNLSRCF-NLI-----DF----------WVHTNNLVG  148 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~~~l~-~L~-----~L----------~l~~n~~~~  148 (973)
                      .+++.|+|++|++.|.+|++|++|++|++|+| ++|.++|..|....... .+.     .+          .....++.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            46899999999999999999999999999999 99999887554322110 000     00          001111111


Q ss_pred             chhhhh-----------ccccccceeeccC--CcccccCCCCCCCCCcccEEEccCCcCCC-----------------CC
Q 039720          149 EIQAII-----------GNWLKIERLSLYG--NQLTGQLPPSIGNLSALQTFDIAGNKLDG-----------------RI  198 (973)
Q Consensus       149 ~~~~~~-----------~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~  198 (973)
                      .++..+           .....++.+.+..  |++++ +|.+|+++++|++|+|++|++++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence            221111           1222344444544  77877 78888888888888888888886                 37


Q ss_pred             CCccc--CCCccceeccCCCCccccCCccccCCCCCcEEEccCCc-ccc-CCCcccc------cCCCCCcEEEccCCccc
Q 039720          199 PDSLG--QLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR-FKG-SLPVCLG------FNLPKLTVLVVAQNNLT  268 (973)
Q Consensus       199 p~~~~--~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~ip~~~~------~~l~~L~~L~Ls~N~l~  268 (973)
                      |..++  ++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ ++| .+|..++      ..+++|++|+|++|.++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            87777  88888888888888888888888888888888888887 777 6776554      23458999999999988


Q ss_pred             ccCCc--cccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeecccccccc
Q 039720          269 GFLPQ--SLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFG  346 (973)
Q Consensus       269 ~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~  346 (973)
                       .+|.  .|.++++|++|+|++|+++ .+| .|..+++|+.|+|++|+++.                             
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~-----------------------------  609 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-----------------------------  609 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSC-----------------------------
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCcccc-----------------------------
Confidence             7787  8889999999999999988 555 88888888888888887653                             


Q ss_pred             CCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCC-cCEEEcccccCCCCCCccccCCCC--CCeEEccCcccCCCCC
Q 039720          347 GALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN-LNGLGLEYNQLTGTIPPAIGELRN--LQYLGLVGNNIRGIIP  423 (973)
Q Consensus       347 ~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p  423 (973)
                                                 +|..+..+++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|++.+.+|
T Consensus       610 ---------------------------lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip  661 (876)
T 4ecn_A          610 ---------------------------IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGR  661 (876)
T ss_dssp             ---------------------------CCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSS
T ss_pred             ---------------------------chHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccc
Confidence                                       3334445555 666666666666 45555555433  6666666666665444


Q ss_pred             Ccc---C--CcCccceEEcCCCcccccccccc-ccccccccccccCcccccCCCcccccccc-------ccceeeccCCc
Q 039720          424 DPI---G--NLTLLNVLQLGFNKLQGSIPSYL-GKCQNLMQLSAPNNKLNGTLPPQIFGITT-------LSKLLDLSENH  490 (973)
Q Consensus       424 ~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~~~~-------l~~~L~Ls~N~  490 (973)
                      ...   .  .+++|++|+|++|+++ .+|..+ ..+++|+.|++++|++. .+|..++....       .++.|+|++|+
T Consensus       662 ~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~  739 (876)
T 4ecn_A          662 NISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNK  739 (876)
T ss_dssp             SCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSC
T ss_pred             cchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCC
Confidence            322   1  2335666666666666 344433 35666666666666666 66665554331       23467777777


Q ss_pred             ccccCCcccc--cccccceeccccCcccccccccccCccchhhhcccC------cccccccccchhhhccCCeecCCCCc
Q 039720          491 LSGSIPLEVG--NLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQG------NSFNGSIPQSLNALKSIKELDLSCNN  562 (973)
Q Consensus       491 l~~~~p~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~L~Ls~N~  562 (973)
                      ++ .+|..+.  .+++|+.|+|++|++++ +|..+.++++|+.|+|++      |++.+.+|..+..+++|+.|+|++|+
T Consensus       740 L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~  817 (876)
T 4ecn_A          740 LT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND  817 (876)
T ss_dssp             CC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred             Cc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCC
Confidence            77 5666665  67777777777777775 677777777777777755      88888999999999999999999999


Q ss_pred             cccccCCCCCCCCccceEeccCCcCcCcCCCCC-CCCCccccccccCcccc--CCC
Q 039720          563 LSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKG-VFSNETRISLTGNEQFC--GGL  615 (973)
Q Consensus       563 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~~~~~~l~~~~N~~~c--g~~  615 (973)
                      | +.+|..+.  ++|+.|+|++|++....+... .........+.+|++.|  ||+
T Consensus       818 L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~  870 (876)
T 4ecn_A          818 I-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD  870 (876)
T ss_dssp             C-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCG
T ss_pred             C-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCC
Confidence            9 68998876  699999999999987665431 11223445666666543  654

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.4e-48  Score=475.02  Aligned_cols=561  Identities=17%  Similarity=0.144  Sum_probs=438.3

Q ss_pred             CCcCCCCCCCCCCCCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCE
Q 039720           35 DPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLET  114 (973)
Q Consensus        35 d~~~~l~sw~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  114 (973)
                      |+...+++|..+. +..|....|......   .|-++.+++ .+|+.+-  +++++|||++|+|++..|.+|.++++|++
T Consensus         8 ~~~~~~~~~~~~~-p~~~~~c~~~~~~~~---~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~   80 (635)
T 4g8a_A            8 DDDDKLAAANSSI-PESWEPCVEVVPNIT---YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQV   80 (635)
T ss_dssp             ------------------CCSEEEETTTE---EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             CCcchhhcccCCC-CCCCCCccccCCCCE---EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCE
Confidence            3344577887543 456766666543322   355666665 5776542  47999999999999766778999999999


Q ss_pred             EeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcC
Q 039720          115 IVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKL  194 (973)
Q Consensus       115 L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  194 (973)
                      |||++|+|++..|..|.++++|++|++++|++.+..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++
T Consensus        81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l  160 (635)
T 4g8a_A           81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI  160 (635)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcc
Confidence            99999999977777899999999999999999988889999999999999999999987777899999999999999999


Q ss_pred             CC-CCCCcccCCCccceeccCCCCccccCCccccCCCCCc----EEEccCCccccCCCcccccCCCCCcEEEccCCcccc
Q 039720          195 DG-RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLD----EAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTG  269 (973)
Q Consensus       195 ~~-~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~  269 (973)
                      ++ .+|..++.+++|++|+|++|+|++..+..+..+.+++    .++++.|.+. .++...+ ....++.+++++|....
T Consensus       161 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~-~~~~~~~l~l~~n~~~~  238 (635)
T 4g8a_A          161 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF-KEIRLHKLTLRNNFDSL  238 (635)
T ss_dssp             CCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESCCSSH
T ss_pred             ccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc-ccCcccc-cchhhhhhhhhcccccc
Confidence            75 4688899999999999999999999888887766544    6889999998 5666555 45678889999987653


Q ss_pred             -cCCccccCCCCCCEEEccCCc------ccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeecccc
Q 039720          270 -FLPQSLSNASKLEWLELNENH------FSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVF  342 (973)
Q Consensus       270 -~~p~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~  342 (973)
                       ..+..+.++..++...+..+.      +.......+..+..+..+.+..+.........   ...+..+.+++.+.+..
T Consensus       239 ~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~---~~~~~~~~~l~~l~~~~  315 (635)
T 4g8a_A          239 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGI---IDLFNCLTNVSSFSLVS  315 (635)
T ss_dssp             HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEEC---TTTTGGGTTCSEEEEES
T ss_pred             cccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccch---hhhhhhhcccccccccc
Confidence             345567888888887775443      33344455666777777776666543322211   12344556777777777


Q ss_pred             ccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCC--
Q 039720          343 NRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRG--  420 (973)
Q Consensus       343 N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--  420 (973)
                      +.+....+..   ....++.|++.+|.+.+..+   ..+..|+.++++.|.+...  .....+++|+.|++++|.+..  
T Consensus       316 ~~~~~~~~~~---~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~  387 (635)
T 4g8a_A          316 VTIERVKDFS---YNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKG  387 (635)
T ss_dssp             CEEEECGGGG---SCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEE
T ss_pred             cccccccccc---cchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhcccccccc
Confidence            7665433221   12457788899998875544   3467788999999988743  345678999999999999863  


Q ss_pred             CCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccc
Q 039720          421 IIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVG  500 (973)
Q Consensus       421 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~  500 (973)
                      ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.+++++|......+...+.....++.++++.|.+++..|..+.
T Consensus       388 ~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~  466 (635)
T 4g8a_A          388 CCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  466 (635)
T ss_dssp             ECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             ccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccc
Confidence            34556778899999999999998 56677889999999999999988777766665555556999999999999999999


Q ss_pred             cccccceeccccCcc-cccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccce
Q 039720          501 NLKSLVQLDISRNNF-SNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEY  579 (973)
Q Consensus       501 ~l~~L~~L~ls~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  579 (973)
                      .+++|+.|++++|++ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++
T Consensus       467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  546 (635)
T 4g8a_A          467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  546 (635)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred             cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence            999999999999985 4567889999999999999999999999999999999999999999999888889999999999


Q ss_pred             EeccCCcCcCcCCCC-CCC-CCccccccccCccccCCCC
Q 039720          580 LNLSYNHFEGKVPKK-GVF-SNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       580 L~ls~N~l~~~~p~~-~~~-~~~~~l~~~~N~~~cg~~~  616 (973)
                      |+|++|+|++.+|.. ..+ ++++.+++.+|||.|+|-.
T Consensus       547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            999999999999875 234 6799999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.6e-50  Score=437.65  Aligned_cols=250  Identities=21%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+.+.+|++++++++|||||++++++.+     .+..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEE
Confidence            58999999999999999999999999999999997553  3345779999999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      |+|||||+||+|.+++...+  .+++.+++.|+.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+..
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            99999999999999997543  346778899999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        .......+||+.|||||++.+..|+.++||||+||++|||+||+.||......  .+  .......   
T Consensus       176 ~~~--------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~--~~~i~~~---  240 (350)
T 4b9d_A          176 NST--------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NL--VLKIISG---  240 (350)
T ss_dssp             CHH--------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH--HHHHHHT---
T ss_pred             cCC--------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HH--HHHHHcC---
Confidence            321        12234567999999999999999999999999999999999999999754221  11  1111000   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                            ..      +..+..++.++.+++.+||+.||++|||++|+++.
T Consensus       241 ------~~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 ------SF------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ------CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CC------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00      11112334567789999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=428.98  Aligned_cols=262  Identities=27%  Similarity=0.427  Sum_probs=204.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .+++.+.++||+|+||+||+|++.   ..||||+++...  ....+.|.+|++++++++|||||+++++|..      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            357888999999999999999874   369999997543  3345789999999999999999999998743      45


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++|||||++|+|.++++.. ..+++.++..|+.|||.||+|||++   +||||||||+|||+++++++||+|||+|+..
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            79999999999999999754 4577888999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ....      .........||+.|||||++.+   .+|+.++|||||||++|||+||+.||......... .......  
T Consensus       183 ~~~~------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-~~~~~~~--  253 (307)
T 3omv_A          183 SRWS------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-IFMVGRG--  253 (307)
T ss_dssp             -----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHHTT--
T ss_pred             ccCC------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-HHHHhcC--
Confidence            4321      1223345679999999999864   46899999999999999999999999764332111 1111100  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                           ...+..      +..+.+++..+.+++.+||+.||++||||+||++.|+.+...+
T Consensus       254 -----~~~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          254 -----YASPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             -----CCCCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             -----CCCCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                 011111      1222345667889999999999999999999999999886543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-49  Score=433.52  Aligned_cols=258  Identities=23%  Similarity=0.272  Sum_probs=208.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .+.|++.++||+|+||+||+|+++.+|+.||||+++.+..     ..+|+.+++.++|||||++++++.+     ++..|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-----GPWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            3568888999999999999999999999999999975433     2469999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~~~~~  831 (973)
                      +|||||+||+|.++++..+.+++..+..++.||+.||+|||++   +||||||||+|||++.+| ++||+|||+|+....
T Consensus       127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            9999999999999999888899999999999999999999999   999999999999999988 699999999987654


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      ....   .........+||+.|||||++.+..|+.++||||+||++|||+||+.||......... ........      
T Consensus       204 ~~~~---~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~~~~------  273 (336)
T 4g3f_A          204 DGLG---KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-LKIASEPP------  273 (336)
T ss_dssp             -------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-HHHHHSCC------
T ss_pred             CCcc---cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHcCCC------
Confidence            2200   0011222357999999999999999999999999999999999999999865443221 11111000      


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                          ..      ...+..++..+.+++.+||+.||++|||++|+++.+....
T Consensus       274 ----~~------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          274 ----PI------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             ----GG------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----Cc------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                00      0112234556778899999999999999999999887653

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.4e-49  Score=473.06  Aligned_cols=491  Identities=18%  Similarity=0.202  Sum_probs=360.5

Q ss_pred             CCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeecc
Q 039720           87 FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLY  166 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~  166 (973)
                      .....|+++|+++ .+|..+.  ++|++|+|++|.+++..|..|+++++|++|++++|++.+..|..|.++++|++|+|+
T Consensus         6 ~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls   82 (549)
T 2z81_A            6 ASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS   82 (549)
T ss_dssp             TTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred             CCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence            3445688889998 7887764  789999999999987778888888888777777777777777777777777777777


Q ss_pred             CCcccccCCCCCCCCCcccEEEccCCcCCC-CCCCcccCCCccceeccCCCCc-cccCCccccCCCCCcEEEccCCcccc
Q 039720          167 GNQLTGQLPPSIGNLSALQTFDIAGNKLDG-RIPDSLGQLRNLNYLGTSENDF-SGMFPLSVCNISSLDEAYLFKNRFKG  244 (973)
Q Consensus       167 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~L~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~  244 (973)
                      +|.+++..|..|+++++|++|++++|++++ ..|..|+++++|++|++++|.+ ....+..|.++++|++|++++|++++
T Consensus        83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~  162 (549)
T 2z81_A           83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN  162 (549)
T ss_dssp             TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred             CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence            777776555557777777777777777765 2456677777777777777763 33333567777777777777777776


Q ss_pred             CCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccC---cccccCcccccceecccccCCCCCCC
Q 039720          245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQV---RINFNSLPNLSKLYLGRNNLGTRTST  321 (973)
Q Consensus       245 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~~  321 (973)
                      .+|..+. .+++|++|+++.|.+....+..+..+++|++|+|++|++++..   ......+++|+.|++++|.++.....
T Consensus       163 ~~~~~l~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  241 (549)
T 2z81_A          163 YQSQSLK-SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN  241 (549)
T ss_dssp             ECTTTTT-TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH
T ss_pred             cChhhhh-ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH
Confidence            6666555 5677777777777766333323355677777777777776542   12234456677777777665431111


Q ss_pred             ChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCC----
Q 039720          322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT----  397 (973)
Q Consensus       322 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----  397 (973)
                        .....+..+++|+.+++++|.+.+...-                   .......+..+.+|+.|++.++.+...    
T Consensus       242 --~l~~~~~~~~~L~~l~l~~~~~~~~~~~-------------------~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~  300 (549)
T 2z81_A          242 --ELLKLLRYILELSEVEFDDCTLNGLGDF-------------------NPSESDVVSELGKVETVTIRRLHIPQFYLFY  300 (549)
T ss_dssp             --HHHGGGGGCTTCCEEEEESCEEECCSCC-------------------CCCTTTCCCCCTTCCEEEEESCBCSCGGGSC
T ss_pred             --HHHHHhhhhccccccccccccccccccc-------------------cccchhhhhhhcccccccccccccchhhhcc
Confidence              1222334455666666666555432110                   001123456788999999999987632    


Q ss_pred             -CCccccCCCCCCeEEccCcccCCCCCCcc-CCcCccceEEcCCCccccccc---cccccccccccccccCcccccCCC-
Q 039720          398 -IPPAIGELRNLQYLGLVGNNIRGIIPDPI-GNLTLLNVLQLGFNKLQGSIP---SYLGKCQNLMQLSAPNNKLNGTLP-  471 (973)
Q Consensus       398 -~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~p-  471 (973)
                       ++..+...++|+.|++++|.+. .+|..+ ..+++|++|++++|++++.+|   ..++.+++|+.|++++|++++ +| 
T Consensus       301 ~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~  378 (549)
T 2z81_A          301 DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS-MQK  378 (549)
T ss_dssp             CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCC-HHH
T ss_pred             cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccc-ccc
Confidence             2333455689999999999998 667665 579999999999999998774   447889999999999999984 43 


Q ss_pred             --ccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhh
Q 039720          472 --PQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA  549 (973)
Q Consensus       472 --~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  549 (973)
                        ..+..+..+ +.|++++|+++ .+|..+..+++|+.|++++|+++ .+|..+.  ++|++|+|++|+|++.+    ..
T Consensus       379 ~~~~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~  449 (549)
T 2z81_A          379 TGEILLTLKNL-TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LF  449 (549)
T ss_dssp             HHHHGGGCTTC-CEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CC
T ss_pred             chhhhhcCCCC-CEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----cc
Confidence              234455555 59999999999 68999999999999999999998 4555443  68999999999999643    47


Q ss_pred             hccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCC-CCCCCCccccccccCccccCCC
Q 039720          550 LKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK-KGVFSNETRISLTGNEQFCGGL  615 (973)
Q Consensus       550 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~l~~~~N~~~cg~~  615 (973)
                      +++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|. ...+++++.+++.+|||.|+++
T Consensus       450 l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          450 LPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             CChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            899999999999999 7886 46799999999999999999887 3678899999999999999886

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=5.5e-50  Score=484.31  Aligned_cols=473  Identities=19%  Similarity=0.259  Sum_probs=321.6

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCC------C------CCCcccccCCCccceEecccccccchhhh
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFS------G------KIPTNLSRCFNLIDFWVHTNNLVGEIQAI  153 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~------~------~~p~~~~~l~~L~~L~l~~n~~~~~~~~~  153 (973)
                      .+++.|+|++|+++|.+|++|++|++|++|+|++|.+.      |      .+|...  +..|+ ++++.|.+.+.+|..
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            36889999999999999999999999999999999872      2      233322  22233 444444444444443


Q ss_pred             hcc-ccccceeeccCCcccccCCCCCCCCCcccEEEc--cCCcCCCCCCCcccCCCccceeccCCCCcccc-CCccccCC
Q 039720          154 IGN-WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDI--AGNKLDGRIPDSLGQLRNLNYLGTSENDFSGM-FPLSVCNI  229 (973)
Q Consensus       154 ~~~-l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L--~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~l  229 (973)
                      +.. +.++..+++....+..      .....++.+.+  .+|++++ +|.+|+++++|++|+|++|.+++. ++....  
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~--  228 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE--  228 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS--
T ss_pred             HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccc--
Confidence            331 1222333333222210      01111222222  1345554 555555555555555555555543 000000  


Q ss_pred             CCCcEEEccCCccccCCCcccc-cCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCc-ccc-cCcccccCc----
Q 039720          230 SSLDEAYLFKNRFKGSLPVCLG-FNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH-FSG-QVRINFNSL----  302 (973)
Q Consensus       230 ~~L~~L~L~~N~l~~~ip~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l----  302 (973)
                      +      -..+...+.+|..++ .++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+..+    
T Consensus       229 ~------~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~  302 (636)
T 4eco_A          229 N------ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP  302 (636)
T ss_dssp             C------TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSG
T ss_pred             c------cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccc
Confidence            0      000000000444432 135555555555555555555555555555555555555 554 444444443    


Q ss_pred             --ccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccC
Q 039720          303 --PNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRN  380 (973)
Q Consensus       303 --~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~  380 (973)
                        ++|++|+|++|+++.++.     ...+.++++|+.|++++                         |+++|.+| .+..
T Consensus       303 ~l~~L~~L~L~~n~l~~ip~-----~~~l~~l~~L~~L~L~~-------------------------N~l~g~ip-~~~~  351 (636)
T 4eco_A          303 VGEKIQIIYIGYNNLKTFPV-----ETSLQKMKKLGMLECLY-------------------------NQLEGKLP-AFGS  351 (636)
T ss_dssp             GGGTCCEEECCSSCCSSCCC-----HHHHTTCTTCCEEECCS-------------------------CCCEEECC-CCEE
T ss_pred             cCCCCCEEECCCCcCCccCc-----hhhhccCCCCCEEeCcC-------------------------CcCccchh-hhCC
Confidence              555555555555543221     00223333444433333                         33345666 7788


Q ss_pred             CCCcCEEEcccccCCCCCCccccCCCC-CCeEEccCcccCCCCCCccCCcC--ccceEEcCCCccccccccccc------
Q 039720          381 LFNLNGLGLEYNQLTGTIPPAIGELRN-LQYLGLVGNNIRGIIPDPIGNLT--LLNVLQLGFNKLQGSIPSYLG------  451 (973)
Q Consensus       381 l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~------  451 (973)
                      +++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|++|++++|++++.+|..+.      
T Consensus       352 l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~  429 (636)
T 4eco_A          352 EIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP  429 (636)
T ss_dssp             EEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSC
T ss_pred             CCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccccc
Confidence            899999999999999 88999999999 999999999999 7888888765  999999999999999999998      


Q ss_pred             -cccccccccccCcccccCCCccccccccccceeeccCCcccccCCccccc-c-------cccceeccccCccccccccc
Q 039720          452 -KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGN-L-------KSLVQLDISRNNFSNEIPVT  522 (973)
Q Consensus       452 -~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~ls~N~l~~~~p~~  522 (973)
                       .+++|+.|++++|++. .+|..++.....++.|+|++|+++ .+|..+.. .       ++|+.|+|++|+++ .+|..
T Consensus       430 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~  506 (636)
T 4eco_A          430 FKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDD  506 (636)
T ss_dssp             CCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGG
T ss_pred             ccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChh
Confidence             8889999999999999 889888764444469999999999 56654433 2       39999999999999 78888


Q ss_pred             cc--CccchhhhcccCcccccccccchhhhccCCeecC------CCCccccccCCCCCCCCccceEeccCCcCcCcCCCC
Q 039720          523 LS--ACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDL------SCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK  594 (973)
Q Consensus       523 ~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  594 (973)
                      +.  .+++|+.|+|++|+|++ +|..+..+++|++|+|      ++|++.+.+|..+..+++|++|+|++|++ +.+|..
T Consensus       507 ~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~  584 (636)
T 4eco_A          507 FRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK  584 (636)
T ss_dssp             GSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC
T ss_pred             hhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh
Confidence            87  99999999999999997 8999999999999999      56889999999999999999999999999 566765


Q ss_pred             CCCCCccccccccCccccCCC
Q 039720          595 GVFSNETRISLTGNEQFCGGL  615 (973)
Q Consensus       595 ~~~~~~~~l~~~~N~~~cg~~  615 (973)
                       .+++++.+++.+|++.|-..
T Consensus       585 -~~~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          585 -ITPNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             -CCTTCCEEECCSCTTCEEEC
T ss_pred             -HhCcCCEEECcCCCCccccH
Confidence             34899999999999988543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-49  Score=422.04  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=201.8

Q ss_pred             CcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          677 SSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       677 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      ++.++||+|+||+||+|+++.++..||+|++....  ....+.+.+|++++++++|||||++++++... .......++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence            66778999999999999999999999999997543  33456799999999999999999999987653 2344678999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEecC-CCcEEEeccccchhccC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLDH-DMVAHVSDFGLARFLSH  831 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~~-~~~~kl~Dfg~a~~~~~  831 (973)
                      ||||++|+|.+++.+.+.+++..+..|+.||+.||+|||++   +  ||||||||+|||++. ++.+||+|||+|+....
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999999888888999999999999999999998   6  999999999999984 79999999999985422


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                                ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||........ +   ......     
T Consensus       185 ----------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~---~~~i~~-----  244 (290)
T 3fpq_A          185 ----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-I---YRRVTS-----  244 (290)
T ss_dssp             ----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-H---HHHHTT-----
T ss_pred             ----------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-H---HHHHHc-----
Confidence                      23345689999999998865 699999999999999999999999975432211 1   111000     


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...+        ...+....+++.+++.+||+.||++|||++|++++
T Consensus       245 ~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          245 GVKP--------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             TCCC--------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCC--------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000        01111223456789999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-49  Score=431.45  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=208.5

Q ss_pred             hcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++++.++||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|..     
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----  100 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----  100 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----
Confidence            35677889999999999999874     367899999997543 3345789999999999999999999999764     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc----------------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT----------------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NIL  811 (973)
                      ....++|||||++|+|.+++...                ..+++.++.+|+.|||+||+|||++   +||||||||+|||
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL  177 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL  177 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence            36789999999999999999653                2345677899999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 039720          812 LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM  890 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~  890 (973)
                      +++++++||+|||+|+.....+      .........||+.|+|||++.+..|+.++|||||||++|||+| |+.||...
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAAD------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGG------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             ECCCCCEEECCcccceeccCCC------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999998764321      1222334579999999999999999999999999999999999 89999865


Q ss_pred             CCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ...  ++......                 ......+.+++..+.+++.+||+.||++||||+||++.|++..+
T Consensus       252 ~~~--~~~~~i~~-----------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          252 SNQ--DVVEMIRN-----------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             CHH--HHHHHHHT-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             CHH--HHHHHHHc-----------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            322  11111110                 00112234566778899999999999999999999999998764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-49  Score=429.23  Aligned_cols=249  Identities=21%  Similarity=0.329  Sum_probs=207.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   .....+.+.+|+++|++++|||||++++++.     +++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            5799999999999999999999999999999999753   2334577999999999999999999999854     4589


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            999999999999999999988899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...      ........+||+.|||||++.+..|+.++||||+||++|||++|+.||......  .+  +...... .  
T Consensus       184 ~~~------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~--~~~i~~~-~--  250 (311)
T 4aw0_A          184 PES------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LI--FAKIIKL-E--  250 (311)
T ss_dssp             TTT------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH--HHHHHHT-C--
T ss_pred             CCC------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HH--HHHHHcC-C--
Confidence            321      123344578999999999999999999999999999999999999999753221  11  1111100 0  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVV  956 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  956 (973)
                          ..+      +   .....++.+++.+|++.||++|||++|++
T Consensus       251 ----~~~------p---~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 ----YDF------P---EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----CCC------C---TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----CCC------C---cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                001      1   12234567888899999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.8e-49  Score=416.54  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=192.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...   ....+.+.+|+++++.++|||||++++++.     +++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence            68999999999999999999999999999999997542   334567899999999999999999999854     4588


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .|+||||+ +|+|.+++.+.+.+++.++..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+...
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            99999999 689999999888899999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         ......+||+.|+|||++.+..| +.++||||+||++|||+||+.||......  .+.......   . 
T Consensus       164 ~~---------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i~~~---~-  228 (275)
T 3hyh_A          164 DG---------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNISNG---V-  228 (275)
T ss_dssp             --------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT---C-
T ss_pred             CC---------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcC---C-
Confidence            32         22335679999999999998876 57999999999999999999999753211  111111000   0 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                    ...+...+..+.+++.+||+.||++|||++|++++
T Consensus       229 --------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 --------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                          00011223456788999999999999999999874

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.6e-49  Score=467.15  Aligned_cols=454  Identities=20%  Similarity=0.249  Sum_probs=247.5

Q ss_pred             EEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEeccccc
Q 039720           67 LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNL  146 (973)
Q Consensus        67 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~  146 (973)
                      +|+++++++ .+|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|.+++                      
T Consensus         5 l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~----------------------   59 (520)
T 2z7x_B            5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY----------------------   59 (520)
T ss_dssp             EECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCE----------------------
T ss_pred             EecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCC----------------------
Confidence            455555554 3444443  455555555555554444455555555555555555554                      


Q ss_pred             ccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCC-CCCCcccCCCccceeccCCCCccccCCcc
Q 039720          147 VGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDG-RIPDSLGQLRNLNYLGTSENDFSGMFPLS  225 (973)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~  225 (973)
                        ..|..|.++++|++|+|++|+++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++   ..
T Consensus        60 --~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~  131 (520)
T 2z7x_B           60 --LDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SS  131 (520)
T ss_dssp             --EEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GG
T ss_pred             --cChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hh
Confidence              44444444555555555555554 34433  45555555555555543 244555555555555555555543   23


Q ss_pred             ccCCCCC--cEEEccCCcc--ccCCCcccccCCC-CCcEEEccCCcccccCCc-cccCCCCCCEEEccCCc-------cc
Q 039720          226 VCNISSL--DEAYLFKNRF--KGSLPVCLGFNLP-KLTVLVVAQNNLTGFLPQ-SLSNASKLEWLELNENH-------FS  292 (973)
Q Consensus       226 ~~~l~~L--~~L~L~~N~l--~~~ip~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-------l~  292 (973)
                      +..+++|  ++|++++|++  .+.+|..+. .+. +...+++++|.+.+.++. .+.++++|+.|++++|.       +.
T Consensus       132 ~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~  210 (520)
T 2z7x_B          132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQ-DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL  210 (520)
T ss_dssp             GGGGTTSCEEEEEEEECTTTTSSCCTTTTT-TCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHH
T ss_pred             ccccccceeeEEEeeccccccccccccccc-ccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceee
Confidence            3444444  5555555555  444443332 222 122445555555443332 45555666666666655       44


Q ss_pred             ccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCcccc
Q 039720          293 GQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG  372 (973)
Q Consensus       293 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~  372 (973)
                      +.++ .|..+++|+.|++++|.++....   ........+++|++|++++|++.                         |
T Consensus       211 ~~~~-~l~~l~~L~~L~l~~~~l~~~~~---~~~~~~~~~~~L~~L~l~~n~l~-------------------------~  261 (520)
T 2z7x_B          211 SILA-KLQTNPKLSNLTLNNIETTWNSF---IRILQLVWHTTVWYFSISNVKLQ-------------------------G  261 (520)
T ss_dssp             HHHH-GGGGCTTCCEEEEEEEEEEHHHH---HHHHHHHHTSSCSEEEEEEEEEE-------------------------S
T ss_pred             cchh-hhccccchhhccccccccCHHHH---HHHHHHhhhCcccEEEeeccccc-------------------------C
Confidence            4443 55566666666666655432100   00000001223444444444333                         3


Q ss_pred             CCCccc-----cCCCCcCEEEcccccCCCCCC-ccccCC---CCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccc
Q 039720          373 TIPPEI-----RNLFNLNGLGLEYNQLTGTIP-PAIGEL---RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ  443 (973)
Q Consensus       373 ~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  443 (973)
                      .+|..+     ..+++|+.+++++|.+  .+| .++..+   .+|+.|++++|.+....  .+..+++|++|++++|+++
T Consensus       262 ~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~  337 (520)
T 2z7x_B          262 QLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLT  337 (520)
T ss_dssp             CCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCC
T ss_pred             ccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccC
Confidence            344444     6666777777777776  344 445444   56777777777665322  1256667777777777777


Q ss_pred             cccccccccccccccccccCccccc--CCCccccccccccceeeccCCcccccCCc-ccccccccceeccccCccccccc
Q 039720          444 GSIPSYLGKCQNLMQLSAPNNKLNG--TLPPQIFGITTLSKLLDLSENHLSGSIPL-EVGNLKSLVQLDISRNNFSNEIP  520 (973)
Q Consensus       444 ~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p  520 (973)
                      +.+|..+..+++|++|++++|++.+  .+|..+..+..+. .|++++|++++.+|. .+..+++|+.|++++|++++.+|
T Consensus       338 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~-~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~  416 (520)
T 2z7x_B          338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ-QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF  416 (520)
T ss_dssp             TTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCC-EEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGG
T ss_pred             hhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCC-EEECCCCcCCcccccchhccCccCCEEECcCCCCCcchh
Confidence            6667677777777777777776663  3333344444442 566666666553443 35566677777777777766666


Q ss_pred             ccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCC-CCCCCccceEeccCCcCcCcCC
Q 039720          521 VTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNHFEGKVP  592 (973)
Q Consensus       521 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p  592 (973)
                      ..+.  ++|+.|++++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|++|++++|++++..+
T Consensus       417 ~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          417 RCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             GSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence            5554  56777777777776 66666667777777777777777 45554 6667777777777777766544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=436.55  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=210.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .+.|++.++||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||++++++..     .+..|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEE
Confidence            3579999999999999999999999999999999987766666779999999999999999999998655     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +|||||+||+|.+++... .+.+.+++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+...
T Consensus       225 iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999999998754 578889999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                              .......+||+.|||||++.+..|+.++|||||||++|||++|+.||......  .+.......        
T Consensus       301 --------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~--------  362 (423)
T 4fie_A          301 --------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDN--------  362 (423)
T ss_dssp             --------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS--------
T ss_pred             --------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcC--------
Confidence                    22334578999999999999999999999999999999999999999753221  111111110        


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..+..       .....+...+.+++.+||+.||++|||++|++++
T Consensus       363 ~~~~~-------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          363 LPPRL-------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCCCC-------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCC-------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00110       1112234566788899999999999999999874

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.9e-49  Score=465.12  Aligned_cols=464  Identities=20%  Similarity=0.160  Sum_probs=379.7

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCC
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN  168 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  168 (973)
                      ++||+++|+++ .+|..+.  ++|++|+|++|.++                        +..|..|.++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~------------------------~~~~~~~~~l~~L~~L~Ls~n   55 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYIS------------------------ELWTSDILSLSKLRILIISHN   55 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCC------------------------CCCHHHHTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCccc------------------------ccChhhccccccccEEecCCC
Confidence            35666666666 4665554  56666666666655                        344566777889999999999


Q ss_pred             cccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccc-cCCccccCCCCCcEEEccCCccccCCC
Q 039720          169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG-MFPLSVCNISSLDEAYLFKNRFKGSLP  247 (973)
Q Consensus       169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~ip  247 (973)
                      ++++..|..|+++++|++|+|++|+++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|++++   
T Consensus        56 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---  129 (520)
T 2z7x_B           56 RIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---  129 (520)
T ss_dssp             CCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---
T ss_pred             ccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---
Confidence            999888999999999999999999999 67766  89999999999999997 478999999999999999999985   


Q ss_pred             cccccCCCCC--cEEEccCCcc--cccCCccccCCC-CCCEEEccCCcccccCc-ccccCcccccceecccccCCCCCCC
Q 039720          248 VCLGFNLPKL--TVLVVAQNNL--TGFLPQSLSNAS-KLEWLELNENHFSGQVR-INFNSLPNLSKLYLGRNNLGTRTST  321 (973)
Q Consensus       248 ~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~  321 (973)
                      .. +..+++|  ++|++++|.+  ++..|..+..+. +...+++++|++.+..+ ..+..+++|+.|++++|........
T Consensus       130 ~~-~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~  208 (520)
T 2z7x_B          130 SS-VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY  208 (520)
T ss_dssp             GG-GGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred             hh-ccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence            22 3367788  9999999999  888898888876 45578899999876554 5688999999999999972111111


Q ss_pred             ChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCcc
Q 039720          322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPA  401 (973)
Q Consensus       322 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  401 (973)
                      ....+..+..+++|+.|+++.|.+.+..+..+..                     .+ ..++|++|++++|++++.+|..
T Consensus       209 ~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~---------------------~~-~~~~L~~L~l~~n~l~~~~p~~  266 (520)
T 2z7x_B          209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ---------------------LV-WHTTVWYFSISNVKLQGQLDFR  266 (520)
T ss_dssp             HHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHH---------------------HH-HTSSCSEEEEEEEEEESCCCCC
T ss_pred             eecchhhhccccchhhccccccccCHHHHHHHHH---------------------Hh-hhCcccEEEeecccccCccccc
Confidence            1123346778889999999998877533322211                     11 1358999999999999999999


Q ss_pred             c-----cCCCCCCeEEccCcccCCCCC-CccCCc---CccceEEcCCCccccccccccccccccccccccCcccccCCCc
Q 039720          402 I-----GELRNLQYLGLVGNNIRGIIP-DPIGNL---TLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPP  472 (973)
Q Consensus       402 ~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  472 (973)
                      +     ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+.+..  .+..+++|++|++++|++.+.+|.
T Consensus       267 ~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~  342 (520)
T 2z7x_B          267 DFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFE  342 (520)
T ss_dssp             CCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred             hhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhh
Confidence            8     9999999999999999  455 555555   67999999999987432  126889999999999999988898


Q ss_pred             cccccccccceeeccCCcccc--cCCcccccccccceeccccCcccccccc-cccCccchhhhcccCcccccccccchhh
Q 039720          473 QIFGITTLSKLLDLSENHLSG--SIPLEVGNLKSLVQLDISRNNFSNEIPV-TLSACTTLEYLLMQGNSFNGSIPQSLNA  549 (973)
Q Consensus       473 ~~~~~~~l~~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~  549 (973)
                      .+..+..+. .|++++|++++  .+|..++.+++|+.|++++|++++.+|. .+..+++|+.|++++|++++.+|..+. 
T Consensus       343 ~~~~l~~L~-~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-  420 (520)
T 2z7x_B          343 NCGHLTELE-TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-  420 (520)
T ss_dssp             TCCCCSSCC-EEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred             hhccCCCCC-EEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-
Confidence            888887775 99999999997  5667899999999999999999985665 488999999999999999988887764 


Q ss_pred             hccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCC-CCCCCCccccccccCccccCCCC
Q 039720          550 LKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK-KGVFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       550 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~l~~~~N~~~cg~~~  616 (973)
                       ++|+.|+|++|+|+ .+|..+..+++|++|++++|++++.++. ...+++++.+++.+||+.|+|..
T Consensus       421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence             79999999999999 8999888999999999999999976655 46688899999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.5e-49  Score=422.45  Aligned_cols=264  Identities=20%  Similarity=0.250  Sum_probs=204.7

Q ss_pred             hcCCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|++.+.||+|+||+||+|++.   .+++.||||+++...  ......+.+|++++++++|||||++++++.+     +
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            57999999999999999999884   468899999997442  2233468889999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +..|+|||||+||+|.+++.+.+.+++.++..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+.
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            88999999999999999999988899999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        .......+||+.|||||++.+..|+.++||||+||++|||+||+.||......  .+..  .... . 
T Consensus       176 ~~~~--------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~--~i~~-~-  241 (304)
T 3ubd_A          176 SIDH--------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMT--MILK-A-  241 (304)
T ss_dssp             -------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH--HHHH-C-
T ss_pred             ccCC--------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHH--HHHc-C-
Confidence            5332        22334567999999999999999999999999999999999999999754221  1111  1100 0 


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHHH--H-----HhccccccCCCCCC
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM-----TAVVKK--L-----CAVGEIFIGPPIIG  973 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~--L-----~~~~~~~~~~~~~~  973 (973)
                             .       ...+..++.++.+++.+||+.||++|||+     +|++++  +     +++...-..||.+|
T Consensus       242 -------~-------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          242 -------K-------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             -------C-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             -------C-------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence                   0       01112234566788999999999999985     677753  2     22333344677765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.3e-48  Score=421.03  Aligned_cols=274  Identities=22%  Similarity=0.278  Sum_probs=204.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|.+.++||+|+||+||+|++  +|+.||||+++.... .......|+..+.+++|||||+++++|... .......++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~-~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEec-CCCceEEEE
Confidence            5688889999999999999998  789999999964432 222334566666788999999999998763 222346899


Q ss_pred             EEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          754 VYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC-----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      |||||++|+|.++++.. ..++..+.+++.|++.||+|||+++     .++||||||||+|||++.++++||+|||+|+.
T Consensus        79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999999765 5677888999999999999999762     45899999999999999999999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCC------CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc-------
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG------DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL-------  895 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~-------  895 (973)
                      .......    .........||+.|+|||++.+.      .|+.++|||||||++|||+||+.||........       
T Consensus       158 ~~~~~~~----~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          158 HDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             EETTTTE----ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccCCCCc----eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            6543210    01122345799999999998764      467899999999999999999888754332211       


Q ss_pred             ---cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          896 ---TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       896 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                         ..........    ....++.+..    .....++.+.+.+++.+||+.||++||||+||++.|+++.+
T Consensus       234 ~~~~~~~~~~~~~----~~~~rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          234 SDPSVEEMRKVVC----EQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             SSCCHHHHHHHHT----TSCCCCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHh----cccCCCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence               1111111110    1111111111    11223567788999999999999999999999999998854

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.8e-48  Score=424.84  Aligned_cols=266  Identities=21%  Similarity=0.341  Sum_probs=212.2

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCC-----CcEEEEEEeecccc-hhHHHHHHHHHHHHhcCC-CCceeEEeE
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGED-----GMSVAVKVMNLDKK-GATKSFVAECEALRNIRH-RNLIKIITI  739 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~~  739 (973)
                      ++++...++|++.+.||+|+||+||+|++..+     ++.||||+++.... ...+.+.+|+++|+++.| ||||+++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            33444567899999999999999999998643     36899999975433 345679999999999965 999999999


Q ss_pred             eeecccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 039720          740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG  803 (973)
Q Consensus       740 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  803 (973)
                      |...    ....++|||||++|+|.++++...                .+++.++..++.|||+||+|||++   +||||
T Consensus       137 ~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          137 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             ECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            7542    356899999999999999997532                245677899999999999999999   99999


Q ss_pred             CCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-
Q 039720          804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-  882 (973)
Q Consensus       804 Dik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-  882 (973)
                      ||||+|||++.++.+||+|||+|+.+....      .........||+.|||||++.+..|+.++|||||||++|||+| 
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~  283 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  283 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCC------CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence            999999999999999999999998664322      1223334679999999999999999999999999999999998 


Q ss_pred             CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          883 RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       883 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      |+.||........ +......                 ...+..+..++.++.++|.+||+.||++||||+||+++|+.+
T Consensus       284 G~~Pf~~~~~~~~-~~~~i~~-----------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          284 GASPYPGVKIDEE-FCRRLKE-----------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             SCCSSTTCCCSHH-HHHHHHH-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHH-HHHHHHc-----------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            9999986543221 1111111                 001122233456788999999999999999999999999876


Q ss_pred             c
Q 039720          963 G  963 (973)
Q Consensus       963 ~  963 (973)
                      .
T Consensus       346 l  346 (353)
T 4ase_A          346 L  346 (353)
T ss_dssp             H
T ss_pred             H
Confidence            4

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.8e-47  Score=409.93  Aligned_cols=261  Identities=22%  Similarity=0.373  Sum_probs=193.2

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-------
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDF-------  745 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------  745 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+...       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            569999999999999999999999999999999975543 345778999999999999999999998765321       


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCCCch---hhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTNDKLE---VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                      ......|+|||||++|+|.+++.......+   ..++.++.||++||+|||++   +||||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence            123457999999999999999987665443   34778999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccC----CCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh
Q 039720          823 FGLARFLSHHPFLVA----PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH  898 (973)
Q Consensus       823 fg~a~~~~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~  898 (973)
                      ||+|+..........    ..........+||+.|||||++.+..|+.++|||||||++|||++   ||.....   ...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HHH
Confidence            999987654321000    011122334679999999999999999999999999999999996   7753211   111


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......               ....+...........+++.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~---------------~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTDVR---------------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHH---------------TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHh---------------cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111100               011122334444566789999999999999999999873

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.6e-46  Score=455.20  Aligned_cols=522  Identities=20%  Similarity=0.201  Sum_probs=427.0

Q ss_pred             eeEeeCC---------CCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCC
Q 039720           54 GVTCGHR---------HQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG  124 (973)
Q Consensus        54 gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~  124 (973)
                      -|.|...         ...++.|||++|.+++..+.++.++++|++|||++|+|++..|..|++|++|++|+|++|+|++
T Consensus        35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~  114 (635)
T 4g8a_A           35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS  114 (635)
T ss_dssp             EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred             EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence            5778743         2368999999999997767789999999999999999997777789999999999999999996


Q ss_pred             CCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccc-cCCCCCCCCCcccEEEccCCcCCCCCCCccc
Q 039720          125 KIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTG-QLPPSIGNLSALQTFDIAGNKLDGRIPDSLG  203 (973)
Q Consensus       125 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  203 (973)
                      ..|..|.++++|++|++++|++.+..+..|+++++|++|+|++|.+++ .+|..++++++|++|+|++|++++..|..|.
T Consensus       115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~  194 (635)
T 4g8a_A          115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR  194 (635)
T ss_dssp             ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred             CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccccc
Confidence            666779999999999999999998888889999999999999999975 4688899999999999999999988888888


Q ss_pred             CCCccc----eeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCc------ccccCCc
Q 039720          204 QLRNLN----YLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNN------LTGFLPQ  273 (973)
Q Consensus       204 ~L~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~------l~~~~p~  273 (973)
                      .+.+++    .++++.|.++...+..+. ...++.+++..|.....++...+.++..++...+..+.      +......
T Consensus       195 ~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~  273 (635)
T 4g8a_A          195 VLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS  273 (635)
T ss_dssp             HHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTT
T ss_pred             chhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccc
Confidence            877665    588999999876665554 45678899999887766666656678888877765433      3333445


Q ss_pred             cccCCCCCCEEEccCCcccc---cCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCC
Q 039720          274 SLSNASKLEWLELNENHFSG---QVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALP  350 (973)
Q Consensus       274 ~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p  350 (973)
                      .+..+..+..+++..+....   .....+..+.+++.+.+.+|.+..+.        .+.....|+.|++..|.+.+..+
T Consensus       274 ~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~~~~~L~~L~l~~~~~~~~~~  345 (635)
T 4g8a_A          274 ALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--------DFSYNFGWQHLELVNCKFGQFPT  345 (635)
T ss_dssp             TTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--------GGGSCCCCSEEEEESCEESSCCC
T ss_pred             ccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--------ccccchhhhhhhcccccccCcCc
Confidence            56666667766666554332   23345667778888888888765432        23455678888888888775544


Q ss_pred             hhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCC--CCCCccccCCCCCCeEEccCcccCCCCCCccCC
Q 039720          351 HSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT--GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGN  428 (973)
Q Consensus       351 ~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  428 (973)
                      ..+    ..++.+.+.+|.+...  .....+++|+.|++++|.+.  +..+..+..+.+|++|+++.|.+. ..+..+..
T Consensus       346 ~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~  418 (635)
T 4g8a_A          346 LKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLG  418 (635)
T ss_dssp             CBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTT
T ss_pred             ccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccc
Confidence            333    3456677778877533  34567899999999999986  346777888999999999999988 45667889


Q ss_pred             cCccceEEcCCCccccccc-cccccccccccccccCcccccCCCccccccccccceeeccCCcc-cccCCcccccccccc
Q 039720          429 LTLLNVLQLGFNKLQGSIP-SYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHL-SGSIPLEVGNLKSLV  506 (973)
Q Consensus       429 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l-~~~~p~~~~~l~~L~  506 (973)
                      +++|+.++++.|......+ ..+..+++++.++++.|.+.+..|..+.....+ +.|++++|.+ .+..|..|..+++|+
T Consensus       419 l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L-~~L~Ls~N~~~~~~~~~~~~~l~~L~  497 (635)
T 4g8a_A          419 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLT  497 (635)
T ss_dssp             CTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred             cccccchhhhhccccccccccccccccccccccccccccccccccccccchhh-hhhhhhhcccccccCchhhhhccccC
Confidence            9999999999988875554 567889999999999999996666555555555 5999999985 446788999999999


Q ss_pred             eeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCC-CccceEeccCC
Q 039720          507 QLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNL-PFLEYLNLSYN  585 (973)
Q Consensus       507 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N  585 (973)
                      .|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|||++|+|++..|..+..+ ++|++|+|++|
T Consensus       498 ~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N  577 (635)
T 4g8a_A          498 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN  577 (635)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC
T ss_pred             EEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC
Confidence            99999999999999999999999999999999998889999999999999999999999999999998 68999999999


Q ss_pred             cCcCcCC
Q 039720          586 HFEGKVP  592 (973)
Q Consensus       586 ~l~~~~p  592 (973)
                      ++.+...
T Consensus       578 p~~C~C~  584 (635)
T 4g8a_A          578 DFACTCE  584 (635)
T ss_dssp             CBCCSGG
T ss_pred             CCcccCC
Confidence            9987654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.2e-46  Score=446.50  Aligned_cols=461  Identities=16%  Similarity=0.136  Sum_probs=260.8

Q ss_pred             EEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEeccc
Q 039720           65 TKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTN  144 (973)
Q Consensus        65 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n  144 (973)
                      ..+|++++++++ +|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            667888888875 776654  78889999999888777778888888999999888888777777777777777777777


Q ss_pred             ccccchhhhhccccccceeeccCCcccc-cCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCcc--ceeccCCCCc--c
Q 039720          145 NLVGEIQAIIGNWLKIERLSLYGNQLTG-QLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNL--NYLGTSENDF--S  219 (973)
Q Consensus       145 ~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L--~~L~Ls~N~l--~  219 (973)
                      ++. .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|++++.   .+..+++|  ++|++++|.+  +
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~  184 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK  184 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence            766 44444  56667777777777664 2345666677777777777766542   34444444  6666666666  5


Q ss_pred             ccCCccccCCC-CCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCccc
Q 039720          220 GMFPLSVCNIS-SLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRIN  298 (973)
Q Consensus       220 ~~~p~~~~~l~-~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  298 (973)
                      +..|..+..+. ..-.++++.|.+.+.++...+.++++|+.|++++|...-.                   .+.+. ...
T Consensus       185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~-------------------~l~~~-~~~  244 (562)
T 3a79_B          185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-------------------RLMTF-LSE  244 (562)
T ss_dssp             SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-------------------HHHHH-HHH
T ss_pred             ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-------------------hHHHH-HHH
Confidence            55565555443 1113345555555444444444444455555544421000                   01111 123


Q ss_pred             ccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccc
Q 039720          299 FNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI  378 (973)
Q Consensus       299 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~  378 (973)
                      |..+++|+.|+|+++.+....   +.........++|++|++++|++.|                         .+|..+
T Consensus       245 l~~l~~L~~L~L~~~~l~~~~---~~~~~~~~~~~~L~~L~l~~n~l~~-------------------------~ip~~~  296 (562)
T 3a79_B          245 LTRGPTLLNVTLQHIETTWKC---SVKLFQFFWPRPVEYLNIYNLTITE-------------------------RIDREE  296 (562)
T ss_dssp             HHSCSSCEEEEEEEEEECHHH---HHHHHHHHTTSSEEEEEEEEEEECS-------------------------CCCCCC
T ss_pred             HhccCcceEEEecCCcCcHHH---HHHHHHhhhcccccEEEEeccEeec-------------------------cccchh
Confidence            444445555555444432100   0000001112244444444444443                         344433


Q ss_pred             -----cCCCCcCEEEcccccCCCCCC-ccccCC---CCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccc
Q 039720          379 -----RNLFNLNGLGLEYNQLTGTIP-PAIGEL---RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSY  449 (973)
Q Consensus       379 -----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  449 (973)
                           ..++.|+.++++.|.+  .+| .++..+   .+|++|++++|.+....  ....+++|++|++++|++++.+|..
T Consensus       297 ~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~  372 (562)
T 3a79_B          297 FTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQG  372 (562)
T ss_dssp             CCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred             hhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhh
Confidence                 5666677777777776  344 333332   56888888888875332  1257788888888888888777888


Q ss_pred             cccccccccccccCccccc--CCCccccccccccceeeccCCcccccCCc-ccccccccceeccccCcccccccccccCc
Q 039720          450 LGKCQNLMQLSAPNNKLNG--TLPPQIFGITTLSKLLDLSENHLSGSIPL-EVGNLKSLVQLDISRNNFSNEIPVTLSAC  526 (973)
Q Consensus       450 ~~~l~~L~~L~l~~N~l~~--~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l  526 (973)
                      +..+++|+.|++++|++++  .+|..+..+..+ +.|++++|++++.+|. .+..+++|+.|++++|++++.+|..+.  
T Consensus       373 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--  449 (562)
T 3a79_B          373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--  449 (562)
T ss_dssp             CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTC-CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--
T ss_pred             hcccCCCCEEECCCCCcCCcccchhhhcCCCCC-CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--
Confidence            8888888888888777773  112223333333 2455555555542332 244455555555555555444443332  


Q ss_pred             cchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCC-CCCCCccceEeccCCcCcCcC
Q 039720          527 TTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH-LGNLPFLEYLNLSYNHFEGKV  591 (973)
Q Consensus       527 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~  591 (973)
                      ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|+.|++++|++.+..
T Consensus       450 ~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c  513 (562)
T 3a79_B          450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC  513 (562)
T ss_dssp             TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred             CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence            34555555555554 34444444555555555555554 33333 444555555555555544433

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=410.36  Aligned_cols=276  Identities=22%  Similarity=0.287  Sum_probs=208.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeec-ccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSI-DFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++... .+.+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999996443  33456788999999999999999999987643 2455678


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .|+|||||. |+|.+++...+.+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            999999996 67999999888899999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc--Cc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL--PK  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~  907 (973)
                      ...    ..........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+....+ .+........  +.
T Consensus       210 ~~~----~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~  284 (398)
T 4b99_A          210 TSP----AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSP  284 (398)
T ss_dssp             ----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCG
T ss_pred             cCc----cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCh
Confidence            321    1112234457899999999998875 56999999999999999999999997543211 1111111110  00


Q ss_pred             ccccccCc--------ccccccCCC--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDP--------SLLMEARGP--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~--------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....+..        .+....+.+  .........+.+++.+||+.||++|||++|++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000000        000000000  0011224566789999999999999999999874

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4.7e-44  Score=393.80  Aligned_cols=293  Identities=25%  Similarity=0.413  Sum_probs=275.3

Q ss_pred             ccchhhHHHHHHHHhhccCCCcCCCCCCCCCCCCCc--eeeeEeeCCC--CeEEEEEeeccCccc--cccCCCcCCCCCC
Q 039720           16 HATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQ--WTGVTCGHRH--QRVTKLDLESQNIGG--FLSPYIGNLSFLR   89 (973)
Q Consensus        16 ~~~~~~~~~ll~~~~~~~~d~~~~l~sw~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~   89 (973)
                      .|.+.|++||++||++. .||. .+++|..+++||.  |.||+|+..+  ++|+.|+|+++++.|  .+|+.++++++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~-~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDL-GNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHT-TCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhc-CCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence            46678999999999976 6876 7999998889998  9999998755  799999999999999  9999999999999


Q ss_pred             EEEccC-CCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCC
Q 039720           90 VINLAN-NSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN  168 (973)
Q Consensus        90 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  168 (973)
                      +|+|++ |++++.+|..|+++++|++|+|++|.+++.+|..++++++|++|++++|.+.+.+|..+..+++|++|+|++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999995 9999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCC-cccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCC
Q 039720          169 QLTGQLPPSIGNLS-ALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLP  247 (973)
Q Consensus       169 ~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip  247 (973)
                      ++++.+|..+++++ +|++|++++|++++.+|..|..++ |++|++++|.+++..|..|..+++|+.|+|++|++++.+|
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  238 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG  238 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecC
Confidence            99999999999998 999999999999999999999998 9999999999999999999999999999999999997777


Q ss_pred             cccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceeccccc
Q 039720          248 VCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNN  314 (973)
Q Consensus       248 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  314 (973)
                      . + ..+++|++|+|++|.|++.+|..|..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus       239 ~-~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          239 K-V-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             G-C-CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             c-c-cccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence            6 3 47899999999999999999999999999999999999999888876 889999999999997

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1e-43  Score=410.59  Aligned_cols=423  Identities=20%  Similarity=0.260  Sum_probs=243.8

Q ss_pred             ccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccc
Q 039720           78 LSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNW  157 (973)
Q Consensus        78 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l  157 (973)
                      |.|.-...++|++|++++|++ |.+|.+|+++++|++|++++|.++|.+|..++++.+|+.+++..|..           
T Consensus         3 ~~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------   70 (454)
T 1jl5_A            3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------   70 (454)
T ss_dssp             --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------
T ss_pred             ccccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------
Confidence            344445678999999999999 79999999999999999999999999999999999988877776642           


Q ss_pred             cccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEc
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYL  237 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  237 (973)
                      .++++|++++|.+++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++. |..   .++|++|++
T Consensus        71 ~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L  138 (454)
T 1jl5_A           71 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGV  138 (454)
T ss_dssp             HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEEC
T ss_pred             cCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEEC
Confidence            578889999998884 5552   3678899999999886 6653   37888889998888753 221   167888888


Q ss_pred             cCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          238 FKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       238 ~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      ++|++++ +| . +.++++|++|++++|++++ +|..+   .+|++|++++|++++. | .|..+++|++|++++|+++.
T Consensus       139 ~~n~l~~-lp-~-~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~  209 (454)
T 1jl5_A          139 SNNQLEK-LP-E-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKK  209 (454)
T ss_dssp             CSSCCSS-CC-C-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS
T ss_pred             cCCCCCC-Cc-c-cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCc
Confidence            8888884 77 3 3478888888888888885 45443   4788888888888874 4 57888888888888888765


Q ss_pred             CCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCC
Q 039720          318 RTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT  397 (973)
Q Consensus       318 ~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  397 (973)
                      ++..          .++|++|++                         ++|+++ .+| .++.+++|++|++++|++++ 
T Consensus       210 l~~~----------~~~L~~L~l-------------------------~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-  251 (454)
T 1jl5_A          210 LPDL----------PLSLESIVA-------------------------GNNILE-ELP-ELQNLPFLTTIYADNNLLKT-  251 (454)
T ss_dssp             CCCC----------CTTCCEEEC-------------------------CSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-
T ss_pred             CCCC----------cCcccEEEC-------------------------cCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-
Confidence            4321          123444444                         444444 444 36677778888888888774 


Q ss_pred             CCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccccc
Q 039720          398 IPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGI  477 (973)
Q Consensus       398 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  477 (973)
                      +|..   +++|++|++++|++++ +|..   +++|++|++++|++++ +|..   .++|+.|++++|++.+ ++.    .
T Consensus       252 l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~----~  315 (454)
T 1jl5_A          252 LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCD----L  315 (454)
T ss_dssp             CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECC----C
T ss_pred             cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccC----C
Confidence            4442   3677888888888775 4443   3677788888887774 2221   1567777777777763 321    2


Q ss_pred             ccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCccccc--ccccchhhhccCCe
Q 039720          478 TTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNG--SIPQSLNALKSIKE  555 (973)
Q Consensus       478 ~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~  555 (973)
                      ...++.|++++|++++ +|..   +++|+.|++++|+++ .+|.   .+++|++|++++|++++  .+|.++..+     
T Consensus       316 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L-----  382 (454)
T 1jl5_A          316 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL-----  382 (454)
T ss_dssp             CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE-----
T ss_pred             cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh-----
Confidence            2233577777777775 5543   467777777777777 4555   35677777777777776  555554432     


Q ss_pred             ecCCCCccccccCCCCCCCCccceEeccCCcCcC--cCCCCCCCCCccccccccCccc
Q 039720          556 LDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG--KVPKKGVFSNETRISLTGNEQF  611 (973)
Q Consensus       556 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~~~~~~l~~~~N~~~  611 (973)
                         +.|.+.|.+|..   +++|+.|++++|++++  .+|.     .+..+.+.+|...
T Consensus       383 ---~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~  429 (454)
T 1jl5_A          383 ---RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVV  429 (454)
T ss_dssp             ---ECCC---------------------------------------------------
T ss_pred             ---hhcccccccccc---cCcCCEEECCCCcCCccccchh-----hHhheeCcCcccC
Confidence               345556666653   4678888888888887  4443     3445556555433

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.2e-44  Score=415.39  Aligned_cols=251  Identities=22%  Similarity=0.260  Sum_probs=201.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHH---HHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAE---CEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...   ........+|   +.+++.++|||||++++++     +
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence            467999999999999999999999999999999997432   1222333444   5566677899999999985     4


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      +.+..|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccccee
Confidence            4589999999999999999999988999999999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +.....          .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||........  ........
T Consensus       340 ~~~~~~----------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~  407 (689)
T 3v5w_A          340 CDFSKK----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL  407 (689)
T ss_dssp             EECSSC----------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHH
T ss_pred             eecCCC----------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhc
Confidence            865432          2335689999999999874 5899999999999999999999999976433321  11111110


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                      ...               ...+.....++.+++.+||+.||++|++     ++||+++
T Consensus       408 ~~~---------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          408 TMA---------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HCC---------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCC---------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            000               0111223345678888999999999998     6887764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.3e-44  Score=396.44  Aligned_cols=208  Identities=22%  Similarity=0.292  Sum_probs=170.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEEC---CCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  747 (973)
                      ..++|++.++||+|+||+||+|+++   .+++.||||++....  ...++.+|+++++.+ +||||+++++++..     
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-----   91 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-----   91 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----
Confidence            4578999999999999999999874   467899999986443  356788999999988 69999999998654     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~Dfg~a  826 (973)
                      .++.++||||+++|+|.+++.   .+++.+++.++.|++.||+|||++   ||+||||||+|||++.+ +.+||+|||+|
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            489999999999999999984   467888999999999999999999   99999999999999877 79999999999


Q ss_pred             hhccCCCCccC--------------------CCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCC
Q 039720          827 RFLSHHPFLVA--------------------PEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRR  885 (973)
Q Consensus       827 ~~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~  885 (973)
                      +..........                    ..........+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86543211000                    0001122345799999999998876 58999999999999999999999


Q ss_pred             CCCCCCC
Q 039720          886 PTDNMFN  892 (973)
Q Consensus       886 Pf~~~~~  892 (973)
                      ||.....
T Consensus       246 Pf~~~~~  252 (361)
T 4f9c_A          246 PFYKASD  252 (361)
T ss_dssp             SSSCCSS
T ss_pred             CCCCCCC
Confidence            9965443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7e-43  Score=412.81  Aligned_cols=253  Identities=19%  Similarity=0.287  Sum_probs=209.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|+.++|||||++++++.     +....+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence            368999999999999999999999999999999998766666778999999999999999999999854     458999


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC--CcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD--MVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~--~~~kl~Dfg~a~~~  829 (973)
                      +|||||+||+|.+++.. .+.+.+.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            99999999999999864 45678889999999999999999999   99999999999999854  89999999999876


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+    .........  
T Consensus       308 ~~---------~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~i~~~~--  372 (573)
T 3uto_A          308 DP---------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSCD--  372 (573)
T ss_dssp             CT---------TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTC--
T ss_pred             cC---------CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHhCC--
Confidence            53         223345679999999999999999999999999999999999999997543211    111111000  


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           ..+.     ...+......+.++|.+||+.||++|||++|++++
T Consensus       373 -----~~~~-----~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          373 -----WNMD-----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -----CCCC-----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCC-----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0000     11112234556788999999999999999999874

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.5e-42  Score=414.66  Aligned_cols=437  Identities=19%  Similarity=0.165  Sum_probs=309.5

Q ss_pred             CeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEe
Q 039720           62 QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWV  141 (973)
Q Consensus        62 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l  141 (973)
                      .+++.|||+++.+.+..+..++.+++|++|+|++|++++..|..|+++++|++|+|++|.++ .+|..  .+++|++|++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            46899999999999877789999999999999999999888999999999999999999999 78887  8999999999


Q ss_pred             ccccccc-chhhhhccccccceeeccCCcccccCCCCCCCCCcc--cEEEccCCcC--CCCCCCcccCCC--ccceeccC
Q 039720          142 HTNNLVG-EIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSAL--QTFDIAGNKL--DGRIPDSLGQLR--NLNYLGTS  214 (973)
Q Consensus       142 ~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~L~--~L~~L~Ls  214 (973)
                      ++|++.+ .+|..|+++++|++|+|++|++++   ..+..+++|  ++|++++|++  ++..|..|..+.  .| .++++
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~  204 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFH  204 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEEC
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEec
Confidence            9999987 457999999999999999999985   456666766  9999999999  888999888876  44 56889


Q ss_pred             CCCccccCCc-cccCCCCCcEEEccCCc-----cccCCCcccccCCCCCcEEEccCCcccccC----CccccCCCCCCEE
Q 039720          215 ENDFSGMFPL-SVCNISSLDEAYLFKNR-----FKGSLPVCLGFNLPKLTVLVVAQNNLTGFL----PQSLSNASKLEWL  284 (973)
Q Consensus       215 ~N~l~~~~p~-~~~~l~~L~~L~L~~N~-----l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L  284 (973)
                      .|.+.+.++. .+..+++|+.++++.|+     +.+.++ .+ ..+++|+.|+++++.+++..    +..+ ..++|++|
T Consensus       205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~-~l-~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L  281 (562)
T 3a79_B          205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLS-EL-TRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYL  281 (562)
T ss_dssp             SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHH-HH-HSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEE
T ss_pred             CccchhhhhhhcccccceEEEecccccccccchHHHHHH-HH-hccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEE
Confidence            9999876655 57889999999999995     222222 22 36888888988888776421    2222 33589999


Q ss_pred             EccCCcccccCcccc-----cCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCC-hhhhhhhh
Q 039720          285 ELNENHFSGQVRINF-----NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALP-HSIANLST  358 (973)
Q Consensus       285 ~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~  358 (973)
                      ++++|++++.+|..+     ..+++|+.++++.|.+ .                               +| ..+..+. 
T Consensus       282 ~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~-------------------------------~p~~~~~~~~-  328 (562)
T 3a79_B          282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-L-------------------------------FSKEALYSVF-  328 (562)
T ss_dssp             EEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-S-------------------------------SCHHHHHHHH-
T ss_pred             EEeccEeeccccchhhhcccccchheehhhccccee-e-------------------------------cChhhhhhhh-
Confidence            999999987777766     5555555555555544 1                               22 1111110 


Q ss_pred             hhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcC
Q 039720          359 TMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLG  438 (973)
Q Consensus       359 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  438 (973)
                                           ...+|+.|++++|.+....  ....+++|++|++++|++++..|..+.++++|++|+++
T Consensus       329 ---------------------~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  385 (562)
T 3a79_B          329 ---------------------AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ  385 (562)
T ss_dssp             ---------------------HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECC
T ss_pred             ---------------------ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECC
Confidence                                 0124555555555543211  11445555555555555555555555555555555555


Q ss_pred             CCcccc--ccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCccc
Q 039720          439 FNKLQG--SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS  516 (973)
Q Consensus       439 ~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  516 (973)
                      +|++++  .+|..+..+++|+.|++++|++.+.+|...+.....++.|++++|++++.+|..+.  ++|+.|+|++|+++
T Consensus       386 ~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~  463 (562)
T 3a79_B          386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM  463 (562)
T ss_dssp             SSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC
T ss_pred             CCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc
Confidence            555553  22344555566666666666665445554433333334666666666655555443  57788888888887


Q ss_pred             ccccccccCccchhhhcccCcccccccccc-hhhhccCCeecCCCCccccccC
Q 039720          517 NEIPVTLSACTTLEYLLMQGNSFNGSIPQS-LNALKSIKELDLSCNNLSGQIP  568 (973)
Q Consensus       517 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p  568 (973)
                       .+|..+.++++|+.|+|++|+|+ .+|.. +..+++|+.|+|++|.+++..|
T Consensus       464 -~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          464 -SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             -CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             -ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence             56666667888888888888887 45554 7788888888888888876443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=6e-42  Score=398.99  Aligned_cols=355  Identities=18%  Similarity=0.210  Sum_probs=200.1

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCC-CcccccCCCccceEecccccccchhhhhccccccceee
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKI-PTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLS  164 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  164 (973)
                      ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|++++|.+.+..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            56677777777776666666777777777777777666554 34566677777777777777666666777777777777


Q ss_pred             ccCCcccccCCCC--CCCCCcccEEEccCCcCCCCCCCc-ccCCCccceeccCCCCccccCCccccCC--CCCcEEEccC
Q 039720          165 LYGNQLTGQLPPS--IGNLSALQTFDIAGNKLDGRIPDS-LGQLRNLNYLGTSENDFSGMFPLSVCNI--SSLDEAYLFK  239 (973)
Q Consensus       165 L~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~L~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~  239 (973)
                      |++|++++..|..  |+++++|++|+|++|++++..|.. +.++++|++|++++|++++..|..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            7777766544333  666777777777777776655655 6667777777777777776666666555  5667777777


Q ss_pred             CccccCCCccc-------ccCCCCCcEEEccCCcccccCCccccCC---CCCCEEEccCCcccccC----------cccc
Q 039720          240 NRFKGSLPVCL-------GFNLPKLTVLVVAQNNLTGFLPQSLSNA---SKLEWLELNENHFSGQV----------RINF  299 (973)
Q Consensus       240 N~l~~~ip~~~-------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~----------~~~~  299 (973)
                      |.+.+..+..+       ...+++|++|++++|.+++..|..+..+   ++|+.|++++|.+.+..          +..|
T Consensus       190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~  269 (455)
T 3v47_A          190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF  269 (455)
T ss_dssp             CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred             CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence            77663222111       1145667777777777776666665544   67777777777554321          1112


Q ss_pred             cCc--ccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCcc
Q 039720          300 NSL--PNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPE  377 (973)
Q Consensus       300 ~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~  377 (973)
                      ..+  ++|++|++++|+++.....      .+..+++|++|                         ++++|++++..|..
T Consensus       270 ~~~~~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L-------------------------~Ls~n~l~~~~~~~  318 (455)
T 3v47_A          270 KGLEASGVKTCDLSKSKIFALLKS------VFSHFTDLEQL-------------------------TLAQNEINKIDDNA  318 (455)
T ss_dssp             GGGTTSCCCEEECCSSCCCEECTT------TTTTCTTCCEE-------------------------ECTTSCCCEECTTT
T ss_pred             ccccccCceEEEecCccccccchh------hcccCCCCCEE-------------------------ECCCCcccccChhH
Confidence            221  3444444444444321111      11112222222                         22222222333444


Q ss_pred             ccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccc
Q 039720          378 IRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLM  457 (973)
Q Consensus       378 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  457 (973)
                      |..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+
T Consensus       319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  398 (455)
T 3v47_A          319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ  398 (455)
T ss_dssp             TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCccc
Confidence            44555555555555555544455555555555555555555554455555555555555555555544444445555555


Q ss_pred             cccccCcccccCCC
Q 039720          458 QLSAPNNKLNGTLP  471 (973)
Q Consensus       458 ~L~l~~N~l~~~~p  471 (973)
                      .|++++|++++..|
T Consensus       399 ~L~l~~N~l~~~~~  412 (455)
T 3v47_A          399 KIWLHTNPWDCSCP  412 (455)
T ss_dssp             EEECCSSCBCCCTT
T ss_pred             EEEccCCCcccCCC
Confidence            55555555554443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=9.9e-42  Score=394.02  Aligned_cols=399  Identities=22%  Similarity=0.254  Sum_probs=276.4

Q ss_pred             ccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEE
Q 039720          108 RLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTF  187 (973)
Q Consensus       108 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  187 (973)
                      ..++|++|++++|.+ |.+|.+++++++|++|++++|.+.+.+|..++++.+|+.+++.+|..           .+|++|
T Consensus         9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L   76 (454)
T 1jl5_A            9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL   76 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred             ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence            468899999999999 78999999998888888888888888888888888888888877753           467999


Q ss_pred             EccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcc
Q 039720          188 DIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL  267 (973)
Q Consensus       188 ~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l  267 (973)
                      ++++|.+++ +|..   .++|++|++++|.+++ +|..   +++|++|++++|+++ .+|..    .++|++|++++|.+
T Consensus        77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l  143 (454)
T 1jl5_A           77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQL  143 (454)
T ss_dssp             ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCC
T ss_pred             EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCC
Confidence            999999985 5552   4789999999999997 5643   488999999999998 45532    26899999999999


Q ss_pred             cccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccC
Q 039720          268 TGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGG  347 (973)
Q Consensus       268 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~  347 (973)
                      ++ +| .|+++++|++|++++|++++. |..   .++|++|++++|+++.++        .+.++++|+.|++++|++.+
T Consensus       144 ~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~  209 (454)
T 1jl5_A          144 EK-LP-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKK  209 (454)
T ss_dssp             SS-CC-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS
T ss_pred             CC-Cc-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCc
Confidence            96 67 599999999999999999874 433   358999999999988753        24677788888887776653


Q ss_pred             CCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccC
Q 039720          348 ALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIG  427 (973)
Q Consensus       348 ~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  427 (973)
                       +                         |..   .++|++|++++|+++ .+|. ++.+++|++|++++|++++ +|..  
T Consensus       210 -l-------------------------~~~---~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~--  255 (454)
T 1jl5_A          210 -L-------------------------PDL---PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL--  255 (454)
T ss_dssp             -C-------------------------CCC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC--
T ss_pred             -C-------------------------CCC---cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc--
Confidence             2                         221   148999999999999 6674 8999999999999999985 4543  


Q ss_pred             CcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccc-cccc
Q 039720          428 NLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNL-KSLV  506 (973)
Q Consensus       428 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l-~~L~  506 (973)
                       +++|++|++++|++++ +|..   +++|+.|++++|++++ +|..    ...++.|++++|++++ ++    .+ ++|+
T Consensus       256 -~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~----~~~L~~L~l~~N~l~~-i~----~~~~~L~  320 (454)
T 1jl5_A          256 -PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL----PPNLYYLNASSNEIRS-LC----DLPPSLE  320 (454)
T ss_dssp             -CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC----CTTCCEEECCSSCCSE-EC----CCCTTCC
T ss_pred             -ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc----CCcCCEEECcCCcCCc-cc----CCcCcCC
Confidence             4789999999999995 6654   3789999999999985 3321    1234589999999985 22    23 5899


Q ss_pred             eeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCcccc--ccCCCCCCCCccceEeccC
Q 039720          507 QLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSG--QIPIHLGNLPFLEYLNLSY  584 (973)
Q Consensus       507 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~  584 (973)
                      .|++++|++++ +|..   +++|++|++++|+++ .+|.   .+++|++|+|++|++++  .+|.++..        ++.
T Consensus       321 ~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~  384 (454)
T 1jl5_A          321 ELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRM  384 (454)
T ss_dssp             EEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EEC
T ss_pred             EEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhh
Confidence            99999999996 6654   578999999999998 5666   47899999999999997  67766543        356


Q ss_pred             CcCcCcCCCCCCCCCccccccccCcccc
Q 039720          585 NHFEGKVPKKGVFSNETRISLTGNEQFC  612 (973)
Q Consensus       585 N~l~~~~p~~~~~~~~~~l~~~~N~~~c  612 (973)
                      |.+.|.+|..  +++++.+++.+|+...
T Consensus       385 n~~~~~i~~~--~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          385 NSHLAEVPEL--PQNLKQLHVETNPLRE  410 (454)
T ss_dssp             CC--------------------------
T ss_pred             cccccccccc--cCcCCEEECCCCcCCc
Confidence            8888888874  6889999999998654

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.1e-41  Score=391.10  Aligned_cols=381  Identities=19%  Similarity=0.175  Sum_probs=214.3

Q ss_pred             ceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccC-CccccCCCCCcEEEccC
Q 039720          161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF-PLSVCNISSLDEAYLFK  239 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~  239 (973)
                      +.++.+++.++ .+|. +.  ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++
T Consensus        13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            45666666666 4555 22  56677777777776656666666777777777666665333 34455555555555555


Q ss_pred             CccccCCCcccccCCCCCcEEEccCCcccccCCcc--ccCCCCCCEEEccCCcccccCccc-ccCcccccceecccccCC
Q 039720          240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQS--LSNASKLEWLELNENHFSGQVRIN-FNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~  316 (973)
                      |++++..|..+. ++++|++|+|++|.+++..|..  |.++++|++|+|++|++++..|.. |..+++|++|+|++|+++
T Consensus        89 n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           89 NQFLQLETGAFN-GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             CTTCEECTTTTT-TCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             CccCccChhhcc-CcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence            555433333332 4444444444444444432222  444444444444444444443332 344444444444444332


Q ss_pred             CCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCC--CCcCEEEcccccC
Q 039720          317 TRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL--FNLNGLGLEYNQL  394 (973)
Q Consensus       317 ~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l  394 (973)
                      .                              .                         .+..+..+  .+|+.|++++|.+
T Consensus       168 ~------------------------------~-------------------------~~~~l~~l~~~~L~~L~l~~n~l  192 (455)
T 3v47_A          168 S------------------------------I-------------------------CEEDLLNFQGKHFTLLRLSSITL  192 (455)
T ss_dssp             C------------------------------C-------------------------CTTTSGGGTTCEEEEEECTTCBC
T ss_pred             c------------------------------c-------------------------ChhhhhccccccccccccccCcc
Confidence            2                              1                         12222222  4566677777776


Q ss_pred             CCCCCccc--------cCCCCCCeEEccCcccCCCCCCccCCc---CccceEEcCCCccccccccccccccccccccccC
Q 039720          395 TGTIPPAI--------GELRNLQYLGLVGNNIRGIIPDPIGNL---TLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPN  463 (973)
Q Consensus       395 ~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  463 (973)
                      .+..+.++        ..+++|++|++++|++.+..|..+..+   ++|+.|++++|.+.+....              .
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~--------------~  258 (455)
T 3v47_A          193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG--------------H  258 (455)
T ss_dssp             TTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTT--------------C
T ss_pred             cccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccc--------------h
Confidence            65444432        244566666666666665555554433   5666666666654432110              0


Q ss_pred             cccccCCCcccccc-ccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccc
Q 039720          464 NKLNGTLPPQIFGI-TTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGS  542 (973)
Q Consensus       464 N~l~~~~p~~~~~~-~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  542 (973)
                      +.+.+..+..+.+. ...++.|++++|.+++..|..++.+++|+.|+|++|++++..|..|.++++|++|+|++|++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  338 (455)
T 3v47_A          259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI  338 (455)
T ss_dssp             CSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             hhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCc
Confidence            01110111111111 01234677777777776677777777777777777777766666777777777777777777766


Q ss_pred             cccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCC-CCCCCccccccccCccccCCC
Q 039720          543 IPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQFCGGL  615 (973)
Q Consensus       543 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~l~~~~N~~~cg~~  615 (973)
                      .|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++.++.. ..+++++.+++.+||+.|+++
T Consensus       339 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          339 DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            6667777777777777777777666777777777777777777777655543 456667777777777777665

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.2e-41  Score=365.10  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=209.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++..     .+..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence            4689999999999999999999999999999999987766667789999999999999999999998765     37899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+++|+|.+++... ...+..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999999999765 567788999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI  912 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  912 (973)
                              ........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .........       
T Consensus       170 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~-------  233 (297)
T 3fxz_A          170 --------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGT-------  233 (297)
T ss_dssp             --------TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCS-------
T ss_pred             --------ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC-------
Confidence                    1223345799999999999999999999999999999999999999975422111 101000000       


Q ss_pred             cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                               .....+......+.+++.+||+.||++|||++|+++.
T Consensus       234 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 ---------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ---------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                     0011123344567789999999999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=366.37  Aligned_cols=272  Identities=22%  Similarity=0.330  Sum_probs=216.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            3689999999999999999999999999999999876666667889999999999999999999999765     37899


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++|+|.+++.. ....++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999999987 45667788999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCccCC------CCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          832 HPFLVAP------EGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       832 ~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      .......      ..........||+.|+|||++.+..++.++|||||||++|||++|..||..................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  240 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL  240 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence            3211000      0011112457999999999999999999999999999999999999998765433221111000000


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCC
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGP  969 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  969 (973)
                              +..         .+..++..+.+++.+||+.||++|||++|+++.|+++...+.++
T Consensus       241 --------~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          241 --------DRY---------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             --------HHT---------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             --------ccc---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence                    000         01223345778999999999999999999999999997665543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-40  Score=370.29  Aligned_cols=286  Identities=35%  Similarity=0.570  Sum_probs=228.7

Q ss_pred             cCCCcccHHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEE
Q 039720          659 QQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKII  737 (973)
Q Consensus       659 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~  737 (973)
                      .....++..++....++|++.+.||+|+||+||+|++. +++.||||++..... .....+.+|+++++.++||||++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            34556788999999999999999999999999999864 799999999975432 2234688999999999999999999


Q ss_pred             eEeeecccCCCceEEEEEeeccCCCHHHHhhhcCC----CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND----KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       738 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                      +++..     ....++||||+.+|+|.+++.....    ..+..+..++.|++.||+|||+.+.++|+||||||+||+++
T Consensus        94 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           94 GFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD  168 (326)
T ss_dssp             EEECC-----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred             EEEec-----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence            98654     4678999999999999999976442    56678899999999999999998777899999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC---
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM---  890 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~---  890 (973)
                      .++.+||+|||+++......       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...   
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  241 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA  241 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSS-------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred             CCCCEEeccCccccccCccc-------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence            99999999999998664321       22333456999999999998889999999999999999999999999632   


Q ss_pred             CCCCccHhhhhhHhcCcc-cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          891 FNDGLTLHGYAKMALPKK-VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .........+........ .....+....     .....++...+.+++.+||+.||++|||++||+++|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQ-----GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTSCSBHHHHHTTTTSSCCSTTSSCTTCT-----TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             cccchhHHHHHHHHhhchhhhhhcChhhc-----cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            122223333433332222 2223332222     334467788999999999999999999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.9e-41  Score=367.14  Aligned_cols=264  Identities=27%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..++|++.+.||+|+||+||+|++  +|+.||||++....  ....+.+.+|++++++++||||+++++++..     ..
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            456899999999999999999988  78999999997543  2344678999999999999999999998643     46


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCC---CchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEecCCCcEEEeccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                      ..++||||+++|+|.+++.....   ..+..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            78999999999999999987553   66788899999999999999999   8  9999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      +++.....        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ........
T Consensus       185 ~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~  254 (309)
T 3p86_A          185 LSRLKAST--------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFK  254 (309)
T ss_dssp             -------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHS
T ss_pred             CCcccccc--------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhc
Confidence            99754321        122334579999999999999999999999999999999999999997543221  11111000


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPI  971 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~  971 (973)
                        .              .....+..++..+.+++.+||+.||++|||++|+++.|+++.+....||.
T Consensus       255 --~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~  305 (309)
T 3p86_A          255 --C--------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN  305 (309)
T ss_dssp             --C--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred             --C--------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence              0              00111223345678899999999999999999999999999887777764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-40  Score=366.76  Aligned_cols=278  Identities=33%  Similarity=0.505  Sum_probs=224.1

Q ss_pred             HHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       668 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ++...+++|++.+.||+|+||+||+|++. +++.||||++........+.+.+|+.+++.++||||+++++++..     
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----  106 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----  106 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence            34456789999999999999999999974 799999999987666667889999999999999999999998643     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcC----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTN----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                      ....++||||+++|+|.+++....    ...+..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            478899999999999999997643    356678899999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC-ccHhhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG-LTLHGYAK  902 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~-~~~~~~~~  902 (973)
                      |+++......      .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+..
T Consensus       184 g~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          184 GISKKGTELD------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             TTCEECSSSS------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             cccccccccc------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            9998653321      1222334568999999999988899999999999999999999999997654432 22333322


Q ss_pred             Hhc-CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          903 MAL-PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       903 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      ... .......+++...     .....+++..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus       258 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLA-----DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHTTTCCCSSSSSSCT-----TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hccccccHHHhcChhhc-----cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            211 1222333333322     223467788899999999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-40  Score=367.88  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....  ....+.+.+|+++++.++||||+++++++..     ...
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence            468999999999999999999999999999999997543  3345678899999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++...+...+..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            999999999999999998888888999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLS-MTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         .......||+.|+|||++.+..+. .++||||+||++|+|++|+.||......     ........   
T Consensus       166 ~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~---  228 (328)
T 3fe3_A          166 VG---------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-----ELRERVLR---  228 (328)
T ss_dssp             SS---------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH---
T ss_pred             CC---------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh---
Confidence            32         233456799999999999988874 8999999999999999999999754221     11111000   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                               .....+   ......+.+++.+||+.||++|||++|+++.
T Consensus       229 ---------~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          229 ---------GKYRIP---FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---------CCCCCC---TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---------CCCCCC---CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                     000011   1223456788899999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.9e-40  Score=365.42  Aligned_cols=250  Identities=24%  Similarity=0.286  Sum_probs=206.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++..   .......+.+|+.+++.++||||+++++++..     .+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence            36899999999999999999999999999999999754   23345678899999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++|+|.+++...+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            8999999999999999999888888899999999999999999999   9999999999999999999999999999854


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+..  .... .. 
T Consensus       156 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~--~i~~-~~-  221 (337)
T 1o6l_A          156 ISD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFE--LILM-EE-  221 (337)
T ss_dssp             CCT--------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH--HHHH-CC-
T ss_pred             ccC--------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHH--HHHc-CC-
Confidence            321        22334567999999999999999999999999999999999999999753221  1111  1100 00 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                                    ...+......+.+++.+||+.||++||     +++|++++
T Consensus       222 --------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 --------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                          001112334567888999999999999     89998875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.3e-40  Score=366.46  Aligned_cols=282  Identities=22%  Similarity=0.279  Sum_probs=210.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++  .++.||||+++.... .......|+.++++++||||+++++++... .......+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRG-TSVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccC-CCCCceEE
Confidence            46899999999999999999998  489999999975432 344566689999999999999999998763 22235689


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC-------QPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      +||||+++|+|.+++... ..++..++.++.|++.||+|||+.+       .++|+||||||+||+++.++.+||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            999999999999999764 4778889999999999999999751       23899999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-----DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      ++......      .........||+.|+|||++.+.     .++.++|||||||++|||++|+.||.............
T Consensus       178 a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          178 ALKFEAGK------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             CEEECTTS------CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             cccccccc------CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            98765432      11222335799999999998873     55678899999999999999999998654432211110


Q ss_pred             hhHhcC--ccccc-ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          901 AKMALP--KKVMG-IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       901 ~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      .....+  ..... ..................++..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            000000  00000 001111111110112235567789999999999999999999999999988653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.7e-40  Score=359.82  Aligned_cols=262  Identities=21%  Similarity=0.360  Sum_probs=208.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++..     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence            368999999999999999999999999999999986443   2345678999999999999999999998643     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++++|.+++...+..++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            8999999999999999999888888899999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....       ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||........    ..... ... 
T Consensus       162 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----~~~~~-~~~-  228 (294)
T 4eqm_A          162 SETS-------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----AIKHI-QDS-  228 (294)
T ss_dssp             --------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----HHHHH-SSC-
T ss_pred             cccc-------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHh-hcc-
Confidence            4321       1222345699999999999999999999999999999999999999975432111    11100 000 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHhccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-QMTAVVKKLCAVGE  964 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~  964 (973)
                         . +....     ......+..+.+++.+|++.||++|| +++++.+.|+++..
T Consensus       229 ---~-~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          229 ---V-PNVTT-----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             ---C-CCHHH-----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ---C-CCcch-----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence               0 00000     00122345678899999999999999 99999999998743

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.9e-41  Score=366.70  Aligned_cols=281  Identities=22%  Similarity=0.346  Sum_probs=210.6

Q ss_pred             hhcCCcCCccccccceeEEEEE----ECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGN----LGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|+    +..+++.||||++........+.+.+|+++++.++||||+++++++...   +.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            4689999999999999999998    5668999999999876666667899999999999999999999987542   23


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++|+|.+++.... ..++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            45889999999999999997654 367788899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC-
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP-  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~-  906 (973)
                      .......     .........++..|+|||++.+..++.++||||||+++|||++|..||.....+..   ........ 
T Consensus       163 ~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~  234 (295)
T 3ugc_A          163 VLPQDKE-----FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQG  234 (295)
T ss_dssp             ------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH---HHHCTTCCT
T ss_pred             cccCCcc-----eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH---hhhcCcccc
Confidence            7643220     11122234577789999999999999999999999999999999999875422100   00000000 


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccC
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG  968 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  968 (973)
                      ......... ..........+..++..+.+++.+||+.||++|||++|+++.|+++.+.+.|
T Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~g  295 (295)
T 3ugc_A          235 QMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG  295 (295)
T ss_dssp             HHHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             chhHHHHHH-HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhccC
Confidence            000000000 0000111222334556788999999999999999999999999999876643

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=6e-39  Score=371.07  Aligned_cols=193  Identities=22%  Similarity=0.231  Sum_probs=107.2

Q ss_pred             cccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcc
Q 039720           77 FLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGN  156 (973)
Q Consensus        77 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  156 (973)
                      ..+..++++++|++|+|++|++++ +| .++.+++|++|+|++|.+++ +|  ++.+++|++|++++|++.+. +  +++
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~  104 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTP  104 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred             ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCC
Confidence            344456777888888888888875 45 67888888888888888875 33  55555555555555554432 1  444


Q ss_pred             ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEE
Q 039720          157 WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY  236 (973)
Q Consensus       157 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  236 (973)
                      +++|++|++++|++++                         +|  ++++++|++|++++|++++.   .++++++|++|+
T Consensus       105 l~~L~~L~L~~N~l~~-------------------------l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~  154 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTK-------------------------LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELD  154 (457)
T ss_dssp             CTTCCEEECCSSCCSC-------------------------CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEE
T ss_pred             CCcCCEEECCCCcCCe-------------------------ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEE
Confidence            4444444444444443                         22  44444444444444444432   144444555555


Q ss_pred             ccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       237 L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      +++|+..+.++   +..+++|++|++++|++++. |  +..+++|++|++++|++++.   .+..+++|++|+|++|+++
T Consensus       155 l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~  225 (457)
T 3bz5_A          155 CHLNKKITKLD---VTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT  225 (457)
T ss_dssp             CTTCSCCCCCC---CTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCS
T ss_pred             CCCCCcccccc---cccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccc
Confidence            55553333332   12455566666666665542 3  55556666666666666543   2555555555555555543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-39  Score=355.29  Aligned_cols=268  Identities=25%  Similarity=0.389  Sum_probs=209.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHh--cCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN--IRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++  +++.||||++...   ....+..|.+++..  ++||||+++++++... ......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence            46899999999999999999998  7999999999643   34556667777766  7899999999987653 344567


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH--------NHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                      .++||||+++|+|.++++.. ..++..++.++.|++.||+|||        +.   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred             eEEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence            89999999999999999654 5677889999999999999999        77   999999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCC------CCCcccchHHHHHHHHHHHhC----------CCC
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG------DLSMTGDVYSFGILLLEMFTR----------RRP  886 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~ll~elltg----------~~P  886 (973)
                      ||+|+.........    ........||+.|+|||++.+.      .++.++|||||||++|||++|          +.|
T Consensus       157 fg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          157 LGLAVMHSQSTNQL----DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             CTTCEEEETTTTEE----ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             CCCeeecccccccc----cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            99998654422100    1112234799999999998876      456799999999999999999          888


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      |......................    .+..    ........++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQ----RPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCC----CCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCC----CCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            87655544333333222211110    1111    00112345678899999999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-39  Score=364.55  Aligned_cols=252  Identities=19%  Similarity=0.282  Sum_probs=206.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch------hHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG------ATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++.....      ..+.+.+|+.+++.++||||+++++++..    
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----   86 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN----   86 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence            46799999999999999999999999999999999754321      34678999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC----cEEEec
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSD  822 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~----~~kl~D  822 (973)
                       ....++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        87 -~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           87 -RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence             478999999999999999998888888999999999999999999999   999999999999998877    799999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      ||+++.....         .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+  .  ...
T Consensus       163 FG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~--~~~  229 (361)
T 2yab_A          163 FGLAHEIEDG---------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--T--LAN  229 (361)
T ss_dssp             CSSCEECCTT---------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--H--HHH
T ss_pred             cCCceEcCCC---------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--H--HHH
Confidence            9999866432         12234579999999999999999999999999999999999999997542211  1  111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .... .  ...+         ...+......+.+++.+||..||++|||++|+++
T Consensus       230 i~~~-~--~~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          230 ITAV-S--YDFD---------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHTT-C--CCCC---------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhc-C--CCCC---------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1000 0  0000         0111233456778999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-39  Score=367.39  Aligned_cols=260  Identities=23%  Similarity=0.402  Sum_probs=208.9

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-------CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-------EDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      .++|++.+.||+|+||+||+|++.       .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.. 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            468999999999999999999874       355689999997553 33456799999999999 89999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                          ....++||||+++|+|.+++....                .....+++.++.||+.||+|||++   +|+||||||
T Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence                467899999999999999998653                245677889999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +|||++.++.+||+|||+++.......      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p  305 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  305 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCT------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             hhEEECCCCCEEEccccCCcccCcccc------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999986644221      112233457889999999999999999999999999999999 9999


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      |......+  +.......                 .....+..+...+.+++.+||+.||++||+++|+++.|+++...
T Consensus       306 ~~~~~~~~--~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          306 YPGIPVEE--LFKLLKEG-----------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             STTCCGGG--HHHHHHTT-----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHH--HHHHHhcC-----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            97643221  11111000                 00111233455678999999999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=356.33  Aligned_cols=276  Identities=19%  Similarity=0.239  Sum_probs=215.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++...   .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            368999999999999999999999999999999997543 33456788999999999999999999987542   34578


Q ss_pred             EEEEeeccCCCHHHHhhhcCC---CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----cCCCcEEEeccc
Q 039720          752 AIVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFG  824 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl----~~~~~~kl~Dfg  824 (973)
                      ++||||+++|+|.+++.....   .++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            999999999999999986543   67788999999999999999999   99999999999999    788889999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCccccc--------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM--------GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT  896 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~  896 (973)
                      +++.....         .......||+.|+|||++.        +..++.++|||||||++|||++|+.||.........
T Consensus       162 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          162 AARELEDD---------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             TCEECCTT---------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             CceecCCC---------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            99866432         1223456999999999876        578899999999999999999999999765443222


Q ss_pred             Hhhhh---hHhcCcccccc---cCcccc--ccc-CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          897 LHGYA---KMALPKKVMGI---VDPSLL--MEA-RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       897 ~~~~~---~~~~~~~~~~~---~~~~~~--~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .....   ....+......   ......  ... ............+.+++.+||+.||++|||++|+++...+..
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            21111   11111111111   111110  000 112334567788899999999999999999999999988653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.9e-39  Score=355.44  Aligned_cols=262  Identities=22%  Similarity=0.293  Sum_probs=211.1

Q ss_pred             cccHHHHHHHhh----------cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCC
Q 039720          663 IVSYAELSKATK----------EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN  732 (973)
Q Consensus       663 ~~~~~~~~~~~~----------~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n  732 (973)
                      .++.+++..+++          .|...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            345555555554          3777789999999999999999899999999998776666788999999999999999


Q ss_pred             ceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 039720          733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL  812 (973)
Q Consensus       733 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl  812 (973)
                      |+++++++...     +..++||||+++|+|.+++... ...+..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       104 iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          104 VVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             BCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             cceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            99999987653     7899999999999999998754 567888999999999999999999   99999999999999


Q ss_pred             cCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 039720          813 DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN  892 (973)
Q Consensus       813 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~  892 (973)
                      +.++.+||+|||++......        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~  246 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKD--------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP  246 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSS--------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             CCCCcEEEeeeeeeeecccC--------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999865432        1122345799999999999999999999999999999999999999975422


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .  ........        ...+..       ......+..+.+++.+||+.||++|||++|+++.
T Consensus       247 ~--~~~~~~~~--------~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          247 V--QAMKRLRD--------SPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             H--HHHHHHHH--------SSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             H--HHHHHHhc--------CCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1  11111100        001110       1112234567789999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.9e-40  Score=362.93  Aligned_cols=263  Identities=26%  Similarity=0.387  Sum_probs=208.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc---EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM---SVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|++..++.   .||||+++.. .....+.+.+|+.+++.++||||+++++++..     .
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----G  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-----G
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence            3679999999999999999999976554   5999999754 33345679999999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++|+|.+++... ..+.+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            7789999999999999999654 4667788999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......     ..........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  +.......  
T Consensus       200 ~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~--  270 (325)
T 3kul_A          200 VLEDDP-----DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEG--  270 (325)
T ss_dssp             ECC---------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT--
T ss_pred             ccccCc-----cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcC--
Confidence            764321     11112223346778999999998999999999999999999999 999997643221  11110000  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFI  967 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  967 (973)
                                     .....+..++..+.+++.+||+.||++||+++|+++.|+++.....
T Consensus       271 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          271 ---------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             ---------------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                           0011122345677899999999999999999999999999864433

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.5e-40  Score=361.32  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=206.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeE
Confidence            3689999999999999999999999999999999975432 234668899999999999999999998654     4788


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++|+|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            99999999999999998887888899999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..      .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+......    
T Consensus       158 ~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----  227 (323)
T 3tki_A          158 NN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----  227 (323)
T ss_dssp             TT------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----
T ss_pred             CC------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----
Confidence            21      1122234579999999999988776 788999999999999999999998654433222222111100    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                   ..........+.+++.+||+.||++|||++|+++.
T Consensus       228 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 -------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                         01112334566789999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=358.08  Aligned_cols=253  Identities=18%  Similarity=0.276  Sum_probs=206.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++..     ....+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-----MEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEE
Confidence            468999999999999999999999999999999997543 345668899999999999999999998755     37899


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC--CCcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~--~~~~kl~Dfg~a~~~  829 (973)
                      +||||+++|+|.+++.... ..++.+++.++.|++.|++|||+.   +|+||||||+||+++.  ++.+||+|||+++..
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9999999999999997654 577888999999999999999999   9999999999999987  789999999999866


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         ........||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .+.........   
T Consensus       155 ~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~---  221 (321)
T 1tki_A          155 KP---------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT---  221 (321)
T ss_dssp             CT---------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC---
T ss_pred             CC---------CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCC---
Confidence            43         223345679999999999999889999999999999999999999997543211 01111000000   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                         .+         .......+..+.+++.+||..||++|||++|+++.-
T Consensus       222 ---~~---------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          222 ---FD---------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             ---CC---------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ---CC---------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence               00         011123355678999999999999999999999854

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=357.34  Aligned_cols=253  Identities=20%  Similarity=0.306  Sum_probs=206.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch------hHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG------ATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++......      ..+.+.+|+.+++.++||||+++++++..    
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   85 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----   85 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            35799999999999999999999999999999999754321      35778999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC----cEEEec
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSD  822 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~----~~kl~D  822 (973)
                       ....++||||+++|+|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        86 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           86 -KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             -CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence             478999999999999999998887888899999999999999999999   999999999999999887    899999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      ||+++.....         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ .+.....
T Consensus       162 fg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~  231 (326)
T 2y0a_A          162 FGLAHKIDFG---------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSA  231 (326)
T ss_dssp             CTTCEECCTT---------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHH
T ss_pred             CCCCeECCCC---------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHh
Confidence            9999866432         12234569999999999999999999999999999999999999997542211 0111000


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .          .....     .......+..+.+++.+||+.||++|||++|+++.
T Consensus       232 ~----------~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          232 V----------NYEFE-----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             T----------CCCCC-----HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             c----------CCCcC-----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0          00000     01112334567789999999999999999999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2e-39  Score=359.33  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++....   ......+.+|+.+++.++||||+++++++..     ..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence            368999999999999999999999999999999997432   2234578899999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+ +|+|.+++...+..++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            899999999 789999998888888999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ...         ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........             
T Consensus       159 ~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------  216 (336)
T 3h4j_B          159 TDG---------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------  216 (336)
T ss_dssp             TTS---------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------
T ss_pred             cCC---------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------
Confidence            432         22334579999999999988876 7899999999999999999999975432211             


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                       ...+...   .   ...+...+..+.+++.+||+.||++|||++|+++.-
T Consensus       217 -~~~i~~~---~---~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          217 -FKKVNSC---V---YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             -BCCCCSS---C---CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             -HHHHHcC---C---CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence             0000000   0   011122345667899999999999999999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-38  Score=348.65  Aligned_cols=281  Identities=28%  Similarity=0.434  Sum_probs=222.6

Q ss_pred             CCCcccHHHHHHHhhcCCcC------CccccccceeEEEEEECCCCcEEEEEEeeccc----chhHHHHHHHHHHHHhcC
Q 039720          660 QFPIVSYAELSKATKEFSSS------NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK----KGATKSFVAECEALRNIR  729 (973)
Q Consensus       660 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~  729 (973)
                      ..+.+++.++..+++.|...      +.||+|+||+||+|++  +++.||||++....    ....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            45678889999999888777      8999999999999997  68899999996432    334577999999999999


Q ss_pred             CCCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhc---CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 039720          730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT---NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLK  806 (973)
Q Consensus       730 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik  806 (973)
                      ||||+++++++..     ....++||||+++|+|.+++...   ....+..++.++.|++.||.|||+.   +|+|||||
T Consensus        89 h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlk  160 (307)
T 2nru_A           89 HENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIK  160 (307)
T ss_dssp             CTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred             CCCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCC
Confidence            9999999998654     46789999999999999998742   3466788899999999999999999   99999999


Q ss_pred             CCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 039720          807 PSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP  886 (973)
Q Consensus       807 ~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~P  886 (973)
                      |+||+++.++.+||+|||+++......      .........||+.|+|||++.+ .++.++||||||+++|+|++|+.|
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFA------QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCS------SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             HHHEEEcCCCcEEEeeccccccccccc------ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence            999999999999999999998654321      1112233568999999998765 588999999999999999999999


Q ss_pred             CCCCCCCCccHhhhhhHh--cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          887 TDNMFNDGLTLHGYAKMA--LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      |......... ..+....  ....+.+.+++..      ......++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          234 VDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BCTTBSSSBT-THHHHHHHTTSCCHHHHSCSSC------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cccCcchHHH-HHHHHHhhhhhhhhhhhccccc------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            9876543221 1111111  1111222222222      23345677889999999999999999999999999998753

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.1e-38  Score=368.72  Aligned_cols=368  Identities=20%  Similarity=0.189  Sum_probs=279.1

Q ss_pred             cCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCccccc
Q 039720           94 ANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQ  173 (973)
Q Consensus        94 ~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  173 (973)
                      ......+..+..++++++|++|+|++|.+++ +| .+                        +.+++|++|+|++|++++ 
T Consensus        26 ~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l------------------------~~l~~L~~L~Ls~n~l~~-   78 (457)
T 3bz5_A           26 AAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GI------------------------EKLTGLTKLICTSNNITT-   78 (457)
T ss_dssp             HHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TG------------------------GGCTTCSEEECCSSCCSC-
T ss_pred             HhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hh------------------------cccCCCCEEEccCCcCCe-
Confidence            3444555566678888888888888888874 34 33                        455777888888888886 


Q ss_pred             CCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccC
Q 039720          174 LPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFN  253 (973)
Q Consensus       174 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~  253 (973)
                      +|  ++++++|++|++++|++++. |  ++++++|++|++++|++++. |  +..+++|++|++++|++++ +|  + .+
T Consensus        79 ~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~--l-~~  146 (457)
T 3bz5_A           79 LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID--V-SH  146 (457)
T ss_dssp             CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC--C-TT
T ss_pred             Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce-ec--c-cc
Confidence            44  88999999999999999964 4  89999999999999999974 4  8999999999999999995 54  3 37


Q ss_pred             CCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccc
Q 039720          254 LPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCS  333 (973)
Q Consensus       254 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  333 (973)
                      +++|++|++++|...+.+  .+..+++|++|++++|++++..   +..+++|+.|++++|+++.++         +..++
T Consensus       147 l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~~---------l~~l~  212 (457)
T 3bz5_A          147 NTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKLD---------LNQNI  212 (457)
T ss_dssp             CTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCCC---------CTTCT
T ss_pred             CCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec---cccCCCCCEEECcCCcCCeec---------cccCC
Confidence            999999999999665555  5889999999999999999853   889999999999999987642         34556


Q ss_pred             cceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEc
Q 039720          334 KLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGL  413 (973)
Q Consensus       334 ~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  413 (973)
                      +|+.|++++|+++                         + +|  +..+++|+.|++++|++++..   ++.+++|+.|++
T Consensus       213 ~L~~L~Ls~N~l~-------------------------~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l  261 (457)
T 3bz5_A          213 QLTFLDCSSNKLT-------------------------E-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHC  261 (457)
T ss_dssp             TCSEEECCSSCCS-------------------------C-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEEC
T ss_pred             CCCEEECcCCccc-------------------------c-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEec
Confidence            6666666655544                         2 33  566777888888888887653   345667777777


Q ss_pred             cCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccc
Q 039720          414 VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSG  493 (973)
Q Consensus       414 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~  493 (973)
                      ++|              +|+.|++++|.+.+.+|  ++.+++|+.|++++|.+.+.+|...   ..+ +.|+++      
T Consensus       262 ~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~---~~L-~~L~l~------  315 (457)
T 3bz5_A          262 IQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA---AGI-TELDLS------  315 (457)
T ss_dssp             TTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT---CCC-SCCCCT------
T ss_pred             cCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC---Ccc-eEechh------
Confidence            665              35567788888777777  4677888888888888776666422   112 234443      


Q ss_pred             cCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCC
Q 039720          494 SIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGN  573 (973)
Q Consensus       494 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  573 (973)
                             .+++|+.|++++|++++. +  ++++++|+.|++++|+|++        ++.|..|++++|+++|.     ..
T Consensus       316 -------~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~  372 (457)
T 3bz5_A          316 -------QNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQ  372 (457)
T ss_dssp             -------TCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EE
T ss_pred             -------hcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ce
Confidence                   336788888888888873 3  7888888888888888885        24566778888888875     35


Q ss_pred             CCccceEeccCCcCcCcCCCC
Q 039720          574 LPFLEYLNLSYNHFEGKVPKK  594 (973)
Q Consensus       574 l~~L~~L~ls~N~l~~~~p~~  594 (973)
                      +..|+.+++++|+++|.+|..
T Consensus       373 ~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          373 TITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             EEECCCBCCBTTBEEEECCTT
T ss_pred             eeecCccccccCcEEEEcChh
Confidence            566778888888888888864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=366.94  Aligned_cols=249  Identities=24%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|..+++.+ +||||+++++++..     .
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence            46899999999999999999999999999999999754   233456788999999988 69999999998643     5


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+++|+|.+++.....+++..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+.
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            78999999999999999999888889999999999999999999999   999999999999999999999999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+  +  +......  
T Consensus       174 ~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~--~~~i~~~--  239 (353)
T 3txo_A          174 GICN--------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--L--FEAILND--  239 (353)
T ss_dssp             SCC-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H--HHHHHHC--
T ss_pred             cccC--------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--H--HHHHHcC--
Confidence            3221        223345679999999999999899999999999999999999999997543211  1  1111000  


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM------TAVVK  957 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  957 (973)
                             .       ...+......+.+++.+|++.||++||++      +|+++
T Consensus       240 -------~-------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          240 -------E-------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------C-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------C-------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   0       00111233456788889999999999998      77765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=361.66  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=205.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++..     ..
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence            368999999999999999999999999999999997432   3345678899999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+.+|+|.+++.....+.+..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            8999999999999999999888888899999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ..         ........||+.|+|||++.+   ..|+.++|||||||++|||++|+.||........  .........
T Consensus       166 ~~---------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~  234 (384)
T 4fr4_A          166 PR---------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFET  234 (384)
T ss_dssp             CT---------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHH
T ss_pred             cC---------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhh
Confidence            43         223345679999999999864   4689999999999999999999999975433211  111111000


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-MTAVVK  957 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  957 (973)
                      .               ....+..+...+.+++.+||+.||++||+ ++++.+
T Consensus       235 ~---------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 T---------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             C---------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             c---------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0               01111223456778999999999999998 676654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-39  Score=364.85  Aligned_cols=255  Identities=21%  Similarity=0.255  Sum_probs=203.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++...   ....+.+..|..+++++ +||||+++++++.     +.
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence            468999999999999999999999999999999997543   22335578899999877 8999999999854     35


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+++|+|.+++...+.+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            78999999999999999999888889999999999999999999999   999999999999999999999999999985


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc----HhhhhhHh
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT----LHGYAKMA  904 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~----~~~~~~~~  904 (973)
                      ....        .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........    ........
T Consensus       203 ~~~~--------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i  274 (396)
T 4dc2_A          203 GLRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  274 (396)
T ss_dssp             CCCT--------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred             cccC--------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence            3221        22344567999999999999999999999999999999999999999654321110    00000000


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM------TAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  958 (973)
                      ..        .    .   ...+......+.+++.+||+.||++||++      +|++++
T Consensus       275 ~~--------~----~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          275 LE--------K----Q---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HH--------C----C---CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             hc--------c----c---cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            00        0    0   01112234456788999999999999996      566553

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.9e-39  Score=368.70  Aligned_cols=256  Identities=20%  Similarity=0.277  Sum_probs=206.6

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+     .
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----E   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----S
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----C
Confidence            345789999999999999999999999999999999975542  334678999999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec---CCCcEEEecccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGL  825 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~---~~~~~kl~Dfg~  825 (973)
                      ...++||||+.+|+|.+.+.......+..+..++.||+.|+.|||++   +|+||||||+||+++   .++.+||+|||+
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            78999999999999999999888888999999999999999999999   999999999999998   467899999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ++.....        ........||+.|+|||++.+..|+.++||||+||++|+|++|+.||......  .+........
T Consensus       160 a~~~~~~--------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~  229 (444)
T 3soa_A          160 AIEVEGE--------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQIKAGA  229 (444)
T ss_dssp             CBCCCTT--------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTC
T ss_pred             eEEecCC--------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhCC
Confidence            9765432        12223457999999999999999999999999999999999999999754221  1111110000


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                             .+  ..     .......+..+.+++.+||+.||++|||++|+++.
T Consensus       230 -------~~--~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          230 -------YD--FP-----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -------CC--CC-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -------CC--CC-----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                   00  00     01112334567789999999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.6e-39  Score=360.58  Aligned_cols=254  Identities=20%  Similarity=0.319  Sum_probs=206.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+     ..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence            3568999999999999999999999999999999997543  2344678899999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---cEEEeccccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLA  826 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---~~kl~Dfg~a  826 (973)
                      ..++||||+.+|+|.+++.......+..+..++.||+.||+|||++   +|+||||||+||+++.++   .+||+|||++
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            8999999999999999998887888899999999999999999999   999999999999998654   5999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......         .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||......  .+........ 
T Consensus       179 ~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i~~~~-  246 (362)
T 2bdw_A          179 IEVNDS---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGA-  246 (362)
T ss_dssp             BCCTTC---------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC-
T ss_pred             eEecCC---------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC-
Confidence            865432         1223457999999999999999999999999999999999999999754221  1111110000 


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                            .+  .     ........+..+.+++.+||+.||++||+++|+++.
T Consensus       247 ------~~--~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 ------YD--Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ------CC--C-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------CC--C-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  00  0     011112344567789999999999999999999865

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-39  Score=366.77  Aligned_cols=269  Identities=21%  Similarity=0.351  Sum_probs=213.0

Q ss_pred             cHHHHHHHhhcCCcCCccccccceeEEEEE-----ECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEE
Q 039720          665 SYAELSKATKEFSSSNRIGKGSFGFVYKGN-----LGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKII  737 (973)
Q Consensus       665 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~  737 (973)
                      ....+....++|++.+.||+|+||.||+|+     ...+++.||||+++... ....+.+.+|+++++++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            334444567899999999999999999998     55677999999997543 33456799999999999 799999999


Q ss_pred             eEeeecccCCCceEEEEEeeccCCCHHHHhhhcCC---------------------------------------------
Q 039720          738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND---------------------------------------------  772 (973)
Q Consensus       738 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  772 (973)
                      +++...    ....++||||+++|+|.++++....                                             
T Consensus        93 ~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           93 GACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             EEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            987542    3558999999999999999976543                                             


Q ss_pred             ---------------------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          773 ---------------------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       773 ---------------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                                           +++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                                 56677899999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..      .........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......... ........    
T Consensus       246 ~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~~~----  314 (359)
T 3vhe_A          246 DP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-RRLKEGTR----  314 (359)
T ss_dssp             CT------TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-HHHHHTCC----
T ss_pred             cc------cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-HHHHcCCC----
Confidence            21      1222334568899999999999999999999999999999998 999997654332111 11111000    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                   ...+..+...+.+++.+||+.||++|||++|++++|+++.+
T Consensus       315 -------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          315 -------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                         01112234567789999999999999999999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5e-39  Score=350.79  Aligned_cols=269  Identities=19%  Similarity=0.251  Sum_probs=202.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ......+.+|+.++++++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            57999999999999999999999999999999997543  2345778899999999999999999999765     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+.++.+..+....+..++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            99999998644444444456778888999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc--
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK--  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  908 (973)
                      .        ........||+.|+|||++.+.. ++.++||||+||++|+|++|..||.........+...........  
T Consensus       154 ~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~  225 (292)
T 3o0g_A          154 P--------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             C--------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             c--------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            2        22223456899999999987765 799999999999999999988886543332222222211111000  


Q ss_pred             ----cccccCcc----cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ----VMGIVDPS----LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ----~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          .....+..    .................+.+++.+|++.||++|||++|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                00000000    000000111122344567789999999999999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-39  Score=348.51  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=207.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++. ++..||+|+++.... ..+.+.+|++++++++||||+++++++..     ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceE
Confidence            468999999999999999999985 677899999975443 34678999999999999999999998643     47789


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++++|.+++.... ..++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            9999999999999998754 367788999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..       ........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.........  .  .......  
T Consensus       157 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~--~~~~~~~--  223 (268)
T 3sxs_A          157 DQ-------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--L--KVSQGHR--  223 (268)
T ss_dssp             TC-------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--H--HHHTTCC--
T ss_pred             hh-------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH--H--HHHcCCC--
Confidence            22       112223446778999999998899999999999999999999 99999754322110  0  0000000  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                                   ...+...+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       224 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 -------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                         001111234677899999999999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=360.68  Aligned_cols=253  Identities=22%  Similarity=0.323  Sum_probs=192.0

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...  ..+.+.+|++++++++||||+++++++..     ....
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeE
Confidence            3467999999999999999999999999999999997543  34568889999999999999999998754     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~kl~Dfg~a~~  828 (973)
                      ++||||+++|+|.+++...+...+.+++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++.
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999999998887788899999999999999999999   9999999999999975   88999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....         .......||+.|+|||++.+..++.++|||||||++|||++|+.||..................   
T Consensus       201 ~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~---  268 (349)
T 2w4o_A          201 VEHQ---------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---  268 (349)
T ss_dssp             ---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC---
T ss_pred             cCcc---------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC---
Confidence            5431         1223456899999999999999999999999999999999999999754332211111111000   


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                             ...     .......+..+.+++.+||+.||++|||++|+++.
T Consensus       269 -------~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 -------YFI-----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -------CCC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------ccC-----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   000     01112334567789999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-39  Score=354.64  Aligned_cols=247  Identities=25%  Similarity=0.313  Sum_probs=204.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++..     ..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence            367999999999999999999999999999999997542   2345678899999999999999999998653     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++|+|.+++.....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceec
Confidence            8999999999999999999888888889999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..           ......||+.|+|||++.+..++.++||||+||++|||++|+.||......    ..+......   
T Consensus       157 ~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~---  218 (318)
T 1fot_A          157 PD-----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNA---  218 (318)
T ss_dssp             SS-----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHC---
T ss_pred             CC-----------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhC---
Confidence            32           123457999999999999999999999999999999999999999754221    111111100   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                            ..    ..+   ......+.+++.+|++.||++||     +++|++++
T Consensus       219 ------~~----~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          219 ------EL----RFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ------CC----CCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CC----CCC---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                  00    001   12234567888899999999999     89998854

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.5e-39  Score=361.19  Aligned_cols=253  Identities=20%  Similarity=0.283  Sum_probs=202.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++|++.+.||+|+||+||+|+++.+++.||||++....     ....+.+.+|+.+++.++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            357999999999999999999999999999999996432     1235778999999999999999999998765     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcC----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc---EEE
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTN----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV---AHV  820 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~---~kl  820 (973)
                      ....++||||+++|+|.+.+....    ...+..++.++.||+.||+|||++   +|+||||||+||+++.++.   +||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEE
Confidence            478999999999999998876432    357788899999999999999999   9999999999999987654   999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      +|||+++......        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....  ......
T Consensus       175 ~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i  244 (351)
T 3c0i_A          175 GGFGVAIQLGESG--------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGI  244 (351)
T ss_dssp             CCCTTCEECCTTS--------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHH
T ss_pred             ecCcceeEecCCC--------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHH
Confidence            9999998764321        122345699999999999999999999999999999999999999975321  001010


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....      ...         +......+..+.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~------~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          245 IKGKY------KMN---------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHTCC------CCC---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HcCCC------CCC---------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000      000         01112334567889999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.7e-39  Score=363.88  Aligned_cols=276  Identities=17%  Similarity=0.194  Sum_probs=206.8

Q ss_pred             hhcCCcCCccccc--cceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKG--SFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|  +||+||+|++..+|+.||||+++...  ....+.+.+|+.+++.++||||+++++++..     .
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----D   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----C
Confidence            4689999999999  99999999999999999999997553  3345678889999999999999999999765     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      ...++||||+++|+|.+++...  ....+..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            7899999999999999999765  5677888999999999999999999   9999999999999999999999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      .......... ...........||+.|+|||++.+  ..++.++|||||||++|||++|+.||............... .
T Consensus       176 ~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~  253 (389)
T 3gni_B          176 LSMISHGQRQ-RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-T  253 (389)
T ss_dssp             EECEETTEEC-SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             eeeccccccc-cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-C
Confidence            7543221100 011112233468999999999887  67899999999999999999999999865443222111111 0


Q ss_pred             cCccc-----------------------ccccCc----ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          905 LPKKV-----------------------MGIVDP----SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       905 ~~~~~-----------------------~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .+...                       .+....    ..................+.+++.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00000                       000000    000000001122334567889999999999999999999986


Q ss_pred             H
Q 039720          958 K  958 (973)
Q Consensus       958 ~  958 (973)
                      .
T Consensus       334 h  334 (389)
T 3gni_B          334 H  334 (389)
T ss_dssp             S
T ss_pred             C
Confidence            5

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=361.55  Aligned_cols=285  Identities=24%  Similarity=0.326  Sum_probs=205.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHH--HHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEA--LRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++  +++.||||++....   ...+..|.++  +..++||||+++++++......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46899999999999999999988  78999999997443   2334444444  45689999999998776655566677


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC------QPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                      .++||||+++|+|.+++.... .....++.++.|++.||+|||+.+      .++|+||||||+|||++.++.+||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            899999999999999997654 366778899999999999999762      2389999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-------GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      +++.+...................||+.|+|||++.+       ..++.++|||||||++|||++|+.||..........
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987654322111122223334579999999999887       456778999999999999999977764332211111


Q ss_pred             hhhhhHhcCcc----cc-----cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          898 HGYAKMALPKK----VM-----GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       898 ~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                      ..+........    ..     ....+.+...   ......++..+.+++.+||+.||++|||++|+++.|+++.+.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            11110000000    00     0001111100   1122346678999999999999999999999999999986544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.8e-39  Score=356.26  Aligned_cols=255  Identities=22%  Similarity=0.264  Sum_probs=204.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++...   ....+.+.+|..+++++ +||||+++++++..     .
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence            357999999999999999999999999999999997542   33456688999999988 89999999998643     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+++|+|.+++...+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++.
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccc
Confidence            78999999999999999999888888899999999999999999999   999999999999999999999999999985


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc----cHhhhhhHh
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL----TLHGYAKMA  904 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~----~~~~~~~~~  904 (973)
                      ....        .......+||+.|+|||++.+..++.++||||+||++|||++|+.||........    .........
T Consensus       160 ~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i  231 (345)
T 3a8x_A          160 GLRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  231 (345)
T ss_dssp             SCCT--------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred             ccCC--------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence            3221        2233456799999999999999999999999999999999999999975322110    000000000


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM------TAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  958 (973)
                      .        ...       ...+......+.+++.+||+.||++||++      +|++++
T Consensus       232 ~--------~~~-------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          232 L--------EKQ-------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             H--------HCC-------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             H--------cCC-------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            0        000       00112234456788899999999999996      566653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.6e-40  Score=370.85  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=208.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|.+.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++..     ....
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCCc
Confidence            467999999999999999999999899999999997543 2334568899999999999999999999754     3678


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+++|+|.+++...+ ......+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999999998654 466788899999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....      ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.......  ........     
T Consensus       265 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~-----  331 (377)
T 3cbl_A          265 DGVY------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKG-----  331 (377)
T ss_dssp             TSEE------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTT-----
T ss_pred             CCce------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----
Confidence            2110      011112235778999999998899999999999999999999 999997653221  11111100     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                                  .....+..++..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       332 ------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          332 ------------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                        00111223455678999999999999999999999999988653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.1e-39  Score=360.41  Aligned_cols=250  Identities=22%  Similarity=0.249  Sum_probs=204.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...   ....+.+..|..++..+ +||+|+++++++.     +.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----CS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----cC
Confidence            468999999999999999999999999999999997542   23456788999999887 7999999999854     35


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +..++||||+++|+|.+++...+.+.+..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            78999999999999999999888888899999999999999999999   999999999999999999999999999985


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+..  .... . 
T Consensus       171 ~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~--~i~~-~-  236 (353)
T 2i0e_A          171 NIWD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQ--SIME-H-  236 (353)
T ss_dssp             CCCT--------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH--HHHH-C-
T ss_pred             cccC--------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHHH--HHHh-C-
Confidence            3221        22334567999999999999999999999999999999999999999754221  1111  1100 0 


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                             .       ...+......+.+++.+||+.||++||+     ++|++++
T Consensus       237 -------~-------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          237 -------N-------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -------C-------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -------C-------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                   0       0011123456778899999999999995     5777654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-39  Score=361.03  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=204.3

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccC
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFK  746 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  746 (973)
                      ...++|.+.+.||+|+||+||+|+++.+|+.||||+++...   ....+.+..|..+++.+ +||||+++++++..    
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----   89 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----   89 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence            34578999999999999999999999999999999997542   23456688899999877 89999999998643    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                       ....++||||+++|+|.+++.....+.+..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|
T Consensus        90 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           90 -KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence             578999999999999999999888888899999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      +.....        .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......  .+..  .....
T Consensus       166 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~--~i~~~  233 (345)
T 1xjd_A          166 KENMLG--------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH--SIRMD  233 (345)
T ss_dssp             BCCCCT--------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH--HHHHC
T ss_pred             hhcccC--------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHH--HHHhC
Confidence            754321        22234567999999999999999999999999999999999999999754221  1111  11100


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT-AVVK  957 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  957 (973)
                             ..         ..+......+.+++.+||+.||++||++. |+++
T Consensus       234 -------~~---------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          234 -------NP---------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -------CC---------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -------CC---------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                   00         01112334567888999999999999997 6653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=351.28  Aligned_cols=273  Identities=23%  Similarity=0.311  Sum_probs=203.6

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-----hhHHHHHHHHHHHHhc---CCCCceeEEeEeeec
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-----GATKSFVAECEALRNI---RHRNLIKIITICSSI  743 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  743 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++....     .....+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            35799999999999999999999999999999999974331     1234566777776666   599999999998765


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                      ........++||||+. |+|.+++.....  +++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence            3333446899999997 599999987654  67888999999999999999999   99999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      |||+++....         ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +....
T Consensus       163 Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~  232 (308)
T 3g33_A          163 DFGLARIYSY---------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIF  232 (308)
T ss_dssp             SCSCTTTSTT---------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHH
T ss_pred             eCccccccCC---------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence            9999986543         2223456789999999999999999999999999999999999999976433211 11111


Q ss_pred             hHh-cCc--ccccc---cCcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMA-LPK--KVMGI---VDPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~-~~~--~~~~~---~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ... .+.  .....   ....+......  .....+....+.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            111 000  00000   00000000000  01112344667889999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-39  Score=348.35  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=206.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+     ....+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence            368999999999999999999996 688899999975443 34678999999999999999999998654     46789


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++++|.+++.... ..++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999999999997543 467788899999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..       ........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.......  ........      
T Consensus       159 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~------  223 (269)
T 4hcu_A          159 DQ-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTG------  223 (269)
T ss_dssp             HH-------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTT------
T ss_pred             cc-------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcC------
Confidence            21       112223446778999999998999999999999999999999 999997543211  11110000      


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                        ..         ...+...+..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus       224 --~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 --FR---------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             --CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cc---------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence              00         01111224567789999999999999999999999998854

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=360.57  Aligned_cols=253  Identities=17%  Similarity=0.234  Sum_probs=206.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++..........+.+|+++++.++||||+++++++..     ....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence            4689999999999999999999999999999999986655566788999999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC--CCcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~--~~~~kl~Dfg~a~~~  829 (973)
                      +||||+.+|+|.+++.... .+++..++.++.||+.||+|||+.   +|+||||||+||+++.  ++.+||+|||+++..
T Consensus       125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            9999999999999997654 577888999999999999999999   9999999999999974  578999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...         .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ........... 
T Consensus       202 ~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~-  267 (387)
T 1kob_A          202 NPD---------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDW-  267 (387)
T ss_dssp             CTT---------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHCCC-
T ss_pred             CCC---------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCC-
Confidence            432         2223456999999999999999999999999999999999999999754221    11111110000 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ..+         .......+..+.+++.+||+.||++|||++|+++.
T Consensus       268 --~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 --EFD---------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             --CCC---------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --CCC---------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence              000         11112334567789999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.4e-39  Score=365.18  Aligned_cols=260  Identities=26%  Similarity=0.411  Sum_probs=197.2

Q ss_pred             hhcCCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|.+.+.||+|+||+||+|++.   .++..||||+++... ....+.+.+|+.++++++||||+++++++..     .
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----S  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----C
Confidence            358999999999999999999986   467789999997543 3345679999999999999999999999654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++|+|.++++... ...+.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            67899999999999999998654 567788899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......     .........+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .+......   
T Consensus       196 ~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~---  265 (373)
T 2qol_A          196 VLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDE---  265 (373)
T ss_dssp             -----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHT---
T ss_pred             ccccCCc-----cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc---
Confidence            7643210     0111122345778999999999999999999999999999998 99999754321  11111000   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                               ...     ...+..++..+.+++.+||+.||++||+++||++.|+++..
T Consensus       266 ---------~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          266 ---------GYR-----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ---------TEE-----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCC-----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                     000     11112345678899999999999999999999999998853

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-39  Score=350.90  Aligned_cols=258  Identities=27%  Similarity=0.449  Sum_probs=200.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++  .++.||||++...  ...+.+.+|++++++++||||+++++++.       +..+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~   75 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVC   75 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcE
Confidence            35799999999999999999998  5789999998633  34677899999999999999999999754       3478


Q ss_pred             EEEeeccCCCHHHHhhhcCC---CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc-EEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-AHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~-~kl~Dfg~a~~  828 (973)
                      +||||+++|+|.+++.....   .....++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            99999999999999986553   345778899999999999999932129999999999999998886 79999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.................    
T Consensus       156 ~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----  220 (307)
T 2eva_A          156 IQTH-----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG----  220 (307)
T ss_dssp             --------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT----
T ss_pred             cccc-----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC----
Confidence            4321           1234589999999999999999999999999999999999999976543321111110000    


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCC
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGP  969 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  969 (973)
                          .         .+.....++..+.+++.+||+.||++|||++|+++.|+++...+.++
T Consensus       221 ----~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          221 ----T---------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             ----C---------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             ----C---------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence                0         01111233456778999999999999999999999999997766543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-38  Score=347.45  Aligned_cols=253  Identities=27%  Similarity=0.419  Sum_probs=202.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchh-------HHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA-------TKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.......       .+.+.+|+++++.++||||+++++++..   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   94 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---   94 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence            368999999999999999999999999999999996543211       1678999999999999999999998643   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEecCCCc-----
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLDHDMV-----  817 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~~~~~-----  817 (973)
                          ..++||||+++|+|.+++.... ...+..++.++.|++.|++|||+.   +  |+||||||+||+++.++.     
T Consensus        95 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           95 ----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             ----TTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             ----CCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCcee
Confidence                2269999999999998886543 567788899999999999999999   8  999999999999988776     


Q ss_pred             EEEeccccchhccCCCCccCCCCCcccccccccccccCcccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 039720          818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG--MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL  895 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~  895 (973)
                      +||+|||+++....           ......||+.|+|||++  ....++.++||||+||++|||++|+.||........
T Consensus       168 ~kl~Dfg~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  236 (287)
T 4f0f_A          168 AKVADFGLSQQSVH-----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI  236 (287)
T ss_dssp             EEECCCTTCBCCSS-----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred             EEeCCCCccccccc-----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence            99999999974322           23345689999999998  445678999999999999999999999986544322


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ..........       ..         +..+..++..+.+++.+||+.||++||+++|+++.|+++
T Consensus       237 ~~~~~~~~~~-------~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          237 KFINMIREEG-------LR---------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHHSC-------CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHHhccC-------CC---------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            2111111100       00         111223455678999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.1e-39  Score=358.05  Aligned_cols=247  Identities=21%  Similarity=0.246  Sum_probs=205.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++..     ..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence            468999999999999999999999999999999997542   2345678899999999999999999998653     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++|+|.+++...+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence            8999999999999999999888888899999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..           ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+  +......   
T Consensus       192 ~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~--~~~i~~~---  253 (350)
T 1rdq_E          192 KG-----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QI--YEKIVSG---  253 (350)
T ss_dssp             SS-----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH--HHHHHHC---
T ss_pred             cC-----------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HH--HHHHHcC---
Confidence            32           123457999999999999999999999999999999999999999754221  11  1111100   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                            .       ...+......+.+++.+||+.||++||+     ++|++++
T Consensus       254 ------~-------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          254 ------K-------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------C-------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------C-------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                  0       0011123456778999999999999998     8888764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.5e-39  Score=356.98  Aligned_cols=258  Identities=22%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEE----EEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSV----AVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++|++.+.||+|+||+||+|++..+++.|    |+|.++... ....+.+.+|+.++++++||||++++++|..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence            357999999999999999999998777654    777765332 3345789999999999999999999999764     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                       ...++|+||+.+|+|.+++... ....+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence             3478999999999999999874 4567788899999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +......      .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  +........
T Consensus       165 ~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~  236 (327)
T 3poz_A          165 KLLGAEE------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE  236 (327)
T ss_dssp             HHHTTTC------C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC
T ss_pred             eEccCCc------ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCC
Confidence            8765432      1222233456889999999999999999999999999999999 999997643321  111111000


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                       ....+..+...+.+++.+||+.||++||++.|+++.|+++..
T Consensus       237 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 -----------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                             011112334567889999999999999999999999988753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-38  Score=357.89  Aligned_cols=255  Identities=22%  Similarity=0.255  Sum_probs=196.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.+++.++||||+++++++..     ....+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence            4689999999999999999999999999999999975432 34668899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc--EEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV--AHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~--~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++...+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||+++...
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999999999998888888999999999999999999999   9999999999999987765  9999999997432


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMT-GDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      .         ........||+.|+|||++.+..++.+ +||||+||++|+|++|+.||............. ....... 
T Consensus       170 ~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~-~~~~~~~-  238 (361)
T 3uc3_A          170 L---------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI-QRILSVK-  238 (361)
T ss_dssp             --------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH-HHHHTTC-
T ss_pred             c---------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH-HHHhcCC-
Confidence            2         122234569999999999988887655 899999999999999999998654432211111 1111000 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                           ...      + ........+.+++.+||+.||++|||++|++++-
T Consensus       239 -----~~~------~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          239 -----YSI------P-DDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             -----CCC------C-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             -----CCC------C-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence                 000      0 0011234567899999999999999999999763

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-39  Score=357.69  Aligned_cols=265  Identities=21%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...   ......+.+|+.+++.++||||+++++++... .....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE-ETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc-CCCCc
Confidence            468999999999999999999999999999999997543   23346788999999999999999999987653 22234


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++++|.++++..+...+..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            5699999999999999999888888899999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....     ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.........   +.... ..  
T Consensus       167 ~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~---~~~~~-~~--  235 (311)
T 3ork_A          167 ADSG-----NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA---YQHVR-ED--  235 (311)
T ss_dssp             --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH-CC--
T ss_pred             cccc-----cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHhc-CC--
Confidence            4321     1112223456899999999999999999999999999999999999999754321110   00000 00  


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHH-HHHHHHhc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTA-VVKKLCAV  962 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~~  962 (973)
                        ...+        .......+..+.+++.+||+.||++||++.+ +.+.+.++
T Consensus       236 --~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          236 --PIPP--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             --CCCH--------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --CCCc--------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence              0000        0001123456788999999999999996555 55556555

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-39  Score=352.98  Aligned_cols=258  Identities=20%  Similarity=0.359  Sum_probs=202.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC-------cEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG-------MSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      .++|.+.+.||+|+||+||+|++..++       ..||+|++........+.+.+|+.+++.++||||+++++++..   
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC---   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence            468999999999999999999998776       4799999977666677889999999999999999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCC-CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc-------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-------  817 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~-------  817 (973)
                        ....++||||+++|+|.+++..... .++..++.++.|++.||+|||++   +|+||||||+||+++.++.       
T Consensus        84 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 --GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             --CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence              4678999999999999999987654 67788899999999999999999   9999999999999998887       


Q ss_pred             -EEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 039720          818 -AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL  895 (973)
Q Consensus       818 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~  895 (973)
                       +||+|||.+.....            .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus       159 ~~kl~Dfg~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~  226 (289)
T 4fvq_A          159 FIKLSDPGISITVLP------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR  226 (289)
T ss_dssp             EEEECCCCSCTTTSC------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eeeeccCcccccccC------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence             99999999875422            123468899999999887 6789999999999999999995554432222111


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCCC
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPP  970 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  970 (973)
                      .. .....  .        ....         ......+.+++.+||+.||++|||++|+++.|+++-..-.+||
T Consensus       227 ~~-~~~~~--~--------~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~  281 (289)
T 4fvq_A          227 KL-QFYED--R--------HQLP---------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR  281 (289)
T ss_dssp             HH-HHHHT--T--------CCCC---------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred             HH-HHhhc--c--------CCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence            10 00000  0        0000         0112346688899999999999999999999999976555544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8e-39  Score=360.60  Aligned_cols=279  Identities=16%  Similarity=0.226  Sum_probs=209.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCC-----CcEEEEEEeecccchh-----------HHHHHHHHHHHHhcCCCCceeE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGED-----GMSVAVKVMNLDKKGA-----------TKSFVAECEALRNIRHRNLIKI  736 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~  736 (973)
                      .++|++.+.||+|+||+||+|++..+     ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            45899999999999999999999754     5889999987553211           1234456667778889999999


Q ss_pred             EeEeeecccCCCceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec--
Q 039720          737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD--  813 (973)
Q Consensus       737 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~--  813 (973)
                      ++++... ..+....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.   +|+||||||+|||++  
T Consensus       114 ~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred             Eeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence            9998653 33346689999999 99999999875 5677888999999999999999999   999999999999999  


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND  893 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~  893 (973)
                      .++.+||+|||+|+.+..... .............||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGV-HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGC-CCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCeEEEEECCcceecccCCc-ccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            889999999999987643221 0001111223456999999999999999999999999999999999999999864333


Q ss_pred             CccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          894 GLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                      .. ............+...+++.+.        ...++..+.+++..||+.||++||+++++++.|+++.+..
T Consensus       268 ~~-~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          268 PK-YVRDSKIRYRENIASLMDKCFP--------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             HH-HHHHHHHHHHHCHHHHHHHHSC--------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HH-HHHHHHHHhhhhHHHHHHHhcc--------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            22 1111111111112112211111        0122456788999999999999999999999999875443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.4e-39  Score=369.17  Aligned_cols=262  Identities=21%  Similarity=0.227  Sum_probs=206.7

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeec
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSI  743 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  743 (973)
                      .++....++|++.++||+|+||+||+|+++.+++.||+|+++...   ......+.+|+.++..++||||+++++++.+ 
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-  145 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-  145 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            344445689999999999999999999999999999999997432   2223448899999999999999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                          ....++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       146 ----~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          146 ----DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ----SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             ----CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence                4789999999999999999987 46678888999999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      ||+|+......       .......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||......+   
T Consensus       219 FGla~~~~~~~-------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---  288 (437)
T 4aw2_A          219 FGSCLKLMEDG-------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---  288 (437)
T ss_dssp             CTTCEECCTTS-------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---
T ss_pred             hhhhhhcccCC-------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---
Confidence            99997654321       22233457999999999987     5678999999999999999999999997542211   


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE--RMQMTAVVKK  958 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  958 (973)
                       .+....         ....  ....+.........+.+++.+|+..+|++  ||+++|++++
T Consensus       289 -~~~~i~---------~~~~--~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          289 -TYGKIM---------NHKE--RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -HHHHHH---------THHH--HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -HHHhhh---------hccc--cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             111110         0000  00001111123345678888999999988  9999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=364.38  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=205.0

Q ss_pred             hhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|++     ..++..||||+++.. .......+.+|+.++++++||||+++++++..    
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            36799999999999999999994     457789999999644 23345678899999999999999999998643    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC-------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN-------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---  816 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---  816 (973)
                       ....++||||+++|+|.+++....       .....+++.++.||+.||+|||++   +|+||||||+|||++.++   
T Consensus       146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence             467799999999999999998653       355677899999999999999999   999999999999999555   


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGL  895 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~  895 (973)
                      .+||+|||+|+......      .........||+.|+|||++.+..++.++|||||||++|||++ |+.||......  
T Consensus       222 ~~kL~DFG~a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--  293 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAG------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--  293 (367)
T ss_dssp             CEEECCCHHHHHHHHHS------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             eEEECCCcccccccccc------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            59999999998653321      1122234568899999999999999999999999999999998 99999754321  


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      .+.......   .              ....+..++..+.+++.+||+.||++||+++||++.|+.+..
T Consensus       294 ~~~~~i~~~---~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          294 EVLEFVTSG---G--------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHHHHHTT---C--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcC---C--------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            111111100   0              011112334567899999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-39  Score=359.95  Aligned_cols=264  Identities=23%  Similarity=0.397  Sum_probs=209.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      ..++|++.+.||+|+||+||+|++.     .+++.||||+++... ....+.+.+|+.+++.++||||+++++++..   
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence            4578999999999999999999996     355899999997543 3345678999999999999999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhc------------------------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHT------------------------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIV  801 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv  801 (973)
                        ....++||||+++|+|.+++...                        ..+.+.+++.++.||+.||+|||++   +|+
T Consensus       122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence              47789999999999999999764                        3456678899999999999999999   999


Q ss_pred             ecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHH
Q 039720          802 HGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF  881 (973)
Q Consensus       802 HrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ell  881 (973)
                      ||||||+||+++.++.+||+|||+++......      .........+|+.|+|||++.+..++.++|||||||++|||+
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  270 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSAD------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  270 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGG------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCc------cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence            99999999999999999999999998764321      011222345788999999999899999999999999999999


Q ss_pred             h-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          882 T-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       882 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      + |+.||......+  +.....   ...        .      ...+..++..+.+++.+||+.||++||+++|+++.|+
T Consensus       271 t~g~~p~~~~~~~~--~~~~~~---~~~--------~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          271 SYGLQPYYGMAHEE--VIYYVR---DGN--------I------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             TTTCCTTTTSCHHH--HHHHHH---TTC--------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hcCCCcCCCCChHH--HHHHHh---CCC--------c------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence            9 999997543211  111100   000        0      1111233456788999999999999999999999999


Q ss_pred             hccccccC
Q 039720          961 AVGEIFIG  968 (973)
Q Consensus       961 ~~~~~~~~  968 (973)
                      ++.+...+
T Consensus       332 ~~~~~~~~  339 (343)
T 1luf_A          332 RMCERAEG  339 (343)
T ss_dssp             HTTC----
T ss_pred             HHHhhhhh
Confidence            99877665

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-38  Score=368.57  Aligned_cols=251  Identities=30%  Similarity=0.402  Sum_probs=206.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++  .|+.||||+++...  ..+.+.+|+.++++++||||+++++++...    ....+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence            46799999999999999999999  57899999997543  457799999999999999999999987542    34789


Q ss_pred             EEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++...+.  .....+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999999987654  46677899999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..           .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  +.......     
T Consensus       341 ~~-----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~-----  402 (450)
T 1k9a_A          341 ST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG-----  402 (450)
T ss_dssp             -----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTT-----
T ss_pred             cc-----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----
Confidence            21           112356789999999999999999999999999999999 999998654332  11111100     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                  .....+..++..+.++|.+||+.||++|||+.|+++.|+++..
T Consensus       403 ------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          403 ------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                        0011223455678899999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.2e-38  Score=348.70  Aligned_cols=267  Identities=22%  Similarity=0.341  Sum_probs=200.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.++||+|+||+||+|++. +|+.||+|+++...  ......+.+|+++++.++||||+++++++.     +...
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence            478999999999999999999995 69999999997543  223567889999999999999999999864     3478


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++ ++.+++... ...++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            9999999985 777777654 3467788999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc---
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL---  905 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~---  905 (973)
                      ...        ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. +........   
T Consensus       170 ~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~  240 (311)
T 3niz_A          170 GIP--------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPN  240 (311)
T ss_dssp             TSC--------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCC
T ss_pred             CCC--------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCC
Confidence            432        122234568999999999876 5689999999999999999999999987654432 211111110   


Q ss_pred             CcccccccCcc------cc--cccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPS------LL--MEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~------~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +.......+..      ..  ...........+..++.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00000000000      00  0000001112234567889999999999999999999873

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-38  Score=353.26  Aligned_cols=267  Identities=18%  Similarity=0.220  Sum_probs=208.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....  .+.+.+|+.+++.+ +||||+++++++..     ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCcc
Confidence            3689999999999999999999999999999999975432  34588999999999 89999999998655     3788


Q ss_pred             EEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc-----EEEecccc
Q 039720          752 AIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-----AHVSDFGL  825 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~-----~kl~Dfg~  825 (973)
                      ++||||+ +++|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999999 99999999863 5677888999999999999999999   9999999999999999887     99999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ++......... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.....
T Consensus       157 a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~  234 (330)
T 2izr_A          157 AKEYIDPETKK-HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGD  234 (330)
T ss_dssp             CEESBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHH
T ss_pred             ceeeecCCCCc-cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHh
Confidence            98764432100 0011123456799999999999999999999999999999999999999987543321 111111100


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ...   .....        .....++ .+.+++.+||+.||++||++++|.+.|+++.+
T Consensus       235 ~~~---~~~~~--------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          235 TKR---ATPIE--------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHH---HSCHH--------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhc---cCCHH--------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            000   00000        0001123 77899999999999999999999999987753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.6e-38  Score=348.29  Aligned_cols=266  Identities=23%  Similarity=0.334  Sum_probs=201.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||.||+|++..+|+.||||+++..   .......+.+|+.+++.++||||+++++++..     ..
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence            35799999999999999999999999999999999753   23345678999999999999999999998765     37


Q ss_pred             eEEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ..++||||+++++|.+++..    ....++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            89999999999999999864    34567788899999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +......        ........|++.|+|||++.+..++.++||||||+++|+|++|+.||.........+.....   
T Consensus       183 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---  251 (310)
T 2wqm_A          183 GRFFSSK--------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---  251 (310)
T ss_dssp             ------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH---
T ss_pred             eeeecCC--------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh---
Confidence            9865432        11223456899999999999999999999999999999999999999754322111111110   


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCCC
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPP  970 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  970 (973)
                      ....     +        ......++..+.+++.+||+.||++||+++|+++.|+++.....+||
T Consensus       252 ~~~~-----~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          252 QCDY-----P--------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             TTCS-----C--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             cccC-----C--------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            0000     0        00012234567789999999999999999999999999988888776

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.5e-39  Score=347.72  Aligned_cols=256  Identities=23%  Similarity=0.402  Sum_probs=204.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++. ++..||+|+++.... ..+.+.+|+++++.++||||+++++++..     ....+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   95 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIF   95 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCeE
Confidence            468999999999999999999985 778999999975433 34678999999999999999999998643     47789


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++++|.+++.. .....+..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999976 45677788999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..       ........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.......  .......       
T Consensus       173 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~-------  236 (283)
T 3gen_A          173 DE-------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQ-------  236 (283)
T ss_dssp             HH-------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHT-------
T ss_pred             cc-------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhc-------
Confidence            21       111223346788999999998899999999999999999998 999997643221  1110000       


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                       ...         ...+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       237 -~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          237 -GLR---------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             -TCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -ccC---------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence             000         00111223467789999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=365.74  Aligned_cols=262  Identities=23%  Similarity=0.246  Sum_probs=205.2

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeee
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSS  742 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  742 (973)
                      ..+.....++|++.+.||+|+||+||+|+++.+|+.||||+++...   ....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455689999999999999999999999999999999997432   2233458899999999999999999998644


Q ss_pred             cccCCCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          743 IDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       743 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                           ....++||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++   +|+||||||+|||++.++++||+
T Consensus       133 -----~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          133 -----ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             -----CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence                 578999999999999999998754 677888999999999999999999   99999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCccccc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-------GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG  894 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~  894 (973)
                      |||+|+......       .......+||+.|+|||++.       ...|+.++|||||||++|||++|+.||......+
T Consensus       205 DFGla~~~~~~~-------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  277 (412)
T 2vd5_A          205 DFGSCLKLRADG-------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE  277 (412)
T ss_dssp             CCTTCEECCTTS-------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             echhheeccCCC-------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence            999998654321       11223457999999999987       4578999999999999999999999997543211


Q ss_pred             ccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCC---CCHHHHHHH
Q 039720          895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER---MQMTAVVKK  958 (973)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~  958 (973)
                          .+........           ....+......+..+.+++.+||. +|++|   |+++|++++
T Consensus       278 ----~~~~i~~~~~-----------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          278 ----TYGKIVHYKE-----------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ----HHHHHHTHHH-----------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ----HHHHHHhccc-----------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                1111100000           000011112234566788899999 99998   589998865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-38  Score=364.92  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=197.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCceeEEeEeeec
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------GATKSFVAECEALRNIRHRNLIKIITICSSI  743 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  743 (973)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++.....        .....+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            45789999999999999999999999999999999975421        112347899999999999999999998643 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---cEEE
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---VAHV  820 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---~~kl  820 (973)
                           +..++||||+++|+|.+++.......+..++.++.|++.||+|||++   +|+||||||+|||++.++   .+||
T Consensus       212 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence                 56799999999999999998888888899999999999999999999   999999999999997544   5999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      +|||+|+.....         .......||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..........
T Consensus       284 ~DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  354 (419)
T 3i6u_A          284 TDFGHSKILGET---------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK  354 (419)
T ss_dssp             CCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred             eecccceecCCC---------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence            999999865432         22334679999999999753   678899999999999999999999998654332211


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .........          .     .+.........+.+++.+||+.||++||+++|++++
T Consensus       355 ~~i~~~~~~----------~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          355 DQITSGKYN----------F-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHHTTCCC----------C-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhcCCCC----------C-----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            111111000          0     011112345667899999999999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.5e-38  Score=342.52  Aligned_cols=253  Identities=20%  Similarity=0.239  Sum_probs=207.6

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||+||+|++..++..||+|++........+.+.+|+++++.++||||+++++++..     ....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeE
Confidence            35689999999999999999999999999999999987666667889999999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---cCCCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl---~~~~~~kl~Dfg~a~~  828 (973)
                      ++||||+++++|.+++.......+..++.++.|++.|++|||++   +|+||||||+||++   +.++.+||+|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999999999998888888899999999999999999999   99999999999999   7889999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....         .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+. .........   
T Consensus       159 ~~~~---------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~---  224 (277)
T 3f3z_A          159 FKPG---------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTF---  224 (277)
T ss_dssp             CCTT---------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC---
T ss_pred             ccCc---------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCC---
Confidence            5432         222345689999999997654 89999999999999999999999976432110 001000000   


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                             ...     .......+..+.+++.+|++.||++||++.|+++.
T Consensus       225 -------~~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 -------TFP-----EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -------CCC-----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -------CCC-----chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   000     00011234667899999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.2e-38  Score=344.54  Aligned_cols=269  Identities=14%  Similarity=0.158  Sum_probs=211.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++....  ..+.+.+|+.+++.+ +|++++++++++..     ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----Ccee
Confidence            467999999999999999999999999999999986433  334578899999999 79999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc-----EEEecccc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV-----AHVSDFGL  825 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~-----~kl~Dfg~  825 (973)
                      ++||||+ +++|.+++...+ ..++..+..++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||+
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999999 999999998654 477888999999999999999999   9999999999999987776     99999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH--hhhhhH
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL--HGYAKM  903 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~--~~~~~~  903 (973)
                      ++......... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||..........  ......
T Consensus       158 ~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          158 VKFYRDPVTKQ-HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             CEESBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             ccccccccccc-cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            98765432100 001122345579999999999999999999999999999999999999998654322110  010000


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccccc
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFI  967 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  967 (973)
                      ......              ......++..+.+++.+||+.||++||++++|++.|+++.+...
T Consensus       237 ~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          237 KQSTPL--------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHSCH--------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccCccH--------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            000000              01111335678899999999999999999999999998865543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.6e-39  Score=347.27  Aligned_cols=257  Identities=21%  Similarity=0.341  Sum_probs=196.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCC---CcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|++..+   +..||+|+++... ....+.+.+|+.+++.++||||+++++++.      .
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence            46899999999999999999998653   4579999986533 334567899999999999999999999863      2


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +..++||||+++|+|.+++.... ..++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            56789999999999999998654 567788899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......       ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  ........  
T Consensus       165 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~--  233 (281)
T 1mp8_A          165 YMEDST-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENG--  233 (281)
T ss_dssp             ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT--
T ss_pred             ccCccc-------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcC--
Confidence            764322       112223456788999999998999999999999999999997 999997653321  11111000  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                               .      ....+..++..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus       234 ---------~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          234 ---------E------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ---------C------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------C------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                     0      011112344567789999999999999999999999998743

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=356.24  Aligned_cols=277  Identities=20%  Similarity=0.235  Sum_probs=207.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECC---CCcEEEEEEeecccch-----------hHHHHHHHHHHHHhcCCCCceeEEe
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE---DGMSVAVKVMNLDKKG-----------ATKSFVAECEALRNIRHRNLIKIIT  738 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~  738 (973)
                      .++|++.+.||+|+||+||+|++..   ++..||||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3689999999999999999999987   7899999999755321           1134667888999999999999999


Q ss_pred             EeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC--
Q 039720          739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM--  816 (973)
Q Consensus       739 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~--  816 (973)
                      ++... +.+....++||||+ +++|.+++...+.+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++  
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence            98763 45568899999999 999999998877788899999999999999999999   999999999999999887  


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT  896 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~  896 (973)
                      .+||+|||+++.+..... .............||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGN-HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGC-CCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccc-cccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            999999999987643211 0011122224457999999999999999999999999999999999999999654333222


Q ss_pred             HhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          897 LHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ..........     .+.........    ...++..+.+++.+||+.||++||++++|++.|+.+.-
T Consensus       270 ~~~~~~~~~~-----~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTAKTNLLD-----ELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHH-----TTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHhhcc-----cccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            2111111100     00000000000    01234567889999999999999999999999998753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=351.15  Aligned_cols=276  Identities=19%  Similarity=0.219  Sum_probs=211.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++... .......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence            36899999999999999999999999999999999776666678899999999999999999999987642 22346789


Q ss_pred             EEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +||||+.+|+|.+++..    ....++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999876    35567888999999999999999999   999999999999999999999999999875


Q ss_pred             ccCCCCccC-CCCCcccccccccccccCcccccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          829 LSHHPFLVA-PEGQSSSIEMKGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       829 ~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ......... ...........||+.|+|||++.+..   ++.++|||||||++|+|++|+.||................ 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence            421100000 00000112345799999999987654   6889999999999999999999996432221111111100 


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCC
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGP  969 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  969 (973)
                                 ...     ......++..+.+++.+||+.||++||+++|+++.|+++.....++
T Consensus       263 -----------~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          263 -----------QLS-----IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             -----------C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             -----------cCC-----CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence                       000     0001223456788999999999999999999999999987655544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.2e-39  Score=355.00  Aligned_cols=264  Identities=22%  Similarity=0.367  Sum_probs=193.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc---EEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC-
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM---SVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFK-  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-  746 (973)
                      .++|++.+.||+|+||+||+|++..++.   .||||+++..  .....+.+.+|+++++.++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4689999999999999999999876665   8999999754  334567899999999999999999999987653211 


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEE
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV  820 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl  820 (973)
                      .....++||||+.+|+|.+++....      ..++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence            1123489999999999999986543      466788999999999999999999   9999999999999999999999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhh
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHG  899 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~  899 (973)
                      +|||+++......      .........+++.|+|||++.+..++.++|||||||++|||++ |+.||.......  ...
T Consensus       179 ~Dfg~a~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~  250 (323)
T 3qup_A          179 ADFGLSRKIYSGD------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYN  250 (323)
T ss_dssp             CCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH
T ss_pred             eeccccccccccc------cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHH
Confidence            9999998664322      1122223456788999999999999999999999999999999 999998653321  111


Q ss_pred             hhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          900 YAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      .....   .              ....+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       251 ~~~~~---~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 YLIGG---N--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHTT---C--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcC---C--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            10000   0              011112334567899999999999999999999999998853

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=362.43  Aligned_cols=277  Identities=20%  Similarity=0.259  Sum_probs=215.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++...   .....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            468999999999999999999999999999999997543 23456788999999999999999999987642   33578


Q ss_pred             EEEEeeccCCCHHHHhhhcCC---CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----cCCCcEEEeccc
Q 039720          752 AIVYEYMQYGSVDDWLHHTND---KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFG  824 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl----~~~~~~kl~Dfg  824 (973)
                      ++||||+++|+|.+++.....   +++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            999999999999999986443   67788999999999999999999   99999999999999    777889999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--------GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT  896 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~  896 (973)
                      +++.....         .......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........
T Consensus       162 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          162 AARELEDD---------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             GCEECCCG---------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             CceEccCC---------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            99865432         22234569999999998765        56788999999999999999999999765443322


Q ss_pred             HhhhhhHhc--C-cccccc---cCcccc--ccc-CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          897 LHGYAKMAL--P-KKVMGI---VDPSLL--MEA-RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       897 ~~~~~~~~~--~-~~~~~~---~~~~~~--~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      .........  + ..+...   .+....  ... ............+.+++.+||+.||++||+++|+++.++++.+
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            222222111  1 111111   110000  000 0122335677888999999999999999999999999988743

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.2e-37  Score=363.07  Aligned_cols=190  Identities=25%  Similarity=0.329  Sum_probs=91.7

Q ss_pred             CCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcccccccee
Q 039720           84 NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERL  163 (973)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  163 (973)
                      .+++|+.|++++|.++ .+| .+..+++|++|+|++|.+++. |. ++++++|++|++++|.+.+..+            
T Consensus        44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~------------  107 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP------------  107 (466)
T ss_dssp             HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG------------
T ss_pred             HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh------------
Confidence            3566777777777776 355 366677777777777777632 32 5555444444444444443322            


Q ss_pred             eccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccc
Q 039720          164 SLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       164 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                                    ++++++|++|++++|++++. +. +.++++|++|++++|.+++. + .+..+++|++|++. |.+.
T Consensus       108 --------------~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~  168 (466)
T 1o6v_A          108 --------------LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVT  168 (466)
T ss_dssp             --------------GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCC
T ss_pred             --------------hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Cccc
Confidence                          44444444444444444422 11 44444444444444444421 1 23344444444442 2222


Q ss_pred             cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccC
Q 039720          244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       244 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      + ++.  +.++++|++|++++|.+++.  ..+..+++|++|++++|++++..+  +..+++|++|++++|++
T Consensus       169 ~-~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l  233 (466)
T 1o6v_A          169 D-LKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL  233 (466)
T ss_dssp             C-CGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             C-chh--hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCc
Confidence            1 111  12445555555555554432  234555555555555555554433  44445555555555544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.5e-38  Score=345.99  Aligned_cols=268  Identities=21%  Similarity=0.350  Sum_probs=188.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++.... ...+.+.+|+++++.++||||+++++++..     .+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence            4689999999999999999999999999999999975532 344678899999999999999999998643     4789


Q ss_pred             EEEEeeccCCCHHHHhhhc------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          752 AIVYEYMQYGSVDDWLHHT------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ++||||++ |+|.+++...      ....+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999998 5999988654      2356677889999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ++.....        ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.......
T Consensus       155 ~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~  225 (317)
T 2pmi_A          155 ARAFGIP--------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIM  225 (317)
T ss_dssp             CEETTSC--------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             ceecCCC--------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence            9865422        112234568999999999876 468999999999999999999999997643321 111111110


Q ss_pred             -cC-cc----cccc--cCcccccccC-------CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 -LP-KK----VMGI--VDPSLLMEAR-------GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 -~~-~~----~~~~--~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .+ ..    ....  ..+.......       .+.........+.+++.+||+.||++|||++|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence             00 00    0000  0000000000       000011234567899999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.6e-39  Score=355.95  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcE----EEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMS----VAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|++.+.||+|+||+||+|++..+++.    ||+|++.... ......+.+|+.+++.++||||+++++++..      
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence            5799999999999999999999888775    7777764332 2233567789999999999999999998742      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+.+|+|.+++... ....+..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence            5688999999999999998764 4567788999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......      .........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.......  +.........
T Consensus       164 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~  235 (325)
T 3kex_A          164 LLPPDD------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGER  235 (325)
T ss_dssp             GSCCCT------TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCB
T ss_pred             ccCccc------ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCC
Confidence            765432      1222334567889999999999999999999999999999999 999998654321  1111111000


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                       ...+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 -----------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -----------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -----------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                             00111123346688899999999999999999999998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-38  Score=351.86  Aligned_cols=258  Identities=22%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             hhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|.+.+.||+|+||.||+|++     ..+++.||||+++... ....+.+.+|+++++.++||||+++++++..    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ----   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec----
Confidence            46899999999999999999988     3456899999997543 3345778999999999999999999998643    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCC------------------------CchhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTND------------------------KLEVGKLNIVIEVASVIEYLHNHCQPPIVH  802 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH  802 (973)
                       ....++||||+++|+|.+++.....                        ..+.+++.++.|++.||+|||++   +|+|
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A           98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence             4678999999999999999986543                        55678899999999999999999   9999


Q ss_pred             cCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh
Q 039720          803 GDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT  882 (973)
Q Consensus       803 rDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt  882 (973)
                      |||||+||+++.++.+||+|||+++.......      ........+|+.|+|||++.+..++.++|||||||++|||++
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSC------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             cccchheEEEcCCCCEEEcccccccccccccc------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999986643221      112223457888999999999899999999999999999999


Q ss_pred             -CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHh
Q 039720          883 -RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCA  961 (973)
Q Consensus       883 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  961 (973)
                       |+.||.......  +........                 ....+..++..+.+++.+||+.||++||+++|+++.|++
T Consensus       248 ~g~~p~~~~~~~~--~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          248 LGGNPYPGIPPER--LFNLLKTGH-----------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             TSCCSSTTCCGGG--HHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHH--HHHHhhcCC-----------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             999997653321  111111000                 011112334567889999999999999999999999998


Q ss_pred             cc
Q 039720          962 VG  963 (973)
Q Consensus       962 ~~  963 (973)
                      +.
T Consensus       309 ~~  310 (314)
T 2ivs_A          309 MM  310 (314)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2e-38  Score=352.90  Aligned_cols=263  Identities=22%  Similarity=0.334  Sum_probs=202.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-----
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDF-----  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  745 (973)
                      ..++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++.+...     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3568999999999999999999999999999999997544 3356789999999999999999999998765321     


Q ss_pred             -----------------------------------------------CCCceEEEEEeeccCCCHHHHhhhcCCCch---
Q 039720          746 -----------------------------------------------KGADFKAIVYEYMQYGSVDDWLHHTNDKLE---  775 (973)
Q Consensus       746 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---  775 (973)
                                                                     ......++||||+++|+|.+++........   
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                           112348999999999999999987654433   


Q ss_pred             hhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCC----CCCcccccccccc
Q 039720          776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAP----EGQSSSIEMKGTI  851 (973)
Q Consensus       776 ~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~----~~~~~~~~~~gt~  851 (973)
                      ..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...........    ..........||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            34789999999999999999   9999999999999999999999999999876543210000    0011223456999


Q ss_pred             cccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHH
Q 039720          852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECL  931 (973)
Q Consensus       852 ~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (973)
                      .|+|||++.+..++.++||||+||++|||++|..|+...       .......              .....+.......
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~--------------~~~~~~~~~~~~~  299 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDV--------------RNLKFPLLFTQKY  299 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHH--------------HTTCCCHHHHHHC
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHh--------------hccCCCcccccCC
Confidence            999999999999999999999999999999987764311       0000000              0011123334555


Q ss_pred             HHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          932 VAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       932 ~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..+.+++.+||+.||++||+++|+++.
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            677899999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.7e-38  Score=347.98  Aligned_cols=253  Identities=19%  Similarity=0.281  Sum_probs=206.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch------hHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG------ATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++.....      ..+.+.+|+.+++.++||||+++++++..    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----   86 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN----   86 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            46799999999999999999999999999999999754321      35779999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC----cEEEec
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSD  822 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~----~~kl~D  822 (973)
                       ....++||||+++++|.+++......++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           87 -RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence             478999999999999999998877788889999999999999999999   999999999999999888    799999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      ||+++.....         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+  .  ...
T Consensus       163 fg~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~--~~~  229 (321)
T 2a2a_A          163 FGLAHEIEDG---------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--T--LAN  229 (321)
T ss_dssp             CTTCEECCTT---------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--H--HHH
T ss_pred             CccceecCcc---------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--H--HHH
Confidence            9999865432         12234568999999999999999999999999999999999999997542211  0  111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ... ..  ...+         .......+..+.+++.+||+.||++|||++|+++.
T Consensus       230 i~~-~~--~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          230 ITS-VS--YDFD---------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHT-TC--CCCC---------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             HHh-cc--cccC---------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000 00  0000         01112234567889999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.7e-38  Score=365.23  Aligned_cols=270  Identities=19%  Similarity=0.229  Sum_probs=199.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  .....+++.+|+.+++.++||||+++++++.... ..+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999999999999999999754  3344577899999999999999999999976432 13446


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||++++ +.+.+..  ...+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            789999999865 6666543  367788899999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC-c
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP-K  907 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~-~  907 (973)
                      ..         ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .+....... .+ .
T Consensus       215 ~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          215 GT---------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCP  284 (464)
T ss_dssp             -----------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCH
T ss_pred             CC---------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence            43         222345679999999999999999999999999999999999999997543211 111111100 00 0


Q ss_pred             ccccccCc------------------cccccc---CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDP------------------SLLMEA---RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~------------------~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .......+                  ......   ............+.+++.+||+.||++|||++|++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000                  000000   0011122335678899999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=348.37  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=197.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--------------------------hhHHHHHHHHHHHH
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------------------------GATKSFVAECEALR  726 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  726 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4689999999999999999999999999999999975421                          11356889999999


Q ss_pred             hcCCCCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 039720          727 NIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLK  806 (973)
Q Consensus       727 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik  806 (973)
                      .++||||+++++++...   .....++||||+++++|.++... ..+++..++.++.|++.||+|||++   +|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            99999999999987642   34789999999999999886543 4567788999999999999999999   99999999


Q ss_pred             CCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCC---CCcccchHHHHHHHHHHHhC
Q 039720          807 PSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD---LSMTGDVYSFGILLLEMFTR  883 (973)
Q Consensus       807 ~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~ll~elltg  883 (973)
                      |+||+++.++.+||+|||+++.....        ........||+.|+|||++.+..   ++.++|||||||++|+|++|
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGS--------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSS--------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             HHHEEECCCCCEEEecCCCccccccc--------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            99999999999999999999865432        11223457999999999987765   37889999999999999999


Q ss_pred             CCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          884 RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       884 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +.||......  .+......   ..    ..  .       ......+..+.+++.+||+.||++||+++|+++.
T Consensus       237 ~~pf~~~~~~--~~~~~~~~---~~----~~--~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          237 QCPFMDERIM--CLHSKIKS---QA----LE--F-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SCSSCCSSHH--HHHHHHHH---CC----CC--C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCCCccHH--HHHHHHhc---cc----CC--C-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            9999753211  11111000   00    00  0       0011233467789999999999999999998753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-38  Score=346.23  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=210.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||+||+|++..++..||+|+++.+. ...+.+.+|+++++.++||||+++++++..     ....
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCE
Confidence            4578999999999999999999999899999999997543 355778999999999999999999998643     4778


Q ss_pred             EEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ++||||+++++|.+++....  ...+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            99999999999999998643  366788899999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....       ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......  ........    
T Consensus       162 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~----  228 (288)
T 3kfa_A          162 TGDT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKD----  228 (288)
T ss_dssp             CSSS-------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTT----
T ss_pred             cCCc-------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcc----
Confidence            4321       222334457889999999998999999999999999999999 999997643221  11111100    


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                          ..         ...+..++..+.+++.+|++.||++||+++|+++.|+++.
T Consensus       229 ----~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          229 ----YR---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ----CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CC---------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                00         1111233456789999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=359.32  Aligned_cols=262  Identities=24%  Similarity=0.390  Sum_probs=210.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-------CCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-------DGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      .++|.+.+.||+|+||+||+|++..       ++..||||+++... ......+.+|+++++.+ +||||+++++++.. 
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence            4689999999999999999999753       34689999997553 33457789999999999 89999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                          ....++||||+++|+|.+++....                .+++..++.++.|++.||+|||+.   +|+||||||
T Consensus       147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence                467899999999999999998654                366788999999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +||+++.++.+||+|||+|+.......      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCT------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ceEEEcCCCcEEEcccCcccccccccc------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999986644221      122233457889999999999999999999999999999999 9999


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                      |......  .+.......   .              ....+..+...+.+++.+||+.||++||+++|+++.|+++....
T Consensus       294 ~~~~~~~--~~~~~~~~~---~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          294 YPGVPVE--ELFKLLKEG---H--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             STTCCHH--HHHHHHHTT---C--------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             CCCCCHH--HHHHHHHcC---C--------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            9754321  111111100   0              01111233456788999999999999999999999999986544


Q ss_pred             c
Q 039720          967 I  967 (973)
Q Consensus       967 ~  967 (973)
                      .
T Consensus       355 ~  355 (382)
T 3tt0_A          355 S  355 (382)
T ss_dssp             C
T ss_pred             h
Confidence            3

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-38  Score=351.44  Aligned_cols=254  Identities=19%  Similarity=0.256  Sum_probs=183.8

Q ss_pred             cCCc---CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCce
Q 039720          675 EFSS---SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       675 ~y~~---~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +|.+   .+.||+|+||+||+|++..+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+     ...
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~   80 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLH   80 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCE
Confidence            4544   37899999999999999999999999999643   3466788999999997 9999999999654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---cEEEeccccch
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLAR  827 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---~~kl~Dfg~a~  827 (973)
                      .++||||+++|+|.+++.....+++.++..++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999999999888888999999999999999999999   999999999999998766   89999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--ccHhhhhhHhc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG--LTLHGYAKMAL  905 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~--~~~~~~~~~~~  905 (973)
                      .....        ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.......  ...........
T Consensus       158 ~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~  229 (325)
T 3kn6_A          158 LKPPD--------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK  229 (325)
T ss_dssp             ECCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT
T ss_pred             ecCCC--------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH
Confidence            65432        222334568999999999999999999999999999999999999997653321  11111111100


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              .....   ............+.+++.+||+.||++|||++|+++.
T Consensus       230 --------~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          230 --------KGDFS---FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             --------TTCCC---CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             --------cCCCC---CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                    00000   0011223345678899999999999999999998854

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.3e-39  Score=359.88  Aligned_cols=246  Identities=26%  Similarity=0.301  Sum_probs=192.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHH-HHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEA-LRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...   ......+..|..+ ++.++||||+++++++..     .
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence            357999999999999999999999999999999997543   2234456677776 567899999999998643     5


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +..++||||+++|+|.+++...+.+.+..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+++.
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            78999999999999999999888888888999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+    .+.....   
T Consensus       189 ~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~---  253 (373)
T 2r5t_A          189 NIEH--------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILN---  253 (373)
T ss_dssp             GBCC--------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHHHHHH---
T ss_pred             cccC--------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHh---
Confidence            4321        223345679999999999999999999999999999999999999997542211    1111110   


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTA  954 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  954 (973)
                            ...       ..+......+.+++.+||+.||++||++.+
T Consensus       254 ------~~~-------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          254 ------KPL-------QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ------SCC-------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ------ccc-------CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                  000       001122345678888999999999999853

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-38  Score=344.00  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=192.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc----hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK----GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|++  +++.||||+++....    ...+.+.+|+++++.++||||+++++++..     .
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence            36899999999999999999998  589999999875432    234678899999999999999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCcEEecC--------CCc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP---IVHGDLKPSNVLLDH--------DMV  817 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~---ivHrDik~~NILl~~--------~~~  817 (973)
                      ...++||||+++++|.+++.. ...++..++.++.|++.|++|||++   +   |+||||||+||+++.        ++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             CceEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcc
Confidence            678999999999999999864 4667788999999999999999999   7   999999999999986        678


Q ss_pred             EEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      +||+|||.++.....          ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........  
T Consensus       155 ~kl~Dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--  222 (271)
T 3dtc_A          155 LKITDFGLAREWHRT----------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--  222 (271)
T ss_dssp             EEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--
T ss_pred             eEEccCCcccccccc----------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence            999999999865432          12234689999999999999999999999999999999999999975432111  


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                        ...... ..        .     ....+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       223 --~~~~~~-~~--------~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          223 --AYGVAM-NK--------L-----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --HHHHHT-SC--------C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --HHhhhc-CC--------C-----CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence              000000 00        0     0111123345678999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.9e-38  Score=340.95  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=204.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      +.|++.+.||+|+||+||+|.+..++..||+|++....  ....+.+.+|+.+++.++||||+++++++... ..+....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence            45888899999999999999999999999999997543  33457789999999999999999999987653 3445778


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEec-CCCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLD-HDMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~-~~~~~kl~Dfg~a~~  828 (973)
                      ++||||+++|+|.+++..........++.++.|++.||.|||+.   +  |+||||||+||+++ .++.+||+|||++..
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999999877888888999999999999999998   7  99999999999998 789999999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ...          .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.................    
T Consensus       182 ~~~----------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----  246 (290)
T 1t4h_A          182 KRA----------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----  246 (290)
T ss_dssp             CCT----------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC----
T ss_pred             ccc----------cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC----
Confidence            432          2223456899999999876 4589999999999999999999999976433211111110000    


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           .+        ..........+.+++.+||+.||++|||++|+++.
T Consensus       247 -----~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          247 -----KP--------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----CC--------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----Cc--------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                 00        01111223467899999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=354.10  Aligned_cols=244  Identities=23%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCceeEEeEeeec
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------GATKSFVAECEALRNIRHRNLIKIITICSSI  743 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  743 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++....        .....+.+|+.+++.++||||+++++++.. 
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            45789999999999999999999999999999999975431        123457789999999999999999998654 


Q ss_pred             ccCCCceEEEEEeeccCC-CHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          744 DFKGADFKAIVYEYMQYG-SVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                          ....++||||+.+| +|.+++.......+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       101 ----~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          101 ----QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             ----SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             ----CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence                47899999999777 9999999888888899999999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ||+++.....         .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......        
T Consensus       174 fg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------  236 (335)
T 3dls_A          174 FGSAAYLERG---------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------  236 (335)
T ss_dssp             CTTCEECCTT---------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------
T ss_pred             cccceECCCC---------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------
Confidence            9999866432         22334569999999999988887 88999999999999999999999742110        


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                 ......       .+..+...+.+++.+||+.||++|||++|+++.
T Consensus       237 -----------~~~~~~-------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----------VEAAIH-------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------TTTCCC-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------HhhccC-------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       000000       011123457789999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-38  Score=365.96  Aligned_cols=248  Identities=27%  Similarity=0.382  Sum_probs=205.2

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|.+.+.||+|+||+||+|++..+|+.||||++....   ......+.+|+.+++.++||||+++++++..     ...
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~~   90 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PSD   90 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence            57999999999999999999999999999999997542   2235678999999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++...+.+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999999999888888899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||......  .+..  ...     
T Consensus       168 ~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~--~i~-----  229 (476)
T 2y94_A          168 DG---------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFK--KIC-----  229 (476)
T ss_dssp             TT---------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHH--HHH-----
T ss_pred             cc---------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHH--HHh-----
Confidence            32         22234579999999999988876 78999999999999999999999754321  1111  110     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          +...    ..+   ......+.+++.+||+.||++|||++|+++.
T Consensus       230 ----~~~~----~~p---~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          230 ----DGIF----YTP---QYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ----TTCC----CCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----cCCc----CCC---ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                0000    001   1123456788999999999999999999974

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.2e-39  Score=364.28  Aligned_cols=261  Identities=20%  Similarity=0.253  Sum_probs=206.2

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeec
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSI  743 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  743 (973)
                      .++....++|++.+.||+|+||+||+|+++.+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+ 
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-  140 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  140 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence            344455689999999999999999999999999999999997432   2223457899999999999999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                          ....++||||+++|+|.++++.. .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       141 ----~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 ----DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             ----SSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ----CCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence                57899999999999999998764 577888999999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD----LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG  899 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~  899 (973)
                      |+|+......       .......+||+.|+|||++.+..    |+.++|||||||++|||++|+.||.......    .
T Consensus       213 G~a~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~  281 (410)
T 3v8s_A          213 GTCMKMNKEG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----T  281 (410)
T ss_dssp             TTCEECCTTS-------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH----H
T ss_pred             ceeEeeccCC-------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh----H
Confidence            9998654321       12233567999999999988765    7899999999999999999999997542211    1


Q ss_pred             hhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHHH
Q 039720          900 YAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSE--RMQMTAVVKKL  959 (973)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  959 (973)
                      +....         ........  + ........+.+++.+|++.+|++  ||+++||+++-
T Consensus       282 ~~~i~---------~~~~~~~~--p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          282 YSKIM---------NHKNSLTF--P-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             HHHHH---------THHHHCCC--C-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             HHHHH---------hccccccC--C-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            11110         00000000  0 00122345678888999999999  99999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.6e-38  Score=357.25  Aligned_cols=258  Identities=19%  Similarity=0.257  Sum_probs=195.9

Q ss_pred             hhcCCcC-CccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHH-HhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSS-NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|.+. +.||+|+||+||+|++..+++.||||+++..     ..+.+|+.++ +..+||||+++++++... +.+...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence            3467766 6899999999999999999999999999632     3466788887 455899999999987642 344578


Q ss_pred             EEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEEEecccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGL  825 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~kl~Dfg~  825 (973)
                      .++||||+++|+|.+++....  .+.+..++.++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            899999999999999998654  467888999999999999999999   9999999999999997   78999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ++.....         .......||+.|+|||++.+..|+.++|||||||++|||++|+.||..................
T Consensus       211 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          211 AKETTSH---------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             CEECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             ccccCCC---------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            9865321         2233557899999999999999999999999999999999999999765432211000001000


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      ...       ...     ......+...+.+++.+||+.||++|||++|++++-.
T Consensus       282 ~~~-------~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          282 GQY-------EFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             TCC-------CCC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             Ccc-------cCC-----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            000       000     0111234456788999999999999999999998643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-38  Score=366.19  Aligned_cols=207  Identities=23%  Similarity=0.295  Sum_probs=162.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  .....+++.+|+++++.++||||+++++++....+.....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36899999999999999999999999999999999643  2334577899999999999999999999987655566678


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .|+||||+. |+|.+++.....+.+..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            999999984 79999998887888899999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccCC-------------------CCCcccccccccccccCcccc-cCCCCCcccchHHHHHHHHHHHhC
Q 039720          831 HHPFLVAP-------------------EGQSSSIEMKGTIGYIGPEYG-MGGDLSMTGDVYSFGILLLEMFTR  883 (973)
Q Consensus       831 ~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~ll~elltg  883 (973)
                      ........                   .........+||+.|+|||++ .+..|+.++|||||||++|||++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            32110000                   001123456789999999976 566799999999999999999993

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.4e-38  Score=369.02  Aligned_cols=253  Identities=23%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....   ......+.+|+++++.++||||+++++++..     ..
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----CC
Confidence            467999999999999999999999999999999997532   2345678899999999999999999998643     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ..++||||++||+|.+++...+.  +++..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccce
Confidence            89999999999999999876543  67888999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .....         .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ......... 
T Consensus       335 ~~~~~---------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~i~~-  403 (576)
T 2acx_A          335 HVPEG---------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-  403 (576)
T ss_dssp             ECCTT---------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHHHHH-
T ss_pred             ecccC---------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHHhhc-
Confidence            65432         1223457999999999999999999999999999999999999999865432211 111110000 


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                           ...         ..+......+.+++.+||+.||++||     +++|++++
T Consensus       404 -----~~~---------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 -----VPE---------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -----CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -----ccc---------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                 000         01122335667888999999999999     78888764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.7e-39  Score=370.25  Aligned_cols=250  Identities=24%  Similarity=0.275  Sum_probs=196.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++..   .......+.+|+.+++.++||||+++++++..     .+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence            46799999999999999999999999999999999753   23344567889999999999999999998765     37


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++|+|.+++.....+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            899999999999999999988888889999999999999999998 7   999999999999999999999999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        ........||+.|+|||++.+..|+.++|||||||++|||++|+.||......  .+......   ..
T Consensus       299 ~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~---~~  365 (446)
T 4ejn_A          299 GIKD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM---EE  365 (446)
T ss_dssp             TCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH---CC
T ss_pred             ccCC--------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHh---CC
Confidence            4321        22233467999999999999999999999999999999999999999754221  11111100   00


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                                     ...+......+.+++.+||+.||++||     +++|++++
T Consensus       366 ---------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          366 ---------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                           001112335677899999999999999     99999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-38  Score=370.06  Aligned_cols=256  Identities=24%  Similarity=0.408  Sum_probs=207.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++. ++..||||+++... ...+.+.+|+.+++.++||||+++++++.      .+..+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~  258 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIY  258 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred             hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccE
Confidence            468999999999999999999995 67899999997543 34678999999999999999999999864      25689


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+.+|+|.++++...  ..+...++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999999997542  456677889999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  +.......     
T Consensus       336 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~-----  401 (454)
T 1qcf_A          336 DNE-------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERG-----  401 (454)
T ss_dssp             CHH-------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHT-----
T ss_pred             CCc-------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----
Confidence            321       011122346778999999998999999999999999999999 999997643221  11111100     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                             .     ....+..++..+.++|.+||+.||++|||+++|++.|+++...
T Consensus       402 -------~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          402 -------Y-----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -------C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -------C-----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                   0     0111233456788999999999999999999999999998653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.9e-38  Score=340.30  Aligned_cols=253  Identities=20%  Similarity=0.311  Sum_probs=205.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++..     ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence            468999999999999999999999999999999997543  2344678899999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc---EEEeccccch
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV---AHVSDFGLAR  827 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~---~kl~Dfg~a~  827 (973)
                      .++||||+++++|.+.+......++..+..++.|++.|++|||+.   +|+||||||+||+++.++.   +||+|||.+.
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            899999999999999998888888899999999999999999999   9999999999999986655   9999999997


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .....         .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||......  ........... 
T Consensus       157 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~-  224 (284)
T 3kk8_A          157 EVNDS---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAY-  224 (284)
T ss_dssp             ECCSS---------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC-
T ss_pred             EcccC---------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhccc-
Confidence            65432         1223456899999999999999999999999999999999999999754321  11111110000 


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         ...          .......+..+.+++.+||+.||++|||++|+++.
T Consensus       225 ---~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 ---DYP----------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ---CCC----------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---cCC----------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence               000          01112234567789999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=347.72  Aligned_cols=268  Identities=20%  Similarity=0.284  Sum_probs=201.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.....  ...+.+.+|++++++++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            689999999999999999999999999999999865433  235678899999999999999999999765     3789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++++|.+++......++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            99999999999999988877888889999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC--cc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP--KK  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~  908 (973)
                      .        ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. ..........  ..
T Consensus       155 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~  225 (311)
T 4agu_A          155 P--------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPR  225 (311)
T ss_dssp             -------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHH
T ss_pred             c--------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccccc
Confidence            2        122234568999999999876 6789999999999999999999999976533211 1111110000  00


Q ss_pred             cc------cccC-cccccccCC---CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VM------GIVD-PSLLMEARG---PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~------~~~~-~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..      .... .........   ..........+.+++.+||+.||++|||++|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00      0000 000000000   00112344567899999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-38  Score=345.13  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=196.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.++||+|+||+||+|++.   ..||+|+++...  ....+.+.+|+++++.++||||+++++++.      ...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCc
Confidence            468999999999999999999874   359999997553  334567899999999999999999999753      256


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++++|.+++... ....+..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            88999999999999999644 4566788899999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ....      .........||+.|+|||++.   +..++.++||||||+++|+|++|+.||...................
T Consensus       171 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (289)
T 3og7_A          171 SRWS------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS  244 (289)
T ss_dssp             -------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred             cccc------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence            4321      122233456899999999986   6678999999999999999999999997654322111111111110


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ..        .      ......++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       245 ~~--------~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          245 PD--------L------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CC--------T------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cc--------h------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            00        0      11112345678899999999999999999999999998853

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=355.15  Aligned_cols=246  Identities=21%  Similarity=0.281  Sum_probs=195.4

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      .+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|++++++++||||+++++++..     ....++||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEEeCC
Confidence            5689999999999999999999999999987665667789999999999999999999998654     47899999999


Q ss_pred             cCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe--cCCCcEEEeccccchhccCCCCc
Q 039720          759 QYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL--DHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       759 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl--~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ++|+|.+++... ....+..++.++.||+.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++......  
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--  243 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--  243 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--
Confidence            999999988654 3467788899999999999999999   99999999999999  567899999999998764321  


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCc
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP  915 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (973)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.........      .. 
T Consensus       244 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~------~~-  308 (373)
T 2x4f_A          244 -------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWD------LE-  308 (373)
T ss_dssp             -------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC------SC-
T ss_pred             -------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC------CC-
Confidence                   2223469999999999999999999999999999999999999997543211 11111110000      00 


Q ss_pred             ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                              ..........+.+++.+||+.||++||+++|+++
T Consensus       309 --------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 --------DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             --------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    1111233456788999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.8e-38  Score=350.27  Aligned_cols=250  Identities=22%  Similarity=0.270  Sum_probs=194.5

Q ss_pred             hhcCCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK----KGATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||+||+|++.   .+++.||+|+++...    ......+.+|+.+++.++||||+++++++..   
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence            368999999999999999999985   689999999997542    2234567889999999999999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                        ....++||||+++|+|.+++...+...+..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           93 --GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             --SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence              478999999999999999999888888888999999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ++.....        ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+......  
T Consensus       168 ~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~--  236 (327)
T 3a62_A          168 CKESIHD--------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKC--  236 (327)
T ss_dssp             C------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHT--
T ss_pred             ccccccC--------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC--
Confidence            9754321        122234579999999999999999999999999999999999999997543211 01010000  


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                                .       ...+......+.+++.+||+.||++||     +++|++++
T Consensus       237 ----------~-------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          237 ----------K-------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----------C-------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----------C-------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                      0       000112334567888999999999999     77888764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-38  Score=372.47  Aligned_cols=256  Identities=25%  Similarity=0.441  Sum_probs=209.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..+|++.+.||+|+||+||+|++..++..||||+++.... ..+.+.+|+.++++++||||++++++|..     ....+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence            3578999999999999999999988899999999975433 46779999999999999999999999754     36789


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++....  ......++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            9999999999999998643  356677889999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .+......      
T Consensus       370 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~------  434 (495)
T 1opk_A          370 GDT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK------  434 (495)
T ss_dssp             TCC-------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT------
T ss_pred             CCc-------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc------
Confidence            321       111223346778999999999999999999999999999999 99999765322  11111110      


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                            ..     ....+..++..+.++|.+||+.||++|||++|+++.|+.+.
T Consensus       435 ------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 ------DY-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ------TC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ------CC-----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                  00     01112334567789999999999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-38  Score=342.31  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=203.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..++..||+|++....   ......+.+|+.+++.++||||+++++++..     ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----CC
Confidence            468999999999999999999999999999999996432   2235678899999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++|+|.+++.......+..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++...
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            8999999999999999998888888889999999999999999999   9999999999999999999999999998644


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..          .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......    .+......   
T Consensus       160 ~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~---  222 (279)
T 3fdn_A          160 PS----------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRV---  222 (279)
T ss_dssp             ------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHT---
T ss_pred             Cc----------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHHHHHhC---
Confidence            32          12234568999999999999999999999999999999999999997542211    11111000   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                          .         ...+......+.+++.+||+.||++||+++|+++.-
T Consensus       223 ----~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          223 ----E---------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ----C---------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ----C---------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                0         001112334567889999999999999999999754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-38  Score=353.69  Aligned_cols=263  Identities=21%  Similarity=0.322  Sum_probs=206.9

Q ss_pred             HhhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSID  744 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  744 (973)
                      ..++|.+.+.||+|+||+||+|++     ..++..||||+++... ....+.+.+|+.+++++ +||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            347899999999999999999997     3467789999997442 23457789999999999 89999999998654  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCC-----------------------CchhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTND-----------------------KLEVGKLNIVIEVASVIEYLHNHCQPPIV  801 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------~~~~~~~~i~~qi~~aL~~LH~~~~~~iv  801 (973)
                         ....++||||+++|+|.+++.....                       +++..++.++.|++.||+|||+.   +|+
T Consensus       121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence               4678999999999999999976532                       46677889999999999999999   999


Q ss_pred             ecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHH
Q 039720          802 HGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF  881 (973)
Q Consensus       802 HrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ell  881 (973)
                      ||||||+||+++.++.+||+|||++.......      .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDS------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCc------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            99999999999999999999999998654321      112233456788999999999999999999999999999999


Q ss_pred             h-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          882 T-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       882 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      | |+.||........ +.......        ..         ...+..++..+.+++.+||+.||++||+++|+++.|+
T Consensus       269 t~g~~p~~~~~~~~~-~~~~~~~~--------~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          269 SLGVNPYPGIPVDAN-FYKLIQNG--------FK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             TTSCCSSTTCCCSHH-HHHHHHTT--------CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCCcccCCcHHH-HHHHHhcC--------CC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            8 9999976543221 11111100        00         1111223456778999999999999999999999999


Q ss_pred             hccccc
Q 039720          961 AVGEIF  966 (973)
Q Consensus       961 ~~~~~~  966 (973)
                      .+....
T Consensus       331 ~~~~~~  336 (344)
T 1rjb_A          331 CQLADA  336 (344)
T ss_dssp             HHC---
T ss_pred             HHHHHH
Confidence            886543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.8e-39  Score=357.01  Aligned_cols=278  Identities=23%  Similarity=0.299  Sum_probs=213.0

Q ss_pred             hhcCCcCCccccccceeEEEEE----ECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGN----LGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|+    +..+++.||||++........+.+.+|+++++.++||||+++++++..   .+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence            3689999999999999999999    467899999999987766667789999999999999999999998653   245


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++++|.+++... ....+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence            7789999999999999999863 4567788999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .......     .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....+........  ....
T Consensus       176 ~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~  248 (327)
T 3lxl_A          176 LLPLDKD-----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE--RDVP  248 (327)
T ss_dssp             ECCTTCS-----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CC
T ss_pred             ecccCCc-----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc--cccc
Confidence            7643221     01122234578889999999999999999999999999999999999864322100000000  0000


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      .......  ..........+..++..+.+++.+||+.||++|||++|+++.|+++...
T Consensus       249 ~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          249 ALSRLLE--LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             cHHHHHH--HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            0000000  0000011122234556788999999999999999999999999988543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-38  Score=346.47  Aligned_cols=263  Identities=17%  Similarity=0.190  Sum_probs=201.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++..     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence            35789999999999999999999999999999999975432   234678999999999999999999998765     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+++++|.+++.......+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            78999999999999999999887888889999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      .....       ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......  .+........   
T Consensus       184 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~---  251 (309)
T 2h34_A          184 TTDEK-------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI---  251 (309)
T ss_dssp             --------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC---
T ss_pred             ccccc-------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC---
Confidence            54321       12223456899999999999999999999999999999999999999754221  1111000000   


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHhccccc
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-QMTAVVKKLCAVGEIF  966 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  966 (973)
                          ...        ......++..+.+++.+||+.||++|| +++++++.|+++....
T Consensus       252 ----~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          252 ----PRP--------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ----CCG--------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ----CCc--------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                000        001122344677899999999999999 9999999999875443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3e-37  Score=359.83  Aligned_cols=348  Identities=27%  Similarity=0.376  Sum_probs=212.6

Q ss_pred             cccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEE
Q 039720          156 NWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEA  235 (973)
Q Consensus       156 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  235 (973)
                      .+.+|+.|++++|.++ .+| .+..+++|++|+|++|++++.. . +.++++|++|++++|.+++..+  +.++++|++|
T Consensus        44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  117 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT-P-LKNLTKLVDILMNNNQIADITP--LANLTNLTGL  117 (466)
T ss_dssp             HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCch-h-hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence            3456677777777766 344 3666777777777777776433 3 7777777777777777765444  6666777777


Q ss_pred             EccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccC
Q 039720          236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       236 ~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      ++++|+++ .+|.  +.++++|++|++++|.+++. + .+.++++|++|+++ |.+.+..  .+..+++|++|++++|.+
T Consensus       118 ~L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l  189 (466)
T 1o6v_A          118 TLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV  189 (466)
T ss_dssp             ECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             ECCCCCCC-CChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence            77777666 3333  33667777777777776643 2 36677777777775 4444332  266666666666666665


Q ss_pred             CCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCC
Q 039720          316 GTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT  395 (973)
Q Consensus       316 ~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  395 (973)
                      +.++        .+..+++|+.|++++|.+.+                         ..|  ++.+++|+.|++++|+++
T Consensus       190 ~~~~--------~l~~l~~L~~L~l~~n~l~~-------------------------~~~--~~~l~~L~~L~l~~n~l~  234 (466)
T 1o6v_A          190 SDIS--------VLAKLTNLESLIATNNQISD-------------------------ITP--LGILTNLDELSLNGNQLK  234 (466)
T ss_dssp             CCCG--------GGGGCTTCSEEECCSSCCCC-------------------------CGG--GGGCTTCCEEECCSSCCC
T ss_pred             CCCh--------hhccCCCCCEEEecCCcccc-------------------------ccc--ccccCCCCEEECCCCCcc
Confidence            4321        12333333333333333221                         111  333445555555555554


Q ss_pred             CCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccc
Q 039720          396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF  475 (973)
Q Consensus       396 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  475 (973)
                      +.  ..+..+++|++|++++|++.+..+  +..+++|++|++++|++++..+  +..+++|+                  
T Consensus       235 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~------------------  290 (466)
T 1o6v_A          235 DI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT------------------  290 (466)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS------------------
T ss_pred             cc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccC------------------
Confidence            32  234455555555555555554332  4445555555555555543222  34444444                  


Q ss_pred             ccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCe
Q 039720          476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKE  555 (973)
Q Consensus       476 ~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  555 (973)
                             .|++++|++++..|  ++.+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.
T Consensus       291 -------~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~  357 (466)
T 1o6v_A          291 -------NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINW  357 (466)
T ss_dssp             -------EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred             -------eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCE
Confidence                   55555555554333  6677788888888888886655  67788888888888888754  46778888888


Q ss_pred             ecCCCCccccccCCCCCCCCccceEeccCCcCcCcC
Q 039720          556 LDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKV  591 (973)
Q Consensus       556 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  591 (973)
                      |++++|++++..|  +..+++|+.|++++|++++.+
T Consensus       358 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             EECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred             EeCCCCccCccch--hhcCCCCCEEeccCCcccCCc
Confidence            8888888887766  788888888888888888753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-37  Score=343.71  Aligned_cols=277  Identities=26%  Similarity=0.365  Sum_probs=206.9

Q ss_pred             HHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc--CCCCceeEEeEeeecccCC
Q 039720          670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI--RHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       670 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~  747 (973)
                      ....++|++.+.||+|+||+||+|++  +++.||||++....   ......|.+++...  +||||+++++++... ...
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~~~  106 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG-TGS  106 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-CGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-CCC
Confidence            34567999999999999999999998  58999999996432   34445566665554  899999999987653 222


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEecCCCcEEEec
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC-----QPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                      ....++||||+++|+|.+++... ...+..++.++.|++.||+|||+.+     .++|+||||||+||+++.++.+||+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            36789999999999999999764 5777889999999999999999752     33899999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcc------cchHHHHHHHHHHHhC----------CCC
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMT------GDVYSFGILLLEMFTR----------RRP  886 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~ll~elltg----------~~P  886 (973)
                      ||+++.......    ..........||+.|+|||++.+..+..+      +|||||||++|||++|          +.|
T Consensus       186 fg~a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          186 LGLAVKFISDTN----EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             CTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             CCCceeeccccc----cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999976543221    00111224569999999999988776665      9999999999999999          666


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      |.....................    ..+..    .......+++..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKK----LRPSF----PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSC----CCCCC----CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HhhhcCCCCchhhhHHHHhhhc----cCccc----cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            6554443332222222211111    11111    11112346788899999999999999999999999999988643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-38  Score=348.43  Aligned_cols=260  Identities=22%  Similarity=0.361  Sum_probs=209.1

Q ss_pred             hhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKK-GATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++..   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence            46899999999999999999985     45778999999975543 3457789999999999 89999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                        ....++||||+++|+|.+++....                  ...+..++.++.|++.||+|||+.   +|+||||||
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A           99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence              467899999999999999998654                  256788899999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +||+++.++.+||+|||+++......      .........+|+.|+|||++.+..++.++||||||+++|+|++ |+.|
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDS------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCT------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccc------cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999998664322      1112223457889999999999999999999999999999999 9999


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      |........ .........        .         ...+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       248 ~~~~~~~~~-~~~~~~~~~--------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          248 YPGMPVDSK-FYKMIKEGF--------R---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             STTCCSSHH-HHHHHHHTC--------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccchhH-HHHHhccCC--------C---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            976543321 111111100        0         00112234567789999999999999999999999998743

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.7e-38  Score=343.15  Aligned_cols=266  Identities=22%  Similarity=0.356  Sum_probs=198.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||+||+|++ .+|+.||+|+++....  ...+.+.+|+++++.++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            5799999999999999999999 5899999999975432  234678899999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+.+ +|.+++... +...+..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            999999985 899888764 5567788899999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cCc-
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LPK-  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~-  907 (973)
                      ..        ........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. +....... .+. 
T Consensus       152 ~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  222 (288)
T 1ob3_A          152 IP--------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNS  222 (288)
T ss_dssp             C-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCT
T ss_pred             cc--------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCCh
Confidence            32        1122344689999999998764 589999999999999999999999976432211 11111110 000 


Q ss_pred             -c---ccc--ccCcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 -K---VMG--IVDPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 -~---~~~--~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .   ...  ..++........  ..........+.+++.+||+.||++|||++|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0   000  001111000000  01112234567789999999999999999999864

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=368.86  Aligned_cols=348  Identities=22%  Similarity=0.198  Sum_probs=223.8

Q ss_pred             EEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCC
Q 039720          186 TFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQN  265 (973)
Q Consensus       186 ~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N  265 (973)
                      .++.+++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..+ .++++|++|+|++|
T Consensus        15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~n   90 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF-NNLFNLRTLGLRSN   90 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT-TTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhh-hCCccCCEEECCCC
Confidence            3444444444 3443332  344455555555544444444444444444444444432222222 25666677777777


Q ss_pred             cccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccc
Q 039720          266 NLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRF  345 (973)
Q Consensus       266 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l  345 (973)
                      .++...+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+..                            
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------------  142 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY----------------------------  142 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE----------------------------
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce----------------------------
Confidence            7765555566667777777777776666666666666666666666555432                            


Q ss_pred             cCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCc
Q 039720          346 GGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDP  425 (973)
Q Consensus       346 ~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  425 (973)
                                                 ..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+..+..
T Consensus       143 ---------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~  195 (477)
T 2id5_A          143 ---------------------------ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS  195 (477)
T ss_dssp             ---------------------------ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTC
T ss_pred             ---------------------------eChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhh
Confidence                                       23344555666666666666666555556666666666666666666655556


Q ss_pred             cCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCccccccccc
Q 039720          426 IGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSL  505 (973)
Q Consensus       426 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L  505 (973)
                      |..+++|++|++++|.+.+.+|.......+|+                         .|++++|++++..+..+..+++|
T Consensus       196 ~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~-------------------------~L~l~~n~l~~~~~~~~~~l~~L  250 (477)
T 2id5_A          196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-------------------------SLSITHCNLTAVPYLAVRHLVYL  250 (477)
T ss_dssp             SCSCTTCCEEEEECCTTCCEECTTTTTTCCCS-------------------------EEEEESSCCCSCCHHHHTTCTTC
T ss_pred             cccCcccceeeCCCCccccccCcccccCcccc-------------------------EEECcCCcccccCHHHhcCcccc
Confidence            66666666666666655544444333333333                         56666666664444567788889


Q ss_pred             ceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCC
Q 039720          506 VQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN  585 (973)
Q Consensus       506 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  585 (973)
                      +.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus       251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  330 (477)
T 2id5_A          251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN  330 (477)
T ss_dssp             CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred             CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence            99999999988777778888899999999999998888888889999999999999998766677888999999999999


Q ss_pred             cCcCcCCCCCCCCCccccccccCccccCCCCC
Q 039720          586 HFEGKVPKKGVFSNETRISLTGNEQFCGGLGE  617 (973)
Q Consensus       586 ~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~~~  617 (973)
                      ++.+..+....+.......+.++...|++|..
T Consensus       331 ~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          331 PLACDCRLLWVFRRRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             CEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred             CccCccchHhHHhhhhccccCccCceeCCchH
Confidence            98876554322333445667788888887654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.7e-38  Score=348.69  Aligned_cols=267  Identities=24%  Similarity=0.404  Sum_probs=199.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECC---CCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGE---DGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      ..++|.+.+.||+|+||+||+|++..   ++..||+|+++...  ....+.+.+|+.++++++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45789999999999999999998865   45689999997543  33456789999999999999999999998764333


Q ss_pred             CCceEEEEEeeccCCCHHHHhhh------cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEE
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHH------TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHV  820 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl  820 (973)
                      .....++||||+++|+|.+++..      ....++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence            33467999999999999999842      34566788999999999999999999   9999999999999999999999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhh
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHG  899 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~  899 (973)
                      +|||+++......      .........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......  ...
T Consensus       189 ~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~  260 (313)
T 3brb_A          189 ADFGLSKKIYSGD------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYD  260 (313)
T ss_dssp             CSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH
T ss_pred             eecCcceeccccc------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHH
Confidence            9999998654321      1122233457889999999999999999999999999999999 999987643321  111


Q ss_pred             hhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          900 YAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                      .....        .         ....+..++..+.+++.+||+.||++||+++|+++.|+++.+.+
T Consensus       261 ~~~~~--------~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          261 YLLHG--------H---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHTT--------C---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHcC--------C---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            10000        0         01112234456789999999999999999999999999886543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.3e-38  Score=351.16  Aligned_cols=255  Identities=23%  Similarity=0.304  Sum_probs=201.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCce
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++......    ..+|++++.++ +||||+++++++.+     ...
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDD-----GKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEEC-----SSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEc-----CCE
Confidence            356899999999999999999999999999999999755432    34688888887 79999999998643     578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC----CcEEEeccccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD----MVAHVSDFGLA  826 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~----~~~kl~Dfg~a  826 (973)
                      .++||||+++|+|.+++...+.+.+..+..++.||+.||+|||++   +|+||||||+||++..+    +.+||+|||++
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            999999999999999998888888899999999999999999999   99999999999998543    35999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      +.....        ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.......  ..........
T Consensus       168 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~  237 (342)
T 2qr7_A          168 KQLRAE--------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIGS  237 (342)
T ss_dssp             EECBCT--------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHHH
T ss_pred             ccCcCC--------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHcc
Confidence            865432        122334578999999999988889999999999999999999999997543221  1111111000


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ..    .  ...     ...+......+.+++.+||+.||++||+++|++++-
T Consensus       238 ~~----~--~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          238 GK----F--SLS-----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             CC----C--CCC-----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             CC----c--ccC-----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            00    0  000     011123345677899999999999999999998753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.8e-38  Score=346.60  Aligned_cols=274  Identities=20%  Similarity=0.259  Sum_probs=201.3

Q ss_pred             hhcCCcC-CccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSS-NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|.+. +.||+|+||+||+|++..+++.||||++........+.+.+|++++.++ +||||+++++++..     .+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence            3578885 7899999999999999999999999999866655677899999999985 79999999999765     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc---EEEeccccch
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV---AHVSDFGLAR  827 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~---~kl~Dfg~a~  827 (973)
                      .++||||+++|+|.+++......++..++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++.
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999999999888888889999999999999999999   9999999999999998776   9999999997


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      ......... ...........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+........
T Consensus       163 ~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          163 GIKLNGDCS-PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             --------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             ccccCCccc-cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            653221000 001112223469999999999875     56789999999999999999999999865432211000000


Q ss_pred             -HhcCcccccccCcccccccCCCc-hhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          903 -MALPKKVMGIVDPSLLMEARGPS-KFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       903 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       ..........+..   .....+. .....+..+.+++.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          242 CPACQNMLFESIQE---GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CHHHHHHHHHHHHH---CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhHHHHHHHHHhc---cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             0000000000000   0000010 011234567899999999999999999999884

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.8e-38  Score=342.34  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=203.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++  +++.||||+++...  ....+.+.+|+.++++++||||+++++++...   ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            36899999999999999999999  58999999997653  33456799999999999999999999987532   2367


Q ss_pred             EEEEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEecCCCcEEEeccccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .++||||+++|+|.+++.....  .++..++.++.|++.||.|||+.   +  |+||||||+||+++.++.++++|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccce
Confidence            8999999999999999987653  67788999999999999999998   7  999999999999999999999999987


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCc---ccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSM---TGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      .....             ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||........    ....
T Consensus       161 ~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~  223 (271)
T 3kmu_A          161 FSFQS-------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----GMKV  223 (271)
T ss_dssp             CTTSC-------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----HHHH
T ss_pred             eeecc-------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----HHHH
Confidence            64321             1345899999999988765544   79999999999999999999975432211    0000


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ..     ....         +..+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       224 ~~-----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          224 AL-----EGLR---------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HH-----SCCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             Hh-----cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            00     0000         11112334567889999999999999999999999998864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.1e-38  Score=338.66  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=208.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence            468999999999999999999999999999999997543 3345778999999999999999999998764     3788


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++++|.+++......++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            99999999999999998877788888999999999999999999   999999999999999999999999999976532


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..      .........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............+......    
T Consensus       158 ~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----  227 (276)
T 2yex_A          158 NN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----  227 (276)
T ss_dssp             TT------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT----
T ss_pred             Cc------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc----
Confidence            21      0112234568999999999988775 788999999999999999999998654433222222111000    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                   .......+..+.+++.+||+.||++|||++|+++.
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 -------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                         01112234567789999999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-38  Score=342.76  Aligned_cols=257  Identities=22%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECC---CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE---DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|++..   ++..||+|+++... ....+.+.+|+.+++.++||||+++++++..      
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence            4689999999999999999998753   34569999997553 3356779999999999999999999998643      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++++|.+++.... ...+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            45689999999999999997654 467788899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......       ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......  ..........
T Consensus       162 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~  232 (281)
T 3cc6_A          162 YIEDED-------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDR  232 (281)
T ss_dssp             CC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCC
T ss_pred             cccccc-------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCC
Confidence            654321       112223457889999999998999999999999999999998 999997543321  1111111000


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                       ...+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       233 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          233 -----------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                             01112234567789999999999999999999999998753

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-37  Score=339.91  Aligned_cols=271  Identities=18%  Similarity=0.226  Sum_probs=210.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....  .+.+.+|+.+++.++|++++..+.++..    .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence            4689999999999999999999999999999999875433  3458899999999999888877776543    347889


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---cCCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl---~~~~~~kl~Dfg~a~~  828 (973)
                      +||||+ +++|.+++.. ....++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||.++.
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999999 8999999974 44567888999999999999999999   99999999999999   4888999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--ccHhhhhhHhcC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG--LTLHGYAKMALP  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~--~~~~~~~~~~~~  906 (973)
                      ......... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+.........
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          158 YRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCB-CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccccccccc-cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            654321000 00112334579999999999999999999999999999999999999998653321  111111111100


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccC
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG  968 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  968 (973)
                      ...              ......++..+.+++.+||+.||++||+++|+++.|+++......
T Consensus       237 ~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          237 TPI--------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             SCH--------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             Cch--------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            000              000122345678999999999999999999999999988654433

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-38  Score=350.92  Aligned_cols=262  Identities=20%  Similarity=0.266  Sum_probs=201.0

Q ss_pred             HHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCceeEEeEeeec
Q 039720          669 LSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-----KGATKSFVAECEALRNIRHRNLIKIITICSSI  743 (973)
Q Consensus       669 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  743 (973)
                      +....++|++.+.||+|+||+||+|++..+++.||+|++....     ....+.+.+|+++++.++||||+++++++.. 
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-   99 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-   99 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence            3456679999999999999999999999999999999997442     3445789999999999999999999999754 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcC----------------------------------------CCchhhHHHHHH
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTN----------------------------------------DKLEVGKLNIVI  783 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------------------------~~~~~~~~~i~~  783 (973)
                          ....++||||+++|+|.+++....                                        ...+..++.++.
T Consensus       100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A          100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence                478999999999999999985210                                        113455778999


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC--cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC
Q 039720          784 EVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM--VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG  861 (973)
Q Consensus       784 qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  861 (973)
                      |++.||+|||+.   +|+||||||+||+++.++  .+||+|||+++.+....    ...........||+.|+|||++.+
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~  248 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN----NGEYYGMTTKAGTPYFVAPEVLNT  248 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTT----CC--------CCCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccC----ccccccccccCCCccccCchhhcc
Confidence            999999999999   999999999999998776  89999999998654321    011112334569999999999875


Q ss_pred             --CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHh
Q 039720          862 --GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGV  939 (973)
Q Consensus       862 --~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  939 (973)
                        ..++.++|||||||++|||++|+.||......+. .......            ....   ...........+.+++.
T Consensus       249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~------------~~~~---~~~~~~~~~~~~~~li~  312 (345)
T 3hko_A          249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNK------------KLCF---ENPNYNVLSPLARDLLS  312 (345)
T ss_dssp             SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC------------CCCT---TSGGGGGSCHHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhc------------cccc---CCcccccCCHHHHHHHH
Confidence              6789999999999999999999999975432211 1110000            0000   01111233456788999


Q ss_pred             hcCCCCCCCCCCHHHHHHH
Q 039720          940 ACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       940 ~cl~~dP~~RPs~~evl~~  958 (973)
                      +||+.||++||++.|+++.
T Consensus       313 ~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          313 NLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHSCSCTTTSCCHHHHHHS
T ss_pred             HHcCCChhHCCCHHHHhcC
Confidence            9999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.3e-38  Score=343.80  Aligned_cols=268  Identities=24%  Similarity=0.388  Sum_probs=207.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC---cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG---MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..+|++.+.||+|+||+||+|++..++   ..||+|++.... ....+.+.+|+.++++++||||+++++++..    ..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence            357899999999999999999975433   468999986433 3445778999999999999999999998643    34


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++|+|.+++.... ......++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            67889999999999999997643 456778899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......    ..........+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||........ ........  
T Consensus       177 ~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~~~~--  249 (298)
T 3f66_A          177 DMYDKEY----YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQGR--  249 (298)
T ss_dssp             CCSCGGG----CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHHTTC--
T ss_pred             cccccch----hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhcCC--
Confidence            6643221    01122234457889999999999999999999999999999999 5666654433221 11110000  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCCC
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPP  970 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  970 (973)
                                      ....+..++..+.+++.+||+.||++||+++|+++.|+++...+.+..
T Consensus       250 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~  297 (298)
T 3f66_A          250 ----------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  297 (298)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCSC
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence                            001112234567889999999999999999999999999988877653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=351.06  Aligned_cols=258  Identities=22%  Similarity=0.372  Sum_probs=200.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEE----EEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSV----AVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++|++.+.||+|+||+||+|++..+++.|    |+|.+... .....+.+.+|+.+++.++||||+++++++..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            368999999999999999999998888765    66665432 33456789999999999999999999998764     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                       ...++|+||+.+|+|.+++... ....+..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             -CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence             3478999999999999999764 4567788999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +......      .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  +........
T Consensus       165 ~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~  236 (327)
T 3lzb_A          165 KLLGAEE------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE  236 (327)
T ss_dssp             ---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC
T ss_pred             eEccCcc------ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC
Confidence            8764322      1222223456788999999999999999999999999999999 999997653321  111111000


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                       ....+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       237 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 -----------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                             011112234567789999999999999999999999998853

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-37  Score=339.68  Aligned_cols=271  Identities=18%  Similarity=0.232  Sum_probs=207.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.....  ...+.+|+.+++.++|++++..+.++..    .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence            45789999999999999999999999999999999764432  2357889999999999888887777643    34788


Q ss_pred             EEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---cCCCcEEEeccccch
Q 039720          752 AIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAR  827 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl---~~~~~~kl~Dfg~a~  827 (973)
                      ++||||+ +++|.+++.. ....++..++.++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||+++
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999999 9999999974 44567888999999999999999999   99999999999999   788999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc--cHhhhhhHhc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL--TLHGYAKMAL  905 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~--~~~~~~~~~~  905 (973)
                      .......... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||........  .+........
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCB-CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eccCcccCcc-CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            7654321000 001223345799999999999999999999999999999999999999986543321  1111111110


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccccc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFI  967 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  967 (973)
                      ....              ......++..+.+++.+||+.||++||+++|+++.|+++.....
T Consensus       236 ~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          236 STPI--------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HSCH--------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cchh--------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            0000              00011224577899999999999999999999999998865443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.4e-38  Score=348.41  Aligned_cols=267  Identities=21%  Similarity=0.358  Sum_probs=211.6

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEE-----CCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCCceeEEeE
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKK-GATKSFVAECEALRNI-RHRNLIKIITI  739 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~  739 (973)
                      .......++|++.+.||+|+||+||+|++     ..+++.||||+++.... ...+.+.+|+.+++++ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            33444567999999999999999999985     35778999999975433 3446789999999999 79999999998


Q ss_pred             eeecccCCCceEEEEEeeccCCCHHHHhhhcCC----------------CchhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 039720          740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTND----------------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHG  803 (973)
Q Consensus       740 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  803 (973)
                      +...    ....++||||+++|+|.+++.....                ..+..++.++.|++.||.|||+.   +|+||
T Consensus       100 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A          100 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             ECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            7542    3568999999999999999987554                56678899999999999999999   99999


Q ss_pred             CCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-
Q 039720          804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-  882 (973)
Q Consensus       804 Dik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-  882 (973)
                      ||||+||+++.++.+||+|||+++......      .........||+.|+|||++.+..++.++|||||||++|+|++ 
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~  246 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  246 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             cCccceEEECCCCCEEECCCccccccccCc------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence            999999999999999999999998654321      1122334567889999999999999999999999999999998 


Q ss_pred             CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          883 RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       883 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      |+.||................. .                 ...+..+...+.+++.+||+.||++|||++|+++.|+++
T Consensus       247 g~~p~~~~~~~~~~~~~~~~~~-~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          247 GASPYPGVKIDEEFCRRLKEGT-R-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTC-C-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcccchhHHHHHHhccCc-c-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            9999976543321111111100 0                 001112344677899999999999999999999999987


Q ss_pred             cc
Q 039720          963 GE  964 (973)
Q Consensus       963 ~~  964 (973)
                      ..
T Consensus       309 ~~  310 (316)
T 2xir_A          309 LQ  310 (316)
T ss_dssp             HH
T ss_pred             Hh
Confidence            53

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.2e-39  Score=354.44  Aligned_cols=279  Identities=24%  Similarity=0.347  Sum_probs=211.7

Q ss_pred             cC-CcCCccccccceeEEEEEE----CCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          675 EF-SSSNRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       675 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      +| ++.+.||+|+||+||+|++    ..+++.||||+++... ....+.+.+|+++++.++||||+++++++...   +.
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~  107 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GA  107 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TT
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CC
Confidence            45 9999999999999988764    3478999999997653 23456789999999999999999999997652   34


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+++|+|.+++.... ..+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             ceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence            67899999999999999997654 67788999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-Cc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-PK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~  907 (973)
                      ......     .........+|+.|+|||++.+..++.++||||||+++|+|++|+.||............+..... ..
T Consensus       184 ~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          184 VPEGHE-----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL  258 (318)
T ss_dssp             CCTTCS-----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred             cccccc-----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence            643220     011223345788899999999989999999999999999999999998753221100000000000 00


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCCC
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPP  970 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  970 (973)
                      .....+..     ......+..++..+.+++.+||+.||++|||++|+++.|+++.+.+.+++
T Consensus       259 ~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          259 RLTELLER-----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             HHHHHHHT-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             HHHHHHhc-----ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            00000000     01112223445678899999999999999999999999999988887664

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-38  Score=345.45  Aligned_cols=245  Identities=21%  Similarity=0.248  Sum_probs=192.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.++||+|+||+||+|++..+|+.||||++....  .........|+..+..+ +||||++++++|.+     ...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence            57999999999999999999999999999999986543  22334555666666555 89999999999765     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+ +++|.+++...+ .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            99999999 678998887644 467888999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...         .......||+.|+|||++.+ .++.++|||||||++|||++|..|+....    .   +.....    
T Consensus       208 ~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~---~~~~~~----  266 (311)
T 3p1a_A          208 GTA---------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G---WQQLRQ----  266 (311)
T ss_dssp             C---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H---HHHHTT----
T ss_pred             ccC---------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H---HHHHhc----
Confidence            432         12234468999999999876 78999999999999999999977654321    1   111100    


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       ....         +.........+.+++.+||+.||++|||++|+++.
T Consensus       267 -~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 -GYLP---------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             -TCCC---------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -cCCC---------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence             0000         11122345678899999999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.8e-38  Score=348.86  Aligned_cols=271  Identities=19%  Similarity=0.249  Sum_probs=194.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecc---cCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSID---FKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~---~~~~  748 (973)
                      ..+|++.+.||+|+||+||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++....   ....
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            358999999999999999999999999999999997766666778999999999996 999999999875321   2345


Q ss_pred             ceEEEEEeeccCCCHHHHhhh---cCCCchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEecCCCcEEEecc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHH---TNDKLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                      ...++||||+. |+|.+++..   .+.+.+..++.++.||+.||+|||+.   +  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence            66899999996 789888864   44567788999999999999999998   8  999999999999999999999999


Q ss_pred             ccchhccCCCCccCCC----CCcccccccccccccCcccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 039720          824 GLARFLSHHPFLVAPE----GQSSSIEMKGTIGYIGPEYG---MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT  896 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~  896 (973)
                      |+++............    .........||+.|+|||++   .+..++.++|||||||++|+|++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765432100000    00111234589999999998   56678999999999999999999999997532210  


Q ss_pred             HhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCC
Q 039720          897 LHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGP  969 (973)
Q Consensus       897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  969 (973)
                         .            .......     .........+.+++.+||+.||++||+++|+++.|+++......+
T Consensus       261 ---~------------~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          261 ---I------------VNGKYSI-----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             --------------------CCC-----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---h------------hcCcccC-----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence               0            0000000     000111223668889999999999999999999999886544433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.9e-38  Score=350.76  Aligned_cols=271  Identities=20%  Similarity=0.298  Sum_probs=197.4

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++....  ...+.+.+|+.+++.++||||+++++++..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            455789999999999999999999999999999999975432  234567899999999999999999999765     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec-----CCCcEEEecc
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-----HDMVAHVSDF  823 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~-----~~~~~kl~Df  823 (973)
                      ...++||||+. |+|.+++.......+..++.++.||+.||+|||++   +|+||||||+||+++     .++.+||+||
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             CEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            78999999998 59999999888888899999999999999999999   999999999999994     4556999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      |+++.....        ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus       182 g~a~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  253 (329)
T 3gbz_A          182 GLARAFGIP--------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV  253 (329)
T ss_dssp             THHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             CCccccCCc--------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence            999876432        1223345689999999998874 5899999999999999999999999764332111111111


Q ss_pred             HhcCcc--c---ccccCcc-cccccCCC----chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          903 MALPKK--V---MGIVDPS-LLMEARGP----SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       903 ~~~~~~--~---~~~~~~~-~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...+..  .   ....+.. ........    .........+.+++.+||+.||++|||++|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            111100  0   0000000 00000000    0011134567899999999999999999999873

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.9e-38  Score=346.57  Aligned_cols=272  Identities=23%  Similarity=0.351  Sum_probs=206.0

Q ss_pred             hcCCcCCccccccceeEEEEE----ECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGN----LGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|++.+.||+|+||+||+|+    +..+++.||+|+++... ....+.+.+|+++++.++||||+++++++...   +.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            568999999999999999999    56689999999997443 33457789999999999999999999987642   23


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++|+|.+++... ....+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            5689999999999999999544 4567788999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .......     .........||..|+|||++.+..++.++||||+|+++|+|++|+.|+......      ......+.
T Consensus       175 ~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~  243 (302)
T 4e5w_A          175 AIETDKE-----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL------FLKMIGPT  243 (302)
T ss_dssp             ECCTTCC-----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHHHCSC
T ss_pred             cccCCCc-----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH------HhhccCCc
Confidence            7654321     011223345788899999999999999999999999999999999986532110      00000000


Q ss_pred             c---cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 K---VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .   ....+.... ........+..++..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       244 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          244 HGQMTVTRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CGGGHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHH-hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0   000000000 000011122334567889999999999999999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-37  Score=363.49  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=203.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|.+.+.||+|+||+||+|+++.+|+.||+|++....   ......+.+|+++++.++||||+++++++..     ..
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence            367999999999999999999999999999999997542   2334678899999999999999999998543     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC----CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN----DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ..++||||++||+|.+++....    .+.+..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecce
Confidence            8999999999999999987643    567788899999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ++.....        ........||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ........
T Consensus       336 a~~~~~~--------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~  406 (543)
T 3c4z_A          336 AVELKAG--------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVL  406 (543)
T ss_dssp             CEECCTT--------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHH
T ss_pred             eeeccCC--------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHh
Confidence            9865432        11223457999999999999999999999999999999999999999865332111 11111110


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM-----TAVVK  957 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  957 (973)
                      ...               ...+...+..+.+++.+||+.||++||++     +|+++
T Consensus       407 ~~~---------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          407 EQA---------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HCC---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             hcc---------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            000               01112234566788899999999999965     66664

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.6e-37  Score=337.31  Aligned_cols=258  Identities=20%  Similarity=0.292  Sum_probs=206.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK------GATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++....      ...+.+.+|+++++.++||||+++++++..    
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   79 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----   79 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence            3679999999999999999999999999999999975432      135779999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC----cEEEec
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSD  822 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~----~~kl~D  822 (973)
                       ....++||||+++++|.+++......++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           80 -KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             -CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence             478999999999999999998877888899999999999999999999   999999999999998877    899999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      ||.+......         .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......    ....
T Consensus       156 fg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~  222 (283)
T 3bhy_A          156 FGIAHKIEAG---------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE----TLTN  222 (283)
T ss_dssp             CTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH
T ss_pred             cccceeccCC---------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----HHHH
Confidence            9999865432         12234568999999999999999999999999999999999999997543211    1111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HHHhcc
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK--KLCAVG  963 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  963 (973)
                      ....       .....     .......+..+.+++.+||+.||++||+++|+++  .+++++
T Consensus       223 ~~~~-------~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          223 ISAV-------NYDFD-----EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHTT-------CCCCC-----HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             hHhc-------ccCCc-----chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            0000       00000     1111233456778999999999999999999997  345543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.8e-38  Score=341.44  Aligned_cols=260  Identities=24%  Similarity=0.404  Sum_probs=207.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||+||+|++. ++..||+|+++... ...+.+.+|+++++.++||||+++++++..      +..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~   82 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI   82 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCc
Confidence            3468999999999999999999985 67899999997543 245778999999999999999999998642      458


Q ss_pred             EEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ++||||+++++|.+++....  ..++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+...
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            89999999999999997643  567788999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....       ........+++.|+|||++.+..++.++||||||+++|||++ |+.||.......  ........    
T Consensus       160 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~----  226 (279)
T 1qpc_A          160 EDNE-------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERG----  226 (279)
T ss_dssp             SSSC-------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT----
T ss_pred             cCcc-------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhcc----
Confidence            4322       112223446788999999988899999999999999999999 999997543211  11110000    


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccC
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG  968 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  968 (973)
                          ..         ...+..++..+.+++.+||+.||++|||++++++.|+++.....+
T Consensus       227 ----~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          227 ----YR---------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             ----CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             ----cC---------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence                00         011123345678899999999999999999999999988655443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-37  Score=338.43  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=196.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|.+.++||+|+||+||+|++..++..||+|++.... ....+.+.+|+++++.++||||+++++++..     ....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeE
Confidence            368999999999999999999999999999999997654 3345788999999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---cCCCcEEEeccc
Q 039720          752 AIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFG  824 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl---~~~~~~kl~Dfg  824 (973)
                      ++||||+++|+|.+++...    ...++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            9999999999999988543    5677788999999999999999999   99999999999999   456789999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      ++......         .......||+.|+|||++. ..++.++||||||+++|||++|+.||.......  ........
T Consensus       173 ~a~~~~~~---------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~  240 (285)
T 3is5_A          173 LAELFKSD---------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYK  240 (285)
T ss_dssp             CCCC-------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC
T ss_pred             cceecCCc---------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccC
Confidence            99765432         1223456899999999875 568999999999999999999999997543211  11111110


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .         ......      .......+.+++.+||+.||++|||++|+++.
T Consensus       241 ~---------~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          241 E---------PNYAVE------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             C---------CCCCC--------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             C---------cccccc------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0         000000      01123456788999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-38  Score=339.70  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=206.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|+++++.++||||+++++++..     ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeE
Confidence            368999999999999999999996 788999999975543 34678999999999999999999998654     46789


Q ss_pred             EEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+++++|.+++... ....+..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++....
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999999999865 3467788899999999999999999   999999999999999999999999999986533


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..       ........+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.......  ........      
T Consensus       157 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~------  221 (267)
T 3t9t_A          157 DQ-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTG------  221 (267)
T ss_dssp             HH-------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTT------
T ss_pred             cc-------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcC------
Confidence            11       111223456788999999998899999999999999999999 899997542211  11100000      


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                        ..         ...+...+..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus       222 --~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 --FR---------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --Cc---------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              00         00111224567789999999999999999999999998854

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-37  Score=338.27  Aligned_cols=256  Identities=20%  Similarity=0.285  Sum_probs=208.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++..     ..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence            368999999999999999999999999999999996432   2234678999999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++|+|.+++...+...+..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            8999999999999999999887888889999999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...          ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......    ...... ..  
T Consensus       165 ~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~-~~--  227 (284)
T 2vgo_A          165 PSL----------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRIV-NV--  227 (284)
T ss_dssp             SSS----------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHH-TT--
T ss_pred             ccc----------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----HHHHHh-cc--
Confidence            321          1224568999999999999999999999999999999999999997542211    010100 00  


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HHHhccccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK--KLCAVGEIF  966 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~  966 (973)
                          +..         .+......+.+++.+|++.||++||+++|+++  .++......
T Consensus       228 ----~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          228 ----DLK---------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             ----CCC---------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             ----ccC---------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence                000         01122345678999999999999999999997  444444333

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=353.60  Aligned_cols=277  Identities=21%  Similarity=0.352  Sum_probs=213.1

Q ss_pred             hhcCCcCCccccccceeEEEEE----ECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGN----LGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||.||+|+    +..+++.||||++........+.+.+|+++++.++||||+++++++...   +.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence            4679999999999999999999    4568999999999876666677899999999999999999999986532   23


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++++|.+++.... ...+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            46899999999999999998754 467788899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC-
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP-  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~-  906 (973)
                      .......     .........++..|+|||++.+..++.++||||||+++|||++|..||.....+.   ......... 
T Consensus       194 ~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~---~~~~~~~~~~  265 (326)
T 2w1i_A          194 VLPQDKE-----YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGNDKQG  265 (326)
T ss_dssp             ECCSSCS-----EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH---HHHHCTTCCT
T ss_pred             hcccccc-----ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH---HHhhccccch
Confidence            7643220     0011223356778999999998889999999999999999999999986431110   000000000 


Q ss_pred             ----cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccC
Q 039720          907 ----KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG  968 (973)
Q Consensus       907 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  968 (973)
                          ..+.+.+..     ......+..++..+.+++.+||+.||++||+++|+++.|+++.+.+.|
T Consensus       266 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~g  326 (326)
T 2w1i_A          266 QMIVFHLIELLKN-----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG  326 (326)
T ss_dssp             HHHHHHHHHHHHT-----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             hhhHHHHHHHhhc-----CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcC
Confidence                000000000     001112233456788999999999999999999999999999887654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.3e-38  Score=349.19  Aligned_cols=269  Identities=22%  Similarity=0.314  Sum_probs=203.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++..     ...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence            4689999999999999999999999999999999865432  234668899999999999999999999765     378


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||++++++.++........+..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++...
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            999999999999999887777788889999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc----
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL----  905 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~----  905 (973)
                      ..        ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||........ +........    
T Consensus       176 ~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  246 (331)
T 4aaa_A          176 AP--------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIP  246 (331)
T ss_dssp             ----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCH
T ss_pred             CC--------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCh
Confidence            32        1222345689999999998875 789999999999999999999999976533211 111110000    


Q ss_pred             --------CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 --------PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              .........+..............++..+.+++.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                    00000000011100000001112345678899999999999999999998864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.9e-38  Score=337.94  Aligned_cols=250  Identities=23%  Similarity=0.394  Sum_probs=183.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|+.+++.++||||+++++++..     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence            468999999999999999999999899999999997442   2234678999999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++++|.+++... ...++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            899999999999999999865 4567788999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....        ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.........            
T Consensus       162 ~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------  221 (278)
T 3cok_A          162 LKMP--------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------------  221 (278)
T ss_dssp             CC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------
T ss_pred             ccCC--------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------------
Confidence            5422        11222456899999999999999999999999999999999999999754322110            


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .......    ...+   ......+.+++.+||+.||++||+++|+++.
T Consensus       222 -~~~~~~~----~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          222 -NKVVLAD----YEMP---SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ---CCSSC----CCCC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -HHHhhcc----cCCc---cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence             0000000    0001   1233467789999999999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-37  Score=354.12  Aligned_cols=278  Identities=22%  Similarity=0.343  Sum_probs=195.6

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  748 (973)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++...  .......+.+|+.+++.+. ||||+++++++..   .+.
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence            457899999999999999999999999999999998533  3345567889999999997 9999999998754   234


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||||+. |+|.+++... ...+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CEEEEEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            57899999998 5899988763 567788889999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccC-------------CCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 039720          829 LSHHPFLVA-------------PEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG  894 (973)
Q Consensus       829 ~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~  894 (973)
                      .........             ...........||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            543210000             011222344679999999999876 678999999999999999999999997643211


Q ss_pred             ccHhhhhhH-hcCcc--cccccCcc-------ccc-----ccCCCchhH-------------HHHHHHHHHHhhcCCCCC
Q 039720          895 LTLHGYAKM-ALPKK--VMGIVDPS-------LLM-----EARGPSKFE-------------ECLVAVVRTGVACSMESP  946 (973)
Q Consensus       895 ~~~~~~~~~-~~~~~--~~~~~~~~-------~~~-----~~~~~~~~~-------------~~~~~l~~li~~cl~~dP  946 (973)
                       .+...... ..+..  +.....+.       +..     .........             .+...+.+++.+||+.||
T Consensus       239 -~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          239 -QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             -HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             -HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence             11111110 00000  00000000       000     000000000             234567899999999999


Q ss_pred             CCCCCHHHHHHH
Q 039720          947 SERMQMTAVVKK  958 (973)
Q Consensus       947 ~~RPs~~evl~~  958 (973)
                      ++|||++|++++
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-37  Score=341.70  Aligned_cols=253  Identities=22%  Similarity=0.292  Sum_probs=204.0

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|.+.+.||+|+||+||+|++..+|+.||+|+++.........+.+|+.+++.++||||+++++++..     ....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEE
Confidence            34689999999999999999999999999999999986655455678899999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---cCCCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl---~~~~~~kl~Dfg~a~~  828 (973)
                      ++||||+++++|.+++...+..++..+..++.|++.|+.|||+.   +|+||||||+||++   +.++.+||+|||.++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            99999999999999998887888889999999999999999999   99999999999999   7889999999999874


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ...          .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......  .+.........  
T Consensus       159 ~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~--  224 (304)
T 2jam_A          159 EQN----------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGYY--  224 (304)
T ss_dssp             CCC----------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCCC--
T ss_pred             cCC----------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCC--
Confidence            321          1223456899999999999999999999999999999999999999754321  11111000000  


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        . ..         .......+..+.+++.+||+.||++||+++|+++.
T Consensus       225 --~-~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 --E-FE---------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             --C-CC---------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             --C-CC---------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0 00         01112334567789999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-37  Score=340.80  Aligned_cols=268  Identities=23%  Similarity=0.357  Sum_probs=208.0

Q ss_pred             cCCcCCccccccceeEEEEEECCCCc---EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGM---SVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .|.+.+.||+|+||+||+|++..++.   .||+|++.... ....+.+.+|+.+++.++||||+++++++...    ...
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCC
Confidence            56677999999999999999765544   79999987433 33457789999999999999999999987542    344


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+.+|+|.+++... ....+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            58999999999999999763 4456778899999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ......    .........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+....... .+........    
T Consensus       175 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~----  245 (298)
T 3pls_A          175 LDREYY----SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQGR----  245 (298)
T ss_dssp             TTGGGG----CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTTC----
T ss_pred             cCCccc----ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcCC----
Confidence            432110    1122234567889999999999999999999999999999999665544322221 1111111100    


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGPPI  971 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~  971 (973)
                                   ....+..++..+.+++.+||+.||++|||++|+++.|+++.+.+.+...
T Consensus       246 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~  294 (298)
T 3pls_A          246 -------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY  294 (298)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred             -------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence                         0111122345677899999999999999999999999999887776554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.7e-38  Score=341.37  Aligned_cols=251  Identities=18%  Similarity=0.257  Sum_probs=207.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++..     .+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CC
Confidence            468999999999999999999999999999999997542   3345678899999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++++|.+++.......+.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            8999999999999999998887888899999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||......+    .+......   
T Consensus       166 ~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~---  230 (294)
T 2rku_A          166 EYD--------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKN---  230 (294)
T ss_dssp             CST--------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTT---
T ss_pred             ccC--------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhhc---
Confidence            422        112234568999999999999999999999999999999999999997543211    11111000   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                            .       ...+......+.+++.+||+.||++||+++|+++.-
T Consensus       231 ------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          231 ------E-------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             ------C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ------c-------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                  0       000112234567889999999999999999999853

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-38  Score=355.65  Aligned_cols=266  Identities=24%  Similarity=0.413  Sum_probs=199.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCC---CcEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..|.+.+.||+|+||+||+|++..+   +..||+|+++.. .....+.+.+|+.++++++||||++++++|..    ...
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCC
Confidence            4577889999999999999987533   246899998643 33456789999999999999999999998643    346


Q ss_pred             eEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++|+|.+++.... ......++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence            7889999999999999997654 356677889999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ......    ..........+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+.  .......  .
T Consensus       242 ~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~~~--~  313 (373)
T 3c1x_A          242 MYDKEF----DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQG--R  313 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHHTT--C
T ss_pred             cccccc----ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHHcC--C
Confidence            543211    01112233457889999999999999999999999999999999 7778875533221  1111100  0


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCC
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGP  969 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  969 (973)
                                     ....+..++..+.+++.+||+.||++||+++|+++.|+++...+.+.
T Consensus       314 ---------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          314 ---------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                           01111233456789999999999999999999999999987666543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.9e-38  Score=349.23  Aligned_cols=260  Identities=23%  Similarity=0.398  Sum_probs=206.6

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-------CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-------EDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      .++|++.+.||+|+||+||+|++.       .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.. 
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence            468999999999999999999985       467889999997543 23456789999999999 89999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCC----------------CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTND----------------KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                          ....++||||+++|+|.+++.....                .....++.++.|++.||+|||+.   +|+||||||
T Consensus       113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  185 (334)
T 2pvf_A          113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  185 (334)
T ss_dssp             ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence                4688999999999999999986542                56677899999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +||+++.++.+||+|||+++.......      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSS------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ceEEEcCCCCEEEcccccccccccccc------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999986643221      112223457788999999988899999999999999999999 9999


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      |......  .+........                 ....+..++..+.+++.+||+.||++||+++|+++.|+++...
T Consensus       260 ~~~~~~~--~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          260 YPGIPVE--ELFKLLKEGH-----------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             STTCCHH--HHHHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCcCCHH--HHHHHHhcCC-----------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9754221  1111111000                 0111123345678899999999999999999999999988543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1e-37  Score=345.57  Aligned_cols=253  Identities=22%  Similarity=0.280  Sum_probs=200.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCceeEEeEeeec
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------GATKSFVAECEALRNIRHRNLIKIITICSSI  743 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  743 (973)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.....        .....+.+|+++++.++||||+++++++.. 
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence            34689999999999999999999999999999999964321        123457899999999999999999998643 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc---EEE
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV---AHV  820 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~---~kl  820 (973)
                           ...++||||+++++|.+++.......+..++.++.|++.||+|||++   +|+||||||+||+++.++.   +||
T Consensus        87 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           87 -----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             -----SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             -----CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence                 34899999999999999998887888888999999999999999999   9999999999999987664   999


Q ss_pred             eccccchhccCCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          821 SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       821 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      +|||+++....         ........||+.|+|||++.   ...++.++|||||||++|+|++|+.||..........
T Consensus       159 ~Dfg~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (322)
T 2ycf_A          159 TDFGHSKILGE---------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK  229 (322)
T ss_dssp             CCCTTCEECCC---------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH
T ss_pred             ccCccceeccc---------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH
Confidence            99999986532         12223456899999999863   5678999999999999999999999997654332211


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .........      .         .+......+..+.+++.+||+.||++||+++|+++
T Consensus       230 ~~~~~~~~~------~---------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          230 DQITSGKYN------F---------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHTCCC------C---------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhCccc------c---------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            111111000      0         01111233566789999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-38  Score=364.23  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=203.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.++||+|+||+||+|++. .+..||||+++.... ..+.+.+|++++++++||||+++++++..      ...+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            467899999999999999999996 457799999975432 45679999999999999999999998643      5688


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++...  ......++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            999999999999999753  3467788999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  +......      
T Consensus       332 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~------  396 (452)
T 1fmk_A          332 DNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER------  396 (452)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT------
T ss_pred             CCc-------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc------
Confidence            321       111223446788999999999999999999999999999999 999997643221  1111000      


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                            ..     ....+..++..+.++|.+||+.||++|||++++++.|+++....
T Consensus       397 ------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          397 ------GY-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ------TC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ------CC-----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                  00     01112344567889999999999999999999999999886543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.7e-38  Score=343.69  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=205.5

Q ss_pred             hhcCCcCC-ccccccceeEEEEEE--CCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          673 TKEFSSSN-RIGKGSFGFVYKGNL--GEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       673 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      .++|.+.+ .||+|+||+||+|.+  ..+++.||||+++...  ....+.+.+|+++++.++||||+++++++.      
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------   88 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------   88 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence            46788888 999999999999954  5678899999997543  233577999999999999999999999873      


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      .+..++||||+++++|.+++.......+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            257889999999999999999887788889999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......     .........+++.|+|||++.+..++.++||||||+++|+|++ |+.||......  .+........ 
T Consensus       166 ~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~-  237 (291)
T 1xbb_A          166 ALRADEN-----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE-  237 (291)
T ss_dssp             ECCTTCS-----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC-
T ss_pred             eeccCCC-----cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC-
Confidence            6643221     0111222346788999999988889999999999999999999 99999764321  1111111000 


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                                      ....+..++..+.+++.+||+.||++||+++|+++.|+++-
T Consensus       238 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          238 ----------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                            01111234456789999999999999999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.2e-37  Score=344.89  Aligned_cols=272  Identities=23%  Similarity=0.242  Sum_probs=205.4

Q ss_pred             ccHHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-----CCCceeEEe
Q 039720          664 VSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-----HRNLIKIIT  738 (973)
Q Consensus       664 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~  738 (973)
                      +++.+.....++|++.++||+|+||+||+|++..+++.||||+++.. ......+..|+.+++.+.     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            33344344567999999999999999999999999999999999743 234566788999999996     999999999


Q ss_pred             EeeecccCCCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC--
Q 039720          739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH--  814 (973)
Q Consensus       739 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~--  814 (973)
                      ++...     +..++||||+ +++|.+++....  ......++.++.||+.||+|||+.   +|+||||||+|||++.  
T Consensus       104 ~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          104 KFMYY-----DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEET-----TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             eeeEC-----CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            87653     7899999999 899999998654  467788999999999999999999   9999999999999975  


Q ss_pred             -----------------------CCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchH
Q 039720          815 -----------------------DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVY  871 (973)
Q Consensus       815 -----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw  871 (973)
                                             ++.+||+|||+|+....           ......||+.|+|||++.+..++.++|||
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  243 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----------YHGSIINTRQYRAPEVILNLGWDVSSDMW  243 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----------CCCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCC-----------CCcCccCcccccCcHHHcCCCCCCccchH
Confidence                                   78999999999986432           12245689999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh--cCccc---------ccccC-cccccccC---------------CC
Q 039720          872 SFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA--LPKKV---------MGIVD-PSLLMEAR---------------GP  924 (973)
Q Consensus       872 SlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~---------~~~~~-~~~~~~~~---------------~~  924 (973)
                      ||||++|+|++|+.||......+ .+.......  .+...         ....+ ........               .+
T Consensus       244 slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  322 (360)
T 3llt_A          244 SFGCVLAELYTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP  322 (360)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence            99999999999999997643211 111111110  00000         00000 00000000               00


Q ss_pred             chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          925 SKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       925 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .........+.+++.+||+.||++|||++|+++
T Consensus       323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            011111256779999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.5e-38  Score=341.70  Aligned_cols=254  Identities=21%  Similarity=0.352  Sum_probs=205.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc------
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF------  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  745 (973)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...    +.+.+|+++++.++||||+++++++....+      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3468999999999999999999999899999999997543    346689999999999999999998754221      


Q ss_pred             -----CCCceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcE
Q 039720          746 -----KGADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA  818 (973)
Q Consensus       746 -----~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~  818 (973)
                           ......++||||+++|+|.+++...  ...++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence                 2245689999999999999999754  4567788899999999999999999   99999999999999999999


Q ss_pred             EEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh
Q 039720          819 HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH  898 (973)
Q Consensus       819 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~  898 (973)
                      ||+|||.+.......         ......||+.|+|||++.+..++.++||||||+++|+|++|..|+....       
T Consensus       162 kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------  225 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------  225 (284)
T ss_dssp             EECCCTTCEESSCCS---------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------
T ss_pred             EECcchhheeccccc---------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------
Confidence            999999998664321         2223468999999999999999999999999999999999998864210       


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      .......        +...      +   ...+..+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus       226 ~~~~~~~--------~~~~------~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          226 KFFTDLR--------DGII------S---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHHHH--------TTCC------C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHHHHhh--------cccc------c---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            0100000        0000      0   11234567889999999999999999999999988654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.5e-38  Score=347.55  Aligned_cols=250  Identities=18%  Similarity=0.263  Sum_probs=206.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++..     ..
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence            468999999999999999999999999999999997542   3445778999999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++++|.+++.....+.+.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            8999999999999999998887888899999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+    .+.......  
T Consensus       192 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~--  257 (335)
T 2owb_A          192 EYD--------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKNE--  257 (335)
T ss_dssp             CST--------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTC--
T ss_pred             ccC--------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHhcCC--
Confidence            432        112234568999999999999999999999999999999999999997543211    111110000  


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                    ...+..+...+.+++.+||+.||++||+++|+++.
T Consensus       258 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 --------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                          00011223456788999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.2e-38  Score=340.90  Aligned_cols=251  Identities=30%  Similarity=0.410  Sum_probs=198.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++.+.  ..+.+.+|+++++.++||||+++++++..    .....+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence            46899999999999999999998  58999999997443  45778999999999999999999998643    235789


Q ss_pred             EEEeeccCCCHHHHhhhcCC--CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTND--KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++++|.+++.....  .++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            99999999999999976543  56677899999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..           .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......  ......    .. 
T Consensus       169 ~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~----~~-  230 (278)
T 1byg_A          169 ST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE----KG-  230 (278)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHT----TT-
T ss_pred             cc-----------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh----cC-
Confidence            21           112357889999999998999999999999999999998 999997643221  111100    00 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                         ..         ...+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       231 ---~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          231 ---YK---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ---CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CC---------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence               00         11112334567889999999999999999999999998854

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-37  Score=361.74  Aligned_cols=253  Identities=27%  Similarity=0.327  Sum_probs=204.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||++....  ......+.+|++++++++||||+++++++..     ..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CC
Confidence            3468999999999999999999999999999999996432  2345778999999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec---CCCcEEEeccccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLA  826 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~---~~~~~kl~Dfg~a  826 (973)
                      ..++||||+.+|+|.+.+.....+++..++.++.||+.||.|||++   +|+||||||+||+++   .++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            8999999999999999998888888899999999999999999999   999999999999995   4568999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      +.....         .......||+.|+|||++.+ .|+.++||||+||++|+|++|+.||......+ .+.........
T Consensus       172 ~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~  240 (486)
T 3mwu_A          172 TCFQQN---------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYA  240 (486)
T ss_dssp             TTBCCC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred             eECCCC---------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence            865432         22234569999999999876 58999999999999999999999997543211 11111010000


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                            .+         .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       241 ------~~---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 ------FD---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ------SC---------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ------CC---------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  00         11122344567789999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.8e-38  Score=341.38  Aligned_cols=257  Identities=22%  Similarity=0.276  Sum_probs=205.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++...   ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence            468999999999999999999999999999999997543  33456789999999999999999999987532   3468


Q ss_pred             EEEEEeeccCCCHHHHhhhcC----CCchhhHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCcEEecCCCcEEEe
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN----DKLEVGKLNIVIEVASVIEYLHNHCQPP-----IVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~-----ivHrDik~~NILl~~~~~~kl~  821 (973)
                      .++||||+++++|.+++....    ..++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+||+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            899999999999999987532    367788999999999999999999   7     9999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      |||.++.....        ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......  .+....
T Consensus       159 dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i  228 (279)
T 2w5a_A          159 DFGLARILNHD--------TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKI  228 (279)
T ss_dssp             CCCHHHHC-----------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred             cCchheeeccc--------cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHH
Confidence            99999875432        12223456899999999999999999999999999999999999999764321  111111


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ....        .         ...+..++..+.+++.+||+.||++||+++|+++.+...
T Consensus       229 ~~~~--------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          229 REGK--------F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             HHTC--------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             hhcc--------c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            1000        0         011122345677899999999999999999999876544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.6e-37  Score=341.24  Aligned_cols=277  Identities=22%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHh--cCCCCceeEEeEeeecc
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRN--IRHRNLIKIITICSSID  744 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~  744 (973)
                      ..-....++|++.+.||+|+||+||+|++  +++.||||++...   ....+.+|.+++..  ++||||+++++++... 
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~-  108 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD-  108 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC-
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc-
Confidence            33345667999999999999999999998  6999999999633   34567889999887  7899999999987653 


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEecCCC
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH--------NHCQPPIVHGDLKPSNVLLDHDM  816 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivHrDik~~NILl~~~~  816 (973)
                      .......++||||+++|+|.+++... ...+.+++.++.|++.||+|||        +.   +|+||||||+||+++.++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence            11123789999999999999999764 5677889999999999999999        77   999999999999999999


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC------CCCcccchHHHHHHHHHHHhC-------
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG------DLSMTGDVYSFGILLLEMFTR-------  883 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~ll~elltg-------  883 (973)
                      .+||+|||+++.........    ........||+.|+|||++.+.      .++.++|||||||++|||++|       
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEE----EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CEEEEECCCceecccccccc----ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999998664422000    0022345699999999998775      234789999999999999999       


Q ss_pred             ---CCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          884 ---RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       884 ---~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                         +.||............+........    ..+.+..    .....++...+.+++.+||+.||++|||++||++.|+
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccCccccCcCcccHHHHHHHHHHHH----hCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence               7788765444333333332221111    1111111    0122466778999999999999999999999999999


Q ss_pred             hcccc
Q 039720          961 AVGEI  965 (973)
Q Consensus       961 ~~~~~  965 (973)
                      ++.+.
T Consensus       333 ~i~~~  337 (342)
T 1b6c_B          333 QLSQQ  337 (342)
T ss_dssp             HHHHT
T ss_pred             HHHHH
Confidence            98654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-37  Score=358.40  Aligned_cols=212  Identities=23%  Similarity=0.286  Sum_probs=174.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..  .....+++.+|+++++.++||||+++++++....+.....
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            36899999999999999999999999999999999743  2334578899999999999999999999986654444578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+. |+|.+++.....+.+..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            999999987 59999998887788899999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccC--------------CCCCcccccccccccccCcccc-cCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 039720          831 HHPFLVA--------------PEGQSSSIEMKGTIGYIGPEYG-MGGDLSMTGDVYSFGILLLEMFTRRRPTD  888 (973)
Q Consensus       831 ~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~ll~elltg~~Pf~  888 (973)
                      .......              ...........||+.|+|||++ ....|+.++||||+||++|||++|..||.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            3221000              0000123566899999999985 56679999999999999999998666654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-38  Score=351.21  Aligned_cols=272  Identities=14%  Similarity=0.162  Sum_probs=207.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECC--------CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCcee---------
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE--------DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK---------  735 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  735 (973)
                      .++|++.+.||+|+||+||+|++..        .++.||||++...     +.+.+|++++++++|||+++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999987        3889999999744     35788999999999999987         


Q ss_pred             ------EEeEeeecccCCCceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          736 ------IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       736 ------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                            +++++..    .....++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++   +|+||||||
T Consensus       116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp  187 (352)
T 2jii_A          116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA  187 (352)
T ss_dssp             TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred             ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence                  4555432    347899999999 99999999875  6678889999999999999999999   999999999


Q ss_pred             CcEEecCCC--cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCC
Q 039720          808 SNVLLDHDM--VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRR  885 (973)
Q Consensus       808 ~NILl~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~  885 (973)
                      +||+++.++  .+||+|||+++......... ...........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV-AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCC-CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccc-cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999998  99999999998664321100 011112234579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          886 PTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       886 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      ||.........+........ .......+..        ......+..+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus       267 pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          267 PWTNCLPNTEDIMKQKQKFV-DKPGPFVGPC--------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTGGGTTCHHHHHHHHHHHH-HSCCCEECTT--------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcccCCcCHHHHHHHHHhcc-CChhhhhhhc--------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            99865433222222211110 0000000000        00112235677899999999999999999999999988655


Q ss_pred             cc
Q 039720          966 FI  967 (973)
Q Consensus       966 ~~  967 (973)
                      ..
T Consensus       338 ~~  339 (352)
T 2jii_A          338 LR  339 (352)
T ss_dssp             TT
T ss_pred             cC
Confidence            43

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.5e-37  Score=346.73  Aligned_cols=258  Identities=22%  Similarity=0.341  Sum_probs=206.1

Q ss_pred             HHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--------hhHHHHHHHHHHHHhc-CCCCceeEEe
Q 039720          668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------GATKSFVAECEALRNI-RHRNLIKIIT  738 (973)
Q Consensus       668 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~  738 (973)
                      ......++|.+.+.||+|+||.||+|++..+|+.||||+++....        ...+.+.+|+.+++.+ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            334556789999999999999999999988999999999975431        1245678999999999 7999999999


Q ss_pred             EeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcE
Q 039720          739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVA  818 (973)
Q Consensus       739 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~  818 (973)
                      ++..     ....++||||+++++|.+++.......+..+..++.||+.||.|||+.   ||+||||||+||+++.++.+
T Consensus       168 ~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          168 SYES-----SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEB-----SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEee-----CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            8654     478999999999999999998877788888999999999999999999   99999999999999999999


Q ss_pred             EEeccccchhccCCCCccCCCCCcccccccccccccCccccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 039720          819 HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM------GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN  892 (973)
Q Consensus       819 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~  892 (973)
                      ||+|||++......         .......||+.|+|||++.      ...++.++|||||||++|+|++|+.||.....
T Consensus       240 kl~DfG~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  310 (365)
T 2y7j_A          240 RLSDFGFSCHLEPG---------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ  310 (365)
T ss_dssp             EECCCTTCEECCTT---------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEecCcccccCCC---------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence            99999999866432         1223457999999999875      33688999999999999999999999975321


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .  .........       .....       .......+..+.+++.+||+.||++||+++|+++.
T Consensus       311 ~--~~~~~i~~~-------~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          311 I--LMLRMIMEG-------QYQFS-------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             H--HHHHHHHHT-------CCCCC-------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             H--HHHHHHHhC-------CCCCC-------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1  111110000       00000       00111234567889999999999999999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.9e-38  Score=353.88  Aligned_cols=266  Identities=23%  Similarity=0.314  Sum_probs=206.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..++..||+|+++... ....+.+.+|+.+++.++||||+++++++..     ....
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence            368999999999999999999999999999999998653 3345778999999999999999999998765     3789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++++|.+++...+..++..+..++.|++.|++|||+.+  +|+||||||+||+++.++.+||+|||++.....
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999999999998888888889999999999999999832  899999999999999999999999999976532


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC-----
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP-----  906 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----  906 (973)
                                .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ........     
T Consensus       185 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~  252 (360)
T 3eqc_A          185 ----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGCQVEGDAAE  252 (360)
T ss_dssp             ----------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH--HHHC---------
T ss_pred             ----------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcccccccCCC
Confidence                      1122456899999999999999999999999999999999999999754322110  00000000     


Q ss_pred             ----------------------cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 ----------------------KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                            .......+. .............+...+.+++.+||+.||++|||++|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDY-IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------------------CCCHHHHHHH-HHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhH-HhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                  000000000 000000001111234567899999999999999999999874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=347.56  Aligned_cols=253  Identities=22%  Similarity=0.350  Sum_probs=195.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCC--CCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRH--RNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|.+. +++.||||++....  ....+.+.+|+.+++.++|  |||+++++++..     .
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----C
Confidence            467999999999999999999984 79999999997543  3344678999999999976  999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||| +.+++|.+++.......+.++..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++.
T Consensus        82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            78999999 56789999999888888889999999999999999999   999999999999997 68899999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----------GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      .....      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+
T Consensus       157 ~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  230 (343)
T 3dbq_A          157 MQPDT------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  230 (343)
T ss_dssp             C------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred             cCccc------ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH
Confidence            54321      1112234579999999999764           678999999999999999999999997543321111


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ..   .         +++......  +   ......+.+++.+||+.||++|||++|+++.-
T Consensus       231 ~~---~---------~~~~~~~~~--~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          231 HA---I---------IDPNHEIEF--P---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             HH---H---------HCTTSCCCC--C---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HH---H---------hcCCcccCC--c---ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            11   1         111110001  1   11124567889999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-37  Score=348.22  Aligned_cols=249  Identities=27%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .+.|.+.+.||+|+||+||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++..     ..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            356999999999999999999999999999999997543   2234678999999999999999999998765     37


Q ss_pred             eEEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+. |++.+++.. .....+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            8999999997 678877754 45567788999999999999999999   999999999999999999999999999975


Q ss_pred             ccCCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ...            .....||+.|+|||++.   ...++.++|||||||++|||++|+.||......    ........
T Consensus       204 ~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~~~~~~  267 (348)
T 1u5q_A          204 MAP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQ  267 (348)
T ss_dssp             SSS------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH
T ss_pred             cCC------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHh
Confidence            432            12346899999999874   567899999999999999999999999754221    11111110


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      ..      .+..        ....++..+.+++.+||+.||++|||++|+++...
T Consensus       268 ~~------~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          268 NE------SPAL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             SC------CCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             cC------CCCC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            00      0000        01122345778899999999999999999987644

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=339.16  Aligned_cols=263  Identities=21%  Similarity=0.322  Sum_probs=208.1

Q ss_pred             hcCCcCC-ccccccceeEEEEEEC--CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSN-RIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|.+.+ .||+|+||+||+|.+.  .++..||||+++... ....+.+.+|+++++.++||||+++++++..      +
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence            4666666 8999999999999864  467889999997643 3456779999999999999999999998732      5


Q ss_pred             eEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++++|.+++... ...++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            689999999999999998754 3467788999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ......     .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......  +.......   
T Consensus       160 ~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~---  229 (287)
T 1u59_A          160 LGADDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQG---  229 (287)
T ss_dssp             CTTCSC-----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTT---
T ss_pred             eccCcc-----eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcC---
Confidence            643221     0111223346889999999988899999999999999999999 999997653321  11111100   


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccCC
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIGP  969 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  969 (973)
                           .         ....+..++..+.+++.+||+.||++||+++|+++.|+++-....++
T Consensus       230 -----~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          230 -----K---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             -----C---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             -----C---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence                 0         01112234567789999999999999999999999999886544443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.3e-37  Score=341.87  Aligned_cols=265  Identities=18%  Similarity=0.236  Sum_probs=204.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..   ..+.+.+|+.+++.++ ||||+++++++...   .....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCce
Confidence            36899999999999999999999999999999999643   3467889999999997 99999999987642   24678


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~~~~  830 (973)
                      ++||||+.+++|.+++..   ..+..+..++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||+++...
T Consensus       109 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            999999999999998854   56778899999999999999999   999999999999999777 89999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+............
T Consensus       183 ~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~  253 (330)
T 3nsz_A          183 PG---------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  253 (330)
T ss_dssp             TT---------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             CC---------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence            32         12234468999999999877 678999999999999999999999996543332222221111110000


Q ss_pred             cc---------------c---cCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MG---------------I---VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~---------------~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .+               .   .....+...............+.+++.+||+.||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00               0   0001111111112223345678899999999999999999999874

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.4e-37  Score=368.60  Aligned_cols=317  Identities=21%  Similarity=0.229  Sum_probs=175.6

Q ss_pred             ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEE
Q 039720          157 WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY  236 (973)
Q Consensus       157 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  236 (973)
                      +++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|.         
T Consensus        74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~---------  144 (597)
T 3oja_B           74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFH---------  144 (597)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT---------
T ss_pred             CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhc---------
Confidence            34445555555555544555666666666677776666666666666666666666666666533222222         


Q ss_pred             ccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       237 L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                                      ++++|++|+|++|.+++..|..|.++++|++|+|++|++++..   +..+++|+.|++++|.++
T Consensus       145 ----------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          145 ----------------NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             ----------------TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             ----------------cCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence                            4445555555555555555555666666666666666665432   333444555555544432


Q ss_pred             CCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCC
Q 039720          317 TRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG  396 (973)
Q Consensus       317 ~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  396 (973)
                      .+                                                            ....+|+.|++++|.++.
T Consensus       206 ~l------------------------------------------------------------~~~~~L~~L~ls~n~l~~  225 (597)
T 3oja_B          206 TL------------------------------------------------------------AIPIAVEELDASHNSINV  225 (597)
T ss_dssp             EE------------------------------------------------------------ECCTTCSEEECCSSCCCE
T ss_pred             cc------------------------------------------------------------cCCchhheeeccCCcccc
Confidence            10                                                            111234444454444442


Q ss_pred             CCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccc
Q 039720          397 TIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFG  476 (973)
Q Consensus       397 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  476 (973)
                      ..+. +  .++|+.|+|++|.+++  +..+..+++|++|+|++|.+++.+|                             
T Consensus       226 ~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~-----------------------------  271 (597)
T 3oja_B          226 VRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMY-----------------------------  271 (597)
T ss_dssp             EECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEES-----------------------------
T ss_pred             cccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCH-----------------------------
Confidence            2111 1  1234444444444442  1233333344444444443333333                             


Q ss_pred             cccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCee
Q 039720          477 ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKEL  556 (973)
Q Consensus       477 ~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  556 (973)
                                          ..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|
T Consensus       272 --------------------~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L  329 (597)
T 3oja_B          272 --------------------HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL  329 (597)
T ss_dssp             --------------------GGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred             --------------------HHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence                                333444455555555555553 3444455566666666666666 566677778888888


Q ss_pred             cCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCCCCCccccccccCccccCCCCCCCCC
Q 039720          557 DLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGELHLP  621 (973)
Q Consensus       557 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~~~~~~~  621 (973)
                      +|++|+|++ +|  +..+++|+.|++++|++.+..+. ..+..+....+.+++..|+.+......
T Consensus       330 ~L~~N~l~~-~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~~~~~  390 (597)
T 3oja_B          330 YLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQLEHG  390 (597)
T ss_dssp             ECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCEEETT
T ss_pred             ECCCCCCCC-cC--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchhccCC
Confidence            888888874 33  66778889999999998876432 346666677788999999986654443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=346.22  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=198.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCC----cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|++.+.||+|+||+||+|++..++    ..||||+++... ......+.+|+.+++.++||||+++++++..     .
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-----C
Confidence            57888899999999999999986543    469999997543 3345678999999999999999999998643     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++|+|.+++... ....+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            7899999999999999999764 4567788999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .......     .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .+......   
T Consensus       196 ~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~---  265 (333)
T 1mqb_A          196 VLEDDPE-----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIND---  265 (333)
T ss_dssp             --------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT---
T ss_pred             hhccccc-----cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHC---
Confidence            7643210     1111222346788999999999999999999999999999999 99999754321  11111000   


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .     .         ....+..++..+.+++.+||+.||++||+++|+++.|+++.
T Consensus       266 ~-----~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          266 G-----F---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             T-----C---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             C-----C---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0     0         01111234456788999999999999999999999998874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.6e-37  Score=375.46  Aligned_cols=250  Identities=22%  Similarity=0.266  Sum_probs=205.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  747 (973)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+..|..++..+ +||+|+++++++     .+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            346899999999999999999999999999999999753   233456788899999887 799999999874     45


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      .+..++||||+++|+|.++++..+.+.+..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence            688999999999999999999888889999999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .....        ........||+.|+|||++.+..|+.++|||||||++|||++|+.||......  .+  +.... ..
T Consensus       491 ~~~~~--------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~--~~~i~-~~  557 (674)
T 3pfq_A          491 ENIWD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL--FQSIM-EH  557 (674)
T ss_dssp             ECCCT--------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH--HHHHH-SS
T ss_pred             ccccC--------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HH--HHHHH-hC
Confidence            54321        22334567999999999999999999999999999999999999999754221  11  11111 00


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQM-----TAVVK  957 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  957 (973)
                              .       ...+.....++.+++.+||+.||++||++     +||++
T Consensus       558 --------~-------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 --------N-------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------C-------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------C-------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    0       01112234567788999999999999997     77765

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1e-37  Score=347.39  Aligned_cols=259  Identities=21%  Similarity=0.349  Sum_probs=207.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCc-----EEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGM-----SVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|.+.+.||+|+||+||+|++..++.     .||+|+++... ....+.+.+|+.+++.+ +||||+++++++..   
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  121 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH---  121 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence            4689999999999999999999976654     89999997543 33456789999999999 89999999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhc--------------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHT--------------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVL  811 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NIL  811 (973)
                        ....++||||+++|+|.+++...              ...+...++.++.|++.||+|||+.   +|+||||||+||+
T Consensus       122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence              46789999999999999998753              2346678899999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 039720          812 LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNM  890 (973)
Q Consensus       812 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~  890 (973)
                      ++.++.+||+|||+++......      .........+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDS------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCT------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ECCCCeEEECcccccccccccc------ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999998654321      1112223457889999999999999999999999999999999 99999765


Q ss_pred             CCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      ..... ..........                 ...+..++..+.+++.+||+.||++||+++|+++.|+++.
T Consensus       271 ~~~~~-~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          271 LVNSK-FYKLVKDGYQ-----------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             CSSHH-HHHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHH-HHHHHhcCCC-----------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            43321 1111111100                 0011122456778999999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-37  Score=334.47  Aligned_cols=249  Identities=26%  Similarity=0.357  Sum_probs=196.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.+++.++||||+++++++..     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            368999999999999999999999899999999997542   2335678899999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++++|.+++.......+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            8999999999999999998887888889999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ...         .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......  ..........   
T Consensus       162 ~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~---  227 (276)
T 2h6d_A          162 SDG---------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGV---  227 (276)
T ss_dssp             CC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC---
T ss_pred             CCC---------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCc---
Confidence            432         12234468999999999888766 68999999999999999999999753211  1111110000   


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                     ...+......+.+++.+||+.||++||+++|+++.
T Consensus       228 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 ---------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                           00011223457789999999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.3e-37  Score=361.62  Aligned_cols=252  Identities=21%  Similarity=0.319  Sum_probs=200.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..++..||+|+++...  ......+.+|+.+++.++||||+++++++..     ...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence            457999999999999999999999999999999997543  3345778999999999999999999999754     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC---CcEEEeccccch
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLAR  827 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~---~~~kl~Dfg~a~  827 (973)
                      .++||||+.+|+|.+.+.......+..++.++.||+.||.|||+.   +|+||||||+||+++..   +.+||+|||+|+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999999999998888888899999999999999999999   99999999999999764   559999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .....         .......||+.|+|||++. ..|+.++||||+||++|+|++|+.||......  .+........  
T Consensus       188 ~~~~~---------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~--  253 (494)
T 3lij_A          188 VFENQ---------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGK--  253 (494)
T ss_dssp             ECBTT---------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC--
T ss_pred             ECCCC---------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC--
Confidence            66432         2233456999999999876 56999999999999999999999999764322  1111111000  


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .   ..+         .......+..+.+++.+||+.||++|||++|+++.
T Consensus       254 ~---~~~---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          254 Y---TFD---------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             C---CCC---------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             C---CCC---------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0   000         11112334567789999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-37  Score=363.06  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=206.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|+.++++++||||+++++++..     ..
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence            458999999999999999999999999999999996542   3356789999999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---cCCCcEEEeccccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLA  826 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl---~~~~~~kl~Dfg~a  826 (973)
                      ..++||||+.+|+|.+++......++..++.++.||+.||.|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            8999999999999999998888888899999999999999999999   99999999999999   56789999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      +.....         .......||+.|+|||++.+ .|+.++||||+||++|+|++|+.||......  .+.......  
T Consensus       177 ~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~--  242 (484)
T 3nyv_A          177 THFEAS---------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKG--  242 (484)
T ss_dssp             HHBCCC---------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC--
T ss_pred             EEcccc---------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcC--
Confidence            876432         22344579999999999876 6899999999999999999999999754321  111111100  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .     ...       ........+..+.+++.+||+.||++|||++|++++
T Consensus       243 ~-----~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          243 K-----YTF-------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             C-----CCC-------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C-----CCC-------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            0     000       011122344567789999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-37  Score=348.00  Aligned_cols=269  Identities=20%  Similarity=0.255  Sum_probs=197.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+++++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            35799999999999999999999999999999999543  2334567899999999999999999999876431 12234


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+ +++|.+++.. ....+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            579999999 8899999876 4567788999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh--cC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA--LP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~--~~  906 (973)
                      ..           ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+.......  .+
T Consensus       179 ~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~  246 (367)
T 1cm8_A          179 DS-----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPP  246 (367)
T ss_dssp             CS-----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred             cc-----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCC
Confidence            32           1234568999999999877 689999999999999999999999997543211 111111100  00


Q ss_pred             cccccccCc--------cccc--ccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDP--------SLLM--EARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......+..        .+..  ..............+.+++.+|++.||++|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000000000        0000  000001112334567789999999999999999999884

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-38  Score=347.13  Aligned_cols=274  Identities=21%  Similarity=0.286  Sum_probs=197.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++..... ....+.+|+++++.++||||+++++++..     ....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            5799999999999999999999999999999999754321 12245679999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +||||+. |+|.+++...+ ...+..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9999998 58888887654 466788899999999999999999   999999999999999999999999999975432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc---Cc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL---PK  907 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~---~~  907 (973)
                      .        ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .+........   ..
T Consensus       153 ~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          153 P--------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEE  223 (324)
T ss_dssp             ------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred             C--------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChH
Confidence            1        122234568999999999876 578999999999999999999999998653321 1111111110   00


Q ss_pred             ccccccCccccc-----ccCC---CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HHHhcccc
Q 039720          908 KVMGIVDPSLLM-----EARG---PSKFEECLVAVVRTGVACSMESPSERMQMTAVVK--KLCAVGEI  965 (973)
Q Consensus       908 ~~~~~~~~~~~~-----~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~  965 (973)
                      ............     ....   ..........+.+++.+||+.||++|||++|+++  .+.++.+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            000000000000     0000   0011123456778999999999999999999988  34455443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-37  Score=346.27  Aligned_cols=264  Identities=25%  Similarity=0.394  Sum_probs=207.0

Q ss_pred             cCCCcccHHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEE--EEEEeeccc-chhHHHHHHHHHHHHhc-CCCCce
Q 039720          659 QQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSV--AVKVMNLDK-KGATKSFVAECEALRNI-RHRNLI  734 (973)
Q Consensus       659 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv  734 (973)
                      ..+|.+.+       ++|++.+.||+|+||.||+|++..++..+  |+|+++... ....+.+.+|+++++++ +||||+
T Consensus        17 ~~~p~~~~-------~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv   89 (327)
T 1fvr_A           17 TIYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII   89 (327)
T ss_dssp             CCSSBCCG-------GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBC
T ss_pred             cccccccH-------HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchh
Confidence            44565554       57999999999999999999998888865  999887432 33456788999999999 899999


Q ss_pred             eEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCC
Q 039720          735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQP  798 (973)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~  798 (973)
                      ++++++..     ....++||||+++|+|.+++....                ..++..++.++.|++.||+|||+.   
T Consensus        90 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---  161 (327)
T 1fvr_A           90 NLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---  161 (327)
T ss_dssp             CEEEEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             hhceeeee-----CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            99999755     378999999999999999997654                567788999999999999999999   


Q ss_pred             CeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHH
Q 039720          799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLL  878 (973)
Q Consensus       799 ~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~  878 (973)
                      +|+||||||+||+++.++.+||+|||+++....         ........+++.|+|||++.+..++.++|||||||++|
T Consensus       162 ~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  232 (327)
T 1fvr_A          162 QFIHRDLAARNILVGENYVAKIADFGLSRGQEV---------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  232 (327)
T ss_dssp             TEECSCCSGGGEEECGGGCEEECCTTCEESSCE---------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             CccCCCCccceEEEcCCCeEEEcccCcCccccc---------cccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence            999999999999999999999999999874321         11122345788999999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          879 EMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       879 ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ||++ |+.||......     ...... ...    ..         ...+..++..+.+++.+||+.||++||+++|+++
T Consensus       233 ellt~g~~pf~~~~~~-----~~~~~~-~~~----~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  293 (327)
T 1fvr_A          233 EIVSLGGTPYCGMTCA-----ELYEKL-PQG----YR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  293 (327)
T ss_dssp             HHHTTSCCTTTTCCHH-----HHHHHG-GGT----CC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCCCCCcHH-----HHHHHh-hcC----CC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9998 99999754321     111100 000    00         1111233456788999999999999999999999


Q ss_pred             HHHhcccc
Q 039720          958 KLCAVGEI  965 (973)
Q Consensus       958 ~L~~~~~~  965 (973)
                      .|+++.+.
T Consensus       294 ~L~~~~~~  301 (327)
T 1fvr_A          294 SLNRMLEE  301 (327)
T ss_dssp             HHHHHHHS
T ss_pred             HHHHHHHh
Confidence            99987543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-37  Score=373.74  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=200.5

Q ss_pred             CccccccceeEEEEEE--CCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNL--GEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      +.||+|+||+||+|.+  ..+++.||||+++...  ....+++.+|++++++++||||++++++|..      +..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999955  4567899999997543  2345789999999999999999999998743      4588999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++.......+..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....... 
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-  524 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-  524 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-
Confidence            9999999999998888888889999999999999999999   999999999999999999999999999987654221 


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                          .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  +.......          
T Consensus       525 ----~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~----------  588 (635)
T 4fl3_A          525 ----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKG----------  588 (635)
T ss_dssp             --------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT----------
T ss_pred             ----ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------
Confidence                1112223456788999999999999999999999999999998 999997653321  11111100          


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                             .....+..++..+.++|.+||+.||++||++++|++.|+++-
T Consensus       589 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          589 -------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   001112334567889999999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-37  Score=345.31  Aligned_cols=271  Identities=22%  Similarity=0.316  Sum_probs=197.5

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch-----hHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-----ATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      ...++|++.+.||+|+||+||+|++..+|+.||||+++.....     ....+.+|+++++.++||||+++++++..   
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---   83 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence            4457899999999999999999999999999999999753321     12467899999999999999999998643   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                        ....++||||+++ +|.+++.... ...+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        84 --~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           84 --KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             --TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             --CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence              4788999999986 8888887643 466788999999999999999999   99999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      +++.....        ........||+.|+|||++.+. .++.++|||||||++|||++|..||....... .+......
T Consensus       158 ~a~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~  228 (346)
T 1ua2_A          158 LAKSFGSP--------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFET  228 (346)
T ss_dssp             GGSTTTSC--------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred             cceeccCC--------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHH
Confidence            99865432        1223345689999999998764 58999999999999999999999987643221 11111111


Q ss_pred             -hcC--cccc---cccCcccccccCC-C--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          904 -ALP--KKVM---GIVDPSLLMEARG-P--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       904 -~~~--~~~~---~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                       ..+  ....   ...+......... +  .........+.+++.+||+.||++|||++|+++.-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence             000  0000   0000000000000 0  01123346788999999999999999999998764

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=355.04  Aligned_cols=320  Identities=19%  Similarity=0.195  Sum_probs=229.8

Q ss_pred             ceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCC
Q 039720          161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN  240 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  240 (973)
                      +.++.++++++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|.+|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            56777788887 6777664  57888999999998777888899999999999999998888888999999999999999


Q ss_pred             ccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCC
Q 039720          241 RFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTS  320 (973)
Q Consensus       241 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  320 (973)
                      +++ .+|...+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++.++ 
T Consensus        91 ~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-  168 (477)
T 2id5_A           91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP-  168 (477)
T ss_dssp             CCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC-
T ss_pred             cCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC-
Confidence            988 677776668999999999999999888899999999999999999999888889999999999999988875422 


Q ss_pred             CChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCc
Q 039720          321 TDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPP  400 (973)
Q Consensus       321 ~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  400 (973)
                                                                            +..+..+++|+.|+|++|.+++..+.
T Consensus       169 ------------------------------------------------------~~~l~~l~~L~~L~l~~n~i~~~~~~  194 (477)
T 2id5_A          169 ------------------------------------------------------TEALSHLHGLIVLRLRHLNINAIRDY  194 (477)
T ss_dssp             ------------------------------------------------------HHHHTTCTTCCEEEEESCCCCEECTT
T ss_pred             ------------------------------------------------------hhHhcccCCCcEEeCCCCcCcEeChh
Confidence                                                                  22345556666777777776666666


Q ss_pred             cccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccc
Q 039720          401 AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTL  480 (973)
Q Consensus       401 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l  480 (973)
                      .|..+++|++|++++|.+.+.+|..+....+|++|++++|++++..+..+..+++|+.|++++|++.+..+..+..+..+
T Consensus       195 ~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  274 (477)
T 2id5_A          195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL  274 (477)
T ss_dssp             CSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTC
T ss_pred             hcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccC
Confidence            66677777777777766666666655555667777777777764444556666666666666666653222222222222


Q ss_pred             cceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccc
Q 039720          481 SKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFN  540 (973)
Q Consensus       481 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  540 (973)
                       +.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus       275 -~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  333 (477)
T 2id5_A          275 -QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA  333 (477)
T ss_dssp             -CEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred             -CEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence             24555555555555555556666666666666666555555556666666666666655

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-37  Score=350.04  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=195.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcC--CCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIR--HRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||+||+|.+. +++.||||++....  ....+.+.+|+.+++.+.  ||||+++++++..     .+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            46999999999999999999986 59999999997543  334577899999999996  5999999998654     36


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||| +.+++|.+++.......+.+++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++..
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            7999999 66889999999887778888999999999999999999   999999999999995 589999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----------GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH  898 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~  898 (973)
                      ....      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+.
T Consensus       205 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  278 (390)
T 2zmd_A          205 QPDT------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  278 (390)
T ss_dssp             ---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             cCCC------ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH
Confidence            4321      1112234579999999999865           4689999999999999999999999975432211111


Q ss_pred             hhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          899 GYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .   .         ++.......  +.   .....+.+++.+||+.||++||+++|+++.
T Consensus       279 ~---~---------~~~~~~~~~--~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 A---I---------IDPNHEIEF--PD---IPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             H---H---------HCTTSCCCC--CC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H---H---------hCccccCCC--Cc---cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1   1         111111011  11   113456788999999999999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-37  Score=352.43  Aligned_cols=270  Identities=19%  Similarity=0.221  Sum_probs=196.3

Q ss_pred             HHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc----
Q 039720          670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF----  745 (973)
Q Consensus       670 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  745 (973)
                      ....++|++.+.||+|+||+||+|++..+|+.||||++..+...    ..+|+++++.++||||+++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999999999999999999754332    2369999999999999999998754321    


Q ss_pred             -----------------------------CCCceEEEEEeeccCCCHHHHhh----hcCCCchhhHHHHHHHHHHHHHHH
Q 039720          746 -----------------------------KGADFKAIVYEYMQYGSVDDWLH----HTNDKLEVGKLNIVIEVASVIEYL  792 (973)
Q Consensus       746 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~aL~~L  792 (973)
                                                   .+....++||||+++ +|.+.+.    .....++..++.++.||+.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                         334568899999984 7766654    345677888999999999999999


Q ss_pred             HhcCCCCeEecCCCCCcEEec-CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccch
Q 039720          793 HNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDV  870 (973)
Q Consensus       793 H~~~~~~ivHrDik~~NILl~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv  870 (973)
                      |+.   +|+||||||+||+++ .++.+||+|||+|+.....         .......||+.|+|||++.+. .++.++||
T Consensus       158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---------EPSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---------CCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            999   999999999999998 6889999999999865432         222345689999999998775 48999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc--ccccCcc-----c---ccccCCCchhHHHHHHHHHHHhh
Q 039720          871 YSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV--MGIVDPS-----L---LMEARGPSKFEECLVAVVRTGVA  940 (973)
Q Consensus       871 wSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~---~~~~~~~~~~~~~~~~l~~li~~  940 (973)
                      ||+||++|||++|+.||......+ .+............  ....++.     +   .........+...+..+.+++.+
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  304 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ  304 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence            999999999999999998643221 11111111100000  0000000     0   00000000111234567899999


Q ss_pred             cCCCCCCCCCCHHHHHH
Q 039720          941 CSMESPSERMQMTAVVK  957 (973)
Q Consensus       941 cl~~dP~~RPs~~evl~  957 (973)
                      ||+.||++|||+.|+++
T Consensus       305 ~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HCCSSGGGSCCHHHHHT
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.8e-38  Score=348.24  Aligned_cols=262  Identities=21%  Similarity=0.367  Sum_probs=207.8

Q ss_pred             HHHhhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeec
Q 039720          670 SKATKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSI  743 (973)
Q Consensus       670 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  743 (973)
                      ....++|++.+.||+|+||+||+|++.     .+++.||||++..... .....+.+|+.+++.++||||+++++++.. 
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-
Confidence            345678999999999999999999875     3578999999975432 345678999999999999999999998643 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhc----------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHT----------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                          ....++||||+++|+|.+++...          .......++.++.|++.||.|||++   +|+||||||+||+++
T Consensus       100 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~  172 (322)
T 1p4o_A          100 ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA  172 (322)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred             ----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence                46789999999999999998753          2345678899999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFN  892 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~  892 (973)
                      .++.+||+|||+++......      .........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  246 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN  246 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGG------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred             CCCeEEECcCcccccccccc------ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence            99999999999998654321      1112223457889999999999999999999999999999999 8999875422


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      .  ....   ......        .      ...+..++..+.+++.+||+.||++||++.|+++.|+++.+
T Consensus       247 ~--~~~~---~~~~~~--------~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 E--QVLR---FVMEGG--------L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             H--HHHH---HHHTTC--------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H--HHHH---HHHcCC--------c------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1  1111   110000        0      11112334567789999999999999999999999998743

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.2e-37  Score=342.19  Aligned_cols=277  Identities=20%  Similarity=0.309  Sum_probs=203.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc---CC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDF---KG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  747 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  .....+.+|+.+++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4689999999999999999999999999999999865432  234678899999999999999999999876321   12


Q ss_pred             CceEEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      ....++||||+.+ ++.+.+.. ....++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4578999999986 66666654 35677888999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-  904 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-  904 (973)
                      +.+.....    ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ......... 
T Consensus       172 ~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~  246 (351)
T 3mi9_A          172 RAFSLAKN----SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCG  246 (351)
T ss_dssp             EECCCCSS----SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             cccccccc----ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence            87643221    11222334568999999998876 467999999999999999999999998643321 111111111 


Q ss_pred             -cCccc-ccccCcccc-----cccCCCchhHH-----HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 -LPKKV-MGIVDPSLL-----MEARGPSKFEE-----CLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 -~~~~~-~~~~~~~~~-----~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .+... .........     ...........     ....+.+++.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence             00000 000000000     00000111111     13457899999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-38  Score=359.35  Aligned_cols=251  Identities=14%  Similarity=0.168  Sum_probs=190.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHH---HHHHhcCCCCceeEE-------eE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAEC---EALRNIRHRNLIKII-------TI  739 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  739 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...   .....+.+.+|+   ++++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999999889999999999743   334567788999   455566899999988       44


Q ss_pred             eeecc-------cCCCc-----eEEEEEeeccCCCHHHHhhhcCCCch-------hhHHHHHHHHHHHHHHHHhcCCCCe
Q 039720          740 CSSID-------FKGAD-----FKAIVYEYMQYGSVDDWLHHTNDKLE-------VGKLNIVIEVASVIEYLHNHCQPPI  800 (973)
Q Consensus       740 ~~~~~-------~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~i~~qi~~aL~~LH~~~~~~i  800 (973)
                      +....       +.+..     ..++||||+ +|+|.+++...+...+       ..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            33210       00111     378999999 6899999987554444       66778999999999999999   99


Q ss_pred             EecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-----------CCCcccc
Q 039720          801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-----------DLSMTGD  869 (973)
Q Consensus       801 vHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sD  869 (973)
                      +||||||+|||++.++.+||+|||+|+...           .......| +.|+|||++.+.           .++.++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC-----------CcccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            999999999999999999999999998532           12234467 899999999887           8999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCC
Q 039720          870 VYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER  949 (973)
Q Consensus       870 vwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  949 (973)
                      ||||||++|||++|+.||.........             ..+..     .      ...++..+.+++.+||+.||++|
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~~~-------------~~~~~-----~------~~~~~~~~~~li~~~L~~dp~~R  351 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALGGS-------------EWIFR-----S------CKNIPQPVRALLEGFLRYPKEDR  351 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------CCS-------------GGGGS-----S------CCCCCHHHHHHHHHHTCSSGGGC
T ss_pred             HHHHHHHHHHHHHCCCCCcccccccch-------------hhhhh-----h------ccCCCHHHHHHHHHHcCCCchhC
Confidence            999999999999999999754322110             00000     0      01223467789999999999999


Q ss_pred             CCHHHHHH--HHHhcc
Q 039720          950 MQMTAVVK--KLCAVG  963 (973)
Q Consensus       950 Ps~~evl~--~L~~~~  963 (973)
                      |++.|+++  .++++.
T Consensus       352 pt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          352 LLPLQAMETPEYEQLR  367 (377)
T ss_dssp             CCHHHHHTSHHHHHHH
T ss_pred             CCHHHHhhChHHHHHH
Confidence            99999986  444443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.9e-37  Score=335.56  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      +|.....||+|+||+||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++..     ....++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEE
Confidence            45555689999999999999999999999999987666667789999999999999999999998765     3789999


Q ss_pred             EeeccCCCHHHHhhhcC---CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-CCcEEEeccccchhcc
Q 039720          755 YEYMQYGSVDDWLHHTN---DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLS  830 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-~~~~kl~Dfg~a~~~~  830 (973)
                      |||+++++|.+++....   ...+..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||.++...
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999997653   234567788999999999999999   9999999999999987 8999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD--LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ..        ........||+.|+|||++.+..  ++.++||||||+++|+|++|+.||................     
T Consensus       175 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----  241 (295)
T 2clq_A          175 GI--------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-----  241 (295)
T ss_dssp             C-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-----
T ss_pred             CC--------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-----
Confidence            32        11223456899999999987643  7899999999999999999999997543221111110000     


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         ...         +..+..++..+.+++.+||+.||++||+++|+++.
T Consensus       242 ---~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          242 ---KVH---------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ---CCC---------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ---ccc---------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               000         11112334567789999999999999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.3e-37  Score=337.45  Aligned_cols=251  Identities=24%  Similarity=0.306  Sum_probs=205.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .+.|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..     ....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence            457999999999999999999999999999999997553 3456789999999999999999999998765     3789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++++|.+++.. ...++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999999999875 4567788999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .        ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  ........       
T Consensus       172 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~-------  234 (303)
T 3a7i_A          172 T--------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKN-------  234 (303)
T ss_dssp             T--------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHS-------
T ss_pred             c--------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcC-------
Confidence            2        112234568999999999999999999999999999999999999997542211  11110000       


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                       ..         +.....++..+.+++.+||+.||++|||++|+++..
T Consensus       235 -~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          235 -NP---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -CC---------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -CC---------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence             00         011112234577899999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.5e-37  Score=342.96  Aligned_cols=257  Identities=19%  Similarity=0.284  Sum_probs=202.9

Q ss_pred             HHHHhhcCCcC-CccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcC-CCCceeEEeEeeecc
Q 039720          669 LSKATKEFSSS-NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIR-HRNLIKIITICSSID  744 (973)
Q Consensus       669 ~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  744 (973)
                      .....++|.+. +.||+|+||+||+|++..+++.||+|+++...  ......+.+|+.+++.+. ||||+++++++..  
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--  100 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--  100 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--
Confidence            33456788887 88999999999999999999999999997543  334578899999999995 6999999998654  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEE
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAH  819 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~k  819 (973)
                         ....++||||+.+|+|.+++...  ....+..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+|
T Consensus       101 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          101 ---TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ---SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred             ---CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence               47899999999999999998653  5567788999999999999999999   9999999999999988   78999


Q ss_pred             EeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhh
Q 039720          820 VSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHG  899 (973)
Q Consensus       820 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~  899 (973)
                      |+|||+++.....         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........    
T Consensus       175 L~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----  241 (327)
T 3lm5_A          175 IVDFGMSRKIGHA---------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET----  241 (327)
T ss_dssp             ECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----
T ss_pred             EeeCccccccCCc---------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----
Confidence            9999999866432         122345699999999999999999999999999999999999999975432211    


Q ss_pred             hhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          900 YAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .......       ....     .......+...+.+++.+||+.||++|||++|+++.
T Consensus       242 ~~~i~~~-------~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          242 YLNISQV-------NVDY-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHT-------CCCC-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHhc-------cccc-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            1110000       0000     011122344567789999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-37  Score=351.50  Aligned_cols=259  Identities=9%  Similarity=0.023  Sum_probs=182.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhc--CCCCceeEE-------eEe
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNI--RHRNLIKII-------TIC  740 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~  740 (973)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||+++....   ...+.+.+|+.+++.+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3459999999999999999999999999999999986542   3345677785544444  699988855       332


Q ss_pred             eeccc------------CCCceEEEEEeeccCCCHHHHhhhcCC-CchhhH------HHHHHHHHHHHHHHHhcCCCCeE
Q 039720          741 SSIDF------------KGADFKAIVYEYMQYGSVDDWLHHTND-KLEVGK------LNIVIEVASVIEYLHNHCQPPIV  801 (973)
Q Consensus       741 ~~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~------~~i~~qi~~aL~~LH~~~~~~iv  801 (973)
                      .....            ......++||||++ |+|.+++...+. .....+      ..++.||+.||+|||++   +|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence            22100            00145899999999 899999986432 233444      57779999999999999   999


Q ss_pred             ecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHH
Q 039720          802 HGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLE  879 (973)
Q Consensus       802 HrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~e  879 (973)
                      ||||||+|||++.++.+||+|||+|+....           ......+|+.|+|||++.+  ..++.++|||||||++||
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence            999999999999999999999999986532           1114457799999999987  689999999999999999


Q ss_pred             HHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          880 MFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       880 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      |++|+.||..........  +....    ..........     ......++..+.+++.+||+.||++|||++|+++
T Consensus       286 lltg~~Pf~~~~~~~~~~--~~~~~----~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGS--WKRPS----LRVPGTDSLA-----FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTC--CCBCC----TTSCCCCSCC-----CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHhCCCCCCCcCcccccc--hhhhh----hhhccccccc-----hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999998664331110  00000    0000000000     0111234556778999999999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.6e-37  Score=335.32  Aligned_cols=245  Identities=20%  Similarity=0.260  Sum_probs=197.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  748 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++...  ......+.+|+..+..+ +||||+++++++..     .
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence            3568999999999999999999999999999999997542  33456788999999999 89999999998765     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc----CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC---------
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT----NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---------  815 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~---------  815 (973)
                      +..++||||+++++|.+++...    ...++..++.++.||+.||+|||++   +|+||||||+||+++.+         
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccc
Confidence            7899999999999999999764    5567888999999999999999999   99999999999999844         


Q ss_pred             ----------CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCC
Q 039720          816 ----------MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRR  884 (973)
Q Consensus       816 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~  884 (973)
                                ..+||+|||.+......            ....||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSP------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE  228 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCS------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred             cccccccCCceEEEEcccccccccCCc------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence                      47999999999865432            123489999999998776 5678999999999999999998


Q ss_pred             CCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          885 RPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       885 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .|+...    ...........                  +..+..++..+.+++.+||+.||++|||++|+++.
T Consensus       229 ~~~~~~----~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          229 PLPRNG----DQWHEIRQGRL------------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             CCCSSS----HHHHHHHTTCC------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCcch----hHHHHHHcCCC------------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            876432    11111111000                  11112234567789999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-37  Score=347.09  Aligned_cols=256  Identities=21%  Similarity=0.282  Sum_probs=202.7

Q ss_pred             hhcCCcCCccccccceeEEEEEEC---CCCcEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG---EDGMSVAVKVMNLDK----KGATKSFVAECEALRNI-RHRNLIKIITICSSID  744 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  744 (973)
                      .++|++.+.||+|+||+||+|++.   .+++.||||+++...    ....+.+.+|+++++.+ +||||+++++++..  
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  130 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  130 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence            368999999999999999999984   589999999986432    23345677899999999 69999999998654  


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                         ....++||||+++|+|.+++.....+.+..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       131 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          131 ---ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             ---TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             ---CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence               378999999999999999999888888889999999999999999999   99999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      +++......       ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||......... .....
T Consensus       205 ~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~  276 (355)
T 1vzo_A          205 LSKEFVADE-------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISR  276 (355)
T ss_dssp             EEEECCGGG-------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHH
T ss_pred             CCeecccCC-------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHH
Confidence            998653211       222334579999999999886  35789999999999999999999999754333221 11111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKKL  959 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  959 (973)
                      .....               .+..+......+.+++.+||+.||++||     +++|+++..
T Consensus       277 ~~~~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          277 RILKS---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHC---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHhcc---------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            11000               0111123345667899999999999999     999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-36  Score=344.06  Aligned_cols=268  Identities=19%  Similarity=0.208  Sum_probs=196.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999999999999999997532  334567889999999999999999999876432 23345


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++ +|.+.+..  ...+..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            78999999975 78887753  466778899999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc--Cc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL--PK  907 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~  907 (973)
                      ...         .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......    ..+.....  ..
T Consensus       178 ~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~  244 (371)
T 2xrw_A          178 GTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKVIEQLGT  244 (371)
T ss_dssp             ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHC-CCC
T ss_pred             ccc---------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCC
Confidence            431         1223457899999999999999999999999999999999999999764321    11111100  00


Q ss_pred             ---ccccccCc----------cc--------ccc---cCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          908 ---KVMGIVDP----------SL--------LME---ARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       908 ---~~~~~~~~----------~~--------~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                         .......+          ..        ...   .............+.+++.+||+.||++|||++|+++.-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence               00000000          00        000   000112234467788999999999999999999998853

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.1e-37  Score=343.77  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=200.0

Q ss_pred             hhcCCcCCccccccceeEEEEE-----ECCCCcEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGN-----LGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|+     ...++..||||++... .......+.+|+.++++++||||+++++++..    
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence            4689999999999999999999     4567889999999643 23445678999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC-------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CC
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN-------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DM  816 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~  816 (973)
                       ....++||||+++|+|.+++....       ......++.++.|++.||.|||+.   +|+||||||+||+++.   +.
T Consensus       105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence             467899999999999999998653       255677899999999999999999   9999999999999984   44


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGL  895 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~  895 (973)
                      .+||+|||+++......      .........||+.|+|||++.+..++.++||||||+++|+|++ |+.||......  
T Consensus       181 ~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  252 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--  252 (327)
T ss_dssp             CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             eEEECcccccccccccc------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--
Confidence            69999999998654322      1122234567889999999988999999999999999999998 99999754221  


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      .+.......   .              ....+..++..+.+++.+||+.||++||+++|+++.|+.+.
T Consensus       253 ~~~~~~~~~---~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          253 EVLEFVTSG---G--------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHHHHHTT---C--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcC---C--------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            111111000   0              01111233456788999999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.9e-37  Score=360.50  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=202.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-------------hhHHHHHHHHHHHHhcCCCCceeEEeE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-------------GATKSFVAECEALRNIRHRNLIKIITI  739 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~  739 (973)
                      .++|.+.++||+|+||+||+|++..+++.||||++.....             ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4689999999999999999999999999999999975421             234678999999999999999999999


Q ss_pred             eeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC---
Q 039720          740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM---  816 (973)
Q Consensus       740 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~---  816 (973)
                      +..     ....++||||+++|+|.+++......++..++.++.||+.||+|||+.   +|+||||||+||+++.++   
T Consensus       115 ~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          115 FED-----KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEC-----SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEc-----CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            654     478999999999999999998888888999999999999999999999   999999999999998776   


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT  896 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~  896 (973)
                      .+||+|||+|+.....         .......||+.|+|||++. ..|+.++||||+||++|+|++|+.||......  .
T Consensus       187 ~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~  254 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD---------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--D  254 (504)
T ss_dssp             SEEECCCTTCEECCTT---------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H
T ss_pred             cEEEEECCCCEEcCCC---------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence            6999999999866432         2223456999999999976 56899999999999999999999999764321  1


Q ss_pred             HhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          897 LHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +.......  ..   ..+         .......+..+.+++.+||+.||.+|||++|+++.
T Consensus       255 ~~~~i~~~--~~---~~~---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          255 IIKKVEKG--KY---YFD---------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHHHC--CC---CCC---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcC--CC---CCC---------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11111000  00   000         01112234567889999999999999999999864

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.1e-36  Score=346.60  Aligned_cols=236  Identities=16%  Similarity=0.152  Sum_probs=126.0

Q ss_pred             CCCCCCCCCCCCc-eeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCcc-ccccCCCCEEe
Q 039720           39 VTKSWNNSINLCQ-WTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKE-VGRLFRLETIV  116 (973)
Q Consensus        39 ~l~sw~~~~~~c~-w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~  116 (973)
                      .+++|..+.+||. |.++.|.....++     ............-..+++++.|++++|.++ .+|.. +.++++|++|+
T Consensus         2 ~~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~   75 (390)
T 3o6n_A            2 NVKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN   75 (390)
T ss_dssp             -----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEE
T ss_pred             CcCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEE
Confidence            3678998888885 6655554322222     222222222333345788899999999887 45544 67888999999


Q ss_pred             eecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCC
Q 039720          117 LSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDG  196 (973)
Q Consensus       117 Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  196 (973)
                      |++|.+++..|..|+.+++|++|++++|.+.+..|..++++++|++|+|++|+++...+..|+++++|++|++++|++++
T Consensus        76 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~  155 (390)
T 3o6n_A           76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER  155 (390)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             CCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCc
Confidence            99888886555666666666555555555555555555555555555555555553222224555555555555555554


Q ss_pred             CCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCcccc
Q 039720          197 RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLS  276 (973)
Q Consensus       197 ~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  276 (973)
                      ..|..|.++++|++|++++|++++.   .+.                         .+++|+.|++++|.+++.     .
T Consensus       156 ~~~~~~~~l~~L~~L~l~~n~l~~~---~~~-------------------------~l~~L~~L~l~~n~l~~~-----~  202 (390)
T 3o6n_A          156 IEDDTFQATTSLQNLQLSSNRLTHV---DLS-------------------------LIPSLFHANVSYNLLSTL-----A  202 (390)
T ss_dssp             CCTTTTSSCTTCCEEECCSSCCSBC---CGG-------------------------GCTTCSEEECCSSCCSEE-----E
T ss_pred             cChhhccCCCCCCEEECCCCcCCcc---ccc-------------------------cccccceeeccccccccc-----C
Confidence            4444455555555555555555432   122                         345555555555555432     2


Q ss_pred             CCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          277 NASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       277 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      ...+|++|++++|+++.....   ..++|++|+|++|.++
T Consensus       203 ~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~  239 (390)
T 3o6n_A          203 IPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLT  239 (390)
T ss_dssp             CCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCC
T ss_pred             CCCcceEEECCCCeeeecccc---ccccccEEECCCCCCc
Confidence            334566666666666544221   1245556666555554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-36  Score=333.57  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=204.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---------chhHHHHHHHHHHHHhcC-CCCceeEEeEee
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---------KGATKSFVAECEALRNIR-HRNLIKIITICS  741 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  741 (973)
                      ..++|++.+.||+|+||.||+|++..+|+.||||+++...         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999999999999999997543         122456889999999996 999999999865


Q ss_pred             ecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEe
Q 039720          742 SIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVS  821 (973)
Q Consensus       742 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~  821 (973)
                      .     ....++||||+++++|.+++......++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        95 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           95 T-----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             C-----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             c-----CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence            4     478999999999999999999887888889999999999999999999   99999999999999999999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCccccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM------GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL  895 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~  895 (973)
                      |||.+......         .......||+.|+|||++.      ...++.++||||||+++|+|++|+.||......  
T Consensus       167 dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--  235 (298)
T 1phk_A          167 DFGFSCQLDPG---------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--  235 (298)
T ss_dssp             CCTTCEECCTT---------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             cccchhhcCCC---------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--
Confidence            99999865432         1223456899999999874      457899999999999999999999999754221  


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .........   .    .  ..     ........+..+.+++.+||+.||++||+++|+++
T Consensus       236 ~~~~~~~~~---~----~--~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          236 LMLRMIMSG---N----Y--QF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHHT---C----C--CC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhcC---C----c--cc-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111110000   0    0  00     01111234566789999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-37  Score=340.57  Aligned_cols=253  Identities=22%  Similarity=0.298  Sum_probs=199.1

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++..     ....
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeE
Confidence            34689999999999999999999999999999999986666667889999999999999999999998754     3688


Q ss_pred             EEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+++++|.+++.. ....++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999998875 44577888999999999999999999   99999999999999999999999999986432


Q ss_pred             CCCCccCCCCCcccccccccccccCcccc-----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYG-----MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      ..        ........||+.|+|||++     .+..++.++||||||+++|+|++|+.||........ .......  
T Consensus       169 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~--  237 (302)
T 2j7t_A          169 KT--------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKS--  237 (302)
T ss_dssp             HH--------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS--
T ss_pred             cc--------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhcc--
Confidence            11        1112234689999999987     467789999999999999999999999975432110 1111000  


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                       .      .+.       ...+..++..+.+++.+||+.||++|||++|+++
T Consensus       238 -~------~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 -D------PPT-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -C------CCC-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -C------Ccc-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             0      000       0112233456788999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=369.84  Aligned_cols=255  Identities=21%  Similarity=0.336  Sum_probs=200.0

Q ss_pred             CCcCC-ccccccceeEEEEEEC--CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          676 FSSSN-RIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       676 y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      +.+.+ .||+|+||+||+|.+.  .++..||||+++... ....+.+.+|++++++++||||++++++|..      +..
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~  410 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL  410 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence            33444 7999999999999875  356779999997543 3356789999999999999999999999753      458


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+.+|+|.+++.... .+.+..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            99999999999999987543 467788999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....     .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  +.......     
T Consensus       488 ~~~~-----~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~-----  555 (613)
T 2ozo_A          488 ADDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQG-----  555 (613)
T ss_dssp             -------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTT-----
T ss_pred             CCCc-----eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC-----
Confidence            3210     0111122345688999999999999999999999999999998 999998654321  11111100     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                                  .....+..++..+.++|.+||+.||++||++++|++.|+++-
T Consensus       556 ------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          556 ------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                        001122345567889999999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5e-37  Score=345.91  Aligned_cols=275  Identities=20%  Similarity=0.250  Sum_probs=207.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999999999999999997433 3345778999999999999999999999876555556789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+. |+|.+++... ..++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            99999998 5899988764 577788999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc--
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK--  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  908 (973)
                      ..     ..........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. +...........  
T Consensus       181 ~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          181 DH-----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQE  254 (364)
T ss_dssp             GG-----CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHH
T ss_pred             CC-----CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHH
Confidence            21     11112234579999999998654 4589999999999999999999999976543221 111111100000  


Q ss_pred             -cccccCcc-------cccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 -VMGIVDPS-------LLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 -~~~~~~~~-------~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       .....+..       .......  ..........+.+++.+||+.||++|||++|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00000000       0000000  00112234567899999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=336.24  Aligned_cols=252  Identities=24%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++....  ..+.+.+|+.+++.++||||+++++++..     ....
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            4568999999999999999999999999999999997543  35678899999999999999999998765     3788


Q ss_pred             EEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+++++|.+++.. .....+..++.++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||.+....
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999999999873 45677888999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..        ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......    ........     
T Consensus       177 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-----  239 (314)
T 3com_A          177 DT--------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIFMIPT-----  239 (314)
T ss_dssp             TT--------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH-----
T ss_pred             hh--------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhc-----
Confidence            32        11223456899999999999999999999999999999999999999754221    11000000     


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       ...+.       ...+..++..+.+++.+||+.||++||+++|+++.
T Consensus       240 -~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          240 -NPPPT-------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -SCCCC-------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -CCCcc-------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             00000       01112234567889999999999999999999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-37  Score=366.93  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=206.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.++||+|+||+||+|++. .+..||||+++.... ..+.+.+|+++|++++||||+++++++..      ...+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            467899999999999999999996 457899999975442 45679999999999999999999998643      5689


Q ss_pred             EEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+.+|+|.+++...  ......+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            999999999999999753  3467788999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...       ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+  +.......     
T Consensus       415 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~-----  480 (535)
T 2h8h_A          415 DNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG-----  480 (535)
T ss_dssp             CHH-------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTT-----
T ss_pred             CCc-------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----
Confidence            211       011122346778999999999999999999999999999999 999997643221  11110000     


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                             .     ....+..++..+.++|.+||+.||++||++++|++.|+++-...
T Consensus       481 -------~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          481 -------Y-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -------C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -------C-----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                   0     01112234567789999999999999999999999999886543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.8e-37  Score=351.66  Aligned_cols=198  Identities=22%  Similarity=0.293  Sum_probs=170.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc------CCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI------RHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~  746 (973)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.+      .|+||+++++++..    
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~----  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF----  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence            357999999999999999999999999999999997542 3445677888888877      57799999998765    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc--EEEec
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV--AHVSD  822 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~--~kl~D  822 (973)
                       ....++||||+. ++|.+++....  .+.+..++.++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|
T Consensus       171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence             378999999996 68999987654  367788999999999999999999   9999999999999999987  99999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF  891 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~  891 (973)
                      ||+|+....           ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       246 FG~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          246 FGSSCYEHQ-----------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CTTCEETTC-----------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccceecCC-----------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999975432           1224578999999999999999999999999999999999999997653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.4e-37  Score=335.08  Aligned_cols=251  Identities=20%  Similarity=0.268  Sum_probs=185.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++....  .....+.++...++.++||||+++++++..     ...
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence            4689999999999999999999999999999999975432  223334555556788899999999998754     478


Q ss_pred             EEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          751 KAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                      .++||||++ |+|.+++..    ....++..++.++.|++.|++|||+++  +|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            999999998 488777653    456778889999999999999999853  8999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG----MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      +.....         .......||+.|+|||++    .+..++.++||||+||++|+|++|+.||.........+.....
T Consensus       158 ~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  228 (290)
T 3fme_A          158 GYLVDD---------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE  228 (290)
T ss_dssp             ---------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred             cccccc---------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence            865432         122234689999999995    5667899999999999999999999999754332222111111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ...         +        .......+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~---------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          229 EPS---------P--------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             SCC---------C--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCC---------C--------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            100         0        0011123456788999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.3e-37  Score=348.44  Aligned_cols=270  Identities=18%  Similarity=0.234  Sum_probs=203.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC--------CCCceeEEeEeeecc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR--------HRNLIKIITICSSID  744 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~  744 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.++        ||||+++++++... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~-  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS-  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence            36899999999999999999999999999999999743 334567889999999885        78899999987642 


Q ss_pred             cCCCceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC------
Q 039720          745 FKGADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM------  816 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~------  816 (973)
                      .......++||||+ ++++.+.+...  ..+++..++.++.||+.||+|||+++  +|+||||||+|||++.++      
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence            22456899999999 56666666543  35677889999999999999999864  899999999999999775      


Q ss_pred             -------------------------------------------cEEEeccccchhccCCCCccCCCCCcccccccccccc
Q 039720          817 -------------------------------------------VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY  853 (973)
Q Consensus       817 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y  853 (973)
                                                                 .+||+|||.++....           ......||+.|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----------~~~~~~gt~~y  259 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----------HFTEDIQTRQY  259 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----------CSCSCCSCGGG
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----------cCccCCCCCcc
Confidence                                                       799999999986532           12234689999


Q ss_pred             cCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH-----hhhhhHh--cCcc-------cccccCcc--c
Q 039720          854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL-----HGYAKMA--LPKK-------VMGIVDPS--L  917 (973)
Q Consensus       854 ~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~-----~~~~~~~--~~~~-------~~~~~~~~--~  917 (973)
                      +|||++.+..++.++|||||||++|||++|+.||..........     .......  .+..       ........  .
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            99999999999999999999999999999999998655432211     1110000  0000       00000000  0


Q ss_pred             --cccc----------CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          918 --LMEA----------RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       918 --~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ....          ............+.+++.+||+.||++|||++|++++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence              0000          0012235667789999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=347.12  Aligned_cols=251  Identities=16%  Similarity=0.140  Sum_probs=198.1

Q ss_pred             HhhcCCcCCccccccceeEEEE-----EECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC---CCCceeEEeEeeec
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKG-----NLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR---HRNLIKIITICSSI  743 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  743 (973)
                      ..++|.+.+.||+|+||+||+|     .+..+++.||||+++..   ...++..|+++++.++   |+|++++++++.. 
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-
Confidence            3468999999999999999999     46678999999999644   3456778888888887   9999999998654 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhh-----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC----
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHH-----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH----  814 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~----  814 (973)
                          .+..++||||+++|+|.+++..     ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.    
T Consensus       139 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          139 ----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             ----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred             ----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence                3788999999999999999974     44567788999999999999999999   9999999999999998    


Q ss_pred             -------CCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 039720          815 -------DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT  887 (973)
Q Consensus       815 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf  887 (973)
                             ++.+||+|||+|+.+....      .........||+.|+|||++.+..|+.++|||||||++|||++|+.||
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFP------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSC------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccccccccCCEEEeeCchhhhhhccC------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence                   8999999999997653211      123334567999999999999999999999999999999999999998


Q ss_pred             CCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCC-CCHHHHHHHHHhcc
Q 039720          888 DNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER-MQMTAVVKKLCAVG  963 (973)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~  963 (973)
                      .........                ....+    ....    ....+.+++..|++.+|.+| |+++++.+.|+++-
T Consensus       286 ~~~~~~~~~----------------~~~~~----~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          286 VKNEGGECK----------------PEGLF----RRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             EEEETTEEE----------------ECSCC----TTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccCCCCcee----------------echhc----cccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            643322110                00000    0001    12345577779999999999 57888888887764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-37  Score=340.71  Aligned_cols=266  Identities=22%  Similarity=0.314  Sum_probs=184.0

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..     .+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KDE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SSC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cCC
Confidence            4578999999999999999999998899999999986543 3345678899999999999999999998654     367


Q ss_pred             EEEEEeeccCCCHHHHhhh--------cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          751 KAIVYEYMQYGSVDDWLHH--------TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                      .++||||+++++|.+++..        ....++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEe
Confidence            9999999999999999874        34467788999999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ||.+.........   ..........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............ .
T Consensus       165 fg~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~  240 (303)
T 2vwi_A          165 FGVSAFLATGGDI---TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-L  240 (303)
T ss_dssp             CHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-H
T ss_pred             ccchheeccCCCc---cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-h
Confidence            9999876432100   01112234568999999999876 56899999999999999999999999765332111100 0


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      . .......        ...........++..+.+++.+||+.||++||+++|+++.
T Consensus       241 ~-~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          241 Q-NDPPSLE--------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             T-SSCCCTT--------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             c-cCCCccc--------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0 0000000        0000011112233567789999999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-36  Score=351.34  Aligned_cols=266  Identities=17%  Similarity=0.246  Sum_probs=205.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.++||+|+||+||+|++..+++.||||++.....  ...+..|+++++.+.|++.+..+.++..    ..+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence            4689999999999999999999999999999999875433  3357889999999987554444444322    247889


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---cCCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl---~~~~~~kl~Dfg~a~~  828 (973)
                      +||||+ +++|.+++.. ...+.+..++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999999 9999999985 44677888999999999999999999   99999999999999   6889999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc--HhhhhhHhcC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT--LHGYAKMALP  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~--~~~~~~~~~~  906 (973)
                      +....... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  +.........
T Consensus       156 ~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          156 YRDTSTHQ-HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             CBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             ccCCcccc-ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            65432100 00011223567999999999999999999999999999999999999999875443211  1111111000


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      ...              ......++.++.+++.+||+.||++||++++|++.|+++.
T Consensus       235 ~~~--------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          235 TSI--------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             SCH--------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccH--------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            000              0011223467889999999999999999999999999873

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.6e-37  Score=347.53  Aligned_cols=268  Identities=19%  Similarity=0.267  Sum_probs=186.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeec-ccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSI-DFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~~~  750 (973)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+++++.++||||+++++++... .......
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            6899999999999999999999999999999999643  233456788999999999999999999987542 1223356


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++|+||+ +++|.+++.. ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            89999998 6899988875 4577888999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-C-c
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-P-K  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-~-~  907 (973)
                      .           ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+........ + .
T Consensus       184 ~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          184 D-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGA  251 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCH
T ss_pred             c-----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence            2           1234578999999999877 67899999999999999999999999764321 11111111100 0 0


Q ss_pred             ccccccCcc----cc---cccCCC---chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPS----LL---MEARGP---SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~----~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....+...    ..   ......   .........+.+++.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000000000    00   000000   0111234567889999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.6e-37  Score=344.97  Aligned_cols=278  Identities=20%  Similarity=0.217  Sum_probs=201.2

Q ss_pred             HHHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-----------hhHHHHHHHHHHHHhcCCCCce
Q 039720          666 YAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-----------GATKSFVAECEALRNIRHRNLI  734 (973)
Q Consensus       666 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv  734 (973)
                      .+++....++|++.+.||+|+||+||+|++. +|+.||||++.....           ...+.+.+|+.+++.++||||+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4567778899999999999999999999986 599999999864321           1237789999999999999999


Q ss_pred             eEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                      ++++++...........++||||+. |+|.+++.... ...+..+..++.|++.||.|||+.   +|+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence            9999986654445568899999998 57887776543 567788999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFN  892 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~  892 (973)
                      .++.+||+|||+++....         ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.....
T Consensus       169 ~~~~~kl~Dfg~~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTA---------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             TTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCCEEEEecCccccccc---------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999975432         122334568999999999877 6789999999999999999999999976432


Q ss_pred             CCccHhhhhhHhcCcc-----------cccccCcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          893 DGLTLHGYAKMALPKK-----------VMGIVDPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .. .+...........           ..+............  ..........+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          240 YN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11 1111111000000           000000000000000  01112234567899999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=342.28  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=198.1

Q ss_pred             HHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccC-C
Q 039720          670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFK-G  747 (973)
Q Consensus       670 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~  747 (973)
                      ....++|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.+++++ +||||+++++++...... .
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            3456789999999999999999999999999999999975433 456788999999999 799999999998653211 1


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ....++||||+++|+|.+++...  ....+..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            46889999999999999999764  3566778899999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      +......        ........||+.|+|||++.     +..++.++|||||||++|+|++|+.||.......    ..
T Consensus       176 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~  243 (326)
T 2x7f_A          176 SAQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----AL  243 (326)
T ss_dssp             TC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----HH
T ss_pred             ceecCcC--------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HH
Confidence            9765431        11223456899999999987     5678999999999999999999999997542211    11


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .....      ...+..        ....++..+.+++.+||..||++||+++|+++.
T Consensus       244 ~~~~~------~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          244 FLIPR------NPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHHH------SCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhc------CccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000      000000        011223467789999999999999999999873

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.4e-37  Score=343.72  Aligned_cols=264  Identities=20%  Similarity=0.256  Sum_probs=201.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchh-----------------HHHHHHHHHHHHhcCCCCcee
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA-----------------TKSFVAECEALRNIRHRNLIK  735 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~  735 (973)
                      .++|++.+.||+|+||+||+|++  +++.||||++.......                 .+.+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            36899999999999999999999  89999999997442211                 178999999999999999999


Q ss_pred             EEeEeeecccCCCceEEEEEeeccCCCHHHH------hhh--cCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCC
Q 039720          736 IITICSSIDFKGADFKAIVYEYMQYGSVDDW------LHH--TNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLK  806 (973)
Q Consensus       736 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik  806 (973)
                      +++++..     .+..++||||+++|+|.++      +..  ....++..++.++.|++.||+|||+ .   +|+|||||
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~  179 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVK  179 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCC
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCC
Confidence            9998654     4789999999999999998      665  4566778899999999999999999 8   99999999


Q ss_pred             CCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCc-ccchHHHHHHHHHHHhCC
Q 039720          807 PSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSM-TGDVYSFGILLLEMFTRR  884 (973)
Q Consensus       807 ~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~ll~elltg~  884 (973)
                      |+||+++.++.+||+|||.+......          ......||+.|+|||++.+. .++. ++|||||||++|||++|+
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred             hHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999865321          22345689999999998887 6666 999999999999999999


Q ss_pred             CCCCCCCCCCccHhhhhhHhcCcc--cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          885 RPTDNMFNDGLTLHGYAKMALPKK--VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       885 ~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .||.....................  ......+ .. ...........+..+.+++.+||+.||++||+++|+++.
T Consensus       250 ~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          250 VPFSLKISLVELFNNIRTKNIEYPLDRNHFLYP-LT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTT-TC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCcHHHHHHHHhccCcCCccchhhhhcc-cc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999865442211111111100000  0000000 00 000001112345677899999999999999999999873

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-36  Score=341.71  Aligned_cols=277  Identities=21%  Similarity=0.276  Sum_probs=192.8

Q ss_pred             HHHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-
Q 039720          667 AELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF-  745 (973)
Q Consensus       667 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  745 (973)
                      .+.....++|++.+.||+|+||+||+|++..+|+.||||++..+.. ....+.++++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3445667899999999999999999999999999999999865432 33456778888999999999999999865322 


Q ss_pred             -CCCceEEEEEeeccCCCHHHHh----hhcCCCchhhHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEecC-CCc
Q 039720          746 -KGADFKAIVYEYMQYGSVDDWL----HHTNDKLEVGKLNIVIEVASVIEYLH--NHCQPPIVHGDLKPSNVLLDH-DMV  817 (973)
Q Consensus       746 -~~~~~~~lv~e~~~~gsL~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~~ivHrDik~~NILl~~-~~~  817 (973)
                       ......++||||+.++ +.+.+    .......+..+..++.|++.|+.|||  +.   +|+||||||+||+++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence             2233478999999864 44333    34556667788999999999999999  77   9999999999999997 899


Q ss_pred             EEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 039720          818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLT  896 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~  896 (973)
                      +||+|||+++.....         .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .
T Consensus       171 ~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~  240 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPS---------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-Q  240 (360)
T ss_dssp             EEECCCTTCBCCCTT---------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred             EEEeeCCCceecCCC---------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-H
Confidence            999999999866432         122345689999999998665 48999999999999999999999998643221 1


Q ss_pred             HhhhhhHhc-C-cccccccCc-----ccccccC------CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          897 LHGYAKMAL-P-KKVMGIVDP-----SLLMEAR------GPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       897 ~~~~~~~~~-~-~~~~~~~~~-----~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +........ + .......++     .......      ...........+.+++.+||+.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111111110 0 000000000     0000000      011111245678899999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=330.64  Aligned_cols=254  Identities=21%  Similarity=0.297  Sum_probs=198.2

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK----KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...    ....+.+.+|+++++.++||||+++++++..   .+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence            3478999999999999999999999999999999997542    2345778999999999999999999998742   23


Q ss_pred             CceEEEEEeeccCCCHHHHhhh--cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHH--TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      ....++||||+.++ +.+++..  ....++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccc
Confidence            46789999999977 7777654  34566788899999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD--LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      +.......      .........||+.|+|||++.+..  ++.++||||||+++|+|++|+.||......  ....  ..
T Consensus       156 ~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~--~i  225 (305)
T 2wtk_C          156 AEALHPFA------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFE--NI  225 (305)
T ss_dssp             CEECCTTC------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH--HH
T ss_pred             ccccCccc------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHH--HH
Confidence            98654321      122223456899999999987654  378999999999999999999999753211  1101  00


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ... .               ...+..+...+.+++.+||+.||++||+++|+++.
T Consensus       226 ~~~-~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 GKG-S---------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHC-C---------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hcC-C---------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000 0               00111234567789999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-36  Score=341.42  Aligned_cols=280  Identities=22%  Similarity=0.277  Sum_probs=205.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++.... ......+.+|+++++.++||||+++++++....+......
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999999999999999996433 3345678899999999999999999999876556666889


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+. |+|.+++.. ...++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            99999997 589998876 4567788999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCccCC--CCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cCc
Q 039720          832 HPFLVAP--EGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LPK  907 (973)
Q Consensus       832 ~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~  907 (973)
                      .......  ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +....... .+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~  243 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTPH  243 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCc
Confidence            2210000  00112234578999999998654 7789999999999999999999999976432111 11111100 000


Q ss_pred             --cccccc-Cccc---c---cccCC---CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 --KVMGIV-DPSL---L---MEARG---PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 --~~~~~~-~~~~---~---~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ...... ....   .   .....   .......+..+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000 0000   0   00000   00112345667899999999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=334.18  Aligned_cols=274  Identities=20%  Similarity=0.308  Sum_probs=199.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeec---------
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSI---------  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  743 (973)
                      .++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++...         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            36899999999999999999999999999999999877666678899999999999999999999987432         


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec-CCCcEEEec
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSD  822 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~-~~~~~kl~D  822 (973)
                      .+.+....++||||+. |+|.+++.. +...+..++.++.|++.||+|||++   +|+||||||+||+++ .++.+||+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            1234578899999998 699999875 4567788899999999999999999   999999999999997 567999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ||.++......     ..........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+....
T Consensus       165 fg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~  238 (320)
T 2i6l_A          165 FGLARIMDPHY-----SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLIL  238 (320)
T ss_dssp             CTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH
T ss_pred             CccccccCCCc-----ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence            99998654321     01122234467899999998765 678999999999999999999999997643211 111111


Q ss_pred             hHhcCcc-------cccccCcccccccCCC-----chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKK-------VMGIVDPSLLMEARGP-----SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~-------~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .. .+..       ....+..........+     ......+..+.+++.+||+.||++|||++|+++.
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ES-IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HH-SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             Hh-cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00 0000       0000000000000000     0112345678899999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.6e-36  Score=334.91  Aligned_cols=273  Identities=22%  Similarity=0.349  Sum_probs=202.7

Q ss_pred             HhhcCCcCCccccccceeEEEEEEC-CCCcEEEEEEeecccc--hhHHHHHHHHHHHHhc---CCCCceeEEeEeeeccc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLG-EDGMSVAVKVMNLDKK--GATKSFVAECEALRNI---RHRNLIKIITICSSIDF  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~  745 (973)
                      ..++|++.+.||+|+||+||+|++. .+|+.||+|+++....  .....+.+|+.+++.+   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 6789999999975432  1233466777776666   89999999999864333


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                      ......++||||+. |+|.+++....  ..++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence            45678999999998 69999987654  367788999999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      |.++....         ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+......
T Consensus       165 g~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~  234 (326)
T 1blx_A          165 GLARIYSF---------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV  234 (326)
T ss_dssp             CSCCCCCG---------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred             cccccccC---------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHH
Confidence            99975432         112334568999999999999999999999999999999999999997643221 11111111


Q ss_pred             -hcCcc--ccc-ccCcc--cccc--cCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 -ALPKK--VMG-IVDPS--LLME--ARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 -~~~~~--~~~-~~~~~--~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                       ..+..  ... ...+.  +...  ..........+..+.+++.+||+.||++||+++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             00000  000 00000  0000  00001112344567789999999999999999999853

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.4e-37  Score=335.23  Aligned_cols=260  Identities=26%  Similarity=0.378  Sum_probs=195.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-CCc--EEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-DGM--SVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|++.. +++  .||||+++..   .....+.+.+|+++++.++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            3689999999999999999998643 333  6899998754   23456788999999999999999999998653    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                        ...++|+||+++++|.+++... ....+..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        93 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           93 --PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             --CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccc
Confidence              3478999999999999999764 4567788999999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHh
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      +........     .........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......  .   ....
T Consensus       168 ~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~---~~~~  237 (291)
T 1u46_A          168 MRALPQNDD-----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I---LHKI  237 (291)
T ss_dssp             CEECCC-CC-----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHH
T ss_pred             ccccccccc-----chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--H---HHHH
Confidence            987643220     0112223457788999999988889999999999999999999 999997543211  1   1100


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ....             ........++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       238 ~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          238 DKEG-------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HTSC-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HccC-------------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            0000             0011112344567899999999999999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.5e-36  Score=327.35  Aligned_cols=253  Identities=26%  Similarity=0.313  Sum_probs=203.8

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++..     ..
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   94 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS   94 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CC
Confidence            4578999999999999999999999899999999997543  2346778999999999999999999998654     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC---CcEEEeccccc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLA  826 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~---~~~kl~Dfg~a  826 (973)
                      ..++||||+++++|.+++......++..++.++.|++.||+|||+.   +|+||||||+||+++.+   +.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            8999999999999999998877888899999999999999999999   99999999999999764   47999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......         .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......  .+.......  
T Consensus       172 ~~~~~~---------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~--  237 (287)
T 2wei_A          172 TCFQQN---------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETG--  237 (287)
T ss_dssp             GTBCCC---------SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC--
T ss_pred             eeecCC---------CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC--
Confidence            865432         12223468999999998765 4899999999999999999999999754321  111110000  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .     ....       .......+..+.+++.+||+.||++|||++|+++.
T Consensus       238 ~-----~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 K-----YAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             C-----CCCC-------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             C-----CCCC-------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0     0000       01112334567889999999999999999999973

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=9.9e-37  Score=337.39  Aligned_cols=270  Identities=17%  Similarity=0.200  Sum_probs=186.2

Q ss_pred             cccchhhHHHHHHHHhhccCCCcCCCCCC----CCCCCCCceeeeEeeC--------CCCeEEEEEeeccCccccccCCC
Q 039720           15 RHATSHVKHATVTFNMQQLHDPLGVTKSW----NNSINLCQWTGVTCGH--------RHQRVTKLDLESQNIGGFLSPYI   82 (973)
Q Consensus        15 ~~~~~~~~~~ll~~~~~~~~d~~~~l~sw----~~~~~~c~w~gv~C~~--------~~~~v~~l~l~~~~l~g~~~~~l   82 (973)
                      .++...+++||++||+....|+.+.+++|    ..+.++|.|.||+|+.        ...+|+.|+|+++++. .+|+.+
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l  100 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA  100 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence            45567789999999998878998888999    4567899999999952        3457889999999987 788888


Q ss_pred             cCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcc------
Q 039720           83 GNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGN------  156 (973)
Q Consensus        83 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~------  156 (973)
                      +++++|++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++++++|++|++++|++.+.+|..+..      
T Consensus       101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~  178 (328)
T 4fcg_A          101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE  178 (328)
T ss_dssp             GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred             hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence            89999999999999998 88988999999999999999998 78888888888888888888888888876654      


Q ss_pred             ---ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCc
Q 039720          157 ---WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLD  233 (973)
Q Consensus       157 ---l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  233 (973)
                         +++|++|+|++|+++ .+|..|+++++|++|+|++|+++ .+|..++++++|++|+|++|.+.+.+|..+.++++|+
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~  256 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK  256 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred             hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence               555566666655555 45555555555555555555555 3444555555555555555555555555555555555


Q ss_pred             EEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCc
Q 039720          234 EAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH  290 (973)
Q Consensus       234 ~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  290 (973)
                      +|+|++|.+.+.+|..+. ++++|++|+|++|.+.+.+|..+.++++|+.+++..|.
T Consensus       257 ~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~  312 (328)
T 4fcg_A          257 RLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL  312 (328)
T ss_dssp             EEECTTCTTCCBCCTTGG-GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred             EEECCCCCchhhcchhhh-cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence            555554444444444433 34444444444444444444444444444444444433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-36  Score=348.94  Aligned_cols=266  Identities=23%  Similarity=0.292  Sum_probs=195.2

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  752 (973)
                      .+|++.+.||+|+||+||+|++..+|+.||||++..+..    ...+|+++++.++||||+++++++..... .+....+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            479999999999999999999999999999999965432    23469999999999999999998754321 2334567


Q ss_pred             EEEeeccCCCHHHHhh----hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEeccccch
Q 039720          753 IVYEYMQYGSVDDWLH----HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAR  827 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~Dfg~a~  827 (973)
                      +||||+++ ++.+.+.    ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 5665554    245567788899999999999999999   99999999999999965 578999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc-
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL-  905 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~-  905 (973)
                      .....         .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||...... ..+....+... 
T Consensus       206 ~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~  275 (420)
T 1j1b_A          206 QLVRG---------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGT  275 (420)
T ss_dssp             ECCTT---------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCS
T ss_pred             hcccC---------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            65432         122345689999999998765 7899999999999999999999999864322 11222111110 


Q ss_pred             Cc--ccccccCcc-----cccccCCCc---hhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PK--KVMGIVDPS-----LLMEARGPS---KFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~--~~~~~~~~~-----~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      +.  .+.. .++.     +......+.   ........+.+++.+||+.||++||++.|++++
T Consensus       276 p~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          276 PTREQIRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCHHHHHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00  0000 0000     000000000   011234567899999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-36  Score=336.26  Aligned_cols=264  Identities=19%  Similarity=0.234  Sum_probs=200.8

Q ss_pred             hhcCCcCCccccccceeEEEEEE-CCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCC------CceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNL-GEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR------NLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||+||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|+      +++++++++..   
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~---   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH---   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence            36899999999999999999998 568899999999743 23456788899999888665      48999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---------  814 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---------  814 (973)
                        ....++||||+ +++|.+++....  ...+..+..++.|++.||+|||++   +|+||||||+||+++.         
T Consensus        89 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           89 --HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             --CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence              37899999999 899999998765  456788899999999999999999   9999999999999987         


Q ss_pred             ----------CCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCC
Q 039720          815 ----------DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR  884 (973)
Q Consensus       815 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~  884 (973)
                                ++.+||+|||.++....           ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDE-----------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTS-----------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccCCCceEeeCcccccCcc-----------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence                      66899999999975432           122456899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCccHhhhhhHh--cCcccccccC-ccc-------cc---------------ccCCCchhHHHHHHHHHHHh
Q 039720          885 RPTDNMFNDGLTLHGYAKMA--LPKKVMGIVD-PSL-------LM---------------EARGPSKFEECLVAVVRTGV  939 (973)
Q Consensus       885 ~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~-------~~---------------~~~~~~~~~~~~~~l~~li~  939 (973)
                      .||......+ .........  .+........ ...       +.               ..........+...+.+++.
T Consensus       232 ~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          232 TVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             CSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            9997643221 111111110  1110000000 000       00               00001112345678899999


Q ss_pred             hcCCCCCCCCCCHHHHHHH
Q 039720          940 ACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       940 ~cl~~dP~~RPs~~evl~~  958 (973)
                      +||+.||++|||++|+++.
T Consensus       311 ~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          311 KMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTTS
T ss_pred             HHhCcCcccccCHHHHhcC
Confidence            9999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-36  Score=330.33  Aligned_cols=265  Identities=21%  Similarity=0.315  Sum_probs=194.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-------
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSID-------  744 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  744 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.++||||+++++++....       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            356899999999999999999999999999999999643 334577899999999999999999999876521       


Q ss_pred             -cCCCceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEec
Q 039720          745 -FKGADFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSD  822 (973)
Q Consensus       745 -~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~D  822 (973)
                       .......++||||+++|+|.+++.... ...+..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence             123577899999999999999998644 345577889999999999999999   999999999999999999999999


Q ss_pred             cccchhccCCCCccC------CCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 039720          823 FGLARFLSHHPFLVA------PEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGL  895 (973)
Q Consensus       823 fg~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~  895 (973)
                      ||.++..........      ...........||+.|+|||++.+. .++.++|||||||++|+|++   ||......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--  234 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence            999986543210000      0001222345689999999998765 78999999999999999998   55422111  


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        .........      ......     +......+..+.+++.+||+.||++|||++|+++.
T Consensus       235 --~~~~~~~~~------~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 --VNILKKLRS------VSIEFP-----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HHHHHHHHS------TTCCCC-----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --HHHHHhccc------cccccC-----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence              011110000      000010     11112334557789999999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-36  Score=341.93  Aligned_cols=267  Identities=22%  Similarity=0.280  Sum_probs=193.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  752 (973)
                      .+|++.+.||+|+||+||+|++..++. ||+|++..+...    ..+|+++++.++||||+++++++..... .+....+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            579999999999999999999976555 888888644321    2369999999999999999999865422 3344578


Q ss_pred             EEEeeccCCCHHHHhh---hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec-CCCcEEEeccccchh
Q 039720          753 IVYEYMQYGSVDDWLH---HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARF  828 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~-~~~~~kl~Dfg~a~~  828 (973)
                      +||||++++.+.....   .....++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754443322   245667788899999999999999999   999999999999999 799999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP  906 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~  906 (973)
                      ....         .......||+.|+|||++.+. .|+.++||||+||++|||++|+.||......+ .+....+.. .+
T Consensus       192 ~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p  261 (394)
T 4e7w_A          192 LIAG---------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTP  261 (394)
T ss_dssp             CCTT---------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred             ccCC---------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            5432         222345689999999998765 58999999999999999999999998653221 111111110 00


Q ss_pred             cc-cccccCccccc---ccCCCch-----hHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KK-VMGIVDPSLLM---EARGPSK-----FEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~-~~~~~~~~~~~---~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .. .....++....   .......     .......+.+++.+||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00 00000000000   0000000     11234567899999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=344.31  Aligned_cols=273  Identities=18%  Similarity=0.252  Sum_probs=184.9

Q ss_pred             hcCCc-CCccccccceeEEEEEEC--CCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSS-SNRIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +.|.+ .++||+|+||+||+|+++  .+++.||||++....  ....+.+|+.+++.++||||+++++++..   .....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence            45766 568999999999999975  478999999996432  34568899999999999999999998754   23578


Q ss_pred             EEEEEeeccCCCHHHHhhhcC---------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----cCCCc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN---------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL----DHDMV  817 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl----~~~~~  817 (973)
                      .++||||+. |+|.+++....         .+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            999999997 47887775321         366778899999999999999999   99999999999999    67789


Q ss_pred             EEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--
Q 039720          818 AHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG--  894 (973)
Q Consensus       818 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~--  894 (973)
                      +||+|||+|+......     ..........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+.  
T Consensus       171 ~kl~Dfg~a~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          171 VKIADMGFARLFNSPL-----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             EEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             EEEEECCCceecCCCC-----cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            9999999998764321     111223346789999999998874 58999999999999999999999997543321  


Q ss_pred             ------ccHhhhhhHh-cCc--ccccc---cCc-----ccccccCCCchhH--------HHHHHHHHHHhhcCCCCCCCC
Q 039720          895 ------LTLHGYAKMA-LPK--KVMGI---VDP-----SLLMEARGPSKFE--------ECLVAVVRTGVACSMESPSER  949 (973)
Q Consensus       895 ------~~~~~~~~~~-~~~--~~~~~---~~~-----~~~~~~~~~~~~~--------~~~~~l~~li~~cl~~dP~~R  949 (973)
                            ..+....... .+.  ....+   ...     .+...........        .....+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                  1111111100 000  00000   000     0000000000000        013456789999999999999


Q ss_pred             CCHHHHHHHHH
Q 039720          950 MQMTAVVKKLC  960 (973)
Q Consensus       950 Ps~~evl~~L~  960 (973)
                      ||++|++++-.
T Consensus       326 ~ta~e~L~hp~  336 (405)
T 3rgf_A          326 ITSEQAMQDPY  336 (405)
T ss_dssp             CCHHHHHTSGG
T ss_pred             CCHHHHhcChh
Confidence            99999998644

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.2e-36  Score=334.21  Aligned_cols=257  Identities=19%  Similarity=0.255  Sum_probs=175.8

Q ss_pred             hhcCCcCC-ccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSN-RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|.+.+ .||+|+||+||+|++..+++.||||++.....    ...+....++.+.||||+++++++... .......
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENM-HHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCceE
Confidence            46898865 59999999999999999999999999964321    122223345677999999999987653 2334668


Q ss_pred             EEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEEEeccccc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLA  826 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~kl~Dfg~a  826 (973)
                      ++||||+++|+|.+++....  .+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998754  467788999999999999999999   9999999999999976   456999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      +....          .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................  
T Consensus       179 ~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--  246 (336)
T 3fhr_A          179 KETTQ----------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR--  246 (336)
T ss_dssp             EEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eeccc----------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh--
Confidence            75532          122345689999999999888999999999999999999999999976543211100000000  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ..     ....     .......++..+.+++.+||+.||++|||++|+++.-
T Consensus       247 ~~-----~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          247 LG-----QYGF-----PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ---------CC-----CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             cc-----cccc-----CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00     0000     0111123455677899999999999999999999843

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.7e-36  Score=340.65  Aligned_cols=268  Identities=20%  Similarity=0.247  Sum_probs=198.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  749 (973)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++....  ....+.+.+|+.+++.++||||+++++++..... ....
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            358999999999999999999999999999999997542  3345778899999999999999999998765321 1122


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+. ++|.+.+..  ..++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence            3489999998 688887753  367788999999999999999999   9999999999999999999999999999855


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-cC-
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-LP-  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~~-  906 (973)
                      ..           ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+....... .+ 
T Consensus       195 ~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~  262 (371)
T 4exu_A          195 DA-----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPG  262 (371)
T ss_dssp             ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             cc-----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCc
Confidence            32           1234568999999999887 688999999999999999999999997543211 111111100 00 


Q ss_pred             cccccccCcccc-------cccCCC---chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLL-------MEARGP---SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ............       ......   .....+...+.+++.+||+.||++|||++|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            001000000000       000000   1112235678899999999999999999999875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.2e-35  Score=338.10  Aligned_cols=336  Identities=19%  Similarity=0.213  Sum_probs=181.2

Q ss_pred             cccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEc
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYL  237 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  237 (973)
                      .++++|++++|.++...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            34444444444444222222344445555555555554444444555555555555555554444444444444444444


Q ss_pred             cCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          238 FKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       238 ~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      ++|+++ .+|..++.++++|++|++++|.+++..|..|.++++|++|+|++|++++.   .+..+++|++|++++|.++.
T Consensus       125 ~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             CSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred             CCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence            444444 45544444566666666666666665566666666666666666666543   23344455555555544321


Q ss_pred             CCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCC
Q 039720          318 RTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT  397 (973)
Q Consensus       318 ~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  397 (973)
                      +                                                            ...++|+.|++++|+++..
T Consensus       201 ~------------------------------------------------------------~~~~~L~~L~l~~n~l~~~  220 (390)
T 3o6n_A          201 L------------------------------------------------------------AIPIAVEELDASHNSINVV  220 (390)
T ss_dssp             E------------------------------------------------------------ECCSSCSEEECCSSCCCEE
T ss_pred             c------------------------------------------------------------CCCCcceEEECCCCeeeec
Confidence            0                                                            1112344455555544422


Q ss_pred             CCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccccc
Q 039720          398 IPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGI  477 (973)
Q Consensus       398 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  477 (973)
                       |..  ..++|+.|++++|++++.  ..+..+++|++|++++|++++.                                
T Consensus       221 -~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~--------------------------------  263 (390)
T 3o6n_A          221 -RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKI--------------------------------  263 (390)
T ss_dssp             -ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEE--------------------------------
T ss_pred             -ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCc--------------------------------
Confidence             111  123444444444444321  2333333333333333333322                                


Q ss_pred             ccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeec
Q 039720          478 TTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELD  557 (973)
Q Consensus       478 ~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  557 (973)
                                       .|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+
T Consensus       264 -----------------~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~  324 (390)
T 3o6n_A          264 -----------------MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  324 (390)
T ss_dssp             -----------------ESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             -----------------ChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence                             33344455555566666666553 4445555666777777777776 5666677888888888


Q ss_pred             CCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCCCCCccccccccCccccCCCCC
Q 039720          558 LSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLGE  617 (973)
Q Consensus       558 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~~~  617 (973)
                      |++|+|++ +|  +..+++|+.|++++|++.+.... ..+..+....+.+++..|+++..
T Consensus       325 L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~~  380 (390)
T 3o6n_A          325 LDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQ  380 (390)
T ss_dssp             CCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTCE
T ss_pred             CCCCccce-eC--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccccc
Confidence            88888874 44  67788899999999998865332 34566667778888888886543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.8e-36  Score=363.39  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=203.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCC---CcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|++..+   +..||||+++... ....+.+.+|+.+++.++||||+++++++.+      
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------  462 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------  462 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec------
Confidence            46899999999999999999998643   4679999986533 3345779999999999999999999998632      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ...++||||+++|+|.+++.... ..++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            46889999999999999998654 466778899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......       ........+|+.|+|||++.+..++.++|||||||++|||++ |..||......  .......... 
T Consensus       540 ~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~-  609 (656)
T 2j0j_A          540 YMEDST-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGE-  609 (656)
T ss_dssp             SCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTC-
T ss_pred             ecCCCc-------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCC-
Confidence            664322       112223456789999999998999999999999999999997 99999754322  1111111000 


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                      ....+..++..+.+++.+||+.||++||++.|+++.|+++.+
T Consensus       610 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          610 ----------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                            011122345677899999999999999999999999998743

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-35  Score=336.20  Aligned_cols=201  Identities=23%  Similarity=0.292  Sum_probs=169.2

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CC-----CceeEEeEeeeccc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HR-----NLIKIITICSSIDF  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~  745 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++.. ......+..|+.+++.+. |+     +++++++++..   
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~---  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF---  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE---
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc---
Confidence            357899999999999999999999999999999999743 234566778888888885 55     48999988654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec--CCCcEEEe
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD--HDMVAHVS  821 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~--~~~~~kl~  821 (973)
                        ....++||||+. |+|.+++....  ...+..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+
T Consensus       128 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 --RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             --TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             --CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence              378999999996 59999987653  467788899999999999999952 22899999999999995  47789999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF  891 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~  891 (973)
                      |||+|+....           ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       204 DFG~a~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          204 DFGSSCQLGQ-----------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCTTCEETTC-----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eccCceeccc-----------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999986532           1224568999999999999999999999999999999999999998643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.1e-36  Score=334.47  Aligned_cols=243  Identities=20%  Similarity=0.283  Sum_probs=199.3

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch------hHHHHHHHHHHHHhcC--CCCceeEEeEeeec
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG------ATKSFVAECEALRNIR--HRNLIKIITICSSI  743 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  743 (973)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++.....      ....+.+|+.++++++  |||++++++++.. 
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-  119 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-  119 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence            457899999999999999999999999999999999754321      2245678999999996  5999999998654 


Q ss_pred             ccCCCceEEEEEeeccC-CCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec-CCCcEEEe
Q 039720          744 DFKGADFKAIVYEYMQY-GSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVS  821 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~-~~~~~kl~  821 (973)
                          .+..++|+||+.+ ++|.+++.......+..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+||+
T Consensus       120 ----~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 ----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             ----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             ----CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence                4789999999986 89999999888888888999999999999999999   999999999999999 78999999


Q ss_pred             ccccchhccCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          822 DFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       822 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      |||+++.....          ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....       ..
T Consensus       193 Dfg~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~  255 (320)
T 3a99_A          193 DFGSGALLKDT----------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI  255 (320)
T ss_dssp             CCTTCEECCSS----------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH
T ss_pred             eCccccccccc----------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh
Confidence            99999865431          1223468999999999887766 788999999999999999999996421       00


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ....            ..       .....+..+.+++.+||+.||++||+++|+++.
T Consensus       256 ~~~~------------~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          256 IRGQ------------VF-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             HHCC------------CC-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hccc------------cc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000            00       001123457789999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.6e-36  Score=331.75  Aligned_cols=255  Identities=22%  Similarity=0.261  Sum_probs=177.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHH-HHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECE-ALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++.... .....+..|.. +++.++||||+++++++..     .+.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence            3689999999999999999999999999999999975432 23445566665 6777899999999998754     478


Q ss_pred             EEEEEeeccCCCHHHHhhh-----cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          751 KAIVYEYMQYGSVDDWLHH-----TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                      .++||||+.+ +|.+++..     .....+..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||+
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            9999999985 88877763     455677888999999999999999853  899999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG----MGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ++.....         .......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.........+... 
T Consensus       173 ~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-  242 (327)
T 3aln_A          173 SGQLVDS---------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-  242 (327)
T ss_dssp             SCC---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-
T ss_pred             ceecccc---------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-
Confidence            9765432         112234689999999998    45678999999999999999999999997543211111000 


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              .....+.+.     ......+...+.+++.+||+.||++||+++|+++.
T Consensus       243 --------~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          243 --------VKGDPPQLS-----NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             --------CCSCCCCCC-----CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --------hcCCCCCCC-----CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                    000000010     01112234567889999999999999999999763

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.5e-36  Score=338.37  Aligned_cols=270  Identities=17%  Similarity=0.220  Sum_probs=200.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-----------CCCceeEEeEee
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-----------HRNLIKIITICS  741 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  741 (973)
                      .++|++.+.||+|+||+||+|++..+++.||||++..+. ...+.+.+|+++++++.           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            358999999999999999999999999999999997432 34566888999988886           899999999876


Q ss_pred             ecccCCCceEEEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec------
Q 039720          742 SIDFKGADFKAIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD------  813 (973)
Q Consensus       742 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~------  813 (973)
                      .. .......++||||+ +++|.+++...  ...+...++.++.||+.||+|||+++  +|+||||||+||+++      
T Consensus        97 ~~-~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HK-GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EE-ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred             cc-CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence            53 12334789999999 89999999763  34677889999999999999999853  899999999999994      


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFND  893 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~  893 (973)
                      ..+.+||+|||+++....           ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       173 ~~~~~kl~Dfg~a~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE-----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             TEEEEEECCCTTCEETTB-----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             CcceEEEcccccccccCC-----------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence            444899999999986532           122346899999999999999999999999999999999999999865432


Q ss_pred             Cc-----cHhhhhhHh--cCcc----------------ccccc-Cccccc----ccCCCchhHHHHHHHHHHHhhcCCCC
Q 039720          894 GL-----TLHGYAKMA--LPKK----------------VMGIV-DPSLLM----EARGPSKFEECLVAVVRTGVACSMES  945 (973)
Q Consensus       894 ~~-----~~~~~~~~~--~~~~----------------~~~~~-~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~d  945 (973)
                      ..     .+.......  .+..                ....+ ....+.    .......+..+...+.+++.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence            11     111111100  0000                00000 000000    00011233567788999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 039720          946 PSERMQMTAVVKK  958 (973)
Q Consensus       946 P~~RPs~~evl~~  958 (973)
                      |++|||++|+++.
T Consensus       322 P~~Rpt~~ell~h  334 (373)
T 1q8y_A          322 PRKRADAGGLVNH  334 (373)
T ss_dssp             TTTCBCHHHHHTC
T ss_pred             ccccCCHHHHhhC
Confidence            9999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=331.86  Aligned_cols=246  Identities=22%  Similarity=0.294  Sum_probs=193.3

Q ss_pred             HHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch------hHHHHHHHHHHHHhc----CCCCceeEEe
Q 039720          669 LSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG------ATKSFVAECEALRNI----RHRNLIKIIT  738 (973)
Q Consensus       669 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~  738 (973)
                      .....++|++.+.||+|+||.||+|++..+++.||||+++.....      ....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999999999999999999754321      223456799999988    8999999999


Q ss_pred             EeeecccCCCceEEEEEee-ccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec-CCC
Q 039720          739 ICSSIDFKGADFKAIVYEY-MQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD-HDM  816 (973)
Q Consensus       739 ~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~-~~~  816 (973)
                      ++..     .+..++|+|| +.+++|.+++.......+..++.++.|++.||+|||+.   +|+||||||+||+++ .++
T Consensus       106 ~~~~-----~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          106 WFET-----QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred             EEec-----CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence            8543     4778999999 78999999999887888899999999999999999999   999999999999999 889


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGL  895 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~  895 (973)
                      .+||+|||+++.....          ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....    
T Consensus       178 ~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----  243 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE----------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----  243 (312)
T ss_dssp             EEEECCCSSCEECCSS----------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred             eEEEEEcchhhhcccC----------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----
Confidence            9999999999865432          1234568999999999887766 458999999999999999999996421    


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         ......                   ..........+.+++.+||+.||++||+++|+++.
T Consensus       244 ---~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 ---EILEAE-------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ---HHHHTC-------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---HHhhhc-------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000000                   00011233456789999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-35  Score=326.17  Aligned_cols=253  Identities=22%  Similarity=0.348  Sum_probs=194.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcC--CCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIR--HRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|++. +++.||||++....  ....+.+.+|++++++++  ||||+++++++..     .
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----S
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----C
Confidence            468999999999999999999985 69999999997543  334577899999999997  5999999998654     4


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ...++||| +.+++|.+++.......+..++.++.|++.||.|||+.   +|+||||||+||+++ ++.+||+|||+++.
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecccccc
Confidence            68999999 66789999999887788888999999999999999999   999999999999996 48999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-----------GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      .....      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+
T Consensus       176 ~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (313)
T 3cek_A          176 MQPDT------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  249 (313)
T ss_dssp             --------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred             ccCcc------ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence            54321      1112234568999999999875           478899999999999999999999997543321111


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL  959 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  959 (973)
                      ..   .         .+.......  +   ......+.+++.+||+.||++||+++|+++.-
T Consensus       250 ~~---~---------~~~~~~~~~--~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          250 HA---I---------IDPNHEIEF--P---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HH---H---------HCTTSCCCC--C---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HH---H---------HhcccccCC--c---ccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            11   1         111100000  1   11134677889999999999999999998753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=335.93  Aligned_cols=261  Identities=22%  Similarity=0.280  Sum_probs=196.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..   .||+|+++...  ....+.+.+|+.++++++||||+++++++..     ...
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~  103 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PPH  103 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SSC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CCc
Confidence            4789999999999999999999853   49999997543  2233557789999999999999999998764     367


Q ss_pred             EEEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++++|.+++.... ...+..++.++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|||+++..
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999999999999999998755 567788999999999999999999   999999999999998 689999999998765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC---------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhh
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---------GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY  900 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~  900 (973)
                      .....   ...........||+.|+|||++.+         ..++.++|||||||++|||++|+.||.......  ....
T Consensus       180 ~~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~  254 (319)
T 2y4i_B          180 GVLQA---GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--IIWQ  254 (319)
T ss_dssp             -----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--HHHH
T ss_pred             ccccc---cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            32210   111222334468999999999864         457899999999999999999999997543221  1100


Q ss_pred             hhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccc
Q 039720          901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIF  966 (973)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  966 (973)
                      ...        ...+...        ...++..+.+++.+||+.||++||+++|+++.|+++.+..
T Consensus       255 ~~~--------~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          255 MGT--------GMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHT--------TCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             hcc--------CCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            000        0000000        0112335678999999999999999999999999987554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=332.64  Aligned_cols=268  Identities=20%  Similarity=0.232  Sum_probs=198.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  749 (973)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++....  ....+.+.+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357999999999999999999999999999999996532  3345678999999999999999999998754311 1123


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+. ++|.+++..  ..++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            4589999998 588887753  467788999999999999999999   9999999999999999999999999999754


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh-c-C
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA-L-P  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~-~-~  906 (973)
                      ..           ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+....... . +
T Consensus       177 ~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~  244 (353)
T 3coi_A          177 DA-----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPG  244 (353)
T ss_dssp             ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCC
T ss_pred             CC-----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            32           1224568999999999877 678999999999999999999999997543211 111111100 0 0


Q ss_pred             cccccccCcc--------ccc--ccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPS--------LLM--EARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......+...        ...  ..............+.+++.+|++.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000000000        000  000011122345677899999999999999999999864

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.4e-36  Score=328.89  Aligned_cols=257  Identities=29%  Similarity=0.495  Sum_probs=239.1

Q ss_pred             hhhHhhhcCCcccc--CCCccccCCCCcCEEEccc-ccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceE
Q 039720          359 TMTLIAMAGNQISG--TIPPEIRNLFNLNGLGLEY-NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVL  435 (973)
Q Consensus       359 ~l~~L~l~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  435 (973)
                      .++.|++++|++++  .+|..+..+++|++|+|++ |.+++.+|..|+++++|++|+|++|++++.+|..|..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            45566667777777  7888899999999999995 99999999999999999999999999999999999999999999


Q ss_pred             EcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcc
Q 039720          436 QLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNF  515 (973)
Q Consensus       436 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  515 (973)
                      ++++|++++.+|..+..+++|++|++++|++++.+|..++.+...++.|++++|++++.+|..+..++ |+.|++++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            99999999999999999999999999999999999999998885556999999999999999999997 99999999999


Q ss_pred             cccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCC
Q 039720          516 SNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKG  595 (973)
Q Consensus       516 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  595 (973)
                      ++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..+..+++|+.|+|++|+++|.+|..+
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            999999999999999999999999977765 8889999999999999999999999999999999999999999999998


Q ss_pred             CCCCccccccccCccccCCCCC
Q 039720          596 VFSNETRISLTGNEQFCGGLGE  617 (973)
Q Consensus       596 ~~~~~~~l~~~~N~~~cg~~~~  617 (973)
                      .+++++.+++.+||++||.|..
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTSS
T ss_pred             cccccChHHhcCCCCccCCCCC
Confidence            8999999999999999998663

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-35  Score=348.54  Aligned_cols=274  Identities=21%  Similarity=0.300  Sum_probs=203.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|.+..+|+.||||+++.. .....+.+.+|+++++.++||||+++++++.... +.....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            46899999999999999999999999999999998754 3344567899999999999999999999865421 233677


Q ss_pred             EEEEEeeccCCCHHHHhhhcC---CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc---EEEeccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN---DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV---AHVSDFG  824 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~---~kl~Dfg  824 (973)
                      .++||||+++|+|.+++....   ..++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998644   467788999999999999999999   9999999999999997764   9999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      .+......         .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......    ..|....
T Consensus       170 ~a~~~~~~---------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i  236 (676)
T 3qa8_A          170 YAKELDQG---------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKV  236 (676)
T ss_dssp             CCCBTTSC---------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTC
T ss_pred             cccccccc---------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhh
Confidence            99866432         1223457899999999999999999999999999999999999999754211    1111110


Q ss_pred             cCc-----ccccccCccccc--ccC-CCchhHHHHHHHHHHHhhcCCCCCCCCCCHHH-----HHHHHHhc
Q 039720          905 LPK-----KVMGIVDPSLLM--EAR-GPSKFEECLVAVVRTGVACSMESPSERMQMTA-----VVKKLCAV  962 (973)
Q Consensus       905 ~~~-----~~~~~~~~~~~~--~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~  962 (973)
                      ...     ............  ..+ ........+..+.+++.+||..||++|||++|     +.+.++.+
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i  307 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI  307 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence            000     000001111100  000 01223345677889999999999999999987     44555544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-35  Score=330.91  Aligned_cols=264  Identities=19%  Similarity=0.239  Sum_probs=197.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC-cEEEEEEeecccchhHHHHHHHHHHHHhcCCCC------ceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG-MSVAVKVMNLDKKGATKSFVAECEALRNIRHRN------LIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||+||+|++..++ +.||+|+++.. ....+.+.+|+.+++.++|++      ++.+++++..   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~---   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF---   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence            368999999999999999999998777 78999999743 234567888999999997665      8888887654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-----------
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLL-----------  812 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl-----------  812 (973)
                        ....++||||+ ++++.+++....  ..++..++.++.||+.||+|||++   +|+||||||+||++           
T Consensus        94 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           94 --HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             --CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence              47899999999 567777776543  567788999999999999999999   99999999999999           


Q ss_pred             --------cCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCC
Q 039720          813 --------DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR  884 (973)
Q Consensus       813 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~  884 (973)
                              +.++.+||+|||+++....           ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHE-----------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTS-----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccccccCCCcEEEeecCccccccc-----------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence                    5678999999999975432           122456899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCccHhhhhhHh--cCccccccc-Cccc-------ccc---------------cCCCchhHHHHHHHHHHHh
Q 039720          885 RPTDNMFNDGLTLHGYAKMA--LPKKVMGIV-DPSL-------LME---------------ARGPSKFEECLVAVVRTGV  939 (973)
Q Consensus       885 ~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~-------~~~---------------~~~~~~~~~~~~~l~~li~  939 (973)
                      .||....... .+.......  .+....... ....       +..               .........+...+.+++.
T Consensus       237 ~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          237 TLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             CSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            9998643321 111111111  111000000 0000       000               0000111234567889999


Q ss_pred             hcCCCCCCCCCCHHHHHHH
Q 039720          940 ACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       940 ~cl~~dP~~RPs~~evl~~  958 (973)
                      +||+.||++|||++|+++.
T Consensus       316 ~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTTS
T ss_pred             HHhcCChhhCcCHHHHhcC
Confidence            9999999999999999853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=324.87  Aligned_cols=252  Identities=21%  Similarity=0.266  Sum_probs=179.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch-h-HHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-A-TKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...... . .+.+.++..+++.++||||+++++++..     .+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CCc
Confidence            46799999999999999999999999999999999755332 2 2334455567888899999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          751 KAIVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      .++||||+ ++.+..+... ....++..++.++.|++.||.|||+ .   +|+||||||+||+++.++.+||+|||++..
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999 5566665543 4556778889999999999999998 5   899999999999999999999999999976


Q ss_pred             ccCCCCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      ....         .......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.........+......
T Consensus       175 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (318)
T 2dyl_A          175 LVDD---------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE  245 (318)
T ss_dssp             ---------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred             ccCC---------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence            5432         1222446899999999984     5578899999999999999999999997543221111111110


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .         .+...       ....++..+.+++.+||+.||++||+++|+++.
T Consensus       246 ~---------~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          246 E---------PPLLP-------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             C---------CCCCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             C---------CCCCC-------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0         00000       001233467789999999999999999999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.4e-35  Score=335.44  Aligned_cols=252  Identities=22%  Similarity=0.257  Sum_probs=184.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      +.|.+.+.||+|+||+||.+.. .+|+.||||++..+   ..+.+.+|+++++++ +||||+++++++.     +....+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~   85 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLY   85 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEE
Confidence            4566678899999999987644 58999999998643   245678899999876 8999999998854     347899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCc-------hhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC----------
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKL-------EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD----------  815 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~----------  815 (973)
                      +||||+. |+|.+++.......       +..++.++.||+.||+|||++   +|+||||||+|||++.+          
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccC
Confidence            9999996 69999998654332       234578999999999999999   99999999999999754          


Q ss_pred             ---CcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccC-------CCCCcccchHHHHHHHHHHHh-CC
Q 039720          816 ---MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-------GDLSMTGDVYSFGILLLEMFT-RR  884 (973)
Q Consensus       816 ---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~ll~ellt-g~  884 (973)
                         +.+||+|||+++.......    ..........||+.|+|||++.+       ..++.++|||||||++|||++ |+
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQS----SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             CCceEEEEcccccceecCCCCc----cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence               4899999999987654220    00111234579999999999875       678999999999999999999 99


Q ss_pred             CCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          885 RPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       885 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .||.........   .....        ....    .............+.+++.+||+.||++|||+.|+++
T Consensus       238 ~Pf~~~~~~~~~---i~~~~--------~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          238 HPFGDKYSRESN---IIRGI--------FSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CTTCSTTTHHHH---HHHTC--------CCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCchhhHHH---HhcCC--------CCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            999754332111   11100        0000    0001112455677889999999999999999999986

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-34  Score=347.56  Aligned_cols=314  Identities=21%  Similarity=0.226  Sum_probs=228.3

Q ss_pred             CCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEE
Q 039720          205 LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWL  284 (973)
Q Consensus       205 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  284 (973)
                      +.+++.|++++|.+..                         +|..++.++++|++|+|++|.|++..|..|.++++|++|
T Consensus        50 l~~l~~l~l~~~~l~~-------------------------lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  104 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRK-------------------------LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKL  104 (597)
T ss_dssp             GCCCSEEEESSCEESE-------------------------ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCCC-------------------------cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEE
Confidence            4566677777776653                         444444455666666666666666666666666677777


Q ss_pred             EccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhh
Q 039720          285 ELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIA  364 (973)
Q Consensus       285 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~  364 (973)
                      +|++|.|++..+..|.++++|++|+|++|.|+.+                                              
T Consensus       105 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l----------------------------------------------  138 (597)
T 3oja_B          105 YMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL----------------------------------------------  138 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC----------------------------------------------
T ss_pred             ECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCC----------------------------------------------
Confidence            7777776666666666666666666666655431                                              


Q ss_pred             hcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccc
Q 039720          365 MAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG  444 (973)
Q Consensus       365 l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  444 (973)
                               .+..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++.   .+..+++|+.|++++|.+++
T Consensus       139 ---------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          139 ---------PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             ---------CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred             ---------CHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc
Confidence                     222345556666666666666666666666666666666666666643   24455666666666666653


Q ss_pred             ccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCccccccccccc
Q 039720          445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLS  524 (973)
Q Consensus       445 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  524 (973)
                           +...++|+.|++++|.+. .+|..+.   ..++.|+|++|.+++  +..++.+++|+.|+|++|.+++..|..|+
T Consensus       207 -----l~~~~~L~~L~ls~n~l~-~~~~~~~---~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (597)
T 3oja_B          207 -----LAIPIAVEELDASHNSIN-VVRGPVN---VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV  275 (597)
T ss_dssp             -----EECCTTCSEEECCSSCCC-EEECSCC---SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             -----ccCCchhheeeccCCccc-ccccccC---CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence                 223346677777777766 3333322   233588888888885  46789999999999999999999999999


Q ss_pred             CccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCCCCCccccc
Q 039720          525 ACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRIS  604 (973)
Q Consensus       525 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~l~  604 (973)
                      ++++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..+  ..+++++.++
T Consensus       276 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~L~~L~  351 (597)
T 3oja_B          276 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL--STHHTLKNLT  351 (597)
T ss_dssp             TCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC--CTTCCCSEEE
T ss_pred             CccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcCh--hhcCCCCEEE
Confidence            99999999999999995 6778888999999999999999 788889999999999999999998753  4588999999


Q ss_pred             cccCccccCCCC
Q 039720          605 LTGNEQFCGGLG  616 (973)
Q Consensus       605 ~~~N~~~cg~~~  616 (973)
                      +.+|||.|.+..
T Consensus       352 l~~N~~~~~~~~  363 (597)
T 3oja_B          352 LSHNDWDCNSLR  363 (597)
T ss_dssp             CCSSCEEHHHHH
T ss_pred             eeCCCCCChhHH
Confidence            999999998653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-34  Score=313.50  Aligned_cols=233  Identities=10%  Similarity=0.059  Sum_probs=184.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....   ...+.+.+|+.+++.++||||+++++++..     .+.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence            579999999999999999999998999999999975532   334778999999999999999999998755     378


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++++|.+++...  ....++.+++.|++.||+|||++   +|+||||||+||+++.++.+||++++      
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            99999999999999999653  34556889999999999999999   99999999999999999999997443      


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                                            |++       +++.++|||||||++|||++|+.||............          .
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------~  215 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------E  215 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------C
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------H
Confidence                                  222       2678999999999999999999999865432110000          0


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      ..........   ......++..+.+++.+||+.||++| |++|+++.|+++...
T Consensus       216 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          216 RDTAGQPIEP---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             BCTTSCBCCH---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             HHhccCCCCh---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            0000000000   01112344567899999999999999 999999999998643

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.8e-33  Score=314.88  Aligned_cols=306  Identities=22%  Similarity=0.349  Sum_probs=179.7

Q ss_pred             cCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccce
Q 039720           83 GNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIER  162 (973)
Q Consensus        83 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~  162 (973)
                      ..+++|++|++++|.++ .+| .+..+++|++|+|++|.+++ +|. +..+++|++|++++|.+.+. + .+..+++|++
T Consensus        41 ~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~-~-~~~~l~~L~~  114 (347)
T 4fmz_A           41 EELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI-S-ALQNLTNLRE  114 (347)
T ss_dssp             HHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSE
T ss_pred             hhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc-h-HHcCCCcCCE
Confidence            35667777777777776 344 36777777777777777763 333 66666666666666655542 2 3556666666


Q ss_pred             eeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCcc
Q 039720          163 LSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRF  242 (973)
Q Consensus       163 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  242 (973)
                      |++++|.+++ +|. +..+++|++|++++|.....+ ..+..+++|++|++++|.+.+..+  +..+++|++|++++|++
T Consensus       115 L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l  189 (347)
T 4fmz_A          115 LYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI  189 (347)
T ss_dssp             EECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred             EECcCCcccC-chh-hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence            6666666653 222 566666666666666544332 236666666666666666654333  45555555555555555


Q ss_pred             ccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCC
Q 039720          243 KGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTD  322 (973)
Q Consensus       243 ~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  322 (973)
                      . .++.  +..+++|+.|++++|.+++..+  +..+++|++|+|++|++++..+  +..+++|++|++++|.++.+    
T Consensus       190 ~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~----  258 (347)
T 4fmz_A          190 E-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI----  258 (347)
T ss_dssp             C-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC----
T ss_pred             c-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC----
Confidence            4 2332  2245555555555555554322  5555555555555555554333  44555555555555544321    


Q ss_pred             hhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccc
Q 039720          323 LDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI  402 (973)
Q Consensus       323 ~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  402 (973)
                                                                           +.+..+++|+.|++++|++++.  ..+
T Consensus       259 -----------------------------------------------------~~~~~l~~L~~L~l~~n~l~~~--~~~  283 (347)
T 4fmz_A          259 -----------------------------------------------------NAVKDLTKLKMLNVGSNQISDI--SVL  283 (347)
T ss_dssp             -----------------------------------------------------GGGTTCTTCCEEECCSSCCCCC--GGG
T ss_pred             -----------------------------------------------------hhHhcCCCcCEEEccCCccCCC--hhh
Confidence                                                                 2345556677777777777643  456


Q ss_pred             cCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccc
Q 039720          403 GELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN  467 (973)
Q Consensus       403 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  467 (973)
                      ..+++|++|++++|++.+..|..+..+++|++|++++|++++..|  +..+++|+.|++++|.|+
T Consensus       284 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             cCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            667777777777777776666667777777777777777775545  666777777777777664

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-34  Score=328.55  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=182.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .+|.+.+.||+|+||+||.... .+++.||||++.....   ..+.+|+++++.+ +||||+++++++..     ....+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEEE
Confidence            4688899999999999664333 4899999999964432   2356799999999 79999999998654     47889


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---C--CcEEEeccccc
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---D--MVAHVSDFGLA  826 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~--~~~kl~Dfg~a  826 (973)
                      +||||+. |+|.+++.... ...+..++.++.||+.||+|||+.   +|+||||||+||+++.   +  ..+||+|||+|
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9999997 59999987654 334556789999999999999999   9999999999999953   2  36889999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCccccc---CCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhh
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM---GGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~  902 (973)
                      +......     ..........||+.|+|||++.   ...++.++|||||||++|||++ |..||........      .
T Consensus       171 ~~~~~~~-----~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------~  239 (432)
T 3p23_A          171 KKLAVGR-----HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------N  239 (432)
T ss_dssp             ECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------H
T ss_pred             eeccCCC-----cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------H
Confidence            8664321     0112233457999999999987   4567889999999999999999 9999964322110      1


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      .......     .    ..  ..........+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~-----~----~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ILLGACS-----L----DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHTTCCC-----C----TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCC-----c----cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1000000     0    00  0111234455678999999999999999999984

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=4.3e-33  Score=309.61  Aligned_cols=218  Identities=22%  Similarity=0.309  Sum_probs=131.4

Q ss_pred             CCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeecc
Q 039720           87 FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLY  166 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~  166 (973)
                      +++.+++++|.++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|++++|++.+..|..+.++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            3455555555555 4555442  456666666666654445555555555555555555555556666667777777777


Q ss_pred             CCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCcc--ccCCccccCCCCCcEEEccCCcccc
Q 039720          167 GNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS--GMFPLSVCNISSLDEAYLFKNRFKG  244 (973)
Q Consensus       167 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~  244 (973)
                      +|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++  +..|..+..+ +|++|++++|+++ 
T Consensus       111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-  185 (332)
T 2ft3_A          111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-  185 (332)
T ss_dssp             SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-
T ss_pred             CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-
Confidence            77777 5666554  67888888888887655666788888888888888875  3556666655 6666666666665 


Q ss_pred             CCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccC
Q 039720          245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       245 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      .+|..++   ++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus       186 ~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  253 (332)
T 2ft3_A          186 GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL  253 (332)
T ss_dssp             SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCC
T ss_pred             ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcC
Confidence            3554432   4555555555555554445555555555555555555544444444444444444444433

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6.4e-33  Score=310.48  Aligned_cols=305  Identities=26%  Similarity=0.413  Sum_probs=147.3

Q ss_pred             cccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEE
Q 039720          156 NWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEA  235 (973)
Q Consensus       156 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  235 (973)
                      .+++|++|++++|.++ .+| .+..+++|++|++++|++++ ++. +.++++|++|++++|.+++.  .++.        
T Consensus        42 ~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~--~~~~--------  107 (347)
T 4fmz_A           42 ELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI--SALQ--------  107 (347)
T ss_dssp             HHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGT--------
T ss_pred             hcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc--hHHc--------
Confidence            3445555555555554 233 25555555555555555552 222 55555555555555555431  1334        


Q ss_pred             EccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccC
Q 039720          236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       236 ~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                                       ++++|++|++++|.+++..+  +..+++|++|++++|......+ .+..+++|++|++++|.+
T Consensus       108 -----------------~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~  167 (347)
T 4fmz_A          108 -----------------NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKV  167 (347)
T ss_dssp             -----------------TCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCC
T ss_pred             -----------------CCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCc
Confidence                             44555555555555553222  5555555555555554332222 255555555555555544


Q ss_pred             CCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCC
Q 039720          316 GTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT  395 (973)
Q Consensus       316 ~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  395 (973)
                      ..+.                                                         .+..+++|+.|++++|.++
T Consensus       168 ~~~~---------------------------------------------------------~~~~l~~L~~L~l~~n~l~  190 (347)
T 4fmz_A          168 KDVT---------------------------------------------------------PIANLTDLYSLSLNYNQIE  190 (347)
T ss_dssp             CCCG---------------------------------------------------------GGGGCTTCSEEECTTSCCC
T ss_pred             CCch---------------------------------------------------------hhccCCCCCEEEccCCccc
Confidence            3211                                                         0233344444444444444


Q ss_pred             CCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccc
Q 039720          396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF  475 (973)
Q Consensus       396 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  475 (973)
                      +..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|++|++++|.+.+ +     
T Consensus       191 ~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-----  258 (347)
T 4fmz_A          191 DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-----  258 (347)
T ss_dssp             CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-----
T ss_pred             cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-----
Confidence            2221  4444555555555555543322  4445555555555555553222  4445555544444444431 1     


Q ss_pred             ccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCe
Q 039720          476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKE  555 (973)
Q Consensus       476 ~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  555 (973)
                                           ..+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|..+..+++|++
T Consensus       259 ---------------------~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  315 (347)
T 4fmz_A          259 ---------------------NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT  315 (347)
T ss_dssp             ---------------------GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred             ---------------------hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence                                 1223344555555555555532  23455555555555555555555555556666666


Q ss_pred             ecCCCCccccccCCCCCCCCccceEeccCCcCc
Q 039720          556 LDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE  588 (973)
Q Consensus       556 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  588 (973)
                      |+|++|++++..|  +..+++|+.|++++|+++
T Consensus       316 L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEccCCccccccC--hhhhhccceeehhhhccc
Confidence            6666666654433  555666666666666554

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.4e-34  Score=347.24  Aligned_cols=244  Identities=21%  Similarity=0.308  Sum_probs=195.1

Q ss_pred             hcCCcCCccccccceeEEEEEECC-CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGE-DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||+||+|++.. +|+.||||++.... ......+.+|++++++++||||+++++++......+....
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999976 78999999986443 3345678899999999999999999999876533233347


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++++|.+++..  .+++.+++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||+++....
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            999999999999988765  577888999999999999999999   99999999999999885 899999999986532


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .            ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........                
T Consensus       234 ~------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------  284 (681)
T 2pzi_A          234 F------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------  284 (681)
T ss_dssp             C------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------
T ss_pred             C------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------
Confidence            1            2456999999999987654 8899999999999999999988764221100                


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHhc
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-QMTAVVKKLCAV  962 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~  962 (973)
                       .         ...........+.+++.+||+.||++|| +++++.+.+.++
T Consensus       285 -~---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 -P---------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -C---------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -c---------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             0         0111223446788999999999999999 566677766654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.4e-33  Score=306.77  Aligned_cols=233  Identities=19%  Similarity=0.291  Sum_probs=180.7

Q ss_pred             hcCCcC-CccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHH-HhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSS-NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|.+. +.||+|+||+||+|++..+++.||+|+++..     ..+.+|+.++ +..+||||+++++++... .......
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence            567777 7799999999999999999999999999632     3466788887 666899999999987652 3345778


Q ss_pred             EEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEEEeccccc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLA  826 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~kl~Dfg~a  826 (973)
                      ++||||+++|+|.+++....  ..++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754  467888999999999999999999   9999999999999998   789999999998


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ....                              +..++.++||||+||++|||++|+.||.........          
T Consensus       168 ~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------  207 (299)
T 3m2w_A          168 KETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------  207 (299)
T ss_dssp             EECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------
T ss_pred             cccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------
Confidence            6431                              134577999999999999999999999754322100          


Q ss_pred             cccccccCcccccccCCC-chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGP-SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ......+..   .....+ .....++..+.+++.+||+.||++|||++|+++.
T Consensus       208 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          208 PGMKTRIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSCCSSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000000000   000001 1112345678899999999999999999999984

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.3e-32  Score=305.60  Aligned_cols=200  Identities=24%  Similarity=0.286  Sum_probs=138.4

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeec
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSL  165 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L  165 (973)
                      +.|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|++                        +++|++|+|
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~------------------------l~~L~~L~L  107 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP------------------------LVKLERLYL  107 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT------------------------CTTCCEEEC
T ss_pred             CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcC------------------------CCCCCEEEC
Confidence            46677777777777555556777777777777777776554555544                        455666666


Q ss_pred             cCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccc--cCCccccCCCCCcEEEccCCccc
Q 039720          166 YGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG--MFPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       166 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                      ++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.+..  ..+..+.++++|++|++++|+++
T Consensus       108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~  184 (330)
T 1xku_A          108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  184 (330)
T ss_dssp             CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence            666666 4555554  677888888888876666677788888888888887753  56667777777777777777776


Q ss_pred             cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       244 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                       .+|..++   ++|++|++++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++
T Consensus       185 -~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  253 (330)
T 1xku_A          185 -TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV  253 (330)
T ss_dssp             -SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred             -cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence             5665543   67777777777777777777777777777777777777666666666666666666666553

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.8e-32  Score=303.01  Aligned_cols=295  Identities=20%  Similarity=0.218  Sum_probs=210.8

Q ss_pred             cccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEc
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYL  237 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  237 (973)
                      .+++.+++++|.++ .+|..+.  ++|++|++++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            46888999999988 6787764  68999999999998777888999999999999999999888889999999999999


Q ss_pred             cCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCccc--ccCcccccCcccccceecccccC
Q 039720          238 FKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS--GQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       238 ~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      ++|+++ .+|..++   ++|++|++++|.+++..+..|.++++|++|++++|.++  +..+..|..+ +|++|++++|++
T Consensus       110 ~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          110 SKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             CSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             CCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence            999998 7887765   78999999999999877778999999999999999986  3667778777 888888888877


Q ss_pred             CCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCC
Q 039720          316 GTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT  395 (973)
Q Consensus       316 ~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  395 (973)
                      +.++..                                                        +.  ++|++|+|++|+++
T Consensus       185 ~~l~~~--------------------------------------------------------~~--~~L~~L~l~~n~i~  206 (332)
T 2ft3_A          185 TGIPKD--------------------------------------------------------LP--ETLNELHLDHNKIQ  206 (332)
T ss_dssp             SSCCSS--------------------------------------------------------SC--SSCSCCBCCSSCCC
T ss_pred             CccCcc--------------------------------------------------------cc--CCCCEEECCCCcCC
Confidence            643221                                                        11  35666666666666


Q ss_pred             CCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccc
Q 039720          396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF  475 (973)
Q Consensus       396 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  475 (973)
                      +..+..|..+++|++|+|++|++++..+..+..+++|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|...+
T Consensus       207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~-~~~~~~~  284 (332)
T 2ft3_A          207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDF  284 (332)
T ss_dssp             CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCC-BCCTTSS
T ss_pred             ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCC-ccChhHc
Confidence            665666666666666666666666665666666666666666666666 56666666666666666666666 3333222


Q ss_pred             ccccccceeeccCCcccccCCcccccccccceeccccCccc--ccccccccCccchhhhcccCcc
Q 039720          476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS--NEIPVTLSACTTLEYLLMQGNS  538 (973)
Q Consensus       476 ~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~  538 (973)
                      .....                  -....+|+.|++++|.+.  +..|..|..+++|+.|++++|+
T Consensus       285 ~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          285 CPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccccc------------------ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            11000                  001244566666666665  4555666666666666666653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.7e-34  Score=323.90  Aligned_cols=245  Identities=16%  Similarity=0.170  Sum_probs=177.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCC-CCcee-------------
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRH-RNLIK-------------  735 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~-------------  735 (973)
                      ...|+..+.||+|+||+||+|++..+|+.||||+++....   ...+.+.+|+.+++.+.| ++...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3468888999999999999999999999999999974332   235778999999999977 22111             


Q ss_pred             --------EEeEeeecccCCCceEEEEEeeccCCCHHHHhhh-------cCCCchhhHHHHHHHHHHHHHHHHhcCCCCe
Q 039720          736 --------IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHH-------TNDKLEVGKLNIVIEVASVIEYLHNHCQPPI  800 (973)
Q Consensus       736 --------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~i  800 (973)
                              ++.+............+++|+++ +++|.+++..       .....+..+..++.|++.||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                    11111100000123356666655 6899988842       11234466788899999999999999   99


Q ss_pred             EecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccc----------cCCCCCcccch
Q 039720          801 VHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYG----------MGGDLSMTGDV  870 (973)
Q Consensus       801 vHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv  870 (973)
                      +||||||+|||++.++.+||+|||+++....           ......| +.|+|||++          .+..++.++||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC-----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence            9999999999999999999999999875432           1334567 899999998          66678999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC
Q 039720          871 YSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM  950 (973)
Q Consensus       871 wSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  950 (973)
                      |||||++|||++|+.||........             ...++.     ..  .    ..+..+.+++.+||+.||++||
T Consensus       301 wSlGvil~elltg~~Pf~~~~~~~~-------------~~~~~~-----~~--~----~~~~~~~~li~~~l~~dP~~Rp  356 (413)
T 3dzo_A          301 WTLGLAIYWIWCADLPNTDDAALGG-------------SEWIFR-----SC--K----NIPQPVRALLEGFLRYPKEDRL  356 (413)
T ss_dssp             HHHHHHHHHHHHSSCCCCTTGGGSC-------------SGGGGS-----SC--C----CCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhh-------------HHHHHh-----hc--c----cCCHHHHHHHHHHccCChhhCc
Confidence            9999999999999999975432211             000000     00  0    1235677899999999999999


Q ss_pred             CHHHHHH
Q 039720          951 QMTAVVK  957 (973)
Q Consensus       951 s~~evl~  957 (973)
                      ++.|+++
T Consensus       357 t~~~~l~  363 (413)
T 3dzo_A          357 LPLQAME  363 (413)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHHh
Confidence            9766643

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=6.2e-32  Score=300.06  Aligned_cols=296  Identities=21%  Similarity=0.244  Sum_probs=218.8

Q ss_pred             cccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEc
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYL  237 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  237 (973)
                      .+++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|.++++|++|++
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            46888999998888 5777665  68899999999999777778999999999999999999888999999999999999


Q ss_pred             cCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccc--cCcccccCcccccceecccccC
Q 039720          238 FKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSG--QVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       238 ~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      ++|+++ .+|..++   ++|++|++++|.+++..+..|.++++|++|++++|+++.  ..+..|..+++|++|++++|.+
T Consensus       108 s~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l  183 (330)
T 1xku_A          108 SKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI  183 (330)
T ss_dssp             CSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred             CCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence            999998 7887765   789999999999998878889999999999999999864  6677788888888888888877


Q ss_pred             CCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCC
Q 039720          316 GTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT  395 (973)
Q Consensus       316 ~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  395 (973)
                      +.++.                                                        .+.  ++|++|+|++|+++
T Consensus       184 ~~l~~--------------------------------------------------------~~~--~~L~~L~l~~n~l~  205 (330)
T 1xku_A          184 TTIPQ--------------------------------------------------------GLP--PSLTELHLDGNKIT  205 (330)
T ss_dssp             CSCCS--------------------------------------------------------SCC--TTCSEEECTTSCCC
T ss_pred             ccCCc--------------------------------------------------------ccc--ccCCEEECCCCcCC
Confidence            54322                                                        111  46677777777777


Q ss_pred             CCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCcccc
Q 039720          396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIF  475 (973)
Q Consensus       396 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  475 (973)
                      +..|..|..+++|++|+|++|++++..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|...+
T Consensus       206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~-~~~~~~f  283 (330)
T 1xku_A          206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDF  283 (330)
T ss_dssp             EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSS
T ss_pred             ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCC-ccChhhc
Confidence            666677777777777777777777666666777777777777777777 66666777777777777777776 3443332


Q ss_pred             ccccccceeeccCCcccccCCcccccccccceeccccCcccc--cccccccCccchhhhcccCcc
Q 039720          476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSN--EIPVTLSACTTLEYLLMQGNS  538 (973)
Q Consensus       476 ~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~  538 (973)
                      ....                  .......|+.|++++|.+..  ..|..|..+.+|+.++|++|+
T Consensus       284 ~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          284 CPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CCcc------------------cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            1110                  00123456667777776653  455677777777777777774

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=9.6e-33  Score=307.42  Aligned_cols=247  Identities=16%  Similarity=0.162  Sum_probs=188.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--------chhHHHHHHHHHHHHhcC---------CCCcee
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--------KGATKSFVAECEALRNIR---------HRNLIK  735 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~  735 (973)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++...        ....+.+.+|+.+++.++         |||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999999  78999999997553        223377889999998885         888888


Q ss_pred             EEeEeeec-------------------------ccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHH
Q 039720          736 IITICSSI-------------------------DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE  790 (973)
Q Consensus       736 ~~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~  790 (973)
                      +.+++...                         ++.+....++||||+++|++.+.+.+ ...++..++.++.||+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            88765321                         01236789999999999977666654 45678889999999999999


Q ss_pred             HHH-hcCCCCeEecCCCCCcEEecCCC--------------------cEEEeccccchhccCCCCccCCCCCcccccccc
Q 039720          791 YLH-NHCQPPIVHGDLKPSNVLLDHDM--------------------VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG  849 (973)
Q Consensus       791 ~LH-~~~~~~ivHrDik~~NILl~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g  849 (973)
                      ||| +.   +|+||||||+|||++.++                    .+||+|||+|+....             ....|
T Consensus       176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------------~~~~g  239 (336)
T 2vuw_A          176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------------GIVVF  239 (336)
T ss_dssp             HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------------TEEEC
T ss_pred             HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------------CcEEE
Confidence            999 88   999999999999999887                    899999999986532             13479


Q ss_pred             cccccCcccccCCCCCcccchHHHHHH-HHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhH
Q 039720          850 TIGYIGPEYGMGGDLSMTGDVYSFGIL-LLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFE  928 (973)
Q Consensus       850 t~~y~aPE~~~~~~~~~~sDvwSlG~l-l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (973)
                      |+.|+|||++.+.. +.++||||+|++ .+++++|..||...        .|..... ..+..   ..............
T Consensus       240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~-~~~~~---~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT-DKMLK---QMTFKTKCNTPAMK  306 (336)
T ss_dssp             CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH-HHHHH---TCCCSSCCCSHHHH
T ss_pred             eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH-Hhhhh---hhccCcccchhhhh
Confidence            99999999988776 899999998777 77888899998531        0100000 00000   00000111123345


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 039720          929 ECLVAVVRTGVACSMESPSERMQMTAVV  956 (973)
Q Consensus       929 ~~~~~l~~li~~cl~~dP~~RPs~~evl  956 (973)
                      .....+.+++.+||+.|     |++|++
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHH
Confidence            67888999999999976     999988

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=7.6e-35  Score=339.62  Aligned_cols=362  Identities=20%  Similarity=0.189  Sum_probs=214.8

Q ss_pred             cccceeeccCCcccccCCCC-CCCCCcccEEEccCCcCCC----CCCCcccCCCccceeccCCCCccccCCccccCCCCC
Q 039720          158 LKIERLSLYGNQLTGQLPPS-IGNLSALQTFDIAGNKLDG----RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSL  232 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L  232 (973)
                      ++|++|+|++|+++...... +..+++|++|+|++|+++.    .++..+..+++|++|+|++|.+++..          
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~----------   72 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVG----------   72 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHH----------
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHH----------
Confidence            45666666666665322222 4455666666666666552    23444555566666666666554322          


Q ss_pred             cEEEccCCccccCCCcccccCCC----CCcEEEccCCcccc----cCCccccCCCCCCEEEccCCcccccCcccc-----
Q 039720          233 DEAYLFKNRFKGSLPVCLGFNLP----KLTVLVVAQNNLTG----FLPQSLSNASKLEWLELNENHFSGQVRINF-----  299 (973)
Q Consensus       233 ~~L~L~~N~l~~~ip~~~~~~l~----~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----  299 (973)
                                    +..++..++    +|++|+|++|.|+.    .++..+..+++|++|+|++|++++..+..+     
T Consensus        73 --------------~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~  138 (461)
T 1z7x_W           73 --------------VHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL  138 (461)
T ss_dssp             --------------HHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred             --------------HHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHh
Confidence                          222222333    56777777776663    446667777777777777777764433322     


Q ss_pred             cCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCcccc
Q 039720          300 NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIR  379 (973)
Q Consensus       300 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~  379 (973)
                      ...++|++|+|++|+++....  ......+..+++|++|++++|.+++..+..+....                    ..
T Consensus       139 ~~~~~L~~L~L~~n~l~~~~~--~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l--------------------~~  196 (461)
T 1z7x_W          139 DPQCRLEKLQLEYCSLSAASC--EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGL--------------------KD  196 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGH--HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHH--------------------HH
T ss_pred             cCCCcceEEECCCCCCCHHHH--HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHH--------------------hc
Confidence            234567777777777654221  12234556667777777777766533332222110                    01


Q ss_pred             CCCCcCEEEcccccCCCC----CCccccCCCCCCeEEccCcccCCCC-----CCccCCcCccceEEcCCCccccc----c
Q 039720          380 NLFNLNGLGLEYNQLTGT----IPPAIGELRNLQYLGLVGNNIRGII-----PDPIGNLTLLNVLQLGFNKLQGS----I  446 (973)
Q Consensus       380 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~  446 (973)
                      ..++|++|+|++|++++.    ++..+..+++|++|+|++|++....     +..+..+++|++|++++|++++.    +
T Consensus       197 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l  276 (461)
T 1z7x_W          197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL  276 (461)
T ss_dssp             SCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred             CCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHH
Confidence            345788888888888754    4667777888888888888876432     22333577888888888888754    5


Q ss_pred             ccccccccccccccccCcccccCCCcccccc----ccccceeeccCCccccc----CCcccccccccceeccccCccccc
Q 039720          447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGI----TTLSKLLDLSENHLSGS----IPLEVGNLKSLVQLDISRNNFSNE  518 (973)
Q Consensus       447 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~----~~l~~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~  518 (973)
                      +..+..+++|++|++++|.+.+..+..+...    ...++.|++++|.+++.    ++..+..+++|+.|++++|++++.
T Consensus       277 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  356 (461)
T 1z7x_W          277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA  356 (461)
T ss_dssp             HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence            6677778888888888888764322222211    12234666666666543    344455566677777777766654


Q ss_pred             ccccccC-----ccchhhhcccCccccc----ccccchhhhccCCeecCCCCcccc
Q 039720          519 IPVTLSA-----CTTLEYLLMQGNSFNG----SIPQSLNALKSIKELDLSCNNLSG  565 (973)
Q Consensus       519 ~p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~  565 (973)
                      .+..+..     .++|++|+|++|++++    .+|..+..+++|++|+|++|++++
T Consensus       357 ~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             cHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            4443332     4566666666666664    556666666666666666666654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.4e-34  Score=337.37  Aligned_cols=359  Identities=18%  Similarity=0.153  Sum_probs=204.2

Q ss_pred             CCEEEccCCCCCCCCCcc-ccccCCCCEEeeecccCCC----CCCcccccCCCccceEecccccccchhhhh-cccc---
Q 039720           88 LRVINLANNSFHGQIPKE-VGRLFRLETIVLSNNSFSG----KIPTNLSRCFNLIDFWVHTNNLVGEIQAII-GNWL---  158 (973)
Q Consensus        88 L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~-~~l~---  158 (973)
                      |++|||++|+++...... +..+++|++|+|++|.+++    .+|..+..+++|++|++++|.+.+..+..+ ..++   
T Consensus         5 l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~   84 (461)
T 1z7x_W            5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS   84 (461)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred             ceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCC
Confidence            444444444443221111 3444445555555544442    233344444445555555554444333222 2233   


Q ss_pred             -ccceeeccCCcccc----cCCCCCCCCCcccEEEccCCcCCCCCCCccc-----CCCccceeccCCCCccccC----Cc
Q 039720          159 -KIERLSLYGNQLTG----QLPPSIGNLSALQTFDIAGNKLDGRIPDSLG-----QLRNLNYLGTSENDFSGMF----PL  224 (973)
Q Consensus       159 -~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~L~~L~~L~Ls~N~l~~~~----p~  224 (973)
                       +|++|+|++|+++.    .+|..+..+++|++|+|++|+++...+..+.     ..++|++|++++|++++..    +.
T Consensus        85 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  164 (461)
T 1z7x_W           85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS  164 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHH
Confidence             46666666666552    3455566666666666666665432222221     2445666666666665432    44


Q ss_pred             cccCCCCCcEEEccCCccccCCCcccc----cCCCCCcEEEccCCccccc----CCccccCCCCCCEEEccCCcccccC-
Q 039720          225 SVCNISSLDEAYLFKNRFKGSLPVCLG----FNLPKLTVLVVAQNNLTGF----LPQSLSNASKLEWLELNENHFSGQV-  295 (973)
Q Consensus       225 ~~~~l~~L~~L~L~~N~l~~~ip~~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~-  295 (973)
                      .+..+++|++|++++|++.+..+..+.    ...++|++|+|++|.+++.    ++..+..+++|++|+|++|++++.. 
T Consensus       165 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~  244 (461)
T 1z7x_W          165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM  244 (461)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred             HHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHH
Confidence            455556666666666666533222222    1355777788877777753    4666777788888888888776533 


Q ss_pred             ----cccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccc
Q 039720          296 ----RINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS  371 (973)
Q Consensus       296 ----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~  371 (973)
                          +..+..+++|++|+|++|.++....  ......+.++++|++|++++|++++..+..+....              
T Consensus       245 ~~l~~~~~~~~~~L~~L~L~~n~l~~~~~--~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l--------------  308 (461)
T 1z7x_W          245 AELCPGLLHPSSRLRTLWIWECGITAKGC--GDLCRVLRAKESLKELSLAGNELGDEGARLLCETL--------------  308 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCCHHHH--HHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHH--------------
T ss_pred             HHHHHHHhcCCCCceEEECcCCCCCHHHH--HHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHh--------------
Confidence                2333457788888888887754211  11344566677888888888876644333333211              


Q ss_pred             cCCCccccCCCCcCEEEcccccCCCC----CCccccCCCCCCeEEccCcccCCCCCCccCC-----cCccceEEcCCCcc
Q 039720          372 GTIPPEIRNLFNLNGLGLEYNQLTGT----IPPAIGELRNLQYLGLVGNNIRGIIPDPIGN-----LTLLNVLQLGFNKL  442 (973)
Q Consensus       372 ~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l  442 (973)
                            ....++|+.|+|++|.+++.    ++.++..+++|++|+|++|++.+..+..+..     .++|++|++++|++
T Consensus       309 ------~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          309 ------LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             ------TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             ------ccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence                  11234677777777777654    4555666677777777777776544443332     56777777777777


Q ss_pred             cc----ccccccccccccccccccCccccc
Q 039720          443 QG----SIPSYLGKCQNLMQLSAPNNKLNG  468 (973)
Q Consensus       443 ~~----~~p~~~~~l~~L~~L~l~~N~l~~  468 (973)
                      ++    .+|..+..+++|++|++++|++++
T Consensus       383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          383 SDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             ChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            75    567777777777777777777763

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=8.8e-33  Score=305.69  Aligned_cols=292  Identities=15%  Similarity=0.196  Sum_probs=242.6

Q ss_pred             hhHHHHHHHHhhccCCCcCCCCCCCC--CCCCCceeeeEeeCCCCeEEEEEeeccCccccccCCC--cCCCCCCEEEccC
Q 039720           20 HVKHATVTFNMQQLHDPLGVTKSWNN--SINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYI--GNLSFLRVINLAN   95 (973)
Q Consensus        20 ~~~~~ll~~~~~~~~d~~~~l~sw~~--~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l--~~l~~L~~L~L~~   95 (973)
                      ..+++...-.+....|+..++.+|+.  ..++|.|.++-|.............+.... .++..+  ...+.+++|+|++
T Consensus        12 ~~~~~~~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~-~~~~~l~~~~~~~l~~L~L~~   90 (328)
T 4fcg_A           12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRS   90 (328)
T ss_dssp             -----CCCC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHH-HHHHHHHHHTSTTCCEEEEES
T ss_pred             ccccceeeeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchh-hhHHHHhcccccceeEEEccC
Confidence            33444444455566777888999975  257899998887432211100111111111 111111  2357899999999


Q ss_pred             CCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCC
Q 039720           96 NSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLP  175 (973)
Q Consensus        96 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p  175 (973)
                      |+++ .+|..++++++|++|+|++|.++ .+|..++++++|++|++++|++. .+|..++++++|++|+|++|++.+.+|
T Consensus        91 n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p  167 (328)
T 4fcg_A           91 VPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP  167 (328)
T ss_dssp             SCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCC
T ss_pred             CCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccC
Confidence            9998 89999999999999999999999 89999999999999999999998 789999999999999999999999999


Q ss_pred             CCCCC---------CCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCC
Q 039720          176 PSIGN---------LSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSL  246 (973)
Q Consensus       176 ~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i  246 (973)
                      ..++.         +++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..+..+++|++|+|++|.+.+.+
T Consensus       168 ~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~  245 (328)
T 4fcg_A          168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNY  245 (328)
T ss_dssp             SCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBC
T ss_pred             hhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhh
Confidence            98875         999999999999999 899999999999999999999995 6668999999999999999999999


Q ss_pred             CcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCC
Q 039720          247 PVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTR  318 (973)
Q Consensus       247 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  318 (973)
                      |..+. ++++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..+..+++|+.+++..|.+..+
T Consensus       246 p~~~~-~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l  316 (328)
T 4fcg_A          246 PPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL  316 (328)
T ss_dssp             CCCTT-CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred             HHHhc-CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence            98776 899999999999999999999999999999999999999999999999999999999998877543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.9e-31  Score=296.51  Aligned_cols=213  Identities=18%  Similarity=0.202  Sum_probs=164.4

Q ss_pred             CCCCCCCCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeeccc
Q 039720           42 SWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS  121 (973)
Q Consensus        42 sw~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~  121 (973)
                      .|.....+|.|.|+ |+-          ++++++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|.
T Consensus        22 ~~~~~~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~   87 (353)
T 2z80_A           22 SSNQASLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG   87 (353)
T ss_dssp             -----CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CCCccCCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence            56656678999988 753          445554 4676554  589999999999997666689999999999999999


Q ss_pred             CCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCC--CCCCCCcccEEEccCC-cCCCCC
Q 039720          122 FSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPP--SIGNLSALQTFDIAGN-KLDGRI  198 (973)
Q Consensus       122 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~N-~l~~~~  198 (973)
                      +++..|..|+++++|++|++++|++.+..+..++++++|++|+|++|++++ +|.  .|+++++|++|++++| .+++..
T Consensus        88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~  166 (353)
T 2z80_A           88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQ  166 (353)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccC
Confidence            998778889999999999999999887777778888999999999998884 554  7888889999999888 466556


Q ss_pred             CCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCccccc
Q 039720          199 PDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGF  270 (973)
Q Consensus       199 p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~  270 (973)
                      +..|.++++|++|++++|++++..|..+.++++|++|++++|++. .+|..++..+++|++|++++|.+++.
T Consensus       167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~  237 (353)
T 2z80_A          167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF  237 (353)
T ss_dssp             TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTC
T ss_pred             HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccc
Confidence            778888888888888888888777877777777777777777765 55555544456666666666666544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=9.1e-30  Score=279.41  Aligned_cols=250  Identities=19%  Similarity=0.243  Sum_probs=209.5

Q ss_pred             CceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCc-cccccCCCCEEeeecccCCC--CC
Q 039720           50 CQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPK-EVGRLFRLETIVLSNNSFSG--KI  126 (973)
Q Consensus        50 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~n~l~~--~~  126 (973)
                      |.|.+|.|+..            +++ .+|..+.  ++|++|+|++|+++ .+|. .|+++++|++|+|++|.++.  .+
T Consensus         7 C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~   70 (306)
T 2z66_A            7 CSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCC   70 (306)
T ss_dssp             EETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred             eCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCc
Confidence            78999999753            222 3454332  68999999999998 4554 57899999999999999973  34


Q ss_pred             CcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCC-CCCCCCCcccEEEccCCcCCCCCCCcccCC
Q 039720          127 PTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLP-PSIGNLSALQTFDIAGNKLDGRIPDSLGQL  205 (973)
Q Consensus       127 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L  205 (973)
                      |..+..+++|++|++++|.+. .+|..+..+++|++|++++|++++..+ ..+.++++|++|++++|++++..+..|.++
T Consensus        71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  149 (306)
T 2z66_A           71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL  149 (306)
T ss_dssp             EHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC
T ss_pred             ccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC
Confidence            677888999999999999887 466678889999999999999986554 578899999999999999988888889999


Q ss_pred             CccceeccCCCCccc-cCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEE
Q 039720          206 RNLNYLGTSENDFSG-MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWL  284 (973)
Q Consensus       206 ~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  284 (973)
                      ++|++|++++|.+++ ..|..+..+++|++|+|++|++++..|..+. ++++|++|+|++|.+++..+..|..+++|++|
T Consensus       150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  228 (306)
T 2z66_A          150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN-SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL  228 (306)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred             cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhc-CCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence            999999999999987 6788899999999999999999855555554 78999999999999998777788999999999


Q ss_pred             EccCCcccccCcccccCcc-cccceecccccCCC
Q 039720          285 ELNENHFSGQVRINFNSLP-NLSKLYLGRNNLGT  317 (973)
Q Consensus       285 ~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~  317 (973)
                      +|++|++++..+..+..++ +|++|+|++|.++.
T Consensus       229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             ECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            9999999988888888885 89999999998865

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.6e-31  Score=292.21  Aligned_cols=267  Identities=16%  Similarity=0.166  Sum_probs=160.3

Q ss_pred             CCCCCCCCCCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCC-CCCCCcccc-------ccCC
Q 039720           40 TKSWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSF-HGQIPKEVG-------RLFR  111 (973)
Q Consensus        40 l~sw~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~  111 (973)
                      ..+|.....|+.|..+.......+++.++++++.+  .+|..+...  |+.|+|++|++ .+.+|..+.       ++++
T Consensus        21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~   96 (312)
T 1wwl_A           21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG   96 (312)
T ss_dssp             SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred             ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence            45777656666676654432233566667777776  566555544  77777777777 345666555       6777


Q ss_pred             CCEEeeecccCCCCCCccc--ccCCCccceEecccccccchhhhhccc-----cccceeeccCCcccccCCCCCCCCCcc
Q 039720          112 LETIVLSNNSFSGKIPTNL--SRCFNLIDFWVHTNNLVGEIQAIIGNW-----LKIERLSLYGNQLTGQLPPSIGNLSAL  184 (973)
Q Consensus       112 L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~L  184 (973)
                      |++|+|++|.+++.+|..+  +.+++|++|++++|++.+. |+.++.+     ++|++|+|++|++++..|..|+++++|
T Consensus        97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  175 (312)
T 1wwl_A           97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL  175 (312)
T ss_dssp             CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred             ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence            7777777777777777765  6677777777777766665 5666655     666666666666666555666666666


Q ss_pred             cEEEccCCcCCCC--CCCcc--cCCCccceeccCCCCccc---cCCccccCCCCCcEEEccCCccccCCCcccccCCCCC
Q 039720          185 QTFDIAGNKLDGR--IPDSL--GQLRNLNYLGTSENDFSG---MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKL  257 (973)
Q Consensus       185 ~~L~L~~N~l~~~--~p~~~--~~L~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L  257 (973)
                      ++|+|++|++.+.  .|..+  +++++|++|+|++|++++   .....+.++++|++|+|++|++++.+|...+..+++|
T Consensus       176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L  255 (312)
T 1wwl_A          176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL  255 (312)
T ss_dssp             CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTC
T ss_pred             CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCC
Confidence            6666666665543  22223  566666666666666652   1112334555666666666666554443333345566


Q ss_pred             cEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          258 TVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       258 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      ++|+|++|.|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|+++
T Consensus       256 ~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             CEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             CEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            66666666665 4454444  5566666666666554 33 555555666666555554

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=1.1e-29  Score=301.78  Aligned_cols=296  Identities=23%  Similarity=0.284  Sum_probs=207.7

Q ss_pred             CCcCCCCCCCCCCCCCceeeeEee------CCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccc
Q 039720           35 DPLGVTKSWNNSINLCQWTGVTCG------HRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGR  108 (973)
Q Consensus        35 d~~~~l~sw~~~~~~c~w~gv~C~------~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~  108 (973)
                      |...++++|..+.+||.|+|..|.      -....++.|++++++++ .+|..+.  ++|++|+|++|+|+ .+|.   .
T Consensus         7 ~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~   79 (622)
T 3g06_A            7 EYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---L   79 (622)
T ss_dssp             ---CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---C
T ss_pred             HHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---c
Confidence            456677899877889999775321      11124677777777776 5666655  67777777777777 5665   4


Q ss_pred             cCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEE
Q 039720          109 LFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFD  188 (973)
Q Consensus       109 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  188 (973)
                      +++|++|+|++|.++ .+|.   .                        +++|++|+|++|.+++ +|.   .+++|++|+
T Consensus        80 l~~L~~L~Ls~N~l~-~lp~---~------------------------l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~  127 (622)
T 3g06_A           80 PPELRTLEVSGNQLT-SLPV---L------------------------PPGLLELSIFSNPLTH-LPA---LPSGLCKLW  127 (622)
T ss_dssp             CTTCCEEEECSCCCS-CCCC---C------------------------CTTCCEEEECSCCCCC-CCC---CCTTCCEEE
T ss_pred             CCCCCEEEcCCCcCC-cCCC---C------------------------CCCCCEEECcCCcCCC-CCC---CCCCcCEEE
Confidence            677777777777776 4554   2                        3556666666666663 444   456777777


Q ss_pred             ccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCccc
Q 039720          189 IAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLT  268 (973)
Q Consensus       189 L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~  268 (973)
                      +++|+++ .+|..   +++|++|+|++|++++ +|.   .+++|+.|++++|+++ .+|    ..+++|+.|++++|.|+
T Consensus       128 L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-~l~----~~~~~L~~L~Ls~N~l~  194 (622)
T 3g06_A          128 IFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLT-SLP----MLPSGLQELSVSDNQLA  194 (622)
T ss_dssp             CCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCC----CCCTTCCEEECCSSCCS
T ss_pred             CCCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCC-CCc----ccCCCCcEEECCCCCCC
Confidence            7777777 35543   3777777787777774 333   3467778888888887 566    24678888888888888


Q ss_pred             ccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCC
Q 039720          269 GFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGA  348 (973)
Q Consensus       269 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~  348 (973)
                      + +|..   +++|+.|++++|+++.+..    .+++|++|+|++|+|+.                               
T Consensus       195 ~-l~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~-------------------------------  235 (622)
T 3g06_A          195 S-LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTS-------------------------------  235 (622)
T ss_dssp             C-CCCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC-------------------------------
T ss_pred             C-CCCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCc-------------------------------
Confidence            5 4442   4788888888888885432    23667777777776543                               


Q ss_pred             CChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCC
Q 039720          349 LPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGN  428 (973)
Q Consensus       349 ~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  428 (973)
                                               +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+.+
T Consensus       236 -------------------------lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~  282 (622)
T 3g06_A          236 -------------------------LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIH  282 (622)
T ss_dssp             -------------------------CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGG
T ss_pred             -------------------------CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhh
Confidence                                     22   23467888899999888 4555   5688999999999998 67888999


Q ss_pred             cCccceEEcCCCcccccccccccccc
Q 039720          429 LTLLNVLQLGFNKLQGSIPSYLGKCQ  454 (973)
Q Consensus       429 l~~L~~L~Ls~N~l~~~~p~~~~~l~  454 (973)
                      +++|+.|+|++|.+++.+|..+..++
T Consensus       283 l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          283 LSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             SCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ccccCEEEecCCCCCCcCHHHHHhcc
Confidence            99999999999999988888777665

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=284.01  Aligned_cols=283  Identities=16%  Similarity=0.140  Sum_probs=147.9

Q ss_pred             CCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceee
Q 039720           85 LSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLS  164 (973)
Q Consensus        85 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  164 (973)
                      ++.....++++|+++ .+|..+.  ++|++|+|++|.+++.                        .+..+.++++|++|+
T Consensus        30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~------------------------~~~~~~~l~~L~~L~   82 (353)
T 2z80_A           30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYI------------------------SNSDLQRCVNLQALV   82 (353)
T ss_dssp             ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEE------------------------CTTTTTTCTTCCEEE
T ss_pred             CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCccc------------------------CHHHhccCCCCCEEE
Confidence            344444555555555 4555443  3555555555555432                        222334445556666


Q ss_pred             ccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCC-ccccCCCCCcEEEccCCccc
Q 039720          165 LYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFP-LSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       165 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~  243 (973)
                      |++|++++..|..|+++++|++|+|++|++++..+..|+++++|++|++++|++++..+ ..+.++++|++|++++|...
T Consensus        83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~  162 (353)
T 2z80_A           83 LTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF  162 (353)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred             CCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccc
Confidence            66666665555566666666666666666664333346666666666666666653332 24445555555555554211


Q ss_pred             cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCCh
Q 039720          244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL  323 (973)
Q Consensus       244 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  323 (973)
                      +.++...+.++++|++|++++|.+++..|..|.++++|++|++++|+++......+..+++|++|+|++|+++..     
T Consensus       163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~-----  237 (353)
T 2z80_A          163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF-----  237 (353)
T ss_dssp             CEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTC-----
T ss_pred             cccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccc-----
Confidence            133222223445555555555555544455555555555555555555433333333344444444444444332     


Q ss_pred             hhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCC----CCC
Q 039720          324 DFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG----TIP  399 (973)
Q Consensus       324 ~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~p  399 (973)
                                               .+..+.                      .......++.++|++|.+++    .+|
T Consensus       238 -------------------------~~~~l~----------------------~~~~~~~l~~l~L~~~~l~~~~l~~l~  270 (353)
T 2z80_A          238 -------------------------HFSELS----------------------TGETNSLIKKFTFRNVKITDESLFQVM  270 (353)
T ss_dssp             -------------------------CCC----------------------------CCCCCCEEEEESCBCCHHHHHHHH
T ss_pred             -------------------------cccccc----------------------cccccchhhccccccccccCcchhhhH
Confidence                                     211111                      01223445666666666654    356


Q ss_pred             ccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccc
Q 039720          400 PAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI  446 (973)
Q Consensus       400 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  446 (973)
                      .++..+++|++|+|++|+|+.+.+..|..+++|++|++++|++.+..
T Consensus       271 ~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~  317 (353)
T 2z80_A          271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  317 (353)
T ss_dssp             HHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             HHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence            66777777777777777777433333577777777777777777443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=3.8e-32  Score=327.42  Aligned_cols=431  Identities=16%  Similarity=0.128  Sum_probs=270.4

Q ss_pred             CCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCC---CCCCCcccc------------ccCCCC
Q 039720           49 LCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSF---HGQIPKEVG------------RLFRLE  113 (973)
Q Consensus        49 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L~  113 (973)
                      |++|.++.+... .++   .+. +.....++..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        41 ck~W~~~~~~~~-~~l---~~~-~~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSETR-EHV---TMA-LCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHHC-CEE---EES-CGGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhccc-cEE---EEe-eccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            347999965422 122   222 223333444566789999999988532   245665555            789999


Q ss_pred             EEeeecccCCCCCCcccccC--CCccceEecccccc--cchhhhhccccccceeeccCCccccc----CCCCCCCCCccc
Q 039720          114 TIVLSNNSFSGKIPTNLSRC--FNLIDFWVHTNNLV--GEIQAIIGNWLKIERLSLYGNQLTGQ----LPPSIGNLSALQ  185 (973)
Q Consensus       114 ~L~Ls~n~l~~~~p~~~~~l--~~L~~L~l~~n~~~--~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~  185 (973)
                      +|+|++|.+++..+..++..  .+|++|++++|...  ..++....++++|++|+|++|.+++.    ++..+.++++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            99999999887777777764  45999999988732  23455556889999999999998755    333455788999


Q ss_pred             EEEccCCcCCC----CCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccc---cCCCcccccCCCCCc
Q 039720          186 TFDIAGNKLDG----RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK---GSLPVCLGFNLPKLT  258 (973)
Q Consensus       186 ~L~L~~N~l~~----~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~ip~~~~~~l~~L~  258 (973)
                      +|++++|.+++    .++..+.++++|++|++++|.+.+ +|..+.++++|++|+++.....   +..+..+. .+++|+
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~-~~~~L~  273 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV-FPRKLC  273 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC-CCTTCC
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhh-cccccc
Confidence            99999999873    334446678999999999999886 6678888999999999753322   22233333 678889


Q ss_pred             EEEccCCcccccCCccccCCCCCCEEEccCCcccccCc-ccccCcccccceecccccCCCCCCCChhhhhhhccccccee
Q 039720          259 VLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVR-INFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVK  337 (973)
Q Consensus       259 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  337 (973)
                      .|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+|+ |.+..     .........+++|++
T Consensus       274 ~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~-----~~l~~~~~~~~~L~~  346 (592)
T 3ogk_B          274 RLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGD-----RGLEVLAQYCKQLKR  346 (592)
T ss_dssp             EEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHH-----HHHHHHHHHCTTCCE
T ss_pred             ccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCH-----HHHHHHHHhCCCCCE
Confidence            9998886444 567788888899999999988765443 346788889999888 44422     122334456788888


Q ss_pred             ecccc-----------ccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccC-C
Q 039720          338 LGLVF-----------NRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE-L  405 (973)
Q Consensus       338 L~l~~-----------N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l  405 (973)
                      |+++.           |.+++.....+                        +..+++|++|+++.|++++..+..+.. +
T Consensus       347 L~L~~g~~~~~~~~~~~~~~~~~~~~l------------------------~~~~~~L~~L~l~~~~l~~~~~~~l~~~~  402 (592)
T 3ogk_B          347 LRIERGADEQGMEDEEGLVSQRGLIAL------------------------AQGCQELEYMAVYVSDITNESLESIGTYL  402 (592)
T ss_dssp             EEEECCCCSSTTSSTTCCCCHHHHHHH------------------------HHHCTTCSEEEEEESCCCHHHHHHHHHHC
T ss_pred             EEeecCccccccccccCccCHHHHHHH------------------------HhhCccCeEEEeecCCccHHHHHHHHhhC
Confidence            88882           44442211111                        223455666666555555544444444 5


Q ss_pred             CCCCeEEcc----CcccCCC-----CCCccCCcCccceEEcCCCc--ccccccccccc-ccccccccccCcccccC-CCc
Q 039720          406 RNLQYLGLV----GNNIRGI-----IPDPIGNLTLLNVLQLGFNK--LQGSIPSYLGK-CQNLMQLSAPNNKLNGT-LPP  472 (973)
Q Consensus       406 ~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~-l~~L~~L~l~~N~l~~~-~p~  472 (973)
                      ++|+.|+++    .|.+++.     ++..+.++++|++|++++|.  +++..+..+.. +++|+.|++++|.+++. ++.
T Consensus       403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~  482 (592)
T 3ogk_B          403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME  482 (592)
T ss_dssp             CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred             CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence            566666664    4445432     12224445566666665322  44433333332 55566666666665531 222


Q ss_pred             cccccccccceeeccCCccccc-CCcccccccccceeccccCccccc
Q 039720          473 QIFGITTLSKLLDLSENHLSGS-IPLEVGNLKSLVQLDISRNNFSNE  518 (973)
Q Consensus       473 ~~~~~~~l~~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~  518 (973)
                      .+.++.++ +.|++++|.+++. ++..+..+++|+.|+|++|++++.
T Consensus       483 ~~~~~~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          483 FSRGCPNL-QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHTCCTTC-CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHhcCccc-CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            22233333 3566666665533 233344566777777777776644

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=9.8e-29  Score=271.18  Aligned_cols=230  Identities=21%  Similarity=0.194  Sum_probs=116.4

Q ss_pred             ccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCC--CCCcccCCCccceeccCCCCccccCCccccCCCCCcEEE
Q 039720          159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGR--IPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY  236 (973)
Q Consensus       159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  236 (973)
                      +|++|+|++|+++...+..|.++++|++|+|++|+++..  .|..+..+++|++|++++|.+++ +|..+..+++|++|+
T Consensus        29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~  107 (306)
T 2z66_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD  107 (306)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEE
T ss_pred             CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEE
Confidence            445555555555532223345555555555555555411  13444455555555555555552 333444455555555


Q ss_pred             ccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccc-cCcccccCcccccceecccccC
Q 039720          237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSG-QVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       237 L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      +++|++++..+...+..+++|++|++++|.+++..+..|.++++|++|+|++|.+++ ..|..|..+++|++|+|++|++
T Consensus       108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  187 (306)
T 2z66_A          108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  187 (306)
T ss_dssp             CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence            555554422221223344555555555555554444455555555555555555543 3344444444444444444433


Q ss_pred             CCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCC
Q 039720          316 GTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT  395 (973)
Q Consensus       316 ~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  395 (973)
                      +                                                       +..|..+..+++|+.|+|++|+++
T Consensus       188 ~-------------------------------------------------------~~~~~~~~~l~~L~~L~L~~N~l~  212 (306)
T 2z66_A          188 E-------------------------------------------------------QLSPTAFNSLSSLQVLNMSHNNFF  212 (306)
T ss_dssp             C-------------------------------------------------------EECTTTTTTCTTCCEEECTTSCCS
T ss_pred             C-------------------------------------------------------CcCHHHhcCCCCCCEEECCCCccC
Confidence            2                                                       123344455556666666666666


Q ss_pred             CCCCccccCCCCCCeEEccCcccCCCCCCccCCc-CccceEEcCCCcccc
Q 039720          396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNL-TLLNVLQLGFNKLQG  444 (973)
Q Consensus       396 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~  444 (973)
                      +..+..+..+++|++|+|++|++.+..|..+..+ ++|++|+|++|.+++
T Consensus       213 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             ccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            5555555666666666666666665555555555 356666666666653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3.3e-28  Score=282.24  Aligned_cols=242  Identities=21%  Similarity=0.200  Sum_probs=180.3

Q ss_pred             eccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccc
Q 039720           70 ESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGE  149 (973)
Q Consensus        70 ~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~  149 (973)
                      ++.+++ .+|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|.++++|++|++++|++.+.
T Consensus        62 ~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~  138 (452)
T 3zyi_A           62 TRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVI  138 (452)
T ss_dssp             CSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBC
T ss_pred             CCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCcc
Confidence            334443 3555443  6788899999988887788888899999999999988877778888888888888888888777


Q ss_pred             hhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCC-cCCCCCCCcccCCCccceeccCCCCccccCCccccC
Q 039720          150 IQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGN-KLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCN  228 (973)
Q Consensus       150 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~  228 (973)
                      .+..|..+++|++|+|++|++++..+..|.++++|++|++++| .+....+..|.++++|++|+|++|++++. | .+..
T Consensus       139 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~  216 (452)
T 3zyi_A          139 PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTP  216 (452)
T ss_dssp             CTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTT
T ss_pred             ChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccc
Confidence            7777788888888888888887666667788888888888874 44433344677888888888888887753 3 4667


Q ss_pred             CCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccce
Q 039720          229 ISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKL  308 (973)
Q Consensus       229 l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  308 (973)
                      +++|++|+|++|++++..|..+ .++++|+.|+|++|.+++..|..|.++++|++|+|++|+|++..+..|..+++|+.|
T Consensus       217 l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  295 (452)
T 3zyi_A          217 LVGLEELEMSGNHFPEIRPGSF-HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL  295 (452)
T ss_dssp             CTTCCEEECTTSCCSEECGGGG-TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEE
T ss_pred             cccccEEECcCCcCcccCcccc-cCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEE
Confidence            7777777777777774444444 377777777777777777777777777777777777777777777777777777777


Q ss_pred             ecccccCCC
Q 039720          309 YLGRNNLGT  317 (973)
Q Consensus       309 ~L~~N~l~~  317 (973)
                      +|++|.+..
T Consensus       296 ~L~~Np~~C  304 (452)
T 3zyi_A          296 HLHHNPWNC  304 (452)
T ss_dssp             ECCSSCEEC
T ss_pred             EccCCCcCC
Confidence            777777643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=3.4e-31  Score=319.08  Aligned_cols=439  Identities=17%  Similarity=0.107  Sum_probs=265.2

Q ss_pred             EEEccCCCCCCCCCccccccCCCCEEeeecccC---CCCCCcccc------------cCCCccceEecccccccchhhhh
Q 039720           90 VINLANNSFHGQIPKEVGRLFRLETIVLSNNSF---SGKIPTNLS------------RCFNLIDFWVHTNNLVGEIQAII  154 (973)
Q Consensus        90 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L~~L~l~~n~~~~~~~~~~  154 (973)
                      .+.+.++ +...++..+.++++|++|+|+++..   .+.+|..++            .+++|++|++++|.+.+..+..+
T Consensus        54 ~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l  132 (592)
T 3ogk_B           54 HVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRL  132 (592)
T ss_dssp             EEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred             EEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHH
Confidence            3444433 3334455567899999999988543   245555544            67888899999888887777777


Q ss_pred             ccc--cccceeeccCCc-ccc-cCCCCCCCCCcccEEEccCCcCCCC----CCCcccCCCccceeccCCCCcc----ccC
Q 039720          155 GNW--LKIERLSLYGNQ-LTG-QLPPSIGNLSALQTFDIAGNKLDGR----IPDSLGQLRNLNYLGTSENDFS----GMF  222 (973)
Q Consensus       155 ~~l--~~L~~L~L~~n~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~L~~L~~L~Ls~N~l~----~~~  222 (973)
                      ...  .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++.    ++..+.++++|++|++++|.++    +.+
T Consensus       133 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l  212 (592)
T 3ogk_B          133 AKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDL  212 (592)
T ss_dssp             HHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHH
T ss_pred             HHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHH
Confidence            764  448889888886 221 1222234678888888888887655    2334566788888888888886    334


Q ss_pred             CccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCccc---ccCCccccCCCCCCEEEccCCcccccCcccc
Q 039720          223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLT---GFLPQSLSNASKLEWLELNENHFSGQVRINF  299 (973)
Q Consensus       223 p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  299 (973)
                      +..+.++++|+.|++++|.+. .+|..+. ++++|+.|+++.+...   ...+..+..+++|+.|+++++... ..+..+
T Consensus       213 ~~~~~~~~~L~~L~L~~~~~~-~l~~~~~-~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~  289 (592)
T 3ogk_B          213 ETIARNCRSLVSVKVGDFEIL-ELVGFFK-AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILF  289 (592)
T ss_dssp             HHHHHHCTTCCEEECSSCBGG-GGHHHHH-HCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGG
T ss_pred             HHHHhhCCCCcEEeccCccHH-HHHHHHh-hhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHH
Confidence            445566778888888888777 3664443 6778888887754332   234456677777788777775333 455666


Q ss_pred             cCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCcccc
Q 039720          300 NSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIR  379 (973)
Q Consensus       300 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~  379 (973)
                      ..+++|++|+|++|.++.     ......+..+++|+.|+++ +.+..                        +.++..+.
T Consensus       290 ~~~~~L~~L~Ls~~~l~~-----~~~~~~~~~~~~L~~L~L~-~~~~~------------------------~~l~~~~~  339 (592)
T 3ogk_B          290 PFAAQIRKLDLLYALLET-----EDHCTLIQKCPNLEVLETR-NVIGD------------------------RGLEVLAQ  339 (592)
T ss_dssp             GGGGGCCEEEETTCCCCH-----HHHHHHHTTCTTCCEEEEE-GGGHH------------------------HHHHHHHH
T ss_pred             hhcCCCcEEecCCCcCCH-----HHHHHHHHhCcCCCEEecc-CccCH------------------------HHHHHHHH
Confidence            777777777777776532     1122334566666666665 22211                        01111223


Q ss_pred             CCCCcCEEEcc-----------cccCCCCC-CccccCCCCCCeEEccCcccCCCCCCccCC-cCccceEEcC----CCcc
Q 039720          380 NLFNLNGLGLE-----------YNQLTGTI-PPAIGELRNLQYLGLVGNNIRGIIPDPIGN-LTLLNVLQLG----FNKL  442 (973)
Q Consensus       380 ~l~~L~~L~Ls-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l  442 (973)
                      .+++|++|+|+           .|.+++.. +..+..+++|++|+++.|++++..+..+.. +++|+.|+++    .|.+
T Consensus       340 ~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l  419 (592)
T 3ogk_B          340 YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI  419 (592)
T ss_dssp             HCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCC
T ss_pred             hCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccc
Confidence            45567777777           24444321 122334666666666666666544444443 5666666664    4555


Q ss_pred             ccc-----cccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccc-cccccceeccccCccc
Q 039720          443 QGS-----IPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVG-NLKSLVQLDISRNNFS  516 (973)
Q Consensus       443 ~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~  516 (973)
                      ++.     ++..+..+++|+.|+++++.                       +.+++..+..+. .+++|+.|++++|+++
T Consensus       420 ~~~p~~~~~~~~~~~~~~L~~L~L~~~~-----------------------~~l~~~~~~~~~~~~~~L~~L~L~~n~l~  476 (592)
T 3ogk_B          420 TDLPLDNGVRSLLIGCKKLRRFAFYLRQ-----------------------GGLTDLGLSYIGQYSPNVRWMLLGYVGES  476 (592)
T ss_dssp             SSCCCHHHHHHHHHHCTTCCEEEEECCG-----------------------GGCCHHHHHHHHHSCTTCCEEEECSCCSS
T ss_pred             cCchHHHHHHHHHHhCCCCCEEEEecCC-----------------------CCccHHHHHHHHHhCccceEeeccCCCCC
Confidence            532     22234445555555544221                       113322222232 2667888888888877


Q ss_pred             c-cccccccCccchhhhcccCcccccc-cccchhhhccCCeecCCCCccccccCCCC-CCCCccceEeccCC
Q 039720          517 N-EIPVTLSACTTLEYLLMQGNSFNGS-IPQSLNALKSIKELDLSCNNLSGQIPIHL-GNLPFLEYLNLSYN  585 (973)
Q Consensus       517 ~-~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N  585 (973)
                      + .++..+.++++|++|++++|+|++. ++..+..+++|++|+|++|+++..-...+ ..++.+....+..+
T Consensus       477 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          477 DEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             HHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             HHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            5 3445556778888888888887654 34444677888888888888875422222 34566655555544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=4.9e-28  Score=262.64  Aligned_cols=234  Identities=19%  Similarity=0.172  Sum_probs=150.1

Q ss_pred             eEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCC
Q 039720           55 VTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCF  134 (973)
Q Consensus        55 v~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~  134 (973)
                      ..|....  .+.++.+++++. .+|..+  .++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..+..++
T Consensus         6 C~C~~~~--~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~   80 (285)
T 1ozn_A            6 CVCYNEP--KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA   80 (285)
T ss_dssp             CEEECSS--SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             ceECCCC--CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc
Confidence            4565432  245566666665 345433  46788888888888866666788888888888888888765566666555


Q ss_pred             CccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccC
Q 039720          135 NLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTS  214 (973)
Q Consensus       135 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls  214 (973)
                      +|++|++++|..                       ++...|..|.++++|++|++++|++++..|..|.++++|++|+++
T Consensus        81 ~L~~L~l~~n~~-----------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  137 (285)
T 1ozn_A           81 LLEQLDLSDNAQ-----------------------LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ  137 (285)
T ss_dssp             TCCEEECCSCTT-----------------------CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEeCCCCCC-----------------------ccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECC
Confidence            555544444431                       443334455555555555555555554445555555555555555


Q ss_pred             CCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCccccc
Q 039720          215 ENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQ  294 (973)
Q Consensus       215 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  294 (973)
                      +|++++..+..|.++++|++|+|++|+++ .+|...+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++.
T Consensus       138 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  216 (285)
T 1ozn_A          138 DNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL  216 (285)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcccccCHhHhccCCCccEEECCCCccc-ccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcC
Confidence            55555444444555555555555555555 34444344677777777777777777777888888888888888888877


Q ss_pred             CcccccCcccccceecccccCCC
Q 039720          295 VRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       295 ~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      .+..|..+++|++|+|++|.+..
T Consensus       217 ~~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          217 PTEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             CHHHHTTCTTCCEEECCSSCEEC
T ss_pred             CHHHcccCcccCEEeccCCCccC
Confidence            77777888888888888887754

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.3e-29  Score=276.70  Aligned_cols=205  Identities=17%  Similarity=0.171  Sum_probs=132.8

Q ss_pred             ccccCCCCEEeeecccCCCCCCcccccCCCccceEeccccc-ccchhhhhc-------cccccceeeccCCcccccCCCC
Q 039720          106 VGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNL-VGEIQAIIG-------NWLKIERLSLYGNQLTGQLPPS  177 (973)
Q Consensus       106 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~-~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~p~~  177 (973)
                      ++..++|++|++++|.+  .+|..+...  |+.|++++|++ ...+|..+.       ++++|++|+|++|.+++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            44555666666666666  556555544  55666666665 334555544       6788888888888888888887


Q ss_pred             C--CCCCcccEEEccCCcCCCCCCCcccCC-----CccceeccCCCCccccCCccccCCCCCcEEEccCCccccCC--Cc
Q 039720          178 I--GNLSALQTFDIAGNKLDGRIPDSLGQL-----RNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSL--PV  248 (973)
Q Consensus       178 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~L-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i--p~  248 (973)
                      +  +.+++|++|+|++|++++. |..++++     ++|++|+|++|++++..|..|+++++|++|+|++|++.+.+  |.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            6  8888888888888888866 7777777     88888888888888777777877777777777777766442  22


Q ss_pred             cc-ccCCCCCcEEEccCCcccc---cCCccccCCCCCCEEEccCCcccccCc-ccccCcccccceecccccC
Q 039720          249 CL-GFNLPKLTVLVVAQNNLTG---FLPQSLSNASKLEWLELNENHFSGQVR-INFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       249 ~~-~~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l  315 (973)
                      .+ +.++++|++|+|++|.|++   .....+.++++|++|+|++|++++..+ ..+..+++|++|+|++|+|
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l  265 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL  265 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc
Confidence            22 2356666666666666662   112334455666666666666665442 2333344444444444443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=276.84  Aligned_cols=248  Identities=23%  Similarity=0.286  Sum_probs=187.7

Q ss_pred             ccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEcc
Q 039720          159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLF  238 (973)
Q Consensus       159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  238 (973)
                      ....++.+++.++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            3456777777777 6777665  578888888888887777888888888888888888887777788888888888888


Q ss_pred             CCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccC-CcccccCcccccCcccccceecccccCCC
Q 039720          239 KNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNE-NHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       239 ~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      +|+++ .+|...+.++++|++|+|++|.|+...+..|.++++|++|+|++ |.++.+.+..|.++++|++|+|++|+++.
T Consensus       121 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  199 (440)
T 3zyj_A          121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE  199 (440)
T ss_dssp             SSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred             CCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence            88887 66665555788888888888888877777888888888888887 45555556677888888888888777653


Q ss_pred             CCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCC
Q 039720          318 RTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT  397 (973)
Q Consensus       318 ~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  397 (973)
                      ++                                                         .+..+++|+.|+|++|++++.
T Consensus       200 ~~---------------------------------------------------------~~~~l~~L~~L~Ls~N~l~~~  222 (440)
T 3zyj_A          200 IP---------------------------------------------------------NLTPLIKLDELDLSGNHLSAI  222 (440)
T ss_dssp             CC---------------------------------------------------------CCTTCSSCCEEECTTSCCCEE
T ss_pred             cc---------------------------------------------------------ccCCCcccCEEECCCCccCcc
Confidence            21                                                         245566777777777777777


Q ss_pred             CCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccc
Q 039720          398 IPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN  467 (973)
Q Consensus       398 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  467 (973)
                      .|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+..+..+++|+.|++++|.+.
T Consensus       223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            7777777777777777777777777777777777777777777777666666777777777777777765

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=1.2e-27  Score=277.46  Aligned_cols=247  Identities=21%  Similarity=0.254  Sum_probs=186.3

Q ss_pred             cceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC
Q 039720          160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK  239 (973)
Q Consensus       160 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  239 (973)
                      ...++.+++.++ .+|..+.  ++|++|+|++|+|++..|+.|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            455667777776 5676654  5788888888888877778888888888888888888877777888888888888888


Q ss_pred             CccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccC-CcccccCcccccCcccccceecccccCCCC
Q 039720          240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNE-NHFSGQVRINFNSLPNLSKLYLGRNNLGTR  318 (973)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  318 (973)
                      |+++ .+|...+.++++|++|+|++|.|+...+..|.++++|++|+|++ |.++.+.+..|.++++|++|+|++|+++.+
T Consensus       133 n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          133 NWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             SCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            8877 56666555788888888888888877777888888888888887 556656666788888888888887776532


Q ss_pred             CCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCC
Q 039720          319 TSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTI  398 (973)
Q Consensus       319 ~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  398 (973)
                      +                                                         .+..+++|+.|+|++|++++..
T Consensus       212 ~---------------------------------------------------------~~~~l~~L~~L~Ls~N~l~~~~  234 (452)
T 3zyi_A          212 P---------------------------------------------------------NLTPLVGLEELEMSGNHFPEIR  234 (452)
T ss_dssp             C---------------------------------------------------------CCTTCTTCCEEECTTSCCSEEC
T ss_pred             c---------------------------------------------------------cccccccccEEECcCCcCcccC
Confidence            1                                                         2445667777777777777777


Q ss_pred             CccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccc
Q 039720          399 PPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN  467 (973)
Q Consensus       399 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  467 (973)
                      |..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+.
T Consensus       235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             GGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             cccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            777777777777777777777777777777777777777777777666666777777777777777765

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=3.4e-27  Score=272.71  Aligned_cols=242  Identities=23%  Similarity=0.231  Sum_probs=137.7

Q ss_pred             eeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEeccccccc
Q 039720           69 LESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVG  148 (973)
Q Consensus        69 l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~  148 (973)
                      .++.++. .+|..+.  +.++.|+|++|++++..+..|.++++|++|+|++|.+++..|                     
T Consensus        50 c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~---------------------  105 (440)
T 3zyj_A           50 CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI---------------------  105 (440)
T ss_dssp             CCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECG---------------------
T ss_pred             eCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccCh---------------------
Confidence            3334443 3555443  567777777777776666667777777777777776664333                     


Q ss_pred             chhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCC-CccccCCcccc
Q 039720          149 EIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEN-DFSGMFPLSVC  227 (973)
Q Consensus       149 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N-~l~~~~p~~~~  227 (973)
                         ..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++| .+....+..|.
T Consensus       106 ---~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~  182 (440)
T 3zyj_A          106 ---GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE  182 (440)
T ss_dssp             ---GGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTT
T ss_pred             ---hhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhh
Confidence               33444455566666666665444445666666666666666666444455666666666666653 33322223344


Q ss_pred             CCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccc
Q 039720          228 NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSK  307 (973)
Q Consensus       228 ~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  307 (973)
                      +++                         +|++|+|++|.++. +| .+..+++|++|+|++|+|++..+..|.++++|++
T Consensus       183 ~l~-------------------------~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  235 (440)
T 3zyj_A          183 GLS-------------------------NLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK  235 (440)
T ss_dssp             TCS-------------------------SCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             ccc-------------------------ccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCE
Confidence            444                         44444444444442 22 2445555555555555555555555555555555


Q ss_pred             eecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEE
Q 039720          308 LYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGL  387 (973)
Q Consensus       308 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L  387 (973)
                      |+|++|+++.                                                       ..+..|..+++|+.|
T Consensus       236 L~L~~n~l~~-------------------------------------------------------~~~~~~~~l~~L~~L  260 (440)
T 3zyj_A          236 LWMIQSQIQV-------------------------------------------------------IERNAFDNLQSLVEI  260 (440)
T ss_dssp             EECTTCCCCE-------------------------------------------------------ECTTSSTTCTTCCEE
T ss_pred             EECCCCceeE-------------------------------------------------------EChhhhcCCCCCCEE
Confidence            5555554432                                                       223445556667777


Q ss_pred             EcccccCCCCCCccccCCCCCCeEEccCcccC
Q 039720          388 GLEYNQLTGTIPPAIGELRNLQYLGLVGNNIR  419 (973)
Q Consensus       388 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  419 (973)
                      +|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       261 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             ECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            77777777777777777777777777777775

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.6e-29  Score=294.80  Aligned_cols=215  Identities=20%  Similarity=0.185  Sum_probs=114.8

Q ss_pred             hhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcC
Q 039720          359 TMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLG  438 (973)
Q Consensus       359 ~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  438 (973)
                      .++.|++++|.+++..|..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.|++..+     .++|++|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            44445555555555555555555566666666666554433  5555566666666665553221     2555566666


Q ss_pred             CCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccc-cccccceeccccCcccc
Q 039720          439 FNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVG-NLKSLVQLDISRNNFSN  517 (973)
Q Consensus       439 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~  517 (973)
                      +|.+++..+.   .+++|+.|++++|.+++..|..+..+..+ +.|+|++|.+++..|..+. .+++|+.|+|++|.+++
T Consensus       108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            6665544433   23455555555555554444444444444 2555555555555555544 45556666666665554


Q ss_pred             cccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCc
Q 039720          518 EIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFE  588 (973)
Q Consensus       518 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  588 (973)
                      ..+  +..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++.
T Consensus       184 ~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~  250 (487)
T 3oja_A          184 VKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH  250 (487)
T ss_dssp             EEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBC
T ss_pred             ccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCc
Confidence            321  2235555566666666553 3333555555666666666555 35555555555666666665555

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=2.8e-27  Score=256.61  Aligned_cols=256  Identities=21%  Similarity=0.222  Sum_probs=152.5

Q ss_pred             cEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceeccc
Q 039720          233 DEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR  312 (973)
Q Consensus       233 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  312 (973)
                      +.++.+++.++ .+|..+   .++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus        14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            44555555555 566543   35777777777777776667777778888888888877777777777777777777777


Q ss_pred             cc-CCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEccc
Q 039720          313 NN-LGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEY  391 (973)
Q Consensus       313 N~-l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~  391 (973)
                      |. ++.                                                       ..|..+..+++|++|+|++
T Consensus        90 n~~l~~-------------------------------------------------------~~~~~~~~l~~L~~L~l~~  114 (285)
T 1ozn_A           90 NAQLRS-------------------------------------------------------VDPATFHGLGRLHTLHLDR  114 (285)
T ss_dssp             CTTCCC-------------------------------------------------------CCTTTTTTCTTCCEEECTT
T ss_pred             CCCccc-------------------------------------------------------cCHHHhcCCcCCCEEECCC
Confidence            65 432                                                       2234455566677777777


Q ss_pred             ccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCC
Q 039720          392 NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLP  471 (973)
Q Consensus       392 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  471 (973)
                      |++++..|..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|++.+   
T Consensus       115 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---  191 (285)
T 1ozn_A          115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH---  191 (285)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE---
T ss_pred             CcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc---
Confidence            77766666666667777777777777766555566666777777777776664444456666666555555555543   


Q ss_pred             ccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhc
Q 039720          472 PQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALK  551 (973)
Q Consensus       472 ~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  551 (973)
                                            ..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++....+. ..-+.
T Consensus       192 ----------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~  248 (285)
T 1ozn_A          192 ----------------------VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWA  248 (285)
T ss_dssp             ----------------------ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHH
T ss_pred             ----------------------cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHH
Confidence                                  2333444444555555555555544444455555555555555555432221 11122


Q ss_pred             cCCeecCCCCccccccCCCCCC
Q 039720          552 SIKELDLSCNNLSGQIPIHLGN  573 (973)
Q Consensus       552 ~L~~L~Ls~N~l~~~~p~~~~~  573 (973)
                      .++.+..+.|.+....|..+..
T Consensus       249 ~l~~~~~~~~~~~c~~p~~l~g  270 (285)
T 1ozn_A          249 WLQKFRGSSSEVPCSLPQRLAG  270 (285)
T ss_dssp             HHHHCCSEECCCBEEESGGGTT
T ss_pred             HHHhcccccCccccCCchHhCC
Confidence            3344445555555555555433

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1.3e-26  Score=275.47  Aligned_cols=269  Identities=25%  Similarity=0.290  Sum_probs=220.7

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeec
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSL  165 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L  165 (973)
                      ..++.|++++|+++ .+|..+.  ++|++|+|++|.++ .+|.                           .+++|++|+|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---------------------------~l~~L~~L~L   88 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---------------------------LPPELRTLEV   88 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---------------------------CCTTCCEEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---------------------------cCCCCCEEEc
Confidence            45899999999998 8888776  78999999999988 5554                           1367888899


Q ss_pred             cCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccC
Q 039720          166 YGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGS  245 (973)
Q Consensus       166 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  245 (973)
                      ++|+++ .+|.   .+++|++|+|++|++++ +|.   .+++|++|++++|++++ +|..   +++|++|+|++|+++ .
T Consensus        89 s~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~-~  155 (622)
T 3g06_A           89 SGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-S  155 (622)
T ss_dssp             CSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-C
T ss_pred             CCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCC-C
Confidence            999988 5676   67899999999999995 555   67899999999999996 4543   489999999999998 5


Q ss_pred             CCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhh
Q 039720          246 LPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDF  325 (973)
Q Consensus       246 ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  325 (973)
                      +|.    .+++|+.|++++|.|++ +|   ..+++|++|+|++|+|+++..    .+++|+.|++++|.++.+       
T Consensus       156 l~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l-------  216 (622)
T 3g06_A          156 LPA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSL-------  216 (622)
T ss_dssp             CCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC-------
T ss_pred             cCC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCccccc-------
Confidence            664    35789999999999996 55   567899999999999986443    246788888887776431       


Q ss_pred             hhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCC
Q 039720          326 ITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGEL  405 (973)
Q Consensus       326 ~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  405 (973)
                                                                       |.   .+++|+.|+|++|+|++ +|   ..+
T Consensus       217 -------------------------------------------------~~---~~~~L~~L~Ls~N~L~~-lp---~~l  240 (622)
T 3g06_A          217 -------------------------------------------------PA---LPSGLKELIVSGNRLTS-LP---VLP  240 (622)
T ss_dssp             -------------------------------------------------CC---CCTTCCEEECCSSCCSC-CC---CCC
T ss_pred             -------------------------------------------------CC---CCCCCCEEEccCCccCc-CC---CCC
Confidence                                                             21   13679999999999996 55   456


Q ss_pred             CCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccc
Q 039720          406 RNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGIT  478 (973)
Q Consensus       406 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  478 (973)
                      ++|+.|+|++|+|+. +|.   .+++|++|+|++|+|+ .+|..+..+++|+.|++++|.+++..|..+..+.
T Consensus       241 ~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          241 SELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            899999999999994 555   6789999999999999 7899999999999999999999987777655443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=5.9e-29  Score=274.07  Aligned_cols=215  Identities=16%  Similarity=0.115  Sum_probs=103.4

Q ss_pred             eEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEec
Q 039720           63 RVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVH  142 (973)
Q Consensus        63 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~  142 (973)
                      +....+++.+++...+......+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|  +..+         
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l---------   79 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESL---------   79 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTC---------
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhc---------
Confidence            34445555555544433334455666667777666665555666666666666666666654322  4444         


Q ss_pred             ccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccC
Q 039720          143 TNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF  222 (973)
Q Consensus       143 ~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~  222 (973)
                                     ++|++|+|++|++++..     ..++|++|++++|++++..+.   .+++|++|++++|++++..
T Consensus        80 ---------------~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~  136 (317)
T 3o53_A           80 ---------------STLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLR  136 (317)
T ss_dssp             ---------------TTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGG
T ss_pred             ---------------CCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCcc
Confidence                           44444444444444211     124455555555555433222   2344555555555555444


Q ss_pred             CccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCc
Q 039720          223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSL  302 (973)
Q Consensus       223 p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  302 (973)
                      +..+..+++|++|+|++|++++..|..++..+++|++|+|++|.|++. + ....+++|++|+|++|+|++..+. |..+
T Consensus       137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~-~~~l  213 (317)
T 3o53_A          137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPE-FQSA  213 (317)
T ss_dssp             GBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGG-GGGG
T ss_pred             chhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchhh-hccc
Confidence            444444444444444444444333333322344555555555555433 1 122345555555555555433222 4444


Q ss_pred             ccccceeccccc
Q 039720          303 PNLSKLYLGRNN  314 (973)
Q Consensus       303 ~~L~~L~L~~N~  314 (973)
                      ++|++|+|++|+
T Consensus       214 ~~L~~L~L~~N~  225 (317)
T 3o53_A          214 AGVTWISLRNNK  225 (317)
T ss_dssp             TTCSEEECTTSC
T ss_pred             CcccEEECcCCc
Confidence            444444444443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=2e-28  Score=269.88  Aligned_cols=260  Identities=18%  Similarity=0.227  Sum_probs=164.3

Q ss_pred             ccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccC
Q 039720          143 TNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF  222 (973)
Q Consensus       143 ~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~  222 (973)
                      .+++...+...+..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..+  |..+++|++|++++|++++..
T Consensus        19 ~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~   96 (317)
T 3o53_A           19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL   96 (317)
T ss_dssp             TTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE
T ss_pred             ccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc
Confidence            333333344444455566666666666665555556666666666666666654332  566666666666666655322


Q ss_pred             CccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccc-cC
Q 039720          223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINF-NS  301 (973)
Q Consensus       223 p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~  301 (973)
                           ..++|++|++++|++++ ++..   .+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..+ ..
T Consensus        97 -----~~~~L~~L~l~~n~l~~-~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  167 (317)
T 3o53_A           97 -----VGPSIETLHAANNNISR-VSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS  167 (317)
T ss_dssp             -----ECTTCCEEECCSSCCSE-EEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGG
T ss_pred             -----CCCCcCEEECCCCccCC-cCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhc
Confidence                 12455555555555552 2211   23455555555555555555555555555555555555555444443 24


Q ss_pred             cccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCC
Q 039720          302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL  381 (973)
Q Consensus       302 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l  381 (973)
                      +++|++|+|++|.++.                                                       . + ....+
T Consensus       168 l~~L~~L~L~~N~l~~-------------------------------------------------------~-~-~~~~l  190 (317)
T 3o53_A          168 SDTLEHLNLQYNFIYD-------------------------------------------------------V-K-GQVVF  190 (317)
T ss_dssp             TTTCCEEECTTSCCCE-------------------------------------------------------E-E-CCCCC
T ss_pred             cCcCCEEECCCCcCcc-------------------------------------------------------c-c-ccccc
Confidence            5555555555554432                                                       1 1 12247


Q ss_pred             CCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccc-ccccccccccccccccc
Q 039720          382 FNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ-GSIPSYLGKCQNLMQLS  460 (973)
Q Consensus       382 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~  460 (973)
                      ++|++|+|++|++++ +|..+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+++ +.+|..+..+++|+.++
T Consensus       191 ~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~  268 (317)
T 3o53_A          191 AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA  268 (317)
T ss_dssp             TTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHH
T ss_pred             ccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEE
Confidence            789999999999985 4555889999999999999998 56888899999999999999998 78888999999999999


Q ss_pred             ccC-cccccCCCc
Q 039720          461 APN-NKLNGTLPP  472 (973)
Q Consensus       461 l~~-N~l~~~~p~  472 (973)
                      +++ +.+.|..|.
T Consensus       269 l~~~~~l~~~~~~  281 (317)
T 3o53_A          269 KQTVKKLTGQNEE  281 (317)
T ss_dssp             HHHHHHHHSSSSC
T ss_pred             CCCchhccCCchh
Confidence            984 456655443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=2.5e-26  Score=246.91  Aligned_cols=219  Identities=21%  Similarity=0.298  Sum_probs=156.8

Q ss_pred             CCCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCC
Q 039720           47 INLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKI  126 (973)
Q Consensus        47 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~  126 (973)
                      .++|.|.|+.|+-. ..++.+++++++++. +|..+.  +.|++|+|++|++++..+..|+++++|++|+|++|.+++..
T Consensus         2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCN-NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEE-TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeC-CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            47899999988632 245678888888874 666554  57888888888888666667888888888888888887333


Q ss_pred             CcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCC
Q 039720          127 PTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLR  206 (973)
Q Consensus       127 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~  206 (973)
                      +..|.+                        +++|++|+|++|++++..+..|.++++|++|++++|++++..+..|.+++
T Consensus        78 ~~~~~~------------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  133 (270)
T 2o6q_A           78 AGIFKE------------------------LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT  133 (270)
T ss_dssp             TTTTSS------------------------CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             hhhhcC------------------------CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCc
Confidence            333344                        45566666666666655555566667777777777777666666667777


Q ss_pred             ccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEc
Q 039720          207 NLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLEL  286 (973)
Q Consensus       207 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  286 (973)
                      +|++|+|++|++++..+..|..+++|++|+|++|+++ .+|...+.++++|++|+|++|.|++..+..|..+++|++|+|
T Consensus       134 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  212 (270)
T 2o6q_A          134 KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL  212 (270)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc-EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence            7777777777776655556677777777777777776 455555557888888888888888777777888999999999


Q ss_pred             cCCccccc
Q 039720          287 NENHFSGQ  294 (973)
Q Consensus       287 s~N~l~~~  294 (973)
                      ++|.+...
T Consensus       213 ~~N~~~c~  220 (270)
T 2o6q_A          213 QENPWDCT  220 (270)
T ss_dssp             CSSCBCCS
T ss_pred             cCCCeeCC
Confidence            99988743

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=9.7e-28  Score=283.46  Aligned_cols=186  Identities=15%  Similarity=0.038  Sum_probs=132.4

Q ss_pred             ccccccceeEEEEEECCCCcEEEEEEeeccc----------chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCc
Q 039720          681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK----------KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       681 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ..+.|+.|.+..++..-.|+.||+|++..+.          ....+++.+|+++|+++ +|+||+++++++     +++.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            3667788888877777789999999997542          12235699999999999 699999999985     4468


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..|+||||++|++|.+++...+....   .+|+.||+.||+|+|++   |||||||||+|||++.+|.+||+|||+|+..
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            99999999999999999988776553   36899999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP  886 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~P  886 (973)
                      ...        .......+||+.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus       390 ~~~--------~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          390 PQD--------CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C-----------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCC--------CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            432        233445789999999999875 456789999999998877655444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=2.4e-26  Score=267.98  Aligned_cols=234  Identities=16%  Similarity=0.156  Sum_probs=189.0

Q ss_pred             EeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccc
Q 039720           68 DLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLV  147 (973)
Q Consensus        68 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~  147 (973)
                      ++...++...+.......++|++|+|++|++++..|..|+.+++|++|+|++|.+++..|  ++.+++|++|++++|.+.
T Consensus        16 ~~~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~   93 (487)
T 3oja_A           16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ   93 (487)
T ss_dssp             SCCTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE
T ss_pred             cCchhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC
Confidence            333344433333434455689999999999998888899999999999999999987655  889999999999999887


Q ss_pred             cchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCcccc
Q 039720          148 GEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC  227 (973)
Q Consensus       148 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~  227 (973)
                      +..+     .++|++|+|++|.+++..+..   +++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..+.
T Consensus        94 ~l~~-----~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  165 (487)
T 3oja_A           94 ELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA  165 (487)
T ss_dssp             EEEE-----CTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred             CCCC-----CCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh
Confidence            5443     378999999999998766553   57789999999999988888899999999999999999988888876


Q ss_pred             -CCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCccccc
Q 039720          228 -NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLS  306 (973)
Q Consensus       228 -~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  306 (973)
                       .+++|+.|+|++|.+++. |...  .+++|++|+|++|.|++.. ..|..+++|++|+|++|+|++ +|..+..+++|+
T Consensus       166 ~~l~~L~~L~Ls~N~l~~~-~~~~--~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~  240 (487)
T 3oja_A          166 ASSDTLEHLNLQYNFIYDV-KGQV--VFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLE  240 (487)
T ss_dssp             GGTTTCCEEECTTSCCCEE-ECCC--CCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCC
T ss_pred             hhCCcccEEecCCCccccc-cccc--cCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCC
Confidence             788999999999998844 4333  4888999999999998654 458888999999999999886 456688888888


Q ss_pred             ceecccccCC
Q 039720          307 KLYLGRNNLG  316 (973)
Q Consensus       307 ~L~L~~N~l~  316 (973)
                      .|++++|.+.
T Consensus       241 ~L~l~~N~l~  250 (487)
T 3oja_A          241 HFDLRGNGFH  250 (487)
T ss_dssp             EEECTTCCBC
T ss_pred             EEEcCCCCCc
Confidence            8888888875

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=5.6e-29  Score=299.86  Aligned_cols=455  Identities=14%  Similarity=0.117  Sum_probs=292.9

Q ss_pred             CCceeeeEeeCCCCeEEEEEeeccCccccccC-CCcCCCCCCEEEccCCCCC---CCCCcc------------ccccCCC
Q 039720           49 LCQWTGVTCGHRHQRVTKLDLESQNIGGFLSP-YIGNLSFLRVINLANNSFH---GQIPKE------------VGRLFRL  112 (973)
Q Consensus        49 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~-~l~~l~~L~~L~L~~n~l~---~~~p~~------------~~~l~~L  112 (973)
                      |++|.++...    ....+++++..  +..|. .+..+++|++|+|+++...   +..|..            ...+++|
T Consensus        34 ck~W~~~~~~----~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           34 CKSWYEIERW----CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             CHHHHHHHHH----HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHhhhh----hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            3479988322    23344554322  22232 3567899999999998532   122222            3468899


Q ss_pred             CEEeeecccCCCCCCcccc-cCCCccceEecccccccc--hhhhhccccccceeeccCCcccccCCCCC----CCCCccc
Q 039720          113 ETIVLSNNSFSGKIPTNLS-RCFNLIDFWVHTNNLVGE--IQAIIGNWLKIERLSLYGNQLTGQLPPSI----GNLSALQ  185 (973)
Q Consensus       113 ~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~--~~~~~~~l~~L~~L~L~~n~l~~~~p~~~----~~l~~L~  185 (973)
                      ++|+|++|.+++..+..+. .+++|++|++++|...+.  ++..+.++++|++|+|++|.+++..+..+    ..+++|+
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~  187 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV  187 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence            9999999999887777776 689999999999944333  66667789999999999999876544433    3677999


Q ss_pred             EEEccCCcCCCCCC-Cc----ccCCCccceeccCCC-CccccCCccccCCCCCcEEEccCC-------ccccCCCccccc
Q 039720          186 TFDIAGNKLDGRIP-DS----LGQLRNLNYLGTSEN-DFSGMFPLSVCNISSLDEAYLFKN-------RFKGSLPVCLGF  252 (973)
Q Consensus       186 ~L~L~~N~l~~~~p-~~----~~~L~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N-------~l~~~ip~~~~~  252 (973)
                      +|++++|. . .++ ..    +.++++|++|++++| .+.+ +|..+..+++|++|++..+       .+. .++..+ .
T Consensus       188 ~L~l~~~~-~-~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~~l-~  262 (594)
T 2p1m_B          188 SLNISCLA-S-EVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSVAL-S  262 (594)
T ss_dssp             EEECTTCC-S-CCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHHHH-H
T ss_pred             EEEecccC-C-cCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHH-HHHHHH-h
Confidence            99999997 2 232 22    345699999999998 4444 7778888999999996544       333 244444 3


Q ss_pred             CCCCCcEE-EccCCcccccCCccccCCCCCCEEEccCCcccccCc-ccccCcccccceecccccCCCCCCCChhhhhhhc
Q 039720          253 NLPKLTVL-VVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVR-INFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLT  330 (973)
Q Consensus       253 ~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~  330 (973)
                      ++++|+.| .+.+... +.++..+..+++|++|+|++|.+++... ..+..+++|++|++++| ++.     ........
T Consensus       263 ~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~-----~~l~~l~~  335 (594)
T 2p1m_B          263 GCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IED-----AGLEVLAS  335 (594)
T ss_dssp             TCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHH-----HHHHHHHH
T ss_pred             cCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCH-----HHHHHHHH
Confidence            78888888 4444333 2455556678889999999988764332 23567888999998887 331     12223334


Q ss_pred             ccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccc-cCCCCcCEEEcccccCCCCCCcccc-CCCCC
Q 039720          331 NCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEI-RNLFNLNGLGLEYNQLTGTIPPAIG-ELRNL  408 (973)
Q Consensus       331 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L  408 (973)
                      .+++|++|++..+.-.|                ....+.+++.....+ ..+++|+.|.++.|.+++..+..+. .+++|
T Consensus       336 ~~~~L~~L~L~~~~~~g----------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L  399 (594)
T 2p1m_B          336 TCKDLRELRVFPSEPFV----------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM  399 (594)
T ss_dssp             HCTTCCEEEEECSCTTC----------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTC
T ss_pred             hCCCCCEEEEecCcccc----------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCc
Confidence            57788888874421000                001112211111112 2356788887777777765555554 47788


Q ss_pred             CeEEcc--C----cccCCCC-----CCccCCcCccceEEcCCCcccccccccccc-ccccccccccCcccccCCCccc-c
Q 039720          409 QYLGLV--G----NNIRGII-----PDPIGNLTLLNVLQLGFNKLQGSIPSYLGK-CQNLMQLSAPNNKLNGTLPPQI-F  475 (973)
Q Consensus       409 ~~L~L~--~----N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~  475 (973)
                      +.|+|+  +    |.++...     +..+..+++|+.|++++ .+++..+..+.. +++|+.|++++|.+++..+..+ .
T Consensus       400 ~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~  478 (594)
T 2p1m_B          400 TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS  478 (594)
T ss_dssp             CEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHH
T ss_pred             ceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHh
Confidence            888887  4    4554221     11245677888888876 666555555555 7788888888888764433333 2


Q ss_pred             ccccccceeeccCCcccccCCc-ccccccccceeccccCcccccccccc-cCccchhhhcccCccc
Q 039720          476 GITTLSKLLDLSENHLSGSIPL-EVGNLKSLVQLDISRNNFSNEIPVTL-SACTTLEYLLMQGNSF  539 (973)
Q Consensus       476 ~~~~l~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l  539 (973)
                      .+..+ +.|+|++|.+++.... .+..+++|+.|++++|+++......+ ..+++|+...+..+.-
T Consensus       479 ~~~~L-~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          479 GCDSL-RKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HCTTC-CEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             cCCCc-CEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            23344 5888888888644333 34568899999999998864433334 4456666666665543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=7e-25  Score=236.52  Aligned_cols=215  Identities=17%  Similarity=0.200  Sum_probs=138.5

Q ss_pred             cccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcc
Q 039720           77 FLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGN  156 (973)
Q Consensus        77 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  156 (973)
                      .+|..+.  +.|++|+|++|++++..+..|+++++|++|+|++|.+++..+..+..+++|++|++++|.+.+..+..+.+
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence            3555443  57899999999998766668889999999999999988666667777777777777777776666666666


Q ss_pred             ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCC-CCCcccCCCccceeccCCCCccccCCccccCCCCCcEE
Q 039720          157 WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGR-IPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEA  235 (973)
Q Consensus       157 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  235 (973)
                      +++|++|++++|.+++..+..++++++|++|++++|++++. +|..|.++++|++|++++|++++..+..+..+.+|+  
T Consensus        99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~--  176 (276)
T 2z62_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP--  176 (276)
T ss_dssp             CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT--
T ss_pred             CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc--
Confidence            67777777777776655555666666777777777766642 466666666666666666666655555554444443  


Q ss_pred             EccCCccccCCCcccccCCCCCc-EEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceeccccc
Q 039720          236 YLFKNRFKGSLPVCLGFNLPKLT-VLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNN  314 (973)
Q Consensus       236 ~L~~N~l~~~ip~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  314 (973)
                                          .|. .|++++|.+++..+..+.. .+|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus       177 --------------------~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~  235 (276)
T 2z62_A          177 --------------------LLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  235 (276)
T ss_dssp             --------------------TCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred             --------------------ccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence                                111 4555555555433333332 255555555555555555555555555555565555


Q ss_pred             CC
Q 039720          315 LG  316 (973)
Q Consensus       315 l~  316 (973)
                      +.
T Consensus       236 ~~  237 (276)
T 2z62_A          236 WD  237 (276)
T ss_dssp             BC
T ss_pred             cc
Confidence            54

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=8.9e-25  Score=235.72  Aligned_cols=225  Identities=20%  Similarity=0.247  Sum_probs=152.8

Q ss_pred             EEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcc
Q 039720           91 INLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQL  170 (973)
Q Consensus        91 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l  170 (973)
                      .+.++.+++ .+|..+.  ++|++|+|++|.+++..+..|.++++|                        ++|+|++|++
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L------------------------~~L~l~~n~l   64 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPEL------------------------QVLDLSRCEI   64 (276)
T ss_dssp             EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTC------------------------SEEECTTCCC
T ss_pred             EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCC------------------------cEEECCCCcC
Confidence            344555565 6776663  578888888888875555556555555                        4555555555


Q ss_pred             cccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCcccc-CCCcc
Q 039720          171 TGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKG-SLPVC  249 (973)
Q Consensus       171 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~ip~~  249 (973)
                      ++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|.+++..+..+.++++|++|++++|++++ .+|..
T Consensus        65 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~  144 (276)
T 2z62_A           65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY  144 (276)
T ss_dssp             CEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred             CccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchh
Confidence            44444455555555555555555554444555555555555555555555444455555555566666665553 24555


Q ss_pred             cccCCCCCcEEEccCCcccccCCccccCCCCCC----EEEccCCcccccCcccccCcccccceecccccCCCCCCCChhh
Q 039720          250 LGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLE----WLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDF  325 (973)
Q Consensus       250 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  325 (973)
                      +. ++++|++|+|++|.+++..+..|..+.+|+    +|++++|++++..+..+... +|++|+|++|+++.++..    
T Consensus       145 ~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~----  218 (276)
T 2z62_A          145 FS-NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDG----  218 (276)
T ss_dssp             GG-GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSC-CEEEEECCSSCCSCCCTT----
T ss_pred             hc-cCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCC-cccEEECCCCceeecCHh----
Confidence            54 678888888888888877777787777777    99999999998877776654 899999999999987653    


Q ss_pred             hhhhcccccceeeccccccccCCCC
Q 039720          326 ITLLTNCSKLVKLGLVFNRFGGALP  350 (973)
Q Consensus       326 ~~~l~~l~~L~~L~l~~N~l~~~~p  350 (973)
                        .+..+++|+.|++++|++.+..|
T Consensus       219 --~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          219 --IFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             --TTTTCCSCCEEECCSSCBCCCTT
T ss_pred             --HhcccccccEEEccCCcccccCC
Confidence              35678999999999999998765

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=6.1e-28  Score=290.75  Aligned_cols=223  Identities=16%  Similarity=0.151  Sum_probs=119.7

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCC---CCCcc------------cccCCCccceEecccccccchhhh
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG---KIPTN------------LSRCFNLIDFWVHTNNLVGEIQAI  153 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~---~~p~~------------~~~l~~L~~L~l~~n~~~~~~~~~  153 (973)
                      +.+++++.... ..+..+.++++|++|+|+++....   ..|..            ...+++|++|++++|.+.+..+..
T Consensus        46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~  124 (594)
T 2p1m_B           46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL  124 (594)
T ss_dssp             CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred             eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence            45666655432 222346778999999999976432   22221            235667777888877777766666


Q ss_pred             hc-cccccceeeccCC-ccccc-CCCCCCCCCcccEEEccCCcCCCCCCCccc----CCCccceeccCCCC--cccc-CC
Q 039720          154 IG-NWLKIERLSLYGN-QLTGQ-LPPSIGNLSALQTFDIAGNKLDGRIPDSLG----QLRNLNYLGTSEND--FSGM-FP  223 (973)
Q Consensus       154 ~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~L~~L~~L~Ls~N~--l~~~-~p  223 (973)
                      +. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++|++++|.  ++.. ++
T Consensus       125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~  204 (594)
T 2p1m_B          125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE  204 (594)
T ss_dssp             HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred             HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence            65 5777777777777 44422 333344677777777777776654444333    45577777777765  2111 11


Q ss_pred             ccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccC-------CcccccCCccccCCCCCCEE-EccCCcccccC
Q 039720          224 LSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQ-------NNLTGFLPQSLSNASKLEWL-ELNENHFSGQV  295 (973)
Q Consensus       224 ~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~-------N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~  295 (973)
                      ..+.++++|+.|++++|...+.+|..+. .+++|+.|+++.       |.+.+ ++..+.++++|+.| .+.+... ...
T Consensus       205 ~l~~~~~~L~~L~L~~~~~~~~l~~~~~-~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l  281 (594)
T 2p1m_B          205 RLVTRCPNLKSLKLNRAVPLEKLATLLQ-RAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYL  281 (594)
T ss_dssp             HHHHHCTTCCEEECCTTSCHHHHHHHHH-HCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGG
T ss_pred             HHHHhCCCCcEEecCCCCcHHHHHHHHh-cCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhH
Confidence            1123345666666665522212443333 455666665332       22332 23345555555555 2322221 122


Q ss_pred             cccccCcccccceecccccC
Q 039720          296 RINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       296 ~~~~~~l~~L~~L~L~~N~l  315 (973)
                      +..+..+++|++|+|++|.+
T Consensus       282 ~~~~~~~~~L~~L~L~~~~l  301 (594)
T 2p1m_B          282 PAVYSVCSRLTTLNLSYATV  301 (594)
T ss_dssp             GGGHHHHTTCCEEECTTCCC
T ss_pred             HHHHHhhCCCCEEEccCCCC
Confidence            22333445555555555543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=1.2e-23  Score=225.98  Aligned_cols=204  Identities=22%  Similarity=0.225  Sum_probs=174.9

Q ss_pred             CCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeecc
Q 039720           87 FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLY  166 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~  166 (973)
                      ..+.+++++|+++ .+|..+.  ++|++|+|++|.+++..+                        ..|.++++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~------------------------~~~~~l~~L~~L~l~   69 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPS------------------------KAFHRLTKLRLLYLN   69 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCT------------------------TSSSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCH------------------------HHhcCCCCCCEEECC
Confidence            4567777777777 5676553  567777777777764333                        344556778888888


Q ss_pred             CCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCC
Q 039720          167 GNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSL  246 (973)
Q Consensus       167 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i  246 (973)
                      +|+++...+..|.++++|++|+|++|++++..+..|.++++|++|++++|.+++..+..|.++++|++|+|++|+++ .+
T Consensus        70 ~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~  148 (270)
T 2o6q_A           70 DNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SL  148 (270)
T ss_dssp             SSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred             CCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-cc
Confidence            88888655666799999999999999999777788999999999999999999988889999999999999999999 67


Q ss_pred             CcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCC
Q 039720          247 PVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTR  318 (973)
Q Consensus       247 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  318 (973)
                      |...+..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+...
T Consensus       149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            777666899999999999999988888899999999999999999998888899999999999999998764

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=5.5e-24  Score=230.63  Aligned_cols=204  Identities=25%  Similarity=0.267  Sum_probs=120.6

Q ss_pred             CcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccc
Q 039720           82 IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIE  161 (973)
Q Consensus        82 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~  161 (973)
                      ++++++++++++++|+++ .+|..+.  ++|++|+|++|.+++..|..|..+                        ++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l------------------------~~L~   58 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPY------------------------TRLT   58 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTC------------------------TTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcC------------------------CCCC
Confidence            445666666666666666 4555553  466666666666654444444444                        4455


Q ss_pred             eeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCc
Q 039720          162 RLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR  241 (973)
Q Consensus       162 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  241 (973)
                      +|+|++|.+++. +.. +.+++|++|+|++|+++ .+|..+.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        59 ~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~  135 (290)
T 1p9a_G           59 QLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE  135 (290)
T ss_dssp             EEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence            555555555432 221 45555555555555555 455555555556666666666555555555566666666666666


Q ss_pred             cccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       242 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      ++ .+|...+..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|+. +|..+..+++|+.|+|++|.+..
T Consensus       136 l~-~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          136 LK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CC-ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCccC
Confidence            65 4455544466667777777777765555566667777777777777763 44455556677777777777654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2.5e-24  Score=231.49  Aligned_cols=150  Identities=21%  Similarity=0.319  Sum_probs=79.7

Q ss_pred             ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEE
Q 039720          157 WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY  236 (973)
Q Consensus       157 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  236 (973)
                      +.++..+++..+.+...  ..+..+++|+.|++++|.++ .++ .+..+++|++|++++|.+++.  ..+.++++|++|+
T Consensus        18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            34556667777766543  23556777888888888776 333 477777777777777777642  2444444444444


Q ss_pred             ccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccc
Q 039720          237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN  313 (973)
Q Consensus       237 L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  313 (973)
                      |++|+++ .+|...+.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        92 L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n  167 (272)
T 3rfs_A           92 LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN  167 (272)
T ss_dssp             CTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCC
Confidence            4444444 222222224444444444444444444444444444555555444444444333444444444444433

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.9e-24  Score=232.41  Aligned_cols=229  Identities=21%  Similarity=0.268  Sum_probs=140.9

Q ss_pred             CCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcccccccee
Q 039720           84 NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERL  163 (973)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  163 (973)
                      .+..+..+++..+.+...  ..+..+++|+.|++++|.++ .++ .++.+++|++|                        
T Consensus        17 ~~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L------------------------   68 (272)
T 3rfs_A           17 AFAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYL------------------------   68 (272)
T ss_dssp             HHHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEE------------------------
T ss_pred             hHHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEE------------------------
Confidence            345566677777777643  33567888888888888876 333 35555555444                        


Q ss_pred             eccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccc
Q 039720          164 SLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       164 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                      +|++|.+++ + +.++++++|++|+|++|++++..+..|+++++|++|++++|++++..+..|.++++|++|++++|+++
T Consensus        69 ~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  146 (272)
T 3rfs_A           69 ALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ  146 (272)
T ss_dssp             ECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccC
Confidence            444444443 1 24455555555555555555444444555555555555555555544445555555555555555555


Q ss_pred             cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCCh
Q 039720          244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL  323 (973)
Q Consensus       244 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  323 (973)
                       .+|...+.++++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+..      
T Consensus       147 -~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~------  219 (272)
T 3rfs_A          147 -SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC------  219 (272)
T ss_dssp             -CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC------
T ss_pred             -ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc------
Confidence             3444433466777777777777776666667777777777777777777777777777777777777776643      


Q ss_pred             hhhhhhcccccceeeccccccccCCCChhhhhh
Q 039720          324 DFITLLTNCSKLVKLGLVFNRFGGALPHSIANL  356 (973)
Q Consensus       324 ~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l  356 (973)
                             .+++|+.+++..|.+.|.+|.+++.+
T Consensus       220 -------~~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          220 -------TCPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             -------CTTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             -------cCcHHHHHHHHHHhCCCcccCccccc
Confidence                   34456666666666666666666554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=5.2e-24  Score=226.12  Aligned_cols=190  Identities=18%  Similarity=0.224  Sum_probs=130.5

Q ss_pred             CCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCC
Q 039720           48 NLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIP  127 (973)
Q Consensus        48 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p  127 (973)
                      +||.|.|++|...   ...++++++++. .+|..+.  +.|+.|+|++|++++..|..|+++++|++|+|++|.+++..|
T Consensus         3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            5889999999643   335788888886 5676655  688999999999998878889999999999999999987777


Q ss_pred             cccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCc
Q 039720          128 TNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRN  207 (973)
Q Consensus       128 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~  207 (973)
                      ..|..+++|++|++++|++.+..+..+..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|+++++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  156 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN  156 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence            76777777766666666666655566666666666666666666544444566666666666666666544455666666


Q ss_pred             cceeccCCCCccccCCccccCCCCCcEEEccCCccc
Q 039720          208 LNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       208 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                      |++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence            666666666666555555555555555555555554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=1.5e-23  Score=227.11  Aligned_cols=206  Identities=24%  Similarity=0.201  Sum_probs=180.2

Q ss_pred             cccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcc
Q 039720          105 EVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSAL  184 (973)
Q Consensus       105 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  184 (973)
                      +++++++|+++++++|.++ .+|..+.                          +++++|+|++|.+++..|..|.++++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--------------------------~~l~~L~L~~N~l~~~~~~~~~~l~~L   57 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDLP--------------------------KDTTILHLSENLLYTFSLATLMPYTRL   57 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCCC--------------------------TTCCEEECTTSCCSEEEGGGGTTCTTC
T ss_pred             cccccCCccEEECCCCCCC-cCCCCCC--------------------------CCCCEEEcCCCcCCccCHHHhhcCCCC
Confidence            3677888889999888887 5665442                          467889999999998888899999999


Q ss_pred             cEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccC
Q 039720          185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQ  264 (973)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~  264 (973)
                      ++|+|++|++++. +.. +.+++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|...+.++++|++|+|++
T Consensus        58 ~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~  133 (290)
T 1p9a_G           58 TQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKG  133 (290)
T ss_dssp             CEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTT
T ss_pred             CEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCC
Confidence            9999999999854 433 88999999999999998 67888999999999999999999 66666666899999999999


Q ss_pred             CcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeecccccc
Q 039720          265 NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR  344 (973)
Q Consensus       265 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~  344 (973)
                      |+|++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|+.++...       ..+.+|+.+++++|.
T Consensus       134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~-------~~~~~L~~l~L~~Np  206 (290)
T 1p9a_G          134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGF-------FGSHLLPFAFLHGNP  206 (290)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------TTTCCCSEEECCSCC
T ss_pred             CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhh-------cccccCCeEEeCCCC
Confidence            9999888888999999999999999999988889999999999999999999877643       345689999999999


Q ss_pred             ccCC
Q 039720          345 FGGA  348 (973)
Q Consensus       345 l~~~  348 (973)
                      +...
T Consensus       207 ~~C~  210 (290)
T 1p9a_G          207 WLCN  210 (290)
T ss_dssp             BCCS
T ss_pred             ccCc
Confidence            8743

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=1.9e-25  Score=250.97  Aligned_cols=270  Identities=16%  Similarity=0.131  Sum_probs=155.4

Q ss_pred             EEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCC----ccccccC-CCCEEeeecccCCCCCCcccccC-----CCc
Q 039720           67 LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIP----KEVGRLF-RLETIVLSNNSFSGKIPTNLSRC-----FNL  136 (973)
Q Consensus        67 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l-----~~L  136 (973)
                      .+|+.+++.|.+|..+...+.|++|||++|++++..+    ..|.+++ +|++|+|++|.+++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4566667766666666666667777777777765444    4556666 67777777777665555555543     445


Q ss_pred             cceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCC-CcccEEEccCCcCCCCCCCcc----cCC-Cccce
Q 039720          137 IDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNL-SALQTFDIAGNKLDGRIPDSL----GQL-RNLNY  210 (973)
Q Consensus       137 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~----~~L-~~L~~  210 (973)
                      ++|++++|.+.+..+..+...                    +..+ ++|++|+|++|++++..+..+    ..+ ++|++
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~  142 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKT--------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS  142 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCE
T ss_pred             cEEECcCCcCChHHHHHHHHH--------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeE
Confidence            555555554444443332222                    1112 445555555555543333222    221 35555


Q ss_pred             eccCCCCccccC----CccccCCC-CCcEEEccCCccccCCCcccc---cCC-CCCcEEEccCCccccc----CCccccC
Q 039720          211 LGTSENDFSGMF----PLSVCNIS-SLDEAYLFKNRFKGSLPVCLG---FNL-PKLTVLVVAQNNLTGF----LPQSLSN  277 (973)
Q Consensus       211 L~Ls~N~l~~~~----p~~~~~l~-~L~~L~L~~N~l~~~ip~~~~---~~l-~~L~~L~Ls~N~l~~~----~p~~~~~  277 (973)
                      |+|++|.+++..    +..+..++ +|++|+|++|++++..+..+.   ... ++|++|+|++|.|++.    ++..+..
T Consensus       143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence            555555555322    22223333 556666666655543332221   133 4777777777777752    3445555


Q ss_pred             -CCCCCEEEccCCcccccCc----ccccCcccccceecccccCCCCCCCChh-hhhhhcccccceeeccccccccCCCCh
Q 039720          278 -ASKLEWLELNENHFSGQVR----INFNSLPNLSKLYLGRNNLGTRTSTDLD-FITLLTNCSKLVKLGLVFNRFGGALPH  351 (973)
Q Consensus       278 -l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~l~~l~~L~~L~l~~N~l~~~~p~  351 (973)
                       .++|++|+|++|+|++..+    ..+..+++|++|+|++|.+..+...... ....+.++++|+.|++++|++.+..+.
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~  302 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI  302 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence             3578888888888876544    3456778888888888886665544222 234567788888899999888877666


Q ss_pred             hhhhh
Q 039720          352 SIANL  356 (973)
Q Consensus       352 ~~~~l  356 (973)
                      .+.+.
T Consensus       303 ~~~~~  307 (362)
T 3goz_A          303 PISNL  307 (362)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            65543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=2.2e-23  Score=219.54  Aligned_cols=204  Identities=14%  Similarity=0.148  Sum_probs=130.5

Q ss_pred             cccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeeccc-CCCCCCcccccCCCccceEecc-cccccchhhhh
Q 039720           77 FLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS-FSGKIPTNLSRCFNLIDFWVHT-NNLVGEIQAII  154 (973)
Q Consensus        77 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~l~~-n~~~~~~~~~~  154 (973)
                      .+|. +.  +.|++|+|++|++++..+..|+++++|++|+|++|. +++..+..|.++++|++|++++ |++.+..+   
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~---   98 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP---   98 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT---
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH---
Confidence            4555 33  378999999999986666688899999999999997 7644444566665555555554 44444333   


Q ss_pred             ccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccc---eeccCCC-CccccCCccccCCC
Q 039720          155 GNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLN---YLGTSEN-DFSGMFPLSVCNIS  230 (973)
Q Consensus       155 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~---~L~Ls~N-~l~~~~p~~~~~l~  230 (973)
                                           ..|.++++|++|++++|++++ +|+ |..+++|+   +|++++| .+++..+..|.+++
T Consensus        99 ---------------------~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~  155 (239)
T 2xwt_C           99 ---------------------DALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC  155 (239)
T ss_dssp             ---------------------TSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTB
T ss_pred             ---------------------HHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchh
Confidence                                 444455555555555555542 443 44444444   5555555 55544445555555


Q ss_pred             CCc-EEEccCCccccCCCcccccCCCCCcEEEccCCc-ccccCCccccCC-CCCCEEEccCCcccccCcccccCcccccc
Q 039720          231 SLD-EAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNN-LTGFLPQSLSNA-SKLEWLELNENHFSGQVRINFNSLPNLSK  307 (973)
Q Consensus       231 ~L~-~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  307 (973)
                      +|+ +|++++|+++ .+|...+.. ++|+.|+|++|. +++..+..|.++ ++|++|+|++|++++..+.   .+++|+.
T Consensus       156 ~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~  230 (239)
T 2xwt_C          156 NETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKE  230 (239)
T ss_dssp             SSEEEEECCSCCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSE
T ss_pred             cceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCce
Confidence            555 5555555555 566655533 678888888884 776667778888 8888888888888765544   5667777


Q ss_pred             eeccccc
Q 039720          308 LYLGRNN  314 (973)
Q Consensus       308 L~L~~N~  314 (973)
                      |+++++.
T Consensus       231 L~l~~~~  237 (239)
T 2xwt_C          231 LIARNTW  237 (239)
T ss_dssp             EECTTC-
T ss_pred             eeccCcc
Confidence            7777653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=1.7e-23  Score=220.37  Aligned_cols=203  Identities=22%  Similarity=0.218  Sum_probs=168.4

Q ss_pred             CCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCc-ccccCCCCCC
Q 039720          101 QIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQ-LTGQLPPSIG  179 (973)
Q Consensus       101 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~~~  179 (973)
                      .+|. +.  ++|++|+|++|++++..+..|                        .++++|++|++++|. +++..+..|.
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~------------------------~~l~~L~~L~l~~n~~l~~i~~~~f~   77 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAF------------------------SNLPNISRIYVSIDVTLQQLESHSFY   77 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTT------------------------TTCTTCCEEEEECCSSCCEECTTTEE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHc------------------------cCCCCCcEEeCCCCCCcceeCHhHcC
Confidence            5666 43  378888888888874333344                        445677888888886 7766666899


Q ss_pred             CCCcccEEEccC-CcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCc---EEEccCC-ccccCCCcccccCC
Q 039720          180 NLSALQTFDIAG-NKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLD---EAYLFKN-RFKGSLPVCLGFNL  254 (973)
Q Consensus       180 ~l~~L~~L~L~~-N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~ip~~~~~~l  254 (973)
                      ++++|++|++++ |++++..+..|.++++|++|++++|++++ +|. |..+++|+   +|++++| +++ .+|...+.++
T Consensus        78 ~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l  154 (239)
T 2xwt_C           78 NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGL  154 (239)
T ss_dssp             SCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTT
T ss_pred             CCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchh-hcCcccccch
Confidence            999999999998 99997777899999999999999999997 665 88999998   9999999 888 6777766689


Q ss_pred             CCCc-EEEccCCcccccCCccccCCCCCCEEEccCCc-ccccCcccccCc-ccccceecccccCCCCCCCChhhhhhhcc
Q 039720          255 PKLT-VLVVAQNNLTGFLPQSLSNASKLEWLELNENH-FSGQVRINFNSL-PNLSKLYLGRNNLGTRTSTDLDFITLLTN  331 (973)
Q Consensus       255 ~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~~l~~  331 (973)
                      ++|+ +|++++|.++.+.+..|.. ++|++|+|++|+ ++++.+..|.++ ++|++|+|++|+++.++..         .
T Consensus       155 ~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---------~  224 (239)
T 2xwt_C          155 CNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---------G  224 (239)
T ss_dssp             BSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---------T
T ss_pred             hcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---------H
Confidence            9999 9999999999555555655 899999999995 998888999999 9999999999999987654         3


Q ss_pred             cccceeeccccc
Q 039720          332 CSKLVKLGLVFN  343 (973)
Q Consensus       332 l~~L~~L~l~~N  343 (973)
                      +++|+.|+++++
T Consensus       225 ~~~L~~L~l~~~  236 (239)
T 2xwt_C          225 LEHLKELIARNT  236 (239)
T ss_dssp             CTTCSEEECTTC
T ss_pred             hccCceeeccCc
Confidence            567888888765

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.8e-23  Score=229.41  Aligned_cols=226  Identities=15%  Similarity=0.135  Sum_probs=170.1

Q ss_pred             CCCEEEccCCCCCCCC-Cc--cccccCCCCEEeeecccCCCCCCccc--ccCCCccceEecccccccchh----hhhccc
Q 039720           87 FLRVINLANNSFHGQI-PK--EVGRLFRLETIVLSNNSFSGKIPTNL--SRCFNLIDFWVHTNNLVGEIQ----AIIGNW  157 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~~----~~~~~l  157 (973)
                      .++.|.+.++.++... ..  .+..+++|++|+|++|.+++.+|..+  ..+++|++|++++|.+.+..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            4788888888775211 10  12346779999999999999999888  889999999999999887544    455678


Q ss_pred             cccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCC--C--CCcccCCCccceeccCCCCccccCC--c-cccCCC
Q 039720          158 LKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGR--I--PDSLGQLRNLNYLGTSENDFSGMFP--L-SVCNIS  230 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~L~~L~~L~Ls~N~l~~~~p--~-~~~~l~  230 (973)
                      ++|++|+|++|++++..|..|+++++|++|+|++|++.+.  +  +..++++++|++|+|++|+++...+  . .+.+++
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~  224 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV  224 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence            8999999999999888888899999999999999987642  2  3345788899999999998863221  1 246778


Q ss_pred             CCcEEEccCCccccCCCcccccC--CCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccce
Q 039720          231 SLDEAYLFKNRFKGSLPVCLGFN--LPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKL  308 (973)
Q Consensus       231 ~L~~L~L~~N~l~~~ip~~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  308 (973)
                      +|++|+|++|++.+.+|..++.-  +++|++|+|++|.|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|+.|
T Consensus       225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L  299 (310)
T 4glp_A          225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL  299 (310)
T ss_dssp             CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred             CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence            88888888888886667665521  268888888888888 4566654  6888888888888865 22 6777888888


Q ss_pred             ecccccCCC
Q 039720          309 YLGRNNLGT  317 (973)
Q Consensus       309 ~L~~N~l~~  317 (973)
                      +|++|+|+.
T Consensus       300 ~L~~N~l~~  308 (310)
T 4glp_A          300 TLDGNPFLV  308 (310)
T ss_dssp             ECSSTTTSC
T ss_pred             ECcCCCCCC
Confidence            888887753

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=2.7e-25  Score=247.26  Aligned_cols=269  Identities=17%  Similarity=0.223  Sum_probs=158.9

Q ss_pred             CCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCC--CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCC-
Q 039720           49 LCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNL--SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGK-  125 (973)
Q Consensus        49 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~-  125 (973)
                      |.+|.++.|+..  .++.+|++++.+.   +..++.+  +.++.|++++|.+++..|. +.++++|++|+|++|.+++. 
T Consensus        36 c~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~  109 (336)
T 2ast_B           36 CKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST  109 (336)
T ss_dssp             CHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred             HHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence            447999988743  4667788777664   3445555  7778888888877765554 55677777777777777644 


Q ss_pred             CCcccccCCCccceEecccccccchhhhhccccccceeeccCC-cccc-cCCCCCCCCCcccEEEccCC-cCCCC-CCCc
Q 039720          126 IPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN-QLTG-QLPPSIGNLSALQTFDIAGN-KLDGR-IPDS  201 (973)
Q Consensus       126 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n-~l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~  201 (973)
                      +|..+..+++|++|++++|.+.+..+..+..+++|++|+|++| .+++ .++..+.++++|++|++++| ++++. ++..
T Consensus       110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~  189 (336)
T 2ast_B          110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA  189 (336)
T ss_dssp             HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred             HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence            5555666666666666666655555555555556666666555 3443 13444445555555555555 54422 3344


Q ss_pred             ccCCC-ccceeccCCCCccccCCccccCCCCCcEEEccCCccc-cCCCcccccCCCCCcEEEccCCc-ccccCCccccCC
Q 039720          202 LGQLR-NLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK-GSLPVCLGFNLPKLTVLVVAQNN-LTGFLPQSLSNA  278 (973)
Q Consensus       202 ~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~ip~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l  278 (973)
                      +..++ +|++|++++|.+                      .++ +.+|..+. ++++|++|++++|. +++..+..+.++
T Consensus       190 ~~~l~~~L~~L~l~~~~~----------------------~~~~~~l~~~~~-~~~~L~~L~l~~~~~l~~~~~~~l~~l  246 (336)
T 2ast_B          190 VAHVSETITQLNLSGYRK----------------------NLQKSDLSTLVR-RCPNLVHLDLSDSVMLKNDCFQEFFQL  246 (336)
T ss_dssp             HHHSCTTCCEEECCSCGG----------------------GSCHHHHHHHHH-HCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred             HHhcccCCCEEEeCCCcc----------------------cCCHHHHHHHHh-hCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence            44455 555555555521                      222 23333332 56667777777776 555566667777


Q ss_pred             CCCCEEEccCCc-ccccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhh
Q 039720          279 SKLEWLELNENH-FSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIAN  355 (973)
Q Consensus       279 ~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~  355 (973)
                      ++|++|+|++|. +.......+..+++|++|+|++| ++   ...+..   +.  ..+..|+++.|++++..|..++.
T Consensus       247 ~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~---l~--~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQL---LK--EALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHH---HH--HHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHH---HH--hhCcceEEecccCccccCCcccc
Confidence            777777777774 33222235666777777777777 32   222221   11  23556667778888777776664

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=4e-24  Score=251.24  Aligned_cols=191  Identities=17%  Similarity=0.146  Sum_probs=143.7

Q ss_pred             CcCCccccccceeEEEEEECCCCcEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          677 SSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--------GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       677 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ...+.||+|+||+||+|+.  .+..+|+|+......        ...+++.+|++++++++||||+++..++..     .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L  411 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence            4456899999999999965  688999998753221        123458999999999999999954444332     2


Q ss_pred             ceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      +..++||||+++++|.+++..        +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+|+.
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            456999999999999999876        468999999999999999   9999999999999998  999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccC--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG--GDLSMTGDVYSFGILLLEMFTRRRPTD  888 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~ll~elltg~~Pf~  888 (973)
                      ......... ..........||+.|+|||++..  ..|+..+|+|+..+-..+-+.++.+|.
T Consensus       479 ~~~~~~~~~-~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          479 SNLDEDKAV-DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCHHHHHH-HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCCcccccc-chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            643110000 00001235679999999999887  678888999999999888888887764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=3e-23  Score=227.68  Aligned_cols=224  Identities=19%  Similarity=0.166  Sum_probs=188.2

Q ss_pred             eEEEEEeeccCccccccC---CCcCCCCCCEEEccCCCCCCCCCccc--cccCCCCEEeeecccCCCCCC----cccccC
Q 039720           63 RVTKLDLESQNIGGFLSP---YIGNLSFLRVINLANNSFHGQIPKEV--GRLFRLETIVLSNNSFSGKIP----TNLSRC  133 (973)
Q Consensus        63 ~v~~l~l~~~~l~g~~~~---~l~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~n~l~~~~p----~~~~~l  133 (973)
                      ++..+.+.+..+...--.   ....++.|++|+|++|++++.+|..+  +.+++|++|+|++|.+++..|    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            356666666655331111   12245679999999999999999998  999999999999999998766    445679


Q ss_pred             CCccceEecccccccchhhhhccccccceeeccCCccccc--C--CCCCCCCCcccEEEccCCcCCCCCCC----cccCC
Q 039720          134 FNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQ--L--PPSIGNLSALQTFDIAGNKLDGRIPD----SLGQL  205 (973)
Q Consensus       134 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~L  205 (973)
                      ++|++|++++|++.+..+..++.+++|++|+|++|++.+.  +  +..++++++|++|+|++|+++ .++.    .++++
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l  223 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG  223 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence            9999999999999999999999999999999999998642  2  344578999999999999997 4444    35788


Q ss_pred             CccceeccCCCCccccCCccccCC---CCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCC
Q 039720          206 RNLNYLGTSENDFSGMFPLSVCNI---SSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLE  282 (973)
Q Consensus       206 ~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  282 (973)
                      ++|++|+|++|++++..|..+..+   ++|++|+|++|+++ .+|..++   ++|++|+|++|+|++. |. +..+++|+
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC---SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc---CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            999999999999999888887777   69999999999999 8898775   7999999999999975 44 78899999


Q ss_pred             EEEccCCcccc
Q 039720          283 WLELNENHFSG  293 (973)
Q Consensus       283 ~L~Ls~N~l~~  293 (973)
                      +|+|++|+|+.
T Consensus       298 ~L~L~~N~l~~  308 (310)
T 4glp_A          298 NLTLDGNPFLV  308 (310)
T ss_dssp             CEECSSTTTSC
T ss_pred             EEECcCCCCCC
Confidence            99999999974

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=1.1e-24  Score=244.56  Aligned_cols=236  Identities=17%  Similarity=0.164  Sum_probs=152.7

Q ss_pred             CeEEEEEeeccCcccccc----CCCcCCC-CCCEEEccCCCCCCCCCcccccc-----CCCCEEeeecccCCCCCCcccc
Q 039720           62 QRVTKLDLESQNIGGFLS----PYIGNLS-FLRVINLANNSFHGQIPKEVGRL-----FRLETIVLSNNSFSGKIPTNLS  131 (973)
Q Consensus        62 ~~v~~l~l~~~~l~g~~~----~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~Ls~n~l~~~~p~~~~  131 (973)
                      ..++.|||+++.+++..+    ..+..++ +|++|+|++|++++..+..++.+     ++|++|+|++|.+++..+..+.
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  101 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV  101 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence            358999999999987665    5677888 89999999999998888888886     9999999999999977776555


Q ss_pred             cC-----CCccceEecccccccchhhhhccc-----cccceeeccCCcccccC----CCCCCCCC-cccEEEccCCcCCC
Q 039720          132 RC-----FNLIDFWVHTNNLVGEIQAIIGNW-----LKIERLSLYGNQLTGQL----PPSIGNLS-ALQTFDIAGNKLDG  196 (973)
Q Consensus       132 ~l-----~~L~~L~l~~n~~~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~----p~~~~~l~-~L~~L~L~~N~l~~  196 (973)
                      ..     ++|++|++++|.+.+..+..+...     ++|++|+|++|++++..    +..+..+. +|++|+|++|++++
T Consensus       102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~  181 (362)
T 3goz_A          102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS  181 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred             HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence            43     677777777777766655544332     46666666666666322    22223333 56666666666654


Q ss_pred             CCCCccc----CC-CccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccC
Q 039720          197 RIPDSLG----QL-RNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL  271 (973)
Q Consensus       197 ~~p~~~~----~L-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~  271 (973)
                      ..+..+.    .+ ++|++|+|++|.|++....                    .++..+....++|++|+|++|.|++..
T Consensus       182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~--------------------~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYA--------------------ELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH--------------------HHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH--------------------HHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            4443332    22 3555555555555531110                    133333322346666666666666543


Q ss_pred             C----ccccCCCCCCEEEccCCcccccC-------cccccCcccccceecccccCCC
Q 039720          272 P----QSLSNASKLEWLELNENHFSGQV-------RINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       272 p----~~~~~l~~L~~L~Ls~N~l~~~~-------~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      +    ..+..+++|++|+|++|.+.+..       +..+..+++|+.|+|++|++..
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~  298 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP  298 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred             HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence            3    33456677777777777744332       2356677778888888887764

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=7.8e-24  Score=235.44  Aligned_cols=224  Identities=18%  Similarity=0.244  Sum_probs=162.6

Q ss_pred             CCCEEEccCCCCCCCCCcccccc--CCCCEEeeecccCCCCCCcccccCCCccceEecccccccc-hhhhhcccccccee
Q 039720           87 FLRVINLANNSFHGQIPKEVGRL--FRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGE-IQAIIGNWLKIERL  163 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-~~~~~~~l~~L~~L  163 (973)
                      .++.|++++|.+.   |..++++  +++++|++++|.+.+..|. +..+++|++|++++|.+.+. ++..+..+++|++|
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            4788999999886   5667777  8999999999999866554 55677777777777777655 66677777777777


Q ss_pred             eccCCcccccCCCCCCCCCcccEEEccCC-cCCCC-CCCcccCCCccceeccCCC-CccccCCccccCCCCCcEEEccCC
Q 039720          164 SLYGNQLTGQLPPSIGNLSALQTFDIAGN-KLDGR-IPDSLGQLRNLNYLGTSEN-DFSGMFPLSVCNISSLDEAYLFKN  240 (973)
Q Consensus       164 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~L~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N  240 (973)
                      +|++|.+++..|..|+.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++.                   
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~-------------------  184 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-------------------  184 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-------------------
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH-------------------
Confidence            77777666656666666666666666666 45431 3444555555555555555 44421                   


Q ss_pred             ccccCCCcccccCCC-CCcEEEccCC--ccc-ccCCccccCCCCCCEEEccCCc-ccccCcccccCcccccceecccccC
Q 039720          241 RFKGSLPVCLGFNLP-KLTVLVVAQN--NLT-GFLPQSLSNASKLEWLELNENH-FSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       241 ~l~~~ip~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                          .++..+. .++ +|++|++++|  .++ +.+|..+.++++|++|+|++|. +++..+..+..+++|++|+|++|. 
T Consensus       185 ----~~~~~~~-~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~-  258 (336)
T 2ast_B          185 ----HVQVAVA-HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY-  258 (336)
T ss_dssp             ----HHHHHHH-HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT-
T ss_pred             ----HHHHHHH-hcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC-
Confidence                1333333 688 9999999999  555 4567788899999999999999 787778899999999999999996 


Q ss_pred             CCCCCCChhhhhhhcccccceeeccccc
Q 039720          316 GTRTSTDLDFITLLTNCSKLVKLGLVFN  343 (973)
Q Consensus       316 ~~~~~~~~~~~~~l~~l~~L~~L~l~~N  343 (973)
                       .+..   ..+..+.++++|+.|++++|
T Consensus       259 -~~~~---~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          259 -DIIP---ETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             -TCCG---GGGGGGGGCTTCCEEECTTS
T ss_pred             -CCCH---HHHHHHhcCCCCCEEeccCc
Confidence             2221   22345678999999999988

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.88  E-value=2.3e-23  Score=244.40  Aligned_cols=214  Identities=20%  Similarity=0.295  Sum_probs=142.5

Q ss_pred             CCCCCCCCCCCC-----ceeee-EeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCC
Q 039720           39 VTKSWNNSINLC-----QWTGV-TCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRL  112 (973)
Q Consensus        39 ~l~sw~~~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  112 (973)
                      .+.+|..+.++|     .|.|+ .|..  .+++.|+|+++++++ +|+.++  ++|++|+|++|+|+ .+|   +.+++|
T Consensus        32 ~l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L  102 (571)
T 3cvr_A           32 AWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL  102 (571)
T ss_dssp             HHHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred             HHHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence            466787667778     79999 7864  368899999999987 787664  88999999999998 788   457899


Q ss_pred             CEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCC
Q 039720          113 ETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGN  192 (973)
Q Consensus       113 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N  192 (973)
                      ++|+|++|.|++ +|. +++  +|++|++++|++.+                         +|.   .+++|++|+|++|
T Consensus       103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-------------------------lp~---~l~~L~~L~Ls~N  150 (571)
T 3cvr_A          103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-------------------------LPE---LPALLEYINADNN  150 (571)
T ss_dssp             CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-------------------------CCC---CCTTCCEEECCSS
T ss_pred             CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-------------------------CCC---cCccccEEeCCCC
Confidence            999999999986 776 543  45555555554443                         333   3445555555555


Q ss_pred             cCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCccccc----CCCCCcEEEccCCccc
Q 039720          193 KLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGF----NLPKLTVLVVAQNNLT  268 (973)
Q Consensus       193 ~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~----~l~~L~~L~Ls~N~l~  268 (973)
                      +|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|. +..    ..+.|+.|+|++|.|+
T Consensus       151 ~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l~  220 (571)
T 3cvr_A          151 QLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRENRIT  220 (571)
T ss_dssp             CCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCSSCCC
T ss_pred             ccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCCCcce
Confidence            5543 333   34455555555555554 333 33  55555555555555 5555 321    1122388888888888


Q ss_pred             ccCCccccCCCCCCEEEccCCcccccCcccccCccc
Q 039720          269 GFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPN  304 (973)
Q Consensus       269 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  304 (973)
                       .+|..+..+++|++|+|++|.+++..|..|..++.
T Consensus       221 -~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             -CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             -ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence             46777777888888888888888877777666544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=1.3e-22  Score=226.57  Aligned_cols=204  Identities=15%  Similarity=0.086  Sum_probs=129.7

Q ss_pred             CceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCc-
Q 039720           50 CQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPT-  128 (973)
Q Consensus        50 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~-  128 (973)
                      |.|..|.|++            ++++ .+|..+  .+++++|+|++|+|+...+..|+++++|++|+|++|.+.+.+|. 
T Consensus         9 C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~   73 (350)
T 4ay9_X            9 CSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD   73 (350)
T ss_dssp             EETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred             eeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence            5677777764            3443 466655  36899999999999944445799999999999999999877765 


Q ss_pred             ccccCCCccc-eEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccC-CcCCCCCCCcccCCC
Q 039720          129 NLSRCFNLID-FWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAG-NKLDGRIPDSLGQLR  206 (973)
Q Consensus       129 ~~~~l~~L~~-L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~L~  206 (973)
                      .|.+++++++ +.+..|++.+..|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+.
T Consensus        74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~  153 (350)
T 4ay9_X           74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS  153 (350)
T ss_dssp             SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred             HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence            4677777765 34445666666666677777777777777777655555555566666666654 455544444555553


Q ss_pred             -ccceeccCCCCccccCCccccCCCCCcEEEccC-CccccCCCcccccCCCCCcEEEccCCccccc
Q 039720          207 -NLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK-NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGF  270 (973)
Q Consensus       207 -~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~  270 (973)
                       .|+.|+|++|+|+.+.+..| ...+|+++++.+ |.++ .+|...|.++++|++|+|++|+|+.+
T Consensus       154 ~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~l  217 (350)
T 4ay9_X          154 FESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL  217 (350)
T ss_dssp             SSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred             hhhhhhccccccccCCChhhc-cccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCcc
Confidence             46666666666664333333 334555555553 3333 55555555555555555555555543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.87  E-value=1.5e-24  Score=246.03  Aligned_cols=265  Identities=16%  Similarity=0.199  Sum_probs=182.9

Q ss_pred             ccCCcccccCCccccCCCCCCEEEccCCcccccCc----ccccCcccccceecccccCCCCCCCChhhhhhhccccccee
Q 039720          262 VAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVR----INFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVK  337 (973)
Q Consensus       262 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  337 (973)
                      ++...+. .++..+..+++|++|+|++|+|+...+    ..|..+++|++|+|++|.+..                    
T Consensus        16 l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~--------------------   74 (386)
T 2ca6_A           16 ITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR--------------------   74 (386)
T ss_dssp             CCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTS--------------------
T ss_pred             CCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCc--------------------
Confidence            3333343 456677778888888888888876533    336677778888877776532                    


Q ss_pred             eccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCC----CCCccccCCCCCCeEEc
Q 039720          338 LGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG----TIPPAIGELRNLQYLGL  413 (973)
Q Consensus       338 L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L  413 (973)
                             +.+.+|..+..+                  ...+..+++|++|+|++|++++    .+|..+..+++|++|+|
T Consensus        75 -------l~~~~~~~~~~l------------------~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L  129 (386)
T 2ca6_A           75 -------VKDEIPEALRLL------------------LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL  129 (386)
T ss_dssp             -------CGGGSHHHHHHH------------------HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEEC
T ss_pred             -------cccchhHHHHHH------------------HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEEC
Confidence                   333444443332                  1345677888888998888886    36777888888888888


Q ss_pred             cCcccCCCCCCccCC----c---------CccceEEcCCCccc-cccc---cccccccccccccccCcccccCCCccccc
Q 039720          414 VGNNIRGIIPDPIGN----L---------TLLNVLQLGFNKLQ-GSIP---SYLGKCQNLMQLSAPNNKLNGTLPPQIFG  476 (973)
Q Consensus       414 ~~N~l~~~~p~~~~~----l---------~~L~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  476 (973)
                      ++|.+....+..+..    +         ++|++|+|++|+++ +.+|   ..+..+++|+.|++++|++...   .   
T Consensus       130 ~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~---g---  203 (386)
T 2ca6_A          130 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE---G---  203 (386)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH---H---
T ss_pred             cCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh---H---
Confidence            888886444433333    3         78888888888886 3444   3555666777777766666410   0   


Q ss_pred             cccccceeeccCCcccccCCcccccccccceeccccCccc----ccccccccCccchhhhcccCcccccc----cccchh
Q 039720          477 ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS----NEIPVTLSACTTLEYLLMQGNSFNGS----IPQSLN  548 (973)
Q Consensus       477 ~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~  548 (973)
                                    +....|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|+|++.    ++..+.
T Consensus       204 --------------~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~  269 (386)
T 2ca6_A          204 --------------IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS  269 (386)
T ss_dssp             --------------HHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred             --------------HHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHh
Confidence                          00023335667778888888888885    56777788888888888888888765    455663


Q ss_pred             h--hccCCeecCCCCcccc----ccCCCC-CCCCccceEeccCCcCcCcCC
Q 039720          549 A--LKSIKELDLSCNNLSG----QIPIHL-GNLPFLEYLNLSYNHFEGKVP  592 (973)
Q Consensus       549 ~--l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~p  592 (973)
                      .  +++|+.|+|++|+|++    .+|..+ .++++|++|++++|++++..+
T Consensus       270 ~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             TCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             hccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            3  7888889999998886    477777 568889999999998887664

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.87  E-value=2e-24  Score=245.06  Aligned_cols=215  Identities=20%  Similarity=0.252  Sum_probs=113.9

Q ss_pred             ccCCCcCCCCCCEEEccCCCCCCCC----CccccccCCCCEEeeecc---cCCCCCCccc-------ccCCCccceEecc
Q 039720           78 LSPYIGNLSFLRVINLANNSFHGQI----PKEVGRLFRLETIVLSNN---SFSGKIPTNL-------SRCFNLIDFWVHT  143 (973)
Q Consensus        78 ~~~~l~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~Ls~n---~l~~~~p~~~-------~~l~~L~~L~l~~  143 (973)
                      ++..+..+++|++|+|++|++++..    +..+..+++|++|+|++|   .+++.+|..+       ..+++|++|++++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            4445666777888888888777543    334667778888888775   4444555544       4556666666666


Q ss_pred             ccccc----chhhhhccccccceeeccCCcccccCCCCCC----CC---------CcccEEEccCCcCC-CCCC---Ccc
Q 039720          144 NNLVG----EIQAIIGNWLKIERLSLYGNQLTGQLPPSIG----NL---------SALQTFDIAGNKLD-GRIP---DSL  202 (973)
Q Consensus       144 n~~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p---~~~  202 (973)
                      |.+.+    .+|..+..+++|++|+|++|.++...+..+.    .+         ++|++|+|++|+++ +.+|   ..+
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  183 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  183 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence            66555    3555556666666666666665432222222    22         55666666666654 2233   244


Q ss_pred             cCCCccceeccCCCCcc--c---cCCccccCCCCCcEEEccCCccc----cCCCcccccCCCCCcEEEccCCccccc---
Q 039720          203 GQLRNLNYLGTSENDFS--G---MFPLSVCNISSLDEAYLFKNRFK----GSLPVCLGFNLPKLTVLVVAQNNLTGF---  270 (973)
Q Consensus       203 ~~L~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~ip~~~~~~l~~L~~L~Ls~N~l~~~---  270 (973)
                      ..+++|++|+|++|+++  |   ..|..+..+++|+.|+|++|+++    +.+|..+. .+++|++|+|++|.|++.   
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~-~~~~L~~L~L~~n~i~~~~~~  262 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK-SWPNLRELGLNDCLLSARGAA  262 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG-GCTTCCEEECTTCCCCHHHHH
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc-cCCCcCEEECCCCCCchhhHH
Confidence            45555666666666554  1   22334444455555555555543    23333332 344455555555544433   


Q ss_pred             -CCcccc--CCCCCCEEEccCCcccc
Q 039720          271 -LPQSLS--NASKLEWLELNENHFSG  293 (973)
Q Consensus       271 -~p~~~~--~l~~L~~L~Ls~N~l~~  293 (973)
                       ++..+.  .+++|++|+|++|.|++
T Consensus       263 ~l~~~l~~~~~~~L~~L~L~~n~i~~  288 (386)
T 2ca6_A          263 AVVDAFSKLENIGLQTLRLQYNEIEL  288 (386)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             HHHHHHhhccCCCeEEEECcCCcCCH
Confidence             233332  24445555555544443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=3.6e-22  Score=222.91  Aligned_cols=240  Identities=17%  Similarity=0.125  Sum_probs=199.7

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhh-hhccccccce-eecc
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQA-IIGNWLKIER-LSLY  166 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~-~~~~l~~L~~-L~L~  166 (973)
                      ++++.++++++ .||..+  .+++++|+|++|+|+..-+..|.++++|++|++++|++.+.+|. .|.+++++.+ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            56788999999 899877  47899999999999943345789999999999999999887764 6788988765 6777


Q ss_pred             CCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCC-CCccccCCccccCCC-CCcEEEccCCcccc
Q 039720          167 GNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSE-NDFSGMFPLSVCNIS-SLDEAYLFKNRFKG  244 (973)
Q Consensus       167 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~  244 (973)
                      +|+++...|..|.++++|++|++++|++++..+..+....++..|++++ |++....+..|..+. .++.|+|++|+|+ 
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-  167 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-  167 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence            8999988889999999999999999999977777788888899999965 678877777888775 6899999999998 


Q ss_pred             CCCcccccCCCCCcEEEccC-CcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCCh
Q 039720          245 SLPVCLGFNLPKLTVLVVAQ-NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDL  323 (973)
Q Consensus       245 ~ip~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  323 (973)
                      .+|..++ ...+|+.|++++ |.++.+.++.|.++++|++|||++|+|+.+.+..|.++++|+.+++  ++++.++.   
T Consensus       168 ~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~lP~---  241 (350)
T 4ay9_X          168 EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT---  241 (350)
T ss_dssp             EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCCCC---
T ss_pred             CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcCcCCC---
Confidence            7888887 678899999985 6777665668999999999999999999888888888888877765  34555442   


Q ss_pred             hhhhhhcccccceeeccccc
Q 039720          324 DFITLLTNCSKLVKLGLVFN  343 (973)
Q Consensus       324 ~~~~~l~~l~~L~~L~l~~N  343 (973)
                           +.++++|+.+++.++
T Consensus       242 -----l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          242 -----LEKLVALMEASLTYP  256 (350)
T ss_dssp             -----TTTCCSCCEEECSCH
T ss_pred             -----chhCcChhhCcCCCC
Confidence                 556788888888654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=1.1e-21  Score=208.00  Aligned_cols=157  Identities=24%  Similarity=0.290  Sum_probs=91.1

Q ss_pred             cceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC
Q 039720          160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK  239 (973)
Q Consensus       160 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  239 (973)
                      |+.|+|++|.+++..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus        37 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  116 (251)
T 3m19_A           37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGG  116 (251)
T ss_dssp             CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCC
Confidence            34444444444444444444444455555555555444444445555555555555555444444444555555555555


Q ss_pred             CccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      |+++ .+|...+.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++..
T Consensus       117 N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          117 NQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            5554 4444444456677777777777776666667777777777777777777777677777777777777777654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=5.5e-22  Score=217.05  Aligned_cols=193  Identities=23%  Similarity=0.333  Sum_probs=107.4

Q ss_pred             CCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcccccccee
Q 039720           84 NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERL  163 (973)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  163 (973)
                      .+++|++|++++|+++ .+| .+..+++|++|+|++|.+++ +|. +.                        .+++|++|
T Consensus        39 ~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~------------------------~l~~L~~L   90 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LK------------------------NLTKITEL   90 (308)
T ss_dssp             HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GT------------------------TCCSCCEE
T ss_pred             HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-Hc------------------------cCCCCCEE
Confidence            4556666666666665 344 45566666666666666553 222 44                        44555555


Q ss_pred             eccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccc
Q 039720          164 SLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       164 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                      +|++|.+++ ++ .+..+++|++|++++|++++ ++. +..+++|++|++++|.+++..+  +..+++|++|++++|+++
T Consensus        91 ~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~  164 (308)
T 1h6u_A           91 ELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS  164 (308)
T ss_dssp             ECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             EccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCC
Confidence            555555543 22 35555555555555555553 222 5555555555555555554332  555555555555555555


Q ss_pred             cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       244 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                       .++.  +..+++|+.|++++|.+++..+  +..+++|++|+|++|++++..+  +..+++|+.|+|++|+++.
T Consensus       165 -~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          165 -DLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             -CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             -CChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence             2333  2356666666666666664432  6666666666666666665442  5666666666666666644

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=7.5e-22  Score=216.01  Aligned_cols=192  Identities=22%  Similarity=0.344  Sum_probs=130.3

Q ss_pred             eEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEec
Q 039720           63 RVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVH  142 (973)
Q Consensus        63 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~  142 (973)
                      +++.|+++++.+.. ++ .+..+++|++|+|++|++++ ++. ++.+++|++|+|++|.+++ +| .+..+++|      
T Consensus        42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L------  109 (308)
T 1h6u_A           42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSI------  109 (308)
T ss_dssp             TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTC------
T ss_pred             CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCC------
Confidence            68899999999875 44 68999999999999999985 554 9999999999999999984 33 45555554      


Q ss_pred             ccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccC
Q 039720          143 TNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMF  222 (973)
Q Consensus       143 ~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~  222 (973)
                                        ++|+|++|++++ +|. +..+++|++|++++|++++..+  +..+++|++|++++|++++..
T Consensus       110 ------------------~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~  167 (308)
T 1h6u_A          110 ------------------KTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT  167 (308)
T ss_dssp             ------------------CEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG
T ss_pred             ------------------CEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCCh
Confidence                              555555555543 222 5555555555555555553222  555556666666666555433


Q ss_pred             CccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccC
Q 039720          223 PLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQV  295 (973)
Q Consensus       223 p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  295 (973)
                      +  +..+++|++|++++|+++ .++.  +..+++|++|+|++|.+++..  .+..+++|++|+|++|++++..
T Consensus       168 ~--l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~~  233 (308)
T 1h6u_A          168 P--LANLSKLTTLKADDNKIS-DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQP  233 (308)
T ss_dssp             G--GTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECCC
T ss_pred             h--hcCCCCCCEEECCCCccC-cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecCC
Confidence            2  555666666666666665 3333  236778888888888887654  3788888888888888887543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=5e-22  Score=213.71  Aligned_cols=138  Identities=19%  Similarity=0.206  Sum_probs=112.3

Q ss_pred             HHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc------------------hhHHHHHHHHHHHHhcCC
Q 039720          669 LSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK------------------GATKSFVAECEALRNIRH  730 (973)
Q Consensus       669 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h  730 (973)
                      +......|.+.+.||+|+||.||+|++ .+|+.||||+++....                  .....+.+|+.+++.++|
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            334455677779999999999999999 7999999999964321                  134568899999999984


Q ss_pred             CCceeEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 039720          731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNV  810 (973)
Q Consensus       731 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NI  810 (973)
                         +++.+++..      ...++||||++||+|.+ +..      .....++.|++.|++|||+.   +|+||||||+||
T Consensus       164 ---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI  224 (282)
T 1zar_A          164 ---LAVPKVYAW------EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  224 (282)
T ss_dssp             ---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             ---CCcCeEEec------cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence               444444322      45689999999999998 422      33567999999999999999   999999999999


Q ss_pred             EecCCCcEEEeccccch
Q 039720          811 LLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       811 Ll~~~~~~kl~Dfg~a~  827 (973)
                      |++ ++.+||+|||+|+
T Consensus       225 Ll~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             EEE-TTEEEECCCTTCE
T ss_pred             EEE-CCcEEEEECCCCe
Confidence            999 9999999999986

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=2e-21  Score=199.88  Aligned_cols=185  Identities=18%  Similarity=0.197  Sum_probs=127.8

Q ss_pred             CCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCc
Q 039720           49 LCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPT  128 (973)
Q Consensus        49 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~  128 (973)
                      .|.|.+|.|+...            +. .+|..+  .++|++|+|++|++++..+..|+++++|++|+|++|.+++..+.
T Consensus         6 ~C~~~~v~c~~~~------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~   70 (208)
T 2o6s_A            6 SCSGTTVECYSQG------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG   70 (208)
T ss_dssp             EEETTEEECCSSC------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred             EECCCEEEecCCC------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence            3789999997532            21 244333  45889999999999866666788899999999999988854343


Q ss_pred             ccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCcc
Q 039720          129 NLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNL  208 (973)
Q Consensus       129 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L  208 (973)
                      .|..+                        ++|++|+|++|++++..+..|+++++|++|++++|++++..+..|.++++|
T Consensus        71 ~~~~l------------------------~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  126 (208)
T 2o6s_A           71 VFNKL------------------------TSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQL  126 (208)
T ss_dssp             TTTTC------------------------TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             hcCCC------------------------CCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcC
Confidence            34444                        555666666666664444556666667777777777665555556667777


Q ss_pred             ceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCC
Q 039720          209 NYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASK  280 (973)
Q Consensus       209 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  280 (973)
                      ++|++++|++++..+..+..+++|+.|++++|.+.+        .+++|+.|+++.|.++|.+|..++.++.
T Consensus       127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          127 KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC--------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CEEECCCCccceeCHHHhccCCCccEEEecCCCeec--------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            777777777766555556667777777777776653        4567788888888888888887777665

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=9.4e-21  Score=194.78  Aligned_cols=181  Identities=18%  Similarity=0.231  Sum_probs=151.3

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCC
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN  168 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  168 (973)
                      +.++++++.++ .+|..+  .++|++|+|++|.+++..+.                        .+..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~------------------------~~~~l~~L~~L~l~~n   62 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNG------------------------VFDELTSLTQLYLGGN   62 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTT------------------------TTTTCTTCSEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChh------------------------hhcccccCcEEECCCC
Confidence            45677777777 566555  45788888888887743333                        3445677888888899


Q ss_pred             cccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCc
Q 039720          169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPV  248 (973)
Q Consensus       169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~  248 (973)
                      ++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|+++ .+|.
T Consensus        63 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~  141 (208)
T 2o6s_A           63 KLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPD  141 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCT
T ss_pred             ccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-eeCH
Confidence            888666677899999999999999999777778999999999999999999888888999999999999999999 5666


Q ss_pred             ccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCccc
Q 039720          249 CLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPN  304 (973)
Q Consensus       249 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  304 (973)
                      ..+..+++|++|++++|.+.+       .+++|++|+++.|+++|.+|..++.++.
T Consensus       142 ~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          142 GVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             HHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            666689999999999998774       4568999999999999999999888765

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=1.3e-20  Score=221.21  Aligned_cols=178  Identities=22%  Similarity=0.340  Sum_probs=144.8

Q ss_pred             CCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeecc
Q 039720           87 FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLY  166 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~  166 (973)
                      +|+.|+|++|++++ +|..+.  ++|++|+|++|.|+ .+|                           ..+++|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---------------------------~~l~~L~~L~Ls  108 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---------------------------ELPASLEYLDAC  108 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---------------------------CCCTTCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---------------------------cccCCCCEEEcc
Confidence            67777777777764 666553  66777777777776 455                           124688999999


Q ss_pred             CCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCC
Q 039720          167 GNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSL  246 (973)
Q Consensus       167 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i  246 (973)
                      +|+|++ +|. |.+  +|++|+|++|+|++ +|.   .+++|++|+|++|.|++ +|.   .+++|++|+|++|++++ +
T Consensus       109 ~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-l  175 (571)
T 3cvr_A          109 DNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-L  175 (571)
T ss_dssp             SSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred             CCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-c
Confidence            999996 777 766  99999999999996 776   68999999999999997 555   67899999999999995 8


Q ss_pred             CcccccCCCCCcEEEccCCcccccCCccccCCCCC-------CEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          247 PVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKL-------EWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       247 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      |. +.   ++|+.|+|++|.|+ .+|. |..  +|       ++|+|++|+|+. +|..+..+++|+.|+|++|+++.
T Consensus       176 p~-l~---~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~  244 (571)
T 3cvr_A          176 PE-LP---ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSS  244 (571)
T ss_dssp             CC-CC---TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCH
T ss_pred             ch-hh---CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCC
Confidence            88 43   89999999999999 5666 655  77       999999999996 56667779999999999999976

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=5.7e-22  Score=241.54  Aligned_cols=223  Identities=21%  Similarity=0.172  Sum_probs=120.5

Q ss_pred             cchhhHHHHHHHHhhccCCCcCCCCCCC-CCCCCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCE-----
Q 039720           17 ATSHVKHATVTFNMQQLHDPLGVTKSWN-NSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRV-----   90 (973)
Q Consensus        17 ~~~~~~~~ll~~~~~~~~d~~~~l~sw~-~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~-----   90 (973)
                      -+..+|++|+++..+...+....-..|. .++.++.|.+++++.  .+++.|+|.++++.+ ++..+.....|+.     
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~  205 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDE  205 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccC
Confidence            4566789999998776444444555774 444567899999975  579999999988876 3443333333333     


Q ss_pred             EEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcc
Q 039720           91 INLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQL  170 (973)
Q Consensus        91 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l  170 (973)
                      ++++.|.+. ..|..+..+++|++|+|++|.+. .+|..++.+++|++|+|++|.+. .+|..|+++++|++|+|++|.|
T Consensus       206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l  282 (727)
T 4b8c_D          206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL  282 (727)
T ss_dssp             -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred             cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence            333444454 56778889999999999999998 78888888888888888888887 7777788888888888888888


Q ss_pred             cccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCC-CcEEEccCCccccCCC
Q 039720          171 TGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISS-LDEAYLFKNRFKGSLP  247 (973)
Q Consensus       171 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~ip  247 (973)
                      + .+|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|++.+|..+..+.. +..++|++|.+++.+|
T Consensus       283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence            8 67888888888888888888886 67777888888888888888888777766644322 1235566666665554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.83  E-value=1.1e-22  Score=240.32  Aligned_cols=203  Identities=17%  Similarity=0.188  Sum_probs=122.1

Q ss_pred             cCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccce
Q 039720           83 GNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIER  162 (973)
Q Consensus        83 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~  162 (973)
                      ...++|+.|+|++|+++ .+|.++++|++|+.|++++|.....+|.           .+..++..+.+|..++.+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence            44556666666666665 5666666666666666655431000000           00111244555666666666666


Q ss_pred             ee-ccC-------------CcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccC
Q 039720          163 LS-LYG-------------NQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCN  228 (973)
Q Consensus       163 L~-L~~-------------n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~  228 (973)
                      |+ ++.             |.++...+      ..|+.|+|++|+|++ +|. |+++++|++|+|++|.|+ .+|..+++
T Consensus       414 L~~l~~n~~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~  484 (567)
T 1dce_A          414 VDPMRAAYLDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA  484 (567)
T ss_dssp             HCGGGHHHHHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred             CcchhhcccchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence            65 444             44442211      247777888887774 565 777777888888777777 56777777


Q ss_pred             CCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccC-CccccCCCCCCEEEccCCcccccCccc---ccCccc
Q 039720          229 ISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL-PQSLSNASKLEWLELNENHFSGQVRIN---FNSLPN  304 (973)
Q Consensus       229 l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~  304 (973)
                      +++|+.|+|++|++++ +| .+. ++++|++|+|++|.|++.. |..|.++++|++|+|++|++++.++..   +..+++
T Consensus       485 l~~L~~L~Ls~N~l~~-lp-~l~-~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~  561 (567)
T 1dce_A          485 LRCLEVLQASDNALEN-VD-GVA-NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS  561 (567)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGT-TCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTT
T ss_pred             CCCCCEEECCCCCCCC-Cc-ccC-CCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcc
Confidence            7777777777777773 66 333 6777777777777777665 777777777777777777777654422   233555


Q ss_pred             cccee
Q 039720          305 LSKLY  309 (973)
Q Consensus       305 L~~L~  309 (973)
                      |+.|+
T Consensus       562 L~~L~  566 (567)
T 1dce_A          562 VSSIL  566 (567)
T ss_dssp             CSEEE
T ss_pred             cCccC
Confidence            55554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=5.3e-20  Score=191.98  Aligned_cols=162  Identities=23%  Similarity=0.274  Sum_probs=105.2

Q ss_pred             CCCCCCCCCceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeeccc
Q 039720           42 SWNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS  121 (973)
Q Consensus        42 sw~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~  121 (973)
                      -|..+++.|+|.+|.|+..            ++ +.+|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus        11 ~~~~~~~~Cs~~~v~c~~~------------~l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~   75 (229)
T 3e6j_A           11 AACPSQCSCSGTTVDCRSK------------RH-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ   75 (229)
T ss_dssp             CCCCTTCEEETTEEECTTS------------CC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCCCEEeCCEeEccCC------------Cc-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence            3444678899999999753            22 24565443  889999999999998888889999999999999999


Q ss_pred             CCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCc
Q 039720          122 FSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDS  201 (973)
Q Consensus       122 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  201 (973)
                      +++..+..|..+++                        |++|+|++|++++..+..|..+++|++|+|++|+|+ .+|..
T Consensus        76 l~~i~~~~~~~l~~------------------------L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~  130 (229)
T 3e6j_A           76 LGALPVGVFDSLTQ------------------------LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG  130 (229)
T ss_dssp             CCCCCTTTTTTCTT------------------------CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTT
T ss_pred             CCCcChhhcccCCC------------------------cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcc
Confidence            97433344555554                        455555555555444444555555555555555555 45555


Q ss_pred             ccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccc
Q 039720          202 LGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       202 ~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                      +.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       131 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             GGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             cccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            555555555555555555544455555555555666555555

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.79  E-value=2e-19  Score=194.93  Aligned_cols=172  Identities=20%  Similarity=0.313  Sum_probs=87.3

Q ss_pred             cccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccE
Q 039720          107 GRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQT  186 (973)
Q Consensus       107 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  186 (973)
                      ..+++|++|++++|.+. .+| .+..+++|++|++++|++.+..+  +.++++|++|+|++|.+++ +| .++.+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence            34455555555555544 222 24444444444444444433322  4455555555555555553 22 2555666666


Q ss_pred             EEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCc
Q 039720          187 FDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNN  266 (973)
Q Consensus       187 L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~  266 (973)
                      |++++|++++ + ..+..+++|++|++++|++++.  ..+..+++|++|++++|++++ ++.  +..+++|+.|+|++|.
T Consensus       117 L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~-~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          117 LSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             EECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG--GTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc-chh--hcCCCccCEEECCCCc
Confidence            6666666653 2 3455566666666666666543  344555555555555555542 222  2245555555555555


Q ss_pred             ccccCCccccCCCCCCEEEccCCcccc
Q 039720          267 LTGFLPQSLSNASKLEWLELNENHFSG  293 (973)
Q Consensus       267 l~~~~p~~~~~l~~L~~L~Ls~N~l~~  293 (973)
                      |++. + .+..+++|++|+|++|+++.
T Consensus       190 i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          190 ISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCCC-h-hhccCCCCCEEECcCCcccC
Confidence            5542 2 25556666666666665554

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=1.9e-19  Score=213.65  Aligned_cols=206  Identities=19%  Similarity=0.272  Sum_probs=146.1

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeec
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSL  165 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L  165 (973)
                      ..+..++|+.+.++..++  +..|++|++|+|++|.+. .+| .+..+++|+.|++++|.+.+..+  +..+++|+.|+|
T Consensus        21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L   94 (605)
T 1m9s_A           21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL   94 (605)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred             HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence            344555666666654333  456777777777777776 344 46667777777777777666554  777788888888


Q ss_pred             cCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccC
Q 039720          166 YGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGS  245 (973)
Q Consensus       166 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  245 (973)
                      ++|.+++ +| .|..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++.  ..++.+++|+.|+|++|++.+.
T Consensus        95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~  168 (605)
T 1m9s_A           95 DENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI  168 (605)
T ss_dssp             CSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred             cCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence            8888874 33 68888888888888888874 3 4588888888888888888865  5677888888888888888754


Q ss_pred             CCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccce
Q 039720          246 LPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKL  308 (973)
Q Consensus       246 ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  308 (973)
                      .|   +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++++.....+..+..+..|
T Consensus       169 ~~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~l  226 (605)
T 1m9s_A          169 VP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV  226 (605)
T ss_dssp             GG---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEECCC
T ss_pred             hh---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEEecccc
Confidence            44   34778888888888888764  357888888888888888876555545444444433

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=5.4e-19  Score=183.02  Aligned_cols=153  Identities=20%  Similarity=0.331  Sum_probs=137.9

Q ss_pred             ceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCC
Q 039720          161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN  240 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  240 (973)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|.+|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            57888888888 6777665  68999999999999777778999999999999999999888999999999999999999


Q ss_pred             ccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          241 RFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       241 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      +++ .+|...+.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+..
T Consensus        91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            998 7888877789999999999999999889999999999999999999999988899999999999999998854

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=4.3e-19  Score=198.79  Aligned_cols=176  Identities=21%  Similarity=0.293  Sum_probs=98.7

Q ss_pred             CEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCC-CCCcccEEEccC
Q 039720          113 ETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIG-NLSALQTFDIAG  191 (973)
Q Consensus       113 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~  191 (973)
                      +++++++|.++ .+|..+..                          .++.|+|++|++++..+..|. ++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~~--------------------------~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~   73 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLPS--------------------------YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSH   73 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCCT--------------------------TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCCC--------------------------CCCEEECCCCCCCccChhhhhhcccccCEEECCC
Confidence            56777777776 46654432                          244555555555544444444 555555555555


Q ss_pred             CcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccC
Q 039720          192 NKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL  271 (973)
Q Consensus       192 N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~  271 (973)
                      |+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++ ++...+.++++|+.|+|++|.|++..
T Consensus        74 N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~l~  152 (361)
T 2xot_A           74 NHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFP  152 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred             CcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccE-ECHHHhCCcccCCEEECCCCcCCeeC
Confidence            55554444555555555555555555555444455555555555555555542 22222235556666666666665443


Q ss_pred             Cccc---cCCCCCCEEEccCCcccccCcccccCccc--ccceecccccCC
Q 039720          272 PQSL---SNASKLEWLELNENHFSGQVRINFNSLPN--LSKLYLGRNNLG  316 (973)
Q Consensus       272 p~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~  316 (973)
                      +..|   ..+++|++|+|++|+|+.+.+..|..+++  |+.|+|++|.+.
T Consensus       153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            3334   45677777777777777666666666666  367777777764

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=1.1e-19  Score=188.14  Aligned_cols=110  Identities=19%  Similarity=0.212  Sum_probs=78.9

Q ss_pred             eeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCc
Q 039720          483 LLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNN  562 (973)
Q Consensus       483 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  562 (973)
                      .|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus        61 ~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  140 (220)
T 2v70_A           61 KINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ  140 (220)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSC
T ss_pred             EEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCc
Confidence            44444444444445566677777777777777776666677777777777777777777667777777777777777777


Q ss_pred             cccccCCCCCCCCccceEeccCCcCcCcCC
Q 039720          563 LSGQIPIHLGNLPFLEYLNLSYNHFEGKVP  592 (973)
Q Consensus       563 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  592 (973)
                      |++..|..|..+++|+.|+|++|++.+..+
T Consensus       141 l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          141 ITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            777667777777777777777777776554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=3.4e-19  Score=193.06  Aligned_cols=174  Identities=21%  Similarity=0.310  Sum_probs=147.0

Q ss_pred             CcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccc
Q 039720           82 IGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIE  161 (973)
Q Consensus        82 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~  161 (973)
                      +..+++|++|++++|.++ .+| .++.+++|++|+|++|.+++ ++. +..+++|++|++++|.+.+ ++ .+..+++|+
T Consensus        42 ~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~  115 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK  115 (291)
T ss_dssp             HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred             hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence            456788899999999887 445 48888999999999999885 444 8889999999999998876 33 488999999


Q ss_pred             eeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCc
Q 039720          162 RLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR  241 (973)
Q Consensus       162 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  241 (973)
                      +|+|++|++++.  +.+..+++|++|++++|++++.  ..+..+++|++|++++|++++..|  +..+++|++|++++|+
T Consensus       116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence            999999999853  5688999999999999999854  679999999999999999997665  8899999999999999


Q ss_pred             cccCCCcccccCCCCCcEEEccCCccccc
Q 039720          242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGF  270 (973)
Q Consensus       242 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~  270 (973)
                      ++ .+|.  +..+++|+.|++++|.++..
T Consensus       190 i~-~l~~--l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          190 IS-DLRA--LAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             CC-BCGG--GTTCTTCSEEEEEEEEEECC
T ss_pred             CC-CChh--hccCCCCCEEECcCCcccCC
Confidence            98 5664  34899999999999999853

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=4.6e-19  Score=210.46  Aligned_cols=78  Identities=15%  Similarity=0.254  Sum_probs=36.7

Q ss_pred             ccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEcc
Q 039720          159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLF  238 (973)
Q Consensus       159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  238 (973)
                      ++..+.++.+.++...+  +..|.+|+.|++++|.+. .+| .|..+++|+.|+|++|+|++..|  +..+++|+.|+|+
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            34444555555443222  344555555555555554 233 35555555555555555554332  3334444444444


Q ss_pred             CCcc
Q 039720          239 KNRF  242 (973)
Q Consensus       239 ~N~l  242 (973)
                      +|++
T Consensus        96 ~N~l   99 (605)
T 1m9s_A           96 ENKI   99 (605)
T ss_dssp             SSCC
T ss_pred             CCCC
Confidence            4433

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=1.7e-18  Score=179.32  Aligned_cols=145  Identities=23%  Similarity=0.288  Sum_probs=85.8

Q ss_pred             cCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchh
Q 039720           72 QNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQ  151 (973)
Q Consensus        72 ~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~  151 (973)
                      ++++ .+|..+.  +.|+.|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++                  
T Consensus        21 ~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l------------------   79 (220)
T 2v9t_B           21 KGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL------------------   79 (220)
T ss_dssp             SCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTC------------------
T ss_pred             CCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCC------------------
Confidence            3443 3555443  578888888888876556677788888888888887775555555554                  


Q ss_pred             hhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCC
Q 039720          152 AIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISS  231 (973)
Q Consensus       152 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~  231 (973)
                            ++|++|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++
T Consensus        80 ------~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  153 (220)
T 2v9t_B           80 ------RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA  153 (220)
T ss_dssp             ------SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             ------cCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCC
Confidence                  44455555555555333334455555555555555555555555555555555555555555544444554555


Q ss_pred             CcEEEccCCccc
Q 039720          232 LDEAYLFKNRFK  243 (973)
Q Consensus       232 L~~L~L~~N~l~  243 (973)
                      |+.|+|++|.+.
T Consensus       154 L~~L~L~~N~~~  165 (220)
T 2v9t_B          154 IQTMHLAQNPFI  165 (220)
T ss_dssp             CCEEECCSSCEE
T ss_pred             CCEEEeCCCCcC
Confidence            555555554443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.77  E-value=2.1e-18  Score=178.61  Aligned_cols=153  Identities=20%  Similarity=0.227  Sum_probs=132.9

Q ss_pred             ceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCC-CcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC
Q 039720          161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK  239 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  239 (973)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..+.+|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            57889999888 5787765  356899999999987654 5688999999999999999988888999999999999999


Q ss_pred             CccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      |+++ .+|...+.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+..
T Consensus        91 N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SCCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            9998 5555555689999999999999998889999999999999999999999989999999999999999998864

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.76  E-value=9.4e-19  Score=196.01  Aligned_cols=115  Identities=23%  Similarity=0.243  Sum_probs=60.4

Q ss_pred             CCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccc---cCC
Q 039720          178 IGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLG---FNL  254 (973)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~---~~l  254 (973)
                      |.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|..++   ..+
T Consensus        84 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l  162 (361)
T 2xot_A           84 FVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL  162 (361)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----C
T ss_pred             ccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccC
Confidence            333333334444444433333333444444444444444444333444444444444444444444 3444443   257


Q ss_pred             CCCcEEEccCCcccccCCccccCCCC--CCEEEccCCcccc
Q 039720          255 PKLTVLVVAQNNLTGFLPQSLSNASK--LEWLELNENHFSG  293 (973)
Q Consensus       255 ~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~  293 (973)
                      ++|+.|+|++|.|+...+..|..++.  |+.|+|++|.+..
T Consensus       163 ~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             TTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             CcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence            77778888888887665567777776  4788899888874

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1e-20  Score=223.28  Aligned_cols=195  Identities=20%  Similarity=0.203  Sum_probs=134.0

Q ss_pred             cccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccE
Q 039720          107 GRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQT  186 (973)
Q Consensus       107 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  186 (973)
                      ..+++|+.|+|++|.++ .+|.++++|++|++|++++|.....+|..+.           .+.+.+.+|..++++++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~-----------~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR-----------ALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHH-----------HHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHH-----------hcccccCCHHHHHHHHhccc
Confidence            56777777788777776 6677777777777777655443322232111           11244567888888899998


Q ss_pred             EE-ccCCcCCCCCCC------cccC--CCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCC
Q 039720          187 FD-IAGNKLDGRIPD------SLGQ--LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKL  257 (973)
Q Consensus       187 L~-L~~N~l~~~~p~------~~~~--L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L  257 (973)
                      |+ ++.|.+. .++.      .+..  ...|++|+|++|.|++ +|. ++++++|+.|+|++|+++ .+|..+. ++++|
T Consensus       414 L~~l~~n~~~-~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L  488 (567)
T 1dce_A          414 VDPMRAAYLD-DLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA-ALRCL  488 (567)
T ss_dssp             HCGGGHHHHH-HHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG-GCTTC
T ss_pred             Ccchhhcccc-hhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh-cCCCC
Confidence            88 6666432 1111      0111  1247788888888875 454 778888888888888887 7777665 78888


Q ss_pred             cEEEccCCcccccCCccccCCCCCCEEEccCCcccccC-cccccCcccccceecccccCCCCCC
Q 039720          258 TVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQV-RINFNSLPNLSKLYLGRNNLGTRTS  320 (973)
Q Consensus       258 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~  320 (973)
                      +.|+|++|.|++ +| .|+++++|++|+|++|+|++.. |..|..+++|+.|+|++|+++..+.
T Consensus       489 ~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          489 EVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            888888888886 45 7888888888888888888776 7778888888888888888776654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.76  E-value=5.5e-18  Score=176.62  Aligned_cols=154  Identities=19%  Similarity=0.203  Sum_probs=129.4

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCC
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN  168 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  168 (973)
                      +.++.++++++ .+|..+.  ++|++|+|++|.+++..|..|                        ..+++|++|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~------------------------~~l~~L~~L~L~~N   74 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVF------------------------DSLINLKELYLGSN   74 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTT------------------------TTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHh------------------------hCccCCcEEECCCC
Confidence            45777788876 6776654  778888888888876555544                        44567888888888


Q ss_pred             cccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCc
Q 039720          169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPV  248 (973)
Q Consensus       169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~  248 (973)
                      ++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+++ .+|.
T Consensus        75 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~~~~  152 (229)
T 3e6j_A           75 QLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPH  152 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC-CCCT
T ss_pred             CCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC-ccCH
Confidence            887666677899999999999999999877788999999999999999999 67889999999999999999999 6776


Q ss_pred             ccccCCCCCcEEEccCCcccccC
Q 039720          249 CLGFNLPKLTVLVVAQNNLTGFL  271 (973)
Q Consensus       249 ~~~~~l~~L~~L~Ls~N~l~~~~  271 (973)
                      ..+..+++|+.|+|++|.+....
T Consensus       153 ~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          153 GAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             TTTTTCTTCCEEECTTSCBCTTB
T ss_pred             HHHhCCCCCCEEEeeCCCccCCc
Confidence            66668999999999999998543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.74  E-value=8.8e-19  Score=213.46  Aligned_cols=182  Identities=24%  Similarity=0.294  Sum_probs=95.8

Q ss_pred             CCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccccccccc
Q 039720          373 TIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGK  452 (973)
Q Consensus       373 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  452 (973)
                      ..+..+..+++|+.|+|++|++. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|+.
T Consensus       215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  291 (727)
T 4b8c_D          215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS  291 (727)
T ss_dssp             -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred             cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence            45666777777777777777777 56666667777777777777777 66777777777777777777777 56666666


Q ss_pred             ccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccc-hhh
Q 039720          453 CQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTT-LEY  531 (973)
Q Consensus       453 l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~-L~~  531 (973)
                      +++|+.|+|++|.|.                          .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..
T Consensus       292 l~~L~~L~L~~N~l~--------------------------~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~  345 (727)
T 4b8c_D          292 CFQLKYFYFFDNMVT--------------------------TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLI  345 (727)
T ss_dssp             GTTCSEEECCSSCCC--------------------------CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHH
T ss_pred             CCCCCEEECCCCCCC--------------------------ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhH
Confidence            666665555555554                          34555666677777777777777776766655432 234


Q ss_pred             hcccCcccccccccchhhhccCCeecCCCC--------ccccccCCCCCCCCccceEeccCCcCcC
Q 039720          532 LLMQGNSFNGSIPQSLNALKSIKELDLSCN--------NLSGQIPIHLGNLPFLEYLNLSYNHFEG  589 (973)
Q Consensus       532 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~ls~N~l~~  589 (973)
                      |+|++|.+++.+|..      |+.|++++|        .|.+..+..+.++..++...+++|-+.+
T Consensus       346 l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          346 FYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             HHHHHCCCCCCCCCC-----------------------------------------------CCCG
T ss_pred             HhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence            677777777766653      344555555        3333444445555566666666666653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.74  E-value=3.1e-18  Score=181.93  Aligned_cols=138  Identities=18%  Similarity=0.162  Sum_probs=109.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcE--EEEEEeecccch------------------------hHHHHHHHHHHHHhc
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMS--VAVKVMNLDKKG------------------------ATKSFVAECEALRNI  728 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  728 (973)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999999778999  999998643211                        123688999999999


Q ss_pred             CCCCc--eeEEeEeeecccCCCceEEEEEeeccC-C----CHHHHhhhcCCCchhhHHHHHHHHHHHHHHHH-hcCCCCe
Q 039720          729 RHRNL--IKIITICSSIDFKGADFKAIVYEYMQY-G----SVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH-NHCQPPI  800 (973)
Q Consensus       729 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~~i  800 (973)
                      .|+++  ..++++         ...++||||+.+ |    +|.++...   ..+..+..++.|++.|+.||| +.   +|
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---gi  192 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---EL  192 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CE
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CE
Confidence            88764  334432         356899999942 3    77776543   234567899999999999999 88   99


Q ss_pred             EecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          801 VHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       801 vHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      +||||||+|||++.  .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999999998  9999999999754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=2.3e-18  Score=183.52  Aligned_cols=171  Identities=22%  Similarity=0.292  Sum_probs=99.1

Q ss_pred             CCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcccccccee
Q 039720           84 NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERL  163 (973)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  163 (973)
                      .+..+..+++++|.++ .++ .+.++++|++|++++|.++ .+| .+..+++|++|++++|++.+..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4666777788888887 344 5778888888888888877 455 56666666666666665554433  5555666666


Q ss_pred             eccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccc
Q 039720          164 SLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       164 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                      +|++|++++ +|... . ++|++|+|++|++++ ++ .+.++++|++|+|++|++++. + .+..               
T Consensus        91 ~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~---------------  148 (263)
T 1xeu_A           91 SVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGF---------------  148 (263)
T ss_dssp             ECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGG---------------
T ss_pred             ECCCCccCC-cCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHcc---------------
Confidence            666666653 33222 2 556666666666553 22 355555555555555555532 1 3444               


Q ss_pred             cCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCccccc
Q 039720          244 GSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQ  294 (973)
Q Consensus       244 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  294 (973)
                                +++|++|+|++|.|++.  ..+..+++|++|+|++|.++..
T Consensus       149 ----------l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          149 ----------LSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             ----------CTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             ----------CCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence                      45555555555555543  4455555555555555555543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=8e-18  Score=171.11  Aligned_cols=153  Identities=17%  Similarity=0.229  Sum_probs=106.1

Q ss_pred             ccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcE
Q 039720          155 GNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDE  234 (973)
Q Consensus       155 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  234 (973)
                      ..+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..++.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            45567777777777777 455 5777777888888877664  3346777777888888887777766777777777777


Q ss_pred             EEccCCccccCCCcccccCCCCCcEEEccCCc-ccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccc
Q 039720          235 AYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNN-LTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN  313 (973)
Q Consensus       235 L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  313 (973)
                      |++++|++++..|..+. .+++|++|++++|. ++ .+| .+..+++|++|++++|++++..  .+..+++|++|++++|
T Consensus       117 L~Ls~n~i~~~~~~~l~-~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          117 LDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             EECCSSBCBGGGHHHHT-TCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC
T ss_pred             EEecCCccCcHhHHHHh-hCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCc
Confidence            77777777755555554 67777777777776 55 334 5777777777777777777543  5677777777777777


Q ss_pred             cCC
Q 039720          314 NLG  316 (973)
Q Consensus       314 ~l~  316 (973)
                      ++.
T Consensus       192 ~i~  194 (197)
T 4ezg_A          192 TIG  194 (197)
T ss_dssp             ---
T ss_pred             ccC
Confidence            664

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=2.2e-18  Score=190.47  Aligned_cols=293  Identities=14%  Similarity=0.092  Sum_probs=159.2

Q ss_pred             cccccCCCcC--CCCCCEEEccCCCCCCCCCccccc-cCCCCEEeeecccCC--CCCCcccccCCCccceEecccccccc
Q 039720           75 GGFLSPYIGN--LSFLRVINLANNSFHGQIPKEVGR-LFRLETIVLSNNSFS--GKIPTNLSRCFNLIDFWVHTNNLVGE  149 (973)
Q Consensus        75 ~g~~~~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~Ls~n~l~--~~~p~~~~~l~~L~~L~l~~n~~~~~  149 (973)
                      .|.++..+..  +..++.|.++++ +.+.--..+.. +++|++||||+|++.  ...+..+   +.+..+.+..|.   .
T Consensus        12 ~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I   84 (329)
T 3sb4_A           12 PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---V   84 (329)
T ss_dssp             TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---E
T ss_pred             CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccc---c
Confidence            3445555553  778899998864 22111123444 788999999999987  2222222   223333443332   2


Q ss_pred             hhhhhcc--------ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCc---
Q 039720          150 IQAIIGN--------WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF---  218 (973)
Q Consensus       150 ~~~~~~~--------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l---  218 (973)
                      .+..|.+        +++|+.|+|.+ .++..-+..|.+|++|+.|++++|.+....+.+|.+..++..+.+..+..   
T Consensus        85 ~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~  163 (329)
T 3sb4_A           85 PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRF  163 (329)
T ss_dssp             CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHT
T ss_pred             CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhc
Confidence            2344555        77777777777 66655566677777777777777777656666777777776666655321   


Q ss_pred             -cccCCccccCCCCCc-EEEccCCccccCCCccccc---CCCCCcEEEccCCcccccCCccc-cCCCCCCEEEccCCccc
Q 039720          219 -SGMFPLSVCNISSLD-EAYLFKNRFKGSLPVCLGF---NLPKLTVLVVAQNNLTGFLPQSL-SNASKLEWLELNENHFS  292 (973)
Q Consensus       219 -~~~~p~~~~~l~~L~-~L~L~~N~l~~~ip~~~~~---~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~  292 (973)
                       ......+|.++.+|+ .+.+...   +.++..++.   ...+++.+.+.++-.. .....+ ..+++|++|+|++|+++
T Consensus       164 ~~~i~~~~f~~~~~L~~~i~~~~~---~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~  239 (329)
T 3sb4_A          164 KNRWEHFAFIEGEPLETTIQVGAM---GKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNAT  239 (329)
T ss_dssp             STTTTTSCEEESCCCEEEEEECTT---CCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCC
T ss_pred             cccccccccccccccceeEEecCC---CcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcc
Confidence             222334455555555 3333221   122222221   2344555555444221 111111 12566666666666666


Q ss_pred             ccCcccccCcccccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCcccc
Q 039720          293 GQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG  372 (973)
Q Consensus       293 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~  372 (973)
                      .+...+|.++++|+.|+|.+| ++.                                                       
T Consensus       240 ~I~~~aF~~~~~L~~l~l~~n-i~~-------------------------------------------------------  263 (329)
T 3sb4_A          240 TIPDFTFAQKKYLLKIKLPHN-LKT-------------------------------------------------------  263 (329)
T ss_dssp             EECTTTTTTCTTCCEEECCTT-CCE-------------------------------------------------------
T ss_pred             eecHhhhhCCCCCCEEECCcc-cce-------------------------------------------------------
Confidence            666666666666666666554 332                                                       


Q ss_pred             CCCccccCCCCcC-EEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEE
Q 039720          373 TIPPEIRNLFNLN-GLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQ  436 (973)
Q Consensus       373 ~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  436 (973)
                      +.+..|.++.+|+ .+++.+ +++.+.+.+|.++++|+.|++++|+++.+.+..|.++++|+.++
T Consensus       264 I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          264 IGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             ehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            2233455555555 555555 45545555566666666666655655555555555555555554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.72  E-value=6.2e-18  Score=171.91  Aligned_cols=153  Identities=18%  Similarity=0.274  Sum_probs=83.3

Q ss_pred             cCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccce
Q 039720           83 GNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIER  162 (973)
Q Consensus        83 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~  162 (973)
                      +.+++|++|++++|+++ .+| .+..+++|++|++++|.++  .+.                        .+..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~------------------------~l~~l~~L~~   92 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYN------------------------PISGLSNLER   92 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCG------------------------GGTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cch------------------------hhhcCCCCCE
Confidence            34455556666666555 444 4555556666666555443  122                        3344455555


Q ss_pred             eeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCC-ccccCCccccCCCCCcEEEccCCc
Q 039720          163 LSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEND-FSGMFPLSVCNISSLDEAYLFKNR  241 (973)
Q Consensus       163 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~  241 (973)
                      |++++|++++..|..|+.+++|++|++++|++++..|..++++++|++|++++|. ++ .+| .+..+++|++|++++|+
T Consensus        93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A           93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred             EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence            5555555555555555556666666666666655455555566666666666665 33 233 45556666666666666


Q ss_pred             cccCCCcccccCCCCCcEEEccCCccc
Q 039720          242 FKGSLPVCLGFNLPKLTVLVVAQNNLT  268 (973)
Q Consensus       242 l~~~ip~~~~~~l~~L~~L~Ls~N~l~  268 (973)
                      ++ .++ .+ ..+++|++|++++|+|.
T Consensus       171 i~-~~~-~l-~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          171 VH-DYR-GI-EDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CC-CCT-TG-GGCSSCCEEEECBC---
T ss_pred             Cc-ChH-Hh-ccCCCCCEEEeeCcccC
Confidence            65 333 22 25667777777777665

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=7.3e-18  Score=179.57  Aligned_cols=150  Identities=18%  Similarity=0.264  Sum_probs=86.9

Q ss_pred             hccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCc
Q 039720          154 IGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLD  233 (973)
Q Consensus       154 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  233 (973)
                      +..+++|++|++++|.++ .+| .++.+++|++|+|++|++++..+  +.++++|++|+|++|++++..+  +.. ++|+
T Consensus        37 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~--~~~-~~L~  109 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG--IPS-ACLS  109 (263)
T ss_dssp             HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT--CCC-SSCC
T ss_pred             hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc--ccc-Cccc
Confidence            344555566666666655 334 45566666666666666653322  6666666666666666654222  111 5566


Q ss_pred             EEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccc
Q 039720          234 EAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRN  313 (973)
Q Consensus       234 ~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  313 (973)
                      +|+|++|+++ .+|.  +..+++|++|+|++|+|++. + .+..+++|++|+|++|+|++.  ..+..+++|+.|++++|
T Consensus       110 ~L~L~~N~l~-~~~~--l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N  182 (263)
T 1xeu_A          110 RLFLDNNELR-DTDS--LIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQ  182 (263)
T ss_dssp             EEECCSSCCS-BSGG--GTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEE
T ss_pred             EEEccCCccC-CChh--hcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCC
Confidence            6666666665 2332  22566666666666666643 2 566666666666666666655  45666666666666666


Q ss_pred             cCCC
Q 039720          314 NLGT  317 (973)
Q Consensus       314 ~l~~  317 (973)
                      ++..
T Consensus       183 ~~~~  186 (263)
T 1xeu_A          183 KCVN  186 (263)
T ss_dssp             EEEC
T ss_pred             cccC
Confidence            6554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=5.4e-18  Score=171.43  Aligned_cols=156  Identities=23%  Similarity=0.284  Sum_probs=116.3

Q ss_pred             cccccCcccccCCCccccccccccceeeccCCcccccCCc-ccccccccceeccccCcccccccccccCccchhhhcccC
Q 039720          458 QLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPL-EVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQG  536 (973)
Q Consensus       458 ~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~  536 (973)
                      .+++++|.+. .+|..++.   .++.|++++|++++..+. .|+.+++|+.|+|++|++++..|..|.++++|++|+|++
T Consensus        12 ~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           12 TVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            4444444443 44544332   224677777777755554 478889999999999999988888999999999999999


Q ss_pred             cccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCCCCCccccccccCccccCCCC
Q 039720          537 NSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       537 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~~  616 (973)
                      |+|++..|..|..+++|++|+|++|+|++..|..+..+++|++|+|++|++++..+.......++...+.++...|+.|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~  167 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence            99998888888899999999999999998889999999999999999999988766432112233334556666777665


Q ss_pred             C
Q 039720          617 E  617 (973)
Q Consensus       617 ~  617 (973)
                      .
T Consensus       168 ~  168 (192)
T 1w8a_A          168 K  168 (192)
T ss_dssp             T
T ss_pred             H
Confidence            4

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.69  E-value=5.6e-18  Score=187.26  Aligned_cols=289  Identities=16%  Similarity=0.169  Sum_probs=146.3

Q ss_pred             cchhhhhcc--ccccceeeccCCcccccCCCCCCC-CCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCc
Q 039720          148 GEIQAIIGN--WLKIERLSLYGNQLTGQLPPSIGN-LSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPL  224 (973)
Q Consensus       148 ~~~~~~~~~--l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~  224 (973)
                      |.++..+..  +.++++|.++++- ...--..+.. +++|++|||++|++. .....-+.++.++.+.+..|.|   .+.
T Consensus        13 g~l~~~l~~~~~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~I---~~~   87 (329)
T 3sb4_A           13 GTLISMMTEEEANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANFV---PAY   87 (329)
T ss_dssp             TCGGGGSCHHHHHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTEE---CTT
T ss_pred             CcHHhhccchhhCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeE-EecCcccccccccccccccccc---CHH
Confidence            344444443  6778888888652 1111112223 677888888888887 1111112233345555555532   234


Q ss_pred             cccC--------CCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCc----cc
Q 039720          225 SVCN--------ISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENH----FS  292 (973)
Q Consensus       225 ~~~~--------l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~----l~  292 (973)
                      +|.+        +++|++++|.. .++ .|+...|.++++|+.|++++|.++.+.+.+|.++.++.++.++.+.    ..
T Consensus        88 aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~  165 (329)
T 3sb4_A           88 AFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKN  165 (329)
T ss_dssp             TTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTST
T ss_pred             HhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccc
Confidence            5555        66666666666 555 5666666666666666666666665666666666666555555432    12


Q ss_pred             ccCcccccCccccc-ceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccc
Q 039720          293 GQVRINFNSLPNLS-KLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS  371 (973)
Q Consensus       293 ~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~  371 (973)
                      .....+|.++.+|+ .+.+....  .++.   .....-....++..+.+.++-.. .-...+.                 
T Consensus       166 ~i~~~~f~~~~~L~~~i~~~~~~--~l~~---~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~-----------------  222 (329)
T 3sb4_A          166 RWEHFAFIEGEPLETTIQVGAMG--KLED---EIMKAGLQPRDINFLTIEGKLDN-ADFKLIR-----------------  222 (329)
T ss_dssp             TTTTSCEEESCCCEEEEEECTTC--CHHH---HHHHTTCCGGGCSEEEEEECCCH-HHHHHHH-----------------
T ss_pred             cccccccccccccceeEEecCCC--cHHH---HHhhcccCccccceEEEeeeecH-HHHHHHH-----------------
Confidence            22333444444444 23222111  0000   00000001122222222221000 0000000                 


Q ss_pred             cCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccc-eEEcCCCcccccccccc
Q 039720          372 GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLN-VLQLGFNKLQGSIPSYL  450 (973)
Q Consensus       372 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~  450 (973)
                             ..+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| ++.+.+..|.++++|+ .+++.+ .++...+.+|
T Consensus       223 -------~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF  293 (329)
T 3sb4_A          223 -------DYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAF  293 (329)
T ss_dssp             -------HHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTT
T ss_pred             -------HhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhh
Confidence                   12456666666666666555556666666666666665 5555555666666666 666666 5554445666


Q ss_pred             ccccccccccccCcccccCCCccccc
Q 039720          451 GKCQNLMQLSAPNNKLNGTLPPQIFG  476 (973)
Q Consensus       451 ~~l~~L~~L~l~~N~l~~~~p~~~~~  476 (973)
                      ..+++|+.+++++|.+. .++...|.
T Consensus       294 ~~c~~L~~l~l~~n~i~-~I~~~aF~  318 (329)
T 3sb4_A          294 MGCDNLRYVLATGDKIT-TLGDELFG  318 (329)
T ss_dssp             TTCTTEEEEEECSSCCC-EECTTTTC
T ss_pred             hCCccCCEEEeCCCccC-ccchhhhc
Confidence            66666666666666666 45544443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.66  E-value=2.8e-16  Score=158.83  Aligned_cols=125  Identities=22%  Similarity=0.283  Sum_probs=62.8

Q ss_pred             EeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCc-cccccCCCCEEeeecccCCCCCCcccccCCCccceEeccccc
Q 039720           68 DLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPK-EVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNL  146 (973)
Q Consensus        68 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~  146 (973)
                      +++++++ +.+|..+..  +|++|+|++|++++..+. .|+++++|++|+|++|.+++..|..|+.+             
T Consensus        14 ~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-------------   77 (192)
T 1w8a_A           14 DCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA-------------   77 (192)
T ss_dssp             ECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC-------------
T ss_pred             EcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCc-------------
Confidence            3444444 245554433  566666666666543332 25566666666666666654444444333             


Q ss_pred             ccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCcc
Q 039720          147 VGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS  219 (973)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~  219 (973)
                                 ++|++|+|++|++++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus        78 -----------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (192)
T 1w8a_A           78 -----------SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             -----------TTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             -----------ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence                       34444444444444444444444555555555555555444444444555555555444444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=3.3e-16  Score=154.71  Aligned_cols=134  Identities=19%  Similarity=0.270  Sum_probs=101.0

Q ss_pred             CCCCCCEEEccCCCCC-CCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccce
Q 039720           84 NLSFLRVINLANNSFH-GQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIER  162 (973)
Q Consensus        84 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~  162 (973)
                      ..++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|++|++++|++.+.+|..+.++++|++
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            3477888999988887 78888888888899999998888754  67777777777777777777767777777777777


Q ss_pred             eeccCCcccccC-CCCCCCCCcccEEEccCCcCCCCCC---CcccCCCccceeccCCCCcc
Q 039720          163 LSLYGNQLTGQL-PPSIGNLSALQTFDIAGNKLDGRIP---DSLGQLRNLNYLGTSENDFS  219 (973)
Q Consensus       163 L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~L~~L~~L~Ls~N~l~  219 (973)
                      |+|++|.+++.. +..++.+++|++|++++|++++..+   ..+..+++|++|++++|.+.
T Consensus       100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            777777777431 2567777777777777777774443   36777777777777777765

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.64  E-value=5.5e-16  Score=153.08  Aligned_cols=136  Identities=21%  Similarity=0.206  Sum_probs=84.1

Q ss_pred             cccceeeccCCccc-ccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEE
Q 039720          158 LKIERLSLYGNQLT-GQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY  236 (973)
Q Consensus       158 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  236 (973)
                      ++|++|+|++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|+|++|++++.+|..+.         
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------   92 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAE---------   92 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHH---------
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHh---------
Confidence            55666666666665 55566666666666666666666533  5555566666666666655543333333         


Q ss_pred             ccCCccccCCCcccccCCCCCcEEEccCCcccccC-CccccCCCCCCEEEccCCcccccCc---ccccCcccccceeccc
Q 039720          237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL-PQSLSNASKLEWLELNENHFSGQVR---INFNSLPNLSKLYLGR  312 (973)
Q Consensus       237 L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~  312 (973)
                                      ++++|++|+|++|.|++.. +..+..+++|++|+|++|.+++..+   ..|..+++|++|++++
T Consensus        93 ----------------~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~  156 (168)
T 2ell_A           93 ----------------KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD  156 (168)
T ss_dssp             ----------------HCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred             ----------------hCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence                            4566666666666666432 2567777777777777777776555   4677777777777777


Q ss_pred             ccCCCCCC
Q 039720          313 NNLGTRTS  320 (973)
Q Consensus       313 N~l~~~~~  320 (973)
                      |.+..++.
T Consensus       157 n~~~~~~~  164 (168)
T 2ell_A          157 REDQEAPD  164 (168)
T ss_dssp             TTSCBCCS
T ss_pred             CChhhccc
Confidence            77665543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.62  E-value=3e-16  Score=151.59  Aligned_cols=130  Identities=18%  Similarity=0.259  Sum_probs=99.1

Q ss_pred             CCCCCCEEEccCCCCC-CCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccce
Q 039720           84 NLSFLRVINLANNSFH-GQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIER  162 (973)
Q Consensus        84 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~  162 (973)
                      ..++|+.|++++|+++ +.+|..++.+++|++|+|++|.+++.  ..++.+++|++|++++|.+.+.+|..+..+++|++
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            3467888888888887 77888888888888888888888754  66777777777777777777777777777788888


Q ss_pred             eeccCCccccc-CCCCCCCCCcccEEEccCCcCCCCCC---CcccCCCccceeccCC
Q 039720          163 LSLYGNQLTGQ-LPPSIGNLSALQTFDIAGNKLDGRIP---DSLGQLRNLNYLGTSE  215 (973)
Q Consensus       163 L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~L~~L~~L~Ls~  215 (973)
                      |++++|.+++. .+..++++++|++|++++|++++..+   ..+..+++|++|++++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            88888887753 34667777888888888888775444   4677777777777753

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.61  E-value=2.3e-15  Score=151.99  Aligned_cols=109  Identities=25%  Similarity=0.299  Sum_probs=57.3

Q ss_pred             CCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeec
Q 039720           86 SFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSL  165 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L  165 (973)
                      +.|++|+|++|+|+ .+|..|.++++|++|+|++|.+++..|..                        |..+++|++|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~------------------------f~~l~~L~~L~L   85 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQS------------------------FSNMTQLLTLIL   85 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTT------------------------TTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhH------------------------ccCCCCCCEEEC
Confidence            35555566655555 45555555555555555555555333332                        333344555555


Q ss_pred             cCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCcc
Q 039720          166 YGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS  219 (973)
Q Consensus       166 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~  219 (973)
                      ++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            555555444455555555555555555555433344555555555555555543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.60  E-value=1.4e-14  Score=163.49  Aligned_cols=254  Identities=13%  Similarity=0.113  Sum_probs=137.2

Q ss_pred             CCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCC
Q 039720          175 PPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNL  254 (973)
Q Consensus       175 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l  254 (973)
                      ...|.++ +|+.+.+..| ++.....+|.+ .+|+.+.+.. .++.+-+.+|.++.+|+.+++..|+++ .+|...|. .
T Consensus       129 ~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~-~  202 (401)
T 4fdw_A          129 KDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFV-Y  202 (401)
T ss_dssp             TTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTT-T
T ss_pred             HhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEe-e
Confidence            3344443 4555555444 33233334444 2455555543 344444445555555555555555554 45555443 3


Q ss_pred             CCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhhccccc
Q 039720          255 PKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSK  334 (973)
Q Consensus       255 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~  334 (973)
                      .+|+.+.|.++ ++.+...+|.++++|+.++|..| ++.+...+|.+ .+|+.+.| .|.++.+...      .+.+|++
T Consensus       203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~------aF~~c~~  272 (401)
T 4fdw_A          203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASR------AFYYCPE  272 (401)
T ss_dssp             CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTT------TTTTCTT
T ss_pred             cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChh------HhhCCCC
Confidence            55555555532 44444555555555555555543 44444555555 45555555 2334333332      2234444


Q ss_pred             ceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEcc
Q 039720          335 LVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLV  414 (973)
Q Consensus       335 L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  414 (973)
                      |+.+.+..|.+.                    .+.+....+..|..+++|+.++|. +.++.+...+|.++++|+.++|.
T Consensus       273 L~~l~l~~~~~~--------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          273 LAEVTTYGSTFN--------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             CCEEEEESSCCC--------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEEC
T ss_pred             CCEEEeCCcccc--------------------CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEEC
Confidence            444444433322                    111122345567777788888887 44666667777778888888885


Q ss_pred             CcccCCCCCCccCCcCccceEEcCCCcccccccccccccc-ccccccccCcccc
Q 039720          415 GNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQ-NLMQLSAPNNKLN  467 (973)
Q Consensus       415 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~  467 (973)
                      .| ++.+....|.++ +|+.+++++|.+....+..|..++ +++.|++..+.+.
T Consensus       332 ~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          332 AN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             TT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             cc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            44 665666777777 788888888777755556666664 5666666666544

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.59  E-value=5.9e-15  Score=148.99  Aligned_cols=127  Identities=26%  Similarity=0.380  Sum_probs=80.9

Q ss_pred             ceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCC
Q 039720          161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN  240 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  240 (973)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..+.+|.+++          
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~----------   78 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT----------   78 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT----------
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCC----------
Confidence            46777777777 5666553  46777777777776 6667777777777777777777765555555444          


Q ss_pred             ccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          241 RFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       241 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                                     +|++|+|++|.|++..|..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        79 ---------------~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           79 ---------------QLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             ---------------TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             ---------------CCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence                           4555555555555455555566666666666666666555555666666666666666654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.59  E-value=1.6e-15  Score=146.38  Aligned_cols=128  Identities=22%  Similarity=0.232  Sum_probs=79.4

Q ss_pred             ccccceeeccCCccc-ccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEE
Q 039720          157 WLKIERLSLYGNQLT-GQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEA  235 (973)
Q Consensus       157 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  235 (973)
                      .++|++|++++|.++ +.+|..++.+++|++|++++|++++.  ..++++++|++|++++|.+++.+|..+.+       
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-------   86 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEK-------   86 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHH-------
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhh-------
Confidence            356777777777776 66777777777777777777777644  55666777777777777666544444444       


Q ss_pred             EccCCccccCCCcccccCCCCCcEEEccCCccccc-CCccccCCCCCCEEEccCCcccccCc---ccccCcccccceecc
Q 039720          236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGF-LPQSLSNASKLEWLELNENHFSGQVR---INFNSLPNLSKLYLG  311 (973)
Q Consensus       236 ~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~  311 (973)
                                        +++|++|++++|.+++. .+..+..+++|++|++++|++++..+   ..+..+++|++|+++
T Consensus        87 ------------------l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           87 ------------------CPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ------------------CTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ------------------CCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence                              44555555555555542 23555666666666666666665544   356666666666654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.58  E-value=3.9e-14  Score=159.71  Aligned_cols=219  Identities=9%  Similarity=0.059  Sum_probs=120.9

Q ss_pred             cceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC
Q 039720          160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK  239 (973)
Q Consensus       160 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  239 (973)
                      |+.+.+.. .++..-+..|.+|++|+.+++.+|+++.....+|. ..+|+.+.|..+ ++.+-..+|.++++|+.+.+..
T Consensus       159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~  235 (401)
T 4fdw_A          159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE  235 (401)
T ss_dssp             CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred             ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence            44444443 33333334455555555555555555432223333 345555555422 4434444455555555555544


Q ss_pred             CccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCccc-----ccCcccccCcccccceeccccc
Q 039720          240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS-----GQVRINFNSLPNLSKLYLGRNN  314 (973)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~L~~N~  314 (973)
                      | ++ .|+...|.+ .+|+.+.+ .+.++.+...+|.++++|+.+++.+|.+.     .+...+|.++++|+.++|.+ .
T Consensus       236 ~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~  310 (401)
T 4fdw_A          236 N-VS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-S  310 (401)
T ss_dssp             T-CC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-T
T ss_pred             C-cc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-c
Confidence            3 22 344444433 44555555 23344344445555555555555544443     23344444444444444431 1


Q ss_pred             CCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccC
Q 039720          315 LGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQL  394 (973)
Q Consensus       315 l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  394 (973)
                      ++                                                       ......|.++++|+.+.|..| +
T Consensus       311 i~-------------------------------------------------------~I~~~aF~~c~~L~~l~lp~~-l  334 (401)
T 4fdw_A          311 IR-------------------------------------------------------ILGQGLLGGNRKVTQLTIPAN-V  334 (401)
T ss_dssp             CC-------------------------------------------------------EECTTTTTTCCSCCEEEECTT-C
T ss_pred             eE-------------------------------------------------------EEhhhhhcCCCCccEEEECcc-c
Confidence            22                                                       233456778888888888654 7


Q ss_pred             CCCCCccccCCCCCCeEEccCcccCCCCCCccCCcC-ccceEEcCCCccc
Q 039720          395 TGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLT-LLNVLQLGFNKLQ  443 (973)
Q Consensus       395 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~  443 (973)
                      +.+.+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..+.+.
T Consensus       335 ~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          335 TQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             cEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            76777888888 899999999988877777788774 7888888887765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=1.6e-15  Score=166.66  Aligned_cols=137  Identities=15%  Similarity=0.210  Sum_probs=103.7

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccch----------------------hHHHHHHHHHHHHhcCCCC
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG----------------------ATKSFVAECEALRNIRHRN  732 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n  732 (973)
                      -|.+.+.||+|+||.||+|.+. +|+.||||+++.....                      ......+|+..|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            4899999999999999999984 7999999998632100                      0112345777788876554


Q ss_pred             ce--eEEeEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 039720          733 LI--KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNV  810 (973)
Q Consensus       733 iv--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NI  810 (973)
                      +.  ..+++         ...++||||++|+++..+..      ......++.|++.++.|||+.   |||||||||.||
T Consensus       175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NI  236 (397)
T 4gyi_A          175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNI  236 (397)
T ss_dssp             CSCCCEEEE---------ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             CCCCeeeec---------cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            43  22322         23479999999988866532      233567899999999999998   999999999999


Q ss_pred             EecCCC----------cEEEeccccchhcc
Q 039720          811 LLDHDM----------VAHVSDFGLARFLS  830 (973)
Q Consensus       811 Ll~~~~----------~~kl~Dfg~a~~~~  830 (973)
                      |+++++          .+.|+||+-+....
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccCC
Confidence            998776          38999999876543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.57  E-value=1.3e-14  Score=144.49  Aligned_cols=129  Identities=21%  Similarity=0.294  Sum_probs=73.2

Q ss_pred             cceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC
Q 039720          160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK  239 (973)
Q Consensus       160 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  239 (973)
                      .+.+++++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            356666777666 4554443  5677777777777755555666777777777777776654444455444444444444


Q ss_pred             CccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      |++                         ++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        86 N~l-------------------------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           86 NKL-------------------------QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             SCC-------------------------CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCc-------------------------cccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence            444                         4444444455555555555555555444444455555555555555544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.57  E-value=7.6e-15  Score=146.20  Aligned_cols=132  Identities=18%  Similarity=0.229  Sum_probs=81.1

Q ss_pred             CceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcc
Q 039720           50 CQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTN  129 (973)
Q Consensus        50 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~  129 (973)
                      |.|.+|.|+..            ++. .+|..+  .++|++|+|++|++++..+..|+++++|++|+|++|.+++..+..
T Consensus         7 C~~~~l~~~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (177)
T 2o6r_A            7 CSGTEIRCNSK------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV   71 (177)
T ss_dssp             EETTEEECCSS------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             eCCCEEEecCC------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence            67888888643            232 244333  367888888888888655566788888888888888887433333


Q ss_pred             cccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccc
Q 039720          130 LSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLN  209 (973)
Q Consensus       130 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~  209 (973)
                      ++.                        +++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|+
T Consensus        72 ~~~------------------------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  127 (177)
T 2o6r_A           72 FDK------------------------LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQ  127 (177)
T ss_dssp             TTT------------------------CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             ccC------------------------CCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccC
Confidence            333                        34555555555555544444455566666666666666544444455566666


Q ss_pred             eeccCCCCccc
Q 039720          210 YLGTSENDFSG  220 (973)
Q Consensus       210 ~L~Ls~N~l~~  220 (973)
                      +|+|++|.+.+
T Consensus       128 ~L~l~~N~~~~  138 (177)
T 2o6r_A          128 KIWLHTNPWDC  138 (177)
T ss_dssp             EEECCSSCBCC
T ss_pred             EEEecCCCeec
Confidence            66666665553

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=1.2e-16  Score=162.54  Aligned_cols=133  Identities=23%  Similarity=0.247  Sum_probs=67.2

Q ss_pred             CCCCEEEccCCCCCCCCCc------cccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccc
Q 039720           86 SFLRVINLANNSFHGQIPK------EVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLK  159 (973)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~  159 (973)
                      ..++.++++.+.++|.+|.      .++++++|++|+|++|.+++ +| .+..+++|+.|++++|.+. .+|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            3444444444444444443      45555555555555555553 44 4444555555555444444 33444444455


Q ss_pred             cceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCC-CcccCCCccceeccCCCCccccCC
Q 039720          160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIP-DSLGQLRNLNYLGTSENDFSGMFP  223 (973)
Q Consensus       160 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~L~~L~~L~Ls~N~l~~~~p  223 (973)
                      |++|+|++|++++ +| .++++++|++|++++|++++..+ ..+..+++|++|++++|.+.+..|
T Consensus        95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence            5555555555553 33 35555555666666665552211 245555666666666665554433

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.52  E-value=2.5e-13  Score=153.82  Aligned_cols=331  Identities=11%  Similarity=0.033  Sum_probs=156.0

Q ss_pred             hhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCC
Q 039720          150 IQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNI  229 (973)
Q Consensus       150 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l  229 (973)
                      ...+|.++.+|+.+.|..+ ++..-...|.++++|+.+++.++ ++..-..+|.++.+|+.+.+..+ +..+-..+|.+.
T Consensus        63 g~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~  139 (394)
T 4fs7_A           63 GYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGC  139 (394)
T ss_dssp             CTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTC
T ss_pred             HHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecc
Confidence            3445555566666666533 44344455666666666666544 44333455666666666655543 332334444444


Q ss_pred             CCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCccccccee
Q 039720          230 SSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLY  309 (973)
Q Consensus       230 ~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  309 (973)
                      ..++......  .. .+....|.++++|+.+.+.++. +.+....|.++.+|+.+++..| ++.+...+|.++..|+.+.
T Consensus       140 ~~~~~~~~~~--~~-~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~  214 (394)
T 4fs7_A          140 DFKEITIPEG--VT-VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME  214 (394)
T ss_dssp             CCSEEECCTT--CC-EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred             cccccccCcc--cc-ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence            3222221111  11 2233333344444444444332 2133334444444444444433 3333333444444444443


Q ss_pred             cccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEc
Q 039720          310 LGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGL  389 (973)
Q Consensus       310 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~L  389 (973)
                      +..+..                                                         .+...+....+|+.+.+
T Consensus       215 ~~~~~~---------------------------------------------------------~i~~~~~~~~~l~~i~i  237 (394)
T 4fs7_A          215 FPNSLY---------------------------------------------------------YLGDFALSKTGVKNIII  237 (394)
T ss_dssp             CCTTCC---------------------------------------------------------EECTTTTTTCCCCEEEE
T ss_pred             cCCCce---------------------------------------------------------EeehhhcccCCCceEEE
Confidence            332211                                                         01111222334455544


Q ss_pred             ccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccC
Q 039720          390 EYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGT  469 (973)
Q Consensus       390 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  469 (973)
                      ..+ ++.+....|..+.+|+.+.+..+... +....|..+..++.+....+.+.   ...|..+.+|+.+.+.++     
T Consensus       238 p~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-----  307 (394)
T 4fs7_A          238 PDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-----  307 (394)
T ss_dssp             CTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-----
T ss_pred             CCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-----
Confidence            322 22233444555555555555544332 34445555555555554443321   223444444444433222     


Q ss_pred             CCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhh
Q 039720          470 LPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNA  549 (973)
Q Consensus       470 ~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  549 (973)
                                           ++..-...|.++.+|+.++|.++ ++..-..+|.+|.+|+.+++..| ++..-..+|.+
T Consensus       308 ---------------------i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~  364 (394)
T 4fs7_A          308 ---------------------VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQG  364 (394)
T ss_dssp             ---------------------CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTT
T ss_pred             ---------------------cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhC
Confidence                                 22222344556666666666543 54344556666667777666655 55444556677


Q ss_pred             hccCCeecCCCCccccccCCCCCCCCccceE
Q 039720          550 LKSIKELDLSCNNLSGQIPIHLGNLPFLEYL  580 (973)
Q Consensus       550 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  580 (973)
                      +.+|+.+++..+ ++ .+...|.++++|+.+
T Consensus       365 C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          365 CINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             CTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             CCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            777777777654 22 334566677766654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.51  E-value=3.4e-16  Score=159.15  Aligned_cols=154  Identities=26%  Similarity=0.353  Sum_probs=88.7

Q ss_pred             cCCCCcCEEEcccccCCCCCCc------cccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccccccccc
Q 039720          379 RNLFNLNGLGLEYNQLTGTIPP------AIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGK  452 (973)
Q Consensus       379 ~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  452 (973)
                      .....++.++++.|.+++.+|.      .|..+++|++|+|++|++++ +| .+..+++|++|++++|+++ .+|..+..
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            3444566666777777666665      67777777777777777765 44 6666677777777777666 45555555


Q ss_pred             ccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCccccccc-ccccCccchhh
Q 039720          453 CQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIP-VTLSACTTLEY  531 (973)
Q Consensus       453 l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~  531 (973)
                      +++|+.|++++|+++                         + +| .+..+++|+.|++++|++++..+ ..+..+++|++
T Consensus        92 ~~~L~~L~L~~N~l~-------------------------~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~  144 (198)
T 1ds9_A           92 ADTLEELWISYNQIA-------------------------S-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLED  144 (198)
T ss_dssp             HHHCSEEEEEEEECC-------------------------C-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSE
T ss_pred             CCcCCEEECcCCcCC-------------------------c-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCE
Confidence            555555555444443                         1 12 34455666666666666653221 24555555666


Q ss_pred             hcccCcccccccccc----------hhhhccCCeecCCCCccc
Q 039720          532 LLMQGNSFNGSIPQS----------LNALKSIKELDLSCNNLS  564 (973)
Q Consensus       532 L~L~~N~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~  564 (973)
                      |++++|++++.+|..          +..+++|+.||  +|.++
T Consensus       145 L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          145 LLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            666666555444432          45555555554  44443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.51  E-value=3e-13  Score=153.15  Aligned_cols=318  Identities=11%  Similarity=0.036  Sum_probs=207.0

Q ss_pred             ccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcc
Q 039720          170 LTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVC  249 (973)
Q Consensus       170 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~  249 (973)
                      ++..-...|.++++|+.+.|..+ ++..-..+|.++++|+.+++.++ ++.+-..+|.++.+|+.+.+..+ +. .+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecce
Confidence            45445567889999999999754 76455678999999999999765 66566677888888887766544 33 45555


Q ss_pred             cccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChhhhhhh
Q 039720          250 LGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLL  329 (973)
Q Consensus       250 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l  329 (973)
                      .|.+...+.......  +......+|.++++|+.+.+.++. ..+...+|.++.+|+.+.+..| ++.            
T Consensus       135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~------------  198 (394)
T 4fs7_A          135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKI------------  198 (394)
T ss_dssp             TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCE------------
T ss_pred             eeecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceE------------
Confidence            554544333322222  222345567777777777776543 3355566666666666665443 211            


Q ss_pred             cccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCC
Q 039720          330 TNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQ  409 (973)
Q Consensus       330 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  409 (973)
                                                                 .....|.++..|+.+.+..+...  +.+.+....+|+
T Consensus       199 -------------------------------------------I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~  233 (394)
T 4fs7_A          199 -------------------------------------------IRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVK  233 (394)
T ss_dssp             -------------------------------------------ECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCC
T ss_pred             -------------------------------------------eCchhhccccccceeecCCCceE--eehhhcccCCCc
Confidence                                                       22334556666666666655432  233344456777


Q ss_pred             eEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCC
Q 039720          410 YLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSEN  489 (973)
Q Consensus       410 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N  489 (973)
                      .+.+..+ +..+....|.++..|+.+.+..+... .....|..+..++.+....                         +
T Consensus       234 ~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~-------------------------~  286 (394)
T 4fs7_A          234 NIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGS-------------------------V  286 (394)
T ss_dssp             EEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECS-------------------------S
T ss_pred             eEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCc-------------------------e
Confidence            7776543 33344456667777777777666443 4444555555554443322                         2


Q ss_pred             cccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCC
Q 039720          490 HLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPI  569 (973)
Q Consensus       490 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  569 (973)
                      .+   ....|..+.+|+.+.+.++ ++..-..+|.++.+|+.++|.++ ++..-..+|.++.+|+.+++..| ++..-..
T Consensus       287 ~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~  360 (394)
T 4fs7_A          287 IV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGAN  360 (394)
T ss_dssp             EE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred             ee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHH
Confidence            21   1235667788999988765 66566778999999999999755 77566788999999999999887 7756677


Q ss_pred             CCCCCCccceEeccCC
Q 039720          570 HLGNLPFLEYLNLSYN  585 (973)
Q Consensus       570 ~~~~l~~L~~L~ls~N  585 (973)
                      .|.++++|+.+++..+
T Consensus       361 aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          361 AFQGCINLKKVELPKR  376 (394)
T ss_dssp             TBTTCTTCCEEEEEGG
T ss_pred             HhhCCCCCCEEEECCC
Confidence            8999999999999765

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.50  E-value=1.8e-14  Score=143.32  Aligned_cols=132  Identities=21%  Similarity=0.296  Sum_probs=74.8

Q ss_pred             CCCCCcccEEEccCCcCCCCCCCcccCCC-ccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCC
Q 039720          178 IGNLSALQTFDIAGNKLDGRIPDSLGQLR-NLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPK  256 (973)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~p~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~  256 (973)
                      +.++.+|++|++++|+++ .+|. +..+. +|++|++++|.+++.  ..+..+++|++|+|++|+++ .+|..++..+++
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~   89 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPD   89 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTT
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCC
Confidence            344555666666666665 3333 33333 666666666666543  34555555555555555555 344444335666


Q ss_pred             CcEEEccCCcccccCCc--cccCCCCCCEEEccCCcccccCcc---cccCcccccceecccccC
Q 039720          257 LTVLVVAQNNLTGFLPQ--SLSNASKLEWLELNENHFSGQVRI---NFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       257 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l  315 (973)
                      |++|+|++|.|+. +|.  .+..+++|++|+|++|.++.....   .+..+++|+.|++++|.+
T Consensus        90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence            6666666666653 343  566677777777777777643222   366666666666666654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.49  E-value=1.3e-14  Score=144.39  Aligned_cols=133  Identities=16%  Similarity=0.173  Sum_probs=87.6

Q ss_pred             CCcCCCCCCEEEccCCCCCCCCCccccccC-CCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccc
Q 039720           81 YIGNLSFLRVINLANNSFHGQIPKEVGRLF-RLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLK  159 (973)
Q Consensus        81 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~  159 (973)
                      .+.+++.|++|+|++|+++ .+|. +..+. +|++|+|++|.+++.  ..++.+++|++|++++|.+.+..+..+..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            3556778888888888888 4554 55555 888888888888753  56666666666666666666544444566666


Q ss_pred             cceeeccCCcccccCCC--CCCCCCcccEEEccCCcCCCCCCCc----ccCCCccceeccCCCCcc
Q 039720          160 IERLSLYGNQLTGQLPP--SIGNLSALQTFDIAGNKLDGRIPDS----LGQLRNLNYLGTSENDFS  219 (973)
Q Consensus       160 L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~L~~L~~L~Ls~N~l~  219 (973)
                      |++|+|++|+++ .+|.  .++.+++|++|++++|.++ .+|..    +..+++|++||+++|.+.
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            666666666664 3444  5666666666666666665 44543    666666666666666554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.44  E-value=1.2e-13  Score=136.31  Aligned_cols=109  Identities=20%  Similarity=0.208  Sum_probs=89.5

Q ss_pred             ceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCC
Q 039720          482 KLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN  561 (973)
Q Consensus       482 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  561 (973)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            36778888887 4666553  78888899999998877888888889999999999998777777788999999999999


Q ss_pred             ccccccCCCCCCCCccceEeccCCcCcCcCCC
Q 039720          562 NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       562 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  593 (973)
                      +|++..|..|..+++|++|+|++|++++..+.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            99876666788899999999999998877653

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.41  E-value=2.3e-13  Score=134.74  Aligned_cols=108  Identities=19%  Similarity=0.256  Sum_probs=88.8

Q ss_pred             ceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCC
Q 039720          482 KLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN  561 (973)
Q Consensus       482 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  561 (973)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            46788888886 5676654  78889999999998888888888999999999999998666666788999999999999


Q ss_pred             ccccccCCCCCCCCccceEeccCCcCcCcCC
Q 039720          562 NLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP  592 (973)
Q Consensus       562 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  592 (973)
                      +|++..+..|..+++|+.|+|++|++....+
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            9986555568889999999999998886654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.39  E-value=1.3e-12  Score=128.85  Aligned_cols=105  Identities=22%  Similarity=0.268  Sum_probs=50.1

Q ss_pred             cEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccC
Q 039720          185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQ  264 (973)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~  264 (973)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|...+.++++|++|+|++
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEECCC
Confidence            34444444444 2333332  44444444444444443444433333333333333333 33333333455555555555


Q ss_pred             CcccccCCccccCCCCCCEEEccCCcccc
Q 039720          265 NNLTGFLPQSLSNASKLEWLELNENHFSG  293 (973)
Q Consensus       265 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  293 (973)
                      |+|++..+..|.++++|++|+|++|.++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            55555545556666666666666666553

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.37  E-value=1.9e-12  Score=128.04  Aligned_cols=104  Identities=18%  Similarity=0.278  Sum_probs=50.1

Q ss_pred             cEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccC
Q 039720          185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQ  264 (973)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~  264 (973)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|...+.++++|++|+|++
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECCC
Confidence            34455555443 3444332  44455555555554444444444444444444444443 33333333455555555555


Q ss_pred             CcccccCCccccCCCCCCEEEccCCccc
Q 039720          265 NNLTGFLPQSLSNASKLEWLELNENHFS  292 (973)
Q Consensus       265 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  292 (973)
                      |+|++..+..|.++++|++|+|++|.+.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcc
Confidence            5555444444555666666666666555

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.24  E-value=4.1e-12  Score=141.22  Aligned_cols=131  Identities=19%  Similarity=0.194  Sum_probs=103.4

Q ss_pred             eeeccCC-cccccCCcccccccccceecccc-CcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCC
Q 039720          483 LLDLSEN-HLSGSIPLEVGNLKSLVQLDISR-NNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSC  560 (973)
Q Consensus       483 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  560 (973)
                      .++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|..|++|+.|||++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            5788888 888 4787 99999999999996 999988888999999999999999999998888999999999999999


Q ss_pred             CccccccCCCCCCCCccceEeccCCcCcCcCCCC--CCCCCccccccccCccccCCCC
Q 039720          561 NNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKK--GVFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       561 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--~~~~~~~~l~~~~N~~~cg~~~  616 (973)
                      |+|++..|..+..++ |+.|+|++|+|.......  ..+.......+..+...|..+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            999965555666666 999999999998654321  0111122334455667777655

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.19  E-value=1.4e-11  Score=136.98  Aligned_cols=109  Identities=21%  Similarity=0.227  Sum_probs=97.8

Q ss_pred             ceeccccC-cccccccccccCccchhhhcccC-cccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEecc
Q 039720          506 VQLDISRN-NFSNEIPVTLSACTTLEYLLMQG-NSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS  583 (973)
Q Consensus       506 ~~L~ls~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  583 (973)
                      ..++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|..|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35789998 898 5888 99999999999996 99998888899999999999999999999889999999999999999


Q ss_pred             CCcCcCcCCCCCCCCCccccccccCccccCCCC
Q 039720          584 YNHFEGKVPKKGVFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       584 ~N~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~~  616 (973)
                      +|+|++.++.......++.+++.+|++.|+|..
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l  121 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCAL  121 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccCCCcc
Confidence            999999888764444499999999999998753

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.19  E-value=3.6e-10  Score=127.73  Aligned_cols=133  Identities=11%  Similarity=0.079  Sum_probs=66.7

Q ss_pred             chhhhhcccc-ccceeeccCCcccccCCCCCCCCCcccEEEccCCc---CCCCCCCcccCCCccceeccCCCCccccCCc
Q 039720          149 EIQAIIGNWL-KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNK---LDGRIPDSLGQLRNLNYLGTSENDFSGMFPL  224 (973)
Q Consensus       149 ~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~  224 (973)
                      ....+|.+.. .|+.+.+..+ ++..-...|.++++|+.+.+..|.   ++..-..+|.++.+|+.+.+..+ ++.+...
T Consensus        54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~  131 (394)
T 4gt6_A           54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE  131 (394)
T ss_dssp             ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred             cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence            3344555553 4666666543 454445667777777777776653   44333455666666666655443 3334444


Q ss_pred             cccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcc
Q 039720          225 SVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELN  287 (973)
Q Consensus       225 ~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  287 (973)
                      +|.++.+|+.+.+..+. . .++...|.+..+|+.+.+.++ ++.+...+|.+ .+|+.+.+.
T Consensus       132 aF~~c~~L~~i~lp~~~-~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip  190 (394)
T 4gt6_A          132 AFHHCEELDTVTIPEGV-T-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP  190 (394)
T ss_dssp             TTTTCTTCCEEECCTTC-C-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred             hhhhhccccccccccee-e-eecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence            55555555555554322 1 344444444555555555433 22233333332 344444444

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.18  E-value=5e-13  Score=149.21  Aligned_cols=164  Identities=17%  Similarity=0.202  Sum_probs=95.9

Q ss_pred             CCCCCeEEccCcccCCCCCCccCCc-----CccceEEcCCCccccccccccc-cccccccccccCcccccCCCccccccc
Q 039720          405 LRNLQYLGLVGNNIRGIIPDPIGNL-----TLLNVLQLGFNKLQGSIPSYLG-KCQNLMQLSAPNNKLNGTLPPQIFGIT  478 (973)
Q Consensus       405 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~~~  478 (973)
                      +++|+.|+|++|.|+......+..+     ++|++|+|++|.++......+. .+++|+.|+|++|.+...-...+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~---  147 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLR---  147 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHH---
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHH---
Confidence            4678888888888875433333322     6788888888887644333332 345666666666666421111111   


Q ss_pred             cccceeeccCCcccccCCccc-ccccccceeccccCccccc----ccccccCccchhhhcccCcccccc----cccchhh
Q 039720          479 TLSKLLDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNE----IPVTLSACTTLEYLLMQGNSFNGS----IPQSLNA  549 (973)
Q Consensus       479 ~l~~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~  549 (973)
                                        ..+ ...++|+.|+|++|.++..    ++..+..+++|++|+|++|+|+..    ++..+..
T Consensus       148 ------------------~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~  209 (372)
T 3un9_A          148 ------------------DLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDR  209 (372)
T ss_dssp             ------------------HHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGG
T ss_pred             ------------------HHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhc
Confidence                              011 1234566667777766532    333445566677777777776642    2445556


Q ss_pred             hccCCeecCCCCcccc----ccCCCCCCCCccceEeccCCcCcC
Q 039720          550 LKSIKELDLSCNNLSG----QIPIHLGNLPFLEYLNLSYNHFEG  589 (973)
Q Consensus       550 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~  589 (973)
                      .++|++|||++|.|+.    .++..+...++|++|+|++|+++.
T Consensus       210 ~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          210 NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             CSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             CCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            6677777777777764    233344455777777777777653

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.18  E-value=5.8e-10  Score=126.03  Aligned_cols=157  Identities=10%  Similarity=0.052  Sum_probs=96.8

Q ss_pred             ccccC-CCccceEecccccccchhhhhccccccceeeccCCc---ccccCCCCCCCCCcccEEEccCCcCCCCCCCcccC
Q 039720          129 NLSRC-FNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQ---LTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQ  204 (973)
Q Consensus       129 ~~~~l-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  204 (973)
                      .|.++ ..|+.+.+..+ ++.....+|.++.+|+.+.+..|.   ++..-...|.++.+|+.+.+..+ ++.....+|.+
T Consensus        58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~  135 (394)
T 4gt6_A           58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH  135 (394)
T ss_dssp             TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred             hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence            34455 34667766543 555566677777777777777653   54444556777777777766554 44344556777


Q ss_pred             CCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEE
Q 039720          205 LRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWL  284 (973)
Q Consensus       205 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  284 (973)
                      +.+|+.+.+..+ +..+...+|..+.+|+.+.+..+ ++ .|....|. -.+|+.+.+..+-.. ....+|.++.+|+..
T Consensus       136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~  210 (394)
T 4gt6_A          136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTI  210 (394)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred             hcccccccccce-eeeecccceecccccccccccce-ee-Eecccccc-ccceeEEEECCcccc-cccchhhhcccccee
Confidence            777777777644 33355566777777777777654 33 45555553 456777777655333 455666677777766


Q ss_pred             EccCCccc
Q 039720          285 ELNENHFS  292 (973)
Q Consensus       285 ~Ls~N~l~  292 (973)
                      ....+...
T Consensus       211 ~~~~~~~~  218 (394)
T 4gt6_A          211 TSDSESYP  218 (394)
T ss_dssp             EECCSSSC
T ss_pred             cccccccc
Confidence            66555443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.18  E-value=3.6e-13  Score=150.33  Aligned_cols=38  Identities=13%  Similarity=0.263  Sum_probs=22.1

Q ss_pred             CcccEEEccCCcCCCCCCCcccCC-----CccceeccCCCCcc
Q 039720          182 SALQTFDIAGNKLDGRIPDSLGQL-----RNLNYLGTSENDFS  219 (973)
Q Consensus       182 ~~L~~L~L~~N~l~~~~p~~~~~L-----~~L~~L~Ls~N~l~  219 (973)
                      +.|++|+|++|.++......+...     ++|++|+|++|.++
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~  114 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD  114 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCC
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCC
Confidence            467777777777763333333222     56666666666664

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.13  E-value=2.9e-10  Score=120.84  Aligned_cols=145  Identities=17%  Similarity=0.154  Sum_probs=112.0

Q ss_pred             HHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCc
Q 039720          671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       671 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  749 (973)
                      .....|++....+.|+.+.||++..  .+..+++|+...........+.+|+.+++.+. +..+.++++++..     ..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~   83 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DG   83 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TT
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CC
Confidence            3445788888899999999999986  47899999987532223346888999999885 5667788887643     36


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC---------------------------------
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC---------------------------------  796 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---------------------------------  796 (973)
                      ..++||||++|.++.+...     .......++.++++++..||+..                                 
T Consensus        84 ~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             ceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            7899999999999987632     12234578899999999999810                                 


Q ss_pred             -----------------------CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          797 -----------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       797 -----------------------~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                                             .+.++|+|+++.||+++.+..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   1359999999999999876566799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.87  E-value=3.2e-09  Score=112.45  Aligned_cols=136  Identities=14%  Similarity=0.112  Sum_probs=96.9

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCC--ceeEEeEeeecccCCCceEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN--LIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~  752 (973)
                      .|.+....+.|..+.||++.. .+|..+++|+....   ....+..|+.+++.+.+.+  +.+++++...     ....+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~   91 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDW   91 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCE
Confidence            444443344666799999975 46788999997643   2345778999998886544  4457776432     35689


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC------------------------------------
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC------------------------------------  796 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------------------------------------  796 (973)
                      +||||++|.++.  ...      .....++.++++++..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998874  211      123467788888888888751                                    


Q ss_pred             -------------------CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          797 -------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       797 -------------------~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                                         ...++|+|++|.||+++.++.+.++||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                               1139999999999999877667799999875

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.86  E-value=6.3e-08  Score=108.66  Aligned_cols=134  Identities=11%  Similarity=0.144  Sum_probs=62.0

Q ss_pred             CccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccc
Q 039720          399 PPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGIT  478 (973)
Q Consensus       399 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  478 (973)
                      ...+....+|+.+.+..+ +..+....|.++..|+.+.+..+ ++.....+|..+.+|+.+.+..+ +. .         
T Consensus       210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~---------  276 (379)
T 4h09_A          210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-T---------  276 (379)
T ss_dssp             TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-E---------
T ss_pred             ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-e---------
Confidence            344445555555555433 23233444555555555555443 33233344444444544443221 11 1         


Q ss_pred             cccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecC
Q 039720          479 TLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDL  558 (973)
Q Consensus       479 ~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  558 (973)
                                     .....|.++.+|+.+++.++.++..-..+|.++.+|+.+.|..+ ++..-..+|.++.+|+.+.+
T Consensus       277 ---------------i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i  340 (379)
T 4h09_A          277 ---------------VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY  340 (379)
T ss_dssp             ---------------ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred             ---------------ccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence                           11223444555555555555554333445555555555555433 44333445555555665555


Q ss_pred             CCC
Q 039720          559 SCN  561 (973)
Q Consensus       559 s~N  561 (973)
                      ..+
T Consensus       341 p~~  343 (379)
T 4h09_A          341 PKS  343 (379)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.86  E-value=1.6e-11  Score=128.52  Aligned_cols=192  Identities=15%  Similarity=0.147  Sum_probs=104.4

Q ss_pred             hhhHHHHHHHHhhccCCCcCCCCCCC--------------CCCCCCceeeeEeeCCCCeEEEEEeec---cCccccccC-
Q 039720           19 SHVKHATVTFNMQQLHDPLGVTKSWN--------------NSINLCQWTGVTCGHRHQRVTKLDLES---QNIGGFLSP-   80 (973)
Q Consensus        19 ~~~~~~ll~~~~~~~~d~~~~l~sw~--------------~~~~~c~w~gv~C~~~~~~v~~l~l~~---~~l~g~~~~-   80 (973)
                      --+++-|++|-.+...-|.. .-.|.              .+...|.|.|+.|+....+|..+..++   ..+.|.+++ 
T Consensus        34 ky~k~~ll~~i~~~~~~~f~-p~~~~~~~~~~~ffV~~~~~A~~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~  112 (267)
T 3rw6_A           34 KYDKAWLLSMIQSKCSVPFT-PIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPPHTILNELKPE  112 (267)
T ss_dssp             GSCHHHHHHHHHHTCSSCCC-CEEEEEETTEEEEEESCHHHHHHHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHH
T ss_pred             ccCHHHHHHHHHHhCCCCcE-eEEEEEeCCEEEEEeCChHHHHHHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHH
Confidence            44577777776655433321 11232              112358999999997766777766655   334444432 


Q ss_pred             CCcCCCCCCEEEccCCCCCCCCCc-cccccCCCCE--EeeecccCCCCCCcccccCCCccceEecccccccchhhhhccc
Q 039720           81 YIGNLSFLRVINLANNSFHGQIPK-EVGRLFRLET--IVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNW  157 (973)
Q Consensus        81 ~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~--L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l  157 (973)
                      .+..++.  .|....|..++.++- .|...+.|+.  ++++.|...                     .+.+.++-...++
T Consensus       113 ~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~---------------------~~~~~l~i~~~~l  169 (267)
T 3rw6_A          113 QVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS---------------------CMAATLRIIEENI  169 (267)
T ss_dssp             HHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH---------------------HHHHHHHHHHHHC
T ss_pred             HHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH---------------------HHHHHHHHHHhhC
Confidence            1222221  122222222222111 1233333333  333433221                     1112222233566


Q ss_pred             cccceeeccCCcccc--cCCCCCCCCCcccEEEccCCcCCCCCCCcccCCC--ccceeccCCCCccccCCc-------cc
Q 039720          158 LKIERLSLYGNQLTG--QLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLR--NLNYLGTSENDFSGMFPL-------SV  226 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~--~L~~L~Ls~N~l~~~~p~-------~~  226 (973)
                      ++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+.+|.       .+
T Consensus       170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il  247 (267)
T 3rw6_A          170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR  247 (267)
T ss_dssp             TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred             CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence            778888888888876  4556666788888888888888754  3344444  788888888888766552       35


Q ss_pred             cCCCCCcEEE
Q 039720          227 CNISSLDEAY  236 (973)
Q Consensus       227 ~~l~~L~~L~  236 (973)
                      ..+++|+.|+
T Consensus       248 ~~~P~L~~LD  257 (267)
T 3rw6_A          248 ERFPKLLRLD  257 (267)
T ss_dssp             HHCTTCCEES
T ss_pred             HHCcccCeEC
Confidence            6677777664

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.85  E-value=5.7e-10  Score=123.29  Aligned_cols=206  Identities=11%  Similarity=0.138  Sum_probs=115.3

Q ss_pred             CeEEEEEeeccCccc-c-------ccCCCcCCCCCCEEEccCCCCC---------CCCCccccccCCCCEEeeecccCCC
Q 039720           62 QRVTKLDLESQNIGG-F-------LSPYIGNLSFLRVINLANNSFH---------GQIPKEVGRLFRLETIVLSNNSFSG  124 (973)
Q Consensus        62 ~~v~~l~l~~~~l~g-~-------~~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~l~~  124 (973)
                      .+|+.|.+......| .       +..++..+++|+.|.+.++.+.         +.++..+..+++|+.|+|++|.-. 
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-  185 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-  185 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence            357777776555542 2       2345667899999999776432         234455677889999999887322 


Q ss_pred             CCCcccccCCCccceEecccccccchhhhhc--cccccceeeccC--CcccccCCCCCCCCCcccEEEccCCcCCCCCCC
Q 039720          125 KIPTNLSRCFNLIDFWVHTNNLVGEIQAIIG--NWLKIERLSLYG--NQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPD  200 (973)
Q Consensus       125 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  200 (973)
                      .+|. + .+++|++|++..|.+.......+.  .+++|++|+|+.  |...+..  .+..+..+         +.     
T Consensus       186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~~~l~~~---------l~-----  247 (362)
T 2ra8_A          186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--DMNVFRPL---------FS-----  247 (362)
T ss_dssp             BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--CGGGTGGG---------SC-----
T ss_pred             eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--hHHHHHHH---------Hh-----
Confidence            3444 3 378888888888887665555554  677888888753  2211100  00000000         00     


Q ss_pred             cccCCCccceeccCCCCccccCCccc---cCCCCCcEEEccCCccccC----CCcccccCCCCCcEEEccCCcccccCCc
Q 039720          201 SLGQLRNLNYLGTSENDFSGMFPLSV---CNISSLDEAYLFKNRFKGS----LPVCLGFNLPKLTVLVVAQNNLTGFLPQ  273 (973)
Q Consensus       201 ~~~~L~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~----ip~~~~~~l~~L~~L~Ls~N~l~~~~p~  273 (973)
                       ...+++|++|+|++|.+.+..+..+   ..+++|++|+|+.|.+.+.    ++..+. .+++|+.|+|++|.|+...-.
T Consensus       248 -~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~-~l~~L~~L~L~~n~i~d~~~~  325 (362)
T 2ra8_A          248 -KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD-KIKHLKFINMKYNYLSDEMKK  325 (362)
T ss_dssp             -TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHH-HHTTCSEEECCSBBCCHHHHH
T ss_pred             -cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcc-cCCcceEEECCCCcCCHHHHH
Confidence             0124455555555555442221111   1345556666665555532    222211 467888888888887754333


Q ss_pred             cccC-CCCCCEEEccCCc
Q 039720          274 SLSN-ASKLEWLELNENH  290 (973)
Q Consensus       274 ~~~~-l~~L~~L~Ls~N~  290 (973)
                      .+.. +  ...++++.|+
T Consensus       326 ~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          326 ELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHC--CSEEECCSBC
T ss_pred             HHHHHc--CCEEEecCCc
Confidence            4443 2  4668888887

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.84  E-value=7.3e-10  Score=122.40  Aligned_cols=215  Identities=13%  Similarity=0.215  Sum_probs=118.4

Q ss_pred             CCCCCEEEccCCCCCC-CC-------CccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcc
Q 039720           85 LSFLRVINLANNSFHG-QI-------PKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGN  156 (973)
Q Consensus        85 l~~L~~L~L~~n~l~~-~~-------p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  156 (973)
                      ++.++.|.+....+.| ..       ..++.++++|+.|.+..+.....   .++        ++.    .+.+...+..
T Consensus       106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~---~is--------~~~----~~~L~~ll~~  170 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ---EIS--------WIE----QVDLSPVLDA  170 (362)
T ss_dssp             GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC---CGG--------GCB----CCBCHHHHHT
T ss_pred             chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc---ccc--------ccc----ccCHHHHHhc
Confidence            3467888888766553 21       33456788888888866432110   010        000    1235566677


Q ss_pred             ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCccc--CCCccceeccCC--CCccccCCccccCCCCC
Q 039720          157 WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLG--QLRNLNYLGTSE--NDFSGMFPLSVCNISSL  232 (973)
Q Consensus       157 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~L~~L~~L~Ls~--N~l~~~~p~~~~~l~~L  232 (973)
                      +++|+.|+|++|.-. .++. +. +++|++|+|..|.+.......+.  .+++|++|+|+.  |...+..  .+   .. 
T Consensus       171 ~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~---~~-  241 (362)
T 2ra8_A          171 MPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--DM---NV-  241 (362)
T ss_dssp             CTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--CG---GG-
T ss_pred             CCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--hH---HH-
Confidence            788888888887311 2333 43 77888888888876532222333  678888887753  2111100  00   00 


Q ss_pred             cEEEccCCccccCCCcccc-cCCCCCcEEEccCCcccccCCcccc---CCCCCCEEEccCCcccccC----cccccCccc
Q 039720          233 DEAYLFKNRFKGSLPVCLG-FNLPKLTVLVVAQNNLTGFLPQSLS---NASKLEWLELNENHFSGQV----RINFNSLPN  304 (973)
Q Consensus       233 ~~L~L~~N~l~~~ip~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~  304 (973)
                                   +...+. ..+++|++|+|++|.+++..+..+.   .+++|++|+|+.|.|++..    +..+..+++
T Consensus       242 -------------l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~  308 (362)
T 2ra8_A          242 -------------FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH  308 (362)
T ss_dssp             -------------TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTT
T ss_pred             -------------HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCc
Confidence                         000000 1356777777777776643333332   4667788888777777532    223345677


Q ss_pred             ccceecccccCCCCCCCChhhhhhhcc-cccceeecccccc
Q 039720          305 LSKLYLGRNNLGTRTSTDLDFITLLTN-CSKLVKLGLVFNR  344 (973)
Q Consensus       305 L~~L~L~~N~l~~~~~~~~~~~~~l~~-l~~L~~L~l~~N~  344 (973)
                      |+.|+|++|.|+.      .....+.. +  ..+++++.++
T Consensus       309 L~~L~L~~n~i~d------~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          309 LKFINMKYNYLSD------EMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             CSEEECCSBBCCH------HHHHHHHHHC--CSEEECCSBC
T ss_pred             ceEEECCCCcCCH------HHHHHHHHHc--CCEEEecCCc
Confidence            8888888777653      11222222 1  3556777665

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.81  E-value=1.4e-07  Score=105.84  Aligned_cols=152  Identities=11%  Similarity=0.082  Sum_probs=100.5

Q ss_pred             CCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccccccccce
Q 039720          404 ELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKL  483 (973)
Q Consensus       404 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~  483 (973)
                      ....+..+.+..+.- ......+....+|+.+.+..+ ++.....++..+.+|+.+.+..                    
T Consensus       192 ~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~--------------------  249 (379)
T 4h09_A          192 AAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPK--------------------  249 (379)
T ss_dssp             TTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECT--------------------
T ss_pred             cccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCC--------------------
Confidence            334444444433222 233445555666666666544 2223344455555555544332                    


Q ss_pred             eeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCcc
Q 039720          484 LDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNL  563 (973)
Q Consensus       484 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  563 (973)
                           + ++..-...|.++.+|+.+.+..+ ++......|.++.+|+.+.+.++.++.....+|.++.+|+.++|..+ +
T Consensus       250 -----~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l  321 (379)
T 4h09_A          250 -----N-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-L  321 (379)
T ss_dssp             -----T-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-C
T ss_pred             -----C-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-c
Confidence                 2 23233456777888888888755 65455678999999999999999998666788999999999999865 6


Q ss_pred             ccccCCCCCCCCccceEeccCC
Q 039720          564 SGQIPIHLGNLPFLEYLNLSYN  585 (973)
Q Consensus       564 ~~~~p~~~~~l~~L~~L~ls~N  585 (973)
                      +..-...|.++++|+.+.+..+
T Consensus       322 ~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          322 KTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             CEECTTTTTTCTTCCCCCCCTT
T ss_pred             cEEHHHHhhCCCCCCEEEECCc
Confidence            6455678999999999988654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.73  E-value=2.4e-08  Score=111.26  Aligned_cols=145  Identities=17%  Similarity=0.184  Sum_probs=103.7

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEee--cccc-hhHHHHHHHHHHHHhcC--CCCceeEEeEeeecccCCCceEE
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN--LDKK-GATKSFVAECEALRNIR--HRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ..+.++.|.++.||+++.  .+..+++|+..  .... .....+.+|+.+++.+.  +..+.+++.++.+.  ......+
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            356789999999999987  45688889875  3221 12356788999999987  44577888876542  1124578


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC------------------------------------
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC------------------------------------  796 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------------------------------------  796 (973)
                      +||||++|..+.+...  ......+...++.+++.+|..||+..                                    
T Consensus       118 ~vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999999987754211  22345667788999999999999731                                    


Q ss_pred             -------------------CCCeEecCCCCCcEEecCCCc--EEEeccccchh
Q 039720          797 -------------------QPPIVHGDLKPSNVLLDHDMV--AHVSDFGLARF  828 (973)
Q Consensus       797 -------------------~~~ivHrDik~~NILl~~~~~--~kl~Dfg~a~~  828 (973)
                                         .+.++|||+++.||+++.++.  +.++||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               247999999999999997753  68999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.65  E-value=1.7e-08  Score=109.52  Aligned_cols=196  Identities=14%  Similarity=0.143  Sum_probs=119.7

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCC--ceeEEeEeeecccCCCceEEEEE
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRN--LIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      .+.++.|.+..||++.     ..+++|+....  .....+.+|..+++.+. +..  +.+++.....  ...-...|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence            4568999999999863     46888986422  34567889999998884 332  3344443221  11112457899


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC---------------------------------------  796 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------  796 (973)
                      ++++|.++.+...  ...+..++..++.+++..+..||+..                                       
T Consensus        96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9999988765332  22345566778888888888888610                                       


Q ss_pred             ----------------CCCeEecCCCCCcEEecC--CCcEEEeccccchhccCCCCccCCC------CCccccccccccc
Q 039720          797 ----------------QPPIVHGDLKPSNVLLDH--DMVAHVSDFGLARFLSHHPFLVAPE------GQSSSIEMKGTIG  852 (973)
Q Consensus       797 ----------------~~~ivHrDik~~NILl~~--~~~~kl~Dfg~a~~~~~~~~~~~~~------~~~~~~~~~gt~~  852 (973)
                                      .+.++|+|+++.||+++.  ...+.++||+.+..-..........      ...........++
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            135899999999999998  4567899999886432210000000      0000000111111


Q ss_pred             ccC-cccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 039720          853 YIG-PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPT  887 (973)
Q Consensus       853 y~a-PE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf  887 (973)
                      +.. |+.....  ....+.|++|.++|.+.+|+.+|
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            122 2221111  12268999999999999998875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.34  E-value=2.6e-08  Score=99.24  Aligned_cols=123  Identities=14%  Similarity=0.134  Sum_probs=77.7

Q ss_pred             cccCCCcCCCCCCEEEccCC-CCCCC----CCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchh
Q 039720           77 FLSPYIGNLSFLRVINLANN-SFHGQ----IPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQ  151 (973)
Q Consensus        77 ~~~~~l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~  151 (973)
                      .+...+...+.|++|+|++| .+...    +...+...++|++|+|++|.+...-..                    .+.
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~--------------------~l~   86 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF--------------------ALA   86 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH--------------------HHH
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHH--------------------HHH
Confidence            34445667788888888888 77532    334455667788888888877532111                    223


Q ss_pred             hhhccccccceeeccCCccccc----CCCCCCCCCcccEEEc--cCCcCCCC----CCCcccCCCccceeccCCCCcc
Q 039720          152 AIIGNWLKIERLSLYGNQLTGQ----LPPSIGNLSALQTFDI--AGNKLDGR----IPDSLGQLRNLNYLGTSENDFS  219 (973)
Q Consensus       152 ~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~L~~L~~L~Ls~N~l~  219 (973)
                      ..+...++|++|+|++|.++..    +...+...++|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus        87 ~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            3444455677777777766532    3445566677888888  77777633    2334555678888888888875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.30  E-value=1.1e-07  Score=99.49  Aligned_cols=80  Identities=24%  Similarity=0.333  Sum_probs=59.8

Q ss_pred             cCCCCcCEEEcccccCCC--CCCccccCCCCCCeEEccCcccCCCCCCccCCcC--ccceEEcCCCcccccccc------
Q 039720          379 RNLFNLNGLGLEYNQLTG--TIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLT--LLNVLQLGFNKLQGSIPS------  448 (973)
Q Consensus       379 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~------  448 (973)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+.+|.      
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            567789999999999987  3457777889999999999998865  3344444  888888888888876652      


Q ss_pred             -cccccccccccc
Q 039720          449 -YLGKCQNLMQLS  460 (973)
Q Consensus       449 -~~~~l~~L~~L~  460 (973)
                       .+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence             355677776665

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.15  E-value=1.7e-07  Score=93.30  Aligned_cols=121  Identities=12%  Similarity=0.089  Sum_probs=87.0

Q ss_pred             CccccccCCCCEEeeecc-cCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCccccc----CCCC
Q 039720          103 PKEVGRLFRLETIVLSNN-SFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQ----LPPS  177 (973)
Q Consensus       103 p~~~~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~  177 (973)
                      ...+...++|++|+|++| .+...-.                    ..+...+...++|++|+|++|.+...    +...
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~--------------------~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~   88 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTL--------------------KACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM   88 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHH--------------------HHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHH--------------------HHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHH
Confidence            344566777788888777 6652110                    12345556667888888888887632    3344


Q ss_pred             CCCCCcccEEEccCCcCCCC----CCCcccCCCccceecc--CCCCcccc----CCccccCCCCCcEEEccCCccc
Q 039720          178 IGNLSALQTFDIAGNKLDGR----IPDSLGQLRNLNYLGT--SENDFSGM----FPLSVCNISSLDEAYLFKNRFK  243 (973)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~L~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~  243 (973)
                      +...++|++|+|++|.|...    +...+...++|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus        89 L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           89 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            55568899999999999743    3566788889999999  88999754    3345566789999999999986

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.05  E-value=3.7e-05  Score=81.44  Aligned_cols=135  Identities=18%  Similarity=0.142  Sum_probs=97.4

Q ss_pred             ccccccce-eEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceEEEEEeec
Q 039720          681 RIGKGSFG-FVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       681 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      .+..|..| .||+......+..+++|+-..   .....+.+|...|+.+. +--+.+++.++.+     .+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEee
Confidence            34556555 699988876778899998653   34556788999998875 2235667776654     36789999999


Q ss_pred             cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 039720          759 QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC------------------------------------------  796 (973)
Q Consensus       759 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------------------------------------------  796 (973)
                      +|.++.+.....    ......++.+++..+..||...                                          
T Consensus       103 ~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          103 PGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             CSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             CCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            998887765432    2234456777777777777531                                          


Q ss_pred             -------------CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          797 -------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       797 -------------~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                                   .+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                         1137999999999999987777799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.98  E-value=2.4e-05  Score=84.52  Aligned_cols=136  Identities=16%  Similarity=0.191  Sum_probs=91.4

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCC---CceeEEeEeeecccCCCceEEEEE
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR---NLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      .+.++.|....||+.     |..+++|+..  .......+..|.++++.+.+.   .+.+++.++..    .....++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence            346788888999988     4678888853  233456789999999999753   24555555431    235578999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhc----------------------------------------
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH----------------------------------------  795 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------------------------------------  795 (973)
                      ||++|.++.+..-  ......+...++.+++..+..||+.                                        
T Consensus        93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9999988765321  1122333444555555555555542                                        


Q ss_pred             -----------------CCCCeEecCCCCCcEEecC---CCc-EEEeccccch
Q 039720          796 -----------------CQPPIVHGDLKPSNVLLDH---DMV-AHVSDFGLAR  827 (973)
Q Consensus       796 -----------------~~~~ivHrDik~~NILl~~---~~~-~kl~Dfg~a~  827 (973)
                                       ..+.++|+|+++.||+++.   ++. +.|+||+.+.
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                             1235799999999999987   455 4799999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.68  E-value=6.4e-05  Score=84.54  Aligned_cols=76  Identities=16%  Similarity=0.133  Sum_probs=48.7

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccc-------hhHHHHHHHHHHHHhcCC--CC-ceeEEeEeeecccCCC
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-------GATKSFVAECEALRNIRH--RN-LIKIITICSSIDFKGA  748 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~~  748 (973)
                      .+.+|.|.++.||+++...+++.|+||.......       ...+++..|.++++.+..  |. +.+++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            4679999999999997755678999998653211       123456778888887742  33 34455431       1


Q ss_pred             ceEEEEEeeccCC
Q 039720          749 DFKAIVYEYMQYG  761 (973)
Q Consensus       749 ~~~~lv~e~~~~g  761 (973)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            3457999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.65  E-value=5e-05  Score=84.03  Aligned_cols=84  Identities=10%  Similarity=-0.014  Sum_probs=53.6

Q ss_pred             CCcc-ccccceeEEEEEEC--C----CCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCC---CCceeEEeEeeeccc
Q 039720          679 SNRI-GKGSFGFVYKGNLG--E----DGMSVAVKVMNLDK---KGATKSFVAECEALRNIRH---RNLIKIITICSSIDF  745 (973)
Q Consensus       679 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~  745 (973)
                      .+.| +.|....+|+....  .    ++..+++|+.....   ......+..|+.+++.+..   -.+.+++.++.... 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence            3567 88999999998752  0    16788899875432   1012456778888877742   34666777654321 


Q ss_pred             CCCceEEEEEeeccCCCHH
Q 039720          746 KGADFKAIVYEYMQYGSVD  764 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~  764 (973)
                       .....++||||++|.++.
T Consensus       104 -~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 -VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             -TTSSCEEEEECCCCBCCC
T ss_pred             -ccCCceEEEEecCCCChh
Confidence             113467899999986654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.55  E-value=2.8e-05  Score=75.14  Aligned_cols=82  Identities=4%  Similarity=-0.005  Sum_probs=36.2

Q ss_pred             CCEEeeecccCCCCCCcccccCCCccceEecccc-cccchhhhhccc----cccceeeccCCc-ccccCCCCCCCCCccc
Q 039720          112 LETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNN-LVGEIQAIIGNW----LKIERLSLYGNQ-LTGQLPPSIGNLSALQ  185 (973)
Q Consensus       112 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~-~~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~p~~~~~l~~L~  185 (973)
                      |++||||++.++..--..+..+++|++|++++|. ++..--..+..+    ++|++|+|++|. +|..--..+.++++|+
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~  142 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK  142 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence            4444444444433222233344444444444442 333333334432    246666666653 4422222344555666


Q ss_pred             EEEccCCc
Q 039720          186 TFDIAGNK  193 (973)
Q Consensus       186 ~L~L~~N~  193 (973)
                      +|+|++|.
T Consensus       143 ~L~L~~c~  150 (176)
T 3e4g_A          143 YLFLSDLP  150 (176)
T ss_dssp             EEEEESCT
T ss_pred             EEECCCCC
Confidence            66666553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.40  E-value=7e-05  Score=72.38  Aligned_cols=83  Identities=11%  Similarity=0.083  Sum_probs=56.3

Q ss_pred             CCCEEEccCCCCCCCCCccccccCCCCEEeeeccc-CCCCCCcccccC----CCccceEecccc-cccchhhhhcccccc
Q 039720           87 FLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS-FSGKIPTNLSRC----FNLIDFWVHTNN-LVGEIQAIIGNWLKI  160 (973)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l----~~L~~L~l~~n~-~~~~~~~~~~~l~~L  160 (973)
                      .|++|||+++.++..--..+.++++|++|+|++|. ++..--..++.+    ++|++|++++|. ++...-..+.++++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            57777777777764434456777778888888774 554333344443    367788888774 666666677788888


Q ss_pred             ceeeccCCc
Q 039720          161 ERLSLYGNQ  169 (973)
Q Consensus       161 ~~L~L~~n~  169 (973)
                      ++|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            888888875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.39  E-value=0.00026  Score=77.66  Aligned_cols=43  Identities=21%  Similarity=0.258  Sum_probs=33.8

Q ss_pred             HHHHHHHHHh----------cCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          785 VASVIEYLHN----------HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       785 i~~aL~~LH~----------~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +..++++|++          .....++|+|+++.||+++.++.+.++||+.+.
T Consensus       199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            4446666763          023489999999999999888899999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.10  E-value=0.003  Score=67.73  Aligned_cols=75  Identities=17%  Similarity=0.164  Sum_probs=56.7

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC---CCCceeEEeEeeecccCCCceEEEEE
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR---HRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      .+.++.|....+|+...  ++..+++|+....   ....+..|...|+.+.   ...+.+++.++..     ....++||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence            45689999999999986  5778889987633   3566788988888774   3557777776543     36789999


Q ss_pred             eeccCCCH
Q 039720          756 EYMQYGSV  763 (973)
Q Consensus       756 e~~~~gsL  763 (973)
                      ||+++..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.04  E-value=0.0015  Score=69.65  Aligned_cols=78  Identities=19%  Similarity=0.238  Sum_probs=55.8

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCC---CceeEEeEeeecccCCCceE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR---NLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~  751 (973)
                      +....+.+|.|..+.||+.+. .+|+.|++|+...........+..|...|+.+.-.   -+.+++++         +..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DDR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ETT
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cCc
Confidence            344567799999999999998 58999999987654443445678899999888422   34455543         234


Q ss_pred             EEEEeeccCCC
Q 039720          752 AIVYEYMQYGS  762 (973)
Q Consensus       752 ~lv~e~~~~gs  762 (973)
                      ++||||++++.
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            68999987764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.95  E-value=0.00083  Score=61.83  Aligned_cols=60  Identities=17%  Similarity=0.110  Sum_probs=31.1

Q ss_pred             eecCCCCccc-cccCCCCCCCCccceEeccCCcCcCcCCCC-CCCCCccccccccCccccCCCC
Q 039720          555 ELDLSCNNLS-GQIPIHLGNLPFLEYLNLSYNHFEGKVPKK-GVFSNETRISLTGNEQFCGGLG  616 (973)
Q Consensus       555 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~l~~~~N~~~cg~~~  616 (973)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+...+.. ..+++++.+++.+|||.|++-.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l   73 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL   73 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence            4455555554 23443321  24555555555555544433 2345556666777777777643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.86  E-value=0.0023  Score=72.25  Aligned_cols=78  Identities=14%  Similarity=0.199  Sum_probs=46.6

Q ss_pred             CCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccc--cccccCcccccCCC---CCcccchH
Q 039720          797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG--TIGYIGPEYGMGGD---LSMTGDVY  871 (973)
Q Consensus       797 ~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~sDvw  871 (973)
                      .+.++|+|+++.|||++.++ ++++||+.+..-..         .........  ...|++|+......   -....++.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p---------~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM---------GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWIL  300 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH---------HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch---------HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHH
Confidence            34899999999999998876 99999998864211         000000011  12356665543211   11234555


Q ss_pred             HHHHHHHHHHhCC
Q 039720          872 SFGILLLEMFTRR  884 (973)
Q Consensus       872 SlG~ll~elltg~  884 (973)
                      .....+|+.+++.
T Consensus       301 ~~~~~~~~~y~~~  313 (420)
T 2pyw_A          301 RTIEQTWNLFNKR  313 (420)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            7777778777653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.79  E-value=0.0022  Score=69.51  Aligned_cols=161  Identities=13%  Similarity=0.103  Sum_probs=86.0

Q ss_pred             cccHHHHHHHhhcCCc-----CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCC--cee
Q 039720          663 IVSYAELSKATKEFSS-----SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN--LIK  735 (973)
Q Consensus       663 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~  735 (973)
                      .++.+++.....+|.+     .+.|+.|....+|+.... +| .+++|+....  .....+..|+.+++.+...+  +.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence            3455555555556654     235677888999999873 33 6889998642  12234556777776664222  222


Q ss_pred             EEeEeeecc-cCCCceEEEEEeeccCCCHHH--------------HhhhcC-CC--c-----hhhHHH------------
Q 039720          736 IITICSSID-FKGADFKAIVYEYMQYGSVDD--------------WLHHTN-DK--L-----EVGKLN------------  780 (973)
Q Consensus       736 ~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~-~~--~-----~~~~~~------------  780 (973)
                      ++....... ....+..+++++|++|..+..              .+|... .+  +     ....+.            
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            222100000 001245789999998764311              122110 00  0     000000            


Q ss_pred             ----HHHHHHHHHHHHHhc----CCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          781 ----IVIEVASVIEYLHNH----CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       781 ----i~~qi~~aL~~LH~~----~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                          +...+...++++++.    ...+++|+|+.+.||+++.++.+.++||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                011244556666532    13379999999999999887666899999875

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.71  E-value=0.00041  Score=68.35  Aligned_cols=117  Identities=12%  Similarity=0.192  Sum_probs=53.7

Q ss_pred             cCCCCCcEEEccCC-ccccC----CCcccccCCCCCcEEEccCCccccc----CCccccCCCCCCEEEccCCcccccC--
Q 039720          227 CNISSLDEAYLFKN-RFKGS----LPVCLGFNLPKLTVLVVAQNNLTGF----LPQSLSNASKLEWLELNENHFSGQV--  295 (973)
Q Consensus       227 ~~l~~L~~L~L~~N-~l~~~----ip~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~--  295 (973)
                      .+-++|++|+|++| +|...    +-..+. .-+.|+.|+|++|.|...    +.+.+..-+.|++|+|++|+|+...  
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~-~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAAC-NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHT-TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHh-hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            34456666777664 55311    111121 234566666666666532    2233344556666666666665322  


Q ss_pred             --cccccCcccccceecccccCCCCC-CCChhhhhhhcccccceeecccccc
Q 039720          296 --RINFNSLPNLSKLYLGRNNLGTRT-STDLDFITLLTNCSKLVKLGLVFNR  344 (973)
Q Consensus       296 --~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~~~~l~~l~~L~~L~l~~N~  344 (973)
                        ..++..-+.|++|+|++|....+. .........+...+.|+.|++++|.
T Consensus       117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence              123344445666666543221111 1111233344444555555555443

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.67  E-value=0.00053  Score=67.56  Aligned_cols=113  Identities=16%  Similarity=0.150  Sum_probs=75.6

Q ss_pred             ccCCCccceeccCCC-Ccccc----CCccccCCCCCcEEEccCCccccC----CCcccccCCCCCcEEEccCCccccc--
Q 039720          202 LGQLRNLNYLGTSEN-DFSGM----FPLSVCNISSLDEAYLFKNRFKGS----LPVCLGFNLPKLTVLVVAQNNLTGF--  270 (973)
Q Consensus       202 ~~~L~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----ip~~~~~~l~~L~~L~Ls~N~l~~~--  270 (973)
                      +.+-+.|++|+|++| .|...    +-.++..-+.|+.|+|++|++...    |-..+. .-+.|++|+|++|.|+..  
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~-~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIE-TSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHH-HCSSCCEEECCSSBCCHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHh-cCCccCeEecCCCcCCHHHH
Confidence            345577888999885 77532    344566678899999999988732    222222 346789999999988743  


Q ss_pred             --CCccccCCCCCCEEEccCC---cccc----cCcccccCcccccceecccccC
Q 039720          271 --LPQSLSNASKLEWLELNEN---HFSG----QVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       271 --~p~~~~~l~~L~~L~Ls~N---~l~~----~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                        +.+.+..-+.|++|+|++|   .+..    .+...+..-+.|+.|+++.|.+
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence              3445666778999999865   3342    1334556667888888887764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.51  E-value=0.0084  Score=65.01  Aligned_cols=143  Identities=15%  Similarity=0.139  Sum_probs=78.3

Q ss_pred             CccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCC--ceeEEeEeeecccCCCceEEEEEee
Q 039720          680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN--LIKIITICSSIDFKGADFKAIVYEY  757 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~  757 (973)
                      ..++ |....||++.. .+|+.+++|+.+.... ....+..|..+++.+....  +.+++..-........+..+++|+|
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 88889998865 3566899999863321 3455667888877774222  3333332000000113466789999


Q ss_pred             ccCCCHH-----HH---------hhhc---CC------Cchhh----HHH---------------HHHHHHHHHHHHHhc
Q 039720          758 MQYGSVD-----DW---------LHHT---ND------KLEVG----KLN---------------IVIEVASVIEYLHNH  795 (973)
Q Consensus       758 ~~~gsL~-----~~---------l~~~---~~------~~~~~----~~~---------------i~~qi~~aL~~LH~~  795 (973)
                      ++|.++.     ..         +|..   ..      .....    ...               +...+...++.+.+.
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875321     11         1110   00      00000    000               011112223333321


Q ss_pred             ----CCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          796 ----CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       796 ----~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                          ....++|+|+++.||+++ + .+.++||+.+.
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                233689999999999999 4 89999999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.32  E-value=0.011  Score=66.98  Aligned_cols=74  Identities=12%  Similarity=0.048  Sum_probs=46.8

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCc-eeEEeEeeecccCCCceEEEEEee
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL-IKIITICSSIDFKGADFKAIVYEY  757 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  757 (973)
                      .+.|+.|-...+|++.....+..+++|+....... ......|..+++.+...++ .++++++     .  .  .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~-----~--~--G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF-----T--N--GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE-----T--T--EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe-----C--C--eEEEEe
Confidence            45688899999999988543588999988532211 1123578888988875555 4455543     1  1  249999


Q ss_pred             ccCCC
Q 039720          758 MQYGS  762 (973)
Q Consensus       758 ~~~gs  762 (973)
                      ++|.+
T Consensus       183 I~G~~  187 (458)
T 2qg7_A          183 MDGYA  187 (458)
T ss_dssp             CCSEE
T ss_pred             eCCcc
Confidence            98744

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.26  E-value=0.0059  Score=56.05  Aligned_cols=37  Identities=24%  Similarity=0.237  Sum_probs=20.8

Q ss_pred             CCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          280 KLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       280 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      +|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3555555555555555555555555555666665553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.25  E-value=0.0028  Score=67.99  Aligned_cols=71  Identities=10%  Similarity=0.131  Sum_probs=43.2

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCc-eeEEeEeeecccCCCceEEEEEee
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL-IKIITICSSIDFKGADFKAIVYEY  757 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  757 (973)
                      .+.|+.|....+|++      ..+++|+....... .....+|+.+++.+...++ .+++++.       .+.-++++||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEEee
Confidence            677999999999998      46888988643211 1123457777776643233 3455432       1335689999


Q ss_pred             c-cCCCH
Q 039720          758 M-QYGSV  763 (973)
Q Consensus       758 ~-~~gsL  763 (973)
                      + +|.++
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 55443

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.17  E-value=0.02  Score=56.61  Aligned_cols=99  Identities=13%  Similarity=0.122  Sum_probs=64.1

Q ss_pred             CCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCC
Q 039720          761 GSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPE  839 (973)
Q Consensus       761 gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~  839 (973)
                      .+|.+.++.. ..+.++++|.++.|.+.+|.-.-....+  ..+=+.|..|++..+|.|.+.+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence            4799998854 4677899999999999998776321111  1223456899999999988764 2110            


Q ss_pred             CCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhC
Q 039720          840 GQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR  883 (973)
Q Consensus       840 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg  883 (973)
                              .....+.|||... ...+.+.=|||+|+++|.-+-=
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence                    0122466888753 4557888999999999998863

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.16  E-value=0.0084  Score=67.60  Aligned_cols=73  Identities=22%  Similarity=0.261  Sum_probs=48.4

Q ss_pred             CCccccccceeEEEEEECC-------CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCc-eeEEeEeeecccCCCce
Q 039720          679 SNRIGKGSFGFVYKGNLGE-------DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL-IKIITICSSIDFKGADF  750 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  750 (973)
                      .+.|+.|....||++....       ++..+++|+....  ...+.+..|..+++.+...++ .++++.+     .  + 
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~--~-  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----S--G-  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----T--T-
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----C--C-
Confidence            4568889999999998742       2578999998432  112456679888888753344 4555542     1  1 


Q ss_pred             EEEEEeeccCCC
Q 039720          751 KAIVYEYMQYGS  762 (973)
Q Consensus       751 ~~lv~e~~~~gs  762 (973)
                       .+|+||++|.+
T Consensus       148 -g~v~e~l~G~~  158 (429)
T 1nw1_A          148 -GRLEEYIPSRP  158 (429)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEeCCcc
Confidence             27899998643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.01  E-value=0.029  Score=60.80  Aligned_cols=31  Identities=29%  Similarity=0.334  Sum_probs=27.1

Q ss_pred             CCeEecCCCCCcEEecCC----CcEEEeccccchh
Q 039720          798 PPIVHGDLKPSNVLLDHD----MVAHVSDFGLARF  828 (973)
Q Consensus       798 ~~ivHrDik~~NILl~~~----~~~kl~Dfg~a~~  828 (973)
                      +.++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999875    6899999998863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.94  E-value=0.021  Score=62.96  Aligned_cols=139  Identities=14%  Similarity=0.208  Sum_probs=79.4

Q ss_pred             CCccccccceeEEEEEECC-------CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCc-eeEEeEeeecccCCCce
Q 039720          679 SNRIGKGSFGFVYKGNLGE-------DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL-IKIITICSSIDFKGADF  750 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  750 (973)
                      .+.+..|-...+|++....       ++..|++|+.... ........+|..+++.+.-.++ .++++++.       + 
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-------~-  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP-------E-  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-------T-
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-------C-
Confidence            4567778899999998742       3578999986322 1234556689988887753233 44555421       1 


Q ss_pred             EEEEEeeccCCCHHHH-----------------hhhcC----C-C--chhhHHHHHHHHH-------------------H
Q 039720          751 KAIVYEYMQYGSVDDW-----------------LHHTN----D-K--LEVGKLNIVIEVA-------------------S  787 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~-----------------l~~~~----~-~--~~~~~~~i~~qi~-------------------~  787 (973)
                       .+||||++|.++..-                 +|...    . .  ...++.++..++.                   .
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence             289999987554310                 11111    0 0  1123334443332                   1


Q ss_pred             HHHHHHh----c-CCCCeEecCCCCCcEEecCC----CcEEEeccccch
Q 039720          788 VIEYLHN----H-CQPPIVHGDLKPSNVLLDHD----MVAHVSDFGLAR  827 (973)
Q Consensus       788 aL~~LH~----~-~~~~ivHrDik~~NILl~~~----~~~kl~Dfg~a~  827 (973)
                      .++.|.+    . ....++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2333322    1 12379999999999999876    789999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.70  E-value=0.014  Score=64.58  Aligned_cols=74  Identities=11%  Similarity=0.114  Sum_probs=43.0

Q ss_pred             CCccccccceeEEEEEECC--------CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCC-ceeEEeEeeecccCCCc
Q 039720          679 SNRIGKGSFGFVYKGNLGE--------DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN-LIKIITICSSIDFKGAD  749 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~  749 (973)
                      .+.++.|....+|++....        .+..+++|+....... ......|..+++.+...+ +.++++..         
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---------  107 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---------  107 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---------
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---------
Confidence            3567888889999998742        1368889987543221 112356777777775333 33555431         


Q ss_pred             eEEEEEeeccCCC
Q 039720          750 FKAIVYEYMQYGS  762 (973)
Q Consensus       750 ~~~lv~e~~~~gs  762 (973)
                      .-++||||++|.+
T Consensus       108 ~~~~v~e~i~G~~  120 (369)
T 3c5i_A          108 NGGRIEEWLYGDP  120 (369)
T ss_dssp             TTEEEEECCCSEE
T ss_pred             CCcEEEEEecCCc
Confidence            1257999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.97  E-value=0.067  Score=58.11  Aligned_cols=31  Identities=19%  Similarity=0.341  Sum_probs=27.6

Q ss_pred             CCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       798 ~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3799999999999999888899999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.21  E-value=0.19  Score=56.09  Aligned_cols=74  Identities=11%  Similarity=0.079  Sum_probs=46.6

Q ss_pred             CCccccccceeEEEEEECCC-------CcEEEEEEeecccchhHHHHHHHHHHHHhcCCCC-ceeEEeEeeecccCCCce
Q 039720          679 SNRIGKGSFGFVYKGNLGED-------GMSVAVKVMNLDKKGATKSFVAECEALRNIRHRN-LIKIITICSSIDFKGADF  750 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~  750 (973)
                      .+.+..|-...+|++.....       +..|++|+...... ......+|..+++.+.-.+ ..++++.+         .
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~---------~  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF---------P  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE---------T
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc---------C
Confidence            45677788999999987421       67899998743221 1223456777777775323 34444421         1


Q ss_pred             EEEEEeeccCCC
Q 039720          751 KAIVYEYMQYGS  762 (973)
Q Consensus       751 ~~lv~e~~~~gs  762 (973)
                      -+.|+||++|.+
T Consensus       145 ~~~I~efI~G~~  156 (424)
T 3mes_A          145 EGRIEEFIDGEP  156 (424)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CCEEEEEeCCcc
Confidence            268899999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.79  E-value=1  Score=49.97  Aligned_cols=30  Identities=23%  Similarity=0.425  Sum_probs=25.0

Q ss_pred             CeEecCCCCCcEEe------cCCCcEEEeccccchh
Q 039720          799 PIVHGDLKPSNVLL------DHDMVAHVSDFGLARF  828 (973)
Q Consensus       799 ~ivHrDik~~NILl------~~~~~~kl~Dfg~a~~  828 (973)
                      .++|+|+.+.||++      +++..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567899999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	973
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-48
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-47
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-42
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-41
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-34
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-28
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.001
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-25
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-10
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-10
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	4e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-57
 Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 38/286 (13%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKII 737
            RIG GSFG VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +
Sbjct: 14  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHC 796
              ++         AIV ++ +  S+   LH    K E+ K ++I  + A  ++YLH   
Sbjct: 71  GYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK- 123

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
              I+H DLK +N+ L  D+   + DFGLA   S         G     ++ G+I ++ P
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFEQLSGSILWMAP 175

Query: 857 EYGMGGD---LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV 913
           E     D    S   DVY+FGI+L E+ T + P  N+ N            +     G +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGYL 227

Query: 914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
            P L            C  A+ R    C  +   ER     ++  +
Sbjct: 228 SPDL------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (458), Expect = 2e-51
 Identities = 65/309 (21%), Positives = 132/309 (42%), Gaps = 43/309 (13%)

Query: 665 SYAELSKATKEFSSS---------NRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDK- 711
           ++ + ++A +EF+             IG G FG V  G+L   G+  + VA+K +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 712 KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN 771
           +   + F++E   +    H N+I +  + +      +    I+ E+M+ GS+D +L   +
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122

Query: 772 DKLEVGK-LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
            +  V + + ++  +A+ ++YL +      VH DL   N+L++ ++V  VSDFGL+RFL 
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
                 +    +S++  K  I +  PE       +   DV+S+GI++ E+ +        
Sbjct: 180 DD---TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236

Query: 891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM 950
                           + V+  ++    +    P      L  ++     C  +  + R 
Sbjct: 237 MT-------------NQDVINAIEQDYRLPP--PMDCPSALHQLML---DCWQKDRNHRP 278

Query: 951 QMTAVVKKL 959
           +   +V  L
Sbjct: 279 KFGQIVNTL 287

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 7e-50
 Identities = 61/292 (20%), Positives = 115/292 (39%), Gaps = 22/292 (7%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            IGKG FG V++G     G  VAVK+ +  ++  +    AE      +RH N++  I   
Sbjct: 10  SIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC---- 796
           +  +        +V +Y ++GS+ D+L+     +E G + + +  AS + +LH       
Sbjct: 67  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-GMIKLALSTASGLAHLHMEIVGTQ 124

Query: 797 -QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            +P I H DLK  N+L+  +    ++D GLA         +      +     GT  Y+ 
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI----DIAPNHRVGTKRYMA 180

Query: 856 PEY------GMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM--ALPK 907
           PE           +     D+Y+ G++  E+  R        +  L  +       ++ +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
               + +  L        +  E L  + +    C   + + R+    + K L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-49
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 18/219 (8%)

Query: 669 LSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRN 727
           +     +F   + +G G+ G V+K +    G+ +A K+++L+ K       + E + L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
                ++       S         +I  E+M  GS+D  L       E     + I V  
Sbjct: 61  CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            + YL       I+H D+KPSN+L++      + DFG++  L            S +   
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----------SMANSF 163

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT  Y+ PE   G   S+  D++S G+ L+EM   R P
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-48
 Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 38/288 (13%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           +      ++G+G FG V+ G        VA+K +        ++F+ E + ++ +RH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKL 74

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEY 791
           +++  + S       +   IV EYM  GS+ D+L     K       +++  ++AS + Y
Sbjct: 75  VQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +        VH DL+ +N+L+  ++V  V+DFGLAR +  + +       ++    K  I
Sbjct: 129 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPI 178

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG 911
            +  PE  + G  ++  DV+SFGILL E+ T+ R                     ++V+ 
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NREVLD 225

Query: 912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
            V+    M    P +  E L  ++     C  + P ER     +   L
Sbjct: 226 QVERGYRMPC--PPECPESLHDLMC---QCWRKEPEERPTFEYLQAFL 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 9e-48
 Identities = 63/288 (21%), Positives = 117/288 (40%), Gaps = 38/288 (13%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           +      R+G G FG V+ G        VAVK +         +F+AE   ++ ++H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRL 70

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGK-LNIVIEVASVIEY 791
           +++  + +       +   I+ EYM+ GS+ D+L   +  KL + K L++  ++A  + +
Sbjct: 71  VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           +        +H DL+ +N+L+   +   ++DFGLAR +            ++    K  I
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPI 174

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG 911
            +  PE    G  ++  DV+SFGILL E+ T  R       +   +              
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ------------- 221

Query: 912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
                 L       + + C   + +    C  E P +R     +   L
Sbjct: 222 -----NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (430), Expect = 1e-47
 Identities = 70/305 (22%), Positives = 135/305 (44%), Gaps = 38/305 (12%)

Query: 657 MEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK 716
           M+   P  +Y +      + +  +++G G +G VY+G   +  ++VAVK +  D     +
Sbjct: 2   MDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVE 58

Query: 717 SFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-- 774
            F+ E   ++ I+H NL++++ +C+           I+ E+M YG++ D+L   N +   
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQEVS 113

Query: 775 EVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPF 834
            V  L +  +++S +EYL        +H DL   N L+  + +  V+DFGL+R ++    
Sbjct: 114 AVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--- 167

Query: 835 LVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDG 894
               +  ++    K  I +  PE       S+  DV++FG+LL E+ T         +  
Sbjct: 168 ----DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-- 221

Query: 895 LTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTA 954
                        +V  +++    ME   P    E +  ++R   AC   +PS+R     
Sbjct: 222 -----------LSQVYELLEKDYRMER--PEGCPEKVYELMR---ACWQWNPSDRPSFAE 265

Query: 955 VVKKL 959
           + +  
Sbjct: 266 IHQAF 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 57/282 (20%), Positives = 115/282 (40%), Gaps = 36/282 (12%)

Query: 682 IGKGSFGFVYKG--NLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIIT 738
           +G G+FG V +G   + +  + VA+KV+    +K  T+  + E + +  + +  ++++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQ 797
           +C +          +V E    G +  +L    +++ V     ++ +V+  ++YL     
Sbjct: 77  VCQAEAL------MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
              VH DL   NVLL +   A +SDFGL++ L            ++    K  + +  PE
Sbjct: 129 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-----DSYYTARSAGKWPLKWYAPE 182

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSL 917
                  S   DV+S+G+ + E  +  +                      +VM  ++   
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------------GPEVMAFIEQGK 229

Query: 918 LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
            ME   P +    L A++     C +    +R     V +++
Sbjct: 230 RMEC--PPECPPELYALMS---DCWIYKWEDRPDFLTVEQRM 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 4e-47
 Identities = 60/296 (20%), Positives = 112/296 (37%), Gaps = 39/296 (13%)

Query: 670 SKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRN 727
           S+A  ++     IG GS+G   K     DG  +  K ++     +   +  V+E   LR 
Sbjct: 1   SRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL----EVGKLNIVI 783
           ++H N+++          +      IV EY + G +   +     +     E   L ++ 
Sbjct: 60  LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116

Query: 784 EVASVIEYLH--NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
           ++   ++  H  +     ++H DLKP+NV LD      + DFGLAR L+H          
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--------DT 168

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA 901
           S +    GT  Y+ PE       +   D++S G LL E+     P             ++
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----------FTAFS 218

Query: 902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK 957
           +  L  K+       +      P ++ + L  ++             R  +  +++
Sbjct: 219 QKELAGKIREGKFRRI------PYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 4e-47
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 35/290 (12%)

Query: 675 EFSSSNRIGKGSFGFVYKGNL----GEDGMSVAVKVMNLD-KKGATKSFVAECEALRNIR 729
             +    IG G FG VYKG L    G+  + VA+K +     +     F+ E   +    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I++  + S           I+ EYM+ G++D +L   + +  V  L +V  +  + 
Sbjct: 68  HHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIA 120

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
             +        VH DL   N+L++ ++V  VSDFGL+R L        PE   ++   K 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATYTTSGGKI 175

Query: 850 TIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV 909
            I +  PE       +   DV+SFGI++ E+ T         +               +V
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NHEV 222

Query: 910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
           M  ++    +         +C  A+ +  + C  +  + R +   +V  L
Sbjct: 223 MKAINDGFRLP-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 6e-47
 Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 33/281 (11%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKII 737
             IG+GSF  VYKG   E  + VA   +   K  K   + F  E E L+ ++H N+++  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
               S   KG     +V E M  G++  +L            +   ++   +++LH    
Sbjct: 75  DSWES-TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT- 132

Query: 798 PPIVHGDLKPSNVLL-DHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
           PPI+H DLK  N+ +        + D GLA                 +  + GT  ++ P
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----------AKAVIGTPEFMAP 182

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E         + DVY+FG+ +LEM T   P     N            + ++V   V P+
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKPA 232

Query: 917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK 957
                         +  ++     C  ++  ER  +  ++ 
Sbjct: 233 SF-----DKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-46
 Identities = 60/287 (20%), Positives = 116/287 (40%), Gaps = 36/287 (12%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           K+ +    +G G FG V  G        VA+K++          F+ E + + N+ H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKL 61

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +++  +C+           I+ EYM  G + ++L     + +  +L  +  +V   +EYL
Sbjct: 62  VQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
            +      +H DL   N L++   V  VSDFGL+R++         +  +SS+  K  + 
Sbjct: 117 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-------DDEYTSSVGSKFPVR 166

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGI 912
           +  PE  M    S   D+++FG+L+ E+++  +     F                +    
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NSETAEH 213

Query: 913 VDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
           +   L +    P    E +  ++    +C  E   ER     ++  +
Sbjct: 214 IAQGLRLYR--PHLASEKVYTIMY---SCWHEKADERPTFKILLSNI 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-46
 Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 34/286 (11%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
            E +    IG G FG V+ G    +   VA+K +        + F+ E E +  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKL 62

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLH 793
           +++  +C            +V+E+M++G + D+L           L  +     V E + 
Sbjct: 63  VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD--VCEGMA 115

Query: 794 NHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGY 853
              +  ++H DL   N L+  + V  VSDFG+ RF+    +       +SS   K  + +
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVKW 168

Query: 854 IGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV 913
             PE       S   DV+SFG+L+ E+F+  +      ++           + + +    
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------SEVVEDISTGF 219

Query: 914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
                     P      +  ++     C  E P +R   + ++++L
Sbjct: 220 RLYK------PRLASTHVYQIMN---HCWKERPEDRPAFSRLLRQL 256

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-46
 Identities = 70/326 (21%), Positives = 126/326 (38%), Gaps = 37/326 (11%)

Query: 651 LSSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVM 707
           L+  L+   Q  ++  + L      F+    IG+G FG VY G L ++    +  AVK +
Sbjct: 9   LNPELVQAVQHVVIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63

Query: 708 NLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDW 766
           N     G    F+ E   +++  H N++ ++ IC     +      +V  YM++G + ++
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRNF 119

Query: 767 LHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 826
           + +      V    ++     V + +        VH DL   N +LD      V+DFGLA
Sbjct: 120 IRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

Query: 827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           R +    F    +   +    K  + ++  E       +   DV+SFG+LL E+ TR  P
Sbjct: 178 RDMYDKEF----DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

Query: 887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESP 946
                   +                      L++ R   + E C   +    + C     
Sbjct: 234 ----PYPDVNTFDITVY--------------LLQGRRLLQPEYCPDPLYEVMLKCWHPKA 275

Query: 947 SERMQMTAVVKKLCAVGEIFIGPPII 972
             R   + +V ++ A+   FIG   +
Sbjct: 276 EMRPSFSELVSRISAIFSTFIGEHYV 301

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-46
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 36/284 (12%)

Query: 680 NRIGKGSFGFVYKGNL--GEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIK 735
             +G G+FG V KG     +   +VAVK++  +          +AE   ++ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 736 IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNH 795
           +I IC +      +   +V E  + G ++ +L       +   + +V +V+  ++YL   
Sbjct: 73  MIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 796 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
                VH DL   NVLL     A +SDFGL++ L             +    K  + +  
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-----ENYYKAQTHGKWPVKWYA 178

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP 915
           PE       S   DV+SFG+L+ E F+  +        G+            +V  +++ 
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK----PYRGMK---------GSEVTAMLEK 225

Query: 916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
              M    P+     +  ++     C       R    AV  +L
Sbjct: 226 GERMGC--PAGCPREMYDLMN---LCWTYDVENRPGFAAVELRL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 6e-46
 Identities = 78/288 (27%), Positives = 117/288 (40%), Gaps = 42/288 (14%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL 733
           KE      IGKG FG V  G+    G  VAVK   +      ++F+AE   +  +RH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNL 62

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEY 791
           ++++ +      +      IV EYM  GS+ D+L      +      L   ++V   +EY
Sbjct: 63  VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTI 851
           L  +     VH DL   NVL+  D VA VSDFGL +  S           S+    K  +
Sbjct: 119 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----------STQDTGKLPV 164

Query: 852 GYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG 911
            +  PE       S   DV+SFGILL E+++  R                     K V+ 
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------------LKDVVP 211

Query: 912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
            V+    M+A  P      +  V++    C     + R     + ++L
Sbjct: 212 RVEKGYKMDA--PDGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQL 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 8e-46
 Identities = 63/306 (20%), Positives = 116/306 (37%), Gaps = 37/306 (12%)

Query: 652 SSALLMEQQFPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK 711
           S   ++E+   IVS  +     K+++   +IG+G+ G VY       G  VA++ MNL +
Sbjct: 1   SDEEILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57

Query: 712 KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTN 771
           +   +  + E   +R  ++ N++  +           D   +V EY+  GS+ D +  T 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTETC 112

Query: 772 DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
                    +  E    +E+LH++    ++H D+K  N+LL  D    ++DFG    ++ 
Sbjct: 113 MDEGQ-IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168

Query: 832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMF 891
                    QS    M GT  ++ PE           D++S GI+ +EM     P     
Sbjct: 169 E--------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----- 215

Query: 892 NDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ 951
                      +     +     P L    + P K        +     C      +R  
Sbjct: 216 -----YLNENPLRALYLIATNGTPEL----QNPEKLSAIFRDFLN---RCLDMDVEKRGS 263

Query: 952 MTAVVK 957
              +++
Sbjct: 264 AKELLQ 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 8e-46
 Identities = 67/291 (23%), Positives = 105/291 (36%), Gaps = 44/291 (15%)

Query: 673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIR 729
            K FS    IG GSFG VY      +   VA+K M+   K      +  + E   L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N I+                 +V EY    + D    H     EV    +       +
Sbjct: 74  HPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
            YLH+H    ++H D+K  N+LL    +  + DFG A  +            + +    G
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANSFVG 173

Query: 850 TIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP 906
           T  ++ PE  +    G      DV+S GI  +E+  R+ P  NM            M+  
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------MSAL 223

Query: 907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK 957
             +     P+L         + E     V    +C  + P +R     ++K
Sbjct: 224 YHIAQNESPALQ-----SGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 4e-44
 Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 39/284 (13%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITI 739
             +G G+FG VYK    E  +  A KV++   +   + ++ E + L +  H N++K++  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 740 CSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQP 798
                    +   I+ E+   G+VD  +      L E     +  +    + YLH++   
Sbjct: 78  FYY-----ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--- 129

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            I+H DLK  N+L   D    ++DFG++                      GT  ++ PE 
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--------TRTIQRRDSFIGTPYWMAPEV 181

Query: 859 GMGGDLSMTG-----DVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV 913
            M             DV+S GI L+EM     P           H    M +  K+    
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----------HHELNPMRVLLKIAKSE 231

Query: 914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK 957
            P+L      PS++       ++    C  ++   R   + +++
Sbjct: 232 PPTL----AQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 4e-44
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 22/240 (9%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRNIRH 730
           ++F     +GKG FG VY     +    +A+KV+    L+K G       E E   ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
            N++++           A    ++ EY   G+V   L   +   E      + E+A+ + 
Sbjct: 66  PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           Y H+     ++H D+KP N+LL       ++DFG +               S    + GT
Sbjct: 121 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----------SRRTTLCGT 167

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP-TDNMFNDGLTLHGYAKMALPKKV 909
           + Y+ PE   G       D++S G+L  E    + P   N + +        +   P  V
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 227

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 52/247 (21%), Positives = 98/247 (39%), Gaps = 16/247 (6%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRN 732
           +++     +G+G++G V          +VAVK++++ +     ++   E    + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
           ++K             + + +  EY   G + D +       E        ++ + + YL
Sbjct: 65  VVKFYGHRRE-----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H      I H D+KP N+LLD      +SDFGLA    ++        +    +M GT+ 
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKMCGTLP 170

Query: 853 YIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG 911
           Y+ PE     +  +   DV+S GI+L  M     P D   +       + +         
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230

Query: 912 IVDPSLL 918
            +D + L
Sbjct: 231 KIDSAPL 237

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-43
 Identities = 72/293 (24%), Positives = 109/293 (37%), Gaps = 38/293 (12%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLD---KKGATKSFVAECEALRN 727
           K+     ++G GSFG V +G         +SVAVK +  D   +  A   F+ E  A+ +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVA 786
           + HRNLI++  +  +   K      +V E    GS+ D L        +G L    ++VA
Sbjct: 68  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 787 SVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIE 846
             + YL +      +H DL   N+LL    +  + DFGL R L         +       
Sbjct: 122 EGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-----NDDHYVMQEH 173

Query: 847 MKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP 906
            K    +  PE       S   D + FG+ L EMFT  +      N    LH        
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------- 225

Query: 907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
                     +  E     + E+C   +    V C    P +R    A+   L
Sbjct: 226 ---------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 57/291 (19%), Positives = 116/291 (39%), Gaps = 39/291 (13%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVM-----NLDKKGATKSFVAECEALRNIR 729
           EF     +G G+FG VYKG    +G  V + V            A K  + E   + ++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKLNIVIEVASV 788
           + ++ +++ IC +   +      ++ + M +G + D++  H ++      LN  +++A  
Sbjct: 70  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           + YL +     +VH DL   NVL+       ++DFGLA+ L         E +  +   K
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHAEGGK 174

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK 908
             I ++  E  +    +   DV+S+G+ + E+ T          DG+            +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIP---------ASE 221

Query: 909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
           +  I++    +    P      +  ++     C M     R +   ++ + 
Sbjct: 222 ISSILEKGERLPQ--PPICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 3e-42
 Identities = 61/325 (18%), Positives = 119/325 (36%), Gaps = 62/325 (19%)

Query: 665 SYAELSKATKEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLD-KKGATKSF 718
               L            IG+G+FG V++         E    VAVK++  +        F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 719 VAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK 778
             E   +    + N++K++ +C+           +++EYM YG ++++L   +       
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 779 ------------------------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH 814
                                   L I  +VA+ + YL        VH DL   N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 815 DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFG 874
           +MV  ++DFGL+R +         +   +       I ++ PE       +   DV+++G
Sbjct: 176 NMVVKIADFGLSRNIYS------ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229

Query: 875 ILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAV 934
           ++L E+F+                 Y  MA  + +  + D ++       +  E C + +
Sbjct: 230 VVLWEIFSYGLQP------------YYGMAHEEVIYYVRDGNI------LACPENCPLEL 271

Query: 935 VRTGVACSMESPSERMQMTAVVKKL 959
                 C  + P++R    ++ + L
Sbjct: 272 YNLMRLCWSKLPADRPSFCSIHRIL 296

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 5e-42
 Identities = 61/316 (19%), Positives = 113/316 (35%), Gaps = 56/316 (17%)

Query: 661 FPIVSYAELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKS 717
           +P++ +        +    + IG+G+FG V K  + +DG+ +   +  + +   K   + 
Sbjct: 4   YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 718 FVAECEALRNI-RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEV 776
           F  E E L  +  H N+I ++  C     +   +  +  EY  +G++ D+L  +      
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111

Query: 777 GKLNIVIEVAS-------------VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 823
               I    AS             V   +    Q   +H DL   N+L+  + VA ++DF
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 171

Query: 824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR 883
           GL+R    +               +  + ++  E       +   DV+S+G+LL E+ + 
Sbjct: 172 GLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222

Query: 884 RRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSM 943
                     G+T     +               L +     K   C   V      C  
Sbjct: 223 GGT----PYCGMTCAELYEK--------------LPQGYRLEKPLNCDDEVYDLMRQCWR 264

Query: 944 ESPSERMQMTAVVKKL 959
           E P ER     ++  L
Sbjct: 265 EKPYERPSFAQILVSL 280

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-41
 Identities = 57/310 (18%), Positives = 111/310 (35%), Gaps = 56/310 (18%)

Query: 675 EFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDKK-GATKSFVAECEALRNI 728
             S    +G G+FG V +         +  M+VAVK++         ++ ++E + L  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 729 -RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--------- 778
             H N++ ++  C+           ++ EY  YG + ++L    D     K         
Sbjct: 84  GNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 779 ---------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 829
                    L+   +VA  + +L +      +H DL   N+LL H  +  + DFGLAR +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDN 889
            +                +  + ++ PE       +   DV+S+GI L E+F+       
Sbjct: 196 KN------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 890 MFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSER 949
                             K   ++     M +  P      +  +++    C    P +R
Sbjct: 250 GMPV------------DSKFYKMIKEGFRMLS--PEHAPAEMYDIMK---TCWDADPLKR 292

Query: 950 MQMTAVVKKL 959
                +V+ +
Sbjct: 293 PTFKQIVQLI 302

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 4e-41
 Identities = 58/309 (18%), Positives = 113/309 (36%), Gaps = 61/309 (19%)

Query: 681 RIGKGSFGFVYKG-----NLGEDGMSVAVKVMNLD-KKGATKSFVAECEALRNI-RHRNL 733
            +G G+FG V        +     + VAVK++         ++ ++E + +  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--------------- 778
           + ++  C+      +    +++EY  YG + ++L    +K    +               
Sbjct: 104 VNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 779 --------LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS 830
                   L    +VA  +E+L        VH DL   NVL+ H  V  + DFGLAR + 
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNM 890
                            +  + ++ PE    G  ++  DV+S+GILL E+F+        
Sbjct: 216 SD------SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--- 266

Query: 891 FNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM 950
                    Y  + +      ++     M+   P    E +  +++   +C      +R 
Sbjct: 267 ---------YPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQ---SCWAFDSRKRP 312

Query: 951 QMTAVVKKL 959
               +   L
Sbjct: 313 SFPNLTSFL 321

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 6e-41
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 17/219 (7%)

Query: 671 KATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMN---LDKKGATKSFVAECEALRN 727
           K  ++F     +G+GSF  V            A+K++    + K+        E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
           + H   +K+            +       Y + G +  ++       E        E+ S
Sbjct: 65  LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119

Query: 788 VIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEM 847
            +EYLH      I+H DLKP N+LL+ DM   ++DFG A+ LS          Q+ +   
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQARANSF 170

Query: 848 KGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            GT  Y+ PE         + D+++ G ++ ++     P
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-40
 Identities = 54/283 (19%), Positives = 105/283 (37%), Gaps = 37/283 (13%)

Query: 681 RIGKGSFGFVYKG---NLGEDGMSVAVKVM-NLDKKGATKSFVAECEALRNIRHRNLIKI 736
            IG+G FG V++G   +     ++VA+K   N       + F+ E   +R   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 737 ITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC 796
           I + +       +   I+ E    G +  +L      L++  L +      +   L    
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA--YQLSTALAYLE 125

Query: 797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGP 856
               VH D+   NVL+  +    + DFGL+R++    +  A +G       K  I ++ P
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMAP 178

Query: 857 EYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPS 916
           E       +   DV+ FG+ + E+            +           +  ++       
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---------NDVIGRIENGERLP 229

Query: 917 LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
           +      P      L +++     C    PS R + T +  +L
Sbjct: 230 M------PPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  149 bits (376), Expect = 8e-40
 Identities = 43/209 (20%), Positives = 84/209 (40%), Gaps = 20/209 (9%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            +G G+FG V++      G + A K +    +   ++   E + +  +RH  L+ +    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQPP 799
                   +   ++YE+M  G + + +   ++K+ E   +  + +V   + ++H +    
Sbjct: 93  ED-----DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--- 144

Query: 800 IVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
            VH DLKP N++        +   DFGL   L             S     GT  +  PE
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---------QSVKVTTGTAEFAAPE 195

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              G  +    D++S G+L   + +   P
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-39
 Identities = 51/299 (17%), Positives = 104/299 (34%), Gaps = 42/299 (14%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRN 727
           ++ + S  +G+GSFG VY+G        E    VA+K +N          F+ E   ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 728 IRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVAS 787
               ++++++ + S           ++ E M  G +  +L      +    +     ++ 
Sbjct: 80  FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 788 VIEY-------LHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           +I+        +        VH DL   N ++  D    + DFG+ R +         + 
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET------DY 188

Query: 841 QSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGY 900
                +    + ++ PE    G  +   DV+SFG++L E+ T         ++   L   
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-- 246

Query: 901 AKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
                            +ME     K + C   +      C   +P  R     ++  +
Sbjct: 247 ----------------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  145 bits (367), Expect = 1e-38
 Identities = 40/209 (19%), Positives = 79/209 (37%), Gaps = 20/209 (9%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            +G G+FG V++      G     K +N        +   E   +  + H  LI +    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK-LNIVIEVASVIEYLHNHCQPP 799
                       ++ E++  G + D +   + K+   + +N + +    ++++H H    
Sbjct: 96  ED-----KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---S 147

Query: 800 IVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
           IVH D+KP N++ +    + V   DFGLA  L+                   T  +  PE
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---------DEIVKVTTATAEFAAPE 198

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 +    D+++ G+L   + +   P
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (360), Expect = 2e-38
 Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 12/209 (5%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKII 737
            +G G    V+          VAVKV+  D          F  E +    + H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
               + +        IV EY+   ++ D +H          + ++ +    + + H +  
Sbjct: 74  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG- 131

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H D+KP+N+++       V DFG+AR ++           + +  + GT  Y+ PE
Sbjct: 132 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NSVTQTAAVIGTAQYLSPE 184

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
              G  +    DVYS G +L E+ T   P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP 213

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (354), Expect = 2e-37
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 22/216 (10%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRH 730
           ++F     +G GSFG V+      +G   A+KV+  +   +    +    E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
             +I++           A    ++ +Y++ G +   L  +             EV   +E
Sbjct: 64  PFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           YLH+     I++ DLKP N+LLD +    ++DFG A+++    +            + GT
Sbjct: 119 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----------TLCGT 164

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             YI PE       + + D +SFGIL+ EM     P
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-36
 Identities = 40/209 (19%), Positives = 84/209 (40%), Gaps = 21/209 (10%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
            +G+G FG V++        +   K + +           E   L   RHRN++ +    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEYLHNHCQPP 799
            S      +   +++E++    + + ++ +  +L E   ++ V +V   +++LH+H    
Sbjct: 71  ES-----MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---N 122

Query: 800 IVHGDLKPSNVLLDHDMVAHV--SDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
           I H D++P N++      + +   +FG AR L             +   +     Y  PE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---------DNFRLLFTAPEYYAPE 173

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 +S   D++S G L+  + +   P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 4e-36
 Identities = 56/282 (19%), Positives = 102/282 (36%), Gaps = 25/282 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           +IG GSFG +Y G     G  VA+K+  +  K        E +  + ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                   D+  +V E +     D +   +        L +  ++ S IEY+H+      
Sbjct: 72  ----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 124

Query: 801 VHGDLKPSNVL---LDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
           +H D+KP N L        + ++ DFGLA+             + +   + GT  Y    
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTARYASIN 183

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSL 917
             +G + S   D+ S G +L+       P   +         Y +++  K    +  P  
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKK----MSTPIE 238

Query: 918 LMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
           ++    PS+F   L         C      ++   + + +  
Sbjct: 239 VLCKGYPSEFATYL-------NFCRSLRFDDKPDYSYLRQLF 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-35
 Identities = 61/302 (20%), Positives = 111/302 (36%), Gaps = 51/302 (16%)

Query: 680 NRIGKGSFGFVYKG-------NLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RH 730
             +G+G+FG V          +       VAVK++  D  +      ++E E ++ I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIE------ 784
           +N+I ++  C+           ++ EY   G++ ++L            N          
Sbjct: 79  KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 785 -------VASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
                     V   +        +H DL   NVL+  D V  ++DFGLAR + H      
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH------ 187

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 897
            +    +   +  + ++ PE       +   DV+SFG+LL E+FT               
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 242

Query: 898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK 957
                    +++  ++     M+   PS     L  ++R    C    PS+R     +V+
Sbjct: 243 --------VEELFKLLKEGHRMDK--PSNCTNELYMMMR---DCWHAVPSQRPTFKQLVE 289

Query: 958 KL 959
            L
Sbjct: 290 DL 291

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  136 bits (342), Expect = 3e-35
 Identities = 50/250 (20%), Positives = 88/250 (35%), Gaps = 25/250 (10%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK------KGATKSFVAECEALRNI 728
           +FS    IG+G FG VY     + G   A+K ++  +      +    +       +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 729 RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASV 788
               ++ +     +      D  + + + M  G +   L       E        E+   
Sbjct: 65  DCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119

Query: 789 IEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           +E++HN     +V+ DLKP+N+LLD      +SD GLA   S          +       
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----------KKKPHASV 166

Query: 849 GTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK 907
           GT GY+ PE    G     + D +S G +L ++     P                + +  
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226

Query: 908 KVMGIVDPSL 917
           ++     P L
Sbjct: 227 ELPDSFSPEL 236

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-35
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 7/214 (3%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKII 737
            +IG+G+FG V+K    + G  VA+K + ++  K+G   + + E + L+ ++H N++ +I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            IC +        K  +Y    +   D     +N  ++     I   +  ++  L+   +
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             I+H D+K +NVL+  D V  ++DFGLAR  S    L      +       T+ Y  PE
Sbjct: 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFS----LAKNSQPNRYTNRVVTLWYRPPE 191

Query: 858 YGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNM 890
             +G  D     D++  G ++ EM+TR       
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 5e-35
 Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 19/225 (8%)

Query: 669 LSKATKEFSSSNRIGKGSFGFVYKG-NLGEDGMSVAVKVMNLDK--KGATKSFVAECEAL 725
           L +A +++     IG+G++G V+K  +L   G  VA+K + +    +G   S + E   L
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 726 RNI---RHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNI 781
           R++    H N++++  +C+           +V+E++               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 782 VIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQ 841
           + ++   +++LH+H    +VH DLKP N+L+       ++DFGLAR  S           
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--------- 169

Query: 842 SSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
            +   +  T+ Y  PE  +    +   D++S G +  EMF R+  
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 8e-35
 Identities = 56/302 (18%), Positives = 110/302 (36%), Gaps = 51/302 (16%)

Query: 680 NRIGKGSFGFVYKGNL-----GEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNL 733
             +G+G+FG V + +           +VAVK++         ++ ++E + L +I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGK--------------- 778
           +  +        K      ++ E+ ++G++  +L    ++    K               
Sbjct: 79  VVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 779 -LNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVA 837
            +    +VA  +E+L +      +H DL   N+LL    V  + DFGLAR +   P    
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---- 188

Query: 838 PEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 897
                   + +  + ++ PE       ++  DV+SFG+LL E+F+               
Sbjct: 189 --DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246

Query: 898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK 957
                               L E       +     + +T + C    PS+R   + +V+
Sbjct: 247 C-----------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

Query: 958 KL 959
            L
Sbjct: 290 HL 291

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 1e-34
 Identities = 43/208 (20%), Positives = 73/208 (35%), Gaps = 15/208 (7%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIIT 738
           + +G G+F  V           VA+K +     +G   S   E   L  I+H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           I  S          ++ + +  G + D +       E     ++ +V   ++YLH+    
Sbjct: 75  IYES-----GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
                        LD D    +SDFGL++              S      GT GY+ PE 
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---------SVLSTACGTPGYVAPEV 180

Query: 859 GMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                 S   D +S G++   +     P
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPP 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-34
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 20/216 (9%)

Query: 675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEAL-RNIRH 730
           +F     +GKGSFG V+     +     A+K +  D        +  + E   L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
             L  +     +      +    V EY+  G +   +   +            E+   ++
Sbjct: 63  PFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +LH+     IV+ DLK  N+LLD D    ++DFG+ +            G + +    GT
Sbjct: 118 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--------GDAKTNTFCGT 166

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             YI PE  +G   + + D +SFG+LL EM   + P
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-34
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK 735
           ++ +  IG GSFG VY+  L + G  VA+K +  DK    +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 736 IITIC-SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVASVIEY 791
           +     SS + K   +  +V +Y+         H++  K     +     + ++   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
           +H+     I H D+KP N+LLD D  V  + DFG A+ L              ++    +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---------EPNVSYICS 185

Query: 851 IGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRP 886
             Y  PE   G  D + + DV+S G +L E+   +  
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  129 bits (326), Expect = 6e-34
 Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 33/223 (14%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---------KGATKSFVAECEALRNIR- 729
             +G+G    V +          AVK++++           +   ++ + E + LR +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
           H N+I++     +       F  +V++ M+ G + D+L       E     I+  +  VI
Sbjct: 69  HPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKG 849
             LH      IVH DLKP N+LLD DM   ++DFG +  L                E+ G
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---------GEKLREVCG 171

Query: 850 TIGYIGPEYGMGGDLSMTG------DVYSFGILLLEMFTRRRP 886
           T  Y+ PE                 D++S G+++  +     P
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-33
 Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 12/209 (5%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMN-LDKKGATKSFVAECEALRNIRHRNLIKIIT 738
           + IG+G++G V       + + VA+K ++  + +   +  + E + L   RH N+I I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 739 ICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQP 798
           I  +   +      +V   M    +   L   +   +      + ++   ++Y+H+    
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSA--- 128

Query: 799 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEY 858
            ++H DLKPSN+LL+      + DFGLAR           +      E   T  Y  PE 
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-----HDHTGFLTEYVATRWYRAPEI 183

Query: 859 GMGGDLSMT-GDVYSFGILLLEMFTRRRP 886
            +         D++S G +L EM + R  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 4e-33
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 22/213 (10%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD-----KKGATKSFVAECEALRNIRHRNLI 734
           + +G+G F  VYK         VA+K + L      K G  ++ + E + L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            ++              ++V+++M+         ++           ++     +EYLH 
Sbjct: 64  GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYI 854
           H    I+H DLKP+N+LLD + V  ++DFGLA+               +      T  Y 
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--------SPNRAYTHQVVTRWYR 167

Query: 855 GPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRP 886
            PE   G  +  +  D+++ G +L E+  R   
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 44/209 (21%), Positives = 89/209 (42%), Gaps = 17/209 (8%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKII 737
            +IG+G++G V+K    E    VA+K + LD   +G   S + E   L+ ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            +  S          +V+E+        +     D       + + ++   + + H+   
Sbjct: 68  DVLHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             ++H DLKP N+L++ +    +++FGLAR             +  S E+          
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGI-------PVRCYSAEVVTLWYRPPDV 172

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                  S + D++S G +  E+    RP
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  126 bits (316), Expect = 1e-32
 Identities = 40/284 (14%), Positives = 86/284 (30%), Gaps = 27/284 (9%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITIC 740
           RIG+GSFG +++G    +   VA+K     ++        E    + +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPI 800
                       +V + +     D                   ++ + ++ +H      +
Sbjct: 70  GQEG----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122

Query: 801 VHGDLKPSNVLLD-----HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
           V+ D+KP N L+      +  + +V DFG+ +F    P             + GT  Y+ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD-PVTKQHIPYREKKNLSGTARYMS 181

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDP 915
               +G + S   D+ + G + +       P   +                +++      
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------TNKQKYERIGEKKQS 234

Query: 916 SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKL 959
           + L E    + F E     +         +         +    
Sbjct: 235 TPLREL--CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-32
 Identities = 42/216 (19%), Positives = 79/216 (36%), Gaps = 27/216 (12%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK------KGATKSFVAECEALRNIRHRNLI 734
            +G G F  V K      G+  A K +   +        + +    E   L+ I+H N+I
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 735 KIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN 794
            +  +  +          ++ E +  G + D+L       E         +  ++  ++ 
Sbjct: 77  TLHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEF---LKQILNGVYY 128

Query: 795 HCQPPIVHGDLKPSNVLLDHDMVA----HVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
                I H DLKP N++L    V      + DFGLA  +            +    + GT
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---------NEFKNIFGT 179

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             ++ PE      L +  D++S G++   + +   P
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-32
 Identities = 50/216 (23%), Positives = 77/216 (35%), Gaps = 19/216 (8%)

Query: 674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRH 730
            +F     +GKG+FG V        G   A+K++  +    K      V E   L+N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 731 RNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIE 790
             L  +     +      D    V EY   G +   L       E        E+     
Sbjct: 65  PFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV---S 116

Query: 791 YLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            L       +V+ D+K  N++LD D    ++DFGL +              ++     GT
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--------GATMKTFCGT 168

Query: 851 IGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             Y+ PE     D     D +  G+++ EM   R P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 9e-32
 Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 18/214 (8%)

Query: 676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNL 733
           F    +IG+G++G VYK      G  VA+K + LD   +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 734 IKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKL-NIVIEVASVIEYL 792
           +K++ +  +      +   +V+E++               + +  + + + ++   + + 
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
           H+H    ++H DLKP N+L++ +    ++DFGLAR             ++ + E+     
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG-------VPVRTYTHEVVTLWY 168

Query: 853 YIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                       S   D++S G +  EM TRR  
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 5e-31
 Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 24/211 (11%)

Query: 682 IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEAL-RNIRHRNLIKIITIC 740
           +G G  G V +          A+K++    K        E E   R  +  ++++I+ + 
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVY 74

Query: 741 SSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL--EVGKLNIVIEVASVIEYLHNHCQP 798
            ++ + G     IV E +  G +   +    D+   E     I+  +   I+YLH+    
Sbjct: 75  ENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131

Query: 799 PIVHGDLKPSNVLLDH---DMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIG 855
            I H D+KP N+L      + +  ++DFG A+  + H         +S      T  Y+ 
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---------NSLTTPCYTPYYVA 181

Query: 856 PEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
           PE         + D++S G+++  +     P
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 6e-31
 Identities = 47/209 (22%), Positives = 81/209 (38%), Gaps = 22/209 (10%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKII 737
            +G GSFG V      E G   A+K+++  K       +  + E   L+ +    L+K+ 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
                          +V EY+  G +   L       E        ++    EYLH+   
Sbjct: 108 FSFKDNSNLY-----MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD- 161

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             +++ DLKP N+L+D      V+DFG A+ +    +            + GT   + PE
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-----------TLCGTPEALAPE 208

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             +    +   D ++ G+L+ EM     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  118 bits (295), Expect = 6e-30
 Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 20/210 (9%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKII 737
            +IG+G++G VYK      G + A+K + L+K  +G   + + E   L+ ++H N++K+ 
Sbjct: 8   EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
            +  +        + ++        +   L      LE         +  ++  +     
Sbjct: 67  DVIHT------KKRLVLVFEHLDQDLKKLLDVCEGGLESVT--AKSFLLQLLNGIAYCHD 118

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
             ++H DLKP N+L++ +    ++DFGLAR                      T+ Y  P+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG--------IPVRKYTHEIVTLWYRAPD 170

Query: 858 YGMG-GDLSMTGDVYSFGILLLEMFTRRRP 886
             MG    S T D++S G +  EM      
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 6e-29
 Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 23/216 (10%)

Query: 680 NRIGKGSFGFVYKG---NLGEDGMSVAVKVMN----LDKKGATKSFVAECEALRNIRHRN 732
             +G G++G V+     +  + G   A+KV+     + K   T+    E + L +IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYL 792
            +  +       F+      ++ +Y+  G +   L       E     + I V  ++  L
Sbjct: 90  FLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTE---HEVQIYVGEIVLAL 142

Query: 793 HNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIG 852
            +  +  I++ D+K  N+LLD +    ++DFGL++                + +  GTI 
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-------TERAYDFCGTIE 195

Query: 853 YIGPEYGMGGDLSMTG--DVYSFGILLLEMFTRRRP 886
           Y+ P+   GGD       D +S G+L+ E+ T   P
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-28
 Identities = 43/231 (18%), Positives = 89/231 (38%), Gaps = 20/231 (8%)

Query: 662 PIVSYAELSKATKEFSSS----NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGAT-- 715
           P     EL+K   E        + +G G++G V      + G+ VAVK ++   +     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 716 KSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLE 775
           K    E   L++++H N+I ++ + +            +  ++    +++         +
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTD 120

Query: 776 VGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL 835
                ++ ++   ++Y+H+       H DLKPSN+ ++ D    + DFGLAR        
Sbjct: 121 DHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM-- 175

Query: 836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
                   +  +                 + T D++S G ++ E+ T R  
Sbjct: 176 --------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 45/217 (20%), Positives = 76/217 (35%), Gaps = 29/217 (13%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGA------TKSFVAECEALRNIR--HRN 732
            +G G FG VY G    D + VA+K +  D+               E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 733 LIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL-EVGKLNIVIEVASVIEY 791
           +I+++           D   ++ E  +              L E    +   +V   + +
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 792 LHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGT 850
            HN     ++H D+K  N+L+D +     + DFG    L    +           +  GT
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----------TDFDGT 172

Query: 851 IGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRP 886
             Y  PE+         +  V+S GILL +M     P
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-28
 Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 24/227 (10%)

Query: 668 ELSKATKEFSSS----NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAE 721
           E++K   E  +       +G G++G V     G  G  VA+K +      +   K    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 722 CEALRNIRHRNLIKIITICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLN 780
              L+++RH N+I ++ + +  +         +V  +M  G+    L       E     
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQF 125

Query: 781 IVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEG 840
           +V ++   + Y+H        H DLKP N+ ++ D    + DFGLAR             
Sbjct: 126 LVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-------- 174

Query: 841 QSSSIEMKGTIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRRRP 886
                    T  Y  PE  +     + T D++S G ++ EM T +  
Sbjct: 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  114 bits (286), Expect = 2e-28
 Identities = 48/231 (20%), Positives = 91/231 (39%), Gaps = 30/231 (12%)

Query: 665 SYAELSKATKEFSSSNR------IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSF 718
            Y +      E+ + +       +G+G +  V++     +   V VK++   KK   K  
Sbjct: 20  EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKI 76

Query: 719 VAECEALRNIR-HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVG 777
             E + L N+R   N+I +  I      +     A+V+E++                +  
Sbjct: 77  KREIKILENLRGGPNIITLADIVKDPVSR---TPALVFEHVNNTDFKQLYQTLT---DYD 130

Query: 778 KLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLSHHPFLV 836
               + E+   ++Y H+     I+H D+KP NV++DH+     + D+GLA F        
Sbjct: 131 IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---- 183

Query: 837 APEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRP 886
                        +  + GPE  +   +   + D++S G +L  M  R+ P
Sbjct: 184 -----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  111 bits (277), Expect = 9e-27
 Identities = 89/430 (20%), Positives = 144/430 (33%), Gaps = 66/430 (15%)

Query: 156 NWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSE 215
              +  +  L    +T     S  +L  + T       +     D +  L NL  +  S 
Sbjct: 20  ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75

Query: 216 NDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSL 275
           N  + + PL   N++ L +  +  N+     P+    NL  LT+      +         
Sbjct: 76  NQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD--------- 124

Query: 276 SNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKL 335
                     L       ++ ++ N++ ++S L    +         +  +  L N + L
Sbjct: 125 -------IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177

Query: 336 VKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT 395
            +L +  N+        +A L+   +LI    NQIS   P  I    NL+ L L  NQL 
Sbjct: 178 ERLDISSNKVSD--ISVLAKLTNLESLI-ATNNQISDITPLGILT--NLDELSLNGNQLK 232

Query: 396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQN 455
                 +  L NL  L L  N I  + P  +  LT L  L+LG N++    P        
Sbjct: 233 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAG 283

Query: 456 LMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNF 515
           L  L+      N                L L  N++S   P+   +L  L +L  + N  
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKV 341

Query: 516 SNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLP 575
           S+                            SL  L +I  L    N +S   P  L NL 
Sbjct: 342 SD--------------------------VSSLANLTNINWLSAGHNQISDLTP--LANLT 373

Query: 576 FLEYLNLSYN 585
            +  L L+  
Sbjct: 374 RITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.5 bits (218), Expect = 4e-19
 Identities = 65/362 (17%), Positives = 123/362 (33%), Gaps = 26/362 (7%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
           +L ++T L   +  +       +   + L  +  + N  +        +L  L  + +  
Sbjct: 42  DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNN 97

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
           N +   T                    +   +    L     + +T   + A++G     
Sbjct: 98  NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157

Query: 373 TIPPEIRNLFNLNGLGLEYNQLTGTIP------PAIGELRNLQYLGLVGNNIRGIIPDPI 426
            +    +         L   +              + +L NL+ L    N I  I P  I
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217

Query: 427 GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDL 486
              T L+ L L  N+L+      L    NL  L   NN+++   P       T    L L
Sbjct: 218 L--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKL 270

Query: 487 SENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
             N +S   PL    L +L  L+++ N   +  P++      L YL +  N+ +   P  
Sbjct: 271 GANQISNISPLA--GLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP-- 324

Query: 547 LNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLT 606
           +++L  ++ L  + N +S      L NL  + +L+  +N      P     +  T++ L 
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN-LTRITQLGLN 381

Query: 607 GN 608
             
Sbjct: 382 DQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.1 bits (217), Expect = 4e-19
 Identities = 72/379 (18%), Positives = 131/379 (34%), Gaps = 39/379 (10%)

Query: 62  QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNS 121
            +VT L  +   I       +  L+ L  IN +NN      P  +  L +L  I+++NN 
Sbjct: 44  DQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99

Query: 122 FSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNL 181
            +   P         +  + +    +  ++ +              N +       I  L
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL----SSNTI-----SDISAL 150

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
           S L +               L  L  L  L  S N  S +    +  +++L+      N+
Sbjct: 151 SGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQ 208

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
                P+ +  N   L  L +  N L      +L++ + L  L+L  N  S       + 
Sbjct: 209 ISDITPLGILTN---LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL--APLSG 261

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMT 361
           L  L++L LG N +             ++  + L  L  +          S  +    +T
Sbjct: 262 LTKLTELKLGANQISN-----------ISPLAGLTALTNLELNENQLEDISPISNLKNLT 310

Query: 362 LIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGI 421
            + +  N IS   P  + +L  L  L    N+++     ++  L N+ +L    N I  +
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366

Query: 422 IPDPIGNLTLLNVLQLGFN 440
              P+ NLT +  L L   
Sbjct: 367 T--PLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 73.5 bits (179), Expect = 2e-14
 Identities = 37/227 (16%), Positives = 78/227 (34%), Gaps = 30/227 (13%)

Query: 10  FWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTKLDL 69
                 + T+  +    +  +  +     +T   +      Q + +T       + +L L
Sbjct: 167 DLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSL 226

Query: 70  ESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIP-- 127
               +       + +L+ L  ++LANN      P  +  L +L  + L  N  S   P  
Sbjct: 227 NGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 282

Query: 128 ------------------TNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQ 169
                             + +S   NL    ++ NN+       + +  K++RL    N+
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340

Query: 170 LTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEN 216
           ++     S+ NL+ +       N++    P  L  L  +  LG ++ 
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.002
 Identities = 10/61 (16%), Positives = 20/61 (32%), Gaps = 4/61 (6%)

Query: 532 LLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKV 591
            ++   +   ++ Q+   L  +  L      +   I   +  L  L  +N S N      
Sbjct: 27  TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT 82

Query: 592 P 592
           P
Sbjct: 83  P 83

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 9e-27
 Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 18/209 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIIT 738
            IG G+ G V          +VA+K ++     +   K    E   ++ + H+N+I ++ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 739 ICSSID-FKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQ 797
           + +     +      +V E M            + +       ++ ++   I++LH+   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER---MSYLLYQMLCGIKHLHSAGI 140

Query: 798 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPE 857
              +H DLKPSN+++  D    + DFGLAR       +              T  Y  PE
Sbjct: 141 ---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRYYRAPE 188

Query: 858 YGMGGDLSMTGDVYSFGILLLEMFTRRRP 886
             +G       D++S G ++ EM   +  
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  104 bits (259), Expect = 5e-25
 Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 13/293 (4%)

Query: 31  QQLHDPLGVTKSWNNSINLCQ--WTGVTC--GHRHQRVTKLDLESQNIGGF--LSPYIGN 84
           + L +P     SW  + + C   W GV C    +  RV  LDL   N+     +   + N
Sbjct: 16  KDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74

Query: 85  LSFLRVINLANN-SFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHT 143
           L +L  + +    +  G IP  + +L +L  + +++ + SG IP  LS+   L+      
Sbjct: 75  LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134

Query: 144 NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQT-FDIAGNKLDGRIPDSL 202
           N L G +   I +   +  ++  GN+++G +P S G+ S L T   I+ N+L G+IP + 
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF 194

Query: 203 GQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVV 262
             L       +          L   +    +   +   +   +  +        L  L +
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDK---NTQKIHLAKNSLAFDLGKVGLSKNLNGLDL 251

Query: 263 AQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL 315
             N + G LPQ L+    L  L ++ N+  G++     +L          N  
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 95.2 bits (235), Expect = 7e-22
 Identities = 67/270 (24%), Positives = 103/270 (38%), Gaps = 31/270 (11%)

Query: 380 NLFNLNGLGLEYNQLTG--TIPPAIGELRNLQYLGLVGN-NIRGIIPDPIGNLTLLNVLQ 436
             + +N L L    L     IP ++  L  L +L + G  N+ G IP  I  LT L+ L 
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 437 LGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIP 496
           +    + G+IP +L + + L+ L    N L+GTLPP I  +      +    N +SG+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN-LVGITFDGNRISGAIP 166

Query: 497 LEVGNLKSLVQLDISRNN-----------------------FSNEIPVTLSACTTLEYLL 533
              G+   L        N                               L         +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 534 MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK 593
               +        +   K++  LDL  N + G +P  L  L FL  LN+S+N+  G++P+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 594 KGVFSNETRISLTGNEQFCGGLGELHLPAC 623
            G        +   N+  CG      LPAC
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS----PLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.6 bits (197), Expect = 6e-17
 Identities = 64/275 (23%), Positives = 103/275 (37%), Gaps = 15/275 (5%)

Query: 155 GNWLKIERLSLYGNQLTG--QLPPSIGNLSALQTFDIAGN-KLDGRIPDSLGQLRNLNYL 211
               ++  L L G  L     +P S+ NL  L    I G   L G IP ++ +L  L+YL
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 212 GTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFL 271
             +  + SG  P  +  I +L       N   G+LP  +  +LP L  +    N ++G +
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAI 165

Query: 272 PQSLSNASKLEW-LELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLT 330
           P S  + SKL   + ++ N  +G++   F +L             G  +           
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225

Query: 331 NCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLE 390
                  L     + G +   +  +L           N+I GT+P  +  L  L+ L + 
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLR---------NNRIYGTLPQGLTQLKFLHSLNVS 276

Query: 391 YNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDP 425
           +N L G IP   G L+         N      P P
Sbjct: 277 FNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 68.2 bits (165), Expect = 9e-13
 Identities = 38/208 (18%), Positives = 61/208 (29%), Gaps = 24/208 (11%)

Query: 43  WNNSINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQI 102
              +             + + +  LD     + G L P I +L  L  I    N   G I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 103 PKEVGRLFRL-----------------------ETIVLSNNSFSGKIPTNLSRCFNLIDF 139
           P   G   +L                          V  + +      + L         
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225

Query: 140 WVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIP 199
                N +      +G    +  L L  N++ G LP  +  L  L + +++ N L G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 200 DSLGQLRNLNYLGTSENDFSGMFPLSVC 227
              G L+  +    + N      PL  C
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 47.1 bits (110), Expect = 5e-06
 Identities = 25/172 (14%), Positives = 56/172 (32%), Gaps = 27/172 (15%)

Query: 7   IFLFWLYSRHATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLCQWTGVTCGHRHQRVTK 66
           I   +       + +  +      +       +  ++ +          +      + T+
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 67  LDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKI 126
               ++N   F    +G    L  ++L NN  +G +P+ + +L  L ++ +S N+  G+I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 127 PTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQ-LTG-QLPP 176
           P                           GN  + +  +   N+ L G  LP 
Sbjct: 285 PQ-------------------------GGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 39.7 bits (91), Expect = 0.001
 Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 4/147 (2%)

Query: 419 RGIIPDPIGNLTLLNVLQLGFNKLQG--SIPSYLGKCQNLMQLS-APNNKLNGTLPPQIF 475
            G++ D       +N L L    L     IPS L     L  L     N L G +PP I 
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 476 GITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQ 535
            +T L   L ++  ++SG+IP  +  +K+LV LD S N  S  +P ++S+   L  +   
Sbjct: 99  KLTQLHY-LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157

Query: 536 GNSFNGSIPQSLNALKSIKELDLSCNN 562
           GN  +G+IP S  +   +        N
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRN 184

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (262), Expect = 6e-25
 Identities = 49/259 (18%), Positives = 95/259 (36%), Gaps = 22/259 (8%)

Query: 681 RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIK----- 735
           ++G G F  V+      +   VA+K++  D K  T++   E + L+ +   +  K     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 736 ---IITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKL---EVGKLNIVIEVASVI 789
              I+ +    + KG +   +V  +   G     L    +      +    I  ++   +
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMK 848
           +Y+H  C   I+H D+KP NVL++  D   ++    +A   +      A           
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN------ACWYDEHYTNSI 190

Query: 849 GTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK 908
            T  Y  PE  +G       D++S   L+ E+ T     +              +A   +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP-DEGHSYTKDDDHIAQIIE 249

Query: 909 VMGIVDPSLLMEARGPSKF 927
           ++G +   LL   +    F
Sbjct: 250 LLGELPSYLLRNGKYTRTF 268

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 96.6 bits (239), Expect = 2e-22
 Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 6/236 (2%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGL 413
            +L     L+ +  N+I+     + +NL NL+ L L  N+++   P A   L  L+ L L
Sbjct: 27  KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86

Query: 414 VGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQ 473
             N ++ +       L  L V +    K++ S+ + L +   + +L     K +G     
Sbjct: 87  SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGA 145

Query: 474 IFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLL 533
             G+  LS  + +++ +++    +  G   SL +L +  N  +     +L     L  L 
Sbjct: 146 FQGMKKLS-YIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201

Query: 534 MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEG 589
           +  NS +     SL     ++EL L+ N L  ++P  L +  +++ + L  N+   
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.3 bits (220), Expect = 7e-20
 Identities = 49/286 (17%), Positives = 98/286 (34%), Gaps = 21/286 (7%)

Query: 160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFS 219
              L L  N++T        NL  L T  +  NK+    P +   L  L  L  S+N   
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 220 GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNAS 279
            +       +  L        + + S+   L  N   +  L       +G    +     
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 280 KLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLG 339
           KL ++ + + + +    I     P+L++L+L  N +    +  L         + L KLG
Sbjct: 151 KLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLK------GLNNLAKLG 201

Query: 340 LVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG--- 396
           L FN       +     +  +  + +  N++   +P  + +   +  + L  N ++    
Sbjct: 202 LSFNSISAV-DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 259

Query: 397 ---TIPPAIGELRNLQYLGLVGNNIR--GIIPDPIGNLTLLNVLQL 437
                P    +  +   + L  N ++   I P     + +   +QL
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.8 bits (216), Expect = 2e-19
 Identities = 49/281 (17%), Positives = 85/281 (30%), Gaps = 21/281 (7%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHG 100
           C    V C                  LDL++  I         NL  L  + L NN    
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 101 QIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKI 160
             P     L +LE + LS N               L         +   +   +   + +
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG 220
           E L     + +G    +   +  L    IA   +   IP  L    +L  L    N  + 
Sbjct: 130 E-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK 185

Query: 221 MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASK 280
           +   S+  +++L +          ++      N P L  L +  N L    P  L++   
Sbjct: 186 VDAASLKGLNNLAKLG-LSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKY 243

Query: 281 LEWLELNENHFSG------QVRINFNSLPNLSKLYLGRNNL 315
           ++ + L+ N+ S                 + S + L  N +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.5 bits (210), Expect = 1e-18
 Identities = 54/269 (20%), Positives = 86/269 (31%), Gaps = 21/269 (7%)

Query: 255 PKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNN 314
           P   +L +  N +T        N   L  L L  N  S      F  L  L +LYL +N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 315 LGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAM-AGNQISGT 373
           L          +  L             N            L+  + +       + SG 
Sbjct: 91  LKELPEKMPKTLQELRVHE---------NEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 374 IPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLN 433
                + +  L+ + +    +T TIP  +    +L  L L GN I  +    +  L  L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 434 VLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSG 493
            L L FN +       L    +L +L   NNKL    P  +     + +++ L  N++S 
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYI-QVVYLHNNNISA 256

Query: 494 ------SIPLEVGNLKSLVQLDISRNNFS 516
                   P       S   + +  N   
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 63.9 bits (154), Expect = 2e-11
 Identities = 32/168 (19%), Positives = 55/168 (32%), Gaps = 5/168 (2%)

Query: 425 PIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLL 484
           P        +L L  NK+           +NL  L   NNK++   P     +  L + L
Sbjct: 26  PKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL-ERL 84

Query: 485 DLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP 544
            LS+N L          L+ L   +         +   L+    +  L       +G   
Sbjct: 85  YLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIEN 143

Query: 545 QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
            +   +K +  + ++  N++    I  G  P L  L+L  N       
Sbjct: 144 GAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDA 188

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 2e-21
 Identities = 25/162 (15%), Positives = 48/162 (29%), Gaps = 23/162 (14%)

Query: 680 NRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATK----------SFVAECEALRNIR 729
             +G+G    V+     E      VK   +      K           F           
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 730 HRNLIKIITICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVI 789
            R L K+  +         +  A++ E +    +        D+       ++  +   +
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDE-------VLDMILEEV 116

Query: 790 EYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH 831
              ++     IVHGDL   NVL+  +    + DF  +  +  
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGE 154

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (213), Expect = 3e-19
 Identities = 47/255 (18%), Positives = 78/255 (30%), Gaps = 5/255 (1%)

Query: 335 LVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQL 394
             ++ L  NR       S         L   +                       +  QL
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 395 TGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQ 454
               P     L  L  L L    ++ + P     L  L  L L  N LQ           
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 455 NLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNN 514
           NL  L    N+++        G+ +L   L L +N ++   P    +L  L+ L +  NN
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSL-DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 515 FSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNL 574
            S      L+    L+YL +  N +      +      +++   S + +   +P  L   
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271

Query: 575 PFLEYLNLSYNHFEG 589
                  L+ N  +G
Sbjct: 272 DL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.8 bits (187), Expect = 8e-16
 Identities = 39/255 (15%), Positives = 72/255 (28%), Gaps = 30/255 (11%)

Query: 64  VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQI--------------------- 102
             ++ L    I    +        L ++ L +N                           
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 103 ----PKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWL 158
               P     L RL T+ L         P        L   ++  N L         +  
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
            +  L L+GN+++     +   L +L    +  N++    P +   L  L  L    N+ 
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
           S +   ++  + +L    L  N +              L     + + +   LPQ L+  
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQRLAG- 270

Query: 279 SKLEWLELNENHFSG 293
              +   L  N   G
Sbjct: 271 --RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (178), Expect = 1e-14
 Identities = 50/252 (19%), Positives = 78/252 (30%), Gaps = 27/252 (10%)

Query: 392 NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLG 451
             L   +P  I      Q + L GN I  +          L +L L  N L     +   
Sbjct: 21  QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 452 KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLS------------------------ 487
               L QL   +N    ++ P  F        L L                         
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137

Query: 488 ENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSL 547
           +N L         +L +L  L +  N  S+          +L+ LL+  N      P + 
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 548 NALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTG 607
             L  +  L L  NNLS      L  L  L+YL L+ N +      + +++   +   + 
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSS 257

Query: 608 NEQFCGGLGELH 619
           +E  C     L 
Sbjct: 258 SEVPCSLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (174), Expect = 4e-14
 Identities = 60/283 (21%), Positives = 94/283 (33%), Gaps = 14/283 (4%)

Query: 162 RLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGM 221
             S     L   +P  I      Q   + GN++      S    RNL  L    N  + +
Sbjct: 15  TTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 222 FPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKL 281
              +   ++ L++  L  N    S+       L +L  L + +  L    P      + L
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 282 EWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLV 341
           ++L L +N         F  L NL+ L+L  N + +                 L +L L 
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV------PERAFRGLHSLDRLLLH 185

Query: 342 FNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPA 401
            NR     PH+  +L   MT + +  N +S      +  L  L  L L  N        A
Sbjct: 186 QNRVAHVHPHAFRDLGRLMT-LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RA 243

Query: 402 IGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
                 LQ      + +   +P  +    L     L  N LQG
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.0 bits (172), Expect = 6e-14
 Identities = 37/267 (13%), Positives = 70/267 (26%), Gaps = 14/267 (5%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLE-WLELNENHFSGQVRINFNSLPNLSKLYL 310
            +P     + +  N ++     S      L      +                       
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 311 GRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQI 370
               L +        +  L           +       L   +      +  + +  N +
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLH-------LDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 371 SGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLT 430
                   R+L NL  L L  N+++     A   L +L  L L  N +  + P    +L 
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 431 LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENH 490
            L  L L  N L       L   + L  L   +N        +   +    +    S + 
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD--CRARPLWAWLQKFRGSSSE 259

Query: 491 LSGSIPLEVGNLKSLVQLDISRNNFSN 517
           +  S+P     L       ++ N+   
Sbjct: 260 VPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.1 bits (141), Expect = 6e-10
 Identities = 28/175 (16%), Positives = 53/175 (30%), Gaps = 4/175 (2%)

Query: 46  SINLCQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKE 105
                Q  G         +  L L+   +         +L  L  + L  N       + 
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172

Query: 106 VGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSL 165
              L  L+ ++L  N  +   P        L+  ++  NNL       +     ++ L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232

Query: 166 YGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG 220
             N        +    + LQ F  + +++   +P     L   +    + ND  G
Sbjct: 233 NDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 59.3 bits (142), Expect = 2e-10
 Identities = 38/221 (17%), Positives = 69/221 (31%), Gaps = 29/221 (13%)

Query: 380 NLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGF 439
            L N   +    + +T T+  A  +L  +  L   G  +  I  + +  L  L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 440 NKLQGS-----------------IPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSK 482
           N++                        +     L  +   +               +  +
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 483 LLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGS 542
           +L L  N ++   PL            +S  N        L+  + L  L    N  +  
Sbjct: 133 VLYLDLNQITNISPLAGLT----NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188

Query: 543 IPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS 583
            P  L +L ++ E+ L  N +S   P  L N   L  + L+
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 3e-06
 Identities = 34/192 (17%), Positives = 63/192 (32%), Gaps = 13/192 (6%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI-NFNSLPNLSKLYLG 311
           +L  +T L      +T    + +   + L  LEL +N  +    + N   +  L      
Sbjct: 39  DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNP 96

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQI- 370
             N+             LT+        L        L   +  ++    L  +   Q  
Sbjct: 97  LKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYL 156

Query: 371 -----SGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDP 425
                  +    + NL  L  L  + N+++   P  +  L NL  + L  N I  +   P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--P 212

Query: 426 IGNLTLLNVLQL 437
           + N + L ++ L
Sbjct: 213 LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 32/218 (14%), Positives = 63/218 (28%), Gaps = 15/218 (6%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
            L     +   ++N+T  + Q+  +   +  L       +         L NL  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKD 72

Query: 313 NNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISG 372
           N +                 S      +       ++       +    +  +AG     
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 373 TIPPEIRNLFNLNGLGLE-------YNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDP 425
            +  ++  + N++ L                +    +  L  L  L    N I  I P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 426 IGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPN 463
           + +L  L  + L  N++    P  L    NL  ++  N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 7e-04
 Identities = 41/237 (17%), Positives = 75/237 (31%), Gaps = 30/237 (12%)

Query: 277 NASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLV 336
             +    +   +++ +    +    L  ++ L      +     T ++ +  L N   L+
Sbjct: 17  ALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGV-----TTIEGVQYLNN---LI 66

Query: 337 KLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG 396
            L L  N+     P       T + L       +S     +     +             
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLD-------LTSTQI 119

Query: 397 TIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNL 456
           T    +  L NLQ L          I +      L N+  L     Q S  + L     L
Sbjct: 120 TDVTPLAGLSNLQVL----YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175

Query: 457 MQLSAPNNKLNGTLPPQIFGITTLSKL--LDLSENHLSGSIPLEVGNLKSLVQLDIS 511
             L A +NK++      I  + +L  L  + L  N +S   PL   N  +L  + ++
Sbjct: 176 TTLKADDNKISD-----ISPLASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.002
 Identities = 30/216 (13%), Positives = 60/216 (27%), Gaps = 19/216 (8%)

Query: 84  NLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSG-------KIPTNLSRCFNL 136
            L+    I    ++    + +    L  + T+       +             L    N 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQ 74

Query: 137 IDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAG----- 191
           I       NL    +  +         ++ G Q    L  +   ++ +            
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 192 NKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLG 251
                +I +        N    S  +        + N+S L       N+     P+   
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA-- 192

Query: 252 FNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELN 287
            +LP L  + +  N ++   P  L+N S L  + L 
Sbjct: 193 -SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.3 bits (130), Expect = 2e-09
 Identities = 27/110 (24%), Positives = 43/110 (39%), Gaps = 6/110 (5%)

Query: 482 KLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNG 541
           ++L L+   L+  +   +  L  +  LD+S N      P  L+A   LE   +Q +    
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEV--LQASDNAL 55

Query: 542 SIPQSLNALKSIKELDLSCNNL-SGQIPIHLGNLPFLEYLNLSYNHFEGK 590
                +  L  ++EL L  N L        L + P L  LNL  N    +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 1e-07
 Identities = 24/129 (18%), Positives = 46/129 (35%), Gaps = 9/129 (6%)

Query: 89  RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVG 148
           RV++LA+      +   + +L  +  + LS+N      P  L+    L       N L  
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 149 EIQAIIGNWLKIERLSLYGNQLTG-QLPPSIGNLSALQTFDIAGNKL---DGRIPDSLGQ 204
                      ++ L L  N+L        + +   L   ++ GN L   +G        
Sbjct: 58  VDGVANLPR--LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 205 LRNLNYLGT 213
           L +++ + T
Sbjct: 116 LPSVSSILT 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 29/125 (23%), Positives = 47/125 (37%), Gaps = 8/125 (6%)

Query: 387 LGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI 446
           L L +  LT  +   + +L  + +L L  N +R + P  +  L  L VLQ   N L+   
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 447 PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLE---VGNLK 503
                     + L   NN+L  +   Q         LL+L  N L     ++      L 
Sbjct: 60  GVANLPRLQELLLC--NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 504 SLVQL 508
           S+  +
Sbjct: 118 SVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 17/126 (13%), Positives = 35/126 (27%), Gaps = 14/126 (11%)

Query: 284 LELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFN 343
           L L     +  V  +   L  ++ L L  N L                 + L  L ++  
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----------ALAALRCLEVLQA 50

Query: 344 RFGGALPHSIANLSTTMTLIAMAGNQISGTIPPE-IRNLFNLNGLGLEYNQLTGTIPPAI 402
                           +  + +  N++  +   + + +   L  L L+ N L        
Sbjct: 51  SDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQ 109

Query: 403 GELRNL 408
             L  +
Sbjct: 110 ERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 11/39 (28%), Positives = 20/39 (51%), Gaps = 2/39 (5%)

Query: 554 KELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
           + L L+  +L+  +  HL  L  + +L+LS+N      P
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP 37

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.003
 Identities = 27/152 (17%), Positives = 46/152 (30%), Gaps = 29/152 (19%)

Query: 185 QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKG 244
           +   +A   L   +   L QL  + +L  S N    + P     +++L    + +     
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54

Query: 245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPN 304
              V    NLP+L  L++  N L                                 S P 
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQ-----------------------PLVSCPR 91

Query: 305 LSKLYLGRNNLGTRTSTDLDFITLLTNCSKLV 336
           L  L L  N+L            +L + S ++
Sbjct: 92  LVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.6 bits (135), Expect = 3e-09
 Identities = 48/219 (21%), Positives = 72/219 (32%), Gaps = 15/219 (6%)

Query: 225 SVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWL 284
            V  ++S  E    K     +LP  L  +    T+L +++N L  F   +L   ++L  L
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDT---TILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 285 ELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNR 344
            L  +           +LP L  L L  N L +          L            V   
Sbjct: 61  NL--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLD--------VSFN 110

Query: 345 FGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGE 404
              +LP         +  + + GN++    P  +     L  L L  N LT      +  
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 405 LRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ 443
           L NL  L L  N++   IP       LL    L  N   
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 4e-07
 Identities = 43/236 (18%), Positives = 72/236 (30%), Gaps = 31/236 (13%)

Query: 377 EIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQ 436
           E+  + +   +  +   LT  +PP +   ++   L L  N +       +   T L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 437 LGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIP 496
           L  ++ + +     G    L  L   +N+L                              
Sbjct: 62  L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL----------------- 102

Query: 497 LEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKEL 556
                      LD+S N  ++     L     L+ L ++GN      P  L     +++L
Sbjct: 103 ---------TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153

Query: 557 DLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFC 612
            L+ NNL+      L  L  L+ L L  N                   L GN   C
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 4e-05
 Identities = 29/180 (16%), Positives = 62/180 (34%), Gaps = 5/180 (2%)

Query: 88  LRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLV 147
             +++L+ N  +      +    RL  + L     +            ++     ++N +
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG---TLPVLGTLDLSHNQL 89

Query: 148 GEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRN 207
             +  +      +  L +  N+LT     ++  L  LQ   + GN+L    P  L     
Sbjct: 90  QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149

Query: 208 LNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNL 267
           L  L  + N+ + +    +  + +LD   L +N    ++P    F    L    +  N  
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF-FGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 49/211 (23%), Positives = 80/211 (37%), Gaps = 8/211 (3%)

Query: 105 EVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLS 164
           EV ++     +     + +  +P +L +  +     +  N L     A +  + ++ +L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 165 LYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPL 224
           L   +         G L  L T D++ N+L          L  L  L  S N  + +   
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLG 118

Query: 225 SVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWL 284
           ++  +  L E YL  N  K +LP  L    PKL  L +A NNLT      L+    L+ L
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 285 ELNENHFSGQVRINFNSLPNLSKLYLGRNNL 315
            L EN     +   F     L   +L  N  
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 3e-04
 Identities = 42/240 (17%), Positives = 76/240 (31%), Gaps = 39/240 (16%)

Query: 177 SIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY 236
            +  +++    +     L   +P  L   ++   L  SEN        ++   + L +  
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVR 296
           L +        + +   LP L  L ++ N L             L  L+++ N  +    
Sbjct: 62  LDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPL 117

Query: 297 INFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANL 356
                L  L +LYL  N                                   LP  +   
Sbjct: 118 GALRGLGELQELYLKGN-------------------------------ELKTLPPGLLTP 146

Query: 357 STTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGN 416
           +  +  +++A N ++      +  L NL+ L L+ N L  TIP        L +  L GN
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 7e-04
 Identities = 15/77 (19%), Positives = 23/77 (29%), Gaps = 1/77 (1%)

Query: 119 NNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSI 178
            N      P  L+    L    +  NNL      ++     ++ L L  N L   +P   
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191

Query: 179 GNLSALQTFDIAGNKLD 195
                L    + GN   
Sbjct: 192 FGSHLLPFAFLHGNPWL 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 2e-08
 Identities = 42/217 (19%), Positives = 78/217 (35%), Gaps = 23/217 (10%)

Query: 373 TIPPEIRNLFNLNGL------GLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPI 426
           T+P  I+ +F+ +         L+   +T  +     EL ++  +    ++I+ +    I
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGI 64

Query: 427 GNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDL 486
             L  +  L L  NKL    P    K    + L     K   +L       +        
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL------- 117

Query: 487 SENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQS 546
           S  H   S    + +L  L  L +  N  ++   ++           ++ N  +  +P  
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS--LEDNQISDIVP-- 173

Query: 547 LNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS 583
           L  L  ++ L LS N++S  +   L  L  L+ L L 
Sbjct: 174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 17/194 (8%)

Query: 253 NLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGR 312
              +     + + ++T  + Q+    + ++ +  N +       I +  LPN++KL+L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNG 77

Query: 313 N---------NLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLI 363
           N         NL       LD   +    S      L            I  L     L 
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 364 AMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIP 423
           ++       T    +  L  L+ L LE NQ++  +P  +  L  LQ L L  N+I  +  
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-- 193

Query: 424 DPIGNLTLLNVLQL 437
             +  L  L+VL+L
Sbjct: 194 RALAGLKNLDVLEL 207

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 1e-07
 Identities = 48/252 (19%), Positives = 82/252 (32%), Gaps = 14/252 (5%)

Query: 65  TKLDLESQNIGGFLSPYIGNLSFLRVINL-ANNSFHGQIPKEVGRLFRLETIVLSNNSFS 123
             LDL  +N         G L    VI      SF  Q   E    FR++ + LSN+   
Sbjct: 3   QTLDLTGKN---LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59

Query: 124 GK-IPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLY--------GNQLTGQL 174
              +   LS+C  L +  +    L   I   +     + RL+L           Q     
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 175 PPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDE 234
              +  L+    FD     +   +      +  LN  G  +N         V    +L  
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 235 AYLFKNRFKGSLPVCLGFNLPKLTVLVVAQ-NNLTGFLPQSLSNASKLEWLELNENHFSG 293
             L  +    +      F L  L  L +++  ++       L     L+ L++      G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 294 QVRINFNSLPNL 305
            +++   +LP+L
Sbjct: 240 TLQLLKEALPHL 251

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 1e-07
 Identities = 47/269 (17%), Positives = 87/269 (32%), Gaps = 17/269 (6%)

Query: 319 TSTDLDFITLLTNC-SKLVKLGLVFNRFGGAL---PHSIANLSTTMTLIAMAGNQISGTI 374
            + DL    L  +   +L+  G++  R   +    P +       +  + ++ + I  + 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62

Query: 375 PPEI-RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLN 433
              I      L  L LE  +L+  I   + +  NL  L L G +            +   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 434 VLQL--------GFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLD 485
           + +L            +Q ++         L       N     L   +     L  L  
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 486 LSENHLSGSIPLEVGNLKSLVQLDISR-NNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP 544
                L      E   L  L  L +SR  +   E  + L    TL+ L + G   +G++ 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 545 QSLNALKSIKELDLSCNNLSGQIPIHLGN 573
               AL     L ++C++ +      +GN
Sbjct: 243 LLKEALPH---LQINCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 4e-07
 Identities = 39/254 (15%), Positives = 78/254 (30%), Gaps = 13/254 (5%)

Query: 349 LPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI-GELRN 407
            P     L +   +              E  + F +  + L  + +  +    I  +   
Sbjct: 13  HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK 72

Query: 408 LQYLGLVGNNIRGIIPDPIGNLTLLNVL--QLGFNKLQGSIPSYLGKCQNLMQLSAPNNK 465
           LQ L L G  +   I + +   + L  L         + ++ + L  C  L +L+     
Sbjct: 73  LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132

Query: 466 LNGTLP-----PQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRN-NFSNEI 519
                        +    T   L    +N     +   V    +LV LD+S +    N+ 
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192

Query: 520 PVTLSACTTLEYLLMQG-NSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLE 578
                    L++L +             L  + ++K L +      G + +    LP   
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP--- 249

Query: 579 YLNLSYNHFEGKVP 592
           +L ++ +HF     
Sbjct: 250 HLQINCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 6e-06
 Identities = 42/297 (14%), Positives = 93/297 (31%), Gaps = 28/297 (9%)

Query: 265 NNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLD 324
            NL   +   L  +  +       +     +  +F S   +  + L  + +         
Sbjct: 10  KNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVI-----EVST 62

Query: 325 FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNL 384
              +L+ CSKL  L L   R    + +++A  S  + L     +  S      + +  + 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 385 NGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQG 444
                       T                   +++  +      +T LN+     N  + 
Sbjct: 123 LDELNLSWCFDFTE-----------------KHVQVAVAHVSETITQLNLSGYRKNLQKS 165

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSE-NHLSGSIPLEVGNLK 503
            + + + +C NL+ L   ++ +      Q F      + L LS    +     LE+G + 
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225

Query: 504 SLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSC 560
           +L  L +        + +   A   L+      + F      ++   K+ +   + C
Sbjct: 226 TLKTLQVFGIVPDGTLQLLKEALPHLQINC---SHFTTIARPTIGNKKNQEIWGIKC 279

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 1e-07
 Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 13/97 (13%)

Query: 501 NLKSLVQLDISRNNFSNE-IPVTLSACTTLEYLLMQGNSFNG----SIPQSLNALKSIKE 555
           +++SL   DI     S+      L      + + +            I  +L    ++ E
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 556 LDLSCNNLSGQIPIHLG-----NLPFLEYLNLSYNHF 587
           L+L  N L       +          ++ L+L     
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 17/79 (21%), Positives = 34/79 (43%), Gaps = 9/79 (11%)

Query: 482 KLLDLSENHLSG----SIPLEVGNLKSLVQLDISRNNFSNEIPVTLSA-----CTTLEYL 532
           ++L L++  +S     S+   +    SL +LD+S N   +   + L          LE L
Sbjct: 372 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQL 431

Query: 533 LMQGNSFNGSIPQSLNALK 551
           ++    ++  +   L AL+
Sbjct: 432 VLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 18/77 (23%), Positives = 30/77 (38%), Gaps = 9/77 (11%)

Query: 526 CTTLEYLLMQGNSFNG----SIPQSLNALKSIKELDLSCNNLSGQIPIHLG-----NLPF 576
            + L  L +     +     S+  +L A  S++ELDLS N L     + L          
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 577 LEYLNLSYNHFEGKVPK 593
           LE L L   ++  ++  
Sbjct: 428 LEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 5/70 (7%)

Query: 529 LEYLLMQGNSFNGS-IPQSLNALKSIKELDLSCNNLSGQ----IPIHLGNLPFLEYLNLS 583
           ++ L +Q    + +   + L  L+  + + L    L+      I   L   P L  LNL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 584 YNHFEGKVPK 593
            N        
Sbjct: 64  SNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 9e-06
 Identities = 15/83 (18%), Positives = 31/83 (37%), Gaps = 9/83 (10%)

Query: 501 NLKSLVQLDISRNNFSNE----IPVTLSACTTLEYLLMQGNSFNGSIPQSL-NALKS--- 552
               L  L ++  + S+     +  TL A  +L  L +  N    +    L  +++    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 553 -IKELDLSCNNLSGQIPIHLGNL 574
            +++L L     S ++   L  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 10/89 (11%)

Query: 484 LDLSENHLSGSIPLEV-GNLKSLVQLDISRNNFSNE----IPVTLSACTTLEYLLMQGNS 538
           LD+    LS +   E+   L+    + +     +      I   L     L  L ++ N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 539 FNGSIPQSL-NALKS----IKELDLSCNN 562
                   +   L++    I++L L    
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 14/89 (15%), Positives = 30/89 (33%), Gaps = 10/89 (11%)

Query: 383 NLNGLGLEYNQLTGT-IPPAIGELRNLQYLGLVGNNIRGI----IPDPIGNLTLLNVLQL 437
           ++  L ++  +L+       +  L+  Q + L    +       I   +     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 438 GFNKLQGSIPSYLGKCQNLMQLSAPNNKL 466
             N+L       + +      L  P+ K+
Sbjct: 63  RSNELGDVGVHCVLQG-----LQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 14/92 (15%), Positives = 27/92 (29%), Gaps = 6/92 (6%)

Query: 298 NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGG----ALPHSI 353
                  L  L+L   ++   + + L     L     L +L L  N  G      L  S+
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLFNLN 385
                 +  + +     S  +   ++ L    
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 10/95 (10%), Positives = 33/95 (34%), Gaps = 9/95 (9%)

Query: 455 NLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSG----SIPLEVGNLKSLVQLDI 510
           ++  L     +L+     ++  +    +++ L +  L+      I   +    +L +L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 511 SRNNFSNEIPVTL-----SACTTLEYLLMQGNSFN 540
             N   +     +     +    ++ L +Q     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 12/100 (12%), Positives = 29/100 (29%), Gaps = 9/100 (9%)

Query: 133 CFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQ----LPPSIGNLSALQTFD 188
              + +  +    +    Q +      +  L L    ++      L  ++    +L+  D
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 403

Query: 189 IAGNKLDGRIPDSLGQ-----LRNLNYLGTSENDFSGMFP 223
           ++ N L       L +        L  L   +  +S    
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 11/88 (12%), Positives = 29/88 (32%), Gaps = 5/88 (5%)

Query: 64  VTKLDLESQNIGGF-LSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFR----LETIVLS 118
           +  LD++ + +     +  +  L   +V+ L +        K++    R    L  + L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 119 NNSFSGKIPTNLSRCFNLIDFWVHTNNL 146
           +N         + +        +   +L
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 12/85 (14%), Positives = 24/85 (28%), Gaps = 9/85 (10%)

Query: 379 RNLFNLNGLGLEYNQLTGT----IPPAIGELRNLQYLGLVGNNIRGIIPDPIG-----NL 429
           +    L  L L    ++ +    +   +    +L+ L L  N +       +        
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 430 TLLNVLQLGFNKLQGSIPSYLGKCQ 454
            LL  L L        +   L   +
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 24/113 (21%), Positives = 37/113 (32%), Gaps = 24/113 (21%)

Query: 228 NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELN 287
           +I SLD   +       +    L   L +  V+ +    LT    + +S+A         
Sbjct: 3   DIQSLD---IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--------- 50

Query: 288 ENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGL 340
                          P L++L L  N LG      +    L T   K+ KL L
Sbjct: 51  -----------LRVNPALAELNLRSNELGDVGVHCV-LQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 13/76 (17%), Positives = 23/76 (30%), Gaps = 5/76 (6%)

Query: 158 LKIERLSLYGNQLT-GQLPPSIGNLSALQTFDIAGNKLDGR----IPDSLGQLRNLNYLG 212
           L I+ L +   +L+  +    +  L   Q   +    L       I  +L     L  L 
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 213 TSENDFSGMFPLSVCN 228
              N+   +    V  
Sbjct: 62  LRSNELGDVGVHCVLQ 77

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 16/86 (18%), Positives = 27/86 (31%), Gaps = 5/86 (5%)

Query: 275 LSNASKLEWLELNENHFSGQVRINFNS----LPNLSKLYLGRNNLGTRTSTDLDFITLLT 330
               S L  L L +   S     +  +      +L +L L  N LG      L   ++  
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423

Query: 331 NCSKLVKLGLVFNRFGGALPHSIANL 356
               L +L L    +   +   +  L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 51/325 (15%), Positives = 86/325 (26%), Gaps = 17/325 (5%)

Query: 159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
           +   L L    L+  LP    +L   ++   + N L   +P+    L++L     +    
Sbjct: 39  QAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
           S + PL      S ++          S    +  +   L  L     +L      +    
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 279 SKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFIT---LLTNCSKL 335
              E   L           +   LP+L                  +      L T  +  
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 336 VKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLT 395
             L  + +        ++ +   T                     L  L       N  +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 396 GTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQN 455
             I        +L+ L +  N +   +P     L  L      FN L   +P      QN
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPELP---QN 325

Query: 456 LMQLSAPNNKLNGTLPPQIFGITTL 480
           L QL    N L    P     +  L
Sbjct: 326 LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.4 bits (116), Expect = 1e-06
 Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 10/96 (10%)

Query: 486 LSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQ 545
              N  S  I        SL +L++S N    E+P        LE L+   N     +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 546 SLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLN 581
                +++K+L +  N L  + P    ++  L  +N
Sbjct: 322 LP---QNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 1e-05
 Identities = 21/79 (26%), Positives = 32/79 (40%), Gaps = 8/79 (10%)

Query: 511 SRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH 570
             N  SNEI        +LE L +  N     +P     L+    L  S N+L+ ++P  
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPEL 322

Query: 571 LGNLPFLEYLNLSYNHFEG 589
             NL   + L++ YN    
Sbjct: 323 PQNL---KQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.7 bits (101), Expect = 7e-05
 Identities = 15/77 (19%), Positives = 32/77 (41%), Gaps = 9/77 (11%)

Query: 358 TTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNN 417
            ++  + ++ N++   +P     L  L      +N L   +P      +NL+ L +  N 
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE---LPQNLKQLHVEYNP 335

Query: 418 IRGIIPDPIGNLTLLNV 434
           +R   PD   ++  L +
Sbjct: 336 LRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.7 bits (101), Expect = 8e-05
 Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 9/100 (9%)

Query: 133 CFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGN 192
              L     + N    EI+++      +E L++  N+L  +LP     L  L     + N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFN 314

Query: 193 KLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSL 232
            L   +P+    L+ L+      N     FP    ++  L
Sbjct: 315 HL-AEVPELPQNLKQLH---VEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 22/127 (17%), Positives = 39/127 (30%), Gaps = 40/127 (31%)

Query: 283 WLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVF 342
                 N  S ++R   +  P+L +L +  N L                           
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE------------------------- 298

Query: 343 NRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAI 402
                 LP     L      +  + N ++  +P   +NL  L+   +EYN L    P   
Sbjct: 299 ------LPALPPRLER----LIASFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIP 343

Query: 403 GELRNLQ 409
             + +L+
Sbjct: 344 ESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.001
 Identities = 19/75 (25%), Positives = 35/75 (46%), Gaps = 7/75 (9%)

Query: 534 MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK 593
              N+ +  I    +   S++EL++S N L  ++P        LE L  S+NH   +VP+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE 321

Query: 594 KGVFSNETRISLTGN 608
             +  N  ++ +  N
Sbjct: 322 --LPQNLKQLHVEYN 334

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (110), Expect = 2e-06
 Identities = 20/140 (14%), Positives = 38/140 (27%), Gaps = 6/140 (4%)

Query: 376 PEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVL 435
            +  N      L L   ++   I      L     +    N IR +  D    L  L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 68

Query: 436 QLGFNKLQGSIPSYLG--KCQNLMQLSAPN-NKLNGTLPPQIFGITTLSKLLDLSENHLS 492
            +  N++                + L+  +  +L    P       T   +L     +  
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 493 GSIPLEVGNLKSLVQLDISR 512
                 +  +  +  LD  +
Sbjct: 129 HYRLYVIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 2e-04
 Identities = 26/149 (17%), Positives = 48/149 (32%), Gaps = 7/149 (4%)

Query: 143 TNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSL 202
           T  L+ +      N ++   L L G ++   +      L      D + N++  R  D  
Sbjct: 4   TAELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59

Query: 203 GQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVV 262
             LR L  L  + N    +       +  L E  L  N       +    +L  LT L +
Sbjct: 60  PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119

Query: 263 ---AQNNLTGFLPQSLSNASKLEWLELNE 288
                 N   +    +    ++  L+  +
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 6e-04
 Identities = 11/45 (24%), Positives = 18/45 (40%), Gaps = 2/45 (4%)

Query: 543 IPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHF 587
             Q  NA++  +ELDL    +   I      L   + ++ S N  
Sbjct: 11  AAQYTNAVR-DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.1 bits (110), Expect = 2e-06
 Identities = 33/163 (20%), Positives = 58/163 (35%), Gaps = 6/163 (3%)

Query: 354 ANLSTTMTLIAMAGNQISGTIPPEIRNLF-NLNGLGLEYNQLTGTIPPAIGELRNLQYLG 412
            ++    T + +  N++       +     +L  L L+ NQLTG  P A     ++Q L 
Sbjct: 25  RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84

Query: 413 LVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPP 472
           L  N I+ I       L  L  L L  N++   +P       +L  L+  +N  N     
Sbjct: 85  LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144

Query: 473 QIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNF 515
             F      +   L+        P     ++ +   D+  + F
Sbjct: 145 AWF--AEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 4e-04
 Identities = 32/188 (17%), Positives = 54/188 (28%), Gaps = 38/188 (20%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNIGGFL-SPYIGNLSFLRVIN------- 92
           C+ T V C  R             T+L L    +G        G L  L  +        
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 93  -----------------LANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFN 135
                            L  N       K    L +L+T+ L +N  S  +P +     +
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 136 LIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLD 195
           L    + +N        +      + + SL G       P     +  +Q  D+  ++  
Sbjct: 128 LTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183

Query: 196 GRIPDSLG 203
               +S G
Sbjct: 184 CSSENSEG 191

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 4e-06
 Identities = 34/201 (16%), Positives = 57/201 (28%), Gaps = 17/201 (8%)

Query: 380 NLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGF 439
            L       L    +T T+     +L  +  L      I+ I  D +  L  L  +    
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 440 NKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEV 499
           N+L    P         + ++         L                +           +
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF----NNQITDIDPLKNL 127

Query: 500 GNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLS 559
            NL  L          SN I    +         +  +S   +  + L  L +++ LD+S
Sbjct: 128 TNLNRL-------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDIS 180

Query: 560 CNNLSGQIPIHLGNLPFLEYL 580
            N +S      L  L  LE L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 25/190 (13%), Positives = 47/190 (24%), Gaps = 22/190 (11%)

Query: 159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDF 218
           +  +  L    +T     S  +L  + T       +  +  D +  L NL  +  S N  
Sbjct: 19  EKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQL 74

Query: 219 SGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNA 278
           + + PL              +      L          L    +   +    L       
Sbjct: 75  TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 134

Query: 279 SKLEWLELNENHFSGQVR-------------INFNSLPNLSKLYLGRNNLGTRTSTDLDF 325
                +                             +L  L +L +  N +     +D+  
Sbjct: 135 LSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKV-----SDISV 189

Query: 326 ITLLTNCSKL 335
           +  LTN   L
Sbjct: 190 LAKLTNLESL 199

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 2e-05
 Identities = 31/219 (14%), Positives = 54/219 (24%), Gaps = 30/219 (13%)

Query: 392 NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLG 451
           +++T  IP  +   RN   L  V   +R I          L  +++  N +   I + + 
Sbjct: 18  SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74

Query: 452 KCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPL-------------- 497
                +         N             +    L  N     +P               
Sbjct: 75  SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134

Query: 498 -------------EVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIP 544
                         VG     V L +++N          +     E  L   N+      
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194

Query: 545 QSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLS 583
              +       LD+S   +       L NL  L   +  
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 29/265 (10%), Positives = 59/265 (22%), Gaps = 40/265 (15%)

Query: 50  CQWTGVTCGHRH---------QRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHG 100
           C      C             +   +L      +             L  I ++ N    
Sbjct: 8   CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 101 QIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKI 160
            I  +V             ++        + +  NL+         +  +Q ++ +   I
Sbjct: 68  VIEADV------------FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 115

Query: 161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSG 220
           + L       + Q        +         + +       +  L            F+G
Sbjct: 116 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG 175

Query: 221 MFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASK 280
                +             N     LP  +        +L +++  +       L N  K
Sbjct: 176 TQLDELNLSD---------NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 226

Query: 281 LEWLELNENHFSGQVRINFNSLPNL 305
           L                N   LP L
Sbjct: 227 LRARSTY----------NLKKLPTL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 30/221 (13%), Positives = 57/221 (25%), Gaps = 7/221 (3%)

Query: 253 NLPK-LTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG 311
           +LP+    L      L      + S    LE +E+++N     +  +  S          
Sbjct: 26  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85

Query: 312 RNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQIS 371
                        F  L      L+    + +       HS+  +   +           
Sbjct: 86  EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 145

Query: 372 GTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTL 431
            +          L    L  N +      A    +  +      NN+  +  D     + 
Sbjct: 146 NSFVGLSFESVILW---LNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASG 202

Query: 432 LNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPP 472
             +L +   ++       L   + L   S  N K    LP 
Sbjct: 203 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 2e-05
 Identities = 19/113 (16%), Positives = 36/113 (31%), Gaps = 7/113 (6%)

Query: 482 KLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGN--SF 539
           + LDL           ++      V L+   ++ +  + +       L  L +  N    
Sbjct: 25  QALDLKGLR----SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYR 79

Query: 540 NGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVP 592
              +   +    ++K L+LS N L  +  +       LE L L  N       
Sbjct: 80  LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 1e-04
 Identities = 22/147 (14%), Positives = 49/147 (33%), Gaps = 15/147 (10%)

Query: 445 SIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLS-ENHLSGSIPLEVGNLK 503
            +   + K  +  Q +     L          +   +  + L+  + ++ ++ +   N+ 
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIP 65

Query: 504 SLVQLDISRNNFSN--EIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN 561
            L+ L++S N      ++   +     L+ L + GN               ++EL L  N
Sbjct: 66  ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125

Query: 562 NLSGQIPIH-------LGNLPFLEYLN 581
           +LS                 P L  L+
Sbjct: 126 SLSDTFRDQSTYISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 20/89 (22%), Positives = 38/89 (42%), Gaps = 3/89 (3%)

Query: 253 NLPKLTVLVVAQNNLTGF--LPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYL 310
           N+P+L  L ++ N L     +   +  A  L+ L L+ N    +  ++      L +L+L
Sbjct: 63  NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122

Query: 311 GRNNLGTRTSTDLDFI-TLLTNCSKLVKL 338
             N+L         +I  +     KL++L
Sbjct: 123 DGNSLSDTFRDQSTYISAIRERFPKLLRL 151

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 3e-04
 Identities = 12/93 (12%), Positives = 33/93 (35%), Gaps = 13/93 (13%)

Query: 133 CFNLIDFWVHTNNLVGEIQAIIGNWL------KIERLSLYGNQLTGQLPPSI-----GNL 181
             NL +  ++   L     A + +         ++ L L  N++      ++       +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 182 SALQTFDIAGNKL--DGRIPDSLGQLRNLNYLG 212
             L   ++ GN+   +  + D + ++ +    G
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 7e-04
 Identities = 15/94 (15%), Positives = 35/94 (37%), Gaps = 8/94 (8%)

Query: 382 FNLNGLGLEYNQLTG----TIPPAIGELRNLQYLGLVGNNIRG----IIPDPIGNLTLLN 433
           F++ G  L+ + +T     ++   + E  +++ + L GN I       + + I +   L 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 434 VLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLN 467
           + +                 + L+Q      KL+
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 11/48 (22%), Positives = 17/48 (35%), Gaps = 5/48 (10%)

Query: 546 SLNALKSIKELDLSCNNLSGQIPIHL-----GNLPFLEYLNLSYNHFE 588
           S      ++ L L  N +       L       +P L +L L+ N F 
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 0.001
 Identities = 14/86 (16%), Positives = 30/86 (34%), Gaps = 5/86 (5%)

Query: 482 KLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNE----IPVTLSACTTLEYLLMQGN 537
           KL  ++      S+   +    S+ ++ +S N    E    +   +++   LE       
Sbjct: 11  KLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69

Query: 538 SFNGSIPQSLNALKSIKELDLSCNNL 563
                  +   AL+ + +  L C  L
Sbjct: 70  FTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 0.001
 Identities = 43/333 (12%), Positives = 87/333 (26%), Gaps = 19/333 (5%)

Query: 66  KLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFR----LETIVLSNNS 121
           KLD  +      +   +     ++ I L+ N+   +  + +         LE    S+  
Sbjct: 11  KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70

Query: 122 FSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNL 181
                         L+   +    L         + +++   +         +     + 
Sbjct: 71  TGRVKDEIPEALRLLLQALLKCPKL---------HTVRLSDNAFGPTAQEPLIDFLSKHT 121

Query: 182 SALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNR 241
                +                 L+ L     ++N       +   N         +   
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181

Query: 242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNS 301
           F+    +     +         ++ L   L                 +  S  + I   S
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 302 LPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGG----ALPHSIANLS 357
            PNL +L L    L  R +  +           L  L L +N         L   I    
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 358 TTMTLIAMAGNQIS--GTIPPEIRNLFNLNGLG 388
             +  + + GN+ S    +  EIR +F+  G G
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.002
 Identities = 43/334 (12%), Positives = 92/334 (27%), Gaps = 28/334 (8%)

Query: 158 LKIERLSLYGNQLTGQ----LPPSIGNLSALQTFDIAGNKLDGR----IPDSLGQLRNLN 209
             IE  SL  + +T +    +   +    +++   ++GN +       + +++   ++L 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 210 YLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTG 269
               S+     +       +  L +A L   +          F       L+   +  T 
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 270 FLPQSLSNASKLEWLELNENHFSGQVRIN--FNSLPNLSKLYLGRNNLGTRTSTDLD--- 324
                L N                ++ +N    + P L  +  GRN L   +  +     
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 325 ---FITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNL 381
               +       +                     L           +  S  +   +++ 
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 382 FNLNGLGLEYNQLTGTIPPAIGE------LRNLQYLGLVGNNIRGIIPDPI-----GNLT 430
            NL  LGL    L+     A+ +         LQ L L  N I       +       + 
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 431 LLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNN 464
            L  L+L  N+        + + + +        
Sbjct: 303 DLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 11/50 (22%), Positives = 20/50 (40%), Gaps = 4/50 (8%)

Query: 542 SIPQSLNALKSIKELDLSCNNLSGQ----IPIHLGNLPFLEYLNLSYNHF 587
           S+   L    S+KE+ LS N +  +    +  ++ +   LE    S    
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 41/310 (13%), Positives = 75/310 (24%), Gaps = 26/310 (8%)

Query: 271 LPQSLSNASKLEWLELNENHFSGQ----VRINFNSLPNLSKLYLGRNNLGTRTSTDLDFI 326
           +   L     ++ + L+ N    +    +  N  S  +L          G       + +
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 327 TLLT----NCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLF 382
            LL      C KL  + L  N FG      + +  +  T +       +G  P     + 
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 383 NLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKL 442
                     +     P           L                 L  + ++Q G    
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGR-NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201

Query: 443 QGSIPSYLGKCQ-----NLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSI-- 495
                   G         L         L  +            + L L++  LS     
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261

Query: 496 ----PLEVGNLKSLVQLDISRNNFSNEIPVTLSA-----CTTLEYLLMQGNSFNGSIPQS 546
                        L  L +  N    +   TL          L +L + GN F       
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDV 320

Query: 547 LNALKSIKEL 556
           ++ ++ +   
Sbjct: 321 VDEIREVFST 330

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 19/73 (26%), Positives = 27/73 (36%), Gaps = 11/73 (15%)

Query: 373 TIPPEIRNLFNLNG---LGLEYNQLTGTIPP------AIGELRNLQYLGLVGNNIRGIIP 423
           TI   IR             E  +L G IPP       +  L+  ++L L  NNI  I  
Sbjct: 6   TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-- 63

Query: 424 DPIGNLTLLNVLQ 436
             +  +  L +L 
Sbjct: 64  SSLSGMENLRILS 76

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.003
 Identities = 17/148 (11%), Positives = 39/148 (26%), Gaps = 12/148 (8%)

Query: 50  CQWTGVTCGHRH-----------QRVTKLDLESQN-IGGFLSPYIGNLSFLRVINLANNS 97
              +G+ C               + +T+L +E+Q  +       +  L  LR + +  + 
Sbjct: 8   HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 98  FHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNW 157
                P       RL  + LS N+        +                       +  W
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 158 LKIERLSLYGNQLTGQLPPSIGNLSALQ 185
            +     +   +L       + ++    
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	973
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.77
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.71
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.53
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.51
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.46
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.46
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.41
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.29
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.29
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.26
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.19
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.43
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.32
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.19
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.33
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.3
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.29
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.5
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.4
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.79
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.82

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-49  Score=415.90  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=206.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+     ++..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            3579999999999999999999999999999999975532 334678999999999999999999999765     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999999998888888999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ..      ........+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..................     
T Consensus       156 ~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-----  224 (271)
T d1nvra_         156 NN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----  224 (271)
T ss_dssp             TT------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-----
T ss_pred             CC------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Confidence            21      1223345679999999999988876 67899999999999999999999765443222211111100     


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                  ...........+.+++.+||+.||++|||++|+++.
T Consensus       225 ------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         225 ------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                        011112234556788899999999999999998763

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=415.13  Aligned_cols=251  Identities=24%  Similarity=0.300  Sum_probs=209.2

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++++.++|||||++++++..     .+..++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            579999999999999999999999999999999987666667789999999999999999999998765     478999


Q ss_pred             EEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          754 VYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      ||||+++|+|.+++.+. .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+..... 
T Consensus        95 vmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-  169 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-  169 (293)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred             EEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc-
Confidence            99999999999987654 578888999999999999999999   9999999999999999999999999999876432 


Q ss_pred             CccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                             ........||+.|+|||++.+..|+.++||||+||++|+|++|+.||....... .+........        
T Consensus       170 -------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~--------  233 (293)
T d1yhwa1         170 -------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGT--------  233 (293)
T ss_dssp             -------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCS--------
T ss_pred             -------cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCC--------
Confidence                   223345679999999999999999999999999999999999999997542211 1111111000        


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                              .....+..++..+.+++.+||+.||++|||++|++++
T Consensus       234 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         234 --------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    0011123345567789999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=410.84  Aligned_cols=246  Identities=23%  Similarity=0.350  Sum_probs=206.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|+++++.++|||||++++++.+     +..
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence            5799999999999999999999999999999999743   23345778999999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++...+.+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence            999999999999999999888889999999999999999999999   99999999999999999999999999997653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .          .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+  +  +..... .   
T Consensus       158 ~----------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~--~~~i~~-~---  219 (263)
T d2j4za1         158 S----------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--T--YKRISR-V---  219 (263)
T ss_dssp             C----------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H--HHHHHT-T---
T ss_pred             C----------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--H--HHHHHc-C---
Confidence            2          22335679999999999999999999999999999999999999997542211  1  111100 0   


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                           .       ...+...++.+.+++.+||+.||++|||++|+++
T Consensus       220 -----~-------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 -----E-------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -----C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----C-------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                 0       0011223456678889999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=411.50  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=203.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|++.   ..||||+++...  ....+.+.+|++++++++|||||++++++..      +.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            468999999999999999999874   369999997543  3456789999999999999999999998643      46


Q ss_pred             EEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          751 KAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      .++||||+++|+|.+++... ..+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+..
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            79999999999999999754 4567788999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ....      .........||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+...............  
T Consensus       155 ~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~--  226 (276)
T d1uwha_         155 SRWS------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY--  226 (276)
T ss_dssp             -----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS--
T ss_pred             cccC------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC--
Confidence            4321      1223345679999999999864   3589999999999999999999999986543221111111111  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                            ..+..      ......+++.+.+++.+||+.||++||||+||++.|+.+..
T Consensus       227 ------~~p~~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         227 ------LSPDL------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ------CCCCG------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCcc------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  01110      11123445678899999999999999999999999998864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=403.36  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=201.6

Q ss_pred             CcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          677 SSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       677 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      +..++||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++|||||++++++... ..+....++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence            56678999999999999999999999999997543  33456789999999999999999999997653 3445678999


Q ss_pred             EeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEec-CCCcEEEeccccchhccC
Q 039720          755 YEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPP--IVHGDLKPSNVLLD-HDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivHrDik~~NILl~-~~~~~kl~Dfg~a~~~~~  831 (973)
                      |||+++|+|.+++.+...+++..+..++.||++||+|||++   +  |+||||||+|||++ .++.+||+|||+|+....
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999999888888899999999999999999998   6  99999999999996 578999999999985432


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                                .......||+.|+|||++.+ +|+.++||||+||++|||++|+.||................        
T Consensus       168 ----------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~--------  228 (270)
T d1t4ha_         168 ----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--------  228 (270)
T ss_dssp             ----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--------
T ss_pred             ----------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC--------
Confidence                      22345679999999999865 69999999999999999999999997543221111111000        


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                       ..+        ........+.+.+++.+||+.||++|||++|+++
T Consensus       229 -~~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 -VKP--------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -CCC--------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CCC--------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence             000        0111222345778999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-48  Score=408.50  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=194.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....  ....+.+.+|++++++++|||||++++++.+.   ....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence            368999999999999999999999999999999997543  33456789999999999999999999987532   3456


Q ss_pred             EEEEEeeccCCCHHHHhhh----cCCCchhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          751 KAIVYEYMQYGSVDDWLHH----TNDKLEVGKLNIVIEVASVIEYLHNHC--QPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                      .++||||+++|+|.+++..    ...+++..++.++.|++.||.|||++.  ..+|+||||||+|||++.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            8999999999999999864    345778899999999999999999871  1139999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      +|+.....        ........||+.|+|||++.+..|+.++|||||||++|||+||+.||......  .+.......
T Consensus       160 ~a~~~~~~--------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~  229 (269)
T d2java1         160 LARILNHD--------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREG  229 (269)
T ss_dssp             HHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT
T ss_pred             ceeecccC--------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcC
Confidence            99976542        22233567999999999999999999999999999999999999999754221  111111000


Q ss_pred             cCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          905 LPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                         .        .      +..+..+++.+.+++.+||+.||++|||++|+++
T Consensus       230 ---~--------~------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 ---K--------F------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---C--------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C--------C------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               0        0      0111223456778999999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-48  Score=412.72  Aligned_cols=252  Identities=22%  Similarity=0.306  Sum_probs=206.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      +.|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++.+     ++..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            468999999999999999999999999999999987666667789999999999999999999999765     478999


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ||||+++|+|.+++.+. ..+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            99999999999997754 4578888999999999999999999   9999999999999999999999999999754321


Q ss_pred             CCccCCCCCcccccccccccccCccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGM-----GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                              ........||+.|+|||++.     ...|+.++||||+||++|||++|+.||......+. +.......   
T Consensus       164 --------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~---  231 (288)
T d2jfla1         164 --------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSE---  231 (288)
T ss_dssp             --------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSC---
T ss_pred             --------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCC---
Confidence                    11223457999999999874     45689999999999999999999999976433211 11111100   


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                   ......+..++.++.+++.+||+.||++|||++|++++
T Consensus       232 -------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 -------------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -------------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                         00111223345667889999999999999999999873

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.6e-48  Score=413.77  Aligned_cols=259  Identities=24%  Similarity=0.425  Sum_probs=210.3

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++.+.. ..+++.+|++++++++|||||+++++|.+     .+..
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~   88 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF   88 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEee-----CCee
Confidence            34689999999999999999999998999999999975543 45679999999999999999999998754     4788


Q ss_pred             EEEEeeccCCCHHHHhhhc--CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          752 AIVYEYMQYGSVDDWLHHT--NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ++||||+++|+|.+++...  ...++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999998754  3456778899999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....       ........||+.|+|||++.+..|+.++|||||||++|||++|..||....... .+......      
T Consensus       166 ~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~------  231 (287)
T d1opja_         166 TGDT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEK------  231 (287)
T ss_dssp             CSSS-------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHT------
T ss_pred             CCCC-------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhc------
Confidence            4322       222334468899999999999999999999999999999999777654322211 11111110      


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                            ..     .+..+..++..+.+++.+||+.||++|||++||++.|+.+..
T Consensus       232 ------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 ------DY-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ------TC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ------CC-----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  00     112223345678899999999999999999999999988743

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=405.15  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=196.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||+++++|..     ++..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence            57889999999999999999996 67889999997543 345679999999999999999999999754     367899


Q ss_pred             EEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ||||+++|+|.+++... ....+..+..++.|||.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            99999999999998755 3456778899999999999999999   9999999999999999999999999999876442


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .       ........||+.|+|||++.+..|+.++|||||||++|||+|+ ++||.....  ..+.......       
T Consensus       155 ~-------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~-------  218 (263)
T d1sm2a_         155 Q-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTG-------  218 (263)
T ss_dssp             -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHHT-------
T ss_pred             C-------ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHhc-------
Confidence            2       2223345689999999999999999999999999999999995 555543221  1111111110       


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                .....+..++..+.+++.+||+.||++|||++||++.|+++.+
T Consensus       219 ----------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         219 ----------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                      0011122334567899999999999999999999999998854

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=418.61  Aligned_cols=268  Identities=23%  Similarity=0.310  Sum_probs=207.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.++||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|+.+++.++|||||++++++.+     +...
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            578999999999999999999999999999999997653 3345778999999999999999999999654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+++|+|.+++.+.+.+++..++.++.|++.||.|||+ +   +|+||||||+|||++.++++||+|||+|+...
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            9999999999999999988888999999999999999999996 5   89999999999999999999999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc--Ccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL--PKK  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~  908 (973)
                      .          ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..................  ...
T Consensus       157 ~----------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  226 (322)
T d1s9ja_         157 D----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  226 (322)
T ss_dssp             H----------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred             C----------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence            2          1223467999999999999999999999999999999999999999764432211110000000  000


Q ss_pred             ------cccc-----cCcc-----------cccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ------VMGI-----VDPS-----------LLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ------~~~~-----~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                            ....     .+..           ................++.+++.+||+.||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                  0000     0000           000000000001123467789999999999999999999873

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=409.69  Aligned_cols=249  Identities=20%  Similarity=0.299  Sum_probs=203.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...   ....+.+.+|++++++++||||+++++++.+     ++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence            57999999999999999999999999999999997432   3345679999999999999999999998643     588


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+++|+|.+++...+.+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecc
Confidence            999999999999999999888899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...      .........||+.|+|||++.+..|+.++||||+||++|||++|+.||......  .+  +.... ...  
T Consensus       160 ~~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~--~~~i~-~~~--  226 (288)
T d1uu3a_         160 PES------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LI--FQKII-KLE--  226 (288)
T ss_dssp             ----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH--HHHHH-TTC--
T ss_pred             cCC------cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HH--HHHHH-cCC--
Confidence            321      122333457999999999999999999999999999999999999999753211  11  11111 000  


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVV  956 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  956 (973)
                          ..         .+......+.+++.+||+.||++|||++|++
T Consensus       227 ----~~---------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 ----YD---------FPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ----CC---------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ----CC---------CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence                00         1112334567899999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=404.16  Aligned_cols=254  Identities=23%  Similarity=0.399  Sum_probs=204.0

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++|||||++++++.+      +..+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            468999999999999999999985 77899999997543 345679999999999999999999998743      4578


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++....  .+++..+.+++.||++||.|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence            9999999999999876543  467788999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...       ........||+.|+|||++.+..++.++|||||||++|||+||..|+....... .+......       
T Consensus       161 ~~~-------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~-------  225 (272)
T d1qpca_         161 DNE-------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLER-------  225 (272)
T ss_dssp             SSC-------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT-------
T ss_pred             CCc-------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh-------
Confidence            422       222334568999999999999999999999999999999999655543322211 11111000       


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                                ...+..+..+++.+.+++.+||+.||++||||+||++.|+.+
T Consensus       226 ----------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                      000111233455678999999999999999999999998865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.6e-47  Score=408.04  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=196.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCc---EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGM---SVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||+||+|+++.+++   .||||++.... ....+.+.+|+++|++++|||||+++++|..     ++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----ST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----CC
Confidence            568888999999999999999976664   58889886543 3345679999999999999999999999754     47


Q ss_pred             eEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++|+|.+++... +..++.++..++.||++||+|||++   +|+||||||+|||++.++++||+|||+|+.
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence            789999999999999988764 4567788999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ......   ...........||+.|+|||++.+..|+.++|||||||++|||+| |+.||......  .+......    
T Consensus       178 ~~~~~~---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~----  248 (299)
T d1jpaa_         178 LEDDTS---DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQ----  248 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT----
T ss_pred             ccCCCC---cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHc----
Confidence            654321   011112223468899999999999999999999999999999998 89999765322  11111110    


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                              .     .....+.+++..+.+++.+||+.||++||||+||++.|+++.
T Consensus       249 --------~-----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         249 --------D-----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             --------T-----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --------C-----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                    0     011122345567889999999999999999999999998763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=395.58  Aligned_cols=253  Identities=24%  Similarity=0.413  Sum_probs=208.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.++||+|+||+||+|+++ +++.||||+++.... ..+++.+|+.++++++||||++++++|.+     +...++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEE
Confidence            58999999999999999999995 888999999986543 45679999999999999999999999754     478999


Q ss_pred             EEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          754 VYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      ||||+++|++.+++.. .....+..+++++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            9999999999998654 44566788999999999999999999   9999999999999999999999999999866443


Q ss_pred             CCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccccc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMG  911 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  911 (973)
                      .       ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||......+  +.......       
T Consensus       154 ~-------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~-------  217 (258)
T d1k2pa_         154 E-------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG-------  217 (258)
T ss_dssp             S-------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT-------
T ss_pred             C-------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC-------
Confidence            2       222334568999999999999999999999999999999998 899998654321  11111100       


Q ss_pred             ccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          912 IVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                       .         ....+..+++.+.+++.+||+.||++|||++|+++.|.++
T Consensus       218 -~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 -L---------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -C---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -C---------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             0         0111223445788999999999999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-46  Score=407.95  Aligned_cols=253  Identities=21%  Similarity=0.299  Sum_probs=192.1

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+++++.++|||||++++++.     ++...
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            357999999999999999999999999999999997543 223456889999999999999999999864     45889


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec---CCCcEEEeccccchh
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARF  828 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~---~~~~~kl~Dfg~a~~  828 (973)
                      ++||||++||+|.+++...+.+++..+..++.||+.||+|||++   +|+||||||+||++.   .++.+||+|||+|+.
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999999999888889999999999999999999999   999999999999995   578999999999986


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK  908 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  908 (973)
                      ....         ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.....  +  +......  
T Consensus       160 ~~~~---------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~--~~~i~~~--  224 (307)
T d1a06a_         160 EDPG---------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--L--FEQILKA--  224 (307)
T ss_dssp             ----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H--HHHHHTT--
T ss_pred             ccCC---------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--H--HHHHhcc--
Confidence            5432         22334679999999999999999999999999999999999999997543211  1  1111100  


Q ss_pred             cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                             .....   .......++.+.+++.+||+.||++|||++|++++
T Consensus       225 -------~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         225 -------EYEFD---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -------CCCCC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -------CCCCC---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                   00000   11112334567789999999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.7e-46  Score=409.43  Aligned_cols=253  Identities=21%  Similarity=0.307  Sum_probs=208.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++.+     ....+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            3589999999999999999999999999999999987666667789999999999999999999998655     47899


Q ss_pred             EEEeeccCCCHHHHhhh-cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC--CCcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHH-TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~--~~~~kl~Dfg~a~~~  829 (973)
                      +|||||++|+|.+++.. .+.+++..+..++.||+.||+|||++   +||||||||+|||++.  ++.+||+|||+|+..
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            99999999999999854 45678899999999999999999999   9999999999999964  578999999999876


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         ........||+.|+|||++.+..|+.++||||+||++|||++|+.||......+ .+.......   . 
T Consensus       177 ~~---------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~---~-  242 (350)
T d1koaa2         177 DP---------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCD---W-  242 (350)
T ss_dssp             CT---------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC---C-
T ss_pred             cc---------ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC---C-
Confidence            43         223345679999999999999999999999999999999999999997542211 111110000   0 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                        ...         ........+.+.+++.+||+.||++|||++|++++
T Consensus       243 --~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 --NMD---------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CSC---------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CCC---------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000         11112334567789999999999999999999885

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=402.03  Aligned_cols=257  Identities=21%  Similarity=0.336  Sum_probs=206.6

Q ss_pred             hcCCcCC-ccccccceeEEEEEECC--CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSN-RIGKGSFGFVYKGNLGE--DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|.+.+ +||+|+||+||+|.++.  ++..||||+++... ....+.+.+|++++++++|||||+++++|..      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence            4566677 49999999999998754  45589999997543 3345789999999999999999999998753      4


Q ss_pred             eEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchh
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF  828 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~  828 (973)
                      ..++||||+++|+|.+++... ...++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            589999999999999987654 4678888999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          829 LSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       829 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ......     .........||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .+......    
T Consensus       159 ~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~----  227 (285)
T d1u59a_         159 LGADDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ----  227 (285)
T ss_dssp             CTTCSC-----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHT----
T ss_pred             cccccc-----ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHc----
Confidence            654321     1112223468899999999999999999999999999999998 99999865432  11111110    


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                                   ...+..+..++.++.+++.+||+.||++|||+.+|++.|+++-
T Consensus       228 -------------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         228 -------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             -------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                         0112222345567889999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=407.01  Aligned_cols=250  Identities=24%  Similarity=0.278  Sum_probs=208.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.+|+.++||||+++++++.     +.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----ccc
Confidence            35799999999999999999999999999999999743   2334577899999999999999999999855     458


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+++|+|.+++...+.+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence            9999999999999999999988899999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        .......+||+.|+|||++.+..|+.++||||+||++|||++|++||......  .+.......   . 
T Consensus       156 ~~~--------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~i~~~---~-  221 (337)
T d1o6la_         156 ISD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILME---E-  221 (337)
T ss_dssp             CCT--------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC---C-
T ss_pred             ccC--------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHHHHHhcC---C-
Confidence            432        22334568999999999999999999999999999999999999999764321  111111000   0 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                                    ...+......+.+++.+||+.||++||+     ++|++++
T Consensus       222 --------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 --------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                          0111223345678889999999999995     8888774

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-46  Score=406.34  Aligned_cols=246  Identities=26%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      +.|+..+.||+|+||+||+|++..+|+.||||+++....   ...+.+.+|++++++++|||||++++++.+     .+.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            469999999999999999999999999999999975432   334678999999999999999999999765     378


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++|||||.+|++..++.....+++.+++.++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+...
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            999999999999988887777888999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG---GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      .            .....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......    ......... 
T Consensus       167 ~------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~~~i~~~-  229 (309)
T d1u5ra_         167 P------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQN-  229 (309)
T ss_dssp             S------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHS-
T ss_pred             C------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhC-
Confidence            2            124569999999999864   46899999999999999999999999754221    111111100 


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                           ..+..        ....+++.+.+++.+||+.||++|||++|+++
T Consensus       230 -----~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         230 -----ESPAL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -----CCCCC--------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCC--------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                 00000        01123456778899999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=400.32  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=200.7

Q ss_pred             CccccccceeEEEEEEC--CCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEEE
Q 039720          680 NRIGKGSFGFVYKGNLG--EDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIVY  755 (973)
Q Consensus       680 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  755 (973)
                      ++||+|+||+||+|.+.  .+++.||||+++...  ....+++.+|++++++++|||||+++++|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            46999999999999864  355789999996432  3345789999999999999999999998743      4578999


Q ss_pred             eeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCCCc
Q 039720          756 EYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFL  835 (973)
Q Consensus       756 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~  835 (973)
                      ||+++|+|.+++......++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+|+....... 
T Consensus        87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~-  162 (277)
T d1xbba_          87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-  162 (277)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS-
T ss_pred             EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc-
Confidence            9999999999999888888999999999999999999999   999999999999999999999999999987643221 


Q ss_pred             cCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCcccccccC
Q 039720          836 VAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVD  914 (973)
Q Consensus       836 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (973)
                          .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....  .+......           
T Consensus       163 ----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~-----------  225 (277)
T d1xbba_         163 ----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEK-----------  225 (277)
T ss_dssp             ----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT-----------
T ss_pred             ----ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHc-----------
Confidence                1122234568999999999999999999999999999999998 89999864322  11111110           


Q ss_pred             cccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          915 PSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                            ...+..+..++.++.+++.+||+.||++|||++||++.|+..
T Consensus       226 ------~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         226 ------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                  001122234456788999999999999999999999888764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=397.55  Aligned_cols=252  Identities=19%  Similarity=0.295  Sum_probs=207.3

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc------chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK------KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...      ....+.+.+|++++++++|||||++++++.+    
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----   84 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----   84 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence            357999999999999999999999999999999997432      1235779999999999999999999998654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC----cEEEec
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM----VAHVSD  822 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~----~~kl~D  822 (973)
                       ....++|||||++|+|.+++...+..++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+|++|
T Consensus        85 -~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          85 -KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             -CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence             588999999999999999999888889999999999999999999999   999999999999998876    599999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAK  902 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~  902 (973)
                      ||+|+.....         .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+  .  +..
T Consensus       161 fG~a~~~~~~---------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~--~~~  227 (293)
T d1jksa_         161 FGLAHKIDFG---------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--T--LAN  227 (293)
T ss_dssp             CTTCEECTTS---------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H--HHH
T ss_pred             hhhhhhcCCC---------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--H--HHH
Confidence            9999876432         22334578999999999999999999999999999999999999997543211  1  111


Q ss_pred             HhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          903 MALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                      ....       .....     ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       228 i~~~-------~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         228 VSAV-------NYEFE-----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHTT-------CCCCC-----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHhc-------CCCCC-----chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1000       00000     1112234456778999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-45  Score=406.42  Aligned_cols=252  Identities=17%  Similarity=0.236  Sum_probs=207.9

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++.     ++...++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            57999999999999999999999999999999998766556677889999999999999999999864     4588999


Q ss_pred             EEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec--CCCcEEEeccccchhcc
Q 039720          754 VYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLARFLS  830 (973)
Q Consensus       754 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~--~~~~~kl~Dfg~a~~~~  830 (973)
                      |||||++|+|.+++...+ .+++.+++.++.||+.||+|||++   ||+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence            999999999999876544 578899999999999999999999   999999999999998  57899999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .         ........||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.....  .  .......    
T Consensus       181 ~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~--~~~i~~~----  243 (352)
T d1koba_         181 P---------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--T--LQNVKRC----  243 (352)
T ss_dssp             T---------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--H--HHHHHHC----
T ss_pred             C---------CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--H--HHHHHhC----
Confidence            3         223445679999999999999999999999999999999999999997543211  1  1111000    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         +....     .......+..+.+++.+||+.||++|||++|++++
T Consensus       244 ---~~~~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 ---DWEFD-----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---CCCCC-----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCC-----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00000     11112334567789999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-45  Score=395.63  Aligned_cols=266  Identities=20%  Similarity=0.302  Sum_probs=207.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...   ....+.+.+|+++++.++||||+++++++... .....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCc
Confidence            367999999999999999999999999999999997543   33456789999999999999999999987653 23345


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.++++|||.+...
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence            6899999999999999999888889999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ....     ..........||+.|+|||++.+..|+.++||||+||++|||+||++||......+    .......... 
T Consensus       162 ~~~~-----~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~~~~~~~-  231 (277)
T d1o6ya_         162 ADSG-----NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----VAYQHVREDP-  231 (277)
T ss_dssp             C---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCC-
T ss_pred             cccc-----ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH----HHHHHHhcCC-
Confidence            3321     11223345679999999999999999999999999999999999999997542211    1111100000 


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHhcc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-QMTAVVKKLCAVG  963 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  963 (973)
                         ..+        .......+..+.+++.+||+.||++|| |++|+++.|.+++
T Consensus       232 ---~~~--------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 ---IPP--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ---CCG--------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---CCC--------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence               000        001122345677899999999999999 8999999998874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=395.64  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=198.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCC----cEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDG----MSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      ++|++.+.||+|+||+||+|+++.++    ..||||+++... .....++.+|++++++++|||||+++++|..     .
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----C
Confidence            46888999999999999999987554    479999997543 3345678999999999999999999999754     3


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +..++||||+.+|++.+.+... ....+.++..++.||+.|++|||+.   +|+||||||+|||++.++.+||+|||+|+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            7789999999999999987654 4567788899999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCc
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPK  907 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  907 (973)
                      ......     ..........||+.|+|||++.+..++.++|||||||++|||++|..|+....... .+.....     
T Consensus       159 ~~~~~~-----~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~-----  227 (283)
T d1mqba_         159 VLEDDP-----EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIN-----  227 (283)
T ss_dssp             --------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHH-----
T ss_pred             cccCCC-----ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHh-----
Confidence            764422     11122233468999999999999999999999999999999999666654332211 1111110     


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                             ..     ..+..+.+++..+.+++.+||+.||++||||+||++.|+++.
T Consensus       228 -------~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         228 -------DG-----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             -------TT-----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------cc-----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence                   00     011222345567889999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=404.11  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCc-----EEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGM-----SVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDFK  746 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  746 (973)
                      ++|++.+.||+|+||+||+|++..+++     .||+|++.... ......+.+|+.+++++ +|||||++++++..    
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~----  112 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL----  112 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee----
Confidence            579999999999999999999865543     79999986432 33456789999999998 89999999999654    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC-----------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN-----------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHG  803 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHr  803 (973)
                       .+..++||||+++|+|.++++...                       .+++..++.++.||++||+|||++   +||||
T Consensus       113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence             478899999999999999997643                       245677889999999999999999   99999


Q ss_pred             CCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-
Q 039720          804 DLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-  882 (973)
Q Consensus       804 Dik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-  882 (973)
                      ||||+||+++.++.+||+|||+|+......      .........||+.|+|||++.+..|+.++|||||||++|||+| 
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDS------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             cCchhccccccCCeEEEeeccccccccCCC------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence            999999999999999999999998654322      1222334568999999999999999999999999999999998 


Q ss_pred             CCCCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          883 RRRPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       883 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      |+.||....... .+.......                 ..+..+..++..+.++|.+||+.||++|||++||+++|.
T Consensus       263 g~~Pf~~~~~~~-~~~~~~~~~-----------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         263 GVNPYPGIPVDA-NFYKLIQNG-----------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SCCSSTTCCCSH-HHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHH-HHHHHHhcC-----------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            899998654332 111111110                 011222334567889999999999999999999999985

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-45  Score=399.42  Aligned_cols=246  Identities=24%  Similarity=0.300  Sum_probs=205.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.+++.++|||||++++++..     .+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence            5799999999999999999999999999999999743   23345778999999999999999999998654     589


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+.||++..++.......+..+..++.||+.|++|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence            999999999999999999888888888899999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .           ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......  .+  .......    
T Consensus       156 ~-----------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~--~~~i~~~----  216 (316)
T d1fota_         156 D-----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KT--YEKILNA----  216 (316)
T ss_dssp             S-----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH--HHHHHHC----
T ss_pred             c-----------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HH--HHHHHcC----
Confidence            3           223467999999999999999999999999999999999999999754221  11  1111000    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVKK  958 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  958 (973)
                               ..   ..+...++.+.+++.+||+.||++||     |++|++++
T Consensus       217 ---------~~---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 ---------EL---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---------CC---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---------CC---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                     00   01112234567888899999999996     89999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-44  Score=401.72  Aligned_cols=250  Identities=21%  Similarity=0.257  Sum_probs=200.3

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHH---HHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVA---ECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....   ......+.+   |+++++.++|||||++++++..     
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-----   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence            67999999999999999999999999999999996432   122233444   4666777789999999998654     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      .+..|+||||+++|+|.+++.......+..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            478999999999999999999888888899999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      .....          ......||+.|+|||++.. ..|+.++||||+||++|||+||+.||........  .........
T Consensus       156 ~~~~~----------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~  223 (364)
T d1omwa3         156 DFSKK----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT  223 (364)
T ss_dssp             ECSSS----------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSS
T ss_pred             ecCCC----------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccc
Confidence            66432          2234579999999999864 5789999999999999999999999986543321  111111110


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVKK  958 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  958 (973)
                      ..               ...+..+++.+.++|.+||+.||++|||     ++|++++
T Consensus       224 ~~---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         224 MA---------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             CC---------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CC---------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            00               0111123445678899999999999999     6888764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.2e-45  Score=400.53  Aligned_cols=245  Identities=21%  Similarity=0.249  Sum_probs=205.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+++++.++|||||++++++..     ...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence            58999999999999999999999999999999997432   2345678999999999999999999998654     478


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .++||||+.+|++.+++...+.+++..++.++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+.+.
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            999999999999999999888899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      .           ......||+.|+|||++.+..|+.++|||||||++|||+||+.||......  .+  .......    
T Consensus       193 ~-----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~--~~~i~~~----  253 (350)
T d1rdqe_         193 G-----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QI--YEKIVSG----  253 (350)
T ss_dssp             S-----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH--HHHHHHC----
T ss_pred             c-----------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HH--HHHHhcC----
Confidence            2           223467999999999999999999999999999999999999999753211  11  1111100    


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERM-----QMTAVVK  957 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  957 (973)
                           .       ...+...+..+.+++.+||+.||.+|+     |++|+++
T Consensus       254 -----~-------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         254 -----K-------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----C-------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----C-------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 0       011122345667889999999999995     8999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-45  Score=390.16  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=200.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.++++++|||||+++++|.+      +..+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence            368999999999999999999996 456799999975443 45679999999999999999999998743      4578


Q ss_pred             EEEeeccCCCHHHHhhh--cCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHH--TNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|++.+++..  ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+...
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence            99999999999998865  34577888999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVM  910 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  910 (973)
                      ...       ........||+.|+|||++.+..++.++|||||||++|||++|..|+.........+......       
T Consensus       165 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-------  230 (285)
T d1fmka3         165 DNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------  230 (285)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------
T ss_pred             CCC-------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------
Confidence            322       223334568999999999999999999999999999999999766655432221111111100       


Q ss_pred             cccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          911 GIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                        .         ....+..+++.+.+++.+||+.||++||++++|++.|+..-.
T Consensus       231 --~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         231 --Y---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             --C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --C---------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence              0         011223445678899999999999999999999999988643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-44  Score=384.20  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=205.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc---------hhHHHHHHHHHHHHhcC-CCCceeEEeEeeec
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK---------GATKSFVAECEALRNIR-HRNLIKIITICSSI  743 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  743 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++.  
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence            689999999999999999999999999999999975431         12346889999999997 999999999865  


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecc
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDF  823 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Df  823 (973)
                         +++..|+||||+++|+|.+++...+..++.+++.++.||++||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        81 ---~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          81 ---TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ---cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence               4589999999999999999999888899999999999999999999999   9999999999999999999999999


Q ss_pred             ccchhccCCCCccCCCCCcccccccccccccCccccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccH
Q 039720          824 GLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGM------GGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTL  897 (973)
Q Consensus       824 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~  897 (973)
                      |+|+.....         .......||+.|+|||++.      ...++.++||||+||++|||++|+.||.......  .
T Consensus       155 G~a~~~~~~---------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~  223 (277)
T d1phka_         155 GFSCQLDPG---------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--M  223 (277)
T ss_dssp             TTCEECCTT---------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H
T ss_pred             hheeEccCC---------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--H
Confidence            999876532         2233467999999999875      3467889999999999999999999998543211  1


Q ss_pred             hhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          898 HGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .......   .    .  ..     ........++.+.+++.+||+.||++|||++||++.
T Consensus       224 ~~~i~~~---~----~--~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         224 LRMIMSG---N----Y--QF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHHHT---C----C--CC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhC---C----C--CC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1110000   0    0  00     011223345567789999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=386.57  Aligned_cols=251  Identities=30%  Similarity=0.401  Sum_probs=198.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++.+  ...+.+.+|++++++++||||++++++|.+    +.+..+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEE
Confidence            35788999999999999999999  5889999999643  345779999999999999999999998753    235679


Q ss_pred             EEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          753 IVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      +||||+++|+|.+++....  ..++..+++++.||+.||.|||+.   +|+||||||+||+++.++.+|++|||+++...
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            9999999999999997543  356788999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..           .....+|+.|+|||++.+..++.++|||||||++|||+| |++||......  ++......      
T Consensus       155 ~~-----------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~------  215 (262)
T d1byga_         155 ST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK------  215 (262)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTT------
T ss_pred             CC-----------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc------
Confidence            31           223457889999999999999999999999999999998 78887754322  22211110      


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                 ...+..+..++..+.+++.+||+.||++||||.|++++|+.++.
T Consensus       216 -----------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 -----------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                       01122223344567899999999999999999999999998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=396.86  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=203.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc---chhHHHHHHHHHHHH-hcCCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK---KGATKSFVAECEALR-NIRHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.+.   ....+.+..|..++. .++|||||++++++.+     ++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence            57999999999999999999999999999999997532   334456677777665 6899999999998654     58


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..|+||||+++|+|.+++......++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhc
Confidence            8999999999999999999988889999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ...        ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....  .+..  .....   
T Consensus       154 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~--~i~~~---  218 (320)
T d1xjda_         154 MLG--------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH--SIRMD---  218 (320)
T ss_dssp             CCT--------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH--HHHHC---
T ss_pred             ccc--------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHH--HHHcC---
Confidence            432        22333457999999999999999999999999999999999999999754321  1111  11100   


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMT-AVVK  957 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  957 (973)
                          .         +..+..++.++.+++.+||+.||++||++. |+++
T Consensus       219 ----~---------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 ----N---------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----C---------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----C---------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                0         111122345577899999999999999995 6754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=394.94  Aligned_cols=256  Identities=22%  Similarity=0.386  Sum_probs=201.8

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCc----EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGM----SVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .+|++.+.||+|+||+||+|++..+|+    +||+|+++.. .....+.+.+|++++++++|||||+++++|.+      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            469999999999999999999987776    5888887543 33456789999999999999999999999864      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +..++++||+.+|+|.+++... ...++..+.+++.|||.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence            4577889999999999988764 4566778899999999999999999   99999999999999999999999999999


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......      .........||+.|+|||++.+..|+.++|||||||++|||+| |+.||......+  +.......  
T Consensus       160 ~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~--  229 (317)
T d1xkka_         160 LLGAEE------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKG--  229 (317)
T ss_dssp             HTTTTC------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHT--
T ss_pred             eccccc------ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC--
Confidence            765432      1222233468999999999999999999999999999999999 899987653321  11111110  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                                     ..+..+..++..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       230 ---------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         230 ---------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ---------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                           011222344567789999999999999999999999988764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-45  Score=389.10  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=197.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCC---CcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGED---GMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGA  748 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  748 (973)
                      .++|++.+.||+|+||+||+|++..+   +..||||+++... ....+.+.+|++++++++||||+++++++.+      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35899999999999999999998654   3568899886433 3345779999999999999999999998743      


Q ss_pred             ceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          749 DFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       749 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +..++||||+++|++.+++... ...++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence            5689999999999999987654 3567788999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhcC
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMALP  906 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  906 (973)
                      ......       ........||+.|+|||++.+..|+.++|||||||++|||++ |++||......+  +.......  
T Consensus       157 ~~~~~~-------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~--  225 (273)
T d1mp8a_         157 YMEDST-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENG--  225 (273)
T ss_dssp             ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT--
T ss_pred             eccCCc-------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcC--
Confidence            764322       223334568999999999999999999999999999999998 899997654321  11111100  


Q ss_pred             cccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          907 KKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                                     .....+..++..+.++|.+||+.||++|||++||++.|+.+.+
T Consensus       226 ---------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         226 ---------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                           0011223345678899999999999999999999999988743

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-45  Score=394.17  Aligned_cols=260  Identities=23%  Similarity=0.397  Sum_probs=207.3

Q ss_pred             HhhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDKK-GATKSFVAECEALRNIRHRNLIKIITICSSIDF  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  745 (973)
                      ..++|++.+.||+|+||+||+|+++     .+++.||||+++.... ...+++.+|+++++.++||||++++++|..   
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~---   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc---
Confidence            4578999999999999999999975     3568999999975443 345679999999999999999999999754   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIV  801 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv  801 (973)
                        ....+++|||+++|+|.+++....                        .+....+..++.|++.||+|||++   +||
T Consensus        88 --~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          88 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             --CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence              478899999999999999987533                        244567899999999999999999   999


Q ss_pred             ecCCCCCcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHH
Q 039720          802 HGDLKPSNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMF  881 (973)
Q Consensus       802 HrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ell  881 (973)
                      ||||||+|||++.++++||+|||+|+......      .........||+.|+|||.+.+..|+.++|||||||++|||+
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell  236 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSAD------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  236 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGG------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCc------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH
Confidence            99999999999999999999999998664321      122233456889999999999999999999999999999999


Q ss_pred             hCC-CCCCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 039720          882 TRR-RPTDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLC  960 (973)
Q Consensus       882 tg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  960 (973)
                      +|. +||......+  +......                 ...+..+..++..+.+++.+||+.||++||||.||++.|+
T Consensus       237 ~~~~~p~~~~~~~e--~~~~v~~-----------------~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         237 SYGLQPYYGMAHEE--VIYYVRD-----------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             TTTCCTTTTSCHHH--HHHHHHT-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccCCCCCCCCCHHH--HHHHHHc-----------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            985 5676543221  1111110                 0011222344557889999999999999999999999999


Q ss_pred             hccc
Q 039720          961 AVGE  964 (973)
Q Consensus       961 ~~~~  964 (973)
                      ++.+
T Consensus       298 ~i~~  301 (301)
T d1lufa_         298 RMCE  301 (301)
T ss_dssp             HTTC
T ss_pred             HhcC
Confidence            8753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=391.26  Aligned_cols=252  Identities=17%  Similarity=0.271  Sum_probs=205.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+++|+.++|||||++++++.+     ....|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES-----MEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence            3689999999999999999999999999999999976543 34568899999999999999999998654     47899


Q ss_pred             EEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC--CcEEEeccccchhc
Q 039720          753 IVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD--MVAHVSDFGLARFL  829 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~--~~~kl~Dfg~a~~~  829 (973)
                      +|||||+||+|.+++...+ .+++.+++.++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++..
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999999999999998665 578899999999999999999999   99999999999999854  48999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKV  909 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  909 (973)
                      ..         ........+|+.|+|||...+..|+.++||||+||++|+|++|+.||.......  +  +.......  
T Consensus       155 ~~---------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~--~~~i~~~~--  219 (321)
T d1tkia_         155 KP---------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--I--IENIMNAE--  219 (321)
T ss_dssp             CT---------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H--HHHHHHTC--
T ss_pred             cc---------CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--H--HHHHHhCC--
Confidence            43         223345679999999999999999999999999999999999999997643211  1  11110000  


Q ss_pred             ccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          910 MGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                           ..+.     ..........+.+++.+|++.||++|||++|++++
T Consensus       220 -----~~~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         220 -----YTFD-----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -----CCCC-----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCC-----hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0000     01112234567789999999999999999999873

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=391.61  Aligned_cols=255  Identities=19%  Similarity=0.261  Sum_probs=201.6

Q ss_pred             hhcCCcCC-ccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSN-RIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|.+.. .||+|+||+||+|++..+++.||||+++.     ...+.+|+.++.++ +|||||++++++.+. +.....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            35788875 59999999999999999999999999963     24567899887554 899999999987652 344577


Q ss_pred             EEEEEeeccCCCHHHHhhhcC--CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEEEecccc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTN--DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGL  825 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~kl~Dfg~  825 (973)
                      .|+|||||+||+|.+++...+  .+++.+++.++.||+.||+|||++   +|+||||||+|||++.   ++.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence            899999999999999997643  567888999999999999999999   9999999999999985   56799999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      |+.....         .......||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+........ .      
T Consensus       161 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-~------  224 (335)
T d2ozaa1         161 AKETTSH---------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-G------  224 (335)
T ss_dssp             CEECCCC---------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------
T ss_pred             eeeccCC---------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-H------
Confidence            9876442         22334579999999999999999999999999999999999999997543321100 0      


Q ss_pred             CcccccccCcccccccCC-CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          906 PKKVMGIVDPSLLMEARG-PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                         +...+   ....... .......++++.+++.+||+.||++|||++|++++
T Consensus       225 ---~~~~i---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         225 ---MKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ------CC---CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---HHHHH---hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               00000   0000001 12234556778899999999999999999999884

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-44  Score=387.90  Aligned_cols=284  Identities=21%  Similarity=0.243  Sum_probs=204.4

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++|...+.||+|+||+||+|++  +|+.||||+++.+.. .......|+..+..++||||++++++|... .......+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~-~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeC-CCcceEEE
Confidence            35788899999999999999998  789999999964432 122233455555678999999999998764 23345789


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC-----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      +||||+++|+|.+++++. ..+..++++++.|+|.||+|+|+.+     .++||||||||+|||++.++.+||+|||+++
T Consensus        78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999999865 5677888999999999999999731     2389999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD------LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ........    .........||+.|+|||++.+..      ++.++|||||||++|||+||..||..............
T Consensus       157 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         157 RHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             EEETTTTE----ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             cccCCCcc----eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            76543210    111223457999999999987653      57789999999999999999988764432211110000


Q ss_pred             hHhcC-cc-cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcccc
Q 039720          902 KMALP-KK-VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEI  965 (973)
Q Consensus       902 ~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  965 (973)
                      ..... .. .....+..............+....+.+++.+||+.||++|||+.||++.|+++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            00000 00 000111111111111112345667789999999999999999999999999988643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=388.50  Aligned_cols=261  Identities=22%  Similarity=0.362  Sum_probs=197.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.++||+|+||+||+|++..     +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++..   
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~---   88 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---   88 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence            4689999999999999999999753     45789999997543 33456678888888776 68999999998643   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSN  809 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~N  809 (973)
                       .....++|||||++|+|.+++....                .+++.++..++.||++||+|||++   +||||||||+|
T Consensus        89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N  164 (299)
T d1ywna1          89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  164 (299)
T ss_dssp             -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence             3467899999999999999997532                245678899999999999999999   99999999999


Q ss_pred             EEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhC-CCCCC
Q 039720          810 VLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTR-RRPTD  888 (973)
Q Consensus       810 ILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg-~~Pf~  888 (973)
                      ||++.++++||+|||+|+......      .........||+.|+|||++.+..++.++|||||||++|||+|| ..||.
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             EEECGGGCEEECC------CCSCT------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             eeECCCCcEEEccCcchhhccccc------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999998664332      12223345799999999999999999999999999999999996 56776


Q ss_pred             CCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          889 NMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ...... .+.......                 ..+..+..+++.+.+++.+||+.||++|||++|++++|+.+-+
T Consensus       239 ~~~~~~-~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         239 GVKIDE-EFCRRLKEG-----------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             TCCCSH-HHHHHHHHT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHH-HHHHHHhcC-----------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            543321 111111110                 0111222344567899999999999999999999999998743

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=385.33  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=195.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCC-C--cEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCC
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGED-G--MSVAVKVMNLD---KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKG  747 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  747 (973)
                      ++|++.+.||+|+||+||+|++..+ +  ..||||+++.+   .....+++.+|+.++++++||||++++++|.+     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            5799999999999999999987432 2  47899998644   23445789999999999999999999998753     


Q ss_pred             CceEEEEEeeccCCCHHHHhhhc-CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHT-NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA  826 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a  826 (973)
                       +..++||||+++|++.+++... +.+++..+..++.|+|.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhh
Confidence             4568999999999999887654 4567788999999999999999999   9999999999999999999999999999


Q ss_pred             hhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCccHhhhhhHhc
Q 039720          827 RFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      +......     ..........|+..|+|||++.+..++.++|||||||++|||+| |+.||......+  ...  ... 
T Consensus       159 ~~~~~~~-----~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~--~i~-  228 (273)
T d1u46a_         159 RALPQND-----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILH--KID-  228 (273)
T ss_dssp             EECCC-C-----CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH--HHH-
T ss_pred             hhcccCC-----CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHH--HHH-
Confidence            9765432     11112223457889999999999999999999999999999998 899997543221  111  110 


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      ..             ...+..+..++..+.+++.+||+.||++||||+||++.|++.
T Consensus       229 ~~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 KE-------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TS-------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hC-------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            00             001112233445678999999999999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=383.22  Aligned_cols=261  Identities=25%  Similarity=0.411  Sum_probs=204.2

Q ss_pred             CCccccccceeEEEEEECCCC---cEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEEE
Q 039720          679 SNRIGKGSFGFVYKGNLGEDG---MSVAVKVMNLD-KKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAIV  754 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  754 (973)
                      .++||+|+||+||+|++..++   ..||||+++.. .....+++.+|++++++++||||++++++|...    +...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence            467999999999999986543   36899999643 444567899999999999999999999997653    3578999


Q ss_pred             EeeccCCCHHHHhhhcCC-CchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCCC
Q 039720          755 YEYMQYGSVDDWLHHTND-KLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHHP  833 (973)
Q Consensus       755 ~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~~  833 (973)
                      |||+++|+|.+++..... .....+.+++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999999999886543 44567889999999999999999   99999999999999999999999999998765432


Q ss_pred             CccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCccccccc
Q 039720          834 FLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKKVMGIV  913 (973)
Q Consensus       834 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (973)
                      .    ..........||+.|+|||.+....++.++||||||+++|||+||+.||................          
T Consensus       185 ~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g----------  250 (311)
T d1r0pa_         185 F----DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----------  250 (311)
T ss_dssp             C----CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT----------
T ss_pred             c----ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----------
Confidence            1    11222233568999999999999999999999999999999999888876543221111111000          


Q ss_pred             CcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccccccC
Q 039720          914 DPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGEIFIG  968 (973)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  968 (973)
                              ..+..+..++..+.+++.+||+.||++||++.||++.|+++.+.+.+
T Consensus       251 --------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         251 --------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             --------CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence                    00111223445678999999999999999999999999999766554

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=385.68  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=198.0

Q ss_pred             cCCccccccceeEEEEEECCCCcEEEEEEeecccch-----hHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEE
Q 039720          678 SSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKG-----ATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       678 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      .++.||+|+||+||+|+++.+|+.||||+++.....     ..+.+.+|+.++++++|||||++++++..     .+..+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence            357899999999999999999999999999754322     13468899999999999999999998643     47899


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccCC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSHH  832 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~~  832 (973)
                      +||||+.++++..+......+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.|+.....
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC
Confidence            9999999998888887777788889999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC---cc
Q 039720          833 PFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP---KK  908 (973)
Q Consensus       833 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~~  908 (973)
                              ........||+.|+|||++.+. .|+.++||||+||++|||++|++||......+ .+.........   ..
T Consensus       154 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~  224 (299)
T d1ua2a_         154 --------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQ  224 (299)
T ss_dssp             --------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred             --------cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhh
Confidence                    2223345799999999988654 67999999999999999999999997543221 11111111100   00


Q ss_pred             cccc---cCcccccccCC-C--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGI---VDPSLLMEARG-P--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~---~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ..+.   ........... +  .......+.+.+++.+||+.||++||||+|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0000   00000000000 0  0111234567889999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-43  Score=379.55  Aligned_cols=273  Identities=22%  Similarity=0.304  Sum_probs=203.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK--GATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++....  ...+.+.+|++++++++|||||++++++.+     ....
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            579999999999999999999999999999999975432  235788999999999999999999999755     4789


Q ss_pred             EEEEeeccCCCHHHHhh-hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          752 AIVYEYMQYGSVDDWLH-HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      ++||||+.++.+..... ....+++..++.++.|++.||+|||++   +||||||||+|||++.++.+|++|||.|+...
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceecc
Confidence            99999998654444333 344578899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH-hcCcc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM-ALPKK  908 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~  908 (973)
                      ..        ........||+.|+|||+.....+ +.++||||+||++|+|++|+.||......+ .+...... ..+..
T Consensus       154 ~~--------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~  224 (298)
T d1gz8a_         154 VP--------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDE  224 (298)
T ss_dssp             CC--------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             CC--------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCch
Confidence            32        233344579999999998777664 889999999999999999999997543221 11111111 11110


Q ss_pred             -----cccccCccc-ccccCCCc---hhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcc
Q 039720          909 -----VMGIVDPSL-LMEARGPS---KFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVG  963 (973)
Q Consensus       909 -----~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  963 (973)
                           .....+... ........   ......+.+.+++.+|++.||++|||++|++++  ++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                 000000000 00000010   111233567789999999999999999999986  55553

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=386.23  Aligned_cols=255  Identities=25%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcE--EEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCceeEEeEeeecccCCCc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMS--VAVKVMNLD-KKGATKSFVAECEALRNI-RHRNLIKIITICSSIDFKGAD  749 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  749 (973)
                      ++|++.+.||+|+||+||+|+++.+|..  ||||+++.. .....+.+.+|+++++++ +|||||+++++|..     ++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence            5799999999999999999999888764  667776532 233456799999999998 79999999999865     37


Q ss_pred             eEEEEEeeccCCCHHHHhhhc----------------CCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEec
Q 039720          750 FKAIVYEYMQYGSVDDWLHHT----------------NDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLD  813 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~  813 (973)
                      ..++||||+++|+|.++++..                ..+++..+.+++.||+.|+.|+|++   +|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            899999999999999999754                3456778899999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCC
Q 039720          814 HDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR-RPTDNMFN  892 (973)
Q Consensus       814 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~-~Pf~~~~~  892 (973)
                      .++.+||+|||+|+.....         .......||+.|+|||.+.+..|+.++|||||||++|||++|. +||.....
T Consensus       162 ~~~~~kl~DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~  232 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  232 (309)
T ss_dssp             GGGCEEECCTTCEESSCEE---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CCCceEEcccccccccccc---------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999754321         1222446899999999999999999999999999999999965 56654321


Q ss_pred             CCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          893 DGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      .  .+.....            .     ...+..+..++..+.++|.+||+.||++||||+||++.|+++.+
T Consensus       233 ~--~~~~~i~------------~-----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         233 A--ELYEKLP------------Q-----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             H--HHHHHGG------------G-----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--HHHHHHH------------h-----cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1  1111100            0     00122223345677899999999999999999999999998753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=381.86  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=202.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCC-------cEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCCceeEEeEeeec
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDG-------MSVAVKVMNLDKK-GATKSFVAECEALRNI-RHRNLIKIITICSSI  743 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  743 (973)
                      .++|++.+.||+|+||.||+|++..++       ..||||+++.+.. ....++.+|+..+.++ +|||||+++++|.+ 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            368999999999999999999976544       4799999976543 3457788999999888 79999999999754 


Q ss_pred             ccCCCceEEEEEeeccCCCHHHHhhhcC----------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          744 DFKGADFKAIVYEYMQYGSVDDWLHHTN----------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                          +...++||||+++|+|.+++....                .+++.++++++.||+.||+|||+.   +||||||||
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence                478999999999999999997543                356788999999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +|||++.++.+||+|||+++......      .........||+.|+|||.+.+..|+.++|||||||++|||++ |+.|
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHID------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCC------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cceeecCCCCeEeccchhhccccccc------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence            99999999999999999998765432      1223344568999999999999999999999999999999998 7888


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhcc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVG  963 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  963 (973)
                      |......  .+.......                 ..+..+..++..+.+++.+||+.||++||||+||++.|+++-
T Consensus       238 ~~~~~~~--~~~~~i~~~-----------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         238 YPGVPVE--ELFKLLKEG-----------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             STTCCHH--HHHHHHHTT-----------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHH--HHHHHHHcC-----------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            8754322  111111100                 001112233456789999999999999999999999999873

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-43  Score=380.86  Aligned_cols=274  Identities=20%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             HhhcCCcCCccccccceeEEEEEECCC-CcEEEEEEeecccc--hhHHHHHHHHHHHHhc---CCCCceeEEeEeeeccc
Q 039720          672 ATKEFSSSNRIGKGSFGFVYKGNLGED-GMSVAVKVMNLDKK--GATKSFVAECEALRNI---RHRNLIKIITICSSIDF  745 (973)
Q Consensus       672 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~  745 (973)
                      ..++|++.++||+|+||+||+|++..+ ++.||||+++....  .....+.+|+.+++.+   +||||+++++++.....
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357899999999999999999999765 67799999975432  2233466777776655   79999999999876555


Q ss_pred             CCCceEEEEEeeccCCCHHHHhh-hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLH-HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG  824 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg  824 (973)
                      ......+++|||+.++.+..... .....++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence            56678999999999887765443 344567788889999999999999999   99999999999999999999999999


Q ss_pred             cchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh
Q 039720          825 LARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA  904 (973)
Q Consensus       825 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~  904 (973)
                      .++....         ........||+.|+|||++.+.+|+.++||||+||++|||++|+.||......+ .+.......
T Consensus       162 ~~~~~~~---------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~  231 (305)
T d1blxa_         162 LARIYSF---------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVI  231 (305)
T ss_dssp             SCCCCCG---------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             hhhhhcc---------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhh
Confidence            9875432         223345679999999999999999999999999999999999999997543221 111111111


Q ss_pred             c-Ccc--cccc-c-Cc-cccccc--CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 L-PKK--VMGI-V-DP-SLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~-~~~--~~~~-~-~~-~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      . +..  .... . .. ......  ..........+.+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0 000  0000 0 00 000000  0001112234566788999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-43  Score=379.86  Aligned_cols=258  Identities=22%  Similarity=0.353  Sum_probs=206.6

Q ss_pred             hhcCCcCCccccccceeEEEEEEC-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCceeEEeEeeeccc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLG-----EDGMSVAVKVMNLDK-KGATKSFVAECEALRNI-RHRNLIKIITICSSIDF  745 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  745 (973)
                      .++|++.+.||+|+||.||+|++.     .+++.||||+++... ......+.+|+.+++++ +|||||+++++|..   
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~---   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence            368999999999999999999863     467899999997544 33456789999999999 69999999999754   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcC------------------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTN------------------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKP  807 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~  807 (973)
                        .+..++||||+++|+|.++++...                  ..++..+..++.||+.|++|||++   +||||||||
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence              367899999999999999987543                  345677899999999999999999   999999999


Q ss_pred             CcEEecCCCcEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 039720          808 SNVLLDHDMVAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFT-RRRP  886 (973)
Q Consensus       808 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~ellt-g~~P  886 (973)
                      +||+++.++.+|++|||.++......      .........||+.|+|||++.+..++.++|||||||++|||+| |.+|
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDS------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCT------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccccccccCcccccccchheeccCCC------cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            99999999999999999998765432      1223334678999999999999999999999999999999999 5555


Q ss_pred             CCCCCCCCccHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          887 TDNMFNDGLTLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       887 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      |..... ...+........                 .+..+..++..+.++|.+||+.||++||||+||++.|+++
T Consensus       248 ~~~~~~-~~~~~~~i~~~~-----------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         248 YPGMPV-DSKFYKMIKEGF-----------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             STTCCS-SHHHHHHHHHTC-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCH-HHHHHHHHhcCC-----------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            544322 222222221111                 0111223445678999999999999999999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-44  Score=380.30  Aligned_cols=242  Identities=20%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccc------hhHHHHHHHHHHHHhcC--CCCceeEEeEeeecc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK------GATKSFVAECEALRNIR--HRNLIKIITICSSID  744 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  744 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....      ....++.+|+.++++++  |||||++++++..  
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--   80 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--   80 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence            3689999999999999999999999999999999975421      11234678999999997  8999999998644  


Q ss_pred             cCCCceEEEEEeeccC-CCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCC-CcEEEec
Q 039720          745 FKGADFKAIVYEYMQY-GSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHD-MVAHVSD  822 (973)
Q Consensus       745 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~-~~~kl~D  822 (973)
                         .+..++||||+.+ +++.+++.....+++.+++.++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|
T Consensus        81 ---~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          81 ---PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             ---SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             ---CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECc
Confidence               5789999999976 68889998888889999999999999999999999   99999999999999854 7999999


Q ss_pred             cccchhccCCCCccCCCCCcccccccccccccCcccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhh
Q 039720          823 FGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDL-SMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYA  901 (973)
Q Consensus       823 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~  901 (973)
                      ||+|+....          .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....    .+   .
T Consensus       155 FG~a~~~~~----------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i---~  217 (273)
T d1xwsa_         155 FGSGALLKD----------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI---I  217 (273)
T ss_dssp             CTTCEECCS----------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH---H
T ss_pred             cccceeccc----------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HH---h
Confidence            999986532          22334679999999999887765 677999999999999999999997421    00   0


Q ss_pred             hHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          902 KMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      ...          ..+      +   ...+.++.+++.+||+.||++|||++|+++.
T Consensus       218 ~~~----------~~~------~---~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         218 RGQ----------VFF------R---QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HCC----------CCC------S---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hcc----------cCC------C---CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            000          000      0   1123456788899999999999999999874

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.2e-42  Score=380.59  Aligned_cols=293  Identities=25%  Similarity=0.417  Sum_probs=267.1

Q ss_pred             cchhhHHHHHHHHhhccCCCcCCCCCCCCCCCCC--ceeeeEeeCCC--CeEEEEEeeccCccc--cccCCCcCCCCCCE
Q 039720           17 ATSHVKHATVTFNMQQLHDPLGVTKSWNNSINLC--QWTGVTCGHRH--QRVTKLDLESQNIGG--FLSPYIGNLSFLRV   90 (973)
Q Consensus        17 ~~~~~~~~ll~~~~~~~~d~~~~l~sw~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~   90 (973)
                      |..+||+||++||+.+ .||. .++||..++|||  .|+||+|+..+  +||+.|||+++++.|  .+|+++++|++|++
T Consensus         3 c~~~e~~aLl~~k~~~-~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~   80 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDL-GNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             SCHHHHHHHHHHHHHT-TCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCHHHHHHHHHHHHHC-CCCC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence            5678999999999986 4664 699999889999  49999999644  489999999999988  57899999999999


Q ss_pred             EEccC-CCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCc
Q 039720           91 INLAN-NSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQ  169 (973)
Q Consensus        91 L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~  169 (973)
                      |+|++ |+++|.+|.+|++|++|++|+|++|++.+..|..+..+..|+.++++.|++.+.+|..+.++++|+.+++++|.
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~  160 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence            99997 89999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCcc-cEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCc
Q 039720          170 LTGQLPPSIGNLSAL-QTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPV  248 (973)
Q Consensus       170 l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~  248 (973)
                      +++.+|+.+..+..+ +.+++++|++++..|..+.++..+ +++++.|.+.+.+|..+..+++|+.+++++|.+.+.+|.
T Consensus       161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~  239 (313)
T d1ogqa_         161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK  239 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            999999999988886 899999999999999999888665 799999999999999999999999999999999977664


Q ss_pred             ccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccC
Q 039720          249 CLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       249 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                       +. .+++|++|+|++|+++|.+|.+|+++++|++|+|++|+|+|.+| .+..+++|+.+++++|+.
T Consensus       240 -~~-~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~~  303 (313)
T d1ogqa_         240 -VG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC  303 (313)
T ss_dssp             -CC-CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSSE
T ss_pred             -cc-cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCcc
Confidence             33 68999999999999999999999999999999999999998887 467888999999998873

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-42  Score=373.05  Aligned_cols=266  Identities=21%  Similarity=0.322  Sum_probs=201.7

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.++||+|+||+||+|+++ +|+.||||+++...  ....+.+.+|+.+|++++||||+++++++..     ....
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence            58999999999999999999996 88999999997543  2335789999999999999999999998654     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++++||+.++.+..+.+..+.+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+|++|||.|.....
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            99999999888888888788889999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc--
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK--  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  908 (973)
                      .        ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+ .+...........  
T Consensus       153 ~--------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~  223 (286)
T d1ob3a_         153 P--------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSK  223 (286)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred             C--------ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChh
Confidence            2        1223344689999999998764 56999999999999999999999997653221 1111111110000  


Q ss_pred             ----ccccc--CcccccccCC--CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          909 ----VMGIV--DPSLLMEARG--PSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       909 ----~~~~~--~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                          .....  ..........  ..........+.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000  0000000000  1111223456778899999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=375.77  Aligned_cols=259  Identities=20%  Similarity=0.353  Sum_probs=205.8

Q ss_pred             hhcCCcCCccccccceeEEEEEECC-----CCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGE-----DGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFK  746 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  746 (973)
                      .++|.+.++||+|+||+||+|+++.     +++.||||+++... ......+.+|++++++++||||++++++|..    
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence            3689999999999999999998852     45789999997443 3344678999999999999999999998754    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcC----------CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTN----------DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM  816 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~  816 (973)
                       .+..++||||+++|+|.+++....          ......+.+++.|+++||.|||++   +|+||||||+|||++.++
T Consensus        95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence             467899999999999999986432          234567889999999999999999   999999999999999999


Q ss_pred             cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCCCc
Q 039720          817 VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRR-RPTDNMFNDGL  895 (973)
Q Consensus       817 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~-~Pf~~~~~~~~  895 (973)
                      ++||+|||+|+......      .........||+.|+|||.+.+..++.++|||||||++|||+||. .||......  
T Consensus       171 ~~Kl~DFGla~~~~~~~------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--  242 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--  242 (308)
T ss_dssp             CEEECCTTCCCGGGGGG------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--
T ss_pred             eEEEeecccceeccCCc------ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999998764322      122233456899999999999999999999999999999999974 677543221  


Q ss_pred             cHhhhhhHhcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          896 TLHGYAKMALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                         +......        +.      ..+..+..++..+.+++.+||+.||++|||++||++.|++..+
T Consensus       243 ---~~~~~i~--------~~------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         243 ---QVLRFVM--------EG------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ---HHHHHHH--------TT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---HHHHHHH--------hC------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence               1111110        00      0111223345678899999999999999999999999987643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=372.15  Aligned_cols=278  Identities=20%  Similarity=0.275  Sum_probs=202.9

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecc---cCC
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSID---FKG  747 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~  747 (973)
                      .++|++.++||+|+||+||+|++..+|+.||||++..+.  ....+++.+|+++|++++|||++++++++....   ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999999999999999986543  334577899999999999999999999875532   123


Q ss_pred             CceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          748 ADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       748 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ....++||||+.++.+...........+..++.++.|++.||.|||++   +|+||||||+|||++.++.+|++|||+|+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence            456899999999888887777777788888999999999999999999   99999999999999999999999999998


Q ss_pred             hccCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh--
Q 039720          828 FLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA--  904 (973)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~--  904 (973)
                      ........    .........||+.|+|||++.+. .|+.++||||+||++|||++|+.||....... .........  
T Consensus       166 ~~~~~~~~----~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~  240 (318)
T d3blha1         166 AFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGS  240 (318)
T ss_dssp             ECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred             eccccccc----ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence            76543211    11222345699999999998765 68999999999999999999999997543211 111111111  


Q ss_pred             cCcc-cccccCccccccc----CCCchhH------HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          905 LPKK-VMGIVDPSLLMEA----RGPSKFE------ECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       905 ~~~~-~~~~~~~~~~~~~----~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .... .............    .......      .....+.+++.+||+.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            1111 1111111000000    0001111      123456789999999999999999999876

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=376.20  Aligned_cols=276  Identities=20%  Similarity=0.260  Sum_probs=200.7

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK-KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ..+|++.++||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|+.++||||+++++++....+......
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357999999999999999999999999999999997543 3445788999999999999999999999876544444445


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      +++ +|+.+|+|.+++... .+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            554 567799999999764 578888999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc--
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK--  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  908 (973)
                      ..     ..........||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+...........+..  
T Consensus       162 ~~-----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         162 DH-----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             GG-----CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             CC-----ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            21     11122334579999999999754 56789999999999999999999999764321111000000000000  


Q ss_pred             cccccCc-------ccccccCCC--chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 VMGIVDP-------SLLMEARGP--SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ~~~~~~~-------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                      .......       ........+  .........+.+++.+|++.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000       000000000  0011223457789999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-41  Score=364.41  Aligned_cols=269  Identities=19%  Similarity=0.249  Sum_probs=208.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  751 (973)
                      ++|++.++||+|+||+||+|++..+|+.||||+++...  .....++.+|+.+++.++||||+++++++..     ....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence            58999999999999999999999999999999997553  3346789999999999999999999998755     4789


Q ss_pred             EEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhccC
Q 039720          752 AIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLSH  831 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~~  831 (973)
                      ++|++++.++++..+++..+...+..++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.|+....
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence            99999999999999988888888899999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcCcc--
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGD-LSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALPKK--  908 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  908 (973)
                      .        ........+++.|+|||++.+.. ++.++||||+||++|||++|+.||.........+...........  
T Consensus       154 ~--------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (292)
T d1unla_         154 P--------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             C--------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             C--------CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence            2        22223345778899999987765 689999999999999999999997543332222222111111100  


Q ss_pred             ----cccccCc----ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          909 ----VMGIVDP----SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       909 ----~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                          .....+.    ................+.+.+++.+|++.||.+||||+|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0000000    0000111112223334567788999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-41  Score=367.10  Aligned_cols=264  Identities=19%  Similarity=0.244  Sum_probs=200.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCceEEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADFKAI  753 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  753 (973)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.....  .+++..|+++++.++|++++..+..+..    +.+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence            579999999999999999999999999999999875433  3457889999999988877666655533    3478899


Q ss_pred             EEeeccCCCHHHHhh-hcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC---CCcEEEeccccchhc
Q 039720          754 VYEYMQYGSVDDWLH-HTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLARFL  829 (973)
Q Consensus       754 v~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~---~~~~kl~Dfg~a~~~  829 (973)
                      ||||+. +++.+.+. ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..+|++|||+|+..
T Consensus        81 vme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          81 VMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            999995 55555554 455678888999999999999999999   9999999999999864   457999999999977


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHh--hhhhHhcCc
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH--GYAKMALPK  907 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~--~~~~~~~~~  907 (973)
                      ....... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||...........  .........
T Consensus       157 ~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         157 RDARTHQ-HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             BCTTTCC-BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccc-ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            5433111 1112233456799999999999999999999999999999999999999986544322111  111110000


Q ss_pred             ccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhc
Q 039720          908 KVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAV  962 (973)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  962 (973)
                      .              .+.....++.++.+++.+||+.||++||+++++.+.|+.+
T Consensus       236 ~--------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         236 P--------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             C--------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             C--------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0              0011123446678899999999999999999998888865

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-41  Score=369.35  Aligned_cols=253  Identities=21%  Similarity=0.286  Sum_probs=202.7

Q ss_pred             hcCCcCCccccccceeEEEEEE---CCCCcEEEEEEeeccc----chhHHHHHHHHHHHHhcCC-CCceeEEeEeeeccc
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNL---GEDGMSVAVKVMNLDK----KGATKSFVAECEALRNIRH-RNLIKIITICSSIDF  745 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  745 (973)
                      ++|++.+.||+|+||+||+|++   +.+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+   
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~---  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence            5799999999999999999987   4478999999986432    2345678899999999976 899999998654   


Q ss_pred             CCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEecccc
Q 039720          746 KGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL  825 (973)
Q Consensus       746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~  825 (973)
                        ....+++|||+.+|+|.+++...+...+..+..++.||+.|++|+|++   +|+||||||+||+++.++.+||+|||+
T Consensus       101 --~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         101 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             --CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence              478999999999999999999988888888999999999999999999   999999999999999999999999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhH
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG--DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKM  903 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~  903 (973)
                      |+.+....       ........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||...........-....
T Consensus       176 a~~~~~~~-------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~  248 (322)
T d1vzoa_         176 SKEFVADE-------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  248 (322)
T ss_dssp             EEECCGGG-------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             hhhhcccc-------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            98654321       2233456799999999998765  46889999999999999999999998664433211111111


Q ss_pred             hcCcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 039720          904 ALPKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQ-----MTAVVK  957 (973)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  957 (973)
                      ...                .+..+..+...+.+++.+||+.||++|||     ++|+++
T Consensus       249 ~~~----------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 LKS----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHC----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ccC----------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            100                01112234556778899999999999994     889886

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-41  Score=372.84  Aligned_cols=272  Identities=21%  Similarity=0.247  Sum_probs=198.1

Q ss_pred             cCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCceEEE
Q 039720          675 EFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGADFKAI  753 (973)
Q Consensus       675 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l  753 (973)
                      +|+..++||+|+||+||+|+++.+|+.||||+++.+...    ..+|+++|++++||||+++++++..... .+..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688899999999999999999999999999999755432    3469999999999999999999865322 34456789


Q ss_pred             EEeeccCCCHHHHh---hhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccchhc
Q 039720          754 VYEYMQYGSVDDWL---HHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFL  829 (973)
Q Consensus       754 v~e~~~~gsL~~~l---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~~~  829 (973)
                      ||||++++.+..+.   .....+++.+++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            99999876544433   3445677888999999999999999999   999999999999999775 8999999999876


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC--
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMG-GDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP--  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~--  906 (973)
                      ...         .......||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||......+ .+....+....  
T Consensus       174 ~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~  243 (350)
T d1q5ka_         174 VRG---------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPT  243 (350)
T ss_dssp             CTT---------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred             cCC---------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCCh
Confidence            432         22234579999999998765 578999999999999999999999997543221 11111110000  


Q ss_pred             c-ccc----cccCcccccccCC---CchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcc
Q 039720          907 K-KVM----GIVDPSLLMEARG---PSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVG  963 (973)
Q Consensus       907 ~-~~~----~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  963 (973)
                      . ...    ...+..+......   ..........+.+++.+||+.||++|||++|++++  ++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            0 000    0000000000000   00011234457788999999999999999999964  45543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-40  Score=365.64  Aligned_cols=263  Identities=19%  Similarity=0.244  Sum_probs=200.5

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccCCCceEE
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFKGADFKA  752 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  752 (973)
                      ++|++.++||+|+||+||+|+++.+|+.||||+++..   ..+++.+|+++|++++ ||||+++++++..   ......+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence            5899999999999999999999999999999999643   3467889999999995 9999999998753   2346789


Q ss_pred             EEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCC-cEEEeccccchhccC
Q 039720          753 IVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLSH  831 (973)
Q Consensus       753 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~-~~kl~Dfg~a~~~~~  831 (973)
                      +||||+.+++|....   ..+.+.+++.++.||+.||+|||++   +|+||||||+|||++.++ .+|++|||+|+....
T Consensus       109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999999988764   3577888999999999999999999   999999999999998765 689999999987643


Q ss_pred             CCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHh------
Q 039720          832 HPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMA------  904 (973)
Q Consensus       832 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~------  904 (973)
                      .         .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.................      
T Consensus       183 ~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         183 G---------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             T---------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             C---------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence            2         223345689999999997765 579999999999999999999999976543221111111100      


Q ss_pred             -------c--CcccccccCc---ccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 039720          905 -------L--PKKVMGIVDP---SLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVK  957 (973)
Q Consensus       905 -------~--~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  957 (973)
                             .  ..........   ................+++.+++.+|++.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0  0000001100   001111111222334456788999999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-41  Score=372.34  Aligned_cols=274  Identities=20%  Similarity=0.244  Sum_probs=199.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCceeEEeEeeecc-cCCCc
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD--KKGATKSFVAECEALRNIRHRNLIKIITICSSID-FKGAD  749 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  749 (973)
                      .++|++.++||+|+||+||+|+++.+|+.||||+++..  .....+.+.+|+++|+.++|||||++++++.... .....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            36899999999999999999999999999999999743  2334567899999999999999999999976532 22345


Q ss_pred             eEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhc
Q 039720          750 FKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL  829 (973)
Q Consensus       750 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~  829 (973)
                      ..++||||+ +.++..+++. ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.|+..
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence            679999999 5677776654 5678889999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc--C
Q 039720          830 SHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL--P  906 (973)
Q Consensus       830 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~--~  906 (973)
                      ..           ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||....... .+........  +
T Consensus       172 ~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~  239 (346)
T d1cm8a_         172 DS-----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPP  239 (346)
T ss_dssp             CS-----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred             CC-----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCc
Confidence            32           22345799999999998764 56899999999999999999999997653211 1111111110  0


Q ss_pred             cccccccCc--------cccccc--CCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcc
Q 039720          907 KKVMGIVDP--------SLLMEA--RGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVG  963 (973)
Q Consensus       907 ~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  963 (973)
                      .........        ......  ............+.+++.+|++.||++|||++|++++  ++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            000000000        000000  0001112233456789999999999999999999985  55554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-40  Score=357.00  Aligned_cols=268  Identities=15%  Similarity=0.188  Sum_probs=206.2

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCC-CCceeEEeEeeecccCCCceE
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRH-RNLIKIITICSSIDFKGADFK  751 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  751 (973)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....  ...+.+|++.++.+.| +|++.+++++..     ....
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCcc
Confidence            3689999999999999999999999999999999864432  3456788999999975 899999988654     4788


Q ss_pred             EEEEeeccCCCHHHHhhhcC-CCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecC-----CCcEEEecccc
Q 039720          752 AIVYEYMQYGSVDDWLHHTN-DKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDH-----DMVAHVSDFGL  825 (973)
Q Consensus       752 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~-----~~~~kl~Dfg~  825 (973)
                      ++||||+ +++|.++++..+ .+...++..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            9999998 689999987654 567788899999999999999999   9999999999999974     57899999999


Q ss_pred             chhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc
Q 039720          826 ARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL  905 (973)
Q Consensus       826 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~  905 (973)
                      |+......... ...........||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .......
T Consensus       153 a~~~~~~~~~~-~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-~~~~i~~  230 (293)
T d1csna_         153 VKFYRDPVTKQ-HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGE  230 (293)
T ss_dssp             CEESBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHH
T ss_pred             eEEcccCcccc-ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-HHHHHHh
Confidence            98765432111 111223345679999999999999999999999999999999999999998654432211 1111000


Q ss_pred             CcccccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHhccc
Q 039720          906 PKKVMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKKLCAVGE  964 (973)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  964 (973)
                      ...   ...   .     .+....+++.+.+++..|+..+|++||+++.+.+.|+++-+
T Consensus       231 ~~~---~~~---~-----~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         231 KKQ---STP---L-----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHH---HSC---H-----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccC---CCC---h-----HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            000   000   0     00112234567889999999999999999999888887643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-40  Score=364.43  Aligned_cols=267  Identities=18%  Similarity=0.188  Sum_probs=195.6

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeeccc-CCCce
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDF-KGADF  750 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  750 (973)
                      ++|++.++||+|+||+||+|+++.+|+.||||+++...  ....+++.+|+.+++.++||||+++++++..... +....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999999999999999997543  3345678999999999999999999998754322 35578


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .|+||||+.++.+.. +.  ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+|++|||.++...
T Consensus        97 ~~iv~Ey~~~~l~~~-~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-IQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSEEHHHH-HT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccchHHHHh-hh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence            999999997665544 43  3567888999999999999999999   99999999999999999999999999988654


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhcC----
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMALP----  906 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~~----  906 (973)
                      .         ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||....... ...........    
T Consensus       171 ~---------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         171 T---------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPE  240 (355)
T ss_dssp             -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHH
T ss_pred             c---------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHH
Confidence            3         233345679999999999999999999999999999999999999997542211 00000000000    


Q ss_pred             --------------cc-------cccccCcccccccCCCchhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 039720          907 --------------KK-------VMGIVDPSLLMEARGPSKFEECLVAVVRTGVACSMESPSERMQMTAVVKK  958 (973)
Q Consensus       907 --------------~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  958 (973)
                                    ..       .........  ..............+.+++.+|++.||++||||+|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG--SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhHHHHhhcCcccccccccccccccc--ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                          00       000000000  000112234567778899999999999999999999865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-40  Score=365.88  Aligned_cols=275  Identities=17%  Similarity=0.224  Sum_probs=201.6

Q ss_pred             hhcCCcCCccccccceeEEEEEECCCCcEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCceeEEeEeeecccCCCce
Q 039720          673 TKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDK--KGATKSFVAECEALRNIRHRNLIKIITICSSIDFKGADF  750 (973)
Q Consensus       673 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  750 (973)
                      .++|++.++||+|+||+||+|++..+|+.||||+++...  ....+++.+|+++++.++|||+|++++++......+...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            358999999999999999999999999999999997543  234567899999999999999999999876543333455


Q ss_pred             EEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCcEEEeccccchhcc
Q 039720          751 KAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLS  830 (973)
Q Consensus       751 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~~~~  830 (973)
                      .+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.|....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             eEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence            56778888999999998654 678889999999999999999999   99999999999999999999999999997542


Q ss_pred             CCCCccCCCCCcccccccccccccCcccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCccHhhhhhHhc--Cc
Q 039720          831 HHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGG-DLSMTGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHGYAKMAL--PK  907 (973)
Q Consensus       831 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~ll~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~  907 (973)
                                 .......||+.|+|||+..+. .++.++||||+||++|+|++|+.||........ .........  ..
T Consensus       173 -----------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~  240 (348)
T d2gfsa1         173 -----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGA  240 (348)
T ss_dssp             -----------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCH
T ss_pred             -----------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCh
Confidence                       233345789999999987665 468999999999999999999999975422110 011101000  00


Q ss_pred             ccccccCccc-------ccccCCC---chhHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHhcc
Q 039720          908 KVMGIVDPSL-------LMEARGP---SKFEECLVAVVRTGVACSMESPSERMQMTAVVKK--LCAVG  963 (973)
Q Consensus       908 ~~~~~~~~~~-------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  963 (973)
                      ..........       .......   .........+.+++.+|++.||++|||++|++++  +++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            0000000000       0000000   0011234556789999999999999999999983  55443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-35  Score=330.60  Aligned_cols=267  Identities=18%  Similarity=0.213  Sum_probs=190.1

Q ss_pred             hcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-----------CCCceeEEeEeee
Q 039720          674 KEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-----------HRNLIKIITICSS  742 (973)
Q Consensus       674 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  742 (973)
                      .+|++.++||+|+||+||+|+++.+|+.||||+++.+.. ..+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            469999999999999999999999999999999975432 3466788998888775           5789999887653


Q ss_pred             cccCCCceEEEEEeeccCCCHHHH---hhhcCCCchhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCC--
Q 039720          743 IDFKGADFKAIVYEYMQYGSVDDW---LHHTNDKLEVGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDM--  816 (973)
Q Consensus       743 ~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~--  816 (973)
                         ......+++++++..+.....   ........+..++.++.||+.|++|||+ .   +|+||||||+|||++.++  
T Consensus        92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          92 ---KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             ---EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred             ---ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence               234566667776654432222   2233455678889999999999999998 5   999999999999998665  


Q ss_pred             ----cEEEeccccchhccCCCCccCCCCCcccccccccccccCcccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 039720          817 ----VAHVSDFGLARFLSHHPFLVAPEGQSSSIEMKGTIGYIGPEYGMGGDLSMTGDVYSFGILLLEMFTRRRPTDNMFN  892 (973)
Q Consensus       817 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ll~elltg~~Pf~~~~~  892 (973)
                          .++++|||.|.....           ......||+.|+|||++.+..|+.++||||+||++++|++|+.||.....
T Consensus       166 ~~~~~~kl~dfg~s~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDE-----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             TTEEEEEECCCTTCEETTB-----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cccceeeEeeccccccccc-----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence                499999999875432           22345699999999999999999999999999999999999999975433


Q ss_pred             CCc-----cHhhhhhHh--cCccc-------ccccCcc-cc---cc----------cCCCchhHHHHHHHHHHHhhcCCC
Q 039720          893 DGL-----TLHGYAKMA--LPKKV-------MGIVDPS-LL---ME----------ARGPSKFEECLVAVVRTGVACSME  944 (973)
Q Consensus       893 ~~~-----~~~~~~~~~--~~~~~-------~~~~~~~-~~---~~----------~~~~~~~~~~~~~l~~li~~cl~~  944 (973)
                      ...     .+.......  .+...       ....+.. ..   ..          ...........+.+.+++.+|++.
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            210     011111000  00000       0000000 00   00          001223356677889999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 039720          945 SPSERMQMTAVVKK  958 (973)
Q Consensus       945 dP~~RPs~~evl~~  958 (973)
                      ||++||||+|++++
T Consensus       315 dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         315 DPRKRADAGGLVNH  328 (362)
T ss_dssp             STTTCBCHHHHHTC
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1e-33  Score=309.20  Aligned_cols=258  Identities=29%  Similarity=0.511  Sum_probs=239.3

Q ss_pred             hhHhhhcCCcccc--CCCccccCCCCcCEEEccc-ccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEE
Q 039720          360 MTLIAMAGNQISG--TIPPEIRNLFNLNGLGLEY-NQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQ  436 (973)
Q Consensus       360 l~~L~l~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  436 (973)
                      ++.|++++|.++|  .+|..++++++|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..+..+..+..|++++
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~  131 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence            4555666666665  4788999999999999996 899999999999999999999999999999999999999999999


Q ss_pred             cCCCccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCccc
Q 039720          437 LGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS  516 (973)
Q Consensus       437 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  516 (973)
                      +++|++.+.+|..+..+++|+.+++++|.+.|.+|..++.+..+.+.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus       132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~  210 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred             cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            999999999999999999999999999999999999999998888899999999999999999887655 6999999999


Q ss_pred             ccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCC
Q 039720          517 NEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGV  596 (973)
Q Consensus       517 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  596 (973)
                      +.+|..+..+++|+.+++++|.+.+.+| .+..+++|+.|+|++|+|+|.+|.+++++++|++|+|++|+|+|.+|+.+.
T Consensus       211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~  289 (313)
T d1ogqa_         211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence            9999999999999999999999997655 688899999999999999999999999999999999999999999999888


Q ss_pred             CCCccccccccCccccCCCCCCCCCCC
Q 039720          597 FSNETRISLTGNEQFCGGLGELHLPAC  623 (973)
Q Consensus       597 ~~~~~~l~~~~N~~~cg~~~~~~~~~~  623 (973)
                      +++++.+++.||+.+||.|+    |+|
T Consensus       290 L~~L~~l~l~~N~~l~g~pl----p~c  312 (313)
T d1ogqa_         290 LQRFDVSAYANNKCLCGSPL----PAC  312 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTTS----SCC
T ss_pred             CCCCCHHHhCCCccccCCCC----CCC
Confidence            99999999999999999876    677

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.4e-28  Score=276.50  Aligned_cols=195  Identities=32%  Similarity=0.437  Sum_probs=148.6

Q ss_pred             CCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccc
Q 039720          374 IPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKC  453 (973)
Q Consensus       374 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  453 (973)
                      ....+..+++++.+++++|.+++..|  +...++|++|++++|+++..  ..+..+++|+.|++++|++++..+  +..+
T Consensus       189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~  262 (384)
T d2omza2         189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL  262 (384)
T ss_dssp             CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred             cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--cccc
Confidence            34456677778888888888876543  45567888888888888742  357778888888888888875443  6777


Q ss_pred             cccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhc
Q 039720          454 QNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLL  533 (973)
Q Consensus       454 ~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~  533 (973)
                      ++|+.|++++|++.+ +++ +.....+ +.++++.|++++  ...+..+++++.|++++|++++..  .+..+++|+.|+
T Consensus       263 ~~L~~L~l~~~~l~~-~~~-~~~~~~l-~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~  335 (384)
T d2omza2         263 TKLTELKLGANQISN-ISP-LAGLTAL-TNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLF  335 (384)
T ss_dssp             TTCSEEECCSSCCCC-CGG-GTTCTTC-SEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEE
T ss_pred             ccCCEeeccCcccCC-CCc-ccccccc-cccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEE
Confidence            888888888888873 332 3344444 478888888874  335778889999999999998653  378899999999


Q ss_pred             ccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCC
Q 039720          534 MQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYN  585 (973)
Q Consensus       534 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  585 (973)
                      +++|+|++ ++ .+..+++|++|+|++|+|++..|  +.++++|+.|+|++|
T Consensus       336 L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         336 FANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            99999984 44 68889999999999999996554  888999999999988

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=1.4e-27  Score=268.11  Aligned_cols=73  Identities=27%  Similarity=0.369  Sum_probs=55.5

Q ss_pred             eeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCC
Q 039720          483 LLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN  561 (973)
Q Consensus       483 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  561 (973)
                      .|++++|++++..  .+..+++|+.|++++|++++ ++ .++++++|++|++++|+|++..|  +.++++|+.|+|++|
T Consensus       311 ~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         311 YLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             EEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             eEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            5666666666432  26777888888888888874 44 58888888888888888886554  788888888988887

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=5.7e-26  Score=246.35  Aligned_cols=284  Identities=23%  Similarity=0.266  Sum_probs=192.5

Q ss_pred             ccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEcc
Q 039720          159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLF  238 (973)
Q Consensus       159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  238 (973)
                      ..+.+|=++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....|.+|.++++|+.|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4566777777787 6777664  578888888888885555678888888888888888887778888888888888888


Q ss_pred             CCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCccc--ccCcccccCcccccceecccccCC
Q 039720          239 KNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS--GQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       239 ~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      +|+++ .+|...+   ..++.|++++|.+.+..+..+.....+..++...|...  ...+..|..+++|+.+++++|.+.
T Consensus        88 ~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~  163 (305)
T d1xkua_          88 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  163 (305)
T ss_dssp             SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCccC-cCccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence            88887 6776543   57888888888888777777778888888888877543  333455666777777777776654


Q ss_pred             CCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCC
Q 039720          317 TRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTG  396 (973)
Q Consensus       317 ~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  396 (973)
                      .++.                                                        .  .+++|+.|++++|.+++
T Consensus       164 ~l~~--------------------------------------------------------~--~~~~L~~L~l~~n~~~~  185 (305)
T d1xkua_         164 TIPQ--------------------------------------------------------G--LPPSLTELHLDGNKITK  185 (305)
T ss_dssp             SCCS--------------------------------------------------------S--CCTTCSEEECTTSCCCE
T ss_pred             ccCc--------------------------------------------------------c--cCCccCEEECCCCcCCC
Confidence            3221                                                        1  12456666666666666


Q ss_pred             CCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccccCcccccCCCccccc
Q 039720          397 TIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFG  476 (973)
Q Consensus       397 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  476 (973)
                      ..+..|..++.+++|++++|.+.+..+..+.++++|++|+|++|+|+ .+|.++..+++|++|++++|+|+ .++...|.
T Consensus       186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~  263 (305)
T d1xkua_         186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFC  263 (305)
T ss_dssp             ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSS
T ss_pred             CChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhcc
Confidence            66666666666666766666666666666666667777777777666 55666666777777777777666 44443332


Q ss_pred             cccccceeeccCCcccccCCcccccccccceeccccCccc--ccccccccCcc
Q 039720          477 ITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFS--NEIPVTLSACT  527 (973)
Q Consensus       477 ~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--~~~p~~~~~l~  527 (973)
                      .                  +.....+.+|+.|+|++|.++  ...|.+|..+.
T Consensus       264 ~------------------~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~  298 (305)
T d1xkua_         264 P------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY  298 (305)
T ss_dssp             C------------------SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred             C------------------cchhcccCCCCEEECCCCcCccCcCCHhHhcccc
Confidence            1                  112234556777777777664  23344444433

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=5.6e-26  Score=246.37  Aligned_cols=220  Identities=24%  Similarity=0.306  Sum_probs=139.4

Q ss_pred             CceeeeEeeCCCCeEEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcc
Q 039720           50 CQWTGVTCGHRHQRVTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTN  129 (973)
Q Consensus        50 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~  129 (973)
                      |.|.+|.|++            ++++ .+|+.+.  +.+++|+|++|+|+...+.+|.++++|++|++++|.+....|..
T Consensus        10 c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~   74 (305)
T d1xkua_          10 CHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   74 (305)
T ss_dssp             EETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             ecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence            6788888864            2333 4566553  56888888888887433446788888888888888777544555


Q ss_pred             cccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccc
Q 039720          130 LSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLN  209 (973)
Q Consensus       130 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~  209 (973)
                      |.+                        +++|++|++++|+++ .+|..+.  ..|+.|++++|.+.+..+..+.....+.
T Consensus        75 f~~------------------------l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~  127 (305)
T d1xkua_          75 FAP------------------------LVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMI  127 (305)
T ss_dssp             TTT------------------------CTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCC
T ss_pred             hhC------------------------CCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhcccccc
Confidence            544                        455666666666666 3454332  4667777777777755555566666677


Q ss_pred             eeccCCCCcc--ccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcc
Q 039720          210 YLGTSENDFS--GMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELN  287 (973)
Q Consensus       210 ~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  287 (973)
                      .++...|...  ...+..+..+++|+.+++.+|.+. .+|..+   +++|+.|++++|.+++..+..|.+++.+++|+++
T Consensus       128 ~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s  203 (305)
T d1xkua_         128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS  203 (305)
T ss_dssp             EEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred             ccccccccccccCCCccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhccccccccccc
Confidence            7777666443  233445666666666666666665 455443   3566667777766666666666666666666666


Q ss_pred             CCcccccCcccccCcccccceecccccC
Q 039720          288 ENHFSGQVRINFNSLPNLSKLYLGRNNL  315 (973)
Q Consensus       288 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l  315 (973)
                      +|.+++..+..|.++++|++|+|++|+|
T Consensus       204 ~n~l~~~~~~~~~~l~~L~~L~L~~N~L  231 (305)
T d1xkua_         204 FNSISAVDNGSLANTPHLRELHLNNNKL  231 (305)
T ss_dssp             SSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred             cccccccccccccccccceeeecccccc
Confidence            6666666555555555555555555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.4e-25  Score=237.39  Aligned_cols=222  Identities=23%  Similarity=0.286  Sum_probs=120.1

Q ss_pred             eeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC-Cc
Q 039720          163 LSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK-NR  241 (973)
Q Consensus       163 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~  241 (973)
                      ++.++++++ .+|..+.  +++++|+|++|+|++..+.+|.++++|++|++++|++..+.+..+.++..++.+.... |.
T Consensus        16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~   92 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ   92 (284)
T ss_dssp             EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred             EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence            455566666 5666554  4567777777777755556677777777777777777766666666555555555432 23


Q ss_pred             cccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCC
Q 039720          242 FKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTST  321 (973)
Q Consensus       242 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  321 (973)
                      ++ .++...+.++++|++|++++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|++|++++|+++.    
T Consensus        93 ~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~----  167 (284)
T d1ozna_          93 LR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS----  167 (284)
T ss_dssp             CC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE----
T ss_pred             cc-cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc----
Confidence            32 3433333345555555555555544444445555555555555555554444444444444444444443321    


Q ss_pred             ChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCcc
Q 039720          322 DLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPA  401 (973)
Q Consensus       322 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  401 (973)
                                                                         ..+..|..+++|+.+++++|++++..|.+
T Consensus       168 ---------------------------------------------------l~~~~f~~l~~L~~l~l~~N~l~~i~~~~  196 (284)
T d1ozna_         168 ---------------------------------------------------VPERAFRGLHSLDRLLLHQNRVAHVHPHA  196 (284)
T ss_dssp             ---------------------------------------------------ECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred             ---------------------------------------------------cchhhhccccccchhhhhhccccccChhH
Confidence                                                               22333444555555555555555555555


Q ss_pred             ccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccc
Q 039720          402 IGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQ  443 (973)
Q Consensus       402 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  443 (973)
                      |..+++|++|++++|++.+..+..|.++++|++|++++|.+.
T Consensus       197 f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             hhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            555555555555555555444445555555555555555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=9.7e-25  Score=233.75  Aligned_cols=223  Identities=20%  Similarity=0.171  Sum_probs=159.8

Q ss_pred             EeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccc
Q 039720           68 DLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLV  147 (973)
Q Consensus        68 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~  147 (973)
                      +.++.+++ .+|..+.  +.+++|+|++|+|++..+..|.++++|++|++++|.+.+..+..+..+..+.++...     
T Consensus        17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~-----   88 (284)
T d1ozna_          17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS-----   88 (284)
T ss_dssp             ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC-----
T ss_pred             EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc-----
Confidence            44555555 5666553  567889999999885555678888889999988888876555555555444444332     


Q ss_pred             cchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCcccc
Q 039720          148 GEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC  227 (973)
Q Consensus       148 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~  227 (973)
                                        ..|.++...|..|+++++|++|++++|.+....+..+....+|+.+++++|.|+++.+..|.
T Consensus        89 ------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~  150 (284)
T d1ozna_          89 ------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR  150 (284)
T ss_dssp             ------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             ------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhc
Confidence                              23444444566666677777777777776655556666677777777777777666666666


Q ss_pred             CCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccc
Q 039720          228 NISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSK  307 (973)
Q Consensus       228 ~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  307 (973)
                      .+++|++|++++|+++ .+|...+.++++|+++++++|++++..|..|.++++|++|++++|++++..+..|..+++|++
T Consensus       151 ~~~~L~~L~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~  229 (284)
T d1ozna_         151 DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY  229 (284)
T ss_dssp             TCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred             cccchhhcccccCccc-ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence            6777777777777776 555555567888888888888888888888888888888888888888888888888888888


Q ss_pred             eecccccCCC
Q 039720          308 LYLGRNNLGT  317 (973)
Q Consensus       308 L~L~~N~l~~  317 (973)
                      |+|++|.+..
T Consensus       230 L~l~~N~l~C  239 (284)
T d1ozna_         230 LRLNDNPWVC  239 (284)
T ss_dssp             EECCSSCEEC
T ss_pred             EEecCCCCCC
Confidence            8888888754

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=7.3e-24  Score=224.28  Aligned_cols=206  Identities=23%  Similarity=0.206  Sum_probs=130.9

Q ss_pred             cCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccccccccccccccc
Q 039720          379 RNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQ  458 (973)
Q Consensus       379 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  458 (973)
                      .+...+.+++.+++.|+ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+ .+|. ++.+++|+.
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccc
Confidence            34455666777777777 4565553  46777888888877666667777777888888877777 4442 455666666


Q ss_pred             ccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcc
Q 039720          459 LSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNS  538 (973)
Q Consensus       459 L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  538 (973)
                      |++++|++. .                         .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.
T Consensus        82 L~Ls~N~l~-~-------------------------~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~  135 (266)
T d1p9ag_          82 LDLSHNQLQ-S-------------------------LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE  135 (266)
T ss_dssp             EECCSSCCS-S-------------------------CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred             ccccccccc-c-------------------------cccccccccccccccccccccceeeccccccccccccccccccc
Confidence            666666555 2                         23344455566666666666665555555666666666666666


Q ss_pred             cccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccCCcCcCcCCCCCCCCCccccccccCccccCCC
Q 039720          539 FNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPKKGVFSNETRISLTGNEQFCGGL  615 (973)
Q Consensus       539 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~l~~~~N~~~cg~~  615 (973)
                      ++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+..++....+.+++.+++.||||.|+|-
T Consensus       136 l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            66555555566666666666666666555555666666666666666666444444445666677777778888764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=8.3e-23  Score=216.09  Aligned_cols=201  Identities=26%  Similarity=0.277  Sum_probs=149.3

Q ss_pred             CCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceee
Q 039720           85 LSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLS  164 (973)
Q Consensus        85 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  164 (973)
                      .+.+.+.|.++++++ .+|+.+.  ++|++|+|++|.|+                        +..+..|.++++|++|+
T Consensus         9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~------------------------~l~~~~f~~l~~L~~L~   61 (266)
T d1p9ag_           9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLY------------------------TFSLATLMPYTRLTQLN   61 (266)
T ss_dssp             STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCS------------------------EEEGGGGTTCTTCCEEE
T ss_pred             cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCC------------------------CcCHHHhhccccccccc
Confidence            344455566666666 4565553  35666666666665                        33344555666777777


Q ss_pred             ccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCcccc
Q 039720          165 LYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKG  244 (973)
Q Consensus       165 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  244 (973)
                      |++|+|+ .+| .++.+++|++|+|++|+++ ..+..+.++++|++|++++|.+.+..+..+..+.++++|++++|.++ 
T Consensus        62 L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-  137 (266)
T d1p9ag_          62 LDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-  137 (266)
T ss_dssp             CTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-
T ss_pred             ccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc-
Confidence            7777776 344 3567788888888888887 45667888888888888888888777777888888888888888887 


Q ss_pred             CCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          245 SLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       245 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                      .+|...+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus       138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            677777768888999999999998888888888999999999999988 456667778889999999988753

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=7.8e-20  Score=201.52  Aligned_cols=137  Identities=23%  Similarity=0.330  Sum_probs=83.2

Q ss_pred             ccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEcc
Q 039720          159 KIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLF  238 (973)
Q Consensus       159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  238 (973)
                      ++++|||++|.++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++. ++.-   .+.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccc
Confidence            5788888888887 57764   357888888888888 677654   467777888887763 2211   1346666666


Q ss_pred             CCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCC
Q 039720          239 KNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLG  316 (973)
Q Consensus       239 ~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  316 (973)
                      +|++. .+|..  ..+++|++|++++|.++.. +.   ....+..+.+.++....  ...+..++.++.|++++|.+.
T Consensus       107 ~n~l~-~lp~~--~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         107 NNQLE-KLPEL--QNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             SSCCS-SCCCC--TTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCS
T ss_pred             ccccc-cccch--hhhccceeecccccccccc-cc---ccccccchhhccccccc--cccccccccceeccccccccc
Confidence            66665 55542  2466666666666666532 22   23445555555554432  234455555555555555543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=5e-20  Score=203.11  Aligned_cols=199  Identities=25%  Similarity=0.337  Sum_probs=109.4

Q ss_pred             EEEEEeeccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecc
Q 039720           64 VTKLDLESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHT  143 (973)
Q Consensus        64 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~  143 (973)
                      ++.|||++++++ .+|+.   .++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++.    +          
T Consensus        40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----l----------   96 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----L----------   96 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----C----------
T ss_pred             CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----h----------
Confidence            445666666664 35542   345666666666665 555432   34566666666555 2221    1          


Q ss_pred             cccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCC
Q 039720          144 NNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFP  223 (973)
Q Consensus       144 n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p  223 (973)
                                   .+.|++|++++|.++ .+|. ++.+++|++|++++|.+. ..+..   ...+..|.+..+...  .+
T Consensus        97 -------------p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~---~~~l~~l~~~~~~~~--~~  155 (353)
T d1jl5a_          97 -------------PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLE--EL  155 (353)
T ss_dssp             -------------CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS--SC
T ss_pred             -------------ccccccccccccccc-cccc-hhhhccceeecccccccc-ccccc---cccccchhhcccccc--cc
Confidence                         024667777777766 4553 566777777777777765 33332   234445555544443  23


Q ss_pred             ccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcc
Q 039720          224 LSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLP  303 (973)
Q Consensus       224 ~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  303 (973)
                      ..+..++.++.+++..|.+. .++..    ....+.+..+++.+. .++ .+..++.|+.+++++|......    ....
T Consensus       156 ~~l~~l~~l~~L~l~~n~~~-~~~~~----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~  224 (353)
T d1jl5a_         156 PELQNLPFLTAIYADNNSLK-KLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DLPP  224 (353)
T ss_dssp             CCCTTCTTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SCCT
T ss_pred             ccccccccceeccccccccc-ccccc----ccccccccccccccc-ccc-cccccccccccccccccccccc----cccc
Confidence            44556667777777777665 33322    223455566555554 222 3566777777777777655321    2334


Q ss_pred             cccceecccccCCC
Q 039720          304 NLSKLYLGRNNLGT  317 (973)
Q Consensus       304 ~L~~L~L~~N~l~~  317 (973)
                      ++..+.+.+|.+..
T Consensus       225 ~l~~~~~~~~~~~~  238 (353)
T d1jl5a_         225 SLEALNVRDNYLTD  238 (353)
T ss_dssp             TCCEEECCSSCCSC
T ss_pred             cccccccccccccc
Confidence            56666666666544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=9.2e-22  Score=196.58  Aligned_cols=134  Identities=18%  Similarity=0.165  Sum_probs=106.6

Q ss_pred             CCcCCccccccceeEEEEEECCCCcEEEEEEeecccc------------------hhHHHHHHHHHHHHhcCCCCceeEE
Q 039720          676 FSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKK------------------GATKSFVAECEALRNIRHRNLIKII  737 (973)
Q Consensus       676 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~  737 (973)
                      +.+.++||+|+||+||+|++. +|+.||||+++....                  ........|+..+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356789999999999999984 899999998763211                  1123456788899999999999887


Q ss_pred             eEeeecccCCCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEecCCCc
Q 039720          738 TICSSIDFKGADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHCQPPIVHGDLKPSNVLLDHDMV  817 (973)
Q Consensus       738 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivHrDik~~NILl~~~~~  817 (973)
                      ++         ...+++|||++++.+.+       .....+..++.|++.|++|||+.   +|+||||||+|||++++ .
T Consensus        81 ~~---------~~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~  140 (191)
T d1zara2          81 AW---------EGNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G  140 (191)
T ss_dssp             EE---------ETTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred             Ee---------cCCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-C
Confidence            65         22479999998765433       23455678999999999999999   99999999999999865 5


Q ss_pred             EEEeccccchhcc
Q 039720          818 AHVSDFGLARFLS  830 (973)
Q Consensus       818 ~kl~Dfg~a~~~~  830 (973)
                      ++++|||.|....
T Consensus       141 ~~liDFG~a~~~~  153 (191)
T d1zara2         141 IWIIDFPQSVEVG  153 (191)
T ss_dssp             EEECCCTTCEETT
T ss_pred             EEEEECCCcccCC
Confidence            8999999997654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=7.8e-19  Score=182.54  Aligned_cols=215  Identities=14%  Similarity=0.089  Sum_probs=135.2

Q ss_pred             eccCccccccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCC-cccccCCCccceEecc-cccc
Q 039720           70 ESQNIGGFLSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIP-TNLSRCFNLIDFWVHT-NNLV  147 (973)
Q Consensus        70 ~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~l~~-n~~~  147 (973)
                      ++.+++ .+|+.+.  +.+++|+|++|+++...+..|.++++|++|+|++|.+...+| ..|.++++++++.+.. |++.
T Consensus        16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~   92 (242)
T d1xwdc1          16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL   92 (242)
T ss_dssp             ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred             eCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence            344554 5666553  578999999999984444568999999999999999876554 3466666666665543 3444


Q ss_pred             cchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCcccc
Q 039720          148 GEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVC  227 (973)
Q Consensus       148 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~  227 (973)
                      ...+..|..+++|++|++++|.++...+.                       ..+..+..|..+..+++.+....+..|.
T Consensus        93 ~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-----------------------~~~~~l~~l~~~~~~n~~l~~i~~~~~~  149 (242)
T d1xwdc1          93 YINPEAFQNLPNLQYLLISNTGIKHLPDV-----------------------HKIHSLQKVLLDIQDNINIHTIERNSFV  149 (242)
T ss_dssp             EECTTSEECCTTCCEEEEESCCCCSCCCC-----------------------TTTCBSSCEEEEEESCTTCCEECTTSST
T ss_pred             ccccccccccccccccccchhhhcccccc-----------------------cccccccccccccccccccccccccccc
Confidence            44444444455555555555444321111                       1223344444444445555444444444


Q ss_pred             CCC-CCcEEEccCCccccCCCcccccCCCCCcEE-EccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccc
Q 039720          228 NIS-SLDEAYLFKNRFKGSLPVCLGFNLPKLTVL-VVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNL  305 (973)
Q Consensus       228 ~l~-~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  305 (973)
                      +++ .++.|++++|+++ .++...+ ..++++.+ ++++|+|+.+.+..|.++++|++|+|++|+|+.+.+..|.++++|
T Consensus       150 ~~~~~l~~L~l~~n~l~-~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L  227 (242)
T d1xwdc1         150 GLSFESVILWLNKNGIQ-EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL  227 (242)
T ss_dssp             TSBSSCEEEECCSSCCC-EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEE
T ss_pred             cccccceeeeccccccc-ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccc
Confidence            443 4555666666665 5555555 44555444 467777876556678888999999999999888777788888888


Q ss_pred             cceeccc
Q 039720          306 SKLYLGR  312 (973)
Q Consensus       306 ~~L~L~~  312 (973)
                      +.|++.+
T Consensus       228 ~~l~~~~  234 (242)
T d1xwdc1         228 RARSTYN  234 (242)
T ss_dssp             ESSSEES
T ss_pred             ccCcCCC
Confidence            8888754

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.1e-18  Score=181.43  Aligned_cols=220  Identities=15%  Similarity=0.142  Sum_probs=157.9

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCC
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN  168 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  168 (973)
                      +.++.++++++ .+|..+.  +++++|||++|.++ .+|.                       ..|.++++|++|+|++|
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~-----------------------~~f~~l~~L~~L~ls~n   63 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQK-----------------------GAFSGFGDLEKIEISQN   63 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECT-----------------------TTTTTCTTCCEEEEESC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccCh-----------------------hHhhccchhhhhhhccc
Confidence            45677777777 6776552  46777777777776 3332                       23445566677777777


Q ss_pred             cccccC-CCCCCCCCcccEEEccC-CcCCCCCCCcccCCCccceeccCCCCccccCCc-cccCCCCCcEEEccCCccccC
Q 039720          169 QLTGQL-PPSIGNLSALQTFDIAG-NKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPL-SVCNISSLDEAYLFKNRFKGS  245 (973)
Q Consensus       169 ~l~~~~-p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~  245 (973)
                      .+...+ +..|.+++.++++++.. |++....+..|.++++|++|++++|.+....+. .+..+..+..+...++++. .
T Consensus        64 ~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~  142 (242)
T d1xwdc1          64 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-T  142 (242)
T ss_dssp             TTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-E
T ss_pred             cccceeeccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccc-c
Confidence            665443 44677788888888764 677767777888889999999998888754333 2344566666677777776 6


Q ss_pred             CCcccccCCC-CCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCCCCCCChh
Q 039720          246 LPVCLGFNLP-KLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGTRTSTDLD  324 (973)
Q Consensus       246 ip~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  324 (973)
                      ++...+.+++ .++.|++++|+++.+.+..|.....++.+++++|+++.+.+..|.++++|++|+|++|+|+.++..   
T Consensus       143 i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~---  219 (242)
T d1xwdc1         143 IERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY---  219 (242)
T ss_dssp             ECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSS---
T ss_pred             ccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHH---
Confidence            6666555554 799999999999966555554443344556888999988888899999999999999999988764   


Q ss_pred             hhhhhcccccceeecccc
Q 039720          325 FITLLTNCSKLVKLGLVF  342 (973)
Q Consensus       325 ~~~~l~~l~~L~~L~l~~  342 (973)
                         .+.++++|+.+++..
T Consensus       220 ---~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         220 ---GLENLKKLRARSTYN  234 (242)
T ss_dssp             ---SCTTCCEEESSSEES
T ss_pred             ---HHcCCcccccCcCCC
Confidence               356788888887754

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=2.5e-18  Score=176.65  Aligned_cols=125  Identities=20%  Similarity=0.305  Sum_probs=65.4

Q ss_pred             ccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEE
Q 039720          157 WLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAY  236 (973)
Q Consensus       157 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  236 (973)
                      +.++..++++.+++++..  .+..+.+|++|++.+|+|+ .++ .+..+++|++|++++|++++..|  +..+++|+.++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~   91 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence            344455566666666432  3455667777777777776 343 46677777777777777664332  44445555555


Q ss_pred             ccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCccc
Q 039720          237 LFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFS  292 (973)
Q Consensus       237 L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  292 (973)
                      +++|.++ .++. + .++++|+.+++++|...+.  ..+.....++.+.++++.+.
T Consensus        92 ~~~n~~~-~i~~-l-~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~  142 (227)
T d1h6ua2          92 LSGNPLK-NVSA-I-AGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQIT  142 (227)
T ss_dssp             CCSCCCS-CCGG-G-TTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred             ccccccc-cccc-c-ccccccccccccccccccc--chhccccchhhhhchhhhhc
Confidence            5555444 2321 1 1344455555544444422  22334444444444444443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=6.9e-21  Score=218.10  Aligned_cols=390  Identities=19%  Similarity=0.162  Sum_probs=202.8

Q ss_pred             cccceeeccCCcccccC-CCCCCCCCcccEEEccCCcCCC----CCCCcccCCCccceeccCCCCccccCCccccCCCCC
Q 039720          158 LKIERLSLYGNQLTGQL-PPSIGNLSALQTFDIAGNKLDG----RIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSL  232 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L  232 (973)
                      .+|+.||+++|++++.. ..-+..+++|++|+|++|.++.    .++..+..+++|++|||++|+|+..-..        
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~--------   73 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH--------   73 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH--------
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHH--------
Confidence            35677777777776321 2223446667777777776651    2233455666666666666666421100        


Q ss_pred             cEEEccCCccccCCCcccccCCCCCcEEEccCCccccc----CCccccCCCCCCEEEccCCcccccCccccc-----Ccc
Q 039720          233 DEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGF----LPQSLSNASKLEWLELNENHFSGQVRINFN-----SLP  303 (973)
Q Consensus       233 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~  303 (973)
                                  .+...+.....+|++|+|++|.++..    ++..+..+++|++|+|++|+++......+.     ...
T Consensus        74 ------------~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~  141 (460)
T d1z7xw1          74 ------------CVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC  141 (460)
T ss_dssp             ------------HHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             ------------HHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccc
Confidence                        11111111234677777777777643    355667778888888888877643222221     111


Q ss_pred             cccceecccccCCCCCCCChhhhhhhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCC
Q 039720          304 NLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFN  383 (973)
Q Consensus       304 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~  383 (973)
                      ....+......+..  .........+.....++.++++.+......-..+.      ..+.              .....
T Consensus       142 ~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~------~~l~--------------~~~~~  199 (460)
T d1z7xw1         142 RLEKLQLEYCSLSA--ASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC------QGLK--------------DSPCQ  199 (460)
T ss_dssp             CCCEEECTTSCCBG--GGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH------HHHH--------------HSCCC
T ss_pred             ccccccccccccch--hhhcccccccccccccccccccccccccccccccc------cccc--------------ccccc
Confidence            12222222222211  11112233445556666666665543311000000      0000              01122


Q ss_pred             cCEEEcccccCCCC----CCccccCCCCCCeEEccCcccCC-----CCCCccCCcCccceEEcCCCccccc----ccccc
Q 039720          384 LNGLGLEYNQLTGT----IPPAIGELRNLQYLGLVGNNIRG-----IIPDPIGNLTLLNVLQLGFNKLQGS----IPSYL  450 (973)
Q Consensus       384 L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~  450 (973)
                      ...+++..+.+...    ....+...+.++.+++++|.+..     ..+..+.....++.+++++|.+...    ....+
T Consensus       200 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l  279 (460)
T d1z7xw1         200 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL  279 (460)
T ss_dssp             CCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH
T ss_pred             ccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccc
Confidence            34555555544321    11223345666667766665432     1122233455677777777766532    22234


Q ss_pred             ccccccccccccCcccccCCCc----cccccccccceeeccCCcccccCCcc----cccccccceeccccCccccc----
Q 039720          451 GKCQNLMQLSAPNNKLNGTLPP----QIFGITTLSKLLDLSENHLSGSIPLE----VGNLKSLVQLDISRNNFSNE----  518 (973)
Q Consensus       451 ~~l~~L~~L~l~~N~l~~~~p~----~~~~~~~l~~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~ls~N~l~~~----  518 (973)
                      ...+.++.+++++|.+......    .+......++.+++++|.++......    +...++|++|+|++|++++.    
T Consensus       280 ~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~  359 (460)
T d1z7xw1         280 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE  359 (460)
T ss_dssp             HHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred             cccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccch
Confidence            4556666777777766421111    11111223346777777776433222    23445788888888888643    


Q ss_pred             cccccc-CccchhhhcccCcccccc----cccchhhhccCCeecCCCCccccccCC----CCC-CCCccceEeccCCcCc
Q 039720          519 IPVTLS-ACTTLEYLLMQGNSFNGS----IPQSLNALKSIKELDLSCNNLSGQIPI----HLG-NLPFLEYLNLSYNHFE  588 (973)
Q Consensus       519 ~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~-~l~~L~~L~ls~N~l~  588 (973)
                      ++..+. ..+.|++|+|++|+|+..    ++..+...++|++|||++|+|+.....    .+. +...|+.|++.+|.+.
T Consensus       360 l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence            233333 356688888888888742    445566678888888888888742222    222 3346888888888876


Q ss_pred             C
Q 039720          589 G  589 (973)
Q Consensus       589 ~  589 (973)
                      .
T Consensus       440 ~  440 (460)
T d1z7xw1         440 E  440 (460)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.4e-18  Score=178.56  Aligned_cols=203  Identities=21%  Similarity=0.276  Sum_probs=90.9

Q ss_pred             CEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCC
Q 039720           89 RVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGN  168 (973)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  168 (973)
                      ..++++.+++++.+  .+..+.+|++|++++|.++ .++ .+..+++|++|++++|++.+..|  +..+++|+.|++++|
T Consensus        22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n   95 (227)
T d1h6ua2          22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN   95 (227)
T ss_dssp             HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred             HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence            33455555555432  2345566666666666655 232 34444444444444444433222  444455555555555


Q ss_pred             cccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCc
Q 039720          169 QLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPV  248 (973)
Q Consensus       169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~  248 (973)
                      .++ .++ .+.++++|+++++++|...+  ...+...+.++.+.++.+.+...  ..+.++++|++|++++|++.+ ++.
T Consensus        96 ~~~-~i~-~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~-~~~  168 (227)
T d1h6ua2          96 PLK-NVS-AIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD-LTP  168 (227)
T ss_dssp             CCS-CCG-GGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC-CGG
T ss_pred             ccc-ccc-cccccccccccccccccccc--cchhccccchhhhhchhhhhchh--hhhcccccccccccccccccc-chh
Confidence            544 222 34455555555555555442  12234445555555555544321  123334444444444444431 111


Q ss_pred             ccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceec
Q 039720          249 CLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYL  310 (973)
Q Consensus       249 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  310 (973)
                        +.++++|++|+|++|++++. + .|+++++|++|+|++|+|+++.+  +.++++|+.|+|
T Consensus       169 --l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~l  224 (227)
T d1h6ua2         169 --LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL  224 (227)
T ss_dssp             --GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEE
T ss_pred             --hcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEe
Confidence              12344444444444444432 1 24444444444444444443321  444444444444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=6.3e-21  Score=218.45  Aligned_cols=395  Identities=17%  Similarity=0.122  Sum_probs=203.8

Q ss_pred             CCCEEeeecccCCCC-CCcccccCCCccceEeccccccc----chhhhhccccccceeeccCCcccc----cCCCCCC-C
Q 039720          111 RLETIVLSNNSFSGK-IPTNLSRCFNLIDFWVHTNNLVG----EIQAIIGNWLKIERLSLYGNQLTG----QLPPSIG-N  180 (973)
Q Consensus       111 ~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~l~~n~~~~----~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~-~  180 (973)
                      +|++||++.|++++. +..-+..+.+++.|++++|.++.    .+...+...++|++|||++|.++.    .+...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            688899999998753 23345667777888888887763    445666777788888888887752    1222232 2


Q ss_pred             CCcccEEEccCCcCCCC----CCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCC
Q 039720          181 LSALQTFDIAGNKLDGR----IPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPK  256 (973)
Q Consensus       181 l~~L~~L~L~~N~l~~~----~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~  256 (973)
                      ..+|++|+|++|+++..    ++..+..+++|++|++++|.++......+.                    ..+......
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~--------------------~~l~~~~~~  142 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC--------------------EGLLDPQCR  142 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHH--------------------HHHTSTTCC
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhh--------------------hcccccccc
Confidence            24677777777777532    234566677777777777776532111110                    000001111


Q ss_pred             CcEEEccCCcccc----cCCccccCCCCCCEEEccCCcccccCccc----c-cCcccccceecccccCCCCCCCChhhhh
Q 039720          257 LTVLVVAQNNLTG----FLPQSLSNASKLEWLELNENHFSGQVRIN----F-NSLPNLSKLYLGRNNLGTRTSTDLDFIT  327 (973)
Q Consensus       257 L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~~~~~~~~~  327 (973)
                      ..........+..    ..-..+.....++.++++++.+.......    + ........+++..+.+...  .......
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~--~~~~~~~  220 (460)
T d1z7xw1         143 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD--NCRDLCG  220 (460)
T ss_dssp             CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTT--HHHHHHH
T ss_pred             cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhcccc
Confidence            2222222222211    01122344456666666666554211100    1 1112344555555544321  1122334


Q ss_pred             hhcccccceeeccccccccCCCChhhhhhhhhhhHhhhcCCccccCCCccccCCCCcCEEEcccccCCCC----CCcccc
Q 039720          328 LLTNCSKLVKLGLVFNRFGGALPHSIANLSTTMTLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGT----IPPAIG  403 (973)
Q Consensus       328 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~~l~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~  403 (973)
                      .+.....++.++++.|++......                    ...+........++.+++++|.+...    ....+.
T Consensus       221 ~l~~~~~~~~l~~~~n~~~~~~~~--------------------~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~  280 (460)
T d1z7xw1         221 IVASKASLRELALGSNKLGDVGMA--------------------ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR  280 (460)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHH--------------------HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred             cccccccccccchhhccccccccc--------------------hhhccccccccccccccccccccccccccccccccc
Confidence            455556666777666654311000                    01112233455678888888877632    223345


Q ss_pred             CCCCCCeEEccCcccCCCCCCcc-----CCcCccceEEcCCCcccccccccc----ccccccccccccCcccccCCCccc
Q 039720          404 ELRNLQYLGLVGNNIRGIIPDPI-----GNLTLLNVLQLGFNKLQGSIPSYL----GKCQNLMQLSAPNNKLNGTLPPQI  474 (973)
Q Consensus       404 ~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~l~~N~l~~~~p~~~  474 (973)
                      ..+.++.+++++|.+.......+     .....|+.+++++|.++......+    ...++|++|+|++|++.+.-..  
T Consensus       281 ~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~--  358 (460)
T d1z7xw1         281 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR--  358 (460)
T ss_dssp             HCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH--
T ss_pred             ccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccc--
Confidence            66778888888887753221111     123567788888887764432222    3334566666666665421000  


Q ss_pred             cccccccceeeccCCcccccCCcccc-cccccceeccccCccccc----ccccccCccchhhhcccCcccccccccchh-
Q 039720          475 FGITTLSKLLDLSENHLSGSIPLEVG-NLKSLVQLDISRNNFSNE----IPVTLSACTTLEYLLMQGNSFNGSIPQSLN-  548 (973)
Q Consensus       475 ~~~~~l~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-  548 (973)
                                         .++..+. ..+.|++|+|++|.++..    ++..+..+++|++|+|++|+|+......+. 
T Consensus       359 -------------------~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~  419 (460)
T d1z7xw1         359 -------------------ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE  419 (460)
T ss_dssp             -------------------HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred             -------------------hhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHH
Confidence                               0111111 234466666666666532    333445556666667777666543332221 


Q ss_pred             ----hhccCCeecCCCCccccccC
Q 039720          549 ----ALKSIKELDLSCNNLSGQIP  568 (973)
Q Consensus       549 ----~l~~L~~L~Ls~N~l~~~~p  568 (973)
                          +...|+.|++.+|.+....+
T Consensus       420 ~l~~~~~~L~~l~l~~~~~~~~~~  443 (460)
T d1z7xw1         420 SVRQPGCLLEQLVLYDIYWSEEME  443 (460)
T ss_dssp             HHTSTTCCCCEEECTTCCCCHHHH
T ss_pred             HHHhCCCccCEEECCCCCCCHHHH
Confidence                22357777777777764333

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.71  E-value=2.3e-17  Score=164.39  Aligned_cols=129  Identities=20%  Similarity=0.279  Sum_probs=78.8

Q ss_pred             ceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCC-CCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccC
Q 039720          161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRI-PDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFK  239 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  239 (973)
                      +.++.++++++ .+|..+.  +++++|+|++|+|++.+ +..|.++++|++|+|++|.+.+..+..|             
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~-------------   74 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF-------------   74 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT-------------
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc-------------
Confidence            34555555555 4554442  35555555555554322 3344555555555555555554333333             


Q ss_pred             CccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecccccCCC
Q 039720          240 NRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (973)
                                  ..+++|++|+|++|+|+.+.|.+|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|.+..
T Consensus        75 ------------~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          75 ------------EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             ------------TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             ------------ccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence                        356666666666666666666677777777777777777777777777777777777777777643

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=1.5e-17  Score=168.25  Aligned_cols=183  Identities=25%  Similarity=0.319  Sum_probs=130.7

Q ss_pred             hHhhhcCCccccCCCccccCCCCcCEEEcccccCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCC
Q 039720          361 TLIAMAGNQISGTIPPEIRNLFNLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFN  440 (973)
Q Consensus       361 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  440 (973)
                      ....+..+.+++.++.  ..+.+|+.|++++|.++.. + .+..+++|++|+|++|+|++..  .++.+++|++|++++|
T Consensus        27 i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n  100 (210)
T d1h6ta2          27 IKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDEN  100 (210)
T ss_dssp             HHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred             HHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccc
Confidence            3456667777655542  3567889999999998854 3 3788899999999999998643  3678889999999999


Q ss_pred             ccccccccccccccccccccccCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCccccccc
Q 039720          441 KLQGSIPSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIP  520 (973)
Q Consensus       441 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  520 (973)
                      +++ .+| .+..+++|+.|++++|.+. .+                          ..+..+++|+.+++++|.+++  +
T Consensus       101 ~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~--------------------------~~l~~l~~l~~l~~~~n~l~~--~  149 (210)
T d1h6ta2         101 KVK-DLS-SLKDLKKLKSLSLEHNGIS-DI--------------------------NGLVHLPQLESLYLGNNKITD--I  149 (210)
T ss_dssp             CCC-CGG-GGTTCTTCCEEECTTSCCC-CC--------------------------GGGGGCTTCCEEECCSSCCCC--C
T ss_pred             ccc-ccc-ccccccccccccccccccc-cc--------------------------ccccccccccccccccccccc--c
Confidence            988 455 4677777777777777654 11                          134556667777777777763  2


Q ss_pred             ccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCCCCCCCccceEeccC
Q 039720          521 VTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIHLGNLPFLEYLNLSY  584 (973)
Q Consensus       521 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  584 (973)
                      ..+..+++|+.+++++|++++ ++ .+.++++|++|+|++|+|+ .+| .+..+++|++|+|++
T Consensus       150 ~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         150 TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence            345667777777777777774 33 2777788888888888887 455 477888888888764

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.70  E-value=6.6e-18  Score=168.35  Aligned_cols=174  Identities=20%  Similarity=0.233  Sum_probs=99.3

Q ss_pred             CCeEEccCcccCCCCCCccCCcCccceEEcCCCcccccc-ccccccccccccccccCcccccCCCccccccccccceeec
Q 039720          408 LQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSI-PSYLGKCQNLMQLSAPNNKLNGTLPPQIFGITTLSKLLDL  486 (973)
Q Consensus       408 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~L  486 (973)
                      .+.++.++|+++ .+|..+.  +++++|+|++|+|++.+ +..|..+++|+.|++++|.+.+..+..+..+..+ +.|+|
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L-~~L~L   85 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI-QELQL   85 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC-CEEEC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccc-ceeee
Confidence            356777777777 4555442  56777777777776433 4556677777777777777764333333334333 36666


Q ss_pred             cCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccc
Q 039720          487 SENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQ  566 (973)
Q Consensus       487 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  566 (973)
                      ++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++....+ ...-...++.+.+..|.++..
T Consensus        86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_          86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBC
T ss_pred             ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeC
Confidence            6666665555566666666666666666665555566666666666666666653222 111122344455555555554


Q ss_pred             cCCCCCCCCccceEeccCCcCcC
Q 039720          567 IPIHLGNLPFLEYLNLSYNHFEG  589 (973)
Q Consensus       567 ~p~~~~~l~~L~~L~ls~N~l~~  589 (973)
                      .|..+   ..++.++|+.|.|..
T Consensus       165 ~p~~l---~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         165 APSKV---RDVQIKDLPHSEFKC  184 (192)
T ss_dssp             SSTTT---TTSBGGGSCTTTCCC
T ss_pred             CChhh---cCCEeeecCHhhCcC
Confidence            44433   233444555555543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=3.3e-17  Score=165.68  Aligned_cols=143  Identities=30%  Similarity=0.416  Sum_probs=76.6

Q ss_pred             cccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEE
Q 039720          156 NWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEA  235 (973)
Q Consensus       156 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  235 (973)
                      .+++|++|+|++|++++ ++ .++++++|++|++++|+++ .+| .+.++++|+.|++++|.+..  ...+.++++++.+
T Consensus        66 ~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l  139 (210)
T d1h6ta2          66 YLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESL  139 (210)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEE
T ss_pred             hCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccccccccc--ccccccccccccc
Confidence            34455555555555553 22 2445555555555555555 233 35555555555555555542  1234455555555


Q ss_pred             EccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccceecc
Q 039720          236 YLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSKLYLG  311 (973)
Q Consensus       236 ~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  311 (973)
                      +++.|.+++ .+. . ..+++|+++++++|++++. + .+.++++|++|+|++|+|+.+ + .|.++++|++|+|+
T Consensus       140 ~~~~n~l~~-~~~-~-~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         140 YLGNNKITD-ITV-L-SRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             ECCSSCCCC-CGG-G-GGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             ccccccccc-ccc-c-ccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            555555542 221 1 2456666666666666643 2 266666666666666666643 2 36666666666664

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=1.9e-17  Score=165.95  Aligned_cols=177  Identities=23%  Similarity=0.313  Sum_probs=85.5

Q ss_pred             EEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccccccceeeccCCc
Q 039720           90 VINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQ  169 (973)
Q Consensus        90 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~  169 (973)
                      .+.++.+.+++.++  ...+.++++|++++|.++. ++ .                        +..+++|++|+|++|+
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~------------------------l~~l~nL~~L~Ls~N~   73 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-G------------------------VEYLNNLTQINFSNNQ   73 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-T------------------------GGGCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-c------------------------cccCCCcCcCcccccc
Confidence            34455555554332  2345666666666666541 21 1                        2334455555555555


Q ss_pred             ccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcc
Q 039720          170 LTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVC  249 (973)
Q Consensus       170 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~  249 (973)
                      +++..|  |+++++|++|++++|.+. .++ .+.++++|++|++++|.+...  ..+..+++|+.|++++|++. .+|. 
T Consensus        74 l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~~-  145 (199)
T d2omxa2          74 LTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DISA-  145 (199)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCGG-
T ss_pred             ccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-cccc-
Confidence            553222  555555555555555554 222 255555555555555555422  22444455555555555444 2321 


Q ss_pred             cccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcccccCcccccc
Q 039720          250 LGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRINFNSLPNLSK  307 (973)
Q Consensus       250 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  307 (973)
                      + ..+++|+.|++++|++++.  ..++++++|++|++++|+++++.  .+.++++|++
T Consensus       146 l-~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~  198 (199)
T d2omxa2         146 L-SGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSDIS--VLAKLTNLES  198 (199)
T ss_dssp             G-TTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSE
T ss_pred             c-cccccccccccccccccCC--ccccCCCCCCEEECCCCCCCCCc--cccCCCCCCc
Confidence            1 2455555555555555532  12555555555555555555421  2444444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=6.6e-17  Score=161.94  Aligned_cols=178  Identities=18%  Similarity=0.289  Sum_probs=136.9

Q ss_pred             ceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCC
Q 039720          138 DFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSEND  217 (973)
Q Consensus       138 ~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~  217 (973)
                      +..+..+++.+.++.  ..+.++++|++++|.++. + +.+..+++|++|++++|++++. +. ++++++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccCH--HHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccc
Confidence            344444554443322  356788999999999884 4 3588899999999999999854 33 8999999999999999


Q ss_pred             ccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEccCCcccccCcc
Q 039720          218 FSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQNNLTGFLPQSLSNASKLEWLELNENHFSGQVRI  297 (973)
Q Consensus       218 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  297 (973)
                      +....  .+.++++|+.|++++|.+.. ++.  +..+++|+.|++++|.+.. + +.+..+++|++|++++|++++..  
T Consensus        96 ~~~~~--~l~~l~~L~~L~l~~~~~~~-~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--  166 (199)
T d2omxa2          96 IADIT--PLANLTNLTGLTLFNNQITD-IDP--LKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--  166 (199)
T ss_dssp             CCCCG--GGTTCTTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--
T ss_pred             ccccc--cccccccccccccccccccc-ccc--cchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--
Confidence            87533  48899999999999998873 332  3378999999999999874 3 46889999999999999998754  


Q ss_pred             cccCcccccceecccccCCCCCCCChhhhhhhcccccceee
Q 039720          298 NFNSLPNLSKLYLGRNNLGTRTSTDLDFITLLTNCSKLVKL  338 (973)
Q Consensus       298 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  338 (973)
                      .|.++++|++|++++|++++++        .+..+++|++|
T Consensus       167 ~l~~l~~L~~L~ls~N~i~~i~--------~l~~L~~L~~L  199 (199)
T d2omxa2         167 PLANLTTLERLDISSNKVSDIS--------VLAKLTNLESL  199 (199)
T ss_dssp             GGTTCTTCCEEECCSSCCCCCG--------GGGGCTTCSEE
T ss_pred             cccCCCCCCEEECCCCCCCCCc--------cccCCCCCCcC
Confidence            4889999999999999987643        24455666543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.2e-15  Score=161.70  Aligned_cols=162  Identities=19%  Similarity=0.215  Sum_probs=83.4

Q ss_pred             hhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCC-cCCCC-CCCcccCCCccceeccCCC-Ccccc-CCcccc
Q 039720          152 AIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGN-KLDGR-IPDSLGQLRNLNYLGTSEN-DFSGM-FPLSVC  227 (973)
Q Consensus       152 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~L~~L~~L~Ls~N-~l~~~-~p~~~~  227 (973)
                      ..+.++++|++|+|+++.+++..+..++.+++|++|++++| .++.. +...+.++++|++|+++++ .++.. +...+.
T Consensus        65 ~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~  144 (284)
T d2astb2          65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA  144 (284)
T ss_dssp             HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHH
T ss_pred             HHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhc
Confidence            33444555555555555554444444555555555555553 22210 0111234555666666553 23211 111121


Q ss_pred             C-CCCCcEEEccCC--ccccCCCcccccCCCCCcEEEccCC-cccccCCccccCCCCCCEEEccCC-cccccCcccccCc
Q 039720          228 N-ISSLDEAYLFKN--RFKGSLPVCLGFNLPKLTVLVVAQN-NLTGFLPQSLSNASKLEWLELNEN-HFSGQVRINFNSL  302 (973)
Q Consensus       228 ~-l~~L~~L~L~~N--~l~~~ip~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l  302 (973)
                      . .++|+.|+++++  .++..--..+..++++|++|++++| .+++.....+.++++|++|+|+++ .+++.....+..+
T Consensus       145 ~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~  224 (284)
T d2astb2         145 HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI  224 (284)
T ss_dssp             HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGC
T ss_pred             ccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcC
Confidence            2 245666666543  2221111122235677777777765 466666667777777777777773 5665555566667


Q ss_pred             ccccceecccc
Q 039720          303 PNLSKLYLGRN  313 (973)
Q Consensus       303 ~~L~~L~L~~N  313 (973)
                      ++|+.|+++++
T Consensus       225 ~~L~~L~l~~~  235 (284)
T d2astb2         225 PTLKTLQVFGI  235 (284)
T ss_dssp             TTCCEEECTTS
T ss_pred             CCCCEEeeeCC
Confidence            77777777665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=7.5e-15  Score=140.79  Aligned_cols=128  Identities=20%  Similarity=0.250  Sum_probs=69.0

Q ss_pred             CCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCC
Q 039720          178 IGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKL  257 (973)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L  257 (973)
                      |.+..+|++|+|++|+|+ .++..+..+++|++|+|++|+|+..  ..|..+++|++|++++|+++ .+|..++..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCcccccccccc
Confidence            445556666677776666 4555556666666666666666632  23444555555555555554 3444444345556


Q ss_pred             cEEEccCCcccccCC-ccccCCCCCCEEEccCCcccccCc---ccccCccccccee
Q 039720          258 TVLVVAQNNLTGFLP-QSLSNASKLEWLELNENHFSGQVR---INFNSLPNLSKLY  309 (973)
Q Consensus       258 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~  309 (973)
                      ++|++++|+|+.... ..+..+++|++|++++|.++....   ..+..+++|++||
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            666666665553211 345556666666666666553321   1244445555444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1e-14  Score=139.79  Aligned_cols=127  Identities=17%  Similarity=0.162  Sum_probs=76.6

Q ss_pred             CCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhcccccc
Q 039720           81 YIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKI  160 (973)
Q Consensus        81 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L  160 (973)
                      .+.+...|++|||++|+|+ .+|..+..+++|++||||+|.++ .++ .+..+++|++|++++|++....+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3556778889999999988 56766677888999999999887 443 35666666666665555554444444455555


Q ss_pred             ceeeccCCcccccCC--CCCCCCCcccEEEccCCcCCCCCCC----cccCCCccceec
Q 039720          161 ERLSLYGNQLTGQLP--PSIGNLSALQTFDIAGNKLDGRIPD----SLGQLRNLNYLG  212 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~L~~L~~L~  212 (973)
                      ++|+|++|+++. ++  ..+..+++|++|++++|.++ ..|.    .+..+++|++||
T Consensus        90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            555555555542 22  23445555555555555554 2332    244445555444

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.46  E-value=1.3e-13  Score=125.45  Aligned_cols=101  Identities=24%  Similarity=0.324  Sum_probs=44.9

Q ss_pred             EEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCCccccCCCcccccCCCCCcEEEccCC
Q 039720          186 TFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKNRFKGSLPVCLGFNLPKLTVLVVAQN  265 (973)
Q Consensus       186 ~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N  265 (973)
                      +|+|++|+|+ .++. +.++++|++|++++|+|++ +|..++.+++|+.|++++|+++ .+|. + .++++|++|++++|
T Consensus         2 ~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~-~l~~-~-~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-V-ANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC-CCGG-G-TTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCcc-cccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccc-ccCc-c-ccccccCeEECCCC
Confidence            3444444444 2222 4444444444444444441 2223333333333333333333 2322 1 24555666666666


Q ss_pred             cccccC-CccccCCCCCCEEEccCCccc
Q 039720          266 NLTGFL-PQSLSNASKLEWLELNENHFS  292 (973)
Q Consensus       266 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~  292 (973)
                      +|+... ...+..+++|++|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            655332 134555555555555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1e-14  Score=154.51  Aligned_cols=79  Identities=14%  Similarity=0.065  Sum_probs=46.6

Q ss_pred             cceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCC-CCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEcc
Q 039720          160 IERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGR-IPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLF  238 (973)
Q Consensus       160 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  238 (973)
                      +..+.++...+...+ .......+|++||+++|.++.. ++..+.++++|++|+|+++.+++..+..++.+++|++|+++
T Consensus        25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence            345555555544222 2233445777777777776532 23445667777777777777665555556555666666665


Q ss_pred             C
Q 039720          239 K  239 (973)
Q Consensus       239 ~  239 (973)
                      +
T Consensus       104 ~  104 (284)
T d2astb2         104 G  104 (284)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.44  E-value=1.6e-13  Score=124.75  Aligned_cols=118  Identities=25%  Similarity=0.323  Sum_probs=83.2

Q ss_pred             ceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCCCCCcccCCCccceeccCCCCccccCCccccCCCCCcEEEccCC
Q 039720          161 ERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGRIPDSLGQLRNLNYLGTSENDFSGMFPLSVCNISSLDEAYLFKN  240 (973)
Q Consensus       161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  240 (973)
                      +.|+|++|+++ .++ .+.++++|++|++++|+|+ .+|..|+.+++|++|++++|.|++. | .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            46778888887 444 4778888888888888887 5677788888888888888888753 3 4778888888888888


Q ss_pred             ccccCCCc-ccccCCCCCcEEEccCCcccccC---CccccCCCCCCEE
Q 039720          241 RFKGSLPV-CLGFNLPKLTVLVVAQNNLTGFL---PQSLSNASKLEWL  284 (973)
Q Consensus       241 ~l~~~ip~-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L  284 (973)
                      +++ .+|. ..+..+++|++|++++|.++...   ...+..+++|+.|
T Consensus        76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCC-SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccC-CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            887 4442 33347888888888888887431   2223445555544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.41  E-value=4.6e-15  Score=162.33  Aligned_cols=246  Identities=18%  Similarity=0.147  Sum_probs=122.9

Q ss_pred             CCcCCCCCCEEEccCCCCCC----CCCccccccCCCCEEeeecccCCCC---CCcccccCCCccceEecccccccchhhh
Q 039720           81 YIGNLSFLRVINLANNSFHG----QIPKEVGRLFRLETIVLSNNSFSGK---IPTNLSRCFNLIDFWVHTNNLVGEIQAI  153 (973)
Q Consensus        81 ~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~---~p~~~~~l~~L~~L~l~~n~~~~~~~~~  153 (973)
                      .+.+.+.|++|+|++|.+..    .+-..+...++|+.|+++++.....   .|..+                 ..+...
T Consensus        26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~-----------------~~l~~~   88 (344)
T d2ca6a1          26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL-----------------RLLLQA   88 (344)
T ss_dssp             HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHH-----------------HHHHHH
T ss_pred             HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHH-----------------HHHHHH
Confidence            35566778888888877742    2333456677788888877654311   11111                 012222


Q ss_pred             hccccccceeeccCCccccc----CCCCCCCCCcccEEEccCCcCCCCCCC-------------cccCCCccceeccCCC
Q 039720          154 IGNWLKIERLSLYGNQLTGQ----LPPSIGNLSALQTFDIAGNKLDGRIPD-------------SLGQLRNLNYLGTSEN  216 (973)
Q Consensus       154 ~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~L~~L~~L~Ls~N  216 (973)
                      +...++|++|+|++|.++..    +...+..+++|++|++++|.+...-..             .....+.|+.|++++|
T Consensus        89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n  168 (344)
T d2ca6a1          89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN  168 (344)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred             HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence            33334444444444444321    111222334444555544443210000             0122344555555555


Q ss_pred             Ccccc----CCccccCCCCCcEEEccCCccccC-----CCcccccCCCCCcEEEccCCccccc----CCccccCCCCCCE
Q 039720          217 DFSGM----FPLSVCNISSLDEAYLFKNRFKGS-----LPVCLGFNLPKLTVLVVAQNNLTGF----LPQSLSNASKLEW  283 (973)
Q Consensus       217 ~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-----ip~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~  283 (973)
                      .++..    +...+...+.|++|+|+.|++...     +... ....++|+.|+|++|.++..    +...+..+++|++
T Consensus       169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~-l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~  247 (344)
T d2ca6a1         169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG-LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE  247 (344)
T ss_dssp             CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTT-GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred             cccccccccccchhhhhhhhcccccccccccccccccchhhh-hcchhhhcccccccccccccccccccccccccccchh
Confidence            54321    122233445566666666655421     1111 22456677777777766532    3345566777777


Q ss_pred             EEccCCcccccCcccc----c--CcccccceecccccCCCCCCCChhhhhhhc-ccccceeecccccccc
Q 039720          284 LELNENHFSGQVRINF----N--SLPNLSKLYLGRNNLGTRTSTDLDFITLLT-NCSKLVKLGLVFNRFG  346 (973)
Q Consensus       284 L~Ls~N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~-~l~~L~~L~l~~N~l~  346 (973)
                      |+|++|.|++.....+    .  ..+.|++|++++|+|+....  ......+. ++++|+.|++++|++.
T Consensus       248 L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~--~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV--RTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH--HHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHH--HHHHHHHHccCCCCCEEECCCCcCC
Confidence            7777777764322222    2  23557777777777653211  11223332 4667888888888775

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.37  E-value=2.4e-14  Score=156.47  Aligned_cols=244  Identities=20%  Similarity=0.231  Sum_probs=143.8

Q ss_pred             CeEEEEEeeccCccc----cccCCCcCCCCCCEEEccCCCCCCC----------CCccccccCCCCEEeeecccCCCC--
Q 039720           62 QRVTKLDLESQNIGG----FLSPYIGNLSFLRVINLANNSFHGQ----------IPKEVGRLFRLETIVLSNNSFSGK--  125 (973)
Q Consensus        62 ~~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~L~~n~l~~~----------~p~~~~~l~~L~~L~Ls~n~l~~~--  125 (973)
                      ..++.|+|++|.++.    .+...+...+.|+.|+++++.+...          +...+...++|++|+|++|.+...  
T Consensus        31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  110 (344)
T d2ca6a1          31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  110 (344)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence            357889999988754    3455678899999999998865421          122355678899999999988753  


Q ss_pred             --CCcccccCCCccceEecccccccchhhhhccccccceeeccCCcccccCCCCCCCCCcccEEEccCCcCCCC----CC
Q 039720          126 --IPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNWLKIERLSLYGNQLTGQLPPSIGNLSALQTFDIAGNKLDGR----IP  199 (973)
Q Consensus       126 --~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p  199 (973)
                        +...+..+++|++|++++|.+.......+..  .|..+....         .......|+.|++++|+++..    +.
T Consensus       111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~~---------~~~~~~~L~~l~l~~n~i~~~~~~~l~  179 (344)
T d2ca6a1         111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVNK---------KAKNAPPLRSIICGRNRLENGSMKEWA  179 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHHH---------HHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred             cchhhhhcccccchheecccccccccccccccc--ccccccccc---------ccccCcccceeeccccccccccccccc
Confidence              2333445666777777766654322222111  011100000         011234556666666655411    11


Q ss_pred             CcccCCCccceeccCCCCcccc-----CCccccCCCCCcEEEccCCccccC----CCcccccCCCCCcEEEccCCccccc
Q 039720          200 DSLGQLRNLNYLGTSENDFSGM-----FPLSVCNISSLDEAYLFKNRFKGS----LPVCLGFNLPKLTVLVVAQNNLTGF  270 (973)
Q Consensus       200 ~~~~~L~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----ip~~~~~~l~~L~~L~Ls~N~l~~~  270 (973)
                      ..+...++|+.|+|++|.|...     +...+..+++|+.|+|++|.++..    +...+ ...++|++|+|++|.|++.
T Consensus       180 ~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l-~~~~~L~~L~Ls~n~i~~~  258 (344)
T d2ca6a1         180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL-KSWPNLRELGLNDCLLSAR  258 (344)
T ss_dssp             HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG-GGCTTCCEEECTTCCCCHH
T ss_pred             chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc-cccccchhhhhhcCccCch
Confidence            2234455666666666665421     233455566677777776666421    22222 2567788888888887754


Q ss_pred             CCcc----cc--CCCCCCEEEccCCcccccCc----ccc-cCcccccceecccccCCC
Q 039720          271 LPQS----LS--NASKLEWLELNENHFSGQVR----INF-NSLPNLSKLYLGRNNLGT  317 (973)
Q Consensus       271 ~p~~----~~--~l~~L~~L~Ls~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~  317 (973)
                      ....    +.  ....|++|+|++|+|+....    ..+ .++++|++|+|++|++..
T Consensus       259 g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         259 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            2222    32  24678999999998874322    223 256789999999998865

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=1.7e-12  Score=123.28  Aligned_cols=104  Identities=17%  Similarity=0.118  Sum_probs=73.4

Q ss_pred             eeeccCCcccccCCcccccccccceeccccC-cccccccccccCccchhhhcccCcccccccccchhhhccCCeecCCCC
Q 039720          483 LLDLSENHLSGSIPLEVGNLKSLVQLDISRN-NFSNEIPVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCN  561 (973)
Q Consensus       483 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  561 (973)
                      .++.+++.++ ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            5677777776 46667777777888888655 477555667777777777777777777666777777777777777777


Q ss_pred             ccccccCCCCCCCCccceEeccCCcCc
Q 039720          562 NLSGQIPIHLGNLPFLEYLNLSYNHFE  588 (973)
Q Consensus       562 ~l~~~~p~~~~~l~~L~~L~ls~N~l~  588 (973)
                      +|+ .+|........|+.|+|++|++.
T Consensus        91 ~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          91 ALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             CCc-ccChhhhccccccccccCCCccc
Confidence            777 44444444445777777777764

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.29  E-value=8.1e-14  Score=138.39  Aligned_cols=127  Identities=24%  Similarity=0.311  Sum_probs=74.4

Q ss_pred             cCEEEcccc--cCCCCCCccccCCCCCCeEEccCcccCCCCCCccCCcCccceEEcCCCccccccccccccccccccccc
Q 039720          384 LNGLGLEYN--QLTGTIPPAIGELRNLQYLGLVGNNIRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSA  461 (973)
Q Consensus       384 L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  461 (973)
                      ++.+++.++  .++ .+|..+..+++|++|+|++|+|+.+ + .+..+++|++|+|++|+|+ .+|..+..+++|+.|++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence            444555543  233 4556677777888888888877743 3 4667777777777777776 44544444445555555


Q ss_pred             cCcccccCCCccccccccccceeeccCCcccccCCcccccccccceeccccCccccccc-ccccCccchhhhcccCcccc
Q 039720          462 PNNKLNGTLPPQIFGITTLSKLLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIP-VTLSACTTLEYLLMQGNSFN  540 (973)
Q Consensus       462 ~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~  540 (973)
                      ++|+++                         . + ..+..+++|+.|++++|+++.... ..+..+++|+.|+|++|++.
T Consensus       101 ~~N~i~-------------------------~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         101 SYNQIA-------------------------S-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEECC-------------------------C-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccc-------------------------c-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            555443                         1 1 124556667777777776663211 34556666666666666665


Q ss_pred             c
Q 039720          541 G  541 (973)
Q Consensus       541 ~  541 (973)
                      .
T Consensus       154 ~  154 (198)
T d1m9la_         154 N  154 (198)
T ss_dssp             H
T ss_pred             c
Confidence            3

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.26  E-value=3.8e-14  Score=140.83  Aligned_cols=113  Identities=19%  Similarity=0.294  Sum_probs=73.2

Q ss_pred             ccCCCcCCCCCCEEEccCCCCCCCCCccccccCCCCEEeeecccCCCCCCcccccCCCccceEecccccccchhhhhccc
Q 039720           78 LSPYIGNLSFLRVINLANNSFHGQIPKEVGRLFRLETIVLSNNSFSGKIPTNLSRCFNLIDFWVHTNNLVGEIQAIIGNW  157 (973)
Q Consensus        78 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l  157 (973)
                      ++.++..|++|++|+|++|+|+ .++ .+.++++|++|+|++|.++ .+|..+..+.+|+.|++++|++...  ..+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence            4456777888888888888887 455 5888888888888888887 5665555555666666666665542  235556


Q ss_pred             cccceeeccCCcccccCC-CCCCCCCcccEEEccCCcCC
Q 039720          158 LKIERLSLYGNQLTGQLP-PSIGNLSALQTFDIAGNKLD  195 (973)
Q Consensus       158 ~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~  195 (973)
                      ++|++|+|++|+++.... ..++.+++|++|+|++|++.
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            666666666666552211 23555556666666666554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=1.9e-11  Score=115.72  Aligned_cols=106  Identities=20%  Similarity=0.114  Sum_probs=65.7

Q ss_pred             CcCEEEcccccCCCCCCccccCCCCCCeEEccCcc-cCCCCCCccCCcCccceEEcCCCccccccccccccccccccccc
Q 039720          383 NLNGLGLEYNQLTGTIPPAIGELRNLQYLGLVGNN-IRGIIPDPIGNLTLLNVLQLGFNKLQGSIPSYLGKCQNLMQLSA  461 (973)
Q Consensus       383 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  461 (973)
                      ..+.++.+++.++ ..|..+..+++|++|++++|+ |+.+.++.|.++++|+.|+|++|+|+...|.+|..+++|++|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3445666666666 455666666677777775543 66555556666777777777777776555666666677766666


Q ss_pred             cCcccccCCCccccccccccceeeccCCcc
Q 039720          462 PNNKLNGTLPPQIFGITTLSKLLDLSENHL  491 (973)
Q Consensus       462 ~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l  491 (973)
                      ++|+|+ .+|...+...++. .|+|++|.+
T Consensus        88 s~N~l~-~l~~~~~~~~~l~-~L~L~~Np~  115 (156)
T d2ifga3          88 SFNALE-SLSWKTVQGLSLQ-ELVLSGNPL  115 (156)
T ss_dssp             CSSCCS-CCCSTTTCSCCCC-EEECCSSCC
T ss_pred             cCCCCc-ccChhhhcccccc-ccccCCCcc
Confidence            666666 5665555444432 555555555

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.43  E-value=1.6e-08  Score=95.90  Aligned_cols=82  Identities=22%  Similarity=0.228  Sum_probs=43.0

Q ss_pred             ccccccceeccccCcccccc--cccccCccchhhhcccCcccccccccchhhhccCCeecCCCCccccccCCC-------
Q 039720          500 GNLKSLVQLDISRNNFSNEI--PVTLSACTTLEYLLMQGNSFNGSIPQSLNALKSIKELDLSCNNLSGQIPIH-------  570 (973)
Q Consensus       500 ~~l~~L~~L~ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------  570 (973)
                      ..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.++......       
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i  141 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI  141 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence            44566666666666666431  233455666666666666666322222333345666666666665433211       


Q ss_pred             CCCCCccceEe
Q 039720          571 LGNLPFLEYLN  581 (973)
Q Consensus       571 ~~~l~~L~~L~  581 (973)
                      +..+|+|+.||
T Consensus       142 ~~~~P~L~~LD  152 (162)
T d1koha1         142 RERFPKLLRLD  152 (162)
T ss_dssp             HTTSTTCCEET
T ss_pred             HHHCCCCCEEC
Confidence            34456666554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.32  E-value=3.5e-08  Score=93.46  Aligned_cols=106  Identities=18%  Similarity=0.096  Sum_probs=75.0

Q ss_pred             eeeccCCcccccCCcccccccccceeccccCcccccccccccCccchhhhcccCcccccc--cccchhhhccCCeecCCC
Q 039720          483 LLDLSENHLSGSIPLEVGNLKSLVQLDISRNNFSNEIPVTLSACTTLEYLLMQGNSFNGS--IPQSLNALKSIKELDLSC  560 (973)
Q Consensus       483 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~  560 (973)
                      .||++++...    ..+..+..+..++..+|... .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|||++
T Consensus        26 ~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~  100 (162)
T d1koha1          26 ALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG  100 (162)
T ss_dssp             CBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTT
T ss_pred             eeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccccc
Confidence            4666654432    13444455566666666554 5555667889999999999999854  245678899999999999


Q ss_pred             CccccccCCCCCCCCccceEeccCCcCcCcCCC
Q 039720          561 NNLSGQIPIHLGNLPFLEYLNLSYNHFEGKVPK  593 (973)
Q Consensus       561 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  593 (973)
                      |+|+...+..+.....|+.|++++|++++....
T Consensus       101 N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~  133 (162)
T d1koha1         101 NELKSERELDKIKGLKLEELWLDGNSLSDTFRD  133 (162)
T ss_dssp             SCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred             CccccchhhhhhhccccceeecCCCCcCcCccc
Confidence            999953332344456799999999999876553

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.19  E-value=6.6e-06  Score=84.23  Aligned_cols=148  Identities=18%  Similarity=0.169  Sum_probs=102.3

Q ss_pred             HHHHHhhcCCcCCccccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCceeEEeEeeecccC
Q 039720          668 ELSKATKEFSSSNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIR-HRNLIKIITICSSIDFK  746 (973)
Q Consensus       668 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  746 (973)
                      ++.+....|++.+..+.++.+.||+...  ++..+++|+...........+.+|...++.+. +--+.+++.+...    
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~----   81 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH----   81 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec----
Confidence            4555566788777766566678998864  67778899886554444556778888887774 3224556655433    


Q ss_pred             CCceEEEEEeeccCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHhcC------------------------------
Q 039720          747 GADFKAIVYEYMQYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHNHC------------------------------  796 (973)
Q Consensus       747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------------------------------  796 (973)
                       ++..++||++++|.++.+.....     .....++.++++.+..||+..                              
T Consensus        82 -~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          82 -DGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             -TTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             -CCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence             36789999999998887654321     223445666667777777521                              


Q ss_pred             --------------------------CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          797 --------------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       797 --------------------------~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                                                ...++|+|+.|.||++++++.+-++||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      1137999999999999987667799999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.33  E-value=0.00019  Score=77.50  Aligned_cols=77  Identities=16%  Similarity=0.125  Sum_probs=48.4

Q ss_pred             CCccccccceeEEEEEECCCCcEEEEEEeecc----c---chhHHHHHHHHHHHHhcC-C--CCceeEEeEeeecccCCC
Q 039720          679 SNRIGKGSFGFVYKGNLGEDGMSVAVKVMNLD----K---KGATKSFVAECEALRNIR-H--RNLIKIITICSSIDFKGA  748 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~  748 (973)
                      .+.||.|....||+++...+++.|+||.-...    .   +...++...|..+++.+. +  ..+.+++.+.       +
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence            44689999999999998767889999975421    1   112345567888887663 2  3455565542       2


Q ss_pred             ceEEEEEeeccCCC
Q 039720          749 DFKAIVYEYMQYGS  762 (973)
Q Consensus       749 ~~~~lv~e~~~~gs  762 (973)
                      +..++|||++.+..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEeccCCcc
Confidence            45678999997643

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.30  E-value=3.7e-05  Score=72.31  Aligned_cols=39  Identities=15%  Similarity=0.170  Sum_probs=18.0

Q ss_pred             CCCCcEEEccCC-ccccc----CCccccCCCCCCEEEccCCccc
Q 039720          254 LPKLTVLVVAQN-NLTGF----LPQSLSNASKLEWLELNENHFS  292 (973)
Q Consensus       254 l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  292 (973)
                      .++|++|+|+++ .++..    +...+...+.|++|+|++|.++
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence            455555555542 34321    2223444455555555555544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.29  E-value=4.9e-05  Score=71.50  Aligned_cols=93  Identities=11%  Similarity=0.228  Sum_probs=62.8

Q ss_pred             CCCCCcEEEccCCcccc----cCCccccCCCCCCEEEccCCcccccC----cccccCcccccceecccccCCCCCCC-Ch
Q 039720          253 NLPKLTVLVVAQNNLTG----FLPQSLSNASKLEWLELNENHFSGQV----RINFNSLPNLSKLYLGRNNLGTRTST-DL  323 (973)
Q Consensus       253 ~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~-~~  323 (973)
                      ..++|++|+|++|.+..    .+...+...+.|++|+|++|.|+...    ...+...++|++|+|++|.+..+... ..
T Consensus        42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~  121 (167)
T d1pgva_          42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM  121 (167)
T ss_dssp             TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred             hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence            34556666666666652    22334556678888888888887432    23466677888888888877665432 23


Q ss_pred             hhhhhhcccccceeeccccccc
Q 039720          324 DFITLLTNCSKLVKLGLVFNRF  345 (973)
Q Consensus       324 ~~~~~l~~l~~L~~L~l~~N~l  345 (973)
                      .+...+...+.|++|+++++..
T Consensus       122 ~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_         122 DMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhCCCccEeeCcCCCc
Confidence            4567778888999999987754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.23  E-value=0.00051  Score=69.16  Aligned_cols=129  Identities=13%  Similarity=0.095  Sum_probs=79.6

Q ss_pred             cccccc-eeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCC--CceeEEeEeeecccCCCceEEEEEeec
Q 039720          682 IGKGSF-GFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHR--NLIKIITICSSIDFKGADFKAIVYEYM  758 (973)
Q Consensus       682 lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~  758 (973)
                      +..|.. +.||+... .++..+++|......   ...+..|...++.+...  .+.+++.++.+     ....++||+++
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECC
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEee
Confidence            444554 67899887 367778889875433   23456677777766432  24556665433     36788999999


Q ss_pred             cCCCHHHHhhhcCCCchhhHHHHHHHHHHHHHHHHh--------------------------------------------
Q 039720          759 QYGSVDDWLHHTNDKLEVGKLNIVIEVASVIEYLHN--------------------------------------------  794 (973)
Q Consensus       759 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~--------------------------------------------  794 (973)
                      +|.++.+..     ..   ....+.+++..+.-||+                                            
T Consensus        89 ~G~~~~~~~-----~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (255)
T d1nd4a_          89 PGQDLLSSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  160 (255)
T ss_dssp             SSEETTTSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             ecccccccc-----cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence            876543210     00   11122233333333332                                            


Q ss_pred             -------cC----CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          795 -------HC----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       795 -------~~----~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                             ..    .+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   11    1248999999999999987777899999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.50  E-value=0.0043  Score=64.66  Aligned_cols=139  Identities=16%  Similarity=0.144  Sum_probs=77.6

Q ss_pred             ccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCc--eeEEeEeeecccCCCceEEEEEeeccCCC
Q 039720          685 GSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL--IKIITICSSIDFKGADFKAIVYEYMQYGS  762 (973)
Q Consensus       685 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~gs  762 (973)
                      +.--.||+++. ++|+.|++|+.+.... ..+++..|.+.+..+...++  +..+.......+......+.+++++.|..
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            34468999988 4889999999875432 34567778888877743222  22221111111233566788999987632


Q ss_pred             H-----HHH---------hhh----cC-----C-------------------CchhhHHHHHHHHHHHHHHHHhc----C
Q 039720          763 V-----DDW---------LHH----TN-----D-------------------KLEVGKLNIVIEVASVIEYLHNH----C  796 (973)
Q Consensus       763 L-----~~~---------l~~----~~-----~-------------------~~~~~~~~i~~qi~~aL~~LH~~----~  796 (973)
                      +     ..+         ++.    ..     .                   ........+...+...++.+...    .
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~  190 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF  190 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence            1     111         111    00     0                   00011112222233333344322    2


Q ss_pred             CCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          797 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       797 ~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                      ..++||+|+.+.|||++++  ..++||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            3478999999999999743  4589999876

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.40  E-value=0.00015  Score=67.91  Aligned_cols=13  Identities=23%  Similarity=0.140  Sum_probs=5.9

Q ss_pred             CcCccceEEcCCC
Q 039720          428 NLTLLNVLQLGFN  440 (973)
Q Consensus       428 ~l~~L~~L~Ls~N  440 (973)
                      ..++|+.|+++.+
T Consensus       130 ~n~~L~~L~l~~~  142 (166)
T d1io0a_         130 KNTTLLKFGYHFT  142 (166)
T ss_dssp             HCSSCCEEECCCS
T ss_pred             hCCCcCEEeCcCC
Confidence            3344444444444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.32  E-value=0.00051  Score=64.16  Aligned_cols=92  Identities=20%  Similarity=0.322  Sum_probs=56.6

Q ss_pred             CCCCCcEEEccCCccccc----CCccccCCCCCCEEEccCCccccc----CcccccCcccccceec--ccccCCCCCCCC
Q 039720          253 NLPKLTVLVVAQNNLTGF----LPQSLSNASKLEWLELNENHFSGQ----VRINFNSLPNLSKLYL--GRNNLGTRTSTD  322 (973)
Q Consensus       253 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~~~~~  322 (973)
                      ..++|++|+|++|.++..    +...+...+.++.|++++|.++..    +...+...++|+.++|  ++|.+..  ...
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~--~~~  121 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN--NVE  121 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH--HHH
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcH--HHH
Confidence            345566666666665432    233455667788888888877643    2245666777876554  4555543  222


Q ss_pred             hhhhhhhcccccceeecccccccc
Q 039720          323 LDFITLLTNCSKLVKLGLVFNRFG  346 (973)
Q Consensus       323 ~~~~~~l~~l~~L~~L~l~~N~l~  346 (973)
                      ......+..+++|+.|+++++...
T Consensus       122 ~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_         122 MEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCcCEEeCcCCCCc
Confidence            344556778888999988877543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.79  E-value=0.019  Score=59.10  Aligned_cols=160  Identities=11%  Similarity=0.052  Sum_probs=79.7

Q ss_pred             ccHHHHHHHhhcCCcCCc-----cccccceeEEEEEECCCCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCc--eeE
Q 039720          664 VSYAELSKATKEFSSSNR-----IGKGSFGFVYKGNLGEDGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL--IKI  736 (973)
Q Consensus       664 ~~~~~~~~~~~~y~~~~~-----lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~  736 (973)
                      ++.+++.....+|.+.+.     |..|.--+.|..+..  +..+++|+++...  ..+++..|++++..+...++  ...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            456777777888877554     345666889999873  4458899986432  22334455666665532221  111


Q ss_pred             EeEee-ecccCCCceEEEEEeeccCCCHHH--------------HhhhcC-CC--------ch-----------------
Q 039720          737 ITICS-SIDFKGADFKAIVYEYMQYGSVDD--------------WLHHTN-DK--------LE-----------------  775 (973)
Q Consensus       737 ~~~~~-~~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~-~~--------~~-----------------  775 (973)
                      +.... ............++.+..+.....              .++... ..        ..                 
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11000 000011234455666655432110              011000 00        00                 


Q ss_pred             -hhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEecCCCcEEEeccccch
Q 039720          776 -VGKLNIVIEVASVIEYLHN-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR  827 (973)
Q Consensus       776 -~~~~~i~~qi~~aL~~LH~-~~~~~ivHrDik~~NILl~~~~~~kl~Dfg~a~  827 (973)
                       ......+..+...+...+. ....|+||+|+.++||+++.+...-++||+.|.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             0011112222222222221 123389999999999999988877899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.82  E-value=0.047  Score=58.07  Aligned_cols=73  Identities=23%  Similarity=0.298  Sum_probs=48.5

Q ss_pred             CCccccccceeEEEEEECC-------CCcEEEEEEeecccchhHHHHHHHHHHHHhcCCCCc-eeEEeEeeecccCCCce
Q 039720          679 SNRIGKGSFGFVYKGNLGE-------DGMSVAVKVMNLDKKGATKSFVAECEALRNIRHRNL-IKIITICSSIDFKGADF  750 (973)
Q Consensus       679 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  750 (973)
                      .+.|+.|-.-.+|++....       ..+.|.+++.- ... ......+|..+++.+.-.++ .++++++.         
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS---------  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence            4578889999999998742       34678788775 222 23456678888887753344 46666532         


Q ss_pred             EEEEEeeccCCC
Q 039720          751 KAIVYEYMQYGS  762 (973)
Q Consensus       751 ~~lv~e~~~~gs  762 (973)
                      -.+|+||++|.+
T Consensus       116 ~g~I~efi~g~~  127 (395)
T d1nw1a_         116 GGRLEEYIPSRP  127 (395)
T ss_dssp             TEEEECCCCEEE
T ss_pred             CceEEEEecccc
Confidence            257899998643